Citrus Sinensis ID: 016082

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-----
Protein Sequence
MDMVCWVLMKVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQSCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINTNIQSTYKHLLFFLFMD
Secondary Structure (PSIPRED)
cccEEHHHHHHHHHHHHHHHHHcccccccccccccccEEEEEEEcccccccHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccEEEcccccccccEEEccccccEEEEEEccEEcEEEEcccccccHHHHHHHHHHHHHHHHccccccEEEEEEEEccccEEEEEEccccccHHHHHHcccccccHHHHHHHHHHHHHHHHHHccccccccccccccEEEcccccEEEccccccEEcccccccccccccccccHHHHcccccccccccHHHHHHHHHHHHccccccccccHHHHHHHHHHccccccccccccHHHHHHHHHHccccccccccHHHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHHHcc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHHHHHHcccHEEEEEEccccccEEEEEEEccccEEEHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccEEEEcHHHEEEEEEEEcccccEEEEEEEcccEEEEEEEcccccccccHHcHHHHHHHHcccccccEccEEEEccccccccEEEEcccccEHHHHHccccccccHHHHHHHHHHHHHHHHHHHHcccccccccHHHEEEcccccEEEcccccccEccccccEccccccHHHccHHHHHccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHccccccccccccHHHHHHHHHHHHccHcccccHHHHHHHHHHHHHccccccccccccccccccccccEEEEccc
Coil and Loop (DISEMBL)
MDMVCWVLMKVGELTSLLGEIGLNIqeahafstvdgfsldvfvvdgwpydeteDLKNVLAKEILKskdqscskrqpalgvpmhsklliesspncieiptdgtdvwEIDAKQLKIECKVasgsygdlykgtycSQEVAIkvlkpecvntEMLKEFSQEVYIMRKIRHKNVVQFIgactrppnlcivtEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSkgmnylhqnniIHRDLKTANLLMDENGVVKVADFGVARVQAqsgvmtaetgtyrwmapeviehkpydykadVFSFGIALWELLTgelpyagltplQAAVGVVQkslrptipkhaHPRLAELLERcwqhdptqrpnfSQITDILKQMMKEVLYWLSPNLINTNIQSTYKHLLFFLFMD
Flexible Loop (DISEMBL)
MDMVCWVLMKVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEIlkskdqscskrqpalgvPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARvqaqsgvmtaetgtyrWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINTNIQSTYKHLLFFLFMD
Low Complexity Region (SEG)
MDMVCWVLMKVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQSCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINTNIQSTYKHLLFFLFMD
Disordered region (IsUnstruct)
**MVCWVLMKVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEIL*******************SKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINTNIQSTYKHLLFFLF**
Disordered Region (DISOPRED)
***VCWVLMKVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDET***************************************************VWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQM*********************KHLLFFLFM*
Disordered Region (DISEMBL)
MDMVCWVLMKVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQSCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINTNIQSTYKHLLFFLFMD
Disordered Region (DISPRO)
*DMVCWVLMKVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQS**KRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVL*********T*******H********
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MDMVCWVLMKVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQSCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINTNIQSTYKHLLFFLFMD
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	395	2.2.26 [Sep-21-2011]
Q2MHE4	390	Serine/threonine-protein	no	no	0.655	0.664	0.435	5e-67
Q55GU0	916	Probable serine/threonine	yes	no	0.703	0.303	0.425	6e-67
Q05609	821	Serine/threonine-protein	no	no	0.734	0.353	0.412	3e-63
Q54H46	642	Probable serine/threonine	no	no	0.660	0.406	0.438	7e-63
Q54H45	690	Probable serine/threonine	no	no	0.660	0.378	0.430	2e-62
Q9FPR3	933	Serine/threonine-protein	no	no	0.683	0.289	0.450	4e-62
Q54TM7	1288	Probable serine/threonine	no	no	0.660	0.202	0.415	1e-56
Q54IP4	653	Dual specificity protein	no	no	0.643	0.388	0.425	2e-55
Q7T6X2	1657	Putative serine/threonine	N/A	no	0.670	0.159	0.407	5e-55
Q55A09	1331	Probable serine/threonine	no	no	0.681	0.202	0.377	3e-54

>sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1

 Score =  255 bits (651), Expect = 5e-67,   Method: Compositional matrix adjust.
 Identities = 115/264 (43%), Positives = 178/264 (67%), Gaps = 5/264 (1%)

Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLK----PECVNTEMLKEFSQEVYI 160
           W  D  QL I  K ASG++  +Y+G Y  + VA+K+++     E    ++ ++F  EV +
Sbjct: 79  WTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPTHKEETRAKLEQQFKSEVAL 138

Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSK 219
           + ++ H N+VQFI AC +PP  CI+TE+M++G++  +L+K++     + ++L++A+D+S+
Sbjct: 139 LSRLFHPNIVQFIAACKKPPVYCIITEYMSQGNLRMYLNKKEPYSLSIETVLRLALDISR 198

Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI 279
           GM YLH   +IHRDLK+ NLL+++   VKVADFG + ++ Q        GTYRWMAPE+I
Sbjct: 199 GMEYLHSQGVIHRDLKSNNLLLNDEMRVKVADFGTSCLETQCREAKGNMGTYRWMAPEMI 258

Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
           + KPY  K DV+SFGI LWEL T  LP+ G+TP+QAA  V +K+ RP +P    P LA L
Sbjct: 259 KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKNERPPLPASCQPALAHL 318

Query: 340 LERCWQHDPTQRPNFSQITDILKQ 363
           ++RCW  +P++RP+FS I  +L++
Sbjct: 319 IKRCWSENPSKRPDFSNIVAVLEK 342

Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2).
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1

 Score =  254 bits (650), Expect = 6e-67,   Method: Compositional matrix adjust.
 Identities = 120/282 (42%), Positives = 191/282 (67%), Gaps = 4/282 (1%)

Query: 87  LIESSPNCIEIPTDGTDVW---EIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLK- 142
           ++++S + +E P+     +   EI   +LKI  K+  G++G +YKG +    VAIK +K 
Sbjct: 634 ILKNSGSVVEPPSQQQQYFSDIEISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKI 693

Query: 143 PECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK 202
            E VN ++L+EF +E+ I+ ++RH N+V  + ACT PPNLC +TE++  GS+YD LH +K
Sbjct: 694 NEDVNNQVLEEFRKELTILSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKK 753

Query: 203 GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262
               +    K+AI +++GMNYLH + +IHRD+K+ NLL+DE+  VK+ DFG+++++++S 
Sbjct: 754 IKMNMQLYKKLAIQIAQGMNYLHLSGVIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKST 813

Query: 263 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322
            MT   G+  WM+PE++  + Y  K DV++FGI LWEL TGELPY+GL  +Q A+ V  K
Sbjct: 814 EMTKSIGSPIWMSPELLMGEDYTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTK 873

Query: 323 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQM 364
           SLRP IP     +L+ L++ CW  DP +RP+F++I ++L ++
Sbjct: 874 SLRPPIPNAWPYQLSHLIQACWHQDPLKRPSFTEILNLLNEI 915

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1

 Score =  242 bits (618), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 123/298 (41%), Positives = 194/298 (65%), Gaps = 8/298 (2%)

Query: 79  GVPMHSKLLIESSPNCI--EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEV 136
             PM++  + +  PN    E+  DG D+ +I    L I+ K+ +GS+G +++  +   +V
Sbjct: 517 AAPMNAPPISQPVPNRANRELGLDGDDM-DIPWCDLNIKEKIGAGSFGTVHRAEWHGSDV 575

Query: 137 AIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYD 196
           A+K+L  +  + E + EF +EV IM+++RH N+V F+GA T+PPNL IVTE+++RGS+Y 
Sbjct: 576 AVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR 635

Query: 197 FLHKQKGVFQLTSL--LKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGVVKVADF 252
            LHK     QL     L +A DV+KGMNYLH  N  I+HRDLK+ NLL+D+   VKV DF
Sbjct: 636 LLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDF 695

Query: 253 GVARVQAQSGVMT-AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT 311
           G++R++A + + + +  GT  WMAPEV+  +P + K+DV+SFG+ LWEL T + P+  L 
Sbjct: 696 GLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN 755

Query: 312 PLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVL 369
           P Q    V  K  R  IP++ +P++A ++E CW ++P +RP+F+ I D+L+ ++K  +
Sbjct: 756 PAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 813

Acts as a negative regulator in the ethylene response pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1

 Score =  241 bits (615), Expect = 7e-63,   Method: Compositional matrix adjust.
 Identities = 117/267 (43%), Positives = 172/267 (64%), Gaps = 6/267 (2%)

Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY 159
           DG D   ID  Q+KI  ++  G+YG++Y GT+   +VA+K L    +N  +LKEF +E+ 
Sbjct: 365 DGKD---IDIHQIKIGVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREIN 421

Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           +M+ +RH NV+QF+G+C  PP++CI TE+M RGS+Y  LH Q    Q + L+K+ ID +K
Sbjct: 422 LMKNLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQLQWSLLIKMMIDAAK 481

Query: 220 GMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 277
           G+ YLH +   I+HRDLK+ NLL+DEN  VKVADFG++ ++ Q   MTA  GT  W +PE
Sbjct: 482 GVIYLHNSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQGATMTA-CGTPCWTSPE 540

Query: 278 VIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 337
           V+  + Y  KADV+SFGI LWE  T + PY G+ P Q    V ++ +RP +P++  P+  
Sbjct: 541 VLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPVPQNGPPKYI 600

Query: 338 ELLERCWQHDPTQRPNFSQITDILKQM 364
           +LL  C   +P+ RP   Q  + L+ +
Sbjct: 601 QLLIDCLNENPSHRPTMEQCLERLESI 627

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1

 Score =  240 bits (612), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 115/267 (43%), Positives = 173/267 (64%), Gaps = 6/267 (2%)

Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY 159
           DG D   ID +Q+KI  ++  G++G++Y GT+   +VA+K L    +N  +LKEF +E+ 
Sbjct: 382 DGKD---IDTQQIKIGVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREIN 438

Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           +M+ +RH NV+QF+G+C   P++CI TE+M RGS+Y  LH +K     + + ++ ID +K
Sbjct: 439 LMKNLRHPNVIQFLGSCLISPDICICTEYMPRGSLYSILHNEKIKISWSLVKRMMIDAAK 498

Query: 220 GMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 277
           G+ YLH +   I+HRDLK+ NLL+DEN  VKVADFG++ ++ Q   MTA  GT  W +PE
Sbjct: 499 GIIYLHGSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQGATMTA-CGTPCWTSPE 557

Query: 278 VIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 337
           V+  + Y  KADV+SFGI LWE  T + PY G+ P Q    V ++ +RP  PK+  P+  
Sbjct: 558 VLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPTPKYGPPKYI 617

Query: 338 ELLERCWQHDPTQRPNFSQITDILKQM 364
           +LL+ C   +P+QRP   Q  +IL+ +
Sbjct: 618 QLLKDCLNENPSQRPTMEQCLEILESI 644

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1

 Score =  238 bits (608), Expect = 4e-62,   Method: Compositional matrix adjust.
 Identities = 124/275 (45%), Positives = 173/275 (62%), Gaps = 5/275 (1%)

Query: 100 DGTDVWE--IDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQE 157
           D  DV E  I    L I  ++  GSYG++Y   +   EVA+K    +  +   L EF  E
Sbjct: 655 DDADVGECEIPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAALAEFRSE 714

Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 217
           V IMR++RH NVV F+GA TRPPNL IVTEF+ RGS+Y  LH+ K        +K+A+DV
Sbjct: 715 VRIMRRLRHPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRPKSHIDERRRIKMALDV 774

Query: 218 SKGMNYLHQN--NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET-GTYRWM 274
           + GMN LH +   I+HRDLKT NLL+D N  VKV DFG++R++  + + +  T GT  WM
Sbjct: 775 AMGMNCLHTSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWM 834

Query: 275 APEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP 334
           APEV+ ++P + K DV+SFG+ LWEL T  LP+ G+ P+Q    V  ++ R  IPK   P
Sbjct: 835 APEVLRNEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGFQNRRLEIPKELDP 894

Query: 335 RLAELLERCWQHDPTQRPNFSQITDILKQMMKEVL 369
            +  ++  CWQ DP  RP+F+Q+T++LK + + VL
Sbjct: 895 VVGRIILECWQTDPNLRPSFAQLTEVLKPLNRLVL 929

MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1

 Score =  220 bits (561), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 110/265 (41%), Positives = 169/265 (63%), Gaps = 4/265 (1%)

Query: 105  WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 164
            WE+   ++ I  ++  G YG +++G++   EVA+K+L  + VN +++ +  +EV ++ K+
Sbjct: 844  WEVPLSEIAIGARIGRGGYGQVFRGSWRGTEVAVKMLFNDNVNLKLISDLRKEVDLLCKL 903

Query: 165  RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
            RH N+V F+GACT P + CIVTE+++RGS+ + L  +         L++  D ++GM YL
Sbjct: 904  RHPNIVLFMGACTEPSSPCIVTEYLSRGSLANILLDESIEMDWGLRLQLGFDCARGMTYL 963

Query: 225  HQNN--IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK 282
            H  N  IIHRDLKT NLL+D++  VKVADFG+A V++ +   T   GT  W+APEV+  +
Sbjct: 964  HSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLATVKSHTFAKTM-CGTTGWVAPEVLAEE 1022

Query: 283  PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER 342
             Y  KADV+S+ I LWELLT  +PYAG   +Q  V  + +  R  +P    P+ A L+ R
Sbjct: 1023 GYTEKADVYSYAIVLWELLTRLIPYAGKNTMQ-VVRSIDRGERLPMPAWCPPKYAALMNR 1081

Query: 343  CWQHDPTQRPNFSQITDILKQMMKE 367
            CW+ DPT RP+F +I  I++ M+ E
Sbjct: 1082 CWETDPTHRPSFPEILPIMEGMISE 1106

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54IP4|SHKB_DICDI Dual specificity protein kinase shkB OS=Dictyostelium discoideum GN=shkB PE=3 SV=1

 Score =  216 bits (551), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 112/263 (42%), Positives = 163/263 (61%), Gaps = 9/263 (3%)

Query: 105 WEIDAKQLKI--ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 162
           WEID  ++    E K+ SG++G +YKG    +EVAIK L         + EF +EV +M 
Sbjct: 165 WEIDRNEISYNREAKLGSGAFGSVYKGIVRGKEVAIKKLTQTVFEENTMNEFKKEVSLMA 224

Query: 163 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLK---VAIDVSK 219
           K+R+ +++ F+GACT P +L IVTE M +GS++  L  ++      +  +   +A D   
Sbjct: 225 KLRNPHLLLFMGACTAPEDLSIVTELMPKGSVHSLLRAKEDTSDFITFKRAILIARDTVL 284

Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA--QSGVMTAETGTYRWMAPE 277
           GM +LH +NI+H DLK ANLL+D+N VVKVADFG+++         +  + G+  +MAPE
Sbjct: 285 GMTWLHASNILHLDLKPANLLVDQNWVVKVADFGLSKYMKPDSKDKLLGQAGSPLYMAPE 344

Query: 278 VIEHKPYDYKADVFSFGIALWELLTGELPYAGL--TPLQAAVGVVQKSLRPTIPKHAHPR 335
           ++ ++PYD K DVFSF I LWELLT + PY  L  +  Q   GVV K  RP IP +   R
Sbjct: 345 MLVNQPYDGKVDVFSFSILLWELLTKQEPYNKLYSSYPQLVEGVVNKKNRPIIPDYFPTR 404

Query: 336 LAELLERCWQHDPTQRPNFSQIT 358
           L +LL RCW H P++RP+F++I+
Sbjct: 405 LKDLLARCWDHYPSRRPSFAEIS 427

Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2

 Score =  215 bits (548), Expect = 5e-55,   Method: Compositional matrix adjust.
 Identities = 113/277 (40%), Positives = 172/277 (62%), Gaps = 12/277 (4%)

Query: 102  TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPE-CVNTEMLKEFSQEVYI 160
            +D WEID  +L++  ++ +G++G+++KGT+   EVA+K++ P+  +  ++ + F  EV +
Sbjct: 776  SDDWEIDFHELELGEQLGTGAFGEVHKGTWRGTEVAVKMISPDKTITKDIERNFKDEVRV 835

Query: 161  MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI--DVS 218
            M  +RH NVV F+ A T+PP +CIV EFMA GS++D L K + +  +   LKV I    S
Sbjct: 836  MTTLRHPNVVLFMAASTKPPKMCIVMEFMALGSLHDLL-KNELIPDIPFALKVKIAYQAS 894

Query: 219  KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE--TGTYRWMAP 276
            KGM++LH + I HRDLK+ NLL+D    VKV+DFG+ + ++    +  E   GT +W AP
Sbjct: 895  KGMHFLHSSGITHRDLKSLNLLLDIKWNVKVSDFGLTKFKSDVKSINPEKFAGTIQWTAP 954

Query: 277  EVI-EHKPYDY-KADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH- 333
            E++ E +  DY  +DV+SFGI +WEL+T + PY G++P   AV V++ + RP I      
Sbjct: 955  EILSEDREVDYILSDVYSFGIIMWELITRDQPYFGMSPAAIAVSVIRDNYRPVISDQLRS 1014

Query: 334  ---PRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
               P   ELL  CW  DPT RP F +I   L  +M +
Sbjct: 1015 EVAPEYIELLTSCWHFDPTIRPTFLEIMTRLSNLMGD 1051

Acanthamoeba polyphaga (taxid: 5757)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q55A09|Y9963_DICDI Probable serine/threonine-protein kinase DDB_G0272254 OS=Dictyostelium discoideum GN=DDB_G0272254 PE=3 SV=1

 Score =  213 bits (541), Expect = 3e-54,   Method: Compositional matrix adjust.
 Identities = 106/281 (37%), Positives = 172/281 (61%), Gaps = 12/281 (4%)

Query: 93   NCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKP--ECVNTEM 150
            N + +P   + V  I+   +KI+ ++  G +  + KG +  ++VA+K L    +    EM
Sbjct: 1055 NTVTLPISSS-VTMINYSDIKIDKEIGKGHFSKVLKGNWKGKDVAVKKLNSNKDKAREEM 1113

Query: 151  LKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLH----KQKGVFQ 206
            ++EF  EV ++  ++H N+V   G    P  +CIV EF+  G++++ +H    +Q+   +
Sbjct: 1114 IQEFKAEVELLGSLQHPNLVTCYGYSLNP--MCIVMEFLPSGNLFELIHSKPSEQQQSIK 1171

Query: 207  LTS--LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 264
            L S  +L +A D+++GM +LH  NIIHRDLK++NLLMD++  +K+AD G+AR  + +  M
Sbjct: 1172 LDSTLILAIAFDIARGMQHLHTRNIIHRDLKSSNLLMDKHFNIKIADLGIARETSFTQTM 1231

Query: 265  TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL 324
            T   GT  W APE++ H+ Y+ KADV+S+ I L+ELLTGE PY G+ P+ A + V  K L
Sbjct: 1232 TT-IGTVAWTAPEILRHESYNQKADVYSYAIVLYELLTGEEPYQGIPPMNAGILVASKGL 1290

Query: 325  RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
            RP +P +  P   +L+  CW  DP +RP+F +IT+ L +  
Sbjct: 1291 RPELPDNCDPNWKKLVVWCWSEDPNKRPSFEEITNYLTKTF 1331

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	395
449456851	579	PREDICTED: mitogen-activated protein kin	0.906	0.618	0.787	1e-173
449495086	579	PREDICTED: mitogen-activated protein kin	0.906	0.618	0.787	1e-173
224117232	587	predicted protein [Populus trichocarpa]	0.906	0.609	0.804	1e-170
356538347	571	PREDICTED: serine/threonine-protein kina	0.906	0.626	0.787	1e-169
356496589	571	PREDICTED: serine/threonine-protein kina	0.906	0.626	0.790	1e-169
357483963	574	Dual specificity protein kinase pyk2 [Me	0.906	0.623	0.784	1e-167
224133576	579	predicted protein [Populus trichocarpa]	0.893	0.609	0.776	1e-166
297798344	570	kinase family protein [Arabidopsis lyrat	0.903	0.626	0.776	1e-165
22329194	570	ACT-like protein tyrosine kinase family	0.903	0.626	0.773	1e-164
116643258	581	flag-tagged protein kinase domain of put	0.903	0.614	0.773	1e-164

>gi|449456851|ref|XP_004146162.1| PREDICTED: mitogen-activated protein kinase kinase kinase 10-like [Cucumis sativus]

 Score =  613 bits (1582), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 282/358 (78%), Positives = 326/358 (91%)

Query: 11  VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQS 70
           + +LTSLL ++GLNIQEAHAFS+VDGFSLDVFV+DGWPY+ETE+LK VL KEIL  K+Q 
Sbjct: 196 LSQLTSLLADVGLNIQEAHAFSSVDGFSLDVFVIDGWPYEETEELKRVLEKEILNFKEQC 255

Query: 71  CSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGT 130
            S++QP+  +  H++  +ES P+C+ IPTDGTDVWE+D  QLK E KV SGS+GDLY+GT
Sbjct: 256 WSEKQPSSALGKHNQNRVESFPSCVGIPTDGTDVWEMDISQLKFENKVGSGSFGDLYRGT 315

Query: 131 YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
           YCSQEVAIKVL+PE +N EMLKEFSQEVYIMRK+RHKNVVQF+GACT+PPNLCIVTEFM+
Sbjct: 316 YCSQEVAIKVLRPERINEEMLKEFSQEVYIMRKVRHKNVVQFLGACTKPPNLCIVTEFMS 375

Query: 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
           RGS+YDFLHKQ+GVF L SLLKVAI++S+GMNYLHQNNIIHRDLKTANLLMDEN VVKVA
Sbjct: 376 RGSVYDFLHKQRGVFNLPSLLKVAINISRGMNYLHQNNIIHRDLKTANLLMDENMVVKVA 435

Query: 251 DFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310
           DFGVARVQ QSGVMTAETGTYRWMAPEVIEHKPYD+KADVFSFGIALWELLTGE+PY+ +
Sbjct: 436 DFGVARVQTQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIALWELLTGEIPYSSM 495

Query: 311 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV 368
           TPLQAAVGVVQK LRPTIPK+AHP LAELLERCW+HDPT+RPNFS+I +ILKQ+ ++V
Sbjct: 496 TPLQAAVGVVQKRLRPTIPKNAHPVLAELLERCWRHDPTERPNFSEILEILKQIAEQV 553

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449495086|ref|XP_004159730.1| PREDICTED: mitogen-activated protein kinase kinase kinase 10-like [Cucumis sativus]

 Score =  613 bits (1581), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 282/358 (78%), Positives = 326/358 (91%)

Query: 11  VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQS 70
           + +LTSLL ++GLNIQEAHAFS+VDGFSLDVFV+DGWPY+ETE+LK VL KEIL  K+Q 
Sbjct: 196 LSQLTSLLADVGLNIQEAHAFSSVDGFSLDVFVIDGWPYEETEELKRVLEKEILNFKEQC 255

Query: 71  CSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGT 130
            S++QP+  +  H++  +ES P+C+ IPTDGTDVWE+D  QLK E KV SGS+GDLY+GT
Sbjct: 256 WSEKQPSSALGKHNQNRVESFPSCVGIPTDGTDVWEMDISQLKFENKVGSGSFGDLYRGT 315

Query: 131 YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
           YCSQEVAIKVL+PE +N EMLKEFSQEVYIMRK+RHKNVVQF+GACT+PPNLCIVTEFM+
Sbjct: 316 YCSQEVAIKVLRPERINEEMLKEFSQEVYIMRKVRHKNVVQFLGACTKPPNLCIVTEFMS 375

Query: 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
           RGS+YDFLHKQ+GVF L SLLKVAI++S+GMNYLHQNNIIHRDLKTANLLMDEN VVKVA
Sbjct: 376 RGSVYDFLHKQRGVFNLPSLLKVAINISRGMNYLHQNNIIHRDLKTANLLMDENMVVKVA 435

Query: 251 DFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310
           DFGVARVQ QSGVMTAETGTYRWMAPEVIEHKPYD+KADVFSFGIALWELLTGE+PY+ +
Sbjct: 436 DFGVARVQTQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIALWELLTGEIPYSSM 495

Query: 311 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV 368
           TPLQAAVGVVQK LRPTIPK+AHP LAELLERCW+HDPT+RPNFS+I +ILKQ+ ++V
Sbjct: 496 TPLQAAVGVVQKRLRPTIPKNAHPVLAELLERCWRHDPTERPNFSEILEILKQIAEQV 553

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224117232|ref|XP_002331754.1| predicted protein [Populus trichocarpa] gi|222874451|gb|EEF11582.1| predicted protein [Populus trichocarpa]

 Score =  602 bits (1553), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 288/358 (80%), Positives = 318/358 (88%)

Query: 11  VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQS 70
           + +LTSLL EIGLNIQEAHAFSTVDGFSLDVFVVDGW  +ETE+L+N L KEILKSK+Q 
Sbjct: 205 LSQLTSLLAEIGLNIQEAHAFSTVDGFSLDVFVVDGWLREETEELRNALEKEILKSKEQC 264

Query: 71  CSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGT 130
            SK+     V   +K  +ES P+C+EIP+DGTDVWEID   LK+E KVASGSYGDLY+GT
Sbjct: 265 FSKQLSVSLVGEQNKTGVESLPDCVEIPSDGTDVWEIDTSLLKVENKVASGSYGDLYRGT 324

Query: 131 YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
           YCSQEVAIKVLKPE V+ EML+EFS+EVYIMRK+RHKNVVQFIGAC R PNLCIVTEFMA
Sbjct: 325 YCSQEVAIKVLKPERVSGEMLREFSREVYIMRKVRHKNVVQFIGACDRSPNLCIVTEFMA 384

Query: 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
           +GS+Y+FLHKQKGVF+L  L+KVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN VVKVA
Sbjct: 385 KGSLYNFLHKQKGVFKLPCLIKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENEVVKVA 444

Query: 251 DFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310
           DFGVARVQ QSGVMTAETGTYRWMAPEVIEHKPYD+KADVFSFGI  WELLTGELPY+ L
Sbjct: 445 DFGVARVQTQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVAWELLTGELPYSYL 504

Query: 311 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV 368
           TPLQAAVGVV+K LRPTIPKH HP+LAELLE CWQ DP QRPNFSQI DIL+Q++KEV
Sbjct: 505 TPLQAAVGVVRKGLRPTIPKHTHPKLAELLETCWQQDPNQRPNFSQIIDILQQIVKEV 562

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356538347|ref|XP_003537665.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Glycine max]

 Score =  602 bits (1551), Expect = e-169,   Method: Compositional matrix adjust.
 Identities = 282/358 (78%), Positives = 319/358 (89%)

Query: 11  VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQS 70
           + +LT++LGE+GLNIQEAHAFST DGFSLDVFVV+GWP +ETE+LK VL KEI K K+Q+
Sbjct: 194 LSQLTAILGEMGLNIQEAHAFSTTDGFSLDVFVVEGWPNEETEELKGVLEKEIFKVKEQN 253

Query: 71  CSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGT 130
            S +          +  +E SP+CI+IP+DG DVWEID  QLK E KV SGS+GDLY+GT
Sbjct: 254 LSNQGIHYATNEQYQARMEPSPHCIQIPSDGADVWEIDTNQLKYENKVGSGSFGDLYRGT 313

Query: 131 YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
           YCSQ+VAIKVLKPE ++T+ML+EF+QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM+
Sbjct: 314 YCSQDVAIKVLKPERISTDMLREFAQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMS 373

Query: 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
           RGS+YDFLHKQ+GVF+L SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN VVKVA
Sbjct: 374 RGSLYDFLHKQRGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENEVVKVA 433

Query: 251 DFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310
           DFGVARVQ QSGVMTAETGTYRWMAPEVIEHKPYD KADVFSFGIALWELLTGELPY+ L
Sbjct: 434 DFGVARVQTQSGVMTAETGTYRWMAPEVIEHKPYDQKADVFSFGIALWELLTGELPYSCL 493

Query: 311 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV 368
           TPLQAAVGVVQK LRPTIPK+ HPRL+ELL+RCWQ DPTQRPNFS++ +IL+Q+ KEV
Sbjct: 494 TPLQAAVGVVQKGLRPTIPKNTHPRLSELLQRCWQQDPTQRPNFSEVIEILQQIAKEV 551

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356496589|ref|XP_003517149.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Glycine max]

 Score =  600 bits (1546), Expect = e-169,   Method: Compositional matrix adjust.
 Identities = 283/358 (79%), Positives = 318/358 (88%)

Query: 11  VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQS 70
           + +LT++LGE+GLNIQEAHAFST DGFSLDVFVV+GWP +ETE+LK VL KEI K K+Q+
Sbjct: 194 LSQLTAILGEMGLNIQEAHAFSTTDGFSLDVFVVEGWPNEETEELKGVLEKEIFKVKEQN 253

Query: 71  CSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGT 130
            S +          +  +E SP+CI IP+DG DVWEID  QLK E KV SGS+GDLY+GT
Sbjct: 254 MSNQGIHYATNEQYQARMEPSPHCILIPSDGADVWEIDTNQLKYENKVGSGSFGDLYRGT 313

Query: 131 YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
           YCSQ+VAIKVLKPE ++T+ML+EF+QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM+
Sbjct: 314 YCSQDVAIKVLKPERISTDMLREFAQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMS 373

Query: 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
           RGS+YDFLHKQ+GVF+L SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN VVKVA
Sbjct: 374 RGSLYDFLHKQRGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENEVVKVA 433

Query: 251 DFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310
           DFGVARVQ QSGVMTAETGTYRWMAPEVIEHKPYD KADVFSFGIALWELLTGELPY+ L
Sbjct: 434 DFGVARVQTQSGVMTAETGTYRWMAPEVIEHKPYDQKADVFSFGIALWELLTGELPYSCL 493

Query: 311 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV 368
           TPLQAAVGVVQK LRPTIPK+ HPRL+ELL+RCWQ DPTQRPNFS+I +IL+Q+ KEV
Sbjct: 494 TPLQAAVGVVQKGLRPTIPKNTHPRLSELLQRCWQQDPTQRPNFSEIIEILQQIAKEV 551

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357483963|ref|XP_003612268.1| Dual specificity protein kinase pyk2 [Medicago truncatula] gi|355513603|gb|AES95226.1| Dual specificity protein kinase pyk2 [Medicago truncatula]

 Score =  593 bits (1530), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 281/358 (78%), Positives = 316/358 (88%)

Query: 11  VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQS 70
           + +LTS+LGEIGLNIQEAHAFST DGFSLDVFVV+GWP +ETE+LK VL KEILK KDQ 
Sbjct: 194 LSQLTSILGEIGLNIQEAHAFSTSDGFSLDVFVVEGWPNEETEELKGVLEKEILKVKDQY 253

Query: 71  CSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGT 130
            S +          +  +ESSP+CI+IP DG DVWEID  QLK E KV SGS+GDL++G+
Sbjct: 254 LSNQGTLYSSNDQYQTRMESSPDCIQIPFDGADVWEIDPSQLKYENKVGSGSFGDLFRGS 313

Query: 131 YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
           YCSQ+VAIKVLKPE ++T+MLKEF+QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM+
Sbjct: 314 YCSQDVAIKVLKPERISTDMLKEFAQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMS 373

Query: 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
           RGS+YDFLH+QKGVF+L SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN +VKVA
Sbjct: 374 RGSLYDFLHRQKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENELVKVA 433

Query: 251 DFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310
           DFGVARVQ QSGVMTAETGTYRWMAPEVIEHKPYD KADVFSFGIALWELLTGELPY+ L
Sbjct: 434 DFGVARVQTQSGVMTAETGTYRWMAPEVIEHKPYDQKADVFSFGIALWELLTGELPYSYL 493

Query: 311 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV 368
           TPLQAAVGVVQK LRPTIPK+ HPR++ELL+RCWQ DP +RP FS+I +IL+ + KEV
Sbjct: 494 TPLQAAVGVVQKGLRPTIPKNTHPRISELLQRCWQQDPKERPAFSEIIEILQHIAKEV 551

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224133576|ref|XP_002327629.1| predicted protein [Populus trichocarpa] gi|222836714|gb|EEE75107.1| predicted protein [Populus trichocarpa]

 Score =  590 bits (1520), Expect = e-166,   Method: Compositional matrix adjust.
 Identities = 291/375 (77%), Positives = 317/375 (84%), Gaps = 22/375 (5%)

Query: 11  VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQ- 69
           + +LTSLL EIGLNIQEAHAFSTVDGFSLDVFVVDGW  +ETE+LKN L KEILK+KDQ 
Sbjct: 201 LSQLTSLLAEIGLNIQEAHAFSTVDGFSLDVFVVDGWLCEETEELKNALEKEILKAKDQC 260

Query: 70  -------SCSKRQPALGV---------PMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLK 113
                  S    Q   GV         P    LL     + ++IP+DGTDVWEID  QLK
Sbjct: 261 FPNQLSVSLIGEQNKTGVKSLLDNVQIPSDGTLL-----DNVQIPSDGTDVWEIDTSQLK 315

Query: 114 IECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
           +E KVASGSYGDLY+G YCSQEVAIKVLKPE V+ EML+EFSQEVYIMRK+RHKNVVQ I
Sbjct: 316 VENKVASGSYGDLYRGIYCSQEVAIKVLKPERVSAEMLREFSQEVYIMRKVRHKNVVQLI 375

Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
           GACTR PNLCIVTEFMA+GS+Y+FLHKQKGVF+L SL+KVAIDVSKGMNYLHQNNIIHRD
Sbjct: 376 GACTRSPNLCIVTEFMAKGSLYNFLHKQKGVFKLPSLIKVAIDVSKGMNYLHQNNIIHRD 435

Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           LKTANLLMDEN VVKVADFGVARVQ QSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF
Sbjct: 436 LKTANLLMDENEVVKVADFGVARVQTQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 495

Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPN 353
           GI +WELLTGELPY+ LTPLQAAVGVVQK LRPTIPKH +P+LAELLERCWQ DPTQRPN
Sbjct: 496 GIVMWELLTGELPYSYLTPLQAAVGVVQKGLRPTIPKHTYPKLAELLERCWQRDPTQRPN 555

Query: 354 FSQITDILKQMMKEV 368
           FSQI DIL+Q+ KE+
Sbjct: 556 FSQIIDILQQIAKEL 570

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297798344|ref|XP_002867056.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297312892|gb|EFH43315.1| kinase family protein [Arabidopsis lyrata subsp. lyrata]

 Score =  587 bits (1514), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 278/358 (77%), Positives = 311/358 (86%), Gaps = 1/358 (0%)

Query: 11  VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQS 70
           + +LTS+LGE+GLNIQEAHAFST DGFSLDVFVVDGW  +ETE LK+ L KEI K KDQ 
Sbjct: 192 LSQLTSMLGELGLNIQEAHAFSTADGFSLDVFVVDGWSQEETEGLKDALTKEIRKLKDQP 251

Query: 71  CSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGT 130
           CSK Q ++    H K   E  P C+EIPTDGTD WEID KQLKIE KVA GSYG+L++GT
Sbjct: 252 CSK-QKSITFFEHDKSTNELLPACVEIPTDGTDEWEIDMKQLKIEKKVACGSYGELFRGT 310

Query: 131 YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
           YCSQEVAIK+LKPE VN EML+EFSQEVYIMRK+RHKNVVQFIGACTR PNLCIVTEFM 
Sbjct: 311 YCSQEVAIKILKPERVNAEMLREFSQEVYIMRKVRHKNVVQFIGACTRSPNLCIVTEFMT 370

Query: 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
           RGSIYDFLHK KGVF++ SLLKVA+DVSKGMNYLHQNNIIHRDLKTANLLMDE+ VVKVA
Sbjct: 371 RGSIYDFLHKHKGVFKIQSLLKVALDVSKGMNYLHQNNIIHRDLKTANLLMDEHEVVKVA 430

Query: 251 DFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310
           DFGVARVQ +SGVMTAETGTYRWMAPEVIEHKPYD++ADVFS+ I LWELLTGELPY+ L
Sbjct: 431 DFGVARVQTESGVMTAETGTYRWMAPEVIEHKPYDHRADVFSYAIVLWELLTGELPYSYL 490

Query: 311 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV 368
           TPLQAAVGVVQK LRP IPK  HP+L ELLE+CWQ DP QRPNF++I ++L Q+++EV
Sbjct: 491 TPLQAAVGVVQKGLRPKIPKETHPKLTELLEKCWQQDPAQRPNFAEIIEMLNQLIREV 548

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|22329194|ref|NP_195303.2| ACT-like protein tyrosine kinase family protein [Arabidopsis thaliana] gi|20260236|gb|AAM13016.1| putative protein [Arabidopsis thaliana] gi|22136520|gb|AAM91338.1| putative protein [Arabidopsis thaliana] gi|332661163|gb|AEE86563.1| ACT-like protein tyrosine kinase family protein [Arabidopsis thaliana]

 Score =  583 bits (1504), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 277/358 (77%), Positives = 310/358 (86%), Gaps = 1/358 (0%)

Query: 11  VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQS 70
           + +LTS+LGE+GLNIQEAHAFST DGFSLDVFVVDGW  +ETE LK+ L KEI K KDQ 
Sbjct: 192 LSQLTSMLGELGLNIQEAHAFSTADGFSLDVFVVDGWSQEETEGLKDALKKEIRKFKDQP 251

Query: 71  CSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGT 130
           CSK Q ++    H K   E  P C+EIPTDGTD WEID KQLKIE KVA GSYG+L++GT
Sbjct: 252 CSK-QKSITFFEHDKSTNELLPACVEIPTDGTDEWEIDMKQLKIEKKVACGSYGELFRGT 310

Query: 131 YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
           YCSQEVAIK+LKPE VN EML+EFSQEVYIMRK+RHKNVVQFIGACTR PNLCIVTEFM 
Sbjct: 311 YCSQEVAIKILKPERVNAEMLREFSQEVYIMRKVRHKNVVQFIGACTRSPNLCIVTEFMT 370

Query: 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
           RGSIYDFLHK KGVF++ SLLKVA+DVSKGMNYLHQNNIIHRDLKTANLLMDE+ VVKVA
Sbjct: 371 RGSIYDFLHKHKGVFKIQSLLKVALDVSKGMNYLHQNNIIHRDLKTANLLMDEHEVVKVA 430

Query: 251 DFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310
           DFGVARVQ +SGVMTAETGTYRWMAPEVIEHKPYD++ADVFS+ I LWELLTGELPY+ L
Sbjct: 431 DFGVARVQTESGVMTAETGTYRWMAPEVIEHKPYDHRADVFSYAIVLWELLTGELPYSYL 490

Query: 311 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV 368
           TPLQAAVGVVQK LRP IPK  HP+L ELLE+CWQ DP  RPNF++I ++L Q+++EV
Sbjct: 491 TPLQAAVGVVQKGLRPKIPKETHPKLTELLEKCWQQDPALRPNFAEIIEMLNQLIREV 548

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|116643258|gb|ABK06437.1| flag-tagged protein kinase domain of putative mitogen-activated protein kinase kinase kinase [synthetic construct]

 Score =  583 bits (1504), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 277/358 (77%), Positives = 310/358 (86%), Gaps = 1/358 (0%)

Query: 11  VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQS 70
           + +LTS+LGE+GLNIQEAHAFST DGFSLDVFVVDGW  +ETE LK+ L KEI K KDQ 
Sbjct: 192 LSQLTSMLGELGLNIQEAHAFSTADGFSLDVFVVDGWSQEETEGLKDALKKEIRKFKDQP 251

Query: 71  CSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGT 130
           CSK Q ++    H K   E  P C+EIPTDGTD WEID KQLKIE KVA GSYG+L++GT
Sbjct: 252 CSK-QKSITFFEHDKSTNELLPACVEIPTDGTDEWEIDMKQLKIEKKVACGSYGELFRGT 310

Query: 131 YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
           YCSQEVAIK+LKPE VN EML+EFSQEVYIMRK+RHKNVVQFIGACTR PNLCIVTEFM 
Sbjct: 311 YCSQEVAIKILKPERVNAEMLREFSQEVYIMRKVRHKNVVQFIGACTRSPNLCIVTEFMT 370

Query: 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
           RGSIYDFLHK KGVF++ SLLKVA+DVSKGMNYLHQNNIIHRDLKTANLLMDE+ VVKVA
Sbjct: 371 RGSIYDFLHKHKGVFKIQSLLKVALDVSKGMNYLHQNNIIHRDLKTANLLMDEHEVVKVA 430

Query: 251 DFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310
           DFGVARVQ +SGVMTAETGTYRWMAPEVIEHKPYD++ADVFS+ I LWELLTGELPY+ L
Sbjct: 431 DFGVARVQTESGVMTAETGTYRWMAPEVIEHKPYDHRADVFSYAIVLWELLTGELPYSYL 490

Query: 311 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV 368
           TPLQAAVGVVQK LRP IPK  HP+L ELLE+CWQ DP  RPNF++I ++L Q+++EV
Sbjct: 491 TPLQAAVGVVQKGLRPKIPKETHPKLTELLEKCWQQDPALRPNFAEIIEMLNQLIREV 548

Source: synthetic construct

Species: synthetic construct

Genus: N/A

Family: N/A

Order: N/A

Class: N/A

Phylum: N/A

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	395
TAIR|locus:2128043	570	STY17 "serine/threonine/tyrosi	0.903	0.626	0.773	8.8e-150
TAIR|locus:2827943	546	STY8 "serine/threonine/tyrosin	0.903	0.653	0.759	2.5e-145
TAIR|locus:2121154	575	STY46 "serine/threonine/tyrosi	0.898	0.617	0.721	9.5e-137
TAIR|locus:2126311	412	AT4G31170 [Arabidopsis thalian	0.688	0.660	0.460	5.8e-66
TAIR|locus:2061092	411	AT2G24360 [Arabidopsis thalian	0.688	0.661	0.457	2e-65
DICTYBASE|DDB_G0267514	916	DDB_G0267514 "protein kinase,	0.701	0.302	0.431	7.1e-63
TAIR|locus:2144613	821	CTR1 "CONSTITUTIVE TRIPLE RESP	0.729	0.350	0.415	5e-60
DICTYBASE|DDB_G0289791	642	drkA "DRK subfamily protein ki	0.660	0.406	0.438	2.2e-59
TAIR|locus:2194055	992	AT1G18160 [Arabidopsis thalian	0.665	0.265	0.432	5e-59
DICTYBASE|DDB_G0289709	690	drkB "DRK subfamily protein ki	0.660	0.378	0.430	7.3e-59

TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)]

 Score = 1462 (519.7 bits), Expect = 8.8e-150, P = 8.8e-150
 Identities = 277/358 (77%), Positives = 310/358 (86%)

Query:    11 VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQS 70
             + +LTS+LGE+GLNIQEAHAFST DGFSLDVFVVDGW  +ETE LK+ L KEI K KDQ 
Sbjct:   192 LSQLTSMLGELGLNIQEAHAFSTADGFSLDVFVVDGWSQEETEGLKDALKKEIRKFKDQP 251

Query:    71 CSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGT 130
             CSK Q ++    H K   E  P C+EIPTDGTD WEID KQLKIE KVA GSYG+L++GT
Sbjct:   252 CSK-QKSITFFEHDKSTNELLPACVEIPTDGTDEWEIDMKQLKIEKKVACGSYGELFRGT 310

Query:   131 YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
             YCSQEVAIK+LKPE VN EML+EFSQEVYIMRK+RHKNVVQFIGACTR PNLCIVTEFM 
Sbjct:   311 YCSQEVAIKILKPERVNAEMLREFSQEVYIMRKVRHKNVVQFIGACTRSPNLCIVTEFMT 370

Query:   191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
             RGSIYDFLHK KGVF++ SLLKVA+DVSKGMNYLHQNNIIHRDLKTANLLMDE+ VVKVA
Sbjct:   371 RGSIYDFLHKHKGVFKIQSLLKVALDVSKGMNYLHQNNIIHRDLKTANLLMDEHEVVKVA 430

Query:   251 DFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310
             DFGVARVQ +SGVMTAETGTYRWMAPEVIEHKPYD++ADVFS+ I LWELLTGELPY+ L
Sbjct:   431 DFGVARVQTESGVMTAETGTYRWMAPEVIEHKPYDHRADVFSYAIVLWELLTGELPYSYL 490

Query:   311 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV 368
             TPLQAAVGVVQK LRP IPK  HP+L ELLE+CWQ DP  RPNF++I ++L Q+++EV
Sbjct:   491 TPLQAAVGVVQKGLRPKIPKETHPKLTELLEKCWQQDPALRPNFAEIIEMLNQLIREV 548

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0016597 "amino acid binding" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0009658 "chloroplast organization" evidence=IGI

GO:0007015 "actin filament organization" evidence=RCA

TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 1420 (504.9 bits), Expect = 2.5e-145, P = 2.5e-145
 Identities = 272/358 (75%), Positives = 309/358 (86%)

Query:    11 VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQS 70
             + +LTSLLGE+GLNIQEAHAFSTVDGFSLDVFVVDGW  +ET+ L++ L+KEILK KDQ 
Sbjct:   186 LSQLTSLLGELGLNIQEAHAFSTVDGFSLDVFVVDGWSQEETDGLRDALSKEILKLKDQP 245

Query:    71 CSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGT 130
              SK Q ++    H K   E  P CIEIPTDGTD WEID  QLKIE KVASGSYGDL++GT
Sbjct:   246 GSK-QKSISFFEHDKSSNELIPACIEIPTDGTDEWEIDVTQLKIEKKVASGSYGDLHRGT 304

Query:   131 YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
             YCSQEVAIK LKP+ VN EML+EFSQEV+IMRK+RHKNVVQF+GACTR P LCIVTEFMA
Sbjct:   305 YCSQEVAIKFLKPDRVNNEMLREFSQEVFIMRKVRHKNVVQFLGACTRSPTLCIVTEFMA 364

Query:   191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
             RGSIYDFLHKQK  F+L +LLKVA+DV+KGM+YLHQNNIIHRDLKTANLLMDE+G+VKVA
Sbjct:   365 RGSIYDFLHKQKCAFKLQTLLKVALDVAKGMSYLHQNNIIHRDLKTANLLMDEHGLVKVA 424

Query:   251 DFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310
             DFGVARVQ +SGVMTAETGTYRWMAPEVIEHKPY++KADVFS+ I LWELLTG++PYA L
Sbjct:   425 DFGVARVQIESGVMTAETGTYRWMAPEVIEHKPYNHKADVFSYAIVLWELLTGDIPYAFL 484

Query:   311 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV 368
             TPLQAAVGVVQK LRP IPK  HP++  LLERCW  DP QRP F +I ++L+Q+MKEV
Sbjct:   485 TPLQAAVGVVQKGLRPKIPKKTHPKVKGLLERCWHQDPEQRPLFEEIIEMLQQIMKEV 542

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0016597 "amino acid binding" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0009658 "chloroplast organization" evidence=IGI

GO:0007015 "actin filament organization" evidence=RCA

TAIR|locus:2121154 STY46 "serine/threonine/tyrosine kinase 46" [Arabidopsis thaliana (taxid:3702)]

 Score = 1339 (476.4 bits), Expect = 9.5e-137, P = 9.5e-137
 Identities = 257/356 (72%), Positives = 300/356 (84%)

Query:    13 ELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQSCS 72
             +LT+LL E+GLNIQEAHAFST DG+SLDVFVVDGWPY+ETE L+  L KE  K + QS S
Sbjct:   192 QLTALLAELGLNIQEAHAFSTTDGYSLDVFVVDGWPYEETERLRISLEKEAAKIELQSQS 251

Query:    73 KRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC 132
                     P        +  + + IP DGTDVWEI+ K LK   K+ASGSYGDLYKGTYC
Sbjct:   252 WPMQQSFSPEKENGQTGARTH-VPIPNDGTDVWEINLKHLKFGHKIASGSYGDLYKGTYC 310

Query:   133 SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARG 192
             SQEVAIKVLKPE +++++ KEF+QEV+IMRK+RHKNVVQFIGACT+PP+LCIVTEFM  G
Sbjct:   311 SQEVAIKVLKPERLDSDLEKEFAQEVFIMRKVRHKNVVQFIGACTKPPHLCIVTEFMPGG 370

Query:   193 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADF 252
             S+YD+LHKQKGVF+L +L KVAID+ KGM+YLHQNNIIHRDLK ANLLMDEN VVKVADF
Sbjct:   371 SVYDYLHKQKGVFKLPTLFKVAIDICKGMSYLHQNNIIHRDLKAANLLMDENEVVKVADF 430

Query:   253 GVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP 312
             GVARV+AQ+GVMTAETGTYRWMAPEVIEHKPYD+KADVFS+GI LWELLTG+LPY  +TP
Sbjct:   431 GVARVKAQTGVMTAETGTYRWMAPEVIEHKPYDHKADVFSYGIVLWELLTGKLPYEYMTP 490

Query:   313 LQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV 368
             LQAAVGVVQK LRPTIPK+ HP+LAELLER W+HD TQRP+FS+I + L+++ KEV
Sbjct:   491 LQAAVGVVQKGLRPTIPKNTHPKLAELLERLWEHDSTQRPDFSEIIEQLQEIAKEV 546

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0016597 "amino acid binding" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0009658 "chloroplast organization" evidence=IGI

GO:0007015 "actin filament organization" evidence=RCA

TAIR|locus:2126311 AT4G31170 [Arabidopsis thaliana (taxid:3702)]

 Score = 671 (241.3 bits), Expect = 5.8e-66, P = 5.8e-66
 Identities = 129/280 (46%), Positives = 187/280 (66%)

Query:    98 PTDGT---DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTE----M 150
             PT+G    + W ID ++L +    A G++G LY+GTY  ++VAIK+L+    N E    +
Sbjct:   114 PTEGLVNYEEWTIDLRKLHMGPAFAQGAFGKLYRGTYNGEDVAIKLLERSDSNPEKAQAL 173

Query:   151 LKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTS 209
              ++F QEV ++  ++H N+V+FIGAC +P   CIVTE+   GS+  FL K Q     L  
Sbjct:   174 EQQFQQEVSMLAFLKHPNIVRFIGACIKPMVWCIVTEYAKGGSVRQFLTKRQNRAVPLKL 233

Query:   210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETG 269
              +  A+DV++GM Y+H+ N IHRDLK+ NLL+  +  +K+ADFGVAR++ Q+  MT ETG
Sbjct:   234 AVMQALDVARGMAYVHERNFIHRDLKSDNLLISADRSIKIADFGVARIEVQTEGMTPETG 293

Query:   270 TYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP 329
             TYRWMAPE+I+H+PY  K DV+SFGI LWEL+TG LP+  +T +QAA  VV + +RPT+P
Sbjct:   294 TYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNRGVRPTVP 353

Query:   330 KHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVL 369
                 P L E++ RCW  DP  RP F++I ++L+    E++
Sbjct:   354 ADCLPVLGEIMTRCWDADPEVRPCFAEIVNLLEAAETEIM 393

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

GO:0006914 "autophagy" evidence=RCA

GO:0010053 "root epidermal cell differentiation" evidence=IMP

TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)]

 Score = 666 (239.5 bits), Expect = 2.0e-65, P = 2.0e-65
 Identities = 128/280 (45%), Positives = 187/280 (66%)

Query:    98 PTDGT---DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVL-KPECVNTE---M 150
             PT+G    D W ID ++L +    A G++G LYKGTY  ++VAIK+L +PE    +   M
Sbjct:   113 PTEGLTNYDEWTIDLRKLNMGPAFAQGAFGKLYKGTYNGEDVAIKILERPENSPEKAQFM 172

Query:   151 LKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL-HKQKGVFQLTS 209
              ++F QEV ++  ++H N+V+FIGAC +P   CIVTE+   GS+  FL  +Q     L  
Sbjct:   173 EQQFQQEVSMLANLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 232

Query:   210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETG 269
              +K A+DV++GM Y+H  N IHRDLK+ NLL+  +  +K+ADFGVAR++ Q+  MT ETG
Sbjct:   233 AVKQALDVARGMAYVHGRNFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG 292

Query:   270 TYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP 329
             TYRWMAPE+I+H+ Y+ K DV+SFGI LWEL+TG LP+  +T +QAA  VV + +RPT+P
Sbjct:   293 TYRWMAPEMIQHRAYNQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNRGVRPTVP 352

Query:   330 KHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVL 369
                 P L++++ RCW  +P  RP F ++  +L+    E++
Sbjct:   353 NDCLPVLSDIMTRCWDANPEVRPCFVEVVKLLEAAETEIM 392

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IDA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

DICTYBASE|DDB_G0267514 DDB_G0267514 "protein kinase, TKL group" [Dictyostelium discoideum (taxid:44689)]

 Score = 643 (231.4 bits), Expect = 7.1e-63, P = 7.1e-63
 Identities = 122/283 (43%), Positives = 194/283 (68%)

Query:    87 LIESSPNCIEIPTDGTDVW---EIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLK- 142
             ++++S + +E P+     +   EI   +LKI  K+  G++G +YKG +    VAIK +K 
Sbjct:   634 ILKNSGSVVEPPSQQQQYFSDIEISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKI 693

Query:   143 PECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK 202
              E VN ++L+EF +E+ I+ ++RH N+V  + ACT PPNLC +TE++  GS+YD LH +K
Sbjct:   694 NEDVNNQVLEEFRKELTILSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKK 753

Query:   203 GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262
                 +    K+AI +++GMNYLH + +IHRD+K+ NLL+DE+  VK+ DFG+++++++S 
Sbjct:   754 IKMNMQLYKKLAIQIAQGMNYLHLSGVIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKST 813

Query:   263 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322
              MT   G+  WM+PE++  + Y  K DV++FGI LWEL TGELPY+GL  +Q A+ V  K
Sbjct:   814 EMTKSIGSPIWMSPELLMGEDYTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTK 873

Query:   323 SLRPTIPKHAHP-RLAELLERCWQHDPTQRPNFSQITDILKQM 364
             SLRP IP +A P +L+ L++ CW  DP +RP+F++I ++L ++
Sbjct:   874 SLRPPIP-NAWPYQLSHLIQACWHQDPLKRPSFTEILNLLNEI 915

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

TAIR|locus:2144613 CTR1 "CONSTITUTIVE TRIPLE RESPONSE 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 615 (221.5 bits), Expect = 5.0e-60, P = 5.0e-60
 Identities = 123/296 (41%), Positives = 194/296 (65%)

Query:    81 PMHSKLLIESSPNCI--EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAI 138
             PM++  + +  PN    E+  DG D+ +I    L I+ K+ +GS+G +++  +   +VA+
Sbjct:   519 PMNAPPISQPVPNRANRELGLDGDDM-DIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAV 577

Query:   139 KVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL 198
             K+L  +  + E + EF +EV IM+++RH N+V F+GA T+PPNL IVTE+++RGS+Y  L
Sbjct:   578 KILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL 637

Query:   199 HKQKGVFQLTSL--LKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGV 254
             HK     QL     L +A DV+KGMNYLH  N  I+HRDLK+ NLL+D+   VKV DFG+
Sbjct:   638 HKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGL 697

Query:   255 ARVQAQSGVMT-AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL 313
             +R++A + + + +  GT  WMAPEV+  +P + K+DV+SFG+ LWEL T + P+  L P 
Sbjct:   698 SRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA 757

Query:   314 QAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVL 369
             Q    V  K  R  IP++ +P++A ++E CW ++P +RP+F+ I D+L+ ++K  +
Sbjct:   758 QVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 813

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009744 "response to sucrose stimulus" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0010105 "negative regulation of ethylene mediated signaling pathway" evidence=TAS

GO:0010182 "sugar mediated signaling pathway" evidence=TAS

GO:0005789 "endoplasmic reticulum membrane" evidence=IDA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0009686 "gibberellin biosynthetic process" evidence=IMP

GO:0048510 "regulation of timing of transition from vegetative to reproductive phase" evidence=IMP

GO:2000035 "regulation of stem cell division" evidence=IMP

GO:2000069 "regulation of post-embryonic root development" evidence=IMP

GO:0071281 "cellular response to iron ion" evidence=IEP

GO:0009750 "response to fructose stimulus" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009723 "response to ethylene stimulus" evidence=IMP

DICTYBASE|DDB_G0289791 drkA "DRK subfamily protein kinase" [Dictyostelium discoideum (taxid:44689)]

 Score = 609 (219.4 bits), Expect = 2.2e-59, P = 2.2e-59
 Identities = 117/267 (43%), Positives = 172/267 (64%)

Query:   100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY 159
             DG D   ID  Q+KI  ++  G+YG++Y GT+   +VA+K L    +N  +LKEF +E+ 
Sbjct:   365 DGKD---IDIHQIKIGVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREIN 421

Query:   160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
             +M+ +RH NV+QF+G+C  PP++CI TE+M RGS+Y  LH Q    Q + L+K+ ID +K
Sbjct:   422 LMKNLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQLQWSLLIKMMIDAAK 481

Query:   220 GMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 277
             G+ YLH +   I+HRDLK+ NLL+DEN  VKVADFG++ ++ Q   MTA  GT  W +PE
Sbjct:   482 GVIYLHNSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQGATMTA-CGTPCWTSPE 540

Query:   278 VIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 337
             V+  + Y  KADV+SFGI LWE  T + PY G+ P Q    V ++ +RP +P++  P+  
Sbjct:   541 VLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPVPQNGPPKYI 600

Query:   338 ELLERCWQHDPTQRPNFSQITDILKQM 364
             +LL  C   +P+ RP   Q  + L+ +
Sbjct:   601 QLLIDCLNENPSHRPTMEQCLERLESI 627

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0044351 "macropinocytosis" evidence=RCA

TAIR|locus:2194055 AT1G18160 [Arabidopsis thaliana (taxid:3702)]

 Score = 612 (220.5 bits), Expect = 5.0e-59, P = 5.0e-59
 Identities = 115/266 (43%), Positives = 175/266 (65%)

Query:   106 EIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
             EI  +++ +  ++  GSYG++Y+G +    VA+K    + +  E L+EF  EV +MR++R
Sbjct:   709 EILWEEITVAERIGLGSYGEVYRGDWHGTAVAVKKFIDQDITGEALEEFRSEVRMMRRLR 768

Query:   166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
             H N+V F+GA TRPPNL IVTEF+ RGS+Y  +H+          L++A+D ++GMNYLH
Sbjct:   769 HPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPNNQLDERKRLRMALDAARGMNYLH 828

Query:   226 QNN--IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET-GTYRWMAPEVIEHK 282
               N  I+HRDLK+ NLL+D+N VVKV DFG++R++  + + +  T GT  WMAPEV+ ++
Sbjct:   829 SCNPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKVSTYLSSKSTAGTAEWMAPEVLRNE 888

Query:   283 PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER 342
             P D K DV+S+G+ LWEL T + P+  + P+Q    V  +  R  IP+   P +A+++ +
Sbjct:   889 PADEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGFQHRRLDIPEFVDPGIADIIRK 948

Query:   343 CWQHDPTQRPNFSQITDILKQMMKEV 368
             CWQ DP  RP+F +I D LKQ+ K +
Sbjct:   949 CWQTDPRLRPSFGEIMDSLKQLQKPI 974

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=IDA

DICTYBASE|DDB_G0289709 drkB "DRK subfamily protein kinase" [Dictyostelium discoideum (taxid:44689)]

 Score = 604 (217.7 bits), Expect = 7.3e-59, P = 7.3e-59
 Identities = 115/267 (43%), Positives = 173/267 (64%)

Query:   100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY 159
             DG D   ID +Q+KI  ++  G++G++Y GT+   +VA+K L    +N  +LKEF +E+ 
Sbjct:   382 DGKD---IDTQQIKIGVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREIN 438

Query:   160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
             +M+ +RH NV+QF+G+C   P++CI TE+M RGS+Y  LH +K     + + ++ ID +K
Sbjct:   439 LMKNLRHPNVIQFLGSCLISPDICICTEYMPRGSLYSILHNEKIKISWSLVKRMMIDAAK 498

Query:   220 GMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 277
             G+ YLH +   I+HRDLK+ NLL+DEN  VKVADFG++ ++ Q   MTA  GT  W +PE
Sbjct:   499 GIIYLHGSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQGATMTA-CGTPCWTSPE 557

Query:   278 VIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 337
             V+  + Y  KADV+SFGI LWE  T + PY G+ P Q    V ++ +RP  PK+  P+  
Sbjct:   558 VLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPTPKYGPPKYI 617

Query:   338 ELLERCWQHDPTQRPNFSQITDILKQM 364
             +LL+ C   +P+QRP   Q  +IL+ +
Sbjct:   618 QLLKDCLNENPSQRPTMEQCLEILESI 644

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: eugene3.01810006 hypothetical protein (587 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	395
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-91
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-91
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-89
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-83
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-74
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-72
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-65
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-64
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-63
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-63
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-62
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-61
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-61
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-61
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-58
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-57
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-56
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-56
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-54
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-54
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-54
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-52
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-52
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-52
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	5e-52
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-52
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	8e-52
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-51
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	6e-51
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	6e-51
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	9e-51
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-50
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-50
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-50
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-50
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-49
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-49
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-48
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-48
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-48
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-47
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-47
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-47
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-46
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	7e-46
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	8e-46
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-45
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-44
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-44
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-44
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-44
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-43
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	7e-43
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	9e-43
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-42
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-42
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	9e-42
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	7e-41
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-40
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-40
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-40
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-39
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-39
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-39
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-39
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-39
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	6e-39
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	8e-39
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-38
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-38
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-38
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-38
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-38
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	5e-38
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	5e-38
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-38
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	8e-38
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-37
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-37
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-37
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	7e-37
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	9e-37
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-36
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-36
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-36
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-36
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	6e-36
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	8e-36
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	8e-36
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-35
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-35
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	7e-35
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-34
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-34
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-34
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-34
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-34
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-34
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	7e-34
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-33
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-33
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-33
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-33
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	8e-33
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-32
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-32
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-32
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-32
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-32
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	5e-32
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	8e-32
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	9e-32
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	9e-32
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-31
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-31
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-31
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-31
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-31
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-31
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-31
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-31
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	6e-31
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	9e-31
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-30
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-30
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-30
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-30
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-30
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-30
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-30
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	7e-30
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	8e-30
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	9e-30
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-29
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-29
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-29
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-29
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-29
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-29
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-29
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	8e-29
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-28
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-28
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-28
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-28
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-28
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	6e-28
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	6e-28
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	8e-28
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-27
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-27
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-27
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-27
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	5e-27
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	6e-27
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	6e-27
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	8e-27
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	8e-27
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	9e-27
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-26
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-26
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-26
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-26
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-26
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	6e-26
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	6e-26
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	9e-26
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	6e-25
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	9e-25
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	9e-25
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-24
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-24
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-24
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-24
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-24
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	6e-24
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	9e-24
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-23
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	7e-22
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	8e-22
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	9e-22
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-21
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-21
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-21
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-21
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-21
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	4e-21
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	6e-21
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-20
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-20
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-20
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-20
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	5e-20
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	6e-20
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	8e-20
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-19
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-19
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-19
cd04928	68	cd04928, ACT_TyrKc, Uncharacterized, N-terminal AC	2e-19
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-19
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-19
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-19
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-19
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-19
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-19
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	6e-19
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	6e-19
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	6e-19
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	6e-19
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	7e-19
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	9e-19
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-18
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-18
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-18
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-18
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-18
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-18
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-18
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-18
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-18
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	6e-18
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	6e-18
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	7e-18
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	7e-18
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	8e-18
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	8e-18
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-17
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-17
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-17
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-17
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-17
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-17
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	4e-17
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-17
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	6e-17
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	9e-17
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-16
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-16
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-16
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-16
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	6e-16
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	7e-16
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	7e-16
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	8e-16
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	9e-16
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	9e-16
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-15
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-15
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-15
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-15
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-15
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-15
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-15
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-15
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-15
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-15
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	5e-15
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-15
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	5e-15
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	6e-15
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	9e-15
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-14
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-14
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-14
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-14
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-14
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-14
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-14
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	4e-14
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-14
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	5e-14
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	7e-14
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	7e-14
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	9e-14
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-13
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-13
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-13
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-13
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-13
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	5e-13
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	6e-13
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	6e-13
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	6e-13
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-12
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-12
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-12
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-12
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-11
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-11
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	6e-11
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	6e-11
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	6e-11
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	7e-11
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	7e-11
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	9e-11
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-10
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-10
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-10
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	7e-10
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-09
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-09
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-09
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-09
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	3e-09
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	4e-09
cd04900	73	cd04900, ACT_UUR-like_1, ACT domain family, ACT_UU	5e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-07
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	4e-07
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	8e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	6e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	7e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-05
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	3e-04
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	9e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.001
cd04873	70	cd04873, ACT_UUR-ACR-like, ACT domains of the bact	0.002
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.003

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  275 bits (705), Expect = 2e-91
 Identities = 97/259 (37%), Positives = 147/259 (56%), Gaps = 11/259 (4%)

Query: 112 LKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
           L +  K+  G++G++YKG           EVA+K LK +  + + ++EF +E  IMRK+ 
Sbjct: 1   LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA-SEQQIEEFLREARIMRKLD 59

Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
           H NVV+ +G CT    L IV E+M  G +  +L K +    L+ LL  A+ +++GM YL 
Sbjct: 60  HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119

Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETG--TYRWMAPEVIEHKP 283
             N IHRDL   N L+ EN VVK++DFG++R            G    RWMAPE ++   
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179

Query: 284 YDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER 342
           +  K+DV+SFG+ LWE+ T GE PY G++  +  +  ++   R   P +  P L +L+ +
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-VLEYLKNGYRLPQPPNCPPELYDLMLQ 238

Query: 343 CWQHDPTQRPNFSQITDIL 361
           CW  DP  RP FS++ +IL
Sbjct: 239 CWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  274 bits (704), Expect = 3e-91
 Identities = 97/260 (37%), Positives = 151/260 (58%), Gaps = 12/260 (4%)

Query: 112 LKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
           L++  K+  G++G++YKGT          +VA+K LK      E  +EF +E  IM+K+ 
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASE-EEREEFLEEASIMKKLS 59

Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
           H N+V+ +G CT+   L IVTE+M  G + DFL K      L  LL++A+ ++KGM YL 
Sbjct: 60  HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119

Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVIEHK 282
             N +HRDL   N L+ EN VVK++DFG++R   +        G     +WMAPE ++  
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDG 179

Query: 283 PYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE 341
            +  K+DV+SFG+ LWE+ T GE PY G++  +  + +++   R   P++    L EL+ 
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-VLELLEDGYRLPRPENCPDELYELML 238

Query: 342 RCWQHDPTQRPNFSQITDIL 361
           +CW +DP  RP FS++ + L
Sbjct: 239 QCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  270 bits (694), Expect = 1e-89
 Identities = 99/260 (38%), Positives = 150/260 (57%), Gaps = 12/260 (4%)

Query: 112 LKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
           L +  K+  G++G++YKGT          EVA+K LK +  + + ++EF +E  IMRK+ 
Sbjct: 1   LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDA-SEQQIEEFLREARIMRKLD 59

Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTS-LLKVAIDVSKGMNYL 224
           H N+V+ +G CT    L IV E+M  G + D+L K +      S LL  A+ +++GM YL
Sbjct: 60  HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119

Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETG--TYRWMAPEVIEHK 282
              N IHRDL   N L+ EN VVK++DFG++R          + G    RWMAPE ++  
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEG 179

Query: 283 PYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE 341
            +  K+DV+SFG+ LWE+ T GE PY G++  +  +  ++K  R   P +  P L +L+ 
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE-VLEYLKKGYRLPKPPNCPPELYKLML 238

Query: 342 RCWQHDPTQRPNFSQITDIL 361
           +CW  DP  RP FS++ +IL
Sbjct: 239 QCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  254 bits (651), Expect = 4e-83
 Identities = 97/260 (37%), Positives = 145/260 (55%), Gaps = 19/260 (7%)

Query: 120 SGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
            G++G++YKG        + EVA+K LK E  + E  K+F +E  +M+K+ H NVV+ +G
Sbjct: 5   EGAFGEVYKGKLKGKDGKTTEVAVKTLK-EDASEEERKDFLKEARVMKKLGHPNVVRLLG 63

Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTS--------LLKVAIDVSKGMNYLHQ 226
            CT    L +V E+M  G + D+L K + VF            LL  AI ++KGM YL  
Sbjct: 64  VCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS 123

Query: 227 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVIEHKP 283
              +HRDL   N L+ E+ VVK++DFG++R          +TG     RWMAPE ++   
Sbjct: 124 KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGI 183

Query: 284 YDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER 342
           +  K+DV+SFG+ LWE+ T G  PY GL+  +  +  ++K  R   P++    L EL+  
Sbjct: 184 FTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-VLEYLRKGYRLPKPEYCPDELYELMLS 242

Query: 343 CWQHDPTQRPNFSQITDILK 362
           CWQ DP  RP FS++ + L+
Sbjct: 243 CWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  232 bits (594), Expect = 1e-74
 Identities = 91/250 (36%), Positives = 144/250 (57%), Gaps = 10/250 (4%)

Query: 117 KVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           K+ SGS+G +YK  +    + VA+K+LK     ++  +   +E+ I+R++ H N+V+ I 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           A     +L +V E+   G ++D+L +  G        K+A+ + +G+ YLH N IIHRDL
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYLSR-GGPLSEDEAKKIALQILRGLEYLHSNGIIHRDL 124

Query: 235 KTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEVI-EHKPYDYKADVFS 292
           K  N+L+DENGVVK+ADFG+A+   +S   +T   GT  +MAPEV+     Y  K DV+S
Sbjct: 125 KPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWS 184

Query: 293 FGIALWELLTGELPYAG---LTPLQAAVGVVQKSLRPTIPKH--AHPRLAELLERCWQHD 347
            G+ L+ELLTG+ P++G   L  LQ    ++   L    PK         +L+++C   D
Sbjct: 185 LGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKD 244

Query: 348 PTQRPNFSQI 357
           P++RP   +I
Sbjct: 245 PSKRPTAEEI 254

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  225 bits (577), Expect = 4e-72
 Identities = 78/249 (31%), Positives = 123/249 (49%), Gaps = 6/249 (2%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           +I  K+  GS+G +Y        + VAIKV+K +    +  +   +E+ I++K++H N+V
Sbjct: 2   EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKK-KIKKDRERILREIKILKKLKHPNIV 60

Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
           +          L +V E+   G ++D L K +G             +   + YLH   I+
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLHSKGIV 119

Query: 231 HRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADV 290
           HRDLK  N+L+DE+G VK+ADFG+AR       +T   GT  +MAPEV+  K Y    D+
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDI 179

Query: 291 FSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH--PRLAELLERCWQHDP 348
           +S G+ L+ELLTG+ P+ G   L      + K   P  P      P   +L+ +    DP
Sbjct: 180 WSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDP 239

Query: 349 TQRPNFSQI 357
            +R    + 
Sbjct: 240 EKRLTAEEA 248

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  207 bits (528), Expect = 2e-65
 Identities = 76/247 (30%), Positives = 130/247 (52%), Gaps = 39/247 (15%)

Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
            G +G +Y        ++VAIK++K E  ++ +L+E  +E+ I++K+ H N+V+  G   
Sbjct: 3   EGGFGTVYLARDKKTGKKVAIKIIKKE-DSSSLLEELLREIEILKKLNHPNIVKLYGVFE 61

Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
              +L +V E+   GS+ D L + +G      +L++ + + +G+ YLH N IIHRDLK  
Sbjct: 62  DENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPE 121

Query: 238 NLLMDE-NGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVIEHKP-YDYKADVFSFG 294
           N+L+D  NG VK+ADFG+++ + +   ++    GT  +MAPEV+  K  Y  K+D++S G
Sbjct: 122 NILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLG 181

Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 354
           + L+EL                                 P L +L+ +  Q DP +RP+ 
Sbjct: 182 VILYEL---------------------------------PELKDLIRKMLQKDPEKRPSA 208

Query: 355 SQITDIL 361
            +I + L
Sbjct: 209 KEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  205 bits (523), Expect = 5e-64
 Identities = 88/240 (36%), Positives = 137/240 (57%), Gaps = 7/240 (2%)

Query: 117 KVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           K+  G +G++YK  +    +EVAIKV+K E  + E  ++   E+ I++K +H N+V++ G
Sbjct: 7   KIGKGGFGEVYKARHKRTGKEVAIKVIKLE--SKEKKEKIINEIQILKKCKHPNIVKYYG 64

Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +  +   L IV EF + GS+ D L         + +  V  ++ KG+ YLH N IIHRD+
Sbjct: 65  SYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDI 124

Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           K AN+L+  +G VK+ DFG++   + +       GT  WMAPEVI  KPYDYKAD++S G
Sbjct: 125 KAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLG 184

Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELLERCWQHDPTQRP 352
           I   EL  G+ PY+ L P++A   +      P +  P+       + L++C Q +P +RP
Sbjct: 185 ITAIELAEGKPPYSELPPMKALFKIATNGP-PGLRNPEKWSDEFKDFLKKCLQKNPEKRP 243

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  204 bits (521), Expect = 1e-63
 Identities = 79/254 (31%), Positives = 130/254 (51%), Gaps = 9/254 (3%)

Query: 111 QLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN 168
           +      +  GS+G +Y        + +A+K ++    + E L+   +E+ I+  ++H N
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 169 VVQFIGAC-TRPPN-LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 226
           +V++ G+      N L I  E+++ GS+   L K  G      + K    + +G+ YLH 
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK-FGKLPEPVIRKYTRQILEGLAYLHS 119

Query: 227 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET---GTYRWMAPEVIEHKP 283
           N I+HRD+K AN+L+D +GVVK+ADFG A+               GT  WMAPEVI  + 
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179

Query: 284 YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-LRPTIPKHAHPRLAELLER 342
           Y   AD++S G  + E+ TG+ P++ L    AA+  +  S   P IP+H      + L +
Sbjct: 180 YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRK 239

Query: 343 CWQHDPTQRPNFSQ 356
           C + DP +RP   +
Sbjct: 240 CLRRDPKKRPTADE 253

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  203 bits (518), Expect = 3e-63
 Identities = 94/256 (36%), Positives = 142/256 (55%), Gaps = 11/256 (4%)

Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
           WEID   +++  K+ +G +G++++G +  +  VA+K LKP    T   K+F  E  IM+K
Sbjct: 1   WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKP---GTMDPKDFLAEAQIMKK 57

Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMN 222
           +RH  ++Q    CT    + IVTE M  GS+ ++L    G   +L  L+ +A  V+ GM 
Sbjct: 58  LRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMA 117

Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVI 279
           YL   N IHRDL   N+L+ EN + KVADFG+ARV  +  +  A  G     +W APE  
Sbjct: 118 YLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED-IYEAREGAKFPIKWTAPEAA 176

Query: 280 EHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE 338
            +  +  K+DV+SFGI L E++T G +PY G+T  +  +  V +  R   P      L +
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-VLQQVDQGYRMPCPPGCPKELYD 235

Query: 339 LLERCWQHDPTQRPNF 354
           ++  CW+ DP  RP F
Sbjct: 236 IMLDCWKEDPDDRPTF 251

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  201 bits (512), Expect = 2e-62
 Identities = 98/257 (38%), Positives = 154/257 (59%), Gaps = 12/257 (4%)

Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 164
           W I++K+LK+   +  G +GD+  G Y  Q+VA+K LK    ++   + F  E  +M  +
Sbjct: 1   WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKD---DSTAAQAFLAEASVMTTL 57

Query: 165 RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLH-KQKGVFQLTSLLKVAIDVSKGMNY 223
           RH N+VQ +G   +   L IVTE+MA+GS+ D+L  + + V  L   L  A+DV +GM Y
Sbjct: 58  RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEY 117

Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIEH 281
           L + N +HRDL   N+L+ E+ V KV+DFG+A+ +A  G    ++G    +W APE +  
Sbjct: 118 LEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK-EASQGQ---DSGKLPVKWTAPEALRE 173

Query: 282 KPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELL 340
           K +  K+DV+SFGI LWE+ + G +PY  + PL+  V  V+K  R   P+   P + +++
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPHVEKGYRMEAPEGCPPEVYKVM 232

Query: 341 ERCWQHDPTQRPNFSQI 357
           + CW+ DP +RP F Q+
Sbjct: 233 KDCWELDPAKRPTFKQL 249

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  199 bits (507), Expect = 1e-61
 Identities = 100/265 (37%), Positives = 154/265 (58%), Gaps = 11/265 (4%)

Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
           WEI  + LK+E K+ +G +G+++ GT+  + +VA+K LKP  ++ E    F QE  IM+K
Sbjct: 1   WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE---AFLQEAQIMKK 57

Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ-LTSLLKVAIDVSKGMN 222
           +RH  +VQ    C+    + IVTE+M++GS+ DFL   +G    L  L+ +A  +++GM 
Sbjct: 58  LRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMA 117

Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVI 279
           YL   N IHRDL   N+L+ EN V K+ADFG+AR+       TA  G     +W APE  
Sbjct: 118 YLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD-EYTAREGAKFPIKWTAPEAA 176

Query: 280 EHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE 338
            +  +  K+DV+SFGI L E++T G +PY G+T  +  +  V++  R   P +    L +
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-VLEQVERGYRMPRPPNCPEELYD 235

Query: 339 LLERCWQHDPTQRPNFSQITDILKQ 363
           L+ +CW  DP +RP F  +   L+ 
Sbjct: 236 LMLQCWDKDPEERPTFEYLQSFLED 260

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  198 bits (504), Expect = 3e-61
 Identities = 89/262 (33%), Positives = 144/262 (54%), Gaps = 14/262 (5%)

Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
           ID  +L    ++ SG +G ++ G +  + +VAIK+++   ++ +   +F +E  +M K+ 
Sbjct: 1   IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLS 57

Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
           H N+VQ  G CT+   + IVTE+MA G + ++L ++KG      LL +  DV + M YL 
Sbjct: 58  HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE 117

Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVAR--VQAQSGVMTAETGT---YRWMAPEVIE 280
            N  IHRDL   N L+ E+ VVKV+DFG+AR  +  Q    T+  GT    +W  PEV +
Sbjct: 118 SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ---YTSSQGTKFPVKWAPPEVFD 174

Query: 281 HKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
           +  +  K+DV+SFG+ +WE+ + G++PY   +  +  V  V    R   PK A   +  +
Sbjct: 175 YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-VVESVSAGYRLYRPKLAPTEVYTI 233

Query: 340 LERCWQHDPTQRPNFSQITDIL 361
           +  CW   P  RP F ++   L
Sbjct: 234 MYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  198 bits (504), Expect = 3e-61
 Identities = 98/267 (36%), Positives = 156/267 (58%), Gaps = 12/267 (4%)

Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 162
           WE++   + ++ K+  G YG++Y+G +   S  VA+K LK +   T  ++EF +E  +M+
Sbjct: 1   WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMK 57

Query: 163 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSKGM 221
           +I+H N+VQ +G CTR P   I+TEFM  G++ D+L +  +       LL +A  +S  M
Sbjct: 58  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 117

Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEV 278
            YL + N IHRDL   N L+ EN +VKVADFG++R+       TA  G     +W APE 
Sbjct: 118 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPES 176

Query: 279 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 337
           + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K  R   P+   P++ 
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKGYRMERPEGCPPKVY 235

Query: 338 ELLERCWQHDPTQRPNFSQITDILKQM 364
           EL+  CWQ +P+ RP+F++I    + M
Sbjct: 236 ELMRACWQWNPSDRPSFAEIHQAFETM 262

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  190 bits (485), Expect = 2e-58
 Identities = 92/250 (36%), Positives = 141/250 (56%), Gaps = 7/250 (2%)

Query: 111 QLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN 168
             ++   +  G++G +YKG        VAIK +  E +  E LK   QE+ +++ ++H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 169 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQN 227
           +V++IG+     +L I+ E+   GS+   + K+ G F   SL+ V +  V +G+ YLH+ 
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQII-KKFGPFP-ESLVAVYVYQVLQGLAYLHEQ 118

Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDY 286
            +IHRD+K AN+L  ++GVVK+ADFGVA ++   S    +  GT  WMAPEVIE      
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAST 178

Query: 287 KADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH 346
            +D++S G  + ELLTG  PY  L P+ A   +VQ    P +P+   P L + L +C+Q 
Sbjct: 179 ASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD-HPPLPEGISPELKDFLMQCFQK 237

Query: 347 DPTQRPNFSQ 356
           DP  RP   Q
Sbjct: 238 DPNLRPTAKQ 247

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  188 bits (480), Expect = 1e-57
 Identities = 85/254 (33%), Positives = 146/254 (57%), Gaps = 7/254 (2%)

Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
           WE   ++  +E K+ SG +G++++G +     VAIK+LK +  +    ++F +EV  +++
Sbjct: 1   WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD--DLLKQQDFQKEVQALKR 58

Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMN 222
           +RHK+++     C+    + I+TE M +GS+  FL   +G V  + SL+ +A  V++GM 
Sbjct: 59  LRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMA 118

Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT-YRWMAPEVIEH 281
           YL + N IHRDL   N+L+ E+ V KVADFG+AR+  +   ++++    Y+W APE   H
Sbjct: 119 YLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASH 178

Query: 282 KPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELL 340
             +  K+DV+SFGI L+E+ T G++PY G+         +    R   P      + +++
Sbjct: 179 GTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-NHEVYDQITAGYRMPCPAKCPQEIYKIM 237

Query: 341 ERCWQHDPTQRPNF 354
             CW  +P  RP+F
Sbjct: 238 LECWAAEPEDRPSF 251

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  186 bits (473), Expect = 1e-56
 Identities = 87/252 (34%), Positives = 144/252 (57%), Gaps = 9/252 (3%)

Query: 117 KVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           K+  G++GD+YKG      EVA+K  +      ++ ++F QE  I+++  H N+V+ IG 
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGV 60

Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
           C +   + IV E +  GS+  FL K+K    +  LL++++D + GM YL   N IHRDL 
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLA 120

Query: 236 TANLLMDENGVVKVADFGVARVQAQSGVMTAETGT----YRWMAPEVIEHKPYDYKADVF 291
             N L+ EN V+K++DFG++R + + G+ T   G      +W APE + +  Y  ++DV+
Sbjct: 121 ARNCLVGENNVLKISDFGMSR-EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVW 179

Query: 292 SFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ 350
           S+GI LWE  + G+ PY G++  Q     ++   R   P+     +  L+ +CW +DP  
Sbjct: 180 SYGILLWETFSLGDTPYPGMSNQQTR-ERIESGYRMPAPQLCPEEIYRLMLQCWAYDPEN 238

Query: 351 RPNFSQITDILK 362
           RP+FS+I + L+
Sbjct: 239 RPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  185 bits (472), Expect = 2e-56
 Identities = 92/267 (34%), Positives = 143/267 (53%), Gaps = 11/267 (4%)

Query: 107 IDAKQLKIECKVASGSYGDLYKGTY---CSQE--VAIKVLKPECVNTEMLKEFSQEVYIM 161
           ID   + IE  +  G +G++ +G       +E  VAIK LK    + + L +F  E  IM
Sbjct: 1   IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL-DFLTEASIM 59

Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
            +  H N+++  G  T+   + I+TE+M  GS+  FL +  G F +  L+ +   ++ GM
Sbjct: 60  GQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGM 119

Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETG--TYRWMAPEV 278
            YL + N +HRDL   N+L++ N V KV+DFG++R    S    T + G    RW APE 
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEA 179

Query: 279 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 337
           I ++ +   +DV+SFGI +WE+++ GE PY  ++  Q  +  V+   R   P      L 
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-QDVIKAVEDGYRLPPPMDCPSALY 238

Query: 338 ELLERCWQHDPTQRPNFSQITDILKQM 364
           +L+  CWQ D  +RP FSQI   L +M
Sbjct: 239 QLMLDCWQKDRNERPTFSQIVSTLDKM 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  180 bits (457), Expect = 2e-54
 Identities = 94/263 (35%), Positives = 151/263 (57%), Gaps = 10/263 (3%)

Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 164
           W ++ K+LK+   +  G +GD+  G Y   +VA+K +K    N    + F  E  +M ++
Sbjct: 1   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQL 56

Query: 165 RHKNVVQFIGACTRPP-NLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMN 222
           RH N+VQ +G        L IVTE+MA+GS+ D+L  + + V     LLK ++DV + M 
Sbjct: 57  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 116

Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK 282
           YL  NN +HRDL   N+L+ E+ V KV+DFG+ + +A S   T +    +W APE +  K
Sbjct: 117 YLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK-EASSTQDTGKLPV-KWTAPEALREK 174

Query: 283 PYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE 341
            +  K+DV+SFGI LWE+ + G +PY  + PL+  V  V+K  +   P    P + ++++
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPVVYDVMK 233

Query: 342 RCWQHDPTQRPNFSQITDILKQM 364
           +CW  D   RP+F Q+ + L+ +
Sbjct: 234 QCWHLDAATRPSFLQLREQLEHI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  179 bits (456), Expect = 3e-54
 Identities = 91/256 (35%), Positives = 144/256 (56%), Gaps = 10/256 (3%)

Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
           I   +L +  ++ SG +G ++ G +  + +VAIK ++   ++ E   +F +E  +M K+ 
Sbjct: 1   IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLS 57

Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
           H  +VQ  G CT    +C+V EFM  G + D+L  Q+G F   +LL + +DV +GM YL 
Sbjct: 58  HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE 117

Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVIEHK 282
            +N+IHRDL   N L+ EN VVKV+DFG+ R        T+ TGT    +W +PEV    
Sbjct: 118 SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWSSPEVFSFS 176

Query: 283 PYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE 341
            Y  K+DV+SFG+ +WE+ + G+ PY   +  +  V  +    R   P+ A   + EL++
Sbjct: 177 KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-VVETINAGFRLYKPRLASQSVYELMQ 235

Query: 342 RCWQHDPTQRPNFSQI 357
            CW+  P  RP+FS +
Sbjct: 236 HCWKERPEDRPSFSLL 251

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  179 bits (457), Expect = 3e-54
 Identities = 73/254 (28%), Positives = 136/254 (53%), Gaps = 12/254 (4%)

Query: 117 KVASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           ++  GS+G   L +     +   +K +    ++ +  ++   EV I++K+ H N++++  
Sbjct: 7   QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66

Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTS---LLKVAIDVSKGMNYLHQNNIIH 231
           +      LCIV E+   G +   + KQK   +      +L   + +   + YLH   I+H
Sbjct: 67  SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILH 126

Query: 232 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKAD 289
           RD+K  N+ +  NG+VK+ DFG+++V + +  + A+T  GT  +++PE+ ++KPY+YK+D
Sbjct: 127 RDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL-AKTVVGTPYYLSPELCQNKPYNYKSD 185

Query: 290 VFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPT 349
           ++S G  L+EL T + P+ G   L+ A+ +++    P IP      L  L+    Q DP 
Sbjct: 186 IWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP-IPSQYSSELRNLVSSLLQKDPE 244

Query: 350 QRPNFSQITDILKQ 363
           +RP+   I  IL+ 
Sbjct: 245 ERPS---IAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  174 bits (444), Expect = 2e-52
 Identities = 84/248 (33%), Positives = 132/248 (53%), Gaps = 18/248 (7%)

Query: 114 IECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQ 171
           I  K+  GSYG +YK  +    Q VAIKV+  E    E++KE S    I+++     +V+
Sbjct: 7   ILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEIS----ILKQCDSPYIVK 62

Query: 172 FIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF---QLTSLLKVAIDVSKGMNYLHQNN 228
           + G+  +  +L IV E+   GS+ D +          ++ ++L       KG+ YLH N 
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILY---QTLKGLEYLHSNK 119

Query: 229 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDY 286
            IHRD+K  N+L++E G  K+ADFGV+  Q    +    T  GT  WMAPEVI+   Y+ 
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSG-QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNN 178

Query: 287 KADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT--IPKHAHPRLAELLERCW 344
           KAD++S GI   E+  G+ PY+ + P++A   ++     PT   P+   P   + +++C 
Sbjct: 179 KADIWSLGITAIEMAEGKPPYSDIHPMRAIF-MIPNKPPPTLSDPEKWSPEFNDFVKKCL 237

Query: 345 QHDPTQRP 352
             DP +RP
Sbjct: 238 VKDPEERP 245

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  174 bits (443), Expect = 3e-52
 Identities = 98/264 (37%), Positives = 156/264 (59%), Gaps = 12/264 (4%)

Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
           WEI  + L++E K+  G +G+++ GT+  +  VAIK LKP  ++ E    F QE  +M+K
Sbjct: 1   WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKK 57

Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKGMN 222
           +RH+ +VQ     +  P + IVTE+M++GS+ DFL  + G + +L  L+ +A  ++ GM 
Sbjct: 58  LRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 116

Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVI 279
           Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE  
Sbjct: 117 YVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAA 175

Query: 280 EHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE 338
            +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L +
Sbjct: 176 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESLHD 234

Query: 339 LLERCWQHDPTQRPNFSQITDILK 362
           L+ +CW+ +P +RP F  +   L+
Sbjct: 235 LMCQCWRKEPEERPTFEYLQAFLE 258

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score =  174 bits (441), Expect = 5e-52
 Identities = 101/264 (38%), Positives = 156/264 (59%), Gaps = 12/264 (4%)

Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
           WEI  + L+++ K+  G +G+++ GT+  + +VAIK LKP    T M + F QE  IM+K
Sbjct: 1   WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKP---GTMMPEAFLQEAQIMKK 57

Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKGMN 222
           +RH  +V      +  P + IVTEFM +GS+ DFL +  G + +L  L+ +A  ++ GM 
Sbjct: 58  LRHDKLVPLYAVVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMA 116

Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVI 279
           Y+ + N IHRDL+ AN+L+ +N V K+ADFG+AR+  +    TA  G     +W APE  
Sbjct: 117 YIERMNYIHRDLRAANILVGDNLVCKIADFGLARL-IEDNEYTARQGAKFPIKWTAPEAA 175

Query: 280 EHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE 338
            +  +  K+DV+SFGI L EL+T G +PY G+   +  +  V++  R   P+     L E
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN-REVLEQVERGYRMPCPQGCPESLHE 234

Query: 339 LLERCWQHDPTQRPNFSQITDILK 362
           L++ CW+ DP +RP F  I   L+
Sbjct: 235 LMKLCWKKDPDERPTFEYIQSFLE 258

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  174 bits (443), Expect = 5e-52
 Identities = 86/261 (32%), Positives = 129/261 (49%), Gaps = 36/261 (13%)

Query: 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK 167
           +   +   +  GS+G++YK      +Q VAIKV+  E    E+ ++  QE+  + + R  
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEI-EDIQQEIQFLSQCRSP 59

Query: 168 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN 227
            + ++ G+  +   L I+ E+   GS  D L  + G    T +  +  +V  G+ YLH+ 
Sbjct: 60  YITKYYGSFLKGSKLWIIMEYCGGGSCLDLL--KPGKLDETYIAFILREVLLGLEYLHEE 117

Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET-------GTYRWMAPEVIE 280
             IHRD+K AN+L+ E G VK+ADFGV      SG +T+         GT  WMAPEVI+
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGV------SGQLTSTMSKRNTFVGTPFWMAPEVIK 171

Query: 281 HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA--- 337
              YD KAD++S GI   EL  GE P + L P+        + L   IPK+  P L    
Sbjct: 172 QSGYDEKADIWSLGITAIELAKGEPPLSDLHPM--------RVLF-LIPKNNPPSLEGNK 222

Query: 338 ------ELLERCWQHDPTQRP 352
                 + +  C   DP +RP
Sbjct: 223 FSKPFKDFVSLCLNKDPKERP 243

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  174 bits (441), Expect = 6e-52
 Identities = 97/264 (36%), Positives = 158/264 (59%), Gaps = 12/264 (4%)

Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
           WEI  + L++  K+ +G +G+++ GT+  + +VA+K LKP  ++ E    F +E  IM+K
Sbjct: 1   WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE---SFLEEAQIMKK 57

Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMN 222
           +RH  +VQ     +  P + IVTE+M++GS+ DFL   +G   +L +L+ +A  V+ GM 
Sbjct: 58  LRHDKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMA 116

Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVI 279
           Y+ + N IHRDL++AN+L+ +  V K+ADFG+AR+  +    TA  G     +W APE  
Sbjct: 117 YIERMNYIHRDLRSANILVGDGLVCKIADFGLARL-IEDNEYTARQGAKFPIKWTAPEAA 175

Query: 280 EHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE 338
            +  +  K+DV+SFGI L EL+T G +PY G+   +  +  V++  R   P+     L E
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-REVLEQVERGYRMPCPQDCPISLHE 234

Query: 339 LLERCWQHDPTQRPNFSQITDILK 362
           L+ +CW+ DP +RP F  +   L+
Sbjct: 235 LMLQCWKKDPEERPTFEYLQSFLE 258

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score =  173 bits (441), Expect = 8e-52
 Identities = 84/271 (30%), Positives = 138/271 (50%), Gaps = 11/271 (4%)

Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVY 159
           +EI  + + +   +  G +GD+Y+G Y S E     VA+K  K     +   K F QE Y
Sbjct: 1   YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAY 59

Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           IMR+  H ++V+ IG  T  P + IV E    G +  +L   K    L SL+  +  +S 
Sbjct: 60  IMRQFDHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLST 118

Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPE 277
            + YL     +HRD+   N+L+     VK+ DFG++R         A  G    +WMAPE
Sbjct: 119 ALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178

Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
            I  + +   +DV+ FG+ +WE+L  G  P+ G+      +G ++   R  +P +  P L
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN-NDVIGRIENGERLPMPPNCPPTL 237

Query: 337 AELLERCWQHDPTQRPNFSQITDILKQMMKE 367
             L+ +CW +DP++RP F+++   L  +++E
Sbjct: 238 YSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  172 bits (438), Expect = 5e-51
 Identities = 83/248 (33%), Positives = 131/248 (52%), Gaps = 13/248 (5%)

Query: 117 KVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           K+  G+ G++YK T  +  +EVAIK ++    N E++     E+ IM+  +H N+V +  
Sbjct: 26  KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEILIMKDCKHPNIVDYYD 82

Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +      L +V E+M  GS+ D + +         +  V  +V +G+ YLH  N+IHRD+
Sbjct: 83  SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDI 142

Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFS 292
           K+ N+L+ ++G VK+ADFG A  Q         +  GT  WMAPEVI+ K Y  K D++S
Sbjct: 143 KSDNILLSKDGSVKLADFGFA-AQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWS 201

Query: 293 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH---PRLAELLERCWQHDPT 349
            GI   E+  GE PY    PL+A   +  K + P   K+     P   + L +C   DP 
Sbjct: 202 LGIMCIEMAEGEPPYLREPPLRALFLITTKGIPP--LKNPEKWSPEFKDFLNKCLVKDPE 259

Query: 350 QRPNFSQI 357
           +RP+  ++
Sbjct: 260 KRPSAEEL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  171 bits (434), Expect = 6e-51
 Identities = 87/261 (33%), Positives = 156/261 (59%), Gaps = 10/261 (3%)

Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 164
           W ++ ++L +   +  G +G + +G Y  Q+VA+K +K  C  T   + F +E  +M K+
Sbjct: 1   WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIK--CDVTA--QAFLEETAVMTKL 56

Query: 165 RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNY 223
            HKN+V+ +G       L IV E M++G++ +FL  + + +  +  LL+ ++DV++GM Y
Sbjct: 57  HHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEY 115

Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKP 283
           L    ++HRDL   N+L+ E+GV KV+DFG+ARV +  GV  ++    +W APE ++HK 
Sbjct: 116 LESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM-GVDNSKLPV-KWTAPEALKHKK 173

Query: 284 YDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER 342
           +  K+DV+S+G+ LWE+ + G  PY  ++ L+     V+K  R   P+     +  L+  
Sbjct: 174 FSSKSDVWSYGVLLWEVFSYGRAPYPKMS-LKEVKECVEKGYRMEPPEGCPADVYVLMTS 232

Query: 343 CWQHDPTQRPNFSQITDILKQ 363
           CW+ +P +RP+F ++ + L++
Sbjct: 233 CWETEPKKRPSFHKLREKLEK 253

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  171 bits (434), Expect = 6e-51
 Identities = 80/256 (31%), Positives = 137/256 (53%), Gaps = 13/256 (5%)

Query: 117 KVASGSYGDLYKGTYCSQ-----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQ 171
           K+  GS+G + +G + +       VA+K LK + + ++++ +F +E  IM  + H+N+++
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL-SDIMDDFLKEAAIMHSLDHENLIR 60

Query: 172 FIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
             G     P L +VTE    GS+ D L K   G F +++L   A+ ++ GM YL     I
Sbjct: 61  LYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFI 119

Query: 231 HRDLKTANLLMDENGVVKVADFGVARVQAQSG---VMTAETGT-YRWMAPEVIEHKPYDY 286
           HRDL   N+L+  +  VK+ DFG+ R   Q+    VM       + W APE +  + + +
Sbjct: 120 HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSH 179

Query: 287 KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 345
            +DV+ FG+ LWE+ T GE P+AGL+  Q    + ++  R   P+     +  ++ +CW 
Sbjct: 180 ASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWA 239

Query: 346 HDPTQRPNFSQITDIL 361
           H+P  RP F+ + + L
Sbjct: 240 HNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  170 bits (433), Expect = 9e-51
 Identities = 87/263 (33%), Positives = 151/263 (57%), Gaps = 10/263 (3%)

Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
           WE+  + LK+  K+ +G +G+++ G Y    +VAIK LK   ++ E    F  E  +M++
Sbjct: 1   WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE---AFLAEANLMKQ 57

Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMN 222
           ++H  +V+     T+ P + I+TE+M  GS+ DFL   +G+   +  L+ +A  +++GM 
Sbjct: 58  LQHPRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMA 116

Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIE 280
           ++ + N IHRDL+ AN+L+ E    K+ADFG+AR+   +     E   +  +W APE I 
Sbjct: 117 FIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 176

Query: 281 HKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
           +  +  K+DV+SFGI L E++T G +PY G+T  +  +  +++  R   P +    L EL
Sbjct: 177 YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE-VIQNLERGYRMPRPDNCPEELYEL 235

Query: 340 LERCWQHDPTQRPNFSQITDILK 362
           +  CW+  P +RP F  +  +L+
Sbjct: 236 MRLCWKEKPEERPTFEYLRSVLE 258

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  170 bits (433), Expect = 1e-50
 Identities = 85/259 (32%), Positives = 141/259 (54%), Gaps = 8/259 (3%)

Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
           I+  +L    ++ SG +G ++ G + +Q +VAIK +    ++ E   +F +E  +M K+ 
Sbjct: 1   INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLS 57

Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
           H  +VQ  G CT+   L IVTEFM  G + ++L +++G      LL +  DV +GM YL 
Sbjct: 58  HPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE 117

Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIEHKP 283
           +N+ IHRDL   N L+   GVVKV+DFG+ R        ++    +  +W  PEV     
Sbjct: 118 RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSK 177

Query: 284 YDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER 342
           Y  K+DV+SFG+ +WE+ T G++P+   +  +  V ++ +  R   PK A   + E++  
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE-VVEMISRGFRLYRPKLASMTVYEVMYS 236

Query: 343 CWQHDPTQRPNFSQITDIL 361
           CW   P  RP F+++   +
Sbjct: 237 CWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  171 bits (434), Expect = 2e-50
 Identities = 76/288 (26%), Positives = 134/288 (46%), Gaps = 41/288 (14%)

Query: 110 KQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
           + LK   ++  G +G +    Y         +VA+K L           +F +E+ I+R 
Sbjct: 4   RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHR-SDFEREIEILRT 62

Query: 164 IRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
           + H+N+V++ G C +P   +L ++ E++  GS+ D+L + +    L  LL  +  + KGM
Sbjct: 63  LDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGM 122

Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG----VMTAETGTYRWMAPE 277
           +YL     IHRDL   N+L++   +VK++DFG+A+V  +      V         W APE
Sbjct: 123 DYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182

Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
            +    +   +DV+SFG+ L+EL T G+       P Q+      + +     +    RL
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGD-------PSQSPPAEFLRMIGIAQGQMIVTRL 235

Query: 337 AELLE--------------------RCWQHDPTQRPNFSQITDILKQM 364
            ELL+                     CW+ +P  RP+F+ +  I+ ++
Sbjct: 236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  169 bits (430), Expect = 3e-50
 Identities = 86/262 (32%), Positives = 152/262 (58%), Gaps = 9/262 (3%)

Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
           WEI  + +K+  K+ +G +G+++ G Y  S +VA+K LKP    T  ++ F +E  +M+ 
Sbjct: 1   WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKP---GTMSVQAFLEEANLMKT 57

Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMN 222
           ++H  +V+     T+   + I+TE+MA+GS+ DFL   +G    L  L+  +  +++GM 
Sbjct: 58  LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 117

Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIE 280
           Y+ + N IHRDL+ AN+L+ E+ + K+ADFG+ARV   +     E   +  +W APE I 
Sbjct: 118 YIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 177

Query: 281 HKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
              +  K+DV+SFGI L+E++T G++PY G++        +Q+  R    ++    L ++
Sbjct: 178 FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA-LQRGYRMPRMENCPDELYDI 236

Query: 340 LERCWQHDPTQRPNFSQITDIL 361
           ++ CW+    +RP F  +  +L
Sbjct: 237 MKTCWKEKAEERPTFDYLQSVL 258

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  169 bits (430), Expect = 5e-50
 Identities = 83/285 (29%), Positives = 138/285 (48%), Gaps = 36/285 (12%)

Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQE 157
           WE+  +++ +  ++  GS+G +Y+G             VAIK +       E + EF  E
Sbjct: 1   WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI-EFLNE 59

Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK---------GVFQLT 208
             +M++    +VV+ +G  +      +V E MA+G +  +L  ++         G   L 
Sbjct: 60  ASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119

Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268
             +++A +++ GM YL     +HRDL   N ++ E+  VK+ DFG+ R          ET
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR-------DIYET 172

Query: 269 GTY----------RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 317
             Y          RWMAPE ++   +  K+DV+SFG+ LWE+ T  E PY GL+  +   
Sbjct: 173 DYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLK 232

Query: 318 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK 362
            V+       +P++   +L EL+  CWQ++P  RP F +I   LK
Sbjct: 233 FVIDGGHLD-LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  167 bits (424), Expect = 2e-49
 Identities = 87/245 (35%), Positives = 141/245 (57%), Gaps = 8/245 (3%)

Query: 118 VASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176
           +  G++G+++KGT   +  VA+K  K E +  E+  +F  E  I+++  H N+V+ IG C
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCK-EDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 177 TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT 236
           T+   + IV E +  G    FL K+K   +   L+K A+D + GM YL   N IHRDL  
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAA 121

Query: 237 ANLLMDENGVVKVADFGVARVQAQSGVMTA---ETGTYRWMAPEVIEHKPYDYKADVFSF 293
            N L+ EN V+K++DFG++R Q   G+ ++   +    +W APE + +  Y  ++DV+S+
Sbjct: 122 RNCLVGENNVLKISDFGMSR-QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSY 180

Query: 294 GIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRP 352
           GI LWE  + G  PY G+T  Q A   V+K  R + P+     + ++++RCW + P  RP
Sbjct: 181 GILLWETFSLGVCPYPGMTN-QQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRP 239

Query: 353 NFSQI 357
            FS++
Sbjct: 240 KFSEL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  167 bits (424), Expect = 3e-49
 Identities = 84/264 (31%), Positives = 135/264 (51%), Gaps = 19/264 (7%)

Query: 110 KQLKIECKVASGSYGDLYKGTYC---SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH 166
              ++   +  G+   +Y    C   +++VAIK +  E   T +  E  +EV  M +  H
Sbjct: 1   DDYELIEVIGVGATAVVYAA-ICLPNNEKVAIKRIDLEKCQTSV-DELRKEVQAMSQCNH 58

Query: 167 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFL-HK-QKGVFQLTSLLKVAIDVSKGMNYL 224
            NVV++  +      L +V  +++ GS+ D +     +G      +  V  +V KG+ YL
Sbjct: 59  PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118

Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET-----GTYRWMAPEVI 279
           H N  IHRD+K  N+L+ E+G VK+ADFGV+   A  G  T +      GT  WMAPEV+
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178

Query: 280 E-HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR--- 335
           E    YD+KAD++SFGI   EL TG  PY+   P++  +  +Q    P++   A  +   
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND-PPSLETGADYKKYS 237

Query: 336 --LAELLERCWQHDPTQRPNFSQI 357
               +++  C Q DP++RP   ++
Sbjct: 238 KSFRKMISLCLQKDPSKRPTAEEL 261

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  166 bits (421), Expect = 1e-48
 Identities = 82/258 (31%), Positives = 137/258 (53%), Gaps = 13/258 (5%)

Query: 120 SGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
           SG++G +YKG +  +       VAIKVL+ E  + +  KE   E Y+M  + H +VV+ +
Sbjct: 17  SGAFGTVYKGVWIPEGEKVKIPVAIKVLR-EETSPKANKEILDEAYVMASVDHPHVVRLL 75

Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
           G C     + ++T+ M  G + D++   K       LL   + ++KGM+YL +  ++HRD
Sbjct: 76  GICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRD 134

Query: 234 LKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAPEVIEHKPYDYKADV 290
           L   N+L+     VK+ DFG+A+ +        AE G    +WMA E I H+ Y +K+DV
Sbjct: 135 LAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDV 194

Query: 291 FSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPT 349
           +S+G+ +WEL+T G  PY G+ P      +++K  R   P      +  +L +CW  D  
Sbjct: 195 WSYGVTVWELMTFGAKPYEGI-PAVEIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAE 253

Query: 350 QRPNFSQITDILKQMMKE 367
            RP F ++ +   +M ++
Sbjct: 254 SRPTFKELINEFSKMARD 271

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  164 bits (416), Expect = 3e-48
 Identities = 81/246 (32%), Positives = 130/246 (52%), Gaps = 7/246 (2%)

Query: 118 VASGSYGDLYKGTYCSQE--VAIKV--LKPECVNT-EMLKEFSQEVYIMRKIRHKNVVQF 172
           + SGS+G +Y+G         A+K   L  +     E +K+  QE+ ++ K++H N+VQ+
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 232
           +G      NL I  E +  GS+   L K  G F    +      +  G+ YLH  N +HR
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHR 126

Query: 233 DLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK-PYDYKADVF 291
           D+K AN+L+D NGVVK+ADFG+A+   +     +  G+  WMAPEVI  +  Y   AD++
Sbjct: 127 DIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIW 186

Query: 292 SFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           S G  + E+ TG+ P++ L  + A   + +    P IP H      + + +C Q DP+ R
Sbjct: 187 SLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLR 246

Query: 352 PNFSQI 357
           P  +++
Sbjct: 247 PTAAEL 252

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score =  164 bits (415), Expect = 4e-48
 Identities = 91/263 (34%), Positives = 153/263 (58%), Gaps = 10/263 (3%)

Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
           WEI  + LK+E K+ +G +G+++  TY    +VA+K +KP  ++ E    F  E  +M+ 
Sbjct: 1   WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE---AFLAEANVMKT 57

Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMN 222
           ++H  +V+     T+ P + I+TEFMA+GS+ DFL   +G    L  L+  +  +++GM 
Sbjct: 58  LQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 116

Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIE 280
           ++ Q N IHRDL+ AN+L+  + V K+ADFG+ARV   +     E   +  +W APE I 
Sbjct: 117 FIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 176

Query: 281 HKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
              +  K+DV+SFGI L E++T G +PY G++  +  +  +++  R   P++    L  +
Sbjct: 177 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-VIRALERGYRMPRPENCPEELYNI 235

Query: 340 LERCWQHDPTQRPNFSQITDILK 362
           + RCW++ P +RP F  I  +L 
Sbjct: 236 MMRCWKNRPEERPTFEYIQSVLD 258

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  162 bits (411), Expect = 2e-47
 Identities = 86/256 (33%), Positives = 141/256 (55%), Gaps = 10/256 (3%)

Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
           ID K L    ++ +G +G +  G +  Q +VAIK++K   ++ +   EF +E  +M K+ 
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLS 57

Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
           H+ +VQ  G CT+   + IVTE+M+ G + ++L +    FQ + LL++  DV +GM YL 
Sbjct: 58  HEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE 117

Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVIEHK 282
               IHRDL   N L+D+ G VKV+DFG++R        T+  G+    RW  PEV+ + 
Sbjct: 118 SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLLYS 176

Query: 283 PYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE 341
            +  K+DV++FG+ +WE+ + G++PY      +    V Q  LR   P  A  ++  ++ 
Sbjct: 177 KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ-GLRLYRPHLASEKVYAIMY 235

Query: 342 RCWQHDPTQRPNFSQI 357
            CW     +RP F Q+
Sbjct: 236 SCWHEKAEERPTFQQL 251

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  161 bits (409), Expect = 4e-47
 Identities = 76/254 (29%), Positives = 130/254 (51%), Gaps = 14/254 (5%)

Query: 120 SGSYGDLYKGTYCSQ-----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
            G++G + KG Y  +     EVA+K LK E +     KEF +E  +M ++ H  +V+ IG
Sbjct: 5   HGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK-KEFLREASVMAQLDHPCIVRLIG 63

Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
            C   P L +V E    G +  +L K++    ++ L ++A  V+ GM YL   + +HRDL
Sbjct: 64  VCKGEP-LMLVMELAPLGPLLKYL-KKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDL 121

Query: 235 KTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADV 290
              N+L+      K++DFG++R + A S    A T      +W APE I +  +  K+DV
Sbjct: 122 AARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDV 181

Query: 291 FSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPT 349
           +S+G+ LWE  + G  PY  +      + +++   R   P+     +  ++  CW++ P 
Sbjct: 182 WSYGVTLWEAFSYGAKPYGEMKG-AEVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPE 240

Query: 350 QRPNFSQITDILKQ 363
            RP FS++    ++
Sbjct: 241 DRPTFSELESTFRR 254

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score =  162 bits (411), Expect = 4e-47
 Identities = 89/296 (30%), Positives = 152/296 (51%), Gaps = 31/296 (10%)

Query: 97  IPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTE 149
           +P D    WE+   +L +   +  G++G + K              VA+K+LK +    +
Sbjct: 1   LPLD--PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKD 58

Query: 150 MLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT 208
            L +   E+ +M+ I +HKN++  +G CT+   L +V E+ A G++ DFL  ++   +  
Sbjct: 59  -LSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYA 117

Query: 209 S---------------LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG 253
           S               L+  A  V++GM +L     IHRDL   N+L+ E+ V+K+ADFG
Sbjct: 118 SPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFG 177

Query: 254 VAR-VQAQSGVMTAETG--TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAG 309
           +AR +           G    +WMAPE +  + Y +++DV+SFG+ LWE+ T G  PY G
Sbjct: 178 LARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 237

Query: 310 LTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
           + P++    ++++  R   P++    L  L+  CW   P+QRP F Q+ + L +M+
Sbjct: 238 I-PVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  159 bits (404), Expect = 2e-46
 Identities = 80/252 (31%), Positives = 129/252 (51%), Gaps = 16/252 (6%)

Query: 118 VASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQ---EVYIMRKIRHKNV 169
           +  G++G +Y    C      +E+A+K +  +  + E  KE +    E+ +++ ++H+ +
Sbjct: 10  LGQGAFGRVY---LCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERI 66

Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
           VQ+ G       L I  E+M  GS+ D L K  G    T   K    + +G+ YLH N I
Sbjct: 67  VQYYGCLRDDETLSIFMEYMPGGSVKDQL-KAYGALTETVTRKYTRQILEGVEYLHSNMI 125

Query: 230 IHRDLKTANLLMDENGVVKVADFGVA-RVQA---QSGVMTAETGTYRWMAPEVIEHKPYD 285
           +HRD+K AN+L D  G VK+ DFG + R+Q        M + TGT  WM+PEVI  + Y 
Sbjct: 126 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYG 185

Query: 286 YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 345
            KADV+S G  + E+LT + P+A    + A   +  +   P +P H  P     L R + 
Sbjct: 186 RKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFV 245

Query: 346 HDPTQRPNFSQI 357
            +  +RP+  ++
Sbjct: 246 ENAKKRPSAEEL 257

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score =  159 bits (404), Expect = 7e-46
 Identities = 85/274 (31%), Positives = 144/274 (52%), Gaps = 14/274 (5%)

Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQE 157
           WE     L     + +G++G + + T           +VA+K+LKP   ++E     S E
Sbjct: 30  WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS-E 88

Query: 158 VYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAI 215
           + IM  +  H+N+V  +GACT    + ++TE+   G + +FL +++  F  L  LL  + 
Sbjct: 89  LKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSY 148

Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY---R 272
            V+KGM +L   N IHRDL   N+L+    +VK+ DFG+AR          +       +
Sbjct: 149 QVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK 208

Query: 273 WMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKH 331
           WMAPE I +  Y +++DV+S+GI LWE+ + G  PY G+        ++++  R   P+H
Sbjct: 209 WMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEH 268

Query: 332 AHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
           A   + ++++ CW  DP +RP F QI  ++ + +
Sbjct: 269 APAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL 302

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score =  157 bits (399), Expect = 8e-46
 Identities = 81/252 (32%), Positives = 141/252 (55%), Gaps = 10/252 (3%)

Query: 117 KVASGSYGDLYKGTYCSQE--VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           ++  G++G+++ G   +    VA+K  + E +  ++  +F QE  I+++  H N+V+ IG
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
            CT+   + IV E +  G    FL  +    ++  L+++  + + GM YL   + IHRDL
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120

Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT----YRWMAPEVIEHKPYDYKADV 290
              N L+ E  V+K++DFG++R + + GV  +  G      +W APE + +  Y  ++DV
Sbjct: 121 AARNCLVTEKNVLKISDFGMSR-EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDV 179

Query: 291 FSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPT 349
           +SFGI LWE  + G +PYA L+  Q     +++ +R   P+     +  L+ERCW++DP 
Sbjct: 180 WSFGILLWEAFSLGAVPYANLSN-QQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPG 238

Query: 350 QRPNFSQITDIL 361
           QRP+FS +   L
Sbjct: 239 QRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score =  158 bits (400), Expect = 1e-45
 Identities = 86/271 (31%), Positives = 139/271 (51%), Gaps = 14/271 (5%)

Query: 107 IDAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           ID   +KIE  + +G +G++ +G           VAIK LK      +  ++F  E  IM
Sbjct: 1   IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIM 59

Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
            +  H N++   G  T+   + I+TEFM  G++  FL +  G F +  L+ +   ++ GM
Sbjct: 60  GQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGM 119

Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY------RWMA 275
            YL + N +HRDL   N+L++ N V KV+DFG++R           T +       RW A
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179

Query: 276 PEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP 334
           PE I ++ +   +DV+S+GI +WE+++ GE PY  ++  Q  +  +++  R   P     
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVINAIEQDYRLPPPMDCPT 238

Query: 335 RLAELLERCWQHDPTQRPNFSQITDILKQMM 365
            L +L+  CWQ D   RP F QI   L +M+
Sbjct: 239 ALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  154 bits (392), Expect = 1e-44
 Identities = 83/245 (33%), Positives = 129/245 (52%), Gaps = 11/245 (4%)

Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           ++ SG+YGD+YK       + VAIKV+K E    +  +   QE+ ++++ RH N+V + G
Sbjct: 10  RIGSGTYGDVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHPNIVAYFG 67

Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +  R   L IV E+   GS+ D     +G      +  V  +  KG+ YLH+   IHRD+
Sbjct: 68  SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDI 127

Query: 235 KTANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVIEHK---PYDYKADV 290
           K AN+L+ E+G VK+ADFGV A++ A      +  GT  WMAPEV   +    YD K D+
Sbjct: 128 KGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDI 187

Query: 291 FSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH---PRLAELLERCWQHD 347
           ++ GI   EL   + P   L P++A   + + +  P   K      P   + +++C   D
Sbjct: 188 WALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKD 247

Query: 348 PTQRP 352
           P +RP
Sbjct: 248 PKKRP 252

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score =  154 bits (391), Expect = 2e-44
 Identities = 82/268 (30%), Positives = 140/268 (52%), Gaps = 10/268 (3%)

Query: 106 EIDAKQLKIECKVASGSYGDLYKGTY---CSQE--VAIKVLKPECVNTEMLKEFSQEVYI 160
           E+D K +KIE  + +G +G+L +G       +E  VAI  L+  C + +    F  E   
Sbjct: 1   ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG-FLAEALT 59

Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
           + +  H N+V+  G  TR   + IVTE+M+ G++  FL K +G      L+ +   ++ G
Sbjct: 60  LGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASG 119

Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETG--TYRWMAPEV 278
           M YL +   +H+ L    +L++ + V K++ F   +      + T  +G     W APE 
Sbjct: 120 MKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEA 179

Query: 279 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 337
           I++  +   +DV+SFGI +WE+++ GE PY  ++  Q  +  V+   R   P++    L 
Sbjct: 180 IQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-QDVIKAVEDGFRLPAPRNCPNLLH 238

Query: 338 ELLERCWQHDPTQRPNFSQITDILKQMM 365
           +L+  CWQ +  +RP FSQI  IL +M+
Sbjct: 239 QLMLDCWQKERGERPRFSQIHSILSKMV 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score =  154 bits (391), Expect = 2e-44
 Identities = 90/269 (33%), Positives = 140/269 (52%), Gaps = 12/269 (4%)

Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQ-----EVAIKVLKPECVNTEMLKEFSQEVYIM 161
           IDA  +KIE  + +G +G++  G           VAIK LK      +  ++F  E  IM
Sbjct: 1   IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR-RDFLSEASIM 59

Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
            +  H N++   G  T+   + IVTE+M  GS+  FL K  G F +  L+ +   ++ GM
Sbjct: 60  GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGM 119

Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGT--YRWMAPE 277
            YL     +HRDL   N+L++ N V KV+DFG++RV         T   G    RW APE
Sbjct: 120 KYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE 179

Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
            I ++ +   +DV+S+GI +WE+++ GE PY  ++  Q  +  +++  R   P      L
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-QDVIKAIEEGYRLPAPMDCPAAL 238

Query: 337 AELLERCWQHDPTQRPNFSQITDILKQMM 365
            +L+  CWQ D  +RP F QI  IL +++
Sbjct: 239 HQLMLDCWQKDRNERPKFEQIVSILDKLI 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  153 bits (390), Expect = 3e-44
 Identities = 77/251 (30%), Positives = 122/251 (48%), Gaps = 15/251 (5%)

Query: 112 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV 169
           L+    +  GS G +YK  +    +  A+K +     + E  K+  +E+  +R      V
Sbjct: 3   LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIH-VDGDEEFRKQLLRELKTLRSCESPYV 61

Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN-N 228
           V+  GA  +   + IV E+M  GS+ D L K+ G      L  +A  + KG++YLH   +
Sbjct: 62  VKCYGAFYKEGEISIVLEYMDGGSLAD-LLKKVGKIPEPVLAYIARQILKGLDYLHTKRH 120

Query: 229 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYK 287
           IIHRD+K +NLL++  G VK+ADFG+++V   +        GT  +M+PE I+ + Y Y 
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYA 180

Query: 288 ADVFSFGIALWELLTGELPYAGLTP------LQAAVGVVQKSLRPTIPKHAHPRLAELLE 341
           AD++S G+ L E   G+ P+           +QA       SL         P   + + 
Sbjct: 181 ADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAE---EFSPEFRDFIS 237

Query: 342 RCWQHDPTQRP 352
            C Q DP +RP
Sbjct: 238 ACLQKDPKKRP 248

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  151 bits (384), Expect = 2e-43
 Identities = 88/267 (32%), Positives = 137/267 (51%), Gaps = 25/267 (9%)

Query: 118 VASGSYGDLYKGTYCS--------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV 169
           + SG++G++Y+GT             VA+K L+    + E  KEF +E ++M    H N+
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK-KEFLKEAHLMSNFNHPNI 61

Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK------GVFQLTSLLKVAIDVSKGMNY 223
           V+ +G C       I+ E M  G +  +L   +       +  L  LL + +DV+KG  Y
Sbjct: 62  VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121

Query: 224 LHQNNIIHRDLKTANLLMDENG-----VVKVADFGVARVQAQSGVMTAETG---TYRWMA 275
           L Q + IHRDL   N L+ E G     VVK+ DFG+AR   +S     E       RWMA
Sbjct: 122 LEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMA 181

Query: 276 PEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP 334
           PE +    +  ++DV+SFG+ +WE+LT G+ PY  L   +  +  V    R   P++   
Sbjct: 182 PESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE-VLQHVTAGGRLQKPENCPD 240

Query: 335 RLAELLERCWQHDPTQRPNFSQITDIL 361
           ++ +L+  CW  DP++RP F +I +IL
Sbjct: 241 KIYQLMTNCWAQDPSERPTFDRIQEIL 267

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  150 bits (381), Expect = 7e-43
 Identities = 73/242 (30%), Positives = 130/242 (53%), Gaps = 12/242 (4%)

Query: 118 VASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH---KNVVQF 172
           +  G+YG +Y+G +    + VA+K++  +  + + + +  +EV ++ ++R     N+ ++
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-VSDIQREVALLSQLRQSQPPNITKY 67

Query: 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 232
            G+  + P L I+ E+   GS+   +       +  S+  +  +V   + Y+H+  +IHR
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV--IIREVLVALKYIHKVGVIHR 125

Query: 233 DLKTANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVI-EHKPYDYKADV 290
           D+K AN+L+   G VK+ DFGV A +   S   +   GT  WMAPEVI E K YD KAD+
Sbjct: 126 DIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADI 185

Query: 291 FSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP-KHAHPRLAELLERCWQHDPT 349
           +S GI ++E+ TG  PY+ +   + A+ ++ KS  P +        L E +  C   +P 
Sbjct: 186 WSLGITIYEMATGNPPYSDVDAFR-AMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPK 244

Query: 350 QR 351
           +R
Sbjct: 245 ER 246

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  150 bits (379), Expect = 9e-43
 Identities = 81/270 (30%), Positives = 137/270 (50%), Gaps = 12/270 (4%)

Query: 106 EIDAKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
           EI    +  +  + +G +G++++G           VAIK LKP     +  ++F  E  I
Sbjct: 1   EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR-QDFLSEASI 59

Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
           M +  H N+++  G  T+     I+TE+M  G++  +L    G F    L+ +   ++ G
Sbjct: 60  MGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAG 119

Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ--SGVMTAETGT--YRWMAP 276
           M YL   N +HRDL   N+L++ N   KV+DFG++RV      G  T   G    RW AP
Sbjct: 120 MKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAP 179

Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I ++ +   +DV+SFGI +WE+++ GE PY  ++     +  +    R   P      
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-HEVMKAINDGFRLPAPMDCPSA 238

Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMM 365
           + +L+ +CWQ D  +RP F  I ++L +++
Sbjct: 239 VYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  148 bits (375), Expect = 3e-42
 Identities = 69/252 (27%), Positives = 129/252 (51%), Gaps = 13/252 (5%)

Query: 114 IECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQ 171
           I  K+  GS+G ++K    +  +  A+K +    +N    +E   E  ++ K+    +++
Sbjct: 4   ILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIR 63

Query: 172 FIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNII 230
           +  +      L IV E+   G ++  L  Q+G       + +  I +  G+ +LH   I+
Sbjct: 64  YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKIL 123

Query: 231 HRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKA 288
           HRD+K+ NL +D    VK+ D GVA++ + +    A T  GT  +++PE+ E KPY+ K+
Sbjct: 124 HRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF-ANTIVGTPYYLSPELCEDKPYNEKS 182

Query: 289 DVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR---PTIPKHAHPRLAELLERCWQ 345
           DV++ G+ L+E  TG+ P+           ++ K +R   P + +    +LA+L+++C  
Sbjct: 183 DVWALGVVLYECCTGKHPFDA----NNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLT 238

Query: 346 HDPTQRPNFSQI 357
            D  QRP+  Q+
Sbjct: 239 KDYRQRPDTFQL 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  149 bits (377), Expect = 3e-42
 Identities = 82/269 (30%), Positives = 136/269 (50%), Gaps = 20/269 (7%)

Query: 99  TDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQ 156
            +  D+WEI  +       +  G++G +YK  +       A K+++ E  + E L++F  
Sbjct: 1   VNPNDIWEIIGE-------LGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMV 51

Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 216
           E+ I+ + +H N+V    A      L I+ EF   G++   + + +       +  V   
Sbjct: 52  EIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQ 111

Query: 217 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMA 275
           + + +N+LH + +IHRDLK  N+L+  +G VK+ADFGV A+ ++         GT  WMA
Sbjct: 112 MLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMA 171

Query: 276 PEVI-----EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI-- 328
           PEV+     +  PYDYKAD++S GI L EL   E P+  L P++  +  + KS  PT+  
Sbjct: 172 PEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLK-ILKSEPPTLDQ 230

Query: 329 PKHAHPRLAELLERCWQHDPTQRPNFSQI 357
           P        + L+ C   DP  RP  +++
Sbjct: 231 PSKWSSSFNDFLKSCLVKDPDDRPTAAEL 259

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score =  148 bits (375), Expect = 9e-42
 Identities = 80/257 (31%), Positives = 126/257 (49%), Gaps = 38/257 (14%)

Query: 136 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
           VA+KVL+P+  +    ++F +EV I+ ++   N+ + +G CT  P LC++ E+M  G + 
Sbjct: 49  VAVKVLRPD-ASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107

Query: 196 DFLHKQKGVFQLTS----------LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 245
            FL K        +          LL +A  ++ GM YL   N +HRDL T N L+ +N 
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNY 167

Query: 246 VVKVADFGVARVQAQSGVMTAETGTY-----------RWMAPEVIEHKPYDYKADVFSFG 294
            +K+ADFG++R           +  Y           RWMA E +    +  K+DV++FG
Sbjct: 168 TIKIADFGMSR--------NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFG 219

Query: 295 IALWELLT--GELPYAGLTPLQ----AAVGVVQKSLRPTIPK-HAHPR-LAELLERCWQH 346
           + LWE+LT   E PY  LT  Q    A         +  +P+    P+ + EL+  CW+ 
Sbjct: 220 VTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRR 279

Query: 347 DPTQRPNFSQITDILKQ 363
           D   RP F +I   L++
Sbjct: 280 DEEDRPTFREIHLFLQR 296

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  145 bits (368), Expect = 7e-41
 Identities = 86/278 (30%), Positives = 141/278 (50%), Gaps = 42/278 (15%)

Query: 118 VASGSYGDLYKGTYCSQE-------VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           +  G++G ++ G     E       VA+K LK    N +  K+F +E  ++   +H+N+V
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN-DARKDFEREAELLTNFQHENIV 71

Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFL--HKQKGVF---------QLT--SLLKVAIDV 217
           +F G CT      +V E+M  G +  FL  H     F         +LT   LL++A+ +
Sbjct: 72  KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131

Query: 218 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY------ 271
           + GM YL   + +HRDL T N L+  + VVK+ DFG++R      V T  T  Y      
Sbjct: 132 ASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR-----DVYT--TDYYRVGGHT 184

Query: 272 ----RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQ-KSLR 325
               RWM PE I ++ +  ++DV+SFG+ LWE+ T G+ P+ GL+  +    + Q + L+
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQ 244

Query: 326 PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQ 363
              P+     + +++  CW+ DP QR N   I + L++
Sbjct: 245 R--PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  144 bits (365), Expect = 1e-40
 Identities = 75/249 (30%), Positives = 129/249 (51%), Gaps = 12/249 (4%)

Query: 120 SGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
           +G+ G + K  +    + +A+K ++ E +N  + K+  +E+ I+ K     +V F GA  
Sbjct: 11  AGNSGVVSKVLHRPTGKIMAVKTIRLE-INEAIQKQILRELDILHKCNSPYIVGFYGAFY 69

Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH-QNNIIHRDLKT 236
              ++ I  E+M  GS+   L + +G      L K+A+ V KG+ YLH ++ IIHRD+K 
Sbjct: 70  NNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKP 129

Query: 237 ANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIA 296
           +N+L++  G +K+ DFGV+     S   T   GT  +MAPE I+   Y  K+D++S G++
Sbjct: 130 SNILVNSRGQIKLCDFGVSGQLVNSLAKT-FVGTSSYMAPERIQGNDYSVKSDIWSLGLS 188

Query: 297 LWELLTGELPYAG-----LTPLQAAVGVVQKSLRPTIPKHAH-PRLAELLERCWQHDPTQ 350
           L EL TG  PY           +    +V +   P +P     P   + +  C   DP +
Sbjct: 189 LIELATGRFPYPPENDPPDGIFELLQYIVNEP-PPRLPSGKFSPDFQDFVNLCLIKDPRE 247

Query: 351 RPNFSQITD 359
           RP++ ++ +
Sbjct: 248 RPSYKELLE 256

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  143 bits (363), Expect = 3e-40
 Identities = 90/269 (33%), Positives = 130/269 (48%), Gaps = 36/269 (13%)

Query: 121 GSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
           G++G++Y+G Y          +VA+K L PE  + +   +F  E  IM K  H+N+V+ I
Sbjct: 17  GAFGEVYEGLYRGRDGDAVELQVAVKTL-PESCSEQDESDFLMEALIMSKFNHQNIVRLI 75

Query: 174 GACTRPPNLCIVTEFMARGSIYDFLH----KQKGVFQLT--SLLKVAIDVSKGMNYLHQN 227
           G         I+ E MA G +  FL     + +    LT   LL  A DV+KG  YL +N
Sbjct: 76  GVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN 135

Query: 228 NIIHRDLKTANLLMDENG---VVKVADFGVARVQAQSGVMTAETGTYR----------WM 274
           + IHRD+   N L+   G   V K+ADFG+AR   ++         YR          WM
Sbjct: 136 HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASY-------YRKGGRAMLPIKWM 188

Query: 275 APEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAH 333
            PE      +  K DV+SFG+ LWE+ + G +PY G T  Q  +  V    R   PK   
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-QEVMEFVTGGGRLDPPKGCP 247

Query: 334 PRLAELLERCWQHDPTQRPNFSQITDILK 362
             +  ++  CWQH P  RPNF+ I + ++
Sbjct: 248 GPVYRIMTDCWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  143 bits (361), Expect = 4e-40
 Identities = 81/244 (33%), Positives = 133/244 (54%), Gaps = 7/244 (2%)

Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           ++  GS+G++YKG      + VAIK++  E    E +++  QE+ ++ +     + ++ G
Sbjct: 11  RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYITRYYG 69

Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +  +   L I+ E++  GS  D L  + G  + T +  +  ++ KG++YLH    IHRD+
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLHSERKIHRDI 127

Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVM-TAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K AN+L+ E G VK+ADFGVA     + +      GT  WMAPEVI+   YD+KAD++S 
Sbjct: 128 KAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSL 187

Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPN 353
           GI   EL  GE P + L P++  + ++ K+  PT+         E +E C   DP  RP 
Sbjct: 188 GITAIELAKGEPPNSDLHPMR-VLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPT 246

Query: 354 FSQI 357
             ++
Sbjct: 247 AKEL 250

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  142 bits (359), Expect = 1e-39
 Identities = 80/256 (31%), Positives = 143/256 (55%), Gaps = 18/256 (7%)

Query: 118 VASGSYGDLYKGTYCS--QEVAIKVLKPECVNTE-------MLKEFSQEVYIMRKIRHKN 168
           + SGS+G +Y G   S  + +A+K ++   V+         ML   ++E+ ++++++H+N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 169 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 228
           +VQ++G+     +L I  E++  GS+   L+   G F+ T +      + KG+NYLH   
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLN-NYGAFEETLVRNFVRQILKGLNYLHNRG 126

Query: 229 IIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAET------GTYRWMAPEVIEH 281
           IIHRD+K AN+L+D  G +K++DFG++ +++A S             G+  WMAPEV++ 
Sbjct: 127 IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ 186

Query: 282 KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE 341
             Y  KAD++S G  + E+LTG+ P+   T LQA   + +    P IP +      + LE
Sbjct: 187 TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN-ASPEIPSNISSEAIDFLE 245

Query: 342 RCWQHDPTQRPNFSQI 357
           + ++ D  +RP  +++
Sbjct: 246 KTFEIDHNKRPTAAEL 261

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score =  143 bits (361), Expect = 1e-39
 Identities = 91/283 (32%), Positives = 145/283 (51%), Gaps = 27/283 (9%)

Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
           WE     +K E  +  G++G + +            AIK+LK E  +    ++F+ E+ +
Sbjct: 1   WE----DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLK-EFASENDHRDFAGELEV 55

Query: 161 MRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-------------GVFQ 206
           + K+  H N++  +GAC     L I  E+   G++ DFL K +                 
Sbjct: 56  LCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST 115

Query: 207 LTS--LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 264
           LTS  LL+ A DV+ GM YL +   IHRDL   N+L+ EN   K+ADFG++R +      
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKK 175

Query: 265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKS 323
           T      RWMA E + +  Y  K+DV+SFG+ LWE+++ G  PY G+T  +    + Q  
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-G 234

Query: 324 LRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
            R   P++    + EL+ +CW+  P +RP F+QI+  L +M++
Sbjct: 235 YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  141 bits (358), Expect = 2e-39
 Identities = 83/274 (30%), Positives = 136/274 (49%), Gaps = 40/274 (14%)

Query: 121 GSYGDLYKG-------TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
           G++G +YKG          +  VAIK LK E    ++ +EF QE  +M  ++H N+V  +
Sbjct: 16  GAFGKVYKGELTGPNERLSATSVAIKTLK-ENAEPKVQQEFRQEAELMSDLQHPNIVCLL 74

Query: 174 GACTRPPNLCIVTEFMARGSIYDFL---------------HKQKGVFQLTSLLKVAIDVS 218
           G CT+    C++ E++A G +++FL                  K     +  L +AI ++
Sbjct: 75  GVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIA 134

Query: 219 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR---------VQAQSGVMTAETG 269
            GM YL  ++ +HRDL   N L+ E   VK++DFG++R         VQ++S +      
Sbjct: 135 AGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL------ 188

Query: 270 TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTI 328
             RWM PE I +  +  ++D++SFG+ LWE+ + G  PY G +  +    +  + L P  
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPC- 247

Query: 329 PKHAHPRLAELLERCWQHDPTQRPNFSQITDILK 362
           P+    R+  L+  CW   P +RP F  I   L+
Sbjct: 248 PEDCPARVYALMIECWNEIPARRPRFKDIHTRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score =  142 bits (358), Expect = 2e-39
 Identities = 85/282 (30%), Positives = 144/282 (51%), Gaps = 23/282 (8%)

Query: 107 IDAKQLKIECKVASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 162
           ++   +K +  +  G++G + K          + AIK +K E  + +  ++F+ E+ ++ 
Sbjct: 4   LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLC 62

Query: 163 KI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQ 206
           K+  H N++  +GAC     L +  E+   G++ DFL K +                   
Sbjct: 63  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 122

Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266
              LL  A DV++GM+YL Q   IHRDL   N+L+ EN V K+ADFG++R Q      T 
Sbjct: 123 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 182

Query: 267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLR 325
                RWMA E + +  Y   +DV+S+G+ LWE+++ G  PY G+T  +    + Q   R
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYR 241

Query: 326 PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
              P +    + +L+ +CW+  P +RP+F+QI   L +M++E
Sbjct: 242 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  140 bits (355), Expect = 3e-39
 Identities = 78/253 (30%), Positives = 127/253 (50%), Gaps = 16/253 (6%)

Query: 121 GSYGDLYKG-TYCSQEVAIK--VLKPECVNT--EMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           G+YG +Y G T   Q +A+K   L    V    +  ++  +EV +++ ++H N+VQ++G 
Sbjct: 11  GAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGT 70

Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
           C     + I  EF+  GSI   L  + G        K    +  G+ YLH N ++HRD+K
Sbjct: 71  CLDDNTISIFMEFVPGGSISSIL-NRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIK 129

Query: 236 TANLLMDENGVVKVADFGVARVQA-------QSGVMTAETGTYRWMAPEVIEHKPYDYKA 288
             N+++  NG++K+ DFG AR  A        S ++ +  GT  WMAPEVI    Y  K+
Sbjct: 130 GNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKS 189

Query: 289 DVFSFGIALWELLTGELPYAGLTPLQA--AVGVVQKSLRPTIPKHAHPRLAELLERCWQH 346
           D++S G  ++E+ TG+ P A +  L A   +G   + L P +P        + +  C   
Sbjct: 190 DIWSIGCTVFEMATGKPPLASMDRLAAMFYIG-AHRGLMPRLPDSFSAAAIDFVTSCLTR 248

Query: 347 DPTQRPNFSQITD 359
           D  +RP+  Q+  
Sbjct: 249 DQHERPSALQLLR 261

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  140 bits (355), Expect = 6e-39
 Identities = 79/253 (31%), Positives = 130/253 (51%), Gaps = 27/253 (10%)

Query: 136 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
           VA+K+LK E  + +M  +F +E  +M +  H N+V+ +G C     +C++ E+MA G + 
Sbjct: 38  VAVKMLKEE-ASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 96

Query: 196 DFLHKQ--KGVFQL-------------------TSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +FL  +  +    L                   T  L +A  V+ GM YL +   +HRDL
Sbjct: 97  EFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDL 156

Query: 235 KTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAPEVIEHKPYDYKADVF 291
            T N L+ EN VVK+ADFG++R + +      +E      RWM PE I +  Y  ++DV+
Sbjct: 157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVW 216

Query: 292 SFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ 350
           ++G+ LWE+ + G  PY G+   +  +  V+     + P +    L  L+  CW   P+ 
Sbjct: 217 AYGVVLWEIFSYGMQPYYGMAHEE-VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSD 275

Query: 351 RPNFSQITDILKQ 363
           RP+F+ I  IL++
Sbjct: 276 RPSFASINRILQR 288

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  140 bits (353), Expect = 8e-39
 Identities = 82/244 (33%), Positives = 135/244 (55%), Gaps = 7/244 (2%)

Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           K+  GS+G+++KG      + VAIK++  E    E +++  QE+ ++ +     V ++ G
Sbjct: 11  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYVTKYYG 69

Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +  +   L I+ E++  GS  D L  + G    T +  +  ++ KG++YLH    IHRD+
Sbjct: 70  SYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSEKKIHRDI 127

Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFSF 293
           K AN+L+ E+G VK+ADFGVA     + +      GT  WMAPEVI+   YD KAD++S 
Sbjct: 128 KAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSL 187

Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPN 353
           GI   EL  GE P++ L P++    ++ K+  PT+  +    L E +E C   +P+ RP 
Sbjct: 188 GITAIELAKGEPPHSELHPMKVLF-LIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPT 246

Query: 354 FSQI 357
             ++
Sbjct: 247 AKEL 250

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score =  140 bits (354), Expect = 1e-38
 Identities = 82/272 (30%), Positives = 144/272 (52%), Gaps = 16/272 (5%)

Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 6   ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 61

Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           +M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++K
Sbjct: 62  VMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 120

Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 276
           GMNYL +  ++HRDL   N+L+     VK+ DFG+A+ + A      AE G    +WMA 
Sbjct: 121 GMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180

Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 239

Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 240 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score =  140 bits (353), Expect = 2e-38
 Identities = 79/253 (31%), Positives = 134/253 (52%), Gaps = 22/253 (8%)

Query: 136 VAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSI 194
           VA+K+LK    + + L +   E+ +M+ I +HKN++  +G CT+   L ++ E+ A+G++
Sbjct: 47  VAVKMLKDNATDKD-LADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNL 105

Query: 195 YDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANL 239
            +FL  ++                      L+  A  V++GM YL     IHRDL   N+
Sbjct: 106 REFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165

Query: 240 LMDENGVVKVADFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIA 296
           L+ E+ V+K+ADFG+AR           +      +WMAPE +  + Y +++DV+SFGI 
Sbjct: 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGIL 225

Query: 297 LWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFS 355
           +WE+ T G  PY G+ P++    ++++  R   P +    L  L+  CW   PTQRP F 
Sbjct: 226 MWEIFTLGGSPYPGI-PVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFK 284

Query: 356 QITDILKQMMKEV 368
           Q+ + L +++  V
Sbjct: 285 QLVEALDKVLAAV 297

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score =  138 bits (349), Expect = 2e-38
 Identities = 78/256 (30%), Positives = 125/256 (48%), Gaps = 22/256 (8%)

Query: 118 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 172
           +  G +G +Y GT    +      A+K L     + E +++F +E  IM+   H NV+  
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLN-RITDLEEVEQFLKEGIIMKDFSHPNVLSL 61

Query: 173 IGACTRPPNL-CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 231
           +G C        +V  +M  G + +F+  +     +  L+   + V+KGM YL     +H
Sbjct: 62  LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVH 121

Query: 232 RDLKTANLLMDENGVVKVADFGVAR---------VQAQSGVMTAETGTYRWMAPEVIEHK 282
           RDL   N ++DE+  VKVADFG+AR         V   +G         +WMA E ++ +
Sbjct: 122 RDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP----VKWMALESLQTQ 177

Query: 283 PYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE 341
            +  K+DV+SFG+ LWEL+T G  PY  +      V ++Q   R   P++    L E++ 
Sbjct: 178 KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR-RLLQPEYCPDPLYEVML 236

Query: 342 RCWQHDPTQRPNFSQI 357
            CW   P  RP FS++
Sbjct: 237 SCWHPKPEMRPTFSEL 252

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  138 bits (348), Expect = 4e-38
 Identities = 84/246 (34%), Positives = 135/246 (54%), Gaps = 11/246 (4%)

Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           ++  GS+G+++KG      Q VAIK++  E    E +++  QE+ ++ +     V ++ G
Sbjct: 11  RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYVTKYYG 69

Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
           +  +   L I+ E++  GS  D L       FQ+ ++LK   ++ KG++YLH    IHRD
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLDYLHSEKKIHRD 126

Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVF 291
           +K AN+L+ E G VK+ADFGVA  Q     +   T  GT  WMAPEVI+   YD KAD++
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAG-QLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIW 185

Query: 292 SFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           S GI   EL  GE P + + P++  + ++ K+  PT+         E ++ C   DP+ R
Sbjct: 186 SLGITAIELAKGEPPNSDMHPMR-VLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFR 244

Query: 352 PNFSQI 357
           P   ++
Sbjct: 245 PTAKEL 250

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  137 bits (348), Expect = 4e-38
 Identities = 69/254 (27%), Positives = 126/254 (49%), Gaps = 15/254 (5%)

Query: 117 KVASGSYGDLYKG-TYCSQEV-AIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           K+  G++G +Y      + E+ A+K ++ +  + + +KE + E+ ++  ++H N+V++ G
Sbjct: 7   KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66

Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                  + I  E+ + G++ + L     +     +    + + +G+ YLH + I+HRD+
Sbjct: 67  VEVHREKVYIFMEYCSGGTLEELLE-HGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDI 125

Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAE-----TGTYRWMAPEVIEHKPYDYK-- 287
           K AN+ +D NGV+K+ DFG A     +     E      GT  +MAPEVI          
Sbjct: 126 KPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGR 185

Query: 288 -ADVFSFGIALWELLTGELPYAGL-TPLQAAVGVVQKSLRPTIPKHAHPRLA--ELLERC 343
            AD++S G  + E+ TG+ P++ L    Q    V     +P IP          + L+RC
Sbjct: 186 AADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGH-KPPIPDSLQLSPEGKDFLDRC 244

Query: 344 WQHDPTQRPNFSQI 357
            + DP +RP  S++
Sbjct: 245 LESDPKKRPTASEL 258

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  137 bits (348), Expect = 5e-38
 Identities = 86/285 (30%), Positives = 135/285 (47%), Gaps = 45/285 (15%)

Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQE 157
           D T ++E+    +++   +  G+YG +YK  +    Q VAIK++       +  +E  +E
Sbjct: 3   DPTGIFEL----VEV---IGEGTYGKVYKARHKKTGQLVAIKIMDII---EDEEEEIKEE 52

Query: 158 VYIMRKI-RHKNVVQFIGA------CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSL 210
             I+RK   H N+  F GA            L +V E    GS+ D +   KG+ +    
Sbjct: 53  YNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV---KGLRKKGKR 109

Query: 211 LKVAI------DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 264
           LK         +  +G+ YLH+N +IHRD+K  N+L+ +N  VK+ DFGV+  Q  S + 
Sbjct: 110 LKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA-QLDSTLG 168

Query: 265 TAET--GTYRWMAPEVI--EHKP---YDYKADVFSFGIALWELLTGELPYAGLTPLQAAV 317
              T  GT  WMAPEVI  + +P   YD ++DV+S GI   EL  G+ P   + P++A  
Sbjct: 169 RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA-- 226

Query: 318 GVVQKSLRPTIPKHAHPRL-----AELLERCWQHDPTQRPNFSQI 357
             + K  R   P    P        + +  C   +  QRP   ++
Sbjct: 227 --LFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEEL 269

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score =  138 bits (348), Expect = 5e-38
 Identities = 78/262 (29%), Positives = 131/262 (50%), Gaps = 28/262 (10%)

Query: 122 SYGDLYKGTYC------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           ++G +YKG         +Q VAIK LK +  N +   EF QE  +M ++ H N+V  +G 
Sbjct: 17  AFGKIYKGHLYLPGMDHAQLVAIKTLK-DINNPQQWGEFQQEASLMAELHHPNIVCLLGV 75

Query: 176 CTRPPNLCIVTEFMARGSIYDFL-----HKQ-----------KGVFQLTSLLKVAIDVSK 219
            T+   +C++ E++ +G +++FL     H             K        L +AI ++ 
Sbjct: 76  VTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAA 135

Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY---RWMAP 276
           GM YL  +  +H+DL   N+L+ E   VK++D G++R    +     +  +    RWM P
Sbjct: 136 GMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPP 195

Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I +  +   +D++SFG+ LWE+ + G  PY G +  +    V ++ L P   +   PR
Sbjct: 196 EAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPC-SEDCPPR 254

Query: 336 LAELLERCWQHDPTQRPNFSQI 357
           +  L+  CWQ  P++RP F  I
Sbjct: 255 MYSLMTECWQEGPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  137 bits (346), Expect = 6e-38
 Identities = 75/252 (29%), Positives = 128/252 (50%), Gaps = 7/252 (2%)

Query: 111 QLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN 168
             K+  K+  GSYG +YK    S  Q  A+K +    ++ +  ++   E+ I+  + H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 169 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV---FQLTSLLKVAIDVSKGMNYLH 225
           ++ +  A      LCIV E+   G +   + K+K          + ++ I + +G+  LH
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYD 285
           +  I+HRDLK+AN+L+  N +VK+ D G+++V  +  +   + GT  +MAPEV + +PY 
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKV-LKKNMAKTQIGTPHYMAPEVWKGRPYS 179

Query: 286 YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 345
           YK+D++S G  L+E+ T   P+   + +Q     VQ+   P IP      L   +    Q
Sbjct: 180 YKSDIWSLGCLLYEMATFAPPFEARS-MQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQ 238

Query: 346 HDPTQRPNFSQI 357
             P  RPN  +I
Sbjct: 239 VKPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  137 bits (346), Expect = 8e-38
 Identities = 76/273 (27%), Positives = 131/273 (47%), Gaps = 37/273 (13%)

Query: 121 GSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           G +G + +G          +VA+K +K +      ++EF  E   M+   H NV++ IG 
Sbjct: 10  GEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGV 69

Query: 176 C------TRPPNLCIVTEFMARGSIYDFL-----HKQKGVFQLTSLLKVAIDVSKGMNYL 224
           C       + P   ++  FM  G ++ FL             L +LLK  +D++ GM YL
Sbjct: 70  CFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYL 129

Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY-----------RW 273
              N IHRDL   N ++ E+  V VADFG+++           +G Y           +W
Sbjct: 130 SNRNFIHRDLAARNCMLREDMTVCVADFGLSK--------KIYSGDYYRQGRIAKMPVKW 181

Query: 274 MAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHA 332
           +A E +  + Y  K+DV++FG+ +WE+ T G+ PY G+   +    +   + R   P+  
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN-RLKQPEDC 240

Query: 333 HPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
              L +L+  CW+ DP  RP F+++ ++L+ ++
Sbjct: 241 LDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score =  137 bits (347), Expect = 1e-37
 Identities = 84/299 (28%), Positives = 150/299 (50%), Gaps = 33/299 (11%)

Query: 96  EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECV 146
           E+P D    WE+   +L +   +  G +G +                 +VA+K+LK +  
Sbjct: 6   ELPEDPR--WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT 63

Query: 147 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK--- 202
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++   
Sbjct: 64  EKD-LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 122

Query: 203 ------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
                              L+  A  V++GM YL     IHRDL   N+L+ E+ V+K+A
Sbjct: 123 MEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 182

Query: 251 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 306
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ LWE+ T G  P
Sbjct: 183 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242

Query: 307 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++
Sbjct: 243 YPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  138 bits (347), Expect = 4e-37
 Identities = 81/303 (26%), Positives = 137/303 (45%), Gaps = 30/303 (9%)

Query: 113 KIECKVASGSYGDLYKGTYCSQEVAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRH-KNVV 170
           +I  K+  GS+G++Y      + VA+KVL  +    ++ ++ F +E+ I+  + H  N+V
Sbjct: 3   RILRKLGEGSFGEVYLA-RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61

Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHK--QKGVFQLTSLLKVAIDVSKGMNYLHQNN 228
           +         +L +V E++  GS+ D L K  +KG    +  L +   +   + YLH   
Sbjct: 62  KLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG 121

Query: 229 IIHRDLKTANLLMDENG-VVKVADFGVARVQAQSGV-------MTAETGTYRWMAPEVIE 280
           IIHRD+K  N+L+D +G VVK+ DFG+A++    G         +   GT  +MAPEV+ 
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 281 HK---PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK-----------SLRP 326
                     +D++S GI L+ELLTG  P+ G     A    ++             L P
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSP 241

Query: 327 TIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINTNIQSTYK 386
           + P+      ++LL++    DP  R      +  L   +   L     +L +        
Sbjct: 242 SNPELISKAASDLLKKLLAKDPKNRL---SSSSDLSHDLLAHLKLKESDLSDLLKPDDSA 298

Query: 387 HLL 389
            L 
Sbjct: 299 PLR 301

Length = 384

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score =  137 bits (345), Expect = 4e-37
 Identities = 87/298 (29%), Positives = 155/298 (52%), Gaps = 33/298 (11%)

Query: 97  IPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE---------VAIKVLKPECVN 147
           +P D    WE+   +L +   +  G +G +        +         VA+K+LK +  +
Sbjct: 1   LPADPK--WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD 58

Query: 148 TEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK--GV 204
            + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++  G+
Sbjct: 59  KD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGM 117

Query: 205 -----------FQLT--SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 251
                       QLT   L+  A  V++GM YL     IHRDL   N+L+ E+ V+K+AD
Sbjct: 118 DYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIAD 177

Query: 252 FGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPY 307
           FG+AR           T      +WMAPE +  + Y +++DV+SFG+ LWE+ T G  PY
Sbjct: 178 FGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237

Query: 308 AGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
            G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++
Sbjct: 238 PGI-PVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score =  135 bits (341), Expect = 7e-37
 Identities = 82/272 (30%), Positives = 145/272 (53%), Gaps = 16/272 (5%)

Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
           E + K++K+   + SG++G +YKG +  +       VAIK+L  E    +   EF  E  
Sbjct: 6   ETELKRVKV---LGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEAL 61

Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           IM  + H ++V+ +G C  P  + +VT+ M  G + D++H+ K       LL   + ++K
Sbjct: 62  IMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAK 120

Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 276
           GM YL +  ++HRDL   N+L+     VK+ DFG+AR ++       A+ G    +WMA 
Sbjct: 121 GMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 180

Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I ++ + +++DV+S+G+ +WEL+T G  PY G+ P +    +++K  R   P      
Sbjct: 181 ECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERLPQPPICTID 239

Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 240 VYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score =  134 bits (338), Expect = 9e-37
 Identities = 83/270 (30%), Positives = 138/270 (51%), Gaps = 23/270 (8%)

Query: 118 VASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQF 172
           +  G++G + K          + AIK +K E  + +  ++F+ E+ ++ K+  H N++  
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDV 217
           +GAC     L +  E+   G++ DFL K +                      LL  A DV
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 218 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 277
           ++GM+YL Q   IHRDL   N+L+ EN V K+ADFG++R Q      T      RWMA E
Sbjct: 122 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIE 181

Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
            + +  Y   +DV+S+G+ LWE+++ G  PY G+T  +    + Q   R   P +    +
Sbjct: 182 SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYRLEKPLNCDDEV 240

Query: 337 AELLERCWQHDPTQRPNFSQITDILKQMMK 366
            +L+ +CW+  P +RP+F+QI   L +M++
Sbjct: 241 YDLMRQCWREKPYERPSFAQILVSLNRMLE 270

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score =  135 bits (340), Expect = 1e-36
 Identities = 82/299 (27%), Positives = 147/299 (49%), Gaps = 33/299 (11%)

Query: 96  EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECV 146
           E+P D    WE    +L +   +  G +G +               +  VA+K+LK +  
Sbjct: 3   ELPED--PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT 60

Query: 147 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV- 204
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++   
Sbjct: 61  EKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 119

Query: 205 --------------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
                              L+     V++GM YL     IHRDL   N+L+ EN V+K+A
Sbjct: 120 MEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 179

Query: 251 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 306
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ +WE+ T G  P
Sbjct: 180 DFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239

Query: 307 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
           Y G+ P++    ++++  R   P +    L  ++  CW   P+ RP F Q+ + L +++
Sbjct: 240 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  133 bits (336), Expect = 2e-36
 Identities = 68/219 (31%), Positives = 113/219 (51%), Gaps = 22/219 (10%)

Query: 149 EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT 208
           E+++   +E+ +M ++ H ++++ +GA     +  +  E+MA GS+   L K  G F+  
Sbjct: 45  EVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKY-GAFKEA 103

Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQSGVMTAE 267
            ++     + +G++YLH+N IIHRD+K ANLL+D  G  +++ADFG A   A  G    E
Sbjct: 104 VIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE 163

Query: 268 -----TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELP---------YAGLTPL 313
                 GT  +MAPEV+  + Y    DV+S G  + E+ T + P          A +  +
Sbjct: 164 FQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKI 223

Query: 314 QAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRP 352
            +A         P+IP+H  P L ++  RC +  P  RP
Sbjct: 224 ASATTA------PSIPEHLSPGLRDVTLRCLELQPEDRP 256

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  133 bits (336), Expect = 2e-36
 Identities = 75/260 (28%), Positives = 128/260 (49%), Gaps = 29/260 (11%)

Query: 121 GSYGDLY----KGTYCSQE---VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
           G +G+++    KG         V +K L+       +  EF +E+ + RK+ HKNVV+ +
Sbjct: 16  GEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE-NLQSEFRRELDMFRKLSHKNVVRLL 74

Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ------LTSLLKVAI--DVSKGMNYLH 225
           G C       ++ E+   G +  FL   K   +      L++  KVA+   ++ GM++L 
Sbjct: 75  GLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS 134

Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY-------RWMAPEV 278
               +HRDL   N L+     VKV+   +++      V  +E           RW+APE 
Sbjct: 135 NARFVHRDLAARNCLVSSQREVKVSLLSLSK-----DVYNSEYYKLRNALIPLRWLAPEA 189

Query: 279 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 337
           ++   +  K+DV+SFG+ +WE+ T GELP+ GL+  +    +    L   +P+    RL 
Sbjct: 190 VQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLY 249

Query: 338 ELLERCWQHDPTQRPNFSQI 357
           +L+ RCW  +P  RP+FS++
Sbjct: 250 KLMTRCWAVNPKDRPSFSEL 269

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  132 bits (335), Expect = 4e-36
 Identities = 75/244 (30%), Positives = 118/244 (48%), Gaps = 27/244 (11%)

Query: 147 NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP--NLCIVTEFMARGS---IYDFLHKQ 201
           N ++ K+  +E+ I +  +   +V++ GA       ++ I  E+   GS   IY  + K+
Sbjct: 39  NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKR 98

Query: 202 KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261
            G      L K+A  V KG++YLH   IIHRD+K +N+L+   G VK+ DFGV+     S
Sbjct: 99  GGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158

Query: 262 GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321
              T  TGT  +MAPE I+ KPY   +DV+S G+ L E+     P+    P +    +  
Sbjct: 159 LAGTF-TGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF----PPEGEPPLGP 213

Query: 322 KSLRPTIPKHAHPRLAE--------------LLERCWQHDPTQRPNFSQITD---ILKQM 364
             L   I    +P L +               +++C + DPT+RP    + +   I  QM
Sbjct: 214 IELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273

Query: 365 MKEV 368
            K+V
Sbjct: 274 KKKV 277

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score =  132 bits (334), Expect = 6e-36
 Identities = 85/300 (28%), Positives = 145/300 (48%), Gaps = 47/300 (15%)

Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQE-------------------VAIKVLKPECV 146
           E   +QL+++ K+  G +G+++    C  E                   VA+K+L+ + V
Sbjct: 1   EFPRQQLRLKEKLGEGQFGEVH---LCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-V 56

Query: 147 NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ 206
                 +F +E+ IM ++++ N+++ +G C     LC++TE+M  G +  FL +++    
Sbjct: 57  TKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIEST 116

Query: 207 LT-----------SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255
            T           +LL +A+ ++ GM YL   N +HRDL T N L+  +  +K+ADFG++
Sbjct: 117 FTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176

Query: 256 RVQAQSGVMTAETG----TYRWMAPEVIEHKPYDYKADVFSFGIALWEL--LTGELPYAG 309
           R    SG      G      RWMA E I    +   +DV++FG+ LWE+  L  E PY+ 
Sbjct: 177 R-NLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235

Query: 310 LTPLQAA--VGVVQKSLRPTIPKHAHP----RLAELLERCWQHDPTQRPNFSQITDILKQ 363
           L+  Q     G   ++    I     P     + +L+ RCW  D   RP F++I   L++
Sbjct: 236 LSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  132 bits (333), Expect = 8e-36
 Identities = 78/249 (31%), Positives = 128/249 (51%), Gaps = 23/249 (9%)

Query: 136 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGS 193
           VA+K LK EC   +    + +E+ I++ + H+N+V++ G C+      L ++ E++  GS
Sbjct: 36  VAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGS 94

Query: 194 IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG 253
           + D+L K K    L  LL  A  + +GM YLH  + IHRDL   N+L+D + +VK+ DFG
Sbjct: 95  LRDYLPKHK--LNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFG 152

Query: 254 VARV--QAQSGVMTAETGTYR--WMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAG 309
           +A+   +        E G     W A E ++   + Y +DV+SFG+ L+ELLT       
Sbjct: 153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQS 212

Query: 310 --------LTPLQAAVGVV------QKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFS 355
                   + P Q  + VV      ++ +R   PK+    +  L++ CW+ +   RP F 
Sbjct: 213 PPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFR 272

Query: 356 QITDILKQM 364
            +  ILK+M
Sbjct: 273 SLIPILKEM 281

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score =  132 bits (332), Expect = 8e-36
 Identities = 82/272 (30%), Positives = 143/272 (52%), Gaps = 16/272 (5%)

Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
           E + K++K+   + SG++G +YKG +          VAIKVL+ E  + +  KE   E Y
Sbjct: 6   ETELKKVKV---LGSGAFGTVYKGIWIPDGENVKIPVAIKVLR-ENTSPKANKEILDEAY 61

Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           +M  +    V + +G C     + +VT+ M  G + D++ + K       LL   + ++K
Sbjct: 62  VMAGVGSPYVCRLLGICL-TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAK 120

Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 276
           GM+YL +  ++HRDL   N+L+     VK+ DFG+AR +        A+ G    +WMA 
Sbjct: 121 GMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMAL 180

Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I H+ + +++DV+S+G+ +WEL+T G  PY G+ P +    +++K  R   P      
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI-PAREIPDLLEKGERLPQPPICTID 239

Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           +  ++ +CW  D   RP F ++ D   +M ++
Sbjct: 240 VYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score =  131 bits (331), Expect = 1e-35
 Identities = 72/260 (27%), Positives = 128/260 (49%), Gaps = 25/260 (9%)

Query: 128 KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI--V 185
           +G    ++VA+K LKPE      + +  +E+ I+R + H+N+V++ G CT      I  +
Sbjct: 28  EGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLI 86

Query: 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 245
            EF+  GS+ ++L + K    L   LK A+ + KGM+YL     +HRDL   N+L++   
Sbjct: 87  MEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH 146

Query: 246 VVKVADFGVAR-VQAQSGVMTAE---TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELL 301
            VK+ DFG+ + ++      T +        W APE +    +   +DV+SFG+ L+ELL
Sbjct: 147 QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206

Query: 302 T----------------GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 345
           T                G  P  G   +   V V+++  R   P +    + +L+ +CW+
Sbjct: 207 TYCDSESSPMTLFLKMIG--PTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWE 264

Query: 346 HDPTQRPNFSQITDILKQMM 365
             P++R  F  + +  + ++
Sbjct: 265 FQPSKRTTFQNLIEGFEAIL 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score =  131 bits (331), Expect = 2e-35
 Identities = 78/289 (26%), Positives = 144/289 (49%), Gaps = 36/289 (12%)

Query: 111 QLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
            L +   +  G +G + K T            VA+K+LK E  ++  L++   E  ++++
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK-ENASSSELRDLLSEFNLLKQ 59

Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV------------------- 204
           + H +V++  GAC++   L ++ E+   GS+  FL + + V                   
Sbjct: 60  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119

Query: 205 ----FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQA 259
                 +  L+  A  +S+GM YL +  ++HRDL   N+L+ E   +K++DFG++R V  
Sbjct: 120 DERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE 179

Query: 260 QSGVMTAETG--TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAA 316
           +   +    G    +WMA E +    Y  ++DV+SFG+ LWE++T G  PY G+ P +  
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-ERL 238

Query: 317 VGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
             +++   R   P++    +  L+  CW+ +P +RP F+ I+  L++MM
Sbjct: 239 FNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score =  129 bits (326), Expect = 7e-35
 Identities = 78/247 (31%), Positives = 132/247 (53%), Gaps = 18/247 (7%)

Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG------ACTRPPNLCIVTE 187
           Q+VA+K+LK +  ++  ++EF +E   M++  H NV++ IG      A  R P   ++  
Sbjct: 28  QKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILP 87

Query: 188 FMARGSIYDFL-----HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD 242
           FM  G ++ FL      ++     L +L++  ID++ GM YL   N IHRDL   N +++
Sbjct: 88  FMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN 147

Query: 243 ENGVVKVADFGVARVQAQSGVM----TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALW 298
           EN  V VADFG+++ +  SG       A     +W+A E +    Y   +DV++FG+ +W
Sbjct: 148 ENMTVCVADFGLSK-KIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMW 206

Query: 299 ELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
           E++T G+ PYAG+   +    ++ K  R   P      + EL+ +CW  +P  RP+F  +
Sbjct: 207 EIMTRGQTPYAGVENSEIYNYLI-KGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHL 265

Query: 358 TDILKQM 364
            D L+ +
Sbjct: 266 RDQLELI 272

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  128 bits (324), Expect = 1e-34
 Identities = 73/246 (29%), Positives = 131/246 (53%), Gaps = 11/246 (4%)

Query: 121 GSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180
           G+YG +Y     S +V I + +    ++  ++   +E+ +   ++H+N+VQ++G+ +   
Sbjct: 19  GTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG 78

Query: 181 NLCIVTEFMARGSIYDFLHKQKGVFQL--TSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN 238
              I  E +  GS+   L  + G  +    +++     + +G+ YLH N I+HRD+K  N
Sbjct: 79  FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDN 138

Query: 239 LLMDE-NGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDY--KADVFSFG 294
           +L++  +GVVK++DFG ++  A     T   TGT ++MAPEVI+  P  Y   AD++S G
Sbjct: 139 VLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLG 198

Query: 295 IALWELLTGELPYAGLTPLQAA---VGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
             + E+ TG+ P+  L   QAA   VG+ +    P IP+         + RC++ DP +R
Sbjct: 199 CTIVEMATGKPPFIELGEPQAAMFKVGMFKI--HPEIPESLSAEAKNFILRCFEPDPDKR 256

Query: 352 PNFSQI 357
            +   +
Sbjct: 257 ASAHDL 262

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  128 bits (324), Expect = 1e-34
 Identities = 79/259 (30%), Positives = 130/259 (50%), Gaps = 28/259 (10%)

Query: 136 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
           VA+K LK         K+F +E  ++  ++H+++V+F G C     L +V E+M  G + 
Sbjct: 38  VAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLN 95

Query: 196 DFLH---------------KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240
            FL                + KG   L+ +L +A  ++ GM YL   + +HRDL T N L
Sbjct: 96  KFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCL 155

Query: 241 MDENGVVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVIEHKPYDYKADVFSFGIAL 297
           +  N +VK+ DFG++R    +        T    RWM PE I ++ +  ++DV+SFG+ L
Sbjct: 156 VGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVIL 215

Query: 298 WELLT-GELPYAGLTPLQAAVGVVQKSL--RPTI-PKHAHPRLAELLERCWQHDPTQRPN 353
           WE+ T G+ P+  L+  +    + Q  +  RP + PK  +    +++  CWQ +P QR N
Sbjct: 216 WEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVY----DIMLGCWQREPQQRLN 271

Query: 354 FSQITDILKQMMKEVLYWL 372
             +I  IL  + K    +L
Sbjct: 272 IKEIYKILHALGKATPIYL 290

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  128 bits (323), Expect = 2e-34
 Identities = 71/202 (35%), Positives = 108/202 (53%), Gaps = 14/202 (6%)

Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 216
           EV IMR  +H N+V+   +      L +V EF+  G++ D +   +       +  V + 
Sbjct: 66  EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLA 123

Query: 217 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG-VARVQAQSGVMTAETGTYRWMA 275
           V K +++LH   +IHRD+K+ ++L+  +G VK++DFG  A+V  +     +  GT  WMA
Sbjct: 124 VLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMA 183

Query: 276 PEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP---KHA 332
           PEVI   PY  + D++S GI + E++ GE PY    PLQA      K +R  +P   K+ 
Sbjct: 184 PEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA-----MKRIRDNLPPKLKNL 238

Query: 333 H---PRLAELLERCWQHDPTQR 351
           H   PRL   L+R    DP QR
Sbjct: 239 HKVSPRLRSFLDRMLVRDPAQR 260

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score =  127 bits (321), Expect = 3e-34
 Identities = 80/286 (27%), Positives = 140/286 (48%), Gaps = 36/286 (12%)

Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQE 157
           WE+  +++ +  ++  GS+G +Y+G             VAIK +       E + EF  E
Sbjct: 1   WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNE 59

Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ---------LT 208
             +M++    +VV+ +G  ++     ++ E M RG +  +L   +   +         L 
Sbjct: 60  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK 119

Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268
            ++++A +++ GM YL+ N  +HRDL   N ++ E+  VK+ DFG+ R          ET
Sbjct: 120 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-------DIYET 172

Query: 269 GTY----------RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 317
             Y          RWM+PE ++   +   +DV+SFG+ LWE+ T  E PY G++  Q   
Sbjct: 173 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR 232

Query: 318 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQ 363
            V++  L    P +    L EL+  CWQ++P  RP+F +I   +K+
Sbjct: 233 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  127 bits (321), Expect = 3e-34
 Identities = 73/255 (28%), Positives = 118/255 (46%), Gaps = 22/255 (8%)

Query: 118 VASGSYGDLYKGTYCSQEVAIKVLKPECVNTE----------MLKEFSQEVYIMRKIRHK 167
           +  G+YG +Y     +    + V + E   T           M+K    E+  ++ + H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 168 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN 227
           N+VQ++G  T    L I  E++  GSI   L    G F+   +      V +G+ YLH  
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSK 127

Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVAR----VQAQSGVMTAETGTYRWMAPEVIE--H 281
            I+HRDLK  NLL+D +G+ K++DFG+++    +      M+ + G+  WMAPEVI    
Sbjct: 128 GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ-GSVFWMAPEVIHSYS 186

Query: 282 KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL----A 337
           + Y  K D++S G  + E+  G  P++    + A   +  K   P IP      L     
Sbjct: 187 QGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVAL 246

Query: 338 ELLERCWQHDPTQRP 352
           + L  C+  +P  RP
Sbjct: 247 DFLNACFTINPDNRP 261

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score =  127 bits (319), Expect = 4e-34
 Identities = 72/250 (28%), Positives = 135/250 (54%), Gaps = 12/250 (4%)

Query: 117 KVASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 172
           ++ SG++G + KG Y      + VA+K+LK +  +  +  E  +E  +M+++ +  +V+ 
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 232
           IG C    +  +V E    G +  FL K K V +  ++ ++   VS GM YL + N +HR
Sbjct: 62  IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTE-KNITELVHQVSMGMKYLEETNFVHR 119

Query: 233 DLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAET-GTY--RWMAPEVIEHKPYDYKA 288
           DL   N+L+      K++DFG+++ + A      A+T G +  +W APE + +  +  K+
Sbjct: 120 DLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKS 179

Query: 289 DVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHD 347
           DV+SFG+ +WE  + G+ PY G+   +    +++   R   P+   P + +L++ CW + 
Sbjct: 180 DVWSFGVLMWEAFSYGQKPYKGMKGNEVTQ-MIESGERMECPQRCPPEMYDLMKLCWTYG 238

Query: 348 PTQRPNFSQI 357
             +RP F+ +
Sbjct: 239 VDERPGFAVV 248

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  126 bits (318), Expect = 7e-34
 Identities = 68/247 (27%), Positives = 131/247 (53%), Gaps = 7/247 (2%)

Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           +  G++G+  LY+ T     V  K +    ++ +  ++   E+ I+  ++H N++ +   
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67

Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                 L I  E+   G++YD + +QKG +F+   +L     +   ++Y+H+  I+HRD+
Sbjct: 68  FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDI 127

Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFS 292
           KT N+ + + G++K+ DFG++++      M AET  GT  +M+PE+ +   Y++K+D+++
Sbjct: 128 KTLNIFLTKAGLIKLGDFGISKILGSEYSM-AETVVGTPYYMSPELCQGVKYNFKSDIWA 186

Query: 293 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRP 352
            G  L+ELLT +  +    PL   V +VQ +  P +       L  L+    Q DP +RP
Sbjct: 187 LGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP-VVSVYSSELISLVHSLLQQDPEKRP 245

Query: 353 NFSQITD 359
              ++ D
Sbjct: 246 TADEVLD 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  125 bits (316), Expect = 1e-33
 Identities = 73/249 (29%), Positives = 121/249 (48%), Gaps = 17/249 (6%)

Query: 121 GSYGDLY----KGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           GS+G +     K T   +  A+KVL K + +  + ++    E  I+ +I H  +V+   A
Sbjct: 4   GSFGKVLLVRKKDT--GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYA 61

Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
                 L +V E+   G ++  L K+ G F        A ++   + YLH   II+RDLK
Sbjct: 62  FQTEEKLYLVLEYAPGGELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120

Query: 236 TANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFSF 293
             N+L+D +G +K+ DFG+A+ +  S      T  GT  ++APEV+  K Y    D +S 
Sbjct: 121 PENILLDADGHIKLTDFGLAK-ELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSL 179

Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ L+E+LTG+ P+      +    + +K L+     P+   P   +L+    Q DPT+R
Sbjct: 180 GVLLYEMLTGKPPFYAEDRKE----IYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKR 235

Query: 352 PNFSQITDI 360
                  +I
Sbjct: 236 LGSGGAEEI 244

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score =  126 bits (319), Expect = 1e-33
 Identities = 82/263 (31%), Positives = 126/263 (47%), Gaps = 42/263 (15%)

Query: 136 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
           VA+K+L+P+  N     +F +EV I+ +++  N+++ +G C     LC++TE+M  G + 
Sbjct: 49  VAVKILRPD-ANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107

Query: 196 DFLHK------------------QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
            FL                           +SLL VA+ ++ GM YL   N +HRDL T 
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATR 167

Query: 238 NLLMDENGVVKVADFGVA---------RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKA 288
           N L+ EN  +K+ADFG++         R+Q ++ +        RWMA E I    +   +
Sbjct: 168 NCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVL------PIRWMAWECILMGKFTTAS 221

Query: 289 DVFSFGIALWELLT--GELPYAGLTPLQA---AVGVVQKSLRPTI---PKHAHPRLAELL 340
           DV++FG+ LWE+L    E PY  LT  Q    A    +   R      P      L EL+
Sbjct: 222 DVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELM 281

Query: 341 ERCWQHDPTQRPNFSQITDILKQ 363
            +CW  D  +RP+FS I   L +
Sbjct: 282 LQCWSRDCRERPSFSDIHAFLTE 304

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  125 bits (316), Expect = 2e-33
 Identities = 86/265 (32%), Positives = 136/265 (51%), Gaps = 37/265 (13%)

Query: 118 VASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG 174
           V +G+YG +YKG +    Q  AIKV+    V  +  +E  QE+ +++K   H+N+  + G
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHHRNIATYYG 70

Query: 175 ACTR--PP----NLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQN 227
           A  +  PP     L +V EF   GS+ D +   KG   +   +  +  ++ +G+++LHQ+
Sbjct: 71  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 130

Query: 228 NIIHRDLKTANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVI--EHKP- 283
            +IHRD+K  N+L+ EN  VK+ DFGV A++    G      GT  WMAPEVI  +  P 
Sbjct: 131 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPD 190

Query: 284 --YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA---- 337
             YD+K+D++S GI   E+  G  P   + P++A            IP++  PRL     
Sbjct: 191 ATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF---------LIPRNPAPRLKSKKW 241

Query: 338 -----ELLERCWQHDPTQRPNFSQI 357
                  +E C   + +QRP   Q+
Sbjct: 242 SKKFQSFIESCLVKNHSQRPTTEQL 266

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score =  124 bits (312), Expect = 3e-33
 Identities = 75/253 (29%), Positives = 133/253 (52%), Gaps = 18/253 (7%)

Query: 117 KVASGSYGDLYKGTYCSQ----EVAIKVLKPE---CVNTEMLKEFSQEVYIMRKIRHKNV 169
           ++ SG++G + KG Y  +    +VAIKVLK E    V  EM++E      IM ++ +  +
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMRE----AEIMHQLDNPYI 57

Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
           V+ IG C     L +V E  + G +  FL  +K    +++++++   VS GM YL   N 
Sbjct: 58  VRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNF 116

Query: 230 IHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETG---TYRWMAPEVIEHKPYD 285
           +HRDL   N+L+      K++DFG+++ + A      A +      +W APE I  + + 
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176

Query: 286 YKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW 344
            ++DV+S+GI +WE  + G+ PY  +   +  +  +++  R   P    P +  L++ CW
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKPYKKMKGPE-VMSFIEQGKRLDCPAECPPEMYALMKDCW 235

Query: 345 QHDPTQRPNFSQI 357
            +    RPNF+++
Sbjct: 236 IYKWEDRPNFAKV 248

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score =  124 bits (312), Expect = 8e-33
 Identities = 77/286 (26%), Positives = 135/286 (47%), Gaps = 36/286 (12%)

Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQE 157
           WE+  +++ +  ++  GS+G +Y+G             VA+K +       E + EF  E
Sbjct: 1   WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNE 59

Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ---------LT 208
             +M+     +VV+ +G  ++     +V E MA G +  +L   +   +         L 
Sbjct: 60  ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 119

Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268
            ++++A +++ GM YL+    +HRDL   N ++  +  VK+ DFG+ R          ET
Sbjct: 120 EMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR-------DIYET 172

Query: 269 GTYR----------WMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 317
             YR          WMAPE ++   +   +D++SFG+ LWE+ +  E PY GL+  Q   
Sbjct: 173 DYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 232

Query: 318 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQ 363
            V+        P +   R+ +L+  CWQ +P  RP F +I ++LK 
Sbjct: 233 FVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  123 bits (309), Expect = 2e-32
 Identities = 82/265 (30%), Positives = 133/265 (50%), Gaps = 37/265 (13%)

Query: 118 VASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG 174
           V +G+YG +YKG +    Q  AIKV+    V  +  +E   E+ +++K   H+N+  + G
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMD---VTEDEEEEIKLEINMLKKYSHHRNIATYYG 80

Query: 175 ACTR--PP----NLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQN 227
           A  +  PP     L +V EF   GS+ D +   KG   +   +  +  ++ +G+ +LH +
Sbjct: 81  AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH 140

Query: 228 NIIHRDLKTANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVI--EHKP- 283
            +IHRD+K  N+L+ EN  VK+ DFGV A++    G      GT  WMAPEVI  +  P 
Sbjct: 141 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPD 200

Query: 284 --YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA---- 337
             YDY++D++S GI   E+  G  P   + P++A            IP++  P+L     
Sbjct: 201 ATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF---------LIPRNPPPKLKSKKW 251

Query: 338 -----ELLERCWQHDPTQRPNFSQI 357
                + +E C   +   RP+  Q+
Sbjct: 252 SKKFIDFIEGCLVKNYLSRPSTEQL 276

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  123 bits (310), Expect = 2e-32
 Identities = 74/251 (29%), Positives = 126/251 (50%), Gaps = 23/251 (9%)

Query: 136 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGS 193
           VA+K L+      E L++F +E+ I++ ++H N+V++ G C      NL +V E++  GS
Sbjct: 36  VAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGS 93

Query: 194 IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG 253
           + D+L K +       LL  A  + KGM YL     +HRDL T N+L++    VK+ DFG
Sbjct: 94  LRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFG 153

Query: 254 VARV--QAQSGVMTAETGTYR--WMAPEVIEHKPYDYKADVFSFGIALWELLT----GEL 305
           + +V  Q +      E G     W APE +    +   +DV+SFG+ L+EL T       
Sbjct: 154 LTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCS 213

Query: 306 PYA-----------GLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 354
           P A           G   +   + +++ + R   P      +  +++ CW +DP+QRP+F
Sbjct: 214 PPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSF 273

Query: 355 SQITDILKQMM 365
           S++   ++ + 
Sbjct: 274 SELALQVEAIR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  122 bits (308), Expect = 2e-32
 Identities = 82/252 (32%), Positives = 131/252 (51%), Gaps = 15/252 (5%)

Query: 118 VASGSYGDLY--KGTYCSQEVAIKVLKPECVNTEMLKEFSQ---EVYIMRKIRHKNVVQF 172
           +  G++G +Y        +E+A K ++ +  + E  KE S    E+ +++ ++H+ +VQ+
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 173 IGACTR---PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
            G C R      L I  E+M  GS+ D L K  G    +   K    + +GM+YLH N I
Sbjct: 70  YG-CLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKYTRQILEGMSYLHSNMI 127

Query: 230 IHRDLKTANLLMDENGVVKVADFGVA-RVQA--QSGV-MTAETGTYRWMAPEVIEHKPYD 285
           +HRD+K AN+L D  G VK+ DFG + R+Q    SG  + + TGT  WM+PEVI  + Y 
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYG 187

Query: 286 YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 345
            KADV+S G  + E+LT + P+A    + A   +  +   P +P H      + L  C  
Sbjct: 188 RKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL-GCIF 246

Query: 346 HDPTQRPNFSQI 357
            +   RP+  ++
Sbjct: 247 VEARHRPSAEEL 258

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score =  123 bits (309), Expect = 2e-32
 Identities = 71/273 (26%), Positives = 142/273 (52%), Gaps = 18/273 (6%)

Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNT-------EMLKEFSQEV 158
           E + ++LK+   + SG +G ++KG +  +  +IK+  P  + T       +  +E +  +
Sbjct: 6   ETELRKLKL---LGSGVFGTVHKGIWIPEGDSIKI--PVAIKTIQDRSGRQTFQEITDHM 60

Query: 159 YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS 218
             M  + H  +V+ +G C    +L +VT+    GS+ D + + +       LL   + ++
Sbjct: 61  LAMGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIA 119

Query: 219 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV---QAQSGVMTAETGTYRWMA 275
           KGM YL ++ ++HR+L   N+L+  + +V++ADFGVA +     +    +      +WMA
Sbjct: 120 KGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179

Query: 276 PEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP 334
            E I    Y +++DV+S+G+ +WE+++ G  PYAG+ P      +++K  R   P+    
Sbjct: 180 LESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-HEVPDLLEKGERLAQPQICTI 238

Query: 335 RLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
            +  ++ +CW  D   RP F ++ +   +M ++
Sbjct: 239 DVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  122 bits (308), Expect = 3e-32
 Identities = 74/244 (30%), Positives = 123/244 (50%), Gaps = 26/244 (10%)

Query: 136 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
           VA+K LK    +    ++F +E  ++  ++H+++V+F G CT    L +V E+M  G + 
Sbjct: 38  VAVKALKE--ASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLN 95

Query: 196 DFLHKQK--------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 241
            FL                  G   L  +L +A  ++ GM YL   + +HRDL T N L+
Sbjct: 96  RFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV 155

Query: 242 DENGVVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVIEHKPYDYKADVFSFGIALW 298
            +  VVK+ DFG++R    +        T    RWM PE I ++ +  ++D++SFG+ LW
Sbjct: 156 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLW 215

Query: 299 ELLT-GELPYAGLTPLQAAVGVVQ-KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQ 356
           E+ T G+ P+  L+  +A   + Q + L    P+   P +  +++ CWQ +P QR     
Sbjct: 216 EIFTYGKQPWYQLSNTEAIECITQGRELER--PRTCPPEVYAIMQGCWQREPQQR---MV 270

Query: 357 ITDI 360
           I DI
Sbjct: 271 IKDI 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  122 bits (307), Expect = 5e-32
 Identities = 72/225 (32%), Positives = 116/225 (51%), Gaps = 18/225 (8%)

Query: 149 EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT 208
            + K+  +E+ IM + R   +V F GA     N+C+  EFM  GS+ D ++K+ G   + 
Sbjct: 45  SVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVE 103

Query: 209 SLLKVAIDVSKGMNYLH-QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE 267
            L K+A+ V +G+ YL+  + I+HRD+K +N+L++  G +K+ DFGV+     S    A+
Sbjct: 104 ILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---IAD 160

Query: 268 T--GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA---GLTPLQAAVGVVQK 322
           T  GT  +M+PE I+   Y  K+DV+S GI++ EL  G+ P+A        Q     +  
Sbjct: 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD 220

Query: 323 SLR-------PTIPKHAHPRLAELL-ERCWQHDPTQRPNFSQITD 359
            L+       P +P    P       + C   DPT+RP   Q+  
Sbjct: 221 LLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCA 265

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  120 bits (303), Expect = 8e-32
 Identities = 67/248 (27%), Positives = 134/248 (54%), Gaps = 7/248 (2%)

Query: 117 KVASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           K+  GS+G   L K     ++  IK +    ++ +  +E  +EV ++  ++H N+VQ+  
Sbjct: 7   KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66

Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
           +     NL IV ++   G +Y  ++ Q+GV F    +L   + +   + ++H   I+HRD
Sbjct: 67  SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRD 126

Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVF 291
           +K+ N+ + ++G +K+ DFG+ARV   S V  A T  GT  +++PE+ E++PY+ K+D++
Sbjct: 127 IKSQNIFLTKDGTIKLGDFGIARV-LNSTVELARTCIGTPYYLSPEICENRPYNNKSDIW 185

Query: 292 SFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           + G  L+E+ T +  +         + +++ S  P +  H    L  L+ + ++ +P  R
Sbjct: 186 ALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY-PPVSSHYSYDLRNLVSQLFKRNPRDR 244

Query: 352 PNFSQITD 359
           P+ + I +
Sbjct: 245 PSVNSILE 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score =  121 bits (304), Expect = 9e-32
 Identities = 83/276 (30%), Positives = 140/276 (50%), Gaps = 32/276 (11%)

Query: 117 KVASGSYGDLYKG---TYCSQE----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV 169
           ++  G++G ++       C ++    VA+K LK    N    K+F +E  ++  ++H+++
Sbjct: 12  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR--KDFHREAELLTNLQHEHI 69

Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFL--HKQKGVF--------QLTS--LLKVAIDV 217
           V+F G C     L +V E+M  G +  FL  H    V         +LT   +L +A  +
Sbjct: 70  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129

Query: 218 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY---RWM 274
           + GM YL   + +HRDL T N L+ EN +VK+ DFG++R    +        T    RWM
Sbjct: 130 AAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189

Query: 275 APEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSL--RP-TIPK 330
            PE I ++ +  ++DV+S G+ LWE+ T G+ P+  L+  +    + Q  +  RP T PK
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPK 249

Query: 331 HAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
             +    +L+  CWQ +P  R N  +I  +L+ + K
Sbjct: 250 EVY----DLMLGCWQREPHMRLNIKEIHSLLQNLAK 281

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  120 bits (303), Expect = 9e-32
 Identities = 80/251 (31%), Positives = 130/251 (51%), Gaps = 13/251 (5%)

Query: 118 VASGSYGDLY--KGTYCSQEVAIKVLKPECVNTEMLKEFSQ---EVYIMRKIRHKNVVQF 172
           +  G++G +Y        +E+A+K ++ +  + E  KE +    E+ +++ + H+ +VQ+
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 173 IGACTRPP--NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
            G    P    L I  E M  GSI D L K  G        K    + +G++YLH N I+
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYTRQILEGVSYLHSNMIV 128

Query: 231 HRDLKTANLLMDENGVVKVADFGVA-RVQA--QSGV-MTAETGTYRWMAPEVIEHKPYDY 286
           HRD+K AN+L D  G VK+ DFG + R+Q    SG  M + TGT  WM+PEVI  + Y  
Sbjct: 129 HRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGR 188

Query: 287 KADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH 346
           KAD++S G  + E+LT + P+A    + A   +  +   P +P H      + L+R +  
Sbjct: 189 KADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV- 247

Query: 347 DPTQRPNFSQI 357
           +   RP+  ++
Sbjct: 248 EAKLRPSADEL 258

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  120 bits (302), Expect = 1e-31
 Identities = 77/253 (30%), Positives = 136/253 (53%), Gaps = 11/253 (4%)

Query: 117 KVASGSYGDLY--KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           K+  GS+G +Y  K    S+   IK +    +  +  +   +EV ++ K++H N+V F  
Sbjct: 7   KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66

Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
           +      L IV E+   G +   +++Q+GV F    +L   + +S G+ ++H   I+HRD
Sbjct: 67  SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRD 126

Query: 234 LKTANLLMDENGVV-KVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADV 290
           +K+ N+ + +NG+V K+ DFG+AR    S +  A T  GT  +++PE+ +++PY+ K D+
Sbjct: 127 IKSQNIFLSKNGMVAKLGDFGIARQLNDS-MELAYTCVGTPYYLSPEICQNRPYNNKTDI 185

Query: 291 FSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ 350
           +S G  L+EL T + P+ G    Q  + + Q    P  P  +   L  L+ + ++  P  
Sbjct: 186 WSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSR-DLRSLISQLFKVSPRD 244

Query: 351 RPNFSQITDILKQ 363
           RP+   IT ILK+
Sbjct: 245 RPS---ITSILKR 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score =  120 bits (304), Expect = 1e-31
 Identities = 81/258 (31%), Positives = 131/258 (50%), Gaps = 14/258 (5%)

Query: 112 LKIECKVASGSYGDLYKGTYCSQEVAIKVLK-PECVNTEMLKEFSQEVYI-MRKIRHKNV 169
           L++  ++  G+YG + K  +      + V +    VN++  K    ++ I MR +     
Sbjct: 3   LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYT 62

Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHK--QKGVFQLTSLL-KVAIDVSKGMNYLHQ 226
           V F GA  R  ++ I  E M   S+  F  K   KG+     +L K+A+ + K + YLH 
Sbjct: 63  VTFYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121

Query: 227 N-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI----EH 281
             ++IHRD+K +N+L++ NG VK+ DFG++     S   T + G   +MAPE I      
Sbjct: 122 KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQ 181

Query: 282 KPYDYKADVFSFGIALWELLTGELPYAGL-TPLQAAVGVVQKSLRPTIPKHA-HPRLAEL 339
           K YD K+DV+S GI + EL TG  PY    TP Q    VV++   P +P     P   + 
Sbjct: 182 KGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP-SPQLPAEKFSPEFQDF 240

Query: 340 LERCWQHDPTQRPNFSQI 357
           + +C + +  +RPN+ ++
Sbjct: 241 VNKCLKKNYKERPNYPEL 258

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  119 bits (301), Expect = 2e-31
 Identities = 67/253 (26%), Positives = 110/253 (43%), Gaps = 13/253 (5%)

Query: 120 SGSYGDLY--KGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176
            G+YG ++  K        AIKV+ K + +    + +   E  I+ + +   VV+   + 
Sbjct: 3   KGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF 62

Query: 177 TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT 236
               NL +V E++  G +   L    G            ++   + YLH N IIHRDLK 
Sbjct: 63  QGKKNLYLVMEYLPGGDLASLLE-NVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKP 121

Query: 237 ANLLMDENGVVKVADFGVARV-----QAQSGVMTAET----GTYRWMAPEVIEHKPYDYK 287
            N+L+D NG +K+ DFG+++V     Q        E     GT  ++APEVI  + +   
Sbjct: 122 DNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKT 181

Query: 288 ADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHD 347
            D +S G  L+E L G  P+ G TP +    ++   +             +L+ +    D
Sbjct: 182 VDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPD 241

Query: 348 PTQRPNFSQITDI 360
           P +R     I +I
Sbjct: 242 PEKRLGAKSIEEI 254

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  120 bits (303), Expect = 2e-31
 Identities = 59/206 (28%), Positives = 106/206 (51%), Gaps = 26/206 (12%)

Query: 113 KIECKVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKE-FSQ----EVYIMRKIR 165
           K+E K+  G+YG +YK       + VA+K ++      +  +E        E+ ++++++
Sbjct: 3   KLE-KLGEGTYGVVYKARDKKTGEIVALKKIR-----LDNEEEGIPSTALREISLLKELK 56

Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
           H N+V+ +        L +V E+     +  +L K+ G      +  +   + +G+ Y H
Sbjct: 57  HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH 115

Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV----MTAETGT--YRWMAPEVI 279
            + I+HRDLK  N+L++ +GV+K+ADFG+AR     G+     T E  T  YR  APE++
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLAR---AFGIPLRTYTHEVVTLWYR--APEIL 170

Query: 280 -EHKPYDYKADVFSFGIALWELLTGE 304
              K Y    D++S G    E++TG+
Sbjct: 171 LGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  119 bits (301), Expect = 2e-31
 Identities = 72/262 (27%), Positives = 135/262 (51%), Gaps = 11/262 (4%)

Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKP-ECVNTEMLKEFSQEVYIMRKIRHKNV 169
           KIE K+  G +  +YK       + VA+K ++  E ++ +  ++  +E+ +++++ H NV
Sbjct: 5   KIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNV 64

Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFL---HKQKGVFQLTSLLKVAIDVSKGMNYLHQ 226
           ++++ +      L IV E    G +   +    KQK +    ++ K  + +   + ++H 
Sbjct: 65  IKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS 124

Query: 227 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPY 284
             I+HRD+K AN+ +   GVVK+ D G+ R    S    A +  GT  +M+PE I    Y
Sbjct: 125 KRIMHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSLVGTPYYMSPERIHENGY 183

Query: 285 DYKADVFSFGIALWELLTGELPYAG-LTPLQAAVGVVQKSLRPTIPK-HAHPRLAELLER 342
           ++K+D++S G  L+E+   + P+ G    L +    ++K   P +P  H    L +L+ R
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSR 243

Query: 343 CWQHDPTQRPNFSQITDILKQM 364
           C   DP +RP+ S +  + K+M
Sbjct: 244 CINPDPEKRPDISYVLQVAKEM 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  119 bits (299), Expect = 3e-31
 Identities = 71/245 (28%), Positives = 125/245 (51%), Gaps = 6/245 (2%)

Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           V  GSYG+  L +     ++  IK L     +    K   QE  ++ +++H N+V +  +
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 176 CTRPPN-LCIVTEFMARGSIYDFLHKQKGVFQLTS-LLKVAIDVSKGMNYLHQNNIIHRD 233
                  L IV  F   G +Y  L +QKG     + +++  + ++  + YLH+ +I+HRD
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRD 127

Query: 234 LKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 292
           LKT N+ +    ++KV D G+ARV + Q  + +   GT  +M+PE+  +KPY+YK+DV++
Sbjct: 128 LKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWA 187

Query: 293 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRP 352
            G  ++E+ T +  +           +++  L P +PK   P L EL+       P +RP
Sbjct: 188 LGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL-PPMPKDYSPELGELIATMLSKRPEKRP 246

Query: 353 NFSQI 357
           +   I
Sbjct: 247 SVKSI 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  119 bits (299), Expect = 3e-31
 Identities = 62/244 (25%), Positives = 124/244 (50%), Gaps = 5/244 (2%)

Query: 118 VASGSYGDLY--KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           V  G++G ++  +     + V IK +  E +  +       E  +++ + H N++++   
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67

Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                 L IV E+   G++ +++ K+   +    ++L   + +   ++++H   I+HRDL
Sbjct: 68  FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDL 127

Query: 235 KTANLLMDENG-VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           KT N+L+D++  VVK+ DFG++++ +         GT  +++PE+ E KPY+ K+D+++ 
Sbjct: 128 KTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWAL 187

Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPN 353
           G  L+EL + +  +     L A V  +       I     P L +L+      DP++RP 
Sbjct: 188 GCVLYELASLKRAFEAAN-LPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQ 246

Query: 354 FSQI 357
            SQI
Sbjct: 247 LSQI 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score =  119 bits (299), Expect = 4e-31
 Identities = 76/273 (27%), Positives = 129/273 (47%), Gaps = 32/273 (11%)

Query: 118 VASGSYGDLYKGTYCSQE----VAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRHKNVVQF 172
           +  G +G + +G     +    VA+K +K   C  +EM ++F  E   M++  H NV++ 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEM-EDFLSEAVCMKEFDHPNVMRL 65

Query: 173 IGACTRP------PNLCIVTEFMARGSIYDFL-----HKQKGVFQLTSLLKVAIDVSKGM 221
           IG C +       P+  ++  FM  G ++ FL                L+K   D++ GM
Sbjct: 66  IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM 125

Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--------QAQSGVMTAETGTYRW 273
            YL   + IHRDL   N +++EN  V VADFG+++         Q +   M       +W
Sbjct: 126 EYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV-----KW 180

Query: 274 MAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHA 332
           +A E +  + Y  K+DV+SFG+ +WE+ T G+ PY G+   +     +++  R   P   
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-IYDYLRQGNRLKQPPDC 239

Query: 333 HPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
              L  L+  CW  +P  RP+F  +   L++ +
Sbjct: 240 LDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  118 bits (297), Expect = 6e-31
 Identities = 75/216 (34%), Positives = 117/216 (54%), Gaps = 9/216 (4%)

Query: 117 KVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           ++ SG+YGD+YK    +  +  AIKV+K E    E      QE+ +M+  +H N+V + G
Sbjct: 16  RIGSGTYGDVYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYFG 73

Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +  R   L I  EF   GS+ D  H   G    + +  V+ +  +G+ YLH    +HRD+
Sbjct: 74  SYLRRDKLWICMEFCGGGSLQDIYH-VTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDI 132

Query: 235 KTANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEV--IEHK-PYDYKADV 290
           K AN+L+ +NG VK+ADFGV A++ A      +  GT  WMAPEV  +E K  Y+   D+
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDI 192

Query: 291 FSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP 326
           ++ GI   EL   + P   L P++A   + + + +P
Sbjct: 193 WAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQP 228

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score =  118 bits (298), Expect = 9e-31
 Identities = 72/262 (27%), Positives = 125/262 (47%), Gaps = 24/262 (9%)

Query: 116 CKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV 169
             +  G++G ++ G          +EV +K +K      + +    QE  ++  + H+N+
Sbjct: 12  DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQ-VTLLLQESCLLYGLSHQNI 70

Query: 170 VQFIGACTR---PPNLCIVTEFMARGSIYDFL----HKQKGVFQLTS---LLKVAIDVSK 219
           +  +  C     PP +     +M  G++  FL      +    Q  S   L+ +AI ++ 
Sbjct: 71  LPILHVCIEDGEPPFVLY--PYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIAC 128

Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYR---WMAP 276
           GM+YLH+  +IH+D+   N ++DE   VK+ D  ++R               R   WMA 
Sbjct: 129 GMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMAL 188

Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E + +K Y   +DV+SFG+ LWEL+T G+ PY  + P + A   ++   R   P +    
Sbjct: 189 ESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA-AYLKDGYRLAQPINCPDE 247

Query: 336 LAELLERCWQHDPTQRPNFSQI 357
           L  ++  CW  DP +RP+FSQ+
Sbjct: 248 LFAVMACCWALDPEERPSFSQL 269

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  118 bits (297), Expect = 1e-30
 Identities = 82/265 (30%), Positives = 135/265 (50%), Gaps = 20/265 (7%)

Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEV--AIKVLKPECVNTEMLKEFSQEVYI 160
           + WEI  +       +  G++G +YK       V  A KV+  +  + E L+++  E+ I
Sbjct: 5   EFWEIIGE-------LGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDI 55

Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
           +    H N+V+ + A     NL I+ EF A G++   + + +       +  V     + 
Sbjct: 56  LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEA 115

Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGTYRWMAPEVI 279
           +NYLH+N IIHRDLK  N+L   +G +K+ADFGV+    ++     +  GT  WMAPEV+
Sbjct: 116 LNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVV 175

Query: 280 -----EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHA 332
                + +PYDYKADV+S GI L E+   E P+  L P++  + +  KS  PT+  P   
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSEPPTLAQPSRW 234

Query: 333 HPRLAELLERCWQHDPTQRPNFSQI 357
                + L++C + +   R   +Q+
Sbjct: 235 SSEFKDFLKKCLEKNVDARWTTTQL 259

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  117 bits (296), Expect = 1e-30
 Identities = 69/258 (26%), Positives = 121/258 (46%), Gaps = 22/258 (8%)

Query: 117 KVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQ---EVYIMRKIRHKNVVQ 171
            +  GS+G + K    S  + +  K +    +     KE  Q   EV I+R+++H N+V+
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE---KEKQQLVSEVNILRELKHPNIVR 63

Query: 172 FIGACTRPPN--LCIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLH- 225
           +        N  L IV E+   G +   + K   ++   +   + ++   +   +   H 
Sbjct: 64  YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123

Query: 226 ----QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVI 279
                N ++HRDLK AN+ +D N  VK+ DFG+A++        A+T  GT  +M+PE +
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI-LGHDSSFAKTYVGTPYYMSPEQL 182

Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
            H  YD K+D++S G  ++EL     P+     LQ A  + +   R  IP      L E+
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRR-IPYRYSSELNEV 241

Query: 340 LERCWQHDPTQRPNFSQI 357
           ++     DP +RP+  ++
Sbjct: 242 IKSMLNVDPDKRPSTEEL 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score =  118 bits (297), Expect = 1e-30
 Identities = 76/250 (30%), Positives = 130/250 (52%), Gaps = 24/250 (9%)

Query: 136 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
           VA+K+L+ +  N     +F +E+ IM +++  N+++ +  C     LC++TE+M  G + 
Sbjct: 49  VAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107

Query: 196 DFL--HKQKG--------VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 245
            FL  H+ +             ++L+ +A  ++ GM YL   N +HRDL T N L+ +N 
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNY 167

Query: 246 VVKVADFGVARVQAQSGVMTAETG----TYRWMAPEVIEHKPYDYKADVFSFGIALWELL 301
            +K+ADFG++R    SG      G      RWM+ E I    +   +DV++FG+ LWE+L
Sbjct: 168 TIKIADFGMSR-NLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226

Query: 302 T--GELPYAGLTPLQAAVGVVQ----KSLRPTIPKHAH-PR-LAELLERCWQHDPTQRPN 353
           T   E PY+ L+  Q      +    +  +  +PK A  P  L +L+  CW+ +  +RP+
Sbjct: 227 TLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPS 286

Query: 354 FSQITDILKQ 363
           F +I   L +
Sbjct: 287 FQEIHATLLE 296

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  117 bits (295), Expect = 3e-30
 Identities = 78/246 (31%), Positives = 130/246 (52%), Gaps = 10/246 (4%)

Query: 117 KVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176
           K+  GS G +   T  S    + V K +    +  +    EV IMR  +H+NVV+   + 
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 177 TRPPNLCIVTEFMARGSIYDFL-HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
                L +V EF+  G++ D + H +    Q+ +   V + V K ++ LH   +IHRD+K
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---VCLAVLKALSVLHAQGVIHRDIK 143

Query: 236 TANLLMDENGVVKVADFG-VARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           + ++L+  +G VK++DFG  A+V  +     +  GT  WMAPE+I   PY  + D++S G
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLG 203

Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH---PRLAELLERCWQHDPTQR 351
           I + E++ GE PY    PL+ A+ +++ +L P + K+ H   P L   L+R    DP QR
Sbjct: 204 IMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPKL-KNLHKVSPSLKGFLDRLLVRDPAQR 261

Query: 352 PNFSQI 357
              +++
Sbjct: 262 ATAAEL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  117 bits (295), Expect = 3e-30
 Identities = 66/281 (23%), Positives = 118/281 (41%), Gaps = 38/281 (13%)

Query: 113 KIECKVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-----R 165
           K    +  GS+  +        ++E AIK+L    +  E  K   + V I +++      
Sbjct: 4   KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEK-KV--KYVKIEKEVLTRLNG 60

Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
           H  +++         NL  V E+   G +  ++ K  G          A ++   + YLH
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLH 119

Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET----------------- 268
              IIHRDLK  N+L+D++  +K+ DFG A+V   +    +                   
Sbjct: 120 SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179

Query: 269 ----GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK-- 322
               GT  +++PE++  KP    +D+++ G  ++++LTG+ P+ G           QK  
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL----TFQKIL 235

Query: 323 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQ 363
            L  + P +  P   +L+E+    DP  R   ++  D LK 
Sbjct: 236 KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  116 bits (294), Expect = 4e-30
 Identities = 72/239 (30%), Positives = 120/239 (50%), Gaps = 16/239 (6%)

Query: 120 SGSYGD----LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +GS+G      +KG+   +  A+K+L K + V  + ++    E  I++ IRH  +V   G
Sbjct: 11  TGSFGRVMLVRHKGSG--KYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++  G ++  L ++ G F        A  V   + YLH  +I++RDL
Sbjct: 69  SFQDDSNLYLVMEYVPGGELFSHL-RKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDL 127

Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           K  NLL+D +G +K+ DFG A+   +    T   GT  ++APE+I  K Y    D ++ G
Sbjct: 128 KPENLLLDSDGYIKITDFGFAKR-VKGRTYTL-CGTPEYLAPEIILSKGYGKAVDWWALG 185

Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSL--RPTIPKHAHPRLAELLERCWQHDPTQR 351
           I ++E+L G  P+    P+Q    + +K L  +   P    P   +L+    Q D T+R
Sbjct: 186 ILIYEMLAGYPPFFDDNPIQ----IYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLTKR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  116 bits (293), Expect = 5e-30
 Identities = 75/256 (29%), Positives = 131/256 (51%), Gaps = 13/256 (5%)

Query: 108 DAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFS-QEVYIMRKI 164
             K  + E K+  G+ G +Y     +  QEVAIK +    +  +  KE    E+ +MR+ 
Sbjct: 18  KKKYTRFE-KIGQGASGTVYTAIDVATGQEVAIKQMN---LQQQPKKELIINEILVMREN 73

Query: 165 RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
           +H N+V ++ +      L +V E++A GS+ D +   +       +  V  +  + + +L
Sbjct: 74  KHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFL 131

Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFG-VARVQAQSGVMTAETGTYRWMAPEVIEHKP 283
           H N +IHRD+K+ N+L+  +G VK+ DFG  A++  +    +   GT  WMAPEV+  K 
Sbjct: 132 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 191

Query: 284 YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELLE 341
           Y  K D++S GI   E++ GE PY    PL+ A+ ++  +  P +  P+       + L 
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-ALYLIATNGTPELQNPEKLSAIFRDFLN 250

Query: 342 RCWQHDPTQRPNFSQI 357
           RC + D  +R +  ++
Sbjct: 251 RCLEMDVEKRGSAKEL 266

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  115 bits (290), Expect = 7e-30
 Identities = 72/254 (28%), Positives = 129/254 (50%), Gaps = 13/254 (5%)

Query: 114 IECKVASGSYGDLY--KGTYCSQEVAIKVLKPECV---NTEMLKEFSQEVYIMRKIRHKN 168
           ++ ++  GS+G +Y  K      E  +KVLK   V   N     + +QE  ++ K+ H  
Sbjct: 4   LQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPA 63

Query: 169 VVQFIGACTRPPNLCIVTEFMARGSIYDF----LHKQKGVFQLTSLLKVAIDVSKGMNYL 224
           +V+F  +       CI+TE+   G   D     L           + +  I +  G++Y+
Sbjct: 64  IVKFHASFLERDAFCIITEY-CEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122

Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGTYRWMAPEVIEHKP 283
           HQ  I+HRDLK  N+ +  N ++K+ DFGV+R+   S  + T  TGT  +M+PE ++H+ 
Sbjct: 123 HQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQG 181

Query: 284 YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC 343
           YD K+D++S G  L+E+      + G   L   + +V+    P++P+    +L  +++  
Sbjct: 182 YDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGP-TPSLPETYSRQLNSIMQSM 240

Query: 344 WQHDPTQRPNFSQI 357
              DP+ RP+ ++I
Sbjct: 241 LNKDPSLRPSAAEI 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  115 bits (289), Expect = 8e-30
 Identities = 75/221 (33%), Positives = 119/221 (53%), Gaps = 14/221 (6%)

Query: 121 GSYGDLY--KGTYCSQEVAIKVL--KPECVNT-EMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           G++G++Y        +E+A+K +   P+   T + +     E+ +++ +RH  +VQ+ G 
Sbjct: 13  GAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYG- 71

Query: 176 CTRPP---NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 232
           C R P    L I  E+M  GSI D L K  G        +    + +G++YLH N I+HR
Sbjct: 72  CLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRYTRQILQGVSYLHSNMIVHR 130

Query: 233 DLKTANLLMDENGVVKVADFGVA-RVQA--QSGV-MTAETGTYRWMAPEVIEHKPYDYKA 288
           D+K AN+L D  G VK+ DFG + R+Q    SG  + + TGT  WM+PEVI  + Y  KA
Sbjct: 131 DIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKA 190

Query: 289 DVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP 329
           DV+S    + E+LT + P+A    + A   +  +  +P +P
Sbjct: 191 DVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLP 231

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  116 bits (292), Expect = 9e-30
 Identities = 73/265 (27%), Positives = 128/265 (48%), Gaps = 16/265 (6%)

Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLK-PECVNTEMLKEFSQEVYIMRK 163
           +  D   L+   ++ SG+ G +YK  +      + V +     N E  K    ++ ++ K
Sbjct: 10  YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLK 69

Query: 164 IRH--KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKG 220
             H    +V+  G      ++ I  E M+  +  D L K+ +G      L K+ + + K 
Sbjct: 70  -SHDCPYIVKCYGYFITDSDVFICMELMS--TCLDKLLKRIQGPIPEDILGKMTVAIVKA 126

Query: 221 MNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI 279
           ++YL +   +IHRD+K +N+L+D +G VK+ DFG++     S   T   G   +MAPE I
Sbjct: 127 LHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERI 186

Query: 280 EHKP----YDYKADVFSFGIALWELLTGELPYAGL-TPLQAAVGVVQKSLRPTIPKHAH- 333
           +       YD +ADV+S GI+L EL TG+ PY    T  +    ++Q+   P++P +   
Sbjct: 187 DPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP-PSLPPNEGF 245

Query: 334 -PRLAELLERCWQHDPTQRPNFSQI 357
            P     ++ C   D  +RP + ++
Sbjct: 246 SPDFCSFVDLCLTKDHRKRPKYREL 270

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  116 bits (293), Expect = 1e-29
 Identities = 85/303 (28%), Positives = 145/303 (47%), Gaps = 31/303 (10%)

Query: 73  KRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAK---QLKIECKVASGSYGDLYKG 129
           +R P+L VP+   L   SS +     +  +      AK   +L+   ++ SG+ G +YK 
Sbjct: 36  QRDPSLAVPL--PLPPPSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKV 93

Query: 130 TY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187
            +    +  A+KV+     +T + ++  +E+ I+R + H NVV+          + ++ E
Sbjct: 94  IHRPTGRLYALKVIYGNHEDT-VRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152

Query: 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 247
           FM  GS+     +   +     L  VA  +  G+ YLH+ +I+HRD+K +NLL++    V
Sbjct: 153 FMDGGSL-----EGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNV 207

Query: 248 KVADFGVARVQAQSGVM---TAETGTYRWMAPEVI----EHKPYD-YKADVFSFGIALWE 299
           K+ADFGV+R+ AQ+  M    +  GT  +M+PE I     H  YD Y  D++S G+++ E
Sbjct: 208 KIADFGVSRILAQT--MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILE 265

Query: 300 LLTGELPYA-----GLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 354
              G  P+          L  A+ + Q    P  P  A       +  C Q +P +R + 
Sbjct: 266 FYLGRFPFGVGRQGDWASLMCAICMSQP---PEAPATASREFRHFISCCLQREPAKRWSA 322

Query: 355 SQI 357
            Q+
Sbjct: 323 MQL 325

Length = 353

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score =  117 bits (294), Expect = 2e-29
 Identities = 54/160 (33%), Positives = 91/160 (56%), Gaps = 4/160 (2%)

Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAET 268
           LL  +  V+KGM++L   N IHRDL   N+L+    + K+ DFG+AR ++  S  +    
Sbjct: 216 LLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGN 275

Query: 269 GTY--RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLR 325
                +WMAPE I +  Y +++DV+S+GI LWE+ + G  PY G+        ++++  R
Sbjct: 276 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR 335

Query: 326 PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
              P+ A   + ++++ CW  DP +RP F QI  +++Q +
Sbjct: 336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQL 375

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  115 bits (289), Expect = 2e-29
 Identities = 79/268 (29%), Positives = 130/268 (48%), Gaps = 20/268 (7%)

Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEV--AIKVLKPECVNTEMLKEFSQE 157
           D  +VWEI  +       +  G++G +YK          A KV+  E  + E L+++  E
Sbjct: 9   DPNEVWEIIGE-------LGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELEDYMVE 59

Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 217
           + I+    H  +V+ +GA      L I+ EF   G++   + +         +  +   +
Sbjct: 60  IEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQM 119

Query: 218 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGTYRWMAP 276
            + + YLH   IIHRDLK  N+L+  +G +K+ADFGV+    ++     +  GT  WMAP
Sbjct: 120 LEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAP 179

Query: 277 EVI-----EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--P 329
           EV+     +  PYDYKAD++S GI L E+   E P+  L P++  + +  KS  PT+  P
Sbjct: 180 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSEPPTLSQP 238

Query: 330 KHAHPRLAELLERCWQHDPTQRPNFSQI 357
                   + L+      P  RP+ +Q+
Sbjct: 239 SKWSMEFRDFLKTALDKHPETRPSAAQL 266

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score =  116 bits (291), Expect = 2e-29
 Identities = 58/170 (34%), Positives = 94/170 (55%), Gaps = 14/170 (8%)

Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--------VQ 258
           L  L+  +  V++GM +L     IHRDL   N+L+ EN VVK+ DFG+AR        V+
Sbjct: 172 LEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 231

Query: 259 AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 317
                +       +WMAPE I  K Y  ++DV+SFG+ LWE+ + G  PY G+   +   
Sbjct: 232 KGDARL-----PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFC 286

Query: 318 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
             +++  R   P++A P +  ++  CW ++P  RP FS++ +IL  +++E
Sbjct: 287 RRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score =  114 bits (288), Expect = 2e-29
 Identities = 72/259 (27%), Positives = 122/259 (47%), Gaps = 17/259 (6%)

Query: 121 GSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEV-YIMRKIRHKNVVQFIGACT 177
           G++G + K  +      +A+K ++      E  K    ++  +MR      +V+F GA  
Sbjct: 15  GAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQ-KRLLMDLDVVMRSSDCPYIVKFYGALF 73

Query: 178 RPPNLCIVTEFM--ARGSIYDFLH-KQKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRD 233
           R  +  I  E M  +    Y +++   K V     L K+A+   K +NYL +   IIHRD
Sbjct: 74  REGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRD 133

Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE---HKPYDYKADV 290
           +K +N+L+D NG +K+ DFG++     S   T + G   +MAPE I+      YD ++DV
Sbjct: 134 VKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDV 193

Query: 291 FSFGIALWELLTGELPYAGLTPLQAAVGVVQKS----LRPTIPKHAHPRLAELLERCWQH 346
           +S GI L+E+ TG+ PY     +   +  V K     L  +  +   P     +  C   
Sbjct: 194 WSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIK 253

Query: 347 DPTQRPNFSQI--TDILKQ 363
           D ++RP + ++     +K 
Sbjct: 254 DESKRPKYKELLEHPFIKD 272

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  114 bits (287), Expect = 3e-29
 Identities = 72/241 (29%), Positives = 127/241 (52%), Gaps = 12/241 (4%)

Query: 117 KVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFS-QEVYIMRKIRHKNVVQFI 173
           K+  G+ G ++     +  QEVAIK +    +  +  KE    E+ +M+++++ N+V F+
Sbjct: 26  KIGQGASGTVFTAIDVATGQEVAIKQIN---LQKQPKKELIINEILVMKELKNPNIVNFL 82

Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
            +      L +V E++A GS+ D +   +       +  V  +  + + +LH N +IHRD
Sbjct: 83  DSFLVGDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCRECLQALEFLHANQVIHRD 140

Query: 234 LKTANLLMDENGVVKVADFG-VARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 292
           +K+ N+L+  +G VK+ DFG  A++  +    +   GT  WMAPEV+  K Y  K D++S
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 200

Query: 293 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELLERCWQHDPTQ 350
            GI   E++ GE PY    PL+ A+ ++  +  P +  P+   P   + L RC + D  +
Sbjct: 201 LGIMAIEMVEGEPPYLNENPLR-ALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEK 259

Query: 351 R 351
           R
Sbjct: 260 R 260

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  114 bits (287), Expect = 3e-29
 Identities = 78/253 (30%), Positives = 132/253 (52%), Gaps = 20/253 (7%)

Query: 117 KVASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEF-SQEVYIMRKIRHKNVVQFI 173
           K+  GS G   + +  +  ++VA+K++    +  +  +E    EV IMR  +H+NVV+  
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHQNVVEMY 84

Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
            +      L ++ EF+  G++ D + + +       +  V   V + + YLH   +IHRD
Sbjct: 85  KSYLVGEELWVLMEFLQGGALTDIVSQTR--LNEEQIATVCESVLQALCYLHSQGVIHRD 142

Query: 234 LKTANLLMDENGVVKVADFG-VARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 292
           +K+ ++L+  +G VK++DFG  A++        +  GT  WMAPEVI   PY  + D++S
Sbjct: 143 IKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWS 202

Query: 293 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP---KHAH---PRLAELLERCWQH 346
            GI + E++ GE PY   +P+QA      K LR + P   K+AH   P L + LER    
Sbjct: 203 LGIMVIEMVDGEPPYFSDSPVQA-----MKRLRDSPPPKLKNAHKISPVLRDFLERMLTR 257

Query: 347 DPTQRPNFSQITD 359
           +P +R    ++ D
Sbjct: 258 EPQERATAQELLD 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  112 bits (282), Expect = 8e-29
 Identities = 70/263 (26%), Positives = 137/263 (52%), Gaps = 11/263 (4%)

Query: 112 LKIECKVASGSYGDLYKGTYC---SQEVAIKVLKP-ECVNTEMLKEFSQEVYIMRKIRHK 167
            +IE K+  G + ++Y+ T C    + VA+K ++  E ++ +  ++  +E+ +++++ H 
Sbjct: 4   FQIEKKIGRGQFSEVYRAT-CLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 168 NVVQFIGACTRPPNLCIVTEFMARGSIYD---FLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
           NV++++ +      L IV E    G +     +  KQK +    ++ K  + +   + ++
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVIEHKP 283
           H   ++HRD+K AN+ +   GVVK+ D G+ R   +++    +  GT  +M+PE I    
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG 182

Query: 284 YDYKADVFSFGIALWELLTGELP-YAGLTPLQAAVGVVQKSLRPTIPK-HAHPRLAELLE 341
           Y++K+D++S G  L+E+   + P Y     L +    +++   P +P  H   +L EL+ 
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVS 242

Query: 342 RCWQHDPTQRPNFSQITDILKQM 364
            C   DP QRP+   +  I KQM
Sbjct: 243 MCIYPDPDQRPDIGYVHQIAKQM 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  112 bits (282), Expect = 2e-28
 Identities = 84/287 (29%), Positives = 133/287 (46%), Gaps = 66/287 (22%)

Query: 116 CKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHKNV 169
             V  G+YG + K   C      + VAIK  K E  + E +K+ +  EV ++R++RH+N+
Sbjct: 7   GVVGEGAYGVVLK---CRNKATGEIVAIKKFK-ESEDDEDVKKTALREVKVLRQLRHENI 62

Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG----------VFQLTSLLKVAIDVSK 219
           V    A  R   L +V E++ R ++ + L    G          ++QL           +
Sbjct: 63  VNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLL----------Q 111

Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTYRWM-APE 277
            + Y H +NIIHRD+K  N+L+ E+GV+K+ DFG AR ++A+      +    RW  APE
Sbjct: 112 AIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPE 171

Query: 278 V-IEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKH----- 331
           + +    Y    DV++ G  + ELL GE  + G + +   + ++QK L P  P H     
Sbjct: 172 LLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID-QLYLIQKCLGPLPPSHQELFS 230

Query: 332 AHPRLA----------ELLER----------------CWQHDPTQRP 352
           ++PR A          E LER                C + DP +R 
Sbjct: 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERL 277

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  112 bits (281), Expect = 2e-28
 Identities = 66/273 (24%), Positives = 113/273 (41%), Gaps = 35/273 (12%)

Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           K+  G+YG +YK       + VAIK +K    +  + K   +E+ +++++ H N+++ + 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                 +L +V EFM    +Y  +  ++     + +      + +G+ + H + I+HRDL
Sbjct: 66  VFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDL 124

Query: 235 KTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWM-APEVI-EHKPYDYKADVF 291
           K  NLL++  GV+K+ADFG+AR         T    T RW  APE++   K Y    D++
Sbjct: 125 KPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVT-RWYRAPELLLGDKGYSTPVDIW 183

Query: 292 SFGIALWELLTGELPYAG------------------------LTPLQAAVGVVQKSLRPT 327
           S G    ELL+    + G                         T L              
Sbjct: 184 SVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGM 243

Query: 328 IPKHAHPRLAE----LLERCWQHDPTQRPNFSQ 356
                 P  +     LL +   +DP +R    Q
Sbjct: 244 PLPKLFPNASPQALDLLSQMLHYDPHKRITAEQ 276

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score =  113 bits (283), Expect = 2e-28
 Identities = 60/170 (35%), Positives = 94/170 (55%), Gaps = 14/170 (8%)

Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--------VQ 258
           +  L+  +  V++GM +L     IHRDL   N+L+ EN VVK+ DFG+AR        V+
Sbjct: 173 MEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 232

Query: 259 AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 317
             S  +       +WMAPE I  K Y  ++DV+SFG+ LWE+ + G  PY G+   +   
Sbjct: 233 KGSARL-----PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFC 287

Query: 318 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
             ++   R   P++A P +  ++  CWQ DP +RP FS + +IL  +++E
Sbjct: 288 QRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  112 bits (280), Expect = 3e-28
 Identities = 72/227 (31%), Positives = 119/227 (52%), Gaps = 18/227 (7%)

Query: 117 KVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           K+  GS G +   T  +  ++VA+K  K +    +  +    EV IMR   H+NVV    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVK--KMDLRKQQRRELLFNEVVIMRDYHHENVVDMYN 86

Query: 175 ACTRPPNLCIVTEFMARGSIYDFL-HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
           +      L +V EF+  G++ D + H +    Q+ +   V + V + ++YLH   +IHRD
Sbjct: 87  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT---VCLSVLRALSYLHNQGVIHRD 143

Query: 234 LKTANLLMDENGVVKVADFG-VARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 292
           +K+ ++L+  +G +K++DFG  A+V  +     +  GT  WMAPEVI   PY  + D++S
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWS 203

Query: 293 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
            GI + E++ GE PY    PLQA      + +R  +P    PR+ + 
Sbjct: 204 LGIMVIEMIDGEPPYFNEPPLQA-----MRRIRDNLP----PRVKDS 241

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  111 bits (280), Expect = 4e-28
 Identities = 65/215 (30%), Positives = 104/215 (48%), Gaps = 36/215 (16%)

Query: 116 CKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
            ++  G+YG +YK       + VA+K ++ E           +E+ +++K+RH N+V+  
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 174 GACTRPPNLCIVTEFMARGSIY--------DF--LHKQKGV-F---QLTSLLKVAIDVSK 219
                     IVT    +GSIY        D   L     V F   Q+   +K  +   +
Sbjct: 65  ---------EIVTS-KGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLL---E 111

Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA--QSGVMTAETGT--YRWMA 275
           G+ YLH N I+HRD+K +N+L++ +GV+K+ADFG+AR      S   T    T  YR   
Sbjct: 112 GLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYR--P 169

Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++     Y  + D++S G  L EL  G+  + G
Sbjct: 170 PELLLGATRYGPEVDMWSVGCILAELFLGKPIFQG 204

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  111 bits (278), Expect = 6e-28
 Identities = 72/241 (29%), Positives = 125/241 (51%), Gaps = 12/241 (4%)

Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFS-QEVYIMRKIRHKNVVQFI 173
           K+  G+ G +Y        QEVAIK +    +  +  KE    E+ +MR+ ++ N+V ++
Sbjct: 26  KIGQGASGTVYTAIDIATGQEVAIKQMN---LQQQPKKELIINEILVMRENKNPNIVNYL 82

Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
            +      L +V E++A GS+ D +   +       +  V  +  + +++LH N +IHRD
Sbjct: 83  DSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALDFLHSNQVIHRD 140

Query: 234 LKTANLLMDENGVVKVADFG-VARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 292
           +K+ N+L+  +G VK+ DFG  A++  +    +   GT  WMAPEV+  K Y  K D++S
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 200

Query: 293 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELLERCWQHDPTQ 350
            GI   E++ GE PY    PL+ A+ ++  +  P +  P+       + L RC + D  +
Sbjct: 201 LGIMAIEMVEGEPPYLNENPLR-ALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDR 259

Query: 351 R 351
           R
Sbjct: 260 R 260

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  110 bits (276), Expect = 6e-28
 Identities = 64/262 (24%), Positives = 133/262 (50%), Gaps = 9/262 (3%)

Query: 112 LKIECKVASGSYGDLYKGTYCSQEVAIKVLKPEC---VNTEMLKEFSQEVYIMRKIRHKN 168
            +IE K+  G + ++Y+ T     V + + K +    ++ +   +  +E+ +++++ H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 169 VVQFIGACTRPPNLCIVTEFMARGSIYDFLH---KQKGVFQLTSLLKVAIDVSKGMNYLH 225
           V+++  +      L IV E    G +   +    KQK +    ++ K  + +   + ++H
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123

Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVIEHKPY 284
              ++HRD+K AN+ +   GVVK+ D G+ R   +++    +  GT  +M+PE I    Y
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183

Query: 285 DYKADVFSFGIALWELLTGELPYAG-LTPLQAAVGVVQKSLRPTIPK-HAHPRLAELLER 342
           ++K+D++S G  L+E+   + P+ G    L +    +++   P +P  H    L +L+  
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNM 243

Query: 343 CWQHDPTQRPNFSQITDILKQM 364
           C   DP +RP+ + + D+ K+M
Sbjct: 244 CINPDPEKRPDITYVYDVAKRM 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score =  112 bits (280), Expect = 8e-28
 Identities = 58/169 (34%), Positives = 93/169 (55%), Gaps = 4/169 (2%)

Query: 202 KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--VQA 259
           K V  L  L+  +  V+KGM +L     IHRDL   N+L+ EN VVK+ DFG+AR   + 
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 232

Query: 260 QSGVMTAETG-TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 317
              V   +     +WMAPE I  + Y  ++DV+SFG+ LWE+ + G  PY G+   +   
Sbjct: 233 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 292

Query: 318 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
             +++  R   P +  P + + +  CW  +P+QRP FS++ + L  +++
Sbjct: 293 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  110 bits (276), Expect = 1e-27
 Identities = 76/245 (31%), Positives = 116/245 (47%), Gaps = 16/245 (6%)

Query: 117 KVASGSYGDLY--KGTYCSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
           ++  GS+G +Y  +    ++ VAIK +      + E  ++  +EV  ++++RH N +++ 
Sbjct: 22  EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81

Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
           G   R     +V E+   GS  D L   K   Q   +  +     +G+ YLH +  IHRD
Sbjct: 82  GCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRD 140

Query: 234 LKTANLLMDENGVVKVADFGVARVQ--AQSGVMTAETGTYRWMAPEVI---EHKPYDYKA 288
           +K  N+L+ E G VK+ADFG A +   A S V     GT  WMAPEVI   +   YD K 
Sbjct: 141 IKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMDEGQYDGKV 195

Query: 289 DVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK-HAHPRLAELLERCWQHD 347
           DV+S GI   EL   + P   +  + A   + Q    PT+            ++ C Q  
Sbjct: 196 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-SPTLSSNDWSDYFRNFVDSCLQKI 254

Query: 348 PTQRP 352
           P  RP
Sbjct: 255 PQDRP 259

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score =  111 bits (279), Expect = 3e-27
 Identities = 54/160 (33%), Positives = 89/160 (55%), Gaps = 4/160 (2%)

Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETG 269
           L+  +  V+ GM +L   N +HRDL   N+L+ E  +VK+ DFG+AR   +     ++  
Sbjct: 241 LVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGS 300

Query: 270 TY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLR 325
           T+   +WMAPE I +  Y   +DV+SFGI LWE+ T G  PY  L   +     +++  R
Sbjct: 301 TFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYR 360

Query: 326 PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
              P HA   + E++++CW+     RP+FSQ+  ++  ++
Sbjct: 361 MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  108 bits (271), Expect = 3e-27
 Identities = 73/245 (29%), Positives = 126/245 (51%), Gaps = 12/245 (4%)

Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +V SG+YGD+YK    +  +  A+K++K E  +   L    QE++++++ +H N+V + G
Sbjct: 16  RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL--IQQEIFMVKECKHCNIVAYFG 73

Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +      L I  E+   GS+ D  H    + +L  +  V  +  +G+ YLH    +HRD+
Sbjct: 74  SYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL-QIAYVCRETLQGLAYLHSKGKMHRDI 132

Query: 235 KTANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVI---EHKPYDYKADV 290
           K AN+L+ +NG VK+ADFGV A++ A      +  GT  WMAPEV    ++  Y+   D+
Sbjct: 133 KGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDI 192

Query: 291 FSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHA---HPRLAELLERCWQHD 347
           ++ GI   EL   + P   L P++A   + + + +P   K            ++     +
Sbjct: 193 WAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKN 252

Query: 348 PTQRP 352
           P +RP
Sbjct: 253 PKKRP 257

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score =  110 bits (277), Expect = 4e-27
 Identities = 52/163 (31%), Positives = 88/163 (53%), Gaps = 4/163 (2%)

Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266
              LL     V++GM +L   N +HRDL   N+L+ +  +VK+ DFG+AR         +
Sbjct: 236 TLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS 295

Query: 267 ETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK 322
           +  T+   +WMAPE I    Y   +DV+S+GI LWE+ + G  PY G+         ++ 
Sbjct: 296 KGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKS 355

Query: 323 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
             R   P HA   + +++ +CW  +P +RP+F  ++DI++ ++
Sbjct: 356 GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  108 bits (271), Expect = 5e-27
 Identities = 76/249 (30%), Positives = 121/249 (48%), Gaps = 18/249 (7%)

Query: 121 GSYGDLYKGTYCSQE--VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR 178
           G+ G +YK  +      +A+KV+ P  +  E+ K+   E+ I+ K     ++ F GA   
Sbjct: 12  GNGGTVYKAYHLLTRRILAVKVI-PLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV 70

Query: 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN 238
              + I TEFM  GS+  +    + V     L ++A+ V KG+ YL    I+HRD+K +N
Sbjct: 71  ENRISICTEFMDGGSLDVYRKIPEHV-----LGRIAVAVVKGLTYLWSLKILHRDVKPSN 125

Query: 239 LLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALW 298
           +L++  G VK+ DFGV+  Q  + +     GT  +MAPE I  + Y   +DV+S GI+  
Sbjct: 126 MLVNTRGQVKLCDFGVST-QLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFM 184

Query: 299 ELLTGELPY-------AGLTPLQAAVGVVQKSLRPTIPKHA-HPRLAELLERCWQHDPTQ 350
           EL  G  PY         L PLQ    +V +   P +P      +    + +C +  P +
Sbjct: 185 ELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-PPVLPVGQFSEKFVHFITQCMRKQPKE 243

Query: 351 RPNFSQITD 359
           RP    + D
Sbjct: 244 RPAPENLMD 252

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  107 bits (270), Expect = 6e-27
 Identities = 64/197 (32%), Positives = 100/197 (50%), Gaps = 8/197 (4%)

Query: 118 VASGSYGDLYKGTYCSQEV--AIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G +G +      S+    A+K + K   V T   +    E  I+ +  H  +V+   
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
                  + ++ E+   G ++  L   +G+F + T+   +A  V     YLH   II+RD
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRD-RGLFDEYTARFYIACVVL-AFEYLHNRGIIYRD 118

Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFS 292
           LK  NLL+D NG VK+ DFG A+ + +SG  T    GT  ++APE+I +K YD+  D +S
Sbjct: 119 LKPENLLLDSNGYVKLVDFGFAK-KLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWS 177

Query: 293 FGIALWELLTGELPYAG 309
            GI L+ELLTG  P+  
Sbjct: 178 LGILLYELLTGRPPFGE 194

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  108 bits (271), Expect = 6e-27
 Identities = 71/241 (29%), Positives = 123/241 (51%), Gaps = 12/241 (4%)

Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFS-QEVYIMRKIRHKNVVQFI 173
           K+  G+ G +Y        QEVAI+ +    +  +  KE    E+ +MR+ ++ N+V ++
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYL 83

Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
            +      L +V E++A GS+ D +   +       +  V  +  + + +LH N +IHRD
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQVIHRD 141

Query: 234 LKTANLLMDENGVVKVADFG-VARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 292
           +K+ N+L+  +G VK+ DFG  A++  +    +   GT  WMAPEV+  K Y  K D++S
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 201

Query: 293 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELLERCWQHDPTQ 350
            GI   E++ GE PY    PL+ A+ ++  +  P +  P+       + L RC   D  +
Sbjct: 202 LGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEK 260

Query: 351 R 351
           R
Sbjct: 261 R 261

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  108 bits (271), Expect = 8e-27
 Identities = 77/242 (31%), Positives = 115/242 (47%), Gaps = 10/242 (4%)

Query: 117 KVASGSYGDLY--KGTYCSQEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNVVQFI 173
           ++  GS+G +Y  +    S+ VAIK +      + E  ++  +EV  ++K+RH N +Q+ 
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
           G   R     +V E+   GS  D L   K   Q   +  V     +G+ YLH +N+IHRD
Sbjct: 82  GCYLREHTAWLVMEY-CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140

Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI---EHKPYDYKADV 290
           +K  N+L+ E G+VK+ DFG A + A +       GT  WMAPEVI   +   YD K DV
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYDGKVDV 197

Query: 291 FSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ 350
           +S GI   EL   + P   +  + A   + Q         H        ++ C Q  P  
Sbjct: 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQD 257

Query: 351 RP 352
           RP
Sbjct: 258 RP 259

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  107 bits (268), Expect = 8e-27
 Identities = 56/221 (25%), Positives = 101/221 (45%), Gaps = 4/221 (1%)

Query: 142 KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQ 201
           K +CV    ++    E  I++++ H  +V    +     N+ +V + +  G +   L  Q
Sbjct: 35  KQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHL-SQ 93

Query: 202 KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261
           K  F    +     ++   + YLH   IIHRD+K  N+L+DE G V + DF +A      
Sbjct: 94  KVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153

Query: 262 GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAG-LTPLQAAVGVV 320
            + T+ +GT  +MAPEV+  + Y    D +S G+  +E L G+ PY G    ++  +   
Sbjct: 154 TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK 213

Query: 321 QKSLRPTIPKHAHPRLAELLERCWQHDPTQR--PNFSQITD 359
           Q++     P        + + +  + DP +R   N   + +
Sbjct: 214 QETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  107 bits (270), Expect = 9e-27
 Identities = 80/279 (28%), Positives = 134/279 (48%), Gaps = 44/279 (15%)

Query: 117 KVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFS-QEVYIMRKIRHKNVV 170
            V  GSYG + K   C      Q VAIK    E  + +M+K+ + +E+ +++++RH+N+V
Sbjct: 8   LVGEGSYGMVMK---CKHKETGQIVAIKKFL-ESEDDKMVKKIAMREIRMLKQLRHENLV 63

Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
             I    R   L +V EF+   ++ D L K       + + K    + +G+ + H +NII
Sbjct: 64  NLIEVFRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNII 122

Query: 231 HRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM-APEVIEHKP-YDYKA 288
           HRD+K  N+L+ ++GVVK+ DFG AR  A  G +  +    RW  APE++     Y    
Sbjct: 123 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAV 182

Query: 289 DVFSFGIALWELLTGELPYAG--------------------------LTPLQAAVGVVQ- 321
           D+++ G  + E+LTGE  + G                            PL A + + + 
Sbjct: 183 DIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEV 242

Query: 322 ---KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
              + L    PK +   + +L ++C + DP  RP+ SQ+
Sbjct: 243 KEIEPLEKRFPKLS-GLVLDLAKQCLRIDPDDRPSSSQL 280

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score =  106 bits (267), Expect = 2e-26
 Identities = 76/257 (29%), Positives = 129/257 (50%), Gaps = 22/257 (8%)

Query: 124 GDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183
           G+ ++G   ++ V +K L+      E L  F QEV   R++ H NV+Q +G C       
Sbjct: 14  GEAHRGMSKAR-VVVKELRASATPDEQL-LFLQEVQPYRELNHPNVLQCLGQCIESIPYL 71

Query: 184 IVTEFMARGSIYDFLHKQKGVF----QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANL 239
           +V EF   G + ++L   +G+     Q   L ++A +V+ G+ +LHQ + IH DL   N 
Sbjct: 72  LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNC 131

Query: 240 LMDENGVVKVADFGVARVQ-AQSGVMTAETGTY--RWMAPEVIEH-----KPYDY--KAD 289
            +  +  VK+ D+G+A  Q  +   +T +      RW+APE++E       P D   K++
Sbjct: 132 QLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSN 191

Query: 290 VFSFGIALWELLT-GELPYAGLTPLQAAVGVVQ----KSLRPTIPKHAHPRLAELLERCW 344
           ++S G+ +WEL T  + PY  L+  Q    VV+    K  +P +      R  E+++ CW
Sbjct: 192 IWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW 251

Query: 345 QHDPTQRPNFSQITDIL 361
             DP  RP   ++ ++L
Sbjct: 252 L-DPETRPTAEEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  107 bits (269), Expect = 2e-26
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 32/208 (15%)

Query: 113 KIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKE---FS--QEVYIMRKIR 165
           +   K+  G+Y  +YK       + VAIK +K      +  K+   F+  +E+ ++++++
Sbjct: 3   EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLG--ERKEAKDGINFTALREIKLLQELK 60

Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS------- 218
           H N++  +       N+ +V EFM      D     + V +  S++    D+        
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFME----TDL----EKVIKDKSIVLTPADIKSYMLMTL 112

Query: 219 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWM-AP 276
           +G+ YLH N I+HRDLK  NLL+  +GV+K+ADFG+AR        MT +  T RW  AP
Sbjct: 113 RGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVT-RWYRAP 171

Query: 277 EVI---EHKPYDYKADVFSFGIALWELL 301
           E++    H  Y    D++S G    ELL
Sbjct: 172 ELLFGARH--YGVGVDMWSVGCIFAELL 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  106 bits (265), Expect = 2e-26
 Identities = 60/204 (29%), Positives = 114/204 (55%), Gaps = 3/204 (1%)

Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVA 214
           +E  ++ K++H N+V F  +     +L IV E+   G +   +  Q+G +F   ++L+  
Sbjct: 47  KEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWF 106

Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRW 273
           + +  G+ ++H+  ++HRD+K+ N+ + +NG VK+ DFG AR+    G       GT  +
Sbjct: 107 VQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYY 166

Query: 274 MAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH 333
           + PE+ E+ PY+ K+D++S G  L+EL T + P+   +     + V Q S +P +P H  
Sbjct: 167 VPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP-LPSHYS 225

Query: 334 PRLAELLERCWQHDPTQRPNFSQI 357
             L  L+++ ++ +P  RP+ + I
Sbjct: 226 YELRSLIKQMFKRNPRSRPSATTI 249

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  106 bits (265), Expect = 2e-26
 Identities = 67/235 (28%), Positives = 116/235 (49%), Gaps = 24/235 (10%)

Query: 135 EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 194
            V +KVL  +  ++     F +   +M ++ HK++V+  G C R  N+ +V E++  G +
Sbjct: 32  SVVLKVLGSDHRDSL---AFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPL 87

Query: 195 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV-------V 247
             FLH++K    L   L VA  ++  ++YL    ++H ++   N+L+   G+       +
Sbjct: 88  DVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFI 147

Query: 248 KVADFGVARVQAQSGVMTAETGTYR--WMAPEVIE--HKPYDYKADVFSFGIALWELLT- 302
           K++D G+        V++ E    R  W+APE I          AD +SFG  L E+ + 
Sbjct: 148 KLSDPGIPI-----TVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202

Query: 303 GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
           GE P + L+  +       +   P +P  A   LA L+ +CW +DPT+RP+F  I
Sbjct: 203 GEEPLSTLSSSEKERFYQDQHRLP-MPDCA--ELANLINQCWTYDPTKRPSFRAI 254

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  106 bits (266), Expect = 5e-26
 Identities = 77/255 (30%), Positives = 123/255 (48%), Gaps = 15/255 (5%)

Query: 117 KVASGSYGDLY--KGTYCSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
           ++  GS+G +Y  +    ++ VAIK +      + E  ++  +EV  +++I+H N +++ 
Sbjct: 32  EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91

Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
           G   R     +V E+   GS  D L   K   Q   +  +     +G+ YLH +N+IHRD
Sbjct: 92  GCYLREHTAWLVMEY-CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 150

Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI---EHKPYDYKADV 290
           +K  N+L+ E G VK+ADFG A + + +       GT  WMAPEVI   +   YD K DV
Sbjct: 151 IKAGNILLTEPGQVKLADFGSASIASPANSF---VGTPYWMAPEVILAMDEGQYDGKVDV 207

Query: 291 FSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHA-HPRLAELLERCWQHDPT 349
           +S GI   EL   + P   +  + A   + Q    PT+  +         ++ C Q  P 
Sbjct: 208 WSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SPTLQSNEWSDYFRNFVDSCLQKIPQ 266

Query: 350 QRPNFSQITDILKQM 364
            RP   +   +LK M
Sbjct: 267 DRPTSEE---LLKHM 278

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score =  107 bits (268), Expect = 6e-26
 Identities = 57/165 (34%), Positives = 96/165 (58%), Gaps = 8/165 (4%)

Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMT 265
           L  LL+ +  V++GM++L   N IHRD+   N+L+ +  V K+ DFG+AR +   S  + 
Sbjct: 211 LDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270

Query: 266 AETGTYR----WMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVV 320
              G  R    WMAPE I    Y  ++DV+S+GI LWE+ + G+ PY G+        +V
Sbjct: 271 --KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV 328

Query: 321 QKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
           ++  + + P  A P +  +++ CW  +PT+RP FSQI+ ++++ +
Sbjct: 329 KRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score =  105 bits (263), Expect = 6e-26
 Identities = 70/283 (24%), Positives = 133/283 (46%), Gaps = 28/283 (9%)

Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEV 158
           EI+   ++   ++    +G +YKG          +Q VAIK LK +     + +EF  E 
Sbjct: 1   EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDK-AEGPLREEFKHEA 59

Query: 159 YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL-----HKQ----------KG 203
            +  +++H N+V  +G  T+   L ++  + +   +++FL     H            K 
Sbjct: 60  MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119

Query: 204 VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQS- 261
             +    + +   ++ GM +L  ++++H+DL T N+L+ +   VK++D G+ R V A   
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADY 179

Query: 262 -GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGV 319
             +M       RWM+PE I +  +   +D++S+G+ LWE+ + G  PY G +  Q  + +
Sbjct: 180 YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-QDVIEM 238

Query: 320 VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK 362
           ++       P      +  L+  CW   P++RP F  I   L+
Sbjct: 239 IRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  105 bits (263), Expect = 9e-26
 Identities = 73/248 (29%), Positives = 122/248 (49%), Gaps = 12/248 (4%)

Query: 117 KVASGSYGDLYKGT--YCSQEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNVVQFI 173
           ++  GS+G +Y  T  + ++ VA+K +      T E  ++  +EV  +++++H N +++ 
Sbjct: 28  EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
           G   +     +V E+   GS  D L   K   Q   +  +     +G+ YLH +N+IHRD
Sbjct: 88  GCYLKEHTAWLVMEY-CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 146

Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI---EHKPYDYKADV 290
           +K  N+L+ E G VK+ADFG A   + +       GT  WMAPEVI   +   YD K DV
Sbjct: 147 IKAGNILLTEPGQVKLADFGSASKSSPANSF---VGTPYWMAPEVILAMDEGQYDGKVDV 203

Query: 291 FSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHA-HPRLAELLERCWQHDPT 349
           +S GI   EL   + P   +  + A   + Q    PT+  +         ++ C Q  P 
Sbjct: 204 WSLGITCIELAERKPPLFNMNAMSALYHIAQND-SPTLQSNEWTDSFRGFVDYCLQKIPQ 262

Query: 350 QRPNFSQI 357
           +RP  +++
Sbjct: 263 ERPASAEL 270

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  102 bits (257), Expect = 6e-25
 Identities = 62/251 (24%), Positives = 127/251 (50%), Gaps = 22/251 (8%)

Query: 111 QLKIECKVASGSYGDLYK------GTYCSQEVAIKVLK-PECVNTEMLKEFSQEVYIMRK 163
            L+    V +G++G ++         Y     A+KV+  PE +  +  +    E  ++++
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYY----ALKVMAIPEVIRLKQEQHVHNEKRVLKE 57

Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 223
           + H  +++          L ++ E++  G ++ +L +  G F  ++ L  A ++   + Y
Sbjct: 58  VSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL-RNSGRFSNSTGLFYASEIVCALEY 116

Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVIEHK 282
           LH   I++RDLK  N+L+D+ G +K+ DFG A+ ++ ++  +    GT  ++APEVI+ K
Sbjct: 117 LHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL---CGTPEYLAPEVIQSK 173

Query: 283 PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELL 340
            ++   D ++ GI ++E+L G  P+    P     G+ +K L   +  P+H      +L+
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPPFFDDNPF----GIYEKILAGKLEFPRHLDLYAKDLI 229

Query: 341 ERCWQHDPTQR 351
           ++    D T+R
Sbjct: 230 KKLLVVDRTRR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  102 bits (257), Expect = 9e-25
 Identities = 61/188 (32%), Positives = 89/188 (47%), Gaps = 9/188 (4%)

Query: 127 YKGTYCSQEVAIKVLKPECV----NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182
           YK T   +  AIK LK   +      E L    +        RH  +V          ++
Sbjct: 20  YKKT--GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHV 77

Query: 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD 242
           C V E+ A G +   +H    VF     +  A  V  G+ YLH+N I++RDLK  NLL+D
Sbjct: 78  CFVMEYAAGGDL--MMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD 135

Query: 243 ENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELL 301
             G VK+ADFG+ +     G  T+   GT  ++APEV+    Y    D +  G+ ++E+L
Sbjct: 136 TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEML 195

Query: 302 TGELPYAG 309
            GE P+ G
Sbjct: 196 VGESPFPG 203

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  102 bits (256), Expect = 9e-25
 Identities = 79/298 (26%), Positives = 124/298 (41%), Gaps = 71/298 (23%)

Query: 113 KIECKVASGSYGDLYKGTY--CSQEVAIKVLK------PECVNTEMLKEFSQEVYIMRKI 164
           K+  ++  G++G +Y        + VAIK +K       EC+N   L+E    V  +RK+
Sbjct: 2   KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN---LRE----VKSLRKL 54

Query: 165 -RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-----------VFQLTSLLK 212
             H N+V+          L  V E+M  G++Y  +  +KG           ++Q+     
Sbjct: 55  NEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQ--- 110

Query: 213 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYR 272
                  G+ ++H++   HRDLK  NLL+    VVK+ADFG+AR        T    T R
Sbjct: 111 -------GLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVST-R 162

Query: 273 WM-APEVIEHKP-YDYKADVFSFGIALWELLTGELPYAGL--------------TP---- 312
           W  APE++     Y    D+++ G  + EL T    + G               TP    
Sbjct: 163 WYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQD 222

Query: 313 ------LQAAVG-----VVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD 359
                 L + +G         SL   IP +A P   +L++   + DP +RP  SQ   
Sbjct: 223 WPEGYKLASKLGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQ 279

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  101 bits (252), Expect = 2e-24
 Identities = 86/283 (30%), Positives = 128/283 (45%), Gaps = 42/283 (14%)

Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYK--GTYCSQEVAIKVLKPECVNTEMLKEFSQE 157
           D +D WEI      IE  +  G+YG ++K        + A+K+L P     ++ +E   E
Sbjct: 15  DPSDTWEI------IE-TIGKGTYGKVFKVLNKKNGSKAAVKILDPI---HDIDEEIEAE 64

Query: 158 VYIMRKIR-HKNVVQFIGACTRPP-----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLL 211
             I++ +  H NVV+F G   +        L +V E    GS+ D +   KG  +    +
Sbjct: 65  YNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV---KGFLKRGERM 121

Query: 212 KVAI------DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV-ARVQAQSGVM 264
           +  I      +   G+ +LH N  IHRD+K  N+L+   G VK+ DFGV A++ +     
Sbjct: 122 EEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 181

Query: 265 TAETGTYRWMAPEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV 319
               GT  WMAPEVI         YD + DV+S GI   EL  G+ P A L P++A    
Sbjct: 182 NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF-- 239

Query: 320 VQKSLRPTIPKHAHPRL-----AELLERCWQHDPTQRPNFSQI 357
             K  R   P    P L      + + +C   D  +RP  S +
Sbjct: 240 --KIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDL 280

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  101 bits (253), Expect = 2e-24
 Identities = 48/177 (27%), Positives = 88/177 (49%), Gaps = 12/177 (6%)

Query: 134 QEVAIKVL----KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM 189
           + VA+K +        +  + L+E    +  ++  +H  VV+ +          +V E+M
Sbjct: 26  ETVALKKVALRRLEGGIPNQALRE----IKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81

Query: 190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV 249
               + + L  ++       +      + KG+ Y+H N I+HRDLK ANLL+  +GV+K+
Sbjct: 82  PS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKI 140

Query: 250 ADFGVARVQA--QSGVMTAETGTYRWMAPEVIEHKP-YDYKADVFSFGIALWELLTG 303
           ADFG+AR+ +  +  + + +  T  + APE++     YD   D+++ G    ELL G
Sbjct: 141 ADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  100 bits (251), Expect = 2e-24
 Identities = 67/245 (27%), Positives = 103/245 (42%), Gaps = 20/245 (8%)

Query: 118 VASGSYGDLY--KGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHK-NVVQFI 173
           ++ G++G +Y  K        AIKVL K + +    +     E  IM        V +  
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
            +      L +V E++  G     + K  G        +   +V  G+  LHQ  IIHRD
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCASLI-KTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRD 122

Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFS 292
           +K  NLL+D+ G +K+ DFG++R     G+   +  GT  ++APE I     D  +D +S
Sbjct: 123 IKPENLLIDQTGHLKLTDFGLSRN----GLENKKFVGTPDYLAPETILGVGDDKMSDWWS 178

Query: 293 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH------PRLAELLERCWQH 346
            G  ++E L G  P+   TP      V    L   I           P   +L+ R    
Sbjct: 179 LGCVIFEFLFGYPPFHAETPDA----VFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234

Query: 347 DPTQR 351
           DP +R
Sbjct: 235 DPAKR 239

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  101 bits (253), Expect = 3e-24
 Identities = 62/241 (25%), Positives = 116/241 (48%), Gaps = 18/241 (7%)

Query: 121 GSYGDL----YKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-----RHKNVVQ 171
           GS+G +     KGT   +  A+KVLK + +  +   E +      +++     +H  + Q
Sbjct: 6   GSFGKVLLAELKGT--DELYAVKVLKKDVILQDDDVECTM---TEKRVLALAGKHPFLTQ 60

Query: 172 FIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 231
                     L  V E++  G +   + +  G F        A ++  G+ +LH+  II+
Sbjct: 61  LHSCFQTKDRLFFVMEYVNGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERGIIY 119

Query: 232 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADV 290
           RDLK  N+L+D  G +K+ADFG+ +     GV T+   GT  ++APE++ ++PY    D 
Sbjct: 120 RDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDW 179

Query: 291 FSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ 350
           ++ G+ L+E+L G+ P+ G    +    +++  +R   P+        +L+     +P +
Sbjct: 180 WALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVR--YPRWLSKEAKSILKSFLTKNPEK 237

Query: 351 R 351
           R
Sbjct: 238 R 238

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score =  100 bits (250), Expect = 4e-24
 Identities = 87/283 (30%), Positives = 133/283 (46%), Gaps = 38/283 (13%)

Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQE 157
           D TD WEI      IE  +  G+YG +YK T        A+K+L P    +++ +E   E
Sbjct: 19  DPTDTWEI------IE-TIGKGTYGKVYKVTNKKDGSLAAVKILDPI---SDVDEEIEAE 68

Query: 158 VYIMRKI-RHKNVVQFIGACTRPPN-----LCIVTEFMARGSIYDFLHKQKGVFQLTSLL 211
             I++ +  H NVV+F G   +        L +V E    GS+ + +   KG+      L
Sbjct: 69  YNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV---KGLLICGQRL 125

Query: 212 KVAI------DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT 265
             A+          G+ +LH N IIHRD+K  N+L+   G VK+ DFGV+  Q  S  + 
Sbjct: 126 DEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS-AQLTSTRLR 184

Query: 266 AET--GTYRWMAPEVIE-HKPYDY----KADVFSFGIALWELLTGELPYAGLTPLQAAVG 318
             T  GT  WMAPEVI   + YDY    + DV+S GI   EL  G+ P   + P++    
Sbjct: 185 RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK 244

Query: 319 VVQKSLRPTI--PKHAHPRLAELLERCWQHDPTQRPNFSQITD 359
            + ++  PT+  P+         + +C   D   RP+ + + +
Sbjct: 245 -IPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 99.5 bits (248), Expect = 6e-24
 Identities = 62/255 (24%), Positives = 122/255 (47%), Gaps = 16/255 (6%)

Query: 120 SGSYGDLYKGTYCSQEVAIKVLK------PECVNTEMLKEFS-----QEVYIMRK-IRHK 167
           SG++G +YK    +    +  LK      P     +  ++ S      EV I+++ +RH 
Sbjct: 10  SGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHP 69

Query: 168 NVVQFIGACTRPPNLCIVTEFMARGSIYDF---LHKQKGVFQLTSLLKVAIDVSKGMNYL 224
           N+V++         L IV + +    + +    L ++K  F    +  + + +   + YL
Sbjct: 70  NIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYL 129

Query: 225 H-QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKP 283
           H +  I+HRDL   N+++ E+  V + DFG+A+ +     +T+  GT  +  PE+++++P
Sbjct: 130 HKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEP 189

Query: 284 YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC 343
           Y  KADV++FG  L+++ T + P+     L  A  +V+    P         + +++  C
Sbjct: 190 YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSC 249

Query: 344 WQHDPTQRPNFSQIT 358
              D   RP+  Q++
Sbjct: 250 LTPDAEARPDIIQVS 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 99.4 bits (248), Expect = 9e-24
 Identities = 60/246 (24%), Positives = 119/246 (48%), Gaps = 11/246 (4%)

Query: 126 LYKGTYCSQEVAIKVLKPECVNTEMLKE-FSQEVYIMRKIRHKNVVQ----FIGACTRPP 180
           +YKG + ++EV I+  K      ++L +    E+  +R+I   N+++     I      P
Sbjct: 36  IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95

Query: 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANL 239
            L ++ E+  RG + + L K+K +    + L +AID  KG+  L++  N  +++L + + 
Sbjct: 96  RLSLILEYCTRGYLREVLDKEKDL-SFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSF 154

Query: 240 LMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH--KPYDYKADVFSFGIAL 297
           L+ EN  +K+   G+ ++ +           Y   + +++      Y  K D++S G+ L
Sbjct: 155 LVTENYKLKIICHGLEKILSSPPFKNVNFMVYF--SYKMLNDIFSEYTIKDDIYSLGVVL 212

Query: 298 WELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
           WE+ TG++P+  LT  +    ++ K+    +P      +  ++E C  HD  +RPN  +I
Sbjct: 213 WEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEI 272

Query: 358 TDILKQ 363
              L  
Sbjct: 273 LYNLSL 278

Length = 283

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 98.7 bits (246), Expect = 1e-23
 Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 15/204 (7%)

Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI-YDFLHKQKGVFQLTSLLKVAI 215
           E  I+ K+  + +V    A     +LC+V   M  G + Y   +  +  F     +  A 
Sbjct: 43  EKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA 102

Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
            +  G+ +LHQ  I++RDLK  N+L+D++G V+++D G+A        +    GT  +MA
Sbjct: 103 QIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMA 162

Query: 276 PEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK--------SLRPT 327
           PEV++ + YD+  D F+ G  L+E++      AG +P +     V+K         +   
Sbjct: 163 PEVLQGEVYDFSVDWFALGCTLYEMI------AGRSPFRQRKEKVEKEELKRRTLEMAVE 216

Query: 328 IPKHAHPRLAELLERCWQHDPTQR 351
            P    P   +L E   Q DP +R
Sbjct: 217 YPDKFSPEAKDLCEALLQKDPEKR 240

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 93.8 bits (233), Expect = 7e-22
 Identities = 56/175 (32%), Positives = 90/175 (51%), Gaps = 4/175 (2%)

Query: 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN 238
           P  L  + + M  G ++  L  Q GVF    +   A ++  G+ ++H   +++RDLK AN
Sbjct: 69  PDKLSFILDLMNGGDLHYHL-SQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPAN 127

Query: 239 LLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIAL 297
           +L+DE+G V+++D G+A          A  GT+ +MAPEV++    YD  AD FS G  L
Sbjct: 128 ILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCML 186

Query: 298 WELLTGELPYAGL-TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           ++LL G  P+    T  +  +  +  ++   +P    P L  LLE   Q D  +R
Sbjct: 187 FKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRR 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 93.8 bits (233), Expect = 8e-22
 Identities = 69/264 (26%), Positives = 129/264 (48%), Gaps = 25/264 (9%)

Query: 117 KVASGSYGDLYKGT----YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 172
           ++ +G +G +  G     Y   +V +K L+      E +K F +E    R ++H N++Q 
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMK-FLEEAQPYRSLQHSNLLQC 60

Query: 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT----SLLKVAIDVSKGMNYLHQNN 228
           +G CT      +V EF   G +  +L   +    +T    +L ++A +++ G+ +LH+NN
Sbjct: 61  LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120

Query: 229 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVIEHKPYD 285
            IH DL   N L+  +  VK+ D+G++  + +          +   RW+APE+++    +
Sbjct: 121 FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGN 180

Query: 286 Y-------KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVV-QKSLRPTIPKHAHP-- 334
                   +++V+S G+ +WEL   G  PY  L+  Q     V ++ L+   P+   P  
Sbjct: 181 LLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLS 240

Query: 335 -RLAELLERCWQHDPTQRPNFSQI 357
            R  E+++ CW   P QRP+  ++
Sbjct: 241 DRWYEVMQFCWLQ-PEQRPSAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 94.5 bits (235), Expect = 9e-22
 Identities = 65/238 (27%), Positives = 120/238 (50%), Gaps = 11/238 (4%)

Query: 121 GSYGDLY-----KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           GS+G ++      G    Q  A+KVLK   +          E  I+ ++ H  +V+   A
Sbjct: 7   GSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYA 66

Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
                 L ++ +F+  G ++  L K+  +F    +     +++  +++LH   II+RDLK
Sbjct: 67  FQTEGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSLGIIYRDLK 125

Query: 236 TANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFSF 293
             N+L+DE G +K+ DFG+++ ++      A +  GT  +MAPEV+  + +   AD +SF
Sbjct: 126 PENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSF 184

Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+LTG LP+ G    +    +++  L   +P+   P    LL   ++ +P  R
Sbjct: 185 GVLMFEMLTGSLPFQGKDRKETMTMILKAKL--GMPQFLSPEAQSLLRALFKRNPANR 240

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 94.5 bits (235), Expect = 1e-21
 Identities = 71/248 (28%), Positives = 120/248 (48%), Gaps = 30/248 (12%)

Query: 118 VASGSYGDL----YKGTYCSQEVAIKVLKP-ECVNTEMLKEFSQEVYIMRKIRHKNVVQF 172
           + +GS+G +    +KGT   +  AIK LK  E +  + ++  +QE  I+ ++ H  +V  
Sbjct: 26  LGTGSFGRVRIAKHKGT--GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNM 83

Query: 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK--------GMNYL 224
           + +      +  + EF+  G ++  L K           +   DV+K           YL
Sbjct: 84  MCSFQDENRVYFLLEFVVGGELFTHLRKAG---------RFPNDVAKFYHAELVLAFEYL 134

Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKP 283
           H  +II+RDLK  NLL+D  G VKV DFG A +V  ++  +    GT  ++APEVI+ K 
Sbjct: 135 HSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTL---CGTPEYLAPEVIQSKG 191

Query: 284 YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC 343
           +    D ++ G+ L+E + G  P+   TP +    ++   L+   P     R  +L++  
Sbjct: 192 HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLK--FPNWFDGRARDLVKGL 249

Query: 344 WQHDPTQR 351
            Q D T+R
Sbjct: 250 LQTDHTKR 257

Length = 329

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 93.7 bits (233), Expect = 2e-21
 Identities = 67/244 (27%), Positives = 121/244 (49%), Gaps = 24/244 (9%)

Query: 121 GSYGDLY----KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-----RHKNVVQ 171
           GS+G +     KGT  ++  AIK LK + V   +  +  +   + R++      H  +  
Sbjct: 6   GSFGKVMLAELKGT--NEFFAIKALKKDVV---LEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 172 FIGACTRPPNLCIVTEFMARGSIYDFLH--KQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
                    +L  V E++  G   D +   +  G F        A ++  G+ +LH+  I
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGG---DLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGI 117

Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYK 287
           I+RDLK  N+L+D++G +K+ADFG+ +    +G   A T  GT  ++APE+++ + Y+  
Sbjct: 118 IYRDLKLDNVLLDKDGHIKIADFGMCKENM-NGEGKASTFCGTPDYIAPEILKGQKYNES 176

Query: 288 ADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHD 347
            D +SFG+ L+E+L G+ P+ G    +    ++    RP  P+       + L + ++ D
Sbjct: 177 VDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND--RPHFPRWISKEAKDCLSKLFERD 234

Query: 348 PTQR 351
           PT+R
Sbjct: 235 PTKR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 93.1 bits (231), Expect = 2e-21
 Identities = 70/245 (28%), Positives = 117/245 (47%), Gaps = 16/245 (6%)

Query: 118 VASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY-----IMRKIRHKNVVQF 172
           +  G +G++Y    C +    K+   +C++ + +K    E       IM  +       F
Sbjct: 2   IGRGGFGEVYG---CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 58

Query: 173 IGACT----RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 228
           I   T     P  LC + + M  G ++  L  Q GVF    +   A ++  G+ ++H   
Sbjct: 59  IVCMTYAFHTPDKLCFILDLMNGGDLHYHL-SQHGVFSEKEMRFYATEIILGLEHMHNRF 117

Query: 229 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 287
           +++RDLK AN+L+DE+G V+++D G+A          A  GT+ +MAPEV++    YD  
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVLQKGTAYDSS 176

Query: 288 ADVFSFGIALWELLTGELPY-AGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH 346
           AD FS G  L++LL G  P+    T  +  +  +  ++   +P    P L  LLE   Q 
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQR 236

Query: 347 DPTQR 351
           D ++R
Sbjct: 237 DVSKR 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 93.5 bits (232), Expect = 2e-21
 Identities = 68/276 (24%), Positives = 129/276 (46%), Gaps = 15/276 (5%)

Query: 118 VASGSYGDLYKGTYCSQEV--AIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKNVVQFI 173
           +  GS+G +    + ++E   A+KVL+ + +    E     S+   +++ ++H  +V   
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
            +      L  V +++  G ++  L +++   +  +    A +++  + YLH  NI++RD
Sbjct: 63  FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA-EIASALGYLHSLNIVYRD 121

Query: 234 LKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 292
           LK  N+L+D  G + + DFG+ +   + +G  +   GT  ++APEV+  +PYD   D + 
Sbjct: 122 LKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWC 181

Query: 293 FGIALWELLTGELPYAGLTPLQAAVGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQ 350
            G  L+E+L G  P+      +    ++ K   L+P I   A      LLE   Q D T+
Sbjct: 182 LGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSAR----HLLEGLLQKDRTK 237

Query: 351 RPNFSQ-ITDILKQMMKEVLYWLSPNLINTNIQSTY 385
           R        +I   +    + W   +LIN  I   +
Sbjct: 238 RLGAKDDFMEIKNHIFFSPINW--DDLINKKITPPF 271

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 93.8 bits (233), Expect = 3e-21
 Identities = 41/145 (28%), Positives = 71/145 (48%), Gaps = 1/145 (0%)

Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 216
           E  +++ + H +V++           C+V        +Y +L K+     +   L +   
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQ 165

Query: 217 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAP 276
           + +G+ YLH   IIHRD+KT N+ +++   V + D G A+    +       GT    AP
Sbjct: 166 ILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAP 225

Query: 277 EVIEHKPYDYKADVFSFGIALWELL 301
           EV+    Y+ KAD++S GI L+E+L
Sbjct: 226 EVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 91.5 bits (227), Expect = 4e-21
 Identities = 67/234 (28%), Positives = 113/234 (48%), Gaps = 21/234 (8%)

Query: 135 EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 194
           +V +KVL P   + ++   F +   +MR++ HK++V   G C R     +V EF+  G +
Sbjct: 34  KVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPL 91

Query: 195 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV-------V 247
             F+H++  V       KVA  ++  ++YL   +++H ++ T N+L+   G+       +
Sbjct: 92  DLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFI 151

Query: 248 KVADFGVARVQAQSGVMTAETGTYR--WMAPEVIE-HKPYDYKADVFSFGIALWEL-LTG 303
           K++D G+        V++ +    R  W+APE +E  K     AD +SFG  LWE+   G
Sbjct: 152 KLSDPGIPIT-----VLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNG 206

Query: 304 ELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
           E+P    T L       +       P  +   LA+L+  C  +DP QRP F  I
Sbjct: 207 EIPLKDKT-LAEKERFYEGQCMLVTP--SCKELADLMTHCMNYDPNQRPFFRAI 257

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 93.8 bits (233), Expect = 6e-21
 Identities = 52/152 (34%), Positives = 89/152 (58%), Gaps = 10/152 (6%)

Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS---GVMTAETGTY 271
           I V   ++++H  ++IHRD+K+AN+L+  NG+VK+ DFG +++ A +    V     GT 
Sbjct: 150 IQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTP 209

Query: 272 RWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR---PTI 328
            ++APE+   KPY  KAD+FS G+ L+ELLT + P+ G    +    V+ K+L      +
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE----VMHKTLAGRYDPL 265

Query: 329 PKHAHPRLAELLERCWQHDPTQRPNFSQITDI 360
           P    P + E++      DP +RP+ S++ ++
Sbjct: 266 PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297

Length = 496

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 90.8 bits (225), Expect = 2e-20
 Identities = 55/173 (31%), Positives = 95/173 (54%), Gaps = 6/173 (3%)

Query: 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240
           +L  V EF+  G +  F  + KG F L      A ++  G+ +LH   II+RDLK  N++
Sbjct: 70  HLFFVMEFLNGGDLM-FHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVM 128

Query: 241 MDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFSFGIALW 298
           +D +G +K+ADFG+ + +   G   A T  GT  ++APE+++   Y +  D +SFG+ L+
Sbjct: 129 LDRDGHIKIADFGMCK-ENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLY 187

Query: 299 ELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           E+L G+ P+ G    +    +   +  P  P+       ++LE+ ++ DPT+R
Sbjct: 188 EMLIGQSPFHGDDEDELFESIRVDT--PHYPRWITKESKDILEKLFERDPTRR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 90.8 bits (225), Expect = 2e-20
 Identities = 79/286 (27%), Positives = 133/286 (46%), Gaps = 35/286 (12%)

Query: 118 VASGSYGDLYKGTYCSQE---VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
           + +GS+G +   TY +++   VAIK   K + +  + +     E  I+  I H   V   
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97

Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQK------GVFQLTSLLKVAIDVSKGMNYLHQN 227
           G+      L +V EF+  G  + FL + K      G F    ++ +         YL   
Sbjct: 98  GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLI-------FEYLQSL 150

Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK 287
           NI++RDLK  NLL+D++G +K+ DFG A+V   +   T   GT  ++APE++ +  +   
Sbjct: 151 NIVYRDLKPENLLLDKDGFIKMTDFGFAKV-VDTRTYTL-CGTPEYIAPEILLNVGHGKA 208

Query: 288 ADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELLERCWQ 345
           AD ++ GI ++E+L G  P+    PL     + QK L   I  PK        L+++   
Sbjct: 209 ADWWTLGIFIYEILVGCPPFYANEPLL----IYQKILEGIIYFPKFLDNNCKHLMKKLLS 264

Query: 346 HDPTQR-PNFSQITDILKQMMKEVLYWLSP----NLINTNIQSTYK 386
           HD T+R  N  +    +K+       W       +L++ N++  YK
Sbjct: 265 HDLTKRYGNLKKGAQNVKEHP-----WFGNIDWVSLLHKNVEVPYK 305

Length = 340

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 90.1 bits (223), Expect = 3e-20
 Identities = 55/217 (25%), Positives = 104/217 (47%), Gaps = 5/217 (2%)

Query: 137 AIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
           A+K+L+ E +   + +     E  +++  RH  +     A      LC V E+   G ++
Sbjct: 24  AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF 83

Query: 196 DFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255
             L +++ VF          ++   + YLH  ++++RD+K  NL++D++G +K+ DFG+ 
Sbjct: 84  FHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC 142

Query: 256 RVQAQSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ 314
           +     G  M    GT  ++APEV+E   Y    D +  G+ ++E++ G LP+      +
Sbjct: 143 KEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 202

Query: 315 AAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
               ++ + +R   P+   P    LL    + DP QR
Sbjct: 203 LFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 90.1 bits (223), Expect = 4e-20
 Identities = 70/249 (28%), Positives = 120/249 (48%), Gaps = 8/249 (3%)

Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKNVVQFI 173
           +  GS+G   L K     +  A+KVL+ + V    E     ++   +++ ++H  +V   
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
            +      L  V +F+  G ++  L +++   +  +    A +++  + YLH  NI++RD
Sbjct: 63  YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLHSINIVYRD 121

Query: 234 LKTANLLMDENGVVKVADFGVARVQ-AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 292
           LK  N+L+D  G V + DFG+ +   AQS   T   GT  ++APEVI  +PYD   D + 
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWC 181

Query: 293 FGIALWELLTGELPYAGLTPLQAAVGVVQKSL--RPTIPKHAHPRLAELLERCWQHDPTQ 350
            G  L+E+L G  P+      +    ++ K L  RP     A   L ELLE+  Q     
Sbjct: 182 LGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLGA 241

Query: 351 RPNFSQITD 359
           + +F +I +
Sbjct: 242 KEDFLEIQE 250

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 88.8 bits (220), Expect = 5e-20
 Identities = 68/253 (26%), Positives = 123/253 (48%), Gaps = 17/253 (6%)

Query: 121 GSYGDLYKGTYCSQEV--AIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR 178
           G+YG +YK  +    V  A+K ++ E ++     +   E+ I+ K     +V F GA   
Sbjct: 12  GNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFI 70

Query: 179 PPNLCIVTEFMARGS---IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL-HQNNIIHRDL 234
              + +  E+M  GS   +Y      +G+ +   L ++   V KG+ +L  ++NIIHRD+
Sbjct: 71  EGAVYMCMEYMDAGSLDKLYAGGVATEGIPE-DVLRRITYAVVKGLKFLKEEHNIIHRDV 129

Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI------EHKPYDYKA 288
           K  N+L++ NG VK+ DFGV+     + +     G   +MAPE I      ++  Y  ++
Sbjct: 130 KPTNVLVNGNGQVKLCDFGVSG-NLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQS 188

Query: 289 DVFSFGIALWELLTGELPYA--GLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH 346
           DV+S G+++ E+  G  PY       + A +  +     PT+P        + + +C   
Sbjct: 189 DVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNK 248

Query: 347 DPTQRPNFSQITD 359
            P +RP ++Q+ +
Sbjct: 249 IPNRRPTYAQLLE 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 89.3 bits (222), Expect = 6e-20
 Identities = 62/225 (27%), Positives = 106/225 (47%), Gaps = 37/225 (16%)

Query: 113 KIECKVASGSYGDLYKG----TYCSQEVAIKVLKPECVNTEMLKEFSQ----EVYIMRKI 164
           +IE  +  G+YG +YK         +E AIK  K +          SQ    E+ ++R++
Sbjct: 3   EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYT---GISQSACREIALLREL 59

Query: 165 RHKNVVQFIGACTRPPNLCI--VTEFMARGSIYDFL-----HKQKGVFQL-TSLLKVAI- 215
           +H+NVV  +       +  +  + ++    + +D       H+Q     +  S++K  + 
Sbjct: 60  KHENVVSLVEVFLEHADKSVYLLFDY----AEHDLWQIIKFHRQAKRVSIPPSMVKSLLW 115

Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLM----DENGVVKVADFGVARV-QAQSGVMTAETG- 269
            +  G++YLH N ++HRDLK AN+L+     E GVVK+ D G+AR+  A    +      
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175

Query: 270 --TYRWMAPEVI---EHKPYDYKADVFSFGIALWELLTGELPYAG 309
             T  + APE++    H  Y    D+++ G    ELLT E  + G
Sbjct: 176 VVTIWYRAPELLLGARH--YTKAIDIWAIGCIFAELLTLEPIFKG 218

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 88.9 bits (220), Expect = 8e-20
 Identities = 62/239 (25%), Positives = 115/239 (48%), Gaps = 8/239 (3%)

Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G++G   L K     +  A+K+LK E  V  + +     E  +++  RH  +     
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH-QNNIIHRD 233
           +      LC V E+   G ++  L +++ VF          ++   ++YLH + N+++RD
Sbjct: 63  SFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRD 121

Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFS 292
           LK  NL++D++G +K+ DFG+ +   + G  M    GT  ++APEV+E   Y    D + 
Sbjct: 122 LKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWG 181

Query: 293 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
            G+ ++E++ G LP+      +    ++ + +R   P+   P    LL    + DP QR
Sbjct: 182 LGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLSPEAKSLLSGLLKKDPKQR 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 87.8 bits (218), Expect = 1e-19
 Identities = 72/285 (25%), Positives = 131/285 (45%), Gaps = 50/285 (17%)

Query: 116 CKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTE---MLKEFS-QEVYIMRKIRH 166
            K+  GSYG ++K   C      Q VAIK    + V +E   ++K+ + +E+ ++++++H
Sbjct: 7   SKIGEGSYGVVFK---CRNRETGQIVAIK----KFVESEDDPVIKKIALREIRMLKQLKH 59

Query: 167 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 226
            N+V  I    R   L +V E+     + +     +GV +   + K+     + +N+ H+
Sbjct: 60  PNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEH-LIKKIIWQTLQAVNFCHK 118

Query: 227 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM-APEVI-EHKPY 284
           +N IHRD+K  N+L+ + G +K+ DFG AR+    G    +    RW  APE++     Y
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQY 178

Query: 285 DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKH------------- 331
               DV++ G    ELLTG+  + G + +   + +++K+L   IP+H             
Sbjct: 179 GPPVDVWAIGCVFAELLTGQPLWPGKSDVD-QLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237

Query: 332 -----------------AHPRLAELLERCWQHDPTQRPNFSQITD 359
                                    L+ C Q DPT+R +  ++ +
Sbjct: 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 88.6 bits (219), Expect = 1e-19
 Identities = 50/194 (25%), Positives = 97/194 (50%), Gaps = 5/194 (2%)

Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G++G   L +     +  A+K+LK E +   + +     E  +++  RH  +     
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +      LC V E++  G ++  L +++ VF          ++   ++YLH   I++RDL
Sbjct: 63  SFQTKDRLCFVMEYVNGGELFFHLSRER-VFSEDRTRFYGAEIVSALDYLHSGKIVYRDL 121

Query: 235 KTANLLMDENGVVKVADFGVARVQ-AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NL++D++G +K+ DFG+ +     +  M    GT  ++APEV+E   Y    D +  
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 181

Query: 294 GIALWELLTGELPY 307
           G+ ++E++ G LP+
Sbjct: 182 GVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 86.8 bits (215), Expect = 2e-19
 Identities = 64/260 (24%), Positives = 123/260 (47%), Gaps = 29/260 (11%)

Query: 124 GDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183
            ++Y  T  ++ V +K LK    + E   EF Q+    R ++H N++Q +G C       
Sbjct: 14  SEIYTDTGVARVV-VKELKANASSKEQ-NEFLQQGDPYRILQHPNILQCLGQCVEAIPYL 71

Query: 184 IVTEFMARGSIYDFLHKQKGVF---QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240
           +V E+   G +  +L +++      QL  L ++A +++ G+ ++H++N +H DL   N  
Sbjct: 72  LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCF 131

Query: 241 MDENGVVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVI-----------EHKPYDY 286
           +  +  VKV D+G+   + +   +  E       RW+APE++           + KP   
Sbjct: 132 LTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKP--- 188

Query: 287 KADVFSFGIALWELL-TGELPYAGLTPLQAAVGVVQ----KSLRPTIPKHAHPRLAELLE 341
            ++V++ G+ LWEL      PY+ L+  +    V++    K  +P +      R  E+L+
Sbjct: 189 -SNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQ 247

Query: 342 RCWQHDPTQRPNFSQITDIL 361
            CW   P +R    ++  +L
Sbjct: 248 FCWL-SPEKRATAEEVHRLL 266

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|153200 cd04928, ACT_TyrKc, Uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains

 Score = 81.1 bits (200), Expect = 2e-19
 Identities = 32/52 (61%), Positives = 39/52 (75%)

Query: 13 ELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEIL 64
          +L+SLLG++GLNI EAHAFST DG +LD+FVV GW   ET  L + L KEI 
Sbjct: 17 QLSSLLGDLGLNIAEAHAFSTDDGLALDIFVVTGWKRGETAALGHALQKEID 68

This CD includes a novel, yet uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 68

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 86.8 bits (215), Expect = 3e-19
 Identities = 74/280 (26%), Positives = 130/280 (46%), Gaps = 48/280 (17%)

Query: 110 KQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLK---PECVNTEMLKEFSQEVYIMRKI 164
           KQL+   K+  G+Y  +YKG      + VA+K +     E   +  ++E S    +M+++
Sbjct: 3   KQLE---KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREIS----LMKEL 55

Query: 165 RHKNVVQFIGACTRPPNLCIVTEFMARG-SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 223
           +H+N+V+          L +V E+M +    Y   H  +G     ++      + KG+ +
Sbjct: 56  KHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF 115

Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV----MTAETGTYRWMAPEVI 279
            H+N ++HRDLK  NLL+++ G +K+ADFG+AR     G+     + E  T  + AP+V+
Sbjct: 116 CHENRVLHRDLKPQNLLINKRGELKLADFGLARA---FGIPVNTFSNEVVTLWYRAPDVL 172

Query: 280 -EHKPYDYKADVFSFGIALWELLTGELPYAGL--------------TPLQAAVGVVQKS- 323
              + Y    D++S G  + E++TG   + G               TP ++    + +  
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP 232

Query: 324 -LRPTIPK-----------HAHPRLAELLERCWQHDPTQR 351
             +PT P+           HA P   +LL R  Q +P  R
Sbjct: 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELR 272

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 87.4 bits (217), Expect = 3e-19
 Identities = 72/288 (25%), Positives = 122/288 (42%), Gaps = 53/288 (18%)

Query: 126 LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185
           L K    +  VA+K +  +  + E LK   QE+   R+++H N++ ++ +      L +V
Sbjct: 18  LAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVV 77

Query: 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAI-----DVSKGMNYLHQNNIIHRDLKTANLL 240
           +  MA GS  D L   K  F    L ++AI     DV   ++Y+H    IHR +K +++L
Sbjct: 78  SPLMAYGSCEDLL---KTHFP-EGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHIL 133

Query: 241 MDENGVVKVADFGVARVQAQSGVMTA--------ETGTYRWMAPEVIEH--KPYDYKADV 290
           +  +G V ++    +    + G                  W++PEV++   + Y+ K+D+
Sbjct: 134 LSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDI 193

Query: 291 FSFGIALWELLTGELPYAGLTP----LQAAVGVVQKSL-RPTIP---------------- 329
           +S GI   EL  G +P+  +      L+   G V   L + T P                
Sbjct: 194 YSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHP 253

Query: 330 ----KHAHP---RLAE----LLERCWQHDPTQRPNFSQITD--ILKQM 364
                  HP     +E     +E C Q DP  RP+ SQ+ +    KQ 
Sbjct: 254 NNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 89.9 bits (223), Expect = 3e-19
 Identities = 64/235 (27%), Positives = 106/235 (45%), Gaps = 20/235 (8%)

Query: 133 SQEVAIKVLKPECVNTEML-KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI-VTEFMA 190
             EVAIK+L+ +    E     F +E  +  ++ H N+V  + +   PP L   V E++ 
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV---V 247
             ++ + L    G        ++ + V   +   H   I+HRDLK  N+++ + GV    
Sbjct: 63  GRTLREVLAAD-GALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121

Query: 248 KVADFGVARV-----QAQSGVMTAET---GTYRWMAPEVIEHKPYDYKADVFSFGIALWE 299
           KV DFG+  +      A    +T  T   GT  + APE +  +P    +D++++G+   E
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLE 181

Query: 300 LLTGELPYAGLTP---LQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
            LTG+    G +    L   +  V  SL P I  H    L ++L +    DP QR
Sbjct: 182 CLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGH---PLGQVLRKALNKDPRQR 233

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 87.0 bits (216), Expect = 4e-19
 Identities = 54/198 (27%), Positives = 101/198 (51%), Gaps = 15/198 (7%)

Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF-- 172
           ++  G+YG +Y+   T   + VA+K ++ +     +     +E+ ++  +RH N+V+   
Sbjct: 14  RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKE 73

Query: 173 IGACTRPPNLCIVTEF----MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 228
           +       ++ +V E+    +A       L      F  + +  + + + +G+ YLH+N 
Sbjct: 74  VVVGKHLDSIFLVMEYCEQDLAS-----LLDNMPTPFSESQVKCLMLQLLRGLQYLHENF 128

Query: 229 IIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVI-EHKPYDY 286
           IIHRDLK +NLL+ + G +K+ADFG+AR     +  MT +  T  + APE++     Y  
Sbjct: 129 IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTT 188

Query: 287 KADVFSFGIALWELLTGE 304
             D+++ G  L ELL  +
Sbjct: 189 AIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 87.0 bits (216), Expect = 4e-19
 Identities = 82/298 (27%), Positives = 136/298 (45%), Gaps = 58/298 (19%)

Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           VWE+  +   +   V SG+YG +     T   ++VAIK L     +    K   +E+ ++
Sbjct: 10  VWEVPDRYQNLS-PVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLL 68

Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQK-----GVFQLTSL 210
           + + H+NV+  +   T   +L       +VT  M    + + +  QK       F +  +
Sbjct: 69  KHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVKCQKLSDDHIQFLVYQI 127

Query: 211 LKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT 270
           L+       G+ Y+H   IIHRDLK +N+ ++E+  +K+ DFG+AR       MT    T
Sbjct: 128 LR-------GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR-HTDDE-MTGYVAT 178

Query: 271 YRW-MAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAG------LTPLQAAVG---- 318
            RW  APE++ +   Y+   D++S G  + ELLTG+  + G      L  +   VG    
Sbjct: 179 -RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE 237

Query: 319 -VVQK-----------SLRPTIPKH--------AHPRLAELLERCWQHDPTQRPNFSQ 356
            ++QK           SL P +PK         A+P   +LLE+    DP +R   ++
Sbjct: 238 ELLQKISSESARNYIQSL-PQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAE 294

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 85.9 bits (213), Expect = 5e-19
 Identities = 64/198 (32%), Positives = 101/198 (51%), Gaps = 10/198 (5%)

Query: 112 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV 169
            KIE K+  G+YG +YKG      Q VA+K ++ E     +     +E+ ++++++H N+
Sbjct: 3   TKIE-KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61

Query: 170 VQFIGACTRPPNLCIVTEF--MARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQ 226
           V       +   L ++ EF  M      D L   KG +    L+K  +  + +G+ + H 
Sbjct: 62  VCLQDVLMQESRLYLIFEFLSMDLKKYLDSL--PKGQYMDAELVKSYLYQILQGILFCHS 119

Query: 227 NNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVIEHKP-Y 284
             ++HRDLK  NLL+D  GV+K+ADFG+AR       V T E  T  + APEV+   P Y
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRY 179

Query: 285 DYKADVFSFGIALWELLT 302
               D++S G    E+ T
Sbjct: 180 STPVDIWSIGTIFAEMAT 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 85.7 bits (212), Expect = 6e-19
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 8/157 (5%)

Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS----IYDFLHKQKGVFQLTSLLK 212
           E  I+ K+  + +V    A     +LC+V   M  G     IY+   +  G F       
Sbjct: 43  EKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPG-FPEPRACF 101

Query: 213 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE--TGT 270
               +  G+ +LHQ  II+RDLK  N+L+D +G V+++D G+A V+ + G    +   GT
Sbjct: 102 YTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKTKGYAGT 160

Query: 271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
             +MAPE+++ + YD+  D F+ G+ L+E++    P+
Sbjct: 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 86.6 bits (214), Expect = 6e-19
 Identities = 45/129 (34%), Positives = 77/129 (59%), Gaps = 2/129 (1%)

Query: 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 241
           L  V E++  G +  +  +Q G F+    +  A +++ G+ +LH   II+RDLK  N+++
Sbjct: 76  LYFVMEYVNGGDLM-YQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134

Query: 242 DENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFSFGIALWEL 300
           D  G +K+ADFG+ +     GV T    GT  ++APE+I ++PY    D ++FG+ L+E+
Sbjct: 135 DSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 194

Query: 301 LTGELPYAG 309
           L G+ P+ G
Sbjct: 195 LAGQAPFEG 203

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 86.7 bits (215), Expect = 6e-19
 Identities = 81/300 (27%), Positives = 134/300 (44%), Gaps = 73/300 (24%)

Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEV 158
           E+D K + I+  +  G+YG       CS       ++VAIK +     N    K   +E+
Sbjct: 2   EVDTKYVPIKP-IGRGAYG-----IVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREI 55

Query: 159 YIMRKIRHKNVVQFIGACTRPPN------LCIVTEFMARGSIYDFL---------HKQKG 203
            ++R + H+NV+  I     PP+      + IV E M    ++  +         H Q  
Sbjct: 56  KLLRHLDHENVIA-IKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYF 113

Query: 204 VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG- 262
           ++QL           +G+ Y+H  N++HRDLK +NLL++ N  +K+ DFG+AR  ++ G 
Sbjct: 114 LYQLL----------RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD 163

Query: 263 VMTAETGTYRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGELPYAGL----------- 310
            MT    T  + APE++     Y    DV+S G    ELL  +  + G            
Sbjct: 164 FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITE 223

Query: 311 ---TPLQAAVGVVQ--------KSLRPTIPK--------HAHPRLAELLERCWQHDPTQR 351
              +P +  +G ++        +SL P  P+        HA+P   +LLE+    DP++R
Sbjct: 224 LLGSPSEEDLGFIRNEKARRYIRSL-PYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKR 282

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 86.7 bits (215), Expect = 6e-19
 Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 34/220 (15%)

Query: 110 KQLKIECKVASGSYGDLY----KGTYCSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI 164
           K  +I  +V  G YG ++    K T   + VA+K +K   +     ++    E  I+   
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDT--GEIVALKRMKKSLLFKLNEVRHVLTERDILTTT 58

Query: 165 RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDF---------LHKQKGVFQLTSLLKVAI 215
           + + +V+ + A      L +  E++  G   DF         L +    F +  +   A+
Sbjct: 59  KSEWLVKLLYAFQDDEYLYLAMEYVPGG---DFRTLLNNLGVLSEDHARFYMAEMF-EAV 114

Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT---AETGTYR 272
           D       LH+   IHRDLK  N L+D +G +K+ DFG++      G++T   +  G+  
Sbjct: 115 DA------LHELGYIHRDLKPENFLIDASGHIKLTDFGLS-----KGIVTYANSVVGSPD 163

Query: 273 WMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP 312
           +MAPEV+  K YD+  D +S G  L+E L G  P++G TP
Sbjct: 164 YMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 85.4 bits (211), Expect = 7e-19
 Identities = 43/153 (28%), Positives = 86/153 (56%), Gaps = 3/153 (1%)

Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI-YDFLHKQKGVFQLTSLLKVAI 215
           E  I+ K+    +V    A     +LC+V   M  G + Y   +  +   ++  ++  + 
Sbjct: 43  EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102

Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWM 274
            ++ G+ +LH  +I++RD+K  N+L+D+ G  +++D G+A V+ + G  +T   GT  +M
Sbjct: 103 QITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLA-VELKDGKTITQRAGTNGYM 161

Query: 275 APEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
           APE+++ +PY Y  D F+ G +++E++ G  P+
Sbjct: 162 APEILKEEPYSYPVDWFAMGCSIYEMVAGRTPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 85.8 bits (212), Expect = 9e-19
 Identities = 45/129 (34%), Positives = 78/129 (60%), Gaps = 2/129 (1%)

Query: 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 241
           L  V E++  G +   + +Q G F+    +  A ++S G+ +LH+  II+RDLK  N+++
Sbjct: 76  LYFVMEYVNGGDLMYHI-QQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML 134

Query: 242 DENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFSFGIALWEL 300
           D  G +K+ADFG+ +     GV T    GT  ++APE+I ++PY    D +++G+ L+E+
Sbjct: 135 DSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEM 194

Query: 301 LTGELPYAG 309
           L G+ P+ G
Sbjct: 195 LAGQPPFDG 203

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 84.9 bits (210), Expect = 1e-18
 Identities = 67/259 (25%), Positives = 120/259 (46%), Gaps = 37/259 (14%)

Query: 116 CKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
            +   G YG+L+K      EV +KVL  +  +    + F +   +M ++ HK++V   G 
Sbjct: 15  IRREVGDYGELHK-----TEVLLKVL--DKSHRNYSESFFEAASMMSQLSHKHLVLNYGV 67

Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
           C       +V E++  GS+  +L K K +  ++  L+VA  ++  +++L    + H ++ 
Sbjct: 68  CVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVC 127

Query: 236 TANLLMDENG--------VVKVADFGVARVQAQSGVMTAETGTYR--WMAPEVIEH-KPY 284
             N+L+             +K++D G++       V+  E    R  W+ PE IE+ +  
Sbjct: 128 AKNVLLIREEDRKTGNPPFIKLSDPGISIT-----VLPKEILLERIPWVPPECIENPQNL 182

Query: 285 DYKADVFSFGIALWELLTG-ELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP-----RLAE 338
              AD +SFG  LWE+ +G + P + L          QK L+    +H  P      LA 
Sbjct: 183 SLAADKWSFGTTLWEIFSGGDKPLSALDS--------QKKLQFYEDRHQLPAPKWTELAN 234

Query: 339 LLERCWQHDPTQRPNFSQI 357
           L+ +C  ++P  RP+F  I
Sbjct: 235 LINQCMDYEPDFRPSFRAI 253

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 85.5 bits (212), Expect = 1e-18
 Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 33/210 (15%)

Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKE-FS----QEVYIMRKIRHKNV 169
           K+  G++G+++K       Q VA+K      V  E  KE F     +E+ I++ ++H+NV
Sbjct: 19  KIGQGTFGEVFKARHKKTKQIVALKK-----VLMENEKEGFPITALREIKILQLLKHENV 73

Query: 170 VQFIGACTRPPNLCIVTEFMARGSIY---DF--------LHKQKGVFQLTSLLKVAIDVS 218
           V  I  C              +GS Y   +F        L  +   F L+ + KV   + 
Sbjct: 74  VNLIEICRTKAT----PYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLL 129

Query: 219 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-----QAQSGVMTAETGTYRW 273
            G+ Y+H+N I+HRD+K AN+L+ ++G++K+ADFG+AR       ++    T    T  +
Sbjct: 130 NGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWY 189

Query: 274 MAPEV-IEHKPYDYKADVFSFGIALWELLT 302
             PE+ +  + Y    D++  G  + E+ T
Sbjct: 190 RPPELLLGERDYGPPIDMWGAGCIMAEMWT 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 55/174 (31%), Positives = 83/174 (47%), Gaps = 34/174 (19%)

Query: 157 EVYIMRKIRHKNVVQFIG-ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL---K 212
           E+ I++K++H NVV  I  A  RP           RGS+Y           L+ LL    
Sbjct: 57  EIKILKKLKHPNVVPLIDMAVERPDK-----SKRKRGSVYMVTPYM--DHDLSGLLENPS 109

Query: 213 VAIDVSK----------GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV----- 257
           V +  S+          G+NYLH+N+I+HRD+K AN+L+D  G++K+ADFG+AR      
Sbjct: 110 VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPP 169

Query: 258 ---QAQSGVMTAE-TG--TYRWM-APEVIEH-KPYDYKADVFSFGIALWELLTG 303
              +   G  T + T     RW   PE++   + Y    D++  G    E+ T 
Sbjct: 170 PNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 85.1 bits (210), Expect = 1e-18
 Identities = 68/262 (25%), Positives = 127/262 (48%), Gaps = 12/262 (4%)

Query: 118 VASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           V  G+YG + K  +    + VAIK  K    N E+ +   +E+ ++R ++ +N+V+   A
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
             R   L +V E++ + ++ + L +         +      + K +++ H+N+I+HRD+K
Sbjct: 69  FRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIK 127

Query: 236 TANLLMDENGVVKVADFGVAR--VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
             NLL+  N V+K+ DFG AR   +  +   T    T  + +PE++   PY    D++S 
Sbjct: 128 PENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSV 187

Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK-----HAHPRLAELLERCWQHDP 348
           G  L EL  G+  + G + +      +QK L P   +     +++PR   L      H  
Sbjct: 188 GCILGELSDGQPLFPGESEIDQLF-TIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQ 246

Query: 349 T-QRPNFSQITDILKQMMKEVL 369
           + +R     ++ +L  +MK +L
Sbjct: 247 SLERRYLGILSGVLLDLMKNLL 268

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 85.2 bits (211), Expect = 1e-18
 Identities = 44/129 (34%), Positives = 76/129 (58%), Gaps = 2/129 (1%)

Query: 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 241
           L  V E++  G +  +  +Q G F+    +  A +++ G+ +LH   II+RDLK  N+++
Sbjct: 76  LYFVMEYVNGGDLM-YHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134

Query: 242 DENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFSFGIALWEL 300
           D  G +K+ADFG+ +     G  T    GT  ++APE+I ++PY    D ++FG+ L+E+
Sbjct: 135 DAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 194

Query: 301 LTGELPYAG 309
           L G+ P+ G
Sbjct: 195 LAGQPPFDG 203

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 84.2 bits (208), Expect = 2e-18
 Identities = 64/233 (27%), Positives = 112/233 (48%), Gaps = 21/233 (9%)

Query: 136 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
           V +KVL P   + ++   F +   +M ++ H ++    G C R     +V EF+  G + 
Sbjct: 47  VVLKVLDPS--HRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD 104

Query: 196 DFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV-------VK 248
             L K+KG   +   + VA  ++  ++YL   N++H ++   N+L+   G+       +K
Sbjct: 105 VCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIK 164

Query: 249 VADFGVARVQAQSGVMTAETGTYR--WMAPEVIEH-KPYDYKADVFSFGIALWEL-LTGE 304
           ++D GV+        ++ E    R  W+APE +         AD +SFG  L E+   GE
Sbjct: 165 LSDPGVS-----FTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGE 219

Query: 305 LPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
           +P    TP +      +K  R  +P+ +   LA L+ +C  ++PTQRP+F  I
Sbjct: 220 VPLKERTPSEKE-RFYEKKHR--LPEPSCKELATLISQCLTYEPTQRPSFRTI 269

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 84.3 bits (208), Expect = 2e-18
 Identities = 44/152 (28%), Positives = 82/152 (53%), Gaps = 1/152 (0%)

Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI-YDFLHKQKGVFQLTSLLKVAI 215
           E  I+ K+  + VV    A      LC+V   M  G + +   H  +  F+    +  A 
Sbjct: 50  EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAA 109

Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
           ++  G+  LHQ  I++RDLK  N+L+D++G ++++D G+A    +   +    GT  +MA
Sbjct: 110 EICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMA 169

Query: 276 PEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
           PEV++++ Y +  D ++ G  L+E++ G+ P+
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 84.1 bits (208), Expect = 4e-18
 Identities = 60/239 (25%), Positives = 114/239 (47%), Gaps = 8/239 (3%)

Query: 118 VASGSYGDLYKGTYCSQEV--AIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKNVVQFI 173
           +  GS+G +    + +     A+KVL+ + +    E     ++   +++ ++H  +V   
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
            +      L  V +++  G ++  L +++   +  +    A +++  + YLH  NII+RD
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLHSLNIIYRD 121

Query: 234 LKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 292
           LK  N+L+D  G V + DFG+ +   + S   +   GT  ++APEV+  +PYD   D + 
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWC 181

Query: 293 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
            G  L+E+L G  P+      +    ++ K LR  +  +       LLE   Q D T+R
Sbjct: 182 LGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLR--LKPNISVSARHLLEGLLQKDRTKR 238

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 83.7 bits (208), Expect = 6e-18
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 36/209 (17%)

Query: 118 VASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           + SG+YG +         ++VAIK +     +    K   +E+ ++R +RH+N++  +  
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDI 67

Query: 176 CTRPP------NLCIVTEFMA--------RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
             RPP      ++ IVTE M                 H Q  ++Q+           +G+
Sbjct: 68  -LRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQIL----------RGL 116

Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ----AQSGVMTAETGT--YRWMA 275
            YLH  N+IHRDLK +N+L++ N  +K+ DFG+AR       + G +T    T  YR  A
Sbjct: 117 KYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR--A 174

Query: 276 PEVI-EHKPYDYKADVFSFGIALWELLTG 303
           PE++     Y    D++S G    ELLT 
Sbjct: 175 PELLLSSSRYTKAIDIWSVGCIFAELLTR 203

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 83.6 bits (206), Expect = 6e-18
 Identities = 58/227 (25%), Positives = 119/227 (52%), Gaps = 15/227 (6%)

Query: 137 AIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHKNVVQFIGACTRPPN-LCIVTEFMARGSI 194
           A+KV+K E VN +   ++ Q E ++  +  +   +  + +C +  + L  V E++  G +
Sbjct: 24  AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 83

Query: 195 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 254
              + +Q+ + +  +    A ++S  +NYLH+  II+RDLK  N+L+D  G +K+ D+G+
Sbjct: 84  MFHMQRQRKLPEEHARFYSA-EISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM 142

Query: 255 ARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY----AG 309
            +   + G  T+   GT  ++APE++  + Y +  D ++ G+ ++E++ G  P+    + 
Sbjct: 143 CKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS 202

Query: 310 LTPLQAAVG-----VVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
             P Q         +++K +R  IP+    + A +L+     DP +R
Sbjct: 203 DNPDQNTEDYLFQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 83.1 bits (205), Expect = 6e-18
 Identities = 43/154 (27%), Positives = 78/154 (50%), Gaps = 1/154 (0%)

Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI-YDFLHKQKGVFQLTSLLKVAI 215
           E  I+ K+  + VV    A      LC+V   M  G + +   +     F+    L  A 
Sbjct: 50  EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA 109

Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
           ++  G+  LH+ N ++RDLK  N+L+D+ G ++++D G+A    +   +    GT  +MA
Sbjct: 110 EILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMA 169

Query: 276 PEVIEHKPYDYKADVFSFGIALWELLTGELPYAG 309
           PEV+ ++ Y    D +  G  ++E++ G+ P+ G
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 83.7 bits (207), Expect = 7e-18
 Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 52/223 (23%)

Query: 121 GSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFS----------------QEVYIMR 162
           G+YG + K   T   + VAIK +K      E+  + +                +E+ IM 
Sbjct: 20  GTYGKVEKAYDTLTGKIVAIKKVK----IIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75

Query: 163 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVA------ID 216
           +I+H+N++  +        + +V + MA     D     K V      L  +      + 
Sbjct: 76  EIKHENIMGLVDVYVEGDFINLVMDIMA----SDL----KKVVDRKIRLTESQVKCILLQ 127

Query: 217 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV------------- 263
           +  G+N LH+   +HRDL  AN+ ++  G+ K+ADFG+AR                    
Sbjct: 128 ILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187

Query: 264 --MTAETGTYRWMAPEVI-EHKPYDYKADVFSFGIALWELLTG 303
             MT++  T  + APE++   + Y +  D++S G    ELLTG
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230

Length = 335

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 83.3 bits (206), Expect = 7e-18
 Identities = 56/217 (25%), Positives = 103/217 (47%), Gaps = 5/217 (2%)

Query: 137 AIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
           A+K+LK E  +  + +     E  +++  RH  +     +      LC V E+   G ++
Sbjct: 24  AMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELF 83

Query: 196 DFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255
             L ++  VF          ++   + YLH  ++++RDLK  NL++D++G +K+ DFG+ 
Sbjct: 84  FHLSRE-RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLC 142

Query: 256 RVQAQSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ 314
           +     G  M    GT  ++APEV+E   Y    D +  G+ ++E++ G LP+      +
Sbjct: 143 KEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 202

Query: 315 AAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
               ++ + +R   P+   P    LL    + DP QR
Sbjct: 203 LFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 82.9 bits (205), Expect = 8e-18
 Identities = 48/176 (27%), Positives = 88/176 (50%), Gaps = 7/176 (3%)

Query: 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 241
           L ++ +++  G ++  L+ Q+  F  + +     ++   +++LHQ  II+RD+K  N+L+
Sbjct: 80  LHLILDYVNGGELFTHLY-QREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL 138

Query: 242 DENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKP--YDYKADVFSFGIAL 297
           D  G V + DFG+++         A +  GT  +MAPEVI      +D   D +S G+  
Sbjct: 139 DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLT 198

Query: 298 WELLTGELPYA--GLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           +ELLTG  P+   G    Q+ +       +P  PK       + +++  + DP +R
Sbjct: 199 FELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKR 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 82.7 bits (205), Expect = 8e-18
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 11/197 (5%)

Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNV 169
           KI  K+  G++ ++ K       +  AIK +K    + E +     E+  +R++  H N+
Sbjct: 2   KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR-EIQALRRLSPHPNI 60

Query: 170 VQFIGACTRPPN--LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN 227
           ++ I          L +V E M   ++Y+ +  +K       +      + K ++++H+N
Sbjct: 61  LRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119

Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM-APE-VIEHKPYD 285
            I HRD+K  N+L+ ++ ++K+ADFG  R        T    T RW  APE ++    Y 
Sbjct: 120 GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYIST-RWYRAPECLLTDGYYG 177

Query: 286 YKADVFSFGIALWELLT 302
            K D+++ G   +E+L+
Sbjct: 178 PKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 83.0 bits (205), Expect = 1e-17
 Identities = 65/252 (25%), Positives = 116/252 (46%), Gaps = 40/252 (15%)

Query: 133 SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP-PNLCIVTEFMAR 191
            Q VAIK +        + K   +E+ +++ +RH+N++        P  ++  VTE +  
Sbjct: 35  GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGT 94

Query: 192 GSIYDFLHK--QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV 249
                 LH+       +   +      + +G+ Y+H   ++HRDLK +N+L++EN  +K+
Sbjct: 95  D-----LHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKI 149

Query: 250 ADFGVARVQAQSGVMTAETGTYRWMAPEV-IEHKPYDYKADVFSFGIALWELLTGELPYA 308
            DFG+AR+Q     MT    T  + APE+ +  + YD + D++S G    E+L G+  + 
Sbjct: 150 CDFGLARIQDPQ--MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFP 207

Query: 309 GLTPL-QAAV----------GVVQ-----------KSL--RPTIP-----KHAHPRLAEL 339
           G   + Q ++           V+            +SL  R  +P     K+A P   +L
Sbjct: 208 GKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDL 267

Query: 340 LERCWQHDPTQR 351
           LE+    DP +R
Sbjct: 268 LEKMLVFDPQKR 279

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 81.9 bits (203), Expect = 1e-17
 Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 25/203 (12%)

Query: 117 KVASGSYGDLYKGTYCSQE--VAIKVLKPECVNTEMLKEFS-------QEVYIMRKIRHK 167
           ++  G+YG +Y+         VA+K LK       M KE         +E+ I+ K++H 
Sbjct: 12  RIEEGTYGVVYRARDKKTGEIVALKKLK-------MEKEKEGFPITSLREINILLKLQHP 64

Query: 168 NVVQF--IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
           N+V    +   +    + +V E++    +   +   K  F  + +  + + +  G+ +LH
Sbjct: 65  NIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH 123

Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGT--YRWMAPEVIEHK 282
            N I+HRDLKT+NLL++  G++K+ DFG+AR   +     T    T  YR  APE++   
Sbjct: 124 DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYR--APELLLGA 181

Query: 283 P-YDYKADVFSFGIALWELLTGE 304
             Y    D++S G    ELLT +
Sbjct: 182 KEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 82.1 bits (203), Expect = 2e-17
 Identities = 47/162 (29%), Positives = 87/162 (53%), Gaps = 3/162 (1%)

Query: 146 VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 205
           +   +  +  +E+ ++ +     +V F GA      + I  E M  GS+ D + K+ G  
Sbjct: 38  IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRI 96

Query: 206 QLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 264
               L K++I V +G+ YL +   I+HRD+K +N+L++  G +K+ DFGV+  Q    + 
Sbjct: 97  PENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMA 155

Query: 265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELP 306
            +  GT  +M+PE ++   Y  ++D++S G++L E+  G  P
Sbjct: 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 81.9 bits (202), Expect = 2e-17
 Identities = 67/254 (26%), Positives = 115/254 (45%), Gaps = 18/254 (7%)

Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKNVVQFI 173
           +  GS+G   L K        A+KVL+ + +    E     ++   +++ ++H  +V   
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
            +      L  V +++  G ++  L +++   +  +    A +V+  + YLH  NII+RD
Sbjct: 63  YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAA-EVASAIGYLHSLNIIYRD 121

Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAET-----GTYRWMAPEVIEHKPYDYKA 288
           LK  N+L+D  G V + DFG+ +     GV   ET     GT  ++APEV+  +PYD   
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCK----EGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTV 177

Query: 289 DVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDP 348
           D +  G  L+E+L G  P+      Q    ++ K L+  +P        +LL      D 
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQ--LPGGKTVAACDLLVGLLHKD- 234

Query: 349 TQRPNFSQITDILK 362
            QR       D L+
Sbjct: 235 -QRRRLGAKADFLE 247

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 81.9 bits (202), Expect = 2e-17
 Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 18/203 (8%)

Query: 118 VASGSYGDLY----KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-----RHKN 168
           +  GS+G ++    KGT  +Q  AIK LK + V   ++ +  +   + +++      H  
Sbjct: 3   LGKGSFGKVFLAELKGT--NQFFAIKALKKDVV---LMDDDVECTMVEKRVLSLAWEHPF 57

Query: 169 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQN 227
           +           NL  V E++  G +    H Q    F L      A ++  G+ +LH  
Sbjct: 58  LTHLYCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGLQFLHSK 115

Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDY 286
            I++RDLK  N+L+D +G +K+ADFG+ +        T    GT  ++APE++  + Y+ 
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNT 175

Query: 287 KADVFSFGIALWELLTGELPYAG 309
             D +SFG+ L+E+L G+ P+ G
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHG 198

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 82.0 bits (203), Expect = 2e-17
 Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 36/218 (16%)

Query: 109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH 166
             + +    +  G+YG +   T+     +VAIK + P    T   +   +E+ I+R+ +H
Sbjct: 4   GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL-REIKILRRFKH 62

Query: 167 KNVVQFIGACTRPPNLC------IVTEFMARGSIYDFL--------HKQKGVFQLTSLLK 212
           +N++  I    RPP+        IV E M    +Y  +        H Q  ++Q+   LK
Sbjct: 63  ENIIG-ILDIIRPPSFESFNDVYIVQELM-ETDLYKLIKTQHLSNDHIQYFLYQILRGLK 120

Query: 213 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ----SGVMTAET 268
                     Y+H  N++HRDLK +NLL++ N  +K+ DFG+AR+       +G +T   
Sbjct: 121 ----------YIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV 170

Query: 269 GTYRWM-APEV-IEHKPYDYKADVFSFGIALWELLTGE 304
            T RW  APE+ +  K Y    D++S G  L E+L+  
Sbjct: 171 AT-RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 81.2 bits (200), Expect = 4e-17
 Identities = 72/303 (23%), Positives = 124/303 (40%), Gaps = 64/303 (21%)

Query: 126 LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185
           L + T     V +++   E    E LK    EV +    RH N++      T    L ++
Sbjct: 18  LARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVI 77

Query: 186 TEFMARGSIYDFL--HKQKGVFQ--LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 241
           + FMA GS    L  +  +G+ +  + ++L  A+   +G+NYLHQN  IHR++K +++L+
Sbjct: 78  SPFMAYGSANSLLKTYFPEGMSEALIGNILFGAL---RGLNYLHQNGYIHRNIKASHILI 134

Query: 242 DENGVVKVADFGVARVQAQSGVMTA--------ETGTYRWMAPEVIEHKPYDY--KADVF 291
             +G+V ++         ++G             T    W++PE++    Y Y  K+D++
Sbjct: 135 SGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIY 194

Query: 292 SFGIALWELLTGELPYAGL---------------TPLQAAV------------------- 317
           S GI   EL TG +P+  +               +PL                       
Sbjct: 195 SVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGI 254

Query: 318 --GVVQKSLRPTI---------PKHAHPRLAELLERCWQHDPTQRPNFSQITD--ILKQM 364
              VV   +  T+          K   P    L+E C Q DP +RP+ S +      KQ+
Sbjct: 255 GESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314

Query: 365 MKE 367
            ++
Sbjct: 315 KEQ 317

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 81.0 bits (200), Expect = 5e-17
 Identities = 64/240 (26%), Positives = 120/240 (50%), Gaps = 13/240 (5%)

Query: 121 GSYGDLYK-----GTYCSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKNVVQFI 173
           G YG +++     G    +  A+KVLK   +  N +       E  I+  ++H  +V  I
Sbjct: 7   GGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLI 66

Query: 174 GACTRPPNLCIVTEFMARGSIYDFLH-KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 232
            A      L ++ E+++ G +  F+H +++G+F   +      ++S  + +LHQ  II+R
Sbjct: 67  YAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYR 124

Query: 233 DLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVF 291
           DLK  N+L+D  G VK+ DFG+ +     G +T    GT  +MAPE++    +    D +
Sbjct: 125 DLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWW 184

Query: 292 SFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           S G  ++++LTG  P+      +    +++  L   +P +  P   +LL++  + +P+ R
Sbjct: 185 SLGALMYDMLTGAPPFTAENRKKTIDKILKGKL--NLPPYLTPEARDLLKKLLKRNPSSR 242

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 82.0 bits (202), Expect = 6e-17
 Identities = 47/147 (31%), Positives = 79/147 (53%), Gaps = 6/147 (4%)

Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS---GVMTAETGTYRWMAPE 277
           ++ +H   ++HRDLK+AN+ +   G++K+ DFG ++  + S    V ++  GT  ++APE
Sbjct: 182 LDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE 241

Query: 278 VIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 337
           + E K Y  KAD++S G+ L+ELLT   P+ G +  +    V+     P  P      + 
Sbjct: 242 LWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP-FPCPVSSGMK 300

Query: 338 ELLERCWQHDPTQRPNFSQI--TDILK 362
            LL+     +P  RP   Q+  T+ LK
Sbjct: 301 ALLDPLLSKNPALRPTTQQLLHTEFLK 327

Length = 478

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 80.8 bits (199), Expect = 9e-17
 Identities = 45/150 (30%), Positives = 76/150 (50%), Gaps = 4/150 (2%)

Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 216
           E +I+R I H +++Q  G  T     C++     +  +Y +L  ++ +  +  +L +   
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILP-RYKTDLYCYLAAKRNI-AICDILAIERS 190

Query: 217 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA--RVQAQSGVMTAETGTYRWM 274
           V + + YLH+N IIHRD+K  N+ ++  G V + DFG A   V   +       GT    
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATN 250

Query: 275 APEVIEHKPYDYKADVFSFGIALWELLTGE 304
           APE++   PY    D++S GI L+E+ T  
Sbjct: 251 APELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 79.9 bits (197), Expect = 1e-16
 Identities = 83/311 (26%), Positives = 132/311 (42%), Gaps = 68/311 (21%)

Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQ 156
           VWE+  +   +  +V SG+YG +     CS       ++VAIK L     +    K   +
Sbjct: 10  VWELPERYTSL-KQVGSGAYGSV-----CSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR 63

Query: 157 EVYIMRKIRHKNVVQFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGV-FQLTS 209
           E+ +++ ++H+NV+  +   T         +  +V  +M        L K  G       
Sbjct: 64  ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD-----LQKIMGHPLSEDK 118

Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETG 269
           +  +   +  G+ Y+H   IIHRDLK  NL ++E+  +K+ DFG+AR       MT    
Sbjct: 119 VQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVV 176

Query: 270 TYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG------LTPLQAAVGV--- 319
           T  + APEVI +   Y+   D++S G  + E+LTG+  + G      LT +    GV   
Sbjct: 177 TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGP 236

Query: 320 --VQK-----------SLRPTIPK--------HAHPRLAELLERCWQHDPTQR------- 351
             VQK           SL P  P+         A P+  +LLE+  + D  +R       
Sbjct: 237 EFVQKLEDKAAKSYIKSL-PKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEAL 295

Query: 352 --PNFSQITDI 360
             P F    D 
Sbjct: 296 EHPYFDSFRDA 306

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 79.7 bits (196), Expect = 1e-16
 Identities = 49/152 (32%), Positives = 85/152 (55%), Gaps = 3/152 (1%)

Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           +E+ ++ +     +V F GA      + I  E M  GS+ D + K+ G      L KV+I
Sbjct: 52  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSI 110

Query: 216 DVSKGMNYLHQNN-IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM 274
            V KG+ YL + + I+HRD+K +N+L++  G +K+ DFGV+  Q    +  +  GT  +M
Sbjct: 111 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYM 169

Query: 275 APEVIEHKPYDYKADVFSFGIALWELLTGELP 306
           +PE ++   Y  ++D++S G++L E+  G  P
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 78.3 bits (193), Expect = 2e-16
 Identities = 43/155 (27%), Positives = 81/155 (52%), Gaps = 3/155 (1%)

Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI-YDFLHKQKGVFQLTSLLKVAI 215
           E  I+ K+  + VV    A      LC+V   M  G + +   +     F     +  A 
Sbjct: 50  EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAA 109

Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWM 274
           +++ G+  LH+  I++RDLK  N+L+D+ G ++++D G+A V+   G  +    GT  +M
Sbjct: 110 EITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGETIRGRVGTVGYM 168

Query: 275 APEVIEHKPYDYKADVFSFGIALWELLTGELPYAG 309
           APEV++++ Y +  D +  G  ++E++ G+ P+  
Sbjct: 169 APEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQ 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 78.9 bits (194), Expect = 3e-16
 Identities = 48/152 (31%), Positives = 85/152 (55%), Gaps = 3/152 (1%)

Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           +E+ ++ +     +V F GA      + I  E M  GS+   L + K + +   L KV+I
Sbjct: 52  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE-EILGKVSI 110

Query: 216 DVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM 274
            V +G+ YL + + I+HRD+K +N+L++  G +K+ DFGV+  Q    +  +  GT  +M
Sbjct: 111 AVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYM 169

Query: 275 APEVIEHKPYDYKADVFSFGIALWELLTGELP 306
           +PE ++   Y  ++D++S G++L EL  G  P
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 77.6 bits (191), Expect = 6e-16
 Identities = 61/251 (24%), Positives = 127/251 (50%), Gaps = 23/251 (9%)

Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHKNVVQFIG 174
           +  GSY    L +     +  A+KV+K E VN +   ++ Q E ++     +   +  + 
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62

Query: 175 ACTRPPN-LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
           +C +  + L  V EF++ G +   + +Q+ + +  +    A ++S  +N+LH+  II+RD
Sbjct: 63  SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSA-EISLALNFLHERGIIYRD 121

Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFS 292
           LK  N+L+D  G +K+ D+G+ +   + G  T+   GT  ++APE++  + Y +  D ++
Sbjct: 122 LKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWA 181

Query: 293 FGIALWELLTGELPY--AGLTP----------LQAAVGVVQKSLRPTIPKHAHPRLAELL 340
            G+ ++E++ G  P+   G++            Q    +++K +R  IP+    + + +L
Sbjct: 182 LGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV---ILEKQIR--IPRSLSVKASSVL 236

Query: 341 ERCWQHDPTQR 351
           +     DP +R
Sbjct: 237 KGFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 77.1 bits (190), Expect = 7e-16
 Identities = 71/262 (27%), Positives = 120/262 (45%), Gaps = 37/262 (14%)

Query: 118 VASGSYGDLY--KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI----RHKNVVQ 171
           +++G+YG +Y  +     Q  A+K +        +L+   Q+V++ R I     +  VV 
Sbjct: 9   ISNGAYGAVYLVRHKETRQRFAMKKI---NKQNLILRNQIQQVFVERDILTFAENPFVVS 65

Query: 172 FIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQL-TSLLKVAIDVSKGMNYLHQNNII 230
              +     +LC+V E++  G     L K  G   +  + +  A  V   + YLH   I+
Sbjct: 66  MFCSFETKRHLCMVMEYVEGGDCATLL-KNIGALPVDMARMYFAETVL-ALEYLHNYGIV 123

Query: 231 HRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--------------------GT 270
           HRDLK  NLL+   G +K+ DFG++++    G+M+  T                    GT
Sbjct: 124 HRDLKPDNLLITSMGHIKLTDFGLSKI----GLMSLTTNLYEGHIEKDTREFLDKQVCGT 179

Query: 271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK 330
             ++APEVI  + Y    D ++ GI L+E L G +P+ G TP +    V+   +      
Sbjct: 180 PEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239

Query: 331 HAHPRLA-ELLERCWQHDPTQR 351
            A P  A +L+ R  + +P +R
Sbjct: 240 EALPADAQDLISRLLRQNPLER 261

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 77.0 bits (189), Expect = 7e-16
 Identities = 56/205 (27%), Positives = 104/205 (50%), Gaps = 15/205 (7%)

Query: 110 KQLKIECKVASGSYGDLYKG---TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR- 165
           +Q +   ++  G+YG ++K        + VA+K ++ +     M     +EV ++R +  
Sbjct: 1   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60

Query: 166 --HKNVVQFIGACT-----RPPNLCIVTEFMARGSIYDFLHK--QKGVFQLTSLLKVAID 216
             H NVV+    CT     R   L +V E + +  +  +L K  + GV   T +  +   
Sbjct: 61  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTET-IKDMMFQ 118

Query: 217 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAP 276
           + +G+++LH + ++HRDLK  N+L+  +G +K+ADFG+AR+ +    +T+   T  + AP
Sbjct: 119 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 178

Query: 277 EVIEHKPYDYKADVFSFGIALWELL 301
           EV+    Y    D++S G    E+ 
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMF 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 76.8 bits (189), Expect = 8e-16
 Identities = 74/277 (26%), Positives = 127/277 (45%), Gaps = 46/277 (16%)

Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFS---QEVYIMRKIRHK 167
           K+E K+  G+YG +YK       + VA+K ++   ++TE     S   +E+ +++++ H 
Sbjct: 4   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNHP 59

Query: 168 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQ 226
           N+V+ +        L +V EF+ +  +  F+           L+K  +  + +G+ + H 
Sbjct: 60  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118

Query: 227 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV----MTAETGTYRWMAPEV-IEH 281
           + ++HRDLK  NLL++  G +K+ADFG+AR     GV     T E  T  + APE+ +  
Sbjct: 119 HRVLHRDLKPQNLLINTEGAIKLADFGLARA---FGVPVRTYTHEVVTLWYRAPEILLGC 175

Query: 282 KPYDYKADVFSFGIALWELLTGELPYAGL--------------TPLQAA-VGVVQ-KSLR 325
           K Y    D++S G    E++T    + G               TP +    GV      +
Sbjct: 176 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK 235

Query: 326 PTIPK-------HAHPRLAE----LLERCWQHDPTQR 351
           P+ PK          P L E    LL +   +DP +R
Sbjct: 236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKR 272

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 77.4 bits (190), Expect = 9e-16
 Identities = 75/287 (26%), Positives = 125/287 (43%), Gaps = 39/287 (13%)

Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 12  IWEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 70

Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 71  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 129

Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 130 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRA 185

Query: 276 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG------LTPLQAAVGVVQKSLRPTI 328
           PE+ +    Y+   D++S G  + ELLTG   + G      L  +   VG     L   I
Sbjct: 186 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 245

Query: 329 PKHAHPRLAELLERCWQHDPTQRP--NFS--------QITDILKQMM 365
              +         R +    TQ P  NF+           D+L++M+
Sbjct: 246 SSES--------ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKML 284

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 77.9 bits (192), Expect = 9e-16
 Identities = 38/99 (38%), Positives = 58/99 (58%), Gaps = 3/99 (3%)

Query: 219 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA--QSGVMTAETGTYRWMAP 276
           +G+ YLH   I+HRD+K  NLL++ N V+K+ DFG+ARV+   +S  MT E  T  + AP
Sbjct: 114 RGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAP 173

Query: 277 EVIEHKP-YDYKADVFSFGIALWELLTGELPYAGLTPLQ 314
           E++     Y    D++S G    ELL   + +   +P+Q
Sbjct: 174 EILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 54/186 (29%), Positives = 85/186 (45%), Gaps = 18/186 (9%)

Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTE 187
           Q VAIK L     N    K   +E+ +M+ + HKN++  +   T   +L       +V E
Sbjct: 42  QNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVME 101

Query: 188 FMARGSI----YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE 243
            M          D  H++        L         G+ +LH   IIHRDLK +N+++  
Sbjct: 102 LMDANLCQVIQMDLDHERMSYLLYQMLC--------GIKHLHSAGIIHRDLKPSNIVVKS 153

Query: 244 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG 303
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++ G
Sbjct: 154 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213

Query: 304 ELPYAG 309
            + + G
Sbjct: 214 TVLFPG 219

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 59/249 (23%), Positives = 125/249 (50%), Gaps = 21/249 (8%)

Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHKNVVQFIG 174
           +  GSY    L +     Q  A+KV+K E V+ +   ++ Q E ++  +      +  + 
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 175 ACTRPPN-LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
           +C +  + L +V E++  G +   + +Q+ + +  +    A ++   +N+LH+  II+RD
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAA-EICIALNFLHERGIIYRD 121

Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFS 292
           LK  N+L+D +G +K+ D+G+ +     G  T+   GT  ++APE++  + Y +  D ++
Sbjct: 122 LKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWA 181

Query: 293 FGIALWELLTGELPYAGLTP----------LQAAVGVVQKSLRPTIPKHAHPRLAELLER 342
            G+ ++E++ G  P+  +T            Q    +++K +R  IP+    + + +L+ 
Sbjct: 182 LGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV---ILEKPIR--IPRFLSVKASHVLKG 236

Query: 343 CWQHDPTQR 351
               DP +R
Sbjct: 237 FLNKDPKER 245

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 75.7 bits (187), Expect = 1e-15
 Identities = 48/208 (23%), Positives = 96/208 (46%), Gaps = 25/208 (12%)

Query: 110 KQLKIEC--KVASGSYG--DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY---IMR 162
           K  +I    K+  G +G   + K     +    K++K +  N       + E     +M+
Sbjct: 14  KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN-------AIEPMVHQLMK 66

Query: 163 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL--KVAIDVSKG 220
              + N ++   + T      ++ +++  G ++D L K+    +L+     K+   + + 
Sbjct: 67  D--NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEA 121

Query: 221 MNYLHQNNIIHRDLKTANLLMDENGV-VKVADFGVARVQAQSGVMTAETGTYRWMAPEVI 279
           +N LH++NIIH D+K  N+L D     + + D+G+ ++           GT  + +PE I
Sbjct: 122 LNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD---GTLDYFSPEKI 178

Query: 280 EHKPYDYKADVFSFGIALWELLTGELPY 307
           +   YD   D ++ G+  +ELLTG+ P+
Sbjct: 179 KGHNYDVSFDWWAVGVLTYELLTGKHPF 206

Length = 267

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 76.0 bits (187), Expect = 2e-15
 Identities = 32/95 (33%), Positives = 60/95 (63%), Gaps = 1/95 (1%)

Query: 214 AIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYR 272
           A +V+  + +LH++ +I+RDLK  N+L+D  G  K+ADFG+ +    +GV T    GT  
Sbjct: 102 AAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPD 161

Query: 273 WMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
           ++APE+++   Y    D ++ G+ ++E++ G+ P+
Sbjct: 162 YIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 75.9 bits (186), Expect = 2e-15
 Identities = 55/204 (26%), Positives = 102/204 (50%), Gaps = 10/204 (4%)

Query: 117 KVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFS--QEVYIMRKIRHKNVVQF 172
           K+  GSY  +YKG      + VA+KV++   +  E    F+  +E  +++ ++H N+V  
Sbjct: 12  KLGEGSYATVYKGKSKVNGKLVALKVIR---LQEEEGTPFTAIREASLLKGLKHANIVLL 68

Query: 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 232
                    L +V E++    +  ++ K  G     ++      + +G++Y+HQ  I+HR
Sbjct: 69  HDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHR 127

Query: 233 DLKTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEV-IEHKPYDYKADV 290
           DLK  NLL+ + G +K+ADFG+AR ++  S   + E  T  +  P+V +    Y    D+
Sbjct: 128 DLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDM 187

Query: 291 FSFGIALWELLTGELPYAGLTPLQ 314
           +  G    E++ G   + G+  +Q
Sbjct: 188 WGVGCIFVEMIQGVAAFPGMKDIQ 211

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 76.1 bits (187), Expect = 2e-15
 Identities = 57/197 (28%), Positives = 93/197 (47%), Gaps = 16/197 (8%)

Query: 121 GSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK------IRHKNVVQF 172
           GS+G   L +     +  A+KVLK + +    L++   E  +  K        H  + Q 
Sbjct: 6   GSFGKVMLARLKESGRLYAVKVLKKDVI----LQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNIIH 231
                 P  L  V EF+  G +    H QK   F        A +++  + +LH   II+
Sbjct: 62  YCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIY 119

Query: 232 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADV 290
           RDLK  N+L+D  G  K+ADFG+ +    +G  T+   GT  ++APE+++   Y    D 
Sbjct: 120 RDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDW 179

Query: 291 FSFGIALWELLTGELPY 307
           ++ G+ L+E+L G  P+
Sbjct: 180 WAMGVLLYEMLCGHAPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 75.4 bits (185), Expect = 2e-15
 Identities = 44/159 (27%), Positives = 79/159 (49%), Gaps = 15/159 (9%)

Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS----IYDF----LHKQKGVFQLT 208
           E  I+ K+  + VV    A      LC+V   M  G     IY+       +Q+ +F   
Sbjct: 50  EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIF--- 106

Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268
                A ++  G+  L +  I++RDLK  N+L+D+ G ++++D G+A    +   +    
Sbjct: 107 ----YAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV 162

Query: 269 GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
           GT  +MAPEVI ++ Y +  D +  G  ++E++ G+ P+
Sbjct: 163 GTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 76.1 bits (187), Expect = 3e-15
 Identities = 68/224 (30%), Positives = 111/224 (49%), Gaps = 33/224 (14%)

Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQ 156
           +WE+  +   ++ +V SG+YG     T CS        +VAIK L     +    K   +
Sbjct: 10  IWEVPDRYRDLK-QVGSGAYG-----TVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR 63

Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNL------CIVTEFMAR--GSI--YDFLHKQKGVFQ 206
           E+ +++ ++H+NV+  +   T   +L       +V  FM    G +  ++ L + +  F 
Sbjct: 64  ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFL 123

Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266
           +  +LK       G+ Y+H   IIHRDLK  NL ++E+  +K+ DFG+AR Q  S  MT 
Sbjct: 124 VYQMLK-------GLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-QTDSE-MTG 174

Query: 267 ETGTYRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGELPYAG 309
              T  + APEVI     Y    D++S G  + E+LTG+  + G
Sbjct: 175 YVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG 218

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 76.2 bits (187), Expect = 3e-15
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 20/218 (9%)

Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTE 187
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T   +L       IV E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109

Query: 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 247
            M   ++   +  +    +++ LL     +  G+ +LH   IIHRDLK +N+++  +  +
Sbjct: 110 LM-DANLCQVIQMELDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 165

Query: 248 KVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
           K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++ G + +
Sbjct: 166 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225

Query: 308 AGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 335
            G   +     V++          K L+PT+  +   R
Sbjct: 226 PGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR 263

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 75.8 bits (187), Expect = 3e-15
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 40/214 (18%)

Query: 113 KIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
           K    + SG+YG       CS       ++VAIK +        + K   +E+ I+R  +
Sbjct: 8   KPIENIGSGAYG-----VVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFK 62

Query: 166 HKNVVQFIGACTRPP-----NLCIVTEFMARGSIYDFLHKQKGV------FQLTSLLKVA 214
           H N++  I    RPP     ++ +V + M    ++  +H  + +      + L  LL+  
Sbjct: 63  HDNIIA-IRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLR-- 118

Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-----GVMTAETG 269
                G+ Y+H  N+IHRDLK +NLL++E+  +++ DFG+AR  + S       MT    
Sbjct: 119 -----GLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA 173

Query: 270 TYRWM-APEVIEHKP-YDYKADVFSFGIALWELL 301
           T RW  APE++   P Y    D++S G    E+L
Sbjct: 174 T-RWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 74.4 bits (183), Expect = 5e-15
 Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 34/212 (16%)

Query: 113 KIECKVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           K+E K+  G+YG ++K       + VA+K ++ +  +  +     +E+ ++++++HKN+V
Sbjct: 4   KLE-KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 62

Query: 171 QFIGACTRPPNLCIVTEFM----------ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
           +          L +V E+             G I D    +  +FQL           KG
Sbjct: 63  RLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDI-DPEIVKSFMFQLL----------KG 111

Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-----VQAQSGVMTAETGTYRWMA 275
           + + H +N++HRDLK  NLL+++NG +K+ADFG+AR     V+  S    AE  T  +  
Sbjct: 112 LAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS----AEVVTLWYRP 167

Query: 276 PEVI-EHKPYDYKADVFSFGIALWELLTGELP 306
           P+V+   K Y    D++S G    EL     P
Sbjct: 168 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 74.6 bits (183), Expect = 5e-15
 Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 10/201 (4%)

Query: 117 KVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFS--QEVYIMRKIRHKNVVQF 172
           K+  GSY  +YKG      Q VA+KV+    + TE    F+  +E  +++ ++H N+V  
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVIS---MKTEEGVPFTAIREASLLKGLKHANIVLL 68

Query: 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 232
                    L  V E+M    +  ++ +  G     ++      + +G+ Y+H  +I+HR
Sbjct: 69  HDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHR 127

Query: 233 DLKTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEVI-EHKPYDYKADV 290
           DLK  NLL+   G +K+ADFG+AR ++  S   ++E  T  +  P+V+     Y    D+
Sbjct: 128 DLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDI 187

Query: 291 FSFGIALWELLTGELPYAGLT 311
           +  G    E+L G+  + G++
Sbjct: 188 WGAGCIFIEMLQGQPAFPGVS 208

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 75.2 bits (185), Expect = 5e-15
 Identities = 52/199 (26%), Positives = 101/199 (50%), Gaps = 27/199 (13%)

Query: 132 CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF--------------IGACT 177
           C + VA+K  K    + + +K   +E+ I+R++ H N+V+               +G+ T
Sbjct: 29  CDKRVAVK--KIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLT 86

Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
              ++ IV E+M    + + L +     +   L      + +G+ Y+H  N++HRDLK A
Sbjct: 87  ELNSVYIVQEYM-ETDLANVLEQGPLSEEHARLF--MYQLLRGLKYIHSANVLHRDLKPA 143

Query: 238 NLLMD-ENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEVIEHKPYDYK--ADV 290
           N+ ++ E+ V+K+ DFG+AR+     +  G ++    T  + +P ++   P +Y    D+
Sbjct: 144 NVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS-PNNYTKAIDM 202

Query: 291 FSFGIALWELLTGELPYAG 309
           ++ G    E+LTG+  +AG
Sbjct: 203 WAAGCIFAEMLTGKPLFAG 221

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 75.0 bits (184), Expect = 6e-15
 Identities = 65/247 (26%), Positives = 118/247 (47%), Gaps = 14/247 (5%)

Query: 118 VASGSYGDLY-----KGTYCSQEVAIKVL-KPECVNTEMLKEFSQ-EVYIMRKIRHKN-V 169
           + +G+YG ++      G    +  A+KVL K   V      E ++ E  ++  +R    +
Sbjct: 8   LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67

Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
           V    A      L ++ ++++ G ++  L+ Q+  F    +   + ++   + +LH+  I
Sbjct: 68  VTLHYAFQTEAKLHLILDYVSGGEMFTHLY-QRDNFSEDEVRFYSGEIILALEHLHKLGI 126

Query: 230 IHRDLKTANLLMDENGVVKVADFGVAR--VQAQSGVMTAETGTYRWMAPEVIEHKPYDYK 287
           ++RD+K  N+L+D  G V + DFG+++  +  +     +  GT  +MAPE+I  K    K
Sbjct: 127 VYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGK 186

Query: 288 A-DVFSFGIALWELLTGELPYA--GLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW 344
           A D +S GI ++ELLTG  P+   G    Q+ V        P  P    P   +LL +  
Sbjct: 187 AVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLL 246

Query: 345 QHDPTQR 351
           + DP +R
Sbjct: 247 RKDPKKR 253

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 73.8 bits (182), Expect = 9e-15
 Identities = 72/288 (25%), Positives = 122/288 (42%), Gaps = 71/288 (24%)

Query: 118 VASGSYGDLYKG--TYCSQEVAIK-VLKPEC---VNTEMLKEFSQEVYIMRKIR---HKN 168
           +  G+YG +YK       + VA+K V  P     +    L+E +    +++++    H N
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIA----LLKQLESFEHPN 62

Query: 169 VVQFIGACTRPPN-----LCIVTEFMARGSIYDFLHK--QKGVFQLTSLLKVAI-DVSK- 219
           +V+ +  C  P       L +V E + +  +  +L K  + G      L    I D+ + 
Sbjct: 63  IVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPG------LPPETIKDLMRQ 115

Query: 220 ---GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT--YRWM 274
              G+++LH + I+HRDLK  N+L+  +G VK+ADFG+AR+ +    +T+   T  YR  
Sbjct: 116 LLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYR-- 173

Query: 275 APEVIEHKPYDYKADVFSFGIALWEL---------------------LTGELPYAGLTPL 313
           APEV+    Y    D++S G    EL                     + G LP     P 
Sbjct: 174 APEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIG-LPSEEEWPR 232

Query: 314 QAAV---------GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRP 352
             ++             KS  P I +       +LL++    +P +R 
Sbjct: 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGL----DLLKKMLTFNPHKRI 276

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 51/199 (25%), Positives = 100/199 (50%), Gaps = 6/199 (3%)

Query: 117 KVASGSYGDLYKGTYCSQE--VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           K+  G+Y  +YKG     +  VA+K ++ E           +EV +++ ++H N+V    
Sbjct: 13  KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHANIVTLHD 71

Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                 +L +V E++ +  +  +L        + ++      + +G+NY H+  ++HRDL
Sbjct: 72  IIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDL 130

Query: 235 KTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEV-IEHKPYDYKADVFS 292
           K  NLL++E G +K+ADFG+AR ++  +   + E  T  +  P++ +    Y  + D++ 
Sbjct: 131 KPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWG 190

Query: 293 FGIALWELLTGELPYAGLT 311
            G   +E+ TG   + G T
Sbjct: 191 VGCIFYEMSTGRPLFPGST 209

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 51/180 (28%), Positives = 90/180 (50%), Gaps = 10/180 (5%)

Query: 136 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTEFM 189
           VA+K L     N    K   +E+ +++ + HKN++  +   T   +L       +V E M
Sbjct: 49  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 108

Query: 190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV 249
              ++   +H +    +++ LL     +  G+ +LH   IIHRDLK +N+++  +  +K+
Sbjct: 109 -DANLCQVIHMELDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 164

Query: 250 ADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAG 309
            DFG+AR    + +MT    T  + APEVI    Y    D++S G  + EL+ G + + G
Sbjct: 165 LDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 31/207 (14%)

Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLK----PECVNTEMLKEFSQEVYIMRKIRH 166
           K+E K+  G+YG +YK       + VA+K ++     E V +  ++E S    +++++ H
Sbjct: 3   KVE-KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREIS----LLKELNH 57

Query: 167 KNVVQFIGACTRPPNLCIVTEFMARGSIYDF-LHK---QKGVFQLTSLL--KVAIDVSKG 220
            N+V+ +        L +V EF+      D  L K      +  L   L       + +G
Sbjct: 58  PNIVRLLDVVHSENKLYLVFEFL------DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQG 111

Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV----MTAETGTYRWMAP 276
           + Y H + ++HRDLK  NLL+D  G +K+ADFG+AR     GV     T E  T  + AP
Sbjct: 112 IAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARA---FGVPVRTYTHEVVTLWYRAP 168

Query: 277 EV-IEHKPYDYKADVFSFGIALWELLT 302
           E+ +  + Y    D++S G    E++ 
Sbjct: 169 EILLGSRQYSTPVDIWSIGCIFAEMVN 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 73.3 bits (180), Expect = 2e-14
 Identities = 75/290 (25%), Positives = 119/290 (41%), Gaps = 56/290 (19%)

Query: 111 QLKIECKVASGSYGDL--YKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN 168
           + KI+  +  GSYG +     T+  ++VAIK +     +        +E+ ++R +RH +
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60

Query: 169 VVQFIGACTRPPN------LCIVTEFMARG-----SIYDFLHKQKGVFQLTSLLKVAIDV 217
           +V+ I     PP+      + +V E M           D L  +   F L  LL+     
Sbjct: 61  IVE-IKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLR----- 114

Query: 218 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV---QAQSGVMTAETGTYRWM 274
              + Y+H  N+ HRDLK  N+L + +  +K+ DFG+ARV      + +   +    RW 
Sbjct: 115 --ALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 172

Query: 275 -APEVIE--HKPYDYKADVFSFGIALWELLTGELPYAGL--------------TPLQAAV 317
            APE+       Y    D++S G    E+LTG+  + G               TP    +
Sbjct: 173 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232

Query: 318 GVVQ--------KSLRPTIP-------KHAHPRLAELLERCWQHDPTQRP 352
             V+         S+R   P        +A P    LLER    DP  RP
Sbjct: 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRP 282

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 73.0 bits (179), Expect = 3e-14
 Identities = 40/132 (30%), Positives = 71/132 (53%), Gaps = 5/132 (3%)

Query: 179 PPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
             +L +VT++M+ G +  F H QK G F          ++   + +LH+ +I++RDLK  
Sbjct: 68  DSDLYLVTDYMSGGEL--FWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPE 125

Query: 238 NLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEV-IEHKPYDYKADVFSFGI 295
           N+L+D  G + + DFG+++        T    GT  ++APEV ++ K Y    D +S G+
Sbjct: 126 NILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGV 185

Query: 296 ALWELLTGELPY 307
            ++E+  G  P+
Sbjct: 186 LVFEMCCGWSPF 197

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 10/211 (4%)

Query: 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN 238
           P  L +V  F+  G ++  L ++ G F L+       ++   +  LH+ N+I+RDLK  N
Sbjct: 65  PEKLYLVLAFINGGELFHHLQRE-GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPEN 123

Query: 239 LLMDENGVVKVADFGVARVQ-AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 297
           +L+D  G + + DFG+ ++            GT  ++APE++    Y    D ++ G+ L
Sbjct: 124 ILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLL 183

Query: 298 WELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLAELLERCWQHDPTQRPNFS 355
           +E+LTG  P+      +    ++Q+ LR      + A   L  LL R    DPT+R  ++
Sbjct: 184 YEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSR----DPTRRLGYN 239

Query: 356 QITDILKQMMKEVLYWLSPNLINTNIQSTYK 386
              +I        L W    L+   IQ  +K
Sbjct: 240 GAQEIKNHPFFSQLSW--KKLLMKGIQPPFK 268

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 72.0 bits (176), Expect = 3e-14
 Identities = 61/248 (24%), Positives = 117/248 (47%), Gaps = 15/248 (6%)

Query: 118 VASGSYGDLY-----KGTYCSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKN-V 169
           + +G+YG ++      G    +  A+KVLK   +    +  +    E  ++  IR    +
Sbjct: 8   LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67

Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
           V    A      L ++ +++  G ++  L  Q+  F+   +   + ++   + +LH+  I
Sbjct: 68  VTLHYAFQTDTKLHLILDYINGGELFTHL-SQRERFKEQEVQIYSGEIVLALEHLHKLGI 126

Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIE--HKPYD 285
           I+RD+K  N+L+D NG V + DFG+++   +  V  A +  GT  +MAP+++      +D
Sbjct: 127 IYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHD 186

Query: 286 YKADVFSFGIALWELLTGELPYA--GLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC 343
              D +S G+ ++ELLTG  P+   G    QA +        P  P+       ++++R 
Sbjct: 187 KAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRL 246

Query: 344 WQHDPTQR 351
              DP +R
Sbjct: 247 LMKDPKKR 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 72.3 bits (177), Expect = 4e-14
 Identities = 54/216 (25%), Positives = 102/216 (47%), Gaps = 21/216 (9%)

Query: 127 YKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186
           YK T   + V ++ +  E    EM+     E+++ +   H N+V +         L +VT
Sbjct: 21  YKPT--GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 78

Query: 187 EFMARGSIYDFL--HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 244
            FMA GS  D +  H   G+ +L  +  +   V K ++Y+H    +HR +K +++L+  +
Sbjct: 79  SFMAYGSAKDLICTHFMDGMSELA-IAYILQGVLKALDYIHHMGYVHRSVKASHILISVD 137

Query: 245 GVVKV----ADFGVARVQAQSGVMTAETGTYR-----WMAPEVIEH--KPYDYKADVFSF 293
           G V +    ++  +     Q   +  +   Y      W++PEV++   + YD K+D++S 
Sbjct: 138 GKVYLSGLRSNLSMIN-HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV 196

Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP 329
           GI   EL  G +P+  +   Q    ++ + L  T+P
Sbjct: 197 GITACELANGHVPFKDMPATQ----MLLEKLNGTVP 228

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 72.5 bits (178), Expect = 5e-14
 Identities = 61/219 (27%), Positives = 106/219 (48%), Gaps = 34/219 (15%)

Query: 108 DAKQLKIECKVASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKE-----FSQEVYI 160
           D   +K+   +  G++G+  L +     Q  A+K+L       EM+K      F +E  I
Sbjct: 44  DFDVIKV---IGRGAFGEVQLVRHKSSKQVYAMKLLS----KFEMIKRSDSAFFWEERDI 96

Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI------YDFLHKQKGVFQLTSLLKVA 214
           M     + +VQ   A      L +V E+M  G +      YD   K    +  T+ + +A
Sbjct: 97  MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFY--TAEVVLA 154

Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYR 272
           +D       +H    IHRD+K  N+L+D++G +K+ADFG       +G++  +T  GT  
Sbjct: 155 LDA------IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPD 208

Query: 273 WMAPEVIE----HKPYDYKADVFSFGIALWELLTGELPY 307
           +++PEV++       Y  + D +S G+ L+E+L G+ P+
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 72.4 bits (177), Expect = 5e-14
 Identities = 56/222 (25%), Positives = 101/222 (45%), Gaps = 28/222 (12%)

Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 193
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T   +L    EF     
Sbjct: 43  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL---EEFQDVYL 99

Query: 194 IYDFLHKQKGVFQLTSLLKVAIDVSK----------GMNYLHQNNIIHRDLKTANLLMDE 243
           + + +        L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 100 VMELMDAN-----LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 154

Query: 244 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG 303
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++  
Sbjct: 155 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 214

Query: 304 ELPYAGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 335
           ++ + G   +     V++          K L+PT+  +   R
Sbjct: 215 KILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 256

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 72.2 bits (177), Expect = 7e-14
 Identities = 62/286 (21%), Positives = 105/286 (36%), Gaps = 38/286 (13%)

Query: 48  PYDETEDLKNV----LAKEILKSKDQSCSKRQPALGVPMHSKLLIESSPNCIEIPTDG-- 101
            Y+    L        +K+    K   C +   +  V   +    ++    +   TD   
Sbjct: 18  GYEAIFSLTGGTDTSDSKDTTGDKFDDCDELGDSDDVTHATD--YDADEESLSPQTDVCQ 75

Query: 102 --------TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKE 153
                   +D   +   Q  I   +  GS G+++  T    E   KV+          K 
Sbjct: 76  EPCETTSSSDPASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---KT 132

Query: 154 FSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKV 213
             +E+ I++ I H+ ++  I A      +C+V          D          L   L+ 
Sbjct: 133 PGREIDILKTISHRAIINLIHAYRWKSTVCMVM----PKYKCDLFTYVDRSGPLP--LEQ 186

Query: 214 AIDVSKGM----NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETG 269
           AI + + +     YLH   IIHRD+KT N+ +DE     + DFG A    +         
Sbjct: 187 AITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAA---CKLDAHPDTPQ 243

Query: 270 TYRWM------APEVIEHKPYDYKADVFSFGIALWELLTGELPYAG 309
            Y W       +PE++   PY  K D++S G+ L+E+    +   G
Sbjct: 244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG 289

Length = 392

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 71.2 bits (174), Expect = 7e-14
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 24/208 (11%)

Query: 117 KVASGSYGDLYKGTYCSQE--VAIKVLKPE------CVNTEMLKEFSQEVYIMRKIRHKN 168
           K+  G+Y  ++KG     E  VA+K ++ E      C          +EV +++ ++H N
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-------REVSLLKNLKHAN 64

Query: 169 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI---DVSKGMNYLH 225
           +V           L +V E++      D          L S+  V I    + +G++Y H
Sbjct: 65  IVTLHDIIHTERCLTLVFEYLDS----DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH 120

Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEV-IEHKP 283
           +  I+HRDLK  NLL++E G +K+ADFG+AR ++  +   + E  T  +  P+V +    
Sbjct: 121 KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTE 180

Query: 284 YDYKADVFSFGIALWELLTGELPYAGLT 311
           Y    D++  G  L+E+ TG   + G T
Sbjct: 181 YSTPIDMWGVGCILYEMATGRPMFPGST 208

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 71.2 bits (174), Expect = 9e-14
 Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 29/222 (13%)

Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           VWE+  +   +   V SG+YG +     T   Q+VA+K L     +    +   +E+ ++
Sbjct: 10  VWEVPERYQNLT-PVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLL 68

Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMAR--GSIYDFL-----HKQKGVFQLT 208
           + ++H+NV+  +   T   ++       +VT  M     +I         H Q  ++QL 
Sbjct: 69  KHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLL 128

Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268
                     +G+ Y+H   IIHRDLK +N+ ++E+  +++ DFG+AR QA    MT   
Sbjct: 129 ----------RGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR-QADDE-MTGYV 176

Query: 269 GTYRWMAPEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 309
            T  + APE+ +    Y+   D++S G  + ELL G+  + G
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 59/241 (24%), Positives = 113/241 (46%), Gaps = 27/241 (11%)

Query: 117 KVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR---HKNVVQ 171
           ++  G+YG +YK    +    VA+K ++ +     +     +EV +++++    H N+V+
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 172 FIGACT-----RPPNLCIVTEFMARGSIYDFLHKQKG----VFQLTSLLKVAIDVSKGMN 222
            +  C      R   + +V E + +  +  +L K          +  L++  +   +G++
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFL---RGLD 122

Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK 282
           +LH N I+HRDLK  N+L+   G VK+ADFG+AR+ +    +T    T  + APEV+   
Sbjct: 123 FLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQS 182

Query: 283 PYDYKADVFSFGIALWELLTGELPYAG------LTPLQAAVGVVQKSLRP---TIPKHAH 333
            Y    D++S G    E+   +  + G      L  +   +G+  +   P   T+P+ A 
Sbjct: 183 TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAF 242

Query: 334 P 334
            
Sbjct: 243 S 243

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 51/204 (25%), Positives = 104/204 (50%), Gaps = 7/204 (3%)

Query: 112 LKIECKVASGSYGDLYKGTYCSQE--VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV 169
           +K+E K+  G+Y  ++KG     E  VA+K ++ E           +EV +++ ++H N+
Sbjct: 9   IKLE-KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHANI 66

Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
           V          +L +V E++ +  +  ++     +  + ++      + +G+ Y H+  +
Sbjct: 67  VTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKV 125

Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEV-IEHKPYDYK 287
           +HRDLK  NLL++E G +K+ADFG+AR ++  +   + E  T  +  P+V +    Y  +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQ 185

Query: 288 ADVFSFGIALWELLTGELPYAGLT 311
            D++  G   +E+ +G   + G T
Sbjct: 186 IDMWGVGCIFFEMASGRPLFPGST 209

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 31/209 (14%)

Query: 118 VASGSYGDLYKGTY-CSQEV-AIKVLKPECVNTEMLKE-----FSQEVYIMRKIRHKNVV 170
           +  G++G++    +  SQ+V A+K+L       EM+K      F +E  IM       VV
Sbjct: 51  IGRGAFGEVQLVRHKSSQKVYAMKLLS----KFEMIKRSDSAFFWEERDIMAFANSPWVV 106

Query: 171 QFIGACTRPPNLCIVTEFMARGSI------YDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
           Q   A      L +V E+M  G +      YD   K    +    +L         ++ +
Sbjct: 107 QLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVL--------ALDAI 158

Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHK 282
           H   +IHRD+K  N+L+D++G +K+ADFG      ++G++  +T  GT  +++PEV++ +
Sbjct: 159 HSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQ 218

Query: 283 P----YDYKADVFSFGIALWELLTGELPY 307
                Y  + D +S G+ L+E+L G+ P+
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 71/292 (24%), Positives = 120/292 (41%), Gaps = 63/292 (21%)

Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKE-----FSQEVYIMRKIRHKNVV 170
           +  G++G+  L +     Q  A+KVL+      +M+K         E  I+       +V
Sbjct: 9   IGRGAFGEVWLVRDKDTGQVYAMKVLRKS----DMIKRNQIAHVRAERDILADADSPWIV 64

Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ------LTSLLKVAIDVSKGMNYL 224
           +   +     +L +V E+M  G + + L + K VF         + L +A+D       +
Sbjct: 65  KLYYSFQDEEHLYLVMEYMPGGDLMNLLIR-KDVFPEETARFYIAELVLALD------SV 117

Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVA----------------------------- 255
           H+   IHRD+K  N+L+D +G +K+ADFG+                              
Sbjct: 118 HKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177

Query: 256 RVQAQSGVMT-AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ 314
           R   Q  V   +  GT  ++APEV+   PY  + D +S G+ L+E+L G  P+   T  +
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237

Query: 315 AAVGVV--QKSLRPTIPKHAH--PRLAELLERCWQHDPTQRPNFSQITDILK 362
               ++  ++SLR   P      P   +L+ R    DP  R       +I  
Sbjct: 238 TYNKIINWKESLR--FPPDPPVSPEAIDLICRLLC-DPEDR--LGSFEEIKS 284

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 69.4 bits (170), Expect = 3e-13
 Identities = 64/221 (28%), Positives = 102/221 (46%), Gaps = 58/221 (26%)

Query: 118 VASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKE-FS----QEVYIMRKIRHKNVV 170
           +  G+YG +YK       + VA+K      V  +  KE F     +E+ I+R++ H+N+V
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKK-----VRLDNEKEGFPITAIREIKILRQLNHRNIV 69

Query: 171 QFIGACTRPPNLC-IVTEFMARGSIYDFLHKQKGVF------------------------ 205
                     NL  IVT+   +    DF  K KG F                        
Sbjct: 70  ----------NLKEIVTD---KQDALDFK-KDKGAFYLVFEYMDHDLMGLLESGLVHFSE 115

Query: 206 -QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSG 262
             + S +K  ++   G+NY H+ N +HRD+K +N+L++  G +K+ADFG+AR+    +S 
Sbjct: 116 DHIKSFMKQLLE---GLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172

Query: 263 VMTAETGTYRWMAPE-VIEHKPYDYKADVFSFGIALWELLT 302
             T +  T  +  PE ++  + Y    DV+S G  L EL T
Sbjct: 173 PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 69.1 bits (169), Expect = 5e-13
 Identities = 52/194 (26%), Positives = 88/194 (45%), Gaps = 18/194 (9%)

Query: 124 GDLYKGTYCSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182
           GD+Y         A+KV+K   +   E +  F +E  I+       + Q   A     NL
Sbjct: 26  GDIY---------AMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNL 76

Query: 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD 242
            +V E+   G +   L++ +  F          ++   ++ +HQ   +HRD+K  N+L+D
Sbjct: 77  YLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLID 136

Query: 243 ENGVVKVADFG-VARVQAQSGVM-TAETGTYRWMAPEVIE------HKPYDYKADVFSFG 294
             G +K+ADFG  AR+ A   V      GT  ++APEV+          Y  + D +S G
Sbjct: 137 RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLG 196

Query: 295 IALWELLTGELPYA 308
           +  +E++ G  P+ 
Sbjct: 197 VIAYEMIYGRSPFH 210

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 69.3 bits (169), Expect = 6e-13
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 27/207 (13%)

Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKE-----FSQEVYIMRKIRHKNVV 170
           +  G++G+  L +     +  A+K+L       EM+K      F +E  IM       VV
Sbjct: 51  IGRGAFGEVQLVRHKSTRKVYAMKLLS----KFEMIKRSDSAFFWEERDIMAFANSPWVV 106

Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHK----QKGVFQLTSLLKVAIDVSKGMNYLHQ 226
           Q   A      L +V E+M  G + + +      +K     T+ + +A+D       +H 
Sbjct: 107 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDA------IHS 160

Query: 227 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKP- 283
              IHRD+K  N+L+D++G +K+ADFG      + G++  +T  GT  +++PEV++ +  
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 220

Query: 284 ---YDYKADVFSFGIALWELLTGELPY 307
              Y  + D +S G+ L+E+L G+ P+
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 70.2 bits (171), Expect = 6e-13
 Identities = 57/232 (24%), Positives = 111/232 (47%), Gaps = 49/232 (21%)

Query: 117 KVASGSYGDLY----KGT---YCSQEVAIKVLKPECVNTEMLKEFSQ---EVYIMRKIRH 166
           K+ +G +G+++    K T   +C + ++ + LK         +E SQ   EV +MR+++H
Sbjct: 20  KIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE--------REKSQLVIEVNVMRELKH 71

Query: 167 KNVVQFIGACTRPPN--LCIVTEFMARGSIYDFL---HKQKGVFQLTSLLKVAIDVSKGM 221
           KN+V++I       N  L I+ EF   G +   +   +K  G  +  +++ +   +   +
Sbjct: 72  KNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131

Query: 222 NYLHQ-------NNIIHRDLKTANLLMDE---------------NG--VVKVADFGVARV 257
            Y H          ++HRDLK  N+ +                 NG  + K+ DFG+++ 
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191

Query: 258 QAQSGVMTAETGTYRWMAPEVIEH--KPYDYKADVFSFGIALWELLTGELPY 307
                +  +  GT  + +PE++ H  K YD K+D+++ G  ++EL +G+ P+
Sbjct: 192 IGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243

Length = 1021

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 68.8 bits (169), Expect = 6e-13
 Identities = 46/134 (34%), Positives = 70/134 (52%), Gaps = 26/134 (19%)

Query: 185 VTEFMA-------RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
           V E+M        R +I + +HK+  ++QL   LK          Y+H  N+IHRDLK +
Sbjct: 87  VFEYMETDLHAVIRANILEDVHKRYIMYQLLKALK----------YIHSGNVIHRDLKPS 136

Query: 238 NLLMDENGVVKVADFGVARVQAQSG------VMTAETGTYRWM-APEV-IEHKPYDYKAD 289
           N+L++ +  VK+ADFG+AR  ++        V+T    T RW  APE+ +    Y    D
Sbjct: 137 NILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT-RWYRAPEILLGSTRYTKGVD 195

Query: 290 VFSFGIALWELLTG 303
           ++S G  L E+L G
Sbjct: 196 MWSVGCILGEMLLG 209

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 61/230 (26%), Positives = 105/230 (45%), Gaps = 43/230 (18%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVN----------TEMLKEFSQEVYI 160
           K+E K+  G+YG +YK    +  + VA+K  + E               +L+  S+ +YI
Sbjct: 5   KLE-KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYI 63

Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFM-----------ARGSIYDFLHK--QKGVFQL 207
           +R +  ++V +  G     P+L +V E++            RG       K  +  ++QL
Sbjct: 64  VRLLDVEHVEEKNGK----PSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119

Query: 208 TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVARV-QAQSGVMT 265
                      KG+ + H++ ++HRDLK  NLL+D + G++K+AD G+ R         T
Sbjct: 120 L----------KGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYT 169

Query: 266 AETGTYRWMAPEV-IEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ 314
            E  T  + APEV +    Y    D++S G    E+   +  + G + LQ
Sbjct: 170 HEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ 219

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 54/168 (32%), Positives = 79/168 (47%), Gaps = 37/168 (22%)

Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-----VQAQSGVMTAETGTYRWM 274
           G+ Y+H  N++HRDLK  NLL++ +  +K+ DFG+AR         +G MT    T RW 
Sbjct: 117 GLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT-RWY 175

Query: 275 -APEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG------LTPLQAAVGV------- 319
            APE+ +  + Y    DV+S G  L ELL  +  + G      L  +   +G        
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235

Query: 320 ------VQKSLR--PTIPK--------HAHPRLAELLERCWQHDPTQR 351
                  Q  +R  P IPK        +A+P   +LLE+    DPT+R
Sbjct: 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKR 283

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 66.9 bits (164), Expect = 3e-12
 Identities = 57/250 (22%), Positives = 100/250 (40%), Gaps = 38/250 (15%)

Query: 137 AIKVLKPECVNTE-MLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
           A+KVL  + +     +K    E  I+  + H  +     +      LC+V ++   G ++
Sbjct: 30  ALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELF 89

Query: 196 DFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADF-- 252
             L +Q G           A +V   + YLH   I++RDLK  N+L+ E+G + ++DF  
Sbjct: 90  RLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDL 149

Query: 253 -------GVARVQAQSG-------------VMTAET--------GTYRWMAPEVIEHKPY 284
                       +A                  + E         GT  ++APEVI    +
Sbjct: 150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH 209

Query: 285 DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE---LLE 341
               D ++ GI L+E+L G  P+ G    +    +++K    T P    P  +    L+ 
Sbjct: 210 GSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKE--VTFPGS-PPVSSSARDLIR 266

Query: 342 RCWQHDPTQR 351
           +    DP++R
Sbjct: 267 KLLVKDPSKR 276

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 66.6 bits (163), Expect = 3e-12
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 28/211 (13%)

Query: 116 CKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFS--QEVYIMRKIRHKNVVQ 171
            K+  GSY  +YKG      Q VA+K ++   +  E    F+  +E  +++ ++H N+V 
Sbjct: 11  DKLGEGSYATVYKGRSKLTGQLVALKEIR---LEHEEGAPFTAIREASLLKDLKHANIVT 67

Query: 172 FIGACTRPPNLCIVTEFMAR---------GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 222
                     L +V E++           G      + +  +FQL           +G+ 
Sbjct: 68  LHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLL----------RGLA 117

Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEVI-E 280
           Y HQ  ++HRDLK  NLL+ E G +K+ADFG+AR ++  S   + E  T  +  P+V+  
Sbjct: 118 YCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLG 177

Query: 281 HKPYDYKADVFSFGIALWELLTGELPYAGLT 311
              Y    D++  G   +E+ TG   + G T
Sbjct: 178 STEYSTSLDMWGVGCIFYEMATGRPLFPGST 208

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 56/221 (25%), Positives = 101/221 (45%), Gaps = 58/221 (26%)

Query: 113 KIECKVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           K+E K+  G+YG +YK      ++ +A+K ++ E  +  +     +E+ ++++++H N+V
Sbjct: 6   KVE-KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIV 64

Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG---VFQLTSL-LKVAIDVS-------- 218
           +                      + D +H +K    VF+   L LK  +D S        
Sbjct: 65  R----------------------LQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPR 102

Query: 219 ----------KGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVADFGVAR-----VQAQSG 262
                     +G+ Y H + ++HRDLK  NLL+D     +K+ADFG+AR     V+    
Sbjct: 103 LIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT--- 159

Query: 263 VMTAETGTYRWMAPEV-IEHKPYDYKADVFSFGIALWELLT 302
             T E  T  + APE+ +  + Y    D++S G    E++ 
Sbjct: 160 -FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199

Length = 294

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 60/244 (24%), Positives = 104/244 (42%), Gaps = 43/244 (17%)

Query: 108 DAKQLKIECKVASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKI 164
           D + LK+   +  G++G+  L +        A+K+L K + +  E +     E  I+ + 
Sbjct: 2   DFESLKV---IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA 58

Query: 165 RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
               VV+   +     NL ++ EF+  G +   L K+  + +  +   +A +    ++ +
Sbjct: 59  DSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSI 117

Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVA-----------------------RVQAQS 261
           HQ   IHRD+K  NLL+D  G VK++DFG+                          Q  +
Sbjct: 118 HQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177

Query: 262 GVMTAET-------------GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 308
               AET             GT  ++APEV     Y+   D +S G+ ++E+L G  P+ 
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237

Query: 309 GLTP 312
             TP
Sbjct: 238 SETP 241

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 62.8 bits (152), Expect = 6e-11
 Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 32/211 (15%)

Query: 118 VASGSYGDL--YKGTYCSQEVAIKVLKPECVNTEMLKE-----FSQEVYIMRKIRHKNVV 170
           +  G++G++   K     +  A+K+L       EMLK      F +E  ++    ++ + 
Sbjct: 9   IGRGAFGEVAVVKLKNADKVFAMKILN----KWEMLKRAETACFREERDVLVNGDNQWIT 64

Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHK-------QKGVFQLTSLLKVAIDVSKGMNY 223
               A     NL +V ++   G +   L K           F L  ++ +AID       
Sbjct: 65  TLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMV-IAIDS------ 117

Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM--TAETGTYRWMAPEVIEH 281
           +HQ + +HRD+K  N+LMD NG +++ADFG      + G +  +   GT  +++PE+++ 
Sbjct: 118 VHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177

Query: 282 KP-----YDYKADVFSFGIALWELLTGELPY 307
                  Y  + D +S G+ ++E+L GE P+
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 60.5 bits (147), Expect = 6e-11
 Identities = 37/148 (25%), Positives = 58/148 (39%), Gaps = 20/148 (13%)

Query: 213 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYR 272
           V +     +  LH+       L T + L+  +G V           A      +    Y 
Sbjct: 22  VCLQCLGALRELHRQAKSGNILLTWDGLLKLDGSV-----------AFKTPEQSRPDPY- 69

Query: 273 WMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKH- 331
           +MAPEVI+ + Y  KAD++S GI L+E L  ELPY     L A + ++   +    P+  
Sbjct: 70  FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDR 129

Query: 332 -------AHPRLAELLERCWQHDPTQRP 352
                  A     + +  C    P +R 
Sbjct: 130 SNLEGVSAARSFEDFMRLCASRLPQRRE 157

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 63.7 bits (155), Expect = 6e-11
 Identities = 41/143 (28%), Positives = 76/143 (53%), Gaps = 4/143 (2%)

Query: 118 VASGSYGDLYKG--TYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           ++ G++G +Y G     S+  A+KV+ K + +N  M+ +   E   +   +   +V    
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71

Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     N+ +V E++  G +   LH   G F     +K   +V+  ++YLH++ IIHRDL
Sbjct: 72  SLQSANNVYLVMEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHGIIHRDL 130

Query: 235 KTANLLMDENGVVKVADFGVARV 257
           K  N+L+   G +K+ DFG+++V
Sbjct: 131 KPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 62.7 bits (152), Expect = 7e-11
 Identities = 61/244 (25%), Positives = 104/244 (42%), Gaps = 43/244 (17%)

Query: 108 DAKQLKIECKVASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKI 164
           D + LK+   +  G++G+  L +        A+K+L K + +  E +     E  I+ + 
Sbjct: 2   DFESLKV---IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA 58

Query: 165 RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
               VV+   +     NL ++ EF+  G +   L K+  + +  +   +A  V   ++ +
Sbjct: 59  DGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVL-AIDAI 117

Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVA-----------------------RVQAQS 261
           HQ   IHRD+K  NLL+D  G VK++DFG+                          Q  +
Sbjct: 118 HQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177

Query: 262 GVMTAET-------------GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 308
               AET             GT  ++APEV     Y+   D +S G+ ++E+L G  P+ 
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237

Query: 309 GLTP 312
             TP
Sbjct: 238 SETP 241

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 62.7 bits (152), Expect = 7e-11
 Identities = 33/115 (28%), Positives = 62/115 (53%), Gaps = 7/115 (6%)

Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM--TAETGTYRWMAPEVIEH 281
           +HQ + +HRD+K  N+L+D NG +++ADFG      Q G +  +   GT  +++PE+++ 
Sbjct: 118 IHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQA 177

Query: 282 K-----PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKH 331
                  Y  + D +S G+ ++E+L GE P+   + ++    ++    R   P H
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSH 232

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 62.0 bits (150), Expect = 9e-11
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 34/215 (15%)

Query: 116 CKVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQ 171
           CKV  G+YG +YK         +E A+K ++     T +     +E+ ++R+++H NV+ 
Sbjct: 7   CKVGRGTYGHVYKAKRKDGKDEKEYALKQIE----GTGISMSACREIALLRELKHPNVIA 62

Query: 172 ----FIGACTRP---------PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS 218
               F+    R           +L  + +F  R S  +    Q     + SLL   +D  
Sbjct: 63  LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFH-RASKANKKPMQLPRSMVKSLLYQILD-- 119

Query: 219 KGMNYLHQNNIIHRDLKTANLLM----DENGVVKVADFGVARVQAQSGVMTAETG----T 270
            G++YLH N ++HRDLK AN+L+     E G VK+AD G AR+        A+      T
Sbjct: 120 -GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178

Query: 271 YRWMAPE-VIEHKPYDYKADVFSFGIALWELLTGE 304
           + + APE ++  + Y    D+++ G    ELLT E
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 49/204 (24%), Positives = 84/204 (41%), Gaps = 61/204 (29%)

Query: 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNIIHRDLKTANL 239
           NL  V +++  G +   L  + G+F+   L +  I +++  +  +H+   IHRD+K  N+
Sbjct: 75  NLYFVMDYIPGGDMMSLL-IRLGIFE-EDLARFYIAELTCAIESVHKMGFIHRDIKPDNI 132

Query: 240 LMDENGVVKVADFGVA-------------------------------------------- 255
           L+D +G +K+ DFG+                                             
Sbjct: 133 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRR 192

Query: 256 -----RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310
                R  A S V     GT  ++APEV+    Y    D +S G+ L+E+L G+ P+   
Sbjct: 193 KRQHQRCLAHSLV-----GTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAD 247

Query: 311 TPLQAAVGVV--QKSLRPTIPKHA 332
           TP +  + V+  + +L   IP  A
Sbjct: 248 TPAETQLKVINWETTLH--IPSQA 269

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 34/215 (15%)

Query: 116 CKVASGSYGDLYKGTYCS----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQ 171
           CKV  G+YG +YK         ++ A+K ++     T +     +E+ ++R+++H NV+ 
Sbjct: 7   CKVGRGTYGHVYKAKRKDGKDDRDYALKQIE----GTGISMSACREIALLRELKHPNVIS 62

Query: 172 ----FIGACTRP---------PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS 218
               F+    R           +L  + +F  R S  +    Q     + SLL   +D  
Sbjct: 63  LQKVFLSHADRKVWLLFDYAEHDLWHIIKFH-RASKANKKPVQLPRGMVKSLLYQILD-- 119

Query: 219 KGMNYLHQNNIIHRDLKTANLLM----DENGVVKVADFGVARVQAQSGVMTAETG----T 270
            G++YLH N ++HRDLK AN+L+     E G VK+AD G AR+        A+      T
Sbjct: 120 -GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178

Query: 271 YRWMAPE-VIEHKPYDYKADVFSFGIALWELLTGE 304
           + + APE ++  + Y    D+++ G    ELLT E
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 61.0 bits (148), Expect = 4e-10
 Identities = 63/282 (22%), Positives = 108/282 (38%), Gaps = 47/282 (16%)

Query: 112 LKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQ 171
           LK E  ++ G  G  YKG      +   V +   VN+    E +     M K++H N+V+
Sbjct: 692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVK 747

Query: 172 FIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN---N 228
            IG C       ++ E++   ++ + L             K+AI ++K + +LH      
Sbjct: 748 LIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPA 803

Query: 229 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYR--WMAPEVIEHKPYDY 286
           ++         L  E  ++   D    R+     + T         ++APE  E K    
Sbjct: 804 VV------VGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSAYVAPETRETKDITE 857

Query: 287 KADVFSFGIALWELLTGELPYAGLTPLQAAVGV----------------VQKSLRPTIPK 330
           K+D++ FG+ L ELLTG+      +P  A  GV                +   + P+I  
Sbjct: 858 KSDIYGFGLILIELLTGK------SPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG 911

Query: 331 HAHPRLAELLE------RCWQHDPTQRPNFSQITDILKQMMK 366
                  E++E       C   DPT RP  + +   L+   +
Sbjct: 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953

Length = 968

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 60.0 bits (145), Expect = 7e-10
 Identities = 65/238 (27%), Positives = 114/238 (47%), Gaps = 32/238 (13%)

Query: 110 KQLKIECKVASGSYGDLYKGTYC---SQEVAIK-VLK-PECVNTEMLKEFSQEVYIMRKI 164
           K  K+   + +GS+G +Y+   C   S++VAIK VL+ P+  N E+L        IM+ +
Sbjct: 66  KSYKLGNIIGNGSFGVVYEAI-CIDTSEKVAIKKVLQDPQYKNRELL--------IMKNL 116

Query: 165 RHKNVV----QFIGACTRPPN----LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI- 215
            H N++     +   C +       L +V EF+ + +++ ++           L  V + 
Sbjct: 117 NHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLY 175

Query: 216 --DVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVAR--VQAQSGVMTAETGT 270
              + + + Y+H   I HRDLK  NLL+D N   +K+ DFG A+  +  Q  V    +  
Sbjct: 176 SYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF 235

Query: 271 YRWMAPEV-IEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT 327
           YR  APE+ +    Y    D++S G  + E++ G   ++G + +   V ++Q    PT
Sbjct: 236 YR--APELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT 291

Length = 440

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 14/153 (9%)

Query: 155 SQEVYIMRKIRHKNV-----VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTS 209
             E  ++R++ H  V     V+ +G  T     C+V     R  +Y +L  +     L  
Sbjct: 208 VHEARLLRRLSHPAVLALLDVRVVGGLT-----CLVLP-KYRSDLYTYLGARLRPLGLAQ 261

Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA---RVQAQSGVMTA 266
           +  VA  +   ++Y+H   IIHRD+KT N+L++    + + DFG A   R    +     
Sbjct: 262 VTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321

Query: 267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWE 299
             GT    APEV+   PY    D++S G+ ++E
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 50/211 (23%), Positives = 87/211 (41%), Gaps = 53/211 (25%)

Query: 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNIIHRDLKTANL 239
           NL  V +++  G +   L +  G+F    L +  I +++  +  +H+   IHRD+K  N+
Sbjct: 75  NLYFVMDYIPGGDMMSLLIRM-GIFP-EDLARFYIAELTCAVESVHKMGFIHRDIKPDNI 132

Query: 240 LMDENGVVKVADFGV--------------------------------------------- 254
           L+D +G +K+ DFG+                                             
Sbjct: 133 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPL 192

Query: 255 ---ARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT 311
              A  Q Q  +  +  GT  ++APEV+    Y    D +S G+ L+E+L G+ P+   T
Sbjct: 193 ERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQT 252

Query: 312 PLQAAVGVVQKSLRPTIPKHAH--PRLAELL 340
           PL+  + V+       IP  A   P  ++L+
Sbjct: 253 PLETQMKVINWQTSLHIPPQAKLSPEASDLI 283

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 53/226 (23%), Positives = 91/226 (40%), Gaps = 38/226 (16%)

Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKE-FSQEVYIMRKIRHKNVVQFI 173
            +  G  G++Y      CS+ VA+K ++ +     +LK+ F +E  I   + H  +V   
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSL-------------LKVAIDVSKG 220
             C+       V   M     Y      K V+Q  SL             L +   +   
Sbjct: 69  SICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125

Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ------------AQSGVMTAE- 267
           + Y+H   ++HRDLK  N+L+   G V + D+G A  +             +  +  +  
Sbjct: 126 IEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185

Query: 268 ------TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
                  GT  +MAPE +   P     D+++ G+ L+++LT   PY
Sbjct: 186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231

Length = 932

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 31/94 (32%), Positives = 57/94 (60%), Gaps = 7/94 (7%)

Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTA-ETGTYRWMAPEV 278
           ++ +HQ   +HRD+K  N+L+D+NG +++ADFG   R+ A   V +    GT  +++PE+
Sbjct: 115 IDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEI 174

Query: 279 IE-----HKPYDYKADVFSFGIALWELLTGELPY 307
           ++        Y  + D +S G+ ++E+L GE P+
Sbjct: 175 LQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 51/233 (21%), Positives = 98/233 (42%), Gaps = 50/233 (21%)

Query: 137 AIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
           A+K L K + +N   +     E  I+ +  ++ VV+   +     NL  V +++  G + 
Sbjct: 30  AMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMM 89

Query: 196 DFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV- 254
             L + +   ++ +   +A +++  +  +H+   IHRD+K  N+L+D +G +K+ DFG+ 
Sbjct: 90  SLLIRMEVFPEVLARFYIA-ELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLC 148

Query: 255 -----------------------------------------------ARVQAQSGVMTAE 267
                                                          A  Q Q  +  + 
Sbjct: 149 TGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSL 208

Query: 268 TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320
            GT  ++APEV+  K Y    D +S G+ L+E+L G+ P+   TP +  + V+
Sbjct: 209 VGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVI 261

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 34/119 (28%), Positives = 62/119 (52%), Gaps = 11/119 (9%)

Query: 95  IEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGT-------YCSQEVAIKVLKPECVN 147
           +++P D    WE+    L +   + SG++G + + T         + +VA+K+LK    +
Sbjct: 24  MQLPYDSA--WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS 81

Query: 148 TEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 205
           +E  +    E+ IM  +  H N+V  +GACT+   + I+TE+   G + D+LH+ K  F
Sbjct: 82  SEK-QALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTF 139

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|153172 cd04900, ACT_UUR-like_1, ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains

 Score = 52.1 bits (126), Expect = 5e-09
 Identities = 21/48 (43%), Positives = 29/48 (60%), Gaps = 3/48 (6%)

Query: 14 LTSLLGEIGLNIQEAHAFSTVDGFSLDVFVV---DGWPYDETEDLKNV 58
          +   L ++GLNI +A  F+T DG++LD FVV   DG P  E E L  +
Sbjct: 18 IAGALDQLGLNILDARIFTTRDGYALDTFVVLDPDGEPIGERERLARI 65

This ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD is the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted tyrosine kinase. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 73

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 37/120 (30%), Positives = 64/120 (53%), Gaps = 11/120 (9%)

Query: 95  IEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC----SQ---EVAIKVLKPECVN 147
           +++P D    WE     L +   + SG++G + +GT      SQ   +VA+K+LKP   +
Sbjct: 24  MQLPYDSR--WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS 81

Query: 148 TEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ 206
           +E  +    E+ IM  +  H N+V  +GACT+   + I+TE+   G + ++LHK +  F 
Sbjct: 82  SEK-QALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFL 140

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 42/184 (22%), Positives = 72/184 (39%), Gaps = 62/184 (33%)

Query: 181 NLCIVTEFMARGSI------YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
            L ++ E++  G +       D   +++  F +   + +AID       +H+   IHRD+
Sbjct: 75  YLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETI-LAID------SIHKLGYIHRDI 127

Query: 235 KTANLLMDENGVVKVADFGVA--------------------------------------- 255
           K  NLL+D  G +K++DFG+                                        
Sbjct: 128 KPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAET 187

Query: 256 -----RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310
                R  A S V     GT  ++APEV     Y+ + D +S G+ ++E+L G  P+   
Sbjct: 188 WKRNRRALAYSTV-----GTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSD 242

Query: 311 TPLQ 314
            P +
Sbjct: 243 NPQE 246

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 50.2 bits (120), Expect = 4e-07
 Identities = 49/212 (23%), Positives = 88/212 (41%), Gaps = 23/212 (10%)

Query: 155 SQEVYIMRKIRHKNVVQFIGACTRP---PNL-CIVTEFMARGSIYDFL-HKQKGVF--QL 207
           +Q+ +I++ +R  +          P   PN+ C+    ++  S++  L H + G     +
Sbjct: 17  TQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76

Query: 208 TSLLKV--------AIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259
           +  L +        A ++   ++ LH+  I+ RDL   N+L+D+ G +++  F       
Sbjct: 77  SKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVE 136

Query: 260 QSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV 319
            S    A    Y   APEV          D +S G  L+ELLT      G T ++     
Sbjct: 137 DSCDGEAVENMY--CAPEVGGISEETEACDWWSLGAILFELLT------GKTLVECHPSG 188

Query: 320 VQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           +       IP+        LL++  Q +PT+R
Sbjct: 189 INTHTTLNIPEWVSEEARSLLQQLLQFNPTER 220

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 50.5 bits (120), Expect = 8e-07
 Identities = 41/191 (21%), Positives = 83/191 (43%), Gaps = 20/191 (10%)

Query: 148 TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQL 207
           +    +   E+  + ++ H+N+++         N  ++T+      +Y F++ +   ++ 
Sbjct: 204 SRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQ-KYDFDLYSFMYDEAFDWKD 262

Query: 208 TSLLKVAIDVSK----GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA------RV 257
             LLK    + K     + Y+H   +IHRD+K  N+ ++ +G + + DFG A      R 
Sbjct: 263 RPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE 322

Query: 258 QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAV 317
               G +    GT    +PE++    Y    D++S G+ L ++L+ +       P+    
Sbjct: 323 AFDYGWV----GTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHD-----FCPIGDGG 373

Query: 318 GVVQKSLRPTI 328
           G   K L   I
Sbjct: 374 GKPGKQLLKII 384

Length = 501

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 47.3 bits (112), Expect = 6e-06
 Identities = 32/110 (29%), Positives = 57/110 (51%), Gaps = 10/110 (9%)

Query: 105 WEIDAKQLKIECKVASGSYGDLYKG-------TYCSQEVAIKVLKPECVNTEMLKEFSQE 157
           WE    +LK+   +  G++G + +        T   + VA+K+LK    ++E  +    E
Sbjct: 2   WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSE 60

Query: 158 VYIMRKI-RHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGVF 205
           + I+  I  H NVV  +GACT+P   L ++ EF   G++ ++L  ++G F
Sbjct: 61  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEF 110

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 47.3 bits (112), Expect = 7e-06
 Identities = 33/111 (29%), Positives = 55/111 (49%), Gaps = 12/111 (10%)

Query: 105 WEIDAKQLKIECKVASGSYGDL--------YKGTYCSQEVAIKVLKPECVNTEMLKEFSQ 156
           WE    +L++   +  G++G +         K + C   VA+K+LK     +E  K    
Sbjct: 2   WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSC-NTVAVKMLKEGATASEH-KALMS 59

Query: 157 EVYIMRKI-RHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGVF 205
           E+ I+  I  H NVV  +GACT+P   L ++ EF   G++ +FL  ++  F
Sbjct: 60  ELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFF 110

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 45.3 bits (107), Expect = 3e-05
 Identities = 29/111 (26%), Positives = 52/111 (46%), Gaps = 13/111 (11%)

Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTE---MLKEF 154
           WE    +L     + +G++G + + T         +  VA+K+LKP    TE   ++ E 
Sbjct: 30  WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSEL 89

Query: 155 SQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 205
               Y+     H N+V  +GACT      ++TE+   G + +FL +++  F
Sbjct: 90  KVLSYLGN---HINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSF 137

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 45.2 bits (107), Expect = 3e-05
 Identities = 29/111 (26%), Positives = 55/111 (49%), Gaps = 9/111 (8%)

Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFS 155
           + WE     L+    + +G++G + + T            VA+K+LK    +T+  +   
Sbjct: 31  EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKAS-AHTDEREALM 89

Query: 156 QEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 205
            E+ I+  + +HKN+V  +GACT    + ++TE+   G + +FL K+   F
Sbjct: 90  SELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETF 140

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 44.8 bits (106), Expect = 4e-05
 Identities = 32/114 (28%), Positives = 55/114 (48%), Gaps = 12/114 (10%)

Query: 105 WEIDAKQLKIECKVASGSYG--------DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ 156
           WE    +LK+   +  G++G         + K   C + VA+K+LK     +E  K    
Sbjct: 2   WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASC-RTVAVKMLKEGATASEY-KALMT 59

Query: 157 EVYIMRKI-RHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGVFQLT 208
           E+ I+  I  H NVV  +GACT+P   L ++ E+   G++ ++L  ++  F   
Sbjct: 60  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPY 113

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 43.8 bits (103), Expect = 1e-04
 Identities = 34/129 (26%), Positives = 57/129 (44%), Gaps = 20/129 (15%)

Query: 196 DFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGV-------- 246
           D++ K  G F    L ++       ++Y H   +++H DLK  N+LM+ +          
Sbjct: 220 DWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNR 278

Query: 247 --------VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALW 298
                   V++ D G    +  S      T  YR  +PEV+    + Y  D++S G  ++
Sbjct: 279 ALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYR--SPEVVLGLGWMYSTDMWSMGCIIY 336

Query: 299 ELLTGELPY 307
           EL TG+L Y
Sbjct: 337 ELYTGKLLY 345

Length = 467

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 42.4 bits (99), Expect = 3e-04
 Identities = 27/70 (38%), Positives = 38/70 (54%), Gaps = 3/70 (4%)

Query: 187 EFMARGS-IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 245
           EFM  G  I D + + K    +  +  V   V  G+  LH+  I+HRD+K  NLL+  +G
Sbjct: 289 EFMMAGKKIPDNMPQDKR--DINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG 346

Query: 246 VVKVADFGVA 255
            VK+ DFG A
Sbjct: 347 QVKIIDFGAA 356

Length = 507

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 39.9 bits (94), Expect = 9e-04
 Identities = 14/47 (29%), Positives = 28/47 (59%), Gaps = 1/47 (2%)

Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256
            L+++ ++ + +  LH   IIH DL T+N+++    +  + DFG+A 
Sbjct: 97  ELELSREIGRLVGKLHSAGIIHGDLTTSNMILSGGKIY-LIDFGLAE 142

Length = 211

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 40.2 bits (94), Expect = 0.001
 Identities = 29/137 (21%), Positives = 52/137 (37%), Gaps = 48/137 (35%)

Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVA-----------------------RVQAQ 260
           +H+   IHRD+K  N+L+D  G +K++DFG++                       R+  +
Sbjct: 117 VHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176

Query: 261 SGVMT-------------------------AETGTYRWMAPEVIEHKPYDYKADVFSFGI 295
           + V                           +  GT  ++APE+   + Y  + D +S G 
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236

Query: 296 ALWELLTGELPYAGLTP 312
            ++E L G  P+     
Sbjct: 237 IMFECLIGWPPFCSENS 253

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|153145 cd04873, ACT_UUR-ACR-like, ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD

 Score = 36.0 bits (84), Expect = 0.002
 Identities = 16/55 (29%), Positives = 27/55 (49%), Gaps = 2/55 (3%)

Query: 13 ELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVV-DGWPYDETEDLKNVLAKEILKS 66
          ++T +L ++GLNI +A   ST    +LDVF V D        +    L + +  +
Sbjct: 16 DITRVLADLGLNIHDAR-ISTTGERALDVFYVTDSDGRPLDPERIARLEEALEDA 69

This ACT domain family, ACT_UUR_ACR-like, includes the two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD are the four ACT domains of a novel protein composed almost entirely of ACT domain repeats (the ACR protein) and like proteins. These ACR proteins, found in Arabidopsis and Oryza, are proposed to function as novel regulatory or sensor proteins in plants. This CD also includes the first of the two ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein and related domains, as well as, the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted tyrosine kinase. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 70

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 39.5 bits (92), Expect = 0.003
 Identities = 23/61 (37%), Positives = 33/61 (54%), Gaps = 4/61 (6%)

Query: 269 GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI 328
           GT  ++APE++  KP+    D ++ G+ L+E LTG  P+   TP Q    V Q  L   I
Sbjct: 542 GTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQ----VFQNILNRDI 597

Query: 329 P 329
           P
Sbjct: 598 P 598

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	395
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.98
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.97
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.97
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.91
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.9
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.9
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.89
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.88
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.87
PRK14879	211	serine/threonine protein kinase; Provisional	99.86
PRK10345	210	hypothetical protein; Provisional	99.85
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.84
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.83
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.83
smart00090	237	RIO RIO-like kinase.	99.82
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.81
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.8
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.77
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.76
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.74
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.73
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.7
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.6
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.55
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.52
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.51
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.48
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.47
KOG1243	690	consensus Protein kinase [General function predict	99.41
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.39
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.38
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.34
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.31
KOG3087	229	consensus Serine/threonine protein kinase [General	99.31
COG4248	637	Uncharacterized protein with protein kinase and he	99.31
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.23
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.15
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.01
cd04928	68	ACT_TyrKc Uncharacterized, N-terminal ACT domain o	99.0
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.99
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.96
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.95
PRK09902	216	hypothetical protein; Provisional	98.84
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.8
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.8
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.72
PF01636	239	APH: Phosphotransferase enzyme family This family	98.66
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.55
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.5
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.5
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.46
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.43
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.39
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.38
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.34
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.24
PLN02876	822	acyl-CoA dehydrogenase	98.24
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.15
PRK10593	297	hypothetical protein; Provisional	98.04
cd04900	73	ACT_UUR-like_1 ACT domain family, ACT_UUR-like_1,	98.03
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.94
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.9
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.82
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.8
cd04927	76	ACT_ACR-like_2 Second ACT domain, of a novel type	97.77
PRK05231	319	homoserine kinase; Provisional	97.75
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.71
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.67
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.63
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.6
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.57
cd04925	74	ACT_ACR_2 ACT domain-containing protein which is c	97.34
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.29
PLN02236	344	choline kinase	97.19
KOG2270	520	consensus Serine/threonine protein kinase involved	97.16
PLN02756	418	S-methyl-5-thioribose kinase	97.08
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.07
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.0
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.77
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.68
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.65
COG2334	331	Putative homoserine kinase type II (protein kinase	96.6
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.59
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.53
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.1
PRK12396	409	5-methylribose kinase; Reviewed	96.07
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.88
PTZ00384	383	choline kinase; Provisional	95.88

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-58  Score=444.15  Aligned_cols=270  Identities=48%  Similarity=0.876  Sum_probs=253.3

Q ss_pred             CCCceeecccCcceeeeeeeeCceEEEEEEECCce-EEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 016082          101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE-VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP  179 (395)
Q Consensus       101 ~~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~~~-vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  179 (395)
                      ....|.|+..++.+.+.+|+|+||+||+|.|.|+. ||||++.....+....+.|.+|+.+|.+++|||||+++|+|.++
T Consensus        32 ~~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~  111 (362)
T KOG0192|consen   32 ELPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP  111 (362)
T ss_pred             cccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            34678999999999999999999999999999988 99999998776666678999999999999999999999999999


Q ss_pred             C-cEEEEEecCCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCCCCeeeCCCC-cEEEeeeccc
Q 016082          180 P-NLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSKGMNYLHQNN-IIHRDLKTANLLMDENG-VVKVADFGVA  255 (395)
Q Consensus       180 ~-~~~lV~E~~~ggsL~~~l~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~-iiHrDlkp~NiLl~~~~-~vkl~DFg~a  255 (395)
                      + .+++||||+++|+|.++++. ....++...++.++.||++||+|||+++ ||||||||+|||++.++ ++||+|||++
T Consensus       112 ~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls  191 (362)
T KOG0192|consen  112 PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLS  191 (362)
T ss_pred             CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence            8 79999999999999999988 4788999999999999999999999999 99999999999999998 9999999999


Q ss_pred             cccccC-CccccCCCCcccccccccC--CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCC
Q 016082          256 RVQAQS-GVMTAETGTYRWMAPEVIE--HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHA  332 (395)
Q Consensus       256 ~~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  332 (395)
                      +..... ..++...||+.|||||++.  ..+|+.|+||||||+++|||+||+.||.+..+.+.+..++....||.+|..+
T Consensus       192 r~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~  271 (362)
T KOG0192|consen  192 REKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKEC  271 (362)
T ss_pred             eeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccC
Confidence            987765 4566689999999999999  6699999999999999999999999999999999999999999999999999


Q ss_pred             cHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHH
Q 016082          333 HPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLY  370 (395)
Q Consensus       333 ~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~~  370 (395)
                      ++.+..+|.+||+.||..||+|.+++..|+.+.+....
T Consensus       272 ~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~  309 (362)
T KOG0192|consen  272 PPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS  309 (362)
T ss_pred             CHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence            99999999999999999999999999999999987763

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-57  Score=439.75  Aligned_cols=261  Identities=35%  Similarity=0.735  Sum_probs=238.6

Q ss_pred             CCceeecccCcceeeeeeeeCceEEEEEEECCc-eEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 016082          102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  180 (395)
Q Consensus       102 ~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (395)
                      .+.|+++.+.+++.++||+|-||.||.|.|.+. +||+|.++.....   .+.|.+|+++|++|+|+|||+++|+|..+.
T Consensus       198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~---~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~  274 (468)
T KOG0197|consen  198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS---PEAFLREAQIMKKLRHEKLVKLYGVCTKQE  274 (468)
T ss_pred             cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC---hhHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence            578999999999999999999999999999876 9999999976444   367889999999999999999999999988


Q ss_pred             cEEEEEecCCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  259 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~  259 (395)
                      .+|||||||+.|+|.++|+. ..+.+...+++.++.||++||+||+++++|||||.++||||+++..+||+|||+|+...
T Consensus       275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~  354 (468)
T KOG0197|consen  275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG  354 (468)
T ss_pred             ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccC
Confidence            99999999999999999997 56789999999999999999999999999999999999999999999999999999655


Q ss_pred             cCCcccc--CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHH
Q 016082          260 QSGVMTA--ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  336 (395)
Q Consensus       260 ~~~~~~~--~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  336 (395)
                      .+.....  ..-+..|.|||.+....++.||||||||++|||++| |+.||.+++..+.... +.++.|.+.|..||+++
T Consensus       355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~-le~GyRlp~P~~CP~~v  433 (468)
T KOG0197|consen  355 DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLEL-LERGYRLPRPEGCPDEV  433 (468)
T ss_pred             CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHH-HhccCcCCCCCCCCHHH
Confidence            4433222  233678999999999999999999999999999999 9999999999886654 77899999999999999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 016082          337 AELLERCWQHDPTQRPNFSQITDILKQMMK  366 (395)
Q Consensus       337 ~~li~~cl~~dp~~RPs~~ell~~l~~~~~  366 (395)
                      .++|..||+.+|++||||+.+...++++..
T Consensus       434 Y~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  434 YELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             HHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence            999999999999999999999999888765

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-54  Score=396.84  Aligned_cols=251  Identities=31%  Similarity=0.537  Sum_probs=227.5

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc-
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-  181 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-  181 (395)
                      ..+..++++..+.||+|+.|+||++.+  +++.+|+|++. ...++...+++.+|++++++.+||+||.+||+|..... 
T Consensus        74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~  152 (364)
T KOG0581|consen   74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE  152 (364)
T ss_pred             cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence            345666889999999999999999988  57899999994 33467788999999999999999999999999999995 


Q ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                      ++|+||||.||||.+++.. .+++++..+.+++.++++||.|||+ .+||||||||.|||++..|.|||||||.++....
T Consensus       153 isI~mEYMDgGSLd~~~k~-~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn  231 (364)
T KOG0581|consen  153 ISICMEYMDGGSLDDILKR-VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN  231 (364)
T ss_pred             EEeehhhcCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence            9999999999999999976 4889999999999999999999995 9999999999999999999999999999987766


Q ss_pred             CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHhhhccCCCCCCCC-CcH
Q 016082          261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL-----TPLQAAVGVVQKSLRPTIPKH-AHP  334 (395)
Q Consensus       261 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~-----~~~~~~~~~~~~~~~~~~~~~-~~~  334 (395)
                      + ...+..||..|||||.+.+..|+.++||||||++++|+++|+.||...     ...+....++. ...|..|.. +|+
T Consensus       232 S-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~-~ppP~lP~~~fS~  309 (364)
T KOG0581|consen  232 S-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD-EPPPRLPEGEFSP  309 (364)
T ss_pred             h-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc-CCCCCCCcccCCH
Confidence            6 557789999999999999999999999999999999999999999874     56666666654 557778886 999


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          335 RLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       335 ~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      +++.|+..||++||.+||++.|+++
T Consensus       310 ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  310 EFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             HHHHHHHHHhcCCcccCCCHHHHhc
Confidence            9999999999999999999999987

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-53  Score=412.35  Aligned_cols=344  Identities=27%  Similarity=0.484  Sum_probs=294.6

Q ss_pred             HHHHHHHH--HHHHHhhh--cCCCeeeeceeccCCCceeeEEEecCCCCcchHHHHHHHHHHHHhhcccCCCCCCCCCCC
Q 016082            5 CWVLMKVG--ELTSLLGE--IGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQSCSKRQPALGV   80 (395)
Q Consensus         5 ~~~~~~~~--~~~~~~~~--~~l~i~~~~~f~~~~~~~l~~~~v~gw~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~   80 (395)
                      .|+|-||+  ||....++  -.||++++.||++|...+|+.+   |+...++++|++++++.....++.+|.++.-....
T Consensus        10 ~wLleLLr~aqL~qf~s~lr~~lnvrr~~hf~yVk~eDLl~I---GMgRp~qRRLrea~kkm~~~~k~kswvkKvf~ga~   86 (1039)
T KOG0199|consen   10 DWLLELLRKAQLDQFISQLRFLLNVRRFDHFSYVKDEDLLEI---GMGRPQQRRLREAIKKMSREMKNKSWVKKVFIGAD   86 (1039)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHhccCchhhhhhcchhhhhhh---ccCcHHHHHHHHHHHHhhhhccccchHHHHhccCC
Confidence            59998886  56666665  4799999999999999999998   99999999999999999888788887765332222


Q ss_pred             CCcccccccCCCCccccCCCCCCceeecccCcceeeeeeeeCceEEEEEEECC-----ceEEEEEecCCCCCHHHHHHHH
Q 016082           81 PMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFS  155 (395)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~  155 (395)
                      |.+.+..      ......+......|..+++++.++||+|+||.|++|.|+.     -.||||+++.+..+. ...+|.
T Consensus        87 p~h~~~t------~~~~~p~~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddfl  159 (1039)
T KOG0199|consen   87 PSHPAQT------NSVANPSIDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFL  159 (1039)
T ss_pred             ccccccc------cCCCCcCCCcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHH
Confidence            2221111      0001123345677888999999999999999999999953     359999999887655 668999


Q ss_pred             HHHHHHHhcCCCceeeEEEEEecCCcEEEEEecCCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 016082          156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL  234 (395)
Q Consensus       156 ~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDl  234 (395)
                      +|+.+|.+|+|||++++||+..+ ..+.||||.+++|||.+.|++ ....|....+..++.||+.||.||.+++.|||||
T Consensus       160 rEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDL  238 (1039)
T KOG0199|consen  160 REASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDL  238 (1039)
T ss_pred             HHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhh
Confidence            99999999999999999999988 568899999999999999998 5678999999999999999999999999999999


Q ss_pred             CCCCeeeCCCCcEEEeeeccccccccCCcccc----CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 016082          235 KTANLLMDENGVVKVADFGVARVQAQSGVMTA----ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAG  309 (395)
Q Consensus       235 kp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~----~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~  309 (395)
                      .++|+|+-....|||+|||++|..+....+-.    ....+.|+|||.+++..++.++|||+|||++|||++ |..||.+
T Consensus       239 AARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G  318 (1039)
T KOG0199|consen  239 AARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVG  318 (1039)
T ss_pred             hhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCC
Confidence            99999999999999999999998776543322    234678999999999999999999999999999999 9999999


Q ss_pred             CCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016082          310 LTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDI  360 (395)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  360 (395)
                      ....++...+- .+.+.+.|+.|+.++++++..||..+|.+||+|..|.+.
T Consensus       319 ~~g~qIL~~iD-~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  319 CRGIQILKNID-AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             CCHHHHHHhcc-ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence            99999887765 788889999999999999999999999999999999743

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.1e-52  Score=403.42  Aligned_cols=248  Identities=27%  Similarity=0.468  Sum_probs=227.4

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  185 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  185 (395)
                      ...|+..+.||+|||+.+|.+++  +|+.||+|++.+... .....+...+||+|.++|+|||||+++++|++.++.|||
T Consensus        17 ~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv   96 (592)
T KOG0575|consen   17 SKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV   96 (592)
T ss_pred             cceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence            35799999999999999999987  789999999976443 455677899999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-Ccc
Q 016082          186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVM  264 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-~~~  264 (395)
                      .|+|+.++|..+++ +++++++++++.++.||+.||.|||+.+|||||||..|++++++-+|||+|||+|...... ...
T Consensus        97 LELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk  175 (592)
T KOG0575|consen   97 LELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERK  175 (592)
T ss_pred             EEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccccc
Confidence            99999999999998 5789999999999999999999999999999999999999999999999999999876644 556


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhh
Q 016082          265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW  344 (395)
Q Consensus       265 ~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  344 (395)
                      .+.+|||.|.|||++....++..+||||+||+||-|+.|++||+..+-.+....+...  .-.+|.+++.+.++||+++|
T Consensus       176 ~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~--~Y~~P~~ls~~A~dLI~~lL  253 (592)
T KOG0575|consen  176 KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN--EYSMPSHLSAEAKDLIRKLL  253 (592)
T ss_pred             ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc--CcccccccCHHHHHHHHHHh
Confidence            6789999999999999999999999999999999999999999998887777776654  34567799999999999999


Q ss_pred             ccCCCCCCCHHHHHH
Q 016082          345 QHDPTQRPNFSQITD  359 (395)
Q Consensus       345 ~~dp~~RPs~~ell~  359 (395)
                      +.||.+|||+++|+.
T Consensus       254 ~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  254 RPNPSERPSLDEVLD  268 (592)
T ss_pred             cCCcccCCCHHHHhc
Confidence            999999999999987

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-52  Score=388.32  Aligned_cols=248  Identities=30%  Similarity=0.550  Sum_probs=226.2

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      .+|.+.++||+|+||+||+|++  ++..||||.+.....+....+-+..|+.+|+.++|||||++++++..++.+|+|||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            4789999999999999999987  57899999999888788888999999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCC------CcEEEeeeccccccccC
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN------GVVKVADFGVARVQAQS  261 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~------~~vkl~DFg~a~~~~~~  261 (395)
                      ||.||+|.+|++. .+.+++.+++.++.||+.||++||+++||||||||.|||++..      -.+||+|||+||.....
T Consensus        90 yC~gGDLs~yi~~-~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~  168 (429)
T KOG0595|consen   90 YCNGGDLSDYIRR-RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG  168 (429)
T ss_pred             eCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence            9999999999987 5689999999999999999999999999999999999999875      35899999999999887


Q ss_pred             CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc-CCCCCCCCCcHHHHHHH
Q 016082          262 GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-LRPTIPKHAHPRLAELL  340 (395)
Q Consensus       262 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li  340 (395)
                      ....+.+|++.|||||++....|+.|+|+||+|+++|++++|+.||...++.+....+.+.. ..+.++...++.+.+++
T Consensus       169 ~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll  248 (429)
T KOG0595|consen  169 SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELL  248 (429)
T ss_pred             hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhhhh
Confidence            77788899999999999999999999999999999999999999999999988877554433 34555667788888999


Q ss_pred             HHhhccCCCCCCCHHHHH
Q 016082          341 ERCWQHDPTQRPNFSQIT  358 (395)
Q Consensus       341 ~~cl~~dp~~RPs~~ell  358 (395)
                      ...++.+|.+|-++.+-.
T Consensus       249 ~~ll~~~~~~~~~~~~~~  266 (429)
T KOG0595|consen  249 ISLLQRNPKDRISFEDFF  266 (429)
T ss_pred             hHHHhcCccccCchHHhh
Confidence            999999999998887644

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-51  Score=381.74  Aligned_cols=246  Identities=28%  Similarity=0.474  Sum_probs=221.6

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  182 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  182 (395)
                      .+..++|++.+.||+|+||.||+++.  +++.+|+|++++...- ....+....|..||.+++||.||+++..|+++.++
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL  100 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL  100 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence            34567999999999999999999976  6789999999876543 33567899999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC
Q 016082          183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~  262 (395)
                      |+|+||+.||.|..+|++ .+.|++..+..++.+|+.||.|||++|||||||||+|||+|.+|+++|+|||+++..-..+
T Consensus       101 ylVld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~  179 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG  179 (357)
T ss_pred             EEEEeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence            999999999999999976 6889999999999999999999999999999999999999999999999999998655443


Q ss_pred             -ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHH
Q 016082          263 -VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE  341 (395)
Q Consensus       263 -~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  341 (395)
                       .....+||+.|||||++.+.+|+..+|.||+|+++|||++|.+||.+.+..+....+.... .+..|..++.+.+++++
T Consensus       180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-~~~~p~~ls~~ardll~  258 (357)
T KOG0598|consen  180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-LPLPPGYLSEEARDLLK  258 (357)
T ss_pred             CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-CCCCCccCCHHHHHHHH
Confidence             3344699999999999999999999999999999999999999999999888877766543 45667779999999999


Q ss_pred             HhhccCCCCCCC
Q 016082          342 RCWQHDPTQRPN  353 (395)
Q Consensus       342 ~cl~~dp~~RPs  353 (395)
                      ++|+.||++|..
T Consensus       259 ~LL~rdp~~RLg  270 (357)
T KOG0598|consen  259 KLLKRDPRQRLG  270 (357)
T ss_pred             HHhccCHHHhcC
Confidence            999999999963

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-51  Score=400.47  Aligned_cols=265  Identities=36%  Similarity=0.730  Sum_probs=236.8

Q ss_pred             CCCceeecccCcceeeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 016082          101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  180 (395)
Q Consensus       101 ~~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (395)
                      ....|+|..++..+..+||+|+||+||+|.|.| +||||+++-...+++..+.|++|+.++++-+|.||+-|.|+|..++
T Consensus       383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP  461 (678)
T ss_pred             cccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence            346899999999999999999999999999986 6999999999889999999999999999999999999999999988


Q ss_pred             cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccc-
Q 016082          181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA-  259 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~-  259 (395)
                      . .||+.+|+|-+|+.+++....+|.+.+.+.||.||++||.|||.++|||||||..||++.++++|||+|||++.... 
T Consensus       462 ~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~  540 (678)
T KOG0193|consen  462 L-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR  540 (678)
T ss_pred             e-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeee
Confidence            6 99999999999999999988899999999999999999999999999999999999999999999999999996433 


Q ss_pred             --cCCccccCCCCcccccccccC---CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCC---CCC
Q 016082          260 --QSGVMTAETGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI---PKH  331 (395)
Q Consensus       260 --~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~  331 (395)
                        .........|...|||||++.   ..+|+..+||||||+++|||++|..||......+....+-+..++|..   ...
T Consensus       541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~  620 (678)
T KOG0193|consen  541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSN  620 (678)
T ss_pred             eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhcc
Confidence              223345568899999999986   458999999999999999999999999976666666554444334333   356


Q ss_pred             CcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 016082          332 AHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE  367 (395)
Q Consensus       332 ~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~  367 (395)
                      +++++++|+..||..++++||.|.+|+..|+.++..
T Consensus       621 ~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  621 CPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             CHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence            788999999999999999999999999988888764

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-52  Score=373.67  Aligned_cols=253  Identities=27%  Similarity=0.497  Sum_probs=223.0

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEE-EEecCCc-EEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG-ACTRPPN-LCI  184 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~l  184 (395)
                      ..+|+++++||+|+||.||+++.  ++..+|.|-++-+..+....+....|+.+|++|+|||||++++ .+.+... ++|
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni   97 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI   97 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence            45899999999999999999986  7899999999988888888899999999999999999999999 4554444 899


Q ss_pred             EEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH--CC--ccccCCCCCCeeeCCCCcEEEeeeccccc
Q 016082          185 VTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQ--NN--IIHRDLKTANLLMDENGVVKVADFGVARV  257 (395)
Q Consensus       185 V~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~--~~--iiHrDlkp~NiLl~~~~~vkl~DFg~a~~  257 (395)
                      |||++.+|+|...++.   .+..+++.++|+++.|+++||.++|+  ..  |+||||||+||+++.+|.|||+|||+++.
T Consensus        98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            9999999999998853   45789999999999999999999999  45  99999999999999999999999999998


Q ss_pred             cccCCc-cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCC-CCCcHH
Q 016082          258 QAQSGV-MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP-KHAHPR  335 (395)
Q Consensus       258 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  335 (395)
                      ...... .....|||.||+||++.+.+|+.||||||+||++|||+.-++||.+.+-.+....+.+ +.-|++| .++|.+
T Consensus       178 l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~q-gd~~~~p~~~YS~~  256 (375)
T KOG0591|consen  178 LSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQ-GDYPPLPDEHYSTD  256 (375)
T ss_pred             hcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHc-CCCCCCcHHHhhhH
Confidence            776543 3456899999999999999999999999999999999999999999977666666554 4556666 789999


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHHHH
Q 016082          336 LAELLERCWQHDPTQRPNFSQITDILK  362 (395)
Q Consensus       336 l~~li~~cl~~dp~~RPs~~ell~~l~  362 (395)
                      +..+|..|+..||+.||+...++..+.
T Consensus       257 l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  257 LRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             HHHHHHHHccCCcccCCCcchHHHHHH
Confidence            999999999999999999655544443

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-51  Score=385.36  Aligned_cols=250  Identities=23%  Similarity=0.392  Sum_probs=216.2

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCH-----HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT-----EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  181 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  181 (395)
                      .+.|.+.+.||+|+||.|.+|..  +++.||||++++.....     .......+|+++|++|+|||||+++++|+.+..
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            45789999999999999999976  68999999997654322     122346799999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCC---CcEEEeeecccccc
Q 016082          182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN---GVVKVADFGVARVQ  258 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~---~~vkl~DFg~a~~~  258 (395)
                      .||||||++||+|.+.+-. ++.+.+..-..++.|++.|+.|||++||+||||||+|||++.+   -.+||+|||+|+..
T Consensus       251 ~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~  329 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS  329 (475)
T ss_pred             eEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence            9999999999999999976 5678888889999999999999999999999999999999876   67999999999999


Q ss_pred             ccCCccccCCCCcccccccccCCCCC---CChhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHhhhcc--CCCCCCCCC
Q 016082          259 AQSGVMTAETGTYRWMAPEVIEHKPY---DYKADVFSFGIALWELLTGELPYAGLTPLQ-AAVGVVQKS--LRPTIPKHA  332 (395)
Q Consensus       259 ~~~~~~~~~~gt~~y~aPE~~~~~~~---~~k~DvwslG~vl~elltg~~pf~~~~~~~-~~~~~~~~~--~~~~~~~~~  332 (395)
                      +....+.+.+||+.|.|||++.++.+   ..+.|+||+||++|-+++|.+||++..... ....+.+..  +.|.....+
T Consensus       330 g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~I  409 (475)
T KOG0615|consen  330 GEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRI  409 (475)
T ss_pred             ccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhh
Confidence            98888999999999999999987643   357899999999999999999998865555 333333322  234444578


Q ss_pred             cHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          333 HPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       333 ~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      +.+..++|.+||..||++|||+.++++
T Consensus       410 seea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  410 SEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             hHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            999999999999999999999999987

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=6.5e-50  Score=360.21  Aligned_cols=249  Identities=28%  Similarity=0.431  Sum_probs=218.4

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      +.|+.+.++|+|+||+||+++.  +|+.||||.+.....++...+-.++|+++|++++|+|+|.++.+|.....+++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            4688889999999999999986  78999999998766566677789999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccc-cCCcccc
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA-QSGVMTA  266 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~-~~~~~~~  266 (395)
                      |++. ++.+-|.......+...+.+++.|+++|+.|+|++++|||||||+|||++.+|.+||||||+||... .+...|.
T Consensus        82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTD  160 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTD  160 (396)
T ss_pred             ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhh
Confidence            9988 7777777777889999999999999999999999999999999999999999999999999999877 5556788


Q ss_pred             CCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhh-------------------ccCCC
Q 016082          267 ETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ-------------------KSLRP  326 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~-------------------~~~~~  326 (395)
                      +..|.+|+|||.+.+ .+|....||||+||++.||++|.+.|++.+..+....+..                   .+.+-
T Consensus       161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~l  240 (396)
T KOG0593|consen  161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRL  240 (396)
T ss_pred             hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeec
Confidence            899999999999987 6899999999999999999999999999887666554332                   11111


Q ss_pred             CCC----------CCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          327 TIP----------KHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       327 ~~~----------~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      +.|          +..+.-+.+++.+||+.||.+|++.+|++.
T Consensus       241 P~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  241 PEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             CCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            111          245667899999999999999999999984

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-50  Score=388.65  Aligned_cols=260  Identities=35%  Similarity=0.662  Sum_probs=239.7

Q ss_pred             cccCCCCCCceeecccCcceeeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEE
Q 016082           95 IEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG  174 (395)
Q Consensus        95 ~~~~~~~~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  174 (395)
                      .+......+.|+|..+...-++-||+|+-|.||+|+..++.||||.++.-         -..+|+-|++|+||||+.|.|
T Consensus       109 ~e~k~qq~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkG  179 (904)
T KOG4721|consen  109 TEHKQQQEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKG  179 (904)
T ss_pred             eehhhhhhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhh---------hhhhHHHHHhccCcceeeEee
Confidence            44555666789999999999999999999999999999999999997622         235788999999999999999


Q ss_pred             EEecCCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecc
Q 016082          175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV  254 (395)
Q Consensus       175 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~  254 (395)
                      +|+..+.+|||||||..|-|+..|+. ..+++...+..+..+|+.||.|||.+.|||||||.-||||+.+..|||+|||.
T Consensus       180 VCtqsPcyCIiMEfCa~GqL~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGT  258 (904)
T KOG4721|consen  180 VCTQSPCYCIIMEFCAQGQLYEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGT  258 (904)
T ss_pred             eecCCceeEEeeeccccccHHHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccc
Confidence            99999999999999999999999987 56788899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcH
Q 016082          255 ARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP  334 (395)
Q Consensus       255 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (395)
                      ++.......+....||..|||||++...+.++|+||||||||||||+||..||.......++.++-...+..+.|..++.
T Consensus       259 S~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~  338 (904)
T KOG4721|consen  259 SKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPD  338 (904)
T ss_pred             hHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCch
Confidence            99877777777889999999999999999999999999999999999999999998888888888788888899999999


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 016082          335 RLAELLERCWQHDPTQRPNFSQITDILKQM  364 (395)
Q Consensus       335 ~l~~li~~cl~~dp~~RPs~~ell~~l~~~  364 (395)
                      .++-||++||+..|..||+|.+|+..|+=.
T Consensus       339 GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  339 GFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             HHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            999999999999999999999999887643

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-49  Score=371.23  Aligned_cols=249  Identities=28%  Similarity=0.512  Sum_probs=217.4

Q ss_pred             ccCcceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC--cEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP--NLCI  184 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~l  184 (395)
                      ..++...+.||+|+||.||+++..  ++..|||......  ....+.+.+|+.+|.+++|||||+++|......  .+++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i   93 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED--SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI   93 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc--chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence            346888999999999999999985  6899999987652  222677899999999999999999999854444  6999


Q ss_pred             EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCC-CCcEEEeeecccccccc---
Q 016082          185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVADFGVARVQAQ---  260 (395)
Q Consensus       185 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~-~~~vkl~DFg~a~~~~~---  260 (395)
                      .|||+++|+|.+++....++++++.+..++.||++||.|||++||+||||||+|||++. ++.+||+|||+++....   
T Consensus        94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT  173 (313)
T ss_pred             eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence            99999999999999887668999999999999999999999999999999999999999 79999999999986653   


Q ss_pred             -CCccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHhhhccCCCCCCCCCcHHHH
Q 016082          261 -SGVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAG-LTPLQAAVGVVQKSLRPTIPKHAHPRLA  337 (395)
Q Consensus       261 -~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwslG~vl~elltg~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~  337 (395)
                       ........||+.|||||++.++ ....++|||||||++.||+||+.||.. .........+......|.+|..++.+.+
T Consensus       174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~  253 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAK  253 (313)
T ss_pred             cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHH
Confidence             1223456899999999999863 233599999999999999999999998 5666666666666677899999999999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHH
Q 016082          338 ELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       338 ~li~~cl~~dp~~RPs~~ell~  359 (395)
                      +|+.+|++.+|.+|||+.++++
T Consensus       254 ~Fl~~C~~~~p~~Rpta~eLL~  275 (313)
T KOG0198|consen  254 DFLRKCFKRDPEKRPTAEELLE  275 (313)
T ss_pred             HHHHHHhhcCcccCcCHHHHhh
Confidence            9999999999999999999988

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2e-48  Score=376.75  Aligned_cols=262  Identities=33%  Similarity=0.661  Sum_probs=222.3

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEE-------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEEEE
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGAC  176 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  176 (395)
                      |+++.++|++.++||+|+||.||+|.+       .++.||||+++... .......+.+|+.+++++ +||||++++++|
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~   80 (338)
T cd05102           2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGAC   80 (338)
T ss_pred             cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence            788889999999999999999999974       23579999997543 334456799999999999 899999999998


Q ss_pred             ecCC-cEEEEEecCCCCCHHHHHhhcc-----------------------------------------------------
Q 016082          177 TRPP-NLCIVTEFMARGSIYDFLHKQK-----------------------------------------------------  202 (395)
Q Consensus       177 ~~~~-~~~lV~E~~~ggsL~~~l~~~~-----------------------------------------------------  202 (395)
                      .... .+++||||+++|+|.+++....                                                     
T Consensus        81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (338)
T cd05102          81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP  160 (338)
T ss_pred             cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence            7654 5899999999999999997532                                                     


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCc---cccCCCCc
Q 016082          203 --------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV---MTAETGTY  271 (395)
Q Consensus       203 --------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~  271 (395)
                              .++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......   .....++.
T Consensus       161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence                    2477788899999999999999999999999999999999999999999999975433211   11234567


Q ss_pred             ccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCC
Q 016082          272 RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ  350 (395)
Q Consensus       272 ~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~  350 (395)
                      .|+|||++.+..++.++|||||||++|||++ |..||.+....+..........++..|..+++++.+++.+||+.||.+
T Consensus       241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~  320 (338)
T cd05102         241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKE  320 (338)
T ss_pred             cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhh
Confidence            8999999999999999999999999999997 999998866544444555555566667788999999999999999999


Q ss_pred             CCCHHHHHHHHHHHHHH
Q 016082          351 RPNFSQITDILKQMMKE  367 (395)
Q Consensus       351 RPs~~ell~~l~~~~~~  367 (395)
                      |||+.++++.|++++++
T Consensus       321 RPs~~el~~~l~~~~~~  337 (338)
T cd05102         321 RPTFSALVEILGDLLQE  337 (338)
T ss_pred             CcCHHHHHHHHHHHHhc
Confidence            99999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3e-49  Score=379.93  Aligned_cols=249  Identities=25%  Similarity=0.448  Sum_probs=223.8

Q ss_pred             cccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcEE
Q 016082          108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       108 ~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  183 (395)
                      ...+|++++.||.|+|++|++|+.  +++.+|||++.+... .+...+-...|..+|.+| .||.|++++..|.+...+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            456899999999999999999987  678999999976543 334456688899999999 7999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCc
Q 016082          184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV  263 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~  263 (395)
                      +|+||+++|+|.+++++ -|.|++...+.++.+|+.|++|||++|||||||||+|||+|.+++++|+|||.|+..+....
T Consensus       151 FvLe~A~nGdll~~i~K-~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~  229 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIKK-YGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK  229 (604)
T ss_pred             EEEEecCCCcHHHHHHH-hCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence            99999999999999988 58899999999999999999999999999999999999999999999999999987654321


Q ss_pred             --------------cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCC
Q 016082          264 --------------MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP  329 (395)
Q Consensus       264 --------------~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  329 (395)
                                    .....||..|.+||++.....+..+|+|+|||++|.|+.|++||.+.++.-.+..++.-  .-.+|
T Consensus       230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l--~y~fp  307 (604)
T KOG0592|consen  230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL--DYEFP  307 (604)
T ss_pred             cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh--cccCC
Confidence                          13357999999999999999999999999999999999999999999998888877653  44678


Q ss_pred             CCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          330 KHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       330 ~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      +..++...+|+++.|..||.+|++..||.+
T Consensus       308 ~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  308 EGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             CCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence            889999999999999999999999988765

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-49  Score=384.57  Aligned_cols=267  Identities=33%  Similarity=0.661  Sum_probs=243.1

Q ss_pred             CceeecccCcceeeeeeeeCceEEEEEEECC-----ce-EEEEEecC-CCCCHHHHHHHHHHHHHHHhcCCCceeeEEEE
Q 016082          103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-----QE-VAIKVLKP-ECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA  175 (395)
Q Consensus       103 ~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~-----~~-vAvK~~~~-~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  175 (395)
                      ..|++..++..+.++||+|+||.||+|+..-     .. ||||..+. .....+...+|.+|+++|++++|||||++||+
T Consensus       150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV  229 (474)
T KOG0194|consen  150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV  229 (474)
T ss_pred             cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            4699999999999999999999999998721     23 89999986 33678889999999999999999999999999


Q ss_pred             EecCCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccc
Q 016082          176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA  255 (395)
Q Consensus       176 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a  255 (395)
                      +.....+++|||++.||+|.++|++..+.++..+...++.+.+.||+|||++++|||||.++|+|++.++.+||+|||++
T Consensus       230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs  309 (474)
T KOG0194|consen  230 AVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLS  309 (474)
T ss_pred             EcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccc
Confidence            99999999999999999999999997778999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCccc-cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCc
Q 016082          256 RVQAQSGVMT-AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAH  333 (395)
Q Consensus       256 ~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (395)
                      +....-.... ...-..+|+|||.+....|+.++|||||||++||+++ |..||.+.+..+....+...+.+...|...+
T Consensus       310 ~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p  389 (474)
T KOG0194|consen  310 RAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTP  389 (474)
T ss_pred             cCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCH
Confidence            8654221111 2235689999999999999999999999999999999 8999999999999999888999999999999


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHH
Q 016082          334 PRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVL  369 (395)
Q Consensus       334 ~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~  369 (395)
                      .++..++.+||..+|++||+|.++.+.++.+.+...
T Consensus       390 ~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  390 KELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             HHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence            999999999999999999999999999999887655

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-48  Score=351.24  Aligned_cols=240  Identities=27%  Similarity=0.470  Sum_probs=221.5

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  183 (395)
                      ...++|.+.+.||.|+||+|.+++.  ++..+|+|++++.. ..-.+.+...+|..+|+.+.||+++++++.|.+.+++|
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence            3456899999999999999999987  67889999997654 34556788999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCc
Q 016082          184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV  263 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~  263 (395)
                      |||||.+||.|.+++++ .++|+++.++.+|.+|+.|++|||+++|++|||||+|||+|.+|.+||+|||+|+.....  
T Consensus       121 mvmeyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--  197 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--  197 (355)
T ss_pred             EEEeccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--
Confidence            99999999999999987 678999999999999999999999999999999999999999999999999999876654  


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHh
Q 016082          264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC  343 (395)
Q Consensus       264 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  343 (395)
                      ..+-+|||.|+|||++..++|..++|.||||+++|||+.|.+||...++.+....++....  ..|+..++++++|+.++
T Consensus       198 T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v--~fP~~fs~~~kdLl~~L  275 (355)
T KOG0616|consen  198 TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV--KFPSYFSSDAKDLLKKL  275 (355)
T ss_pred             EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc--cCCcccCHHHHHHHHHH
Confidence            4567999999999999999999999999999999999999999999999998888887644  57899999999999999


Q ss_pred             hccCCCCC
Q 016082          344 WQHDPTQR  351 (395)
Q Consensus       344 l~~dp~~R  351 (395)
                      |+.|-.+|
T Consensus       276 L~vD~t~R  283 (355)
T KOG0616|consen  276 LQVDLTKR  283 (355)
T ss_pred             HhhhhHhh
Confidence            99999998

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-48  Score=363.75  Aligned_cols=257  Identities=32%  Similarity=0.549  Sum_probs=225.4

Q ss_pred             CCceeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 016082          102 TDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP  179 (395)
Q Consensus       102 ~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  179 (395)
                      ...|.++.+.|++.+.||.|..++||+|++  .++.||||++.-+..+.+ .+.+++|+..|+.++||||++++..|..+
T Consensus        18 ~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~   96 (516)
T KOG0582|consen   18 EKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVD   96 (516)
T ss_pred             cccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence            346778889999999999999999999988  678999999998876666 78999999999999999999999999999


Q ss_pred             CcEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccc
Q 016082          180 PNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  258 (395)
Q Consensus       180 ~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~  258 (395)
                      ..+++||.||.+||+.++++.. ...+++..+..+++++++||.|||++|.||||||+.|||++.+|.|||+|||.+-..
T Consensus        97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l  176 (516)
T KOG0582|consen   97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL  176 (516)
T ss_pred             ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence            9999999999999999999764 466999999999999999999999999999999999999999999999999998654


Q ss_pred             ccCCc----c-ccCCCCcccccccccC--CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCC----C
Q 016082          259 AQSGV----M-TAETGTYRWMAPEVIE--HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP----T  327 (395)
Q Consensus       259 ~~~~~----~-~~~~gt~~y~aPE~~~--~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~----~  327 (395)
                      ...+.    . ....||++|||||++.  ...|+.|+||||||++..||.+|..||..+.|.+....-++.....    .
T Consensus       177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~  256 (516)
T KOG0582|consen  177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSG  256 (516)
T ss_pred             cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccccc
Confidence            44331    1 4458999999999965  3479999999999999999999999999999988877655543221    1


Q ss_pred             C----CCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          328 I----PKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       328 ~----~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      .    ....+..+++++..||++||++|||++++++
T Consensus       257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            1    1245678999999999999999999999986

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.1e-47  Score=360.91  Aligned_cols=260  Identities=22%  Similarity=0.412  Sum_probs=226.2

Q ss_pred             ceeecccCccee--eeeeeeCceEEEEEEECCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCceeeEEEEEec--
Q 016082          104 VWEIDAKQLKIE--CKVASGSYGDLYKGTYCSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--  178 (395)
Q Consensus       104 ~~~i~~~~~~i~--~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--  178 (395)
                      ...|+.+++...  ..||+|++|.||+|.++++.||||.++..... ....+.+.+|+.+|++++||||+++++++.+  
T Consensus        12 ~~~i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~   91 (283)
T PHA02988         12 IKCIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV   91 (283)
T ss_pred             ceecCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc
Confidence            344555555555  67999999999999999999999999865433 3345788999999999999999999999876  


Q ss_pred             --CCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCeeeCCCCcEEEeeeccc
Q 016082          179 --PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVA  255 (395)
Q Consensus       179 --~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~iiHrDlkp~NiLl~~~~~vkl~DFg~a  255 (395)
                        ...+++||||++||+|.+++.. .+.++......++.+++.||.|||+. +++||||||+||++++++.+||+|||++
T Consensus        92 ~~~~~~~lv~Ey~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~  170 (283)
T PHA02988         92 DDLPRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLE  170 (283)
T ss_pred             cCCCceEEEEEeCCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchH
Confidence              4578999999999999999977 45789999999999999999999984 9999999999999999999999999999


Q ss_pred             cccccCCccccCCCCcccccccccCC--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCc
Q 016082          256 RVQAQSGVMTAETGTYRWMAPEVIEH--KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH  333 (395)
Q Consensus       256 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (395)
                      +.....  .....|+..|+|||.+.+  ..++.++|||||||++|||++|+.||.+.+..+....+.....++..|..++
T Consensus       171 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  248 (283)
T PHA02988        171 KILSSP--PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCP  248 (283)
T ss_pred             hhhccc--cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCc
Confidence            865432  234578899999999976  6899999999999999999999999999888877777666667777787899


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 016082          334 PRLAELLERCWQHDPTQRPNFSQITDILKQMMK  366 (395)
Q Consensus       334 ~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~  366 (395)
                      +++.+++.+||+.||.+|||+.++++.|+++.+
T Consensus       249 ~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        249 LEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             HHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence            999999999999999999999999999988754

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.5e-48  Score=393.68  Aligned_cols=265  Identities=30%  Similarity=0.608  Sum_probs=234.9

Q ss_pred             CCCceeecccCcceeeeeeeeCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEE
Q 016082          101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI  173 (395)
Q Consensus       101 ~~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  173 (395)
                      .....+|...+.++.++||+|+||.||+|+..+       ..||||.+|... +.+...+|++|+.++..++|||||+++
T Consensus       477 ~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLl  555 (774)
T KOG1026|consen  477 DLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLL  555 (774)
T ss_pred             ccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEE
Confidence            345678899999999999999999999998633       569999998764 344778999999999999999999999


Q ss_pred             EEEecCCcEEEEEecCCCCCHHHHHhhcc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 016082          174 GACTRPPNLCIVTEFMARGSIYDFLHKQK-------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL  240 (395)
Q Consensus       174 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-------------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiL  240 (395)
                      |+|..++.+|||+|||..|+|.++|+.+.             .+++..+.+.+|.||+.||+||-++.++||||.++|+|
T Consensus       556 GVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCL  635 (774)
T KOG1026|consen  556 GVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCL  635 (774)
T ss_pred             EEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhce
Confidence            99999999999999999999999997652             12777889999999999999999999999999999999


Q ss_pred             eCCCCcEEEeeeccccccccCCccc---cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 016082          241 MDENGVVKVADFGVARVQAQSGVMT---AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAA  316 (395)
Q Consensus       241 l~~~~~vkl~DFg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~  316 (395)
                      |+++-.|||+|||++|-.-......   ...-..+|||||.+..++|+.+||||||||+|||+++ |+.||.+.++.+..
T Consensus       636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI  715 (774)
T KOG1026|consen  636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI  715 (774)
T ss_pred             eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence            9999999999999998544332211   2234689999999999999999999999999999999 99999999999988


Q ss_pred             HHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 016082          317 VGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE  367 (395)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~  367 (395)
                      ..+.+... -+.|+.+|.++++||..||+.+|.+||+|.||-.+|++..+.
T Consensus       716 e~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  716 ECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             HHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence            87666555 788999999999999999999999999999999999887653

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-47  Score=372.80  Aligned_cols=250  Identities=28%  Similarity=0.526  Sum_probs=224.0

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCC---HHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCC
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN---TEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPP  180 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  180 (395)
                      ...+.|.+.+.||+|+||.|++|.+  ++..||+|+++.....   ....+.+.+|+.++++++ ||||++++.++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            4456899999999999999999987  6799999988765222   234566778999999999 999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCC-CcEEEeeecccccc-
Q 016082          181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQ-  258 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~-~~vkl~DFg~a~~~-  258 (395)
                      .+|+||||+.||+|++++.. .+++.+..+.+++.|++.|++|||++||+||||||+|||++.+ +.+||+|||++... 
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~  172 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP  172 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence            99999999999999999998 8899999999999999999999999999999999999999999 99999999999987 


Q ss_pred             ccCCccccCCCCcccccccccCCCC-CC-ChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCC-cHH
Q 016082          259 AQSGVMTAETGTYRWMAPEVIEHKP-YD-YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHA-HPR  335 (395)
Q Consensus       259 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  335 (395)
                      .........+||+.|+|||++.+.. |+ .++||||+|++||-|++|+.||...+.......+..  ....+|..+ +++
T Consensus       173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~--~~~~~p~~~~S~~  250 (370)
T KOG0583|consen  173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK--GEFKIPSYLLSPE  250 (370)
T ss_pred             CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc--CCccCCCCcCCHH
Confidence            4556677889999999999999988 86 789999999999999999999999777666665433  345677778 999


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHH
Q 016082          336 LAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       336 l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      ++.++++|+..||.+|+++.+|++
T Consensus       251 ~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  251 ARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             HHHHHHHHcCCCcccCCCHHHHhh
Confidence            999999999999999999999985

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-49  Score=371.80  Aligned_cols=250  Identities=26%  Similarity=0.407  Sum_probs=221.1

Q ss_pred             cccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCC-cEE
Q 016082          108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPP-NLC  183 (395)
Q Consensus       108 ~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~  183 (395)
                      ..++|.+.++||.|+||.||+|+.  .+..||||.++.....-+ ...-.+|+..|++++ ||||+++.+++.+.. .+|
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e-e~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH-HHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            356899999999999999999976  678899999987654322 233578999999999 999999999998887 899


Q ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCc
Q 016082          184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV  263 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~  263 (395)
                      +|||||+. +|+++++.++..|++..+..|+.||++||+|+|.+|++|||+||+|||+..+..+||+|||+||.......
T Consensus        87 fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP  165 (538)
T KOG0661|consen   87 FVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP  165 (538)
T ss_pred             eeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCC
Confidence            99999987 99999999999999999999999999999999999999999999999999999999999999999988888


Q ss_pred             cccCCCCcccccccccC-CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCC----------------
Q 016082          264 MTAETGTYRWMAPEVIE-HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP----------------  326 (395)
Q Consensus       264 ~~~~~gt~~y~aPE~~~-~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~----------------  326 (395)
                      .|.+..|.+|+|||++. ...|+.+.|+|++||+++|+.+-++.|.|.++.+....++.-.-.|                
T Consensus       166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mn  245 (538)
T KOG0661|consen  166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMN  245 (538)
T ss_pred             cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhc
Confidence            99999999999999976 5678999999999999999999999999998887777665411111                


Q ss_pred             ----CC--------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          327 ----TI--------PKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       327 ----~~--------~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                          ..        -+.+++++.++|.+|+++||.+|||+.|.++
T Consensus       246 f~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~  290 (538)
T KOG0661|consen  246 FRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ  290 (538)
T ss_pred             cCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence                11        1347899999999999999999999999876

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.9e-48  Score=378.60  Aligned_cols=247  Identities=28%  Similarity=0.490  Sum_probs=228.2

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCC-CCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      .-|++++.||.|+.|.|.+|++  +|+.+|||++... ...+.....+.+|+.||+-+.|||++++|++++...++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            3678899999999999999988  7999999999765 445566778999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCcccc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA  266 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~  266 (395)
                      ||++||.|++++.. +|++++.++.+++.||+.|+.|+|..+|+||||||+|+|++..+.+||+|||+|.....+....+
T Consensus        92 Eyv~gGELFdylv~-kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeT  170 (786)
T KOG0588|consen   92 EYVPGGELFDYLVR-KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLET  170 (786)
T ss_pred             EecCCchhHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccccc
Confidence            99999999999987 78999999999999999999999999999999999999999999999999999998888888889


Q ss_pred             CCCCcccccccccCCCCCC-ChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhc
Q 016082          267 ETGTYRWMAPEVIEHKPYD-YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ  345 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~~~~~-~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  345 (395)
                      .||++.|.|||++.|.+|+ .++||||+|++||.|++|++||.+.+-......+.+..+  ++|..++++.++||++|+.
T Consensus       171 SCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f--~MPs~Is~eaQdLLr~ml~  248 (786)
T KOG0588|consen  171 SCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF--EMPSNISSEAQDLLRRMLD  248 (786)
T ss_pred             cCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc--cCCCcCCHHHHHHHHHHhc
Confidence            9999999999999999995 789999999999999999999998887777766555443  5679999999999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 016082          346 HDPTQRPNFSQITD  359 (395)
Q Consensus       346 ~dp~~RPs~~ell~  359 (395)
                      .||..|.|.+||++
T Consensus       249 VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  249 VDPSTRITTEEILK  262 (786)
T ss_pred             cCccccccHHHHhh
Confidence            99999999999987

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.6e-47  Score=366.72  Aligned_cols=252  Identities=22%  Similarity=0.356  Sum_probs=219.9

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  182 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  182 (395)
                      .+..++|.+++.||+|+||.||+|+.  +|..+|+|++++..+ ..+..+..+.|..+|...++|+||+++..|++..++
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            45678999999999999999999975  789999999987653 556778899999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc--
Q 016082          183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ--  260 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~--  260 (395)
                      ||||||++||++..+|.+ .+.+++..+..++.+++.|++.+|+.|||||||||+|+|||..|++||+|||++.....  
T Consensus       217 YLiMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~  295 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH  295 (550)
T ss_pred             EEEEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence            999999999999999976 78899999999999999999999999999999999999999999999999999842110  


Q ss_pred             ---------------------CCc-----c--------------------ccCCCCcccccccccCCCCCCChhhHHHHH
Q 016082          261 ---------------------SGV-----M--------------------TAETGTYRWMAPEVIEHKPYDYKADVFSFG  294 (395)
Q Consensus       261 ---------------------~~~-----~--------------------~~~~gt~~y~aPE~~~~~~~~~k~DvwslG  294 (395)
                                           ...     .                    ....|||.|||||++.+++|+..+|.||||
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG  375 (550)
T KOG0605|consen  296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG  375 (550)
T ss_pred             hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence                                 000     0                    012499999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHhhhcc--CCCCCCCCCcHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 016082          295 IALWELLTGELPYAGLTPLQAAVGVVQKS--LRPTIPKHAHPRLAELLERCWQHDPTQRPN---FSQITD  359 (395)
Q Consensus       295 ~vl~elltg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~ell~  359 (395)
                      |++|||+.|.+||.+.++.+....++.-.  +.-+....++++..+||.+|+. ||++|..   ++||.+
T Consensus       376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~  444 (550)
T KOG0605|consen  376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK  444 (550)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence            99999999999999999999988887654  3333345678999999999999 9999975   555543

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-47  Score=365.36  Aligned_cols=252  Identities=27%  Similarity=0.422  Sum_probs=222.7

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--CcE
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNL  182 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  182 (395)
                      ...+.|..+++||+|.||.||+|++  +++.||+|.++.+...+.......+||.||++|+||||+++.+.....  ..+
T Consensus       114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si  193 (560)
T KOG0600|consen  114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI  193 (560)
T ss_pred             cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence            3456799999999999999999998  678899999998887788888999999999999999999999998876  679


Q ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC
Q 016082          183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~  262 (395)
                      |||+|||+. +|.-++....-.|+++++..++.|++.||+|||++||+|||||..|||||++|.+||+|||+|++.....
T Consensus       194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~  272 (560)
T KOG0600|consen  194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG  272 (560)
T ss_pred             EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence            999999988 9999988766789999999999999999999999999999999999999999999999999999665443


Q ss_pred             --ccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC--------------
Q 016082          263 --VMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--------------  325 (395)
Q Consensus       263 --~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~--------------  325 (395)
                        .+|....|.+|+|||.+.|. .|+.+.|+||.||+|.||++|+++|.+.++.+....+....-.              
T Consensus       273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~  352 (560)
T KOG0600|consen  273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHA  352 (560)
T ss_pred             CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcc
Confidence              57888899999999999875 7999999999999999999999999999988777665542111              


Q ss_pred             ----CCCC---------CCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          326 ----PTIP---------KHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       326 ----~~~~---------~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                          +..+         ...+....+|+.++|..||.+|.|+.+.++
T Consensus       353 ~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  353 TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence                1111         245778999999999999999999998875

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.7e-46  Score=348.79  Aligned_cols=256  Identities=30%  Similarity=0.599  Sum_probs=221.9

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEEC-----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  181 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  181 (395)
                      |+.++|++.+.||+|+||.||+|++.     +..||+|.++... .......+.+|+.++++++||||+++++++..++.
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   80 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT   80 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence            56678999999999999999999752     4689999998653 34445779999999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC
Q 016082          182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  261 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~  261 (395)
                      .++||||+++|+|.+++....+.+++..++.++.|++.||+|||++|++||||||+||+++.++.++++|||.+......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            99999999999999999876678999999999999999999999999999999999999999999999999987654322


Q ss_pred             Cccc--cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHH
Q 016082          262 GVMT--AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE  338 (395)
Q Consensus       262 ~~~~--~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  338 (395)
                      ....  ...++..|+|||.+.+..++.++|||||||++||+++ |..||...+..+....+ ....+++.|..++..+.+
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  239 (266)
T cd05064         161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV-EDGFRLPAPRNCPNLLHQ  239 (266)
T ss_pred             chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-HCCCCCCCCCCCCHHHHH
Confidence            2111  2345678999999999999999999999999999875 99999988876655443 445566678889999999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHHHHH
Q 016082          339 LLERCWQHDPTQRPNFSQITDILKQM  364 (395)
Q Consensus       339 li~~cl~~dp~~RPs~~ell~~l~~~  364 (395)
                      ++.+||+.+|.+||++.+|.+.|..+
T Consensus       240 li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         240 LMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             HHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            99999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-47  Score=393.83  Aligned_cols=265  Identities=34%  Similarity=0.638  Sum_probs=235.7

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT  177 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  177 (395)
                      .+++....++.+.||+|.||.||.|++.+       ..||||.+++.. +.+...+|.+|..+|++++||||++++|+|-
T Consensus       687 p~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l  765 (1025)
T KOG1095|consen  687 PEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCL  765 (1025)
T ss_pred             ccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence            34667889999999999999999998843       238999987664 5667789999999999999999999999999


Q ss_pred             cCCcEEEEEecCCCCCHHHHHhhc------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEee
Q 016082          178 RPPNLCIVTEFMARGSIYDFLHKQ------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD  251 (395)
Q Consensus       178 ~~~~~~lV~E~~~ggsL~~~l~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~D  251 (395)
                      +....+|++|||+||+|..+|++.      ...++...++.++.||++|+.||+++++|||||.++|+|++....|||+|
T Consensus       766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaD  845 (1025)
T KOG1095|consen  766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIAD  845 (1025)
T ss_pred             CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcc
Confidence            999999999999999999999987      56788999999999999999999999999999999999999999999999


Q ss_pred             eccccccccCCcc--ccC-CCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCC
Q 016082          252 FGVARVQAQSGVM--TAE-TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPT  327 (395)
Q Consensus       252 Fg~a~~~~~~~~~--~~~-~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  327 (395)
                      ||+|+-.......  ... .-..+|||||.+....++.|+|||||||++||++| |..||.+.++.+....+...+ |..
T Consensus       846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~  924 (1025)
T KOG1095|consen  846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLD  924 (1025)
T ss_pred             cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccC
Confidence            9999943332211  112 33579999999999999999999999999999999 999999999999888777666 999


Q ss_pred             CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHh
Q 016082          328 IPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYW  371 (395)
Q Consensus       328 ~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~~~  371 (395)
                      .|..|+..++++|..||+.+|++||+|..|++.+.++.+....-
T Consensus       925 ~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~  968 (1025)
T KOG1095|consen  925 PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGT  968 (1025)
T ss_pred             CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccC
Confidence            99999999999999999999999999999999999988866543

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=7.7e-47  Score=334.98  Aligned_cols=249  Identities=26%  Similarity=0.406  Sum_probs=220.1

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      .+|...+++|+|.||.||+|++  +++.||||.++.....+.......+||+.|+.++|+||+.++++|...+++-||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4788899999999999999998  68999999999887666666788999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCc-ccc
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-MTA  266 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~-~~~  266 (395)
                      ||+- +|+..++.....++...+..++.++++|++|||++.|+||||||+|+|++.+|.+||+|||+|+....... .+.
T Consensus        82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~  160 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH  160 (318)
T ss_pred             eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccccc
Confidence            9986 99999999888999999999999999999999999999999999999999999999999999998776543 344


Q ss_pred             CCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCC------------------
Q 016082          267 ETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT------------------  327 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~------------------  327 (395)
                      ...|.+|+|||.+.| +.|+...|+||.||++.||+-|.+.|.|.+..+....+.+..-.|.                  
T Consensus       161 ~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~  240 (318)
T KOG0659|consen  161 QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQ  240 (318)
T ss_pred             ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhc
Confidence            478999999998865 5799999999999999999999999999888777666554222111                  


Q ss_pred             ---CC-----CCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          328 ---IP-----KHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       328 ---~~-----~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                         .+     +.++.+..+++.+||..||.+|++++|.++
T Consensus       241 ~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~  280 (318)
T KOG0659|consen  241 FPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK  280 (318)
T ss_pred             CCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence               11     235778899999999999999999999987

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.3e-47  Score=367.56  Aligned_cols=246  Identities=31%  Similarity=0.578  Sum_probs=224.2

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      ++|.+.+.||+|+||.||+|+.  +.+.||+|.+.+...++...+.+++|++|+++++||||+.+++.|+...++++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            4788899999999999999976  56889999998888788888999999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-cccc
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA  266 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~~  266 (395)
                      |+.| +|..+|.. .+.++++.+..++.++++||.|||+++|+|||+||.|||++.+|++|+||||+|+...... ..+.
T Consensus        82 ~a~g-~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlts  159 (808)
T KOG0597|consen   82 YAVG-DLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTS  159 (808)
T ss_pred             hhhh-hHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeee
Confidence            9988 99999977 7789999999999999999999999999999999999999999999999999999877654 3455


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhcc
Q 016082          267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH  346 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  346 (395)
                      ..|||.|||||+..+++|+..+|+||+||++||+++|++||...+-.+....+...  .+..|...+..+..+++..|.+
T Consensus       160 ikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d--~v~~p~~~S~~f~nfl~gLL~k  237 (808)
T KOG0597|consen  160 IKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD--PVKPPSTASSSFVNFLQGLLIK  237 (808)
T ss_pred             ccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC--CCCCcccccHHHHHHHHHHhhc
Confidence            68999999999999999999999999999999999999999887766666665544  3344568999999999999999


Q ss_pred             CCCCCCCHHHHHH
Q 016082          347 DPTQRPNFSQITD  359 (395)
Q Consensus       347 dp~~RPs~~ell~  359 (395)
                      ||..|.+-.+++.
T Consensus       238 dP~~RltW~~Ll~  250 (808)
T KOG0597|consen  238 DPAQRLTWTDLLG  250 (808)
T ss_pred             ChhhcccHHHHhc
Confidence            9999999998875

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.9e-46  Score=365.93  Aligned_cols=263  Identities=31%  Similarity=0.641  Sum_probs=225.3

Q ss_pred             CCceeecccCcceeeeeeeeCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEE
Q 016082          102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFI  173 (395)
Q Consensus       102 ~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~  173 (395)
                      ...|.+..++|++.+.||+|+||.||+|++.       +..||+|+++... ..+....+.+|+.+++++ +||||++++
T Consensus        30 ~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~  108 (374)
T cd05106          30 NEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLL  108 (374)
T ss_pred             cccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEe
Confidence            3568888999999999999999999998752       2479999998654 234456789999999999 899999999


Q ss_pred             EEEecCCcEEEEEecCCCCCHHHHHhhcc---------------------------------------------------
Q 016082          174 GACTRPPNLCIVTEFMARGSIYDFLHKQK---------------------------------------------------  202 (395)
Q Consensus       174 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------------------------------------------  202 (395)
                      ++|...+..++||||+++|+|.++++...                                                   
T Consensus       109 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (374)
T cd05106         109 GACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS  188 (374)
T ss_pred             eEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence            99999999999999999999999986532                                                   


Q ss_pred             ------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCcc
Q 016082          203 ------------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM  264 (395)
Q Consensus       203 ------------------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~  264 (395)
                                        .++++..+++++.||+.||.|||++||+||||||+|||+++++.++|+|||+++........
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~  268 (374)
T cd05106         189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY  268 (374)
T ss_pred             ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence                              24677889999999999999999999999999999999999999999999999754433211


Q ss_pred             ---ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHH
Q 016082          265 ---TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELL  340 (395)
Q Consensus       265 ---~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  340 (395)
                         ....++..|+|||++.+..++.++|||||||++|+|++ |+.||.................++..+...++++.+++
T Consensus       269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  348 (374)
T cd05106         269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIM  348 (374)
T ss_pred             eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHH
Confidence               12234568999999998899999999999999999997 99999887665555555666666677777899999999


Q ss_pred             HHhhccCCCCCCCHHHHHHHHHHHH
Q 016082          341 ERCWQHDPTQRPNFSQITDILKQMM  365 (395)
Q Consensus       341 ~~cl~~dp~~RPs~~ell~~l~~~~  365 (395)
                      .+||+.||.+||++.++++.|++++
T Consensus       349 ~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         349 KMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             HHHcCCChhhCcCHHHHHHHHHHHh
Confidence            9999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.9e-46  Score=366.99  Aligned_cols=261  Identities=30%  Similarity=0.615  Sum_probs=223.7

Q ss_pred             CceeecccCcceeeeeeeeCceEEEEEEE-------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEE
Q 016082          103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG  174 (395)
Q Consensus       103 ~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~  174 (395)
                      ..|.++.++|++.++||+|+||.||+|++       .+..||||+++.... ....+.+.+|+.+++.+ +||||+++++
T Consensus        28 ~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~  106 (375)
T cd05104          28 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLG  106 (375)
T ss_pred             cccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeee
Confidence            45788888999999999999999999974       245799999976542 33446788999999999 8999999999


Q ss_pred             EEecCCcEEEEEecCCCCCHHHHHhhcc----------------------------------------------------
Q 016082          175 ACTRPPNLCIVTEFMARGSIYDFLHKQK----------------------------------------------------  202 (395)
Q Consensus       175 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------------------------------------------  202 (395)
                      +|......++||||++||+|.++++...                                                    
T Consensus       107 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  186 (375)
T cd05104         107 ACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKR  186 (375)
T ss_pred             eeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccc
Confidence            9999999999999999999999996532                                                    


Q ss_pred             ----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          203 ----------------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       203 ----------------------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                                            ..+++..+..++.||++||.|||++||+||||||+||+++.++.++|+|||+++....
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~  266 (375)
T cd05104         187 RSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRN  266 (375)
T ss_pred             cccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence                                  1467788899999999999999999999999999999999999999999999976543


Q ss_pred             CCcc---ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHH
Q 016082          261 SGVM---TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  336 (395)
Q Consensus       261 ~~~~---~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  336 (395)
                      ....   ....++..|+|||.+.+..++.++||||||+++|||++ |..||.................++..|...+.++
T Consensus       267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  346 (375)
T cd05104         267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEM  346 (375)
T ss_pred             cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHH
Confidence            3211   12234678999999999999999999999999999998 8999988776665666666666777777788999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 016082          337 AELLERCWQHDPTQRPNFSQITDILKQM  364 (395)
Q Consensus       337 ~~li~~cl~~dp~~RPs~~ell~~l~~~  364 (395)
                      .+++.+||+.||++||++.++++.|++.
T Consensus       347 ~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         347 YDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             HHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            9999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=9e-47  Score=366.49  Aligned_cols=264  Identities=30%  Similarity=0.672  Sum_probs=238.5

Q ss_pred             CceeecccCcceeeeeeeeCceEEEEEEECC------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEE
Q 016082          103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC  176 (395)
Q Consensus       103 ~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  176 (395)
                      ...++......+.+.||.|-||.||+|.++.      -.||||.+|.+...+ ..+.|.+|..+|++++||||++++|+|
T Consensus       382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d-~tekflqEa~iMrnfdHphIikLIGv~  460 (974)
T KOG4257|consen  382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPD-DTEKFLQEASIMRNFDHPHIIKLIGVC  460 (974)
T ss_pred             CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChh-hHHHHHHHHHHHHhCCCcchhheeeee
Confidence            3567778888888999999999999999853      249999999876443 368899999999999999999999999


Q ss_pred             ecCCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccc
Q 016082          177 TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR  256 (395)
Q Consensus       177 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~  256 (395)
                      .+.+ .+||||.++-|.|..||+.+...++..++..++.||+.+|.|||+++++||||.++|||+....-|||+|||++|
T Consensus       461 ~e~P-~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR  539 (974)
T KOG4257|consen  461 VEQP-MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSR  539 (974)
T ss_pred             eccc-eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhh
Confidence            8875 899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccCCC--CcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCc
Q 016082          257 VQAQSGVMTAETG--TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAH  333 (395)
Q Consensus       257 ~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (395)
                      .........+..|  ...|||||.++-..++.++|||.||+.+||++. |..||.+..+.+.. ..+..+.|++.|+.||
T Consensus       540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-~~iEnGeRlP~P~nCP  618 (974)
T KOG4257|consen  540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-GHIENGERLPCPPNCP  618 (974)
T ss_pred             hccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-EEecCCCCCCCCCCCC
Confidence            8887766555555  568999999999999999999999999999988 99999998776654 4466789999999999


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHH
Q 016082          334 PRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVL  369 (395)
Q Consensus       334 ~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~  369 (395)
                      +.++.++.+||.++|.+||.|.+|...|.+++++-.
T Consensus       619 p~LYslmskcWayeP~kRPrftei~~~lsdv~qeek  654 (974)
T KOG4257|consen  619 PALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEK  654 (974)
T ss_pred             hHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhh
Confidence            999999999999999999999999999999988543

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.8e-45  Score=348.48  Aligned_cols=255  Identities=33%  Similarity=0.598  Sum_probs=211.7

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEEC------------------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTYC------------------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN  168 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~~------------------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  168 (395)
                      +..++|++.++||+|+||.||++.+.                  +..||+|+++... ......++.+|+.++++++|||
T Consensus         2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~n   80 (304)
T cd05096           2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPN   80 (304)
T ss_pred             CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCC
Confidence            34568999999999999999999752                  2369999998653 3455678999999999999999


Q ss_pred             eeeEEEEEecCCcEEEEEecCCCCCHHHHHhhcc------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 016082          169 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK------------------GVFQLTSLLKVAIDVSKGMNYLHQNNII  230 (395)
Q Consensus       169 iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~------------------~~l~~~~~~~i~~~i~~~l~~LH~~~ii  230 (395)
                      |+++++++...+..++||||+++|+|.+++....                  ..++...+..++.||+.||.|||+.||+
T Consensus        81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv  160 (304)
T cd05096          81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV  160 (304)
T ss_pred             eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            9999999999999999999999999999986532                  2367778999999999999999999999


Q ss_pred             ccCCCCCCeeeCCCCcEEEeeeccccccccCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh--CCC
Q 016082          231 HRDLKTANLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT--GEL  305 (395)
Q Consensus       231 HrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt--g~~  305 (395)
                      ||||||+||+++.++.+||+|||+++.......   .....++..|+|||++.+..++.++||||||+++|+|++  +..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            999999999999999999999999975433221   122345788999999998899999999999999999987  668


Q ss_pred             CCCCCCHHHHHHHhhh------ccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 016082          306 PYAGLTPLQAAVGVVQ------KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK  362 (395)
Q Consensus       306 pf~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~  362 (395)
                      ||...+..+.......      ....+..++.+++.+.++|.+||+.+|.+|||+.+|.+.|+
T Consensus       241 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            8988776554433221      11123345678899999999999999999999999988775

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-46  Score=363.86  Aligned_cols=246  Identities=30%  Similarity=0.530  Sum_probs=219.9

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      ..|.-..+||+|+.|.||.|+.  +++.||||.+.......  .+-+.+|+.+|+..+|+|||.+++.+...+.+++|||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME  350 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME  350 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence            4688889999999999999987  56889999987654322  3568899999999999999999999988899999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-cccc
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA  266 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~~  266 (395)
                      ||+||+|.|.+...  .+++.++..++.++++||+|||.+||||||||.+|||++.+|.+||+|||++....... ....
T Consensus       351 ym~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~T  428 (550)
T KOG0578|consen  351 YMEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRST  428 (550)
T ss_pred             ecCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcccc
Confidence            99999999998653  48999999999999999999999999999999999999999999999999997666544 5667


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC-CCCCCCCcHHHHHHHHHhhc
Q 016082          267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR-PTIPKHAHPRLAELLERCWQ  345 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~  345 (395)
                      ..|||.|||||++..+.|+.|.||||||++.+||+.|.+||-.-++.++...+...+-. -..++.+|+.+++|+.+||+
T Consensus       429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~  508 (550)
T KOG0578|consen  429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLV  508 (550)
T ss_pred             ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhh
Confidence            89999999999999999999999999999999999999999998998887776654432 23467899999999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 016082          346 HDPTQRPNFSQITD  359 (395)
Q Consensus       346 ~dp~~RPs~~ell~  359 (395)
                      .|+++||++.+||+
T Consensus       509 ~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  509 VDVEQRASAKELLE  522 (550)
T ss_pred             cchhcCCCHHHHhc
Confidence            99999999999987

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-47  Score=360.72  Aligned_cols=247  Identities=32%  Similarity=0.555  Sum_probs=219.7

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      ..|+..+.||+|+||.||+|.+  +++.||+|++.-+.. ++.++++++|+.+|.+++++||.++|+.+..+..++++||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe   91 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME   91 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence            3677779999999999999988  578999999987653 4457889999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCc-ccc
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-MTA  266 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~-~~~  266 (395)
                      |+.||++.+.++. .+.+.+..+..++++++.|+.|||..+.+|||||+.|||+..+|.+||+|||.+........ ...
T Consensus        92 y~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~t  170 (467)
T KOG0201|consen   92 YCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKT  170 (467)
T ss_pred             HhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcccc
Confidence            9999999999965 45558889999999999999999999999999999999999999999999999976655432 356


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhcc
Q 016082          267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH  346 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  346 (395)
                      ..||+.|||||++.+..|+.|+||||||++.+||++|.+|+....|...... +.+..+|....++++.+++|+..||++
T Consensus       171 fvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl-Ipk~~PP~L~~~~S~~~kEFV~~CL~k  249 (467)
T KOG0201|consen  171 FVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL-IPKSAPPRLDGDFSPPFKEFVEACLDK  249 (467)
T ss_pred             ccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe-ccCCCCCccccccCHHHHHHHHHHhhc
Confidence            7899999999999999999999999999999999999999999988543332 334556677778999999999999999


Q ss_pred             CCCCCCCHHHHHH
Q 016082          347 DPTQRPNFSQITD  359 (395)
Q Consensus       347 dp~~RPs~~ell~  359 (395)
                      ||+.||++.++++
T Consensus       250 ~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  250 NPEFRPSAKELLK  262 (467)
T ss_pred             CcccCcCHHHHhh
Confidence            9999999999986

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-46  Score=350.90  Aligned_cols=245  Identities=23%  Similarity=0.408  Sum_probs=215.0

Q ss_pred             cCcceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      ++|++.+.||+|+||.||+|.+.  ++.||+|+++.... .......+.+|+.++++++||||+++++++.+....|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            37899999999999999999884  78999999975432 2234567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCcccc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA  266 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~  266 (395)
                      ||+++|+|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.....  ...
T Consensus        81 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~~~  157 (291)
T cd05612          81 EYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--TWT  157 (291)
T ss_pred             eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--ccc
Confidence            99999999999976 567899999999999999999999999999999999999999999999999999765432  234


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhcc
Q 016082          267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH  346 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  346 (395)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+...  ....|...++.+.++|.+||+.
T Consensus       158 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~  235 (291)
T cd05612         158 LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG--KLEFPRHLDLYAKDLIKKLLVV  235 (291)
T ss_pred             ccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CcCCCccCCHHHHHHHHHHcCC
Confidence            57899999999999999999999999999999999999999998877666555443  3456777899999999999999


Q ss_pred             CCCCCCC-----HHHHHH
Q 016082          347 DPTQRPN-----FSQITD  359 (395)
Q Consensus       347 dp~~RPs-----~~ell~  359 (395)
                      ||.+||+     ++++++
T Consensus       236 dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         236 DRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             CHHHccCCccCCHHHHhc
Confidence            9999995     888775

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.1e-45  Score=356.62  Aligned_cols=247  Identities=26%  Similarity=0.436  Sum_probs=216.6

Q ss_pred             cccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Q 016082          108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  184 (395)
Q Consensus       108 ~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  184 (395)
                      ..++|++.+.||+|+||.||+|++  +++.||+|+++.... .....+.+.+|+.++++++||||+++++++..++..|+
T Consensus        16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   95 (329)
T PTZ00263         16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF   95 (329)
T ss_pred             CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence            346899999999999999999988  568899999975422 22345678999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCcc
Q 016082          185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM  264 (395)
Q Consensus       185 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~  264 (395)
                      ||||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......  
T Consensus        96 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--  172 (329)
T PTZ00263         96 LLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT--  172 (329)
T ss_pred             EEcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--
Confidence            9999999999999976 5678999999999999999999999999999999999999999999999999998654332  


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhh
Q 016082          265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW  344 (395)
Q Consensus       265 ~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  344 (395)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.++.+....+...  +...|..++.++.++|.+||
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~L  250 (329)
T PTZ00263        173 FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG--RLKFPNWFDGRARDLVKGLL  250 (329)
T ss_pred             ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CcCCCCCCCHHHHHHHHHHh
Confidence            3457899999999999999999999999999999999999999988877666555433  45567778999999999999


Q ss_pred             ccCCCCCCC-----HHHHHH
Q 016082          345 QHDPTQRPN-----FSQITD  359 (395)
Q Consensus       345 ~~dp~~RPs-----~~ell~  359 (395)
                      +.||.+||+     +.++++
T Consensus       251 ~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        251 QTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             hcCHHHcCCCCCCCHHHHhc
Confidence            999999997     677764

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=5.1e-45  Score=360.46  Aligned_cols=264  Identities=31%  Similarity=0.635  Sum_probs=226.0

Q ss_pred             CCceeecccCcceeeeeeeeCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEE
Q 016082          102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFI  173 (395)
Q Consensus       102 ~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~  173 (395)
                      ...|+++.++|.+.++||+|+||.||+|++.+       ..||||+++... .....+.+.+|+.+++++. ||||++++
T Consensus        29 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~  107 (400)
T cd05105          29 DSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLL  107 (400)
T ss_pred             CCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEE
Confidence            35789999999999999999999999998632       359999997653 3444578999999999996 99999999


Q ss_pred             EEEecCCcEEEEEecCCCCCHHHHHhhcc---------------------------------------------------
Q 016082          174 GACTRPPNLCIVTEFMARGSIYDFLHKQK---------------------------------------------------  202 (395)
Q Consensus       174 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------------------------------------------  202 (395)
                      +++......|+||||+++|+|.++++++.                                                   
T Consensus       108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (400)
T cd05105         108 GACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQ  187 (400)
T ss_pred             EEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccc
Confidence            99999999999999999999999986531                                                   


Q ss_pred             --------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 016082          203 --------------------------------------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN  238 (395)
Q Consensus       203 --------------------------------------------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~N  238 (395)
                                                                  ..+++..+..++.|+++||+|||+.+|+||||||+|
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~N  267 (400)
T cd05105         188 YVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARN  267 (400)
T ss_pred             cchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHh
Confidence                                                        236777889999999999999999999999999999


Q ss_pred             eeeCCCCcEEEeeeccccccccCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 016082          239 LLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQ  314 (395)
Q Consensus       239 iLl~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~  314 (395)
                      |+++.++.+||+|||+++.......   .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus       268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~  347 (400)
T cd05105         268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS  347 (400)
T ss_pred             EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence            9999999999999999976443221   122346778999999999999999999999999999997 999998876555


Q ss_pred             HHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 016082          315 AAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK  366 (395)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~  366 (395)
                      ..........++..+..+++++.+++.+||+.+|++||++.++.+.|+++++
T Consensus       348 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         348 TFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             HHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            5555555666677778899999999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.8e-45  Score=346.53  Aligned_cols=249  Identities=20%  Similarity=0.339  Sum_probs=209.9

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      .|++.+.||+|+||.||+|..  +++.||+|++...... ......+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            377889999999999999986  6789999998755332 2233567899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCcccc
Q 016082          188 FMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA  266 (395)
Q Consensus       188 ~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~  266 (395)
                      |+++|+|.+++... ...+++..+..++.|++.||+|||+.||+||||||+||++++++.++|+|||++...........
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG  160 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecC
Confidence            99999999888653 34689999999999999999999999999999999999999999999999999986544433445


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhh--ccCCCCCCCCCcHHHHHHHHHhh
Q 016082          267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ--KSLRPTIPKHAHPRLAELLERCW  344 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl  344 (395)
                      ..||..|+|||++.+..++.++|||||||++|+|++|+.||.+.........+..  .......+...++++.+++++||
T Consensus       161 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l  240 (285)
T cd05631         161 RVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLL  240 (285)
T ss_pred             CCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHh
Confidence            6789999999999999999999999999999999999999987654322111111  12233456678999999999999


Q ss_pred             ccCCCCCCC-----HHHHHH
Q 016082          345 QHDPTQRPN-----FSQITD  359 (395)
Q Consensus       345 ~~dp~~RPs-----~~ell~  359 (395)
                      +.||.+||+     ++++++
T Consensus       241 ~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         241 TKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             hcCHHHhcCCCCCCHHHHhc
Confidence            999999997     677765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.8e-45  Score=343.07  Aligned_cols=247  Identities=36%  Similarity=0.701  Sum_probs=211.5

Q ss_pred             ceeeeeeeeCceEEEEEEEC------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          113 KIECKVASGSYGDLYKGTYC------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       113 ~i~~~lg~G~~G~Vy~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      ++.+.||.|+||.||+|++.      +..|+||+++.. ...+..+.+.+|++.+++++||||++++|++...+..++|+
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~   80 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM   80 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeecccccccccccccccccccccccccccccc
Confidence            46789999999999999987      578999999764 34556789999999999999999999999999888899999


Q ss_pred             ecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC---
Q 016082          187 EFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---  262 (395)
Q Consensus       187 E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~---  262 (395)
                      ||+++|+|.+++... ...++...+..++.||++||.|||+++++|+||+|+||+++.++.+||+|||+++......   
T Consensus        81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~  160 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK  160 (259)
T ss_dssp             E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999999999886 5789999999999999999999999999999999999999999999999999998663221   


Q ss_pred             ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHH
Q 016082          263 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE  341 (395)
Q Consensus       263 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  341 (395)
                      ......+...|+|||.+.+..++.++||||||+++||+++ |+.||...+..+....+ ....++..+..++..+.++|.
T Consensus       161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~  239 (259)
T PF07714_consen  161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPIPDNCPKDIYSLIQ  239 (259)
T ss_dssp             ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTSBTTSBHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccceeccchhHHHHHHHH
Confidence            1223456789999999998889999999999999999999 78999999887766555 566677788889999999999


Q ss_pred             HhhccCCCCCCCHHHHHHHH
Q 016082          342 RCWQHDPTQRPNFSQITDIL  361 (395)
Q Consensus       342 ~cl~~dp~~RPs~~ell~~l  361 (395)
                      +||+.+|.+||++.++++.|
T Consensus       240 ~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  240 QCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             HHT-SSGGGS--HHHHHHHH
T ss_pred             HHcCCChhhCcCHHHHHhcC
Confidence            99999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-45  Score=354.32  Aligned_cols=247  Identities=24%  Similarity=0.407  Sum_probs=213.6

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      ++|++.++||+|+||.||+|++  +++.||||+++.... ..+....+.+|+.++++++||||+++++++......|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            4789999999999999999988  578999999975432 2234567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCcccc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA  266 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~  266 (395)
                      ||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....  ....
T Consensus        81 e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~  157 (333)
T cd05600          81 EYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANS  157 (333)
T ss_pred             eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCC
Confidence            99999999999976 56789999999999999999999999999999999999999999999999999975543  2345


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccC---CCCCC---CCCcHHHHHHH
Q 016082          267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL---RPTIP---KHAHPRLAELL  340 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~---~~~~~---~~~~~~l~~li  340 (395)
                      ..||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+.....   .+...   ..+++++.++|
T Consensus       158 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li  237 (333)
T cd05600         158 VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLI  237 (333)
T ss_pred             cccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHH
Confidence            6799999999999999999999999999999999999999998887665554432211   11111   24689999999


Q ss_pred             HHhhccCCCCCCCHHHHHH
Q 016082          341 ERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       341 ~~cl~~dp~~RPs~~ell~  359 (395)
                      .+||+.+|.+||++.++++
T Consensus       238 ~~~l~~~~~rr~s~~~ll~  256 (333)
T cd05600         238 TKLINDPSRRFGSLEDIKN  256 (333)
T ss_pred             HHHhhChhhhcCCHHHHHh
Confidence            9999999999999999986

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-45  Score=362.59  Aligned_cols=245  Identities=27%  Similarity=0.456  Sum_probs=222.6

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCc
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPN  181 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  181 (395)
                      .+..++|.+.++||+|+||.|+++..  +++.+|||+++++.. ..+..+..+.|..|+.... ||.+++++..|++..+
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            56678999999999999999999988  567899999988764 6667788999999998886 9999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccc-c
Q 016082          182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA-Q  260 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~-~  260 (395)
                      +|+||||..||++..+.  +.+.|++..+..++..++.||.|||++|||+||||.+|||+|.+|++||+|||+++..- .
T Consensus       444 l~fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~  521 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ  521 (694)
T ss_pred             EEEEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence            99999999999944433  35789999999999999999999999999999999999999999999999999998654 4


Q ss_pred             CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHH
Q 016082          261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELL  340 (395)
Q Consensus       261 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  340 (395)
                      .....+.+||+.|||||++.+..|+.+.|.|||||+||||+.|+.||++.++.+....++..  .+..|..+|.+...+|
T Consensus       522 g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d--~~~yP~~ls~ea~~il  599 (694)
T KOG0694|consen  522 GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND--EVRYPRFLSKEAIAIM  599 (694)
T ss_pred             CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CCCCCCcccHHHHHHH
Confidence            44566789999999999999999999999999999999999999999999999999888754  6678899999999999


Q ss_pred             HHhhccCCCCCCCH
Q 016082          341 ERCWQHDPTQRPNF  354 (395)
Q Consensus       341 ~~cl~~dp~~RPs~  354 (395)
                      +++|.++|++|...
T Consensus       600 ~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  600 RRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHhccCcccccCC
Confidence            99999999999866

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.6e-45  Score=354.50  Aligned_cols=241  Identities=24%  Similarity=0.449  Sum_probs=209.8

Q ss_pred             eeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecCCCC
Q 016082          116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARG  192 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~gg  192 (395)
                      +.||+|+||.||+++.  +++.||+|+++.... .......+.+|+.++++++||||+++++++...+.+|+||||++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999987  578999999975432 2344567889999999999999999999999999999999999999


Q ss_pred             CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-CccccCCCCc
Q 016082          193 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGTY  271 (395)
Q Consensus       193 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-~~~~~~~gt~  271 (395)
                      +|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..... .......||+
T Consensus        81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~  159 (323)
T cd05571          81 ELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP  159 (323)
T ss_pred             cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCc
Confidence            99999976 567899999999999999999999999999999999999999999999999998753222 2233457999


Q ss_pred             ccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCC
Q 016082          272 RWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR  351 (395)
Q Consensus       272 ~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  351 (395)
                      .|+|||++.+..++.++|||||||++|||++|+.||...+.......+...  ...+|..+++++.++|.+||+.||++|
T Consensus       160 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R  237 (323)
T cd05571         160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLSPEAKSLLAGLLKKDPKQR  237 (323)
T ss_pred             cccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence            999999999999999999999999999999999999887776655544432  345677899999999999999999999


Q ss_pred             C-----CHHHHHH
Q 016082          352 P-----NFSQITD  359 (395)
Q Consensus       352 P-----s~~ell~  359 (395)
                      |     ++.++++
T Consensus       238 ~~~~~~~~~~ll~  250 (323)
T cd05571         238 LGGGPEDAKEIME  250 (323)
T ss_pred             CCCCCCCHHHHHc
Confidence            9     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-46  Score=360.27  Aligned_cols=259  Identities=38%  Similarity=0.758  Sum_probs=236.1

Q ss_pred             CceeecccCcceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 016082          103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  180 (395)
Q Consensus       103 ~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (395)
                      +.|+++..+.....+||-|.||.||.|.|.  .-.||||.++.+   ....++|..|..+|+.++|||+|+++|+|+...
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED---tMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep  336 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP  336 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc---chhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence            789999999999999999999999999995  456999999865   345689999999999999999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  259 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~  259 (395)
                      .+|||+|||..|+|.+||++.+ ..++.-.+++++.||..||+||..+++|||||.++|.|+.++..||++|||++|.+.
T Consensus       337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMt  416 (1157)
T KOG4278|consen  337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMT  416 (1157)
T ss_pred             CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence            9999999999999999998864 446666788999999999999999999999999999999999999999999999876


Q ss_pred             cCCccccCCC---CcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHH
Q 016082          260 QSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR  335 (395)
Q Consensus       260 ~~~~~~~~~g---t~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (395)
                      ... .++..|   ...|.|||-+....++.|+|||+||++|||+.| |-.||.+.+..+. .+.+.+++|..-|+.|++.
T Consensus       417 gDT-YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqV-Y~LLEkgyRM~~PeGCPpk  494 (1157)
T KOG4278|consen  417 GDT-YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-YGLLEKGYRMDGPEGCPPK  494 (1157)
T ss_pred             CCc-eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHH-HHHHhccccccCCCCCCHH
Confidence            543 344444   568999999999999999999999999999999 9999999887765 4568889999999999999


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 016082          336 LAELLERCWQHDPTQRPNFSQITDILKQMMK  366 (395)
Q Consensus       336 l~~li~~cl~~dp~~RPs~~ell~~l~~~~~  366 (395)
                      +++||+.||++.|.+||+|.++-+.++.+++
T Consensus       495 VYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  495 VYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             HHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence            9999999999999999999999999998876

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=6e-45  Score=352.70  Aligned_cols=262  Identities=32%  Similarity=0.645  Sum_probs=223.0

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEEEE
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGAC  176 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  176 (395)
                      |+++.++|++.+.||.|+||.||+|...       ++.||+|+++... .......+.+|+.+++++ +|+||++++++|
T Consensus         2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~   80 (337)
T cd05054           2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGAC   80 (337)
T ss_pred             cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence            7888899999999999999999999642       3679999997553 233456788899999999 799999999988


Q ss_pred             ec-CCcEEEEEecCCCCCHHHHHhhcc-----------------------------------------------------
Q 016082          177 TR-PPNLCIVTEFMARGSIYDFLHKQK-----------------------------------------------------  202 (395)
Q Consensus       177 ~~-~~~~~lV~E~~~ggsL~~~l~~~~-----------------------------------------------------  202 (395)
                      .. ...++++|||+++++|.+++....                                                     
T Consensus        81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (337)
T cd05054          81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE  160 (337)
T ss_pred             ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence            64 456899999999999999986432                                                     


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCc---cccCCCCcc
Q 016082          203 -------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYR  272 (395)
Q Consensus       203 -------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~  272 (395)
                             .++++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||+++.......   .....++..
T Consensus       161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence                   2578889999999999999999999999999999999999999999999999986533221   122345678


Q ss_pred             cccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCC
Q 016082          273 WMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR  351 (395)
Q Consensus       273 y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  351 (395)
                      |+|||.+.+..++.++|||||||++|||++ |..||.+....+..........++..+...++++.+++.+||+.+|++|
T Consensus       241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R  320 (337)
T cd05054         241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDR  320 (337)
T ss_pred             ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhC
Confidence            999999999999999999999999999998 9999988665555555556666677777889999999999999999999


Q ss_pred             CCHHHHHHHHHHHHHH
Q 016082          352 PNFSQITDILKQMMKE  367 (395)
Q Consensus       352 Ps~~ell~~l~~~~~~  367 (395)
                      |++.++++.|++++++
T Consensus       321 Ps~~ell~~l~~~~~~  336 (337)
T cd05054         321 PTFSELVEILGDLLQE  336 (337)
T ss_pred             cCHHHHHHHHHHHHhc
Confidence            9999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.8e-44  Score=334.93  Aligned_cols=250  Identities=32%  Similarity=0.639  Sum_probs=216.6

Q ss_pred             cccCcceeeeeeeeCceEEEEEEECC-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          108 DAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       108 ~~~~~~i~~~lg~G~~G~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      +.++|++.+.||+|+||.||++++.. ..+|+|.++.....   ...+.+|+.++++++||||+++++++......++||
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   78 (256)
T cd05114           2 NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT   78 (256)
T ss_pred             CHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence            45689999999999999999998844 58999998755332   357889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCcc--
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM--  264 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~--  264 (395)
                      ||+++|+|.++++...+.+++..+..++.+++.||+|||++||+||||||+||+++.++.++|+|||.++........  
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~  158 (256)
T cd05114          79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS  158 (256)
T ss_pred             EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence            999999999999876667899999999999999999999999999999999999999999999999998754332211  


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHh
Q 016082          265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC  343 (395)
Q Consensus       265 ~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  343 (395)
                      ....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+. ...++..|...+.++.+++.+|
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~li~~c  237 (256)
T cd05114         159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS-RGFRLYRPKLASMTVYEVMYSC  237 (256)
T ss_pred             CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHH
Confidence            22345678999999998899999999999999999999 999999888776655544 3445566777889999999999


Q ss_pred             hccCCCCCCCHHHHHHHH
Q 016082          344 WQHDPTQRPNFSQITDIL  361 (395)
Q Consensus       344 l~~dp~~RPs~~ell~~l  361 (395)
                      |+.+|++||++.++++.|
T Consensus       238 ~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         238 WHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             ccCCcccCcCHHHHHHhh
Confidence            999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.2e-44  Score=336.90  Aligned_cols=255  Identities=33%  Similarity=0.689  Sum_probs=221.4

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  183 (395)
                      |.|..++|++.++||+|+||.||+|.. .+..||+|.++....   ..+.+.+|+.++++++|+||+++++.+......+
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05072           1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY   77 (261)
T ss_pred             CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence            678889999999999999999999987 457799999876432   3467899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC
Q 016082          184 IVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~  262 (395)
                      ++|||+++++|.++++.. ...++...+..++.+++.|++|||+.+++||||||+||+++.++.++|+|||.++......
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05072          78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE  157 (261)
T ss_pred             EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence            999999999999999764 4568889999999999999999999999999999999999999999999999998654432


Q ss_pred             c--cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHH
Q 016082          263 V--MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL  339 (395)
Q Consensus       263 ~--~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  339 (395)
                      .  .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+.......+ ....+.+.+..++.++.++
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l  236 (261)
T cd05072         158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL-QRGYRMPRMENCPDELYDI  236 (261)
T ss_pred             eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHH
Confidence            1  122345678999999998889999999999999999998 99999987776655443 3345555566788999999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHHHH
Q 016082          340 LERCWQHDPTQRPNFSQITDILKQ  363 (395)
Q Consensus       340 i~~cl~~dp~~RPs~~ell~~l~~  363 (395)
                      +.+||+.+|++||+++++.+.|++
T Consensus       237 i~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         237 MKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             HHHHccCCcccCcCHHHHHHHHhc
Confidence            999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.4e-45  Score=354.75  Aligned_cols=250  Identities=26%  Similarity=0.410  Sum_probs=217.7

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEECC---ceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTYCS---QEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  180 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~---~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (395)
                      ..+..++|++.+.||+|+||.||+|++.+   ..||+|++..... .......+.+|+.+++.++||||+++++++...+
T Consensus        25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~  104 (340)
T PTZ00426         25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES  104 (340)
T ss_pred             CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence            45667799999999999999999998632   5799999864322 2344567889999999999999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                      ..|+||||++||+|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       105 ~~~lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        105 YLYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            99999999999999999976 45789999999999999999999999999999999999999999999999999976543


Q ss_pred             CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHH
Q 016082          261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELL  340 (395)
Q Consensus       261 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  340 (395)
                      .  .....||+.|+|||++.+..++.++|+|||||++|||++|..||.+.++......+....  ...|..+++++.++|
T Consensus       184 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li  259 (340)
T PTZ00426        184 R--TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI--IYFPKFLDNNCKHLM  259 (340)
T ss_pred             C--cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHHHH
Confidence            2  234578999999999999899999999999999999999999999988776665555432  345778899999999


Q ss_pred             HHhhccCCCCCC-----CHHHHHH
Q 016082          341 ERCWQHDPTQRP-----NFSQITD  359 (395)
Q Consensus       341 ~~cl~~dp~~RP-----s~~ell~  359 (395)
                      ++||+.||.+|+     +++++++
T Consensus       260 ~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        260 KKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             HHHcccCHHHcCCCCCCCHHHHHc
Confidence            999999999995     7888775

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.1e-44  Score=341.29  Aligned_cols=255  Identities=31%  Similarity=0.634  Sum_probs=219.9

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP  179 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  179 (395)
                      +..++|++.+.||+|+||.||+|...+       ..||+|.++... .......+.+|+.++++++||||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   80 (283)
T cd05048           2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE   80 (283)
T ss_pred             CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence            345689999999999999999998633       469999987543 345567799999999999999999999999999


Q ss_pred             CcEEEEEecCCCCCHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCC
Q 016082          180 PNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN  244 (395)
Q Consensus       180 ~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~  244 (395)
                      ...+++|||+++++|.+++....               ..++...++.++.|++.||.|||++|++||||||+||+++++
T Consensus        81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG  160 (283)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence            99999999999999999997642               457888999999999999999999999999999999999999


Q ss_pred             CcEEEeeeccccccccCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhh
Q 016082          245 GVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVV  320 (395)
Q Consensus       245 ~~vkl~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~  320 (395)
                      +.++|+|||+++......   ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.++.+.... +
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~-i  239 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM-I  239 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-H
Confidence            999999999997543322   1233456788999999988899999999999999999998 9999998887665544 3


Q ss_pred             hccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 016082          321 QKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQ  363 (395)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~  363 (395)
                      .....+..+..+++++.+++.+||+.||.+||++.+|++.|+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         240 RSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            3445566778899999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.9e-44  Score=356.31  Aligned_cols=263  Identities=32%  Similarity=0.619  Sum_probs=227.0

Q ss_pred             CCceeecccCcceeeeeeeeCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEE
Q 016082          102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFI  173 (395)
Q Consensus       102 ~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~  173 (395)
                      ...|++..++|.+.++||+|+||.||+|++.+       +.||+|+++... .....+.+.+|+.+|.++. ||||++++
T Consensus        29 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~  107 (401)
T cd05107          29 DSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLL  107 (401)
T ss_pred             CCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEE
Confidence            34599999999999999999999999998643       579999998653 2334457899999999997 99999999


Q ss_pred             EEEecCCcEEEEEecCCCCCHHHHHhhcc---------------------------------------------------
Q 016082          174 GACTRPPNLCIVTEFMARGSIYDFLHKQK---------------------------------------------------  202 (395)
Q Consensus       174 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------------------------------------------  202 (395)
                      +++...+..++||||+++|+|.++++...                                                   
T Consensus       108 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (401)
T cd05107         108 GACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA  187 (401)
T ss_pred             EEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence            99999999999999999999999997532                                                   


Q ss_pred             ----------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 016082          203 ----------------------------------------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT  236 (395)
Q Consensus       203 ----------------------------------------------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp  236 (395)
                                                                    ..++...+..++.||+.||.|||+.+++||||||
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp  267 (401)
T cd05107         188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAA  267 (401)
T ss_pred             CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCc
Confidence                                                          1356667889999999999999999999999999


Q ss_pred             CCeeeCCCCcEEEeeeccccccccCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCH
Q 016082          237 ANLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTP  312 (395)
Q Consensus       237 ~NiLl~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~  312 (395)
                      +|||++.++.++|+|||+++.......   .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~  347 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM  347 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence            999999999999999999976433221   122356788999999998889999999999999999998 8999988766


Q ss_pred             HHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 016082          313 LQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM  365 (395)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~  365 (395)
                      .+..........++..|..++.++.+++.+||+.+|.+||++.+|++.|++++
T Consensus       348 ~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         348 NEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            66666666667777788889999999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.8e-44  Score=336.46  Aligned_cols=256  Identities=37%  Similarity=0.728  Sum_probs=222.9

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  182 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  182 (395)
                      |+++..+|.+.++||+|+||.||+|.+  .++.||+|+++...   ....++.+|+.++++++||||+++++++...+..
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (263)
T cd05052           1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   77 (263)
T ss_pred             CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence            677888999999999999999999987  47889999987542   2346789999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC
Q 016082          183 CIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  261 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~  261 (395)
                      ++||||+++++|.+++... ...++...++.++.|++.||.|||++|++||||||+||++++++.++|+|||.++.....
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~  157 (263)
T cd05052          78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  157 (263)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence            9999999999999999764 346889999999999999999999999999999999999999999999999999765433


Q ss_pred             Cccc--cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHH
Q 016082          262 GVMT--AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE  338 (395)
Q Consensus       262 ~~~~--~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  338 (395)
                      ....  ...++..|+|||.+.+..++.++||||||+++|||++ |..||.+....+.... .....++..+..+++++.+
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  236 (263)
T cd05052         158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-LEKGYRMERPEGCPPKVYE  236 (263)
T ss_pred             eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HHCCCCCCCCCCCCHHHHH
Confidence            2111  1234568999999999999999999999999999998 9999998776554443 4455677778889999999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHHHHH
Q 016082          339 LLERCWQHDPTQRPNFSQITDILKQM  364 (395)
Q Consensus       339 li~~cl~~dp~~RPs~~ell~~l~~~  364 (395)
                      ++.+||+.+|++||++.++++.|+.+
T Consensus       237 li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         237 LMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             HHHHHccCCcccCCCHHHHHHHHHhh
Confidence            99999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.2e-46  Score=344.64  Aligned_cols=246  Identities=24%  Similarity=0.491  Sum_probs=224.9

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      -+|.+.+.||+|.||.|-+|+.  .|+.||||.++++... +...-.+++||+||..|+||||+++|.+|+..+.+.|||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            4799999999999999999986  6899999999888764 445678999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCcccc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA  266 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~  266 (395)
                      ||..+|.|+||+.. ++.+++.++..++.||..|+.|+|+++++|||||.+|||+|.|+++||+|||++.........++
T Consensus       133 EYaS~GeLYDYiSe-r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqT  211 (668)
T KOG0611|consen  133 EYASGGELYDYISE-RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQT  211 (668)
T ss_pred             EecCCccHHHHHHH-hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHHH
Confidence            99999999999987 67899999999999999999999999999999999999999999999999999999888888899


Q ss_pred             CCCCcccccccccCCCCCC-ChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhc
Q 016082          267 ETGTYRWMAPEVIEHKPYD-YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ  345 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~~~~~-~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  345 (395)
                      .+|++.|.+||+++|.+|. ...|-||||++||-|..|..||.+.+.......+....++.   +..+.+...+|+.||-
T Consensus       212 FCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE---P~~PSdA~gLIRwmLm  288 (668)
T KOG0611|consen  212 FCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE---PETPSDASGLIRWMLM  288 (668)
T ss_pred             hcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC---CCCCchHHHHHHHHHh
Confidence            9999999999999999995 78999999999999999999999998877766666555542   2234578899999999


Q ss_pred             cCCCCCCCHHHHHH
Q 016082          346 HDPTQRPNFSQITD  359 (395)
Q Consensus       346 ~dp~~RPs~~ell~  359 (395)
                      .||++|.|+.+|..
T Consensus       289 VNP~RRATieDiAs  302 (668)
T KOG0611|consen  289 VNPERRATIEDIAS  302 (668)
T ss_pred             cCcccchhHHHHhh
Confidence            99999999999987

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2e-44  Score=345.71  Aligned_cols=260  Identities=28%  Similarity=0.581  Sum_probs=222.5

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE--CCc----eEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY--CSQ----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  180 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~----~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (395)
                      +...+|++.+.||+|+||.||+|++  .++    .||+|+++... .....+++.+|+.+++.++||||++++++|... 
T Consensus         4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-   81 (316)
T cd05108           4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   81 (316)
T ss_pred             cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence            4567899999999999999999986  333    48999997542 344567899999999999999999999999765 


Q ss_pred             cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                      ..++|+||+++|+|.+++......++...+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus        82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence            57899999999999999988777789999999999999999999999999999999999999999999999999986543


Q ss_pred             CCcc---ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHH
Q 016082          261 SGVM---TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  336 (395)
Q Consensus       261 ~~~~---~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  336 (395)
                      ....   ....++..|+|||.+.+..++.++||||||+++|||++ |..||.+....+. ........++..+..++.++
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  240 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGERLPQPPICTIDV  240 (316)
T ss_pred             CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhCCCCCCCCCCCCHHH
Confidence            3221   12234678999999999999999999999999999998 9999998776553 34455566666677889999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHH
Q 016082          337 AELLERCWQHDPTQRPNFSQITDILKQMMKEVL  369 (395)
Q Consensus       337 ~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~  369 (395)
                      .+++.+||+.+|.+||++.+++..+.++.++-.
T Consensus       241 ~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~  273 (316)
T cd05108         241 YMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ  273 (316)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence            999999999999999999999999988876543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-45  Score=348.44  Aligned_cols=251  Identities=28%  Similarity=0.462  Sum_probs=213.3

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCC------------HHHHHHHHHHHHHHHhcCCCceeeE
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN------------TEMLKEFSQEVYIMRKIRHKNVVQF  172 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~niv~l  172 (395)
                      .-.++|++.+.||+|+||.|.+|+.  .++.||||++.+....            ..-.+..++||.||++++|||||++
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            3457899999999999999999988  5788999999643221            1123578999999999999999999


Q ss_pred             EEEEecCC--cEEEEEecCCCCCHHHHHhhccCC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEE
Q 016082          173 IGACTRPP--NLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV  249 (395)
Q Consensus       173 ~~~~~~~~--~~~lV~E~~~ggsL~~~l~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl  249 (395)
                      +.+..++.  .+|||+||+..|.+...=  ..++ +++.++++++.+++.||+|||.+|||||||||.|+|++++|+|||
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKI  251 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKI  251 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEe
Confidence            99997764  699999999998876532  2344 899999999999999999999999999999999999999999999


Q ss_pred             eeeccccccccCC------ccccCCCCcccccccccCCC---CC-CChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q 016082          250 ADFGVARVQAQSG------VMTAETGTYRWMAPEVIEHK---PY-DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV  319 (395)
Q Consensus       250 ~DFg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~---~~-~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~  319 (395)
                      +|||.+....+..      ......|||.|+|||...++   .+ +.+.||||+|++||.|+.|+.||.+....+....+
T Consensus       252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KI  331 (576)
T KOG0585|consen  252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKI  331 (576)
T ss_pred             eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHH
Confidence            9999997653321      22335799999999998763   23 57899999999999999999999999999999988


Q ss_pred             hhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          320 VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       320 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      +...+.-+..+.+..+++++|.++|.+||+.|.+..+|..
T Consensus       332 vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~  371 (576)
T KOG0585|consen  332 VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL  371 (576)
T ss_pred             hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence            8877665555568899999999999999999999998865

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-45  Score=356.64  Aligned_cols=248  Identities=25%  Similarity=0.424  Sum_probs=215.8

Q ss_pred             cCcceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      ++|.+.+.||+|+||.||+|++.  ++.||||+++..... ......+.+|+.++..++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47899999999999999999985  889999999754322 245567899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC----
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG----  262 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~----  262 (395)
                      ||++|++|.+++... +.+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||+++......    
T Consensus        81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (350)
T cd05573          81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY  159 (350)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence            999999999999874 779999999999999999999999999999999999999999999999999997654332    


Q ss_pred             --------------------------ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 016082          263 --------------------------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAA  316 (395)
Q Consensus       263 --------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~  316 (395)
                                                ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~  239 (350)
T cd05573         160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY  239 (350)
T ss_pred             cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence                                      223456899999999999999999999999999999999999999998877766


Q ss_pred             HHhhh--ccCCCCCCCCCcHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 016082          317 VGVVQ--KSLRPTIPKHAHPRLAELLERCWQHDPTQRPN-FSQITD  359 (395)
Q Consensus       317 ~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-~~ell~  359 (395)
                      ..+..  .....+....+++++.++|.+|+. +|.+||+ +.++++
T Consensus       240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~  284 (350)
T cd05573         240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS  284 (350)
T ss_pred             HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence            66555  222222233469999999999997 9999999 999987

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.7e-46  Score=325.57  Aligned_cols=248  Identities=24%  Similarity=0.429  Sum_probs=223.9

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  185 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  185 (395)
                      .++|.+++.||+|-||.||+|+.  ++-.||+|++-++. .......++.+|++|-..|+||||.++|++|.+....|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            46899999999999999999988  45679999985443 2344567899999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCcc
Q 016082          186 TEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM  264 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~  264 (395)
                      +||..+|+++..|+.. ..+|++.....+..|++.|+.|+|.++||||||||+|+|++..|.+|++|||.+...+ .+..
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~~kR  179 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SNKR  179 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-CCCc
Confidence            9999999999999854 4669999999999999999999999999999999999999999999999999997665 5556


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhh
Q 016082          265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW  344 (395)
Q Consensus       265 ~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  344 (395)
                      .+.+||..|.|||...+..++.+.|+|++|++.||++.|.+||+..+..+....+..-  +-.+|..++.+.+++|.+|+
T Consensus       180 ~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~--~~~~p~~is~~a~dlI~~ll  257 (281)
T KOG0580|consen  180 KTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV--DLKFPSTISGGAADLISRLL  257 (281)
T ss_pred             eeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc--cccCCcccChhHHHHHHHHh
Confidence            7789999999999999999999999999999999999999999999877777766543  45677999999999999999


Q ss_pred             ccCCCCCCCHHHHHH
Q 016082          345 QHDPTQRPNFSQITD  359 (395)
Q Consensus       345 ~~dp~~RPs~~ell~  359 (395)
                      .++|.+|.+..|+++
T Consensus       258 ~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  258 VKNPIERLALTEVMD  272 (281)
T ss_pred             ccCccccccHHHHhh
Confidence            999999999999887

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-44  Score=334.37  Aligned_cols=255  Identities=34%  Similarity=0.623  Sum_probs=221.3

Q ss_pred             cccCcceeeeeeeeCceEEEEEEEC-----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Q 016082          108 DAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  182 (395)
Q Consensus       108 ~~~~~~i~~~lg~G~~G~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  182 (395)
                      +.++|++.+.||+|+||.||+|++.     ...||||+++... .......+.+|+.++++++||||+++++.+...+..
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence            4568999999999999999999873     3479999987653 344567789999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-
Q 016082          183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-  261 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-  261 (395)
                      ++||||+++++|.+++....+.++...+..++.+++.|+.|||+++|+||||||+||++++++.++|+|||.++..... 
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE  160 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence            9999999999999999877778999999999999999999999999999999999999999999999999999876421 


Q ss_pred             Ccc--ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHH
Q 016082          262 GVM--TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE  338 (395)
Q Consensus       262 ~~~--~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  338 (395)
                      ...  ....++..|+|||.+.+..++.++||||||+++|++++ |..||...+..+....+ ....+.+.+..+++.+.+
T Consensus       161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~  239 (266)
T cd05033         161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV-EDGYRLPPPMDCPSALYQ  239 (266)
T ss_pred             cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHH
Confidence            111  12244678999999999999999999999999999998 99999887766655443 344555667788999999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHHHHH
Q 016082          339 LLERCWQHDPTQRPNFSQITDILKQM  364 (395)
Q Consensus       339 li~~cl~~dp~~RPs~~ell~~l~~~  364 (395)
                      ++.+||+.+|++||++.++++.|.++
T Consensus       240 li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         240 LMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             HHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            99999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=4e-46  Score=370.12  Aligned_cols=261  Identities=33%  Similarity=0.623  Sum_probs=238.4

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEEC--C---ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTYC--S---QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP  179 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~~--~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  179 (395)
                      .+|+.+..+|.++||.|.||.||+|+..  +   ..||||.+|... .+.+..+|..|..||.+.+||||+++.|+.++.
T Consensus       624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks  702 (996)
T KOG0196|consen  624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS  702 (996)
T ss_pred             hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence            5789999999999999999999999863  2   569999999764 577788999999999999999999999999999


Q ss_pred             CcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccc
Q 016082          180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  259 (395)
Q Consensus       180 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~  259 (395)
                      ....||+|||++|+|..+|+++.+.|+.-++..+++.|+.||.||-+.|++||||.++|||++.+-..|++|||++|...
T Consensus       703 ~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvle  782 (996)
T KOG0196|consen  703 KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  782 (996)
T ss_pred             ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999775


Q ss_pred             cCC--ccccC--CCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcH
Q 016082          260 QSG--VMTAE--TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP  334 (395)
Q Consensus       260 ~~~--~~~~~--~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (395)
                      +..  ..+..  ....+|.|||.+...+++.+|||||+|++|||.++ |..||=.+++.+.... +..++|.+.|-+||.
T Consensus       783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIka-Ie~gyRLPpPmDCP~  861 (996)
T KOG0196|consen  783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKA-IEQGYRLPPPMDCPA  861 (996)
T ss_pred             cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHH-HHhccCCCCCCCCcH
Confidence            443  11221  23579999999999999999999999999999888 9999999999887776 456889899999999


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 016082          335 RLAELLERCWQHDPTQRPNFSQITDILKQMMKE  367 (395)
Q Consensus       335 ~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~  367 (395)
                      .|.+||..||++|-.+||.|.||+..|.+++++
T Consensus       862 aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  862 ALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             HHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence            999999999999999999999999999998773

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1e-44  Score=342.31  Aligned_cols=249  Identities=25%  Similarity=0.373  Sum_probs=208.0

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      ++|++.+.||+|+||.||+|++  +++.||+|+++.........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            4799999999999999999998  46889999998665455556778899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC--ccc
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--VMT  265 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~--~~~  265 (395)
                      |++++++..+ ......+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++......  ...
T Consensus        81 ~~~~~~l~~~-~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (287)
T cd07848          81 YVEKNMLELL-EEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT  159 (287)
T ss_pred             cCCCCHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence            9998766554 4445678999999999999999999999999999999999999999999999999998654322  223


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc-------------------C-C
Q 016082          266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-------------------L-R  325 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~-------------------~-~  325 (395)
                      ...|++.|+|||++.+..++.++|+|||||++|+|++|++||.+.+..+....+....                   . .
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (287)
T cd07848         160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF  239 (287)
T ss_pred             ccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccccc
Confidence            4568999999999999899999999999999999999999998876544333221100                   0 0


Q ss_pred             CC----------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          326 PT----------IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       326 ~~----------~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      +.          ....+++++.++|.+||+.||++|||++++++
T Consensus       240 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             CcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00          01236788999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-45  Score=352.69  Aligned_cols=258  Identities=32%  Similarity=0.583  Sum_probs=211.5

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEECC-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC-cEEE
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP-NLCI  184 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~l  184 (395)
                      -..+.|.-...||+|+||.||+|...+ ..||||.+.....+.  .++|.+|+.++.+++|||+|+++|+|.+.+ ..+|
T Consensus        72 ~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~L  149 (361)
T KOG1187|consen   72 KATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLL  149 (361)
T ss_pred             HHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEE
Confidence            345678888999999999999999855 899999887664332  466999999999999999999999999998 4999


Q ss_pred             EEecCCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          185 VTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQNN---IIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       185 V~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~---iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                      |+|||++|+|.++|+.... ++++..+.+||.++|+||+|||+..   ||||||||.|||+|++...||+|||+|+....
T Consensus       150 VYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~  229 (361)
T KOG1187|consen  150 VYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPE  229 (361)
T ss_pred             EEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCc
Confidence            9999999999999988766 8999999999999999999999854   99999999999999999999999999977654


Q ss_pred             -CCccccC-CCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHhhh-----ccCCCC
Q 016082          261 -SGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT------PLQAAVGVVQ-----KSLRPT  327 (395)
Q Consensus       261 -~~~~~~~-~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~------~~~~~~~~~~-----~~~~~~  327 (395)
                       ....... .||..|+|||.+..+..+.|+||||||+++.|+++|+.|.....      -.+.....+.     ....|.
T Consensus       230 ~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~  309 (361)
T KOG1187|consen  230 GDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPR  309 (361)
T ss_pred             cccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCC
Confidence             3322223 89999999999999999999999999999999999998876432      1111111121     222233


Q ss_pred             CC-CCCc-----HHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 016082          328 IP-KHAH-----PRLAELLERCWQHDPTQRPNFSQITDILKQMMK  366 (395)
Q Consensus       328 ~~-~~~~-----~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~  366 (395)
                      +. ...+     ..+..+..+|++.+|.+||++.|+++.|+.+..
T Consensus       310 l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  310 LKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             ccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            32 2222     236678889999999999999999888855443

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=5.2e-44  Score=345.18  Aligned_cols=250  Identities=24%  Similarity=0.427  Sum_probs=211.6

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  184 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  184 (395)
                      +..++|++.+.||+|+||.||++++  ++..+|+|+++... .......+.+|+.++++++||||+++++++...+..++
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            4567999999999999999999998  47889999997653 34556789999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCeeeCCCCcEEEeeeccccccccCCc
Q 016082          185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV  263 (395)
Q Consensus       185 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~  263 (395)
                      ||||+++|+|.+++.. ...+++..+..++.+++.||.|||+. +|+||||||+||+++.++.++|+|||+++..... .
T Consensus        81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~  158 (331)
T cd06649          81 CMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-M  158 (331)
T ss_pred             EeecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-c
Confidence            9999999999999976 45689999999999999999999986 6999999999999999999999999998755432 2


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhh-----------------------
Q 016082          264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV-----------------------  320 (395)
Q Consensus       264 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~-----------------------  320 (395)
                      .....|++.|+|||++.+..++.++|||||||++|||++|+.||......+......                       
T Consensus       159 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (331)
T cd06649         159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGR  238 (331)
T ss_pred             cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccc
Confidence            344578999999999999999999999999999999999999997655433221110                       


Q ss_pred             ----------------------hccCCCCCC-CCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          321 ----------------------QKSLRPTIP-KHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       321 ----------------------~~~~~~~~~-~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                            ....++..+ ...++++.++|.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~  300 (331)
T cd06649         239 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN  300 (331)
T ss_pred             cccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                                  011112222 246789999999999999999999999987

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.2e-44  Score=342.30  Aligned_cols=271  Identities=31%  Similarity=0.597  Sum_probs=227.2

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE--CCc--eEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCc
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY--CSQ--EVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPN  181 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  181 (395)
                      +..++|++.+.||+|+||.||+|.+  ++.  .+|+|.++... .......+.+|+.++.++ +||||+++++++...+.
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~   82 (303)
T cd05088           4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY   82 (303)
T ss_pred             cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC-CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence            5567899999999999999999986  343  45777766432 345567889999999999 89999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCc
Q 016082          182 LCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV  246 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~  246 (395)
                      .++||||+++++|.++++...               ..+++..++.++.|++.|++|||++|++||||||+|||++.++.
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence            999999999999999997542               35788999999999999999999999999999999999999999


Q ss_pred             EEEeeeccccccccCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCC
Q 016082          247 VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLR  325 (395)
Q Consensus       247 vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~  325 (395)
                      ++|+|||+++............++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+.... .....+
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-~~~~~~  241 (303)
T cd05088         163 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-LPQGYR  241 (303)
T ss_pred             EEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHH-HhcCCc
Confidence            99999999864322212222344678999999988889999999999999999998 9999988776655443 334445


Q ss_pred             CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhccccccc
Q 016082          326 PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINT  379 (395)
Q Consensus       326 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~~~~~~~~~~~  379 (395)
                      +..+...++++.+++.+||+.+|++||++.+++..+.+++.+...+.+...+.+
T Consensus       242 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~~~~~~~~~  295 (303)
T cd05088         242 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEK  295 (303)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhhhhhhhhcc
Confidence            556667889999999999999999999999999999999998887776655543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-45  Score=348.99  Aligned_cols=239  Identities=23%  Similarity=0.415  Sum_probs=206.9

Q ss_pred             eeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecCCCCCH
Q 016082          118 VASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI  194 (395)
Q Consensus       118 lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ggsL  194 (395)
                      ||+|+||.||+|++  +++.||+|+++.... .......+.+|+.++++++||||+++++++...+..|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            69999999999988  467899999975422 334456788999999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-CccccCCCCccc
Q 016082          195 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGTYRW  273 (395)
Q Consensus       195 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-~~~~~~~gt~~y  273 (395)
                      .+++.. .+.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++..... .......||+.|
T Consensus        81 ~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y  159 (312)
T cd05585          81 FHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY  159 (312)
T ss_pred             HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCccc
Confidence            999976 567899999999999999999999999999999999999999999999999999754322 223345799999


Q ss_pred             ccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCC
Q 016082          274 MAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPN  353 (395)
Q Consensus       274 ~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs  353 (395)
                      +|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+...  ....|..+++++.++|.+||+.||.+||+
T Consensus       160 ~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~R~~  237 (312)
T cd05585         160 LAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE--PLRFPDGFDRDAKDLLIGLLSRDPTRRLG  237 (312)
T ss_pred             CCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--CCCCCCcCCHHHHHHHHHHcCCCHHHcCC
Confidence            9999999999999999999999999999999999988777666555433  34567788999999999999999999986


Q ss_pred             H---HHHHH
Q 016082          354 F---SQITD  359 (395)
Q Consensus       354 ~---~ell~  359 (395)
                      +   .+++.
T Consensus       238 ~~~~~e~l~  246 (312)
T cd05585         238 YNGAQEIKN  246 (312)
T ss_pred             CCCHHHHHc
Confidence            4   55543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.3e-44  Score=348.21  Aligned_cols=241  Identities=23%  Similarity=0.452  Sum_probs=208.6

Q ss_pred             eeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecCCCC
Q 016082          116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARG  192 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~gg  192 (395)
                      +.||+|+||.||+++.  +++.||+|+++.... .......+.+|+.++++++||||+++++++......|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4689999999999987  578999999975432 2334567788999999999999999999999999999999999999


Q ss_pred             CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc-CCccccCCCCc
Q 016082          193 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGTY  271 (395)
Q Consensus       193 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~-~~~~~~~~gt~  271 (395)
                      +|..++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||+
T Consensus        81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  159 (323)
T cd05595          81 ELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP  159 (323)
T ss_pred             cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCc
Confidence            99998876 45789999999999999999999999999999999999999999999999999875322 22233457899


Q ss_pred             ccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCC
Q 016082          272 RWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR  351 (395)
Q Consensus       272 ~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  351 (395)
                      .|+|||++.+..++.++|||||||++|+|++|+.||...+.......+...  ...+|..+++++.++|.+||+.||.+|
T Consensus       160 ~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R  237 (323)
T cd05595         160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLLAGLLKKDPKQR  237 (323)
T ss_pred             CcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHccCCHHHh
Confidence            999999999999999999999999999999999999988776655554432  334677889999999999999999999


Q ss_pred             C-----CHHHHHH
Q 016082          352 P-----NFSQITD  359 (395)
Q Consensus       352 P-----s~~ell~  359 (395)
                      |     ++.++++
T Consensus       238 ~~~~~~~~~~~l~  250 (323)
T cd05595         238 LGGGPSDAKEVME  250 (323)
T ss_pred             CCCCCCCHHHHHc
Confidence            8     7888775

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4e-44  Score=332.64  Aligned_cols=253  Identities=34%  Similarity=0.696  Sum_probs=219.2

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEE-ecCCcEE
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC-TRPPNLC  183 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~  183 (395)
                      |.++..+|++.+.||+|+||.||++...+..||+|..+...    ..+.+.+|+.++++++|+|++++++++ ......+
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (256)
T cd05082           1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY   76 (256)
T ss_pred             CCccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence            56778899999999999999999999999999999987442    346788999999999999999999976 4556789


Q ss_pred             EEEecCCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC
Q 016082          184 IVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~  262 (395)
                      ++|||+++++|.++++.... .+++..+..++.+++.||.|||++|++||||||+||++++++.+||+|||.++......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  156 (256)
T cd05082          77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  156 (256)
T ss_pred             EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence            99999999999999976543 47889999999999999999999999999999999999999999999999987543322


Q ss_pred             ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHH
Q 016082          263 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE  341 (395)
Q Consensus       263 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  341 (395)
                        ....++..|+|||++.+..++.++|||||||++|+|++ |+.||...+..+.... ......+..+..+++.+.+++.
T Consensus       157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~  233 (256)
T cd05082         157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMDAPDGCPPVVYDVMK  233 (256)
T ss_pred             --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HhcCCCCCCCCCCCHHHHHHHH
Confidence              23345678999999999899999999999999999998 9999988776554443 3445566777889999999999


Q ss_pred             HhhccCCCCCCCHHHHHHHHHHH
Q 016082          342 RCWQHDPTQRPNFSQITDILKQM  364 (395)
Q Consensus       342 ~cl~~dp~~RPs~~ell~~l~~~  364 (395)
                      +||+.+|++|||+.++++.|+++
T Consensus       234 ~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         234 QCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             HHhcCChhhCcCHHHHHHHHhcC
Confidence            99999999999999999988753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.2e-44  Score=339.79  Aligned_cols=249  Identities=22%  Similarity=0.360  Sum_probs=207.5

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      .++|++.++||.|+||.||+|+.  +++.||+|+++.... ......+.+|+.++++++||||+++++++......++||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF   82 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence            35799999999999999999987  578899999975432 223356778999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-Cccc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMT  265 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-~~~~  265 (395)
                      ||+++ +|.+++......++...+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..... ....
T Consensus        83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~  161 (288)
T cd07871          83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYS  161 (288)
T ss_pred             eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcccc
Confidence            99986 999999876667899999999999999999999999999999999999999999999999999754322 2233


Q ss_pred             cCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccC--------------------
Q 016082          266 AETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL--------------------  324 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~--------------------  324 (395)
                      ...+++.|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.+..+....+.....                    
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (288)
T cd07871         162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYL  241 (288)
T ss_pred             CceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccc
Confidence            4568999999999865 5689999999999999999999999988776554433322100                    


Q ss_pred             CCC--------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          325 RPT--------IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       325 ~~~--------~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      .+.        .....++++.++|.+||+.||.+|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         242 FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            000        01246788999999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.6e-44  Score=330.58  Aligned_cols=253  Identities=37%  Similarity=0.722  Sum_probs=222.8

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  184 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  184 (395)
                      |.++.++|++.+.||.|+||.||+|...++.||+|.++....   ..+++.+|+.++++++|+||+++++++......++
T Consensus         1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   77 (256)
T cd05039           1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI   77 (256)
T ss_pred             CccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence            456778999999999999999999999999999999986532   45789999999999999999999999998889999


Q ss_pred             EEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCc
Q 016082          185 VTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV  263 (395)
Q Consensus       185 V~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~  263 (395)
                      ||||+++++|.+++.... ..+++..+..++.|++.|+.|||+.|++||||||+||+++.++.++|+|||.++...... 
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-  156 (256)
T cd05039          78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-  156 (256)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence            999999999999997654 368999999999999999999999999999999999999999999999999998664322 


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHH
Q 016082          264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER  342 (395)
Q Consensus       264 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  342 (395)
                       ....++..|+|||.+.+..++.++|+||||+++|++++ |..||...+..+.... .....++..+...++++.+++.+
T Consensus       157 -~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~  234 (256)
T cd05039         157 -DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPH-VEKGYRMEAPEGCPPEVYKVMKD  234 (256)
T ss_pred             -ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-HhcCCCCCCccCCCHHHHHHHHH
Confidence             23345678999999988889999999999999999997 9999988876654443 34455666777889999999999


Q ss_pred             hhccCCCCCCCHHHHHHHHHH
Q 016082          343 CWQHDPTQRPNFSQITDILKQ  363 (395)
Q Consensus       343 cl~~dp~~RPs~~ell~~l~~  363 (395)
                      ||+.+|++||++.++++.|++
T Consensus       235 ~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         235 CWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             HhccChhhCcCHHHHHHHHhc
Confidence            999999999999999998875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7e-44  Score=331.97  Aligned_cols=255  Identities=36%  Similarity=0.670  Sum_probs=220.7

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  183 (395)
                      |+++.++|++.+.||+|++|.||+|.+ .++.||+|.++.....   .+.+.+|+.++++++||||+++++++...+..+
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05068           1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY   77 (261)
T ss_pred             CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence            567888999999999999999999987 4567999999865432   466889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC
Q 016082          184 IVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~  262 (395)
                      +||||+++++|.+++.... ..++...+..++.+++.|+.|||++||+||||||+||+++.++.++|+|||+++......
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05068          78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI  157 (261)
T ss_pred             eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence            9999999999999997644 468999999999999999999999999999999999999999999999999998655332


Q ss_pred             ccc--cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHH
Q 016082          263 VMT--AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL  339 (395)
Q Consensus       263 ~~~--~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  339 (395)
                      ...  ....+..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.+..+....+ ....+...+..++..+.++
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l  236 (261)
T cd05068         158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV-DQGYRMPCPPGCPKELYDI  236 (261)
T ss_pred             ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-HcCCCCCCCCcCCHHHHHH
Confidence            111  1123457999999998899999999999999999999 99999988876655544 3344555667789999999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHHHH
Q 016082          340 LERCWQHDPTQRPNFSQITDILKQ  363 (395)
Q Consensus       340 i~~cl~~dp~~RPs~~ell~~l~~  363 (395)
                      +.+||+.+|.+||++.++++.|++
T Consensus       237 i~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         237 MLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             HHHHhhcCcccCCCHHHHHHHHhc
Confidence            999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=7.8e-44  Score=336.87  Aligned_cols=263  Identities=29%  Similarity=0.558  Sum_probs=224.6

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE-------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP  179 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  179 (395)
                      |+..+|.+.+.||+|+||.||++..       .+..+|+|.++..  .......+.+|+.++++++||||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (288)
T cd05093           2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG   79 (288)
T ss_pred             CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            5567899999999999999999974       2345899998754  344567899999999999999999999999999


Q ss_pred             CcEEEEEecCCCCCHHHHHhhcc------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcE
Q 016082          180 PNLCIVTEFMARGSIYDFLHKQK------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV  247 (395)
Q Consensus       180 ~~~~lV~E~~~ggsL~~~l~~~~------------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~v  247 (395)
                      ...++||||+++++|.+++....            ..+++..+..++.|++.||+|||++|++||||||+||++++++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence            99999999999999999997532            248999999999999999999999999999999999999999999


Q ss_pred             EEeeeccccccccCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc
Q 016082          248 KVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKS  323 (395)
Q Consensus       248 kl~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~  323 (395)
                      +|+|||.++......   ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+.. .
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~-~  238 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ-G  238 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-C
Confidence            999999997543322   1122345778999999999999999999999999999998 9999988877665554443 3


Q ss_pred             CCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 016082          324 LRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWL  372 (395)
Q Consensus       324 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~~~~  372 (395)
                      ..+..+...++++.+++.+||+.||.+|||+.++.+.|+++.+....|+
T Consensus       239 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~~~~  287 (288)
T cd05093         239 RVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASPVYL  287 (288)
T ss_pred             CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhccccc
Confidence            3445566788999999999999999999999999999999998765554

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6.8e-44  Score=361.59  Aligned_cols=253  Identities=26%  Similarity=0.407  Sum_probs=219.2

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC---
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP---  180 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  180 (395)
                      ....++|.+.+.||+|+||.||+|++  +++.||||+++....+......+.+|+.++..++|+||+++++.+....   
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            34457999999999999999999987  6789999999877666777778999999999999999999988775432   


Q ss_pred             -----cEEEEEecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeee
Q 016082          181 -----NLCIVTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADF  252 (395)
Q Consensus       181 -----~~~lV~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DF  252 (395)
                           .+++||||+++|+|.++++..   ...+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF  187 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF  187 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence                 368999999999999998653   356899999999999999999999999999999999999999999999999


Q ss_pred             ccccccccC---CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCC
Q 016082          253 GVARVQAQS---GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP  329 (395)
Q Consensus       253 g~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  329 (395)
                      |+++.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....... ......|
T Consensus       188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~-~~~~~~~  266 (496)
T PTZ00283        188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA-GRYDPLP  266 (496)
T ss_pred             ccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCCCC
Confidence            999764432   122345799999999999999999999999999999999999999998877665555443 3344567


Q ss_pred             CCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          330 KHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       330 ~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      ..+++++.+++.+||+.||.+||++.++++
T Consensus       267 ~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        267 PSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             CCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence            889999999999999999999999999976

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3e-44  Score=339.63  Aligned_cols=249  Identities=24%  Similarity=0.426  Sum_probs=205.8

Q ss_pred             cCcceeeeeeeeCceEEEEEEE---CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc---CCCceeeEEEEEe-----c
Q 016082          110 KQLKIECKVASGSYGDLYKGTY---CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI---RHKNVVQFIGACT-----R  178 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~  178 (395)
                      ++|++.+.||+|+||.||+|++   .++.||+|+++...........+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            3789999999999999999987   357899999976544444445667788887776   5999999999885     3


Q ss_pred             CCcEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccc
Q 016082          179 PPNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV  257 (395)
Q Consensus       179 ~~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~  257 (395)
                      ...+++||||+. ++|.+++... ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI  159 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence            456899999997 4999998764 34589999999999999999999999999999999999999999999999999986


Q ss_pred             cccCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCC-----------
Q 016082          258 QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP-----------  326 (395)
Q Consensus       258 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~-----------  326 (395)
                      ...........||+.|+|||.+.+..++.++|||||||++|||++|++||.+.+..+....+......+           
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  239 (290)
T cd07862         160 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL  239 (290)
T ss_pred             ccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcc
Confidence            654444455678999999999998899999999999999999999999999887765554443211000           


Q ss_pred             --------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          327 --------------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       327 --------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                    .+.+..++.+.+++.+||+.||++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         240 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             cchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence                          011346788999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=8.8e-44  Score=338.13  Aligned_cols=260  Identities=32%  Similarity=0.591  Sum_probs=219.8

Q ss_pred             ccCcceeeeeeeeCceEEEEEEEC--C--ceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTYC--S--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~~--~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  183 (395)
                      +++|++.+.||+|+||.||+|...  +  ..+|+|.++... .....+.+.+|+.+++++ +||||+++++++......+
T Consensus         1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            358999999999999999999873  3  247888887432 344557789999999999 6999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEE
Q 016082          184 IVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVK  248 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vk  248 (395)
                      +|+||+++++|.++++...               +.++...++.++.|++.|++|||+.||+||||||+||+++.++.+|
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k  159 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK  159 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence            9999999999999997532               3578889999999999999999999999999999999999999999


Q ss_pred             EeeeccccccccCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCC
Q 016082          249 VADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPT  327 (395)
Q Consensus       249 l~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  327 (395)
                      |+|||++..............+..|+|||.+.+..++.++|||||||++|||++ |..||......+..... ....++.
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~-~~~~~~~  238 (297)
T cd05089         160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL-PQGYRME  238 (297)
T ss_pred             ECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-hcCCCCC
Confidence            999999864332212222234567999999999899999999999999999997 99999988876655543 3455666


Q ss_pred             CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHH
Q 016082          328 IPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLY  370 (395)
Q Consensus       328 ~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~~  370 (395)
                      .+..++.++.+++.+||+.+|.+||+++++++.|..+...-..
T Consensus       239 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~  281 (297)
T cd05089         239 KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA  281 (297)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence            7778999999999999999999999999999999988875543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.8e-44  Score=341.55  Aligned_cols=249  Identities=24%  Similarity=0.397  Sum_probs=203.8

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      .++|++.++||+|+||.||+|++  +++.||||+++.... ......+.+|+.+++.++||||+++++++..+...++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF   82 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence            35899999999999999999988  578899999975432 222346778999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-Cccc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMT  265 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-~~~~  265 (395)
                      ||+. ++|.+++....+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++..... ....
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  161 (303)
T cd07869          83 EYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYS  161 (303)
T ss_pred             ECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCC
Confidence            9996 5899888877778999999999999999999999999999999999999999999999999998754322 2234


Q ss_pred             cCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HhhhccCC----------------CC
Q 016082          266 AETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAV-GVVQKSLR----------------PT  327 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~-~~~~~~~~----------------~~  327 (395)
                      ...+|+.|+|||++.+ ..++.++||||+||++|+|++|..||.+........ .+......                +.
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (303)
T cd07869         162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPE  241 (303)
T ss_pred             CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccc
Confidence            4578999999999865 468999999999999999999999998764432211 11100000                00


Q ss_pred             -----CC---------CCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          328 -----IP---------KHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       328 -----~~---------~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                           .+         ...++++.+++.+||+.||.+|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         242 RFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             cccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence                 00         123567899999999999999999999987

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.2e-43  Score=338.87  Aligned_cols=264  Identities=30%  Similarity=0.629  Sum_probs=225.4

Q ss_pred             CceeecccCcceeeeeeeeCceEEEEEEECC---------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeE
Q 016082          103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQF  172 (395)
Q Consensus       103 ~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~---------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l  172 (395)
                      ..|++..++|.+.+.||+|+||.||++++.+         ..+|+|+++... ......++.+|+.+++++ +||||+++
T Consensus        11 ~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~   89 (307)
T cd05098          11 PRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINL   89 (307)
T ss_pred             CcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence            4688888999999999999999999997632         469999998653 334456788999999999 79999999


Q ss_pred             EEEEecCCcEEEEEecCCCCCHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 016082          173 IGACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA  237 (395)
Q Consensus       173 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~  237 (395)
                      ++++......++||||+++|+|.+++....               ..++..+++.++.|++.||+|||++|++||||||+
T Consensus        90 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~  169 (307)
T cd05098          90 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR  169 (307)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHH
Confidence            999999999999999999999999997642               24788899999999999999999999999999999


Q ss_pred             CeeeCCCCcEEEeeeccccccccCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 016082          238 NLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPL  313 (395)
Q Consensus       238 NiLl~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~  313 (395)
                      ||+++.++.++|+|||.++.......   .....++..|+|||.+.+..++.++|+|||||++|+|++ |..||.+....
T Consensus       170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~  249 (307)
T cd05098         170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  249 (307)
T ss_pred             heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence            99999999999999999875543211   122234578999999998889999999999999999998 89999887665


Q ss_pred             HHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHH
Q 016082          314 QAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  368 (395)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~  368 (395)
                      +... ......++..+..++.++.+++.+||+.+|.+||++.++++.|.+++...
T Consensus       250 ~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~  303 (307)
T cd05098         250 ELFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT  303 (307)
T ss_pred             HHHH-HHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence            4443 34455566777888999999999999999999999999999999988763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.8e-44  Score=347.99  Aligned_cols=241  Identities=23%  Similarity=0.434  Sum_probs=209.3

Q ss_pred             eeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecCCCC
Q 016082          116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARG  192 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~gg  192 (395)
                      +.||+|+||.||+++.  +++.||+|+++.... .......+.+|+.+++.++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4689999999999987  578999999976532 3345567889999999999999999999999999999999999999


Q ss_pred             CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc-CCccccCCCCc
Q 016082          193 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGTY  271 (395)
Q Consensus       193 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~-~~~~~~~~gt~  271 (395)
                      +|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ........||+
T Consensus        81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  159 (328)
T cd05593          81 ELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTP  159 (328)
T ss_pred             CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCc
Confidence            99998876 46789999999999999999999999999999999999999999999999999875322 22234457999


Q ss_pred             ccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCC
Q 016082          272 RWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR  351 (395)
Q Consensus       272 ~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  351 (395)
                      .|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+..  ....+|..+++++.++|++||+.||.+|
T Consensus       160 ~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~--~~~~~p~~~~~~~~~li~~~L~~dP~~R  237 (328)
T cd05593         160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--EDIKFPRTLSADAKSLLSGLLIKDPNKR  237 (328)
T ss_pred             CccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc--CCccCCCCCCHHHHHHHHHHcCCCHHHc
Confidence            99999999999999999999999999999999999988777665544332  2345677899999999999999999999


Q ss_pred             C-----CHHHHHH
Q 016082          352 P-----NFSQITD  359 (395)
Q Consensus       352 P-----s~~ell~  359 (395)
                      |     ++.++++
T Consensus       238 ~~~~~~~~~~il~  250 (328)
T cd05593         238 LGGGPDDAKEIMR  250 (328)
T ss_pred             CCCCCCCHHHHhc
Confidence            7     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.4e-44  Score=350.83  Aligned_cols=249  Identities=23%  Similarity=0.363  Sum_probs=209.9

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      ++|++.+.||+|+||.||+++.  +++.||+|+++.... .......+.+|+.++.+++||||+++++.+.+...+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            4789999999999999999987  578999999975432 2334567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC----
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG----  262 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~----  262 (395)
                      ||++||+|.+++.+ .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......    
T Consensus        81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~  159 (363)
T cd05628          81 EFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF  159 (363)
T ss_pred             cCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence            99999999999976 5679999999999999999999999999999999999999999999999999987432210    


Q ss_pred             --------------------------------ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 016082          263 --------------------------------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL  310 (395)
Q Consensus       263 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~  310 (395)
                                                      .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~  239 (363)
T cd05628         160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE  239 (363)
T ss_pred             cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence                                            012347999999999999999999999999999999999999999998


Q ss_pred             CHHHHHHHhhhccCCCCCCC--CCcHHHHHHHHHhhc--cCCCCCCCHHHHHH
Q 016082          311 TPLQAAVGVVQKSLRPTIPK--HAHPRLAELLERCWQ--HDPTQRPNFSQITD  359 (395)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~--~dp~~RPs~~ell~  359 (395)
                      ++.+....+........+|+  .+++++.++|.+++.  .++..||+++||++
T Consensus       240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~  292 (363)
T cd05628         240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKT  292 (363)
T ss_pred             CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhC
Confidence            88776666554332333333  468899999998654  23345689999987

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=6.4e-44  Score=331.75  Aligned_cols=250  Identities=32%  Similarity=0.639  Sum_probs=215.9

Q ss_pred             cccCcceeeeeeeeCceEEEEEEECC-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          108 DAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       108 ~~~~~~i~~~lg~G~~G~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      +.++|++.+.||+|+||.||+|++.+ ..+|+|.++.....   ...+.+|+.++++++||||+++++++......++||
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05113           2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT   78 (256)
T ss_pred             ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence            45689999999999999999998855 46999998755433   356889999999999999999999999888999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCcc--
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM--  264 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~--  264 (395)
                      ||+.+|+|.+++......+++..++.++.||+.|+.|||+.|++|+||||+||+++.++.+||+|||.++........  
T Consensus        79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~  158 (256)
T cd05113          79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS  158 (256)
T ss_pred             EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence            999999999999876667899999999999999999999999999999999999999999999999998755433211  


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHh
Q 016082          265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC  343 (395)
Q Consensus       265 ~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  343 (395)
                      ....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+. ...++..+...+..+.+++.+|
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~c  237 (256)
T cd05113         159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRLYRPHLASEKVYAIMYSC  237 (256)
T ss_pred             CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHH
Confidence            12235678999999998889999999999999999998 999998877765555443 3455566677889999999999


Q ss_pred             hccCCCCCCCHHHHHHHH
Q 016082          344 WQHDPTQRPNFSQITDIL  361 (395)
Q Consensus       344 l~~dp~~RPs~~ell~~l  361 (395)
                      |+.+|.+||++.+|++.|
T Consensus       238 l~~~p~~Rp~~~~ll~~~  255 (256)
T cd05113         238 WHEKAEERPTFQQLLSSI  255 (256)
T ss_pred             cCCCcccCCCHHHHHHhh
Confidence            999999999999998765

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.3e-44  Score=331.09  Aligned_cols=250  Identities=33%  Similarity=0.642  Sum_probs=216.5

Q ss_pred             cccCcceeeeeeeeCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          108 DAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       108 ~~~~~~i~~~lg~G~~G~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      +..+|++.+.||+|+||.||+|.+. +..+|+|+++......   ..+.+|+.++++++||||+++++++......|+||
T Consensus         2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05059           2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE---DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT   78 (256)
T ss_pred             ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCH---HHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence            4567899999999999999999884 4579999987543332   46788999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCcc--
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM--  264 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~--  264 (395)
                      ||++|++|.+++....+.+++..+..++.|++.|+.|||+.||+||||||+||++++++.+||+|||.++........  
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~  158 (256)
T cd05059          79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS  158 (256)
T ss_pred             ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence            999999999999876678899999999999999999999999999999999999999999999999999765432211  


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHh
Q 016082          265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC  343 (395)
Q Consensus       265 ~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  343 (395)
                      ....++..|+|||.+.+..++.++|+||||+++|++++ |+.||...+..+.... .....++..+..+++++.+++.+|
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~c  237 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVES-VSAGYRLYRPKLAPTEVYTIMYSC  237 (256)
T ss_pred             CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHH-HHcCCcCCCCCCCCHHHHHHHHHH
Confidence            11223457999999998899999999999999999999 8999988777665544 344566677778999999999999


Q ss_pred             hccCCCCCCCHHHHHHHH
Q 016082          344 WQHDPTQRPNFSQITDIL  361 (395)
Q Consensus       344 l~~dp~~RPs~~ell~~l  361 (395)
                      |+.+|++||++.++++.|
T Consensus       238 l~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         238 WHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             hcCChhhCcCHHHHHHHh
Confidence            999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1e-43  Score=330.32  Aligned_cols=244  Identities=28%  Similarity=0.579  Sum_probs=211.6

Q ss_pred             eeeeeCceEEEEEEE----CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecCCCC
Q 016082          117 KVASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARG  192 (395)
Q Consensus       117 ~lg~G~~G~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~gg  192 (395)
                      +||+|+||.||+|.+    ++..+|+|+++....+....+++.+|+.+++.++||||+++++++.. ...++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            689999999999975    46789999998766566677889999999999999999999998864 4679999999999


Q ss_pred             CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCc----cccCC
Q 016082          193 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV----MTAET  268 (395)
Q Consensus       193 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~----~~~~~  268 (395)
                      +|.+++.. .+.+++..+..++.|++.|+.|||++||+||||||.||+++.++.++|+|||.++.......    .....
T Consensus        81 ~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~  159 (257)
T cd05116          81 PLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK  159 (257)
T ss_pred             cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence            99999976 45789999999999999999999999999999999999999999999999999976543321    12223


Q ss_pred             CCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccC
Q 016082          269 GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHD  347 (395)
Q Consensus       269 gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d  347 (395)
                      ++..|+|||.+....++.++|+||||+++||+++ |..||......+.... .....++..|..+++++.++|.+||+.|
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~-i~~~~~~~~~~~~~~~l~~li~~~~~~~  238 (257)
T cd05116         160 WPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQM-IESGERMECPQRCPPEMYDLMKLCWTYG  238 (257)
T ss_pred             CCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHCCCCCCCCCCCCHHHHHHHHHHhccC
Confidence            4578999999988889999999999999999998 9999998776654443 4455667788889999999999999999


Q ss_pred             CCCCCCHHHHHHHHHH
Q 016082          348 PTQRPNFSQITDILKQ  363 (395)
Q Consensus       348 p~~RPs~~ell~~l~~  363 (395)
                      |++||++.+|.+.|+.
T Consensus       239 p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         239 VDERPGFAVVELRLRN  254 (257)
T ss_pred             chhCcCHHHHHHHHhc
Confidence            9999999999998875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=8.6e-44  Score=334.41  Aligned_cols=256  Identities=29%  Similarity=0.558  Sum_probs=216.3

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT  177 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  177 (395)
                      |.+..++|++.++||+|+||.||+|.+.       +..||+|.++... ......++.+|+.+++.++||||+++++++.
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~   79 (277)
T cd05062           1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            6677889999999999999999999764       3569999986543 2334567899999999999999999999999


Q ss_pred             cCCcEEEEEecCCCCCHHHHHhhccC---------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEE
Q 016082          178 RPPNLCIVTEFMARGSIYDFLHKQKG---------VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVK  248 (395)
Q Consensus       178 ~~~~~~lV~E~~~ggsL~~~l~~~~~---------~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vk  248 (395)
                      .....++||||+++|+|.++++....         .++...+..++.|++.|+.|||+.|++||||||+||++++++.++
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEE
Confidence            99999999999999999999975322         346678899999999999999999999999999999999999999


Q ss_pred             EeeeccccccccCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccC
Q 016082          249 VADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSL  324 (395)
Q Consensus       249 l~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~  324 (395)
                      |+|||+++.......   .....+++.|+|||.+.+..++.++||||||+++|||++ |..||.+.+..+....+. ...
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~-~~~  238 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM-EGG  238 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCC
Confidence            999999875433221   112345778999999999899999999999999999999 789999887765554433 333


Q ss_pred             CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 016082          325 RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK  362 (395)
Q Consensus       325 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~  362 (395)
                      .+..+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus       239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         239 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            45566778899999999999999999999999998775

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.4e-44  Score=353.14  Aligned_cols=248  Identities=23%  Similarity=0.384  Sum_probs=209.6

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      .|++.+.||+|+||+||+|++  +++.||||+++... .+......+.+|+.++++++||||+++++++.+.+.+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            688999999999999999987  56889999997543 234556789999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC------
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS------  261 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~------  261 (395)
                      |++||+|.+++.. .+.+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.....      
T Consensus        82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~  160 (381)
T cd05626          82 YIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY  160 (381)
T ss_pred             cCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence            9999999999976 467899999999999999999999999999999999999999999999999987532100      


Q ss_pred             ------------------------------------------CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHH
Q 016082          262 ------------------------------------------GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWE  299 (395)
Q Consensus       262 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~e  299 (395)
                                                                .......||+.|+|||++.+..++.++|||||||++||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e  240 (381)
T cd05626         161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE  240 (381)
T ss_pred             cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence                                                      00122468999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHhhhccCCCCCC--CCCcHHHHHHHHH--hhccCCCCCCCHHHHHH
Q 016082          300 LLTGELPYAGLTPLQAAVGVVQKSLRPTIP--KHAHPRLAELLER--CWQHDPTQRPNFSQITD  359 (395)
Q Consensus       300 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~--cl~~dp~~RPs~~ell~  359 (395)
                      |++|..||...++.+....+.........|  ..+++++.++|.+  |+..+|..||++.+++.
T Consensus       241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~  304 (381)
T cd05626         241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA  304 (381)
T ss_pred             HHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            999999999887766555544322223333  3578999999999  44566667999999986

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=8.5e-44  Score=339.30  Aligned_cols=260  Identities=32%  Similarity=0.654  Sum_probs=223.8

Q ss_pred             ceeecccCcceeeeeeeeCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEEE
Q 016082          104 VWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGA  175 (395)
Q Consensus       104 ~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~  175 (395)
                      .|.+..++|.+.+.||+|+||.||+|++.       +..||+|+++... .....+.+.+|+.+++++ +||||++++++
T Consensus        29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  107 (302)
T cd05055          29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGA  107 (302)
T ss_pred             cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence            46788889999999999999999999752       3479999987653 234457799999999999 79999999999


Q ss_pred             EecCCcEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecc
Q 016082          176 CTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV  254 (395)
Q Consensus       176 ~~~~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~  254 (395)
                      +...+..++||||+.+|+|.++++... ..+++.++..++.+++.|+.|||+++|+|+||||+||+++.++.++++|||.
T Consensus       108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~  187 (302)
T cd05055         108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL  187 (302)
T ss_pred             EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence            999999999999999999999997643 3489999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCC
Q 016082          255 ARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPK  330 (395)
Q Consensus       255 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  330 (395)
                      ++.......   .....++..|+|||.+.+..++.++||||+|+++|++++ |..||.................++..+.
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  267 (302)
T cd05055         188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPE  267 (302)
T ss_pred             cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCC
Confidence            975443221   112345778999999999999999999999999999998 9999988776655555555566666677


Q ss_pred             CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 016082          331 HAHPRLAELLERCWQHDPTQRPNFSQITDILKQM  364 (395)
Q Consensus       331 ~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~  364 (395)
                      ..++++.+++.+||+.+|++||++.++++.|+++
T Consensus       268 ~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         268 HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            7889999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-44  Score=352.67  Aligned_cols=248  Identities=22%  Similarity=0.373  Sum_probs=211.8

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      ++|++.+.||+|+||.||+|++  +++.||||+++.... .......+.+|+.+++.++||||+++++++.++..+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            4789999999999999999987  578999999975422 2345567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC----
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG----  262 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~----  262 (395)
                      ||++||+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++.......    
T Consensus        81 E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~  159 (364)
T cd05599          81 EYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF  159 (364)
T ss_pred             CCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence            99999999999976 4679999999999999999999999999999999999999999999999999986432211    


Q ss_pred             -----------------------------------ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 016082          263 -----------------------------------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY  307 (395)
Q Consensus       263 -----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf  307 (395)
                                                         ......||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf  239 (364)
T cd05599         160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF  239 (364)
T ss_pred             cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCC
Confidence                                               001235899999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhccCCCCCCC--CCcHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 016082          308 AGLTPLQAAVGVVQKSLRPTIPK--HAHPRLAELLERCWQHDPTQRPN---FSQITD  359 (395)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dp~~RPs---~~ell~  359 (395)
                      .+.++.+....+.........|.  .+++++.++|.+|+. +|.+|++   +.++++
T Consensus       240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            99888776665544332223333  468999999999996 9999998   888876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=5e-45  Score=332.55  Aligned_cols=250  Identities=25%  Similarity=0.370  Sum_probs=217.1

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--CcEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCI  184 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  184 (395)
                      .++|+++++|++|+||.||+|++  +++.||+|.++.+...+...-.-.+||.+|.+++|||||.+-.+....  +.+||
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            35799999999999999999988  578899999998765555556678999999999999999999987654  46999


Q ss_pred             EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-Cc
Q 016082          185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GV  263 (395)
Q Consensus       185 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-~~  263 (395)
                      ||||++. +|.+++.....+|...++..+..|+++|++|||.+.|+||||||.|+|++..|.+||+|||+||..+.. ..
T Consensus       155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~  233 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP  233 (419)
T ss_pred             eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCccc
Confidence            9999988 999999998889999999999999999999999999999999999999999999999999999977654 35


Q ss_pred             cccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC-----------------
Q 016082          264 MTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR-----------------  325 (395)
Q Consensus       264 ~~~~~gt~~y~aPE~~~~~-~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~-----------------  325 (395)
                      +|....|.+|+|||.+.+. .|+.+.|+||+||++.||+++++.|.+.+.......+.+..-.                 
T Consensus       234 ~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~  313 (419)
T KOG0663|consen  234 YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKK  313 (419)
T ss_pred             CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhc
Confidence            6777889999999998865 6999999999999999999999999999887776665542111                 


Q ss_pred             ------------CCCCCC-CcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          326 ------------PTIPKH-AHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       326 ------------~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                  ..++.. ++..-.++++.+|..||.+|.|++|.++
T Consensus       314 ~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  314 MTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             cccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence                        111111 4578889999999999999999999887

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.1e-43  Score=334.35  Aligned_cols=263  Identities=27%  Similarity=0.584  Sum_probs=222.1

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE--CCc----eEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY--CSQ----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  180 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~----~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (395)
                      +..++|++.+.||.|+||.||+|.+  +++    .+++|.+.... ......++..|+.++++++||||+++++++.. .
T Consensus         4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~   81 (279)
T cd05111           4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-A   81 (279)
T ss_pred             CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc-chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-C
Confidence            3456889999999999999999987  344    47888875332 23445678889999999999999999998754 4


Q ss_pred             cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                      ..++++||+++|+|.+++....+.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||.++....
T Consensus        82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            57899999999999999987777899999999999999999999999999999999999999999999999999976533


Q ss_pred             CC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHH
Q 016082          261 SG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  336 (395)
Q Consensus       261 ~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  336 (395)
                      ..   ......++..|+|||.+.+..++.++||||||+++||+++ |..||.+..+... ......+.++..+..++.++
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  240 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-PDLLEKGERLAQPQICTIDV  240 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCcCCCCCCCCHHH
Confidence            22   1223356778999999998899999999999999999998 9999998876543 34455666666677788999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 016082          337 AELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWL  372 (395)
Q Consensus       337 ~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~~~~  372 (395)
                      .+++.+||..+|.+|||+.++++.|..+.++-..||
T Consensus       241 ~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~~~~  276 (279)
T cd05111         241 YMVMVKCWMIDENVRPTFKELANEFTRMARDPPRYL  276 (279)
T ss_pred             HHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCccee
Confidence            999999999999999999999999999887655554

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5e-45  Score=350.94  Aligned_cols=250  Identities=24%  Similarity=0.445  Sum_probs=231.5

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc-EEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-LCIVT  186 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lV~  186 (395)
                      ++|..++++|+|+||.+++.++  .+..+++|.+.-....+...+...+|+.++++++|||||.+.+.|..++. +||||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            5788999999999999998776  45789999999888777777889999999999999999999999998888 99999


Q ss_pred             ecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-cc
Q 016082          187 EFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VM  264 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~  264 (395)
                      +|++||++.+.+.+.+ ..|++..+..++.|++.|+.|||+++|.|||||+.||+++.++.|+|+|||+|+...... ..
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a  163 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLA  163 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhhh
Confidence            9999999999998776 679999999999999999999999999999999999999999999999999999887765 55


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhh
Q 016082          265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW  344 (395)
Q Consensus       265 ~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  344 (395)
                      ....||+.||.||++.+.+|..|+|+|||||++|||++-+++|...+.......+.+.. -.++|...+.+++.+|..|+
T Consensus       164 ~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-~~Plp~~ys~el~~lv~~~l  242 (426)
T KOG0589|consen  164 STVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-YSPLPSMYSSELRSLVKSML  242 (426)
T ss_pred             heecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-CCCCCccccHHHHHHHHHHh
Confidence            66789999999999999999999999999999999999999999999888888877654 56788999999999999999


Q ss_pred             ccCCCCCCCHHHHHHH
Q 016082          345 QHDPTQRPNFSQITDI  360 (395)
Q Consensus       345 ~~dp~~RPs~~ell~~  360 (395)
                      ..+|+.||++.+++..
T Consensus       243 ~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  243 RKNPEHRPSALELLRR  258 (426)
T ss_pred             hcCCccCCCHHHHhhC
Confidence            9999999999999985

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.8e-44  Score=333.81  Aligned_cols=256  Identities=31%  Similarity=0.595  Sum_probs=221.0

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT  177 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  177 (395)
                      |+++.++|.+.+.||+|+||.||+|.+.+       ..||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   79 (277)
T cd05032           1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence            67888999999999999999999998642       679999987543 3344567889999999999999999999999


Q ss_pred             cCCcEEEEEecCCCCCHHHHHhhcc---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEE
Q 016082          178 RPPNLCIVTEFMARGSIYDFLHKQK---------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVK  248 (395)
Q Consensus       178 ~~~~~~lV~E~~~ggsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vk  248 (395)
                      .....++||||+++|+|.+++....         ..+++..+..++.|++.|+.|||+.+|+||||||+||+++.++.++
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k  159 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK  159 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence            9999999999999999999996532         2367788999999999999999999999999999999999999999


Q ss_pred             EeeeccccccccCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccC
Q 016082          249 VADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSL  324 (395)
Q Consensus       249 l~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~  324 (395)
                      |+|||.++.......   .....++..|+|||.+.+..++.++||||||+++||+++ |..||.+.++.+...... ...
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~  238 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-DGG  238 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-cCC
Confidence            999999976543321   223356789999999988889999999999999999998 999999888776655544 445


Q ss_pred             CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 016082          325 RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK  362 (395)
Q Consensus       325 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~  362 (395)
                      .+..|..++.++.+++.+||+.+|.+|||+.++++.|+
T Consensus       239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         239 HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            56677888999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.8e-44  Score=345.92  Aligned_cols=241  Identities=25%  Similarity=0.468  Sum_probs=207.9

Q ss_pred             eeeeeeCceEEEEEEE-----CCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Q 016082          116 CKVASGSYGDLYKGTY-----CSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  188 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~-----~~~~vAvK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  188 (395)
                      +.||+|+||.||+++.     .++.||+|+++....  +......+.+|+.++++++||||+++++++..++..|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999975     467899999975432  122345678999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-ccccC
Q 016082          189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAE  267 (395)
Q Consensus       189 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~~~  267 (395)
                      ++||+|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++...... .....
T Consensus        82 ~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (323)
T cd05584          82 LSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF  160 (323)
T ss_pred             CCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence            999999999976 5678889999999999999999999999999999999999999999999999987433222 22345


Q ss_pred             CCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccC
Q 016082          268 TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHD  347 (395)
Q Consensus       268 ~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d  347 (395)
                      .||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+....+...  ...+|..+++++.++|.+||+.+
T Consensus       161 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~  238 (323)
T cd05584         161 CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG--KLNLPPYLTPEARDLLKKLLKRN  238 (323)
T ss_pred             CCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHcccC
Confidence            7899999999999989999999999999999999999999988876655554432  34567788999999999999999


Q ss_pred             CCCCC-----CHHHHHH
Q 016082          348 PTQRP-----NFSQITD  359 (395)
Q Consensus       348 p~~RP-----s~~ell~  359 (395)
                      |++||     ++.++++
T Consensus       239 p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         239 PSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             HhHcCCCCCCCHHHHhc
Confidence            99999     7888766

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.1e-44  Score=349.40  Aligned_cols=249  Identities=22%  Similarity=0.354  Sum_probs=214.4

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      ++|++.+.||+|+||.||+++.  +++.||+|+++.... ..+....+.+|+.+++.++||||+++++++......|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            4789999999999999999987  578999999986533 3345567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCc--c
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV--M  264 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~--~  264 (395)
                      ||++||+|.+++....+.+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++........  .
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  160 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS  160 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence            99999999999988767899999999999999999999999999999999999999999999999999976543322  2


Q ss_pred             ccCCCCcccccccccC------CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCC--CCCcHHH
Q 016082          265 TAETGTYRWMAPEVIE------HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP--KHAHPRL  336 (395)
Q Consensus       265 ~~~~gt~~y~aPE~~~------~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l  336 (395)
                      ....||+.|+|||++.      ...++.++|||||||++|+|++|+.||...+.......+.........|  ..+++++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  240 (330)
T cd05601         161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF  240 (330)
T ss_pred             ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHH
Confidence            2347899999999986      4567899999999999999999999999888776666555433222222  3578999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHH
Q 016082          337 AELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       337 ~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      .+++.+||+ +|.+||++.++++
T Consensus       241 ~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         241 LDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             HHHHHHHcc-ChhhCCCHHHHhC
Confidence            999999998 9999999999875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.7e-43  Score=330.10  Aligned_cols=256  Identities=36%  Similarity=0.680  Sum_probs=217.6

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEECC-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  183 (395)
                      |++..++|++.++||+|+||.||+|++.+ ..||+|+++.....   .+.+.+|+.++++++||||+++++.+.. ...+
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~   76 (262)
T cd05071           1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY   76 (262)
T ss_pred             CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcE
Confidence            56778899999999999999999998743 57999999865433   2568899999999999999999998754 5689


Q ss_pred             EEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC
Q 016082          184 IVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~  262 (395)
                      +||||+++|+|.+++.... ..+++..+..++.+++.||.|||+.+++||||||+||++++++.++|+|||.++......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~  156 (262)
T cd05071          77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  156 (262)
T ss_pred             EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence            9999999999999997643 457889999999999999999999999999999999999999999999999997654432


Q ss_pred             cc--ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHH
Q 016082          263 VM--TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL  339 (395)
Q Consensus       263 ~~--~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  339 (395)
                      ..  ....++..|+|||...+..++.++|+||||+++|++++ |..||.+....+...... ...+...+..++..+.++
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l  235 (262)
T cd05071         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLHDL  235 (262)
T ss_pred             cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh-cCCCCCCccccCHHHHHH
Confidence            21  12345678999999998899999999999999999999 899998887766544432 333445566789999999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHHHHHH
Q 016082          340 LERCWQHDPTQRPNFSQITDILKQMM  365 (395)
Q Consensus       340 i~~cl~~dp~~RPs~~ell~~l~~~~  365 (395)
                      +.+||+.+|++||++.++++.|+..+
T Consensus       236 i~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         236 MCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             HHHHccCCcccCCCHHHHHHHHHHhc
Confidence            99999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=6e-44  Score=343.67  Aligned_cols=241  Identities=23%  Similarity=0.403  Sum_probs=208.5

Q ss_pred             CcceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCC-CceeeEEEEEecCCcEEEEE
Q 016082          111 QLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRH-KNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~  186 (395)
                      +|++.+.||+|+||.||+|++.  ++.||||+++.... .....+.+..|+.++..++| ++|+++++++...+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            5889999999999999999874  57899999976432 23445678889999999986 56888999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc-CCccc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMT  265 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~-~~~~~  265 (395)
                      ||++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++.... .....
T Consensus        81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (324)
T cd05587          81 EYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR  159 (324)
T ss_pred             cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCcee
Confidence            99999999999876 46789999999999999999999999999999999999999999999999999864322 22233


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhc
Q 016082          266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ  345 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  345 (395)
                      ...||+.|+|||++.+.+++.++||||+||++|+|++|+.||.+.+..+....+..  ..+..|..+++++.+++.+||+
T Consensus       160 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~  237 (324)
T cd05587         160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME--HNVSYPKSLSKEAVSICKGLLT  237 (324)
T ss_pred             eecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHHhh
Confidence            45789999999999999999999999999999999999999998887766665543  3456677899999999999999


Q ss_pred             cCCCCCCCH
Q 016082          346 HDPTQRPNF  354 (395)
Q Consensus       346 ~dp~~RPs~  354 (395)
                      .||.+|++.
T Consensus       238 ~~P~~R~~~  246 (324)
T cd05587         238 KHPAKRLGC  246 (324)
T ss_pred             cCHHHcCCC
Confidence            999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=7.9e-44  Score=343.98  Aligned_cols=247  Identities=25%  Similarity=0.399  Sum_probs=201.3

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC-----cEE
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP-----NLC  183 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  183 (395)
                      +|++.++||+|+||.||+|.+  +++.||||.++...........+.+|+.++++++||||+++++++....     .+|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            588999999999999999987  5789999998754433444567889999999999999999999885432     489


Q ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-
Q 016082          184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-  262 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-  262 (395)
                      +||||+. ++|.+++.. .+.+++..+..++.||++||.|||++||+||||||+|||++.++.+||+|||+++...... 
T Consensus        81 lv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  158 (338)
T cd07859          81 VVFELME-SDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP  158 (338)
T ss_pred             EEEecCC-CCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence            9999995 599998875 4578999999999999999999999999999999999999999999999999997543221 


Q ss_pred             ---ccccCCCCcccccccccCC--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhh----------------
Q 016082          263 ---VMTAETGTYRWMAPEVIEH--KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ----------------  321 (395)
Q Consensus       263 ---~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~----------------  321 (395)
                         ......||+.|+|||++.+  ..++.++|||||||++|+|++|+.||.+.+.......+..                
T Consensus       159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  238 (338)
T cd07859         159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE  238 (338)
T ss_pred             ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence               1234578999999999876  6789999999999999999999999987654332111100                


Q ss_pred             ------ccCCCCC-------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          322 ------KSLRPTI-------PKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       322 ------~~~~~~~-------~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                            ...+...       -+..++++.+++.+||+.||++||+++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                  0001111       1246788999999999999999999999987

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.7e-43  Score=330.10  Aligned_cols=256  Identities=26%  Similarity=0.490  Sum_probs=215.2

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      ++|++.+.||+|+||.||+|+.  +++.||||.++... .+......+.+|+.++++++||||+++++++...+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            4789999999999999999987  67899999886532 34555677899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCc
Q 016082          187 EFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV  263 (395)
Q Consensus       187 E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~  263 (395)
                      ||+++++|.+++..   ....+++..+..++.++++||.|||++|++|+||||+||+++.++.++|+|||.+........
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~  161 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence            99999999988853   234578899999999999999999999999999999999999999999999999876543321


Q ss_pred             -cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHhhhccCCCCCCCCCcHHHHHHH
Q 016082          264 -MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP--LQAAVGVVQKSLRPTIPKHAHPRLAELL  340 (395)
Q Consensus       264 -~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li  340 (395)
                       .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||.....  ......+.....++..+...+..+.++|
T Consensus       162 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  241 (267)
T cd08228         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELV  241 (267)
T ss_pred             HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHH
Confidence             2334688899999999988899999999999999999999999965432  2322222222333333456788999999


Q ss_pred             HHhhccCCCCCCCHHHHHHHHHHHH
Q 016082          341 ERCWQHDPTQRPNFSQITDILKQMM  365 (395)
Q Consensus       341 ~~cl~~dp~~RPs~~ell~~l~~~~  365 (395)
                      .+||+.+|++||++.++++.++++.
T Consensus       242 ~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         242 SMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             HHHCCCCcccCcCHHHHHHHHHHhc
Confidence            9999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.5e-44  Score=335.37  Aligned_cols=255  Identities=24%  Similarity=0.369  Sum_probs=224.5

Q ss_pred             ceeecccCcceeeeeeeeCceEEEEEEECC--ceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 016082          104 VWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  180 (395)
Q Consensus       104 ~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~--~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (395)
                      ...+..++|++.+.||.|.-|+||+++..+  ..+|+|++.++.. ..+...+...|..||+.++||.++.+|+.|+.+.
T Consensus        71 ~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~  150 (459)
T KOG0610|consen   71 DGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK  150 (459)
T ss_pred             CCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc
Confidence            346777899999999999999999999855  7899999987654 3556678899999999999999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  259 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~  259 (395)
                      ..|+|||||+||+|..+++++. +.|++..++.++.+++.||+|||-.|||.|||||+||||.++|++.|+||.++....
T Consensus       151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~  230 (459)
T KOG0610|consen  151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP  230 (459)
T ss_pred             eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence            9999999999999999998774 679999999999999999999999999999999999999999999999999974211


Q ss_pred             cC--------------------------------C-c------------------------cccCCCCcccccccccCCC
Q 016082          260 QS--------------------------------G-V------------------------MTAETGTYRWMAPEVIEHK  282 (395)
Q Consensus       260 ~~--------------------------------~-~------------------------~~~~~gt~~y~aPE~~~~~  282 (395)
                      ..                                . .                        .....||-.|.|||++.|.
T Consensus       231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~  310 (459)
T KOG0610|consen  231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE  310 (459)
T ss_pred             CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence            00                                0 0                        0112588999999999999


Q ss_pred             CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCC----HHHHH
Q 016082          283 PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPN----FSQIT  358 (395)
Q Consensus       283 ~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs----~~ell  358 (395)
                      ..+.++|.|+||+++|||+.|..||.+.+..+...+++.+...-+-.+..+..+++||+++|.+||.+|..    +.||.
T Consensus       311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK  390 (459)
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence            99999999999999999999999999999999999999887765555578899999999999999999998    55554

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-44  Score=352.96  Aligned_cols=248  Identities=20%  Similarity=0.317  Sum_probs=208.9

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      ++|++.++||+|+||.||+++.  +++.||||++.... ...+....+.+|+.++++++||||+++++++.+....|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            3789999999999999999987  67899999986532 23345577899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC----
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG----  262 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~----  262 (395)
                      ||++||+|.+++.. .+.+++..+..++.|++.||+|||+.||+||||||+|||++.++.++|+|||+++......    
T Consensus        81 E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  159 (377)
T cd05629          81 EFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY  159 (377)
T ss_pred             eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence            99999999999976 5678999999999999999999999999999999999999999999999999986321100    


Q ss_pred             ---------c-----------------------------------cccCCCCcccccccccCCCCCCChhhHHHHHHHHH
Q 016082          263 ---------V-----------------------------------MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALW  298 (395)
Q Consensus       263 ---------~-----------------------------------~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~  298 (395)
                               .                                   .....||+.|+|||++.+..++.++|||||||++|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~  239 (377)
T cd05629         160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF  239 (377)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhh
Confidence                     0                                   01236899999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHhhhccCCCCCCC--CCcHHHHHHHHHhhccCCCCC---CCHHHHHH
Q 016082          299 ELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK--HAHPRLAELLERCWQHDPTQR---PNFSQITD  359 (395)
Q Consensus       299 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dp~~R---Ps~~ell~  359 (395)
                      ||++|..||.+.++.+....+.........|.  .+++++.++|.+|+. +|.+|   +++.+++.
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~  304 (377)
T cd05629         240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS  304 (377)
T ss_pred             hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc
Confidence            99999999998877666555543222333333  578999999999998 77765   59998886

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2e-43  Score=332.29  Aligned_cols=257  Identities=30%  Similarity=0.602  Sum_probs=219.0

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE--CCc----eEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY--CSQ----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  180 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~----~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (395)
                      +..++|++.++||+|+||.||+|++  +++    .||+|+++... .......+.+|+.+++.+.||||+++++++... 
T Consensus         4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-   81 (279)
T cd05109           4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-   81 (279)
T ss_pred             cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-
Confidence            4567899999999999999999986  333    48999997553 344567899999999999999999999998764 


Q ss_pred             cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                      ..++++||+++|+|.++++...+.+++..+..++.|++.||.|||++||+||||||+||++++++.+||+|||+++....
T Consensus        82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            57899999999999999987677899999999999999999999999999999999999999999999999999986543


Q ss_pred             CCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHH
Q 016082          261 SGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  336 (395)
Q Consensus       261 ~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  336 (395)
                      ...   .....++..|+|||.+.+..++.++|||||||++|||++ |..||......... ........+..+..++.++
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  240 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP-DLLEKGERLPQPPICTIDV  240 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHCCCcCCCCccCCHHH
Confidence            222   122345678999999998999999999999999999998 99999887665543 3444555666677889999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 016082          337 AELLERCWQHDPTQRPNFSQITDILKQMMK  366 (395)
Q Consensus       337 ~~li~~cl~~dp~~RPs~~ell~~l~~~~~  366 (395)
                      .+++.+||+.||++||++.++++.+..+.+
T Consensus       241 ~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         241 YMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            999999999999999999999988876644

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.6e-43  Score=330.83  Aligned_cols=255  Identities=34%  Similarity=0.629  Sum_probs=219.5

Q ss_pred             cccCcceeeeeeeeCceEEEEEEEC-----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Q 016082          108 DAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  182 (395)
Q Consensus       108 ~~~~~~i~~~lg~G~~G~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  182 (395)
                      +..+|++.+.||+|+||.||+|++.     +..+|+|.++... .......+..|+.++++++||||+++++++...+..
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            4568999999999999999999862     2369999987653 344567899999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC
Q 016082          183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~  262 (395)
                      ++||||+++++|.+++....+.++..++..++.|++.|+.|||+.|++||||||+||+++.++.++++|||.++......
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            99999999999999998766778999999999999999999999999999999999999999999999999997654322


Q ss_pred             c--c--ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHH
Q 016082          263 V--M--TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA  337 (395)
Q Consensus       263 ~--~--~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  337 (395)
                      .  .  ....++..|+|||.+.+..++.++|+||||+++|++++ |..||...+..+....+ ....+++.+..+++++.
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  239 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI-EEGYRLPAPMDCPAALH  239 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHH-hCCCcCCCCCCCCHHHH
Confidence            1  1  12233568999999998889999999999999999887 99999888766554443 34455666677899999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHHHHHH
Q 016082          338 ELLERCWQHDPTQRPNFSQITDILKQM  364 (395)
Q Consensus       338 ~li~~cl~~dp~~RPs~~ell~~l~~~  364 (395)
                      +++.+||+.+|.+||++.++++.|+++
T Consensus       240 ~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         240 QLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             HHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=5.9e-44  Score=343.75  Aligned_cols=244  Identities=26%  Similarity=0.470  Sum_probs=207.5

Q ss_pred             cceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHH---HhcCCCceeeEEEEEecCCcEEEE
Q 016082          112 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIM---RKIRHKNVVQFIGACTRPPNLCIV  185 (395)
Q Consensus       112 ~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lV  185 (395)
                      |++.+.||+|+||.||+|.+  +++.||||+++.... .....+.+.+|+.++   ++++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            67899999999999999987  578999999975432 223445677777665   456799999999999999999999


Q ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc-CCcc
Q 016082          186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVM  264 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~-~~~~  264 (395)
                      |||++||+|..+++.  +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.... ....
T Consensus        81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05589          81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT  158 (324)
T ss_pred             EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcc
Confidence            999999999988854  5689999999999999999999999999999999999999999999999999875332 2223


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhh
Q 016082          265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW  344 (395)
Q Consensus       265 ~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  344 (395)
                      ....|++.|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+..+....+...  .+..|..+++++.++|.+||
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~L  236 (324)
T cd05589         159 STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND--EVRYPRFLSREAISIMRRLL  236 (324)
T ss_pred             cccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHHh
Confidence            4457899999999999999999999999999999999999999998877766655443  34567788999999999999


Q ss_pred             ccCCCCCCC-----HHHHHH
Q 016082          345 QHDPTQRPN-----FSQITD  359 (395)
Q Consensus       345 ~~dp~~RPs-----~~ell~  359 (395)
                      +.||.+||+     +.++++
T Consensus       237 ~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         237 RRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             hcCHhHcCCCCCCCHHHHhh
Confidence            999999994     555554

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.1e-43  Score=328.56  Aligned_cols=245  Identities=29%  Similarity=0.606  Sum_probs=210.9

Q ss_pred             eeeeeCceEEEEEEEC----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecCCCC
Q 016082          117 KVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARG  192 (395)
Q Consensus       117 ~lg~G~~G~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~gg  192 (395)
                      .||+|+||.||+|.+.    +..||+|+++... .....+.+.+|+.++++++||||+++++++.. +..++||||++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~   79 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG   79 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence            4899999999999763    3469999997653 34455779999999999999999999998864 5789999999999


Q ss_pred             CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCc----cccCC
Q 016082          193 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV----MTAET  268 (395)
Q Consensus       193 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~----~~~~~  268 (395)
                      +|.+++......+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||.++.......    .+...
T Consensus        80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  159 (257)
T cd05115          80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK  159 (257)
T ss_pred             CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCC
Confidence            99999987677899999999999999999999999999999999999999999999999999975433211    12223


Q ss_pred             CCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccC
Q 016082          269 GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHD  347 (395)
Q Consensus       269 gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d  347 (395)
                      ++..|+|||.+.+..++.++||||||+++|++++ |..||.......... .+..+.++..+..+++++.++|.+||+.+
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~c~~~~  238 (257)
T cd05115         160 WPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMS-FIEQGKRLDCPAECPPEMYALMKDCWIYK  238 (257)
T ss_pred             CCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHH-HHHCCCCCCCCCCCCHHHHHHHHHHcCCC
Confidence            4678999999998889999999999999999996 999999887765443 44556677788889999999999999999


Q ss_pred             CCCCCCHHHHHHHHHHH
Q 016082          348 PTQRPNFSQITDILKQM  364 (395)
Q Consensus       348 p~~RPs~~ell~~l~~~  364 (395)
                      |++||++.+|.+.|+.+
T Consensus       239 ~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         239 WEDRPNFAKVEERMRTY  255 (257)
T ss_pred             hhhCcCHHHHHHHHhhh
Confidence            99999999999988865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=6.6e-44  Score=331.75  Aligned_cols=255  Identities=33%  Similarity=0.660  Sum_probs=221.8

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  184 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  184 (395)
                      +-...+|++.++||.|+||.||+|.+. +..+|+|+++...  ......+..|+.+++.++||||+++++++......++
T Consensus         2 ~~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (261)
T cd05148           2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI   79 (261)
T ss_pred             cCcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence            444568999999999999999999874 5789999987653  3335678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-
Q 016082          185 VTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-  262 (395)
Q Consensus       185 V~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-  262 (395)
                      ||||+++++|.+++... ...++...+..++.+++.|+.|||++||+||||||+||++++++.++|+|||.+....... 
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            99999999999999764 3568999999999999999999999999999999999999999999999999997654332 


Q ss_pred             ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHH
Q 016082          263 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE  341 (395)
Q Consensus       263 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  341 (395)
                      ......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+...... ...++..+..+++++.++|.
T Consensus       160 ~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~  238 (261)
T cd05148         160 LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIYKIML  238 (261)
T ss_pred             cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-hCCcCCCCCCCCHHHHHHHH
Confidence            1223345778999999998899999999999999999998 899999887766555444 45666777889999999999


Q ss_pred             HhhccCCCCCCCHHHHHHHHHH
Q 016082          342 RCWQHDPTQRPNFSQITDILKQ  363 (395)
Q Consensus       342 ~cl~~dp~~RPs~~ell~~l~~  363 (395)
                      +||+.+|.+|||+.++++.|+.
T Consensus       239 ~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         239 ECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             HHcCCCchhCcCHHHHHHHHhc
Confidence            9999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.1e-43  Score=344.65  Aligned_cols=262  Identities=32%  Similarity=0.641  Sum_probs=220.5

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEE-------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEEEE
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGAC  176 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  176 (395)
                      |+...++|++.+.||+|+||.||+|.+       .++.||||+++.... .+....+.+|+.++.++ +||||+++++++
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~   80 (343)
T cd05103           2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGAC   80 (343)
T ss_pred             cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence            778888999999999999999999974       357899999976542 34456788999999999 589999999988


Q ss_pred             ecC-CcEEEEEecCCCCCHHHHHhhcc-----------------------------------------------------
Q 016082          177 TRP-PNLCIVTEFMARGSIYDFLHKQK-----------------------------------------------------  202 (395)
Q Consensus       177 ~~~-~~~~lV~E~~~ggsL~~~l~~~~-----------------------------------------------------  202 (395)
                      ... ...++||||+++|+|.++++...                                                     
T Consensus        81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (343)
T cd05103          81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD  160 (343)
T ss_pred             ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence            654 46899999999999999986532                                                     


Q ss_pred             -------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCc---ccc
Q 016082          203 -------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV---MTA  266 (395)
Q Consensus       203 -------------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~---~~~  266 (395)
                                   ..++...+..++.|+++||.|||++||+||||||.||+++.++.++|+|||+++.......   ...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence                         2367778889999999999999999999999999999999999999999999975432211   112


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhc
Q 016082          267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ  345 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  345 (395)
                      ..+++.|+|||.+.+..++.++|+||||+++|++++ |..||.................++..|...++++.+++.+||+
T Consensus       241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~  320 (343)
T cd05103         241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH  320 (343)
T ss_pred             CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcc
Confidence            345678999999998899999999999999999997 9999987655444555555666667777788999999999999


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHH
Q 016082          346 HDPTQRPNFSQITDILKQMMKE  367 (395)
Q Consensus       346 ~dp~~RPs~~ell~~l~~~~~~  367 (395)
                      .+|.+||++.+|++.|+.+++.
T Consensus       321 ~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         321 GEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             CChhhCcCHHHHHHHHHHHHhc
Confidence            9999999999999999998763

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.2e-43  Score=328.37  Aligned_cols=254  Identities=36%  Similarity=0.687  Sum_probs=218.4

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  183 (395)
                      |++..++|++.++||+|+||.||+|.+ .+..+|+|.++......   +.+.+|+.++++++|+|++++++++.. ...+
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~   76 (260)
T cd05070           1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP---ESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIY   76 (260)
T ss_pred             CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCH---HHHHHHHHHHHhcCCCceEEEEeEECC-CCcE
Confidence            677888999999999999999999987 45679999998765432   568899999999999999999998854 5689


Q ss_pred             EEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC
Q 016082          184 IVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~  262 (395)
                      ++|||+++++|.+++... ...+++..+..++.+++.|+.|||++||+||||||+||++++++.++|+|||.+.......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence            999999999999999764 3458999999999999999999999999999999999999999999999999997654332


Q ss_pred             c--cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHH
Q 016082          263 V--MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL  339 (395)
Q Consensus       263 ~--~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  339 (395)
                      .  .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+....+ ....+++.+...+..+.++
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l  235 (260)
T cd05070         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV-ERGYRMPCPQDCPISLHEL  235 (260)
T ss_pred             cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-HcCCCCCCCCcCCHHHHHH
Confidence            1  122345678999999988889999999999999999999 99999988776655443 3455666777889999999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHHHH
Q 016082          340 LERCWQHDPTQRPNFSQITDILKQ  363 (395)
Q Consensus       340 i~~cl~~dp~~RPs~~ell~~l~~  363 (395)
                      +.+||+++|.+|||+.++.+.|++
T Consensus       236 i~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         236 MLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             HHHHcccCcccCcCHHHHHHHHhc
Confidence            999999999999999999988864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.6e-43  Score=332.22  Aligned_cols=255  Identities=30%  Similarity=0.600  Sum_probs=215.7

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  180 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (395)
                      ++.++|++.++||+|+||.||+|+.      .+..+|+|.++... .......+.+|+.++++++||||+++++++..+.
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   80 (283)
T cd05090           2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ   80 (283)
T ss_pred             CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence            3456899999999999999999974      34679999997543 3445578899999999999999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHhhcc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCC
Q 016082          181 NLCIVTEFMARGSIYDFLHKQK----------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN  244 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~----------------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~  244 (395)
                      ..|+||||+++++|.+++....                ..++...+..++.+++.||.|||++|++||||||+||+++++
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~  160 (283)
T cd05090          81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ  160 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence            9999999999999999986431                246788899999999999999999999999999999999999


Q ss_pred             CcEEEeeeccccccccCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhh
Q 016082          245 GVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVV  320 (395)
Q Consensus       245 ~~vkl~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~  320 (395)
                      +.++|+|||+++......   ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+..+...... .
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~-~  239 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM-V  239 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-H
Confidence            999999999997643321   1223345678999999998889999999999999999998 9999988776544433 3


Q ss_pred             hccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 016082          321 QKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQ  363 (395)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~  363 (395)
                      .....+..+..+++++.+++.+||+.+|.+||++.+|.+.|+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         240 RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            3344455677889999999999999999999999999888753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-43  Score=335.85  Aligned_cols=249  Identities=20%  Similarity=0.348  Sum_probs=210.5

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCH-HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      .|++.+.||+|+||.||++..  +++.||+|++....... .....+.+|+.++++++||||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            378899999999999999987  57899999997543322 233557889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCcccc
Q 016082          188 FMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA  266 (395)
Q Consensus       188 ~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~  266 (395)
                      |+++|+|.+++... ...+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||+++..........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  160 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG  160 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence            99999999988654 35689999999999999999999999999999999999999999999999999986544433345


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhh--ccCCCCCCCCCcHHHHHHHHHhh
Q 016082          267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ--KSLRPTIPKHAHPRLAELLERCW  344 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl  344 (395)
                      ..|+..|+|||++.+..++.++||||+|+++|++++|+.||.+.........+..  ....+..+...+..+.+++.+||
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  240 (285)
T cd05605         161 RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLL  240 (285)
T ss_pred             ccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHc
Confidence            5789999999999999999999999999999999999999988655332222111  12334556678999999999999


Q ss_pred             ccCCCCCC-----CHHHHHH
Q 016082          345 QHDPTQRP-----NFSQITD  359 (395)
Q Consensus       345 ~~dp~~RP-----s~~ell~  359 (395)
                      +.||.+||     ++.++++
T Consensus       241 ~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         241 TKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             cCCHHHhcCCCCCCHHHHhc
Confidence            99999999     7778766

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.3e-43  Score=356.86  Aligned_cols=247  Identities=22%  Similarity=0.352  Sum_probs=213.7

Q ss_pred             cCcceeeeeeeeCceEEEEEEEC---CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTYC---SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      ..|.+.+.||+|+||.||+|...   ++.||+|.+...  .......+.+|+.+++.++||||+++++++..++..|+||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~  144 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM  144 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence            35999999999999999999763   567888876544  3444567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-
Q 016082          187 EFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-  262 (395)
Q Consensus       187 E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-  262 (395)
                      ||++||+|.+++...   ..++++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++...... 
T Consensus       145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999999988643   4568899999999999999999999999999999999999999999999999998654332 


Q ss_pred             --ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHH
Q 016082          263 --VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELL  340 (395)
Q Consensus       263 --~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  340 (395)
                        ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+... ..+..|..+++++.++|
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~li  303 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG-KYDPFPCPVSSGMKALL  303 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCCccCCHHHHHHH
Confidence              123456999999999999999999999999999999999999999988776665554443 33455677899999999


Q ss_pred             HHhhccCCCCCCCHHHHHH
Q 016082          341 ERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       341 ~~cl~~dp~~RPs~~ell~  359 (395)
                      .+||+.+|++||++.+++.
T Consensus       304 ~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        304 DPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             HHHhccChhhCcCHHHHHh
Confidence            9999999999999999875

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.4e-43  Score=332.90  Aligned_cols=254  Identities=30%  Similarity=0.613  Sum_probs=217.1

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP  179 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  179 (395)
                      +..++|.+.+.||+|+||.||+|+..       +..||||+++... ..+....+.+|++++++++||||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   80 (280)
T cd05049           2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEG   80 (280)
T ss_pred             CChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence            34568999999999999999999762       3679999997653 233567899999999999999999999999999


Q ss_pred             CcEEEEEecCCCCCHHHHHhhcc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCc
Q 016082          180 PNLCIVTEFMARGSIYDFLHKQK-------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV  246 (395)
Q Consensus       180 ~~~~lV~E~~~ggsL~~~l~~~~-------------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~  246 (395)
                      ...++||||+++++|.++++...             ..+++..+..++.+++.|+.|||++|++||||||+||+++.++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence            99999999999999999997542             34788889999999999999999999999999999999999999


Q ss_pred             EEEeeeccccccccCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc
Q 016082          247 VKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK  322 (395)
Q Consensus       247 vkl~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~  322 (395)
                      ++|+|||.++......   ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+. .
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~-~  239 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT-Q  239 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-c
Confidence            9999999987543221   1123345788999999999999999999999999999998 999998877666554433 4


Q ss_pred             cCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 016082          323 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK  362 (395)
Q Consensus       323 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~  362 (395)
                      +..+..+..++..+.+++.+||+.||.+||++.|+++.|+
T Consensus       240 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         240 GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            4445556778999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.2e-43  Score=334.28  Aligned_cols=254  Identities=26%  Similarity=0.546  Sum_probs=217.1

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP  179 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  179 (395)
                      ++..+|++.++||+|+||.||+|++.       ++.||+|+++... .....+.+.+|+.++..++||||+++++++...
T Consensus         2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~   80 (283)
T cd05091           2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE   80 (283)
T ss_pred             CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence            45667999999999999999999863       3679999998553 344557789999999999999999999999999


Q ss_pred             CcEEEEEecCCCCCHHHHHhhc---------------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCC
Q 016082          180 PNLCIVTEFMARGSIYDFLHKQ---------------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN  244 (395)
Q Consensus       180 ~~~~lV~E~~~ggsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~  244 (395)
                      ...++++||+.+++|.+++...               ...++...+..++.|++.||.|||++||+||||||+||+++++
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence            9999999999999999998532               2357888899999999999999999999999999999999999


Q ss_pred             CcEEEeeeccccccccCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhh
Q 016082          245 GVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVV  320 (395)
Q Consensus       245 ~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~  320 (395)
                      +.+||+|||+++.......   .....+++.|+|||.+.+..++.++||||||+++|||++ |..||.+....+....+.
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~  240 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR  240 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            9999999999875433221   123345789999999988889999999999999999998 899999887766555544


Q ss_pred             hccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 016082          321 QKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK  362 (395)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~  362 (395)
                      . ......+..++..+.+++.+||+.+|.+||++.+|+..|+
T Consensus       241 ~-~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~  281 (283)
T cd05091         241 N-RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR  281 (283)
T ss_pred             c-CCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence            3 4445567789999999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=4e-43  Score=336.32  Aligned_cols=264  Identities=31%  Similarity=0.634  Sum_probs=224.0

Q ss_pred             CceeecccCcceeeeeeeeCceEEEEEEEC---------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeE
Q 016082          103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQF  172 (395)
Q Consensus       103 ~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l  172 (395)
                      ..|.+..++|.+.++||+|+||.||+++..         ...+|+|+++... .......+.+|+.+++++ +||||+++
T Consensus         5 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~   83 (314)
T cd05099           5 PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINL   83 (314)
T ss_pred             ccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeE
Confidence            457888889999999999999999999752         3469999987543 344567789999999999 59999999


Q ss_pred             EEEEecCCcEEEEEecCCCCCHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 016082          173 IGACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA  237 (395)
Q Consensus       173 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~  237 (395)
                      ++++......++||||+++|+|.+++....               ..++...+..++.|++.||.|||++|++||||||+
T Consensus        84 ~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~  163 (314)
T cd05099          84 LGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAAR  163 (314)
T ss_pred             EEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccce
Confidence            999999999999999999999999997632               34788889999999999999999999999999999


Q ss_pred             CeeeCCCCcEEEeeeccccccccCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 016082          238 NLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPL  313 (395)
Q Consensus       238 NiLl~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~  313 (395)
                      ||+++.++.+||+|||.++.......   .....++..|+|||.+.+..++.++|+||||+++|++++ |..||.+....
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~  243 (314)
T cd05099         164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE  243 (314)
T ss_pred             eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999976543211   122234568999999998899999999999999999999 89999887766


Q ss_pred             HHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHH
Q 016082          314 QAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  368 (395)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~  368 (395)
                      +.... ......+..+..++.++.+++.+||+.+|.+||++.++++.|.++...+
T Consensus       244 ~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~  297 (314)
T cd05099         244 ELFKL-LREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV  297 (314)
T ss_pred             HHHHH-HHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence            55444 3344555667788999999999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.4e-43  Score=325.46  Aligned_cols=245  Identities=31%  Similarity=0.644  Sum_probs=210.8

Q ss_pred             eeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecCCCCC
Q 016082          116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS  193 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ggs  193 (395)
                      ++||+|+||.||+|++  +++.||+|.++... ..+....+.+|+.++++++||||+++++++......++||||+++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD   79 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence            4689999999999987  67889999987543 45556789999999999999999999999999999999999999999


Q ss_pred             HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCccc---cCCCC
Q 016082          194 IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT---AETGT  270 (395)
Q Consensus       194 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~---~~~gt  270 (395)
                      |.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||.++.........   ...++
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  159 (252)
T cd05084          80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP  159 (252)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCc
Confidence            999997766678999999999999999999999999999999999999999999999999987543321111   11234


Q ss_pred             cccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCC
Q 016082          271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPT  349 (395)
Q Consensus       271 ~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~  349 (395)
                      ..|+|||.+.+..++.++||||||+++|++++ |..||...++...... .....++..+..++..+.+++.+||+.+|+
T Consensus       160 ~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  238 (252)
T cd05084         160 VKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREA-IEQGVRLPCPELCPDAVYRLMERCWEYDPG  238 (252)
T ss_pred             eeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHH-HHcCCCCCCcccCCHHHHHHHHHHcCCChh
Confidence            57999999998889999999999999999998 9999988777654443 334456667778899999999999999999


Q ss_pred             CCCCHHHHHHHHH
Q 016082          350 QRPNFSQITDILK  362 (395)
Q Consensus       350 ~RPs~~ell~~l~  362 (395)
                      +|||+.++++.|+
T Consensus       239 ~Rps~~~~~~~l~  251 (252)
T cd05084         239 QRPSFSTVHQELQ  251 (252)
T ss_pred             hCcCHHHHHHHHh
Confidence            9999999998875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.6e-44  Score=346.68  Aligned_cols=238  Identities=26%  Similarity=0.443  Sum_probs=207.1

Q ss_pred             eeeeeeCceEEEEEEE-----CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecCC
Q 016082          116 CKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA  190 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~  190 (395)
                      +.||+|+||.||+++.     .++.||+|+++...........+.+|+.++++++||||+++++++...+..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999865     46889999998654333344567889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-CccccCCC
Q 016082          191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETG  269 (395)
Q Consensus       191 ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-~~~~~~~g  269 (395)
                      +|+|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||+++..... .......|
T Consensus        82 ~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  160 (318)
T cd05582          82 GGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG  160 (318)
T ss_pred             CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccC
Confidence            9999999976 457899999999999999999999999999999999999999999999999999765433 22334578


Q ss_pred             CcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCC
Q 016082          270 TYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPT  349 (395)
Q Consensus       270 t~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~  349 (395)
                      |+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....+...  ...+|..+++++.++|++||+.||.
T Consensus       161 ~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~l~~~P~  238 (318)
T cd05582         161 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA--KLGMPQFLSPEAQSLLRALFKRNPA  238 (318)
T ss_pred             ChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhhcCHh
Confidence            99999999999999999999999999999999999999988877666554433  3456778899999999999999999


Q ss_pred             CCCCHHH
Q 016082          350 QRPNFSQ  356 (395)
Q Consensus       350 ~RPs~~e  356 (395)
                      +||++.+
T Consensus       239 ~R~~a~~  245 (318)
T cd05582         239 NRLGAGP  245 (318)
T ss_pred             HcCCCCC
Confidence            9999554

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-43  Score=326.83  Aligned_cols=249  Identities=29%  Similarity=0.509  Sum_probs=217.7

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCH---HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT---EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  184 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  184 (395)
                      +.|++.+.||+|++|.||+|..  +++.+|+|.+.......   .....+.+|+.++++++||||+++++++......++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            4688999999999999999976  57899999987543322   234678999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCcc
Q 016082          185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM  264 (395)
Q Consensus       185 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~  264 (395)
                      |+||+++++|.+++.. .+.++...+..++.+++.|+.|||+.||+||||+|+||+++.++.++|+|||.++........
T Consensus        82 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~  160 (263)
T cd06625          82 FMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS  160 (263)
T ss_pred             EEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence            9999999999999876 456889999999999999999999999999999999999999999999999998754332111


Q ss_pred             ----ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHH
Q 016082          265 ----TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELL  340 (395)
Q Consensus       265 ----~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  340 (395)
                          ....++..|+|||.+.+..++.++||||||+++|++++|+.||...+..............+..+..++.++.++|
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  240 (263)
T cd06625         161 GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL  240 (263)
T ss_pred             cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence                2346788999999999999999999999999999999999999887776666665656666778888999999999


Q ss_pred             HHhhccCCCCCCCHHHHHH
Q 016082          341 ERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       341 ~~cl~~dp~~RPs~~ell~  359 (395)
                      .+||..+|.+||++.++++
T Consensus       241 ~~~l~~~p~~Rpt~~~ll~  259 (263)
T cd06625         241 RRTFVENAKKRPSAEELLR  259 (263)
T ss_pred             HHHhhcCcccCCCHHHHhh
Confidence            9999999999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.7e-43  Score=340.60  Aligned_cols=250  Identities=24%  Similarity=0.453  Sum_probs=209.5

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  184 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  184 (395)
                      +..++|++.++||.|+||.||++++  ++..+|+|+++... .......+.+|++++++++||||++++++|...+..++
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence            5567999999999999999999988  46789999987653 34456779999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCeeeCCCCcEEEeeeccccccccCCc
Q 016082          185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV  263 (395)
Q Consensus       185 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~  263 (395)
                      ||||+++|+|.+++.. .+.+++..+..++.+++.||.|||+. +|+||||||+||+++.++.+||+|||++...... .
T Consensus        81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~  158 (333)
T cd06650          81 CMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-M  158 (333)
T ss_pred             EEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-c
Confidence            9999999999999976 45689999999999999999999985 7999999999999999999999999998754332 2


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh------------------------
Q 016082          264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV------------------------  319 (395)
Q Consensus       264 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~------------------------  319 (395)
                      .....|+..|+|||++.+..++.++|+|||||++|++++|+.||......+.....                        
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (333)
T cd06650         159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPL  238 (333)
T ss_pred             cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchh
Confidence            23457899999999999989999999999999999999999999765443221100                        


Q ss_pred             -------------------hhccCCCCCCC-CCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          320 -------------------VQKSLRPTIPK-HAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       320 -------------------~~~~~~~~~~~-~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                         ......+..+. ..+.++.+++.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             hhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                               00111122221 35788999999999999999999999976

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=6.9e-44  Score=349.55  Aligned_cols=253  Identities=22%  Similarity=0.343  Sum_probs=215.2

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  181 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  181 (395)
                      +.+..++|++.++||+|+||.||++++  +++.||+|+++.... .......+.+|+.+++.++||||+++++++.++..
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~  117 (370)
T cd05596          38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY  117 (370)
T ss_pred             CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            456677999999999999999999987  578899999965322 22334567899999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC
Q 016082          182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  261 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~  261 (395)
                      .|+||||++||+|.+++..  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||.++.....
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         118 LYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence            9999999999999999865  35888999999999999999999999999999999999999999999999999765433


Q ss_pred             Cc--cccCCCCcccccccccCCC----CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCC--CCc
Q 016082          262 GV--MTAETGTYRWMAPEVIEHK----PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK--HAH  333 (395)
Q Consensus       262 ~~--~~~~~gt~~y~aPE~~~~~----~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~  333 (395)
                      ..  .....||+.|+|||++.+.    .++.++|||||||++|||++|+.||.+.+.......+.........|.  .++
T Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  275 (370)
T cd05596         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEIS  275 (370)
T ss_pred             CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCC
Confidence            21  2345799999999998653    478999999999999999999999999887766666654433333443  578


Q ss_pred             HHHHHHHHHhhccCCCC--CCCHHHHHH
Q 016082          334 PRLAELLERCWQHDPTQ--RPNFSQITD  359 (395)
Q Consensus       334 ~~l~~li~~cl~~dp~~--RPs~~ell~  359 (395)
                      .++.++|.+||+.+|.+  ||++.++++
T Consensus       276 ~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         276 KQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             HHHHHHHHHHccChhhccCCCCHHHHhc
Confidence            99999999999999987  999999976

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.4e-43  Score=333.96  Aligned_cols=261  Identities=33%  Similarity=0.648  Sum_probs=224.3

Q ss_pred             CceeecccCcceeeeeeeeCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEE
Q 016082          103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG  174 (395)
Q Consensus       103 ~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~  174 (395)
                      ..|+++.++|++.+.||+|+||.||++.+.+       ..+|+|.++... ......++.+|+.+++++ +|+||+++++
T Consensus         5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   83 (293)
T cd05053           5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLG   83 (293)
T ss_pred             cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            3578888999999999999999999998632       579999998653 334456789999999999 7999999999


Q ss_pred             EEecCCcEEEEEecCCCCCHHHHHhhc---------------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 016082          175 ACTRPPNLCIVTEFMARGSIYDFLHKQ---------------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANL  239 (395)
Q Consensus       175 ~~~~~~~~~lV~E~~~ggsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~Ni  239 (395)
                      ++...+.++++|||+++|+|.++++..               .+.+++..+..++.|++.|+.|||++||+||||||+||
T Consensus        84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni  163 (293)
T cd05053          84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV  163 (293)
T ss_pred             EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence            999999999999999999999999642               34688899999999999999999999999999999999


Q ss_pred             eeCCCCcEEEeeeccccccccCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 016082          240 LMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQA  315 (395)
Q Consensus       240 Ll~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~  315 (395)
                      +++.++.++|+|||.++.......   .....++..|+|||.+.+..++.++|||||||++||+++ |..||.+....+.
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  243 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL  243 (293)
T ss_pred             EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence            999999999999999986543221   122335678999999998899999999999999999998 9999998876655


Q ss_pred             HHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 016082          316 AVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM  365 (395)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~  365 (395)
                      ... ......+..+..++.++.+++.+||..+|.+|||+.++++.|++++
T Consensus       244 ~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         244 FKL-LKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHH-HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            444 3445566677788999999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4.1e-43  Score=328.43  Aligned_cols=252  Identities=29%  Similarity=0.554  Sum_probs=212.0

Q ss_pred             cceeeeeeeeCceEEEEEEECC----ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC------Cc
Q 016082          112 LKIECKVASGSYGDLYKGTYCS----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP------PN  181 (395)
Q Consensus       112 ~~i~~~lg~G~~G~Vy~~~~~~----~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  181 (395)
                      +.+.++||+|+||.||+|++..    ..||+|.++.........+.+..|+.+++.++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3567899999999999998743    2599999987655666678899999999999999999999987432      24


Q ss_pred             EEEEEecCCCCCHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccc
Q 016082          182 LCIVTEFMARGSIYDFLHKQ-----KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR  256 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~  256 (395)
                      .+++|||+++|+|.+++...     ...++...+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  160 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK  160 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence            78999999999999987432     2457889999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCC
Q 016082          257 VQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHA  332 (395)
Q Consensus       257 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  332 (395)
                      .......   .....+++.|+|||.+.+..++.++|+||||+++|+|++ |+.||.+....+.... .....++..+..+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~  239 (272)
T cd05075         161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDY-LRQGNRLKQPPDC  239 (272)
T ss_pred             ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HHcCCCCCCCCCC
Confidence            6543321   122245678999999999999999999999999999999 8999988776654444 3344455566778


Q ss_pred             cHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 016082          333 HPRLAELLERCWQHDPTQRPNFSQITDILKQM  364 (395)
Q Consensus       333 ~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~  364 (395)
                      +..+.++|.+||+.+|++|||+.++++.|+++
T Consensus       240 ~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         240 LDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            89999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=9e-44  Score=341.39  Aligned_cols=240  Identities=26%  Similarity=0.470  Sum_probs=204.6

Q ss_pred             eeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcEEEEEecCCC
Q 016082          116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMAR  191 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~g  191 (395)
                      +.||+|+||.||+|++  +++.||+|+++.... .....+.+..|..++... +||||+++++++.....+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999987  467899999986432 223344566677777654 799999999999999999999999999


Q ss_pred             CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-CccccCCCC
Q 016082          192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGT  270 (395)
Q Consensus       192 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-~~~~~~~gt  270 (395)
                      |+|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..... .......||
T Consensus        81 g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt  159 (316)
T cd05592          81 GDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGT  159 (316)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCC
Confidence            999999876 467999999999999999999999999999999999999999999999999999754322 233445789


Q ss_pred             cccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCC
Q 016082          271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ  350 (395)
Q Consensus       271 ~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~  350 (395)
                      +.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..  ..+..|..++.++.+++.+||+.||.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~ll~~~l~~~P~~  237 (316)
T cd05592         160 PDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN--DRPHFPRWISKEAKDCLSKLFERDPTK  237 (316)
T ss_pred             ccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence            999999999999999999999999999999999999999887666555432  456677889999999999999999999


Q ss_pred             CCCHH-HHH
Q 016082          351 RPNFS-QIT  358 (395)
Q Consensus       351 RPs~~-ell  358 (395)
                      ||++. +++
T Consensus       238 R~~~~~~l~  246 (316)
T cd05592         238 RLGVDGDIR  246 (316)
T ss_pred             cCCChHHHH
Confidence            99875 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-43  Score=328.30  Aligned_cols=252  Identities=30%  Similarity=0.591  Sum_probs=215.9

Q ss_pred             cceeeeeeeeCceEEEEEEEC-----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc-----
Q 016082          112 LKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-----  181 (395)
Q Consensus       112 ~~i~~~lg~G~~G~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  181 (395)
                      |++.+.||+|+||.||+|+..     +..||+|.++...........+.+|+.+++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            578899999999999999863     2679999998766556667789999999999999999999998866554     


Q ss_pred             -EEEEEecCCCCCHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccc
Q 016082          182 -LCIVTEFMARGSIYDFLHKQ-----KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA  255 (395)
Q Consensus       182 -~~lV~E~~~ggsL~~~l~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a  255 (395)
                       .++++||+++|+|..++...     ...+++..+..++.|++.||.|||+++++||||||+||++++++.+||+|||.+
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  160 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS  160 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence             79999999999999998543     236888999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCC
Q 016082          256 RVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKH  331 (395)
Q Consensus       256 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  331 (395)
                      +.......   .....++..|+|||.+.+..++.++||||||+++|||++ |..||.+..+.+....+ .....+..+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~  239 (273)
T cd05035         161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL-RHGNRLKQPED  239 (273)
T ss_pred             eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCcC
Confidence            86543321   112235678999999988899999999999999999999 99999888776655443 34455667788


Q ss_pred             CcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 016082          332 AHPRLAELLERCWQHDPTQRPNFSQITDILKQM  364 (395)
Q Consensus       332 ~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~  364 (395)
                      +++++.+++.+||+.||.+||++.++++.|+++
T Consensus       240 ~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         240 CLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            999999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=6.9e-44  Score=342.81  Aligned_cols=236  Identities=24%  Similarity=0.395  Sum_probs=204.6

Q ss_pred             eeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcEEEEEecCCC
Q 016082          116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMAR  191 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~g  191 (395)
                      +.||+|+||.||+|++  +++.||||++++... .......+..|..++..+ +||||+++++++...+.+|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999987  468899999975432 233456778899998877 699999999999999999999999999


Q ss_pred             CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc-CCccccCCCC
Q 016082          192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT  270 (395)
Q Consensus       192 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~-~~~~~~~~gt  270 (395)
                      |+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||+++.... ........||
T Consensus        81 g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (320)
T cd05590          81 GDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGT  159 (320)
T ss_pred             chHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccC
Confidence            999999876 46789999999999999999999999999999999999999999999999999875322 2233445789


Q ss_pred             cccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCC
Q 016082          271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ  350 (395)
Q Consensus       271 ~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~  350 (395)
                      +.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+...  ....|..+++++.+++.+||+.||.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~L~~dP~~  237 (320)
T cd05590         160 PDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND--EVVYPTWLSQDAVDILKAFMTKNPTM  237 (320)
T ss_pred             ccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHcccCHHH
Confidence            9999999999999999999999999999999999999998877766555432  34566778999999999999999999


Q ss_pred             CCCH
Q 016082          351 RPNF  354 (395)
Q Consensus       351 RPs~  354 (395)
                      ||++
T Consensus       238 R~~~  241 (320)
T cd05590         238 RLGS  241 (320)
T ss_pred             CCCC
Confidence            9998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4.4e-43  Score=331.74  Aligned_cols=259  Identities=28%  Similarity=0.566  Sum_probs=217.6

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT  177 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  177 (395)
                      |+++.++|++.++||+|+||.||+|...       +..||+|.++... .......+.+|+.++++++||||+++++++.
T Consensus         1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   79 (288)
T cd05061           1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVS   79 (288)
T ss_pred             CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            7888999999999999999999998653       3479999987553 2233456889999999999999999999999


Q ss_pred             cCCcEEEEEecCCCCCHHHHHhhcc---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEE
Q 016082          178 RPPNLCIVTEFMARGSIYDFLHKQK---------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVK  248 (395)
Q Consensus       178 ~~~~~~lV~E~~~ggsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vk  248 (395)
                      .....|+||||+++|+|.++++...         ..++...+..++.|++.||.|||+++|+||||||+||+++.++.++
T Consensus        80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence            9999999999999999999997532         2345667889999999999999999999999999999999999999


Q ss_pred             EeeeccccccccCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccC
Q 016082          249 VADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSL  324 (395)
Q Consensus       249 l~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~  324 (395)
                      |+|||+++.......   .....++..|+|||.+.+..++.++|+|||||++||+++ |..||.+....+....+.. ..
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~-~~  238 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD-GG  238 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CC
Confidence            999999875433221   122345678999999998899999999999999999998 8999998877665444333 33


Q ss_pred             CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 016082          325 RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM  365 (395)
Q Consensus       325 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~  365 (395)
                      .+..+...++.+.+++.+||+.+|++|||+.++++.+++.+
T Consensus       239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         239 YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            44556677899999999999999999999999998887653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.7e-43  Score=343.91  Aligned_cols=247  Identities=25%  Similarity=0.367  Sum_probs=205.5

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC------
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP------  180 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  180 (395)
                      .++|++.+.||+|+||.||++.+  +++.||+|+++...........+.+|+.+++.++||||+++++++....      
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            46899999999999999999987  5789999999866555556678889999999999999999999986543      


Q ss_pred             cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                      ..|+||||+++ +|.+.+.   ..++...+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus       100 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~  175 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT  175 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence            47999999976 6766664   3478899999999999999999999999999999999999999999999999986555


Q ss_pred             CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccC----------------
Q 016082          261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL----------------  324 (395)
Q Consensus       261 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~----------------  324 (395)
                      ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.............                
T Consensus       176 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (359)
T cd07876         176 NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRN  255 (359)
T ss_pred             CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence            4445566889999999999999999999999999999999999999987765433222111000                


Q ss_pred             ----CCC--------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          325 ----RPT--------------------IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       325 ----~~~--------------------~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                          ++.                    .+...++++.++|.+||+.||++|||+.|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         256 YVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence                000                    11224678999999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3e-43  Score=327.55  Aligned_cols=254  Identities=33%  Similarity=0.656  Sum_probs=218.9

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  183 (395)
                      |+|..++|++.++||+|+||.||+|.. .++.||+|.++....+   ...+.+|+.++++++||||+++++++. ....+
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~   76 (260)
T cd05067           1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY   76 (260)
T ss_pred             CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence            678889999999999999999999987 5688999999865443   357889999999999999999999875 45689


Q ss_pred             EEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC
Q 016082          184 IVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~  262 (395)
                      ++|||+.+++|.+++... ...++...+..++.+++.||+|||+.|++||||||+||++++++.++|+|||.+.......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence            999999999999998754 3468889999999999999999999999999999999999999999999999997654322


Q ss_pred             cc--ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHH
Q 016082          263 VM--TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL  339 (395)
Q Consensus       263 ~~--~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  339 (395)
                      ..  ....++..|+|||.+.+..++.++|+||||+++|++++ |+.||.+.+..+.... .....+++.+...+.++.++
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l  235 (260)
T cd05067         157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN-LERGYRMPRPDNCPEELYEL  235 (260)
T ss_pred             cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHH-HHcCCCCCCCCCCCHHHHHH
Confidence            11  22345678999999998889999999999999999999 9999998776555444 34455666777889999999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHHHH
Q 016082          340 LERCWQHDPTQRPNFSQITDILKQ  363 (395)
Q Consensus       340 i~~cl~~dp~~RPs~~ell~~l~~  363 (395)
                      +.+||+.+|++||++++++..|++
T Consensus       236 i~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         236 MRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             HHHHccCChhhCCCHHHHHHHhhc
Confidence            999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=9.1e-44  Score=356.13  Aligned_cols=246  Identities=23%  Similarity=0.381  Sum_probs=201.8

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-----
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP-----  179 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  179 (395)
                      ....+|++.++||+|+||.||+|.+  +++.||||.+....      ....+|+.+|++++||||+++++++...     
T Consensus        63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~  136 (440)
T PTZ00036         63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN  136 (440)
T ss_pred             CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence            3456899999999999999999987  57899999886432      2345799999999999999999876432     


Q ss_pred             ---CcEEEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCC-cEEEeee
Q 016082          180 ---PNLCIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADF  252 (395)
Q Consensus       180 ---~~~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~-~vkl~DF  252 (395)
                         ..+++||||+++ +|.+++..   ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus       137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence               246799999986 78777643   346789999999999999999999999999999999999999665 7999999


Q ss_pred             ccccccccCCccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc--------
Q 016082          253 GVARVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS--------  323 (395)
Q Consensus       253 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~--------  323 (395)
                      |+|+............||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+....+.+..        
T Consensus       216 Gla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~  295 (440)
T PTZ00036        216 GSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL  295 (440)
T ss_pred             ccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            99986655444455678999999999865 469999999999999999999999999877655544433211        


Q ss_pred             -------------------CCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          324 -------------------LRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       324 -------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                         ++..+|...++++.+||.+||++||.+|||+.|+++
T Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence                               111234457889999999999999999999999985

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.7e-44  Score=345.28  Aligned_cols=241  Identities=24%  Similarity=0.454  Sum_probs=208.3

Q ss_pred             eeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecCCCC
Q 016082          116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARG  192 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~gg  192 (395)
                      +.||+|+||.||++++  +++.||+|+++.... .......+.+|+.+++.++||||+++++++.....+|+||||++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4689999999999987  678999999976432 2334567788999999999999999999999999999999999999


Q ss_pred             CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeeeCCCCcEEEeeecccccccc-CCccccCCCC
Q 016082          193 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT  270 (395)
Q Consensus       193 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~-~~~~~~~~gt  270 (395)
                      +|.+++.. .+.+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus        81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (325)
T cd05594          81 ELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGT  159 (325)
T ss_pred             cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCC
Confidence            99998866 4578999999999999999999997 7999999999999999999999999999875322 2223345799


Q ss_pred             cccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCC
Q 016082          271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ  350 (395)
Q Consensus       271 ~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~  350 (395)
                      +.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+...  ...+|..+++++.+++.+||+.||.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~L~~dP~~  237 (325)
T cd05594         160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLSPEAKSLLSGLLKKDPKQ  237 (325)
T ss_pred             cccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence            9999999999999999999999999999999999999988776655544332  34567788999999999999999999


Q ss_pred             CC-----CHHHHHH
Q 016082          351 RP-----NFSQITD  359 (395)
Q Consensus       351 RP-----s~~ell~  359 (395)
                      |+     ++.++++
T Consensus       238 R~~~~~~~~~~il~  251 (325)
T cd05594         238 RLGGGPDDAKEIMQ  251 (325)
T ss_pred             hCCCCCCCHHHHhc
Confidence            96     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=9.2e-45  Score=335.55  Aligned_cols=250  Identities=27%  Similarity=0.440  Sum_probs=209.5

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC-----cEE
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP-----NLC  183 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  183 (395)
                      .|.-.+.+|+|+||.||+|..  +++.||||..-++.      +.-.+|..+|+.++|||||++..+|....     ...
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln   98 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN   98 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence            577788999999999999987  56889999986553      22346999999999999999999885332     457


Q ss_pred             EEEecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCC-CcEEEeeeccccccc
Q 016082          184 IVTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQA  259 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~-~~vkl~DFg~a~~~~  259 (395)
                      +|||||+. +|++.++..   +.+++.-.+.-+..||++||.|||+.||+||||||.|+|+|.+ |.+||||||.|+...
T Consensus        99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~  177 (364)
T KOG0658|consen   99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV  177 (364)
T ss_pred             HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence            99999987 999999753   5678888899999999999999999999999999999999976 899999999999888


Q ss_pred             cCCccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCC------------
Q 016082          260 QSGVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP------------  326 (395)
Q Consensus       260 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~------------  326 (395)
                      .+.....+..|..|+|||.+.+. .|+.+.||||.||++.||+.|++.|.|.+.......+.+-.-.|            
T Consensus       178 ~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y  257 (364)
T KOG0658|consen  178 KGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY  257 (364)
T ss_pred             cCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc
Confidence            77777888999999999998764 79999999999999999999999999988877666654311111            


Q ss_pred             ------C---------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHHHHH
Q 016082          327 ------T---------IPKHAHPRLAELLERCWQHDPTQRPNFSQITD--ILKQMMKE  367 (395)
Q Consensus       327 ------~---------~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~--~l~~~~~~  367 (395)
                            .         .....+++..+|+.++|+++|.+|.++.|++.  ....++..
T Consensus       258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence                  1         22457899999999999999999999999885  34444433

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.5e-43  Score=340.81  Aligned_cols=241  Identities=23%  Similarity=0.401  Sum_probs=208.3

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCcEEEEE
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~  186 (395)
                      +|.+.+.||+|+||.||+|++  +++.||+|+++.... .......+..|..++..+. |++|+++++++...+.+|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            578899999999999999987  457899999976532 2334456778888888774 799999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc-CCccc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMT  265 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~-~~~~~  265 (395)
                      ||+++|+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .....
T Consensus        81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~  159 (323)
T cd05616          81 EYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK  159 (323)
T ss_pred             cCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccc
Confidence            99999999999876 46789999999999999999999999999999999999999999999999999975432 22233


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhc
Q 016082          266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ  345 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  345 (395)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+...  ....|...++++.+++.+||+
T Consensus       160 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~l~  237 (323)
T cd05616         160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--NVAYPKSMSKEAVAICKGLMT  237 (323)
T ss_pred             cCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCcCCHHHHHHHHHHcc
Confidence            457899999999999999999999999999999999999999998877766655543  345677889999999999999


Q ss_pred             cCCCCCCCH
Q 016082          346 HDPTQRPNF  354 (395)
Q Consensus       346 ~dp~~RPs~  354 (395)
                      .+|.+|++.
T Consensus       238 ~~p~~R~~~  246 (323)
T cd05616         238 KHPGKRLGC  246 (323)
T ss_pred             cCHHhcCCC
Confidence            999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=5.7e-43  Score=333.53  Aligned_cols=262  Identities=30%  Similarity=0.621  Sum_probs=223.6

Q ss_pred             ceeecccCcceeeeeeeeCceEEEEEEEC---------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEE
Q 016082          104 VWEIDAKQLKIECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFI  173 (395)
Q Consensus       104 ~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~  173 (395)
                      .|++...+|.+.+.||+|+||.||+|++.         +..||+|.++... .....+.+.+|+.+++.+ +||||++++
T Consensus         9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~   87 (304)
T cd05101           9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLL   87 (304)
T ss_pred             cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchhee
Confidence            46788889999999999999999999752         2469999987543 344557899999999999 799999999


Q ss_pred             EEEecCCcEEEEEecCCCCCHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 016082          174 GACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN  238 (395)
Q Consensus       174 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~N  238 (395)
                      +++......++||||+++|+|.+++....               ..++...+..++.||++||.|||++||+||||||+|
T Consensus        88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N  167 (304)
T cd05101          88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN  167 (304)
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence            99999999999999999999999997642               246778899999999999999999999999999999


Q ss_pred             eeeCCCCcEEEeeeccccccccCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 016082          239 LLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQ  314 (395)
Q Consensus       239 iLl~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~  314 (395)
                      |+++.++.++|+|||.++.......   .....+++.|+|||++.+..++.++||||||+++|++++ |..||.+.+..+
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~  247 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  247 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence            9999999999999999986543221   222345678999999998889999999999999999998 889998887766


Q ss_pred             HHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 016082          315 AAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE  367 (395)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~  367 (395)
                      .... .....+...+..++.++.+++.+||+.+|.+||++.++++.|++++.-
T Consensus       248 ~~~~-~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         248 LFKL-LKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             HHHH-HHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence            5544 344455566778899999999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=8e-44  Score=342.38  Aligned_cols=241  Identities=22%  Similarity=0.360  Sum_probs=207.1

Q ss_pred             eeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcEEEEEecCCC
Q 016082          116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMAR  191 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~g  191 (395)
                      +.||+|+||.||+|++  +++.||+|+++.... ..+....+..|..++..+ +||||+++++++.....+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            4689999999999988  467899999976432 233456678899999876 799999999999999999999999999


Q ss_pred             CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc-CCccccCCCC
Q 016082          192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT  270 (395)
Q Consensus       192 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~-~~~~~~~~gt  270 (395)
                      |+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||+++.... ........||
T Consensus        81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (321)
T cd05591          81 GDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGT  159 (321)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccC
Confidence            999999876 46789999999999999999999999999999999999999999999999999875332 2223445789


Q ss_pred             cccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCC
Q 016082          271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ  350 (395)
Q Consensus       271 ~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~  350 (395)
                      +.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+...  ....|..+++++.+++.+||+.||.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~ll~~~L~~dp~~  237 (321)
T cd05591         160 PDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD--DVLYPVWLSKEAVSILKAFMTKNPNK  237 (321)
T ss_pred             ccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhccCHHH
Confidence            9999999999999999999999999999999999999998887766655543  23456678999999999999999999


Q ss_pred             CC-------CHHHHHH
Q 016082          351 RP-------NFSQITD  359 (395)
Q Consensus       351 RP-------s~~ell~  359 (395)
                      ||       ++.++++
T Consensus       238 R~~~~~~~~~~~~~~~  253 (321)
T cd05591         238 RLGCVASQGGEDAIKQ  253 (321)
T ss_pred             cCCCCCCCCCHHHHhc
Confidence            99       6777765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=5.3e-43  Score=324.30  Aligned_cols=248  Identities=26%  Similarity=0.466  Sum_probs=218.6

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  188 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  188 (395)
                      +|.+.+.||+|++|.||+|+.  +++.|++|.+............+.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            478889999999999999987  578899999976655566678899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-cccc
Q 016082          189 MARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA  266 (395)
Q Consensus       189 ~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~~  266 (395)
                      ++|++|.++++.. ...++...++.++.+++.||.|||+.|++|+||||+||+++.++.++|+|||.++...... ....
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~  160 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT  160 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhc
Confidence            9999999999775 4678999999999999999999999999999999999999999999999999987654432 2234


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhcc
Q 016082          267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH  346 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  346 (395)
                      ..|++.|+|||++.+..++.++|+||||+++|+|++|+.||...+.......+. ....+.++..+++++.+++++||+.
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~  239 (256)
T cd08529         161 IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKII-RGVFPPVSQMYSQQLAQLIDQCLTK  239 (256)
T ss_pred             cccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-cCCCCCCccccCHHHHHHHHHHccC
Confidence            468899999999999999999999999999999999999998887655544433 3445666778899999999999999


Q ss_pred             CCCCCCCHHHHHH
Q 016082          347 DPTQRPNFSQITD  359 (395)
Q Consensus       347 dp~~RPs~~ell~  359 (395)
                      +|++||++.+++.
T Consensus       240 ~p~~Rp~~~~ll~  252 (256)
T cd08529         240 DYRQRPDTFQLLR  252 (256)
T ss_pred             CcccCcCHHHHhh
Confidence            9999999999876

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=9.5e-44  Score=349.98  Aligned_cols=247  Identities=23%  Similarity=0.395  Sum_probs=208.9

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      .|.+.++||+|+||.||+|+.  +++.||+|++..... .......+.+|+.++++++||||+++++.+.+...+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            688999999999999999987  568899999975422 23456778999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC------
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS------  261 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~------  261 (395)
                      |++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....      
T Consensus        82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~  160 (382)
T cd05625          82 YIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (382)
T ss_pred             CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence            9999999999976 467899999999999999999999999999999999999999999999999997522100      


Q ss_pred             ------------------------------------------CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHH
Q 016082          262 ------------------------------------------GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWE  299 (395)
Q Consensus       262 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~e  299 (395)
                                                                .......||+.|+|||++.+..++.++|||||||++||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e  240 (382)
T cd05625         161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  240 (382)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence                                                      00112368999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHhhhccCCCCCC--CCCcHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 016082          300 LLTGELPYAGLTPLQAAVGVVQKSLRPTIP--KHAHPRLAELLERCWQHDPTQRPN---FSQITD  359 (395)
Q Consensus       300 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~RPs---~~ell~  359 (395)
                      |++|+.||.+.++.+....+.........|  ...++++.++|.+|+ .+|.+|++   +.+++.
T Consensus       241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         241 MLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence            999999999988877666555433333333  457899999999976 59999987   777764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4.7e-44  Score=351.36  Aligned_cols=248  Identities=22%  Similarity=0.348  Sum_probs=208.7

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      ++|++.++||+|+||.||+++.  +++.||||++..... .......+.+|+.++++++||||+++++.+.+++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            4799999999999999999987  578999999964322 2234567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-----
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-----  261 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-----  261 (395)
                      ||++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+|......     
T Consensus        81 E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~  159 (376)
T cd05598          81 DYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  159 (376)
T ss_pred             eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence            99999999999976 467899999999999999999999999999999999999999999999999997422100     


Q ss_pred             ---------------------------------------CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh
Q 016082          262 ---------------------------------------GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT  302 (395)
Q Consensus       262 ---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt  302 (395)
                                                             .......||+.|+|||++.+..++.++|||||||++|+|++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~  239 (376)
T cd05598         160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV  239 (376)
T ss_pred             cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhh
Confidence                                                   00112368999999999999999999999999999999999


Q ss_pred             CCCCCCCCCHHHHHHHhhhccCCCCC--CCCCcHHHHHHHHHhhccCCCCCC---CHHHHHH
Q 016082          303 GELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELLERCWQHDPTQRP---NFSQITD  359 (395)
Q Consensus       303 g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dp~~RP---s~~ell~  359 (395)
                      |+.||.+.++.+....+.........  ...+++++.++|.+|+ .+|.+|+   ++.++++
T Consensus       240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~  300 (376)
T cd05598         240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA  300 (376)
T ss_pred             CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence            99999988876655544432222222  2367899999999976 5999999   8898886

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=6e-43  Score=331.01  Aligned_cols=254  Identities=29%  Similarity=0.614  Sum_probs=217.8

Q ss_pred             CcceeeeeeeeCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Q 016082          111 QLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  183 (395)
                      +|++.+.||+|+||.||+|+...       ..+|+|.++.... ......+.+|+.+++.++||||+++++.+......+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence            47888999999999999998632       4689999876542 334567999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhcc-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 016082          184 IVTEFMARGSIYDFLHKQK-----------------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL  240 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiL  240 (395)
                      +++||+.+++|.+++....                       ..++...++.++.|++.|+.|||+.+|+||||||+||+
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil  159 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL  159 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence            9999999999999986421                       34778899999999999999999999999999999999


Q ss_pred             eCCCCcEEEeeeccccccccCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 016082          241 MDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAA  316 (395)
Q Consensus       241 l~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~  316 (395)
                      +++++.++|+|||.++.......   .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+..+.+..
T Consensus       160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~  239 (290)
T cd05045         160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF  239 (290)
T ss_pred             EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence            99999999999999975433221   122345678999999988889999999999999999998 99999988776644


Q ss_pred             HHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 016082          317 VGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK  366 (395)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~  366 (395)
                      . ......++..+..++.++.+++.+||+.+|.+||++.++++.|++++.
T Consensus       240 ~-~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         240 N-LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             H-HHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            4 444556667778899999999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.6e-43  Score=325.01  Aligned_cols=255  Identities=37%  Similarity=0.711  Sum_probs=221.0

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  183 (395)
                      |+++.++|.+.++||+|+||.||+|... +..||||.++.....   ..++.+|+.++++++|+||+++++++......+
T Consensus         1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05034           1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY   77 (261)
T ss_pred             CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence            6788899999999999999999999874 477999999865433   367889999999999999999999999988999


Q ss_pred             EEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC
Q 016082          184 IVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~  262 (395)
                      +||||+++++|.+++.... ..++...+..++.+++.|+.|||++|++|+||||+||++++++.++|+|||.++......
T Consensus        78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            9999999999999997654 468999999999999999999999999999999999999999999999999987654321


Q ss_pred             c--cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHH
Q 016082          263 V--MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL  339 (395)
Q Consensus       263 ~--~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  339 (395)
                      .  .....++..|+|||.+.+..++.++|+||||+++|++++ |+.||.+.+........ ....+...+...+.++.++
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  236 (261)
T cd05034         158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV-ERGYRMPRPPNCPEELYDL  236 (261)
T ss_pred             hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHH
Confidence            1  112234578999999999899999999999999999998 99999988776655543 3445566677789999999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHHHH
Q 016082          340 LERCWQHDPTQRPNFSQITDILKQ  363 (395)
Q Consensus       340 i~~cl~~dp~~RPs~~ell~~l~~  363 (395)
                      +.+||+.+|++||++.++.+.|++
T Consensus       237 i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         237 MLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             HHHHcccCcccCCCHHHHHHHHhc
Confidence            999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=5.4e-43  Score=331.62  Aligned_cols=258  Identities=29%  Similarity=0.570  Sum_probs=220.0

Q ss_pred             cccCcceeeeeeeeCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 016082          108 DAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  180 (395)
Q Consensus       108 ~~~~~~i~~~lg~G~~G~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (395)
                      ...+|.+.+.||+|+||.||+|.+.       ...+|+|.++...  ....+.+.+|+.++++++||||+++++++....
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (291)
T cd05094           3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGD   80 (291)
T ss_pred             chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence            4567899999999999999999752       3458999987543  344567899999999999999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCC
Q 016082          181 NLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG  245 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~  245 (395)
                      ..++||||+++++|.+++....               +.+++..++.++.||+.|+.|||++||+||||||+||+++.++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL  160 (291)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence            9999999999999999997532               3478899999999999999999999999999999999999999


Q ss_pred             cEEEeeeccccccccCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhh
Q 016082          246 VVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQ  321 (395)
Q Consensus       246 ~vkl~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~  321 (395)
                      .++|+|||+++......   ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+.... ..
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~-~~  239 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC-IT  239 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-Hh
Confidence            99999999997544322   1223456788999999999999999999999999999999 9999988777654443 34


Q ss_pred             ccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHH
Q 016082          322 KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  368 (395)
Q Consensus       322 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~  368 (395)
                      ....+..+..++..+.+++.+||+.+|.+||++.++++.|.++.+..
T Consensus       240 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~  286 (291)
T cd05094         240 QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKAT  286 (291)
T ss_pred             CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhc
Confidence            44455566778899999999999999999999999999999997653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4.9e-43  Score=327.74  Aligned_cols=255  Identities=33%  Similarity=0.619  Sum_probs=218.4

Q ss_pred             cccCcceeeeeeeeCceEEEEEEEC--C---ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Q 016082          108 DAKQLKIECKVASGSYGDLYKGTYC--S---QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  182 (395)
Q Consensus       108 ~~~~~~i~~~lg~G~~G~Vy~~~~~--~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  182 (395)
                      +.+.|++.+.||+|+||.||+|+..  +   ..||||+++... ......+|..|+.++++++||||+++++++......
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   80 (269)
T cd05065           2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV   80 (269)
T ss_pred             ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence            3457899999999999999999873  2   359999987653 455667899999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC
Q 016082          183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~  262 (395)
                      ++||||+++++|.+++....+.++...++.++.|++.|+.|||++|++||||||+||+++.++.++|+|||.++......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            99999999999999998766778999999999999999999999999999999999999999999999999987544322


Q ss_pred             cc---ccC---CCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHH
Q 016082          263 VM---TAE---TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR  335 (395)
Q Consensus       263 ~~---~~~---~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (395)
                      ..   ...   ..+..|+|||.+.+..++.++||||||+++||+++ |..||...........+ ....+.+.+..++..
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i-~~~~~~~~~~~~~~~  239 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI-EQDYRLPPPMDCPTA  239 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH-HcCCcCCCcccCCHH
Confidence            11   111   12457999999999999999999999999999887 99999887776555544 344455566778999


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 016082          336 LAELLERCWQHDPTQRPNFSQITDILKQM  364 (395)
Q Consensus       336 l~~li~~cl~~dp~~RPs~~ell~~l~~~  364 (395)
                      +.+++.+||+.+|.+||++.+++..|+++
T Consensus       240 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         240 LHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            99999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.4e-43  Score=347.39  Aligned_cols=253  Identities=22%  Similarity=0.335  Sum_probs=211.7

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  181 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  181 (395)
                      ..+..++|++.+.||+|+||.||++++  +++.+|+|+++... ........+.+|+.+++.++||||+++++++..+..
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  117 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            355567999999999999999999988  56889999986432 223344568899999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC
Q 016082          182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  261 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~  261 (395)
                      +|+||||++||+|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       118 ~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~  195 (371)
T cd05622         118 LYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE  195 (371)
T ss_pred             EEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence            9999999999999999865  35889999999999999999999999999999999999999999999999999865433


Q ss_pred             Cc--cccCCCCcccccccccCCCC----CCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCC--CCCc
Q 016082          262 GV--MTAETGTYRWMAPEVIEHKP----YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP--KHAH  333 (395)
Q Consensus       262 ~~--~~~~~gt~~y~aPE~~~~~~----~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~  333 (395)
                      ..  .....||+.|+|||++.+..    ++.++|||||||++|||++|+.||.+.+.......+.........|  ..++
T Consensus       196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  275 (371)
T cd05622         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS  275 (371)
T ss_pred             CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCC
Confidence            22  23457999999999987543    7899999999999999999999999988776666655433222333  4689


Q ss_pred             HHHHHHHHHhhccCCCC--CCCHHHHHH
Q 016082          334 PRLAELLERCWQHDPTQ--RPNFSQITD  359 (395)
Q Consensus       334 ~~l~~li~~cl~~dp~~--RPs~~ell~  359 (395)
                      +++.++|.+|+..++.+  ||++.++++
T Consensus       276 ~~~~~li~~~L~~~~~r~~r~~~~ei~~  303 (371)
T cd05622         276 KEAKNLICAFLTDREVRLGRNGVEEIKR  303 (371)
T ss_pred             HHHHHHHHHHcCChhhhcCCCCHHHHhc
Confidence            99999999999844433  778888876

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.5e-43  Score=341.71  Aligned_cols=242  Identities=23%  Similarity=0.414  Sum_probs=202.7

Q ss_pred             eeeeeeCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcEEEEEecCCC
Q 016082          116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMAR  191 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~g  191 (395)
                      +.||+|+||.||++++  +++.||+|+++..... ......+..|..++.++ +||||+++++++.....+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4689999999999987  5788999999865432 33456788999999998 699999999999999999999999999


Q ss_pred             CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccc-cCCccccCCCC
Q 016082          192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGT  270 (395)
Q Consensus       192 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~-~~~~~~~~~gt  270 (395)
                      |+|.+++.. .+++++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++... .........||
T Consensus        81 g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (329)
T cd05588          81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGT  159 (329)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCC
Confidence            999998876 4679999999999999999999999999999999999999999999999999987422 22233445789


Q ss_pred             cccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHhhhccCCCCCCCCCcHHHHHHHHH
Q 016082          271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP--------LQAAVGVVQKSLRPTIPKHAHPRLAELLER  342 (395)
Q Consensus       271 ~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  342 (395)
                      +.|+|||++.+..++.++|+|||||++|+|++|+.||.....        ......... .....+|..++.++.++|.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~li~~  238 (329)
T cd05588         160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVIL-EKQIRIPRSLSVKASSVLKG  238 (329)
T ss_pred             ccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHH-cCCCCCCCCCCHHHHHHHHH
Confidence            999999999999999999999999999999999999963211        111111121 22345677889999999999


Q ss_pred             hhccCCCCCCC------HHHHHH
Q 016082          343 CWQHDPTQRPN------FSQITD  359 (395)
Q Consensus       343 cl~~dp~~RPs------~~ell~  359 (395)
                      ||+.||.+||+      +.++++
T Consensus       239 ~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         239 FLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             HhccCHHHcCCCCCCCCHHHHhc
Confidence            99999999997      566654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.5e-43  Score=341.83  Aligned_cols=246  Identities=23%  Similarity=0.406  Sum_probs=206.1

Q ss_pred             CcceeeeeeeeCceEEEEEEE-----CCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCcE
Q 016082          111 QLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNL  182 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~-----~~~~vAvK~~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  182 (395)
                      +|++.++||+|+||.||+++.     +++.||+|+++....  .....+.+..|+.++++++ ||||+++++++.....+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            488999999999999999875     468899999975322  2234567889999999995 89999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC
Q 016082          183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~  262 (395)
                      ++||||+++|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        81 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~  159 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE  159 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence            999999999999999976 4578999999999999999999999999999999999999999999999999997543221


Q ss_pred             --ccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHhhhccCCCCCCCCCcHH
Q 016082          263 --VMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTP----LQAAVGVVQKSLRPTIPKHAHPR  335 (395)
Q Consensus       263 --~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwslG~vl~elltg~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~  335 (395)
                        ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.....    ......+  ....+.++..+++.
T Consensus       160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  237 (332)
T cd05614         160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI--LKCDPPFPSFIGPE  237 (332)
T ss_pred             CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH--hcCCCCCCCCCCHH
Confidence              22345789999999999865 478999999999999999999999964322    2222222  23456677789999


Q ss_pred             HHHHHHHhhccCCCCCC-----CHHHHHH
Q 016082          336 LAELLERCWQHDPTQRP-----NFSQITD  359 (395)
Q Consensus       336 l~~li~~cl~~dp~~RP-----s~~ell~  359 (395)
                      +.+++.+||+.||++||     +++++++
T Consensus       238 ~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         238 AQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             HHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            99999999999999999     6777775

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.8e-43  Score=339.49  Aligned_cols=241  Identities=23%  Similarity=0.428  Sum_probs=207.2

Q ss_pred             eeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcEEEEEecCCC
Q 016082          116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMAR  191 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~g  191 (395)
                      +.||+|+||.||+|++  +++.||||+++.... .......+..|+.+++.+ +||||+++++++...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999988  467899999975432 233456678899999888 699999999999999999999999999


Q ss_pred             CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-CccccCCCC
Q 016082          192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGT  270 (395)
Q Consensus       192 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-~~~~~~~gt  270 (395)
                      |+|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++..... .......|+
T Consensus        81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~  159 (318)
T cd05570          81 GDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGT  159 (318)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecC
Confidence            999998876 457999999999999999999999999999999999999999999999999998753222 222334689


Q ss_pred             cccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCC
Q 016082          271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ  350 (395)
Q Consensus       271 ~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~  350 (395)
                      +.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..+....+...  .+..|..++.++.++|++||+.||.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~dP~~  237 (318)
T cd05570         160 PDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED--EVRYPRWLSKEAKSILKSFLTKNPEK  237 (318)
T ss_pred             ccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC--CCCCCCcCCHHHHHHHHHHccCCHHH
Confidence            9999999999999999999999999999999999999988776655554433  34567788999999999999999999


Q ss_pred             CCCH-----HHHHH
Q 016082          351 RPNF-----SQITD  359 (395)
Q Consensus       351 RPs~-----~ell~  359 (395)
                      ||++     .++++
T Consensus       238 R~s~~~~~~~~ll~  251 (318)
T cd05570         238 RLGCLPTGEQDIKG  251 (318)
T ss_pred             cCCCCCCCHHHHhc
Confidence            9999     77765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=6.6e-43  Score=340.45  Aligned_cols=258  Identities=26%  Similarity=0.428  Sum_probs=211.2

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  183 (395)
                      ....++|++.++||+|+||.||+|++  +++.||||++.... .......+.+|+.++++++|+||+++++++...+.++
T Consensus        70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  148 (353)
T PLN00034         70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ  148 (353)
T ss_pred             CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence            33456889999999999999999987  47899999996543 3445678999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-
Q 016082          184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-  262 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-  262 (395)
                      +||||+++|+|.+.     ...++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... 
T Consensus       149 lv~e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        149 VLLEFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             EEEecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence            99999999998653     234677888999999999999999999999999999999999999999999998654332 


Q ss_pred             ccccCCCCcccccccccCC-----CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHhhhccCCCCCCCCCcHH
Q 016082          263 VMTAETGTYRWMAPEVIEH-----KPYDYKADVFSFGIALWELLTGELPYAGLTPL--QAAVGVVQKSLRPTIPKHAHPR  335 (395)
Q Consensus       263 ~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwslG~vl~elltg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  335 (395)
                      ......||..|+|||.+..     ...+.++|||||||++|||++|+.||......  ............+..+..++.+
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASRE  303 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHH
Confidence            2234578999999998753     23456899999999999999999999743221  1111222233455667788999


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcccccc
Q 016082          336 LAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLIN  378 (395)
Q Consensus       336 l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~~~~~~~~~~  378 (395)
                      +.++|.+||+.||++||++.|+++         +-|+......
T Consensus       304 l~~li~~~l~~~P~~Rpt~~ell~---------hp~~~~~~~~  337 (353)
T PLN00034        304 FRHFISCCLQREPAKRWSAMQLLQ---------HPFILRAQPG  337 (353)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhc---------CcccccCCcc
Confidence            999999999999999999999998         6666665433

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=8.5e-43  Score=324.64  Aligned_cols=254  Identities=37%  Similarity=0.705  Sum_probs=216.2

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEECC-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  183 (395)
                      |++..++|.+.++||+|++|.||+|.+.+ ..+|+|.+.....   ..+.+.+|+.++++++|||++++++++.. ...+
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   76 (260)
T cd05069           1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIY   76 (260)
T ss_pred             CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcE
Confidence            56777889999999999999999998744 5799999875532   23568899999999999999999998754 5689


Q ss_pred             EEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC
Q 016082          184 IVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~  262 (395)
                      +||||+.+++|.++++... ..+++..+..++.+++.||.|||+.|++||||||+||++++++.++|+|||.++......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05069          77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence            9999999999999997643 457889999999999999999999999999999999999999999999999997654332


Q ss_pred             c--cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHH
Q 016082          263 V--MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL  339 (395)
Q Consensus       263 ~--~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  339 (395)
                      .  .....++..|+|||...+..++.++|+||||+++|+|++ |..||.+....+..... .....+..+...+..+.++
T Consensus       157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l  235 (260)
T cd05069         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV-ERGYRMPCPQGCPESLHEL  235 (260)
T ss_pred             ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCcccCHHHHHH
Confidence            1  122345678999999998889999999999999999999 99999988776654443 3445556677889999999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHHHH
Q 016082          340 LERCWQHDPTQRPNFSQITDILKQ  363 (395)
Q Consensus       340 i~~cl~~dp~~RPs~~ell~~l~~  363 (395)
                      +.+||+.+|.+||++.++++.|++
T Consensus       236 i~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         236 MKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             HHHHccCCcccCcCHHHHHHHHhc
Confidence            999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.2e-42  Score=325.22  Aligned_cols=259  Identities=30%  Similarity=0.624  Sum_probs=221.4

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEECC-----ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  180 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (395)
                      ++..++|.+.+.||.|+||.||+|.+..     ..||||...... .....+.+.+|+.++++++||||+++++++... 
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-   79 (270)
T cd05056           2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-   79 (270)
T ss_pred             eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-
Confidence            4566789999999999999999998732     368999987553 244567899999999999999999999988764 


Q ss_pred             cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                      ..++||||+++|+|.+++......++...+..++.+++.|++|||+.|++||||||+||+++.++.++|+|||+++....
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence            57899999999999999987666789999999999999999999999999999999999999999999999999976543


Q ss_pred             CCcc--ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHH
Q 016082          261 SGVM--TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA  337 (395)
Q Consensus       261 ~~~~--~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  337 (395)
                      ....  +...++..|+|||.+....++.++||||||+++|++++ |..||...+..+.... .....++..+..+++++.
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  238 (270)
T cd05056         160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR-IENGERLPMPPNCPPTLY  238 (270)
T ss_pred             ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-HHcCCcCCCCCCCCHHHH
Confidence            3221  22234568999999988889999999999999999986 9999988877655443 344556677788999999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 016082          338 ELLERCWQHDPTQRPNFSQITDILKQMMKE  367 (395)
Q Consensus       338 ~li~~cl~~dp~~RPs~~ell~~l~~~~~~  367 (395)
                      ++|.+||..+|.+|||+.++++.|..++.+
T Consensus       239 ~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         239 SLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             HHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.2e-42  Score=324.81  Aligned_cols=256  Identities=30%  Similarity=0.603  Sum_probs=219.1

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEEC--C---ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTYC--S---QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  181 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~~--~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  181 (395)
                      |..++|+..+.||+|+||.||+|+..  +   ..+|+|.++... .....+.+.+|+.++++++|||++++++++.....
T Consensus         2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (268)
T cd05063           2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP   80 (268)
T ss_pred             CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence            45668899999999999999999863  3   369999987543 34445779999999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC
Q 016082          182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  261 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~  261 (395)
                      .++||||+++++|.+++....+.+++..+..++.+++.|++|||+.|++||||||+||+++.++.++++|||++......
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            99999999999999999876678999999999999999999999999999999999999999999999999998755432


Q ss_pred             Ccc----ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHH
Q 016082          262 GVM----TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  336 (395)
Q Consensus       262 ~~~----~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  336 (395)
                      ...    .....+..|+|||.+.+..++.++||||||+++||+++ |+.||...+..+....+. ...+.+.+..++.++
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~  239 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN-DGFRLPAPMDCPSAV  239 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh-cCCCCCCCCCCCHHH
Confidence            211    11223567999999998889999999999999999998 999998877766554443 344555566789999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 016082          337 AELLERCWQHDPTQRPNFSQITDILKQM  364 (395)
Q Consensus       337 ~~li~~cl~~dp~~RPs~~ell~~l~~~  364 (395)
                      .+++.+||+.+|.+||++.++++.|+++
T Consensus       240 ~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         240 YQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             HHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            9999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-44  Score=329.50  Aligned_cols=253  Identities=26%  Similarity=0.417  Sum_probs=214.6

Q ss_pred             ceeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec---
Q 016082          104 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR---  178 (395)
Q Consensus       104 ~~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---  178 (395)
                      .|++.. .|...+.||.|+||.|+.+.+  +++.||||.+.....+.-..++..+|+.+|+.++|+||+.+.+++..   
T Consensus        17 ~~~i~~-~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~   95 (359)
T KOG0660|consen   17 LFEIPR-YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR   95 (359)
T ss_pred             EEeccc-eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence            344433 566689999999999999987  67899999998666667778899999999999999999999999866   


Q ss_pred             --CCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccc
Q 016082          179 --PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR  256 (395)
Q Consensus       179 --~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~  256 (395)
                        -+.+|+|+|+|+ .+|...++. +..++..-+..+..|+++||.|+|+.||+||||||.|++++.+..+||+|||+||
T Consensus        96 ~~f~DvYiV~elMe-tDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR  173 (359)
T KOG0660|consen   96 DKFNDVYLVFELME-TDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLAR  173 (359)
T ss_pred             cccceeEEehhHHh-hHHHHHHHc-CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEecccccee
Confidence              235899999995 499999976 4559999999999999999999999999999999999999999999999999999


Q ss_pred             cccc---CCccccCCCCcccccccccC-CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhh-----------
Q 016082          257 VQAQ---SGVMTAETGTYRWMAPEVIE-HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ-----------  321 (395)
Q Consensus       257 ~~~~---~~~~~~~~gt~~y~aPE~~~-~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~-----------  321 (395)
                      ....   ...+|.+..|.+|.|||++. ...|+.+.||||.||++.||++|++.|.|.+.......+..           
T Consensus       174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~  253 (359)
T KOG0660|consen  174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ  253 (359)
T ss_pred             eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence            8763   56678889999999999875 56899999999999999999999999998765443332221           


Q ss_pred             -------------ccCCCCCC-----CCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          322 -------------KSLRPTIP-----KHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       322 -------------~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                   ....|..|     +++++...+++++||..||.+|+|++|.++
T Consensus       254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence                         11122222     468899999999999999999999999887

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2e-43  Score=338.99  Aligned_cols=240  Identities=25%  Similarity=0.445  Sum_probs=204.4

Q ss_pred             eeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcEEEEEecCCC
Q 016082          116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMAR  191 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~g  191 (395)
                      +.||+|+||.||+|++  +++.||+|+++.... .......+..|..++... +||||+++++++...+.+|+||||+.|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            4699999999999988  568899999975432 122345667788888754 899999999999999999999999999


Q ss_pred             CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc-CCccccCCCC
Q 016082          192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT  270 (395)
Q Consensus       192 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~-~~~~~~~~gt  270 (395)
                      |+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||+++.... ........||
T Consensus        81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (316)
T cd05620          81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT  159 (316)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCC
Confidence            999999876 46789999999999999999999999999999999999999999999999999874321 2233456789


Q ss_pred             cccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCC
Q 016082          271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ  350 (395)
Q Consensus       271 ~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~  350 (395)
                      +.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.  ...+..|..+++++.++|.+||+.||.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~  237 (316)
T cd05620         160 PDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR--VDTPHYPRWITKESKDILEKLFERDPTR  237 (316)
T ss_pred             cCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence            99999999999999999999999999999999999999887766554433  2345667788999999999999999999


Q ss_pred             CCCHH-HHH
Q 016082          351 RPNFS-QIT  358 (395)
Q Consensus       351 RPs~~-ell  358 (395)
                      ||++. +++
T Consensus       238 R~~~~~~~~  246 (316)
T cd05620         238 RLGVVGNIR  246 (316)
T ss_pred             cCCChHHHH
Confidence            99974 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.6e-43  Score=338.27  Aligned_cols=240  Identities=25%  Similarity=0.429  Sum_probs=203.8

Q ss_pred             eeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcEEEEEecCCC
Q 016082          116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMAR  191 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~g  191 (395)
                      +.||+|+||.||+|++  +++.||||+++.... .......+..|..++... +||||+++++++.+.+.+++||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999987  467899999976432 122345567788888764 899999999999999999999999999


Q ss_pred             CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc-CCccccCCCC
Q 016082          192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT  270 (395)
Q Consensus       192 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~-~~~~~~~~gt  270 (395)
                      |+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++.... ........||
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (316)
T cd05619          81 GDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGT  159 (316)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCC
Confidence            999999976 45789999999999999999999999999999999999999999999999999874322 1223345789


Q ss_pred             cccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCC
Q 016082          271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ  350 (395)
Q Consensus       271 ~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~  350 (395)
                      +.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..  ..+..|..++.++.+++.+||+.||.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~~P~~  237 (316)
T cd05619         160 PDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM--DNPCYPRWLTREAKDILVKLFVREPER  237 (316)
T ss_pred             ccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCccCCHHHHHHHHHHhccCHhh
Confidence            999999999999999999999999999999999999998887665554332  235566778999999999999999999


Q ss_pred             CCCHH-HHH
Q 016082          351 RPNFS-QIT  358 (395)
Q Consensus       351 RPs~~-ell  358 (395)
                      ||++. +++
T Consensus       238 R~~~~~~l~  246 (316)
T cd05619         238 RLGVKGDIR  246 (316)
T ss_pred             cCCChHHHH
Confidence            99997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.2e-43  Score=345.86  Aligned_cols=251  Identities=22%  Similarity=0.346  Sum_probs=212.2

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  183 (395)
                      +..++|++.+.||+|+||.||++++  +++.+|+|+++... ........+.+|+.+++.++||||+++++++.++..+|
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            4456899999999999999999988  46889999986432 12333456889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCc
Q 016082          184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV  263 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~  263 (395)
                      +||||++||+|.+++..  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus       120 lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~  197 (370)
T cd05621         120 MVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM  197 (370)
T ss_pred             EEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence            99999999999999965  3588999999999999999999999999999999999999999999999999986543322


Q ss_pred             --cccCCCCcccccccccCCCC----CCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCC--CCcHH
Q 016082          264 --MTAETGTYRWMAPEVIEHKP----YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK--HAHPR  335 (395)
Q Consensus       264 --~~~~~gt~~y~aPE~~~~~~----~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  335 (395)
                        .....||+.|+|||++.+..    ++.++|+||+||++|+|++|+.||.+.+.......+.........|.  .+++.
T Consensus       198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~  277 (370)
T cd05621         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKH  277 (370)
T ss_pred             eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHH
Confidence              23457999999999987643    78999999999999999999999998887776666665443444444  46899


Q ss_pred             HHHHHHHhhccCCCC--CCCHHHHHH
Q 016082          336 LAELLERCWQHDPTQ--RPNFSQITD  359 (395)
Q Consensus       336 l~~li~~cl~~dp~~--RPs~~ell~  359 (395)
                      +.+++.+|++.++.+  ||++.++++
T Consensus       278 ~~~li~~~L~~~~~r~~R~~~~e~l~  303 (370)
T cd05621         278 AKNLICAFLTDREVRLGRNGVEEIKQ  303 (370)
T ss_pred             HHHHHHHHccCchhccCCCCHHHHhc
Confidence            999999999855543  889999887

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.7e-43  Score=327.20  Aligned_cols=250  Identities=26%  Similarity=0.417  Sum_probs=215.3

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc-eeeEEEEEecCC-----
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN-VVQFIGACTRPP-----  180 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~-----  180 (395)
                      ...|...++||+|+||+||+|+.  +|+.||+|.++.+...+.......+|+.+|+.++|+| |+.+++++.+..     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            45688888999999999999987  6889999999876544445667789999999999999 999999998877     


Q ss_pred             -cEEEEEecCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccc
Q 016082          181 -NLCIVTEFMARGSIYDFLHKQK---GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR  256 (395)
Q Consensus       181 -~~~lV~E~~~ggsL~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~  256 (395)
                       .+++|+||++. +|.+++....   ..++...+..++.||++||+|||+++|+||||||.|||++++|.+||+|||+|+
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr  168 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR  168 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence             79999999977 9999998765   357888999999999999999999999999999999999999999999999999


Q ss_pred             cccc-CCccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCC-------
Q 016082          257 VQAQ-SGVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT-------  327 (395)
Q Consensus       257 ~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~-------  327 (395)
                      ...- ....+.+.+|..|+|||++.+. .|+...|+||+||++.||+++++.|.+.+..+....+.+..-.|.       
T Consensus       169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v  248 (323)
T KOG0594|consen  169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV  248 (323)
T ss_pred             HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence            7663 3447888999999999999877 799999999999999999999999999988777666554211110       


Q ss_pred             ---------C-----C-------CCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          328 ---------I-----P-------KHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       328 ---------~-----~-------~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                               .     +       +..+++..+++.+|++.+|.+|.|+...+.
T Consensus       249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~  301 (323)
T KOG0594|consen  249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALT  301 (323)
T ss_pred             cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhc
Confidence                     0     1       122358899999999999999999999887

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.3e-42  Score=326.73  Aligned_cols=259  Identities=27%  Similarity=0.546  Sum_probs=221.6

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEEC------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec-C
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTYC------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-P  179 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~  179 (395)
                      ++.++|++.+.||+|+||.||+|.+.      +..||+|.++.. ........+.+|+.++++++||||+++++++.. +
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   81 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG   81 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            56789999999999999999999874      477999998754 345556789999999999999999999998766 4


Q ss_pred             CcEEEEEecCCCCCHHHHHhhcc-------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeee
Q 016082          180 PNLCIVTEFMARGSIYDFLHKQK-------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADF  252 (395)
Q Consensus       180 ~~~~lV~E~~~ggsL~~~l~~~~-------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DF  252 (395)
                      ...++++||+++++|.+++....       ..++...++.++.+++.||.|||+++++||||||+||++++++.+||+||
T Consensus        82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence            67899999999999999997642       45889999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCC
Q 016082          253 GVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTI  328 (395)
Q Consensus       253 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  328 (395)
                      |+++......   ......++..|+|||.+.+..++.++||||||+++|++++ |+.||...++.+.... .....++..
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~  240 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAY-LKDGYRLAQ  240 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHH-HHcCCCCCC
Confidence            9997543221   1122345778999999998899999999999999999999 9999998877664433 444555556


Q ss_pred             CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 016082          329 PKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE  367 (395)
Q Consensus       329 ~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~  367 (395)
                      +..+++++.+++.+||..+|++|||+.++++.|.++.++
T Consensus       241 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         241 PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            667889999999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-42  Score=326.89  Aligned_cols=260  Identities=30%  Similarity=0.598  Sum_probs=222.7

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEEC--C----ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTYC--S----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  180 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~~--~----~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (395)
                      +...+|++.+.||+|+||.||+|.+.  +    ..+|+|.++.... .....++.+|+.++++++||||+++++++.. .
T Consensus         4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   81 (279)
T cd05057           4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-S   81 (279)
T ss_pred             cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence            45678999999999999999999862  3    2589999876643 4455788999999999999999999999987 7


Q ss_pred             cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                      ..++||||+++|+|.+++......+++..+..++.|++.|++|||+.|++||||||+||+++.++.++|+|||.++....
T Consensus        82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            89999999999999999988777799999999999999999999999999999999999999999999999999986543


Q ss_pred             CCcc---ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHH
Q 016082          261 SGVM---TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  336 (395)
Q Consensus       261 ~~~~---~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  336 (395)
                      ....   ....++..|+|||.+....++.++|+||||+++||+++ |+.||.+....+.... .........|..++.++
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  240 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDL-LEKGERLPQPPICTIDV  240 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH-HhCCCCCCCCCCCCHHH
Confidence            3211   11223578999999988889999999999999999998 9999998877665443 33444556677788999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHH
Q 016082          337 AELLERCWQHDPTQRPNFSQITDILKQMMKEVL  369 (395)
Q Consensus       337 ~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~  369 (395)
                      .+++.+||..+|.+||++.++++.++++.++-.
T Consensus       241 ~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~  273 (279)
T cd05057         241 YMVLVKCWMIDAESRPTFKELINEFSKMARDPQ  273 (279)
T ss_pred             HHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCc
Confidence            999999999999999999999999999876443

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=6.9e-43  Score=340.40  Aligned_cols=247  Identities=24%  Similarity=0.345  Sum_probs=206.6

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC------C
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP------P  180 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  180 (395)
                      .++|++.+.||+|+||.||++.+  .++.||||.++...........+.+|+.+++.++||||+++++++...      .
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            46899999999999999999986  578899999987655556667888999999999999999999988644      3


Q ss_pred             cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                      ..|+||||+++ ++.+.+..   .++...+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus        96 ~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~  171 (355)
T cd07874          96 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  171 (355)
T ss_pred             eeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence            47999999976 67776643   478889999999999999999999999999999999999999999999999987665


Q ss_pred             CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccC----------------
Q 016082          261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL----------------  324 (395)
Q Consensus       261 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~----------------  324 (395)
                      ........||..|+|||++.+..++.++|||||||++|+|++|+.||.+....+..........                
T Consensus       172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (355)
T cd07874         172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN  251 (355)
T ss_pred             ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHH
Confidence            5555566889999999999999999999999999999999999999988765443322211100                


Q ss_pred             ------------------------CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          325 ------------------------RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       325 ------------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                              ....+...+.++.++|.+||+.||++|||+.|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~  310 (355)
T cd07874         252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ  310 (355)
T ss_pred             HHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence                                    00011223567899999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.5e-42  Score=326.90  Aligned_cols=251  Identities=30%  Similarity=0.586  Sum_probs=207.6

Q ss_pred             cceeeeeeeeCceEEEEEEE------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--CcEE
Q 016082          112 LKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLC  183 (395)
Q Consensus       112 ~~i~~~lg~G~~G~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  183 (395)
                      |++.+.||+|+||+||++.+      .++.||+|+++... .......+.+|+.++++++||||+++++++...  ...+
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ   84 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence            48999999999999988754      35679999997653 233456788999999999999999999988654  3589


Q ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCc
Q 016082          184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV  263 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~  263 (395)
                      +||||+++++|.+++..  ..+++..++.++.+++.|++|||++||+||||||+||++++++.++|+|||+++.......
T Consensus        85 lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  162 (283)
T cd05080          85 LIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE  162 (283)
T ss_pred             EEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence            99999999999999975  3589999999999999999999999999999999999999999999999999976543221


Q ss_pred             ----cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH--------------HHHHHhhhccCC
Q 016082          264 ----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL--------------QAAVGVVQKSLR  325 (395)
Q Consensus       264 ----~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~--------------~~~~~~~~~~~~  325 (395)
                          .....++..|+|||.+.+..++.++||||||+++|+|++|..||......              ............
T Consensus       163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (283)
T cd05080         163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMR  242 (283)
T ss_pred             hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCC
Confidence                12234567799999998888999999999999999999999998653321              111112223344


Q ss_pred             CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 016082          326 PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM  365 (395)
Q Consensus       326 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~  365 (395)
                      ++.+..++.++.+++.+||+.+|++|||+.++++.|+++.
T Consensus       243 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         243 LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            4556778999999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=4.7e-43  Score=329.95  Aligned_cols=244  Identities=21%  Similarity=0.372  Sum_probs=201.0

Q ss_pred             eeeeCceEEEEEEE--CCceEEEEEecCCCCCH-HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecCCCCCH
Q 016082          118 VASGSYGDLYKGTY--CSQEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI  194 (395)
Q Consensus       118 lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ggsL  194 (395)
                      ||+|+||.||+++.  +++.||+|.+....... .....+..|+.++++++||||+++++++..+...|+||||++|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            69999999999986  57899999987543222 2234566799999999999999999999999999999999999999


Q ss_pred             HHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCccccCCCCccc
Q 016082          195 YDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRW  273 (395)
Q Consensus       195 ~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y  273 (395)
                      .+++... ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.............|+..|
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y  160 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGY  160 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCc
Confidence            9888653 345888999999999999999999999999999999999999999999999999766544444456789999


Q ss_pred             ccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC---CCCCCCCcHHHHHHHHHhhccCCCC
Q 016082          274 MAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR---PTIPKHAHPRLAELLERCWQHDPTQ  350 (395)
Q Consensus       274 ~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~  350 (395)
                      +|||++.+..++.++||||+||++|+|++|+.||...........+......   +.....+++++.+++.+||+.||.+
T Consensus       161 ~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~  240 (277)
T cd05607         161 MAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPED  240 (277)
T ss_pred             cCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHhh
Confidence            9999999888999999999999999999999999865432222222222211   1122467899999999999999999


Q ss_pred             CCCHHHHHHHH
Q 016082          351 RPNFSQITDIL  361 (395)
Q Consensus       351 RPs~~ell~~l  361 (395)
                      ||++.|+++.+
T Consensus       241 R~~~~~~~~~~  251 (277)
T cd05607         241 RLGSREKNDDP  251 (277)
T ss_pred             CCCCccchhhh
Confidence            99998776433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-42  Score=321.94  Aligned_cols=244  Identities=39%  Similarity=0.709  Sum_probs=216.0

Q ss_pred             eeeeeeCceEEEEEEEC-----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecCC
Q 016082          116 CKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA  190 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~  190 (395)
                      +.||+|+||.||+|...     +..||+|+++...... ..+.+.+|+.+++.++|+||+++++++......++||||++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME   79 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence            46899999999999885     6789999998765433 56789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhc--------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC
Q 016082          191 RGSIYDFLHKQ--------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       191 ggsL~~~l~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~  262 (395)
                      +++|.+++...        ...+++..++.++.+++.|++|||++|++||||||+||+++.++.++|+|||.++......
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  159 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD  159 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence            99999999876        4779999999999999999999999999999999999999999999999999998665432


Q ss_pred             ---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHH
Q 016082          263 ---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE  338 (395)
Q Consensus       263 ---~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  338 (395)
                         ......++..|+|||.+.+..++.++||||+|+++|+|++ |..||......+....+. ...+...+..+++++.+
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  238 (262)
T cd00192         160 YYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR-KGYRLPKPEYCPDELYE  238 (262)
T ss_pred             ccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCccCChHHHH
Confidence               2233467889999999998889999999999999999999 699999987766555544 35666778888999999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHH
Q 016082          339 LLERCWQHDPTQRPNFSQITDIL  361 (395)
Q Consensus       339 li~~cl~~dp~~RPs~~ell~~l  361 (395)
                      ++.+||+.+|.+|||+.++++.|
T Consensus       239 li~~~l~~~p~~Rps~~~l~~~l  261 (262)
T cd00192         239 LMLSCWQLDPEDRPTFSELVERL  261 (262)
T ss_pred             HHHHHccCCcccCcCHHHHHHhh
Confidence            99999999999999999999876

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.8e-43  Score=340.15  Aligned_cols=237  Identities=25%  Similarity=0.417  Sum_probs=201.3

Q ss_pred             eeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHH-HHHhcCCCceeeEEEEEecCCcEEEEEecCCC
Q 016082          116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVY-IMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR  191 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~g  191 (395)
                      +.||+|+||.||+|++  +++.||+|++..... .......+..|.. +++.++||||+++++.+...+..|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            4699999999999998  578999999975432 1222344555554 56789999999999999999999999999999


Q ss_pred             CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc-CCccccCCCC
Q 016082          192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT  270 (395)
Q Consensus       192 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~-~~~~~~~~gt  270 (395)
                      |+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (323)
T cd05575          81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGT  159 (323)
T ss_pred             CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCC
Confidence            999999876 56789999999999999999999999999999999999999999999999999875322 2233445789


Q ss_pred             cccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCC
Q 016082          271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ  350 (395)
Q Consensus       271 ~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~  350 (395)
                      +.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+...  ....+...++++.++|.+||+.||.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~~p~~  237 (323)
T cd05575         160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK--PLRLKPNISVSARHLLEGLLQKDRTK  237 (323)
T ss_pred             hhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhhcCHHh
Confidence            9999999999999999999999999999999999999988877666555543  23455677999999999999999999


Q ss_pred             CCCHH
Q 016082          351 RPNFS  355 (395)
Q Consensus       351 RPs~~  355 (395)
                      ||++.
T Consensus       238 R~~~~  242 (323)
T cd05575         238 RLGAK  242 (323)
T ss_pred             CCCCC
Confidence            99875

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.5e-42  Score=326.21  Aligned_cols=254  Identities=33%  Similarity=0.608  Sum_probs=214.3

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP  179 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  179 (395)
                      +..++|++.+.||+|+||.||+|.+.       +..||+|.++... .......+.+|+.++++++|+||+++++++.+.
T Consensus         3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (277)
T cd05036           3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER   81 (277)
T ss_pred             CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            44568999999999999999999874       3678999876443 344456799999999999999999999999998


Q ss_pred             CcEEEEEecCCCCCHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCC---cEEEe
Q 016082          180 PNLCIVTEFMARGSIYDFLHKQK------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVA  250 (395)
Q Consensus       180 ~~~~lV~E~~~ggsL~~~l~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~---~vkl~  250 (395)
                      ...++||||++|++|.+++....      ..+++..++.++.||+.|+.|||+++++||||||+||+++.++   .+||+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence            89999999999999999997643      2588899999999999999999999999999999999998765   59999


Q ss_pred             eeccccccccCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCC
Q 016082          251 DFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRP  326 (395)
Q Consensus       251 DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  326 (395)
                      |||+++.......   ......+..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+.... .....++
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~-~~~~~~~  240 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF-VTGGGRL  240 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HHcCCcC
Confidence            9999986532221   112233568999999998889999999999999999997 9999998776654433 4444556


Q ss_pred             CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 016082          327 TIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK  362 (395)
Q Consensus       327 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~  362 (395)
                      ..|..+++.+.+++.+||+.+|++||++.++++.|.
T Consensus       241 ~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         241 DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            667888999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.5e-42  Score=326.77  Aligned_cols=253  Identities=29%  Similarity=0.578  Sum_probs=216.2

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE-------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP  179 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  179 (395)
                      ++..+|.+.++||+|+||.||++..       .+..+|+|.++..  .......+.+|+.++++++|+||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (280)
T cd05092           2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG   79 (280)
T ss_pred             CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence            4567899999999999999999964       2457899988754  345567899999999999999999999999999


Q ss_pred             CcEEEEEecCCCCCHHHHHhhcc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCC
Q 016082          180 PNLCIVTEFMARGSIYDFLHKQK--------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG  245 (395)
Q Consensus       180 ~~~~lV~E~~~ggsL~~~l~~~~--------------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~  245 (395)
                      ...+++|||+++++|.+++....              ..+++..+..++.|++.|+.|||+.|++||||||+||++++++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~  159 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL  159 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence            99999999999999999997643              3478899999999999999999999999999999999999999


Q ss_pred             cEEEeeeccccccccCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhh
Q 016082          246 VVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQ  321 (395)
Q Consensus       246 ~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~  321 (395)
                      .++|+|||+++.......   .....+++.|+|||.+.+..++.++|||||||++|+|++ |.+||............ .
T Consensus       160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-~  238 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI-T  238 (280)
T ss_pred             CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH-H
Confidence            999999999875433221   112234678999999999999999999999999999998 99999887766555443 3


Q ss_pred             ccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 016082          322 KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK  362 (395)
Q Consensus       322 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~  362 (395)
                      ....+..+..+++.+.+++.+||+.||.+||++.++++.|+
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         239 QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            44455667788999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.4e-43  Score=344.41  Aligned_cols=248  Identities=23%  Similarity=0.374  Sum_probs=209.4

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      ++|++.+.||+|+||.||+++.  +++.||+|+++... ........+.+|+.++.+++||||+++++.+.+...+|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            3688999999999999999987  57899999997532 23345567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC----
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG----  262 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~----  262 (395)
                      ||++||+|.+++.+ .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||+++......    
T Consensus        81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~  159 (360)
T cd05627          81 EFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF  159 (360)
T ss_pred             eCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence            99999999999976 4678999999999999999999999999999999999999999999999999986432110    


Q ss_pred             --------------------------------ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 016082          263 --------------------------------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL  310 (395)
Q Consensus       263 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~  310 (395)
                                                      ......||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~  239 (360)
T cd05627         160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE  239 (360)
T ss_pred             ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCC
Confidence                                            011346899999999999999999999999999999999999999998


Q ss_pred             CHHHHHHHhhhccCCCCCCC--CCcHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 016082          311 TPLQAAVGVVQKSLRPTIPK--HAHPRLAELLERCWQHDPTQRPN---FSQITD  359 (395)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dp~~RPs---~~ell~  359 (395)
                      ++......+.........|.  ..++++.++|.+|+ .+|.+|++   +.++++
T Consensus       240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            88776666554322223333  36889999999977 49999985   566654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=6.2e-43  Score=326.48  Aligned_cols=249  Identities=28%  Similarity=0.492  Sum_probs=208.7

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      .++|++.+.||+|+||.||+|+.  +++.||+|+++...  ......+.+|+.++++++||||+++++.+......++||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~   85 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM   85 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence            45799999999999999999987  57889999997542  223456889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-ccc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT  265 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~  265 (395)
                      ||+++++|.++++. .+++++..+..++.|++.|+.|||+.||+||||||+||+++.++.++|+|||+++...... ...
T Consensus        86 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd06646          86 EYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK  164 (267)
T ss_pred             eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccC
Confidence            99999999999875 4678999999999999999999999999999999999999999999999999997654322 223


Q ss_pred             cCCCCcccccccccC---CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCC---CCCCcHHHHHH
Q 016082          266 AETGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI---PKHAHPRLAEL  339 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~---~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~l  339 (395)
                      ...++..|+|||.+.   ...++.++|+||||+++|+|++|+.||....+.+...........+..   +..++.++.++
T Consensus       165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (267)
T cd06646         165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNF  244 (267)
T ss_pred             ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHH
Confidence            456889999999884   445788999999999999999999999776655443332222222222   23468899999


Q ss_pred             HHHhhccCCCCCCCHHHHHHH
Q 016082          340 LERCWQHDPTQRPNFSQITDI  360 (395)
Q Consensus       340 i~~cl~~dp~~RPs~~ell~~  360 (395)
                      |++||+.+|++||+++++++.
T Consensus       245 i~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         245 VKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             HHHHhhCChhhCcCHHHHhcC
Confidence            999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.6e-42  Score=321.62  Aligned_cols=248  Identities=26%  Similarity=0.468  Sum_probs=215.5

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  188 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  188 (395)
                      +|++.++||.|+||.||++++  +++.+|+|.++... .....+.+.+|+.+++.++||||+++++.+...+.+|+||||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY   79 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence            578899999999999999987  57889999986543 234457788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCc-ccc
Q 016082          189 MARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-MTA  266 (395)
Q Consensus       189 ~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~-~~~  266 (395)
                      +++|+|.+++... ...++...+..++.+++.||.|||++||+|+||||+||++++++.++++|||.++....... ...
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (255)
T cd08219          80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT  159 (255)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccccccc
Confidence            9999999998654 35689999999999999999999999999999999999999999999999999976544322 234


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhcc
Q 016082          267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH  346 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  346 (395)
                      ..|+..|+|||++.+..++.++|+||||+++|+|++|..||...+.......+. .......+..++.++.++|.+||+.
T Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  238 (255)
T cd08219         160 YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC-QGSYKPLPSHYSYELRSLIKQMFKR  238 (255)
T ss_pred             ccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh-cCCCCCCCcccCHHHHHHHHHHHhC
Confidence            568899999999999899999999999999999999999999877666555443 3444556778899999999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 016082          347 DPTQRPNFSQITDI  360 (395)
Q Consensus       347 dp~~RPs~~ell~~  360 (395)
                      ||.+||++.+++.+
T Consensus       239 ~P~~Rp~~~~il~~  252 (255)
T cd08219         239 NPRSRPSATTILSR  252 (255)
T ss_pred             CcccCCCHHHHhhc
Confidence            99999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-42  Score=329.82  Aligned_cols=255  Identities=29%  Similarity=0.573  Sum_probs=211.7

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEECC----------------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcee
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTYCS----------------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV  170 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~~~----------------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  170 (395)
                      +..++|++.++||+|+||.||+++..+                ..||+|.++... .......+.+|++++++++|||++
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~   80 (295)
T cd05097           2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNII   80 (295)
T ss_pred             CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcC
Confidence            456789999999999999999987532                248999998653 345566799999999999999999


Q ss_pred             eEEEEEecCCcEEEEEecCCCCCHHHHHhhcc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 016082          171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-----------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANL  239 (395)
Q Consensus       171 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-----------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~Ni  239 (395)
                      ++++++......++||||+.+++|.+++....           ..+++..++.++.+++.||.|||+.|++||||||+||
T Consensus        81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni  160 (295)
T cd05097          81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC  160 (295)
T ss_pred             eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence            99999999999999999999999999986532           1367888999999999999999999999999999999


Q ss_pred             eeCCCCcEEEeeeccccccccCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh--CCCCCCCCCHHH
Q 016082          240 LMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT--GELPYAGLTPLQ  314 (395)
Q Consensus       240 Ll~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt--g~~pf~~~~~~~  314 (395)
                      ++++++.+||+|||+++.......   .....++..|+|||.+.+..++.++|+||||+++|+|++  +..||...+..+
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            999999999999999875433221   122345678999999998889999999999999999998  678998877655


Q ss_pred             HHHHhhh------ccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 016082          315 AAVGVVQ------KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK  362 (395)
Q Consensus       315 ~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~  362 (395)
                      .......      .......++..++.+.+++.+||+.+|++||++.+|++.|+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            4443321      11123345567899999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2e-43  Score=340.17  Aligned_cols=240  Identities=24%  Similarity=0.411  Sum_probs=201.4

Q ss_pred             eeeeeeCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHH-HHHHhcCCCceeeEEEEEecCCcEEEEEecCCC
Q 016082          116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEV-YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR  191 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~g  191 (395)
                      +.||+|+||.||+|++  .++.||+|++...... ......+..|. .+++.++||||+++++++...+..|+||||++|
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            4699999999999988  4578999999754221 12223444444 456788999999999999999999999999999


Q ss_pred             CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc-CCccccCCCC
Q 016082          192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT  270 (395)
Q Consensus       192 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~-~~~~~~~~gt  270 (395)
                      |+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.... ........||
T Consensus        81 ~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  159 (325)
T cd05602          81 GELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGT  159 (325)
T ss_pred             CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCC
Confidence            999999976 46688899999999999999999999999999999999999999999999999875322 2233445799


Q ss_pred             cccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCC
Q 016082          271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ  350 (395)
Q Consensus       271 ~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~  350 (395)
                      +.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+...  ....++.+++++.+++.+||+.||.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~~p~~  237 (325)
T cd05602         160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK--PLQLKPNITNSARHLLEGLLQKDRTK  237 (325)
T ss_pred             ccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC--CcCCCCCCCHHHHHHHHHHcccCHHH
Confidence            9999999999999999999999999999999999999988877766555443  23455678999999999999999999


Q ss_pred             CCCHHHHH
Q 016082          351 RPNFSQIT  358 (395)
Q Consensus       351 RPs~~ell  358 (395)
                      ||++.+.+
T Consensus       238 R~~~~~~~  245 (325)
T cd05602         238 RLGAKDDF  245 (325)
T ss_pred             CCCCCCCH
Confidence            99987543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.1e-42  Score=334.31  Aligned_cols=262  Identities=31%  Similarity=0.628  Sum_probs=223.6

Q ss_pred             CceeecccCcceeeeeeeeCceEEEEEEECC---------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeE
Q 016082          103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQF  172 (395)
Q Consensus       103 ~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~---------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l  172 (395)
                      ..|++...+|++.+.||+|+||.||+|++.+         ..||+|+++... ......++.+|+.+++++ +||||+++
T Consensus         5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~   83 (334)
T cd05100           5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIINL   83 (334)
T ss_pred             cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence            4588888999999999999999999997521         368999987542 344567899999999999 79999999


Q ss_pred             EEEEecCCcEEEEEecCCCCCHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 016082          173 IGACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA  237 (395)
Q Consensus       173 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~  237 (395)
                      ++++......++++||+++|+|.+++....               ..++...+..++.|++.||.|||++||+||||||+
T Consensus        84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~  163 (334)
T cd05100          84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR  163 (334)
T ss_pred             eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence            999999999999999999999999997532               24677888999999999999999999999999999


Q ss_pred             CeeeCCCCcEEEeeeccccccccCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 016082          238 NLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPL  313 (395)
Q Consensus       238 NiLl~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~  313 (395)
                      ||+++.++.++|+|||.++.......   .....++..|+|||++.+..++.++||||||+++|||++ |..||.+.+..
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  243 (334)
T cd05100         164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE  243 (334)
T ss_pred             eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            99999999999999999976543221   222344578999999999999999999999999999998 89999888766


Q ss_pred             HHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 016082          314 QAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK  366 (395)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~  366 (395)
                      +.... .....++..+..++.++.+++.+||+.+|.+||++.++++.|+.+..
T Consensus       244 ~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         244 ELFKL-LKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             HHHHH-HHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence            65444 33445566777889999999999999999999999999999988874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=9.9e-43  Score=340.54  Aligned_cols=247  Identities=25%  Similarity=0.364  Sum_probs=207.6

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC------C
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP------P  180 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  180 (395)
                      .++|++.+.||+|+||.||++.+  .++.||||+++...........+.+|+.+++.++||||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            46899999999999999999987  578899999987655555667888999999999999999999987543      3


Q ss_pred             cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                      ..|+||||+++ +|.+.+..   .++...+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus       103 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  178 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  178 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence            57999999976 78777743   478889999999999999999999999999999999999999999999999987665


Q ss_pred             CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccC----------------
Q 016082          261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL----------------  324 (395)
Q Consensus       261 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~----------------  324 (395)
                      ........+|..|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.....                
T Consensus       179 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (364)
T cd07875         179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT  258 (364)
T ss_pred             CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHH
Confidence            5445566889999999999999999999999999999999999999998776554444332110                


Q ss_pred             ----CC--------------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          325 ----RP--------------------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       325 ----~~--------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                          ++                    ......+.++.++|.+||+.||.+|||+.++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         259 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             HHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                00                    001123467899999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.4e-42  Score=325.55  Aligned_cols=254  Identities=29%  Similarity=0.574  Sum_probs=210.0

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec--CC
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--PP  180 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~  180 (395)
                      ..+|++.+.||+|+||.||++++      .+..||+|.++..  .....+.+.+|+.++++++||||+++++++..  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence            45899999999999999999874      4678999998755  34556789999999999999999999998754  34


Q ss_pred             cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                      .+++||||+++++|.+++....+.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++....
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            68999999999999999977666789999999999999999999999999999999999999999999999999986543


Q ss_pred             CCcc----ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH---------------HHHHhhh
Q 016082          261 SGVM----TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ---------------AAVGVVQ  321 (395)
Q Consensus       261 ~~~~----~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~---------------~~~~~~~  321 (395)
                      ....    ....++..|+|||.+.+..++.++|+||||+++|||++|..|+.......               .......
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK  240 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence            3211    11233456999999998899999999999999999999877764332110               0112233


Q ss_pred             ccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 016082          322 KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQM  364 (395)
Q Consensus       322 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~  364 (395)
                      ...+...+..++.++.+++.+||+.+|++|||+.++++.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            3344455677889999999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.5e-42  Score=327.82  Aligned_cols=254  Identities=31%  Similarity=0.598  Sum_probs=215.4

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE-------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP  179 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  179 (395)
                      ++.++|++.+.||.|+||.||+|.+       .+..||+|+++... .......+.+|+.++++++||||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~   80 (288)
T cd05050           2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVG   80 (288)
T ss_pred             CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            4567899999999999999999986       34789999987553 344557799999999999999999999999999


Q ss_pred             CcEEEEEecCCCCCHHHHHhhcc---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 016082          180 PNLCIVTEFMARGSIYDFLHKQK---------------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN  238 (395)
Q Consensus       180 ~~~~lV~E~~~ggsL~~~l~~~~---------------------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~N  238 (395)
                      ...++||||+++|+|.+++....                     ..++...++.++.+++.||.|||+++++||||||+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n  160 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN  160 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence            99999999999999999997532                     246778889999999999999999999999999999


Q ss_pred             eeeCCCCcEEEeeeccccccccCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 016082          239 LLMDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQ  314 (395)
Q Consensus       239 iLl~~~~~vkl~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~  314 (395)
                      |+++.++.++|+|||.++......   .......+..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999999987543221   1122344678999999998899999999999999999998 889998887766


Q ss_pred             HHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 016082          315 AAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK  362 (395)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~  362 (395)
                      ....+. .......+...+.++.+++.+||+.+|.+||++.|+++.|+
T Consensus       241 ~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         241 VIYYVR-DGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             HHHHHh-cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence            554433 33344456678899999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.9e-43  Score=338.18  Aligned_cols=237  Identities=23%  Similarity=0.410  Sum_probs=198.7

Q ss_pred             eeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcEEEEEecCCC
Q 016082          116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMAR  191 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~g  191 (395)
                      +.||+|+||.||+|++  +++.||+|+++.... .......+.+|+.++.++ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4699999999999987  568899999986533 233456688899998877 799999999999999999999999999


Q ss_pred             CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc-CCccccCCCC
Q 016082          192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT  270 (395)
Q Consensus       192 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~-~~~~~~~~gt  270 (395)
                      |+|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.... ........||
T Consensus        81 ~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (329)
T cd05618          81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGT  159 (329)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCC
Confidence            999998866 46799999999999999999999999999999999999999999999999999875322 2223345789


Q ss_pred             cccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHhhhccCCCCCCCCCcHHHHHHHHH
Q 016082          271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT--------PLQAAVGVVQKSLRPTIPKHAHPRLAELLER  342 (395)
Q Consensus       271 ~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  342 (395)
                      +.|+|||++.+..++.++|||||||++|+|++|+.||....        ......... ......+|...+.++.++|.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i-~~~~~~~p~~~~~~~~~ll~~  238 (329)
T cd05618         160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-LEKQIRIPRSLSVKAASVLKS  238 (329)
T ss_pred             ccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH-hcCCCCCCCCCCHHHHHHHHH
Confidence            99999999999999999999999999999999999995311        111111111 123445778899999999999


Q ss_pred             hhccCCCCCCCH
Q 016082          343 CWQHDPTQRPNF  354 (395)
Q Consensus       343 cl~~dp~~RPs~  354 (395)
                      ||+.||.+||++
T Consensus       239 ~L~~dP~~R~~~  250 (329)
T cd05618         239 FLNKDPKERLGC  250 (329)
T ss_pred             HhcCCHHHcCCC
Confidence            999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.1e-42  Score=322.55  Aligned_cols=250  Identities=33%  Similarity=0.705  Sum_probs=215.9

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  184 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  184 (395)
                      |-+..++|++.+.||+|+||.||++...++.||+|.++...    ....+.+|+.++++++|||++++++++... ..++
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~   75 (254)
T cd05083           1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI   75 (254)
T ss_pred             CcccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence            44566789999999999999999999999999999987542    236788999999999999999999998765 4799


Q ss_pred             EEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCc
Q 016082          185 VTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV  263 (395)
Q Consensus       185 V~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~  263 (395)
                      ||||+.+++|.+++.... ..++...++.++.|++.|+.|||+.|++||||||+||+++.++.++|+|||.+......  
T Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--  153 (254)
T cd05083          76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--  153 (254)
T ss_pred             EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence            999999999999997653 35889999999999999999999999999999999999999999999999998754322  


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHH
Q 016082          264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER  342 (395)
Q Consensus       264 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  342 (395)
                      ......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+.... .....++..+..++.++.+++.+
T Consensus       154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~  232 (254)
T cd05083         154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC-VEKGYRMEPPEGCPADVYVLMTS  232 (254)
T ss_pred             CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHH-HhCCCCCCCCCcCCHHHHHHHHH
Confidence            122344678999999998899999999999999999998 9999998877655444 34455666677789999999999


Q ss_pred             hhccCCCCCCCHHHHHHHHH
Q 016082          343 CWQHDPTQRPNFSQITDILK  362 (395)
Q Consensus       343 cl~~dp~~RPs~~ell~~l~  362 (395)
                      ||+.+|.+||++.++++.|+
T Consensus       233 ~l~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         233 CWETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             HcCCChhhCcCHHHHHHHHc
Confidence            99999999999999998775

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.7e-42  Score=321.26  Aligned_cols=254  Identities=34%  Similarity=0.690  Sum_probs=217.7

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  183 (395)
                      |++..++|++.++||+|+||.||++.+ .+..+|+|.++..   ......+.+|+.++++++|+||+++++.+.. ...+
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~   76 (260)
T cd05073           1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY   76 (260)
T ss_pred             CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence            678889999999999999999999987 4567999998754   2335678899999999999999999999887 7789


Q ss_pred             EEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC
Q 016082          184 IVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~  262 (395)
                      ++|||+++++|.+++... ...++...+..++.+++.|+.|||+.|++||||||+||+++.++.++|+|||.+.......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            999999999999999764 3457888899999999999999999999999999999999999999999999997654322


Q ss_pred             c--cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHH
Q 016082          263 V--MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL  339 (395)
Q Consensus       263 ~--~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  339 (395)
                      .  .....++..|+|||.+.+..++.++|+||||+++|++++ |+.||.+.+....... .......+.+...+.++.++
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  235 (260)
T cd05073         157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA-LERGYRMPRPENCPEELYNI  235 (260)
T ss_pred             cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHH-HhCCCCCCCcccCCHHHHHH
Confidence            1  122345678999999998889999999999999999999 9999998776554443 33444555667788999999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHHHH
Q 016082          340 LERCWQHDPTQRPNFSQITDILKQ  363 (395)
Q Consensus       340 i~~cl~~dp~~RPs~~ell~~l~~  363 (395)
                      +.+||+.+|++||++.++.+.|+.
T Consensus       236 i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         236 MMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             HHHHcccCcccCcCHHHHHHHHhc
Confidence            999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-42  Score=324.16  Aligned_cols=247  Identities=33%  Similarity=0.629  Sum_probs=208.2

Q ss_pred             eeeeeCceEEEEEEEC--Cc--eEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcEEEEEecCCC
Q 016082          117 KVASGSYGDLYKGTYC--SQ--EVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMAR  191 (395)
Q Consensus       117 ~lg~G~~G~Vy~~~~~--~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~g  191 (395)
                      .||+|+||.||+|+..  +.  .+|+|.++... .......+.+|+.+++++ +||||+++++++...+..++||||+++
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            5899999999999873  33  47888887432 344556889999999999 799999999999999999999999999


Q ss_pred             CCHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccc
Q 016082          192 GSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR  256 (395)
Q Consensus       192 gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~  256 (395)
                      |+|.+++....               ..++...+..++.|++.|++|||+.|++||||||+||+++.++.++|+|||+++
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~  160 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR  160 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence            99999997532               247889999999999999999999999999999999999999999999999986


Q ss_pred             ccccCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHH
Q 016082          257 VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR  335 (395)
Q Consensus       257 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (395)
                      .............+..|+|||++.+..++.++|+||||+++|||++ |..||.+.+..+.... .....+...+...+.+
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~  239 (270)
T cd05047         161 GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-LPQGYRLEKPLNCDDE  239 (270)
T ss_pred             ccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHH-HhCCCCCCCCCcCCHH
Confidence            4332211222334667999999998899999999999999999997 9999988776554443 3344555666778899


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 016082          336 LAELLERCWQHDPTQRPNFSQITDILKQMM  365 (395)
Q Consensus       336 l~~li~~cl~~dp~~RPs~~ell~~l~~~~  365 (395)
                      +.+++.+||+.+|.+|||+.++++.|.+++
T Consensus       240 ~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         240 VYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             HHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.4e-42  Score=318.19  Aligned_cols=245  Identities=35%  Similarity=0.655  Sum_probs=211.8

Q ss_pred             eeeeeeCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecCCCCCH
Q 016082          116 CKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI  194 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ggsL  194 (395)
                      +.||+|+||.||+|.. .++.+|+|+++... .......+.+|+.++++++||||+++++++......++||||+++++|
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            3689999999999986 46789999987654 344455789999999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCcc--ccCCCCcc
Q 016082          195 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM--TAETGTYR  272 (395)
Q Consensus       195 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~--~~~~gt~~  272 (395)
                      .+++......+++..+..++.+++.+|.|+|++|++||||||+||+++.++.++|+|||+++........  ....++..
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~  159 (250)
T cd05085          80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK  159 (250)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCccc
Confidence            9999776667899999999999999999999999999999999999999999999999998754332211  12234677


Q ss_pred             cccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCC
Q 016082          273 WMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR  351 (395)
Q Consensus       273 y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  351 (395)
                      |+|||.+.+..++.++|+||||+++|++++ |..||........... .....+...+..++.++.+++.+||+.+|++|
T Consensus       160 y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  238 (250)
T cd05085         160 WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ-VEKGYRMSCPQKCPDDVYKVMQRCWDYKPENR  238 (250)
T ss_pred             ccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH-HHcCCCCCCCCCCCHHHHHHHHHHcccCcccC
Confidence            999999998889999999999999999998 9999998877665544 34556667777889999999999999999999


Q ss_pred             CCHHHHHHHHH
Q 016082          352 PNFSQITDILK  362 (395)
Q Consensus       352 Ps~~ell~~l~  362 (395)
                      |++.++++.|.
T Consensus       239 p~~~~l~~~l~  249 (250)
T cd05085         239 PKFSELQKELA  249 (250)
T ss_pred             CCHHHHHHHhc
Confidence            99999998774

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-43  Score=336.93  Aligned_cols=250  Identities=20%  Similarity=0.346  Sum_probs=209.0

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      ++|++.+.||+|+||.||+++.  +++.||+|++++.. ........+.+|+.++..++|+||+++++++..+..+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            4799999999999999999987  57889999997422 22334566889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCc--c
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV--M  264 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~--~  264 (395)
                      ||++||+|.+++.+....+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++........  .
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS  160 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence            99999999999987667899999999999999999999999999999999999999999999999999875443322  1


Q ss_pred             ccCCCCcccccccccCC-----CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCC---CCCcHHH
Q 016082          265 TAETGTYRWMAPEVIEH-----KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP---KHAHPRL  336 (395)
Q Consensus       265 ~~~~gt~~y~aPE~~~~-----~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l  336 (395)
                      ....||+.|+|||++.+     ..++.++|||||||++|+|++|+.||.+.+..+....+.........+   ..++.++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  240 (331)
T cd05597         161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEA  240 (331)
T ss_pred             cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHH
Confidence            23468999999999863     457889999999999999999999999887766655554433222222   3478999


Q ss_pred             HHHHHHhhccCCC--CCCCHHHHHH
Q 016082          337 AELLERCWQHDPT--QRPNFSQITD  359 (395)
Q Consensus       337 ~~li~~cl~~dp~--~RPs~~ell~  359 (395)
                      +++|++|+..++.  .||++.++++
T Consensus       241 ~~li~~ll~~~~~r~~r~~~~~~l~  265 (331)
T cd05597         241 KDLIRRLICSPETRLGRNGLQDFKD  265 (331)
T ss_pred             HHHHHHHccCcccccCCCCHHHHhc
Confidence            9999998865433  3789998887

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5e-45  Score=319.94  Aligned_cols=250  Identities=20%  Similarity=0.374  Sum_probs=222.6

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      .+.|.+.+.||+|.|+.||++..  +|+.+|+|++..........+++.+|+.|-+.|+||||+++.+........|||+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            45899999999999999999865  7899999999877666667788999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCC---CCcEEEeeeccccccccCCc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NGVVKVADFGVARVQAQSGV  263 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~---~~~vkl~DFg~a~~~~~~~~  263 (395)
                      |+|.|++|..-+-.+ ..+++..+...+.||+.+++|+|.+||||||+||+|+++.+   ..-+||+|||+|...+....
T Consensus        90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~  168 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEA  168 (355)
T ss_pred             ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccc
Confidence            999999998777653 56788999999999999999999999999999999999954   34699999999988775555


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCC--CCCCCcHHHHHHHH
Q 016082          264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT--IPKHAHPRLAELLE  341 (395)
Q Consensus       264 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~  341 (395)
                      .....|||.|||||++...+|+..+|||+.|++||-|+.|.+||.+.+....+.++.+..+...  .-++++++.+++++
T Consensus       169 ~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~Lvr  248 (355)
T KOG0033|consen  169 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIR  248 (355)
T ss_pred             cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHH
Confidence            5667899999999999999999999999999999999999999999888888888776655433  34678999999999


Q ss_pred             HhhccCCCCCCCHHHHHH
Q 016082          342 RCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       342 ~cl~~dp~~RPs~~ell~  359 (395)
                      +||..||.+|.|+.|.++
T Consensus       249 rML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  249 RMLTVNPKKRITADEALK  266 (355)
T ss_pred             HHhccChhhhccHHHHhC
Confidence            999999999999999874

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3e-42  Score=319.71  Aligned_cols=250  Identities=34%  Similarity=0.689  Sum_probs=215.3

Q ss_pred             cccCcceeeeeeeeCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          108 DAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       108 ~~~~~~i~~~lg~G~~G~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      +..+|++.+.||.|+||.||+|.+. +..+|+|+++......   ..+.+|++++++++|||++++++++......++||
T Consensus         2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd05112           2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF   78 (256)
T ss_pred             ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCH---HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence            4568999999999999999999874 7889999987654432   46888999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCc--c
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV--M  264 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~--~  264 (395)
                      ||+++++|.+++....+.+++..+..++.+++.|+.|||+.+++||||||+||+++.++.++|+|||.++.......  .
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  158 (256)
T cd05112          79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS  158 (256)
T ss_pred             EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence            99999999999987667789999999999999999999999999999999999999999999999999875443221  1


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHh
Q 016082          265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC  343 (395)
Q Consensus       265 ~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  343 (395)
                      ....++..|+|||.+.+..++.++|+||||+++|||++ |..||........... .....++..+...+.++.+++.+|
T Consensus       159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~  237 (256)
T cd05112         159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVET-INAGFRLYKPRLASQSVYELMQHC  237 (256)
T ss_pred             CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH-HhCCCCCCCCCCCCHHHHHHHHHH
Confidence            12234678999999998889999999999999999998 9999987766554443 334445555666789999999999


Q ss_pred             hccCCCCCCCHHHHHHHH
Q 016082          344 WQHDPTQRPNFSQITDIL  361 (395)
Q Consensus       344 l~~dp~~RPs~~ell~~l  361 (395)
                      |+.+|++||++.++++.|
T Consensus       238 l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         238 WKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             cccChhhCCCHHHHHHhh
Confidence            999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.2e-42  Score=328.01  Aligned_cols=248  Identities=23%  Similarity=0.409  Sum_probs=202.6

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc---CCCceeeEEEEEec-----CC
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI---RHKNVVQFIGACTR-----PP  180 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~  180 (395)
                      +|++.+.||+|+||.||+|++  +++.||+|.++...........+.+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            588999999999999999987  578899999976543333334556777777766   69999999998864     23


Q ss_pred             cEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  259 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~  259 (395)
                      ..++||||+.+ +|.+++.... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++...
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~  159 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS  159 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence            58999999985 8999887643 458999999999999999999999999999999999999999999999999998665


Q ss_pred             cCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc----------------
Q 016082          260 QSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS----------------  323 (395)
Q Consensus       260 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~----------------  323 (395)
                      .........||..|+|||++.+..++.++||||+||++|+|++|++||.+.........+....                
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07863         160 CQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPR  239 (288)
T ss_pred             CcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccc
Confidence            4444445678999999999998899999999999999999999999998876654443332210                


Q ss_pred             --CCC-------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          324 --LRP-------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       324 --~~~-------~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                        ..+       ...+.++.++.+++.+||+.||++|||+.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         240 GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             cccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence              000       011346778999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.2e-42  Score=327.57  Aligned_cols=254  Identities=33%  Similarity=0.593  Sum_probs=212.9

Q ss_pred             cccCcceeeeeeeeCceEEEEEEECC------------------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCce
Q 016082          108 DAKQLKIECKVASGSYGDLYKGTYCS------------------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV  169 (395)
Q Consensus       108 ~~~~~~i~~~lg~G~~G~Vy~~~~~~------------------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  169 (395)
                      ..++|++.++||+|+||.||+|+...                  ..||+|.+.... .......+.+|+.++++++||||
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i   81 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNI   81 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCE
Confidence            45689999999999999999987632                  458999988654 33556789999999999999999


Q ss_pred             eeEEEEEecCCcEEEEEecCCCCCHHHHHhhcc----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 016082          170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK----------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANL  239 (395)
Q Consensus       170 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~Ni  239 (395)
                      +++++++...+..+++|||+.+++|.+++....          ..+++..++.++.|++.||.|||+.||+||||||+||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni  161 (296)
T cd05051          82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC  161 (296)
T ss_pred             eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence            999999999999999999999999999997643          2689999999999999999999999999999999999


Q ss_pred             eeCCCCcEEEeeeccccccccCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh--CCCCCCCCCHHH
Q 016082          240 LMDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT--GELPYAGLTPLQ  314 (395)
Q Consensus       240 Ll~~~~~vkl~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt--g~~pf~~~~~~~  314 (395)
                      +++.++.++|+|||.++......   ......++..|+|||.+.+..++.++||||||+++|||++  +..||...+..+
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ  241 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence            99999999999999987543322   1223356778999999988889999999999999999998  778998876655


Q ss_pred             HHHHhhhc------cCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 016082          315 AAVGVVQK------SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK  362 (395)
Q Consensus       315 ~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~  362 (395)
                      ........      ......+..++.++.+++.+||+.||.+|||+.+|++.|+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         242 VIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            54433321      1112234567889999999999999999999999988775

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1e-42  Score=328.22  Aligned_cols=242  Identities=24%  Similarity=0.389  Sum_probs=200.4

Q ss_pred             eeeeCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecCCCCCH
Q 016082          118 VASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI  194 (395)
Q Consensus       118 lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ggsL  194 (395)
                      ||+|+||+||++.+  +++.||+|.+...... ....+.+..|+.++++++||||+++++++......|+||||++||+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            69999999999987  5789999998754322 22345678899999999999999999999999999999999999999


Q ss_pred             HHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-ccccCCCC
Q 016082          195 YDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGT  270 (395)
Q Consensus       195 ~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~~~~gt  270 (395)
                      .+++..   ....+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||.+....... ......||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~  160 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT  160 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence            988753   24568999999999999999999999999999999999999999999999999997554332 22345789


Q ss_pred             cccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc--cCCCCCCCCCcHHHHHHHHHhhccCC
Q 016082          271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK--SLRPTIPKHAHPRLAELLERCWQHDP  348 (395)
Q Consensus       271 ~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dp  348 (395)
                      +.|+|||.+.+..++.++|+||||+++|+|++|+.||...............  ......+..+++++.+++.+||+.||
T Consensus       161 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P  240 (280)
T cd05608         161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDP  240 (280)
T ss_pred             cCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCH
Confidence            9999999999999999999999999999999999999865432111111111  12234566789999999999999999


Q ss_pred             CCCC-----CHHHHHH
Q 016082          349 TQRP-----NFSQITD  359 (395)
Q Consensus       349 ~~RP-----s~~ell~  359 (395)
                      ++||     +++++++
T Consensus       241 ~~R~~~~~~~~~~~l~  256 (280)
T cd05608         241 EKRLGFRDGNCDGLRT  256 (280)
T ss_pred             HHhcCCCCCCHHHHhc
Confidence            9999     5566665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3.8e-42  Score=320.53  Aligned_cols=256  Identities=26%  Similarity=0.501  Sum_probs=215.7

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      ++|++.+.||.|+||.||+|..  +++.||+|.++.... .......+.+|+.++++++|+|++++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            5799999999999999999988  588999999875332 3344678999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-
Q 016082          187 EFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-  262 (395)
Q Consensus       187 E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-  262 (395)
                      ||+++++|.+++...   ...++...+..++.+++.|+.|||+.||+||||+|+||+++.++.++|+|||.++...... 
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~  161 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence            999999999998642   3568899999999999999999999999999999999999999999999999987544322 


Q ss_pred             ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHhhhccCCCCCCC-CCcHHHHHHH
Q 016082          263 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP-LQAAVGVVQKSLRPTIPK-HAHPRLAELL  340 (395)
Q Consensus       263 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~-~~~~~l~~li  340 (395)
                      ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... .............+..|. ..+.++.++|
T Consensus       162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  241 (267)
T cd08224         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLV  241 (267)
T ss_pred             ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHH
Confidence            22334688899999999998999999999999999999999999965432 111222222333444444 6788999999


Q ss_pred             HHhhccCCCCCCCHHHHHHHHHHHH
Q 016082          341 ERCWQHDPTQRPNFSQITDILKQMM  365 (395)
Q Consensus       341 ~~cl~~dp~~RPs~~ell~~l~~~~  365 (395)
                      .+||..+|++||++.+|++.++++.
T Consensus       242 ~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         242 SRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             HHHcCCCcccCCCHHHHHHHHHHhc
Confidence            9999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.1e-42  Score=334.94  Aligned_cols=242  Identities=24%  Similarity=0.425  Sum_probs=207.9

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCcEEEEE
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~  186 (395)
                      +|.+.+.||+|+||.||+|++  +++.||+|+++.... .....+.+..|..+++.+. |++|+++++++...+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            467889999999999999987  578899999975432 2334566888999998886 577888999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-ccc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT  265 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~  265 (395)
                      ||++||+|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++...... ...
T Consensus        81 Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~  159 (323)
T cd05615          81 EYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR  159 (323)
T ss_pred             cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcccc
Confidence            99999999999876 4679999999999999999999999999999999999999999999999999987543222 223


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhc
Q 016082          266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ  345 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  345 (395)
                      ...||+.|+|||++.+..++.++|+||+||++|+|++|+.||.+.+.......+...  ....|..+++++.+++.+||+
T Consensus       160 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~l~  237 (323)
T cd05615         160 TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH--NVSYPKSLSKEAVSICKGLMT  237 (323)
T ss_pred             CccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHHHHHHHHHcc
Confidence            446899999999999999999999999999999999999999998877666655543  345677889999999999999


Q ss_pred             cCCCCCCCHH
Q 016082          346 HDPTQRPNFS  355 (395)
Q Consensus       346 ~dp~~RPs~~  355 (395)
                      .+|.+|++..
T Consensus       238 ~~p~~R~~~~  247 (323)
T cd05615         238 KHPSKRLGCG  247 (323)
T ss_pred             cCHhhCCCCC
Confidence            9999999853

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.3e-42  Score=340.72  Aligned_cols=247  Identities=26%  Similarity=0.405  Sum_probs=206.4

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC-----cEE
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP-----NLC  183 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  183 (395)
                      +|++.++||+|+||.||++.+  +++.||||.+.....+....+.+.+|+.+++.++||||+++++++....     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            477899999999999999986  6789999998765444455678899999999999999999999998776     789


Q ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC--
Q 016082          184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS--  261 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~--  261 (395)
                      +||||+.+ +|.+.+.. .+.++...+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....  
T Consensus        81 lv~e~~~~-~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~  158 (372)
T cd07853          81 VVTELMQS-DLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES  158 (372)
T ss_pred             EEeecccc-CHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence            99999974 88888765 567899999999999999999999999999999999999999999999999999764432  


Q ss_pred             CccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhh-------------------
Q 016082          262 GVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ-------------------  321 (395)
Q Consensus       262 ~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~-------------------  321 (395)
                      .......++..|+|||.+.+. .++.++||||+||++|||++|+.||.+.++.+....+..                   
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  238 (372)
T cd07853         159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA  238 (372)
T ss_pred             ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence            223445688999999998874 589999999999999999999999988776544333221                   


Q ss_pred             ----ccCCC-------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          322 ----KSLRP-------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       322 ----~~~~~-------~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                          ....+       ......++++.++|.+||+.||.+|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             HHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence                11111       122346789999999999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-42  Score=320.04  Aligned_cols=245  Identities=30%  Similarity=0.592  Sum_probs=209.4

Q ss_pred             eeeeeeCceEEEEEEECC-----ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecCC
Q 016082          116 CKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA  190 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~  190 (395)
                      ++||+|+||.||+|.+..     ..+|+|.++..... ...+++.+|+.++++++||||+++++++.. ...++||||++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAP   78 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCC
Confidence            479999999999998732     57999999866543 455789999999999999999999998764 46899999999


Q ss_pred             CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCcc----cc
Q 016082          191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM----TA  266 (395)
Q Consensus       191 ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~----~~  266 (395)
                      +|+|.+++... +.+++..+..++.|++.|+.|||+.+++||||||+||+++.++.++|+|||.++........    ..
T Consensus        79 ~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~  157 (257)
T cd05060          79 LGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA  157 (257)
T ss_pred             CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence            99999999764 47899999999999999999999999999999999999999999999999999865433211    11


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhc
Q 016082          267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ  345 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  345 (395)
                      ..++..|+|||.+.+..++.++|+||||+++|++++ |..||...+..+.... .....+...+..+++.+.++|.+||+
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~  236 (257)
T cd05060         158 GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAM-LESGERLPRPEECPQEIYSIMLSCWK  236 (257)
T ss_pred             ccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHH-HHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence            223568999999999999999999999999999998 9999988877654443 34445556777889999999999999


Q ss_pred             cCCCCCCCHHHHHHHHHHH
Q 016082          346 HDPTQRPNFSQITDILKQM  364 (395)
Q Consensus       346 ~dp~~RPs~~ell~~l~~~  364 (395)
                      .+|.+||++.++++.|+.+
T Consensus       237 ~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         237 YRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CChhhCcCHHHHHHHHHhc
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.3e-42  Score=326.57  Aligned_cols=248  Identities=21%  Similarity=0.355  Sum_probs=209.6

Q ss_pred             cceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCH-HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Q 016082          112 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  188 (395)
Q Consensus       112 ~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  188 (395)
                      |+..+.||+|+||+||+|++  +++.||+|+++...... .....+.+|+.++++++|+||+.+++++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            67788999999999999988  57899999997654322 2345678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCccccC
Q 016082          189 MARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE  267 (395)
Q Consensus       189 ~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~~  267 (395)
                      +++++|.+++... ...+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++............
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  161 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR  161 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccCC
Confidence            9999999988654 346999999999999999999999999999999999999999999999999999765443333455


Q ss_pred             CCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc--cCCCCCCCCCcHHHHHHHHHhhc
Q 016082          268 TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK--SLRPTIPKHAHPRLAELLERCWQ  345 (395)
Q Consensus       268 ~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~  345 (395)
                      .|+..|+|||.+.+..++.++|+||||+++|+|++|..||.+.........+...  ......+...++++.+++.+||+
T Consensus       162 ~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  241 (285)
T cd05632         162 VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLT  241 (285)
T ss_pred             CCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHcc
Confidence            7899999999999889999999999999999999999999887654332222221  11234556788999999999999


Q ss_pred             cCCCCCCC-----HHHHHH
Q 016082          346 HDPTQRPN-----FSQITD  359 (395)
Q Consensus       346 ~dp~~RPs-----~~ell~  359 (395)
                      .||++||+     +.+++.
T Consensus       242 ~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         242 KDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             CCHhHcCCCcccChHHHHc
Confidence            99999999     666665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-42  Score=320.94  Aligned_cols=249  Identities=32%  Similarity=0.557  Sum_probs=214.6

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      .++|++.+.||+|+||.||+|..  +++.+|+|++....  ....+.+.+|+.++++++||||+++++++.....+|++|
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~   79 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM   79 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc--hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence            35899999999999999999987  46789999997653  335678999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-ccc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT  265 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~  265 (395)
                      ||+++++|.+++......+++..+..++.|++.|+.|||+.||+|+||+|+||+++.++.++|+|||.+....... ...
T Consensus        80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  159 (262)
T cd06613          80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK  159 (262)
T ss_pred             eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccc
Confidence            9999999999998766789999999999999999999999999999999999999999999999999987654332 233


Q ss_pred             cCCCCcccccccccCCC---CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCC---CCCCCcHHHHHH
Q 016082          266 AETGTYRWMAPEVIEHK---PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT---IPKHAHPRLAEL  339 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~~~---~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~l  339 (395)
                      ...++..|+|||.+.+.   .++.++|+||||+++|+|++|+.||...++.+...........+.   .+...+.++.++
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  239 (262)
T cd06613         160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDF  239 (262)
T ss_pred             cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHH
Confidence            45788899999999776   889999999999999999999999998876665554443333322   233467889999


Q ss_pred             HHHhhccCCCCCCCHHHHHH
Q 016082          340 LERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       340 i~~cl~~dp~~RPs~~ell~  359 (395)
                      +++||+.+|.+||++.+++.
T Consensus       240 i~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         240 IKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             HHHHcCCChhhCCCHHHHhc
Confidence            99999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-42  Score=327.09  Aligned_cols=255  Identities=30%  Similarity=0.524  Sum_probs=218.2

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      .++|++.++||.|+||.||+|.+  ++..+|+|+++..  .....+.+.+|+.++++++||||+++++.+..+...|+||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI   81 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence            45799999999999999999987  4788999998754  3455678999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-Cccc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMT  265 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-~~~~  265 (395)
                      ||+++++|.+++......+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||.+...... ....
T Consensus        82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~  161 (280)
T cd06611          82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD  161 (280)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccc
Confidence            999999999999876678999999999999999999999999999999999999999999999999998654332 2223


Q ss_pred             cCCCCcccccccccC-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCC--CCCCCCcHHHHH
Q 016082          266 AETGTYRWMAPEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP--TIPKHAHPRLAE  338 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~-----~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~  338 (395)
                      ...+++.|+|||.+.     ..+++.++|+||||+++|+|++|+.||....+.+....... ...+  ..+..++.++.+
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  240 (280)
T cd06611         162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK-SEPPTLDQPSKWSSSFND  240 (280)
T ss_pred             eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc-CCCCCcCCcccCCHHHHH
Confidence            446889999999974     34578899999999999999999999998877665544332 2222  235568899999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhccc
Q 016082          339 LLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPN  375 (395)
Q Consensus       339 li~~cl~~dp~~RPs~~ell~~l~~~~~~~~~~~~~~  375 (395)
                      +|.+||+.+|.+||++.++++         +.|+...
T Consensus       241 li~~~l~~~p~~Rps~~~il~---------~~~~~~~  268 (280)
T cd06611         241 FLKSCLVKDPDDRPTAAELLK---------HPFVSDQ  268 (280)
T ss_pred             HHHHHhccChhhCcCHHHHhc---------Chhhccc
Confidence            999999999999999999987         5666554

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.6e-42  Score=323.53  Aligned_cols=255  Identities=25%  Similarity=0.479  Sum_probs=214.1

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      ++|++.+.||+|+||.||+|++  +++.+|||.+.... .+.....++.+|+.+++.++||||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4788999999999999999986  67899999886533 23445568899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-
Q 016082          187 EFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-  262 (395)
Q Consensus       187 E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-  262 (395)
                      ||+++++|.+++..   ....+++..++.++.+++.|+.|||++|++|+||||+||+++.++.++|+|||.+....... 
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence            99999999998864   24568999999999999999999999999999999999999999999999999987654332 


Q ss_pred             ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHhhhccCCCCCCCCCcHHHHHHH
Q 016082          263 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL--QAAVGVVQKSLRPTIPKHAHPRLAELL  340 (395)
Q Consensus       263 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li  340 (395)
                      ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+....  .....+......+..+...++++.+++
T Consensus       162 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  241 (267)
T cd08229         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLV  241 (267)
T ss_pred             ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHH
Confidence            223456889999999999989999999999999999999999999765432  222222222222233346788999999


Q ss_pred             HHhhccCCCCCCCHHHHHHHHHHH
Q 016082          341 ERCWQHDPTQRPNFSQITDILKQM  364 (395)
Q Consensus       341 ~~cl~~dp~~RPs~~ell~~l~~~  364 (395)
                      .+||+.+|++|||+.+|++.++++
T Consensus       242 ~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         242 NMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             HHhcCCCcccCCCHHHHHHHHhhh
Confidence            999999999999999999988875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=7.2e-43  Score=337.26  Aligned_cols=250  Identities=19%  Similarity=0.339  Sum_probs=210.3

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      ++|++.++||+|+||.||++++  +++.||+|+++... ........+.+|+.++..++|+||+++++++...+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            4799999999999999999987  56789999987532 12333456889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCcc--
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM--  264 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~--  264 (395)
                      ||++||+|.+++....+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++........  
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  160 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS  160 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence            999999999999876678999999999999999999999999999999999999999999999999999765443221  


Q ss_pred             ccCCCCcccccccccCC-----CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCC---CCcHHH
Q 016082          265 TAETGTYRWMAPEVIEH-----KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK---HAHPRL  336 (395)
Q Consensus       265 ~~~~gt~~y~aPE~~~~-----~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~l  336 (395)
                      ....||+.|+|||++.+     ..++.++|+||||+++|+|++|+.||...+..+....+.....+...|.   .++.++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~  240 (331)
T cd05624         161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEA  240 (331)
T ss_pred             ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHH
Confidence            23468999999999875     5688999999999999999999999998877766666555443333333   468999


Q ss_pred             HHHHHHhhccCCCC--CCCHHHHHH
Q 016082          337 AELLERCWQHDPTQ--RPNFSQITD  359 (395)
Q Consensus       337 ~~li~~cl~~dp~~--RPs~~ell~  359 (395)
                      .+++.+|+..++.+  |+++.++++
T Consensus       241 ~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         241 KDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             HHHHHHHccCchhhcCCCCHHHHhc
Confidence            99999999866544  467887765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.6e-42  Score=327.67  Aligned_cols=248  Identities=22%  Similarity=0.394  Sum_probs=208.9

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      .|++.+.||+|+||.||++.+  +++.||+|.+...... ......+.+|+.++++++|+|++.+++.+...+..|+|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            367788999999999999987  5789999998754332 2334567889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCcccc
Q 016082          188 FMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA  266 (395)
Q Consensus       188 ~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~  266 (395)
                      |++|++|.+++... ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++...........
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  160 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG  160 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccC
Confidence            99999999998653 34689999999999999999999999999999999999999999999999999976544333344


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHhhhccCCCCCCCCCcHHHHHHHHHh
Q 016082          267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL---QAAVGVVQKSLRPTIPKHAHPRLAELLERC  343 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  343 (395)
                      ..|+..|+|||++.+..++.++|+||+|+++|+|++|+.||......   ....... .......+..+++++.+++++|
T Consensus       161 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~  239 (285)
T cd05630         161 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-KEVQEEYSEKFSPDARSLCKML  239 (285)
T ss_pred             CCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh-hhhhhhcCccCCHHHHHHHHHH
Confidence            57899999999999999999999999999999999999999875432   1111211 2223345667889999999999


Q ss_pred             hccCCCCCCC-----HHHHHH
Q 016082          344 WQHDPTQRPN-----FSQITD  359 (395)
Q Consensus       344 l~~dp~~RPs-----~~ell~  359 (395)
                      |+.||.+|||     +.++++
T Consensus       240 l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         240 LCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             hhcCHHHccCCCCCchHHHHc
Confidence            9999999999     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-43  Score=339.88  Aligned_cols=262  Identities=29%  Similarity=0.556  Sum_probs=223.9

Q ss_pred             CCceeecccCcceeeeeeeeCceEEEEEEECC-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 016082          102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  180 (395)
Q Consensus       102 ~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (395)
                      ....++..+.+.+.++||+|-||.|.++.-.+ ..||||+++++. +.+...+|..|+++|.+++||||+.++|+|..++
T Consensus       530 ~al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De  608 (807)
T KOG1094|consen  530 PALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD  608 (807)
T ss_pred             cchhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC
Confidence            44567888999999999999999999998866 899999999875 4556789999999999999999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHhhccCCC-CHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  259 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~~~l-~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~  259 (395)
                      .+|+|+|||++|+|.+++..+..+. .......++.||+.||+||.+.+++||||.++|+|++.++++||+|||++|..-
T Consensus       609 PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly  688 (807)
T KOG1094|consen  609 PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLY  688 (807)
T ss_pred             chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccc
Confidence            9999999999999999998864333 555667899999999999999999999999999999999999999999998543


Q ss_pred             cCCcc---ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHhhh---ccC---CCCC
Q 016082          260 QSGVM---TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT--GELPYAGLTPLQAAVGVVQ---KSL---RPTI  328 (395)
Q Consensus       260 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt--g~~pf~~~~~~~~~~~~~~---~~~---~~~~  328 (395)
                      .....   ....-..+|||||.+..++++.++|||+||+++||+++  ...||+.++..+...+...   .+-   -+..
T Consensus       689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~  768 (807)
T KOG1094|consen  689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSR  768 (807)
T ss_pred             cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccC
Confidence            32211   12244689999999999999999999999999999877  7899999988776554321   111   2345


Q ss_pred             CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 016082          329 PKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQM  364 (395)
Q Consensus       329 ~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~  364 (395)
                      |.-++.++.++|.+||..+-.+||+|+++-..|++.
T Consensus       769 P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  769 PPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             CCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            678999999999999999999999999998877653

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1e-42  Score=352.86  Aligned_cols=259  Identities=24%  Similarity=0.431  Sum_probs=220.3

Q ss_pred             CCceeecccCcceeeeeeeeCceEEEEEEEC-C-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEEEE-e
Q 016082          102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC-S-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGAC-T  177 (395)
Q Consensus       102 ~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~-~-~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~-~  177 (395)
                      +...+|..-++++.+.|++|||+.||+|+.. + ..+|+|.+-..  ++...+...+||.+|++|. |+|||.+++.. .
T Consensus        29 G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~  106 (738)
T KOG1989|consen   29 GQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAI  106 (738)
T ss_pred             ceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence            4678899999999999999999999999983 3 79999998655  6888899999999999998 99999999932 1


Q ss_pred             cC------CcEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCeeeCCCCcEE
Q 016082          178 RP------PNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGVVK  248 (395)
Q Consensus       178 ~~------~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~--iiHrDlkp~NiLl~~~~~vk  248 (395)
                      ..      -.++|.||||.||+|-|+++++ ...|++.++++|+.|+++|+.+||..+  |||||||-+|||++.+|+.|
T Consensus       107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~K  186 (738)
T KOG1989|consen  107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYK  186 (738)
T ss_pred             cccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEE
Confidence            11      2478999999999999999865 456999999999999999999999997  99999999999999999999


Q ss_pred             EeeeccccccccCCcc----------ccCCCCcccccccccC---CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 016082          249 VADFGVARVQAQSGVM----------TAETGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQA  315 (395)
Q Consensus       249 l~DFg~a~~~~~~~~~----------~~~~gt~~y~aPE~~~---~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~  315 (395)
                      |||||.|.........          ....-|+.|+|||.++   +.+.++|+|||+|||+||-|+....||+...... 
T Consensus       187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la-  265 (738)
T KOG1989|consen  187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA-  265 (738)
T ss_pred             eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee-
Confidence            9999999754332211          1124689999999875   7789999999999999999999999999875443 


Q ss_pred             HHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 016082          316 AVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK  366 (395)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~  366 (395)
                         ++...+.-+..+.++..+.+||+.||+.||.+||++-|++..+..+..
T Consensus       266 ---Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  266 ---ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             ---EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence               333444434446789999999999999999999999999999888765

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.4e-42  Score=320.56  Aligned_cols=245  Identities=31%  Similarity=0.646  Sum_probs=212.8

Q ss_pred             eeeeeeCceEEEEEEECC-----ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecCC
Q 016082          116 CKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA  190 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~  190 (395)
                      ++||+|++|.||+|.+..     ..||||.++..... ...+.+.+|+.++++++||||+++++.+.. ...++||||++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP   78 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence            468999999999998732     36999999877543 567889999999999999999999999988 88999999999


Q ss_pred             CCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC----ccc
Q 016082          191 RGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG----VMT  265 (395)
Q Consensus       191 ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~----~~~  265 (395)
                      +++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||.++......    ...
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  158 (257)
T cd05040          79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEE  158 (257)
T ss_pred             CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceeccc
Confidence            999999998755 578999999999999999999999999999999999999999999999999998654421    112


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhh
Q 016082          266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW  344 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  344 (395)
                      ...++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+.........+...+..+.+++.+||
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  238 (257)
T cd05040         159 HLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCW  238 (257)
T ss_pred             CCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHC
Confidence            3456788999999999999999999999999999998 999998888777665555444555566678899999999999


Q ss_pred             ccCCCCCCCHHHHHHHHH
Q 016082          345 QHDPTQRPNFSQITDILK  362 (395)
Q Consensus       345 ~~dp~~RPs~~ell~~l~  362 (395)
                      +.+|.+||++.++++.|.
T Consensus       239 ~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         239 AHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCCcccCCCHHHHHHHhc
Confidence            999999999999998774

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.3e-42  Score=320.59  Aligned_cols=247  Identities=31%  Similarity=0.604  Sum_probs=213.1

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCC-------HHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-------TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  181 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  181 (395)
                      +|.+.+.||.|+||.||+|.+  .++.+|+|.+......       ....+.+.+|+.++++++||||+++++++.....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            467888999999999999987  5688999998654332       1234678899999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC
Q 016082          182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  261 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~  261 (395)
                      .++||||+++++|.+++.. .+.++...+..++.+++.||.|||++|++||||+|+||++++++.++|+|||.++.....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN  159 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence            9999999999999999976 467899999999999999999999999999999999999999999999999998765422


Q ss_pred             C-------ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcH
Q 016082          262 G-------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP  334 (395)
Q Consensus       262 ~-------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (395)
                      .       ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+...... ....+..+...+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~  238 (267)
T cd06628         160 SLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG-ENASPEIPSNISS  238 (267)
T ss_pred             cccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHh-ccCCCcCCcccCH
Confidence            1       1112357889999999998889999999999999999999999999877655444432 3556777888999


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          335 RLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       335 ~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      ++.++|++||+.+|.+||++.++++
T Consensus       239 ~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         239 EAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             HHHHHHHHHccCCchhCcCHHHHhh
Confidence            9999999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3.8e-43  Score=338.22  Aligned_cols=238  Identities=26%  Similarity=0.411  Sum_probs=201.7

Q ss_pred             eeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHH-HHHhcCCCceeeEEEEEecCCcEEEEEecCCC
Q 016082          116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVY-IMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR  191 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~g  191 (395)
                      +.||+|+||.||+|++  +++.||+|+++.... +......+..|.. +++.++||||+++++++...+..|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999987  578999999975422 2233345556655 56778999999999999999999999999999


Q ss_pred             CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc-CCccccCCCC
Q 016082          192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT  270 (395)
Q Consensus       192 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~-~~~~~~~~gt  270 (395)
                      |+|..++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus        81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (325)
T cd05604          81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGT  159 (325)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCC
Confidence            999998876 56789999999999999999999999999999999999999999999999999875322 2233445789


Q ss_pred             cccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCC
Q 016082          271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ  350 (395)
Q Consensus       271 ~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~  350 (395)
                      +.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+...  ....++..+.++.+++++|++.+|.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ll~~ll~~~p~~  237 (325)
T cd05604         160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK--PLVLRPGASLTAWSILEELLEKDRQR  237 (325)
T ss_pred             hhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC--CccCCCCCCHHHHHHHHHHhccCHHh
Confidence            9999999999999999999999999999999999999988877666555443  23445568899999999999999999


Q ss_pred             CCCHHH
Q 016082          351 RPNFSQ  356 (395)
Q Consensus       351 RPs~~e  356 (395)
                      ||++.+
T Consensus       238 R~~~~~  243 (325)
T cd05604         238 RLGAKE  243 (325)
T ss_pred             cCCCCC
Confidence            998764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.2e-42  Score=330.38  Aligned_cols=249  Identities=21%  Similarity=0.377  Sum_probs=206.7

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      .++|.+.++||+|+||.||+|++  +++.||+|.++.... ......+.+|+.++++++||||+++++++..++..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   83 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF   83 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence            35799999999999999999987  567899999975532 222346778999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-ccc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT  265 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~  265 (395)
                      ||+++ +|.+++......++...+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++...... ...
T Consensus        84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  162 (309)
T cd07872          84 EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYS  162 (309)
T ss_pred             eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccccc
Confidence            99976 8999887766778999999999999999999999999999999999999999999999999997543322 223


Q ss_pred             cCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc---------------------
Q 016082          266 AETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS---------------------  323 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~---------------------  323 (395)
                      ...+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+..+....+....                     
T Consensus       163 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
T cd07872         163 NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYN  242 (309)
T ss_pred             cccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhh
Confidence            4567899999998865 568999999999999999999999998876554433222110                     


Q ss_pred             CCCC-------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          324 LRPT-------IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       324 ~~~~-------~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      ....       ....+++++.++|.+||+.||.+|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         243 FPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             cCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            0000       11246789999999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=5e-43  Score=336.78  Aligned_cols=237  Identities=24%  Similarity=0.406  Sum_probs=200.9

Q ss_pred             eeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHH-HHHhcCCCceeeEEEEEecCCcEEEEEecCCC
Q 016082          116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVY-IMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR  191 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~g  191 (395)
                      +.||+|+||.||+|++  .++.||+|++..... .......+..|.. +++.++||||+++++++.+.+..|+||||++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999988  568899999975432 2223344555554 67889999999999999999999999999999


Q ss_pred             CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc-CCccccCCCC
Q 016082          192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT  270 (395)
Q Consensus       192 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~-~~~~~~~~gt  270 (395)
                      |+|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.... ........||
T Consensus        81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (321)
T cd05603          81 GELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGT  159 (321)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCC
Confidence            999998865 56789999999999999999999999999999999999999999999999999875322 2223445789


Q ss_pred             cccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCC
Q 016082          271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ  350 (395)
Q Consensus       271 ~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~  350 (395)
                      +.|+|||++.+..++.++|||||||++|||++|..||...+..+....+...  ....|...+.++.+++.+||+.||.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~~p~~  237 (321)
T cd05603         160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK--PLQLPGGKTVAACDLLVGLLHKDQRR  237 (321)
T ss_pred             cccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHccCCHhh
Confidence            9999999999999999999999999999999999999988776665555433  34566778899999999999999999


Q ss_pred             CCCHH
Q 016082          351 RPNFS  355 (395)
Q Consensus       351 RPs~~  355 (395)
                      ||+..
T Consensus       238 R~~~~  242 (321)
T cd05603         238 RLGAK  242 (321)
T ss_pred             cCCCC
Confidence            99864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=5.4e-43  Score=344.97  Aligned_cols=260  Identities=28%  Similarity=0.442  Sum_probs=219.3

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-C-----CceeeEEEEEecCCcE
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-H-----KNVVQFIGACTRPPNL  182 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~  182 (395)
                      +|.+.+.||+|+||.|-+|.+  +++.||||+++..   .....+...|+.+|..++ |     -|+|+++++|...+++
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl  263 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL  263 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence            789999999999999999988  5799999999865   456677888999999997 4     5899999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCC--cEEEeeeccccccc
Q 016082          183 CIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG--VVKVADFGVARVQA  259 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~--~vkl~DFg~a~~~~  259 (395)
                      |||+|.++- +|+++++.++ .+|+...++.++.||+.||..||+.||||+||||+|||+.+.+  .|||+|||+|+...
T Consensus       264 ciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~  342 (586)
T KOG0667|consen  264 CIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES  342 (586)
T ss_pred             eeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccC
Confidence            999999966 9999998764 5699999999999999999999999999999999999997644  69999999999776


Q ss_pred             cCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc----------------
Q 016082          260 QSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS----------------  323 (395)
Q Consensus       260 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~----------------  323 (395)
                      +...  .+..+..|+|||++.|.+|+.+.|+|||||++.||++|.+.|.|.++.+....++.-.                
T Consensus       343 q~vy--tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~k  420 (586)
T KOG0667|consen  343 QRVY--TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHK  420 (586)
T ss_pred             Ccce--eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccce
Confidence            6543  6788999999999999999999999999999999999999999988776665543200                


Q ss_pred             ----------------------------------CCCCCC-----------CCCcHHHHHHHHHhhccCCCCCCCHHHHH
Q 016082          324 ----------------------------------LRPTIP-----------KHAHPRLAELLERCWQHDPTQRPNFSQIT  358 (395)
Q Consensus       324 ----------------------------------~~~~~~-----------~~~~~~l~~li~~cl~~dp~~RPs~~ell  358 (395)
                                                        .....|           ..-...+.+++.+||..||.+|+|..|.+
T Consensus       421 ff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal  500 (586)
T KOG0667|consen  421 FFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQAL  500 (586)
T ss_pred             ehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHh
Confidence                                              000011           01234689999999999999999999998


Q ss_pred             HHHHHHHHHHHHhhccccccccccccc
Q 016082          359 DILKQMMKEVLYWLSPNLINTNIQSTY  385 (395)
Q Consensus       359 ~~l~~~~~~~~~~~~~~~~~~~~~~~~  385 (395)
                      +         +-|++..-..-+.+.++
T Consensus       501 ~---------Hpfl~~~~~~~~~~~~~  518 (586)
T KOG0667|consen  501 N---------HPFLTGTSLERRNQSPL  518 (586)
T ss_pred             c---------CcccccccccccCCCCc
Confidence            8         77877655555544443

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=7.3e-42  Score=317.08  Aligned_cols=249  Identities=23%  Similarity=0.436  Sum_probs=218.3

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  188 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  188 (395)
                      +|++.+.||.|+||.||.++.  .++.+++|.+.....+......+.+|+.++++++|+||+++++++...+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            588999999999998888776  678899999876665666677899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-cccc
Q 016082          189 MARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA  266 (395)
Q Consensus       189 ~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~~  266 (395)
                      +++++|.+++... ...++...+..++.+++.|+.|||+.|++|+||+|+||+++.++.+||+|||.++...... ....
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET  160 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccc
Confidence            9999999999765 4568999999999999999999999999999999999999999999999999997654433 2344


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhcc
Q 016082          267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH  346 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  346 (395)
                      ..+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+.... .+..+...+.++.+++.+||+.
T Consensus       161 ~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~  239 (256)
T cd08221         161 VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGN-YTPVVSVYSSELISLVHSLLQQ  239 (256)
T ss_pred             cCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-CCCCccccCHHHHHHHHHHccc
Confidence            578999999999988889999999999999999999999999877766665554433 3445567889999999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 016082          347 DPTQRPNFSQITDI  360 (395)
Q Consensus       347 dp~~RPs~~ell~~  360 (395)
                      +|.+||++.++++.
T Consensus       240 ~p~~R~s~~~ll~~  253 (256)
T cd08221         240 DPEKRPTADEVLDQ  253 (256)
T ss_pred             CcccCCCHHHHhhC
Confidence            99999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=5.3e-43  Score=324.82  Aligned_cols=247  Identities=33%  Similarity=0.587  Sum_probs=207.7

Q ss_pred             cceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecC
Q 016082          112 LKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM  189 (395)
Q Consensus       112 ~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  189 (395)
                      |++.+.||+|+||.||+++..  ++.||+|++..............+|+.++++++||||+++++++......++|||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            688999999999999999984  467999999877544444445567999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccc-ccCCccccCC
Q 016082          190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ-AQSGVMTAET  268 (395)
Q Consensus       190 ~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~-~~~~~~~~~~  268 (395)
                      .+++|.+++.. .+.++...+..++.|+++||++||+.||+|+||||+||+++.++.++|+|||.+... ..........
T Consensus        81 ~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  159 (260)
T PF00069_consen   81 PGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV  159 (260)
T ss_dssp             TTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred             ccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999983 577899999999999999999999999999999999999999999999999999753 2333445667


Q ss_pred             CCcccccccccC-CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HhhhccCCC--CCCCCCcHHHHHHHHH
Q 016082          269 GTYRWMAPEVIE-HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAV---GVVQKSLRP--TIPKHAHPRLAELLER  342 (395)
Q Consensus       269 gt~~y~aPE~~~-~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~---~~~~~~~~~--~~~~~~~~~l~~li~~  342 (395)
                      ++..|+|||++. +..++.++|+||+|+++|+|++|..||..........   .........  ......++++.+++.+
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  239 (260)
T PF00069_consen  160 GTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKK  239 (260)
T ss_dssp             SSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHH
Confidence            899999999998 8889999999999999999999999999873322222   222111111  1112234899999999


Q ss_pred             hhccCCCCCCCHHHHHH
Q 016082          343 CWQHDPTQRPNFSQITD  359 (395)
Q Consensus       343 cl~~dp~~RPs~~ell~  359 (395)
                      ||+.||++||++.++++
T Consensus       240 ~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  240 MLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HSSSSGGGSTTHHHHHT
T ss_pred             HccCChhHCcCHHHHhc
Confidence            99999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=6.1e-42  Score=319.44  Aligned_cols=248  Identities=29%  Similarity=0.553  Sum_probs=212.7

Q ss_pred             CcceeeeeeeeCceEEEEEEE-CCceEEEEEecCCCC----CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Q 016082          111 QLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECV----NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  185 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~-~~~~vAvK~~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  185 (395)
                      +|++.+.||.|+||.||+|.. +++.+|+|.++....    .......+.+|+.++++++|+||+++++++......++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            478899999999999999987 678899999875432    123446689999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC----
Q 016082          186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS----  261 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~----  261 (395)
                      +||++|++|.+++.. .++++...+..++.|++.||+|||+.+|+|+||+|+||++++++.++|+|||.+......    
T Consensus        81 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  159 (265)
T cd06631          81 MEFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG  159 (265)
T ss_pred             EecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence            999999999999976 457899999999999999999999999999999999999999999999999998754221    


Q ss_pred             ---CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc-cCCCCCCCCCcHHHH
Q 016082          262 ---GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK-SLRPTIPKHAHPRLA  337 (395)
Q Consensus       262 ---~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~  337 (395)
                         .......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+........... ...+..+...+.++.
T Consensus       160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (265)
T cd06631         160 THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAI  239 (265)
T ss_pred             cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHH
Confidence               1122346889999999999988999999999999999999999999887665544333322 345667778899999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHH
Q 016082          338 ELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       338 ~li~~cl~~dp~~RPs~~ell~  359 (395)
                      ++|++||+.+|.+||++.+++.
T Consensus       240 ~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         240 DFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             HHHHHHhcCCcccCCCHHHHhc
Confidence            9999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.1e-42  Score=336.10  Aligned_cols=251  Identities=20%  Similarity=0.344  Sum_probs=210.9

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      ++|++.++||+|+||.||+++.  .++.+|+|++.... ........+.+|+.++..++|+||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            4789999999999999999987  46789999986422 12233456889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCc--c
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV--M  264 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~--~  264 (395)
                      ||+++|+|.+++++....+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++........  .
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~  160 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS  160 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence            99999999999987667899999999999999999999999999999999999999999999999999875433222  2


Q ss_pred             ccCCCCcccccccccC-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCC---CCCcHHH
Q 016082          265 TAETGTYRWMAPEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP---KHAHPRL  336 (395)
Q Consensus       265 ~~~~gt~~y~aPE~~~-----~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l  336 (395)
                      ....||+.|+|||++.     ...++.++|||||||++|||++|+.||...+..+....+.....+...|   ..+++++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~  240 (332)
T cd05623         161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDA  240 (332)
T ss_pred             cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHH
Confidence            2357899999999986     3468899999999999999999999999988877776665544333333   4579999


Q ss_pred             HHHHHHhhccCCCC--CCCHHHHHHH
Q 016082          337 AELLERCWQHDPTQ--RPNFSQITDI  360 (395)
Q Consensus       337 ~~li~~cl~~dp~~--RPs~~ell~~  360 (395)
                      .+++++|+..++..  |+++.++++.
T Consensus       241 ~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         241 KDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             HHHHHHHccChhhhcCCCCHHHHhCC
Confidence            99999999664443  6889988863

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.3e-42  Score=334.82  Aligned_cols=237  Identities=22%  Similarity=0.398  Sum_probs=199.9

Q ss_pred             eeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcEEEEEecCCC
Q 016082          116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMAR  191 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~g  191 (395)
                      +.||+|+||.||+|+.  +++.||+|+++.... .....+.+.+|+.++.++ +||||+++++++.....+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999987  568899999986543 234456788999999988 599999999999999999999999999


Q ss_pred             CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc-CCccccCCCC
Q 016082          192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT  270 (395)
Q Consensus       192 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~-~~~~~~~~gt  270 (395)
                      |+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.... ........||
T Consensus        81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (327)
T cd05617          81 GDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGT  159 (327)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCC
Confidence            999998865 45799999999999999999999999999999999999999999999999999875322 2233446799


Q ss_pred             cccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhh
Q 016082          271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL------TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW  344 (395)
Q Consensus       271 ~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  344 (395)
                      +.|+|||++.+..++.++|||||||++|+|++|+.||...      ...+....... .....+|...+..+.+++.+||
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~li~~~L  238 (327)
T cd05617         160 PNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL-EKPIRIPRFLSVKASHVLKGFL  238 (327)
T ss_pred             cccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH-hCCCCCCCCCCHHHHHHHHHHh
Confidence            9999999999999999999999999999999999999642      12222222222 2234567788999999999999


Q ss_pred             ccCCCCCCCH
Q 016082          345 QHDPTQRPNF  354 (395)
Q Consensus       345 ~~dp~~RPs~  354 (395)
                      +.||.+||++
T Consensus       239 ~~dP~~R~~~  248 (327)
T cd05617         239 NKDPKERLGC  248 (327)
T ss_pred             ccCHHHcCCC
Confidence            9999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=5.6e-42  Score=318.96  Aligned_cols=249  Identities=31%  Similarity=0.579  Sum_probs=207.7

Q ss_pred             eeeeeeCceEEEEEEEC-----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEe-cCCcEEEEEecC
Q 016082          116 CKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT-RPPNLCIVTEFM  189 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lV~E~~  189 (395)
                      +.||+|+||.||+|.+.     ...||+|.+.... .....+.+.+|+.+++.++||||+++++++. .++..++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   79 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM   79 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence            46899999999999862     2469999986432 3445678899999999999999999999875 455689999999


Q ss_pred             CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-----cc
Q 016082          190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-----VM  264 (395)
Q Consensus       190 ~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-----~~  264 (395)
                      .+|+|.++++......+...+..++.++++|+.|||+.+++||||||+||++++++.+||+|||+++......     ..
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~  159 (262)
T cd05058          80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH  159 (262)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence            9999999998766667888889999999999999999999999999999999999999999999997543221     11


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHh
Q 016082          265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC  343 (395)
Q Consensus       265 ~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  343 (395)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |.+||...+..+.... .....++..+...++.+.+++.+|
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~c  238 (262)
T cd05058         160 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVY-LLQGRRLLQPEYCPDPLYEVMLSC  238 (262)
T ss_pred             ccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HhcCCCCCCCCcCCHHHHHHHHHH
Confidence            23345778999999988899999999999999999999 5778887776654444 333445556677889999999999


Q ss_pred             hccCCCCCCCHHHHHHHHHHHHH
Q 016082          344 WQHDPTQRPNFSQITDILKQMMK  366 (395)
Q Consensus       344 l~~dp~~RPs~~ell~~l~~~~~  366 (395)
                      |+.+|++||++.++++.|++++.
T Consensus       239 l~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         239 WHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             cCCChhhCCCHHHHHHHHHHHhc
Confidence            99999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=5.3e-42  Score=324.83  Aligned_cols=251  Identities=28%  Similarity=0.491  Sum_probs=213.3

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  184 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  184 (395)
                      ...+.|++.++||.|+||.||+|+.  +++.||+|++...  +....+.+.+|+.++++++||||+++++.+..+...|+
T Consensus         9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (292)
T cd06644           9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI   86 (292)
T ss_pred             CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence            3446799999999999999999987  4688999998754  35556789999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-Cc
Q 016082          185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GV  263 (395)
Q Consensus       185 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-~~  263 (395)
                      ||||+++++|..++.+....+++..+..++.|++.++.|||+.|++||||||+||+++.++.++|+|||.+...... ..
T Consensus        87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~  166 (292)
T cd06644          87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR  166 (292)
T ss_pred             EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence            99999999999988766677999999999999999999999999999999999999999999999999998653322 22


Q ss_pred             cccCCCCcccccccccC-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccC-CCCCCCCCcHHHH
Q 016082          264 MTAETGTYRWMAPEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL-RPTIPKHAHPRLA  337 (395)
Q Consensus       264 ~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~  337 (395)
                      .....+++.|+|||.+.     ...++.++|+|||||++|+|++|..||...++.+.......... ....+..++.++.
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (292)
T cd06644         167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFR  246 (292)
T ss_pred             cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHH
Confidence            23456889999999984     34578899999999999999999999988776655444332211 1223456788999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHH
Q 016082          338 ELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       338 ~li~~cl~~dp~~RPs~~ell~  359 (395)
                      ++|.+||+.+|++||++.++++
T Consensus       247 ~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         247 DFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             HHHHHHhcCCcccCcCHHHHhc
Confidence            9999999999999999999986

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-42  Score=336.02  Aligned_cols=256  Identities=25%  Similarity=0.462  Sum_probs=228.1

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCcEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCI  184 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  184 (395)
                      ...|.+.+.||+|.||.||+++.  +|+.+|+|++++.... ......+.+|+.+|+++. ||||+++++++++...+++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            45799999999999999999987  5789999999766543 234568899999999999 9999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCC----CcEEEeeecccccccc
Q 016082          185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN----GVVKVADFGVARVQAQ  260 (395)
Q Consensus       185 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~----~~vkl~DFg~a~~~~~  260 (395)
                      |||++.||.|.+.+...  .+++..+..++.|++.++.|||+.||+||||||+|+|+...    +.+|++|||+|.....
T Consensus       114 vmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~  191 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP  191 (382)
T ss_pred             EEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence            99999999999999876  39999999999999999999999999999999999999643    4799999999998777


Q ss_pred             CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCC--CCCCCCcHHHHH
Q 016082          261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP--TIPKHAHPRLAE  338 (395)
Q Consensus       261 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~  338 (395)
                      .......+||+.|+|||++...+|+..+|+||+|+++|.|++|.+||.+.+.......+....+.-  +.-..++..+.+
T Consensus       192 ~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd  271 (382)
T KOG0032|consen  192 GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKD  271 (382)
T ss_pred             CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHH
Confidence            666777899999999999999999999999999999999999999999999888877776654432  223457999999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhccc
Q 016082          339 LLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPN  375 (395)
Q Consensus       339 li~~cl~~dp~~RPs~~ell~~l~~~~~~~~~~~~~~  375 (395)
                      +|++|+..||..|+++.++++         +-|++..
T Consensus       272 ~i~~ll~~dp~~R~ta~~~L~---------HpWi~~~  299 (382)
T KOG0032|consen  272 FIRKLLEFDPRKRLTAAQALQ---------HPWIKSI  299 (382)
T ss_pred             HHHHhcccCcccCCCHHHHhc---------CccccCC
Confidence            999999999999999999998         6777764

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.6e-42  Score=324.73  Aligned_cols=255  Identities=28%  Similarity=0.555  Sum_probs=211.3

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--C
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--P  180 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~  180 (395)
                      ..-|++.+.||+|+||.||++++      .+..||+|.++... .......+.+|+.++++++|||++++++++...  .
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence            34679999999999999999874      46789999987653 344557899999999999999999999998775  5


Q ss_pred             cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                      ..++||||++|++|.+++......+++..+..++.+++.||+|||++|++||||||+||+++.++.++|+|||+++....
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            68999999999999999977656789999999999999999999999999999999999999999999999999986543


Q ss_pred             CCc----cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC--------------HHHHHHHhhhc
Q 016082          261 SGV----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT--------------PLQAAVGVVQK  322 (395)
Q Consensus       261 ~~~----~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~--------------~~~~~~~~~~~  322 (395)
                      ...    .....++..|+|||.+.+..++.++||||||+++|+|++++.|+....              ...........
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE  241 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence            321    123346678999999988889999999999999999999876643211              11112222333


Q ss_pred             cCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 016082          323 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQM  364 (395)
Q Consensus       323 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~  364 (395)
                      ..+.+.+..+++++.+++.+||+.+|.+||++.++++.++.+
T Consensus       242 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            444555677899999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=4.6e-42  Score=326.01  Aligned_cols=254  Identities=29%  Similarity=0.563  Sum_probs=209.8

Q ss_pred             cccCcceeeeeeeeCceEEEEEEEC------------------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCce
Q 016082          108 DAKQLKIECKVASGSYGDLYKGTYC------------------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV  169 (395)
Q Consensus       108 ~~~~~~i~~~lg~G~~G~Vy~~~~~------------------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  169 (395)
                      ..++|++.++||+|+||.||++.+.                  +..||+|+++... .......+.+|+.++++++|+||
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i   81 (296)
T cd05095           3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNI   81 (296)
T ss_pred             ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCc
Confidence            3568999999999999999998642                  2358999997553 34456789999999999999999


Q ss_pred             eeEEEEEecCCcEEEEEecCCCCCHHHHHhhcc----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 016082          170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK----------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANL  239 (395)
Q Consensus       170 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~Ni  239 (395)
                      +++++++...+..++||||+.+++|.+++....          ..+++.++..++.|++.|++|||+.|++||||||+||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni  161 (296)
T cd05095          82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC  161 (296)
T ss_pred             ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence            999999999999999999999999999997642          2366778999999999999999999999999999999


Q ss_pred             eeCCCCcEEEeeeccccccccCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh--CCCCCCCCCHHH
Q 016082          240 LMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT--GELPYAGLTPLQ  314 (395)
Q Consensus       240 Ll~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt--g~~pf~~~~~~~  314 (395)
                      +++.++.++|+|||.++.......   .....++..|+|||...+..++.++|+|||||++|||++  |..||...+..+
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999975433221   112234678999999888889999999999999999998  789998776655


Q ss_pred             HHHHhhh------ccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 016082          315 AAVGVVQ------KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK  362 (395)
Q Consensus       315 ~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~  362 (395)
                      .......      .....+.+..+++.+.+++.+||+.||.+||++.+|++.|+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         242 VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            4332211      11122345567899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-43  Score=335.40  Aligned_cols=249  Identities=23%  Similarity=0.429  Sum_probs=230.1

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      ..-|.+.+.||+|-|.+|-+|++  +|..||||++.+...++-.-..+.+|+..|+-++|||||++|.+......+|||+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            34789999999999999999987  8999999999988888777788999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeC-CCCcEEEeeeccccccccCCccc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVARVQAQSGVMT  265 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~-~~~~vkl~DFg~a~~~~~~~~~~  265 (395)
                      |.-.+|+|+||+-++...+.+..+.+++.||+.|+.|+|+..++||||||+||.+- .-|.|||.|||++..+......+
T Consensus        97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~  176 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLT  176 (864)
T ss_pred             EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhh
Confidence            99999999999999888999999999999999999999999999999999998774 57899999999998888877888


Q ss_pred             cCCCCcccccccccCCCCCC-ChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhh
Q 016082          266 AETGTYRWMAPEVIEHKPYD-YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW  344 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~~~~~~-~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  344 (395)
                      ..+|+..|.|||++.|..|+ ++.||||||++||-|.+|++||...+..+....++.=  ...+|.+++.+++++|..||
T Consensus       177 TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDC--KYtvPshvS~eCrdLI~sML  254 (864)
T KOG4717|consen  177 TSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDC--KYTVPSHVSKECRDLIQSML  254 (864)
T ss_pred             cccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcc--cccCchhhhHHHHHHHHHHH
Confidence            89999999999999999998 5789999999999999999999988877776666543  45689999999999999999


Q ss_pred             ccCCCCCCCHHHHHH
Q 016082          345 QHDPTQRPNFSQITD  359 (395)
Q Consensus       345 ~~dp~~RPs~~ell~  359 (395)
                      ..||.+|.+.++|..
T Consensus       255 vRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  255 VRDPKKRASLEEIVS  269 (864)
T ss_pred             hcCchhhccHHHHhc
Confidence            999999999999976

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=6.4e-42  Score=317.06  Aligned_cols=248  Identities=24%  Similarity=0.432  Sum_probs=217.0

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  188 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  188 (395)
                      +|.+.+.||+|+||.||++..  +++.+|+|.+.....+......+.+|+.++++++|||++++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            488899999999999999876  678899999987665666678899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCC-cEEEeeeccccccccCCcccc
Q 016082          189 MARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQSGVMTA  266 (395)
Q Consensus       189 ~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~-~vkl~DFg~a~~~~~~~~~~~  266 (395)
                      +++++|.+++.... ..+++..+..++.+++.|+.|||++|++|+||+|+||+++.++ .++|+|||.+...........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~  160 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT  160 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccc
Confidence            99999999997753 4589999999999999999999999999999999999998654 689999999987655444344


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhcc
Q 016082          267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH  346 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  346 (395)
                      ..++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......... .....++..+++++.+++.+||+.
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~  239 (256)
T cd08220         161 VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS-GTFAPISDRYSPDLRQLILSMLNL  239 (256)
T ss_pred             cccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh-cCCCCCCCCcCHHHHHHHHHHccC
Confidence            5788999999999988899999999999999999999999988776655555443 334456677899999999999999


Q ss_pred             CCCCCCCHHHHHH
Q 016082          347 DPTQRPNFSQITD  359 (395)
Q Consensus       347 dp~~RPs~~ell~  359 (395)
                      +|.+|||+.++++
T Consensus       240 ~p~~Rpt~~~ll~  252 (256)
T cd08220         240 DPSKRPQLSQIMA  252 (256)
T ss_pred             ChhhCCCHHHHhh
Confidence            9999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-44  Score=344.05  Aligned_cols=245  Identities=31%  Similarity=0.509  Sum_probs=219.3

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      ..|.-++.||.|+||.||-|++  +.+.||||.+.... ...+...++..|+..|++++|||++.+-|++......++||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            3577889999999999999987  67889999997554 34556788999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCcccc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA  266 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~  266 (395)
                      |||-| |-.|++.-...++.+..+..|+.+.+.||.|||+.+.||||||+.|||+++.|.|||+|||.|......   ..
T Consensus       106 EYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---ns  181 (948)
T KOG0577|consen  106 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---NS  181 (948)
T ss_pred             HHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch---hc
Confidence            99966 999999888889999999999999999999999999999999999999999999999999999876543   56


Q ss_pred             CCCCcccccccccC---CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCC-CCCCcHHHHHHHHH
Q 016082          267 ETGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI-PKHAHPRLAELLER  342 (395)
Q Consensus       267 ~~gt~~y~aPE~~~---~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~  342 (395)
                      ..|||.|||||++.   .+.|+-|+||||||++..||...++|+..++.-.+...+.+.. .|.+ ..+++..++.|+..
T Consensus       182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe-sPtLqs~eWS~~F~~Fvd~  260 (948)
T KOG0577|consen  182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SPTLQSNEWSDYFRNFVDS  260 (948)
T ss_pred             ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC-CCCCCCchhHHHHHHHHHH
Confidence            79999999999974   5689999999999999999999999999999888777766644 4444 46799999999999


Q ss_pred             hhccCCCCCCCHHHHHH
Q 016082          343 CWQHDPTQRPNFSQITD  359 (395)
Q Consensus       343 cl~~dp~~RPs~~ell~  359 (395)
                      ||++-|.+|||.++++.
T Consensus       261 CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  261 CLQKIPQERPTSEELLK  277 (948)
T ss_pred             HHhhCcccCCcHHHHhh
Confidence            99999999999999874

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.2e-41  Score=315.57  Aligned_cols=248  Identities=27%  Similarity=0.474  Sum_probs=213.9

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec-CCcEEEEEe
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-PPNLCIVTE  187 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~E  187 (395)
                      .|++.+.||+|++|.||++..  +++.||+|.+..........+.+.+|+.++++++|+|++++++.+.. ...+|++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            488999999999999999987  56889999997665555666789999999999999999999998764 445899999


Q ss_pred             cCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-ccc
Q 016082          188 FMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT  265 (395)
Q Consensus       188 ~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~  265 (395)
                      |+++++|.+++... ...+++.+++.++.+++.|+.+||++|++||||||+||+++.++.++|+|||++....... ...
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~  160 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS  160 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence            99999999999764 3468999999999999999999999999999999999999999999999999997654322 223


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhc
Q 016082          266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ  345 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  345 (395)
                      ...+++.|+|||.+.+..++.++|+||||++++++++|+.||...+......... ....+..+...++++.+++.+||+
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~  239 (257)
T cd08223         161 TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII-EGKLPPMPKDYSPELGELIATMLS  239 (257)
T ss_pred             cccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-hcCCCCCccccCHHHHHHHHHHhc
Confidence            4568899999999999999999999999999999999999998877655444433 344456677889999999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 016082          346 HDPTQRPNFSQITD  359 (395)
Q Consensus       346 ~dp~~RPs~~ell~  359 (395)
                      .+|++||++.++++
T Consensus       240 ~~p~~Rp~~~~~l~  253 (257)
T cd08223         240 KRPEKRPSVKSILR  253 (257)
T ss_pred             cCcccCCCHHHHhc
Confidence            99999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=6.1e-42  Score=322.63  Aligned_cols=248  Identities=25%  Similarity=0.398  Sum_probs=205.6

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  188 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  188 (395)
                      +|++.+.||+|++|.||+|+.  +++.||+|+++....+......+.+|+.++++++||||+++++++..+...|+||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            578899999999999999987  578999999976544444456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-Cccc
Q 016082          189 MARGSIYDFLHKQK--GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMT  265 (395)
Q Consensus       189 ~~ggsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-~~~~  265 (395)
                      ++ ++|.+++....  ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++...... ....
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  159 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT  159 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccccc
Confidence            97 58988886533  57899999999999999999999999999999999999999999999999999754432 2223


Q ss_pred             cCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccC----------------C---
Q 016082          266 AETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL----------------R---  325 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~----------------~---  325 (395)
                      ...+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+.............                +   
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
T cd07861         160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTF  239 (285)
T ss_pred             CCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhc
Confidence            4567899999998865 4578999999999999999999999987665443332211100                0   


Q ss_pred             --------CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          326 --------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       326 --------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                              ......+++++.++|++||+.||.+|||+.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         240 PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             cccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                    0112346889999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=7.5e-42  Score=322.07  Aligned_cols=247  Identities=30%  Similarity=0.516  Sum_probs=210.5

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  188 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  188 (395)
                      .|++.++||+|+||.||+|.+  ++..+|+|.+...  .......+.+|+.+++.++||||+++++++...+..++|+||
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~   83 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   83 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence            468889999999999999988  4677899998654  345567889999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-CccccC
Q 016082          189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAE  267 (395)
Q Consensus       189 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-~~~~~~  267 (395)
                      +++++|..++.....++++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++...... ......
T Consensus        84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  163 (282)
T cd06643          84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF  163 (282)
T ss_pred             cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccccc
Confidence            9999999988766678999999999999999999999999999999999999999999999999998654322 122345


Q ss_pred             CCCcccccccccC-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc-CCCCCCCCCcHHHHHHHH
Q 016082          268 TGTYRWMAPEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-LRPTIPKHAHPRLAELLE  341 (395)
Q Consensus       268 ~gt~~y~aPE~~~-----~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~  341 (395)
                      .++..|+|||++.     +..++.++|+|||||++|+|++|+.||...++.+......... .....+..++.++.++|.
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (282)
T cd06643         164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLK  243 (282)
T ss_pred             cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHH
Confidence            6889999999983     4567889999999999999999999999887766555443321 122345668899999999


Q ss_pred             HhhccCCCCCCCHHHHHH
Q 016082          342 RCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       342 ~cl~~dp~~RPs~~ell~  359 (395)
                      +||+.+|.+||++.++++
T Consensus       244 ~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         244 KCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             HHccCChhhCcCHHHHhc
Confidence            999999999999999876

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=9.3e-42  Score=325.24  Aligned_cols=260  Identities=30%  Similarity=0.605  Sum_probs=219.6

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE--CCc----eEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY--CSQ----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  180 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~----~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (395)
                      +..++|+..+.||+|+||.||+|++  .+.    .||+|.+.... ......++.+|+.++++++||||+++++++... 
T Consensus         4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-   81 (303)
T cd05110           4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-   81 (303)
T ss_pred             cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence            4456889999999999999999986  343    47999887553 334455789999999999999999999998764 


Q ss_pred             cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                      ..++++||+++|+|.+++......++...+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus        82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence            47899999999999999987666789999999999999999999999999999999999999999999999999986543


Q ss_pred             CCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHH
Q 016082          261 SGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  336 (395)
Q Consensus       261 ~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  336 (395)
                      ...   .....++..|+|||.+.+..++.++||||||+++||+++ |+.||.+....+ .........++..+..++.++
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  240 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-IPDLLEKGERLPQPPICTIDV  240 (303)
T ss_pred             cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHCCCCCCCCCCCCHHH
Confidence            221   122345678999999999999999999999999999997 999998876544 334455555566667788999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHH
Q 016082          337 AELLERCWQHDPTQRPNFSQITDILKQMMKEVL  369 (395)
Q Consensus       337 ~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~  369 (395)
                      .+++.+||..+|++||++.++++.+.++.++..
T Consensus       241 ~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~  273 (303)
T cd05110         241 YMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ  273 (303)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence            999999999999999999999999998876654

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.7e-42  Score=338.09  Aligned_cols=244  Identities=26%  Similarity=0.381  Sum_probs=198.7

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  183 (395)
                      .+...+|++.++||+|+||.||++.+  +++.||+|....        ..+.+|+.++++++||||+++++++......+
T Consensus        88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~  159 (391)
T PHA03212         88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTC  159 (391)
T ss_pred             ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence            34567899999999999999999987  578899997542        34678999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC--
Q 016082          184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS--  261 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~--  261 (395)
                      +|+|++. ++|.+++.. ...++...++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+|+.....  
T Consensus       160 lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~  237 (391)
T PHA03212        160 LILPRYK-TDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA  237 (391)
T ss_pred             EEEecCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence            9999995 589988866 456899999999999999999999999999999999999999999999999999753221  


Q ss_pred             CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHhh--------------
Q 016082          262 GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP-------LQAAVGVV--------------  320 (395)
Q Consensus       262 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~-------~~~~~~~~--------------  320 (395)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....       ......+.              
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~  317 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA  317 (391)
T ss_pred             cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence            223345799999999999999999999999999999999999987643211       00000000              


Q ss_pred             ------------hccCC-CC-CC-----CCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          321 ------------QKSLR-PT-IP-----KHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       321 ------------~~~~~-~~-~~-----~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                  ....+ +. .+     ...+.++.++|.+||+.||.+|||+.|+++
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                        00000 00 00     124668999999999999999999999987

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.2e-41  Score=315.34  Aligned_cols=248  Identities=32%  Similarity=0.576  Sum_probs=216.5

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCC---CCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC---VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  185 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  185 (395)
                      +|+..+.||+|+||.||+|..  +++.||+|.+....   ...+..+.+.+|+.++++++|+||+++++++.....++++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            467788999999999999987  57899999986543   2244567899999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCccc
Q 016082          186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT  265 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~  265 (395)
                      +||+++++|.+++.. .+.+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.+||+|||.+..........
T Consensus        81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~  159 (258)
T cd06632          81 LELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAK  159 (258)
T ss_pred             EEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccccccc
Confidence            999999999999976 4568999999999999999999999999999999999999999999999999987655444344


Q ss_pred             cCCCCcccccccccCCCC-CCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhh
Q 016082          266 AETGTYRWMAPEVIEHKP-YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW  344 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~~~~-~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  344 (395)
                      ...++..|+|||.+.... ++.++|+||||+++|+|++|+.||....+.+...........+.++..+++++.+++.+||
T Consensus       160 ~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  239 (258)
T cd06632         160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCL  239 (258)
T ss_pred             ccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHh
Confidence            567899999999987776 8999999999999999999999998877655555544435566777888999999999999


Q ss_pred             ccCCCCCCCHHHHHH
Q 016082          345 QHDPTQRPNFSQITD  359 (395)
Q Consensus       345 ~~dp~~RPs~~ell~  359 (395)
                      +.+|.+||++.+++.
T Consensus       240 ~~~p~~Rp~~~~~l~  254 (258)
T cd06632         240 QRDPSLRPTAAELLE  254 (258)
T ss_pred             hcCcccCcCHHHHhc
Confidence            999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=7.8e-42  Score=358.26  Aligned_cols=265  Identities=20%  Similarity=0.374  Sum_probs=215.0

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      ++|++.++||+|+||.||+|++  +++.||+|+++.... +....+++.+|+.++++++||||+++++++.+.+..|+||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            5799999999999999999987  578999999976533 3345567999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhc----------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccc
Q 016082          187 EFMARGSIYDFLHKQ----------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR  256 (395)
Q Consensus       187 E~~~ggsL~~~l~~~----------~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~  256 (395)
                      ||++||+|.+++...          ....+...+..++.||++||+|||++||+||||||+||+++.++.++|+|||+++
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk  161 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI  161 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence            999999999998642          1234566788999999999999999999999999999999999999999999997


Q ss_pred             ccccCC-------------------ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 016082          257 VQAQSG-------------------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAV  317 (395)
Q Consensus       257 ~~~~~~-------------------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~  317 (395)
                      ......                   ......||+.|+|||.+.+.+++.++|||||||++|||++|+.||..........
T Consensus       162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~  241 (932)
T PRK13184        162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY  241 (932)
T ss_pred             ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhh
Confidence            652110                   0112368999999999999999999999999999999999999998755443322


Q ss_pred             Hh-hhccCCCCCCCCCcHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHHHHHHHHhhcc
Q 016082          318 GV-VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRP-NFSQITDILKQMMKEVLYWLSP  374 (395)
Q Consensus       318 ~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~ell~~l~~~~~~~~~~~~~  374 (395)
                      .. ............+++.+.+++.+||+.||++|| +++++++.|+..++....|..+
T Consensus       242 ~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p~w~~~  300 (932)
T PRK13184        242 RDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPEWTVK  300 (932)
T ss_pred             hhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCcccccc
Confidence            21 111111111235788999999999999999996 5777888888887765555433

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=6.8e-42  Score=329.73  Aligned_cols=257  Identities=22%  Similarity=0.424  Sum_probs=205.8

Q ss_pred             eeeeeeee--CceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecC
Q 016082          114 IECKVASG--SYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM  189 (395)
Q Consensus       114 i~~~lg~G--~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  189 (395)
                      +.++||+|  +||+||+++.  +++.||+|.++...........+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            56789999  7899999987  5789999999876555566677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC------
Q 016082          190 ARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG------  262 (395)
Q Consensus       190 ~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~------  262 (395)
                      ++|+|.+++... .+.+++..+..++.|++.||+|||++||+||||||+||+++.++.++++||+.+.......      
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~  161 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV  161 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccc
Confidence            999999999754 3568999999999999999999999999999999999999999999999998754322111      


Q ss_pred             --ccccCCCCcccccccccCC--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC-------------
Q 016082          263 --VMTAETGTYRWMAPEVIEH--KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR-------------  325 (395)
Q Consensus       263 --~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~-------------  325 (395)
                        ......++..|+|||++.+  ..++.++|||||||++|+|++|+.||......+...........             
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (327)
T cd08227         162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEEL  241 (327)
T ss_pred             ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhc
Confidence              0112346778999999976  46899999999999999999999999876544332222111000             


Q ss_pred             -------------------------------CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHHHHHHHH
Q 016082          326 -------------------------------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD--ILKQMMKEVLY  370 (395)
Q Consensus       326 -------------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~--~l~~~~~~~~~  370 (395)
                                                     ......+++++.+++++||+.||++|||+.++++  .++++.+....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~~~~~~  319 (327)
T cd08227         242 TMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASE  319 (327)
T ss_pred             ccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcchhhhh
Confidence                                           0011235678999999999999999999999987  45554444433

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=6e-42  Score=320.52  Aligned_cols=248  Identities=31%  Similarity=0.550  Sum_probs=208.7

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEEEEecC------
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRP------  179 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------  179 (395)
                      .+.|.+.+.||+|+||.||+|..  .++.||+|++....   .....+.+|+.+++++ +||||+++++++...      
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            34788899999999999999987  56889999987543   2235788999999998 699999999998653      


Q ss_pred             CcEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccc
Q 016082          180 PNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  258 (395)
Q Consensus       180 ~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~  258 (395)
                      ..+|+||||+.+++|.+++... ...+++..+..++.|++.|+.|||+++|+||||||+||++++++.++|+|||+++..
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~  161 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  161 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence            3589999999999999999764 356899999999999999999999999999999999999999999999999999764


Q ss_pred             ccC-CccccCCCCcccccccccC-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCC
Q 016082          259 AQS-GVMTAETGTYRWMAPEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHA  332 (395)
Q Consensus       259 ~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  332 (395)
                      ... .......|+..|+|||++.     +..++.++|+|||||++|+|++|+.||....+............+...+..+
T Consensus       162 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (272)
T cd06637         162 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW  241 (272)
T ss_pred             ccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCc
Confidence            332 2234457899999999986     3468899999999999999999999998777665555444444444445678


Q ss_pred             cHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          333 HPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       333 ~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      +.++.+++.+||+.+|.+|||+.++++
T Consensus       242 ~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         242 SKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            899999999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-42  Score=353.71  Aligned_cols=263  Identities=32%  Similarity=0.672  Sum_probs=234.7

Q ss_pred             ceeecccCcceeeeeeeeCceEEEEEEEC---------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEE
Q 016082          104 VWEIDAKQLKIECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFI  173 (395)
Q Consensus       104 ~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~  173 (395)
                      .|+++.+++++.+.||+|.||.|++|...         ...||||.++..... ...+.+..|+++|+.+. |+||+.++
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll  368 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL  368 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence            79999999999999999999999999742         356999999877654 66788999999999995 99999999


Q ss_pred             EEEecCCcEEEEEecCCCCCHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 016082          174 GACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN  238 (395)
Q Consensus       174 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~N  238 (395)
                      |+|.+....++|+||+..|+|.++|+..+               ..++...++.++.||+.||+||++.++|||||.++|
T Consensus       369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRN  448 (609)
T KOG0200|consen  369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARN  448 (609)
T ss_pred             eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhh
Confidence            99999999999999999999999998866               348889999999999999999999999999999999


Q ss_pred             eeeCCCCcEEEeeeccccccccCCccc--cCC--CCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 016082          239 LLMDENGVVKVADFGVARVQAQSGVMT--AET--GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPL  313 (395)
Q Consensus       239 iLl~~~~~vkl~DFg~a~~~~~~~~~~--~~~--gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~  313 (395)
                      ||++.+..+|++|||+|+.........  ...  -...|||||.+....|+.++||||||++|||+++ |..||.+....
T Consensus       449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~  528 (609)
T KOG0200|consen  449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT  528 (609)
T ss_pred             EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence            999999999999999998654433322  122  2457999999999999999999999999999999 99999997634


Q ss_pred             HHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 016082          314 QAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE  367 (395)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~  367 (395)
                      ......+..+.|...|.+++++++++|+.||+.+|++||+|.++.+.+...+++
T Consensus       529 ~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~  582 (609)
T KOG0200|consen  529 EELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD  582 (609)
T ss_pred             HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence            444667889999999999999999999999999999999999999999997665

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=4.5e-42  Score=320.66  Aligned_cols=248  Identities=30%  Similarity=0.518  Sum_probs=208.2

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      .++|++.++||+|+||.||+|++  +++.||+|+++...  ......+.+|+.+++.++||||+++++.+...+..++||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~   85 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM   85 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence            45899999999999999999987  57889999987653  233456889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-Cccc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMT  265 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-~~~~  265 (395)
                      ||+++++|.+++.. .+.+++.+++.++.|++.|+.|||+.|++|+||||+||+++.++.++|+|||.+...... ....
T Consensus        86 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd06645          86 EFCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK  164 (267)
T ss_pred             eccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccc
Confidence            99999999999876 567999999999999999999999999999999999999999999999999998754332 1223


Q ss_pred             cCCCCcccccccccC---CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCC---CCCCcHHHHHH
Q 016082          266 AETGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI---PKHAHPRLAEL  339 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~---~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~l  339 (395)
                      ...|+..|+|||.+.   ...++.++|+|||||++|+|++|..||....+.............+..   ...++..+.++
T Consensus       165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (267)
T cd06645         165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHF  244 (267)
T ss_pred             cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHH
Confidence            457899999999974   456889999999999999999999999776554443332222222221   12467889999


Q ss_pred             HHHhhccCCCCCCCHHHHHH
Q 016082          340 LERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       340 i~~cl~~dp~~RPs~~ell~  359 (395)
                      |.+||+.+|++||++.++++
T Consensus       245 i~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         245 VKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             HHHHccCCchhCcCHHHHhc
Confidence            99999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.4e-41  Score=315.63  Aligned_cols=248  Identities=25%  Similarity=0.438  Sum_probs=216.1

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec--CCcEEEEE
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--PPNLCIVT  186 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~  186 (395)
                      +|++.+.||.|+||.||++.+  +++.+|+|+++.........+.+.+|+.++++++||||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            478899999999999999987  56889999998766666667789999999999999999999998754  34589999


Q ss_pred             ecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHH-----HCCccccCCCCCCeeeCCCCcEEEeeecccccc
Q 016082          187 EFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLH-----QNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  258 (395)
Q Consensus       187 E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH-----~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~  258 (395)
                      ||+++++|.+++...   ..++++..++.++.+|+.|+.|||     +.+++|+||+|+||++++++.++|+|||.+...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999999654   467899999999999999999999     899999999999999999999999999999876


Q ss_pred             ccCCc-cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHH
Q 016082          259 AQSGV-MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA  337 (395)
Q Consensus       259 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  337 (395)
                      ..... .....++..|+|||.+.+..++.++|+||||+++++|++|+.||.......... .......+..+...+.++.
T Consensus       161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  239 (265)
T cd08217         161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLAS-KIKEGKFRRIPYRYSSELN  239 (265)
T ss_pred             cCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHH-HHhcCCCCCCccccCHHHH
Confidence            54432 334578999999999998889999999999999999999999999877544433 3444555667788899999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHH
Q 016082          338 ELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       338 ~li~~cl~~dp~~RPs~~ell~  359 (395)
                      +++.+||+.+|.+||++.+|++
T Consensus       240 ~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         240 EVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             HHHHHHccCCcccCCCHHHHhh
Confidence            9999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-42  Score=319.83  Aligned_cols=246  Identities=31%  Similarity=0.547  Sum_probs=214.7

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      ++|++.+.||.|+||.||+|.+  +++.||+|++.... .......+.+|+.++++++|+||+++++++..+...|+|+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME   79 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence            3688999999999999999987  57889999987553 23345678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-Ccccc
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTA  266 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-~~~~~  266 (395)
                      |+++++|.+++...  ++++..+..++.|++.|+.|||+.+++||||+|+||++++++.++|+|||.++..... .....
T Consensus        80 ~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (274)
T cd06609          80 YCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT  157 (274)
T ss_pred             eeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence            99999999999763  7899999999999999999999999999999999999999999999999999766543 22344


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCC-CcHHHHHHHHHhhc
Q 016082          267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKH-AHPRLAELLERCWQ  345 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~  345 (395)
                      ..++..|+|||.+.+..++.++||||||+++|+|++|+.||...++.+.... ......+..+.. +++++.+++.+||.
T Consensus       158 ~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~l~  236 (274)
T cd06609         158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL-IPKNNPPSLEGNKFSKPFKDFVSLCLN  236 (274)
T ss_pred             ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHH-hhhcCCCCCcccccCHHHHHHHHHHhh
Confidence            5788899999999988899999999999999999999999988776554433 333445555555 88999999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 016082          346 HDPTQRPNFSQITD  359 (395)
Q Consensus       346 ~dp~~RPs~~ell~  359 (395)
                      .+|++||+++++++
T Consensus       237 ~~p~~Rpt~~~il~  250 (274)
T cd06609         237 KDPKERPSAKELLK  250 (274)
T ss_pred             CChhhCcCHHHHhh
Confidence            99999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-41  Score=313.64  Aligned_cols=245  Identities=34%  Similarity=0.675  Sum_probs=211.3

Q ss_pred             eeeeeeCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecCCCCCH
Q 016082          116 CKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI  194 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ggsL  194 (395)
                      ++||.|+||.||++.+. ++.||+|.++..... .....+.+|+.++++++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            46899999999999875 789999998766433 4567899999999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCcc---ccCCCCc
Q 016082          195 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM---TAETGTY  271 (395)
Q Consensus       195 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~---~~~~gt~  271 (395)
                      .+++......++...+..++.+++.|+.|||+++++||||||+||+++.++.++|+|||.++........   ....++.
T Consensus        80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~  159 (251)
T cd05041          80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI  159 (251)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCccee
Confidence            9999776667899999999999999999999999999999999999999999999999999754422111   1123356


Q ss_pred             ccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCC
Q 016082          272 RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ  350 (395)
Q Consensus       272 ~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~  350 (395)
                      .|+|||.+.+..++.++|+||||+++|+|++ |..||....+...... .....+...+...+.++.+++.+||+.+|.+
T Consensus       160 ~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  238 (251)
T cd05041         160 KWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER-IESGYRMPAPQLCPEEIYRLMLQCWAYDPEN  238 (251)
T ss_pred             ccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH-HhcCCCCCCCccCCHHHHHHHHHHhccChhh
Confidence            7999999998899999999999999999999 8999988876554444 3334455667788999999999999999999


Q ss_pred             CCCHHHHHHHHH
Q 016082          351 RPNFSQITDILK  362 (395)
Q Consensus       351 RPs~~ell~~l~  362 (395)
                      ||++.++++.|+
T Consensus       239 Rp~~~ell~~l~  250 (251)
T cd05041         239 RPSFSEIYNELQ  250 (251)
T ss_pred             CcCHHHHHHHhh
Confidence            999999998875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=8.2e-42  Score=316.32  Aligned_cols=247  Identities=32%  Similarity=0.564  Sum_probs=213.4

Q ss_pred             ccCcceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      .++|++.++||+|+||.||+|...  ++.+|+|.++...    ..+.+.+|+.++++++||||+++++.+......|+++
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~   77 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM   77 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence            458999999999999999999884  6889999987542    2678999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-ccc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT  265 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~  265 (395)
                      ||+++++|.+++......+++..+..++.+++.|+.|||+.+++||||+|+||+++.++.++|+|||++....... ...
T Consensus        78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~  157 (256)
T cd06612          78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN  157 (256)
T ss_pred             ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccc
Confidence            9999999999998767789999999999999999999999999999999999999999999999999987654432 223


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccC-CCCCCCCCcHHHHHHHHHhh
Q 016082          266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL-RPTIPKHAHPRLAELLERCW  344 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl  344 (395)
                      ...++..|+|||.+.+..++.++||||||+++|+|++|+.||....+.+....+..... ....+..++.++.++|.+||
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  237 (256)
T cd06612         158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCL  237 (256)
T ss_pred             cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHH
Confidence            34578899999999999999999999999999999999999988776554433222111 11234457789999999999


Q ss_pred             ccCCCCCCCHHHHHH
Q 016082          345 QHDPTQRPNFSQITD  359 (395)
Q Consensus       345 ~~dp~~RPs~~ell~  359 (395)
                      +.+|.+|||+.++++
T Consensus       238 ~~~P~~Rps~~~il~  252 (256)
T cd06612         238 VKDPEERPSAIQLLQ  252 (256)
T ss_pred             hcChhhCcCHHHHhc
Confidence            999999999999876

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.6e-42  Score=359.77  Aligned_cols=253  Identities=22%  Similarity=0.436  Sum_probs=212.1

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec--CC
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--PP  180 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~  180 (395)
                      .+...++|.+.++||+|+||.||++++  .+..||+|+++...........+..|+.++++++||||++++++|..  ..
T Consensus         8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~   87 (1021)
T PTZ00266          8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ   87 (1021)
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence            345567999999999999999999988  46789999998766666667889999999999999999999998854  34


Q ss_pred             cEEEEEecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-------CccccCCCCCCeeeCC-------
Q 016082          181 NLCIVTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQN-------NIIHRDLKTANLLMDE-------  243 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~-------~iiHrDlkp~NiLl~~-------  243 (395)
                      .+||||||+++|+|.++|...   .+.+++..++.++.||+.||.|||+.       +||||||||+|||++.       
T Consensus        88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence            689999999999999999753   35799999999999999999999984       4999999999999964       


Q ss_pred             ----------CCcEEEeeeccccccccCCccccCCCCcccccccccCC--CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 016082          244 ----------NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH--KPYDYKADVFSFGIALWELLTGELPYAGLT  311 (395)
Q Consensus       244 ----------~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwslG~vl~elltg~~pf~~~~  311 (395)
                                .+.+||+|||++.............||+.|+|||++.+  ..++.++|||||||++|+|++|+.||....
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             ccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                      23589999999987654444455679999999999864  458999999999999999999999998766


Q ss_pred             HHHHHHHhhhccCCCCCC-CCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          312 PLQAAVGVVQKSLRPTIP-KHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      ........+...  +..+ ...++++.+||.+||+.+|.+||++.|++.
T Consensus       248 ~~~qli~~lk~~--p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        248 NFSQLISELKRG--PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             cHHHHHHHHhcC--CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            554444433332  2222 356889999999999999999999999985

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2e-41  Score=318.91  Aligned_cols=242  Identities=29%  Similarity=0.502  Sum_probs=203.5

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      ++|++.+.||+|+||.||+|.+  +++.||+|++.... .......+.+|+.++++++||||+++++++...+..++|||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE   79 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence            3678899999999999999986  67889999987553 34455679999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCccccC
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE  267 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~~  267 (395)
                      |+++++|..+     ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++...... .....
T Consensus        80 ~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~~~  153 (279)
T cd06619          80 FMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTY  153 (279)
T ss_pred             cCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-cccCC
Confidence            9999998654     34688899999999999999999999999999999999999999999999999755432 23445


Q ss_pred             CCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHhhhccCCCCC-CCCCcHHHHHH
Q 016082          268 TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL-------QAAVGVVQKSLRPTI-PKHAHPRLAEL  339 (395)
Q Consensus       268 ~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~-------~~~~~~~~~~~~~~~-~~~~~~~l~~l  339 (395)
                      .|+..|+|||.+.+..++.++|+||||+++|+|++|+.||......       ....... ....+.. ....++++.++
T Consensus       154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l  232 (279)
T cd06619         154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV-DEDPPVLPVGQFSEKFVHF  232 (279)
T ss_pred             CCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh-ccCCCCCCCCcCCHHHHHH
Confidence            7899999999999989999999999999999999999999753221       1111111 1122222 23578899999


Q ss_pred             HHHhhccCCCCCCCHHHHHH
Q 016082          340 LERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       340 i~~cl~~dp~~RPs~~ell~  359 (395)
                      +.+||+.+|++||++.++++
T Consensus       233 i~~~l~~~P~~Rp~~~eil~  252 (279)
T cd06619         233 ITQCMRKQPKERPAPENLMD  252 (279)
T ss_pred             HHHHhhCChhhCCCHHHHhc
Confidence            99999999999999999987

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.7e-41  Score=314.27  Aligned_cols=248  Identities=27%  Similarity=0.525  Sum_probs=212.1

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  188 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  188 (395)
                      +|++.+.||+|+||.||+|..  +++.||+|+++.........+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            588899999999999999986  578999999987765556778999999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCcc----
Q 016082          189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM----  264 (395)
Q Consensus       189 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~----  264 (395)
                      +++++|.+++.. .+.+++..+..++.+++.|+.|||+.|++|+||+|+||++++++.++|+|||.+.........    
T Consensus        81 ~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~  159 (264)
T cd06626          81 CSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE  159 (264)
T ss_pred             CCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence            999999999976 456889999999999999999999999999999999999999999999999999765443221    


Q ss_pred             -ccCCCCcccccccccCCCC---CCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCC--cHHHHH
Q 016082          265 -TAETGTYRWMAPEVIEHKP---YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHA--HPRLAE  338 (395)
Q Consensus       265 -~~~~gt~~y~aPE~~~~~~---~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~l~~  338 (395)
                       ....++..|+|||.+.+..   ++.++||||||+++|++++|+.||..................+..|...  ++.+.+
T Consensus       160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (264)
T cd06626         160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD  239 (264)
T ss_pred             ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence             1246788999999998766   8899999999999999999999997663332222222334455555544  899999


Q ss_pred             HHHHhhccCCCCCCCHHHHHH
Q 016082          339 LLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       339 li~~cl~~dp~~RPs~~ell~  359 (395)
                      ++.+||+.+|.+||++.+++.
T Consensus       240 li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         240 FLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             HHHHHccCCcccCCCHHHHhc
Confidence            999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.8e-41  Score=318.00  Aligned_cols=254  Identities=28%  Similarity=0.551  Sum_probs=214.8

Q ss_pred             cccCcceeeeeeeeCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 016082          108 DAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  180 (395)
Q Consensus       108 ~~~~~~i~~~lg~G~~G~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (395)
                      +.++|++.+.||.|+||.||+|+..       .+.+|+|.+.... .......+.+|+.++++++||||+++++++....
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   81 (275)
T cd05046           3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE   81 (275)
T ss_pred             ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence            4468999999999999999999862       3579999986542 2335678999999999999999999999999988


Q ss_pred             cEEEEEecCCCCCHHHHHhhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeee
Q 016082          181 NLCIVTEFMARGSIYDFLHKQK--------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADF  252 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~--------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DF  252 (395)
                      ..++||||+++|+|.+++....        ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++++||
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999999997643        15899999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCC--ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCC
Q 016082          253 GVARVQAQSG--VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIP  329 (395)
Q Consensus       253 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  329 (395)
                      |.+.......  ......++..|+|||.+.+..++.++||||||+++|++++ |..||.....................+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  241 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVP  241 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCC
Confidence            9986433221  1223355778999999988888999999999999999998 889998877666555444333344456


Q ss_pred             CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 016082          330 KHAHPRLAELLERCWQHDPTQRPNFSQITDILK  362 (395)
Q Consensus       330 ~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~  362 (395)
                      ..++..+.+++.+||+.+|.+||++.++++.|.
T Consensus       242 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         242 EGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            678899999999999999999999999998775

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.3e-41  Score=319.81  Aligned_cols=255  Identities=27%  Similarity=0.574  Sum_probs=214.9

Q ss_pred             ccCcceeeeeeeeCceEEEEEEEC------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec--CC
Q 016082          109 AKQLKIECKVASGSYGDLYKGTYC------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--PP  180 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~  180 (395)
                      ...|++.+.||+|+||.||+|++.      +..+|||+++..... .....+.+|+.++++++||||+++++++..  ..
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence            357888999999999999999863      578999999866433 456789999999999999999999999877  55


Q ss_pred             cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                      ..++||||+++++|.+++......++...+..++.+++.||.|||++|++||||||+||+++.++.++|+|||.+.....
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE  161 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence            79999999999999999987666799999999999999999999999999999999999999999999999999986653


Q ss_pred             CCcc----ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH--------------HHHHhhhc
Q 016082          261 SGVM----TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ--------------AAVGVVQK  322 (395)
Q Consensus       261 ~~~~----~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~--------------~~~~~~~~  322 (395)
                      ....    ....++..|+|||.+.+..++.++|+||||+++|+|++|..|+.......              ........
T Consensus       162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05038         162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE  241 (284)
T ss_pred             CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence            2211    12344567999999988889999999999999999999999986543221              12223334


Q ss_pred             cCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 016082          323 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQM  364 (395)
Q Consensus       323 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~  364 (395)
                      ..+...+..++.++.+++.+||+.+|.+||++.++++.|+.+
T Consensus       242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         242 GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            444555667789999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.2e-41  Score=319.97  Aligned_cols=237  Identities=27%  Similarity=0.513  Sum_probs=197.1

Q ss_pred             eeeeeCceEEEEEEEC--------------------------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcee
Q 016082          117 KVASGSYGDLYKGTYC--------------------------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV  170 (395)
Q Consensus       117 ~lg~G~~G~Vy~~~~~--------------------------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  170 (395)
                      .||+|+||.||+|...                          ...||+|++...  .......+.+|+.++++++||||+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv   79 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA   79 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence            6999999999998641                          134899998754  234456789999999999999999


Q ss_pred             eEEEEEecCCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCC-----
Q 016082          171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-----  245 (395)
Q Consensus       171 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~-----  245 (395)
                      ++++++......++||||+++|+|..++....+.+++..+..++.||++||+|||++||+||||||+||+++..+     
T Consensus        80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~  159 (274)
T cd05076          80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT  159 (274)
T ss_pred             eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence            999999999999999999999999999987677899999999999999999999999999999999999997644     


Q ss_pred             --cEEEeeeccccccccCCccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHhhh
Q 016082          246 --VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELL-TGELPYAGLTPLQAAVGVVQ  321 (395)
Q Consensus       246 --~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~ell-tg~~pf~~~~~~~~~~~~~~  321 (395)
                        .++++|||.+.....   .....++..|+|||.+.+ ..++.++||||||+++||++ +|+.||...++.+... ...
T Consensus       160 ~~~~kl~d~g~~~~~~~---~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~  235 (274)
T cd05076         160 SPFIKLSDPGVSFTALS---REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-FYE  235 (274)
T ss_pred             cceeeecCCcccccccc---ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-HHH
Confidence              489999998864322   123457788999998865 56899999999999999985 6999998876654332 222


Q ss_pred             ccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 016082          322 KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDIL  361 (395)
Q Consensus       322 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l  361 (395)
                      .  ....+...++++.++|.+||+.+|++||++.++++.|
T Consensus       236 ~--~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         236 K--KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             h--ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            2  2234455678899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.4e-41  Score=313.68  Aligned_cols=248  Identities=23%  Similarity=0.466  Sum_probs=216.6

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  188 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  188 (395)
                      +|++.++||+|+||.+|+++.  .++.||+|.+...........++.+|+.++++++||||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            588999999999999999987  578999999876544555567899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCc-ccc
Q 016082          189 MARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-MTA  266 (395)
Q Consensus       189 ~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~-~~~  266 (395)
                      +.+++|.+++.... ..+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++++|||.+........ ...
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~  160 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART  160 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhh
Confidence            99999999997643 4688999999999999999999999999999999999999999999999999976543321 123


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhcc
Q 016082          267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH  346 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  346 (395)
                      ..|++.|+|||++.+..++.++|+||||++++++++|+.||......+....+. .+..+..+...+.++.++|.+||+.
T Consensus       161 ~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  239 (256)
T cd08218         161 CIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII-RGSYPPVSSHYSYDLRNLVSQLFKR  239 (256)
T ss_pred             ccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHh-cCCCCCCcccCCHHHHHHHHHHhhC
Confidence            457889999999998889999999999999999999999998877666555544 3445566778899999999999999


Q ss_pred             CCCCCCCHHHHHH
Q 016082          347 DPTQRPNFSQITD  359 (395)
Q Consensus       347 dp~~RPs~~ell~  359 (395)
                      +|.+||++.++++
T Consensus       240 ~p~~Rp~~~~vl~  252 (256)
T cd08218         240 NPRDRPSVNSILE  252 (256)
T ss_pred             ChhhCcCHHHHhh
Confidence            9999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.5e-41  Score=317.21  Aligned_cols=238  Identities=28%  Similarity=0.523  Sum_probs=196.8

Q ss_pred             eeeeeeCceEEEEEEECC--------------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Q 016082          116 CKVASGSYGDLYKGTYCS--------------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  181 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~~~--------------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  181 (395)
                      +.||+|+||.||+|+...              ..||+|++...  ..+....+.+|+.+++.++||||+++++++.....
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~   78 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE   78 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            368999999999997532              25899988754  24445678999999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCc-------EEEeeecc
Q 016082          182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV-------VKVADFGV  254 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~-------vkl~DFg~  254 (395)
                      .++||||+++|+|..++....+.+++..++.++.||++||+|||++||+||||||+|||++.++.       ++++|||.
T Consensus        79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~  158 (262)
T cd05077          79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI  158 (262)
T ss_pred             CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence            99999999999999998876678999999999999999999999999999999999999987664       89999999


Q ss_pred             ccccccCCccccCCCCcccccccccC-CCCCCChhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHhhhccCCCCCCCCC
Q 016082          255 ARVQAQSGVMTAETGTYRWMAPEVIE-HKPYDYKADVFSFGIALWELL-TGELPYAGLTPLQAAVGVVQKSLRPTIPKHA  332 (395)
Q Consensus       255 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~DvwslG~vl~ell-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  332 (395)
                      +.....   .....++..|+|||.+. +..++.++||||||+++|+|+ +|..||......+... ......  ......
T Consensus       159 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~--~~~~~~  232 (262)
T cd05077         159 PITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQC--MLVTPS  232 (262)
T ss_pred             CccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCc--cCCCCC
Confidence            865432   23346788999999886 567899999999999999997 5899998765443322 111111  223335


Q ss_pred             cHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 016082          333 HPRLAELLERCWQHDPTQRPNFSQITDIL  361 (395)
Q Consensus       333 ~~~l~~li~~cl~~dp~~RPs~~ell~~l  361 (395)
                      +.++.++|.+||+.||.+||++.+|+..+
T Consensus       233 ~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         233 CKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             hHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            67899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.4e-41  Score=315.99  Aligned_cols=248  Identities=29%  Similarity=0.497  Sum_probs=211.5

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC---CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--CcE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV---NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNL  182 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  182 (395)
                      .+|+..+.||+|+||.||+|..  ++..||+|.++....   .......+.+|+.++++++||||+++++++...  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            3688999999999999999986  578999999875432   223456789999999999999999999988653  568


Q ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC
Q 016082          183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~  262 (395)
                      ++++||+++++|.+++.. .+.++...++.++.|++.||+|||+.+|+||||+|+||+++.++.++|+|||+++......
T Consensus        82 ~l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  160 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence            999999999999999976 4568999999999999999999999999999999999999999999999999987543211


Q ss_pred             ----ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHH
Q 016082          263 ----VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE  338 (395)
Q Consensus       263 ----~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  338 (395)
                          ......++..|+|||.+.+..++.++|+|||||++|+|++|+.||......+...........+.+|...++.+.+
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (266)
T cd06651         161 MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARD  240 (266)
T ss_pred             ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHH
Confidence                1123457889999999999889999999999999999999999998877666655555555567777888999999


Q ss_pred             HHHHhhccCCCCCCCHHHHHH
Q 016082          339 LLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       339 li~~cl~~dp~~RPs~~ell~  359 (395)
                      ++ +||..+|++||++.+++.
T Consensus       241 li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         241 FL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             HH-HHhcCChhhCcCHHHHhc
Confidence            99 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3.4e-41  Score=314.61  Aligned_cols=248  Identities=29%  Similarity=0.512  Sum_probs=210.7

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC---CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--CcE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV---NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNL  182 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  182 (395)
                      .+|++.+.||+|+||.||+|.+  +++.||||.++....   .......+.+|+.++++++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            4789999999999999999987  568899999864321   233457889999999999999999999988764  458


Q ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-
Q 016082          183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-  261 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-  261 (395)
                      +++|||++|++|.+++.. .+.+++..+..++.+++.||.|||+.+++|+||||+||+++.++.++|+|||.++..... 
T Consensus        82 ~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~  160 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKS-YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC  160 (265)
T ss_pred             EEEEEecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence            899999999999999876 356888999999999999999999999999999999999999999999999998754321 


Q ss_pred             ---CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHH
Q 016082          262 ---GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE  338 (395)
Q Consensus       262 ---~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  338 (395)
                         .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||..................+..|...+..+.+
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (265)
T cd06652         161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD  240 (265)
T ss_pred             ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence               11233468899999999988889999999999999999999999998876666555544444456677778889999


Q ss_pred             HHHHhhccCCCCCCCHHHHHH
Q 016082          339 LLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       339 li~~cl~~dp~~RPs~~ell~  359 (395)
                      ++.+||. +|.+||+++++++
T Consensus       241 ~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         241 FLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             HHHHHhc-ChhhCCCHHHHhc
Confidence            9999995 9999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2e-41  Score=320.73  Aligned_cols=245  Identities=27%  Similarity=0.460  Sum_probs=213.9

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      ++|++.+.||+|+||.||++.+  .++.+|+|+++.... .......+.+|+.++++++||||+++++++......++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            4789999999999999999987  578999999975432 2344577899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCcccc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA  266 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~  266 (395)
                      ||+++++|.+++.. .+.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||+++.....  ...
T Consensus        81 e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~~  157 (290)
T cd05580          81 EYVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TYT  157 (290)
T ss_pred             ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CCC
Confidence            99999999999977 467999999999999999999999999999999999999999999999999999865443  334


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhcc
Q 016082          267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH  346 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  346 (395)
                      ..+++.|+|||.+.+..++.++|+||||+++|+|++|+.||......+....+.  ...+.+|...++.+.+++.+||+.
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~  235 (290)
T cd05580         158 LCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL--EGKVRFPSFFSPDAKDLIRNLLQV  235 (290)
T ss_pred             CCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCccCCccCCHHHHHHHHHHccC
Confidence            578899999999988889999999999999999999999998877655444443  234566778899999999999999


Q ss_pred             CCCCCC-----CHHHHHH
Q 016082          347 DPTQRP-----NFSQITD  359 (395)
Q Consensus       347 dp~~RP-----s~~ell~  359 (395)
                      ||.+||     +++++++
T Consensus       236 ~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         236 DLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             CHHHccCcccCCHHHHHc
Confidence            999999     6677664

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2e-41  Score=318.77  Aligned_cols=247  Identities=32%  Similarity=0.549  Sum_probs=202.4

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHH-HHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI-MRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      ++|++.+.||+|+||.||+|.+  +++.||+|.++........ ..+..|+.+ ++.++||||+++++++...+..|++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~   79 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM   79 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence            4789999999999999999988  5789999999866433333 345555554 66778999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCeeeCCCCcEEEeeeccccccccCC
Q 016082          187 EFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       187 E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~-~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~  262 (395)
                      ||++ |+|.+++...   ...+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||.++......
T Consensus        80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (283)
T cd06617          80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV  158 (283)
T ss_pred             hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            9997 5888887542   35689999999999999999999997 99999999999999999999999999998655443


Q ss_pred             ccccCCCCcccccccccCC----CCCCChhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHhhhccCCCCCC-CCCcHHH
Q 016082          263 VMTAETGTYRWMAPEVIEH----KPYDYKADVFSFGIALWELLTGELPYAGLT-PLQAAVGVVQKSLRPTIP-KHAHPRL  336 (395)
Q Consensus       263 ~~~~~~gt~~y~aPE~~~~----~~~~~k~DvwslG~vl~elltg~~pf~~~~-~~~~~~~~~~~~~~~~~~-~~~~~~l  336 (395)
                      ..+...++..|+|||.+.+    ..++.++|+||||+++|+|++|+.||.... ..+....... ...+..+ ..++.++
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l  237 (283)
T cd06617         159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE-EPSPQLPAEKFSPEF  237 (283)
T ss_pred             ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh-cCCCCCCccccCHHH
Confidence            3344578899999998864    457899999999999999999999997543 2333333332 3334443 3578999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHH
Q 016082          337 AELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       337 ~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      .++|.+||+.+|.+||++.++++
T Consensus       238 ~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         238 QDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             HHHHHHHccCChhhCcCHHHHhc
Confidence            99999999999999999999987

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.5e-41  Score=321.29  Aligned_cols=246  Identities=28%  Similarity=0.486  Sum_probs=210.6

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      .+|++.+.||+|+||.||+|.+  +++.||+|.+......  ....+.+|+.+++.++||||+++++.+......|+|||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e   97 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence            4899999999999999999986  5789999998765432  34678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-cccc
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA  266 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~~  266 (395)
                      |++|++|.+++..  ..++...+..++.|++.|+.|||+.||+||||||+||+++.++.++|+|||.++...... ....
T Consensus        98 ~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~  175 (296)
T cd06654          98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  175 (296)
T ss_pred             ccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCc
Confidence            9999999999864  457899999999999999999999999999999999999999999999999987543322 2234


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccC-CCCCCCCCcHHHHHHHHHhhc
Q 016082          267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL-RPTIPKHAHPRLAELLERCWQ  345 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~  345 (395)
                      ..+++.|+|||.+.+..++.++|||||||++|+|++|+.||...++............ ....+...++.+.+++.+||.
T Consensus       176 ~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  255 (296)
T cd06654         176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD  255 (296)
T ss_pred             ccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCc
Confidence            5788999999999988899999999999999999999999988776544433322221 122355678899999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 016082          346 HDPTQRPNFSQITD  359 (395)
Q Consensus       346 ~dp~~RPs~~ell~  359 (395)
                      .+|++||++.++++
T Consensus       256 ~~p~~Rpt~~eil~  269 (296)
T cd06654         256 MDVEKRGSAKELLQ  269 (296)
T ss_pred             CCcccCcCHHHHhh
Confidence            99999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.8e-41  Score=340.96  Aligned_cols=257  Identities=22%  Similarity=0.360  Sum_probs=203.5

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC------CceeeEEEEEec
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH------KNVVQFIGACTR  178 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~  178 (395)
                      +..++|++.++||+|+||.||+|.+  .++.||||+++..   ......+..|+.+++.++|      ++++.+++++..
T Consensus       126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV---PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc---hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            4457899999999999999999987  5688999999743   2234556778888888765      458889998876


Q ss_pred             C-CcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeeeCCCC-----------
Q 016082          179 P-PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENG-----------  245 (395)
Q Consensus       179 ~-~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~iiHrDlkp~NiLl~~~~-----------  245 (395)
                      . .++|+|||++ |++|.+++.+ .+.+++..+..++.||+.||+|||+ .|||||||||+|||++.++           
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~  280 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL  280 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence            5 4689999988 6699998876 4679999999999999999999998 5999999999999998765           


Q ss_pred             -----cEEEeeeccccccccCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhh
Q 016082          246 -----VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV  320 (395)
Q Consensus       246 -----~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~  320 (395)
                           .+||+|||.+....  ...+...||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+.
T Consensus       281 ~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~  358 (467)
T PTZ00284        281 PPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLME  358 (467)
T ss_pred             CCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence                 49999999886432  22345689999999999999999999999999999999999999998876544332211


Q ss_pred             hcc-------------------------CCCCCC---------------CCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016082          321 QKS-------------------------LRPTIP---------------KHAHPRLAELLERCWQHDPTQRPNFSQITDI  360 (395)
Q Consensus       321 ~~~-------------------------~~~~~~---------------~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  360 (395)
                      ...                         .++...               ...++.+.+||.+||+.||.+|||+.|+++ 
T Consensus       359 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~-  437 (467)
T PTZ00284        359 KTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT-  437 (467)
T ss_pred             HHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc-
Confidence            100                         000000               012456789999999999999999999998 


Q ss_pred             HHHHHHHHHHhhccccccc
Q 016082          361 LKQMMKEVLYWLSPNLINT  379 (395)
Q Consensus       361 l~~~~~~~~~~~~~~~~~~  379 (395)
                              +-|+.+.+...
T Consensus       438 --------Hp~~~~~~~~~  448 (467)
T PTZ00284        438 --------HPYVLKYYPEC  448 (467)
T ss_pred             --------CccccccCCcc
Confidence                    67776654433

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.9e-41  Score=319.21  Aligned_cols=249  Identities=26%  Similarity=0.405  Sum_probs=206.1

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      ++|++.+.||+|+||.||+|++  +++.||+|++..........+.+.+|+.++++++|||++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            3688999999999999999987  47899999987554333344668899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-cccc
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA  266 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~~  266 (395)
                      |+++++|..++.. ...+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||.+....... ....
T Consensus        81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07847          81 YCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD  159 (286)
T ss_pred             ccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence            9999888777654 4578999999999999999999999999999999999999999999999999998654433 2234


Q ss_pred             CCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc-------------------C-C
Q 016082          267 ETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-------------------L-R  325 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~-------------------~-~  325 (395)
                      ..++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+..+....+....                   . .
T Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07847         160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI  239 (286)
T ss_pred             cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccC
Confidence            467889999999876 568899999999999999999999998877654433221100                   0 0


Q ss_pred             CCC---------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          326 PTI---------PKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       326 ~~~---------~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      +..         -...+..+.+++.+||+.+|++||++.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         240 PEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             CCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            000         1245788999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.8e-41  Score=322.68  Aligned_cols=249  Identities=23%  Similarity=0.390  Sum_probs=206.4

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      .++|.+.++||.|+||.||+|++  +++.||+|.++.... ......+.+|+.++++++||||+++++++..+...++||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~   83 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   83 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence            35799999999999999999987  578899999875432 222346778999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-ccc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT  265 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~  265 (395)
                      ||+++ +|.+++......+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||.+....... ...
T Consensus        84 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  162 (301)
T cd07873          84 EYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYS  162 (301)
T ss_pred             ecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCccc
Confidence            99975 9999998767778999999999999999999999999999999999999999999999999997543322 223


Q ss_pred             cCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccC-----------------C--
Q 016082          266 AETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL-----------------R--  325 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~-----------------~--  325 (395)
                      ...+++.|+|||.+.+ ..++.++||||||+++|+|++|++||...+..+....+.....                 .  
T Consensus       163 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (301)
T cd07873         163 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYN  242 (301)
T ss_pred             ccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccc
Confidence            4467899999999865 4578999999999999999999999988776543322211000                 0  


Q ss_pred             -C--------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          326 -P--------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       326 -~--------~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                       +        .....+++++.++|.+||+.||.+|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         243 YPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence             0        011346889999999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.2e-41  Score=315.48  Aligned_cols=245  Identities=29%  Similarity=0.550  Sum_probs=199.8

Q ss_pred             eeeeeeCceEEEEEEE-C---CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecCCC
Q 016082          116 CKVASGSYGDLYKGTY-C---SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR  191 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~-~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~g  191 (395)
                      ++||+|+||.||+|+. .   ...+|+|.+.... .......+.+|+.+++.++||||+++++.+......++||||+++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL   79 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence            3689999999999975 2   3468888876443 344456788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCc---c
Q 016082          192 GSIYDFLHKQKG----VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV---M  264 (395)
Q Consensus       192 gsL~~~l~~~~~----~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~---~  264 (395)
                      |+|.+++.....    ..+...+..++.||+.|+.|||++||+||||||+||+++.++.+||+|||+++.......   .
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~  159 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK  159 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence            999999976532    345778889999999999999999999999999999999999999999999865332211   1


Q ss_pred             ccCCCCcccccccccC-------CCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccC----CCCCCCCC
Q 016082          265 TAETGTYRWMAPEVIE-------HKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSL----RPTIPKHA  332 (395)
Q Consensus       265 ~~~~gt~~y~aPE~~~-------~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~----~~~~~~~~  332 (395)
                      ....++..|+|||++.       ...++.++|||||||++|||++ |..||....+.+..........    .+..+..+
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (269)
T cd05042         160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKY  239 (269)
T ss_pred             CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccC
Confidence            2234567899999874       3457889999999999999999 8899988877665554443322    23445578


Q ss_pred             cHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 016082          333 HPRLAELLERCWQHDPTQRPNFSQITDILK  362 (395)
Q Consensus       333 ~~~l~~li~~cl~~dp~~RPs~~ell~~l~  362 (395)
                      ++.+.+++..|| .||++||++.+|++.|.
T Consensus       240 ~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         240 SDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            899999999999 59999999999998763

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-44  Score=325.15  Aligned_cols=245  Identities=33%  Similarity=0.562  Sum_probs=216.5

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      .-|.++.+||+|+||.||+|.+  .|+.+|||.+.-+    ...+++..|+.||++++.|++|++||.+.....+++|||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME  108 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME  108 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence            3578899999999999999976  7899999998643    346889999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-Ccccc
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTA  266 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-~~~~~  266 (395)
                      ||..||+.|.++-++.++++.++..++.+.++||+|||...-||||||+.|||++.+|..||+|||.|...... ....+
T Consensus       109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNT  188 (502)
T KOG0574|consen  109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNT  188 (502)
T ss_pred             hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999754332 23355


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCC--CCCCCcHHHHHHHHHhh
Q 016082          267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT--IPKHAHPRLAELLERCW  344 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl  344 (395)
                      ..||+.|||||++..-.|+.++||||||++..||..|++||...-|-.+..-+-.+ .+|.  .|+.++.++.+++++||
T Consensus       189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~-PPPTF~KPE~WS~~F~DFi~~CL  267 (502)
T KOG0574|consen  189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTK-PPPTFKKPEEWSSEFNDFIRSCL  267 (502)
T ss_pred             cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCC-CCCCCCChHhhhhHHHHHHHHHh
Confidence            68999999999999999999999999999999999999999998876655433222 2222  35678999999999999


Q ss_pred             ccCCCCCCCHHHHHH
Q 016082          345 QHDPTQRPNFSQITD  359 (395)
Q Consensus       345 ~~dp~~RPs~~ell~  359 (395)
                      -++|++|-|+.++++
T Consensus       268 iK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  268 IKKPEERKTALRLCE  282 (502)
T ss_pred             cCCHHHHHHHHHHhh
Confidence            999999999999985

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=3.1e-41  Score=312.36  Aligned_cols=248  Identities=39%  Similarity=0.745  Sum_probs=214.0

Q ss_pred             cceeeeeeeeCceEEEEEEECC------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Q 016082          112 LKIECKVASGSYGDLYKGTYCS------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  185 (395)
Q Consensus       112 ~~i~~~lg~G~~G~Vy~~~~~~------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  185 (395)
                      +++.+.||.|+||.||++.+..      ..||+|+++.... ....+.+.+|+.++++++|+||+++++.+...+..+++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i   79 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV   79 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence            3567899999999999998854      7799999976642 23567899999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhccCC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCcc
Q 016082          186 TEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM  264 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~  264 (395)
                      |||+++++|.+++...... +++..+..++.|++.|+.|||+.|++||||||+||++++++.++|+|||.++........
T Consensus        80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (258)
T smart00219       80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY  159 (258)
T ss_pred             EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence            9999999999999765444 899999999999999999999999999999999999999999999999999765543221


Q ss_pred             c--cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHH
Q 016082          265 T--AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE  341 (395)
Q Consensus       265 ~--~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  341 (395)
                      .  ...+++.|+|||.+.+..++.++|+||+|+++++|++ |..||...+.......+. ...++..+...+.++.+++.
T Consensus       160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~  238 (258)
T smart00219      160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLK-KGYRLPKPENCPPEIYKLML  238 (258)
T ss_pred             ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCCCcCCHHHHHHHH
Confidence            1  2336789999999988889999999999999999998 899998877666555433 44556667778999999999


Q ss_pred             HhhccCCCCCCCHHHHHHHH
Q 016082          342 RCWQHDPTQRPNFSQITDIL  361 (395)
Q Consensus       342 ~cl~~dp~~RPs~~ell~~l  361 (395)
                      +||+.+|++|||+.++++.|
T Consensus       239 ~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      239 QCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             HHCcCChhhCcCHHHHHhhC
Confidence            99999999999999998753

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-43  Score=343.33  Aligned_cols=246  Identities=31%  Similarity=0.552  Sum_probs=216.3

Q ss_pred             CcceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Q 016082          111 QLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  188 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  188 (395)
                      .|.|+..||.|+||.||+|...  +-..|-|++...  ..+..+++.-||.||..++||+||+++++|...+.++|+.||
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            4567778999999999999764  344677877544  466778999999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccc-ccCCccccC
Q 016082          189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ-AQSGVMTAE  267 (395)
Q Consensus       189 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~-~~~~~~~~~  267 (395)
                      |.||-+...+-.-...++++++..++++++.||.|||+++|||||||+.|||++.+|.++|+|||.+-.. .........
T Consensus       111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsF  190 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSF  190 (1187)
T ss_pred             cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhccc
Confidence            9999999999888889999999999999999999999999999999999999999999999999997432 223344567


Q ss_pred             CCCcccccccccC-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCC--CCCCCcHHHHHHH
Q 016082          268 TGTYRWMAPEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT--IPKHAHPRLAELL  340 (395)
Q Consensus       268 ~gt~~y~aPE~~~-----~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li  340 (395)
                      .|||+|||||+..     ..+|+.++||||||++|.||..+.+|....++-.....+... .+|.  .|.+++..+.+|+
T Consensus       191 IGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS-ePPTLlqPS~Ws~~F~DfL  269 (1187)
T KOG0579|consen  191 IGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-EPPTLLQPSHWSRSFSDFL  269 (1187)
T ss_pred             cCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc-CCCcccCcchhhhHHHHHH
Confidence            9999999999874     568999999999999999999999999999998887775543 3333  4789999999999


Q ss_pred             HHhhccCCCCCCCHHHHHH
Q 016082          341 ERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       341 ~~cl~~dp~~RPs~~ell~  359 (395)
                      .+||.+||..||++.++++
T Consensus       270 k~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  270 KRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             HHHHhcCCccCCCHHHHhh
Confidence            9999999999999999985

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.3e-41  Score=322.30  Aligned_cols=247  Identities=24%  Similarity=0.435  Sum_probs=206.9

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      ++|++.++||+|+||.||++.+  ++..+|+|.++... .......+.+|+.++++++||||+++++++..++.+++|||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME   79 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence            3689999999999999999987  56789999987543 34556678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeeeCCCCcEEEeeeccccccccCCcccc
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA  266 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~  266 (395)
                      |++|++|.++++. .+.+++..+..++.|+++||.|||+ .+++||||||+||+++.++.++|+|||.+....... ...
T Consensus        80 y~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~~  157 (308)
T cd06615          80 HMDGGSLDQVLKK-AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANS  157 (308)
T ss_pred             ccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc-ccc
Confidence            9999999999976 4678999999999999999999997 599999999999999999999999999987543322 234


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhh--------------------------
Q 016082          267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV--------------------------  320 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~--------------------------  320 (395)
                      ..++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.........                          
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (308)
T cd06615         158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPM  237 (308)
T ss_pred             CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchh
Confidence            578899999999988889999999999999999999999997654322211110                          


Q ss_pred             ---------hccCCCCCCC-CCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          321 ---------QKSLRPTIPK-HAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       321 ---------~~~~~~~~~~-~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                               ....++..|. .++.++++++.+||+.+|++||++.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  286 (308)
T cd06615         238 AIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTK  286 (308)
T ss_pred             hHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                     0011122222 36788999999999999999999999987

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4.3e-41  Score=314.77  Aligned_cols=245  Identities=27%  Similarity=0.508  Sum_probs=198.1

Q ss_pred             eeeeeeCceEEEEEEEC----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecCCC
Q 016082          116 CKVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR  191 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~g  191 (395)
                      +.||+|+||.||+|.+.    +..+|+|.++.... ......+.+|+.++++++||||+++++++......++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL   79 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence            36899999999999863    35699999876542 33345788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCc---c
Q 016082          192 GSIYDFLHKQK----GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV---M  264 (395)
Q Consensus       192 gsL~~~l~~~~----~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~---~  264 (395)
                      |+|.++++...    ...+...+..++.|++.|++|||+.+++||||||+||+++.++.++|+|||.++.......   .
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~  159 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP  159 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence            99999997532    2456677889999999999999999999999999999999999999999999975433221   1


Q ss_pred             ccCCCCcccccccccCCC-------CCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-C---CCCCCCCC
Q 016082          265 TAETGTYRWMAPEVIEHK-------PYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKS-L---RPTIPKHA  332 (395)
Q Consensus       265 ~~~~gt~~y~aPE~~~~~-------~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~-~---~~~~~~~~  332 (395)
                      ....++..|+|||++.+.       .++.++|+||||+++|||++ |..||....+.+......... .   .+......
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (269)
T cd05087         160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPL  239 (269)
T ss_pred             CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCC
Confidence            223567889999998642       35789999999999999996 999998877665543322211 1   22333356


Q ss_pred             cHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 016082          333 HPRLAELLERCWQHDPTQRPNFSQITDILK  362 (395)
Q Consensus       333 ~~~l~~li~~cl~~dp~~RPs~~ell~~l~  362 (395)
                      ++.+.+++++|| .+|++|||+.+|...|+
T Consensus       240 ~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         240 SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            788999999999 68999999999998764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=4.2e-41  Score=320.93  Aligned_cols=253  Identities=24%  Similarity=0.405  Sum_probs=211.9

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      ++|++.+.||+|+||.||++..  .++.||+|.++.... .......+.+|+.+++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            3688999999999999999987  467899999875532 2234567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC----
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG----  262 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~----  262 (395)
                      ||++|++|.+++.. .+.+++..+..++.+++.|+.|||+.|++||||||+||+++.++.++|+|||.++......    
T Consensus        81 e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~  159 (305)
T cd05609          81 EYVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL  159 (305)
T ss_pred             ecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence            99999999999976 4678999999999999999999999999999999999999999999999999986421110    


Q ss_pred             ------------ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccC-CCCCC
Q 016082          263 ------------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL-RPTIP  329 (395)
Q Consensus       263 ------------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~  329 (395)
                                  ......++..|+|||.+.+..++.++|+||||+++|++++|..||.+.++.+.......... .+..+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (305)
T cd05609         160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD  239 (305)
T ss_pred             cccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence                        11123568899999999888899999999999999999999999998877765555443322 23333


Q ss_pred             CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 016082          330 KHAHPRLAELLERCWQHDPTQRPNFSQITDILKQ  363 (395)
Q Consensus       330 ~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~  363 (395)
                      ..+++++.++|.+||+.+|++||++.++.+.++.
T Consensus       240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            4678999999999999999999997666665554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.6e-41  Score=317.31  Aligned_cols=248  Identities=25%  Similarity=0.419  Sum_probs=210.9

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  188 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  188 (395)
                      +|++.+.||+|+||.||+|++  +++.||+|++............+.+|+.++++++||||+++++++..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            588999999999999999987  578999999987655555667899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC--cccc
Q 016082          189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--VMTA  266 (395)
Q Consensus       189 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~--~~~~  266 (395)
                      + +++|.+++......+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||.+.......  ....
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~  159 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH  159 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcccc
Confidence            9 999999998767789999999999999999999999999999999999999999999999999998655433  2334


Q ss_pred             CCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCC-------------------
Q 016082          267 ETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP-------------------  326 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~~-~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~-------------------  326 (395)
                      ..++..|+|||.+.+. .++.++||||+|+++++|++|.+||.+.+.......+......+                   
T Consensus       160 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07832         160 QVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITF  239 (286)
T ss_pred             ccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccC
Confidence            5789999999998654 56899999999999999999999998776554443332211110                   


Q ss_pred             ---------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          327 ---------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       327 ---------~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                               ...+..+.++.+++.+||+.+|.+||++++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         240 PESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             CCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                     011245689999999999999999999999876

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.3e-41  Score=315.18  Aligned_cols=252  Identities=23%  Similarity=0.477  Sum_probs=214.7

Q ss_pred             CcceeeeeeeeCceEEEEEEEC---CceEEEEEecCCC--------CCHHHHHHHHHHHHHHHh-cCCCceeeEEEEEec
Q 016082          111 QLKIECKVASGSYGDLYKGTYC---SQEVAIKVLKPEC--------VNTEMLKEFSQEVYIMRK-IRHKNVVQFIGACTR  178 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~~---~~~vAvK~~~~~~--------~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~  178 (395)
                      .|++.+.||+|+||.||+|.+.   ++.+|+|.++...        .......++.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            4788899999999999999874   4789999886432        223455678889998875 789999999999999


Q ss_pred             CCcEEEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeeeCCCCcEEEeeecc
Q 016082          179 PPNLCIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGV  254 (395)
Q Consensus       179 ~~~~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~-~~iiHrDlkp~NiLl~~~~~vkl~DFg~  254 (395)
                      .+..+++|||++|++|.+++..   ....+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            9999999999999999998743   34578999999999999999999996 6899999999999999999999999999


Q ss_pred             ccccccCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcH
Q 016082          255 ARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP  334 (395)
Q Consensus       255 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (395)
                      +.............++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+......+......++
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (269)
T cd08528         161 AKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSE  240 (269)
T ss_pred             eeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCCH
Confidence            98765544445567899999999999888999999999999999999999999887766655555544444433446789


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 016082          335 RLAELLERCWQHDPTQRPNFSQITDILK  362 (395)
Q Consensus       335 ~l~~li~~cl~~dp~~RPs~~ell~~l~  362 (395)
                      ++.++|.+||+.||++||++.|+.++++
T Consensus       241 ~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         241 DVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             HHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            9999999999999999999999998775

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=9.4e-42  Score=321.38  Aligned_cols=248  Identities=23%  Similarity=0.386  Sum_probs=203.1

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  188 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  188 (395)
                      +|++.+.||+|+||.||+|++  +++.||+|.++...........+.+|+.++++++||||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            478899999999999999988  578999999976544444446678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-CccccC
Q 016082          189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAE  267 (395)
Q Consensus       189 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-~~~~~~  267 (395)
                      +++ +|.+++....+.+++..++.++.||++||.|||++||+||||||+||+++.++.++|+|||.++..... ......
T Consensus        81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  159 (284)
T cd07839          81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE  159 (284)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCC
Confidence            975 898888776678999999999999999999999999999999999999999999999999999754432 222345


Q ss_pred             CCCcccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHhhhc------------------cCCC-
Q 016082          268 TGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPY-AGLTPLQAAVGVVQK------------------SLRP-  326 (395)
Q Consensus       268 ~gt~~y~aPE~~~~~-~~~~k~DvwslG~vl~elltg~~pf-~~~~~~~~~~~~~~~------------------~~~~-  326 (395)
                      .++..|+|||.+.+. .++.++|||||||++|+|++|..|+ .+.+..+....+...                  ...+ 
T Consensus       160 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd07839         160 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPM  239 (284)
T ss_pred             ccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCC
Confidence            678999999998764 5799999999999999999988875 444333222211110                  0000 


Q ss_pred             --------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          327 --------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       327 --------~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                              ...+.+++++.++|.+||+.||.+|||++++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         240 YPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             CCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence                    111346789999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-41  Score=322.32  Aligned_cols=250  Identities=22%  Similarity=0.367  Sum_probs=212.9

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCH-HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      ++|++.+.||+|+||.||+|..  +++.||+|.+....... ...+.+.+|+.++++++||||+++++.+......|+||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            3688999999999999999988  46899999997664432 45677999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCc--
Q 016082          187 EFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV--  263 (395)
Q Consensus       187 E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~--  263 (395)
                      ||+.|++|.+++... ...+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++........  
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            999999999998764 35789999999999999999999999999999999999999999999999999864332110  


Q ss_pred             ----------------------------cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 016082          264 ----------------------------MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQA  315 (395)
Q Consensus       264 ----------------------------~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~  315 (395)
                                                  .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||.+.+....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~  240 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET  240 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence                                        0123578899999999998899999999999999999999999998887766


Q ss_pred             HHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCC----HHHHHH
Q 016082          316 AVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPN----FSQITD  359 (395)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs----~~ell~  359 (395)
                      ...+.............++++.+++.+||+.+|++||+    +.+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         241 FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            66555443333323337899999999999999999999    666665

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5.7e-41  Score=315.37  Aligned_cols=246  Identities=32%  Similarity=0.581  Sum_probs=213.7

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      ..|+..++||.|+||.||+|.+  ++..||+|+++... .......+.+|+.++++++||||+++++++.+....++|||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence            3678889999999999999987  57899999987543 23456789999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-cccc
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA  266 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~~  266 (395)
                      |++|++|.+++..  ++++...+..++.+++.|++|||+.+++|+||+|+||+++.++.++++|||++....... ....
T Consensus        83 ~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06640          83 YLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             cCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccccc
Confidence            9999999999864  468899999999999999999999999999999999999999999999999997654322 1223


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhcc
Q 016082          267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH  346 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  346 (395)
                      ..++..|+|||.+.+..++.++|+||||+++|+|++|..||...++...... ......+..+..++.++.+++.+||+.
T Consensus       161 ~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~  239 (277)
T cd06640         161 FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL-IPKNNPPTLTGEFSKPFKEFIDACLNK  239 (277)
T ss_pred             ccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh-hhcCCCCCCchhhhHHHHHHHHHHccc
Confidence            4678899999999988899999999999999999999999998776654443 333445666677889999999999999


Q ss_pred             CCCCCCCHHHHHH
Q 016082          347 DPTQRPNFSQITD  359 (395)
Q Consensus       347 dp~~RPs~~ell~  359 (395)
                      +|++||++.+++.
T Consensus       240 ~p~~Rp~~~~il~  252 (277)
T cd06640         240 DPSFRPTAKELLK  252 (277)
T ss_pred             CcccCcCHHHHHh
Confidence            9999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=7.9e-41  Score=312.60  Aligned_cols=251  Identities=28%  Similarity=0.505  Sum_probs=207.4

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  184 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  184 (395)
                      ++.+.......||+|+||.||+|++  ++..||+|.+....  ....+.+.+|+.++++++|+||+++++++..++..++
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            3444555566899999999999986  45789999987552  4455789999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhccCCC--CHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCC-CCcEEEeeeccccccccC
Q 016082          185 VTEFMARGSIYDFLHKQKGVF--QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVADFGVARVQAQS  261 (395)
Q Consensus       185 V~E~~~ggsL~~~l~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~-~~~vkl~DFg~a~~~~~~  261 (395)
                      |+||+++++|.+++......+  +...+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||.+......
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~  162 (268)
T cd06624          83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI  162 (268)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence            999999999999998755556  78889999999999999999999999999999999976 679999999998754332


Q ss_pred             C-ccccCCCCcccccccccCCC--CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHhhhccCCCCCCCCCcHHHH
Q 016082          262 G-VMTAETGTYRWMAPEVIEHK--PYDYKADVFSFGIALWELLTGELPYAGLTPLQAA-VGVVQKSLRPTIPKHAHPRLA  337 (395)
Q Consensus       262 ~-~~~~~~gt~~y~aPE~~~~~--~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~  337 (395)
                      . ......++..|+|||.+.+.  .++.++|+||||+++|+|++|..||......... .........+.+|...++++.
T Consensus       163 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (268)
T cd06624         163 NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAK  242 (268)
T ss_pred             CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHH
Confidence            2 22334688999999998654  3789999999999999999999999765432222 111122334567778899999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHH
Q 016082          338 ELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       338 ~li~~cl~~dp~~RPs~~ell~  359 (395)
                      +++.+||+.+|.+||++.+++.
T Consensus       243 ~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         243 NFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             HHHHHHcCCCchhCCCHHHHHh
Confidence            9999999999999999999876

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=8.3e-42  Score=317.28  Aligned_cols=246  Identities=22%  Similarity=0.387  Sum_probs=213.6

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      +|++.+.||.|+||.||+|.+  +++.||+|++..... .....+.+.+|++++++++||||+++++.+..+...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            488999999999999999988  478999999975533 22456789999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCccccC
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE  267 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~~  267 (395)
                      |+.|++|.+++... .++++..+..++.+++.||.|||++|++|+||+|+||++++++.++|+|||.+............
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~  159 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST  159 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcccccc
Confidence            99999999999774 67899999999999999999999999999999999999999999999999999866554444556


Q ss_pred             CCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhc
Q 016082          268 TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP--LQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ  345 (395)
Q Consensus       268 ~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  345 (395)
                      .|+..|+|||.+.+..++.++|+||||+++|++++|..||...+.  ......... ...+..|...++++.++|.+||+
T Consensus       160 ~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~  238 (258)
T cd05578         160 SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE-TADVLYPATWSTEAIDAINKLLE  238 (258)
T ss_pred             CCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc-cccccCcccCcHHHHHHHHHHcc
Confidence            788999999999988899999999999999999999999987763  222222222 24566778889999999999999


Q ss_pred             cCCCCCCCH--HHHH
Q 016082          346 HDPTQRPNF--SQIT  358 (395)
Q Consensus       346 ~dp~~RPs~--~ell  358 (395)
                      .||.+||++  .+++
T Consensus       239 ~~p~~R~~~~~~~l~  253 (258)
T cd05578         239 RDPQKRLGDNLKDLK  253 (258)
T ss_pred             CChhHcCCccHHHHh
Confidence            999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-41  Score=330.19  Aligned_cols=250  Identities=25%  Similarity=0.438  Sum_probs=204.3

Q ss_pred             ceeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--
Q 016082          104 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--  179 (395)
Q Consensus       104 ~~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--  179 (395)
                      .|++ .++|++.+.||+|+||.||+|.+  +++.||||+++...........+.+|+.++++++||||+++++++...  
T Consensus        10 ~~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07878          10 VWEV-PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS   88 (343)
T ss_pred             Hhhh-hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence            4444 35899999999999999999987  567899999986543344456788999999999999999999987543  


Q ss_pred             ----CcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccc
Q 016082          180 ----PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA  255 (395)
Q Consensus       180 ----~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a  255 (395)
                          ...|+++|++ +++|.+++..  +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        89 ~~~~~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~  165 (343)
T cd07878          89 IENFNEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA  165 (343)
T ss_pred             ccccCcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccc
Confidence                3479999988 6799888753  56899999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccC----------
Q 016082          256 RVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL----------  324 (395)
Q Consensus       256 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~----------  324 (395)
                      +.....  .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+.....          
T Consensus       166 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T cd07878         166 RQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI  243 (343)
T ss_pred             eecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            865432  345578999999999876 5789999999999999999999999987665443332221100          


Q ss_pred             -----------CCCCC--------CCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          325 -----------RPTIP--------KHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       325 -----------~~~~~--------~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                 .+..+        ...++.+.+++.+||+.||.+|||+.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                       01111        235667899999999999999999999987

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-42  Score=332.47  Aligned_cols=240  Identities=21%  Similarity=0.365  Sum_probs=197.8

Q ss_pred             eeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhc---CCCceeeEEEEEecCCcEEEEEecCCC
Q 016082          118 VASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI---RHKNVVQFIGACTRPPNLCIVTEFMAR  191 (395)
Q Consensus       118 lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lV~E~~~g  191 (395)
                      ||+|+||.||+|++  +++.||||++..... .......+..|..++...   +||||+.+++.+......|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            69999999999987  578999999864321 223344556677777766   699999999999999999999999999


Q ss_pred             CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-CccccCCCC
Q 016082          192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGT  270 (395)
Q Consensus       192 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-~~~~~~~gt  270 (395)
                      |+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++..... .......||
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  159 (330)
T cd05586          81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGT  159 (330)
T ss_pred             ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCC
Confidence            999999876 567999999999999999999999999999999999999999999999999998753322 223445799


Q ss_pred             cccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCC
Q 016082          271 YRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPT  349 (395)
Q Consensus       271 ~~y~aPE~~~~~-~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~  349 (395)
                      +.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.....+ .....+++++.+++.+||+.||.
T Consensus       160 ~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~li~~~L~~~P~  238 (330)
T cd05586         160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVR-FPKNVLSDEGRQFVKGLLNRNPQ  238 (330)
T ss_pred             ccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCC-CCCccCCHHHHHHHHHHcCCCHH
Confidence            999999998754 5899999999999999999999999988776655544433222 11234789999999999999999


Q ss_pred             CCCC----HHHHHH
Q 016082          350 QRPN----FSQITD  359 (395)
Q Consensus       350 ~RPs----~~ell~  359 (395)
                      +||+    +.++++
T Consensus       239 ~R~~~~~~~~~ll~  252 (330)
T cd05586         239 HRLGAHRDAVELKE  252 (330)
T ss_pred             HCCCCCCCHHHHhc
Confidence            9984    555554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.6e-41  Score=316.22  Aligned_cols=247  Identities=30%  Similarity=0.512  Sum_probs=211.7

Q ss_pred             cCcceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      ++|++.+.||+|+||.||++.+.  ++.+|+|.+..... ......+.+|+.++++++||||+++++.+......++++|
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME   79 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence            36788899999999999999884  78899999876542 3456778999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeeeCCCCcEEEeeeccccccccCCcccc
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA  266 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~  266 (395)
                      |+++++|.+++......+++..+..++.+++.|+.|||+ .|++|+||||+||++++++.++|+|||.+......... .
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-~  158 (265)
T cd06605          80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-T  158 (265)
T ss_pred             ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-c
Confidence            999999999998765789999999999999999999999 99999999999999999999999999998755433222 2


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHhhhccCCCCCCCC-CcHHHHHHH
Q 016082          267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT-----PLQAAVGVVQKSLRPTIPKH-AHPRLAELL  340 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~-----~~~~~~~~~~~~~~~~~~~~-~~~~l~~li  340 (395)
                      ..++..|+|||.+.+..++.++|+||||+++|++++|+.||....     ..+..... .....+..+.. ++.++.++|
T Consensus       159 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li  237 (265)
T cd06605         159 FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI-VNEPPPRLPSGKFSPDFQDFV  237 (265)
T ss_pred             ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHH-hcCCCCCCChhhcCHHHHHHH
Confidence            678899999999999999999999999999999999999997642     22222222 22334455554 889999999


Q ss_pred             HHhhccCCCCCCCHHHHHH
Q 016082          341 ERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       341 ~~cl~~dp~~RPs~~ell~  359 (395)
                      .+||..+|.+||++.+++.
T Consensus       238 ~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         238 NLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             HHHcCCCchhCcCHHHHhh
Confidence            9999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=7.2e-41  Score=313.37  Aligned_cols=252  Identities=30%  Similarity=0.574  Sum_probs=211.3

Q ss_pred             cceeeeeeeeCceEEEEEEE-----CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC------
Q 016082          112 LKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP------  180 (395)
Q Consensus       112 ~~i~~~lg~G~~G~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  180 (395)
                      |++.+.||+|+||.||+|.+     +++.||||+++.........+++.+|+.++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            56788999999999999975     3578999999877666666788999999999999999999999886542      


Q ss_pred             cEEEEEecCCCCCHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQ-----KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA  255 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a  255 (395)
                      ..++++||+.+|+|.+++...     ...++...+..++.|++.|++|||++||+||||||+||+++.++.++++|||.+
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~  160 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS  160 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence            247899999999999887532     124788899999999999999999999999999999999999999999999999


Q ss_pred             cccccCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCC
Q 016082          256 RVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKH  331 (395)
Q Consensus       256 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  331 (395)
                      +......   ......+++.|++||.+.+..++.++||||||+++|+|++ |+.||.+.+.......+. .......+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~  239 (273)
T cd05074         161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI-KGNRLKQPPD  239 (273)
T ss_pred             ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH-cCCcCCCCCC
Confidence            8654322   1122345678999999999999999999999999999999 899998887765544433 3334445567


Q ss_pred             CcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 016082          332 AHPRLAELLERCWQHDPTQRPNFSQITDILKQM  364 (395)
Q Consensus       332 ~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~  364 (395)
                      .+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       240 ~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         240 CLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            889999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=4.6e-41  Score=316.53  Aligned_cols=248  Identities=29%  Similarity=0.535  Sum_probs=206.3

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEEEEec------C
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTR------P  179 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------~  179 (395)
                      .+.|++.+.||.|+||.||+|.+  .++.+|+|++...   .....++..|+.+++++ +||||+++++++..      .
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   91 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD   91 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence            45889999999999999999988  5688999998654   33346788899999998 69999999999853      3


Q ss_pred             CcEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccc
Q 016082          180 PNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  258 (395)
Q Consensus       180 ~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~  258 (395)
                      ...|++|||+++|+|.+++... ...+++..+..++.|++.|+.|||+.||+||||+|+||++++++.++|+|||.++..
T Consensus        92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~  171 (282)
T cd06636          92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  171 (282)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence            5689999999999999999764 345888889999999999999999999999999999999999999999999998754


Q ss_pred             ccC-CccccCCCCcccccccccC-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCC
Q 016082          259 AQS-GVMTAETGTYRWMAPEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHA  332 (395)
Q Consensus       259 ~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  332 (395)
                      ... .......|+..|+|||.+.     +..++.++|+||||+++|+|++|..||....+................+..+
T Consensus       172 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (282)
T cd06636         172 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKW  251 (282)
T ss_pred             hccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCccccc
Confidence            322 1223456889999999975     3568889999999999999999999998776655444433332223334467


Q ss_pred             cHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          333 HPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       333 ~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      +.++.++|++||+.||.+||++.+|++
T Consensus       252 ~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         252 SKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             CHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            899999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=6.1e-41  Score=316.14  Aligned_cols=251  Identities=29%  Similarity=0.481  Sum_probs=205.5

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEEEEe-----c
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACT-----R  178 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-----~  178 (395)
                      ...++|++.+.||+|+||.||++..  +++.+|+|+++...   .....+.+|+.+++++ +||||+++++++.     .
T Consensus        15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   91 (286)
T cd06638          15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN   91 (286)
T ss_pred             CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence            3456899999999999999999987  57889999986532   2235678899999999 6999999999874     3


Q ss_pred             CCcEEEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccc
Q 016082          179 PPNLCIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA  255 (395)
Q Consensus       179 ~~~~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a  255 (395)
                      ++..++||||++|++|.+++..   ....+++..+..++.+++.||.|||+.+|+||||||+||+++.++.++|+|||++
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~  171 (286)
T cd06638          92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS  171 (286)
T ss_pred             CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence            4568999999999999998753   2356888999999999999999999999999999999999999999999999998


Q ss_pred             cccccCC-ccccCCCCcccccccccCC-----CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc-CCCCC
Q 016082          256 RVQAQSG-VMTAETGTYRWMAPEVIEH-----KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-LRPTI  328 (395)
Q Consensus       256 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~  328 (395)
                      +...... ......|++.|+|||.+..     ..++.++||||+||++|+|++|+.||....+........... .....
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  251 (286)
T cd06638         172 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQ  251 (286)
T ss_pred             eecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccC
Confidence            7654322 2233468999999999853     457899999999999999999999998876655443322211 11123


Q ss_pred             CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016082          329 PKHAHPRLAELLERCWQHDPTQRPNFSQITDI  360 (395)
Q Consensus       329 ~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  360 (395)
                      +..++.++.++|.+||+.+|++|||+.++++.
T Consensus       252 ~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         252 PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            45568899999999999999999999999863

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=7.8e-41  Score=311.45  Aligned_cols=248  Identities=33%  Similarity=0.582  Sum_probs=212.5

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      ++|++.+.||.|+||+||+|..  ++..+|+|++....... ....+.+|+.+++.++|+|++++++.+......++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   79 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP   79 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence            4789999999999999999986  56889999997654433 56789999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCcc-
Q 016082          188 FMARGSIYDFLHKQ--KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM-  264 (395)
Q Consensus       188 ~~~ggsL~~~l~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~-  264 (395)
                      ++++++|.++++..  ...+++..+..++.|++.|+.|||+.|++||||+|+||++++++.++|+|||.+......... 
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~  159 (267)
T cd06610          80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT  159 (267)
T ss_pred             ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence            99999999999764  256899999999999999999999999999999999999999999999999998765443221 


Q ss_pred             ----ccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCC-----CCCcH
Q 016082          265 ----TAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP-----KHAHP  334 (395)
Q Consensus       265 ----~~~~gt~~y~aPE~~~~~-~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~~~~  334 (395)
                          ....|+..|+|||.+... .++.++|+||||+++|+|++|+.||...++.+......... .+..+     ...++
T Consensus       160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  238 (267)
T cd06610         160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND-PPSLETGADYKKYSK  238 (267)
T ss_pred             ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCC-CCCcCCccccccccH
Confidence                233688999999998766 78999999999999999999999999887766555544432 22222     25678


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          335 RLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       335 ~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      ++.+++.+||+.||++||++.++++
T Consensus       239 ~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         239 SFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhh
Confidence            9999999999999999999999876

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.3e-41  Score=318.15  Aligned_cols=248  Identities=27%  Similarity=0.484  Sum_probs=210.3

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      ++|++.+.||+|+||.||++.+  +++.||+|.++... +......+.+|+.++++++||||+++++.+...+..++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME   79 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence            3688999999999999999988  47899999987542 34455789999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeeeCCCCcEEEeeeccccccccCCcc
Q 016082          188 FMARGSIYDFLHKQ--KGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM  264 (395)
Q Consensus       188 ~~~ggsL~~~l~~~--~~~l~~~~~~~i~~~i~~~l~~LH~-~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~  264 (395)
                      |++|++|.+++...  ...+++..+..++.+++.||.|||+ .||+||||||+||+++.++.++|+|||.+...... ..
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~  158 (286)
T cd06622          80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-LA  158 (286)
T ss_pred             ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-cc
Confidence            99999999998764  3478999999999999999999997 59999999999999999999999999998754332 23


Q ss_pred             ccCCCCcccccccccCCC------CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--hhhccCCCCCCCCCcHHH
Q 016082          265 TAETGTYRWMAPEVIEHK------PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG--VVQKSLRPTIPKHAHPRL  336 (395)
Q Consensus       265 ~~~~gt~~y~aPE~~~~~------~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l  336 (395)
                      ....+++.|+|||.+.+.      .++.++|+|||||++|+|++|+.||...........  .......+..+..+++++
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd06622         159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDA  238 (286)
T ss_pred             ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHH
Confidence            345688899999998543      358899999999999999999999976554333222  122334556777799999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHH
Q 016082          337 AELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       337 ~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      .++|.+||+.+|.+||++.+++.
T Consensus       239 ~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         239 QDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             HHHHHHHcccCcccCCCHHHHhc
Confidence            99999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=9.5e-41  Score=317.40  Aligned_cols=246  Identities=28%  Similarity=0.502  Sum_probs=211.8

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      .+|++.+.||.|+||.||+|.+  +++.||+|.+.....  .....+.+|+.+++.++|||++++++.+......++|+|
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   96 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME   96 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence            4799999999999999999986  678999999875432  234678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-cccc
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA  266 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~~  266 (395)
                      |+++++|.+++..  ..+++..+..++.+++.|+.|||+.|++||||||+||+++.++.++|+|||++....... ....
T Consensus        97 ~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~  174 (296)
T cd06655          97 YLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST  174 (296)
T ss_pred             ecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCC
Confidence            9999999998865  458999999999999999999999999999999999999999999999999987544332 1233


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccC-CCCCCCCCcHHHHHHHHHhhc
Q 016082          267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL-RPTIPKHAHPRLAELLERCWQ  345 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~  345 (395)
                      ..++..|+|||.+.+..++.++|+|||||++|++++|+.||...++......+..... ....+..+++.+.++|++||.
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  254 (296)
T cd06655         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLE  254 (296)
T ss_pred             cCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhh
Confidence            4688999999999988899999999999999999999999998877655444332221 123456688999999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 016082          346 HDPTQRPNFSQITD  359 (395)
Q Consensus       346 ~dp~~RPs~~ell~  359 (395)
                      .+|.+||++.++++
T Consensus       255 ~dp~~Rpt~~~il~  268 (296)
T cd06655         255 MDVEKRGSAKELLQ  268 (296)
T ss_pred             cChhhCCCHHHHhh
Confidence            99999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.9e-41  Score=318.54  Aligned_cols=250  Identities=30%  Similarity=0.502  Sum_probs=210.4

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  184 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  184 (395)
                      +..++|++.+.||+|+||.||++.+.  ++.||+|++.... .......+.+|+.+++.++||||+++++++...+.+++
T Consensus         2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (284)
T cd06620           2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM   80 (284)
T ss_pred             ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence            44578999999999999999999874  7889999987543 24456789999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeeeCCCCcEEEeeeccccccccCCc
Q 016082          185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV  263 (395)
Q Consensus       185 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~  263 (395)
                      ||||+++++|.+++.. .+.++...+..++.+++.||.|||+ .+++||||||+||++++++.++|+|||++....... 
T Consensus        81 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-  158 (284)
T cd06620          81 CMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-  158 (284)
T ss_pred             EEecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence            9999999999999876 4678999999999999999999997 599999999999999999999999999986543221 


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHhhhccCCCCCCCC-
Q 016082          264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL-----------QAAVGVVQKSLRPTIPKH-  331 (395)
Q Consensus       264 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~-----------~~~~~~~~~~~~~~~~~~-  331 (395)
                      .....|+..|+|||++.+..++.++|+|||||++|++++|..||......           ........ ...+.++.. 
T Consensus       159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  237 (284)
T cd06620         159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ-EPPPRLPSSD  237 (284)
T ss_pred             cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh-ccCCCCCchh
Confidence            23457899999999998888999999999999999999999999865542           11112111 222333333 


Q ss_pred             CcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016082          332 AHPRLAELLERCWQHDPTQRPNFSQITDI  360 (395)
Q Consensus       332 ~~~~l~~li~~cl~~dp~~RPs~~ell~~  360 (395)
                      ++.++.+++.+||+.||.+||++.++++.
T Consensus       238 ~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         238 FPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             cCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            77899999999999999999999999873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.3e-41  Score=316.42  Aligned_cols=238  Identities=25%  Similarity=0.480  Sum_probs=199.5

Q ss_pred             eeeeeeCceEEEEEEEC---------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          116 CKVASGSYGDLYKGTYC---------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      +.||+|+||.||+|...         ...+|+|.+...  .....+.+.+|+.+++.++||||+++++++..+...++||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   78 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ   78 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence            36899999999999763         234888887644  2344567899999999999999999999999989999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCc--------EEEeeecccccc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV--------VKVADFGVARVQ  258 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~--------vkl~DFg~a~~~  258 (395)
                      ||+++|+|.++++.....+++..+..++.||+.||+|||++||+||||||+||+++.++.        ++++|||.+...
T Consensus        79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~  158 (258)
T cd05078          79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV  158 (258)
T ss_pred             ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence            999999999999876667899999999999999999999999999999999999987765        699999998654


Q ss_pred             ccCCccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHH
Q 016082          259 AQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTG-ELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  336 (395)
Q Consensus       259 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  336 (395)
                      ..   .....++..|+|||.+.+ ..++.++|+||||+++|+|++| ..||...++..... ...  .+..+|...+.++
T Consensus       159 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~  232 (258)
T cd05078         159 LP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYE--DRHQLPAPKWTEL  232 (258)
T ss_pred             CC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHH--ccccCCCCCcHHH
Confidence            32   233467889999999976 4589999999999999999998 57777666544322 222  2445666777899


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHH
Q 016082          337 AELLERCWQHDPTQRPNFSQITDIL  361 (395)
Q Consensus       337 ~~li~~cl~~dp~~RPs~~ell~~l  361 (395)
                      .+++.+||+.+|++|||+.++++.|
T Consensus       233 ~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         233 ANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             HHHHHHHhccChhhCCCHHHHHHhc
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7e-42  Score=334.16  Aligned_cols=249  Identities=27%  Similarity=0.472  Sum_probs=228.0

Q ss_pred             cccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Q 016082          108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  185 (395)
Q Consensus       108 ~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  185 (395)
                      ....|.+.+.||+|.|+.|.+|++  ++..||||++.+...+....+.+.+|+++|..++|||||+++.+...+..+|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            345799999999999999999987  688999999999888888878899999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCccc
Q 016082          186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT  265 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~  265 (395)
                      |||..+|.+++++.+ +++..+..+..+..|+.++++|||+++|+|||||++|+|++.+-++||+|||++..........
T Consensus       134 ~eya~~ge~~~yl~~-~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lq  212 (596)
T KOG0586|consen  134 MEYASGGELFDYLVK-HGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQ  212 (596)
T ss_pred             EEeccCchhHHHHHh-cccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccccccc
Confidence            999999999999988 4566669999999999999999999999999999999999999999999999999988887788


Q ss_pred             cCCCCcccccccccCCCCCC-ChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhh
Q 016082          266 AETGTYRWMAPEVIEHKPYD-YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW  344 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~~~~~~-~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  344 (395)
                      ..+|++.|.|||++.+..|+ +.+|+||+|+++|-|+.|.+||.+.+-.+....++...++  +|...+.++.++|++++
T Consensus       213 t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~r--Ip~~ms~dce~lLrk~l  290 (596)
T KOG0586|consen  213 TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYR--IPFYMSCDCEDLLRKFL  290 (596)
T ss_pred             ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeec--ccceeechhHHHHHHhh
Confidence            89999999999999999885 7899999999999999999999998766666665555444  66778889999999999


Q ss_pred             ccCCCCCCCHHHHHH
Q 016082          345 QHDPTQRPNFSQITD  359 (395)
Q Consensus       345 ~~dp~~RPs~~ell~  359 (395)
                      -.+|.+|++..++.+
T Consensus       291 vl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  291 VLNPSKRGPCDQIMK  305 (596)
T ss_pred             ccCccccCCHHHhhh
Confidence            999999999999986

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=7.3e-41  Score=311.64  Aligned_cols=241  Identities=26%  Similarity=0.445  Sum_probs=210.4

Q ss_pred             eeeeCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecCCCCCH
Q 016082          118 VASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI  194 (395)
Q Consensus       118 lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ggsL  194 (395)
                      ||.|+||.||++++.  ++.+|+|++..... .....+.+.+|+.++++++||||+++++.+.++...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999985  78999999976543 234557899999999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCccccCCCCcccc
Q 016082          195 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM  274 (395)
Q Consensus       195 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~  274 (395)
                      .+++.+ ...++...+..++.+++.||.|||++|++|+||+|+||+++.++.++|+|||.+.............++..|+
T Consensus        81 ~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~  159 (262)
T cd05572          81 WTILRD-RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYV  159 (262)
T ss_pred             HHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCcc
Confidence            999976 4568999999999999999999999999999999999999999999999999998665543334456889999


Q ss_pred             cccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCC
Q 016082          275 APEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT--PLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRP  352 (395)
Q Consensus       275 aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP  352 (395)
                      |||.+.+..++.++|+||+|+++|++++|..||....  +.+....+......+..|...++++.++|.+||+.+|.+||
T Consensus       160 ~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~  239 (262)
T cd05572         160 APEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERL  239 (262)
T ss_pred             ChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCc
Confidence            9999988889999999999999999999999998876  55555554443456667777799999999999999999999


Q ss_pred             C-----HHHHHH
Q 016082          353 N-----FSQITD  359 (395)
Q Consensus       353 s-----~~ell~  359 (395)
                      +     +.|+++
T Consensus       240 ~~~~~~~~~l~~  251 (262)
T cd05572         240 GNLKGGIKDIKK  251 (262)
T ss_pred             CCcccCHHHHhc
Confidence            9     777776

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-42  Score=303.85  Aligned_cols=261  Identities=21%  Similarity=0.357  Sum_probs=215.6

Q ss_pred             CceeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 016082          103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  180 (395)
Q Consensus       103 ~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (395)
                      .+..|+.++|+|.+.||.|||.-||+++.  ++..+|+|.+....  .+..+..++|+...++++|||+++++++...+.
T Consensus        14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~   91 (302)
T KOG2345|consen   14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREE   91 (302)
T ss_pred             CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhh
Confidence            45679999999999999999999999885  67889999987663  456788999999999999999999999875443


Q ss_pred             -----cEEEEEecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCeeeCCCCcEEEe
Q 016082          181 -----NLCIVTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGVVKVA  250 (395)
Q Consensus       181 -----~~~lV~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~--iiHrDlkp~NiLl~~~~~vkl~  250 (395)
                           ..|++++|+..|+|.+.+...   ...+++.+++.++.++++||++||+..  ++||||||.|||+++++.+++.
T Consensus        92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~  171 (302)
T KOG2345|consen   92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLM  171 (302)
T ss_pred             ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEE
Confidence                 389999999999999998765   246899999999999999999999998  9999999999999999999999


Q ss_pred             eeccccccccC----------CccccCCCCcccccccccCC---CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH--HH
Q 016082          251 DFGVARVQAQS----------GVMTAETGTYRWMAPEVIEH---KPYDYKADVFSFGIALWELLTGELPYAGLTPL--QA  315 (395)
Q Consensus       251 DFg~a~~~~~~----------~~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwslG~vl~elltg~~pf~~~~~~--~~  315 (395)
                      |||.++...-.          +....+..|..|+|||.++-   ...++++|||||||++|.|+.|..||+..-..  ..
T Consensus       172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl  251 (302)
T KOG2345|consen  172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL  251 (302)
T ss_pred             eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE
Confidence            99998743211          12234578999999999974   45789999999999999999999999643211  11


Q ss_pred             HHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 016082          316 AVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM  365 (395)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~  365 (395)
                      +..+....+.-+.....|..+.++|..|++.||.+||++.+++..+++++
T Consensus       252 aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  252 ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            11222223332333458999999999999999999999999999888764

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=4.5e-41  Score=314.08  Aligned_cols=245  Identities=35%  Similarity=0.664  Sum_probs=206.9

Q ss_pred             eeeeeeCceEEEEEEECC--------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          116 CKVASGSYGDLYKGTYCS--------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~~~--------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      +.||+|+||.||+|+...        +.+|+|.+.... .......+.+|+.+++.++||||+++++++......++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME   79 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence            368999999999998642        569999986542 23345678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhc------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCC-----cEEEeeecccc
Q 016082          188 FMARGSIYDFLHKQ------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-----VVKVADFGVAR  256 (395)
Q Consensus       188 ~~~ggsL~~~l~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~-----~vkl~DFg~a~  256 (395)
                      |+++++|.+++...      ...+++..+..++.+++.|+.|||+.+++|+||||+||+++.++     .++++|||+++
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~  159 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR  159 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence            99999999999753      23478889999999999999999999999999999999999887     89999999987


Q ss_pred             ccccCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCC
Q 016082          257 VQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHA  332 (395)
Q Consensus       257 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  332 (395)
                      .......   .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+ ....++..+...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~  238 (269)
T cd05044         160 DIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV-TAGGRLQKPENC  238 (269)
T ss_pred             ccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHH-hcCCccCCcccc
Confidence            5433211   112345688999999998899999999999999999998 99999887776654433 334455667788


Q ss_pred             cHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 016082          333 HPRLAELLERCWQHDPTQRPNFSQITDILK  362 (395)
Q Consensus       333 ~~~l~~li~~cl~~dp~~RPs~~ell~~l~  362 (395)
                      +..+.++|.+||+.+|.+||++.++++.|.
T Consensus       239 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         239 PDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             hHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            999999999999999999999999998875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.9e-41  Score=312.30  Aligned_cols=236  Identities=28%  Similarity=0.521  Sum_probs=196.4

Q ss_pred             eeeeeeCceEEEEEEECCc------------eEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Q 016082          116 CKVASGSYGDLYKGTYCSQ------------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~~~~------------~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  183 (395)
                      +.||+|+||.||+|.+...            .+++|+++....   ....+.+|+.++++++||||+++++++.. ...+
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   76 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI   76 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence            4689999999999988533            378888765421   15788999999999999999999999988 7789


Q ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCC-------cEEEeeecccc
Q 016082          184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-------VVKVADFGVAR  256 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~-------~vkl~DFg~a~  256 (395)
                      +||||+++|+|.+++......++...+..++.||+.||.|||++||+||||||+||+++.++       .++|+|||.++
T Consensus        77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~  156 (259)
T cd05037          77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI  156 (259)
T ss_pred             EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence            99999999999999987665789999999999999999999999999999999999999888       79999999997


Q ss_pred             ccccCCccccCCCCcccccccccCCC--CCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCc
Q 016082          257 VQAQSGVMTAETGTYRWMAPEVIEHK--PYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAH  333 (395)
Q Consensus       257 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (395)
                      ....   .....++..|+|||.+.+.  .++.++|+||||+++|+|++ |..||...+......... ..  ...+....
T Consensus       157 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~--~~~~~~~~  230 (259)
T cd05037         157 TVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQ--HRLPMPDC  230 (259)
T ss_pred             cccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cC--CCCCCCCc
Confidence            6543   2234567789999999876  78999999999999999999 688888775443322221 11  12223334


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 016082          334 PRLAELLERCWQHDPTQRPNFSQITDIL  361 (395)
Q Consensus       334 ~~l~~li~~cl~~dp~~RPs~~ell~~l  361 (395)
                      ..+.+++.+||..+|.+||++.++++.|
T Consensus       231 ~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         231 AELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             hHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            7999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=7.9e-41  Score=312.05  Aligned_cols=248  Identities=28%  Similarity=0.527  Sum_probs=209.8

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC----CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV----NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  184 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  184 (395)
                      +|+..+.||+|+||.||+|..  +++.||+|+++....    +....+.+.+|+.++++++|+||+++++++...+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999986  678999999975432    12345789999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCC-cEEEeeeccccccccCCc
Q 016082          185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQSGV  263 (395)
Q Consensus       185 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~-~vkl~DFg~a~~~~~~~~  263 (395)
                      |+||++|++|.+++.. .+++++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||.+........
T Consensus        81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~  159 (268)
T cd06630          81 FVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT  159 (268)
T ss_pred             EEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence            9999999999999976 46789999999999999999999999999999999999998776 599999999876543211


Q ss_pred             -----cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHhhhccCCCCCCCCCcHH
Q 016082          264 -----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL---QAAVGVVQKSLRPTIPKHAHPR  335 (395)
Q Consensus       264 -----~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  335 (395)
                           .....++..|+|||.+.+..++.++|+||+|+++++|++|..||......   ............+..+...+++
T Consensus       160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (268)
T cd06630         160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG  239 (268)
T ss_pred             cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence                 12245788999999998888999999999999999999999999754322   2222222334456677788999


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHH
Q 016082          336 LAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       336 l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      +.+++.+||..+|.+||++.++++
T Consensus       240 ~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         240 LRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHhc
Confidence            999999999999999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.8e-40  Score=308.53  Aligned_cols=247  Identities=30%  Similarity=0.527  Sum_probs=214.2

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      ++|++.+.||.|++|.||+|+.  +++.||+|++...... .....+.+|+.++.+++|+|++++++++......++|||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE   79 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence            3688899999999999999988  4789999999766432 456789999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeeeCCCCcEEEeeeccccccccCCcc-c
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM-T  265 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~-~  265 (395)
                      |+++++|.+++... ..+++..+..++.|+++|+.|||+ .|++||||+|+||+++.++.++|+|||.+......... .
T Consensus        80 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~  158 (264)
T cd06623          80 YMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN  158 (264)
T ss_pred             ecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCccc
Confidence            99999999999764 678999999999999999999999 99999999999999999999999999999865543322 2


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHhhhccCCCCCCCC-CcHHHHHHHH
Q 016082          266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT---PLQAAVGVVQKSLRPTIPKH-AHPRLAELLE  341 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~---~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~  341 (395)
                      ...++..|+|||.+.+..++.++|+||||+++|+|++|+.||....   ..+.... ......+..+.. ++..+.++|.
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~  237 (264)
T cd06623         159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA-ICDGPPPSLPAEEFSPEFRDFIS  237 (264)
T ss_pred             ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH-HhcCCCCCCCcccCCHHHHHHHH
Confidence            4467889999999999899999999999999999999999998774   3333323 233444555666 8899999999


Q ss_pred             HhhccCCCCCCCHHHHHH
Q 016082          342 RCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       342 ~cl~~dp~~RPs~~ell~  359 (395)
                      +||+.+|++||++.++++
T Consensus       238 ~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         238 ACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             HHccCChhhCCCHHHHHh
Confidence            999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-42  Score=340.51  Aligned_cols=242  Identities=30%  Similarity=0.560  Sum_probs=211.4

Q ss_pred             eeeeeeCceEEEEEEECC--ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecCCCCC
Q 016082          116 CKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS  193 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ggs  193 (395)
                      -+||+|.||+||.|++..  ...|||-+.-.  +....+-+.+||.+.++++|.|||+++|.|.+++.+-|.||-.+|||
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS  658 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS  658 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence            379999999999999854  45688887532  33445678899999999999999999999999999999999999999


Q ss_pred             HHHHHhhccCCC--CHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCC-CCcEEEeeeccccccccC-CccccCCC
Q 016082          194 IYDFLHKQKGVF--QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVADFGVARVQAQS-GVMTAETG  269 (395)
Q Consensus       194 L~~~l~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~-~~~vkl~DFg~a~~~~~~-~~~~~~~g  269 (395)
                      |.++|+..=|++  .+.++-.+.+||++||.|||.+.|+|||||-+|||++. .|.+||+|||.++....- ....+.+|
T Consensus       659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTG  738 (1226)
T KOG4279|consen  659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTG  738 (1226)
T ss_pred             HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccccc
Confidence            999999877888  78899999999999999999999999999999999975 789999999999876543 34456799


Q ss_pred             CcccccccccCCC--CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhh-ccCCCCCCCCCcHHHHHHHHHhhcc
Q 016082          270 TYRWMAPEVIEHK--PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ-KSLRPTIPKHAHPRLAELLERCWQH  346 (395)
Q Consensus       270 t~~y~aPE~~~~~--~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~  346 (395)
                      |..|||||++..+  .|..++|||||||++.||.||++||..+...+++.-.+. -...|++|..++.+.+.+|.+|+.+
T Consensus       739 TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFep  818 (1226)
T KOG4279|consen  739 TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEP  818 (1226)
T ss_pred             chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCC
Confidence            9999999999865  589999999999999999999999998877666553332 2346899999999999999999999


Q ss_pred             CCCCCCCHHHHHH
Q 016082          347 DPTQRPNFSQITD  359 (395)
Q Consensus       347 dp~~RPs~~ell~  359 (395)
                      +|.+||++.+++.
T Consensus       819 d~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  819 DPCDRPSAKDLLQ  831 (1226)
T ss_pred             CcccCccHHHhcc
Confidence            9999999999886

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.1e-40  Score=312.08  Aligned_cols=248  Identities=29%  Similarity=0.532  Sum_probs=207.7

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC--------CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV--------NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  180 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~--------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (395)
                      +|.+.+.||.|+||.||+|..  +++.+|+|.++....        .....+.+.+|+.++++++|||++++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            577889999999999999976  578999998864321        1123457889999999999999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                      ..++||||+++++|.++++.. +.++...+..++.+++.|+.|||++|++||||+|+||+++.++.++++|||.++....
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  160 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD  160 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence            999999999999999999774 6789999999999999999999999999999999999999999999999999975432


Q ss_pred             CC---ccccCCCCcccccccccCCCC--CCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCC----CC
Q 016082          261 SG---VMTAETGTYRWMAPEVIEHKP--YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP----KH  331 (395)
Q Consensus       261 ~~---~~~~~~gt~~y~aPE~~~~~~--~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~----~~  331 (395)
                      ..   ......++..|+|||.+.+..  ++.++|+||||+++|++++|..||......+...........+..+    ..
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (272)
T cd06629         161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMN  240 (272)
T ss_pred             cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccccc
Confidence            21   123346788999999987654  8899999999999999999999998766655444433333333333    34


Q ss_pred             CcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          332 AHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       332 ~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      ++.++.+++.+||+++|.+||++.++++
T Consensus       241 ~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         241 LSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             CCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            5889999999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.2e-41  Score=328.29  Aligned_cols=243  Identities=22%  Similarity=0.386  Sum_probs=196.8

Q ss_pred             cccCcceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Q 016082          108 DAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  185 (395)
Q Consensus       108 ~~~~~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  185 (395)
                      ....|++.+.||+|+||.||+|++.  ++.||+|+....        ....|+.++++++||||+++++++......++|
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  135 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV  135 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence            3457999999999999999999984  578999986533        234689999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCccc
Q 016082          186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT  265 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~  265 (395)
                      ||++. ++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||.++.........
T Consensus       136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  214 (357)
T PHA03209        136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL  214 (357)
T ss_pred             EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcccc
Confidence            99996 59999998777889999999999999999999999999999999999999999999999999997544433344


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCC-CCCCCCCHH--H-------HHHHhhhc-cCC-CCCC----
Q 016082          266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE-LPYAGLTPL--Q-------AAVGVVQK-SLR-PTIP----  329 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~-~pf~~~~~~--~-------~~~~~~~~-~~~-~~~~----  329 (395)
                      ...||+.|+|||++.+..++.++|||||||++|||+++. .+|......  .       ........ ... ...+    
T Consensus       215 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  294 (357)
T PHA03209        215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPG  294 (357)
T ss_pred             cccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCc
Confidence            567899999999999999999999999999999999854 444432110  0       00010100 000 0000    


Q ss_pred             --------------------------CCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          330 --------------------------KHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       330 --------------------------~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                                ..++.++.++|.+||+.||.+|||+.|+++
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~  350 (357)
T PHA03209        295 SRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN  350 (357)
T ss_pred             cHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence                                      134667788999999999999999999986

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.8e-40  Score=306.65  Aligned_cols=248  Identities=29%  Similarity=0.562  Sum_probs=220.3

Q ss_pred             CcceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Q 016082          111 QLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  188 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  188 (395)
                      +|++.+.||+|+||.||++.+.  ++.+|+|++............+.+|++++++++|||++++++.+......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            5788999999999999999985  78999999987766566678899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-cc
Q 016082          189 MARGSIYDFLHKQK---GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VM  264 (395)
Q Consensus       189 ~~ggsL~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~  264 (395)
                      +++++|.+++....   ..++...+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~  160 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA  160 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence            99999999998753   789999999999999999999999999999999999999999999999999997655443 22


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhh
Q 016082          265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW  344 (395)
Q Consensus       265 ~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  344 (395)
                      ....|++.|+|||...+..++.++|+||+|+++++|++|+.||......+....... ...+..+..++.++.+++.+||
T Consensus       161 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l  239 (258)
T cd08215         161 KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK-GQYPPIPSQYSSELRNLVSSLL  239 (258)
T ss_pred             cceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc-CCCCCCCCCCCHHHHHHHHHHc
Confidence            334688899999999988899999999999999999999999988876665555443 3455667788999999999999


Q ss_pred             ccCCCCCCCHHHHHH
Q 016082          345 QHDPTQRPNFSQITD  359 (395)
Q Consensus       345 ~~dp~~RPs~~ell~  359 (395)
                      ..+|++||++.++++
T Consensus       240 ~~~p~~Rp~~~~ll~  254 (258)
T cd08215         240 QKDPEERPSIAQILQ  254 (258)
T ss_pred             CCChhhCcCHHHHhc
Confidence            999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.1e-40  Score=316.42  Aligned_cols=246  Identities=29%  Similarity=0.465  Sum_probs=208.6

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      ..|++.+.||+|+||.||+|+.  .++.||+|.++... ...+...++.+|+.+++.++||||+++++++......++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            4689999999999999999987  57899999986443 23445567899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCcccc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA  266 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~  266 (395)
                      ||+.| ++.+++....+.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++......   ..
T Consensus        95 e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---~~  170 (307)
T cd06607          95 EYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---NS  170 (307)
T ss_pred             HhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC---CC
Confidence            99974 888887765677999999999999999999999999999999999999999999999999998754332   33


Q ss_pred             CCCCcccccccccC---CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHh
Q 016082          267 ETGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC  343 (395)
Q Consensus       267 ~~gt~~y~aPE~~~---~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  343 (395)
                      ..+++.|+|||++.   ...++.++||||||+++|+|++|+.||.+.+.................+..++.++.++|.+|
T Consensus       171 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  250 (307)
T cd06607         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSC  250 (307)
T ss_pred             ccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHH
Confidence            46788999999874   456889999999999999999999999887766554443322222222345788999999999


Q ss_pred             hccCCCCCCCHHHHHH
Q 016082          344 WQHDPTQRPNFSQITD  359 (395)
Q Consensus       344 l~~dp~~RPs~~ell~  359 (395)
                      |+.+|.+||++.+++.
T Consensus       251 l~~~p~~Rp~~~~il~  266 (307)
T cd06607         251 LQKIPQDRPSSEELLK  266 (307)
T ss_pred             hcCChhhCcCHHHHhc
Confidence            9999999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=8.9e-41  Score=317.68  Aligned_cols=246  Identities=28%  Similarity=0.489  Sum_probs=209.6

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      .+|++.+.||+|+||.||+|..  .++.||+|.+......  ..+.+.+|+.+++.++||||+++++++..+...++|||
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   96 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   96 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence            5899999999999999999986  6789999999755322  34668899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-cccc
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA  266 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~~  266 (395)
                      |+++++|.+++.+  ..++...+..++.+++.||.|||+.|++||||||+||+++.++.++|+|||.+....... ....
T Consensus        97 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  174 (297)
T cd06656          97 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  174 (297)
T ss_pred             ccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCc
Confidence            9999999999865  457889999999999999999999999999999999999999999999999987544332 2234


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccC-CCCCCCCCcHHHHHHHHHhhc
Q 016082          267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL-RPTIPKHAHPRLAELLERCWQ  345 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~  345 (395)
                      ..+++.|+|||.+.+..++.++|+||||+++|++++|+.||...++............ ....+...++.+.+++.+||+
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  254 (297)
T cd06656         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLE  254 (297)
T ss_pred             ccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHcc
Confidence            5688999999999998899999999999999999999999987665443322222111 122355678899999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 016082          346 HDPTQRPNFSQITD  359 (395)
Q Consensus       346 ~dp~~RPs~~ell~  359 (395)
                      .+|++||++.++++
T Consensus       255 ~~p~~Rps~~~il~  268 (297)
T cd06656         255 MDVDRRGSAKELLQ  268 (297)
T ss_pred             CChhhCcCHHHHhc
Confidence            99999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=4.3e-41  Score=316.05  Aligned_cols=246  Identities=33%  Similarity=0.591  Sum_probs=212.1

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      +.|+..+.||+|+||.||+|.+  +++.||+|+++.... ....+.+.+|+.++++++||||+++++.+..+...++|||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence            3577888999999999999987  567899999875532 3345789999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-cccc
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA  266 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~~  266 (395)
                      |+++++|.+++..  +.+++..+..++.+++.|+.|||++|++|+||+|+||++++++.++|+|||++....... ....
T Consensus        83 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06642          83 YLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             ccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhc
Confidence            9999999999864  568999999999999999999999999999999999999999999999999997654332 1223


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhcc
Q 016082          267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH  346 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  346 (395)
                      ..++..|+|||.+.+..++.++|+||||+++|+|++|+.||....+...... ......+..+...+.++.+++.+||+.
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~  239 (277)
T cd06642         161 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL-IPKNSPPTLEGQYSKPFKEFVEACLNK  239 (277)
T ss_pred             ccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh-hhcCCCCCCCcccCHHHHHHHHHHccC
Confidence            4678899999999998999999999999999999999999987766554433 333445556667889999999999999


Q ss_pred             CCCCCCCHHHHHH
Q 016082          347 DPTQRPNFSQITD  359 (395)
Q Consensus       347 dp~~RPs~~ell~  359 (395)
                      +|.+||++.++++
T Consensus       240 ~p~~Rp~~~~il~  252 (277)
T cd06642         240 DPRFRPTAKELLK  252 (277)
T ss_pred             CcccCcCHHHHHH
Confidence            9999999999987

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.2e-40  Score=316.16  Aligned_cols=260  Identities=26%  Similarity=0.370  Sum_probs=214.5

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCC---HHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN---TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  185 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  185 (395)
                      +|++.+.||.|+||.||+|.+  +++.||||.++.....   ......+..|+.++++++|+||+++++++......++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            478889999999999999987  5789999999866543   33456678899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-cc
Q 016082          186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VM  264 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~  264 (395)
                      |||+ +++|.+++......+++..+..++.||++||.|||++||+|+||+|+||+++.++.++|+|||.++...... ..
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM  159 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence            9999 889999997654479999999999999999999999999999999999999999999999999997654432 22


Q ss_pred             ccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC------------------
Q 016082          265 TAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR------------------  325 (395)
Q Consensus       265 ~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~------------------  325 (395)
                      ....++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.++.............                  
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (298)
T cd07841         160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF  239 (298)
T ss_pred             cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccc
Confidence            34467888999998854 56789999999999999999999888876654433332211000                  


Q ss_pred             ---CC-----CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcccccccc
Q 016082          326 ---PT-----IPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINTN  380 (395)
Q Consensus       326 ---~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~~~~~~~~~~~~  380 (395)
                         +.     .....+.++.++|.+||+++|.+|||+.+++.         +.|+.+.-..++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~---------~~~~~~~~~~~~  293 (298)
T cd07841         240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE---------HPYFSNDPAPTP  293 (298)
T ss_pred             cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh---------CccccCCCCCCC
Confidence               00     11345788999999999999999999999998         778777666654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.3e-40  Score=304.69  Aligned_cols=248  Identities=31%  Similarity=0.548  Sum_probs=218.2

Q ss_pred             CcceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--CcEEEEE
Q 016082          111 QLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCIVT  186 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~  186 (395)
                      +|++.+.||+|++|.||+|...  ++.|++|+++.........+.+.+|+.++++++||||+++++.+...  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4778899999999999999985  78999999987655556678899999999999999999999999888  7899999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCc---
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV---  263 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~---  263 (395)
                      ||+++++|.+++.... .+++..+..++.+++.|+.|||+.|++|+||+|+||+++.++.++|+|||.+........   
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  159 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG  159 (260)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence            9999999999997744 899999999999999999999999999999999999999999999999999987665543   


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHhhhccCCCCCCCCCcHHHHHHHHH
Q 016082          264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT-PLQAAVGVVQKSLRPTIPKHAHPRLAELLER  342 (395)
Q Consensus       264 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  342 (395)
                      .....++..|+|||.+.+..++.++||||||+++++|++|..||.... ..............+.+|...++++.+++.+
T Consensus       160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~  239 (260)
T cd06606         160 TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRK  239 (260)
T ss_pred             ccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHH
Confidence            345678899999999998889999999999999999999999998765 3333333333345567778889999999999


Q ss_pred             hhccCCCCCCCHHHHHH
Q 016082          343 CWQHDPTQRPNFSQITD  359 (395)
Q Consensus       343 cl~~dp~~RPs~~ell~  359 (395)
                      |++.+|.+||++.+++.
T Consensus       240 ~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         240 CLRRDPKKRPTADELLQ  256 (260)
T ss_pred             hCcCChhhCCCHHHHhh
Confidence            99999999999999976

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-40  Score=327.90  Aligned_cols=244  Identities=24%  Similarity=0.417  Sum_probs=200.2

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEEC----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  182 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  182 (395)
                      +...+|.+.++||.|+||.||++...    +..||+|.+...       ....+|+.++++++||||+++++++......
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~  161 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTV  161 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence            34568999999999999999999753    467999998654       2346799999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC
Q 016082          183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~  262 (395)
                      |+|||++. ++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++......
T Consensus       162 ~lv~e~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        162 CMVMPKYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             EEEehhcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence            99999996 589998843 5789999999999999999999999999999999999999999999999999997554332


Q ss_pred             c---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHhhh---------------
Q 016082          263 V---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL---QAAVGVVQ---------------  321 (395)
Q Consensus       263 ~---~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~---~~~~~~~~---------------  321 (395)
                      .   .....||+.|+|||++.+..|+.++|||||||++|||++|+.||.+....   .....+..               
T Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~  319 (392)
T PHA03207        240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST  319 (392)
T ss_pred             ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence            1   22357899999999999999999999999999999999999999764321   11111110               


Q ss_pred             ----------ccCCCCC--C-----CCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          322 ----------KSLRPTI--P-----KHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       322 ----------~~~~~~~--~-----~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                ...++..  +     ...+.++.++|.+||..||++||++.+++.
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~  374 (392)
T PHA03207        320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS  374 (392)
T ss_pred             hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence                      0111111  1     234678999999999999999999999987

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-42  Score=310.64  Aligned_cols=278  Identities=22%  Similarity=0.423  Sum_probs=237.3

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  182 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  182 (395)
                      .+..++|..++.||+|.||.|-+++.  +++.+|+|+++++.. ..+....-..|-++|+..+||.+..+...|+..+++
T Consensus       164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl  243 (516)
T KOG0690|consen  164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL  243 (516)
T ss_pred             eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence            45567899999999999999999876  688999999998864 455567788899999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-
Q 016082          183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-  261 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-  261 (395)
                      |+||||..||.|+-+|.. ...|+++....+..+|+.||.|||+++||.||||.+|+|+|.+|++||+|||+++..... 
T Consensus       244 CFVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g  322 (516)
T KOG0690|consen  244 CFVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG  322 (516)
T ss_pred             EEEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccccc
Confidence            999999999999999876 567999999999999999999999999999999999999999999999999999854433 


Q ss_pred             CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHH
Q 016082          262 GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE  341 (395)
Q Consensus       262 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  341 (395)
                      ..+...+|||.|+|||++....|..+.|.|.+|+++|||++|+.||...+....+.-+.-..  ..+|..++++.+.++.
T Consensus       323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed--~kFPr~ls~eAktLLs  400 (516)
T KOG0690|consen  323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED--LKFPRTLSPEAKTLLS  400 (516)
T ss_pred             ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh--ccCCccCCHHHHHHHH
Confidence            34567899999999999999999999999999999999999999999998887776665443  3578899999999999


Q ss_pred             HhhccCCCCCC--CHHHHHHHHHHHHHHHHHhhccccccccccccccce
Q 016082          342 RCWQHDPTQRP--NFSQITDILKQMMKEVLYWLSPNLINTNIQSTYKHL  388 (395)
Q Consensus       342 ~cl~~dp~~RP--s~~ell~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (395)
                      .+|.+||.+|.  ...+..+..+.-.-...+|.  ..+.+...+++|++
T Consensus       401 GLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~--~~~~Kki~PPfKPq  447 (516)
T KOG0690|consen  401 GLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWE--ATYRKKIEPPFKPQ  447 (516)
T ss_pred             HHhhcChHhhcCCCchhHHHHHhhhhhccCCHH--HHHHhccCCCCCCC
Confidence            99999999995  35666665555444444553  23445556666654

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=8.5e-41  Score=316.62  Aligned_cols=249  Identities=26%  Similarity=0.394  Sum_probs=207.8

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--CcEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCIV  185 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV  185 (395)
                      ++|++.+.||.|+||.||+|++  +++.+|+|.++...........+.+|+.++++++||||+++++++...  ...|+|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            4799999999999999999998  478899999986654444445678899999999999999999998777  789999


Q ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-Ccc
Q 016082          186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVM  264 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-~~~  264 (395)
                      |||+.+ +|.+++......+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.++..... ...
T Consensus        85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  163 (293)
T cd07843          85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY  163 (293)
T ss_pred             ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcccc
Confidence            999975 999998776667999999999999999999999999999999999999999999999999999865543 223


Q ss_pred             ccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc--------------------
Q 016082          265 TAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS--------------------  323 (395)
Q Consensus       265 ~~~~gt~~y~aPE~~~~~-~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~--------------------  323 (395)
                      ....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+....                    
T Consensus       164 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (293)
T cd07843         164 TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKK  243 (293)
T ss_pred             ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhccc
Confidence            345678899999998754 46899999999999999999999998776654433322110                    


Q ss_pred             ---------CCCCCCCC-CcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          324 ---------LRPTIPKH-AHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       324 ---------~~~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                               .....+.. .++.+.++|++||+.+|++|||+.|++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         244 TFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             ccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                     01112222 5888999999999999999999999976

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1e-40  Score=314.62  Aligned_cols=249  Identities=27%  Similarity=0.418  Sum_probs=207.2

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      ++|++.+.||+|+||.||+|.+  +++.||+|+++....+......+.+|+.++++++|+||+++++++..++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            3689999999999999999987  46889999997655445556789999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC--ccc
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--VMT  265 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~--~~~  265 (395)
                      |++++.+..+... ...++...+..++.+++.|+.|||+.|++||||+|+||+++.++.++|+|||.+.......  ...
T Consensus        81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (288)
T cd07833          81 YVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT  159 (288)
T ss_pred             cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence            9998666655544 5668999999999999999999999999999999999999999999999999987655433  334


Q ss_pred             cCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc----------------CC---
Q 016082          266 AETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS----------------LR---  325 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~~~-~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~----------------~~---  325 (395)
                      ...++..|+|||++.+. .++.++|+||||+++|+|++|+.||.+..............                ..   
T Consensus       160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07833         160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA  239 (288)
T ss_pred             CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccc
Confidence            45678899999999887 88999999999999999999999998765543322211100                00   


Q ss_pred             -----------CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          326 -----------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       326 -----------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                 ...+..+++++.++|++||..+|++||+++++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence                       0112335889999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-41  Score=325.42  Aligned_cols=255  Identities=22%  Similarity=0.381  Sum_probs=213.1

Q ss_pred             CceeecccCcceeeeeeeeCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCC
Q 016082          103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPP  180 (395)
Q Consensus       103 ~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  180 (395)
                      ....+....|++.++||+||.+.||++... .+.+|+|.+.....+...+..|.+|+..|.+++ |.+||++|+|-..++
T Consensus       354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~  433 (677)
T KOG0596|consen  354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG  433 (677)
T ss_pred             eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence            467788999999999999999999999874 467888877766678888999999999999997 899999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                      .+||||||-+- +|..+|++.....+...+..+..||+.++.++|+.||||.||||+|+|+- .|.+||+|||.|.....
T Consensus       434 ~lYmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  434 YLYMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQP  511 (677)
T ss_pred             eEEEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence            99999997755 99999998777677678999999999999999999999999999999995 57999999999987654


Q ss_pred             CC---ccccCCCCcccccccccCCCC-----------CCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc-CC
Q 016082          261 SG---VMTAETGTYRWMAPEVIEHKP-----------YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-LR  325 (395)
Q Consensus       261 ~~---~~~~~~gt~~y~aPE~~~~~~-----------~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~-~~  325 (395)
                      ..   .....+||+.|||||.+....           .+.++|||||||++|+|+.|+.||............+... -.
T Consensus       512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~  591 (677)
T KOG0596|consen  512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHE  591 (677)
T ss_pred             cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcc
Confidence            32   344568999999999985332           4578999999999999999999998766544443333222 11


Q ss_pred             CCCCCCCcHH-HHHHHHHhhccCCCCCCCHHHHHH
Q 016082          326 PTIPKHAHPR-LAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       326 ~~~~~~~~~~-l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      -++|..-+.. +.++|..||+.||.+||++-++++
T Consensus       592 Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  592 IEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             ccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            2333333333 999999999999999999999986

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=3.1e-40  Score=309.07  Aligned_cols=245  Identities=24%  Similarity=0.497  Sum_probs=198.4

Q ss_pred             eeeeeeCceEEEEEEE-CC---ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecCCC
Q 016082          116 CKVASGSYGDLYKGTY-CS---QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR  191 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~-~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~g  191 (395)
                      ++||+|+||.||+|.. .+   ..+++|.++... .....+.+.+|+.+++.++||||+++++.+......|+||||+++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL   79 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence            3689999999999975 22   346677766543 233457899999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC---ccc
Q 016082          192 GSIYDFLHKQK---GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---VMT  265 (395)
Q Consensus       192 gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~---~~~  265 (395)
                      |+|.+++++..   ...+...+..++.||+.||+|||+.+++||||||+|||++.++.++|+|||++.......   ...
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~  159 (268)
T cd05086          80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETED  159 (268)
T ss_pred             CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhccc
Confidence            99999997642   345667788999999999999999999999999999999999999999999986422211   122


Q ss_pred             cCCCCcccccccccCC-------CCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc----CCCCCCCCCc
Q 016082          266 AETGTYRWMAPEVIEH-------KPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKS----LRPTIPKHAH  333 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~~-------~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~----~~~~~~~~~~  333 (395)
                      ...++..|+|||++.+       ..++.++||||||+++|||++ |..||...++.+....+....    .++.++...+
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (268)
T cd05086         160 DKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYS  239 (268)
T ss_pred             CCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCc
Confidence            3467889999998743       345789999999999999997 678998877765555443322    3455566688


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 016082          334 PRLAELLERCWQHDPTQRPNFSQITDILK  362 (395)
Q Consensus       334 ~~l~~li~~cl~~dp~~RPs~~ell~~l~  362 (395)
                      +.+.+++..|| .+|++||++.++++.|.
T Consensus       240 ~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         240 ERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            99999999999 67999999999988764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.6e-40  Score=323.68  Aligned_cols=247  Identities=25%  Similarity=0.373  Sum_probs=205.5

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC------C
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP------P  180 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  180 (395)
                      .++|++.+.||+|+||.||+|.+  +++.||+|+++....+......+.+|+.++++++||||+++++++...      .
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            46899999999999999999987  678999999976544555567788999999999999999999988644      3


Q ss_pred             cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                      ..|+||||+.+ +|.+.+...   ++...+..++.|++.||+|||++||+||||||+||+++.++.++|+|||.++....
T Consensus        95 ~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  170 (353)
T cd07850          95 DVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  170 (353)
T ss_pred             cEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence            57999999965 888887542   88999999999999999999999999999999999999999999999999987655


Q ss_pred             CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC---------------
Q 016082          261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR---------------  325 (395)
Q Consensus       261 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~---------------  325 (395)
                      ........++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+......               
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (353)
T cd07850         171 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRN  250 (353)
T ss_pred             CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhH
Confidence            44444567889999999999999999999999999999999999999876544332222110000               


Q ss_pred             -----C---------------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          326 -----P---------------------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       326 -----~---------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                           +                     ..+...++++.++|.+||+.||++|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         251 YVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                 0                     001134667899999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.7e-40  Score=317.22  Aligned_cols=251  Identities=24%  Similarity=0.397  Sum_probs=207.9

Q ss_pred             cccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--CcEE
Q 016082          108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLC  183 (395)
Q Consensus       108 ~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  183 (395)
                      ..++|++.+.||.|+||.||+|.+  +++.||+|.++...........+.+|+.++++++|+||+++++++...  +..+
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            346899999999999999999987  578999999975543333334567899999999999999999998755  4689


Q ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-C
Q 016082          184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-G  262 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-~  262 (395)
                      +||||+.+ +|.+++......+++..+..++.||++|+.|||+.|++||||||+||+++.++.++|+|||.++..... .
T Consensus        85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~  163 (309)
T cd07845          85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK  163 (309)
T ss_pred             EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence            99999975 899998776678999999999999999999999999999999999999999999999999999865433 2


Q ss_pred             ccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC----------------
Q 016082          263 VMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR----------------  325 (395)
Q Consensus       263 ~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~----------------  325 (395)
                      ..+...++..|+|||.+.+ ..++.++||||+|+++|+|++|++||.+.++.+....+......                
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (309)
T cd07845         164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG  243 (309)
T ss_pred             CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence            2333456788999999865 56899999999999999999999999988877665544331100                


Q ss_pred             ----CCCC--------CCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          326 ----PTIP--------KHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       326 ----~~~~--------~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                          +..+        ...++++.++|.+||+.||++|||+.+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             cccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                0000        125788999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=3.2e-40  Score=310.20  Aligned_cols=245  Identities=23%  Similarity=0.362  Sum_probs=201.4

Q ss_pred             cceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEEEEecC--CcEEEEE
Q 016082          112 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRP--PNLCIVT  186 (395)
Q Consensus       112 ~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lV~  186 (395)
                      |++.++||+|+||.||+|+.  +++.||+|.++........ ....+|+.+++++. |+|++++++++.+.  +..++||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~   79 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF   79 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence            67889999999999999987  5788999998765322222 34457889999886 99999999999887  8899999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCcccc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA  266 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~  266 (395)
                      ||+++ +|.+.+....+.+++..+..++.|++.||.|||+.|++||||+|+||+++. +.++|+|||.++..........
T Consensus        80 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~  157 (282)
T cd07831          80 ELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTE  157 (282)
T ss_pred             ecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcCC
Confidence            99975 888888776678999999999999999999999999999999999999999 9999999999986654444445


Q ss_pred             CCCCcccccccccC-CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc----------------CCCCC-
Q 016082          267 ETGTYRWMAPEVIE-HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS----------------LRPTI-  328 (395)
Q Consensus       267 ~~gt~~y~aPE~~~-~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~----------------~~~~~-  328 (395)
                      ..++..|+|||.+. +..++.++|+|||||++|||++|..||.+.++.+.........                ..... 
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
T cd07831         158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFP  237 (282)
T ss_pred             CCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCc
Confidence            56889999999765 4557899999999999999999999998877654333221100                00001 


Q ss_pred             ----------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          329 ----------PKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       329 ----------~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                ....+.++.++|.+||+++|++||++.+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         238 SKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             ccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence                      1246789999999999999999999999876

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=9.6e-41  Score=314.62  Aligned_cols=249  Identities=28%  Similarity=0.428  Sum_probs=205.9

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      ++|++.++||+|+||.||+|.+  +++.||+|++..........+.+.+|+.+++.++||||+++++++..++..|+|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            3688999999999999999998  47899999987654444455678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-Ccccc
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTA  266 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-~~~~~  266 (395)
                      |+++++|.++... .+.+++..++.++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++...... .....
T Consensus        81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07846          81 FVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD  159 (286)
T ss_pred             cCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence            9999888887654 456899999999999999999999999999999999999999999999999998764432 22334


Q ss_pred             CCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc--------------------CC
Q 016082          267 ETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS--------------------LR  325 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~--------------------~~  325 (395)
                      ..++..|+|||.+.+ ..++.++||||||+++|+|++|++||......+....+....                    ..
T Consensus       160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07846         160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL  239 (286)
T ss_pred             ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccc
Confidence            567899999999875 457889999999999999999999998765543322211100                    00


Q ss_pred             CC---------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          326 PT---------IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       326 ~~---------~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      +.         ..+.++..+.+++.+||+.+|++||++.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            00         12356788999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4.6e-40  Score=311.31  Aligned_cols=248  Identities=28%  Similarity=0.480  Sum_probs=205.9

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEEEEecC-----C
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRP-----P  180 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-----~  180 (395)
                      .++|.+.+.||+|+||.||++..  .++.+|+|++....   .....+.+|+.+++++ +|||++++++++...     .
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   97 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG   97 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence            56899999999999999999987  57889999987542   2335677899999999 799999999998654     3


Q ss_pred             cEEEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV  257 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~  257 (395)
                      ..++||||++|++|.++++.   ....+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||.++.
T Consensus        98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~  177 (291)
T cd06639          98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ  177 (291)
T ss_pred             eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence            58999999999999998864   345789999999999999999999999999999999999999999999999999876


Q ss_pred             cccCC-ccccCCCCcccccccccCCC-----CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccC-CCCCCC
Q 016082          258 QAQSG-VMTAETGTYRWMAPEVIEHK-----PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL-RPTIPK  330 (395)
Q Consensus       258 ~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~  330 (395)
                      ..... ......|+..|+|||.+...     .++.++|+|||||++|+|++|+.||....+.+....+..... ....+.
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  257 (291)
T cd06639         178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPE  257 (291)
T ss_pred             cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCccc
Confidence            44322 22335688999999998643     368999999999999999999999998877655544332211 112345


Q ss_pred             CCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          331 HAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       331 ~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      ..+..+.++|.+||+.+|++||++.++++
T Consensus       258 ~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         258 KWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             ccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            67789999999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.4e-40  Score=314.23  Aligned_cols=248  Identities=29%  Similarity=0.512  Sum_probs=202.8

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCcEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIV  185 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV  185 (395)
                      .++|...++||+|+||.||++.+  +++.||+|.+...... .....+.+|+.++.++. ||||+++++++..+...+++
T Consensus         3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~   81 (288)
T cd06616           3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC   81 (288)
T ss_pred             HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence            35677889999999999999987  5689999998765433 44567889999999996 99999999999999999999


Q ss_pred             EecCCCCCHHHHH---hh-ccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          186 TEFMARGSIYDFL---HK-QKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       186 ~E~~~ggsL~~~l---~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~-~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                      |||+.+ ++.++.   .. ..+.+++..+..++.+++.||+|||+. +++||||||+||+++.++.++|+|||+++....
T Consensus        82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            999865 655543   22 246789999999999999999999975 999999999999999999999999999976554


Q ss_pred             CCccccCCCCcccccccccCCC---CCCChhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHhhhccCCCCC----CCCC
Q 016082          261 SGVMTAETGTYRWMAPEVIEHK---PYDYKADVFSFGIALWELLTGELPYAGLTPL-QAAVGVVQKSLRPTI----PKHA  332 (395)
Q Consensus       261 ~~~~~~~~gt~~y~aPE~~~~~---~~~~k~DvwslG~vl~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~----~~~~  332 (395)
                      ........|+..|+|||.+.+.   .++.++||||||+++|+|++|+.||...... +...... ....+..    +..+
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  239 (288)
T cd06616         161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVV-KGDPPILSNSEEREF  239 (288)
T ss_pred             CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhc-CCCCCcCCCcCCCcc
Confidence            4444455789999999998766   6899999999999999999999999876532 2222211 1122222    2347


Q ss_pred             cHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          333 HPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       333 ~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      +.++.++|.+||+.+|.+|||+.++++
T Consensus       240 ~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         240 SPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            889999999999999999999999987

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1e-41  Score=303.27  Aligned_cols=264  Identities=23%  Similarity=0.396  Sum_probs=221.2

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC------CHHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCC
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV------NTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPP  180 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~------~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  180 (395)
                      +.|...+.||.|..++|.++..  +++..|+|++.-...      ..+..+.-.+|+.||+++. ||+|+++.++++.+.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            3677788899999999998865  678899998853211      2345567788999999996 999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                      -+++|+|.|+.|.|.|+|.. .-.+++....++++|++.|++|||.++|+||||||+|||++++.+++|+|||+|+....
T Consensus        97 F~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~  175 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP  175 (411)
T ss_pred             hhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence            99999999999999999976 56789999999999999999999999999999999999999999999999999998888


Q ss_pred             CCccccCCCCcccccccccC------CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC--CCCCCCC
Q 016082          261 SGVMTAETGTYRWMAPEVIE------HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHA  332 (395)
Q Consensus       261 ~~~~~~~~gt~~y~aPE~~~------~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~  332 (395)
                      +......+|||.|+|||.+.      +..|+...|.|++|++||.|+.|.+||-.....-....+.+..+.  .+--.++
T Consensus       176 GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadi  255 (411)
T KOG0599|consen  176 GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADI  255 (411)
T ss_pred             chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhc
Confidence            87778889999999999985      457889999999999999999999999775554444455544433  3333467


Q ss_pred             cHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHHHHHHHHhhcc
Q 016082          333 HPRLAELLERCWQHDPTQRPNFSQITD--ILKQMMKEVLYWLSP  374 (395)
Q Consensus       333 ~~~l~~li~~cl~~dp~~RPs~~ell~--~l~~~~~~~~~~~~~  374 (395)
                      +...+++|.+||+.||++|.|+.|.++  .+.++.++-.--+||
T Consensus       256 s~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r~msP  299 (411)
T KOG0599|consen  256 SATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQARQMSP  299 (411)
T ss_pred             cccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcccccCC
Confidence            889999999999999999999999987  444444443334444

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=302.45  Aligned_cols=252  Identities=29%  Similarity=0.528  Sum_probs=215.7

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCc
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPN  181 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  181 (395)
                      ...+.++++++..||+|+.|+|+++++.  +...|||.+.... +.+..+++...+.++.... +|+||+.+|+|.....
T Consensus        87 ~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d  165 (391)
T KOG0983|consen   87 YQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD  165 (391)
T ss_pred             cccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch
Confidence            3455677888999999999999999984  5889999998765 4455566777777776654 8999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                      .++.||.|.. -+..+++.-.+++++..+-++...+++||.||..+ ||||||+||.|||+|+.|++|+||||.+.....
T Consensus       166 V~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd  244 (391)
T KOG0983|consen  166 VFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD  244 (391)
T ss_pred             HHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec
Confidence            9999999954 66777777788999999999999999999999865 899999999999999999999999999988877


Q ss_pred             CCccccCCCCcccccccccCC---CCCCChhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHhhhccCCCCCCCC--CcH
Q 016082          261 SGVMTAETGTYRWMAPEVIEH---KPYDYKADVFSFGIALWELLTGELPYAGL-TPLQAAVGVVQKSLRPTIPKH--AHP  334 (395)
Q Consensus       261 ~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwslG~vl~elltg~~pf~~~-~~~~~~~~~~~~~~~~~~~~~--~~~  334 (395)
                      +...+...|.+.|||||.+.-   ..|+.++||||||++++||.||+.||.+. +..+....+.+ ..+|.+|.+  .|+
T Consensus       245 SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L~~~~gFSp  323 (391)
T KOG0983|consen  245 SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLLPGHMGFSP  323 (391)
T ss_pred             ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCCCcccCcCH
Confidence            777788899999999999963   47999999999999999999999999984 44455555554 455666543  699


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          335 RLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       335 ~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      .+.+|+..||++|+.+||.+.++++
T Consensus       324 ~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  324 DFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             HHHHHHHHHhhcCcccCcchHHHhc
Confidence            9999999999999999999999986

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-40  Score=306.30  Aligned_cols=248  Identities=28%  Similarity=0.500  Sum_probs=213.1

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCC---CCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--CcE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC---VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNL  182 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  182 (395)
                      .+|.+.+.||+|+||.||+|+.  +++.||+|++....   ........+.+|+.++++++|+||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4789999999999999999986  57899999875321   1234556899999999999999999999998764  458


Q ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-
Q 016082          183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-  261 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-  261 (395)
                      ++++||+++++|.+++.. .+.+++..+..++.+++.||.|||+.|++|+||||+||+++.++.++|+|||.++..... 
T Consensus        82 ~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  160 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA-YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC  160 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence            899999999999999876 456889999999999999999999999999999999999999999999999999754321 


Q ss_pred             ---CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHH
Q 016082          262 ---GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE  338 (395)
Q Consensus       262 ---~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  338 (395)
                         ...+...++..|+|||.+.+..++.++|+||||+++|+|++|+.||.................++.+|...++++.+
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  240 (264)
T cd06653         161 MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD  240 (264)
T ss_pred             ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence               11233468899999999998889999999999999999999999999887776666655556667788899999999


Q ss_pred             HHHHhhccCCCCCCCHHHHHH
Q 016082          339 LLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       339 li~~cl~~dp~~RPs~~ell~  359 (395)
                      ++.+||+ +|..||+..+++.
T Consensus       241 ~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         241 FLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             HHHHHhc-CcccCccHHHHhc
Confidence            9999999 5799999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-40  Score=309.92  Aligned_cols=245  Identities=29%  Similarity=0.561  Sum_probs=208.0

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC---CCceeeEEEEEecCCcEEEE
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR---HKNVVQFIGACTRPPNLCIV  185 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV  185 (395)
                      .|++.+.||+|+||.||+|.+  +++.||+|+++... ......++.+|+.++++++   |||++++++++......++|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv   80 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII   80 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence            578889999999999999987  57889999987543 2344567889999999997   99999999999999999999


Q ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-cc
Q 016082          186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VM  264 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~  264 (395)
                      |||++|++|.++++.  +.+++..++.++.+++.|+.|||+.||+|+||+|+||+++.++.++|+|||.+....... ..
T Consensus        81 ~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06917          81 MEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR  158 (277)
T ss_pred             EecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccc
Confidence            999999999999865  478999999999999999999999999999999999999999999999999987654432 23


Q ss_pred             ccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCC-CCcHHHHHHHHH
Q 016082          265 TAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK-HAHPRLAELLER  342 (395)
Q Consensus       265 ~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~  342 (395)
                      ....|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||............ .....+..+. ..+.++.+++.+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~  237 (277)
T cd06917         159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI-PKSKPPRLEDNGYSKLLREFVAA  237 (277)
T ss_pred             ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc-ccCCCCCCCcccCCHHHHHHHHH
Confidence            34468899999998864 45789999999999999999999999887765544322 2222334444 378899999999


Q ss_pred             hhccCCCCCCCHHHHHH
Q 016082          343 CWQHDPTQRPNFSQITD  359 (395)
Q Consensus       343 cl~~dp~~RPs~~ell~  359 (395)
                      ||+.||.+||++.+++.
T Consensus       238 ~l~~~p~~R~~~~~il~  254 (277)
T cd06917         238 CLDEEPKERLSAEELLK  254 (277)
T ss_pred             HcCCCcccCcCHHHHhh
Confidence            99999999999999976

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=4.3e-40  Score=312.54  Aligned_cols=267  Identities=27%  Similarity=0.491  Sum_probs=214.7

Q ss_pred             CceeecccCcceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEEEEecC
Q 016082          103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRP  179 (395)
Q Consensus       103 ~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  179 (395)
                      ..|.++.++|++.+.||+|+||.||+|.+.  ++.||||.++.... .....++..|+.++.+.. ||||+++++++...
T Consensus         8 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~   86 (296)
T cd06618           8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFITD   86 (296)
T ss_pred             eeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence            346777889999999999999999999985  88999999976532 233456667777776665 99999999999999


Q ss_pred             CcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeeeCCCCcEEEeeecccccc
Q 016082          180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQ  258 (395)
Q Consensus       180 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~  258 (395)
                      ...|+||||+.+ ++.+++....+.+++..+..++.+++.||.|||+ .||+||||+|+||++++++.++|+|||.+...
T Consensus        87 ~~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~  165 (296)
T cd06618          87 SDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL  165 (296)
T ss_pred             CeEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence            999999999854 8888877656789999999999999999999997 59999999999999999999999999999765


Q ss_pred             ccCCccccCCCCcccccccccCCC----CCCChhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHhhhccCCCCCC--CC
Q 016082          259 AQSGVMTAETGTYRWMAPEVIEHK----PYDYKADVFSFGIALWELLTGELPYAGLTPL-QAAVGVVQKSLRPTIP--KH  331 (395)
Q Consensus       259 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~DvwslG~vl~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~--~~  331 (395)
                      ..........++..|+|||.+.+.    .++.++|+||||+++|+|++|+.||...... +....+... ..+..+  ..
T Consensus       166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~  244 (296)
T cd06618         166 VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE-EPPSLPPNEG  244 (296)
T ss_pred             cCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC-CCCCCCCCCC
Confidence            544444455678899999998755    3889999999999999999999999764332 223332322 222232  24


Q ss_pred             CcHHHHHHHHHhhccCCCCCCCHHHHHH-----HHHHHHHHHHHhh
Q 016082          332 AHPRLAELLERCWQHDPTQRPNFSQITD-----ILKQMMKEVLYWL  372 (395)
Q Consensus       332 ~~~~l~~li~~cl~~dp~~RPs~~ell~-----~l~~~~~~~~~~~  372 (395)
                      ++.++.+++.+||+.||.+||++.+++.     ..+...+++..|+
T Consensus       245 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~~~~  290 (296)
T cd06618         245 FSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEVDVAGWF  290 (296)
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccchhHHHHHHHH
Confidence            6889999999999999999999999975     2234444555554

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-40  Score=309.19  Aligned_cols=247  Identities=30%  Similarity=0.540  Sum_probs=205.6

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCC-----
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPP-----  180 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-----  180 (395)
                      .++|++.+.||.|++|.||+|..  .++.+|+|+++...   .....+.+|+.+++++ +|+||+++++++....     
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            46899999999999999999998  46789999987653   2346789999999999 6999999999996644     


Q ss_pred             -cEEEEEecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccc
Q 016082          181 -NLCIVTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR  256 (395)
Q Consensus       181 -~~~lV~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~  256 (395)
                       .+++||||+++++|.+++...   +..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~  161 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA  161 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence             489999999999999998653   3678999999999999999999999999999999999999999999999999987


Q ss_pred             ccccC-CccccCCCCcccccccccCC-----CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCC--
Q 016082          257 VQAQS-GVMTAETGTYRWMAPEVIEH-----KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--  328 (395)
Q Consensus       257 ~~~~~-~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--  328 (395)
                      ..... .......++..|+|||.+..     ..++.++||||||+++|++++|+.||....+.......... ..+..  
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~  240 (275)
T cd06608         162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN-PPPTLKS  240 (275)
T ss_pred             ecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc-CCCCCCc
Confidence            54332 22234568899999998753     35788999999999999999999999876655544443322 22222  


Q ss_pred             CCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          329 PKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       329 ~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      +..+++++.++|.+||..||++|||+.++++
T Consensus       241 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         241 PENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            2347789999999999999999999999976

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=6.7e-40  Score=308.11  Aligned_cols=245  Identities=33%  Similarity=0.584  Sum_probs=212.3

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  188 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  188 (395)
                      -|++.++||+|+||.||+|.+  ++..||+|+...... ......+.+|+.++++++||||+++++++..+...++||||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            577889999999999999986  568899999865432 33456789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-ccccC
Q 016082          189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAE  267 (395)
Q Consensus       189 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~~~  267 (395)
                      +++++|.+++..  +.++...+..++.+++.++.|||+.|++|+||+|.||+++.++.++|+|||++....... .....
T Consensus        84 ~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06641          84 LGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccc
Confidence            999999999864  468899999999999999999999999999999999999999999999999987544322 12334


Q ss_pred             CCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccC
Q 016082          268 TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHD  347 (395)
Q Consensus       268 ~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d  347 (395)
                      .++..|+|||.+.+..++.++|+||||+++|++++|..||....+...... ......+..+..++.++.+++.+||+.+
T Consensus       162 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~  240 (277)
T cd06641         162 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL-IPKNNPPTLEGNYSKPLKEFVEACLNKE  240 (277)
T ss_pred             cCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH-HhcCCCCCCCcccCHHHHHHHHHHccCC
Confidence            678899999999888899999999999999999999999988776554443 3334455667778999999999999999


Q ss_pred             CCCCCCHHHHHH
Q 016082          348 PTQRPNFSQITD  359 (395)
Q Consensus       348 p~~RPs~~ell~  359 (395)
                      |.+||++.++++
T Consensus       241 p~~Rp~~~~~l~  252 (277)
T cd06641         241 PSFRPTAKELLK  252 (277)
T ss_pred             hhhCcCHHHHHh
Confidence            999999999988

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.8e-40  Score=306.22  Aligned_cols=248  Identities=27%  Similarity=0.501  Sum_probs=212.6

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  188 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  188 (395)
                      +|.+.+.||+|+||.||+|..  .+..+|+|.+..........+.+.+|+.++++++|+||+++++.+......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            478899999999999999987  568899999976544444456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCC-cEEEeeeccccccccCCc-cc
Q 016082          189 MARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQSGV-MT  265 (395)
Q Consensus       189 ~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~-~vkl~DFg~a~~~~~~~~-~~  265 (395)
                      +++++|.+++.... ..+++..+..++.+++.||.|||+.+++|+||||+||++++++ .++++|||.+........ ..
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~  160 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY  160 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence            99999999997644 3578999999999999999999999999999999999999886 469999999976544321 12


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhc
Q 016082          266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ  345 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  345 (395)
                      ...|++.|+|||.+.+..++.++|+||||++++++++|..||...+..+....... ...+..+...+.++.+++.+||+
T Consensus       161 ~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~  239 (257)
T cd08225         161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ-GYFAPISPNFSRDLRSLISQLFK  239 (257)
T ss_pred             ccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc-ccCCCCCCCCCHHHHHHHHHHhc
Confidence            34688999999999888899999999999999999999999988776665554443 33344556778899999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 016082          346 HDPTQRPNFSQITD  359 (395)
Q Consensus       346 ~dp~~RPs~~ell~  359 (395)
                      .+|++|||+.++++
T Consensus       240 ~~p~~Rpt~~~ll~  253 (257)
T cd08225         240 VSPRDRPSITSILK  253 (257)
T ss_pred             cChhhCcCHHHHhh
Confidence            99999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=9.5e-40  Score=313.46  Aligned_cols=248  Identities=29%  Similarity=0.471  Sum_probs=212.8

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      ..|...+.||+|+||.||+|+.  ++..||+|.+..... ..+....+.+|+.++++++|||++++++++..+...++||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            3588899999999999999987  578899999875432 3445678899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCcccc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA  266 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~  266 (395)
                      ||+.| ++.+.+.....++++..+..++.+++.|+.|||+.||+||||+|+||+++.++.++|+|||++.....   ...
T Consensus       105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---~~~  180 (317)
T cd06635         105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---ANS  180 (317)
T ss_pred             eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---ccc
Confidence            99975 88888876677899999999999999999999999999999999999999999999999999865432   234


Q ss_pred             CCCCcccccccccC---CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHh
Q 016082          267 ETGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC  343 (395)
Q Consensus       267 ~~gt~~y~aPE~~~---~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  343 (395)
                      ..+++.|+|||.+.   +..++.++||||||+++|+|++|+.||...........+......+..+..+++.+.+++.+|
T Consensus       181 ~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  260 (317)
T cd06635         181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSC  260 (317)
T ss_pred             ccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHH
Confidence            56889999999973   456899999999999999999999999887766655555544444444556788999999999


Q ss_pred             hccCCCCCCCHHHHHHHH
Q 016082          344 WQHDPTQRPNFSQITDIL  361 (395)
Q Consensus       344 l~~dp~~RPs~~ell~~l  361 (395)
                      |+.+|.+||++.++++..
T Consensus       261 l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         261 LQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             ccCCcccCcCHHHHHhCh
Confidence            999999999999998743

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=7.6e-40  Score=301.05  Aligned_cols=246  Identities=36%  Similarity=0.649  Sum_probs=213.3

Q ss_pred             CcceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Q 016082          111 QLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  188 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  188 (395)
                      +|.+.+.||+|++|.||++...  ++.+++|++.....  .....+.+|+.++++++|+|++++++.+......++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~   78 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF   78 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence            4778899999999999999984  78899999986643  3557899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCccccCC
Q 016082          189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET  268 (395)
Q Consensus       189 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~~~  268 (395)
                      +++++|.+++......+++..+..++.+++.|+.+||+.|++||||+|+||+++.++.++|+|||.+.............
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  158 (253)
T cd05122          79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV  158 (253)
T ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccccccee
Confidence            99999999998765789999999999999999999999999999999999999999999999999997665443234557


Q ss_pred             CCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCC--CcHHHHHHHHHhhcc
Q 016082          269 GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKH--AHPRLAELLERCWQH  346 (395)
Q Consensus       269 gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~cl~~  346 (395)
                      ++..|+|||.+.+..++.++|+||||+++++|++|+.||...+.......... ...+..+..  ++..+.+++.+||+.
T Consensus       159 ~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~  237 (253)
T cd05122         159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKKCLQK  237 (253)
T ss_pred             cCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHHHHccC
Confidence            88999999999988899999999999999999999999988765554443333 333334333  388999999999999


Q ss_pred             CCCCCCCHHHHHH
Q 016082          347 DPTQRPNFSQITD  359 (395)
Q Consensus       347 dp~~RPs~~ell~  359 (395)
                      ||++|||+.++++
T Consensus       238 ~p~~R~t~~~~l~  250 (253)
T cd05122         238 NPEKRPTAEQLLK  250 (253)
T ss_pred             ChhhCCCHHHHhc
Confidence            9999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3.5e-40  Score=315.99  Aligned_cols=240  Identities=23%  Similarity=0.402  Sum_probs=187.1

Q ss_pred             eeeeeeeCceEEEEEEE----CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec--CCcEEEEEec
Q 016082          115 ECKVASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--PPNLCIVTEF  188 (395)
Q Consensus       115 ~~~lg~G~~G~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~E~  188 (395)
                      .++||+|+||.||+|++    .++.||+|.++.....    ..+.+|+.++++++||||+++++++..  ....|++|||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY   81 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence            46899999999999985    3478999999755332    456789999999999999999998854  4568999999


Q ss_pred             CCCCCHHHHHhhc--------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee----CCCCcEEEeeecccc
Q 016082          189 MARGSIYDFLHKQ--------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM----DENGVVKVADFGVAR  256 (395)
Q Consensus       189 ~~ggsL~~~l~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl----~~~~~vkl~DFg~a~  256 (395)
                      +.+ +|.+++...        ...+++..+..++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+++
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07868          82 AEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             cCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence            965 888887532        1258889999999999999999999999999999999999    456789999999998


Q ss_pred             ccccCC----ccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHhhhc
Q 016082          257 VQAQSG----VMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPL---------QAAVGVVQK  322 (395)
Q Consensus       257 ~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~---------~~~~~~~~~  322 (395)
                      ......    ......||+.|+|||++.+ ..++.++|+||+||++|+|++|++||......         .....+...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07868         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV  240 (317)
T ss_pred             ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence            654322    2234578999999999876 46899999999999999999999999753321         001111000


Q ss_pred             c-----------------------CCC-------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          323 S-----------------------LRP-------------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       323 ~-----------------------~~~-------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      .                       ...             ......+.++.++|.+||+.||.+|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~  313 (317)
T cd07868         241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  313 (317)
T ss_pred             cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0                       000             000123457889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3e-40  Score=311.15  Aligned_cols=248  Identities=23%  Similarity=0.397  Sum_probs=205.5

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  188 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  188 (395)
                      +|++.+.||.|++|.||+|++  +++.||||.++...........+.+|+.++++++||||+++++++......++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            478899999999999999987  578999999876544444456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-cccc
Q 016082          189 MARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA  266 (395)
Q Consensus       189 ~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~~  266 (395)
                      +. ++|.+++... ...+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||.++...... ....
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH  159 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccccc
Confidence            96 5899988654 3568999999999999999999999999999999999999999999999999987554322 2233


Q ss_pred             CCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCC-------------------
Q 016082          267 ETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP-------------------  326 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~~-~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~-------------------  326 (395)
                      ..++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+..............+                   
T Consensus       160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd07860         160 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFP  239 (284)
T ss_pred             ccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcc
Confidence            4578899999988764 46889999999999999999999998776554443332211110                   


Q ss_pred             --------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          327 --------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       327 --------~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                              .....+++++.++|.+||+.||.+||++.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         240 KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             cccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                    011346788999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-39  Score=301.39  Aligned_cols=247  Identities=35%  Similarity=0.627  Sum_probs=217.5

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  188 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  188 (395)
                      +|++.+.||+|++|.||+++.  .++.||+|.+............+.+|++++++++|||++++++++......+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            478899999999999999987  568899999987766556778899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCc-cccC
Q 016082          189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-MTAE  267 (395)
Q Consensus       189 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~-~~~~  267 (395)
                      +++++|.+++... +.+++..+..++.+++.|+.|||++||+||||+|+||+++.++.++|+|||.+........ ....
T Consensus        81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  159 (254)
T cd06627          81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV  159 (254)
T ss_pred             CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence            9999999999764 6789999999999999999999999999999999999999999999999999986554332 2345


Q ss_pred             CCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccC
Q 016082          268 TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHD  347 (395)
Q Consensus       268 ~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d  347 (395)
                      .++..|+|||...+..++.++|+||+|+++|+|++|..||....+........ ....+..+...+..+.+++.+||+.+
T Consensus       160 ~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~  238 (254)
T cd06627         160 VGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGISPELKDFLMQCFQKD  238 (254)
T ss_pred             ccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-ccCCCCCCCCCCHHHHHHHHHHHhCC
Confidence            67889999999988889999999999999999999999998877655444433 34455677788999999999999999


Q ss_pred             CCCCCCHHHHHH
Q 016082          348 PTQRPNFSQITD  359 (395)
Q Consensus       348 p~~RPs~~ell~  359 (395)
                      |++||++.+++.
T Consensus       239 p~~R~~~~~~l~  250 (254)
T cd06627         239 PNLRPTAKQLLK  250 (254)
T ss_pred             hhhCcCHHHHhc
Confidence            999999999875

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=4.6e-40  Score=304.35  Aligned_cols=247  Identities=29%  Similarity=0.514  Sum_probs=217.1

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  188 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  188 (395)
                      +|++.++||.|+||.||++++  +++.+|+|.++...........+.+|+.++++++|+||+++++++......++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            478899999999999999987  568899999987655556667888999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCccc
Q 016082          189 MARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT  265 (395)
Q Consensus       189 ~~ggsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~  265 (395)
                      +++++|.+++...   ...+++..+..++.+++.||.|||+.|++|+||+|.||+++.++.++|+|||.+...... ...
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~~  159 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MAK  159 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-Ccc
Confidence            9999999998663   356888999999999999999999999999999999999999999999999999876554 333


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhc
Q 016082          266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ  345 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  345 (395)
                      ...+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||...+.......+. ....+..+...+.++.+++.+||+
T Consensus       160 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~  238 (256)
T cd08530         160 TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ-RGKYPPIPPIYSQDLQNFIRSMLQ  238 (256)
T ss_pred             cccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cCCCCCCchhhCHHHHHHHHHHcC
Confidence            4568899999999999999999999999999999999999999888765544443 344455666789999999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 016082          346 HDPTQRPNFSQITD  359 (395)
Q Consensus       346 ~dp~~RPs~~ell~  359 (395)
                      .+|.+||++.++++
T Consensus       239 ~~p~~Rp~~~~~l~  252 (256)
T cd08530         239 VKPKLRPNCDKILA  252 (256)
T ss_pred             CCcccCCCHHHHhc
Confidence            99999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-40  Score=309.73  Aligned_cols=247  Identities=22%  Similarity=0.383  Sum_probs=205.4

Q ss_pred             cceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecC
Q 016082          112 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM  189 (395)
Q Consensus       112 ~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  189 (395)
                      |++.+.||.|++|.||+|.+  +++.||+|++............+.+|+.++++++|||++++++++...+..|++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            56788999999999999987  5889999999766544444567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-ccccC
Q 016082          190 ARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAE  267 (395)
Q Consensus       190 ~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~~~  267 (395)
                      + ++|.+++.... ..+++..+..++.|+++||.|||+++++||||+|+||+++.++.++|+|||.++...... .....
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  159 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHE  159 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCcc
Confidence            5 59999987644 468999999999999999999999999999999999999999999999999997544321 22334


Q ss_pred             CCCcccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC---------------------
Q 016082          268 TGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR---------------------  325 (395)
Q Consensus       268 ~gt~~y~aPE~~~~~-~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~---------------------  325 (395)
                      .++..|+|||++.+. .++.++|+||||+++|+|++|+.||...+.......+.+....                     
T Consensus       160 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T cd07835         160 VVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPK  239 (283)
T ss_pred             ccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhccc
Confidence            568899999988654 5789999999999999999999999887665443332221100                     


Q ss_pred             ------CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          326 ------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       326 ------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                            ....+..++++.+++.+||+.+|.+||++.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         240 WARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             ccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                  1112456789999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-40  Score=310.72  Aligned_cols=248  Identities=25%  Similarity=0.415  Sum_probs=200.4

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      ++|++.+.||+|++|.||+|..  +++.||+|.++..... .....+.+|+.++++++||||+++++++......++|||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            5799999999999999999987  5788999998754322 223456789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-cccc
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA  266 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~~  266 (395)
                      |+.+ +|.+++....+.+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||.++...... ....
T Consensus        84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  162 (291)
T cd07844          84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN  162 (291)
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccccc
Confidence            9985 9999998766788999999999999999999999999999999999999999999999999987543221 1223


Q ss_pred             CCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHhhhcc---------------------
Q 016082          267 ETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLT-PLQAAVGVVQKS---------------------  323 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~-~~~~~~~~~~~~---------------------  323 (395)
                      ..++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||.+.. ..+....+....                     
T Consensus       163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (291)
T cd07844         163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYS  242 (291)
T ss_pred             cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccccc
Confidence            456889999999865 568999999999999999999999997655 222111111000                     


Q ss_pred             CC---CC----CCCCCc--HHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          324 LR---PT----IPKHAH--PRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       324 ~~---~~----~~~~~~--~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      .+   +.    .....+  .++.+++.+||+.+|++|||+.+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         243 FPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            00   00    001233  78899999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.9e-40  Score=330.01  Aligned_cols=241  Identities=22%  Similarity=0.355  Sum_probs=196.6

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      ...|.+.+.||+|+||.||+|.+  .++.||||....        ..+.+|+.++++++|+||+++++++...+..++||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~  239 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL  239 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            45799999999999999999998  467899996432        23568999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCc---
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV---  263 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~---  263 (395)
                      |++. ++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||+++.......   
T Consensus       240 e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~  318 (461)
T PHA03211        240 PKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF  318 (461)
T ss_pred             EccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence            9995 599999877667899999999999999999999999999999999999999999999999999976543221   


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHhhhc-cC----------
Q 016082          264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT--------PLQAAVGVVQK-SL----------  324 (395)
Q Consensus       264 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~--------~~~~~~~~~~~-~~----------  324 (395)
                      .....||..|+|||++.+..++.++|||||||++|||++|..|+....        ..+. ..+++. ..          
T Consensus       319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l-~~~i~~~~~~~~~~~~~~~  397 (461)
T PHA03211        319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQI-LRIIRQAQVHVDEFPQHAG  397 (461)
T ss_pred             ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHH-HHHHHhhccccccCCCCcc
Confidence            223468999999999999999999999999999999999876543211        1111 111111 00          


Q ss_pred             ---------------CCCCC-------CCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          325 ---------------RPTIP-------KHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       325 ---------------~~~~~-------~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                     ++...       ...+.++.+||.+||+.||.+|||+.|+++
T Consensus       398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~  454 (461)
T PHA03211        398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR  454 (461)
T ss_pred             hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence                           01000       124568999999999999999999999987

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.1e-39  Score=308.61  Aligned_cols=248  Identities=23%  Similarity=0.380  Sum_probs=199.6

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      ++|++.+.||+|+||.||+|..  +++.||+|+++.... ......+.+|+.+++.++|+||+++++++..+...|+|||
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            5899999999999999999986  578999999875432 2223466789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-cccc
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA  266 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~~  266 (395)
                      |+. +++.+++....+.++...+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++...... ....
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  162 (291)
T cd07870          84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSS  162 (291)
T ss_pred             ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCC
Confidence            996 68888876656678888999999999999999999999999999999999999999999999987543322 2233


Q ss_pred             CCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHhhh---------------------cc
Q 016082          267 ETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAA-VGVVQ---------------------KS  323 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~~-~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~-~~~~~---------------------~~  323 (395)
                      ..++..|+|||.+.+. .++.++||||||+++|+|++|..||......... .....                     ..
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (291)
T cd07870         163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEW  242 (291)
T ss_pred             ccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchh
Confidence            4578999999998754 5789999999999999999999999875542211 11100                     00


Q ss_pred             CCCCCC---------CCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          324 LRPTIP---------KHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       324 ~~~~~~---------~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      .....+         ...++++.+++.+|++.||.+|||+.|++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         243 FLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             ccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            000000         012568999999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=5.7e-40  Score=308.59  Aligned_cols=239  Identities=24%  Similarity=0.397  Sum_probs=199.0

Q ss_pred             eeeeCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecCCCCCH
Q 016082          118 VASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI  194 (395)
Q Consensus       118 lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ggsL  194 (395)
                      ||+|+||.||++.+  +++.||+|++...... ......+..|+.++++++||||+++++.+...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999976  5789999998754322 22345677899999999999999999999999999999999999999


Q ss_pred             HHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCccccCCCCccc
Q 016082          195 YDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRW  273 (395)
Q Consensus       195 ~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y  273 (395)
                      .+++.... ..+++..+..++.|++.|+.|||+.|++||||+|+||++++++.++|+|||.++............++..|
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y  160 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY  160 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCc
Confidence            99997643 36899999999999999999999999999999999999999999999999999765543333445678899


Q ss_pred             ccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhh--hccCCCCCCCCCcHHHHHHHHHhhccCCCCC
Q 016082          274 MAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV--QKSLRPTIPKHAHPRLAELLERCWQHDPTQR  351 (395)
Q Consensus       274 ~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  351 (395)
                      +|||.+.+..++.++|+||||+++|+|++|+.||...........+.  ........+...++++.++|.+||+.+|.+|
T Consensus       161 ~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  240 (277)
T cd05577         161 MAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKR  240 (277)
T ss_pred             CCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHc
Confidence            99999988889999999999999999999999997754311111111  1123445566789999999999999999999


Q ss_pred             CCHHH
Q 016082          352 PNFSQ  356 (395)
Q Consensus       352 Ps~~e  356 (395)
                      |++.+
T Consensus       241 ~~~~~  245 (277)
T cd05577         241 LGCRG  245 (277)
T ss_pred             cCCCc
Confidence            94444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=6.5e-40  Score=310.50  Aligned_cols=249  Identities=22%  Similarity=0.359  Sum_probs=203.3

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCc-----
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPN-----  181 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-----  181 (395)
                      ++|++.+.||+|+||.||+|++  +++.||+|..+...........+.+|+.++++++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            3688999999999999999987  5789999998765433334467888999999996 6999999999877665     


Q ss_pred             EEEEEecCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCC-CCcEEEeeecccc
Q 016082          182 LCIVTEFMARGSIYDFLHKQK----GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVADFGVAR  256 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~----~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~-~~~vkl~DFg~a~  256 (395)
                      .|+||||+++ +|.+++....    ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.++|+|||.++
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~  159 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR  159 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence            8999999986 8988886532    35899999999999999999999999999999999999998 8899999999987


Q ss_pred             ccccC-CccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCC--------
Q 016082          257 VQAQS-GVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP--------  326 (395)
Q Consensus       257 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~--------  326 (395)
                      ..... ...+...+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+.......+......+        
T Consensus       160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (295)
T cd07837         160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV  239 (295)
T ss_pred             ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence            54332 22234467889999998865 467999999999999999999999998877665444332211000        


Q ss_pred             ------------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          327 ------------------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       327 ------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                        ...+..++++.++|.+||+.||.+||++.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                              001347889999999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=9.8e-40  Score=308.25  Aligned_cols=248  Identities=33%  Similarity=0.555  Sum_probs=212.4

Q ss_pred             ccCcceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      .+.|.+.+.||+|++|.||+|.+.  ++.+|+|+++....   ....+.+|+.++++++|+|++++++.+......++|+
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            346888899999999999999985  78899999976532   4567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-ccc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT  265 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~  265 (395)
                      ||++|++|.+++......++...+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus        95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  174 (286)
T cd06614          95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN  174 (286)
T ss_pred             eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhc
Confidence            9999999999998755579999999999999999999999999999999999999999999999999986543321 223


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCC-CCCCCcHHHHHHHHHhh
Q 016082          266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT-IPKHAHPRLAELLERCW  344 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl  344 (395)
                      ...++..|+|||.+.+..++.++|+||||+++|+|++|+.||....+.............+. .+..++.++.++|.+||
T Consensus       175 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  254 (286)
T cd06614         175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCL  254 (286)
T ss_pred             cccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHh
Confidence            34578899999999988899999999999999999999999998777655444333322221 22337899999999999


Q ss_pred             ccCCCCCCCHHHHHH
Q 016082          345 QHDPTQRPNFSQITD  359 (395)
Q Consensus       345 ~~dp~~RPs~~ell~  359 (395)
                      +.+|.+||++.+++.
T Consensus       255 ~~~p~~Rpt~~~il~  269 (286)
T cd06614         255 VKDPEKRPSAEELLQ  269 (286)
T ss_pred             ccChhhCcCHHHHhh
Confidence            999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.1e-39  Score=306.41  Aligned_cols=247  Identities=28%  Similarity=0.485  Sum_probs=203.9

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--CcEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCIV  185 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV  185 (395)
                      ++|...++||.|++|.||++.+  +++.+|+|++.... .......+.+|++++++++||||+++++++...  ..+|+|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   79 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA   79 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC-chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence            3688899999999999999998  57889999997553 234567799999999999999999999988653  468999


Q ss_pred             EecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC
Q 016082          186 TEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~  262 (395)
                      |||++|++|.+++..   ....++...+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  159 (287)
T cd06621          80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL  159 (287)
T ss_pred             EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence            999999999988753   24568889999999999999999999999999999999999999999999999987544322


Q ss_pred             ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHhhhccCCCCCC------CC
Q 016082          263 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL-----TPLQAAVGVVQKSLRPTIP------KH  331 (395)
Q Consensus       263 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~-----~~~~~~~~~~~~~~~~~~~------~~  331 (395)
                       .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...     .+.+...... ....+..+      ..
T Consensus       160 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  237 (287)
T cd06621         160 -AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV-NMPNPELKDEPGNGIK  237 (287)
T ss_pred             -cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh-cCCchhhccCCCCCCc
Confidence             22346788999999999999999999999999999999999999765     2223222222 11112221      23


Q ss_pred             CcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          332 AHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       332 ~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      +++++.+++.+||+.+|.+|||+.|+++
T Consensus       238 ~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         238 WSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             hHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            5678999999999999999999999988

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.4e-39  Score=307.54  Aligned_cols=244  Identities=31%  Similarity=0.523  Sum_probs=207.5

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  188 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  188 (395)
                      .|.-.+.||+|++|.||++..  .++.+|+|.++..  .....+.+.+|+.++++++||||+++++++...+..++++||
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~   97 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF   97 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence            455567999999999999986  5688999998643  233446688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-ccccC
Q 016082          189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAE  267 (395)
Q Consensus       189 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~~~  267 (395)
                      ++|++|.+++..  ++++...+..++.+++.|++|||++|++||||+|+||+++.++.++|+|||.+....... .....
T Consensus        98 ~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~  175 (285)
T cd06648          98 LEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL  175 (285)
T ss_pred             cCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccc
Confidence            999999999876  568999999999999999999999999999999999999999999999999886543322 22334


Q ss_pred             CCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCC--CCCCcHHHHHHHHHhhc
Q 016082          268 TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELLERCWQ  345 (395)
Q Consensus       268 ~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~  345 (395)
                      .|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...++......... ...+..  +..++..+.+++++||+
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~  254 (285)
T cd06648         176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRD-NLPPKLKNLHKVSPRLRSFLDRMLV  254 (285)
T ss_pred             cCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHh-cCCCCCcccccCCHHHHHHHHHHcc
Confidence            688999999999988899999999999999999999999988777665544333 222222  23378899999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 016082          346 HDPTQRPNFSQITD  359 (395)
Q Consensus       346 ~dp~~RPs~~ell~  359 (395)
                      .+|++||++.++++
T Consensus       255 ~~p~~Rpt~~~il~  268 (285)
T cd06648         255 RDPAQRATAAELLN  268 (285)
T ss_pred             cChhhCcCHHHHcc
Confidence            99999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=6.6e-40  Score=311.34  Aligned_cols=256  Identities=17%  Similarity=0.265  Sum_probs=193.1

Q ss_pred             ceeecccCcceeeeeeeeCceEEEEEEECC-----ceEEEEEecCCCCCH--HH-------HHHHHHHHHHHHhcCCCce
Q 016082          104 VWEIDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNT--EM-------LKEFSQEVYIMRKIRHKNV  169 (395)
Q Consensus       104 ~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~-----~~vAvK~~~~~~~~~--~~-------~~~~~~E~~~l~~l~h~ni  169 (395)
                      ..++..++|++.++||+|+||.||+|.+.+     ..+|+|+........  +.       ......+...+..++|+|+
T Consensus         6 ~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i   85 (294)
T PHA02882          6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGI   85 (294)
T ss_pred             eeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCC
Confidence            345667899999999999999999998743     467777654332111  10       0112233445566789999


Q ss_pred             eeEEEEEecCC----cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCC
Q 016082          170 VQFIGACTRPP----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG  245 (395)
Q Consensus       170 v~l~~~~~~~~----~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~  245 (395)
                      +++++++....    ..++++|++.. ++.+.+.. ...+++..+..++.|++.||+|||+.+|+||||||+|||++.++
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         86 PKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN  163 (294)
T ss_pred             CcEEEeeeEecCCceEEEEEEehhcc-CHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC
Confidence            99999765443    34788887754 77777654 34467888999999999999999999999999999999999999


Q ss_pred             cEEEeeeccccccccCC--------ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 016082          246 VVKVADFGVARVQAQSG--------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAV  317 (395)
Q Consensus       246 ~vkl~DFg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~  317 (395)
                      .++|+|||+|+......        ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+........
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            99999999997653221        1123469999999999999999999999999999999999999998774322111


Q ss_pred             -----HhhhccCCC-CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 016082          318 -----GVVQKSLRP-TIPKHAHPRLAELLERCWQHDPTQRPNFSQITDIL  361 (395)
Q Consensus       318 -----~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l  361 (395)
                           ........+ .....+++++.+++..||+.+|++||++.+|++.+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        244 HAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence                 111111111 12345688999999999999999999999998865

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3.4e-40  Score=313.04  Aligned_cols=244  Identities=29%  Similarity=0.499  Sum_probs=206.8

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  188 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  188 (395)
                      .|.....||.|+||.||++..  ++..||||.+...  .....+.+.+|+.++++++||||+++++.+..++..++||||
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~  100 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF  100 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence            455567899999999999987  5788999998654  234456789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-ccccC
Q 016082          189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAE  267 (395)
Q Consensus       189 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~~~  267 (395)
                      +++++|.+++..  +.+++..+..++.+|+.||.|||++||+||||||+||++++++.++|+|||++....... .....
T Consensus       101 ~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~  178 (292)
T cd06658         101 LEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL  178 (292)
T ss_pred             CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCcee
Confidence            999999998854  468999999999999999999999999999999999999999999999999987543222 22334


Q ss_pred             CCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCC--CCCCcHHHHHHHHHhhc
Q 016082          268 TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELLERCWQ  345 (395)
Q Consensus       268 ~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~  345 (395)
                      .|+..|+|||.+.+..++.++|+||||+++||+++|+.||....+.+....+. ....+..  ....+..+.+++.+||.
T Consensus       179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~  257 (292)
T cd06658         179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIR-DNLPPRVKDSHKVSSVLRGFLDLMLV  257 (292)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hcCCCccccccccCHHHHHHHHHHcc
Confidence            68899999999998889999999999999999999999998877665444322 2222222  23568899999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 016082          346 HDPTQRPNFSQITD  359 (395)
Q Consensus       346 ~dp~~RPs~~ell~  359 (395)
                      .||.+|||+.++++
T Consensus       258 ~~P~~Rpt~~~il~  271 (292)
T cd06658         258 REPSQRATAQELLQ  271 (292)
T ss_pred             CChhHCcCHHHHhh
Confidence            99999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.2e-39  Score=314.10  Aligned_cols=254  Identities=26%  Similarity=0.468  Sum_probs=204.2

Q ss_pred             eeeeee--CceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecCCC
Q 016082          116 CKVASG--SYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR  191 (395)
Q Consensus       116 ~~lg~G--~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~g  191 (395)
                      ..||.|  +||+||++++  +++.||+|+++......+..+.+.+|+.+++.++||||++++++|..++..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456666  9999999988  689999999987665666678899999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCc-------
Q 016082          192 GSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-------  263 (395)
Q Consensus       192 gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~-------  263 (395)
                      ++|.+++... ...+++..+..++.|++.||+|||++||+||||||+||+++.++.++++||+.+........       
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD  163 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence            9999998764 24588999999999999999999999999999999999999999999999986543221110       


Q ss_pred             -cccCCCCcccccccccCCC--CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc-----------------
Q 016082          264 -MTAETGTYRWMAPEVIEHK--PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-----------------  323 (395)
Q Consensus       264 -~~~~~gt~~y~aPE~~~~~--~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~-----------------  323 (395)
                       .....++..|+|||++.+.  .++.++|||||||++|+|++|+.||......+.........                 
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (328)
T cd08226         164 FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRM  243 (328)
T ss_pred             ccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhh
Confidence             0112346679999998763  57899999999999999999999998776544433222110                 


Q ss_pred             ----------------------------CCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHHHHHHH
Q 016082          324 ----------------------------LRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD--ILKQMMKEVL  369 (395)
Q Consensus       324 ----------------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~--~l~~~~~~~~  369 (395)
                                                  .+...+..+++++.+++++||+.||++|||+.++++  .++.+.++.+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~~~  319 (328)
T cd08226         244 KNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQTQ  319 (328)
T ss_pred             ccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHhcc
Confidence                                        111122345778999999999999999999999986  5555555533

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.6e-39  Score=308.06  Aligned_cols=249  Identities=22%  Similarity=0.385  Sum_probs=204.0

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      ++|++.+.||.|++|.||+|++  +++.||+|.++....+......+.+|+.++++++||||+++++++......|+|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            4789999999999999999987  56889999987654444455678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCC-CCcEEEeeeccccccccCC-cc
Q 016082          188 FMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVADFGVARVQAQSG-VM  264 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~-~~~vkl~DFg~a~~~~~~~-~~  264 (395)
                      |+++ +|.+++.... ..+++..+..++.||+.||+|||++|++||||+|+||+++. ++.+||+|||.+....... ..
T Consensus        82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~  160 (294)
T PLN00009         82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF  160 (294)
T ss_pred             cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcccc
Confidence            9965 8888876543 33678889999999999999999999999999999999985 5679999999997543321 22


Q ss_pred             ccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccC-------------------
Q 016082          265 TAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL-------------------  324 (395)
Q Consensus       265 ~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~-------------------  324 (395)
                      ....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..+.........-                   
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (294)
T PLN00009        161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSA  240 (294)
T ss_pred             ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhh
Confidence            34467889999998865 4679999999999999999999999988766554443221100                   


Q ss_pred             ----CCC----CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          325 ----RPT----IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       325 ----~~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                          ++.    ..+..++++.+++.+|++.+|++||++.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        241 FPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             cccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence                000    12346788999999999999999999999986

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.3e-39  Score=310.22  Aligned_cols=250  Identities=26%  Similarity=0.437  Sum_probs=200.9

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC------
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP------  180 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  180 (395)
                      .++|++.++||+|+||.||+|+.  +++.||||.+............+.+|+.++++++||||+++++++...+      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            45799999999999999999987  5789999998654433333445678999999999999999999986654      


Q ss_pred             --cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccc
Q 016082          181 --NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  258 (395)
Q Consensus       181 --~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~  258 (395)
                        ..++||||+.+ +|.+++......+++.+++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+...
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  169 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF  169 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence              35999999965 899888776667999999999999999999999999999999999999999999999999999755


Q ss_pred             ccCC-----ccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc--CCCC---
Q 016082          259 AQSG-----VMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS--LRPT---  327 (395)
Q Consensus       259 ~~~~-----~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~--~~~~---  327 (395)
                      ....     ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+.++......+....  ..+.   
T Consensus       170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (310)
T cd07865         170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWP  249 (310)
T ss_pred             cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence            4322     11234578899999988664 47899999999999999999999998876543322211100  0000   


Q ss_pred             ------------C-------------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          328 ------------I-------------PKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       328 ------------~-------------~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                  .             +...++.+.++|.+||+.||.+|||+.++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         250 GVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             cccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence                        0             1123567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-39  Score=305.62  Aligned_cols=247  Identities=26%  Similarity=0.439  Sum_probs=205.5

Q ss_pred             cceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--CcEEEEEe
Q 016082          112 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCIVTE  187 (395)
Q Consensus       112 ~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~E  187 (395)
                      |++.++||+|+||.||+|.+  +++.+|+|+++...........+.+|+.++++++|||++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            67889999999999999987  468899999987643444556788999999999999999999999888  78999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC--ccc
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--VMT  265 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~--~~~  265 (395)
                      |+++ +|.+++......+++..++.++.+++.||+|||+.|++|+||+|+||++++++.++|+|||.+.......  ..+
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~  159 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT  159 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccc
Confidence            9975 9999987755689999999999999999999999999999999999999999999999999998655433  233


Q ss_pred             cCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCC------------------
Q 016082          266 AETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP------------------  326 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~------------------  326 (395)
                      ...++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+......+                  
T Consensus       160 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (287)
T cd07840         160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLK  239 (287)
T ss_pred             ccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhcc
Confidence            4467889999998765 467899999999999999999999998877654433322211000                  


Q ss_pred             -----------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          327 -----------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       327 -----------~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                 .....+++++.+++++||+.+|.+||+++++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         240 PKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             ccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                       001113789999999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=7.1e-40  Score=311.56  Aligned_cols=245  Identities=29%  Similarity=0.477  Sum_probs=206.4

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  188 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  188 (395)
                      .|....+||.|+||.||+|..  .++.||+|+++....  ...+.+.+|+.+++.++|||++++++.+..+...++|+||
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~   99 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF   99 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence            344566899999999999987  578999999865432  2346688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-ccccC
Q 016082          189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAE  267 (395)
Q Consensus       189 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~~~  267 (395)
                      +++++|.+++..  ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++....... .....
T Consensus       100 ~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~  177 (297)
T cd06659         100 LQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL  177 (297)
T ss_pred             CCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccce
Confidence            999999998754  468999999999999999999999999999999999999999999999999987543322 22345


Q ss_pred             CCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccC-CCCCCCCCcHHHHHHHHHhhcc
Q 016082          268 TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL-RPTIPKHAHPRLAELLERCWQH  346 (395)
Q Consensus       268 ~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~  346 (395)
                      .++..|+|||.+.+..++.++||||||+++|+|++|+.||....+.+....+..... ....+...++.+.++|++||+.
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~  257 (297)
T cd06659         178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTR  257 (297)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcC
Confidence            688999999999988899999999999999999999999988776655443322111 1122345788999999999999


Q ss_pred             CCCCCCCHHHHHH
Q 016082          347 DPTQRPNFSQITD  359 (395)
Q Consensus       347 dp~~RPs~~ell~  359 (395)
                      +|.+||++.++++
T Consensus       258 ~P~~Rps~~~ll~  270 (297)
T cd06659         258 EPQERATAQELLD  270 (297)
T ss_pred             CcccCcCHHHHhh
Confidence            9999999999988

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.8e-39  Score=305.72  Aligned_cols=247  Identities=26%  Similarity=0.457  Sum_probs=204.2

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  188 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  188 (395)
                      +|++.++||.|++|.||+|++  +++.||||+++.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY   79 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence            488999999999999999998  578899999976532 22335677899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-ccc
Q 016082          189 MARGSIYDFLHKQK--GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT  265 (395)
Q Consensus       189 ~~ggsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~  265 (395)
                      +++ +|.+++....  ..+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||.++...... ...
T Consensus        80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~  158 (284)
T cd07836          80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS  158 (284)
T ss_pred             CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccc
Confidence            986 8998886543  568999999999999999999999999999999999999999999999999997554322 223


Q ss_pred             cCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccC----------------CCC-
Q 016082          266 AETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL----------------RPT-  327 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~~~-~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~----------------~~~-  327 (395)
                      ...++..|+|||.+.+. .++.++|+||||+++|++++|+.||.+.+..+....+.....                ... 
T Consensus       159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07836         159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTF  238 (284)
T ss_pred             cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccc
Confidence            45678899999998654 578999999999999999999999988766544333322110                001 


Q ss_pred             ----------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          328 ----------IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       328 ----------~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                +.+..++.+.+++.+||+.||.+||++.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             cCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                      11245788999999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-40  Score=306.87  Aligned_cols=247  Identities=26%  Similarity=0.427  Sum_probs=209.1

Q ss_pred             cceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecC
Q 016082          112 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM  189 (395)
Q Consensus       112 ~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  189 (395)
                      |++.+.||+|++|.||+|..  +++.+|+|.++...........+.+|+.++++++|+||+++++++..+...++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            56788999999999999987  5788999999876555455678889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-ccccCC
Q 016082          190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAET  268 (395)
Q Consensus       190 ~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~~~~  268 (395)
                      ++ ++.+++......+++..+..++.+++.|+.|||+.||+|+||||+||+++.++.++|+|||.+....... ......
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV  159 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCcc
Confidence            76 9999888766789999999999999999999999999999999999999999999999999997665443 233456


Q ss_pred             CCcccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC----------------------
Q 016082          269 GTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR----------------------  325 (395)
Q Consensus       269 gt~~y~aPE~~~~~-~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~----------------------  325 (395)
                      ++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+...........                      
T Consensus       160 ~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T cd05118         160 VTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPK  239 (283)
T ss_pred             CcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhcc
Confidence            78899999998776 7899999999999999999999999887765543332221110                      


Q ss_pred             ------CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          326 ------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       326 ------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                            ....+..+.++.++|.+||++||.+||++++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         240 KAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             ccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                  0112346789999999999999999999999976

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.1e-39  Score=310.05  Aligned_cols=251  Identities=24%  Similarity=0.379  Sum_probs=205.6

Q ss_pred             cccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC-----
Q 016082          108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP-----  180 (395)
Q Consensus       108 ~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  180 (395)
                      ..++|++.+.||+|+||.||+|+.  +++.||+|+++...........+.+|+.++++++||||+++++++....     
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            456899999999999999999998  5788999999765433444456788999999999999999999987655     


Q ss_pred             -----cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccc
Q 016082          181 -----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA  255 (395)
Q Consensus       181 -----~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a  255 (395)
                           .+++|+||+++ ++.+.+......+++..+..++.|++.||.|||+.||+||||||+||++++++.+||+|||.+
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~  163 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA  163 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccc
Confidence                 79999999986 888888766667999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCC--ccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCC------
Q 016082          256 RVQAQSG--VMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP------  326 (395)
Q Consensus       256 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~------  326 (395)
                      .......  ......++..|+|||.+.+ ..++.++|||||||++|+|++|++||...+..+....+......+      
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (302)
T cd07864         164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWP  243 (302)
T ss_pred             ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence            7654332  1222356788999998865 457899999999999999999999998766554433322211000      


Q ss_pred             ----------------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          327 ----------------------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       327 ----------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                            .....+++.+.+++.+||+.+|.+||++.+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         244 DVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             cccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                                  011246789999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.9e-39  Score=305.86  Aligned_cols=241  Identities=27%  Similarity=0.435  Sum_probs=194.8

Q ss_pred             eeeeeCceEEEEEEE--CCceEEEEEecCCCCCHH-HHHHHHHHHHHHHh---cCCCceeeEEEEEecCCcEEEEEecCC
Q 016082          117 KVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTE-MLKEFSQEVYIMRK---IRHKNVVQFIGACTRPPNLCIVTEFMA  190 (395)
Q Consensus       117 ~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~-~~~~~~~E~~~l~~---l~h~niv~l~~~~~~~~~~~lV~E~~~  190 (395)
                      .||+|+||.||++..  +++.+|+|++........ ....+.+|..+++.   .+||||+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999987  578999999976543222 22334455444443   469999999999999999999999999


Q ss_pred             CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCccccCCCC
Q 016082          191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT  270 (395)
Q Consensus       191 ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~~~gt  270 (395)
                      ||+|.+++.. .+.+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++....... .....|+
T Consensus        81 ~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~  158 (279)
T cd05633          81 GGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGT  158 (279)
T ss_pred             CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccCcCCC
Confidence            9999999876 4679999999999999999999999999999999999999999999999999987543322 2345789


Q ss_pred             cccccccccC-CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCC
Q 016082          271 YRWMAPEVIE-HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ-AAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDP  348 (395)
Q Consensus       271 ~~y~aPE~~~-~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp  348 (395)
                      ..|+|||.+. +..++.++|+||+||++|+|++|..||....... ..............+..+++++.++|.+||+.||
T Consensus       159 ~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  238 (279)
T cd05633         159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDV  238 (279)
T ss_pred             cCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCH
Confidence            9999999986 4668999999999999999999999997543211 1111122234456677889999999999999999


Q ss_pred             CCCC-----CHHHHHH
Q 016082          349 TQRP-----NFSQITD  359 (395)
Q Consensus       349 ~~RP-----s~~ell~  359 (395)
                      .+||     ++.++++
T Consensus       239 ~~R~~~~~~~~~~~~~  254 (279)
T cd05633         239 SKRLGCLGRGAQEVKE  254 (279)
T ss_pred             HHhcCCCCCCHHHHHh
Confidence            9999     5887766

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-39  Score=302.33  Aligned_cols=240  Identities=25%  Similarity=0.385  Sum_probs=198.9

Q ss_pred             eeeeeeCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHH-HhcCCCceeeEEEEEecCCcEEEEEecCCC
Q 016082          116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIM-RKIRHKNVVQFIGACTRPPNLCIVTEFMAR  191 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lV~E~~~g  191 (395)
                      +.||.|+||.||+|+.  .++.||+|+++..... ......+..|..++ ...+|+|++++++++......|+|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5689999999999987  5789999999754322 22333455555544 445799999999999999999999999999


Q ss_pred             CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCccccCCCCc
Q 016082          192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY  271 (395)
Q Consensus       192 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~~~gt~  271 (395)
                      ++|.+++.. .+.+++..+..++.|++.||.|||+.|++||||+|.||+++.++.++|+|||+++....   .....++.
T Consensus        82 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~  157 (260)
T cd05611          82 GDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVGTP  157 (260)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCCCc
Confidence            999999976 45789999999999999999999999999999999999999999999999999875433   23346888


Q ss_pred             ccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccC--CCCCCCCCcHHHHHHHHHhhccCCC
Q 016082          272 RWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL--RPTIPKHAHPRLAELLERCWQHDPT  349 (395)
Q Consensus       272 ~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~  349 (395)
                      .|+|||.+.+..++.++||||||+++|+|++|..||...+..+..........  .+..+..+++++.+++.+||+.+|+
T Consensus       158 ~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~  237 (260)
T cd05611         158 DYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPA  237 (260)
T ss_pred             CccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHH
Confidence            99999999888899999999999999999999999998877665554433222  2334456789999999999999999


Q ss_pred             CCCCHHHHHH
Q 016082          350 QRPNFSQITD  359 (395)
Q Consensus       350 ~RPs~~ell~  359 (395)
                      +||++.++.+
T Consensus       238 ~R~~~~~~~~  247 (260)
T cd05611         238 KRLGANGYQE  247 (260)
T ss_pred             HccCCCcHHH
Confidence            9997755544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=9.3e-40  Score=312.77  Aligned_cols=240  Identities=25%  Similarity=0.411  Sum_probs=186.4

Q ss_pred             eeeeeeeCceEEEEEEEC----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec--CCcEEEEEec
Q 016082          115 ECKVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--PPNLCIVTEF  188 (395)
Q Consensus       115 ~~~lg~G~~G~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~E~  188 (395)
                      .++||+|+||.||+|+..    +..||+|.++....    ...+.+|+.++++++||||+++++++..  ....++||||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY   81 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence            368999999999999863    36799999875532    2457789999999999999999998853  4568999999


Q ss_pred             CCCCCHHHHHhhc--------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee----CCCCcEEEeeecccc
Q 016082          189 MARGSIYDFLHKQ--------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM----DENGVVKVADFGVAR  256 (395)
Q Consensus       189 ~~ggsL~~~l~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl----~~~~~vkl~DFg~a~  256 (395)
                      +++ +|.+++...        ...+++..+..++.||+.||.|||+.||+||||||+||++    +.++.+||+|||+++
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence            875 888877532        2357888999999999999999999999999999999999    566789999999998


Q ss_pred             ccccCC----ccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHhhh-
Q 016082          257 VQAQSG----VMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQ---------AAVGVVQ-  321 (395)
Q Consensus       257 ~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~---------~~~~~~~-  321 (395)
                      ......    ......||+.|+|||++.+ ..++.++|||||||++|||++|++||.......         ....... 
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV  240 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence            654322    1233467999999999876 458999999999999999999999997533210         0000000 


Q ss_pred             ----------------------ccC-C------------CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          322 ----------------------KSL-R------------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       322 ----------------------~~~-~------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                            ... .            .......+..+.+++.+||+.||.+|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~  313 (317)
T cd07867         241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ  313 (317)
T ss_pred             cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence                                  000 0            0001123567889999999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8e-41  Score=333.54  Aligned_cols=264  Identities=30%  Similarity=0.577  Sum_probs=236.2

Q ss_pred             ccCcceeeeeeeeCceEEEEEEEC------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTYC------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  182 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  182 (395)
                      ...++..++||+|+||+||+|.|-      ..+||+|++.... ..+...++.+|+.+|.+++|||+++++|+|.... +
T Consensus       695 Etelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~  772 (1177)
T KOG1025|consen  695 ETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-L  772 (1177)
T ss_pred             hhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-H
Confidence            346777889999999999999882      3579999987543 3445688999999999999999999999998776 8


Q ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC
Q 016082          183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~  262 (395)
                      -||++||++|+|.|+++.+++.+....++.|..||++||.|||.++++||||.++|||+.+..++|+.|||+|+......
T Consensus       773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence            89999999999999999999999999999999999999999999999999999999999999999999999999766543


Q ss_pred             c-cccCC--CCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHH
Q 016082          263 V-MTAET--GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE  338 (395)
Q Consensus       263 ~-~~~~~--gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  338 (395)
                      . .....  -.+.|||-|.+....|++++|||||||++||++| |..||.++...+ ....+..+.|...|+.++.++..
T Consensus       853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-I~dlle~geRLsqPpiCtiDVy~  931 (1177)
T KOG1025|consen  853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-IPDLLEKGERLSQPPICTIDVYM  931 (1177)
T ss_pred             ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-hhHHHhccccCCCCCCccHHHHH
Confidence            2 22223  3578999999999999999999999999999999 999999987655 55667889999999999999999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhccc
Q 016082          339 LLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPN  375 (395)
Q Consensus       339 li~~cl~~dp~~RPs~~ell~~l~~~~~~~~~~~~~~  375 (395)
                      +|.+||..|+..||+|+++..++.++.++-+-++...
T Consensus       932 ~mvkCwmid~~~rp~fkel~~~fs~~ardpqryl~i~  968 (1177)
T KOG1025|consen  932 VMVKCWMIDADSRPTFKELAEEFSRMARDPQRYLVIQ  968 (1177)
T ss_pred             HHHHHhccCcccCccHHHHHHHHHHHhcCcceEeeeh
Confidence            9999999999999999999999999999999888776

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.5e-39  Score=308.65  Aligned_cols=246  Identities=29%  Similarity=0.503  Sum_probs=207.6

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      .++|++.+.||+|+||.||++..  +++.||+|.+....  ....+.+.+|+.++++++||||+++++.+...+..|+|+
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   95 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM   95 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence            35899999999999999999976  57889999986442  233467889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-ccc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT  265 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~  265 (395)
                      ||+++++|.+++.+  ..++...+..++.+++.|+.|||++|++||||||+||+++.++.++|+|||++....... ...
T Consensus        96 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~  173 (293)
T cd06647          96 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  173 (293)
T ss_pred             ecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccccc
Confidence            99999999999865  357889999999999999999999999999999999999999999999999886544322 223


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCC--CCCCCcHHHHHHHHHh
Q 016082          266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT--IPKHAHPRLAELLERC  343 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~c  343 (395)
                      ...+++.|+|||.+.+..++.++|+||||+++|++++|+.||...++......... ...+.  .+...+..+.++|++|
T Consensus       174 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~  252 (293)
T cd06647         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPELQNPEKLSAIFRDFLNRC  252 (293)
T ss_pred             cccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCCCCCCccccCHHHHHHHHHH
Confidence            34688899999999888899999999999999999999999987765443222211 11222  2345678899999999


Q ss_pred             hccCCCCCCCHHHHHH
Q 016082          344 WQHDPTQRPNFSQITD  359 (395)
Q Consensus       344 l~~dp~~RPs~~ell~  359 (395)
                      |..+|++||++.+++.
T Consensus       253 l~~~p~~Rp~~~~il~  268 (293)
T cd06647         253 LEMDVEKRGSAKELLQ  268 (293)
T ss_pred             ccCChhhCcCHHHHhc
Confidence            9999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-39  Score=303.54  Aligned_cols=247  Identities=23%  Similarity=0.389  Sum_probs=204.9

Q ss_pred             cceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhc---CCCceeeEEEEEecCCc-----
Q 016082          112 LKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI---RHKNVVQFIGACTRPPN-----  181 (395)
Q Consensus       112 ~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~-----  181 (395)
                      |++.+.||+|+||.||+|++.  ++.||+|+++...........+.+|+.+++++   +|||++++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            678899999999999999984  78999999986544444455677888888776   59999999999988776     


Q ss_pred             EEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          182 LCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                      .+++|||+.+ +|.+++.... ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~  159 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF  159 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence            9999999975 8999887643 3689999999999999999999999999999999999999999999999999977654


Q ss_pred             CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC---------------
Q 016082          261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR---------------  325 (395)
Q Consensus       261 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~---------------  325 (395)
                      ........++..|+|||.+.+..++.++|+||||+++|+|++|.+||...+..+....+......               
T Consensus       160 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (287)
T cd07838         160 EMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRS  239 (287)
T ss_pred             CcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchh
Confidence            44334446788999999999999999999999999999999999999987766554444321100               


Q ss_pred             ---CC-------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          326 ---PT-------IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       326 ---~~-------~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                         ..       .....++.+.++|.+||+.||.+||++.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         240 SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             hcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence               00       01134578899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3.3e-39  Score=308.47  Aligned_cols=246  Identities=32%  Similarity=0.490  Sum_probs=208.1

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      ..|...+.||+|+||.||+|+.  +++.+|+|.+.... ........+.+|+.+++.++|+|++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            4588889999999999999987  56889999986532 23445567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCcccc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA  266 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~  266 (395)
                      ||+. |++.+.+.....+++...+..++.+++.|+.|||+.+++||||+|+||+++.++.++|+|||.+.....   ...
T Consensus        95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---~~~  170 (308)
T cd06634          95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANX  170 (308)
T ss_pred             EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC---ccc
Confidence            9996 588888876667789999999999999999999999999999999999999999999999999875443   234


Q ss_pred             CCCCcccccccccC---CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHh
Q 016082          267 ETGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC  343 (395)
Q Consensus       267 ~~gt~~y~aPE~~~---~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  343 (395)
                      ..++..|+|||.+.   ...++.++|||||||++|+|++|..||.....................+...+..+.++|++|
T Consensus       171 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  250 (308)
T cd06634         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC  250 (308)
T ss_pred             ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHH
Confidence            56889999999974   356788999999999999999999999887665544443333322233456888999999999


Q ss_pred             hccCCCCCCCHHHHHH
Q 016082          344 WQHDPTQRPNFSQITD  359 (395)
Q Consensus       344 l~~dp~~RPs~~ell~  359 (395)
                      |+.+|.+||++.+++.
T Consensus       251 l~~~P~~Rp~~~~ll~  266 (308)
T cd06634         251 LQKIPQDRPTSEVLLK  266 (308)
T ss_pred             hhCCcccCCCHHHHhh
Confidence            9999999999999886

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=7.4e-39  Score=306.81  Aligned_cols=244  Identities=29%  Similarity=0.473  Sum_probs=207.4

Q ss_pred             cceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Q 016082          112 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  188 (395)
Q Consensus       112 ~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  188 (395)
                      |...++||+|+||.||+|+.  +++.||+|++..... .......+.+|+.+++.++|||++++++++.+....|+||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            66678899999999999986  678999999875433 334556788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCccccCC
Q 016082          189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET  268 (395)
Q Consensus       189 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~~~  268 (395)
                      +. |++.+++.....++++..+..++.|++.|+.|||++|++||||+|+||+++.++.++|+|||.+....   ......
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~---~~~~~~  178 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---PANSFV  178 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---CCCCcc
Confidence            96 48888887767789999999999999999999999999999999999999999999999999986432   223457


Q ss_pred             CCcccccccccC---CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhc
Q 016082          269 GTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ  345 (395)
Q Consensus       269 gt~~y~aPE~~~---~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  345 (395)
                      |+..|+|||.+.   ...++.++||||||+++|+|++|..||...+....................++..+.+++.+||+
T Consensus       179 ~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  258 (313)
T cd06633         179 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQ  258 (313)
T ss_pred             ccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHcc
Confidence            889999999984   45688999999999999999999999988776555554443333333344577889999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 016082          346 HDPTQRPNFSQITD  359 (395)
Q Consensus       346 ~dp~~RPs~~ell~  359 (395)
                      .+|.+||++.+++.
T Consensus       259 ~~P~~Rp~~~~~l~  272 (313)
T cd06633         259 KIPQERPASAELLR  272 (313)
T ss_pred             CChhhCcCHHHHhc
Confidence            99999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.5e-39  Score=301.97  Aligned_cols=241  Identities=26%  Similarity=0.414  Sum_probs=203.9

Q ss_pred             eeeeCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecCCCCCH
Q 016082          118 VASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI  194 (395)
Q Consensus       118 lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ggsL  194 (395)
                      ||.|+||.||++++.  ++.+|+|+++.... .......+.+|+.++++++||||+++++.+......|+++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999984  78999999976533 234567899999999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC---------ccc
Q 016082          195 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---------VMT  265 (395)
Q Consensus       195 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~---------~~~  265 (395)
                      .+++... +.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......         ...
T Consensus        81 ~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~  159 (265)
T cd05579          81 ASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK  159 (265)
T ss_pred             HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccccc
Confidence            9999764 478999999999999999999999999999999999999999999999999987543321         122


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhc
Q 016082          266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ  345 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  345 (395)
                      ...++..|+|||...+..++.++|+||||+++|++++|..||....+.+..................+..+.+++.+||+
T Consensus       160 ~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  239 (265)
T cd05579         160 RIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV  239 (265)
T ss_pred             CcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhc
Confidence            34578899999999888899999999999999999999999998887776655544222222222248999999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 016082          346 HDPTQRPNFSQITD  359 (395)
Q Consensus       346 ~dp~~RPs~~ell~  359 (395)
                      .+|.+||++..+.+
T Consensus       240 ~~p~~Rpt~~~~~~  253 (265)
T cd05579         240 PDPEKRLGAKSIEE  253 (265)
T ss_pred             CCHhhcCCCccHHH
Confidence            99999999944443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.1e-39  Score=310.05  Aligned_cols=248  Identities=24%  Similarity=0.419  Sum_probs=203.6

Q ss_pred             cceeeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecCCC
Q 016082          112 LKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR  191 (395)
Q Consensus       112 ~~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~g  191 (395)
                      +.+.+.+|.|+++.||+++.+++.||||+++.........+.+.+|+.++++++||||+++++++......+++|||+++
T Consensus         4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (314)
T cd08216           4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY   83 (314)
T ss_pred             hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence            45666777778888888888899999999987655566778899999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC--------
Q 016082          192 GSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--------  262 (395)
Q Consensus       192 gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~--------  262 (395)
                      |+|.+++... ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.++++|||.+.......        
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~  163 (314)
T cd08216          84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD  163 (314)
T ss_pred             CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence            9999999764 3568999999999999999999999999999999999999999999999999886443211        


Q ss_pred             ccccCCCCcccccccccCC--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC---------------
Q 016082          263 VMTAETGTYRWMAPEVIEH--KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR---------------  325 (395)
Q Consensus       263 ~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~---------------  325 (395)
                      ......++..|+|||++.+  ..++.++|+||||+++|+|++|+.||..................               
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
T cd08216         164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSM  243 (314)
T ss_pred             ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCc
Confidence            1233456788999999876  45889999999999999999999999876554433222111000               


Q ss_pred             -----------------CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          326 -----------------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       326 -----------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                       ...+...+.++.+++.+||+.||++|||+.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence                             0011223567899999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.9e-39  Score=314.10  Aligned_cols=248  Identities=25%  Similarity=0.392  Sum_probs=203.5

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-----CcE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP-----PNL  182 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  182 (395)
                      ++|++.+.||+|+||.||+|+.  +++.||||.++...........+.+|+.+++.++||||+++++++...     ...
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            4799999999999999999987  578999999876543444456778899999999999999999988654     348


Q ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-
Q 016082          183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-  261 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-  261 (395)
                      |+|+||+. ++|.+++.. .+++++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++..... 
T Consensus        85 ~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~  162 (337)
T cd07858          85 YIVYELMD-TDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG  162 (337)
T ss_pred             EEEEeCCC-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence            99999996 589998875 467999999999999999999999999999999999999999999999999999865443 


Q ss_pred             CccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhh-------------------
Q 016082          262 GVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ-------------------  321 (395)
Q Consensus       262 ~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~-------------------  321 (395)
                      .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+..........                   
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
T cd07858         163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKAR  242 (337)
T ss_pred             ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhh
Confidence            23344578899999998865 5689999999999999999999999987654322211110                   


Q ss_pred             ----cc---CC---CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          322 ----KS---LR---PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       322 ----~~---~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                          ..   .+   ....+.+++++.++|++||+.+|.+|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~  290 (337)
T cd07858         243 RYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALA  290 (337)
T ss_pred             HHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHc
Confidence                00   00   0112457889999999999999999999999987

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-39  Score=309.02  Aligned_cols=248  Identities=25%  Similarity=0.411  Sum_probs=197.7

Q ss_pred             CcceeeeeeeeCceEEEEEEE----CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--CcEE
Q 016082          111 QLKIECKVASGSYGDLYKGTY----CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLC  183 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~----~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  183 (395)
                      +|++.++||+|+||.||+|.+    .++.||+|.+..... .......+.+|+.++++++||||+++++++...  ..++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            478899999999999999987    468999999986431 223346678899999999999999999999888  7899


Q ss_pred             EEEecCCCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCC----CCcEEEeeeccc
Q 016082          184 IVTEFMARGSIYDFLHKQ----KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE----NGVVKVADFGVA  255 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~----~~~vkl~DFg~a  255 (395)
                      +||||+++ ++.+++...    ...+++..++.++.|++.||.|||+.+|+||||||+||+++.    ++.+||+|||++
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            99999975 777776432    236889999999999999999999999999999999999999    999999999999


Q ss_pred             cccccCCc----cccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHhhh
Q 016082          256 RVQAQSGV----MTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQ---------AAVGVVQ  321 (395)
Q Consensus       256 ~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~---------~~~~~~~  321 (395)
                      +.......    .....++..|+|||.+.+ ..++.++|+||||+++++|++|+.||.+.....         ....++.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE  239 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence            86543321    223457889999998866 468999999999999999999999998654322         0000000


Q ss_pred             ------------------------ccCCCCCC-----------CCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          322 ------------------------KSLRPTIP-----------KHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       322 ------------------------~~~~~~~~-----------~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                              .......+           ...+.++.+++.+||+.||++|||+.++++
T Consensus       240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                                    00011111           146678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.1e-39  Score=303.94  Aligned_cols=247  Identities=24%  Similarity=0.466  Sum_probs=213.3

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCcEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIV  185 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV  185 (395)
                      ++|.+.+.||+|+||.||+|+.  +++.||+|++..... .....+.+.+|..++++++ ||||+++++.+......++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            4789999999999999999987  678999999976432 3344577889999999999 99999999999999999999


Q ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCc--
Q 016082          186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV--  263 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~--  263 (395)
                      ||++++++|.+++.+ .+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++++|||++........  
T Consensus        81 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~  159 (280)
T cd05581          81 LEYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE  159 (280)
T ss_pred             EcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence            999999999999987 45799999999999999999999999999999999999999999999999999875443221  


Q ss_pred             -------------------cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccC
Q 016082          264 -------------------MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL  324 (395)
Q Consensus       264 -------------------~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~  324 (395)
                                         .....++..|+|||.+.+..++.++|+||||++++++++|..||...+.........  ..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~  237 (280)
T cd05581         160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL--KL  237 (280)
T ss_pred             cCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH--hc
Confidence                               112356889999999988889999999999999999999999999887655554443  23


Q ss_pred             CCCCCCCCcHHHHHHHHHhhccCCCCCCCH----HHHHH
Q 016082          325 RPTIPKHAHPRLAELLERCWQHDPTQRPNF----SQITD  359 (395)
Q Consensus       325 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~----~ell~  359 (395)
                      ....|..+++.+.+++.+||+.+|.+||++    +++++
T Consensus       238 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         238 EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            445667789999999999999999999999    77664

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=7.2e-39  Score=309.02  Aligned_cols=272  Identities=24%  Similarity=0.396  Sum_probs=212.3

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec-CCcEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-PPNLCIV  185 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV  185 (395)
                      .++|++.+.||.|+||.||+|.+  +++.||+|++..........+.+.+|+.++++++||||+++++++.. ....|++
T Consensus         9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv   88 (328)
T cd07856           9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFV   88 (328)
T ss_pred             ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEE
Confidence            45799999999999999999986  57889999987554344455778899999999999999999998865 5578999


Q ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCccc
Q 016082          186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT  265 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~  265 (395)
                      +||+ +++|.++++.  .+++...+..++.|+++||.|||+.||+||||+|.||++++++.++|+|||.+.....  ...
T Consensus        89 ~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~--~~~  163 (328)
T cd07856          89 TELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP--QMT  163 (328)
T ss_pred             eehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC--CcC
Confidence            9998 5589888864  4678888999999999999999999999999999999999999999999999875432  223


Q ss_pred             cCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhh-----------------------
Q 016082          266 AETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ-----------------------  321 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~-----------------------  321 (395)
                      ...++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||....+......+..                       
T Consensus       164 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (328)
T cd07856         164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ  243 (328)
T ss_pred             CCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHh
Confidence            4567889999998765 5789999999999999999999999987765332211110                       


Q ss_pred             c-cCCCCC-----CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhccccccccccccccceeEEEecC
Q 016082          322 K-SLRPTI-----PKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINTNIQSTYKHLLFFLFMD  395 (395)
Q Consensus       322 ~-~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (395)
                      . ......     .+.+++++.++|.+||+.+|++||++.+++.         +.|+...-...- ++.+--.|.|-|+|
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~---------~~~~~~~~~~~~-~~~~~~~~~~~~~~  313 (328)
T cd07856         244 SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA---------HPYLAPYHDPTD-EPVAEEKFDWSFND  313 (328)
T ss_pred             hccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc---------CCccccccCCcc-ccCchhhcCCchhc
Confidence            0 000111     1346789999999999999999999999876         445543333222 23333455565554

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-40  Score=309.00  Aligned_cols=245  Identities=24%  Similarity=0.422  Sum_probs=217.9

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEECC--ceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCc
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPN  181 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~~~--~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  181 (395)
                      .|...+|.++.+||+|+||.|.+|...|  +.+|||+++++.. +++..+--+.|-++|.-.. -|.+++++.+|++-+.
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            6778899999999999999999998754  6699999998764 4445555677888887664 6899999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC
Q 016082          182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  261 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~  261 (395)
                      +|+||||+.||+|.-.+++ -++|.++.+..+|.+|+.||-+||++|||.||||.+|||++.+|++||+|||+++..-..
T Consensus       425 LyFVMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD  503 (683)
T ss_pred             eeeEEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence            9999999999999988876 688999999999999999999999999999999999999999999999999999854433


Q ss_pred             C-ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHH
Q 016082          262 G-VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELL  340 (395)
Q Consensus       262 ~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  340 (395)
                      . ...+.+||+.|+|||++..++|..++|.||+|++||||+.|++||++.++.+.+..+....  -..|.+.|.+...+.
T Consensus       504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn--vsyPKslSkEAv~ic  581 (683)
T KOG0696|consen  504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN--VSYPKSLSKEAVAIC  581 (683)
T ss_pred             CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc--CcCcccccHHHHHHH
Confidence            3 3345689999999999999999999999999999999999999999999999888877653  457889999999999


Q ss_pred             HHhhccCCCCCCC
Q 016082          341 ERCWQHDPTQRPN  353 (395)
Q Consensus       341 ~~cl~~dp~~RPs  353 (395)
                      ...+.+.|.+|..
T Consensus       582 kg~ltK~P~kRLG  594 (683)
T KOG0696|consen  582 KGLLTKHPGKRLG  594 (683)
T ss_pred             HHHhhcCCccccC
Confidence            9999999999954

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=6.7e-39  Score=301.84  Aligned_cols=241  Identities=26%  Similarity=0.419  Sum_probs=195.7

Q ss_pred             eeeeeCceEEEEEEE--CCceEEEEEecCCCCCHH-HHHHHHHHHH---HHHhcCCCceeeEEEEEecCCcEEEEEecCC
Q 016082          117 KVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTE-MLKEFSQEVY---IMRKIRHKNVVQFIGACTRPPNLCIVTEFMA  190 (395)
Q Consensus       117 ~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~-~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~  190 (395)
                      .||+|+||.||+|.+  +++.||+|++.....+.. ....+..|..   .++...||+|+.+++++...+..++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            479999999999976  578999999876543221 1222344443   4444579999999999999999999999999


Q ss_pred             CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCccccCCCC
Q 016082          191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT  270 (395)
Q Consensus       191 ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~~~gt  270 (395)
                      ||+|.+++.. .+.+++..+..++.|+++|+.|||+.+|+||||||+||+++.++.++|+|||+++...... .....|+
T Consensus        81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~  158 (278)
T cd05606          81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGT  158 (278)
T ss_pred             CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-CcCcCCC
Confidence            9999998865 5679999999999999999999999999999999999999999999999999987543322 2345789


Q ss_pred             cccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCC
Q 016082          271 YRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQ-AAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDP  348 (395)
Q Consensus       271 ~~y~aPE~~~~~-~~~~k~DvwslG~vl~elltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp  348 (395)
                      ..|+|||.+.+. .++.++|+||+|+++|+|++|+.||....... ...........+..|...++++.+++.+||..+|
T Consensus       159 ~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p  238 (278)
T cd05606         159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDV  238 (278)
T ss_pred             cCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCH
Confidence            999999998754 68999999999999999999999998763211 1111122233556677789999999999999999


Q ss_pred             CCCC-----CHHHHHH
Q 016082          349 TQRP-----NFSQITD  359 (395)
Q Consensus       349 ~~RP-----s~~ell~  359 (395)
                      .+||     ++.++++
T Consensus       239 ~~R~~~~~~~~~~ll~  254 (278)
T cd05606         239 NRRLGCLGRGAQEVKE  254 (278)
T ss_pred             HhccCCCCCCHHHHHh
Confidence            9999     8999876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-39  Score=310.65  Aligned_cols=246  Identities=25%  Similarity=0.465  Sum_probs=198.6

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC-----cE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP-----NL  182 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~  182 (395)
                      ++|++.++||+|+||.||+|.+  +++.||+|.++... .......+.+|+.++++++||||+++++++....     ..
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            5899999999999999999987  57899999987532 2334567889999999999999999999875543     47


Q ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC
Q 016082          183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~  262 (395)
                      |+|+||+.+ +|.+++..  .++++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++......
T Consensus        84 ~lv~e~~~~-~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  160 (336)
T cd07849          84 YIVQELMET-DLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH  160 (336)
T ss_pred             EEEehhccc-CHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence            999999975 88888754  568999999999999999999999999999999999999999999999999987543322


Q ss_pred             ----ccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhh---------------c
Q 016082          263 ----VMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ---------------K  322 (395)
Q Consensus       263 ----~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~---------------~  322 (395)
                          ......|+..|+|||.+.+ ..++.++||||+|+++|+|++|+.||.+............               .
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
T cd07849         161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL  240 (336)
T ss_pred             cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence                1223467899999998754 5689999999999999999999999977543322211110               0


Q ss_pred             ---------cCCCCC-----CCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          323 ---------SLRPTI-----PKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       323 ---------~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                               ...+..     .+..++++.++|.+||+.+|.+||++.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~  291 (336)
T cd07849         241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALA  291 (336)
T ss_pred             hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                     000011     1345778999999999999999999999988

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.6e-39  Score=310.75  Aligned_cols=247  Identities=26%  Similarity=0.407  Sum_probs=208.4

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC-----cEE
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP-----NLC  183 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  183 (395)
                      +|++.+.||.|++|.||+|+.  +++.||||.+..........+.+.+|+.++++++||||+++++++....     ..|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            588999999999999999997  4689999999865433455678999999999999999999999987775     789


Q ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-
Q 016082          184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-  262 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-  262 (395)
                      +||||+++ +|.+++.. ...+++..++.++.+++.||+|||+.||+||||||.||+++.++.++|+|||.+....... 
T Consensus        81 lv~e~~~~-~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~  158 (330)
T cd07834          81 IVTELMET-DLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED  158 (330)
T ss_pred             EEecchhh-hHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence            99999985 89998865 4589999999999999999999999999999999999999999999999999998665442 


Q ss_pred             ---ccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCC------------
Q 016082          263 ---VMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP------------  326 (395)
Q Consensus       263 ---~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~------------  326 (395)
                         ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+.+..+....+......+            
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  238 (330)
T cd07834         159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK  238 (330)
T ss_pred             ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence               23445688999999999887 88999999999999999999999998877655443333211100            


Q ss_pred             -----------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          327 -----------------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       327 -----------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                       ...+..++++.++|.+||+.+|.+||++.+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  288 (330)
T cd07834         239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA  288 (330)
T ss_pred             hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence                             011336788999999999999999999999987

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.5e-39  Score=312.81  Aligned_cols=248  Identities=24%  Similarity=0.388  Sum_probs=202.6

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec----CCcEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR----PPNLC  183 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~  183 (395)
                      ++|++.+.||.|+||.||+|..  +++.||+|++............+.+|+.++++++||||+++++++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            5899999999999999999986  57899999997654444456778889999999999999999998753    34689


Q ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-
Q 016082          184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-  262 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-  262 (395)
                      +||||+. ++|.+++.. .+.+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||.+....... 
T Consensus        85 lv~e~~~-~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  162 (334)
T cd07855          85 VVMDLME-SDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT  162 (334)
T ss_pred             EEEehhh-hhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence            9999996 589998865 4568999999999999999999999999999999999999999999999999997543322 


Q ss_pred             ----ccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc---------------
Q 016082          263 ----VMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK---------------  322 (395)
Q Consensus       263 ----~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~---------------  322 (395)
                          ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+.......+...               
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~  242 (334)
T cd07855         163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD  242 (334)
T ss_pred             CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence                1233468899999999865 56899999999999999999999999876543322211110               


Q ss_pred             ---------cCCCCC-----CCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          323 ---------SLRPTI-----PKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       323 ---------~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                               ......     .+..++++.++|.+||+.+|.+||++.+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                     001111     1346889999999999999999999999887

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=7.3e-39  Score=302.92  Aligned_cols=246  Identities=22%  Similarity=0.401  Sum_probs=202.6

Q ss_pred             CcceeeeeeeeCceEEEEEEE-----CCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcE
Q 016082          111 QLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNL  182 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~-----~~~~vAvK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  182 (395)
                      .|++.+.||.|+||.||+++.     +++.||+|+++....  .....+.+.+|+.+++++ +|+||+.+++.+......
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            478899999999999999986     578899999975432  122346788999999999 589999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC
Q 016082          183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~  262 (395)
                      |+||||+++++|.+++.. ..++++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||+++......
T Consensus        81 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  159 (290)
T cd05613          81 HLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE  159 (290)
T ss_pred             EEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence            999999999999999976 4578999999999999999999999999999999999999999999999999997654322


Q ss_pred             --ccccCCCCcccccccccCCC--CCCChhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHhhhccCCCCCCCCCcH
Q 016082          263 --VMTAETGTYRWMAPEVIEHK--PYDYKADVFSFGIALWELLTGELPYAGLTP----LQAAVGVVQKSLRPTIPKHAHP  334 (395)
Q Consensus       263 --~~~~~~gt~~y~aPE~~~~~--~~~~k~DvwslG~vl~elltg~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~  334 (395)
                        ......|+..|+|||.+.+.  .++.++||||||+++|+|++|..||.....    ........  ...+..|..+++
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  237 (290)
T cd05613         160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRIL--KSEPPYPQEMSA  237 (290)
T ss_pred             ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhh--ccCCCCCccCCH
Confidence              12234688999999998753  478899999999999999999999964322    12111111  123456677899


Q ss_pred             HHHHHHHHhhccCCCCCC-----CHHHHHH
Q 016082          335 RLAELLERCWQHDPTQRP-----NFSQITD  359 (395)
Q Consensus       335 ~l~~li~~cl~~dp~~RP-----s~~ell~  359 (395)
                      .+.+++++||+.+|.+||     +..++++
T Consensus       238 ~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         238 LAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             HHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            999999999999999997     6666655

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=4.8e-39  Score=306.50  Aligned_cols=250  Identities=26%  Similarity=0.433  Sum_probs=201.2

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC------
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP------  180 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  180 (395)
                      .++|++.++||+|+||.||+|++  +++.+|+|++............+.+|+.++++++||||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            46899999999999999999987  5788999998654433333456778999999999999999999875433      


Q ss_pred             --cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccc
Q 016082          181 --NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  258 (395)
Q Consensus       181 --~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~  258 (395)
                        .+++|+||+.+ ++.+.+......+++..+..++.|+++||.|||++||+||||||+||++++++.++|+|||+++..
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  165 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY  165 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence              46999999975 788887766678999999999999999999999999999999999999999999999999999754


Q ss_pred             ccCCc------------cccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC
Q 016082          259 AQSGV------------MTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR  325 (395)
Q Consensus       259 ~~~~~------------~~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~  325 (395)
                      .....            .+...+++.|+|||.+.+ ..++.++||||||+++|+|++|++||.+.+.......+......
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~  245 (311)
T cd07866         166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT  245 (311)
T ss_pred             cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            33211            122356788999998765 45899999999999999999999999887765443332221100


Q ss_pred             C---------------------CCC-------CCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          326 P---------------------TIP-------KHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       326 ~---------------------~~~-------~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      +                     ..+       ...++++.+++.+||+.+|.+|||+.+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         246 PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             CChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            0                     000       234568999999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-39  Score=300.58  Aligned_cols=246  Identities=26%  Similarity=0.413  Sum_probs=202.2

Q ss_pred             cceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCcEEEEEec
Q 016082          112 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEF  188 (395)
Q Consensus       112 ~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~  188 (395)
                      |++.+.||+|++|.||+|+.  +++.||||.+....... ......+|+..+++++ |||++++++++..++..++||||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~   79 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY   79 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch-hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence            67889999999999999998  56889999987553222 2234457999999999 99999999999999999999999


Q ss_pred             CCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCccccC
Q 016082          189 MARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE  267 (395)
Q Consensus       189 ~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~~  267 (395)
                      + +|+|.+++.... ..++...+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||.+............
T Consensus        80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~  158 (283)
T cd07830          80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDY  158 (283)
T ss_pred             C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCC
Confidence            9 779999987754 57899999999999999999999999999999999999999999999999999866554444556


Q ss_pred             CCCcccccccccC-CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC---------------------
Q 016082          268 TGTYRWMAPEVIE-HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR---------------------  325 (395)
Q Consensus       268 ~gt~~y~aPE~~~-~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~---------------------  325 (395)
                      .++..|+|||.+. +..++.++|+||||+++++|++|++||...+..............                     
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd07830         159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFP  238 (283)
T ss_pred             CCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccc
Confidence            7889999999874 456799999999999999999999999877654433222110000                     


Q ss_pred             -------CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          326 -------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       326 -------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                             .......+.++.+++++||+.+|++||++.|++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         239 QFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence                   0001223678999999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=6.3e-39  Score=298.25  Aligned_cols=247  Identities=28%  Similarity=0.487  Sum_probs=207.9

Q ss_pred             CcceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCC---CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Q 016082          111 QLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECV---NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  185 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  185 (395)
                      +|.+.++||+|+||.||++.+.  +..+++|+++....   .......+..|+.++++++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            5889999999999999999874  45577777764322   233345677899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC
Q 016082          186 TEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~  262 (395)
                      +||+++++|.+++..   ....+++..++.++.|++.|+.|||+.|++|+||+|+||++++ +.++|+|||.++......
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~  159 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC  159 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence            999999999998864   2457899999999999999999999999999999999999975 579999999987653322


Q ss_pred             -ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHH
Q 016082          263 -VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE  341 (395)
Q Consensus       263 -~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  341 (395)
                       ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||............. ....+..+..++.++.++|.
T Consensus       160 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~  238 (260)
T cd08222         160 DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV-EGPTPSLPETYSRQLNSIMQ  238 (260)
T ss_pred             ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-cCCCCCCcchhcHHHHHHHH
Confidence             2234568889999999988889999999999999999999999998776655544433 34556667788999999999


Q ss_pred             HhhccCCCCCCCHHHHHH
Q 016082          342 RCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       342 ~cl~~dp~~RPs~~ell~  359 (395)
                      +||+.+|++||++.++++
T Consensus       239 ~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         239 SMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             HHhcCChhhCcCHHHHhh
Confidence            999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.8e-39  Score=326.22  Aligned_cols=250  Identities=16%  Similarity=0.300  Sum_probs=189.6

Q ss_pred             ccCcceeeeeeeeCceEEEEEEECC---ceEEEEEe---------------cCCCCCHHHHHHHHHHHHHHHhcCCCcee
Q 016082          109 AKQLKIECKVASGSYGDLYKGTYCS---QEVAIKVL---------------KPECVNTEMLKEFSQEVYIMRKIRHKNVV  170 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~~~---~~vAvK~~---------------~~~~~~~~~~~~~~~E~~~l~~l~h~niv  170 (395)
                      .++|++.++||+|+||.||++....   ..++.|.+               +...........+.+|+.+|++++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            3579999999999999999986522   22222211               11111233456788999999999999999


Q ss_pred             eEEEEEecCCcEEEEEecCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCc
Q 016082          171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQK----GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV  246 (395)
Q Consensus       171 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~  246 (395)
                      ++++++...+..|+|+|++.+ +|.+++....    .......+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~  305 (501)
T PHA03210        227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK  305 (501)
T ss_pred             cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence            999999999999999999954 8888775432    23345678889999999999999999999999999999999999


Q ss_pred             EEEeeeccccccccCC--ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCC-CCCCC--CHHHHHHHhhh
Q 016082          247 VKVADFGVARVQAQSG--VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGEL-PYAGL--TPLQAAVGVVQ  321 (395)
Q Consensus       247 vkl~DFg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~-pf~~~--~~~~~~~~~~~  321 (395)
                      +||+|||+++......  ......||..|+|||++.+..++.++|||||||++|||++|.. ||...  .+......+..
T Consensus       306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~  385 (501)
T PHA03210        306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIID  385 (501)
T ss_pred             EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHH
Confidence            9999999998654332  2233579999999999999999999999999999999999875 44332  22222221111


Q ss_pred             cc------CC---------------CCC---------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          322 KS------LR---------------PTI---------PKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       322 ~~------~~---------------~~~---------~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      ..      +.               ...         ....+.++.++|.+||+.||.+|||+.|+++
T Consensus       386 ~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        386 SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             hcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            00      00               000         0134667888999999999999999999986

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.3e-38  Score=298.31  Aligned_cols=239  Identities=21%  Similarity=0.393  Sum_probs=194.5

Q ss_pred             cCcceeeee--eeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcEEE
Q 016082          110 KQLKIECKV--ASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCI  184 (395)
Q Consensus       110 ~~~~i~~~l--g~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  184 (395)
                      +.|.+.+.+  |+|+||.||++..  ++..+|+|+++.......       |+.....+ +||||+++++.+...+..|+
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~~~~i   86 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHVL   86 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence            356666665  9999999999986  578899999875432211       22222222 69999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCC-cEEEeeeccccccccCCc
Q 016082          185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQSGV  263 (395)
Q Consensus       185 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~-~vkl~DFg~a~~~~~~~~  263 (395)
                      ||||+++++|.+++... ..+++..+..++.|+++|+.|||+.|++||||||+||+++.++ .++|+|||.++.....  
T Consensus        87 v~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--  163 (267)
T PHA03390         87 IMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--  163 (267)
T ss_pred             EEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--
Confidence            99999999999999764 4899999999999999999999999999999999999999998 9999999998765432  


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhh-h-ccCCCCCCCCCcHHHHHHHH
Q 016082          264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV-Q-KSLRPTIPKHAHPRLAELLE  341 (395)
Q Consensus       264 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~l~~li~  341 (395)
                       ....++..|+|||++.+..++.++|+||+|+++|+|++|+.||............. . .......+...++.+.++|.
T Consensus       164 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  242 (267)
T PHA03390        164 -SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQ  242 (267)
T ss_pred             -ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHH
Confidence             23468899999999999999999999999999999999999998654332111111 1 12233445578999999999


Q ss_pred             HhhccCCCCCCC-HHHHHH
Q 016082          342 RCWQHDPTQRPN-FSQITD  359 (395)
Q Consensus       342 ~cl~~dp~~RPs-~~ell~  359 (395)
                      +||+.+|.+||+ ++++++
T Consensus       243 ~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        243 SMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             HHhccChhhCCchHHHHhc
Confidence            999999999995 688875

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-41  Score=297.73  Aligned_cols=258  Identities=26%  Similarity=0.449  Sum_probs=216.4

Q ss_pred             CCCCceeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHh-cCCCceeeEEEEE
Q 016082          100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK-IRHKNVVQFIGAC  176 (395)
Q Consensus       100 ~~~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~  176 (395)
                      +....|....++++-+..||.|+||+|++-.+  .|+..|||.++.... +...+++..|.....+ -+.||||++||++
T Consensus        54 ~~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~  132 (361)
T KOG1006|consen   54 DDAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGAL  132 (361)
T ss_pred             CcccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhh
Confidence            34456888888999999999999999999877  688999999987754 3344667777665554 4689999999999


Q ss_pred             ecCCcEEEEEecCCCCCHHHHHh----hccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCeeeCCCCcEEEee
Q 016082          177 TRPPNLCIVTEFMARGSIYDFLH----KQKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVAD  251 (395)
Q Consensus       177 ~~~~~~~lV~E~~~ggsL~~~l~----~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~iiHrDlkp~NiLl~~~~~vkl~D  251 (395)
                      -.++..+|.||.|.- ||..+-.    .++..+++..+-.+..-.+.||+||-.. +|||||+||.|||++..|.|||||
T Consensus       133 F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCD  211 (361)
T KOG1006|consen  133 FSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCD  211 (361)
T ss_pred             hcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeec
Confidence            999999999999965 6654432    1256799999999999999999999864 899999999999999999999999


Q ss_pred             eccccccccCCccccCCCCcccccccccC--CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCC
Q 016082          252 FGVARVQAQSGVMTAETGTYRWMAPEVIE--HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP  329 (395)
Q Consensus       252 Fg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  329 (395)
                      ||.+.....+...+...|...|||||.+.  ...|+.+|||||||++|||+.||+.||.+.+..-.....+..+..|.+.
T Consensus       212 FGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~  291 (361)
T KOG1006|consen  212 FGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILL  291 (361)
T ss_pred             ccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeec
Confidence            99998777777778889999999999996  3469999999999999999999999999988765555555555555443


Q ss_pred             -----CCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          330 -----KHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       330 -----~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                           -+.+..+..+|.-|+.+|-..||.+.++++
T Consensus       292 ~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  292 FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             CcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence                 247889999999999999999999999876

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-38  Score=307.32  Aligned_cols=250  Identities=26%  Similarity=0.424  Sum_probs=205.3

Q ss_pred             ceeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC-
Q 016082          104 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP-  180 (395)
Q Consensus       104 ~~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-  180 (395)
                      .|.+ .++|++.+.||+|+||.||+|..  +++.||||+++...........+.+|+.++++++||||+++++++.... 
T Consensus        10 ~~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07880          10 IWEV-PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS   88 (343)
T ss_pred             hhcc-ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence            4554 45799999999999999999986  5788999999765444445567889999999999999999999987654 


Q ss_pred             -----cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccc
Q 016082          181 -----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA  255 (395)
Q Consensus       181 -----~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a  255 (395)
                           .+++||||+ |++|.+++..  ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||.+
T Consensus        89 ~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~  165 (343)
T cd07880          89 LDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA  165 (343)
T ss_pred             ccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence                 358999999 6799888754  56899999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC---------
Q 016082          256 RVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR---------  325 (395)
Q Consensus       256 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~---------  325 (395)
                      ......  .....++..|+|||.+.+ ..++.++|+||||+++|++++|..||.+.+.......+......         
T Consensus       166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T cd07880         166 RQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL  243 (343)
T ss_pred             cccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence            754432  234467889999999876 45889999999999999999999999876654333322211100         


Q ss_pred             --------------------CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          326 --------------------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       326 --------------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                          ......+++++.++|.+|++.||.+|||+.+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                                0112456788999999999999999999999885

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.8e-38  Score=301.26  Aligned_cols=243  Identities=30%  Similarity=0.494  Sum_probs=205.1

Q ss_pred             cceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecC
Q 016082          112 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM  189 (395)
Q Consensus       112 ~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  189 (395)
                      |....+||+|+||.||++..  +++.||||.+...  .......+.+|+.++++++|+||+++++.+...+..++||||+
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   99 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL   99 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence            44457899999999999987  5789999998643  2334567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-ccccCC
Q 016082          190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAET  268 (395)
Q Consensus       190 ~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~~~~  268 (395)
                      ++++|.+++..  +++++..+..++.|++.|+.|||+.|++||||+|+||+++.++.++|+|||.+....... ......
T Consensus       100 ~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~  177 (292)
T cd06657         100 EGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV  177 (292)
T ss_pred             CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccc
Confidence            99999998754  468999999999999999999999999999999999999999999999999986543321 223356


Q ss_pred             CCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCC--CCCCCcHHHHHHHHHhhcc
Q 016082          269 GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT--IPKHAHPRLAELLERCWQH  346 (395)
Q Consensus       269 gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~  346 (395)
                      +++.|+|||.+.+..++.++|+||+|+++|+|++|..||.+....+..... ....++.  ....+++++.+++.+||+.
T Consensus       178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~  256 (292)
T cd06657         178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-RDNLPPKLKNLHKVSPSLKGFLDRLLVR  256 (292)
T ss_pred             cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhhCCcccCCcccCCHHHHHHHHHHHhC
Confidence            889999999998888999999999999999999999999887665543332 2222222  2345788999999999999


Q ss_pred             CCCCCCCHHHHHH
Q 016082          347 DPTQRPNFSQITD  359 (395)
Q Consensus       347 dp~~RPs~~ell~  359 (395)
                      +|.+||++.+++.
T Consensus       257 ~P~~R~~~~~ll~  269 (292)
T cd06657         257 DPAQRATAAELLK  269 (292)
T ss_pred             CcccCcCHHHHhc
Confidence            9999999999887

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.1e-38  Score=308.55  Aligned_cols=248  Identities=23%  Similarity=0.401  Sum_probs=202.0

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEEEEecC--CcEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRP--PNLC  183 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~~  183 (395)
                      .++|++.+.||+|+||.||+|.+  +++.+|+|.+.....+......+.+|+.+++++ +||||+++++++...  ...|
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            35799999999999999999987  578899999865433444456778899999999 999999999988643  3689


Q ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-
Q 016082          184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-  262 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-  262 (395)
                      +||||+++ +|.+++...  .+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||.++...... 
T Consensus        86 lv~e~~~~-~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~  162 (337)
T cd07852          86 LVFEYMET-DLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE  162 (337)
T ss_pred             EEeccccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence            99999975 999988653  78888999999999999999999999999999999999999999999999997554322 


Q ss_pred             -----ccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC-----------
Q 016082          263 -----VMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR-----------  325 (395)
Q Consensus       263 -----~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~-----------  325 (395)
                           ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+..+......+......           
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
T cd07852         163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS  242 (337)
T ss_pred             cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHh
Confidence                 2233468889999998754 56789999999999999999999999876554433222111100           


Q ss_pred             ------------------CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          326 ------------------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       326 ------------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                        ......++.++.++|.+||+.+|.+|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~  294 (337)
T cd07852         243 PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE  294 (337)
T ss_pred             hhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence                              0111236889999999999999999999999987

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-38  Score=309.46  Aligned_cols=250  Identities=26%  Similarity=0.433  Sum_probs=203.5

Q ss_pred             CceeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 016082          103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  180 (395)
Q Consensus       103 ~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (395)
                      ..|++. ++|.+.+.||+|+||.||+|++  +++.||+|.++.....+.....+.+|+.++++++||||+++++++....
T Consensus         9 ~~~~~~-~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~   87 (342)
T cd07879           9 TVWELP-ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAV   87 (342)
T ss_pred             hhhccc-cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccc
Confidence            456664 4899999999999999999986  5789999999765434444567889999999999999999999986543


Q ss_pred             ------cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecc
Q 016082          181 ------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV  254 (395)
Q Consensus       181 ------~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~  254 (395)
                            .+++|+||+.+ +|.+++   ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||+
T Consensus        88 ~~~~~~~~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          88 SGDEFQDFYLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             cCCCCceEEEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence                  46999999965 777665   34689999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccC---------
Q 016082          255 ARVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL---------  324 (395)
Q Consensus       255 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~---------  324 (395)
                      ++....  ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.+.+.......+.....         
T Consensus       164 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (342)
T cd07879         164 ARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK  241 (342)
T ss_pred             CcCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            875433  2234567889999999876 4689999999999999999999999988765443332221000         


Q ss_pred             ------------CCCC--------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          325 ------------RPTI--------PKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       325 ------------~~~~--------~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                  .+..        .+..++++.++|++||+.||.+||++.+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~  296 (342)
T cd07879         242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE  296 (342)
T ss_pred             hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                        0011        1246778999999999999999999999985

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-41  Score=349.88  Aligned_cols=248  Identities=27%  Similarity=0.456  Sum_probs=217.8

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  188 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  188 (395)
                      ++.-...||.|.||.||-|..  +|...|+|-++-............+|..++..++|||+|++||+-.+.+..+|.|||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence            456677899999999999976  788899998876554455667789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-----c
Q 016082          189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-----V  263 (395)
Q Consensus       189 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-----~  263 (395)
                      |+||+|.+.+.. .+-.++.....+..|++.|+.|||+.||+||||||+||+++.+|.+|++|||.|.......     .
T Consensus      1316 C~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1316 CEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred             hccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence            999999999865 4445666677788999999999999999999999999999999999999999998655432     2


Q ss_pred             cccCCCCcccccccccCCC---CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHH
Q 016082          264 MTAETGTYRWMAPEVIEHK---PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELL  340 (395)
Q Consensus       264 ~~~~~gt~~y~aPE~~~~~---~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  340 (395)
                      .....||+-|||||++.+.   ....++||||+|||+.||+||+.||...+..-+...-+..+-.|++|..++++-.+||
T Consensus      1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFl 1474 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFL 1474 (1509)
T ss_pred             HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHH
Confidence            3345899999999999754   4668899999999999999999999998887777777788889999999999999999


Q ss_pred             HHhhccCCCCCCCHHHHHH
Q 016082          341 ERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       341 ~~cl~~dp~~RPs~~ell~  359 (395)
                      .+||+.||..|.++.||++
T Consensus      1475 e~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1475 EHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             HHHHhcCchhhhHHHHHHH
Confidence            9999999999999988876

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.2e-38  Score=306.16  Aligned_cols=247  Identities=25%  Similarity=0.396  Sum_probs=200.9

Q ss_pred             Cc-ceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHH------------HHHHHHHHHHHHHhcCCCceeeEEEE
Q 016082          111 QL-KIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTE------------MLKEFSQEVYIMRKIRHKNVVQFIGA  175 (395)
Q Consensus       111 ~~-~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~------------~~~~~~~E~~~l~~l~h~niv~l~~~  175 (395)
                      +| .+.+.||.|+||.||+|.+  .++.||||+++.......            ....+.+|+.++++++||||++++++
T Consensus         9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   88 (335)
T PTZ00024          9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV   88 (335)
T ss_pred             chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence            55 4567899999999999986  578999999875432210            11257789999999999999999999


Q ss_pred             EecCCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccc
Q 016082          176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA  255 (395)
Q Consensus       176 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a  255 (395)
                      +...+..++||||+. |+|.+++.. ...+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||.+
T Consensus        89 ~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~  166 (335)
T PTZ00024         89 YVEGDFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA  166 (335)
T ss_pred             EecCCcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence            999999999999997 499999865 556899999999999999999999999999999999999999999999999999


Q ss_pred             cccccC---------------CccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q 016082          256 RVQAQS---------------GVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV  319 (395)
Q Consensus       256 ~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~  319 (395)
                      +.....               .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+..+....+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i  246 (335)
T PTZ00024        167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI  246 (335)
T ss_pred             eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            765411               112234567889999998764 4789999999999999999999999988766544433


Q ss_pred             hhccCCC--------------------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          320 VQKSLRP--------------------------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       320 ~~~~~~~--------------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      ......+                          ......+.++.+++.+||+.+|++||++++++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        247 FELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            2211100                          011245788999999999999999999999986

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-38  Score=299.32  Aligned_cols=247  Identities=25%  Similarity=0.442  Sum_probs=206.4

Q ss_pred             cceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecC
Q 016082          112 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM  189 (395)
Q Consensus       112 ~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  189 (395)
                      |++.+.||+|++|.||+|+.  +++.+|+|+++...........+.+|+.++++++|+|++++++++......++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            56678899999999999988  4789999999876544445577889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-ccccCC
Q 016082          190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAET  268 (395)
Q Consensus       190 ~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~~~~  268 (395)
                      ++ +|.+++......+++..+..++.+++.||.|||+.||+||||+|+||++++++.++|+|||.++...... ......
T Consensus        81 ~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~  159 (282)
T cd07829          81 DM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEV  159 (282)
T ss_pred             Cc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccc
Confidence            85 9999998765679999999999999999999999999999999999999999999999999997654432 233445


Q ss_pred             CCcccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccC----------------C---CC-
Q 016082          269 GTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL----------------R---PT-  327 (395)
Q Consensus       269 gt~~y~aPE~~~~~-~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~----------------~---~~-  327 (395)
                      ++..|+|||.+.+. .++.++|+||||+++||+++|..||.+.+.......+.....                .   +. 
T Consensus       160 ~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
T cd07829         160 VTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKF  239 (282)
T ss_pred             cCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccccc
Confidence            67889999998766 789999999999999999999999988765544333221100                0   00 


Q ss_pred             -------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          328 -------IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       328 -------~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                             ..+..+.++.+++++||+.+|++||++++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         240 PPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             CccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence                   01134778999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-41  Score=318.16  Aligned_cols=247  Identities=27%  Similarity=0.434  Sum_probs=231.1

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEECCce--EEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTYCSQE--VAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  182 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~~~~~--vAvK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  182 (395)
                      .+..+++++...||-|+||.|-++...++.  +|+|++++.. .+....+....|.+||..++.|.||++|..|.+....
T Consensus       416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv  495 (732)
T KOG0614|consen  416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV  495 (732)
T ss_pred             ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence            455678889999999999999999987766  7999997654 4666778899999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC
Q 016082          183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~  262 (395)
                      ||.||-|-||.|...|++ ++.|+..+...++..++.|++|||++|||.|||||+|++++.+|-+||.|||+|+....+.
T Consensus       496 YmLmEaClGGElWTiLrd-Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~  574 (732)
T KOG0614|consen  496 YMLMEACLGGELWTILRD-RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR  574 (732)
T ss_pred             hhhHHhhcCchhhhhhhh-cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence            999999999999999988 6889999999999999999999999999999999999999999999999999999999888


Q ss_pred             ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHH
Q 016082          263 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER  342 (395)
Q Consensus       263 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  342 (395)
                      ...+.+||+.|.|||++.++..+.++|.||||+++|||++|.+||++.++-.....++.....-.+|..++....++|++
T Consensus       575 KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~  654 (732)
T KOG0614|consen  575 KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKK  654 (732)
T ss_pred             ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHH
Confidence            88889999999999999999999999999999999999999999999999999998888777788899999999999999


Q ss_pred             hhccCCCCCCC
Q 016082          343 CWQHDPTQRPN  353 (395)
Q Consensus       343 cl~~dp~~RPs  353 (395)
                      +-..+|.+|..
T Consensus       655 LCr~~P~ERLG  665 (732)
T KOG0614|consen  655 LCRDNPTERLG  665 (732)
T ss_pred             HHhcCcHhhhc
Confidence            99999999987

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.1e-38  Score=301.39  Aligned_cols=251  Identities=23%  Similarity=0.387  Sum_probs=206.6

Q ss_pred             CcceeeeeeeeCceEEEEEEE-----CCceEEEEEecCCCCC--HHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcE
Q 016082          111 QLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVN--TEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNL  182 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~-----~~~~vAvK~~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  182 (395)
                      +|++.+.||+|+||.||+++.     .++.||||+++.....  ....+.+.+|+.++.++ +||||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            478899999999999999875     3577999999754321  23446788999999999 599999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC
Q 016082          183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~  262 (395)
                      ++||||+++|+|.+++.. .+.+++..+..++.|+++||.|||+.+++||||+|.||+++.++.++|+|||+++......
T Consensus        81 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  159 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE  159 (288)
T ss_pred             EEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence            999999999999999876 4578999999999999999999999999999999999999999999999999987644332


Q ss_pred             c--cccCCCCcccccccccCCCC--CCChhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHhhhccCCCCCCCCCcH
Q 016082          263 V--MTAETGTYRWMAPEVIEHKP--YDYKADVFSFGIALWELLTGELPYAGLTP----LQAAVGVVQKSLRPTIPKHAHP  334 (395)
Q Consensus       263 ~--~~~~~gt~~y~aPE~~~~~~--~~~k~DvwslG~vl~elltg~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~  334 (395)
                      .  .....|+..|+|||.+.+..  .+.++|+||||+++|+|++|..||.....    ........  ...+..+...++
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  237 (288)
T cd05583         160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRIL--KSKPPFPKTMSA  237 (288)
T ss_pred             ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHH--ccCCCCCcccCH
Confidence            1  12345789999999987654  78899999999999999999999964321    22222222  223456677889


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 016082          335 RLAELLERCWQHDPTQRPNFSQITDILKQM  364 (395)
Q Consensus       335 ~l~~li~~cl~~dp~~RPs~~ell~~l~~~  364 (395)
                      ++.+++.+||+.+|++|||+.++.+.|...
T Consensus       238 ~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         238 EARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             HHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence            999999999999999999988887766653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-40  Score=340.06  Aligned_cols=253  Identities=22%  Similarity=0.347  Sum_probs=219.1

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  181 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  181 (395)
                      ..+..++|.|.+.||+|+||.|..++.  +++.||+|++++-. .......-|+.|..+|..-+.+.|++++.+|.+..+
T Consensus        70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~  149 (1317)
T KOG0612|consen   70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY  149 (1317)
T ss_pred             HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence            345678999999999999999999987  57889999997522 123334679999999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC
Q 016082          182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  261 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~  261 (395)
                      +|+|||||+||+|..++.+.. ++++..++.++..|+.||+-||+.|+|||||||+|||+|..|++||+|||.+-.....
T Consensus       150 LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d  228 (1317)
T KOG0612|consen  150 LYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD  228 (1317)
T ss_pred             eEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence            999999999999999998855 8999999999999999999999999999999999999999999999999998766644


Q ss_pred             Cc--cccCCCCcccccccccC----C-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCC--CCC
Q 016082          262 GV--MTAETGTYRWMAPEVIE----H-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP--KHA  332 (395)
Q Consensus       262 ~~--~~~~~gt~~y~aPE~~~----~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~  332 (395)
                      +.  .....|||.|.+||++.    + +.|+..+|.||+||++|||+.|..||...+-.+.+..++.....-.+|  ..+
T Consensus       229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~V  308 (1317)
T KOG0612|consen  229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDV  308 (1317)
T ss_pred             CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCccccc
Confidence            42  34568999999999984    3 568999999999999999999999999988888888888775555566  568


Q ss_pred             cHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 016082          333 HPRLAELLERCWQHDPTQRPN---FSQITD  359 (395)
Q Consensus       333 ~~~l~~li~~cl~~dp~~RPs---~~ell~  359 (395)
                      |.+.++||++.+. +|+.|.+   ++++..
T Consensus       309 SeeakdLI~~ll~-~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  309 SEEAKDLIEALLC-DREVRLGRNGIEDIKN  337 (1317)
T ss_pred             CHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence            9999999998775 6778877   666543

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-40  Score=315.50  Aligned_cols=245  Identities=24%  Similarity=0.398  Sum_probs=213.6

Q ss_pred             eeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecCCCC
Q 016082          115 ECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARG  192 (395)
Q Consensus       115 ~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~gg  192 (395)
                      .+.||+|.||+||-|++  +|+.||||++.+.++.......+++|+.||+++.||.||.+...|++++..+.|||.+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            36899999999999976  7899999999988887777789999999999999999999999999999999999999885


Q ss_pred             CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCC---cEEEeeeccccccccCCccccCCC
Q 016082          193 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADFGVARVQAQSGVMTAETG  269 (395)
Q Consensus       193 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~---~vkl~DFg~a~~~~~~~~~~~~~g  269 (395)
                      -|.=+|....+++++..-..+..||+.||.|||-+||+|+||||+|||+.+..   ++||||||.||..++........|
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVG  728 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVG  728 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcC
Confidence            56666677789999999999999999999999999999999999999997643   799999999999999888888899


Q ss_pred             CcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCC
Q 016082          270 TYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPT  349 (395)
Q Consensus       270 t~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~  349 (395)
                      |+.|+|||++..+.|...-|+||.|+++|--++|..||..............--++|..-.+++++..++|+.+|+..-.
T Consensus       729 TPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~  808 (888)
T KOG4236|consen  729 TPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMR  808 (888)
T ss_pred             CccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHH
Confidence            99999999999999999999999999999999999999765433222221111233344467899999999999999999


Q ss_pred             CCCCHHHHHH
Q 016082          350 QRPNFSQITD  359 (395)
Q Consensus       350 ~RPs~~ell~  359 (395)
                      +|-|..+-+.
T Consensus       809 kRysvdk~ls  818 (888)
T KOG4236|consen  809 KRYSVDKSLS  818 (888)
T ss_pred             HhcchHhhcc
Confidence            9999887653

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-38  Score=292.15  Aligned_cols=236  Identities=28%  Similarity=0.439  Sum_probs=205.3

Q ss_pred             eeeeCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecCCCCCH
Q 016082          118 VASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI  194 (395)
Q Consensus       118 lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ggsL  194 (395)
                      ||.|+||.||++.+  .++.+|+|+++..... ......+..|+.++++++||||+++++.+..++..|+||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            68999999999988  4789999998765432 33567899999999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-CccccCCCCccc
Q 016082          195 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGTYRW  273 (395)
Q Consensus       195 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-~~~~~~~gt~~y  273 (395)
                      .+++... ..+++..+..++.|++.|+.|||+.+++|+||+|+||+++.++.++|+|||.+...... .......++..|
T Consensus        81 ~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  159 (250)
T cd05123          81 FSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY  159 (250)
T ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccc
Confidence            9999764 46899999999999999999999999999999999999999999999999999765443 223445688899


Q ss_pred             ccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCC
Q 016082          274 MAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPN  353 (395)
Q Consensus       274 ~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs  353 (395)
                      +|||...+...+.++|+||||+++|++++|..||......+....+..  .....+...+.++.+++++||..||++||+
T Consensus       160 ~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~  237 (250)
T cd05123         160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFLSPEARDLISGLLQKDPTKRLG  237 (250)
T ss_pred             cChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHhcCCHhhCCC
Confidence            999999988889999999999999999999999988776554444443  445677778999999999999999999999


Q ss_pred             HHH
Q 016082          354 FSQ  356 (395)
Q Consensus       354 ~~e  356 (395)
                      +.+
T Consensus       238 ~~~  240 (250)
T cd05123         238 SGG  240 (250)
T ss_pred             ccc
Confidence            943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-38  Score=309.73  Aligned_cols=250  Identities=26%  Similarity=0.444  Sum_probs=206.2

Q ss_pred             ceeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Q 016082          104 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  181 (395)
Q Consensus       104 ~~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  181 (395)
                      .|++ .++|++.+.||+|++|.||+|++  +++.||+|++............+.+|+.++++++|||++++++++.....
T Consensus        10 ~~~~-~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07851          10 VWEV-PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS   88 (343)
T ss_pred             eecc-cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence            3444 44799999999999999999988  46889999987654444455678889999999999999999988765554


Q ss_pred             ------EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccc
Q 016082          182 ------LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA  255 (395)
Q Consensus       182 ------~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a  255 (395)
                            .++|+||+ +++|.+++..  .++++..+..++.|++.|+.|||+.||+||||||+||+++.++.++|+|||.+
T Consensus        89 ~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~  165 (343)
T cd07851          89 LEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  165 (343)
T ss_pred             ccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence                  89999999 5699998865  56899999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCC--------
Q 016082          256 RVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP--------  326 (395)
Q Consensus       256 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~--------  326 (395)
                      ......  .....++..|+|||.+.+ ..++.++||||||+++|++++|+.||.+....+....+......+        
T Consensus       166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (343)
T cd07851         166 RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI  243 (343)
T ss_pred             cccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence            765432  344567889999999865 467899999999999999999999998876654443322211000        


Q ss_pred             ---------------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          327 ---------------------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       327 ---------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                           ......++++.++|++||+.+|.+|||+.+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence                                 011235889999999999999999999999986

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=293.37  Aligned_cols=243  Identities=24%  Similarity=0.380  Sum_probs=202.2

Q ss_pred             cCccee-eeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEEEEec----CCc
Q 016082          110 KQLKIE-CKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTR----PPN  181 (395)
Q Consensus       110 ~~~~i~-~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~----~~~  181 (395)
                      ++|++. ++||-|-.|.|..+..  +++.+|+|++...       ...++|+++.-... |||||++++++..    ...
T Consensus        61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            356554 4789999999998866  6889999999743       45667888776664 9999999998743    456


Q ss_pred             EEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCC---CCcEEEeeeccccc
Q 016082          182 LCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NGVVKVADFGVARV  257 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~---~~~vkl~DFg~a~~  257 (395)
                      +.+|||+|+||.|++.++.+ ...|++.++..|+.||..|+.|||+.+|.||||||+|+|.+.   |..+||+|||+|+.
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~  213 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE  213 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccc
Confidence            88999999999999999875 357999999999999999999999999999999999999975   45799999999998


Q ss_pred             cccCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHhhhccCCCCC--CCC
Q 016082          258 QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQA----AVGVVQKSLRPTI--PKH  331 (395)
Q Consensus       258 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~----~~~~~~~~~~~~~--~~~  331 (395)
                      ........+.+-|+.|.|||++....|+..+|+||+|+++|-|++|.+||..+.....    ...+....+.-+-  -..
T Consensus       214 t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~  293 (400)
T KOG0604|consen  214 TQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSC  293 (400)
T ss_pred             cCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhH
Confidence            7777778889999999999999999999999999999999999999999986544221    1222222222111  134


Q ss_pred             CcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          332 AHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       332 ~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      +|.+.+++|+++|..+|.+|.|+.++++
T Consensus       294 VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  294 VSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             HHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            6889999999999999999999999987

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-40  Score=308.62  Aligned_cols=251  Identities=22%  Similarity=0.348  Sum_probs=215.3

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCH-HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  181 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  181 (395)
                      +.+..+.|+.-++||+|+||.||-++.  +|+-+|+|.+.+.+... .-..-..+|..||.+++.+.||.+-.+|++++.
T Consensus       180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~  259 (591)
T KOG0986|consen  180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA  259 (591)
T ss_pred             hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence            345667889999999999999997754  78999999886544322 223457889999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          182 LCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                      +|+|+..|.||+|.-+|.+. ++.|++..+..++.+|+.||++||+.+|+.||+||+|||+|+.|++.|+|.|+|.....
T Consensus       260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            99999999999999888664 35799999999999999999999999999999999999999999999999999998887


Q ss_pred             CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhh--ccCCCCCCCCCcHHHHH
Q 016082          261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ--KSLRPTIPKHAHPRLAE  338 (395)
Q Consensus       261 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~  338 (395)
                      ........||.+|||||++.++.|+...|.||+||++|||+.|+.||...........+-+  .......|...|++.++
T Consensus       340 g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eaks  419 (591)
T KOG0986|consen  340 GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKS  419 (591)
T ss_pred             CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHH
Confidence            7777777999999999999999999999999999999999999999976543322222221  22344567889999999


Q ss_pred             HHHHhhccCCCCCCCHH
Q 016082          339 LLERCWQHDPTQRPNFS  355 (395)
Q Consensus       339 li~~cl~~dp~~RPs~~  355 (395)
                      +.+..|++||.+|....
T Consensus       420 lc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  420 LCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             HHHHHHccCHHHhccCC
Confidence            99999999999997765

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-39  Score=318.41  Aligned_cols=244  Identities=27%  Similarity=0.497  Sum_probs=207.1

Q ss_pred             cceeeeeeeeCceEEEEEEE--CCceEEEEEecCCC--CCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc--EEEE
Q 016082          112 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC--VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN--LCIV  185 (395)
Q Consensus       112 ~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lV  185 (395)
                      .++..+||+|+|-+||+|.+  .|-.||.-.++...  -++...++|..|+.+|+.|+||||+++|.++.+..+  +-+|
T Consensus        42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i  121 (632)
T KOG0584|consen   42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI  121 (632)
T ss_pred             eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence            47778999999999999987  46667754443222  245567899999999999999999999999987765  8899


Q ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCCCCeeeCC-CCcEEEeeeccccccccCC
Q 016082          186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN--NIIHRDLKTANLLMDE-NGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--~iiHrDlkp~NiLl~~-~~~vkl~DFg~a~~~~~~~  262 (395)
                      +|.+..|+|..|+++ .++.+...+..|++||++||.|||++  -|||||||.+||+|+. -|.|||+|+|+|.....+.
T Consensus       122 TEL~TSGtLr~Y~kk-~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~  200 (632)
T KOG0584|consen  122 TELFTSGTLREYRKK-HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH  200 (632)
T ss_pred             eecccCCcHHHHHHH-hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence            999999999999987 56789999999999999999999998  4999999999999975 6899999999999877665


Q ss_pred             ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHhhhccCCCCCCCCCcHHHHHHHH
Q 016082          263 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAG-LTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE  341 (395)
Q Consensus       263 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  341 (395)
                      ... ..|||.|||||... ..|++.+||||||+.+.||.|+..||.. .++.+.+..+.....+..+..--++++++||.
T Consensus       201 aks-vIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIe  278 (632)
T KOG0584|consen  201 AKS-VIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIE  278 (632)
T ss_pred             cce-eccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHH
Confidence            433 78999999999988 7799999999999999999999999975 56666666655433332334445889999999


Q ss_pred             HhhccCCCCCCCHHHHHH
Q 016082          342 RCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       342 ~cl~~dp~~RPs~~ell~  359 (395)
                      +|+.. ..+|||+.|+|+
T Consensus       279 kCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  279 KCLAT-KSERLSAKELLK  295 (632)
T ss_pred             HHhcC-chhccCHHHHhh
Confidence            99999 999999999986

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.7e-38  Score=304.80  Aligned_cols=250  Identities=26%  Similarity=0.423  Sum_probs=202.8

Q ss_pred             ceeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--
Q 016082          104 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--  179 (395)
Q Consensus       104 ~~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--  179 (395)
                      .|.+ .++|.+.+.||+|+||.||+|..  +++.||+|+++.........+.+.+|+.++++++||||+++++++...  
T Consensus        12 ~~~~-~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~   90 (345)
T cd07877          12 IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS   90 (345)
T ss_pred             Hhhc-cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence            3444 35799999999999999999986  578999999986543444456788999999999999999999988543  


Q ss_pred             ----CcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccc
Q 016082          180 ----PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA  255 (395)
Q Consensus       180 ----~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a  255 (395)
                          ...|++++++ |++|.+++..  ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++
T Consensus        91 ~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~  167 (345)
T cd07877          91 LEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA  167 (345)
T ss_pred             ccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccc
Confidence                3478888887 6799888754  46899999999999999999999999999999999999999999999999998


Q ss_pred             cccccCCccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccC----------
Q 016082          256 RVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL----------  324 (395)
Q Consensus       256 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~----------  324 (395)
                      +....  ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+.....          
T Consensus       168 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (345)
T cd07877         168 RHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI  245 (345)
T ss_pred             ccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            75433  2234577899999999866 5688999999999999999999999987665443322211100          


Q ss_pred             --------------CCC-----CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          325 --------------RPT-----IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       325 --------------~~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                    .+.     .....++++.++|.+|++.||.+||++.+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence                          000     01135788999999999999999999999887

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=9.6e-38  Score=301.47  Aligned_cols=247  Identities=25%  Similarity=0.388  Sum_probs=198.1

Q ss_pred             CcceeeeeeeeCceEEEEEEEC----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEEEEec----CCc
Q 016082          111 QLKIECKVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTR----PPN  181 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~----~~~  181 (395)
                      +|++.+.||+|+||.||++++.    +..||+|.++.........+.+.+|+.++++++ ||||+++++.+..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4788999999999999999984    568999998754333444567889999999995 9999999987532    245


Q ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC
Q 016082          182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  261 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~  261 (395)
                      .++++||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||.++.....
T Consensus        81 ~~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~  158 (332)
T cd07857          81 LYLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN  158 (332)
T ss_pred             EEEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence            789999986 589998865 567899999999999999999999999999999999999999999999999999754432


Q ss_pred             C-----ccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc------------
Q 016082          262 G-----VMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS------------  323 (395)
Q Consensus       262 ~-----~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~------------  323 (395)
                      .     ......|+..|+|||.+.+ ..++.++|+||+|+++|++++|++||...........+....            
T Consensus       159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (332)
T cd07857         159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG  238 (332)
T ss_pred             cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence            1     1233468999999998765 578999999999999999999999998765433222211100            


Q ss_pred             ------------C--C---CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          324 ------------L--R---PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       324 ------------~--~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                  .  .   .......+..+.+++.+||+.||.+|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                        0  0   0111235789999999999999999999999876

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=4.7e-38  Score=305.02  Aligned_cols=245  Identities=23%  Similarity=0.395  Sum_probs=198.4

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--------
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--------  179 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------  179 (395)
                      ++|.+.+.||.|+||.||+|..  +++.||+|.+.....  ...+.+.+|+.++++++||||+++++++...        
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV   82 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence            5899999999999999999987  578999999865532  3456788999999999999999999876543        


Q ss_pred             ------CcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCC-CCcEEEeee
Q 016082          180 ------PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVADF  252 (395)
Q Consensus       180 ------~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~-~~~vkl~DF  252 (395)
                            ...|+||||+++ +|.+++..  +.+++..++.++.||+.||.|||+.||+||||||+||+++. ++.++++||
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df  159 (342)
T cd07854          83 GSLTELNSVYIVQEYMET-DLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF  159 (342)
T ss_pred             ccccccceEEEEeecccc-cHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence                  357999999975 89888854  46899999999999999999999999999999999999974 557899999


Q ss_pred             ccccccccCC----ccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc----
Q 016082          253 GVARVQAQSG----VMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS----  323 (395)
Q Consensus       253 g~a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~----  323 (395)
                      |.++......    ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.++...........    
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (342)
T cd07854         160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR  239 (342)
T ss_pred             ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            9997543221    1123457889999998754 568899999999999999999999998776654433322110    


Q ss_pred             -------------------CCCC-----CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          324 -------------------LRPT-----IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       324 -------------------~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                         ..+.     ..+..+.++.+++++||+.||.+||++.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence                               0010     11346788999999999999999999999987

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-38  Score=299.12  Aligned_cols=251  Identities=31%  Similarity=0.643  Sum_probs=207.4

Q ss_pred             ccCcceeeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc--CCCceeeEEEEEecCC----cE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI--RHKNVVQFIGACTRPP----NL  182 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~----~~  182 (395)
                      ..+..+.+.||+|.||.||+|.|.|+.||||++....     .+.+.+|.+|++.+  +|+||+.|+++=..+.    ++
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL  284 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL  284 (513)
T ss_pred             hheeEEEEEecCccccceeeccccCCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence            4578999999999999999999999999999997542     25677788877754  8999999998764443    58


Q ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCCCCeeeCCCCcEEEeeecc
Q 016082          183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN--------NIIHRDLKTANLLMDENGVVKVADFGV  254 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------~iiHrDlkp~NiLl~~~~~vkl~DFg~  254 (395)
                      +||++|.+.|||+|||..  ..++....++++..++.||++||..        .|.|||||+.|||+..+|..-|+|+|+
T Consensus       285 wLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL  362 (513)
T KOG2052|consen  285 WLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  362 (513)
T ss_pred             EEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence            999999999999999976  5789999999999999999999953        599999999999999999999999999


Q ss_pred             ccccccCC-----ccccCCCCcccccccccCCCC----CC--ChhhHHHHHHHHHHHHhC----------CCCCCCCCH-
Q 016082          255 ARVQAQSG-----VMTAETGTYRWMAPEVIEHKP----YD--YKADVFSFGIALWELLTG----------ELPYAGLTP-  312 (395)
Q Consensus       255 a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~----~~--~k~DvwslG~vl~elltg----------~~pf~~~~~-  312 (395)
                      |...+...     ..+...||.+|||||++...-    ++  ..+||||||.++||++..          ++||.+..+ 
T Consensus       363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~  442 (513)
T KOG2052|consen  363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS  442 (513)
T ss_pred             eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence            97655432     234568999999999986531    21  358999999999999763          578876533 


Q ss_pred             ----HHHHHHhhhccCCCCCCCCCc-----HHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 016082          313 ----LQAAVGVVQKSLRPTIPKHAH-----PRLAELLERCWQHDPTQRPNFSQITDILKQMMK  366 (395)
Q Consensus       313 ----~~~~~~~~~~~~~~~~~~~~~-----~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~  366 (395)
                          .+...-+..+.+||.+|..+.     ..+.++|+.||..+|..|.|+-.|.+.|.++.+
T Consensus       443 DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  443 DPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             CCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence                333334556788999987653     257789999999999999999999999888763

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.8e-37  Score=325.03  Aligned_cols=147  Identities=28%  Similarity=0.506  Sum_probs=134.2

Q ss_pred             ccCcceeeeeeeeCceEEEEEEEC--CceEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  185 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  185 (395)
                      .++|.+.++||+|+||.||+|.+.  ++.||||+++... .+......+.+|+.+++.++||||+++++++......|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            358999999999999999999985  7899999997543 3455567899999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccc
Q 016082          186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR  256 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~  256 (395)
                      |||+.|++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||+++
T Consensus        83 mEy~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999976 4568999999999999999999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-38  Score=299.25  Aligned_cols=256  Identities=31%  Similarity=0.536  Sum_probs=213.6

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc--CCCceeeEEEEEecCC---
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI--RHKNVVQFIGACTRPP---  180 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~---  180 (395)
                      ..+...+++...+|+|.||.||+|+..++.||||++.     ....+.|.+|.+|.+-.  +|+||++|+++-....   
T Consensus       206 l~~l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~  280 (534)
T KOG3653|consen  206 LLELDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR  280 (534)
T ss_pred             cccCCchhhHHHhhcCccceeehhhccCceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence            3445678889999999999999999999999999997     44557788888888754  6999999999876665   


Q ss_pred             -cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---------CccccCCCCCCeeeCCCCcEEEe
Q 016082          181 -NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN---------NIIHRDLKTANLLMDENGVVKVA  250 (395)
Q Consensus       181 -~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------~iiHrDlkp~NiLl~~~~~vkl~  250 (395)
                       .++||+||.+.|||.+||..  ..+++....+++..+++||+|||+.         .|+|||||..|||+.+|++..|+
T Consensus       281 ~eywLVt~fh~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa  358 (534)
T KOG3653|consen  281 MEYWLVTEFHPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA  358 (534)
T ss_pred             cceeEEeeeccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence             79999999999999999976  4689999999999999999999963         69999999999999999999999


Q ss_pred             eeccccccccC---CccccCCCCcccccccccCCCC-CC-----ChhhHHHHHHHHHHHHhCC------------CCCC-
Q 016082          251 DFGVARVQAQS---GVMTAETGTYRWMAPEVIEHKP-YD-----YKADVFSFGIALWELLTGE------------LPYA-  308 (395)
Q Consensus       251 DFg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~-----~k~DvwslG~vl~elltg~------------~pf~-  308 (395)
                      |||+|......   +......||.+|||||++.+.- +.     .+.||||+|.++||+++..            .||+ 
T Consensus       359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~  438 (534)
T KOG3653|consen  359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA  438 (534)
T ss_pred             ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence            99999866533   2233468999999999997652 22     3589999999999999853            2332 


Q ss_pred             ----CCCHHHHHHHhhhccCCCCCCCCC-----cHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHH
Q 016082          309 ----GLTPLQAAVGVVQKSLRPTIPKHA-----HPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  368 (395)
Q Consensus       309 ----~~~~~~~~~~~~~~~~~~~~~~~~-----~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~  368 (395)
                          ..+-.+....++++..||.+|..+     ...+++.++.||..||+.|.|+.=+-+++.++..-.
T Consensus       439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence                224455566778889999998654     456899999999999999999999999999886633

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-39  Score=316.98  Aligned_cols=254  Identities=26%  Similarity=0.496  Sum_probs=206.9

Q ss_pred             cceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC------cEE
Q 016082          112 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP------NLC  183 (395)
Q Consensus       112 ~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~  183 (395)
                      |...+.||+|+||.||+|+.  +|+.||||.++... +....+...+|+++|++++|||||+++++-++..      ...
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            34456899999999999985  78999999998765 3344578899999999999999999999765443      468


Q ss_pred             EEEecCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeC--CCC--cEEEeeeccccc
Q 016082          184 IVTEFMARGSIYDFLHKQ--KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD--ENG--VVKVADFGVARV  257 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~--~~~--~vkl~DFg~a~~  257 (395)
                      +|||||.||||+..|+..  ...+++.+++.++.++..||.|||++||+||||||.||++-  .+|  ..||+|||.|+.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are  173 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE  173 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence            999999999999999753  46799999999999999999999999999999999999994  334  479999999999


Q ss_pred             cccCCccccCCCCcccccccccC-CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHhhhc----------
Q 016082          258 QAQSGVMTAETGTYRWMAPEVIE-HKPYDYKADVFSFGIALWELLTGELPYAGLTPL----QAAVGVVQK----------  322 (395)
Q Consensus       258 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~----~~~~~~~~~----------  322 (395)
                      .+++...+...||..|.+||... .+.|+..+|.|||||++|+++||..||......    +.......+          
T Consensus       174 l~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~  253 (732)
T KOG4250|consen  174 LDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQ  253 (732)
T ss_pred             CCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeee
Confidence            99888888999999999999998 588999999999999999999999999643222    122221111          


Q ss_pred             ---------cCCCCCCCCCcHH----HHHHHHHhhccCCCCCC--CHHHHHHHHHHHHH
Q 016082          323 ---------SLRPTIPKHAHPR----LAELLERCWQHDPTQRP--NFSQITDILKQMMK  366 (395)
Q Consensus       323 ---------~~~~~~~~~~~~~----l~~li~~cl~~dp~~RP--s~~ell~~l~~~~~  366 (395)
                               ....+.|.+.++.    +...+..+|..+|++|-  .+.+.-+.+.+|+.
T Consensus       254 ~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~  312 (732)
T KOG4250|consen  254 EEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN  312 (732)
T ss_pred             cccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence                     0112224445554    44667778999999998  88888888887766

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=9e-38  Score=262.88  Aligned_cols=248  Identities=23%  Similarity=0.398  Sum_probs=214.0

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  188 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  188 (395)
                      +|.-.++||+|.||+||+|+.  +++.||+|.++.+..++.......+|+-+++.++|+|||++++....++.+.+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            566678999999999999975  678899999988776677778889999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-ccccC
Q 016082          189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAE  267 (395)
Q Consensus       189 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~~~  267 (395)
                      +.. +|..+....++.++...+..++.|+++|+.++|+.++.|||+||.|+|++.+|.+|++|||+++..+-.. ..+++
T Consensus        83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysae  161 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAE  161 (292)
T ss_pred             hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeece
Confidence            976 9999998889999999999999999999999999999999999999999999999999999999876553 45678


Q ss_pred             CCCcccccccccCCC-CCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCC------------------C
Q 016082          268 TGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRP------------------T  327 (395)
Q Consensus       268 ~gt~~y~aPE~~~~~-~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~------------------~  327 (395)
                      ..|..|.+|.++-+. -|+...|+||-||++.|+.. |++.|++.+-.+....+....-.|                  .
T Consensus       162 vvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~  241 (292)
T KOG0662|consen  162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPI  241 (292)
T ss_pred             eeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCC
Confidence            889999999998765 58999999999999999998 888999987776666554321111                  1


Q ss_pred             CC---------CCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          328 IP---------KHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       328 ~~---------~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      .|         +..+..-++++++.+.-+|.+|.++++.++
T Consensus       242 ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  242 YPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             ccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            11         123345679999999999999999998765

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=4.4e-37  Score=282.74  Aligned_cols=218  Identities=22%  Similarity=0.266  Sum_probs=183.4

Q ss_pred             eCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecCCCCCHHHHH
Q 016082          121 GSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL  198 (395)
Q Consensus       121 G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ggsL~~~l  198 (395)
                      |.+|.||++.+  +++.||+|.++...       .+.+|...+....||||+++++++......++||||++||+|.+++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   76 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI   76 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence            88999999987  67889999997542       2334555556667999999999999999999999999999999999


Q ss_pred             hhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCccccCCCCcccccccc
Q 016082          199 HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV  278 (395)
Q Consensus       199 ~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~  278 (395)
                      .. ...+++..+..++.|++.||+|||+.||+||||||+||+++.++.++++|||.+......  .....++..|+|||.
T Consensus        77 ~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~  153 (237)
T cd05576          77 SK-FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEV  153 (237)
T ss_pred             HH-hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccccCCcc
Confidence            76 356899999999999999999999999999999999999999999999999987654432  233456778999999


Q ss_pred             cCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCH
Q 016082          279 IEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF  354 (395)
Q Consensus       279 ~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~  354 (395)
                      +.+..++.++|+||+|+++|++++|..|+......      ........+|..+++.++++|.+||+.||.+||++
T Consensus       154 ~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         154 GGISEETEACDWWSLGAILFELLTGKTLVECHPSG------INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             cCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------cccccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence            98888999999999999999999999887643211      11122234667788999999999999999999996

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-38  Score=284.07  Aligned_cols=245  Identities=24%  Similarity=0.418  Sum_probs=202.5

Q ss_pred             Cccee-eeeeeeCceEEEEEE--ECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCcEEEEE
Q 016082          111 QLKIE-CKVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       111 ~~~i~-~~lg~G~~G~Vy~~~--~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~  186 (395)
                      -|++. +.||+|+|+.|--+.  .++..+|||++.+.  ......+..+|++++.+.+ |+||++++++|+++.++||||
T Consensus        78 ~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVf  155 (463)
T KOG0607|consen   78 MYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVF  155 (463)
T ss_pred             HHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEE
Confidence            35554 468999999998765  48899999999776  3445678899999999996 999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCc---EEEeeeccccccccC--
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV---VKVADFGVARVQAQS--  261 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~---vkl~DFg~a~~~~~~--  261 (395)
                      |.|.||+|.+++++ +..|++.++.++.++|+.||++||.+||.|||+||+|||....+.   ||||||.++......  
T Consensus       156 EKm~GGplLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~  234 (463)
T KOG0607|consen  156 EKMRGGPLLSHIQK-RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND  234 (463)
T ss_pred             ecccCchHHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence            99999999999987 567999999999999999999999999999999999999987654   799999998643221  


Q ss_pred             ------CccccCCCCcccccccccC-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH--------------HHHH
Q 016082          262 ------GVMTAETGTYRWMAPEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGLTP--------------LQAA  316 (395)
Q Consensus       262 ------~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwslG~vl~elltg~~pf~~~~~--------------~~~~  316 (395)
                            ....+++|+..|||||+..     ...|+.++|.||||+++|-|+.|.+||.+.=.              .+..
T Consensus       235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~L  314 (463)
T KOG0607|consen  235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL  314 (463)
T ss_pred             CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHH
Confidence                  1234567889999999864     23589999999999999999999999986411              2223


Q ss_pred             HHhhhccCCCCCC----CCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          317 VGVVQKSLRPTIP----KHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       317 ~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      ...++.+.- ++|    .++|.+.++++..++..|+.+|.++.+++.
T Consensus       315 FesIQEGkY-eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  315 FESIQEGKY-EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HHHHhccCC-cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            333333322 333    367999999999999999999999999886

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-37  Score=306.44  Aligned_cols=238  Identities=22%  Similarity=0.382  Sum_probs=203.6

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIV  185 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV  185 (395)
                      .++|.+...+|.|+|+.|..+..  +++..++|++....      .+-.+|+.++... +||||+++++.+.+..+.|+|
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v  394 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV  394 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeecceecCCceeeee
Confidence            56789999999999999999877  67889999997652      2233566555555 599999999999999999999


Q ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee-CCCCcEEEeeeccccccccCCcc
Q 016082          186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM-DENGVVKVADFGVARVQAQSGVM  264 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl-~~~~~vkl~DFg~a~~~~~~~~~  264 (395)
                      ||.+.|+.+.+.+.... .+. .++..|+.+|+.+++|||++|++||||||+|||+ ++.|+++|+|||.++.....  .
T Consensus       395 ~e~l~g~ell~ri~~~~-~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~  470 (612)
T KOG0603|consen  395 MELLDGGELLRRIRSKP-EFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--C  470 (612)
T ss_pred             ehhccccHHHHHHHhcc-hhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--h
Confidence            99999999988887633 233 7788899999999999999999999999999999 69999999999999866554  4


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhh
Q 016082          265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW  344 (395)
Q Consensus       265 ~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  344 (395)
                      ...+-|..|.|||++....|++++|+||||++||+|++|+.||.......   .+.....++.....+|.+.++|+++||
T Consensus       471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~---ei~~~i~~~~~s~~vS~~AKdLl~~LL  547 (612)
T KOG0603|consen  471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI---EIHTRIQMPKFSECVSDEAKDLLQQLL  547 (612)
T ss_pred             cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH---HHHHhhcCCccccccCHHHHHHHHHhc
Confidence            45677899999999999999999999999999999999999998766552   233344456666889999999999999


Q ss_pred             ccCCCCCCCHHHHHH
Q 016082          345 QHDPTQRPNFSQITD  359 (395)
Q Consensus       345 ~~dp~~RPs~~ell~  359 (395)
                      +.||.+||++.++..
T Consensus       548 ~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  548 QVDPALRLGADEIGA  562 (612)
T ss_pred             cCChhhCcChhhhcc
Confidence            999999999999987

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=7.9e-37  Score=334.11  Aligned_cols=244  Identities=23%  Similarity=0.375  Sum_probs=194.0

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  188 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  188 (395)
                      .++..+.||+|+||.||+|++  .+..||||.++....      ....|+.++++++||||++++++|.+.+..++||||
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            466778899999999999986  578999999874421      123468899999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCccc
Q 016082          189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH---QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT  265 (395)
Q Consensus       189 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~  265 (395)
                      +++|+|.++++.    +++..+.+++.++++||+|||   +.+|+||||||+||+++.++..++. ||.+.....   ..
T Consensus       765 ~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---~~  836 (968)
T PLN00113        765 IEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---DT  836 (968)
T ss_pred             CCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---CC
Confidence            999999999953    788999999999999999999   6799999999999999998888775 666543221   22


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHhh-----hccCCCCCC------
Q 016082          266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP-----LQAAVGVV-----QKSLRPTIP------  329 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~-----~~~~~~~~-----~~~~~~~~~------  329 (395)
                      ...+|+.|+|||++.+..++.++|||||||++|||++|+.||.....     .+......     .....+...      
T Consensus       837 ~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  916 (968)
T PLN00113        837 KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN  916 (968)
T ss_pred             CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCcc
Confidence            34688999999999999999999999999999999999999853211     11110000     001111111      


Q ss_pred             CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHH
Q 016082          330 KHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  368 (395)
Q Consensus       330 ~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~  368 (395)
                      .....++.+++.+||+.+|++||++.|+++.|+++.+..
T Consensus       917 ~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  955 (968)
T PLN00113        917 QNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS  955 (968)
T ss_pred             HHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence            112336788999999999999999999999999887643

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-37  Score=307.58  Aligned_cols=247  Identities=32%  Similarity=0.559  Sum_probs=211.7

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEEEEec-----CC
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTR-----PP  180 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-----~~  180 (395)
                      .+.+.|...||.|.+|.||+++.  .++.+|+||+.+..   +..+++..|.++++... |||++.++|++..     ++
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D   94 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD   94 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence            34577889999999999998865  78999999998764   33367778999998875 8999999999843     45


Q ss_pred             cEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  259 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~  259 (395)
                      .++||||||.|||.-|+.+.. ..++.+..+..|++.++.|+.+||++.+||||||-.|||++.++.|||+|||++...+
T Consensus        95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld  174 (953)
T KOG0587|consen   95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  174 (953)
T ss_pred             eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence            799999999999999998764 4678999999999999999999999999999999999999999999999999987654


Q ss_pred             c-CCccccCCCCcccccccccCCC-----CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCC--CCCC
Q 016082          260 Q-SGVMTAETGTYRWMAPEVIEHK-----PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT--IPKH  331 (395)
Q Consensus       260 ~-~~~~~~~~gt~~y~aPE~~~~~-----~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~  331 (395)
                      . .+...+.+||+.|||||++...     .|+.++|+||||++..||..|.+|+..+-|..+...+.+.. +|.  .|..
T Consensus       175 sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNP-PPkLkrp~k  253 (953)
T KOG0587|consen  175 STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP-PPKLKRPKK  253 (953)
T ss_pred             cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCC-Cccccchhh
Confidence            4 3455677999999999999643     47889999999999999999999999999887766554432 222  2567


Q ss_pred             CcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          332 AHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       332 ~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      +++++-++|..||.+|.++||+..++++
T Consensus       254 Ws~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  254 WSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             HHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            8999999999999999999999999885

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=7.9e-37  Score=316.55  Aligned_cols=243  Identities=27%  Similarity=0.497  Sum_probs=193.4

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec---------
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR---------  178 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------  178 (395)
                      ++|+..+.||+||||.||+++.  .|+.||||.+.... +......+.+|+..+.+|+|||||+++.++.+         
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            4678889999999999999986  79999999998665 66677889999999999999999999853200         


Q ss_pred             --------------------------------------------------------------------------------
Q 016082          179 --------------------------------------------------------------------------------  178 (395)
Q Consensus       179 --------------------------------------------------------------------------------  178 (395)
                                                                                                      
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             ----------------------C--------CcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 016082          179 ----------------------P--------PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN  228 (395)
Q Consensus       179 ----------------------~--------~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~  228 (395)
                                            .        ..+||=||||+...+.++++.+...-.....++++.+|+.||.|+|++|
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g  717 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG  717 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence                                  0        1268889999997777777664322246789999999999999999999


Q ss_pred             ccccCCCCCCeeeCCCCcEEEeeeccccccc-------------------cCCccccCCCCcccccccccCCC---CCCC
Q 016082          229 IIHRDLKTANLLMDENGVVKVADFGVARVQA-------------------QSGVMTAETGTYRWMAPEVIEHK---PYDY  286 (395)
Q Consensus       229 iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~---~~~~  286 (395)
                      ||||||||.||++++++.|||+|||+|....                   ..+..|...||.-|+|||++.+.   .|+.
T Consensus       718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~  797 (1351)
T KOG1035|consen  718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS  797 (1351)
T ss_pred             eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence            9999999999999999999999999997511                   11244667899999999999754   4999


Q ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCC------CcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          287 KADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKH------AHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       287 k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      |+|+||||++++||+.   ||...-+.......++   .+.+|..      -.+.-+.+|++|++.||.+|||+.|++.
T Consensus       798 KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR---~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  798 KIDMYSLGIVLFEMLY---PFGTSMERASILTNLR---KGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             hhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc---cCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            9999999999999974   5654333222222222   3333332      3456789999999999999999999985

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=6.2e-36  Score=272.96  Aligned_cols=236  Identities=34%  Similarity=0.563  Sum_probs=202.4

Q ss_pred             CceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecCCCCCHHHHHh
Q 016082          122 SYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLH  199 (395)
Q Consensus       122 ~~G~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~  199 (395)
                      +||.||+|.+.  ++.+|+|++........ .+.+.+|+..+++++|+|++++++.+......++++||+++++|.+++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence            58999999984  58999999986643322 5789999999999999999999999999899999999999999999997


Q ss_pred             hccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCccccCCCCccccccccc
Q 016082          200 KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI  279 (395)
Q Consensus       200 ~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~  279 (395)
                      ... .++...+..++.+++.++.+||+.+++|+||+|.||++++++.++++|||.+.............++..|+|||.+
T Consensus        80 ~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~  158 (244)
T smart00220       80 KRG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL  158 (244)
T ss_pred             hcc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHH
Confidence            643 3899999999999999999999999999999999999999999999999999876665445566788999999999


Q ss_pred             CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCC--CcHHHHHHHHHhhccCCCCCCCHHHH
Q 016082          280 EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKH--AHPRLAELLERCWQHDPTQRPNFSQI  357 (395)
Q Consensus       280 ~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~cl~~dp~~RPs~~el  357 (395)
                      .+..++.++|+||||++++++++|..||.....................+..  ++.++.+++.+||..+|.+||++.++
T Consensus       159 ~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~  238 (244)
T smart00220      159 LGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEA  238 (244)
T ss_pred             ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHH
Confidence            9888999999999999999999999999874433434444443333332222  78899999999999999999999999


Q ss_pred             HH
Q 016082          358 TD  359 (395)
Q Consensus       358 l~  359 (395)
                      ++
T Consensus       239 ~~  240 (244)
T smart00220      239 LQ  240 (244)
T ss_pred             hh
Confidence            86

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=3.5e-37  Score=278.82  Aligned_cols=250  Identities=26%  Similarity=0.401  Sum_probs=198.5

Q ss_pred             ccCcceeeeeeeeCceEEEEEEEC------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec-CCc
Q 016082          109 AKQLKIECKVASGSYGDLYKGTYC------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-PPN  181 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  181 (395)
                      ...|++..+||+|.||.||+|...      ...+|+|.++.+...........+|+.+++.++|||++.+..++.. +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            347899999999999999999542      2479999998774444444567789999999999999999999876 778


Q ss_pred             EEEEEecCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCC----CcEEEeeec
Q 016082          182 LCIVTEFMARGSIYDFLHKQK----GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN----GVVKVADFG  253 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~----~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~----~~vkl~DFg  253 (395)
                      +++++||.+. +|...++.++    ..++...+..++.||+.|+.|||++=|+||||||+|||+..+    |.|||+|||
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG  181 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG  181 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence            9999999988 9999886543    468889999999999999999999999999999999999887    899999999


Q ss_pred             cccccccCCc----cccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHh
Q 016082          254 VARVQAQSGV----MTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQ---------AAVGV  319 (395)
Q Consensus       254 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~k~DvwslG~vl~elltg~~pf~~~~~~~---------~~~~~  319 (395)
                      ++|.....-.    ......|..|+|||.+.|. .|+.+.|||+.||++.||++.++.|.+....-         ...++
T Consensus       182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI  261 (438)
T KOG0666|consen  182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI  261 (438)
T ss_pred             HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence            9998765421    1233568999999998875 69999999999999999999998886532210         01111


Q ss_pred             hhccCCCC---------CC--------------------------CCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          320 VQKSLRPT---------IP--------------------------KHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       320 ~~~~~~~~---------~~--------------------------~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      ..-.-.|.         .|                          ..-++...+++.++|+.||.+|.|++|.++
T Consensus       262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle  336 (438)
T KOG0666|consen  262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE  336 (438)
T ss_pred             HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence            11000000         00                          112455889999999999999999999876

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-36  Score=259.49  Aligned_cols=222  Identities=31%  Similarity=0.502  Sum_probs=187.5

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCc
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPN  181 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  181 (395)
                      .++..+++.-...||+|++|.|-+-++  +|+..|+|.++... +....++...|+.+..+. .+|.+|.+||...+...
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd  119 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD  119 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence            678888999999999999999866554  88999999998664 455556677777776655 58999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCeeeCCCCcEEEeeeccccc
Q 016082          182 LCIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARV  257 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~-~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~  257 (395)
                      .++.||.|.- ||..+-++   ..+.+++..+-+++..+++||.|||++ ++||||+||.|||++.+|+||+||||.+..
T Consensus       120 vwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~  198 (282)
T KOG0984|consen  120 VWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGY  198 (282)
T ss_pred             EEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccccccee
Confidence            9999999965 77766533   367899999999999999999999976 999999999999999999999999999988


Q ss_pred             cccCCccccCCCCcccccccccC----CCCCCChhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHhhhccCCCCCC
Q 016082          258 QAQSGVMTAETGTYRWMAPEVIE----HKPYDYKADVFSFGIALWELLTGELPYAG-LTPLQAAVGVVQKSLRPTIP  329 (395)
Q Consensus       258 ~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~k~DvwslG~vl~elltg~~pf~~-~~~~~~~~~~~~~~~~~~~~  329 (395)
                      ...+-..+-..|...|||||.++    ...|+.|+||||||+++.||.+++.||+. .++.+...+++.. ..|.+|
T Consensus       199 L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee-p~P~Lp  274 (282)
T KOG0984|consen  199 LVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE-PSPQLP  274 (282)
T ss_pred             ehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC-CCCCCc
Confidence            77776667788999999999986    34799999999999999999999999986 4677776666643 334443

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-37  Score=282.99  Aligned_cols=245  Identities=26%  Similarity=0.409  Sum_probs=199.6

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC--C----ceeeEEEEEecCC
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH--K----NVVQFIGACTRPP  180 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~----niv~l~~~~~~~~  180 (395)
                      ..+|.+...+|+|.||.|-.+.+  .+..||||+++.-   ....+..+-|+++++++.+  |    -++++.++|.-.+
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg  164 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG  164 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence            67899999999999999999877  4678999999854   3445667889999999942  2    3788888999999


Q ss_pred             cEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCC----------------
Q 016082          181 NLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE----------------  243 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~----------------  243 (395)
                      +.|||+|.+ |.|+++++..++ .+|+...+..++.|+++++++||+.+++|.||||+|||+.+                
T Consensus       165 hiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~  243 (415)
T KOG0671|consen  165 HICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFI  243 (415)
T ss_pred             ceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcccee
Confidence            999999988 669999998753 67999999999999999999999999999999999999942                


Q ss_pred             ----CCcEEEeeeccccccccCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---
Q 016082          244 ----NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAA---  316 (395)
Q Consensus       244 ----~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~---  316 (395)
                          +..|+++|||.|+...+..  +.-..|..|.|||++.+-+++.++||||+||+|+|+.+|...|......+-.   
T Consensus       244 r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMM  321 (415)
T KOG0671|consen  244 RPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMM  321 (415)
T ss_pred             ccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHH
Confidence                2358999999998766543  5567899999999999999999999999999999999999999876543321   


Q ss_pred             HHhhh--------cc-------------------------CCCCCC--------CCCcHHHHHHHHHhhccCCCCCCCHH
Q 016082          317 VGVVQ--------KS-------------------------LRPTIP--------KHAHPRLAELLERCWQHDPTQRPNFS  355 (395)
Q Consensus       317 ~~~~~--------~~-------------------------~~~~~~--------~~~~~~l~~li~~cl~~dp~~RPs~~  355 (395)
                      ..++.        +.                         .++..|        .....+|.+||++||..||.+|+|+.
T Consensus       322 erIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~  401 (415)
T KOG0671|consen  322 ERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLR  401 (415)
T ss_pred             HHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHH
Confidence            11111        00                         000001        11234699999999999999999999


Q ss_pred             HHHH
Q 016082          356 QITD  359 (395)
Q Consensus       356 ell~  359 (395)
                      |++.
T Consensus       402 EAL~  405 (415)
T KOG0671|consen  402 EALS  405 (415)
T ss_pred             HHhc
Confidence            9875

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-36  Score=277.75  Aligned_cols=264  Identities=25%  Similarity=0.496  Sum_probs=225.5

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR  178 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  178 (395)
                      .+...+++....+-+|.||.||+|.|..       +.|-+|.++... ++-+...+.+|.-.+..+.|||+.++.+++..
T Consensus       280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-S~iQv~~~L~es~lly~~sH~nll~V~~V~ie  358 (563)
T KOG1024|consen  280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-SQIQVNLLLQESMLLYGASHPNLLSVLGVSIE  358 (563)
T ss_pred             hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-cHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence            3445567778889999999999996532       457788887543 34456789999999999999999999998754


Q ss_pred             -CCcEEEEEecCCCCCHHHHHhhcc-------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEe
Q 016082          179 -PPNLCIVTEFMARGSIYDFLHKQK-------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA  250 (395)
Q Consensus       179 -~~~~~lV~E~~~ggsL~~~l~~~~-------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~  250 (395)
                       ....+.++.++.-|+|..+|...+       ..++..++..++.|++.||+|||+.||||.||.++|.++++.-+|||+
T Consensus       359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt  438 (563)
T KOG1024|consen  359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT  438 (563)
T ss_pred             ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence             456788899999999999998432       346667788899999999999999999999999999999999999999


Q ss_pred             eeccccccccC---CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCC
Q 016082          251 DFGVARVQAQS---GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRP  326 (395)
Q Consensus       251 DFg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  326 (395)
                      |=.++|-.-..   .....+..+..||+||.+.+..|+.++||||||+++|||+| |+.||...+|.+.... +..++|.
T Consensus       439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y-lkdGyRl  517 (563)
T KOG1024|consen  439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY-LKDGYRL  517 (563)
T ss_pred             cchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH-Hhcccee
Confidence            99999854332   22344566789999999999999999999999999999999 9999999999987665 6678999


Q ss_pred             CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHh
Q 016082          327 TIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYW  371 (395)
Q Consensus       327 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~~~  371 (395)
                      ..|.+||.++..+|..||...|++||+|+|+..-|.+.-.++..+
T Consensus       518 aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt~Y  562 (563)
T KOG1024|consen  518 AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLTRY  562 (563)
T ss_pred             cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHhhc
Confidence            999999999999999999999999999999999999988877654

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.2e-38  Score=275.97  Aligned_cols=253  Identities=27%  Similarity=0.427  Sum_probs=208.0

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC----
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP----  179 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----  179 (395)
                      .+..+.|.-..+||+|.||.||+|+.  +++.||+|+.-.+...+.......+|+.+|+.++|+|++.++..|...    
T Consensus        13 ~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~   92 (376)
T KOG0669|consen   13 CDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPT   92 (376)
T ss_pred             eecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence            34456788889999999999999976  567899987654433344456678899999999999999999987432    


Q ss_pred             ----CcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccc
Q 016082          180 ----PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA  255 (395)
Q Consensus       180 ----~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a  255 (395)
                          ..+|+||++|+. +|.-+|....-+++..++.+++.+++.||.|+|++.|+|||+||+|+|++.+|.+||+|||++
T Consensus        93 ~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGla  171 (376)
T KOG0669|consen   93 NRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLA  171 (376)
T ss_pred             ccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence                248999999987 999999887789999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCC-----ccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc------
Q 016082          256 RVQAQSG-----VMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS------  323 (395)
Q Consensus       256 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~------  323 (395)
                      |....+.     ..+....|..|.+||.+.|. .|+.+.|+|.-||++.||+++.+.+.+.++.+....+..-.      
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke  251 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE  251 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence            8665432     34555679999999998764 69999999999999999999999999998877665433210      


Q ss_pred             --------------CCCCCCC-------------CCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          324 --------------LRPTIPK-------------HAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       324 --------------~~~~~~~-------------~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                    ..+++|.             .-+++..+++++++..||.+|+++.+++.
T Consensus       252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence                          0011221             11457889999999999999999999873

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-36  Score=293.60  Aligned_cols=245  Identities=22%  Similarity=0.378  Sum_probs=205.3

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecC-CCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKP-ECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  182 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~-~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  182 (395)
                      .++.+.|..++.||-|+||.|.+++.  +...+|+|.+++ +.+..+.....+.|..||..-+.+.||++|..|.+.+++
T Consensus       625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL  704 (1034)
T KOG0608|consen  625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL  704 (1034)
T ss_pred             hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence            35567888999999999999999975  556799999964 445677788899999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccc----
Q 016082          183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ----  258 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~----  258 (395)
                      |+||||++||++.++|-+ -+-|++..++.++.++..|+++.|..|+|||||||+|||||.+|++||.|||++.-+    
T Consensus       705 YFVMdYIPGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH  783 (1034)
T KOG0608|consen  705 YFVMDYIPGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  783 (1034)
T ss_pred             EEEEeccCCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecc
Confidence            999999999999999976 688999999999999999999999999999999999999999999999999998521    


Q ss_pred             -----ccCC-----cc-----------------------------ccCCCCcccccccccCCCCCCChhhHHHHHHHHHH
Q 016082          259 -----AQSG-----VM-----------------------------TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWE  299 (395)
Q Consensus       259 -----~~~~-----~~-----------------------------~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~e  299 (395)
                           ....     .+                             ....||+.|+|||++....|+..+|.||.|++|||
T Consensus       784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e  863 (1034)
T KOG0608|consen  784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE  863 (1034)
T ss_pred             ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence                 1000     00                             01259999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHhhh--ccCCCCCCCCCcHHHHHHHHHhhccCCCCCC
Q 016082          300 LLTGELPYAGLTPLQAAVGVVQ--KSLRPTIPKHAHPRLAELLERCWQHDPTQRP  352 (395)
Q Consensus       300 lltg~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP  352 (395)
                      |+.|++||-..++.+....+..  ..+.-..-..++++..++|.++. .+++.|.
T Consensus       864 m~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RL  917 (1034)
T KOG0608|consen  864 MLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRL  917 (1034)
T ss_pred             HhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhh
Confidence            9999999998888776655443  22333333578999999998743 3445554

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=270.55  Aligned_cols=248  Identities=21%  Similarity=0.377  Sum_probs=212.1

Q ss_pred             CceeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHH-HHHHHHHHHHHHHhc-CCCceeeEEEEEec
Q 016082          103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTE-MLKEFSQEVYIMRKI-RHKNVVQFIGACTR  178 (395)
Q Consensus       103 ~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  178 (395)
                      ..|.+..++|.+++.||+|+|..|.+++.  +.+.+|+|+++++..+++ .+.=.+.|..+..+. +||.+|-++.+|.+
T Consensus       243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt  322 (593)
T KOG0695|consen  243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT  322 (593)
T ss_pred             cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence            45788889999999999999999999986  568899999998877554 445566777777766 59999999999999


Q ss_pred             CCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccc
Q 016082          179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  258 (395)
Q Consensus       179 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~  258 (395)
                      ...+++|.||.+||+|.-++++ ..+++++-+..+..+|+.||.|||+.|||.||||.+|+|++..|++||.|+|+++..
T Consensus       323 esrlffvieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  323 ESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             cceEEEEEEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcC
Confidence            9999999999999999888866 567999999999999999999999999999999999999999999999999999864


Q ss_pred             ccC-CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHhhhccCCCCCC
Q 016082          259 AQS-GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAG--------LTPLQAAVGVVQKSLRPTIP  329 (395)
Q Consensus       259 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~--------~~~~~~~~~~~~~~~~~~~~  329 (395)
                      -.. ...++.+||+.|.|||++.+..|....|.|+||++++||+.|+.||.-        .++...+.-++.++.  .+|
T Consensus       402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi--rip  479 (593)
T KOG0695|consen  402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI--RIP  479 (593)
T ss_pred             CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc--ccc
Confidence            433 345567999999999999999999999999999999999999999952        222233333444444  467


Q ss_pred             CCCcHHHHHHHHHhhccCCCCCCC
Q 016082          330 KHAHPRLAELLERCWQHDPTQRPN  353 (395)
Q Consensus       330 ~~~~~~l~~li~~cl~~dp~~RPs  353 (395)
                      ...|-....++..-|++||.+|..
T Consensus       480 rslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  480 RSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             ceeehhhHHHHHHhhcCCcHHhcC
Confidence            778888899999999999999954

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.1e-34  Score=286.42  Aligned_cols=255  Identities=20%  Similarity=0.279  Sum_probs=185.8

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEE------------------CCceEEEEEecCCCCCH------------HHHHHH
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTY------------------CSQEVAIKVLKPECVNT------------EMLKEF  154 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~------------------~~~~vAvK~~~~~~~~~------------~~~~~~  154 (395)
                      .....++|++.++||+|+||.||+|.+                  .++.||||.++......            ...+..
T Consensus       140 ~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~  219 (507)
T PLN03224        140 SRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETG  219 (507)
T ss_pred             CCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchh
Confidence            345678999999999999999999964                  23579999987542110            011234


Q ss_pred             HHHHHHHHhcCCCce-----eeEEEEEec--------CCcEEEEEecCCCCCHHHHHhhccC------------------
Q 016082          155 SQEVYIMRKIRHKNV-----VQFIGACTR--------PPNLCIVTEFMARGSIYDFLHKQKG------------------  203 (395)
Q Consensus       155 ~~E~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lV~E~~~ggsL~~~l~~~~~------------------  203 (395)
                      ..|+.++.+++|.++     ++++++|..        .+..++|+||+++++|.++++...+                  
T Consensus       220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~  299 (507)
T PLN03224        220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD  299 (507)
T ss_pred             HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence            457778888876654     667777643        3468999999999999999875322                  


Q ss_pred             -----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCccc--cCCCCcccccc
Q 016082          204 -----VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT--AETGTYRWMAP  276 (395)
Q Consensus       204 -----~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~--~~~gt~~y~aP  276 (395)
                           .+++..+..++.|++.+|.|||+.+|+||||||+||+++.++.++|+|||+++.........  ...+|+.|+||
T Consensus       300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             hcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence                 23456788899999999999999999999999999999999999999999997544332222  23457899999


Q ss_pred             cccCCCC--------------------C--CChhhHHHHHHHHHHHHhCCC-CCCCCCHHHHHHH-----------hhhc
Q 016082          277 EVIEHKP--------------------Y--DYKADVFSFGIALWELLTGEL-PYAGLTPLQAAVG-----------VVQK  322 (395)
Q Consensus       277 E~~~~~~--------------------~--~~k~DvwslG~vl~elltg~~-pf~~~~~~~~~~~-----------~~~~  322 (395)
                      |.+....                    |  ..+.|+||+||++++|++|.. ||...........           ....
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~  459 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ  459 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence            9875432                    1  134799999999999999875 7764322111110           0111


Q ss_pred             cCCCCCCCCCcHHHHHHHHHhhccCC---CCCCCHHHHHH
Q 016082          323 SLRPTIPKHAHPRLAELLERCWQHDP---TQRPNFSQITD  359 (395)
Q Consensus       323 ~~~~~~~~~~~~~l~~li~~cl~~dp---~~RPs~~ell~  359 (395)
                      ..........++...+++.+||..+|   .+|+|+.|+++
T Consensus       460 ~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        460 KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            11222234568899999999999866   68999999987

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=6e-35  Score=293.12  Aligned_cols=241  Identities=25%  Similarity=0.430  Sum_probs=192.7

Q ss_pred             CcceeeeeeeeCceE-EEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCcEEEEEec
Q 016082          111 QLKIECKVASGSYGD-LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEF  188 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~-Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~  188 (395)
                      -+.-.+.+|.|+.|+ ||+|.+.++.||||.+-.+     ......+|+..|+.-+ |||||++++.-.+....||..|.
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL  584 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL  584 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEeeCCceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence            345556789999885 8999999999999998643     4466789999999886 99999999999999999999999


Q ss_pred             CCCCCHHHHHhhccCCC---CHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCC---CC--cEEEeeecccccccc
Q 016082          189 MARGSIYDFLHKQKGVF---QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NG--VVKVADFGVARVQAQ  260 (395)
Q Consensus       189 ~~ggsL~~~l~~~~~~l---~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~---~~--~vkl~DFg~a~~~~~  260 (395)
                      |.. +|.+++......+   .....+.+..|+++|+++||+.+||||||||.||||+.   ++  .++|+|||+++..+.
T Consensus       585 C~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~  663 (903)
T KOG1027|consen  585 CAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG  663 (903)
T ss_pred             hhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence            977 9999997731111   11345778899999999999999999999999999986   33  689999999987654


Q ss_pred             CC----ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCC-CCCCCCcH
Q 016082          261 SG----VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRP-TIPKHAHP  334 (395)
Q Consensus       261 ~~----~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~  334 (395)
                      ..    ......||.+|+|||++....-+.++|+||+||++|+.++ |..||...-..+.  +++.....- .+.+.-+.
T Consensus       664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~~L~~~~d~  741 (903)
T KOG1027|consen  664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLVHLEPLPDC  741 (903)
T ss_pred             CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCccceeeeccCchH
Confidence            32    2345689999999999998888889999999999999999 5999987655443  233222111 11111112


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          335 RLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       335 ~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      +..++|.+|++++|..||++.+++.
T Consensus       742 eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  742 EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            8999999999999999999999983

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-35  Score=274.88  Aligned_cols=250  Identities=19%  Similarity=0.381  Sum_probs=203.2

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-----CHHHHHHHHHHHHHHHhcCCCceeeEEEEEe-cCC
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-----NTEMLKEFSQEVYIMRKIRHKNVVQFIGACT-RPP  180 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~  180 (395)
                      .++|-++..||+|+|+.||+|.+  ..+.||||+-.....     .++..+...+|-.|.+.|+||.||++|++|. +..
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            35688889999999999999987  467899999753321     2345677889999999999999999999996 445


Q ss_pred             cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCCCCeeeCC---CCcEEEeeeccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN--NIIHRDLKTANLLMDE---NGVVKVADFGVA  255 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--~iiHrDlkp~NiLl~~---~~~vkl~DFg~a  255 (395)
                      .+|-|+||++|.+|.-||+. +..+++.++..|+.||+.||.||...  -|||-||||.|||+-+   .|.+||.|||++
T Consensus       542 sFCTVLEYceGNDLDFYLKQ-hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS  620 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQ-HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS  620 (775)
T ss_pred             cceeeeeecCCCchhHHHHh-hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence            68999999999999999976 56789999999999999999999986  5999999999999954   578999999999


Q ss_pred             cccccCC--------ccccCCCCcccccccccCC----CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---hh
Q 016082          256 RVQAQSG--------VMTAETGTYRWMAPEVIEH----KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG---VV  320 (395)
Q Consensus       256 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~----~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~---~~  320 (395)
                      +.++...        ......||++|++||.+.-    ...+.|.||||+|+++|.++.|+-||......+....   ++
T Consensus       621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl  700 (775)
T KOG1151|consen  621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL  700 (775)
T ss_pred             hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence            9876543        2244579999999998753    3478999999999999999999999987655443322   11


Q ss_pred             hcc-CCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          321 QKS-LRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       321 ~~~-~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      ... ..-+..+.++++..+||++||++..++|....++..
T Consensus       701 kAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  701 KATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             cceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            111 111222457899999999999999999999888764

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1e-33  Score=290.32  Aligned_cols=246  Identities=16%  Similarity=0.233  Sum_probs=169.1

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEEC------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEE----
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTYC------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA----  175 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~----  175 (395)
                      ....++|.+.++||+|+||.||+|++.      +..||+|.++.....    +....|  .++...+.++..++..    
T Consensus       128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~----e~~~~e--~l~~~~~~~~~~~~~~~~~~  201 (566)
T PLN03225        128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV----EIWMNE--RVRRACPNSCADFVYGFLEP  201 (566)
T ss_pred             CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh----HHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence            445678999999999999999999883      578999998643211    111111  1111122222222211    


Q ss_pred             --EecCCcEEEEEecCCCCCHHHHHhhccCCC-------------------CHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 016082          176 --CTRPPNLCIVTEFMARGSIYDFLHKQKGVF-------------------QLTSLLKVAIDVSKGMNYLHQNNIIHRDL  234 (395)
Q Consensus       176 --~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l-------------------~~~~~~~i~~~i~~~l~~LH~~~iiHrDl  234 (395)
                        .......++|+||+++++|.+++.......                   ....+..++.||+.||.|||++||+||||
T Consensus       202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL  281 (566)
T PLN03225        202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV  281 (566)
T ss_pred             cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence              245567999999999999999987543211                   12346689999999999999999999999


Q ss_pred             CCCCeeeCC-CCcEEEeeeccccccccC--CccccCCCCcccccccccCCC----------------------CCCChhh
Q 016082          235 KTANLLMDE-NGVVKVADFGVARVQAQS--GVMTAETGTYRWMAPEVIEHK----------------------PYDYKAD  289 (395)
Q Consensus       235 kp~NiLl~~-~~~vkl~DFg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~----------------------~~~~k~D  289 (395)
                      ||+|||++. ++.+||+|||+|+.....  .......+++.|+|||.+...                      .++.++|
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            999999986 579999999999754322  223445789999999976322                      2445679


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc----------cCCCCCC----------CCCcHHHHHHHHHhhccCCC
Q 016082          290 VFSFGIALWELLTGELPYAGLTPLQAAVGVVQK----------SLRPTIP----------KHAHPRLAELLERCWQHDPT  349 (395)
Q Consensus       290 vwslG~vl~elltg~~pf~~~~~~~~~~~~~~~----------~~~~~~~----------~~~~~~l~~li~~cl~~dp~  349 (395)
                      ||||||++|||+++..|+...  ..........          ...+..+          ...+....+||.+||+.||.
T Consensus       362 VwSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~  439 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR  439 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence            999999999999977665432  1111111110          0001100          11123456899999999999


Q ss_pred             CCCCHHHHHH
Q 016082          350 QRPNFSQITD  359 (395)
Q Consensus       350 ~RPs~~ell~  359 (395)
                      +|||+.++++
T Consensus       440 kR~ta~e~L~  449 (566)
T PLN03225        440 QRISAKAALA  449 (566)
T ss_pred             cCCCHHHHhC
Confidence            9999999987

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=8.2e-34  Score=247.21  Aligned_cols=243  Identities=20%  Similarity=0.398  Sum_probs=197.7

Q ss_pred             cccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCC--cE
Q 016082          108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPP--NL  182 (395)
Q Consensus       108 ~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~  182 (395)
                      ..++|++.+++|+|.|+.||.|..  +.+.++||++++-.     .+.+.+|+.||+.++ ||||++++++..++.  ..
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp  110 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP  110 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence            456899999999999999999984  67899999998652     367889999999998 999999999997764  47


Q ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCC-CCcEEEeeeccccccccC
Q 016082          183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVADFGVARVQAQS  261 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~-~~~vkl~DFg~a~~~~~~  261 (395)
                      .+|+||+.+.+...+.    ..++...+..++.++++||+|+|++||+|||+||.|++++. ...++|+|+|+|......
T Consensus       111 aLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  111 SLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             hhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            8999999987766554    35788899999999999999999999999999999999986 457999999999887766


Q ss_pred             CccccCCCCcccccccccC-CCCCCChhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHhhh---------------ccC
Q 016082          262 GVMTAETGTYRWMAPEVIE-HKPYDYKADVFSFGIALWELLTGELPYA-GLTPLQAAVGVVQ---------------KSL  324 (395)
Q Consensus       262 ~~~~~~~gt~~y~aPE~~~-~~~~~~k~DvwslG~vl~elltg~~pf~-~~~~~~~~~~~~~---------------~~~  324 (395)
                      ....-...+..|-.||.+- -+.|+..-|+|||||++..|+..+.||- |.++.+....+..               -.+
T Consensus       187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L  266 (338)
T KOG0668|consen  187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL  266 (338)
T ss_pred             ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence            6555566778889999875 4568999999999999999999888874 4433333322211               001


Q ss_pred             C--------------------CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          325 R--------------------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       325 ~--------------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      .                    +.-..-.+++..+++.+.|..|-++|||+.|.+.
T Consensus       267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            1                    1111235789999999999999999999999875

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-33  Score=265.47  Aligned_cols=255  Identities=24%  Similarity=0.410  Sum_probs=197.7

Q ss_pred             cccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-----C---CceeeEEEEEe
Q 016082          108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-----H---KNVVQFIGACT  177 (395)
Q Consensus       108 ~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~  177 (395)
                      ...+|.+.++||.|-|++||++.+  ..+.||+|+.+..   ....+....||.+|++++     |   ..||++++.|.
T Consensus        76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk  152 (590)
T KOG1290|consen   76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK  152 (590)
T ss_pred             cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence            347899999999999999999988  4578999999865   344567788999999995     2   46999999996


Q ss_pred             c----CCcEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCeeeCCCC------
Q 016082          178 R----PPNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENG------  245 (395)
Q Consensus       178 ~----~~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~-~iiHrDlkp~NiLl~~~~------  245 (395)
                      .    +.++|||+|++ |.+|..++... ...++...+.+|+.||+.||+|||.+ ||||.||||+|||+..+.      
T Consensus       153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~  231 (590)
T KOG1290|consen  153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKD  231 (590)
T ss_pred             ecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhh
Confidence            4    34799999999 56999988765 46799999999999999999999975 999999999999992110      


Q ss_pred             --------------------------------------------------------------------------------
Q 016082          246 --------------------------------------------------------------------------------  245 (395)
Q Consensus       246 --------------------------------------------------------------------------------  245 (395)
                                                                                                      
T Consensus       232 ~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~  311 (590)
T KOG1290|consen  232 AREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRING  311 (590)
T ss_pred             hhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCc
Confidence                                                                                            


Q ss_pred             --------------------------------------------------------------------------------
Q 016082          246 --------------------------------------------------------------------------------  245 (395)
Q Consensus       246 --------------------------------------------------------------------------------  245 (395)
                                                                                                      
T Consensus       312 ~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di  391 (590)
T KOG1290|consen  312 NESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDI  391 (590)
T ss_pred             cccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccce
Confidence                                                                                            


Q ss_pred             cEEEeeeccccccccCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH-----HH--HHH-
Q 016082          246 VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP-----LQ--AAV-  317 (395)
Q Consensus       246 ~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~-----~~--~~~-  317 (395)
                      .+||+|||.|+....  ..+....|..|+|||++.+.+|+..+|+||++|++|||+||...|+..+.     .+  .+. 
T Consensus       392 ~vKIaDlGNACW~~k--hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i  469 (590)
T KOG1290|consen  392 RVKIADLGNACWVHK--HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALI  469 (590)
T ss_pred             eEEEeeccchhhhhh--hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHH
Confidence            256777777765432  24556789999999999999999999999999999999999988853211     11  111 


Q ss_pred             -Hhhh-------------------cc-C---C--------------CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          318 -GVVQ-------------------KS-L---R--------------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       318 -~~~~-------------------~~-~---~--------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                       ..+-                   .+ +   +              ...+..-..++.+|+.-||+.+|++|||+.+.++
T Consensus       470 ~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~  549 (590)
T KOG1290|consen  470 MELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK  549 (590)
T ss_pred             HHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc
Confidence             1000                   00 0   0              0011222457899999999999999999999987


Q ss_pred             HHHHHHHHHHHhhccccc
Q 016082          360 ILKQMMKEVLYWLSPNLI  377 (395)
Q Consensus       360 ~l~~~~~~~~~~~~~~~~  377 (395)
                               +=||++...
T Consensus       550 ---------hPwLn~~~~  558 (590)
T KOG1290|consen  550 ---------HPWLNPVAG  558 (590)
T ss_pred             ---------CccccCCCC
Confidence                     778875543

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-34  Score=258.85  Aligned_cols=246  Identities=24%  Similarity=0.348  Sum_probs=206.3

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC------
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP------  180 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  180 (395)
                      ..+|.-++.+|.|+- .|.-+-+  .+++||+|.+..+..+....++..+|..++..+.|+||+.++.+|+...      
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            447778888898888 5666655  6899999998877767667788999999999999999999999997654      


Q ss_pred             cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                      ..|+|||+|.. +|...+..   .++-.++.++..|++.|+.|||+.||+||||||+||++..++.+||.|||+|+..+.
T Consensus        95 e~y~v~e~m~~-nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~  170 (369)
T KOG0665|consen   95 EVYLVMELMDA-NLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT  170 (369)
T ss_pred             hHHHHHHhhhh-HHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCc
Confidence            47999999976 99888863   457788999999999999999999999999999999999999999999999998877


Q ss_pred             CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCC-------------
Q 016082          261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT-------------  327 (395)
Q Consensus       261 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~-------------  327 (395)
                      .-.++....|..|.|||++.+-.|.+.+||||+||++.||++|+..|.+.+.......+.+....|.             
T Consensus       171 ~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~  250 (369)
T KOG0665|consen  171 DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRN  250 (369)
T ss_pred             ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHH
Confidence            7778889999999999999988899999999999999999999999988766544443332110000             


Q ss_pred             ----------------C-----------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          328 ----------------I-----------PKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       328 ----------------~-----------~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                      +           ++.-+..+++++.+||..||++|.|+.+++.
T Consensus       251 yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  251 YVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence                            0           0122346889999999999999999999874

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-35  Score=260.62  Aligned_cols=247  Identities=24%  Similarity=0.421  Sum_probs=201.2

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC-----cEE
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP-----NLC  183 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  183 (395)
                      +.+..+.||.|+||.||-.++  .++.||+|.+..-..+--..+.+.+|+++|...+|.|++..+++...+.     .+|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            445567899999999999988  6889999988644334445578999999999999999999988775543     378


Q ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC--
Q 016082          184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS--  261 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~--  261 (395)
                      .++|.|.. +|..++-. ...++.+-+.-+..||++||+|||+.||.||||||.|+|+++|..+||||||++|.....  
T Consensus       134 V~TELmQS-DLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~  211 (449)
T KOG0664|consen  134 VLTELMQS-DLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR  211 (449)
T ss_pred             HHHHHHHh-hhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence            89999965 88887755 677899999999999999999999999999999999999999999999999999976543  


Q ss_pred             CccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhh-------------------
Q 016082          262 GVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ-------------------  321 (395)
Q Consensus       262 ~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~-------------------  321 (395)
                      ..|+.+..|..|.|||++.|. .|+.+.||||.||++.||+..+..|...++.+...-+..                   
T Consensus       212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~  291 (449)
T KOG0664|consen  212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN  291 (449)
T ss_pred             hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence            467888899999999999875 699999999999999999999999988777665443322                   


Q ss_pred             ----ccCCC-CCC--------CCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          322 ----KSLRP-TIP--------KHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       322 ----~~~~~-~~~--------~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                          ...++ ..+        .+-..+...++.+++..||+.|.+..+.+.
T Consensus       292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~  342 (449)
T KOG0664|consen  292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQ  342 (449)
T ss_pred             HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcc
Confidence                11111 111        122346778888999999999999887765

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=7.7e-32  Score=239.65  Aligned_cols=209  Identities=36%  Similarity=0.688  Sum_probs=186.5

Q ss_pred             eeeeCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecCCCCCHH
Q 016082          118 VASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY  195 (395)
Q Consensus       118 lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ggsL~  195 (395)
                      ||+|++|.||+++..  ++.+++|++....... ....+.+|+..++.++|++++++++++......++++|++.|++|.
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~   79 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK   79 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence            689999999999986  8999999998764332 3567999999999999999999999999999999999999999999


Q ss_pred             HHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCC-CCcEEEeeeccccccccCC-ccccCCCCccc
Q 016082          196 DFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVADFGVARVQAQSG-VMTAETGTYRW  273 (395)
Q Consensus       196 ~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~-~~~vkl~DFg~a~~~~~~~-~~~~~~gt~~y  273 (395)
                      +++......++...+..++.++++++.+||+.|++|+||+|.||+++. ++.++|+|||.+....... ......+...|
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  159 (215)
T cd00180          80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAY  159 (215)
T ss_pred             HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCc
Confidence            999775457899999999999999999999999999999999999999 8999999999997655432 13345678899


Q ss_pred             ccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCC
Q 016082          274 MAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRP  352 (395)
Q Consensus       274 ~aPE~~~~~-~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP  352 (395)
                      ++||.+... .++.++|+|++|++++++                                 ..+.+++.+|++.+|.+||
T Consensus       160 ~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~p~~R~  206 (215)
T cd00180         160 MAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKDPEKRP  206 (215)
T ss_pred             cChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCCcccCc
Confidence            999999887 788999999999999999                                 5799999999999999999


Q ss_pred             CHHHHHHH
Q 016082          353 NFSQITDI  360 (395)
Q Consensus       353 s~~ell~~  360 (395)
                      ++.++++.
T Consensus       207 ~~~~l~~~  214 (215)
T cd00180         207 SAKEILEH  214 (215)
T ss_pred             CHHHHhhC
Confidence            99998864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-34  Score=283.44  Aligned_cols=248  Identities=29%  Similarity=0.497  Sum_probs=217.0

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      .++|.+..++|+|+||.||++++  +++..|+|+++.+.  .+.....++|+-+++..+|||||.++|.+.....++++|
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep--~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM   91 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP--GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM   91 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccC--CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence            45899999999999999999987  67899999998764  344577889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-ccc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT  265 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~  265 (395)
                      ||+.||+|.+.-+- .+++++.++...+++.++|++|||+.|-+|||||-.||++++.|.+|++|||.+-...... ..-
T Consensus        92 EycgggslQdiy~~-TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krk  170 (829)
T KOG0576|consen   92 EYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRK  170 (829)
T ss_pred             EecCCCcccceeee-cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhh
Confidence            99999999997654 6889999999999999999999999999999999999999999999999999986544322 234


Q ss_pred             cCCCCcccccccccC---CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCC---CCCCcHHHHHH
Q 016082          266 AETGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI---PKHAHPRLAEL  339 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~---~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~l  339 (395)
                      ...||+.|||||+-.   ...|...+|+|++|++..|+-.-++|....-+.+...-.-..++.|+-   +..+++.+-+|
T Consensus       171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~f  250 (829)
T KOG0576|consen  171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNF  250 (829)
T ss_pred             cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHH
Confidence            568999999999863   557999999999999999999999998888887777665555555433   34689999999


Q ss_pred             HHHhhccCCCCCCCHHHHHH
Q 016082          340 LERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       340 i~~cl~~dp~~RPs~~ell~  359 (395)
                      ++.|+.++|.+||+++.++.
T Consensus       251 vK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  251 VKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             HHHHhcCCCccCCChhhhee
Confidence            99999999999999998875

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.3e-33  Score=270.26  Aligned_cols=248  Identities=24%  Similarity=0.417  Sum_probs=205.5

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC------CCceeeEEEEEec
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR------HKNVVQFIGACTR  178 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~  178 (395)
                      +-.++|.+....|.|-|++|.+|.+  .++.|||||++..   +-..+.=+.|+.||++|+      --+.++++..|..
T Consensus       429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN---E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h  505 (752)
T KOG0670|consen  429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN---EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH  505 (752)
T ss_pred             hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc---hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence            3456788999999999999999988  4689999999854   445567788999999996      2478999999999


Q ss_pred             CCcEEEEEecCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCC-CcEEEeeeccc
Q 016082          179 PPNLCIVTEFMARGSIYDFLHKQK--GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVA  255 (395)
Q Consensus       179 ~~~~~lV~E~~~ggsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~-~~vkl~DFg~a  255 (395)
                      .+++|||||-+.- +|.+.|.+..  -.+....+..++.|++.||..|-+.||+|.||||+||||++. ..+||||||.|
T Consensus       506 knHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA  584 (752)
T KOG0670|consen  506 KNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSA  584 (752)
T ss_pred             cceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccc
Confidence            9999999998865 9999998753  357788999999999999999999999999999999999875 46899999999


Q ss_pred             cccccCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc-------------
Q 016082          256 RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK-------------  322 (395)
Q Consensus       256 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~-------------  322 (395)
                      ...+... .+.+..+..|.|||++.|-+|+...|+||.||+||||.||+..|++.++.+...-...-             
T Consensus       585 ~~~~ene-itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgq  663 (752)
T KOG0670|consen  585 SFASENE-ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQ  663 (752)
T ss_pred             ccccccc-ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcc
Confidence            8665543 46677788999999999999999999999999999999999999998877655432210             


Q ss_pred             ------------------------------cCCC------------CCC---CCCcHHHHHHHHHhhccCCCCCCCHHHH
Q 016082          323 ------------------------------SLRP------------TIP---KHAHPRLAELLERCWQHDPTQRPNFSQI  357 (395)
Q Consensus       323 ------------------------------~~~~------------~~~---~~~~~~l~~li~~cl~~dp~~RPs~~el  357 (395)
                                                    ...|            ..|   ...-..|.+|+.+||..||++|.|.+|.
T Consensus       664 F~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqA  743 (752)
T KOG0670|consen  664 FKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQA  743 (752)
T ss_pred             hhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHH
Confidence                                          0000            000   0112368999999999999999999998


Q ss_pred             HH
Q 016082          358 TD  359 (395)
Q Consensus       358 l~  359 (395)
                      |+
T Consensus       744 L~  745 (752)
T KOG0670|consen  744 LK  745 (752)
T ss_pred             hc
Confidence            75

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.98  E-value=1.1e-30  Score=236.14  Aligned_cols=211  Identities=32%  Similarity=0.554  Sum_probs=180.9

Q ss_pred             cceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecC
Q 016082          112 LKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM  189 (395)
Q Consensus       112 ~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  189 (395)
                      |.+.+.||+|++|.||++...  ++.+|+|.+...... .....+.+|+..+++++|+|++++++++......++++|++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   79 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC   79 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence            567889999999999999884  588999999866433 25678999999999999999999999999989999999999


Q ss_pred             CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC--ccccC
Q 016082          190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--VMTAE  267 (395)
Q Consensus       190 ~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~--~~~~~  267 (395)
                      ++++|.+++......+++..+..++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||.+.......  .....
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~  159 (225)
T smart00221       80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTV  159 (225)
T ss_pred             CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccce
Confidence            9999999997754338899999999999999999999999999999999999999999999999998765442  33445


Q ss_pred             CCCccccccccc-CCCCCCChhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHhhhcc
Q 016082          268 TGTYRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGELPYAG-LTPLQAAVGVVQKS  323 (395)
Q Consensus       268 ~gt~~y~aPE~~-~~~~~~~k~DvwslG~vl~elltg~~pf~~-~~~~~~~~~~~~~~  323 (395)
                      .++..|++||.+ ...+++.++|+|+||+++++|++|+.||.. ........+....+
T Consensus       160 ~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~  217 (225)
T smart00221      160 KGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFG  217 (225)
T ss_pred             eccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcC
Confidence            678899999998 677888899999999999999999999977 45544444444433

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=9.8e-32  Score=260.26  Aligned_cols=199  Identities=27%  Similarity=0.434  Sum_probs=173.3

Q ss_pred             ccCcceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCCCHH------HHHHHHHHHHHHHhcC---CCceeeEEEEEe
Q 016082          109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTE------MLKEFSQEVYIMRKIR---HKNVVQFIGACT  177 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~~~~------~~~~~~~E~~~l~~l~---h~niv~l~~~~~  177 (395)
                      ..+|...+.+|.|+||.|++|.+.  ...|+||.+.+++.=.+      ..-..--||+||..++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            346899999999999999999984  46799999987754221      1223567999999998   999999999999


Q ss_pred             cCCcEEEEEecC-CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccc
Q 016082          178 RPPNLCIVTEFM-ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR  256 (395)
Q Consensus       178 ~~~~~~lV~E~~-~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~  256 (395)
                      +.+++||+||-- +|-+|++++.. +..+++.++..|.+|++.|+++||+.||||||||-+|+.++.+|-+||+|||.|.
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa  718 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAA  718 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchh
Confidence            999999999975 45599999976 6779999999999999999999999999999999999999999999999999997


Q ss_pred             ccccCCccccCCCCcccccccccCCCCCC-ChhhHHHHHHHHHHHHhCCCCCCC
Q 016082          257 VQAQSGVMTAETGTYRWMAPEVIEHKPYD-YKADVFSFGIALWELLTGELPYAG  309 (395)
Q Consensus       257 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~k~DvwslG~vl~elltg~~pf~~  309 (395)
                      ... ++......||..|.|||++.|.+|- ...|||++|+++|.+.....||..
T Consensus       719 ~~k-sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  719 YTK-SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhc-CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            544 3445667899999999999999885 558999999999999999999864

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.97  E-value=7.6e-30  Score=224.01  Aligned_cols=256  Identities=23%  Similarity=0.349  Sum_probs=212.2

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC-CceeeEEEEEecCCcE
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH-KNVVQFIGACTRPPNL  182 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~  182 (395)
                      .|-...|+++++||+||||.+|.|..  .|..||||+-+...-.    -.+..|..+.+.+++ ..|+.+..++.+...-
T Consensus        11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn   86 (341)
T KOG1163|consen   11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYN   86 (341)
T ss_pred             heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence            45677999999999999999999987  6899999998765433    345668899999985 8888888889998889


Q ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCC---CcEEEeeeccccccc
Q 016082          183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN---GVVKVADFGVARVQA  259 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~---~~vkl~DFg~a~~~~  259 (395)
                      .+|||.+ |.||.++..-....|+..+++-++-|++.-++|+|.+++|||||||+|+|+.-+   ..+.++|||+|+..-
T Consensus        87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            9999988 679999999888999999999999999999999999999999999999999754   469999999997543


Q ss_pred             cCC--------ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHhhhccCCCCC
Q 016082          260 QSG--------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL---QAAVGVVQKSLRPTI  328 (395)
Q Consensus       260 ~~~--------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~---~~~~~~~~~~~~~~~  328 (395)
                      ...        .....+||.+|.+-....+..-+.+.|+-|+|.++.++..|..||.+..+.   +....+.......++
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i  245 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI  245 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence            321        123457999999999888888899999999999999999999999987553   333344443333222


Q ss_pred             C---CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 016082          329 P---KHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK  366 (395)
Q Consensus       329 ~---~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~  366 (395)
                      .   ...|.++...+..|-..-.++-|++.-+.+.++-++.
T Consensus       246 e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr  286 (341)
T KOG1163|consen  246 EVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR  286 (341)
T ss_pred             HHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence            2   4568899999999999999999999887776666554

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.3e-30  Score=229.15  Aligned_cols=255  Identities=32%  Similarity=0.637  Sum_probs=220.4

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  184 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  184 (395)
                      ..|+.+++.+..+|.....|..|+|+|.|..++.|+++-........++|.+|.-.|+-..||||+.++|+|..++++.+
T Consensus       185 ~gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~  264 (448)
T KOG0195|consen  185 TGIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVI  264 (448)
T ss_pred             cCcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceE
Confidence            35777888999999999999999999999999999998766666677889999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCeeeCCCCcEEE--eeeccccccc
Q 016082          185 VTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGVVKV--ADFGVARVQA  259 (395)
Q Consensus       185 V~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~--iiHrDlkp~NiLl~~~~~vkl--~DFg~a~~~~  259 (395)
                      +..||+-|||+..|+...+ ..+..++.+++.+|++||.|||+..  |----|....+++|++-+.+|  +|--++..  
T Consensus       265 isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq--  342 (448)
T KOG0195|consen  265 ISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ--  342 (448)
T ss_pred             eeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee--
Confidence            9999999999999988643 4567889999999999999999974  334468889999998876554  34222211  


Q ss_pred             cCCccccCCCCcccccccccCCCCCC---ChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHH
Q 016082          260 QSGVMTAETGTYRWMAPEVIEHKPYD---YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  336 (395)
Q Consensus       260 ~~~~~~~~~gt~~y~aPE~~~~~~~~---~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  336 (395)
                          .....-.+.||+||.+..++.+   .++|+|||++++|||-|...||...++-+.-..+.-+++|+.+|+.+++.+
T Consensus       343 ----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm  418 (448)
T KOG0195|consen  343 ----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHM  418 (448)
T ss_pred             ----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHH
Confidence                1122346899999999877654   579999999999999999999999999999888888999999999999999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 016082          337 AELLERCWQHDPTQRPNFSQITDILKQMM  365 (395)
Q Consensus       337 ~~li~~cl~~dp~~RPs~~ell~~l~~~~  365 (395)
                      ..+|.-|++.||.+||.|..|+-.|++++
T Consensus       419 ~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  419 NKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             HHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            99999999999999999999999888764

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-28  Score=237.41  Aligned_cols=255  Identities=23%  Similarity=0.344  Sum_probs=204.4

Q ss_pred             CcceeeeeeeeCceEEEEEEECC---ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC----CceeeEEEEE-ecCCcE
Q 016082          111 QLKIECKVASGSYGDLYKGTYCS---QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH----KNVVQFIGAC-TRPPNL  182 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~  182 (395)
                      +|++.++||+|+||.||.+....   ..+|+|+.........  ..+..|..++..+..    ++++.+++.+ .....-
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~   96 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN   96 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence            89999999999999999999854   3699999875432211  257788899988873    6899999999 477788


Q ss_pred             EEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCC-----CcEEEeeecccc
Q 016082          183 CIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-----GVVKVADFGVAR  256 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~-----~~vkl~DFg~a~  256 (395)
                      ++||+.+ |.+|.++..... +.|+..++..++.|++.+|+++|+.|++||||||+|++++..     ..++|.|||+++
T Consensus        97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar  175 (322)
T KOG1164|consen   97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR  175 (322)
T ss_pred             EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence            9999977 779999886655 789999999999999999999999999999999999999865     469999999998


Q ss_pred             --ccc-cCC-----c---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccC-
Q 016082          257 --VQA-QSG-----V---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL-  324 (395)
Q Consensus       257 --~~~-~~~-----~---~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~-  324 (395)
                        ... ..+     .   .....||.+|.++.++.+...+.+.|+||+++++.+++.|..||.+............... 
T Consensus       176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~  255 (322)
T KOG1164|consen  176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRK  255 (322)
T ss_pred             cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhh
Confidence              321 111     0   1234599999999999999999999999999999999999999987664322222222111 


Q ss_pred             --CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHH
Q 016082          325 --RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  368 (395)
Q Consensus       325 --~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~  368 (395)
                        ........+.++.++...+-..+..++|.+..+...+++.....
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  256 LLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             hccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence              11123445678999999999999999999999999988877764

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=3.3e-29  Score=219.44  Aligned_cols=165  Identities=24%  Similarity=0.394  Sum_probs=134.5

Q ss_pred             CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCccccCCCCc
Q 016082          192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY  271 (395)
Q Consensus       192 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~~~gt~  271 (395)
                      |+|.++++.+..++++..++.++.|+++||.|||+.+      ||+||+++.++.+++  ||.++.....    ...||+
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~g~~   68 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----QSRVDP   68 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----cCCCcc
Confidence            6999999876778999999999999999999999999      999999999999999  9999765442    236899


Q ss_pred             ccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCC------CCCCCcH--HHHHHHHHh
Q 016082          272 RWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT------IPKHAHP--RLAELLERC  343 (395)
Q Consensus       272 ~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~------~~~~~~~--~l~~li~~c  343 (395)
                      .|||||++.+..++.++|||||||++|||++|+.||..................+.      .+...+.  ++.+++.+|
T Consensus        69 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~c  148 (176)
T smart00750       69 YFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVC  148 (176)
T ss_pred             cccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHH
Confidence            99999999999999999999999999999999999976544322222222222222      1122333  699999999


Q ss_pred             hccCCCCCCCHHHHHHHHHHHHHHH
Q 016082          344 WQHDPTQRPNFSQITDILKQMMKEV  368 (395)
Q Consensus       344 l~~dp~~RPs~~ell~~l~~~~~~~  368 (395)
                      |+.+|.+||++.++++.+..+..+.
T Consensus       149 l~~~p~~Rp~~~~ll~~~~~~~~~~  173 (176)
T smart00750      149 ASRLPQRREAANHYLAHCRALFAET  173 (176)
T ss_pred             HhcccccccCHHHHHHHHHHHHHHH
Confidence            9999999999999999887776543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=5.2e-30  Score=274.37  Aligned_cols=192  Identities=15%  Similarity=0.220  Sum_probs=144.1

Q ss_pred             cCC-CceeeEEEEE-------ecCCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q 016082          164 IRH-KNVVQFIGAC-------TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK  235 (395)
Q Consensus       164 l~h-~niv~l~~~~-------~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlk  235 (395)
                      ++| +||+.++++|       .....++.++|++ +++|++++......+++..++.++.||++||+|||++||+|||||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK  107 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR  107 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence            345 5788888877       2334678889988 559999998766779999999999999999999999999999999


Q ss_pred             CCCeeeCCC-------------------CcEEEeeeccccccccCC-----------------ccccCCCCccccccccc
Q 016082          236 TANLLMDEN-------------------GVVKVADFGVARVQAQSG-----------------VMTAETGTYRWMAPEVI  279 (395)
Q Consensus       236 p~NiLl~~~-------------------~~vkl~DFg~a~~~~~~~-----------------~~~~~~gt~~y~aPE~~  279 (395)
                      |+|||++..                   +.+|++|||+++......                 ......||+.|||||++
T Consensus       108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~  187 (793)
T PLN00181        108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED  187 (793)
T ss_pred             chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence            999999654                   445666666665321100                 01123578899999999


Q ss_pred             CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          280 EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       280 ~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      .+..|+.++|||||||++|||++|.+|+......  ........ .+.......+...+++.+||+++|.+||++.|+++
T Consensus       188 ~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        188 NGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT--MSSLRHRV-LPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             ccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH--HHHHHHhh-cChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence            9999999999999999999999999887643221  11111111 22221223456789999999999999999999975

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=2.9e-28  Score=222.91  Aligned_cols=258  Identities=19%  Similarity=0.319  Sum_probs=210.9

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCcE
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNL  182 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  182 (395)
                      .+-.-.|+++++||+|+||.++.|+.  ++++||||.-......    -++..|-...+.|. .++|++.|.+...+.+-
T Consensus        24 ~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A----PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N   99 (449)
T KOG1165|consen   24 LMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA----PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN   99 (449)
T ss_pred             eEecccceeccccccCcceeeecccccccCceEEEEeccccCCc----chHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence            45566999999999999999999985  8999999987543222    34556777777776 69999999999998888


Q ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCC-----cEEEeeeccccc
Q 016082          183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-----VVKVADFGVARV  257 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~-----~vkl~DFg~a~~  257 (395)
                      .||+|.+ |.||.|+..-+..+|+..++..+|+|++.-++|+|++..|.|||||+|+||...+     .+.++|||+|+.
T Consensus       100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            9999988 6799999998889999999999999999999999999999999999999997543     699999999986


Q ss_pred             cccCCc--------cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHhhhccCCC
Q 016082          258 QAQSGV--------MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL---QAAVGVVQKSLRP  326 (395)
Q Consensus       258 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~---~~~~~~~~~~~~~  326 (395)
                      ......        ....+||.+||+-.-..+..-+.+.|+-|||-++++.+.|.+||.+....   +....+-.. .+.
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~-Kr~  257 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGET-KRS  257 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccc-ccc
Confidence            544321        22347999999999999999999999999999999999999999986433   222222111 111


Q ss_pred             C----CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHH
Q 016082          327 T----IPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVL  369 (395)
Q Consensus       327 ~----~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~  369 (395)
                      .    +-...|.++...++-.-..+..+-|.+.-+...+.+++....
T Consensus       258 T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g  304 (449)
T KOG1165|consen  258 TPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLG  304 (449)
T ss_pred             CCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcC
Confidence            1    113567899999999999999999999998888888877543

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.7e-29  Score=223.95  Aligned_cols=245  Identities=19%  Similarity=0.301  Sum_probs=191.0

Q ss_pred             cCcceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEE-EEecCCcEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIG-ACTRPPNLCIV  185 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~-~~~~~~~~~lV  185 (395)
                      +.|.|.+.+|+|.||.+-++++.  .+.+++|.+..+.   -..++|.+|..---.|. |.||+.-|+ +|+..+.+.++
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            57999999999999999999984  5789999987663   34578888877655554 899998776 56777888999


Q ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCC--CCcEEEeeeccccccccCCc
Q 016082          186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE--NGVVKVADFGVARVQAQSGV  263 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~--~~~vkl~DFg~a~~~~~~~~  263 (395)
                      +||++.|+|.+-+..  ..+-+....+++.|+++|++|+|+++++|||||.+|||+-.  ...|||||||.++..+..-.
T Consensus       101 qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~  178 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK  178 (378)
T ss_pred             eccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceeh
Confidence            999999999987754  45788888999999999999999999999999999999943  34799999999976543321


Q ss_pred             cccCCCCcccccccccCCC-----CCCChhhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHhhhccCCCCCCC---CC
Q 016082          264 MTAETGTYRWMAPEVIEHK-----PYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVVQKSLRPTIPK---HA  332 (395)
Q Consensus       264 ~~~~~gt~~y~aPE~~~~~-----~~~~k~DvwslG~vl~elltg~~pf~~---~~~~~~~~~~~~~~~~~~~~~---~~  332 (395)
                        ...-+..|.+||.....     .....+|+|.||++++.++||++||..   +.+.........+...+..|.   ..
T Consensus       179 --~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~f  256 (378)
T KOG1345|consen  179 --YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPF  256 (378)
T ss_pred             --hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhccc
Confidence              12235578899987533     246789999999999999999999974   233333333444555566664   46


Q ss_pred             cHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 016082          333 HPRLAELLERCWQHDPTQRPNFSQITDIL  361 (395)
Q Consensus       333 ~~~l~~li~~cl~~dp~~RPs~~ell~~l  361 (395)
                      ++.+..+.++-|..+|++|=-..+..+..
T Consensus       257 s~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  257 SEKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             CHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence            88899999999999999995555544433

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=2.2e-28  Score=230.15  Aligned_cols=242  Identities=22%  Similarity=0.352  Sum_probs=188.7

Q ss_pred             cCcceeeeeeeeCceEEEEEEE-----CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCcEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  183 (395)
                      +.|+.+++||.|+|++||+++.     ..+.||+|.+....    ....+.+|+++|..+. +.||+.+.+++...++.+
T Consensus        36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~  111 (418)
T KOG1167|consen   36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS----SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA  111 (418)
T ss_pred             hhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc----CchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence            4789999999999999999975     34679999987543    2366889999999996 899999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCC-CCcEEEeeecccccccc-C
Q 016082          184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVADFGVARVQAQ-S  261 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~-~~~vkl~DFg~a~~~~~-~  261 (395)
                      +|+||++.....++...    ++...+..++..+++||.++|.+|||||||||.|+|.+. -+.-.|+|||+|...+. .
T Consensus       112 ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~  187 (418)
T KOG1167|consen  112 IVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ  187 (418)
T ss_pred             EEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence            99999999888888765    678899999999999999999999999999999999985 45689999999961100 0


Q ss_pred             ------C-------c-------------------------------cccCCCCcccccccccCC-CCCCChhhHHHHHHH
Q 016082          262 ------G-------V-------------------------------MTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIA  296 (395)
Q Consensus       262 ------~-------~-------------------------------~~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~v  296 (395)
                            .       .                               .....||++|.|||++.. ..-+.++||||.|++
T Consensus       188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI  267 (418)
T KOG1167|consen  188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI  267 (418)
T ss_pred             hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence                  0       0                               001249999999999864 456889999999999


Q ss_pred             HHHHHhCCCCCCCCCHH-HHHHH---------------------hhh-------------------ccCCC---------
Q 016082          297 LWELLTGELPYAGLTPL-QAAVG---------------------VVQ-------------------KSLRP---------  326 (395)
Q Consensus       297 l~elltg~~pf~~~~~~-~~~~~---------------------~~~-------------------~~~~~---------  326 (395)
                      +..+++++.||-..... .....                     +.+                   ...++         
T Consensus       268 ~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~  347 (418)
T KOG1167|consen  268 LLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTERE  347 (418)
T ss_pred             eehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeec
Confidence            99999999998421110 00000                     000                   00000         


Q ss_pred             CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          327 TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       327 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      ......+..+.+++++|+..||.+|.|+++.|+
T Consensus       348 ~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  348 IGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             cccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence            001123457999999999999999999999886

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.95  E-value=1.3e-25  Score=211.75  Aligned_cols=248  Identities=30%  Similarity=0.511  Sum_probs=205.3

Q ss_pred             cceeeeeeeeCceEEEEEEECCceEEEEEecCCCCCHH-HHHHHHHHHHHHHhcCCC-ceeeEEEEEecCCcEEEEEecC
Q 016082          112 LKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTE-MLKEFSQEVYIMRKIRHK-NVVQFIGACTRPPNLCIVTEFM  189 (395)
Q Consensus       112 ~~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lV~E~~  189 (395)
                      |.+.+.||.|+||.||++.+. ..+|+|.+........ ....+.+|+.+++.+.|+ +++.+++.+......+++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~   80 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV   80 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence            678899999999999999988 8899999987765443 678899999999999988 7999999997777789999999


Q ss_pred             CCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCC-cEEEeeeccccccccCC----
Q 016082          190 ARGSIYDFLHKQK--GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQSG----  262 (395)
Q Consensus       190 ~ggsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~-~vkl~DFg~a~~~~~~~----  262 (395)
                      .++++.+++....  ..++......+..+++.++.|+|+.+++|||+||+||+++..+ .++++|||.++......    
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~  160 (384)
T COG0515          81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSS  160 (384)
T ss_pred             CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcccc
Confidence            9999997776643  2789999999999999999999999999999999999999998 79999999997554432    


Q ss_pred             ---ccccCCCCcccccccccCC---CCCCChhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHhhhccCCC----CCC
Q 016082          263 ---VMTAETGTYRWMAPEVIEH---KPYDYKADVFSFGIALWELLTGELPYAGLTP---LQAAVGVVQKSLRP----TIP  329 (395)
Q Consensus       263 ---~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwslG~vl~elltg~~pf~~~~~---~~~~~~~~~~~~~~----~~~  329 (395)
                         ......|+..|+|||.+.+   ..+....|+|++|++++++++|..||.....   .............+    ...
T Consensus       161 ~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (384)
T COG0515         161 IPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLS  240 (384)
T ss_pred             ccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccC
Confidence               2356689999999999987   5789999999999999999999999887763   22233323222222    111


Q ss_pred             CCC----cHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016082          330 KHA----HPRLAELLERCWQHDPTQRPNFSQITDI  360 (395)
Q Consensus       330 ~~~----~~~l~~li~~cl~~dp~~RPs~~ell~~  360 (395)
                      ...    ...+.+++.+|+..+|..|.+..+....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         241 PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            211    2579999999999999999998887664

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=1e-25  Score=217.65  Aligned_cols=163  Identities=17%  Similarity=0.205  Sum_probs=128.7

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE---CCceEEEEEecCCCC---CHHHHHHHHHHHHHHHhcCCCceee-EEEEEecC
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY---CSQEVAIKVLKPECV---NTEMLKEFSQEVYIMRKIRHKNVVQ-FIGACTRP  179 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~---~~~~vAvK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~  179 (395)
                      .-...|.+.+.||+|+||.||+|.+   .++.||||++.....   .......+.+|+.+|++++|+|++. +++.    
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence            3456899999999999999999986   456789998764321   2344567999999999999999985 4432    


Q ss_pred             CcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC-CCCCeeeCCCCcEEEeeecccccc
Q 016082          180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL-KTANLLMDENGVVKVADFGVARVQ  258 (395)
Q Consensus       180 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDl-kp~NiLl~~~~~vkl~DFg~a~~~  258 (395)
                      ...|+||||++|++|.. +.. .   .   ...++.+++++|.|||+.||+|||| ||+|||++.++.++|+|||+|+..
T Consensus        91 ~~~~LVmE~~~G~~L~~-~~~-~---~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~  162 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHL-ARP-H---G---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF  162 (365)
T ss_pred             CCcEEEEEccCCCCHHH-hCc-c---c---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence            45899999999999973 211 1   1   1467889999999999999999999 999999999999999999999865


Q ss_pred             ccCCcc---------ccCCCCcccccccccCC
Q 016082          259 AQSGVM---------TAETGTYRWMAPEVIEH  281 (395)
Q Consensus       259 ~~~~~~---------~~~~gt~~y~aPE~~~~  281 (395)
                      ......         +...+++.|+|||.+.-
T Consensus       163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            543311         23457888999999853

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.4e-25  Score=221.20  Aligned_cols=234  Identities=25%  Similarity=0.428  Sum_probs=196.4

Q ss_pred             eeeeeCceEEEEEE-----ECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCcEEEEEecCC
Q 016082          117 KVASGSYGDLYKGT-----YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEFMA  190 (395)
Q Consensus       117 ~lg~G~~G~Vy~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~  190 (395)
                      .+|.|+||.|++++     +.+..+|+|++++.............|..++..++ ||.+++++.++..+...++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37899999999753     45677999999876543333336778999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCccccCCCC
Q 016082          191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT  270 (395)
Q Consensus       191 ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~~~gt  270 (395)
                      ||.|...+.+ ...+.+.....+...++-+++++|+.+|+|||+|++||+++.+|++++.|||.++..-....   .+||
T Consensus        81 gg~lft~l~~-~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~---~cgt  156 (612)
T KOG0603|consen   81 GGDLFTRLSK-EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---ACGT  156 (612)
T ss_pred             cchhhhcccc-CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh---cccc
Confidence            9999998866 56678888889999999999999999999999999999999999999999999986554332   2899


Q ss_pred             cccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCC
Q 016082          271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ  350 (395)
Q Consensus       271 ~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~  350 (395)
                      ..|||||+++  ....++|.||||++++||++|..||.+    +....+..  ..+..|...+....+++..++..+|..
T Consensus       157 ~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~--~~~~~p~~l~~~a~~~~~~l~~r~p~n  228 (612)
T KOG0603|consen  157 YEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILK--AELEMPRELSAEARSLFRQLFKRNPEN  228 (612)
T ss_pred             hhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhh--hccCCchhhhHHHHHHHHHHHhhCHHH
Confidence            9999999998  678899999999999999999999988    33444433  245678889999999999999999999


Q ss_pred             CCCH--HHHHHHHH
Q 016082          351 RPNF--SQITDILK  362 (395)
Q Consensus       351 RPs~--~ell~~l~  362 (395)
                      |...  ..+.+..+
T Consensus       229 rLg~~~~~~~eik~  242 (612)
T KOG0603|consen  229 RLGAGPDGVDEIKQ  242 (612)
T ss_pred             HhccCcchhHHHhc
Confidence            9765  34444333

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=4.3e-24  Score=189.71  Aligned_cols=141  Identities=17%  Similarity=0.198  Sum_probs=110.0

Q ss_pred             eeeeeeeCceEEEEEEE-CCceEEEEEecCCCCCHHH------------------------HHHHHHHHHHHHhcCCCce
Q 016082          115 ECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEM------------------------LKEFSQEVYIMRKIRHKNV  169 (395)
Q Consensus       115 ~~~lg~G~~G~Vy~~~~-~~~~vAvK~~~~~~~~~~~------------------------~~~~~~E~~~l~~l~h~ni  169 (395)
                      ...||+|+||.||+|.. +|++||||+++++......                        ......|+.++.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            46799999999999987 6899999999865321111                        1123459999999987776


Q ss_pred             eeEEEEEecCCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH-HHCCccccCCCCCCeeeCCCCcEE
Q 016082          170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL-HQNNIIHRDLKTANLLMDENGVVK  248 (395)
Q Consensus       170 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~iiHrDlkp~NiLl~~~~~vk  248 (395)
                      .........  ..+|||||++|+++...... .++++...+..++.|++.+|.++ |+.||+||||||+||+++ ++.++
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~  157 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY  157 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence            433322222  23899999999877655433 46789999999999999999999 799999999999999998 47899


Q ss_pred             Eeeeccccccc
Q 016082          249 VADFGVARVQA  259 (395)
Q Consensus       249 l~DFg~a~~~~  259 (395)
                      |+|||+|...+
T Consensus       158 LiDFG~a~~~~  168 (190)
T cd05147         158 IIDVSQSVEHD  168 (190)
T ss_pred             EEEccccccCC
Confidence            99999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.91  E-value=4.4e-24  Score=192.80  Aligned_cols=173  Identities=16%  Similarity=0.220  Sum_probs=137.1

Q ss_pred             cccCcceeeeeeeeCceEEEEEEECCceEEEEEecCCCCCHH-HHHH------HHHHHHHHHhcCCCceeeEEEEEecC-
Q 016082          108 DAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTE-MLKE------FSQEVYIMRKIRHKNVVQFIGACTRP-  179 (395)
Q Consensus       108 ~~~~~~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~-~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~-  179 (395)
                      -.++|++.+.+|.|+||.||+....+..+|||++++.....+ ....      +.+|+..+.++.||+|+...+++... 
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            457999999999999999999888888999999987654333 2223      68999999999999999998885533 


Q ss_pred             -------CcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeee
Q 016082          180 -------PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADF  252 (395)
Q Consensus       180 -------~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DF  252 (395)
                             ...++||||++|.+|.++..     +++    ....+++.++..+|+.|++|||++|.||+++.+| ++|+||
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf  178 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL  178 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence                   35899999999999988732     232    2456999999999999999999999999999998 999999


Q ss_pred             ccccccccCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHH
Q 016082          253 GVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELL  301 (395)
Q Consensus       253 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ell  301 (395)
                      |..+........           ........|+.++|+|+||+++.-+.
T Consensus       179 g~~~~~~e~~a~-----------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        179 SGKRCTAQRKAK-----------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCcccccchhhH-----------HHHHHHhHhcccccccceeEeehHHH
Confidence            988654322111           11334556778999999999987654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=8.4e-25  Score=224.34  Aligned_cols=245  Identities=23%  Similarity=0.346  Sum_probs=187.8

Q ss_pred             ceeeeeeeeCceEEEEEEEC--CceEEEEEec----CCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          113 KIECKVASGSYGDLYKGTYC--SQEVAIKVLK----PECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       113 ~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~----~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      +....+|.|++|.|+.....  ....+.|.++    +..........+..|.-+-..+.|||++..+..+.+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            67788999999988876552  2333333332    22222222333677888888899999988777776666665669


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC----
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG----  262 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~----  262 (395)
                      ||+++ +|+..+.. .+.+....+-.+..|++.|++|+|+.||.|||+|++|++++.+|.+|++|||.+.......    
T Consensus       401 E~~~~-Dlf~~~~~-~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~  478 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMS-NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNI  478 (601)
T ss_pred             hcccH-HHHHHHhc-ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhh
Confidence            99999 99999865 4678999999999999999999999999999999999999999999999999997654432    


Q ss_pred             -ccccCCCCcccccccccCCCCCCC-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHhhhccCC-----CCCCCCCc
Q 016082          263 -VMTAETGTYRWMAPEVIEHKPYDY-KADVFSFGIALWELLTGELPYAGLTPLQAA--VGVVQKSLR-----PTIPKHAH  333 (395)
Q Consensus       263 -~~~~~~gt~~y~aPE~~~~~~~~~-k~DvwslG~vl~elltg~~pf~~~~~~~~~--~~~~~~~~~-----~~~~~~~~  333 (395)
                       ......|+..|+|||++.+..|+. ..||||.|+++..|.+|+.||......+..  .........     ..+...++
T Consensus       479 ~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp  558 (601)
T KOG0590|consen  479 HESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLP  558 (601)
T ss_pred             hhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhch
Confidence             234567999999999999999975 589999999999999999999765444322  110100000     01123467


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          334 PRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       334 ~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      .+.+.+|.+||+.+|.+|.|+++|++
T Consensus       559 ~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  559 RETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             hhHHHHHHHHccCChhheecHHHHhh
Confidence            78999999999999999999999987

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=2.7e-23  Score=194.42  Aligned_cols=195  Identities=23%  Similarity=0.375  Sum_probs=151.6

Q ss_pred             CCCceeeEEEEEecC---------------------------CcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHH
Q 016082          165 RHKNVVQFIGACTRP---------------------------PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV  217 (395)
Q Consensus       165 ~h~niv~l~~~~~~~---------------------------~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i  217 (395)
                      +|||||.+.++|.+.                           ..+|+||.-+.. +|..++..+.  .+.....-++.|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence            599999999877442                           258999999876 9999997643  4667778889999


Q ss_pred             HHHHHHHHHCCccccCCCCCCeeeC--CCC--cEEEeeeccccccccCC-------ccccCCCCcccccccccCCCC---
Q 016082          218 SKGMNYLHQNNIIHRDLKTANLLMD--ENG--VVKVADFGVARVQAQSG-------VMTAETGTYRWMAPEVIEHKP---  283 (395)
Q Consensus       218 ~~~l~~LH~~~iiHrDlkp~NiLl~--~~~--~vkl~DFg~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---  283 (395)
                      ++|+.|||++||.|||+|.+|||+.  +++  .+.++|||++-.....+       ..-..-|...-||||+.+..+   
T Consensus       351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~  430 (598)
T KOG4158|consen  351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN  430 (598)
T ss_pred             HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCc
Confidence            9999999999999999999999994  333  58999999985333221       112234677899999987543   


Q ss_pred             ---CCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016082          284 ---YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDI  360 (395)
Q Consensus       284 ---~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  360 (395)
                         --.|+|.|+.|.+.||+++...||.+...........++.--|..|+.+++.+++++...|+.||.+|++..-....
T Consensus       431 avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANv  510 (598)
T KOG4158|consen  431 AVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANV  510 (598)
T ss_pred             eeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhH
Confidence               12689999999999999999999987433322223345555678899999999999999999999999997655554


Q ss_pred             HH
Q 016082          361 LK  362 (395)
Q Consensus       361 l~  362 (395)
                      |.
T Consensus       511 l~  512 (598)
T KOG4158|consen  511 LN  512 (598)
T ss_pred             HH
Confidence            44

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.89  E-value=3.5e-23  Score=192.36  Aligned_cols=232  Identities=18%  Similarity=0.299  Sum_probs=153.6

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCC----------CceeeEEEEE-
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRH----------KNVVQFIGAC-  176 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~-  176 (395)
                      .+...+.||.|+++.||.+++  +++++|+|++.... ......+.+++|.-....+.+          -.++-.++.. 
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            567788999999999999999  56999999985443 223356777777766555322          1222222221 


Q ss_pred             --------ecCC--------cEEEEEecCCCCCHHHHHhh---ccCC---CCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 016082          177 --------TRPP--------NLCIVTEFMARGSIYDFLHK---QKGV---FQLTSLLKVAIDVSKGMNYLHQNNIIHRDL  234 (395)
Q Consensus       177 --------~~~~--------~~~lV~E~~~ggsL~~~l~~---~~~~---l~~~~~~~i~~~i~~~l~~LH~~~iiHrDl  234 (395)
                              ....        +.+++|+-+.+ +|.+++..   ....   +.......+..|+++.+++||+.|++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence                    1111        35788888865 88887542   2221   223344567789999999999999999999


Q ss_pred             CCCCeeeCCCCcEEEeeeccccccccCCccccCCCCcccccccccCC--------CCCCChhhHHHHHHHHHHHHhCCCC
Q 016082          235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH--------KPYDYKADVFSFGIALWELLTGELP  306 (395)
Q Consensus       235 kp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~k~DvwslG~vl~elltg~~p  306 (395)
                      +|+|++++.+|.++|+||+.....+.....  ...+..|.|||....        -.++.+.|.|+||+++|.+++|..|
T Consensus       172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP  249 (288)
T PF14531_consen  172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP  249 (288)
T ss_dssp             SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred             ceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence            999999999999999999988765553322  445577899997643        2578999999999999999999999


Q ss_pred             CCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCC
Q 016082          307 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR  351 (395)
Q Consensus       307 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  351 (395)
                      |...++........    . ... +.+..++.+|+.+|+.+|.+|
T Consensus       250 f~~~~~~~~~~~~f----~-~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  250 FGLSSPEADPEWDF----S-RCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             TCCCGGGSTSGGGG----T-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCccccccccc----h-hcC-CcCHHHHHHHHHHccCCcccC
Confidence            98765443221111    1 122 677899999999999999988

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=1.2e-22  Score=180.72  Aligned_cols=142  Identities=18%  Similarity=0.183  Sum_probs=111.9

Q ss_pred             eeeeeeeeCceEEEEEEE-CCceEEEEEecCCCCCH------------------------HHHHHHHHHHHHHHhcCCCc
Q 016082          114 IECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNT------------------------EMLKEFSQEVYIMRKIRHKN  168 (395)
Q Consensus       114 i~~~lg~G~~G~Vy~~~~-~~~~vAvK~~~~~~~~~------------------------~~~~~~~~E~~~l~~l~h~n  168 (395)
                      +...||+|+||.||+|+. +|+.||||++++.....                        .....+..|...+.++.|++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            356899999999999987 58999999998753210                        01223468999999999998


Q ss_pred             eeeEEEEEecCCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeeeCCCCcE
Q 016082          169 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVV  247 (395)
Q Consensus       169 iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~iiHrDlkp~NiLl~~~~~v  247 (395)
                      +.....+....  .++||||++|+++...... ..+++...+..++.+++.++.++|+ .||+||||||+||+++ ++.+
T Consensus        81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~  156 (190)
T cd05145          81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP  156 (190)
T ss_pred             CCCceEEEecC--CEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence            75444333332  4899999998865443222 3567888999999999999999999 9999999999999998 8899


Q ss_pred             EEeeeccccccc
Q 016082          248 KVADFGVARVQA  259 (395)
Q Consensus       248 kl~DFg~a~~~~  259 (395)
                      +|+|||+++...
T Consensus       157 ~liDFG~a~~~~  168 (190)
T cd05145         157 YIIDVSQAVELD  168 (190)
T ss_pred             EEEEcccceecC
Confidence            999999997644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.88  E-value=7.9e-24  Score=218.42  Aligned_cols=244  Identities=18%  Similarity=0.258  Sum_probs=182.1

Q ss_pred             CcceeeeeeeeCceEEEEEEECCceEEEEEecCCC--CCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Q 016082          111 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPEC--VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  188 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  188 (395)
                      ++...+.||++.|=.|.+|++..-.|+||++-+..  ..-....+...|++ ....++||.+.+.-+-...+..|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            67788999999999999999976679999995443  22222333444555 5556899999998887777888999999


Q ss_pred             CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccc--ccC--Ccc
Q 016082          189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ--AQS--GVM  264 (395)
Q Consensus       189 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~--~~~--~~~  264 (395)
                      ... +|+|.+.. +.-+..-+.+.|+.|++.|+..+|..||+|+|||.+|||++..+-+.|+||..-+..  ...  ...
T Consensus       103 vkh-nLyDRlST-RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf  180 (1431)
T KOG1240|consen  103 VKH-NLYDRLST-RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADF  180 (1431)
T ss_pred             Hhh-hhhhhhcc-chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccc
Confidence            977 99999977 445677788899999999999999999999999999999999999999999887532  111  111


Q ss_pred             c----cCCCCcccccccccCCC----------C-CCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCC--
Q 016082          265 T----AETGTYRWMAPEVIEHK----------P-YDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRP--  326 (395)
Q Consensus       265 ~----~~~gt~~y~aPE~~~~~----------~-~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~--  326 (395)
                      +    +...-..|.|||.+...          + .+.+.||||+||++.||++ |++||....-..-..+   ....+  
T Consensus       181 ~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~---~~~~~e~  257 (1431)
T KOG1240|consen  181 TFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSG---NADDPEQ  257 (1431)
T ss_pred             eEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhcc---CccCHHH
Confidence            1    12234579999998531          2 5678999999999999999 8999854211110000   00000  


Q ss_pred             CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016082          327 TIPKHAHPRLAELLERCWQHDPTQRPNFSQITDI  360 (395)
Q Consensus       327 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  360 (395)
                      .+..--+..+++++..|++.||.+|.++++.++.
T Consensus       258 ~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  258 LLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            0001123479999999999999999999999986

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=6.5e-22  Score=175.28  Aligned_cols=185  Identities=15%  Similarity=0.136  Sum_probs=141.0

Q ss_pred             eeeeeeeeCceEEEEEEECCceEEEEEecCCCCCHH--HHHHHHHHHHHHHhcC-CCceeeEEEEEecCCcEEEEEecCC
Q 016082          114 IECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTE--MLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEFMA  190 (395)
Q Consensus       114 i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~  190 (395)
                      +...|++|+||+||.+...+.+++.+.++....-..  ....+.+|+++|+++. |+++++++++    ...+++|||+.
T Consensus         6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~   81 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA   81 (218)
T ss_pred             cceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence            456899999999999888888888888775533111  1235889999999996 5889999886    34799999999


Q ss_pred             CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC-CCCCeeeCCCCcEEEeeeccccccccCCcc-----
Q 016082          191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL-KTANLLMDENGVVKVADFGVARVQAQSGVM-----  264 (395)
Q Consensus       191 ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDl-kp~NiLl~~~~~vkl~DFg~a~~~~~~~~~-----  264 (395)
                      |.+|.+.+..  +      ...++.+++.++.++|+.||+|||| ||+|||++.+|.++|+|||+|.........     
T Consensus        82 G~~L~~~~~~--~------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~  153 (218)
T PRK12274         82 GAAMYQRPPR--G------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLA  153 (218)
T ss_pred             CccHHhhhhh--h------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHH
Confidence            9998764321  1      1356789999999999999999999 799999999999999999999855443310     


Q ss_pred             ---------ccCCCCcccccccccCCC-CCC-ChhhHHHHHHHHHHHHhCCCCCCCC
Q 016082          265 ---------TAETGTYRWMAPEVIEHK-PYD-YKADVFSFGIALWELLTGELPYAGL  310 (395)
Q Consensus       265 ---------~~~~gt~~y~aPE~~~~~-~~~-~k~DvwslG~vl~elltg~~pf~~~  310 (395)
                               .-...++.|++|+...-- ..+ .+.+.++.|+-+|.++|+..|.-+.
T Consensus       154 ~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        154 REDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence                     011356777777764322 223 5678889999999999988876543

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=1.1e-21  Score=205.76  Aligned_cols=255  Identities=20%  Similarity=0.321  Sum_probs=190.4

Q ss_pred             CCceeecccCcceeeeeeeeCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC---CCceeeEEEEEe
Q 016082          102 TDVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR---HKNVVQFIGACT  177 (395)
Q Consensus       102 ~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~  177 (395)
                      ....++....|.|.+.||.|+||.||+|+. +++.||+|+-++....+     |.--.+++.+|+   -+.|..+..+..
T Consensus       690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE-----fYI~~q~~~RLk~~~~~~~~~~~~a~~  764 (974)
T KOG1166|consen  690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE-----FYICLQVMERLKPQMLPSIMHISSAHV  764 (974)
T ss_pred             cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee-----eeehHHHHHhhchhhhcchHHHHHHHc
Confidence            345788889999999999999999999987 67899999999876432     233334445554   244555555566


Q ss_pred             cCCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCC-------CCcEEEe
Q 016082          178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-------NGVVKVA  250 (395)
Q Consensus       178 ~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~-------~~~vkl~  250 (395)
                      -.+..++|+||.+-|+|.++++. .+..++..+..++.|+++.+++||..+|||+||||+|+|+..       +-.++|+
T Consensus       765 ~~~~S~lv~ey~~~Gtlld~~N~-~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI  843 (974)
T KOG1166|consen  765 FQNASVLVSEYSPYGTLLDLINT-NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLI  843 (974)
T ss_pred             cCCcceeeeeccccccHHHhhcc-CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEE
Confidence            66778999999999999999984 667899999999999999999999999999999999999952       3358999


Q ss_pred             eecccc---ccccCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCC
Q 016082          251 DFGVAR---VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT  327 (395)
Q Consensus       251 DFg~a~---~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  327 (395)
                      |||.+.   ...........++|-.+-.+|...|++++..+|.|.++.+++-|+.|+.--       ...+ .....+..
T Consensus       844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-------~~~g-~~~~~~~~  915 (974)
T KOG1166|consen  844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-------VKNG-SSWMVKTN  915 (974)
T ss_pred             ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-------hcCC-cceecccc
Confidence            999985   333344455667889999999999999999999999999999999986421       0000 00011111


Q ss_pred             CCCCCcHH-HHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHH
Q 016082          328 IPKHAHPR-LAELLERCWQHDPTQRPNFSQITDILKQMMKEVLY  370 (395)
Q Consensus       328 ~~~~~~~~-l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~~  370 (395)
                      ++..+..+ +.+++..+|+.|-..=|...+|...++..+.+--.
T Consensus       916 ~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~~  959 (974)
T KOG1166|consen  916 FPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEHFT  959 (974)
T ss_pred             chhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHHHH
Confidence            23333333 56888888984444447777777777666554433

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=2.8e-20  Score=167.83  Aligned_cols=136  Identities=24%  Similarity=0.395  Sum_probs=116.5

Q ss_pred             eeeeeeCceEEEEEEECCceEEEEEecCCCCCHH------HHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecC
Q 016082          116 CKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTE------MLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM  189 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  189 (395)
                      +.||+|++|.||+|.+.+..|++|+..+......      ....+.+|+.++..+.|++++....++......++||||+
T Consensus         2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   81 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI   81 (211)
T ss_pred             cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence            5789999999999999999999998775443221      1245788999999999999887777776777889999999


Q ss_pred             CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccc
Q 016082          190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV  257 (395)
Q Consensus       190 ~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~  257 (395)
                      +|++|.+.+....    . ....++.+++.+|.++|+.|++|||++|.||+++ ++.++++|||.++.
T Consensus        82 ~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         82 EGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999986532    1 7889999999999999999999999999999999 78999999999864

>PRK10345 hypothetical protein; Provisional

Probab=99.85  E-value=6.1e-21  Score=171.45  Aligned_cols=136  Identities=17%  Similarity=0.262  Sum_probs=105.6

Q ss_pred             ceeeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-----CCCceeeEEEEEecCC---cEE-
Q 016082          113 KIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-----RHKNVVQFIGACTRPP---NLC-  183 (395)
Q Consensus       113 ~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~-  183 (395)
                      .-.+.||+|+||.||.-...+. .+||+......  ...+.+.+|+.+++++     +||||++++|++.++.   ..+ 
T Consensus         5 ~~~~~LG~G~~~~Vy~hp~~~~-k~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          5 SEQSPLGTGRHRKCYAHPEDAQ-RCIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             CCcceecCCCceEEEECCCCcC-eEEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            3456899999999997322333 47998876432  2346789999999999     5799999999998874   333 


Q ss_pred             EEEec--CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHH-HHHHHCCccccCCCCCCeeeCC----CCcEEEee-eccc
Q 016082          184 IVTEF--MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM-NYLHQNNIIHRDLKTANLLMDE----NGVVKVAD-FGVA  255 (395)
Q Consensus       184 lV~E~--~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~iiHrDlkp~NiLl~~----~~~vkl~D-Fg~a  255 (395)
                      +|+||  +.+|+|.+++.+  +.+++.  ..++.+++.++ +|||+++|+||||||+|||++.    ++.++|+| ||..
T Consensus        82 ~I~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~  157 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES  157 (210)
T ss_pred             EEecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence            78999  557999999965  346655  35577888777 9999999999999999999974    34799999 5543

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.84  E-value=3.3e-20  Score=165.84  Aligned_cols=131  Identities=21%  Similarity=0.365  Sum_probs=108.7

Q ss_pred             eeeeCceEEEEEEECCceEEEEEecCCCCCH------HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecCCC
Q 016082          118 VASGSYGDLYKGTYCSQEVAIKVLKPECVNT------EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR  191 (395)
Q Consensus       118 lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~g  191 (395)
                      ||+|+||.||+|.+.+..|++|+........      ....++.+|+.+++.++|+++.....++......++||||++|
T Consensus         2 ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g   81 (199)
T TIGR03724         2 IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEG   81 (199)
T ss_pred             CCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECC
Confidence            7999999999999999999999976433211      1235678999999999988765555455556677999999999


Q ss_pred             CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccc
Q 016082          192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV  257 (395)
Q Consensus       192 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~  257 (395)
                      ++|.+.+.....        .++.+++.+|.+||+.|++|+|++|+||+++ ++.++++|||.++.
T Consensus        82 ~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        82 KPLKDVIEEGND--------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ccHHHHHhhcHH--------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999998755211        7889999999999999999999999999999 88999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.83  E-value=9.9e-21  Score=186.62  Aligned_cols=207  Identities=31%  Similarity=0.580  Sum_probs=166.7

Q ss_pred             HHhcCCCceeeEEEEEecCCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCc-cccCCCCCCe
Q 016082          161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI-IHRDLKTANL  239 (395)
Q Consensus       161 l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i-iHrDlkp~Ni  239 (395)
                      |+.+.|.|+.+++|.+.+++..+.|.+|++.|+|.|.+....-.++.--...+.++|++||.|||+..| .|+.+++.|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            456789999999999999999999999999999999998866677777788899999999999998866 9999999999


Q ss_pred             eeCCCCcEEEeeeccccccccCC---ccccCCCCcccccccccCCCC-------CCChhhHHHHHHHHHHHHhCCCCCCC
Q 016082          240 LMDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKP-------YDYKADVFSFGIALWELLTGELPYAG  309 (395)
Q Consensus       240 Ll~~~~~vkl~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-------~~~k~DvwslG~vl~elltg~~pf~~  309 (395)
                      +++....+|+.|||+........   ......-...|.|||.+....       .+.+.|+||||++++|+++.+.||..
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            99999999999999987654211   111223456799999987641       46679999999999999999999975


Q ss_pred             C----CHHHHHHHhhh---ccCCCCCCC--CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 016082          310 L----TPLQAAVGVVQ---KSLRPTIPK--HAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE  367 (395)
Q Consensus       310 ~----~~~~~~~~~~~---~~~~~~~~~--~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~  367 (395)
                      .    .+.+....+..   ...+|.+..  ..++++..+++.||..+|.+||++.++-..++.+.+.
T Consensus       161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            2    33233333222   234555542  3456799999999999999999999999888877664

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.83  E-value=7.1e-21  Score=196.60  Aligned_cols=211  Identities=28%  Similarity=0.436  Sum_probs=160.3

Q ss_pred             ccCcceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      .++|..++.+-.|+||.||..++.  .+++|+|+=+...    ..+   +   ++.....|.+               | 
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l----ilR---n---ilt~a~npfv---------------v-  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL----ILR---N---ILTFAGNPFV---------------V-  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccccch----hhh---c---cccccCCcce---------------e-
Confidence            347888999999999999999774  7889996633211    001   0   2222223333               2 


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC----
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG----  262 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~----  262 (395)
                           |+....+.. -++++...        +.+++|||+.||+|||+||+|.+|+.-|++|+.|||+++......    
T Consensus       136 -----gDc~tllk~-~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl  201 (1205)
T KOG0606|consen  136 -----GDCATLLKN-IGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL  201 (1205)
T ss_pred             -----chhhhhccc-CCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence                 466666543 45556443        678999999999999999999999999999999999987432211    


Q ss_pred             ------------ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc-CCCCCC
Q 016082          263 ------------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-LRPTIP  329 (395)
Q Consensus       263 ------------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~  329 (395)
                                  .....+||+.|.|||++..+.|...+|.|++|+++||.+.|+.||.+.++++.+..++... .-|+-.
T Consensus       202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~d  281 (1205)
T KOG0606|consen  202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEED  281 (1205)
T ss_pred             hhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccC
Confidence                        1122479999999999999999999999999999999999999999999998877766432 234445


Q ss_pred             CCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          330 KHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       330 ~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      ...+++.++++.++|+.+|..|-.....++
T Consensus       282 ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~e  311 (1205)
T KOG0606|consen  282 EALPPEAQDLIEQLLRQNPLCRLGTGGALE  311 (1205)
T ss_pred             cCCCHHHHHHHHHHHHhChHhhcccchhhh
Confidence            667899999999999999999964444433

>smart00090 RIO RIO-like kinase

Probab=99.82  E-value=5.3e-20  Score=169.01  Aligned_cols=144  Identities=17%  Similarity=0.171  Sum_probs=113.7

Q ss_pred             cCcceeeeeeeeCceEEEEEE---ECCceEEEEEecCCCCCH----------------------HHHHHHHHHHHHHHhc
Q 016082          110 KQLKIECKVASGSYGDLYKGT---YCSQEVAIKVLKPECVNT----------------------EMLKEFSQEVYIMRKI  164 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~---~~~~~vAvK~~~~~~~~~----------------------~~~~~~~~E~~~l~~l  164 (395)
                      ..|++.+.||+|+||.||+|.   .+++.||+|+++......                      .....+..|..++.++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            358899999999999999998   368999999997543110                      0123467899999999


Q ss_pred             CCC--ceeeEEEEEecCCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCCCCeee
Q 016082          165 RHK--NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN-IIHRDLKTANLLM  241 (395)
Q Consensus       165 ~h~--niv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-iiHrDlkp~NiLl  241 (395)
                      .+.  .+++.++.    ...++||||++|++|...... ...+....+..++.+++.++.+||+.| |+||||||+||++
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli  182 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV  182 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence            753  34555543    235899999999888765433 345666678899999999999999999 9999999999999


Q ss_pred             CCCCcEEEeeeccccccc
Q 016082          242 DENGVVKVADFGVARVQA  259 (395)
Q Consensus       242 ~~~~~vkl~DFg~a~~~~  259 (395)
                      + ++.++|+|||.+....
T Consensus       183 ~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      183 H-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             E-CCCEEEEEChhhhccC
Confidence            9 8899999999987533

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.81  E-value=3e-19  Score=183.17  Aligned_cols=137  Identities=21%  Similarity=0.322  Sum_probs=115.0

Q ss_pred             CcceeeeeeeeCceEEEEEEECCceEEEEEecCCCCC-----H-HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Q 016082          111 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVN-----T-EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  184 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~-----~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  184 (395)
                      .|...+.||+|+||.||+|.+.+..+++|+.......     . ...+.+.+|+.++++++|++++....++......++
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l  413 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTI  413 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEE
Confidence            3456889999999999999998877777654322111     1 123568899999999999999988887777777899


Q ss_pred             EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccc
Q 016082          185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV  257 (395)
Q Consensus       185 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~  257 (395)
                      ||||++|++|.+++.         ....++.+++.+|.+||+.|++||||||+||++ +++.++|+|||+++.
T Consensus       414 v~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        414 VMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            999999999999885         346789999999999999999999999999999 678999999999975

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.80  E-value=4.4e-19  Score=158.69  Aligned_cols=138  Identities=16%  Similarity=0.170  Sum_probs=109.3

Q ss_pred             CcceeeeeeeeCceEEEEEEE-CCceEEEEEecCCCCCH--------------------HHHHHHHHHHHHHHhcCCC--
Q 016082          111 QLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNT--------------------EMLKEFSQEVYIMRKIRHK--  167 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~-~~~~vAvK~~~~~~~~~--------------------~~~~~~~~E~~~l~~l~h~--  167 (395)
                      .|.+.+.||+|+||.||++.. +++.||||+++.+....                    .....+..|..++.++.|+  
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            377788999999999999987 68999999986543110                    0112367899999999877  


Q ss_pred             ceeeEEEEEecCCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcE
Q 016082          168 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV  247 (395)
Q Consensus       168 niv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~v  247 (395)
                      .++..++.    ...++||||++|++|.+....       .....++.+++.++.++|+.||+||||||+||+++.++.+
T Consensus        96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~  164 (198)
T cd05144          96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKI  164 (198)
T ss_pred             CCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcE
Confidence            44555542    345899999999998765421       3456788999999999999999999999999999999999


Q ss_pred             EEeeeccccccc
Q 016082          248 KVADFGVARVQA  259 (395)
Q Consensus       248 kl~DFg~a~~~~  259 (395)
                      +|+|||.+....
T Consensus       165 ~liDfg~~~~~~  176 (198)
T cd05144         165 YIIDWPQMVSTD  176 (198)
T ss_pred             EEEECCccccCC
Confidence            999999996543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.77  E-value=9.1e-20  Score=177.03  Aligned_cols=168  Identities=25%  Similarity=0.455  Sum_probs=132.1

Q ss_pred             cEEEEEecCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQ--KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  258 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~  258 (395)
                      .+||.|+++...+|.+++..+  ...-+....+.++.|++.|++|   +|.+|||+||.||....+.++||.|||+....
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~  406 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ  406 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence            589999999999999999643  3456777889999999999999   99999999999999999999999999998765


Q ss_pred             ccCC-------ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCC
Q 016082          259 AQSG-------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPK  330 (395)
Q Consensus       259 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  330 (395)
                      ....       .++...||..||+||.+.+..|+.|+||||||++++||+. =..+++.    ..+...++.+.-|+.-.
T Consensus       407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----~~t~~d~r~g~ip~~~~  482 (516)
T KOG1033|consen  407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----IATLTDIRDGIIPPEFL  482 (516)
T ss_pred             ccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----HHhhhhhhcCCCChHHh
Confidence            5544       5677889999999999999999999999999999999987 2222221    12222222222221111


Q ss_pred             CCcHHHHHHHHHhhccCCCCCCCHH
Q 016082          331 HAHPRLAELLERCWQHDPTQRPNFS  355 (395)
Q Consensus       331 ~~~~~l~~li~~cl~~dp~~RPs~~  355 (395)
                      .-.++=+.|+.+++.+.|.+||++.
T Consensus       483 ~d~p~e~~ll~~lls~~p~~RP~~~  507 (516)
T KOG1033|consen  483 QDYPEEYTLLQQLLSPSPEERPSAI  507 (516)
T ss_pred             hcCcHHHHHHHHhcCCCcccCchHH
Confidence            2234557999999999999999433

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.76  E-value=5.6e-18  Score=149.85  Aligned_cols=137  Identities=20%  Similarity=0.239  Sum_probs=100.4

Q ss_pred             eeeeeeeCceEEEEEEEC-CceEEEEEecCCCCCHHHHHH----------------------HHHHHHHHHhcCCC--ce
Q 016082          115 ECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKE----------------------FSQEVYIMRKIRHK--NV  169 (395)
Q Consensus       115 ~~~lg~G~~G~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~----------------------~~~E~~~l~~l~h~--ni  169 (395)
                      .+.||+|+||.||+|... ++.||||++++..........                      ...|...+.++.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            567999999999999885 899999998865432221111                      13566666666543  34


Q ss_pred             eeEEEEEecCCcEEEEEecCCCCCHHH-HHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeeeCCCCcE
Q 016082          170 VQFIGACTRPPNLCIVTEFMARGSIYD-FLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVV  247 (395)
Q Consensus       170 v~l~~~~~~~~~~~lV~E~~~ggsL~~-~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~iiHrDlkp~NiLl~~~~~v  247 (395)
                      ++.++.    ...++||||++|+.+.. .+.....   ...+..++.+++.++.++|+ .||+||||||+||+++ ++.+
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~---~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~  153 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRL---LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV  153 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhhh---cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence            555543    23589999999954322 1211111   15678899999999999999 9999999999999999 8999


Q ss_pred             EEeeeccccccc
Q 016082          248 KVADFGVARVQA  259 (395)
Q Consensus       248 kl~DFg~a~~~~  259 (395)
                      +++|||.++...
T Consensus       154 ~liDfg~a~~~~  165 (187)
T cd05119         154 YIIDVPQAVEID  165 (187)
T ss_pred             EEEECccccccc
Confidence            999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.74  E-value=3.3e-17  Score=150.77  Aligned_cols=136  Identities=13%  Similarity=0.150  Sum_probs=107.4

Q ss_pred             eeee-eeCceEEEEEEECCceEEEEEecCCCC-----------CHHHHHHHHHHHHHHHhcCCCce--eeEEEEEecCCc
Q 016082          116 CKVA-SGSYGDLYKGTYCSQEVAIKVLKPECV-----------NTEMLKEFSQEVYIMRKIRHKNV--VQFIGACTRPPN  181 (395)
Q Consensus       116 ~~lg-~G~~G~Vy~~~~~~~~vAvK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~~  181 (395)
                      ..|| .|+.|+||.+...+..++||.+.....           +......+.+|+.++.+++|++|  +..+++......
T Consensus        37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~  116 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG  116 (239)
T ss_pred             ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence            4677 889999999988899999998864321           11223568889999999998775  777776543222


Q ss_pred             ----EEEEEecCCC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccc
Q 016082          182 ----LCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR  256 (395)
Q Consensus       182 ----~~lV~E~~~g-gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~  256 (395)
                          .++|||+++| .+|.+++..  .+++...    +.+++.++.+||+.||+||||||+|||++.++.++|+|||.++
T Consensus       117 ~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~  190 (239)
T PRK01723        117 LFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGE  190 (239)
T ss_pred             cceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCcc
Confidence                3599999997 689988854  3455433    5689999999999999999999999999999999999999987


Q ss_pred             c
Q 016082          257 V  257 (395)
Q Consensus       257 ~  257 (395)
                      .
T Consensus       191 ~  191 (239)
T PRK01723        191 L  191 (239)
T ss_pred             c
Confidence            5

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.73  E-value=2.6e-17  Score=138.97  Aligned_cols=132  Identities=15%  Similarity=0.181  Sum_probs=114.7

Q ss_pred             eeeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC--CceeeEEEEEecCCcEEEEEecCCC
Q 016082          114 IECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH--KNVVQFIGACTRPPNLCIVTEFMAR  191 (395)
Q Consensus       114 i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~E~~~g  191 (395)
                      +.+.||.|+++.||+++..+..+++|..+....    ...+.+|+.+++.++|  .++++++++....+..+++|||++|
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g   77 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG   77 (155)
T ss_pred             cceecccccccceEEEEecCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence            457899999999999999888999999876532    4678899999999986  5899999998888889999999998


Q ss_pred             CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCCCCeeeCCCCcEEEeeeccccc
Q 016082          192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN---NIIHRDLKTANLLMDENGVVKVADFGVARV  257 (395)
Q Consensus       192 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~  257 (395)
                      +++..+        +......++.++++++.++|..   +++|+|++|+||++++.+.++++|||.++.
T Consensus        78 ~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          78 ETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             eecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            777654        4456677889999999999985   799999999999999989999999999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.70  E-value=1.1e-18  Score=179.23  Aligned_cols=251  Identities=25%  Similarity=0.396  Sum_probs=199.6

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE---CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCcEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY---CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCI  184 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  184 (395)
                      ...|.+.+.||+|+|+.|-....   ....+|+|.+...............|..+-..+. |+|++.+++........++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            44778888899999999987754   3345677766544333445566677888888887 9999999999999999999


Q ss_pred             EEecCCCCCHHHHH-hhccCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCCCCeeeCCCC-cEEEeeecccccccc-
Q 016082          185 VTEFMARGSIYDFL-HKQKGVFQLTSLLKVAIDVSKGMNYLH-QNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQ-  260 (395)
Q Consensus       185 V~E~~~ggsL~~~l-~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~iiHrDlkp~NiLl~~~~-~vkl~DFg~a~~~~~-  260 (395)
                      .+|+..|+++.+.+ .......+......+..|+..++.|+| ..++.|||+||+|.+++..+ .++++|||+|..... 
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~  178 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK  178 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence            99999999999988 543336677888899999999999999 99999999999999999999 999999999976544 


Q ss_pred             CC---ccccCCC-CcccccccccCCCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHhhhccCC--CCCCCCC
Q 016082          261 SG---VMTAETG-TYRWMAPEVIEHKPY-DYKADVFSFGIALWELLTGELPYAGLTPLQAA-VGVVQKSLR--PTIPKHA  332 (395)
Q Consensus       261 ~~---~~~~~~g-t~~y~aPE~~~~~~~-~~k~DvwslG~vl~elltg~~pf~~~~~~~~~-~~~~~~~~~--~~~~~~~  332 (395)
                      .+   .....+| ++.|+|||...+..| ....|+||.|+++.-+++|..||......... ........+  .......
T Consensus       179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (601)
T KOG0590|consen  179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSI  258 (601)
T ss_pred             CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccC
Confidence            22   2334578 999999999988544 57789999999999999999999765443322 111222111  3334567


Q ss_pred             cHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          333 HPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       333 ~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      +....+++.+++..+|..|.+.+++..
T Consensus       259 ~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  259 SDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             ChhhhhcccccccCCchhccccccccc
Confidence            888999999999999999999998765

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.60  E-value=5e-15  Score=147.74  Aligned_cols=139  Identities=19%  Similarity=0.297  Sum_probs=100.1

Q ss_pred             eeeeeeCceEEEEEEE-CCceEEEEEecCCCCCH----------------------------HHH----------HHHHH
Q 016082          116 CKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNT----------------------------EML----------KEFSQ  156 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~-~~~~vAvK~~~~~~~~~----------------------------~~~----------~~~~~  156 (395)
                      +.||+||+|.||+|+. .|+.||||+.++.....                            +..          -+|.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            5799999999999997 68999999998763110                            000          02555


Q ss_pred             HHHHHHhcC-----CCce--eeEEEEEecCCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHH-HHHHHHHCC
Q 016082          157 EVYIMRKIR-----HKNV--VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK-GMNYLHQNN  228 (395)
Q Consensus       157 E~~~l~~l~-----h~ni--v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~-~l~~LH~~~  228 (395)
                      |...+.+++     ++++  ++.+.  ......+|||||++|++|.+.........+   ...++..++. .+..+|..|
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~--~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYW--DRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEeh--hhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence            666666663     2332  33332  223346899999999999988754322222   3456666665 478899999


Q ss_pred             ccccCCCCCCeeeCCCCcEEEeeeccccccc
Q 016082          229 IIHRDLKTANLLMDENGVVKVADFGVARVQA  259 (395)
Q Consensus       229 iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~  259 (395)
                      ++|+|++|.||+++.++.++++|||++...+
T Consensus       278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            9999999999999999999999999997654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.55  E-value=1.2e-13  Score=139.64  Aligned_cols=142  Identities=17%  Similarity=0.213  Sum_probs=91.6

Q ss_pred             cCcceeeeeeeeCceEEEEEEE-C-CceEEEEEecCCCCC----------------------------H----HHHHH--
Q 016082          110 KQLKIECKVASGSYGDLYKGTY-C-SQEVAIKVLKPECVN----------------------------T----EMLKE--  153 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~-~-~~~vAvK~~~~~~~~----------------------------~----~~~~~--  153 (395)
                      ..|.. +.||+||+|+||+|+. . |+.||||+.++....                            .    +..+.  
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45665 7899999999999997 3 899999999876310                            0    11111  


Q ss_pred             ----HHHHHHHHHhcC----CCceeeEEEEE-ecCCcEEEEEecCCCCCHHHHHhhccCC-----CCHHHHHHHHHHHHH
Q 016082          154 ----FSQEVYIMRKIR----HKNVVQFIGAC-TRPPNLCIVTEFMARGSIYDFLHKQKGV-----FQLTSLLKVAIDVSK  219 (395)
Q Consensus       154 ----~~~E~~~l~~l~----h~niv~l~~~~-~~~~~~~lV~E~~~ggsL~~~l~~~~~~-----l~~~~~~~i~~~i~~  219 (395)
                          +.+|...+.+++    +.+.+.+-.++ .-....+|||||++|+.+.++-.-....     +....+..++.    
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~----  274 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT----  274 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH----
Confidence                344544444443    22222222222 1123467999999999998753211122     22222333333    


Q ss_pred             HHHHHHHCCccccCCCCCCeeeCCCC----cEEEeeeccccccc
Q 016082          220 GMNYLHQNNIIHRDLKTANLLMDENG----VVKVADFGVARVQA  259 (395)
Q Consensus       220 ~l~~LH~~~iiHrDlkp~NiLl~~~~----~vkl~DFg~a~~~~  259 (395)
                         .+...|++|+|++|.||+++.+|    .++++|||++...+
T Consensus       275 ---Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        275 ---QVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             ---HHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence               34569999999999999999988    99999999987543

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.52  E-value=5.6e-14  Score=121.97  Aligned_cols=128  Identities=16%  Similarity=0.199  Sum_probs=98.2

Q ss_pred             eeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc-eeeEEEEEecCCcEEEEEecCCCCC
Q 016082          115 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN-VVQFIGACTRPPNLCIVTEFMARGS  193 (395)
Q Consensus       115 ~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~E~~~ggs  193 (395)
                      .+.++.|.++.||+++..+..+++|+......   ....+..|..+++.+.+.+ +++++....  ...++||||++|.+
T Consensus         3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~   77 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE   77 (170)
T ss_pred             eeecCCcccCceEEEEECCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence            35688999999999999999999999865421   1234678999999887544 445555443  23579999999988


Q ss_pred             HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCc-----cccCCCCCCeeeCCCCcEEEeeeccccc
Q 016082          194 IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI-----IHRDLKTANLLMDENGVVKVADFGVARV  257 (395)
Q Consensus       194 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i-----iHrDlkp~NiLl~~~~~vkl~DFg~a~~  257 (395)
                      +.+.  .    .   .....+.++++++..||+.++     +|+|++|.||+++ ++.++++|||.+..
T Consensus        78 l~~~--~----~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          78 LLTE--D----F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc--c----c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            7643  0    1   113456789999999999985     9999999999999 67899999998863

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.51  E-value=1.5e-14  Score=143.24  Aligned_cols=266  Identities=22%  Similarity=0.251  Sum_probs=197.5

Q ss_pred             ccCcceeeeeee--eCceEEEEEEE----CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCc
Q 016082          109 AKQLKIECKVAS--GSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPN  181 (395)
Q Consensus       109 ~~~~~i~~~lg~--G~~G~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  181 (395)
                      ...+.+.+.+|.  |++|.||.++.    .+..+|+|.-+...........=.+|....++++ |+|.++.+..+...+.
T Consensus       113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~  192 (524)
T KOG0601|consen  113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI  192 (524)
T ss_pred             hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence            345677889999  99999998865    4577899885433222222233445666666665 8999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHH----HHHHHHHCCccccCCCCCCeeeCCC-CcEEEeeecccc
Q 016082          182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK----GMNYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVAR  256 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~iiHrDlkp~NiLl~~~-~~vkl~DFg~a~  256 (395)
                      .++-+|++. .+|.++.+.....++...++....+...    |+.++|+.+++|-|+||+||++..+ ...+++|||+..
T Consensus       193 lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~  271 (524)
T KOG0601|consen  193 LFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS  271 (524)
T ss_pred             ceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence            999999885 6999998887777899999999999999    9999999999999999999999999 889999999988


Q ss_pred             ccccCCcc------ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHhhhccCCCC
Q 016082          257 VQAQSGVM------TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL---TPLQAAVGVVQKSLRPT  327 (395)
Q Consensus       257 ~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~---~~~~~~~~~~~~~~~~~  327 (395)
                      ........      ....|...|++||..++- ++.++|+|++|.++.+..++..+....   ...+...    .....+
T Consensus       272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~----~~ip~e  346 (524)
T KOG0601|consen  272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ----GYIPLE  346 (524)
T ss_pred             EccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc----ccCchh
Confidence            66554311      122678899999997655 688999999999999998876554332   1111111    111222


Q ss_pred             CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHHHHHHH-Hhhcccccccc
Q 016082          328 IPKHAHPRLAELLERCWQHDPTQRPNFSQITD--ILKQMMKEVL-YWLSPNLINTN  380 (395)
Q Consensus       328 ~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~--~l~~~~~~~~-~~~~~~~~~~~  380 (395)
                      .-...+.++...+..++..+|..|++++.+.+  .+....--.. .+.++.++.++
T Consensus       347 ~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~  402 (524)
T KOG0601|consen  347 FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISND  402 (524)
T ss_pred             hhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccc
Confidence            22344667788999999999999999988765  3333333223 56666666654

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.48  E-value=4.4e-14  Score=146.87  Aligned_cols=249  Identities=23%  Similarity=0.313  Sum_probs=188.9

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  182 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  182 (395)
                      ....+.+.+.+.+-+|+++.++.++-  .+...+.|+.+... ......+....+-.++-..++|.++.....+......
T Consensus       800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~  879 (1205)
T KOG0606|consen  800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL  879 (1205)
T ss_pred             cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence            44556777888899999999998765  23334444433211 1111223444455555545667777776666667789


Q ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-
Q 016082          183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-  261 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-  261 (395)
                      +++++|..|++|...|+.. +..+..........+..+.+|||+..+.|||++|.|.+...+|+.++.|||.....+.. 
T Consensus       880 ~L~~~~~~~~~~~Skl~~~-~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~  958 (1205)
T KOG0606|consen  880 PLVGHYLNGGDLPSKLHNS-GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP  958 (1205)
T ss_pred             chhhHHhccCCchhhhhcC-CCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccccc
Confidence            9999999999999999874 45566666677778889999999999999999999999999999999999843211100 


Q ss_pred             -------------------------------CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 016082          262 -------------------------------GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL  310 (395)
Q Consensus       262 -------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~  310 (395)
                                                     ...-...||+.|.+||...+......+|.|+.|++++|.++|.+||...
T Consensus       959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen  959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred             CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence                                           0011235899999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHhhhccCC-CCCCCCCcHHHHHHHHHhhccCCCCCCCHH
Q 016082          311 TPLQAAVGVVQKSLR-PTIPKHAHPRLAELLERCWQHDPTQRPNFS  355 (395)
Q Consensus       311 ~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPs~~  355 (395)
                      ++.+.+.++...... |..+...+++..+++.+.+..+|.+|-.+.
T Consensus      1039 tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1039 TPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             chhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            999988776654433 444567789999999999999999997765

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.47  E-value=4.9e-13  Score=118.40  Aligned_cols=138  Identities=17%  Similarity=0.205  Sum_probs=101.5

Q ss_pred             eeeeeeeCceEEEEEEEC--------CceEEEEEecCCCCC--------------------HHHHHHHH----HHHHHHH
Q 016082          115 ECKVASGSYGDLYKGTYC--------SQEVAIKVLKPECVN--------------------TEMLKEFS----QEVYIMR  162 (395)
Q Consensus       115 ~~~lg~G~~G~Vy~~~~~--------~~~vAvK~~~~~~~~--------------------~~~~~~~~----~E~~~l~  162 (395)
                      ...||.|--+.||.|...        +..+|||+.+....+                    .+..+.+.    +|...|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            346899999999999754        368999998643210                    11122333    8999999


Q ss_pred             hcCC--CceeeEEEEEecCCcEEEEEecCCCCCHHH-HHhhccCCCCHHHHHHHHHHHHHHHHHH-HHCCccccCCCCCC
Q 016082          163 KIRH--KNVVQFIGACTRPPNLCIVTEFMARGSIYD-FLHKQKGVFQLTSLLKVAIDVSKGMNYL-HQNNIIHRDLKTAN  238 (395)
Q Consensus       163 ~l~h--~niv~l~~~~~~~~~~~lV~E~~~ggsL~~-~l~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~iiHrDlkp~N  238 (395)
                      ++..  -++++.+++    ..-++||||+.+..+.. .++.  ..++...+..+..+++.+|..+ |+.|++|+||++.|
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N  155 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN  155 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence            9963  567777764    35689999998754422 2322  2355566778889999999999 89999999999999


Q ss_pred             eeeCCCCcEEEeeeccccccc
Q 016082          239 LLMDENGVVKVADFGVARVQA  259 (395)
Q Consensus       239 iLl~~~~~vkl~DFg~a~~~~  259 (395)
                      |+++ ++.+.++|||.+....
T Consensus       156 IL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         156 MLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             EEEE-CCcEEEEECCCceeCC
Confidence            9997 4689999999886543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.41  E-value=1.1e-11  Score=124.49  Aligned_cols=162  Identities=17%  Similarity=0.270  Sum_probs=125.0

Q ss_pred             CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecCCCCCHHHHHhhccCCCCHHHHH
Q 016082          132 CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL  211 (395)
Q Consensus       132 ~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~  211 (395)
                      .+.+|.|.+.+...  ........+-++-|+.++||||++++......+..|+|+|-+.  .|..++.+..    ...+.
T Consensus        36 ~~~~vsVF~~~~~~--~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v~  107 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSN--GEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEVC  107 (690)
T ss_pred             cCCceEEEEEeCCC--chhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHHH
Confidence            56788888877553  2444567788899999999999999999999999999999885  5777776632    55677


Q ss_pred             HHHHHHHHHHHHHH-HCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCcccc-CCCCcccccccccCCCCCCChhh
Q 016082          212 KVAIDVSKGMNYLH-QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA-ETGTYRWMAPEVIEHKPYDYKAD  289 (395)
Q Consensus       212 ~i~~~i~~~l~~LH-~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~k~D  289 (395)
                      .-+.||+.||.+|| ..+++|++|....|+++..|..||++|..++.......+.. ..---.|..|+.+....  ...|
T Consensus       108 ~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~D  185 (690)
T KOG1243|consen  108 LGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSID  185 (690)
T ss_pred             HHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cchh
Confidence            77889999999998 56899999999999999999999999999865443321111 11112345666543322  5579


Q ss_pred             HHHHHHHHHHHHhC
Q 016082          290 VFSFGIALWELLTG  303 (395)
Q Consensus       290 vwslG~vl~elltg  303 (395)
                      .|.|||+++|++.|
T Consensus       186 ~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  186 SWGLGCLIEELFNG  199 (690)
T ss_pred             hhhHHHHHHHHhCc
Confidence            99999999999998

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.39  E-value=5.5e-12  Score=108.51  Aligned_cols=132  Identities=23%  Similarity=0.328  Sum_probs=101.8

Q ss_pred             eeeeeCceEEEEEEECCceEEEEEecCCCC-CHHH-----HHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecCC
Q 016082          117 KVASGSYGDLYKGTYCSQEVAIKVLKPECV-NTEM-----LKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA  190 (395)
Q Consensus       117 ~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~-~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~  190 (395)
                      .+++|+-+.+|.+.+.+.++.+|.=.+... .++.     ..+..+|..++.+++--.|..-+=+..+++...|+|||++
T Consensus         3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~   82 (204)
T COG3642           3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE   82 (204)
T ss_pred             hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence            578899999999988888888886433322 2221     2357789999999986566555555667778899999999


Q ss_pred             CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccc
Q 016082          191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV  257 (395)
Q Consensus       191 ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~  257 (395)
                      |..|.+.+...    .    ..++..+=.-+.-||..||+|+||.+.||+++.++ +.++|||++..
T Consensus        83 G~~lkd~l~~~----~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          83 GELLKDALEEA----R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             ChhHHHHHHhc----c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            99999998764    2    34455555666779999999999999999998765 99999999974

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.38  E-value=7.6e-13  Score=122.14  Aligned_cols=193  Identities=20%  Similarity=0.336  Sum_probs=139.5

Q ss_pred             HHHHhcCCCceeeEEEEEecCC-----cEEEEEecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC--C
Q 016082          159 YIMRKIRHKNVVQFIGACTRPP-----NLCIVTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQN--N  228 (395)
Q Consensus       159 ~~l~~l~h~niv~l~~~~~~~~-----~~~lV~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~--~  228 (395)
                      .-+-++.|.||++++.++.+..     ...+++|||+-|++..+|++.   ...+......+|+-||+.||.|||+.  -
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp  198 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence            3344557999999999986544     578999999999999999754   35678888999999999999999987  4


Q ss_pred             ccccCCCCCCeeeCCCCcEEEeeecccccccc-----CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhC
Q 016082          229 IIHRDLKTANLLMDENGVVKVADFGVARVQAQ-----SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG  303 (395)
Q Consensus       229 iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg  303 (395)
                      |+|+++..+.|++..+|-+|+.--.-......     .......++-++|.+||.-.....+.++|||+||....+|.-+
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence            99999999999999999888753211111000     0112234677899999987777778899999999999999877


Q ss_pred             CCCCC-CCC---HHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          304 ELPYA-GLT---PLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       304 ~~pf~-~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      ..--. +.+   ..+...++... +       -..--++++.+|++..|..||++.+++-
T Consensus       279 Eiq~tnseS~~~~ee~ia~~i~~-l-------en~lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  279 EIQSTNSESKVEVEENIANVIIG-L-------ENGLQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             eeccCCCcceeehhhhhhhheee-c-------cCccccCcCcccccCCCCCCcchhhhhc
Confidence            64322 111   11111111111 0       1122467899999999999999998763

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.34  E-value=8.9e-13  Score=130.75  Aligned_cols=244  Identities=20%  Similarity=0.220  Sum_probs=181.6

Q ss_pred             cccCcceeeeeeeeCceEEEEEEE---CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCcEE
Q 016082          108 DAKQLKIECKVASGSYGDLYKGTY---CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       108 ~~~~~~i~~~lg~G~~G~Vy~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  183 (395)
                      ...++..+..||.|.|+.|+....   .+..+++|.+............-..|+.+...+. |.+++..+..+..-++.|
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            345788999999999999998754   3567899988766544433344566777777775 889999888888888889


Q ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCC-CcEEEeeeccccccccCC
Q 016082          184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSG  262 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~-~~vkl~DFg~a~~~~~~~  262 (395)
                      +=.||++++++...+.. ...+.+...+++..+++.++.++|++.++|+|+||.||++..+ +.-++.|||......-..
T Consensus       343 ip~e~~~~~s~~l~~~~-~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~  421 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSVT-SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS  421 (524)
T ss_pred             CchhhhcCcchhhhhHH-HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccceec
Confidence            99999999988776632 4567888899999999999999999999999999999999886 778999999986422211


Q ss_pred             ccccCCCCccc-ccccccCCCCCCChhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHH
Q 016082          263 VMTAETGTYRW-MAPEVIEHKPYDYKADVFSFGIALWELLTGELP-YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELL  340 (395)
Q Consensus       263 ~~~~~~gt~~y-~aPE~~~~~~~~~k~DvwslG~vl~elltg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  340 (395)
                       .....++..| .+|.......+..+.|+||||..+.+.+++... ..+...     ..+..+..+..+..- .++..+.
T Consensus       422 -~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~-----~~i~~~~~p~~~~~~-~~~q~~~  494 (524)
T KOG0601|consen  422 -GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS-----LTIRSGDTPNLPGLK-LQLQVLL  494 (524)
T ss_pred             -ccccccccccccchhhccccccccccccccccccccccccCcccCcccccc-----eeeecccccCCCchH-Hhhhhhh
Confidence             1112223333 355556677888999999999999999997643 322221     112223333333333 7888999


Q ss_pred             HHhhccCCCCCCCHHHHHH
Q 016082          341 ERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       341 ~~cl~~dp~~RPs~~ell~  359 (395)
                      ..+...++..||.+.++..
T Consensus       495 kv~~~~~~~~~~l~~~l~~  513 (524)
T KOG0601|consen  495 KVMINPDRKRRPSAVELSL  513 (524)
T ss_pred             hhhcCCccccchhhhhhcc
Confidence            9999999999999988754

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.31  E-value=1.2e-11  Score=111.81  Aligned_cols=139  Identities=18%  Similarity=0.263  Sum_probs=107.3

Q ss_pred             eeeeeeCceEEEEEEECC-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC--CceeeEEEEEecCC---cEEEEEecC
Q 016082          116 CKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH--KNVVQFIGACTRPP---NLCIVTEFM  189 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~---~~~lV~E~~  189 (395)
                      +.|+.|.++.||+++..+ +.+++|+....... .....+.+|..+++.+++  .++++++.+.....   ..++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            568999999999998865 89999998654321 134578899999999976  44677887776542   578999999


Q ss_pred             CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 016082          190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-------------------------------------------  226 (395)
Q Consensus       190 ~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-------------------------------------------  226 (395)
                      +|.++.+.+..  ..++......++.++++++..||+                                           
T Consensus        83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence            99888775432  346666777777788888877773                                           


Q ss_pred             -------------CCccccCCCCCCeeeCC--CCcEEEeeeccccc
Q 016082          227 -------------NNIIHRDLKTANLLMDE--NGVVKVADFGVARV  257 (395)
Q Consensus       227 -------------~~iiHrDlkp~NiLl~~--~~~vkl~DFg~a~~  257 (395)
                                   ..++|+|+.|.||+++.  ++.+.|+||+.+..
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         23699999999999998  67789999998864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.31  E-value=4.1e-11  Score=102.82  Aligned_cols=145  Identities=22%  Similarity=0.277  Sum_probs=108.5

Q ss_pred             eeeeeeeeCceEEEEEEECCceEEEEEecCCCC-----CHH-HHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          114 IECKVASGSYGDLYKGTYCSQEVAIKVLKPECV-----NTE-MLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       114 i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~-----~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      ....+-+|+-+.|+++.+.|+...||.=-+..+     +.. ...+..+|++++.+++--.|.--.=++.+...-.|+||
T Consensus        11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME   90 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME   90 (229)
T ss_pred             cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence            456788899999999999999988886432222     222 23568899999999975555433334555556789999


Q ss_pred             cCCC-CCHHHHHhhccCC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCC---cEEEeeecccccc
Q 016082          188 FMAR-GSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADFGVARVQ  258 (395)
Q Consensus       188 ~~~g-gsL~~~l~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~---~vkl~DFg~a~~~  258 (395)
                      |++| .++.+++...... ........++.+|=+.+.-||.++|||+||...||++..++   .+.++|||++...
T Consensus        91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            9987 5788888665332 33334478889999999999999999999999999997665   3589999998653

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.31  E-value=1.8e-10  Score=110.03  Aligned_cols=256  Identities=18%  Similarity=0.276  Sum_probs=174.8

Q ss_pred             cceeeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEEE------E-ecCCcEE
Q 016082          112 LKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGA------C-TRPPNLC  183 (395)
Q Consensus       112 ~~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~------~-~~~~~~~  183 (395)
                      ....+.||+|+-+.+|-.-.-+..|| |+........     -.+.+..|.+. .||-+-.-+.+      . ..+....
T Consensus        13 i~~gr~LgqGgea~ly~l~e~~d~VA-KIYh~Pppa~-----~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG   86 (637)
T COG4248          13 IPPGRPLGQGGEADLYTLGEVRDQVA-KIYHAPPPAA-----QAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG   86 (637)
T ss_pred             cCCCccccCCccceeeecchhhchhh-eeecCCCchH-----HHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence            34567899999999996543333343 6654432211     11233334443 35533221111      1 1222377


Q ss_pred             EEEecCCCCC-HHHHHh-----hccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccc
Q 016082          184 IVTEFMARGS-IYDFLH-----KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV  257 (395)
Q Consensus       184 lV~E~~~ggs-L~~~l~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~  257 (395)
                      +.|..++|.. +..+++     +....+.++-+++.++.++.+...||..|..-+|++++|+|+++++.|.|.|=..-..
T Consensus        87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceee
Confidence            8888888752 223321     2234577888999999999999999999999999999999999999999999666555


Q ss_pred             cccCCccccCCCCcccccccccC-----CCCCCChhhHHHHHHHHHHHHhC-CCCCCCC-------CHHHHHH--Hh---
Q 016082          258 QAQSGVMTAETGTYRWMAPEVIE-----HKPYDYKADVFSFGIALWELLTG-ELPYAGL-------TPLQAAV--GV---  319 (395)
Q Consensus       258 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwslG~vl~elltg-~~pf~~~-------~~~~~~~--~~---  319 (395)
                      ...........|...|.+||.-+     +-.-+..+|.|.||+++++++.| +.||.+.       .+.+...  +.   
T Consensus       167 ~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~y  246 (637)
T COG4248         167 NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAY  246 (637)
T ss_pred             ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeee
Confidence            55555566778999999999865     33456789999999999999885 9999874       2233111  11   


Q ss_pred             ---hhccCCCC---CC-CCCcHHHHHHHHHhhcc--CCCCCCCHHHHHHHHHHHHHHHHHhhc
Q 016082          320 ---VQKSLRPT---IP-KHAHPRLAELLERCWQH--DPTQRPNFSQITDILKQMMKEVLYWLS  373 (395)
Q Consensus       320 ---~~~~~~~~---~~-~~~~~~l~~li~~cl~~--dp~~RPs~~ell~~l~~~~~~~~~~~~  373 (395)
                         .+.+++|.   +| .-+++++..+..+|+..  ++.-|||++..+..|..+.+++.-|.-
T Consensus       247 a~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v  309 (637)
T COG4248         247 ASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTV  309 (637)
T ss_pred             chhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhh
Confidence               11122211   11 23688999999999985  467999999999999999999887654

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.23  E-value=2.8e-10  Score=106.17  Aligned_cols=132  Identities=14%  Similarity=0.098  Sum_probs=98.7

Q ss_pred             eEEEEEEECCceEEEEEecCCCCCHHHH----------HHHHHHHHHHHhcCCCc--eeeEEEEEec-----CCcEEEEE
Q 016082          124 GDLYKGTYCSQEVAIKVLKPECVNTEML----------KEFSQEVYIMRKIRHKN--VVQFIGACTR-----PPNLCIVT  186 (395)
Q Consensus       124 G~Vy~~~~~~~~vAvK~~~~~~~~~~~~----------~~~~~E~~~l~~l~h~n--iv~l~~~~~~-----~~~~~lV~  186 (395)
                      ..|.+.+..|+.+.||......... ..          ..+.+|...+.++...+  .+..++++..     ....++||
T Consensus        36 rrvvr~~~~g~~~~vKr~~~~~~~~-~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt  114 (268)
T PRK15123         36 RRTLRFELAGKSYFLKWHRGTGWGE-IFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT  114 (268)
T ss_pred             ceEEEEEECCEEEEEEEecCCcHHH-HhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence            3466778888999999775433211 11          14778999998885433  3445555543     23478999


Q ss_pred             ecCCCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCC-------CCcEEEeeecccc
Q 016082          187 EFMARG-SIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-------NGVVKVADFGVAR  256 (395)
Q Consensus       187 E~~~gg-sL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~-------~~~vkl~DFg~a~  256 (395)
                      |++++. +|.+++... ..+.+......++.+++..+.-||+.||+|+|+++.|||++.       +..+.++||+.++
T Consensus       115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            999886 899988542 344566677889999999999999999999999999999975       4679999999885

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.15  E-value=5.3e-10  Score=98.64  Aligned_cols=126  Identities=20%  Similarity=0.260  Sum_probs=83.6

Q ss_pred             EEEEEEE-CCceEEEEEecCCCCC------------------------HHHHHHHHHHHHHHHhcCCC--ceeeEEEEEe
Q 016082          125 DLYKGTY-CSQEVAIKVLKPECVN------------------------TEMLKEFSQEVYIMRKIRHK--NVVQFIGACT  177 (395)
Q Consensus       125 ~Vy~~~~-~~~~vAvK~~~~~~~~------------------------~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~  177 (395)
                      .||.|.. .+..+|||+.+....+                        .-......+|...|.++...  ++++.+++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899987 6789999998753211                        11124578899999999865  567777553 


Q ss_pred             cCCcEEEEEecCC--CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHH-HHHCCccccCCCCCCeeeCCCCcEEEeeecc
Q 016082          178 RPPNLCIVTEFMA--RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY-LHQNNIIHRDLKTANLLMDENGVVKVADFGV  254 (395)
Q Consensus       178 ~~~~~~lV~E~~~--ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~  254 (395)
                         .-++||||++  |..+..+... .  ++......++.+++..+.. +|..||+|+||.+.||+++++ .+.++|||.
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~-~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q  152 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDV-D--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ  152 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHC-G--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred             ---CCEEEEEecCCCccchhhHHhc-c--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence               3479999998  6555443322 1  2244566777788885555 579999999999999999887 999999998


Q ss_pred             cccc
Q 016082          255 ARVQ  258 (395)
Q Consensus       255 a~~~  258 (395)
                      +...
T Consensus       153 av~~  156 (188)
T PF01163_consen  153 AVDS  156 (188)
T ss_dssp             EEET
T ss_pred             ceec
Confidence            8643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.01  E-value=3.5e-09  Score=95.30  Aligned_cols=105  Identities=17%  Similarity=0.267  Sum_probs=84.1

Q ss_pred             HHHHHHHHHHHhcCCC--ceeeEEEEEecCC----cEEEEEecCCCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH
Q 016082          152 KEFSQEVYIMRKIRHK--NVVQFIGACTRPP----NLCIVTEFMARG-SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL  224 (395)
Q Consensus       152 ~~~~~E~~~l~~l~h~--niv~l~~~~~~~~----~~~lV~E~~~gg-sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L  224 (395)
                      ....+|...+..+...  .++..+++.....    ..++|+|++++. +|.+++..... .+......++.+++..+.-|
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence            4577888888887633  3456666655432    358999999984 79998876332 56677889999999999999


Q ss_pred             HHCCccccCCCCCCeeeCCCC---cEEEeeeccccc
Q 016082          225 HQNNIIHRDLKTANLLMDENG---VVKVADFGVARV  257 (395)
Q Consensus       225 H~~~iiHrDlkp~NiLl~~~~---~vkl~DFg~a~~  257 (395)
                      |..||+|+|++|.|||++.++   .+.++||+-++.
T Consensus       135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999999999999999999887   899999998874

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>cd04928 ACT_TyrKc Uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains

Probab=99.00  E-value=9.7e-10  Score=79.47  Aligned_cols=55  Identities=58%  Similarity=0.925  Sum_probs=52.4

Q ss_pred             HHHHHHHHHhhhcCCCeeeeceeccCCCceeeEEEecCCCCcchHHHHHHHHHHH
Q 016082            9 MKVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEI   63 (395)
Q Consensus         9 ~~~~~~~~~~~~~~l~i~~~~~f~~~~~~~l~~~~v~gw~~~~~~~l~~~l~~~~   63 (395)
                      .++++++.+|+..||||..|.+|++.||+.||+|+|.+|..+++++|..++.+++
T Consensus        13 gLFa~iag~L~~~~LnI~~A~i~tt~dG~~LDtF~V~d~~~~~~~~~~~~~~~~~   67 (68)
T cd04928          13 KLLSQLSSLLGDLGLNIAEAHAFSTDDGLALDIFVVTGWKRGETAALGHALQKEI   67 (68)
T ss_pred             chHHHHHHHHHHCCCceEEEEEEEcCCCeEEEEEEEecCCccchHHHHHHHHHhh
Confidence            3789999999999999999999999999999999999999999999999998864

This CD includes a novel, yet uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains. Members of this CD belong to the superfamily of ACT regulatory domains.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.99  E-value=3.1e-08  Score=100.06  Aligned_cols=140  Identities=19%  Similarity=0.299  Sum_probs=96.9

Q ss_pred             eeeeeeCceEEEEEEEC-CceEEEEEecCCCCC----------------------------HHHHH----------HHHH
Q 016082          116 CKVASGSYGDLYKGTYC-SQEVAIKVLKPECVN----------------------------TEMLK----------EFSQ  156 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~~-~~~vAvK~~~~~~~~----------------------------~~~~~----------~~~~  156 (395)
                      ..|+++|-|+||+|+.. |+.||||+.+++...                            .+..+          ++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            57899999999999985 899999999876421                            00011          1455


Q ss_pred             HHHHHHhcC-----CCce--eeEEEEEecCCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 016082          157 EVYIMRKIR-----HKNV--VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI  229 (395)
Q Consensus       157 E~~~l~~l~-----h~ni--v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i  229 (395)
                      |...+.+++     .+++  ++++  .+-...-.|+|||++|-.+.+........++...+.....++  .+..+-..|+
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~--we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~~~dgf  286 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVY--WEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQLLRDGF  286 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceee--hhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHHHhcCc
Confidence            666666663     2333  2332  222344689999999999988854333455644444433332  2444555899


Q ss_pred             cccCCCCCCeeeCCCCcEEEeeeccccccc
Q 016082          230 IHRDLKTANLLMDENGVVKVADFGVARVQA  259 (395)
Q Consensus       230 iHrDlkp~NiLl~~~~~vkl~DFg~a~~~~  259 (395)
                      +|.|..|.||+++.+|.+.+.|||+....+
T Consensus       287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         287 FHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             cccCCCccceEEecCCcEEEEcCcceecCC
Confidence            999999999999999999999999987544

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.96  E-value=5.2e-09  Score=95.45  Aligned_cols=138  Identities=18%  Similarity=0.231  Sum_probs=103.7

Q ss_pred             cceeeeeeeeCceEEEEEEE-CCceEEEEEecCCCCC--------------------HHHHHHHHHHHHHHHhcCCC--c
Q 016082          112 LKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVN--------------------TEMLKEFSQEVYIMRKIRHK--N  168 (395)
Q Consensus       112 ~~i~~~lg~G~~G~Vy~~~~-~~~~vAvK~~~~~~~~--------------------~~~~~~~~~E~~~l~~l~h~--n  168 (395)
                      ..+..+||-|--+.||.|.+ .+.++|||.-+-...+                    .-......+|..+|.+|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            56778999999999999998 5899999986543211                    11234467899999999754  6


Q ss_pred             eeeEEEEEecCCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEE
Q 016082          169 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVK  248 (395)
Q Consensus       169 iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vk  248 (395)
                      ++..+++    +.-.+|||+++|-.|+..-      ++......++..|+.-+.-+-..||||+|+++-||+++++|.+.
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~  242 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV  242 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence            7777653    4568999999997776542      12333445555666666666689999999999999999999999


Q ss_pred             Eeeeccccccc
Q 016082          249 VADFGVARVQA  259 (395)
Q Consensus       249 l~DFg~a~~~~  259 (395)
                      ++||-.+...+
T Consensus       243 vIDwPQ~v~~~  253 (304)
T COG0478         243 VIDWPQAVPIS  253 (304)
T ss_pred             EEeCcccccCC
Confidence            99998775433

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.95  E-value=6.5e-08  Score=94.98  Aligned_cols=213  Identities=15%  Similarity=0.197  Sum_probs=152.8

Q ss_pred             ceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec----CCcEEEEEecCCC-CCHH
Q 016082          123 YGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR----PPNLCIVTEFMAR-GSIY  195 (395)
Q Consensus       123 ~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~E~~~g-gsL~  195 (395)
                      ..+.|+++.  .|..|++|.+...+..  .......-+++++++.|+|+|++..++..    ...+++|++|+++ ++|+
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~--~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQ--STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             cceeEeeeeccCCceeeeeeecccccc--CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence            456788876  6788999998433211  11123345778899999999999998863    3468999999986 5788


Q ss_pred             HHHhhc--------------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC
Q 016082          196 DFLHKQ--------------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  261 (395)
Q Consensus       196 ~~l~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~  261 (395)
                      ++-...              +...++..+|.++.|+..||.++|+.|...+-|.|.+|+++.+.+++|...|........
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            865322              124567889999999999999999999999999999999999888888877776554433


Q ss_pred             CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHH
Q 016082          262 GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELP-YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELL  340 (395)
Q Consensus       262 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  340 (395)
                      .      +       |-+.+   -.+-|.=.||.++..|.||..- +......+....        .+...++.++++++
T Consensus       447 ~------~-------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~--------~I~~~yS~D~rn~v  502 (655)
T KOG3741|consen  447 P------T-------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLT--------RITTTYSTDLRNVV  502 (655)
T ss_pred             C------C-------cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHHHH--------HhhhhhhHHHHHHH
Confidence            2      0       11111   2357889999999999998643 333222222111        22345678999999


Q ss_pred             HHhhccCCCCCCCHHHHHHHHH
Q 016082          341 ERCWQHDPTQRPNFSQITDILK  362 (395)
Q Consensus       341 ~~cl~~dp~~RPs~~ell~~l~  362 (395)
                      .-....++++ -++.+++..+-
T Consensus       503 ~yl~s~~~~~-ksI~~llp~~~  523 (655)
T KOG3741|consen  503 EYLESLNFRE-KSIQDLLPMIG  523 (655)
T ss_pred             HHHHhcCccc-ccHHHHHHHHH
Confidence            9999999987 67777776444

>PRK09902 hypothetical protein; Provisional

Probab=98.84  E-value=8.1e-08  Score=85.55  Aligned_cols=139  Identities=14%  Similarity=0.097  Sum_probs=101.8

Q ss_pred             eeeCceEEEEEEECCceEEEEEecCCC---CC-HHHHHHHHHHHHHHHhcCC--CceeeEEEEEecCC----cEEEEEec
Q 016082          119 ASGSYGDLYKGTYCSQEVAIKVLKPEC---VN-TEMLKEFSQEVYIMRKIRH--KNVVQFIGACTRPP----NLCIVTEF  188 (395)
Q Consensus       119 g~G~~G~Vy~~~~~~~~vAvK~~~~~~---~~-~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~----~~~lV~E~  188 (395)
                      |+||-+-|++-...|+.+-+|.-....   .. +.-...|.+|...++++..  -.+++.........    ..+||+|-
T Consensus        27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~  106 (216)
T PRK09902         27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTED  106 (216)
T ss_pred             CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEe
Confidence            557777788888877778888754110   00 2234679999999999963  22555552221211    36899998


Q ss_pred             CCC-CCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCc--EEEeeeccccc
Q 016082          189 MAR-GSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV--VKVADFGVARV  257 (395)
Q Consensus       189 ~~g-gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~--vkl~DFg~a~~  257 (395)
                      ++| -+|.+++.+.. .+.+......+..++++.+.-||+.|+.|+|+.+.||+++.+|.  +.++||.-++.
T Consensus       107 L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        107 MAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             CCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            864 48988885532 34566677889999999999999999999999999999987777  99999998864

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.80  E-value=8.7e-08  Score=85.70  Aligned_cols=141  Identities=18%  Similarity=0.232  Sum_probs=96.6

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEECCceEEEEEecCCCCCHH-HHH------HHHHHHHHHHhcCC---CceeeEEEEE
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTE-MLK------EFSQEVYIMRKIRH---KNVVQFIGAC  176 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~-~~~------~~~~E~~~l~~l~h---~niv~l~~~~  176 (395)
                      +-..+|++.+.+-......|.+-...++.+.+|..+......+ ...      ...+++..+.+++.   -....++.+.
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            3456888888888888888888888999999999886532111 111      12334444444432   2333333333


Q ss_pred             ec-----CCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEee
Q 016082          177 TR-----PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD  251 (395)
Q Consensus       177 ~~-----~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~D  251 (395)
                      ..     ....+++|||++|..|.+...     +++    .++..+..++.-+|+.|+.|+|..|.|+++++++ ++++|
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID  177 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIID  177 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEE
Confidence            22     234678999999988876532     222    2445677889999999999999999999998655 89999


Q ss_pred             eccccc
Q 016082          252 FGVARV  257 (395)
Q Consensus       252 Fg~a~~  257 (395)
                      |+..+.
T Consensus       178 ~~~k~~  183 (229)
T PF06176_consen  178 TQGKRM  183 (229)
T ss_pred             Cccccc
Confidence            987753

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.80  E-value=2.6e-09  Score=107.95  Aligned_cols=143  Identities=19%  Similarity=0.311  Sum_probs=105.9

Q ss_pred             HHHHHHHHHHHC-CccccCCCCCCeeeCCCCcEEEeeeccccccccCCc-----ccc-----CCCCcccccccccCCCCC
Q 016082          216 DVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-----MTA-----ETGTYRWMAPEVIEHKPY  284 (395)
Q Consensus       216 ~i~~~l~~LH~~-~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~-----~~~-----~~gt~~y~aPE~~~~~~~  284 (395)
                      +++.|+.|+|+. ++||++|.|++|.++.++.+|++.|+.+........     .+.     ......|.|||.+.+...
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~  186 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN  186 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence            444899999965 899999999999999999999999998754333111     111     123467999999999888


Q ss_pred             CChhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHH--hhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHH
Q 016082          285 DYKADVFSFGIALWELL-TGELPYAGLTPLQAAVG--VVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQIT  358 (395)
Q Consensus       285 ~~k~DvwslG~vl~ell-tg~~pf~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell  358 (395)
                      +.++|+||+|+++|.+. .|+..+...........  .....-....+..+++++++=+.+++..++..||++.++.
T Consensus       187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL  263 (700)
T ss_pred             cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence            99999999999999998 57776665433222111  1111112234567889999999999999999999766654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.72  E-value=1.8e-07  Score=85.37  Aligned_cols=135  Identities=17%  Similarity=0.254  Sum_probs=86.4

Q ss_pred             eeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc--eeeEEEEEecCCcEEEEEecCCCCC
Q 016082          116 CKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN--VVQFIGACTRPPNLCIVTEFMARGS  193 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~E~~~ggs  193 (395)
                      ..||.|..+.||+.  .+..+++|+..+...    .....+|.++++.+..-+  +++.+++....+..++|||+++|..
T Consensus         7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~~----~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTH--KTGKWMLKLYNPGFD----KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEe--cCCCEEEEeCCCCCC----HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            57899999999984  356788899875431    234678999999986433  5788888888888899999999963


Q ss_pred             -HHHH---------------------Hhhcc-CCCCHHHHH-HHHH----------HHHH-HHHHHHH----CCccccCC
Q 016082          194 -IYDF---------------------LHKQK-GVFQLTSLL-KVAI----------DVSK-GMNYLHQ----NNIIHRDL  234 (395)
Q Consensus       194 -L~~~---------------------l~~~~-~~l~~~~~~-~i~~----------~i~~-~l~~LH~----~~iiHrDl  234 (395)
                       +...                     ++... ...+..... .+..          .+.. ...+|.+    ..++|+|+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence             1111                     11100 111111110 0100          0111 1222221    24789999


Q ss_pred             CCCCeeeCCCCcEEEeeeccccc
Q 016082          235 KTANLLMDENGVVKVADFGVARV  257 (395)
Q Consensus       235 kp~NiLl~~~~~vkl~DFg~a~~  257 (395)
                      .|.||++++++ +.++||+.+..
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcCc
Confidence            99999999888 99999998864

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.66  E-value=2.5e-07  Score=83.90  Aligned_cols=139  Identities=19%  Similarity=0.281  Sum_probs=86.3

Q ss_pred             eeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCC--ceeeEEEEEec---CCcEEEEEecC
Q 016082          115 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK--NVVQFIGACTR---PPNLCIVTEFM  189 (395)
Q Consensus       115 ~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~---~~~~~lV~E~~  189 (395)
                      ++.++.|..+.||+.+..+..+++|+....    .....+.+|..+++.+...  .+++++.....   ....+++|+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETTSEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECCcEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence            467899999999999998889999997643    4557788999999888633  35677764432   23479999999


Q ss_pred             CCCCHHH----------------HH---hhcc---CCCCHHH---------HHHH------------HHHHHH-HHHHHH
Q 016082          190 ARGSIYD----------------FL---HKQK---GVFQLTS---------LLKV------------AIDVSK-GMNYLH  225 (395)
Q Consensus       190 ~ggsL~~----------------~l---~~~~---~~l~~~~---------~~~i------------~~~i~~-~l~~LH  225 (395)
                      +|..+..                .+   +...   .++....         ....            ...+.. .+..++
T Consensus        78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (239)
T PF01636_consen   78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE  157 (239)
T ss_dssp             SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence            9987777                11   1111   1111100         0000            111222 333333


Q ss_pred             H-------CCccccCCCCCCeeeC-CCCcEEEeeeccccc
Q 016082          226 Q-------NNIIHRDLKTANLLMD-ENGVVKVADFGVARV  257 (395)
Q Consensus       226 ~-------~~iiHrDlkp~NiLl~-~~~~vkl~DFg~a~~  257 (395)
                      +       ..++|+|+.|.||+++ +++.+.|+||+.+..
T Consensus       158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            2       3599999999999999 666778999998864

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.55  E-value=1.1e-06  Score=81.07  Aligned_cols=135  Identities=16%  Similarity=0.133  Sum_probs=85.7

Q ss_pred             eeeeCc-eEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCcEEEEEecCCCCCHH
Q 016082          118 VASGSY-GDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEFMARGSIY  195 (395)
Q Consensus       118 lg~G~~-G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~ggsL~  195 (395)
                      |..|.+ ..||+....+..+.+|+.....     .....+|+.+++.+. +--+++++++....+..++|||+++|.++.
T Consensus         6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             cCCCCCcCeEEEEcCCCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            444544 7899988777788899976542     235667888888884 345678888887766789999999997665


Q ss_pred             HHH-------------------hhccC---CCCHH--HHH-HHHH-------------------HHHHHHHHHH------
Q 016082          196 DFL-------------------HKQKG---VFQLT--SLL-KVAI-------------------DVSKGMNYLH------  225 (395)
Q Consensus       196 ~~l-------------------~~~~~---~l~~~--~~~-~i~~-------------------~i~~~l~~LH------  225 (395)
                      ...                   +....   ++...  ... ....                   .+......|-      
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            331                   11100   11100  000 0000                   0111122221      


Q ss_pred             -HCCccccCCCCCCeeeCCCCcEEEeeeccccc
Q 016082          226 -QNNIIHRDLKTANLLMDENGVVKVADFGVARV  257 (395)
Q Consensus       226 -~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~  257 (395)
                       ...++|+|+.|.||++++++.+.|+||+.+..
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence             23489999999999999988889999998753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.50  E-value=6.6e-07  Score=90.32  Aligned_cols=141  Identities=17%  Similarity=0.258  Sum_probs=95.3

Q ss_pred             eeeeeeCceEEEEEEE-CCceEEEEEecCCCCC-----------------------------HHHHH------HHHHHHH
Q 016082          116 CKVASGSYGDLYKGTY-CSQEVAIKVLKPECVN-----------------------------TEMLK------EFSQEVY  159 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~-~~~~vAvK~~~~~~~~-----------------------------~~~~~------~~~~E~~  159 (395)
                      +.||..+.|.||+|+. .|+.||||+-++....                             ++..+      +|.+|.+
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            5789999999999987 6788999998876421                             11111      1455555


Q ss_pred             HHHhc----CCCc------eeeEEEEEecCCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 016082          160 IMRKI----RHKN------VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI  229 (395)
Q Consensus       160 ~l~~l----~h~n------iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i  229 (395)
                      -..+.    .|-+      |+++|-.++.  ...|+||||+|..+.|.-.-....++...+..-+.+...  +-+=..|+
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st--~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~Gf  322 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDLST--KRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTGF  322 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhcCc--ceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcCC
Confidence            55444    2444      5555544433  468999999999776664434455676655554444322  22334689


Q ss_pred             cccCCCCCCeeeCC----CCcEEEeeecccccccc
Q 016082          230 IHRDLKTANLLMDE----NGVVKVADFGVARVQAQ  260 (395)
Q Consensus       230 iHrDlkp~NiLl~~----~~~vkl~DFg~a~~~~~  260 (395)
                      +|+|-.|.||+++.    ++.+.+.|||+......
T Consensus       323 fHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  323 FHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             ccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            99999999999984    66899999999875443

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.50  E-value=1.3e-06  Score=79.14  Aligned_cols=136  Identities=19%  Similarity=0.209  Sum_probs=92.1

Q ss_pred             eeeeeCceEEEEEEE-CCceEEEEEecCCCCCHHHHH----------------------HHHHHHHHHHhcC--CCceee
Q 016082          117 KVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLK----------------------EFSQEVYIMRKIR--HKNVVQ  171 (395)
Q Consensus       117 ~lg~G~~G~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~----------------------~~~~E~~~l~~l~--h~niv~  171 (395)
                      .|.+|--+.||+|.. .+..+|||+.+.....-....                      =...|..-|+++.  +-.+++
T Consensus        55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~  134 (268)
T COG1718          55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE  134 (268)
T ss_pred             eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence            455666678999876 588999999986543211110                      1344666666664  334455


Q ss_pred             EEEEEecCCcEEEEEecCCCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeeeCCCCcEEE
Q 016082          172 FIGACTRPPNLCIVTEFMARG-SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKV  249 (395)
Q Consensus       172 l~~~~~~~~~~~lV~E~~~gg-sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~iiHrDlkp~NiLl~~~~~vkl  249 (395)
                      -+++.    +-.|||||+... .-.-.|..  -+++......+..++++.|.-|-. .+++|+||+.-|||+. ++.+.+
T Consensus       135 Pi~~~----~nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~i  207 (268)
T COG1718         135 PIAFR----NNVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYI  207 (268)
T ss_pred             ceeec----CCeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEE
Confidence            55443    347999999653 11111211  122333577788899999999887 8999999999999999 889999


Q ss_pred             eeeccccccc
Q 016082          250 ADFGVARVQA  259 (395)
Q Consensus       250 ~DFg~a~~~~  259 (395)
                      +|||.|....
T Consensus       208 ID~~QaV~~~  217 (268)
T COG1718         208 IDVSQAVTID  217 (268)
T ss_pred             EECccccccC
Confidence            9999987544

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.46  E-value=1.7e-06  Score=74.29  Aligned_cols=136  Identities=19%  Similarity=0.244  Sum_probs=98.3

Q ss_pred             cCcceeeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCce-eeEEEEEecCCcEEEEEec
Q 016082          110 KQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV-VQFIGACTRPPNLCIVTEF  188 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E~  188 (395)
                      ...+..+.||+|.+|.||+|.|.+.++|+|+-+.+..    ...+..|+++|..+.-.++ +++|.+..+    ++.|||
T Consensus        22 ~~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~----r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~   93 (201)
T COG2112          22 YELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP----RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEY   93 (201)
T ss_pred             hhhhhhhhhhcccccEEEEeeccCceEEEEEecCCcc----hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhh
Confidence            3456778899999999999999999999999886543    3667889999999986555 455554433    355999


Q ss_pred             CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC-CCCeeeCCCCcEEEeeeccccccccC
Q 016082          189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK-TANLLMDENGVVKVADFGVARVQAQS  261 (395)
Q Consensus       189 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlk-p~NiLl~~~~~vkl~DFg~a~~~~~~  261 (395)
                      +.|.+|.+.-...    +...+    ..++..---|-..||-|..|. |...++.+++.+.|+||..|+....+
T Consensus        94 i~G~~L~~~~~~~----~rk~l----~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~~p  159 (201)
T COG2112          94 IDGRPLGKLEIGG----DRKHL----LRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKKKP  159 (201)
T ss_pred             hcCcchhhhhhcc----cHHHH----HHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhccCC
Confidence            9998888765321    22333    344444555778899999886 44455555569999999999854433

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.43  E-value=1.6e-08  Score=101.30  Aligned_cols=186  Identities=19%  Similarity=0.195  Sum_probs=138.0

Q ss_pred             cceeeeeeeeCceEEEEEEECCce-EEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc-eeeEEEEEecCCcEEEEEecC
Q 016082          112 LKIECKVASGSYGDLYKGTYCSQE-VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN-VVQFIGACTRPPNLCIVTEFM  189 (395)
Q Consensus       112 ~~i~~~lg~G~~G~Vy~~~~~~~~-vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~E~~  189 (395)
                      +....-+++|+++.+++.+...+. ...+.+...       ....-++++|.+++||| .+..++-++.++...++++++
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~  316 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC  316 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence            455667899999999998764432 224443322       44566899999999999 777777777788899999999


Q ss_pred             CCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCccccCC
Q 016082          190 ARG-SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET  268 (395)
Q Consensus       190 ~gg-sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~~~  268 (395)
                      .++ +.........-.+...+...+...-.++++++|+.-=+|||    ||+..+ +..+..||+.+.............
T Consensus       317 s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~  391 (829)
T KOG0576|consen  317 STGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTAI  391 (829)
T ss_pred             cCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcccccccCC
Confidence            887 33222211122344445566777788999999998778998    777655 678999999987665554455678


Q ss_pred             CCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 016082          269 GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAG  309 (395)
Q Consensus       269 gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~  309 (395)
                      +++.|+|||+.....++.+-|+|++|.--.++.-|.+|-..
T Consensus       392 ~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~  432 (829)
T KOG0576|consen  392 GTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS  432 (829)
T ss_pred             CCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence            99999999999999999999999999877777777776544

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.39  E-value=9.8e-06  Score=71.79  Aligned_cols=127  Identities=20%  Similarity=0.279  Sum_probs=94.0

Q ss_pred             cCcceeeeeeeeCc-eEEEEEEECCceEEEEEecC---CCC-------C-H--------HHHHHHHHHHHHHHhcC---C
Q 016082          110 KQLKIECKVASGSY-GDLYKGTYCSQEVAIKVLKP---ECV-------N-T--------EMLKEFSQEVYIMRKIR---H  166 (395)
Q Consensus       110 ~~~~i~~~lg~G~~-G~Vy~~~~~~~~vAvK~~~~---~~~-------~-~--------~~~~~~~~E~~~l~~l~---h  166 (395)
                      .+++..+.||.|+- |.||+++..|+.+|+|+++.   ...       . .        ....-|..|.+...+|+   +
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~  116 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR  116 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence            68899999999999 99999999999999999431   110       0 0        22345888999988886   3


Q ss_pred             Cce--eeEEEEEec------------------CCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH
Q 016082          167 KNV--VQFIGACTR------------------PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ  226 (395)
Q Consensus       167 ~ni--v~l~~~~~~------------------~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~  226 (395)
                      .++  ++++|+..=                  .....||.||.+...          .++...    +.+|.+-|..+|.
T Consensus       117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~~----~~~~~~dl~~~~k  182 (207)
T PF13095_consen  117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIRD----IPQMLRDLKILHK  182 (207)
T ss_pred             cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchhH----HHHHHHHHHHHHH
Confidence            455  999998721                  123578999887633          223333    3466677888999


Q ss_pred             CCccccCCCCCCeeeCCCCcEEEeeeccc
Q 016082          227 NNIIHRDLKTANLLMDENGVVKVADFGVA  255 (395)
Q Consensus       227 ~~iiHrDlkp~NiLl~~~~~vkl~DFg~a  255 (395)
                      .||+-+|+++.|..=     -+|+|||.+
T Consensus       183 ~gI~~~Dv~~~ny~~-----G~lvDfs~~  206 (207)
T PF13095_consen  183 LGIVPRDVKPRNYRG-----GKLVDFSSS  206 (207)
T ss_pred             CCeeeccCccccccC-----CEEEecccC
Confidence            999999999999972     289999965

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.38  E-value=9.8e-07  Score=78.08  Aligned_cols=100  Identities=19%  Similarity=0.343  Sum_probs=81.2

Q ss_pred             HHHHHHHHhcCC-CceeeEEEEEecCCcEEEEEecCCCCCHHHH---HhhccCCCCHHHHHHHHHHHHHHHHHHHH---C
Q 016082          155 SQEVYIMRKIRH-KNVVQFIGACTRPPNLCIVTEFMARGSIYDF---LHKQKGVFQLTSLLKVAIDVSKGMNYLHQ---N  227 (395)
Q Consensus       155 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~E~~~ggsL~~~---l~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~  227 (395)
                      ..|.-+|+.+++ +++++++|+|.+    ++|+||...+++...   +.+ -...++..+.++|.++++.+++|++   .
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            358888888886 699999999943    679999987766532   111 1235889999999999999999998   4


Q ss_pred             CccccCCCCCCeeeCCCCcEEEeeeccccccc
Q 016082          228 NIIHRDLKTANLLMDENGVVKVADFGVARVQA  259 (395)
Q Consensus       228 ~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~  259 (395)
                      .+.-.|++|+|+-++++|.+|++|...+....
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~  113 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVED  113 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence            58889999999999999999999999886543

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.34  E-value=1.5e-05  Score=85.47  Aligned_cols=230  Identities=17%  Similarity=0.218  Sum_probs=159.6

Q ss_pred             eeeeCceEEEEEEECC------ceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc----EEEEE
Q 016082          118 VASGSYGDLYKGTYCS------QEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN----LCIVT  186 (395)
Q Consensus       118 lg~G~~G~Vy~~~~~~------~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~lV~  186 (395)
                      +..-.+|+++..++.-      +++-++.-.-... ....+....-|...+.+..|+|++.++.+......    ..+..
T Consensus       186 ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~~~~~~~~k~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~  265 (1351)
T KOG1035|consen  186 LSHLTQGTLLLVKWVEQAQSLSEPIEISHDYESTPCGKKEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQ  265 (1351)
T ss_pred             eccccCceEEEEehhhhHHhhcCcccccCcccCccchHHHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHH
Confidence            4455677788776532      1222221111101 12234455667788888899999999998765443    33456


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC---CeeeCCCCcEEEe--eeccccccccC
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA---NLLMDENGVVKVA--DFGVARVQAQS  261 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~---NiLl~~~~~vkl~--DFg~a~~~~~~  261 (395)
                      |++..-++.+.+.. -+..+..+++.+..++.+|+.|+|+....|.-+...   +.-++.++.+...  ||+.++..+..
T Consensus       266 ~~~s~~~~~~~~q~-v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~  344 (1351)
T KOG1035|consen  266 EICSKVELRSLLQS-VGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDN  344 (1351)
T ss_pred             hhcCccchHHHHhh-ccccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCCc
Confidence            78888888888865 678899999999999999999999997766666555   5555667777777  99998877666


Q ss_pred             CccccCCCCcccccccccCCCCCCCh--hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHH
Q 016082          262 GVMTAETGTYRWMAPEVIEHKPYDYK--ADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL  339 (395)
Q Consensus       262 ~~~~~~~gt~~y~aPE~~~~~~~~~k--~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  339 (395)
                      ........+..+.+||......++.+  .|+|++|.....+..|..+-.....       ....    .+........+.
T Consensus       345 ~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~-------~~~~----l~~~~~~~~~d~  413 (1351)
T KOG1035|consen  345 EKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAV-------PVSL----LDVLSTSELLDA  413 (1351)
T ss_pred             ccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccc-------hhhh----hccccchhhhhh
Confidence            55555666777889998877766544  7999999999999887654322111       1111    111122278899


Q ss_pred             HHHhhccCCCCCCCHHHHHH
Q 016082          340 LERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       340 i~~cl~~dp~~RPs~~ell~  359 (395)
                      ..+|+..++++|+++.+++.
T Consensus       414 ~~~~~~~~~~~Rl~~~~ll~  433 (1351)
T KOG1035|consen  414 LPKCLDEDSEERLSALELLT  433 (1351)
T ss_pred             hhhhcchhhhhccchhhhhh
Confidence            99999999999999999887

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.24  E-value=2.5e-05  Score=69.53  Aligned_cols=130  Identities=20%  Similarity=0.359  Sum_probs=94.3

Q ss_pred             eeeeeeeCceEEEEEEECCceEEEEEecCCC--------------CCHHHHHHHHHHHHHHHhcC------CCceeeEEE
Q 016082          115 ECKVASGSYGDLYKGTYCSQEVAIKVLKPEC--------------VNTEMLKEFSQEVYIMRKIR------HKNVVQFIG  174 (395)
Q Consensus       115 ~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~--------------~~~~~~~~~~~E~~~l~~l~------h~niv~l~~  174 (395)
                      ...||+|+.=.||.-- .+....||+.++..              ......++..+|+.-..++.      +.+|.+++|
T Consensus         6 ~~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G   84 (199)
T PF10707_consen    6 SDLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG   84 (199)
T ss_pred             CcccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence            4468999998888632 24557899988765              11123466677777776666      788999999


Q ss_pred             EEecCCcEEEEEecCCC------CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCC---
Q 016082          175 ACTRPPNLCIVTEFMAR------GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---  245 (395)
Q Consensus       175 ~~~~~~~~~lV~E~~~g------gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~---  245 (395)
                      +.++..-..+|+|.+..      .+|.+++..  +.++. .+.+.   +-.-.+||-+.+|+.+|++|.||++...+   
T Consensus        85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~-~~~~~---L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~  158 (199)
T PF10707_consen   85 FVETNLGLGLVVELIRDADGNISPTLEDYLKE--GGLTE-ELRQA---LDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE  158 (199)
T ss_pred             EEecCCceEEEEEEEECCCCCcCccHHHHHHc--CCccH-HHHHH---HHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence            99999999999998753      278888854  34555 33333   34456788899999999999999996432   


Q ss_pred             -cEEEee
Q 016082          246 -VVKVAD  251 (395)
Q Consensus       246 -~vkl~D  251 (395)
                       .+.|+|
T Consensus       159 ~~lvlID  165 (199)
T PF10707_consen  159 FRLVLID  165 (199)
T ss_pred             eEEEEEe
Confidence             577887

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=98.24  E-value=1.6e-05  Score=86.12  Aligned_cols=144  Identities=15%  Similarity=0.275  Sum_probs=91.4

Q ss_pred             eeeeeeeCceEEEEEEECC----ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCce--eeEEEEEecC---CcEEE
Q 016082          115 ECKVASGSYGDLYKGTYCS----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNV--VQFIGACTRP---PNLCI  184 (395)
Q Consensus       115 ~~~lg~G~~G~Vy~~~~~~----~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~l  184 (395)
                      .+.++.|.++.+|+.+..+    ..+++|+..+.... .....+.+|..+|+.+. |.++  ++++.+|.+.   +..|+
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl  121 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY  121 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence            4668899999999887644    46777876543211 12346789999999996 6654  8888888765   35789


Q ss_pred             EEecCCCCCHHH--------------------H---HhhccC---CC-----C----HHHHHHHHH--------------
Q 016082          185 VTEFMARGSIYD--------------------F---LHKQKG---VF-----Q----LTSLLKVAI--------------  215 (395)
Q Consensus       185 V~E~~~ggsL~~--------------------~---l~~~~~---~l-----~----~~~~~~i~~--------------  215 (395)
                      ||||++|..+.+                    .   |+....   .+     +    ..++..+..              
T Consensus       122 VME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~  201 (822)
T PLN02876        122 IMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRN  201 (822)
T ss_pred             EEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCC
Confidence            999999864321                    1   111110   00     0    112222111              


Q ss_pred             -HHHHHHHHHHH-----------CCccccCCCCCCeeeCCC--CcEEEeeeccccccc
Q 016082          216 -DVSKGMNYLHQ-----------NNIIHRDLKTANLLMDEN--GVVKVADFGVARVQA  259 (395)
Q Consensus       216 -~i~~~l~~LH~-----------~~iiHrDlkp~NiLl~~~--~~vkl~DFg~a~~~~  259 (395)
                       .+...+++|..           ..+||+|+++.|++++.+  ...-|.||+.+...+
T Consensus       202 ~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd  259 (822)
T PLN02876        202 PKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN  259 (822)
T ss_pred             hhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence             12334566642           249999999999999853  346799999987544

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.15  E-value=1.3e-05  Score=73.45  Aligned_cols=72  Identities=11%  Similarity=0.158  Sum_probs=46.9

Q ss_pred             eeeeeeCce-EEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCC---ceeeEEEEEecC---CcEEEEEec
Q 016082          116 CKVASGSYG-DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK---NVVQFIGACTRP---PNLCIVTEF  188 (395)
Q Consensus       116 ~~lg~G~~G-~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~---~~~~lV~E~  188 (395)
                      +.++.|+.. .||+.   +..+++|+.+...    ....+.+|..+++.+...   .+++.++.....   ...+++|++
T Consensus         3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           3 EPVDSGGTDNATFRL---GDDMSVRLPSAAG----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             eeccCCCcccceEEc---CCceEEEcCCccc----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            456766665 58875   3467788765421    235788899999888632   355666554332   235889999


Q ss_pred             CCCCCH
Q 016082          189 MARGSI  194 (395)
Q Consensus       189 ~~ggsL  194 (395)
                      ++|.++
T Consensus        76 i~G~~l   81 (235)
T cd05155          76 LEGETA   81 (235)
T ss_pred             ecCCCC
Confidence            999765

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10593 hypothetical protein; Provisional

Probab=98.04  E-value=9.5e-05  Score=70.37  Aligned_cols=77  Identities=10%  Similarity=0.020  Sum_probs=58.4

Q ss_pred             eeeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC---CceeeEEEEEecC---CcEEEEEe
Q 016082          114 IECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH---KNVVQFIGACTRP---PNLCIVTE  187 (395)
Q Consensus       114 i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~---~~~~lV~E  187 (395)
                      -.+.||.|..+.||+....+..+.+|..+...    ....+..|...|+.+..   -.++++++++...   +..++|||
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE   93 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQGNPMPLMARSFS----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE   93 (297)
T ss_pred             eeeecCCccceeEEEEEcCCCCEEEEEecccc----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence            35579999999999988766677888855311    12578889999998863   4688999887543   56899999


Q ss_pred             cCCCCCH
Q 016082          188 FMARGSI  194 (395)
Q Consensus       188 ~~~ggsL  194 (395)
                      +++|+++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9998754

>cd04900 ACT_UUR-like_1 ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains

Probab=98.03  E-value=2e-05  Score=58.36  Aligned_cols=55  Identities=27%  Similarity=0.416  Sum_probs=43.7

Q ss_pred             HHHHHHHHHhhhcCCCeeeeceeccCCCceeeEEEecCCCCcc--hHHHHHHHHHHH
Q 016082            9 MKVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDE--TEDLKNVLAKEI   63 (395)
Q Consensus         9 ~~~~~~~~~~~~~~l~i~~~~~f~~~~~~~l~~~~v~gw~~~~--~~~l~~~l~~~~   63 (395)
                      .+|++++.+|++.|+||..|.+|++.+|+.+|+|.|..+....  .++.++.+++.+
T Consensus        13 gLl~~i~~~l~~~~l~I~~A~i~T~~~~~v~D~F~v~~~~~~~~~~~~~~~~l~~~L   69 (73)
T cd04900          13 GLFARIAGALDQLGLNILDARIFTTRDGYALDTFVVLDPDGEPIGERERLARIREAL   69 (73)
T ss_pred             CHHHHHHHHHHHCCCCeEEeEEEEeCCCeEEEEEEEECCCCCCCChHHHHHHHHHHH
Confidence            4789999999999999999999999999999999997654432  344445555544

This ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD is the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted tyrosine kinase. Members of this CD belong to the superfamily of ACT regulatory domains.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.94  E-value=4.6e-05  Score=70.78  Aligned_cols=133  Identities=15%  Similarity=0.176  Sum_probs=79.3

Q ss_pred             eeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc-eeeEEEEEecCCcEEEEEecCCCCCHHH
Q 016082          118 VASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN-VVQFIGACTRPPNLCIVTEFMARGSIYD  196 (395)
Q Consensus       118 lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~E~~~ggsL~~  196 (395)
                      +..|-.+.+|+.+..++.+++|+.....  ........+|..+++.+...+ .+++++...    -++|+||++|..+..
T Consensus         4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~--~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         4 LSGGLTNRSWRIEHPGISFVWRPQSPVC--KALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             CCCcCcCCeEEEEeCCccEEEeeCCccc--ccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            4567788899988778889999865432  111013567889999886432 345555432    368999999865431


Q ss_pred             --------------H---Hhhcc---CCCCHH-HHHHHHHH---------HHHHHHHHHH--------CCccccCCCCCC
Q 016082          197 --------------F---LHKQK---GVFQLT-SLLKVAID---------VSKGMNYLHQ--------NNIIHRDLKTAN  238 (395)
Q Consensus       197 --------------~---l~~~~---~~l~~~-~~~~i~~~---------i~~~l~~LH~--------~~iiHrDlkp~N  238 (395)
                                    .   ++...   .+++.. .+..+..+         +...+..+-.        ..++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence                          1   12111   111111 11121111         1111222222        258999999999


Q ss_pred             eeeCCCCcEEEeeeccccc
Q 016082          239 LLMDENGVVKVADFGVARV  257 (395)
Q Consensus       239 iLl~~~~~vkl~DFg~a~~  257 (395)
                      |++++++ +.++||+.|..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999877 78999998864

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.90  E-value=0.00012  Score=66.80  Aligned_cols=136  Identities=18%  Similarity=0.229  Sum_probs=80.9

Q ss_pred             eeeeeeeCceEEEEEEEC---CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC-CceeeEEEEEecCCcEEEEEecCC
Q 016082          115 ECKVASGSYGDLYKGTYC---SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH-KNVVQFIGACTRPPNLCIVTEFMA  190 (395)
Q Consensus       115 ~~~lg~G~~G~Vy~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~E~~~  190 (395)
                      .+.|..|-...+|+.+..   ++.|++|+......   ......+|..+++.+.. .-.+++++.+..    .++|||++
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i~   75 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFIP   75 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEeeC
Confidence            356777888899998765   47899998764321   11233478888888853 334555554432    37999999


Q ss_pred             CCCHHH--------------HH---hhccCCCC----------H-HHHHHHHH----------------------HHHHH
Q 016082          191 RGSIYD--------------FL---HKQKGVFQ----------L-TSLLKVAI----------------------DVSKG  220 (395)
Q Consensus       191 ggsL~~--------------~l---~~~~~~l~----------~-~~~~~i~~----------------------~i~~~  220 (395)
                      |.++..              .+   +.......          . ..+..+..                      .+...
T Consensus        76 G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  155 (235)
T cd05157          76 GRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDE  155 (235)
T ss_pred             CCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHH
Confidence            865421              11   11111111          1 11112111                      11111


Q ss_pred             HHHH----HH----CCccccCCCCCCeeeCC-CCcEEEeeeccccc
Q 016082          221 MNYL----HQ----NNIIHRDLKTANLLMDE-NGVVKVADFGVARV  257 (395)
Q Consensus       221 l~~L----H~----~~iiHrDlkp~NiLl~~-~~~vkl~DFg~a~~  257 (395)
                      +..|    ..    .+++|+|+.+.|||++. ++.+.++||..|..
T Consensus       156 ~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         156 ISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             HHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            1122    11    35899999999999998 57899999998863

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.82  E-value=0.00022  Score=67.54  Aligned_cols=138  Identities=17%  Similarity=0.169  Sum_probs=85.3

Q ss_pred             eeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCC--ceeeEEEE------EecCCcEEEEE
Q 016082          115 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK--NVVQFIGA------CTRPPNLCIVT  186 (395)
Q Consensus       115 ~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~------~~~~~~~~lV~  186 (395)
                      .+.+..|....+|+....+..+++|+....  +   ......|+.++..+.+.  .+++.+..      ....+..++|+
T Consensus        19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~--~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          19 FEGISAGIENTNYFVTTDSGRYVLTLFEKV--S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV   93 (296)
T ss_pred             eecccCccccceEEEEeCCCcEEEEEcCCC--C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence            445777877889998777778999998641  2   24566788888888533  24555442      12334578999


Q ss_pred             ecCCCCCHHH-----------H---HhhccCCCCH--------HHHH------------HHHHHHHHHHHHHHH------
Q 016082          187 EFMARGSIYD-----------F---LHKQKGVFQL--------TSLL------------KVAIDVSKGMNYLHQ------  226 (395)
Q Consensus       187 E~~~ggsL~~-----------~---l~~~~~~l~~--------~~~~------------~i~~~i~~~l~~LH~------  226 (395)
                      +|++|..+..           .   ++.....+..        ....            .....+..++.++.+      
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            9999865421           1   1111111110        0000            011112334445543      


Q ss_pred             -CCccccCCCCCCeeeCCCCcEEEeeeccccc
Q 016082          227 -NNIIHRDLKTANLLMDENGVVKVADFGVARV  257 (395)
Q Consensus       227 -~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~  257 (395)
                       .+++|+|+.|.||++++++.+.|+||+.+..
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence             4799999999999999987789999998853

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.80  E-value=0.00023  Score=68.04  Aligned_cols=138  Identities=20%  Similarity=0.257  Sum_probs=83.9

Q ss_pred             eeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCC--ceeeEEEEE------ecCCcEEEEE
Q 016082          115 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK--NVVQFIGAC------TRPPNLCIVT  186 (395)
Q Consensus       115 ~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~------~~~~~~~lV~  186 (395)
                      .+.++.|....+|+.+..+..+++|+..... .   ......|..++..|...  .+++++...      ...+..++++
T Consensus        27 i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~-~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~  102 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVGRYILTLYEKRV-K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV  102 (307)
T ss_pred             ccccCCccccceEEEEeCCCcEEEEEecCCC-C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence            4556777778899987666678899876532 1   23445677778777532  244554422      1234578999


Q ss_pred             ecCCCCCHH-----------HH---HhhccCCCC--------HHHHH---------------HHHHHHHHHHHHHHH---
Q 016082          187 EFMARGSIY-----------DF---LHKQKGVFQ--------LTSLL---------------KVAIDVSKGMNYLHQ---  226 (395)
Q Consensus       187 E~~~ggsL~-----------~~---l~~~~~~l~--------~~~~~---------------~i~~~i~~~l~~LH~---  226 (395)
                      ||++|.++.           ..   ++.....++        .....               .....+.+.++++..   
T Consensus       103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~  182 (307)
T TIGR00938       103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP  182 (307)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence            999985431           11   222111111        01000               001123345555543   


Q ss_pred             ----CCccccCCCCCCeeeCCCCcEEEeeecccc
Q 016082          227 ----NNIIHRDLKTANLLMDENGVVKVADFGVAR  256 (395)
Q Consensus       227 ----~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~  256 (395)
                          .+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence                589999999999999998877899999875

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd04927 ACT_ACR-like_2 Second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein)

Probab=97.77  E-value=9.5e-05  Score=55.17  Aligned_cols=54  Identities=22%  Similarity=0.258  Sum_probs=42.0

Q ss_pred             HHHHHHHHhhhcCCCeeeeceeccCCCceeeEEEecCCCCc-chHHHHHHHHHHH
Q 016082           10 KVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYD-ETEDLKNVLAKEI   63 (395)
Q Consensus        10 ~~~~~~~~~~~~~l~i~~~~~f~~~~~~~l~~~~v~gw~~~-~~~~l~~~l~~~~   63 (395)
                      +|++++..|++.|+||..|++++|.+|+.+|+|.|...... ..++.++.+++.+
T Consensus        13 Lfa~i~~~l~~~~l~I~~A~I~Tt~~~~v~D~F~V~d~~~~~~~~~~~~~l~~~L   67 (76)
T cd04927          13 LLHDVTEVLYELELTIERVKVSTTPDGRVLDLFFITDARELLHTKKRREETYDYL   67 (76)
T ss_pred             HHHHHHHHHHHCCCeEEEEEEEECCCCEEEEEEEEeCCCCCCCCHHHHHHHHHHH
Confidence            78999999999999999999999999999999999655443 2223334444444

This CD includes the second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) have been described, however, the ACR-like sequences in this CD are distinct from those characterized. This CD includes the Oryza sativa ACR-like protein (Os05g0113000) encoded on chromosome 5 and the Arabidopsis thaliana predicted gene product, At2g39570. Members of this CD belong to the superfamily of ACT regulatory domains.

>PRK05231 homoserine kinase; Provisional

Probab=97.75  E-value=0.00078  Score=64.61  Aligned_cols=138  Identities=15%  Similarity=0.191  Sum_probs=78.0

Q ss_pred             eeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCC--ceeeEEEE------EecCCcEEEEE
Q 016082          115 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK--NVVQFIGA------CTRPPNLCIVT  186 (395)
Q Consensus       115 ~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~------~~~~~~~~lV~  186 (395)
                      .+.++.|....+|+.+..+..+++|+.. . ...   .....|..+++.|...  .+++.+..      ....+..++++
T Consensus        27 ~~~l~~G~~n~~y~v~t~~g~~vLK~~~-~-~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~  101 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTTQGEYVLTLFE-R-LTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIV  101 (319)
T ss_pred             cchhccccccceEEEEeCCCcEEEEEec-c-CCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEE
Confidence            3456777778899987766689999976 2 122   2333455666665321  23344421      12244578999


Q ss_pred             ecCCCCCH-----------HHHH---hhccCCCC--------HH---H-HHH-----------HHHH-HHHHHHHHH---
Q 016082          187 EFMARGSI-----------YDFL---HKQKGVFQ--------LT---S-LLK-----------VAID-VSKGMNYLH---  225 (395)
Q Consensus       187 E~~~ggsL-----------~~~l---~~~~~~l~--------~~---~-~~~-----------i~~~-i~~~l~~LH---  225 (395)
                      ||++|..+           ...+   +.....++        ..   . ..+           ...+ +...++.+.   
T Consensus       102 ~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  181 (319)
T PRK05231        102 TFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAA  181 (319)
T ss_pred             EecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccc
Confidence            99998643           1111   11111111        00   0 000           1111 111223332   


Q ss_pred             ----HCCccccCCCCCCeeeCCCCcEEEeeeccccc
Q 016082          226 ----QNNIIHRDLKTANLLMDENGVVKVADFGVARV  257 (395)
Q Consensus       226 ----~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~  257 (395)
                          ..++||+|+.|.||+++.+...-|+||+.+..
T Consensus       182 ~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        182 WPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence                23899999999999999776668999998853

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.71  E-value=0.00096  Score=65.78  Aligned_cols=75  Identities=12%  Similarity=0.057  Sum_probs=53.4

Q ss_pred             eeeeeeCceEEEEEEECC--ceEEEEEecCCCC--C---HHHHHHHHHHHHHHHhcC---CCceeeEEEEEecCCcEEEE
Q 016082          116 CKVASGSYGDLYKGTYCS--QEVAIKVLKPECV--N---TEMLKEFSQEVYIMRKIR---HKNVVQFIGACTRPPNLCIV  185 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~~~--~~vAvK~~~~~~~--~---~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV  185 (395)
                      +.||.|.+..||+++..+  +.+.||.-.+...  .   .-..+++..|...|+.+.   ..++++++.+  +....++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            468999999999998854  4899998542211  0   123466778888888864   3567888876  34557899


Q ss_pred             EecCCCC
Q 016082          186 TEFMARG  192 (395)
Q Consensus       186 ~E~~~gg  192 (395)
                      ||++++.
T Consensus       110 ME~L~~~  116 (401)
T PRK09550        110 MEDLSDH  116 (401)
T ss_pred             EecCCCc
Confidence            9999874

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.67  E-value=4.2e-05  Score=71.94  Aligned_cols=136  Identities=15%  Similarity=0.210  Sum_probs=96.7

Q ss_pred             CcceeeeeeeeCceEEEEEEE-CCceEEEEEecCCCCC-------HHH-------------HHHHHHHHHHHHhcCC--C
Q 016082          111 QLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVN-------TEM-------------LKEFSQEVYIMRKIRH--K  167 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~-~~~~vAvK~~~~~~~~-------~~~-------------~~~~~~E~~~l~~l~h--~  167 (395)
                      -+.++++||-|--+.||.+-+ .|++.++|+-+..+.+       .+.             .-....|...|+.+..  -
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            356778999999999999887 4889999875543321       100             1225668888888853  2


Q ss_pred             ceeeEEEEEecCCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcE
Q 016082          168 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV  247 (395)
Q Consensus       168 niv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~v  247 (395)
                      -+++.+++    +..|+|||++.|-.|....+-.    ..+   .+...+..-+--|-..|+||+|..--||++++++.+
T Consensus       173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~----d~~---~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i  241 (465)
T KOG2268|consen  173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHVE----DPP---TLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKI  241 (465)
T ss_pred             CCCCcccc----cceeeHHHhhcccceeeeeecC----ChH---HHHHHHHHHHHHHHHcCceecccchheeEEecCCCE
Confidence            34555543    3578999999998877654321    222   334445555666888999999999999999999999


Q ss_pred             EEeeeccccc
Q 016082          248 KVADFGVARV  257 (395)
Q Consensus       248 kl~DFg~a~~  257 (395)
                      +++||-.+..
T Consensus       242 ~vIDFPQmvS  251 (465)
T KOG2268|consen  242 VVIDFPQMVS  251 (465)
T ss_pred             EEeechHhhc
Confidence            9999987643

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.63  E-value=7.2e-06  Score=89.69  Aligned_cols=209  Identities=11%  Similarity=0.037  Sum_probs=138.0

Q ss_pred             HHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--CcEEEEEecCCCCCHHHHHhhccCCC---CHHHHHHHHHHHHHHHH
Q 016082          148 TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVF---QLTSLLKVAIDVSKGMN  222 (395)
Q Consensus       148 ~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~E~~~ggsL~~~l~~~~~~l---~~~~~~~i~~~i~~~l~  222 (395)
                      +...+....|...++...|+++.....-....  ...+.+++++.+|.+.+.+-+....+   ...-+.....+......
T Consensus      1270 ePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~ 1349 (2724)
T KOG1826|consen 1270 EPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRN 1349 (2724)
T ss_pred             hHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccc
Confidence            34445566677777777899887766544322  24688999999999999986653332   22333333334355556


Q ss_pred             HHHHC-----CccccCCCCCCeeeCCCCcEEEeeeccccccc-cCCccccCCCCcccccccccCCCCCCChhhHHHHHHH
Q 016082          223 YLHQN-----NIIHRDLKTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIA  296 (395)
Q Consensus       223 ~LH~~-----~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~v  296 (395)
                      -+|+.     -.+|+++|+.|.++..+..++++++|+.+... .........+++.|++|++.+.-.++.++|+|..|+.
T Consensus      1350 ~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ 1429 (2724)
T KOG1826|consen 1350 VILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLS 1429 (2724)
T ss_pred             hhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHH
Confidence            66643     26899999999999999999999999999333 2333345578889999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHH
Q 016082          297 LWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI  357 (395)
Q Consensus       297 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el  357 (395)
                      +|....|..+|...... ...+..+......++...|.+.-.....++-..-..||.-...
T Consensus      1430 ly~rs~~n~~fi~flq~-~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~is 1489 (2724)
T KOG1826|consen 1430 LYLRSDGNAYFIFFLQP-ALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYIS 1489 (2724)
T ss_pred             HHHHhcccHHHHHHHHH-HHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhh
Confidence            99998888777543222 1222233333333333333444444444444455566654443

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.60  E-value=0.00045  Score=65.75  Aligned_cols=73  Identities=18%  Similarity=0.357  Sum_probs=47.9

Q ss_pred             eeeeeeCceEEEEEEEC--------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc-eeeEEEEEecCCcEEEEE
Q 016082          116 CKVASGSYGDLYKGTYC--------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN-VVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~~--------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~  186 (395)
                      +.+..|-...+|+.+..        ++.+++|+.....   .......+|..+++.+...+ .+++++++..    .+|+
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~   76 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIE   76 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchh
Confidence            44566777788888754        3789999976542   12234567888888886322 4566666542    3589


Q ss_pred             ecCCCCCHH
Q 016082          187 EFMARGSIY  195 (395)
Q Consensus       187 E~~~ggsL~  195 (395)
                      ||++|..+.
T Consensus        77 e~i~G~~l~   85 (302)
T cd05156          77 EFIPSRTLT   85 (302)
T ss_pred             heeCCCcCC
Confidence            999887553

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.57  E-value=0.00065  Score=64.76  Aligned_cols=138  Identities=17%  Similarity=0.254  Sum_probs=85.7

Q ss_pred             eeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC--CceeeEEEEEecCC--cEEEEEecCCC
Q 016082          116 CKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH--KNVVQFIGACTRPP--NLCIVTEFMAR  191 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~lV~E~~~g  191 (395)
                      +.+-.|-.-.+|.....++.+++. ..+............+|..+++.+.-  --+...++.|.++.  ..+.||+|.+|
T Consensus        31 ~~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veG  109 (321)
T COG3173          31 EEISGGWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEG  109 (321)
T ss_pred             eeccCCcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecc
Confidence            333334444566666667888888 33222334455667788888888753  33556677776665  67999999998


Q ss_pred             CCHHHHHhhccCCCCHHHHHHHHH-HHHHHHHHHH---------------------------------------------
Q 016082          192 GSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLH---------------------------------------------  225 (395)
Q Consensus       192 gsL~~~l~~~~~~l~~~~~~~i~~-~i~~~l~~LH---------------------------------------------  225 (395)
                      ..+.+.+...      ....+++. .+++.|.-||                                             
T Consensus       110 e~~~~~~~~~------~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~  183 (321)
T COG3173         110 EVVWSALPPE------SLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL  183 (321)
T ss_pred             eeccCcCCcc------cchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence            4332221110      00011222 3333344444                                             


Q ss_pred             -----HC--------CccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          226 -----QN--------NIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       226 -----~~--------~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                           .+        .++|+|+.+.|+++++++-+-|.||+.+...+.
T Consensus       184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence                 32        489999999999999999999999999976544

>cd04925 ACT_ACR_2 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein)

Probab=97.34  E-value=0.00053  Score=50.84  Aligned_cols=36  Identities=28%  Similarity=0.314  Sum_probs=33.1

Q ss_pred             HHHHHHHHHhhhcCCCeeeeceeccCCCceeeEEEec
Q 016082            9 MKVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVD   45 (395)
Q Consensus         9 ~~~~~~~~~~~~~~l~i~~~~~f~~~~~~~l~~~~v~   45 (395)
                      .+|+.++.+|++.|+||..|+++ |.+|+.+|+|.|.
T Consensus        12 gLl~~i~~~l~~~~lnI~~A~i~-t~~~~~~d~f~V~   47 (74)
T cd04925          12 GLLSEVFAVLADLHCNVVEARAW-THNGRLACVIYVR   47 (74)
T ss_pred             CHHHHHHHHHHHCCCcEEEEEEE-EECCEEEEEEEEE
Confidence            37899999999999999999999 5599999999985

This CD includes the second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.29  E-value=0.0028  Score=60.39  Aligned_cols=29  Identities=28%  Similarity=0.457  Sum_probs=25.8

Q ss_pred             CCccccCCCCCCeeeCCCCcEEEeeecccc
Q 016082          227 NNIIHRDLKTANLLMDENGVVKVADFGVAR  256 (395)
Q Consensus       227 ~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~  256 (395)
                      .+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            47899999999999987 678999999775

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02236 choline kinase

Probab=97.19  E-value=0.0026  Score=61.83  Aligned_cols=134  Identities=13%  Similarity=0.246  Sum_probs=78.6

Q ss_pred             eeeeeCceEEEEEEEC------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc-eeeEEEEEecCCcEEEEEecC
Q 016082          117 KVASGSYGDLYKGTYC------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN-VVQFIGACTRPPNLCIVTEFM  189 (395)
Q Consensus       117 ~lg~G~~G~Vy~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~E~~  189 (395)
                      .+-.|-...+|+.+..      ++.|++|+.....  +.. -...+|..+++.+...+ -+++++.+..+    .|.||+
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi  115 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELF-FDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI  115 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Cee-echHHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence            3444777788888652      3678999886542  222 22367899998886433 34566666432    589999


Q ss_pred             CCCCHHHH-----------------HhhccCC----CC-HHHHHHHHHH-----------------HHHHHHHHH-----
Q 016082          190 ARGSIYDF-----------------LHKQKGV----FQ-LTSLLKVAID-----------------VSKGMNYLH-----  225 (395)
Q Consensus       190 ~ggsL~~~-----------------l~~~~~~----l~-~~~~~~i~~~-----------------i~~~l~~LH-----  225 (395)
                      +|.++...                 +|....+    .. ...+.++..+                 +...+..|.     
T Consensus       116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~  195 (344)
T PLN02236        116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG  195 (344)
T ss_pred             CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence            87655311                 1211111    11 1222232211                 111122221     


Q ss_pred             ---HCCccccCCCCCCeeeCC-CCcEEEeeeccccc
Q 016082          226 ---QNNIIHRDLKTANLLMDE-NGVVKVADFGVARV  257 (395)
Q Consensus       226 ---~~~iiHrDlkp~NiLl~~-~~~vkl~DFg~a~~  257 (395)
                         ...++|+|+++.||++++ ++.+.++||..+..
T Consensus       196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence               225899999999999986 47899999998864

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.16  E-value=0.0019  Score=62.03  Aligned_cols=141  Identities=21%  Similarity=0.285  Sum_probs=93.8

Q ss_pred             eeeeeeeeCceEEEEEEE-CCceEEEEEecCCCC----------------------CH-HHHHH-HHHHHHHHHhcCCCc
Q 016082          114 IECKVASGSYGDLYKGTY-CSQEVAIKVLKPECV----------------------NT-EMLKE-FSQEVYIMRKIRHKN  168 (395)
Q Consensus       114 i~~~lg~G~~G~Vy~~~~-~~~~vAvK~~~~~~~----------------------~~-~~~~~-~~~E~~~l~~l~h~n  168 (395)
                      |...|..|--+.||.++. .|..+||||.+.+-+                      ++ ..++. ...|+.-|.++....
T Consensus       148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            334566677788999987 678899999875321                      11 11111 345778888886555


Q ss_pred             eeeEEEEEecCCcEEEEEecCCCCCH-HHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeeeCCCCc
Q 016082          169 VVQFIGACTRPPNLCIVTEFMARGSI-YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGV  246 (395)
Q Consensus       169 iv~l~~~~~~~~~~~lV~E~~~ggsL-~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~iiHrDlkp~NiLl~~~~~  246 (395)
                      |+-.--+..  ..-.|||+|+.+... .-.|+  .-.++...+..+-.+++.-|.-|.+ .+.+|.||.--|+|+. +|.
T Consensus       228 IP~PePIlL--k~hVLVM~FlGrdgw~aPkLK--d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~  302 (520)
T KOG2270|consen  228 IPCPEPILL--KNHVLVMEFLGRDGWAAPKLK--DASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGK  302 (520)
T ss_pred             CCCCCceee--ecceEeeeeccCCCCcCcccc--cccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCE
Confidence            432111111  135799999964221 11221  2346777888888899999988865 5899999999999995 578


Q ss_pred             EEEeeeccccccc
Q 016082          247 VKVADFGVARVQA  259 (395)
Q Consensus       247 vkl~DFg~a~~~~  259 (395)
                      +.++|.+.+...+
T Consensus       303 lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  303 LYIIDVSQSVEHD  315 (520)
T ss_pred             EEEEEccccccCC
Confidence            9999988875433

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.08  E-value=0.0073  Score=59.56  Aligned_cols=75  Identities=15%  Similarity=0.034  Sum_probs=52.6

Q ss_pred             eeeeeeeCceEEEEEEECCceEEEEEecCCCC--CH---HHHHHHHHHHHHHHhcC---CCceeeEEEEEecCCcEEEEE
Q 016082          115 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECV--NT---EMLKEFSQEVYIMRKIR---HKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       115 ~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~--~~---~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~  186 (395)
                      .+.||.|....||+.+..+..++||.-.+...  ..   ....+-..|...|+.+.   ...+++++.++.+  ..+++|
T Consensus        37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlvM  114 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIGM  114 (418)
T ss_pred             EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEEE
Confidence            55789999999999988777899998652211  11   12344455677776664   2578889988874  467899


Q ss_pred             ecCCC
Q 016082          187 EFMAR  191 (395)
Q Consensus       187 E~~~g  191 (395)
                      |++++
T Consensus       115 E~L~~  119 (418)
T PLN02756        115 RYLEP  119 (418)
T ss_pred             eecCC
Confidence            99977

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.07  E-value=0.0034  Score=60.63  Aligned_cols=139  Identities=17%  Similarity=0.266  Sum_probs=79.4

Q ss_pred             CcceeeeeeeeCceEEEEEEECC-----ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCce-eeEEEEEecCCcEEE
Q 016082          111 QLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV-VQFIGACTRPPNLCI  184 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~l  184 (395)
                      .+++....| |=...+|+.+..+     ..|.+|+.....   +..-...+|..+++.+..-++ +++++++.. +   +
T Consensus        16 ~i~i~~l~g-GlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~~~IdR~~E~~il~~l~~~gl~P~~l~~~~~-G---~   87 (330)
T PLN02421         16 DFSVERISG-GITNLLLKVSVKEENGNEVSVTVRLFGPNT---DYVIDRERELQAIKYLSAAGFGAKLLGVFGN-G---M   87 (330)
T ss_pred             ceEEEEeCC-cccceEEEEEecCCCCCCceEEEEEecCCc---CeEechHHHHHHHHHHHhcCCCCceeEEeCC-c---E
Confidence            444444433 6677788876543     378999886542   122334678999988875444 466666532 2   5


Q ss_pred             EEecCCCCCHHH--------------H---HhhccCC----CC-HHHHHHHHHHH----------------------HHH
Q 016082          185 VTEFMARGSIYD--------------F---LHKQKGV----FQ-LTSLLKVAIDV----------------------SKG  220 (395)
Q Consensus       185 V~E~~~ggsL~~--------------~---l~~~~~~----l~-~~~~~~i~~~i----------------------~~~  220 (395)
                      |.+|++|..+..              .   +|....+    ++ ...+.++..++                      ..-
T Consensus        88 i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  167 (330)
T PLN02421         88 IQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDE  167 (330)
T ss_pred             eehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHH
Confidence            899998764421              1   1211111    11 12222222111                      111


Q ss_pred             HHHHH----HC----CccccCCCCCCeeeCC-CCcEEEeeeccccc
Q 016082          221 MNYLH----QN----NIIHRDLKTANLLMDE-NGVVKVADFGVARV  257 (395)
Q Consensus       221 l~~LH----~~----~iiHrDlkp~NiLl~~-~~~vkl~DFg~a~~  257 (395)
                      +..+.    ..    -++|.|+.+.||++++ ++.++++||..|..
T Consensus       168 ~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        168 IVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            22221    11    2799999999999975 57899999998864

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.00  E-value=0.0078  Score=56.61  Aligned_cols=31  Identities=29%  Similarity=0.547  Sum_probs=26.0

Q ss_pred             CccccCCCCCCeeeCCCCc-EEEeeecccccc
Q 016082          228 NIIHRDLKTANLLMDENGV-VKVADFGVARVQ  258 (395)
Q Consensus       228 ~iiHrDlkp~NiLl~~~~~-vkl~DFg~a~~~  258 (395)
                      .++|+|++|.||++++++. .-|+||+.+...
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            4899999999999997555 569999998753

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.77  E-value=0.0057  Score=61.17  Aligned_cols=156  Identities=22%  Similarity=0.309  Sum_probs=97.3

Q ss_pred             HHHHHHHHHHHhcCCCceeeEEEEEecCC-cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 016082          152 KEFSQEVYIMRKIRHKNVVQFIGACTRPP-NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII  230 (395)
Q Consensus       152 ~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ii  230 (395)
                      ..+.....+++.+.|+|..+++.+..... ...+|+|++.. ||++++..+.  +......              .+|+.
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~-Sled~~~~~~--l~~~s~~--------------~~~~~   89 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTM-SLEDILKTGN--LKDESLL--------------AHGVL   89 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhcc-chHHHHHhcc--cchhhhc--------------ccccc
Confidence            45667788999999999999999875443 47889999954 9999987643  2211111              12222


Q ss_pred             ccCCCCCCeeeCCCCcEEEeeeccccccccCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 016082          231 HRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL  310 (395)
Q Consensus       231 HrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~  310 (395)
                      |     -|++       +.+| -++...                 |-.     ..+|+||||+|.++.++.-|...+...
T Consensus        90 ~-----~~~~-------~~td-~~~t~~-----------------~~~-----~~pKsdVwsl~~i~~el~L~~~l~~~~  134 (725)
T KOG1093|consen   90 H-----LNII-------YITD-HFLTKY-----------------PSP-----IGPKSDVWSLGFIILELYLGISLEAEL  134 (725)
T ss_pred             e-----ehhh-------hccc-cccccC-----------------CCC-----CCcchhhhhHHHHHHHHHHhhHHHHHH
Confidence            2     1222       2233 111000                 100     113999999999999999998887776


Q ss_pred             CHHHHHHHhhhccCCCC----------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          311 TPLQAAVGVVQKSLRPT----------IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       311 ~~~~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      +..+....+..-...+.          +...++..+.++..+|+-..|..||.+.++.+
T Consensus       135 ~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k  193 (725)
T KOG1093|consen  135 TESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK  193 (725)
T ss_pred             HHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence            65554444332211111          11245667889999999999998887666543

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.68  E-value=0.0065  Score=54.58  Aligned_cols=30  Identities=37%  Similarity=0.614  Sum_probs=21.7

Q ss_pred             CccccCCCCCCeee-CCCCcEEEeeeccccc
Q 016082          228 NIIHRDLKTANLLM-DENGVVKVADFGVARV  257 (395)
Q Consensus       228 ~iiHrDlkp~NiLl-~~~~~vkl~DFg~a~~  257 (395)
                      -++|+|+.|.||++ +.++.++++||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            48999999999999 8899999999999864

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.65  E-value=0.047  Score=52.16  Aligned_cols=30  Identities=23%  Similarity=0.307  Sum_probs=28.0

Q ss_pred             CccccCCCCCCeeeCCCCcEEEeeeccccc
Q 016082          228 NIIHRDLKTANLLMDENGVVKVADFGVARV  257 (395)
Q Consensus       228 ~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~  257 (395)
                      +++|+|+.++|++++.++.+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            799999999999999999999999998864

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.60  E-value=0.02  Score=55.16  Aligned_cols=131  Identities=18%  Similarity=0.258  Sum_probs=82.4

Q ss_pred             CceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc------eeeEEE----EEecCCcEEEEEecCCC
Q 016082          122 SYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN------VVQFIG----ACTRPPNLCIVTEFMAR  191 (395)
Q Consensus       122 ~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~----~~~~~~~~~lV~E~~~g  191 (395)
                      .-..+|+.+..+..+++|+..+. .+.   .++..|...|+.+.-.+      +...-|    ....+...+-+++|++|
T Consensus        37 ~eN~~f~~~~~~g~~iLki~~~~-~~~---~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G  112 (331)
T COG2334          37 EENSNFRVQTEDGRYILKIYRPG-WTR---AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPG  112 (331)
T ss_pred             ccCceEEEEecCCCeEEEEecCC-CCH---HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCC
Confidence            45668988887777799999876 443   45566788887774222      222222    22222467889999999


Q ss_pred             CCHHH------------H---HhhccCCCC-----------HH----H---------HHHHHHHHHHHHHHHHH------
Q 016082          192 GSIYD------------F---LHKQKGVFQ-----------LT----S---------LLKVAIDVSKGMNYLHQ------  226 (395)
Q Consensus       192 gsL~~------------~---l~~~~~~l~-----------~~----~---------~~~i~~~i~~~l~~LH~------  226 (395)
                      ..+..            .   ++.....++           +.    .         -.....++...++.+.+      
T Consensus       113 ~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~l  192 (331)
T COG2334         113 RPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHL  192 (331)
T ss_pred             cCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhC
Confidence            87662            1   111111111           11    0         01233445555666654      


Q ss_pred             --CC--ccccCCCCCCeeeCCCCc-EEEeeecccc
Q 016082          227 --NN--IIHRDLKTANLLMDENGV-VKVADFGVAR  256 (395)
Q Consensus       227 --~~--iiHrDlkp~NiLl~~~~~-vkl~DFg~a~  256 (395)
                        .+  +||+|+.|.||+++.+.. +.++||+.++
T Consensus       193 p~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         193 PALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             CcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence              23  999999999999999884 8999999886

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.59  E-value=0.017  Score=54.58  Aligned_cols=75  Identities=16%  Similarity=0.133  Sum_probs=50.2

Q ss_pred             ceeeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC---CCceeeEEEEEecCCcEEEEEecC
Q 016082          113 KIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR---HKNVVQFIGACTRPPNLCIVTEFM  189 (395)
Q Consensus       113 ~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~E~~  189 (395)
                      +-.+.++.|....+|+.+..++.+.||+-...     ....|..|..-|+.|.   .-.+++.+++....+..+|||||+
T Consensus        20 ~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~-----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l   94 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLDTDGGSYFVKVNSES-----GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL   94 (288)
T ss_dssp             -EEEEE--SSSSEEEEEETTS-EEEEEEEEGG-----GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred             eeeEecCCCChhheEEEECCCccEEEEecChh-----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence            33567888999999999988899999997622     2256788998888884   456889999888777789999999


Q ss_pred             CCC
Q 016082          190 ARG  192 (395)
Q Consensus       190 ~gg  192 (395)
                      +.+
T Consensus        95 ~~~   97 (288)
T PF03881_consen   95 EMG   97 (288)
T ss_dssp             ---
T ss_pred             cCC
Confidence            876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.53  E-value=0.017  Score=56.08  Aligned_cols=74  Identities=12%  Similarity=0.015  Sum_probs=47.6

Q ss_pred             eeeeeCceEEEEEEECC--ceEEEEEecCCC-----CCHHHHHHHHHHHHHHHhcC--CC-ceeeEEEEEecCCcEEEEE
Q 016082          117 KVASGSYGDLYKGTYCS--QEVAIKVLKPEC-----VNTEMLKEFSQEVYIMRKIR--HK-NVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       117 ~lg~G~~G~Vy~~~~~~--~~vAvK~~~~~~-----~~~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lV~  186 (395)
                      .||.|....||++...+  +.|+||.-.+-.     ..+-...+...|...|+...  .| .++++|.+  ++....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            57999999999998754  579999643111     01223455667888887764  24 45555543  444567999


Q ss_pred             ecCCCC
Q 016082          187 EFMARG  192 (395)
Q Consensus       187 E~~~gg  192 (395)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            998653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.10  E-value=0.075  Score=52.06  Aligned_cols=61  Identities=21%  Similarity=0.255  Sum_probs=43.8

Q ss_pred             cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCCCCeeeCC
Q 016082          181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH-QNNIIHRDLKTANLLMDE  243 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~iiHrDlkp~NiLl~~  243 (395)
                      ...|+-+|+.|.++..++....+  ++....+++.-...|+..+- -.+++|.|+.|.||++.-
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~~~~--pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKWKSQ--PEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF  380 (565)
T ss_pred             cceeeeeccccccHHhhhhcccC--hHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence            35688889999999999876443  44455566655555544433 458999999999999954

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.07  E-value=0.035  Score=54.53  Aligned_cols=75  Identities=11%  Similarity=-0.004  Sum_probs=50.1

Q ss_pred             eeeeeeeCceEEEEEEEC--CceEEEEEecCCC----CCHHHHHHHHHHHHHHHhcC--CC-ceeeEEEEEecCCcEEEE
Q 016082          115 ECKVASGSYGDLYKGTYC--SQEVAIKVLKPEC----VNTEMLKEFSQEVYIMRKIR--HK-NVVQFIGACTRPPNLCIV  185 (395)
Q Consensus       115 ~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~----~~~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lV  185 (395)
                      .+.||.|.-..||++...  ++.|+||--.+-.    ..+-..++...|..+|+...  .| .++++|.+  ++....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            456899999999999874  5679998642111    11223466777888888764  34 45666543  44456789


Q ss_pred             EecCCC
Q 016082          186 TEFMAR  191 (395)
Q Consensus       186 ~E~~~g  191 (395)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            999864

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.88  E-value=0.11  Score=50.25  Aligned_cols=120  Identities=20%  Similarity=0.328  Sum_probs=75.7

Q ss_pred             CCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCeeeCCCCcEEEeeeccccc
Q 016082          179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARV  257 (395)
Q Consensus       179 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~  257 (395)
                      ....|++|++- |+++...     ......++..++.+.+..++-+..+ ..=|||+.-.|||++ +|+|.|+||-++|.
T Consensus       298 ~~y~yl~~kdh-gt~is~i-----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl  370 (488)
T COG5072         298 TLYLYLHFKDH-GTPISII-----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL  370 (488)
T ss_pred             ceEEEEEEecC-Cceeeee-----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence            33567778765 4455432     1224567788888887777777655 689999999999999 99999999999995


Q ss_pred             cccCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCC-CCCCCCHH
Q 016082          258 QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGEL-PYAGLTPL  313 (395)
Q Consensus       258 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~-pf~~~~~~  313 (395)
                      ....+...    -.+.--|-.+.|.. +..-+||-+   |--|+.|.. -|...++.
T Consensus       371 ~~~q~~is----y~rldhp~lF~G~d-d~QFeIYrl---Mr~l~~g~wa~F~P~TNv  419 (488)
T COG5072         371 SYSQGIIS----YNRLDHPDLFNGVD-DYQFEIYRL---MRRLLKGRWAQFEPITNV  419 (488)
T ss_pred             ccCCceee----ccccCchhhhcCcc-ceeeeHHHH---HHHHhcCcHHhcccchhh
Confidence            43322111    11222444555443 666678774   445555542 23334443

>PTZ00384 choline kinase; Provisional

Probab=95.88  E-value=0.09  Score=51.83  Aligned_cols=71  Identities=15%  Similarity=0.262  Sum_probs=43.1

Q ss_pred             eeeeeCceEEEEEEECC---ce-----EEEEEecCCCCCHHHHHHHHHHHHHHHhcCCC-ceeeEEEEEecCCcEEEEEe
Q 016082          117 KVASGSYGDLYKGTYCS---QE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK-NVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       117 ~lg~G~~G~Vy~~~~~~---~~-----vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lV~E  187 (395)
                      .|..|-...+|+++..+   ..     |.+++...   ..+..-.-.+|..+++.+... .-+++++.+..    +++.|
T Consensus        57 ~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~---~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e  129 (383)
T PTZ00384         57 KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST---YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE  129 (383)
T ss_pred             EeCCcccceEEEEEecCCCCCccccceEEEEeccC---CCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence            44447778888886532   12     44444211   122223346789999998754 44666776643    59999


Q ss_pred             cCCCCCH
Q 016082          188 FMARGSI  194 (395)
Q Consensus       188 ~~~ggsL  194 (395)
                      |++|.+|
T Consensus       130 fIeGr~l  136 (383)
T PTZ00384        130 WVEGNTM  136 (383)
T ss_pred             EeccccC
Confidence            9998754

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	395
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-63
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-63
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-49
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-49
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-48
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-48
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		5e-48
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-48
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-47
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-47
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-47
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-47
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-47
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-47
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-47
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-47
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-47
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-47
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-47
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-47
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-47
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-47
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		5e-47
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		7e-47
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-46
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-46
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-46
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-46
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-46
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-46
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-46
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-46
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		4e-46
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-46
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		6e-46
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-45
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-45
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-45
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-45
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-45
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		6e-45
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		9e-45
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-44
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-44
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-44
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-44
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-44
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-44
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-44
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-44
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-44
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-44
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-44
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-44
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		6e-44
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-44
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		6e-44
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		6e-44
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		8e-44
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		9e-44
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		9e-44
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-43
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-43
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-43
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-43
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-43
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-43
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		5e-43
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-42
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-42
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-42
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-41
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		9e-41
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		9e-41
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-40
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-40
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-39
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-39
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-39
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-39
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-39
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-39
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-39
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		7e-39
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		8e-39
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-38
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-38
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-38
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-38
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-38
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-38
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-38
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-38
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-38
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-38
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-38
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-38
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-38
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-38
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-38
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-38
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-38
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-38
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-38
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-38
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-38
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-38
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-38
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		5e-38
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-38
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-38
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-37
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-37
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-37
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-37
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-37
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-37
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-37
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-37
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-37
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-37
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-37
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-37
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-37
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		7e-37
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		7e-37
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-37
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		8e-37
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		8e-37
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		8e-37
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		9e-37
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-36
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-36
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-36
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-36
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-36
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-36
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-36
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-36
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-36
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-36
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-36
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-36
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-36
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-36
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-36
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-36
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-36
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-36
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-35
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		5e-35
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-35
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-34
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-34
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-34
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-34
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-34
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-34
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-34
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-34
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-34
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-34
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		4e-34
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-34
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-34
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-34
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-34
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		5e-34
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		5e-34
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		6e-34
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		8e-34
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-33
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-33
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-33
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-33
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		6e-33
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-33
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		6e-33
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		7e-33
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		7e-33
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		7e-33
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		8e-33
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-32
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-32
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-32
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-32
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-32
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-32
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-32
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-32
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-32
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-32
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-32
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-32
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-32
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-32
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-32
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-32
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-32
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-32
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		5e-32
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-32
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		6e-32
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-32
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-32
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-32
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		9e-32
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-31
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-31
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-31
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-31
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-31
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-31
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-31
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-31
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-31
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-31
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-31
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-31
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-31
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-31
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-31
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-31
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-31
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-31
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-31
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-31
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-31
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-31
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-31
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-31
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-31
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-31
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-31
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-31
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-31
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-31
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-31
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-31
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-31
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		5e-31
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-31
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		7e-31
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		7e-31
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		8e-31
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-31
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-31
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		8e-31
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		9e-31
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		9e-31
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		9e-31
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		9e-31
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-30
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-30
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-30
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-30
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-30
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-30
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-30
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-30
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-30
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-30
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-30
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-30
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-30
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-30
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-30
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-30
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-30
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-30
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-30
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-30
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		8e-30
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-29
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-29
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-29
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-29
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-29
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-29
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-29
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		5e-29
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		5e-29
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		5e-29
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		6e-29
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-29
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-29
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		8e-29
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		8e-29
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		9e-29
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-28
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-28
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-28
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-28
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-28
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-28
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-28
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-28
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-28
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-28
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-28
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-28
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-28
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-28
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-28
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-28
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-28
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-28
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-28
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-28
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-28
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-28
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-28
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-28
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		5e-28
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		5e-28
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		7e-28
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		7e-28
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-27
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-27
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-27
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-27
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-27
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-27
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		6e-27
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		8e-27
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		8e-27
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		8e-27
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		8e-27
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		8e-27
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		8e-27
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-27
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		9e-27
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-27
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-26
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-26
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-26
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-26
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-26
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-26
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-26
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-26
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-26
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-26
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-26
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-26
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-26
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		5e-26
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-26
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		5e-26
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		5e-26
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-26
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-26
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		5e-26
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		6e-26
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		6e-26
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		7e-26
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		7e-26
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		9e-26
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		9e-26
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		9e-26
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		9e-26
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		9e-26
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-25
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-25
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-25
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-25
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-25
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-25
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-25
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-25
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-25
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-25
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-25
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-25
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-25
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-25
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		6e-25
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		6e-25
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		7e-25
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		7e-25
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		7e-25
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-24
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-24
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-24
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-24
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-24
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-24
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-24
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-24
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-24
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-24
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-24
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-24
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-24
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-24
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-24
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-24
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-24
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-24
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-24
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		4e-24
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-24
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		5e-24
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-24
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		7e-24
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		7e-24
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		8e-24
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-23
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-23
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-23
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-23
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-23
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-23
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-23
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-23
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-23
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-23
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-23
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-23
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-23
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-23
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-23
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-23
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-23
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-23
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-23
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-23
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-23
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-23
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-23
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-23
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-23
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-23
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-23
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-23
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-23
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-23
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-23
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-23
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-23
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-23
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		5e-23
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-23
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		6e-23
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		6e-23
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		7e-23
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		7e-23
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		8e-23
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		9e-23
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		9e-23
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-22
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-22
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-22
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-22
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-22
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-22
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-22
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-22
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-22
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-22
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-22
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		5e-22
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		7e-22
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		7e-22
3g51_A	325	Structural Diversity Of The Active Conformation Of		8e-22
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		8e-22
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		8e-22
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-21
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-21
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-21
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-21
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-21
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-21
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-21
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-21
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-21
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-21
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		6e-21
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-21
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		7e-21
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-21
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-20
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-20
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-20
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-20
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-20
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-20
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-20
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-20
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-20
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-20
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-20
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-20
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-20
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-20
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-20
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-20
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-20
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-20
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-20
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-20
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-20
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-20
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		5e-20
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-20
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-20
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		6e-20
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		6e-20
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		6e-20
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		6e-20
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		6e-20
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		6e-20
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		7e-20
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		7e-20
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		7e-20
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		7e-20
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		7e-20
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		8e-20
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		8e-20
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		8e-20
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		8e-20
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		8e-20
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		8e-20
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		9e-20
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		9e-20
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-19
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-19
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-19
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-19
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-19
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-19
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-19
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-19
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-19
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-19
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-19
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-19
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-19
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-19
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-19
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-19
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-19
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-19
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-19
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-19
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-19
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-19
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-19
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-19
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-19
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-19
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-19
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-19
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-19
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-19
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-19
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-19
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-19
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-19
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-19
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-19
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-19
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-19
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-19
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-19
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-19
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-19
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-19
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-19
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-19
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		5e-19
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-19
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-19
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		6e-19
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		6e-19
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		7e-19
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		8e-19
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		8e-19
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-18
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-18
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-18
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-18
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-18
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-18
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-18
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-18
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-18
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-18
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-18
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-18
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-18
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-18
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-18
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		4e-18
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-18
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-18
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		4e-18
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		4e-18
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-18
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-18
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-18
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		5e-18
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		5e-18
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-18
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		6e-18
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		6e-18
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		7e-18
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		8e-18
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		9e-18
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-17
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		3e-17
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-17
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-17
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-17
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-17
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-17
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-17
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-17
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-17
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-17
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-17
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		5e-17
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		5e-17
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		5e-17
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		6e-17
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		6e-17
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		6e-17
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		9e-17
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		9e-17
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		9e-17
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		9e-17
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-16
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-16
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-16
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-16
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-16
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-16
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-16
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-16
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-16
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-16
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-16
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-16
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-16
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-16
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-16
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-16
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-16
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-16
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-16
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-16
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-16
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		5e-16
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		5e-16
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-16
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-16
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-16
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-16
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-16
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		5e-16
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		5e-16
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-16
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-16
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-16
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		5e-16
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-16
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-16
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		6e-16
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		6e-16
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-16
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-16
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		7e-16
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		7e-16
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		7e-16
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-16
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		7e-16
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		7e-16
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		8e-16
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-16
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		8e-16
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		9e-16
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		9e-16
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		9e-16
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-15
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-15
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-15
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-15
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-15
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-15
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-15
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-15
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-15
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-15
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-15
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-15
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-15
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-15
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-15
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-15
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-15
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-15
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-15
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-15
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-15
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-15
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-15
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-15
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-15
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-15
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-15
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-15
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-15
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-15
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-15
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-15
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-15
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-15
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-15
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-15
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-15
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		5e-15
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-15
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-15
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		5e-15
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		5e-15
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-15
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-15
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		5e-15
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-15
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-15
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		5e-15
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-15
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		6e-15
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		6e-15
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		6e-15
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		7e-15
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		7e-15
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		7e-15
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		7e-15
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		7e-15
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		8e-15
4exu_A	371	Mapk13, Inactive Form Length = 371		8e-15
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		8e-15
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		8e-15
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		9e-15
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		9e-15
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		9e-15
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		9e-15
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		9e-15
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		9e-15
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-14
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-14
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-14
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-14
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-14
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-14
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-14
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-14
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-14
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-14
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-14
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-14
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-14
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-14
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-14
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-14
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-14
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-14
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-14
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-14
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-14
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-14
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-14
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-14
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-14
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-14
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-14
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-14
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-14
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-14
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-14
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-14
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-14
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-14
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-14
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-14
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-14
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-14
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-14
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-14
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-14
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-14
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-14
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-14
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-14
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-14
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-14
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-14
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-14
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-14
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-14
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-14
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-14
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-14
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-14
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-14
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-14
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		4e-14
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-14
3gni_B	389	Structure Of Strad And Mo25 Length = 389		4e-14
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-14
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		4e-14
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		4e-14
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-14
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-14
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-14
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-14
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-14
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-14
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-14
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-14
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-14
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		5e-14
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-14
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-14
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-14
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-14
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-14
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		6e-14
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		6e-14
3kk8_A	284	Camkii Substrate Complex A Length = 284		6e-14
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		6e-14
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		6e-14
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		6e-14
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-14
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-14
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		8e-14
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		8e-14
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		8e-14
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		8e-14
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		8e-14
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		9e-14
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-14
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		9e-14
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		9e-14
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-13
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-13
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-13
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-13
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-13
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-13
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-13
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-13
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-13
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-13
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-13
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-13
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-13
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-13
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-13
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-13
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-13
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-13
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-13
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-13
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-13
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-13
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-13
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-13
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-13
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-13
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-13
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-13
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-13
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-13
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-13
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-13
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-13
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-13
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-13
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-13
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-13
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-13
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-13
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-13
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-13
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-13
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-13
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-13
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-13
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-13
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-13
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-13
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-13
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-13
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-13
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-13
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-13
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-13
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-13
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-13
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-13
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-13
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-13
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-13
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-13
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-13
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-13
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-13
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-13
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-13
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-13
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-13
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-13
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-13
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-13
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		4e-13
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		5e-13
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		5e-13
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-13
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		5e-13
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		6e-13
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		6e-13
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		9e-13
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-12
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-12
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-12
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-12
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		3e-12
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-12
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-12
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		3e-12
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-12
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-12
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		4e-12
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		4e-12
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		4e-12
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		4e-12
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		4e-12
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-12
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		4e-12
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		4e-12
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		4e-12
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		5e-12
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		5e-12
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		5e-12
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		5e-12
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		5e-12
2oza_A	356	Structure Of P38alpha Complex Length = 356		5e-12
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		5e-12
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		5e-12
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		5e-12
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-12
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		5e-12
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		5e-12
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		5e-12
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		5e-12
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-12
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-12
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		5e-12
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		6e-12
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		6e-12
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		6e-12
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		6e-12
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		6e-12
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		6e-12
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		7e-12
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		7e-12
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		9e-12
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-11
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-11
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-11
3soa_A	444	Full-Length Human Camkii Length = 444		2e-11
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		2e-11
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		2e-11
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-11
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-11
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-11
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-11
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-11
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-11
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-11
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		4e-11
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		4e-11
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-11
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		7e-11
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-10
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-10
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-10
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-10
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-10

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  238 bits (607), Expect = 4e-63,   Method: Compositional matrix adjust.
 Identities = 118/275 (42%), Positives = 182/275 (66%), Gaps = 6/275 (2%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY 159
           DG D+ +I    L I+ K+ +GS+G +++  +   +VA+K+L  +  + E + EF +EV 
Sbjct: 28  DGDDM-DIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVA 86
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSL--LKVAIDV 217
           IM+++RH N+V F+GA T+PPNL IVTE+++RGS+Y  LHK     QL     L +A DV
Sbjct: 87  IMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDV 146
Query: 218 SKGMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT-AETGTYRWM 274
           +KGMNYLH  N  I+HRDLK+ NLL+D+   VKV DFG++R++A   + +    GT  WM
Sbjct: 147 AKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWM 206
Query: 275 APEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP 334
           APEV+  +P + K+DV+SFG+ LWEL T + P+  L P Q    V  K  R  IP++ +P
Sbjct: 207 APEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP 266
Query: 335 RLAELLERCWQHDPTQRPNFSQITDILKQMMKEVL 369
           ++A ++E CW ++P +RP+F+ I D+L+ ++K  +
Sbjct: 267 QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  238 bits (607), Expect = 4e-63,   Method: Compositional matrix adjust.
 Identities = 117/275 (42%), Positives = 184/275 (66%), Gaps = 6/275 (2%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY 159
           DG D+ +I    L I+ K+ +GS+G +++  +   +VA+K+L  +  + E + EF +EV 
Sbjct: 28  DGDDM-DIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVA 86
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSL--LKVAIDV 217
           IM+++RH N+V F+GA T+PPNL IVTE+++RGS+Y  LHK     QL     L +A DV
Sbjct: 87  IMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDV 146
Query: 218 SKGMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT-AETGTYRWM 274
           +KGMNYLH  N  I+HR+LK+ NLL+D+   VKV DFG++R++A + + + +  GT  WM
Sbjct: 147 AKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWM 206
Query: 275 APEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP 334
           APEV+  +P + K+DV+SFG+ LWEL T + P+  L P Q    V  K  R  IP++ +P
Sbjct: 207 APEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP 266
Query: 335 RLAELLERCWQHDPTQRPNFSQITDILKQMMKEVL 369
           ++A ++E CW ++P +RP+F+ I D+L+ ++K  +
Sbjct: 267 QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  193 bits (490), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 101/279 (36%), Positives = 171/279 (61%), Gaps = 12/279 (4%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY 159
           D +D WEI   Q+ +  ++ SGS+G +YKG +   +VA+K+L       + L+ F  EV 
Sbjct: 2   DSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVG 60
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           ++RK RH N++ F+G  T+P  L IVT++    S+Y  LH  +  F++  L+ +A   ++
Sbjct: 61  VLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTAR 119
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAE--TGTYRWMAP 276
           GM+YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A V+++ SG    E  +G+  WMAP
Sbjct: 120 GMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 179
Query: 277 EVI---EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK-SLRPTIPK-- 330
           EVI   +  PY +++DV++FGI L+EL+TG+LPY+ +      + +V + SL P + K  
Sbjct: 180 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR 239
Query: 331 -HAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV 368
            +   R+  L+  C +    +RP+F +I   ++++ +E+
Sbjct: 240 SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAREL 278

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  191 bits (484), Expect = 9e-49,   Method: Compositional matrix adjust.
 Identities = 100/279 (35%), Positives = 170/279 (60%), Gaps = 12/279 (4%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY 159
           D +D WEI   Q+ +  ++ SGS+G +YKG +   +VA+K+L       + L+ F  EV 
Sbjct: 14  DSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVG 72
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           ++RK RH N++ F+G  T+P  L IVT++    S+Y  LH  +  F++  L+ +A   ++
Sbjct: 73  VLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTAR 131
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAE--TGTYRWMAP 276
           GM+YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A  +++ SG    E  +G+  WMAP
Sbjct: 132 GMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191
Query: 277 EVI---EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK-SLRPTIPK-- 330
           EVI   +  PY +++DV++FGI L+EL+TG+LPY+ +      + +V + SL P + K  
Sbjct: 192 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR 251
Query: 331 -HAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV 368
            +   R+  L+  C +    +RP+F +I   ++++ +E+
Sbjct: 252 SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAREL 290

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  189 bits (479), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 100/272 (36%), Positives = 158/272 (58%), Gaps = 12/272 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
           D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + +  E   EF +E  +
Sbjct: 4   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 60
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSK 219
           M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L +  +       LL +A  +S 
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 120
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAP 276
            M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 121 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTFTAHAGAKFPIKWTAP 179
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E + +  +  K+DV++FG+ LWE+ T G  PY G+ P Q    +++K  R   P+    +
Sbjct: 180 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQ-VYELLEKDYRMERPEGCPEK 238
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           + EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 239 VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 270

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  188 bits (478), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 100/278 (35%), Positives = 167/278 (60%), Gaps = 12/278 (4%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY 159
           D  D WEI   Q+ +  ++ SGS+G +YKG +   +VA+K+L       + L+ F  EV 
Sbjct: 14  DAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVG 72
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           ++RK RH N++ F+G  T  P L IVT++    S+Y  LH  +  F++  L+ +A   ++
Sbjct: 73  VLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTAR 131
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAE--TGTYRWMAP 276
           GM+YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A  +++ SG    E  +G+  WMAP
Sbjct: 132 GMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191
Query: 277 EVI---EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK-SLRPTIPK-- 330
           EVI   +  PY +++DV++FGI L+EL+TG+LPY+ +      + +V + SL P + K  
Sbjct: 192 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR 251
Query: 331 -HAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
            +   R+  L+  C +    +RP+F +I   ++++ +E
Sbjct: 252 SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARE 289

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score =  188 bits (477), Expect = 5e-48,   Method: Compositional matrix adjust.
 Identities = 100/277 (36%), Positives = 159/277 (57%), Gaps = 12/277 (4%)
Query: 98  PTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFS 155
           P+   D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + +  E   EF 
Sbjct: 5   PSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFL 61
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVA 214
           +E  +M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L +  +       LL +A
Sbjct: 62  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 121
Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---Y 271
             +S  M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA  G     
Sbjct: 122 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPI 180
Query: 272 RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPK 330
           +W APE + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K  R   P+
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPE 239
Query: 331 HAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
               ++ EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  187 bits (475), Expect = 9e-48,   Method: Compositional matrix adjust.
 Identities = 99/272 (36%), Positives = 158/272 (58%), Gaps = 12/272 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
           D WE++   + ++ K+  G +G++Y+G +   S  VA+K LK + +  E   EF +E  +
Sbjct: 4   DKWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 60
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSK 219
           M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L +  +       LL +A  +S 
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 120
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAP 276
            M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 121 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAP 179
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E + +  +  K+DV++FG+ LWE+ T G  PY G+ P Q    +++K  R   P+    +
Sbjct: 180 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQ-VYELLEKDYRMERPEGCPEK 238
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           + EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 239 VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 270

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score =  187 bits (474), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 103/289 (35%), Positives = 162/289 (56%), Gaps = 20/289 (6%)
Query: 86  LLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKP 143
           L  + SPN         D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK 
Sbjct: 10  LYFQGSPN--------YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE 61
Query: 144 ECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QK 202
           + +  E   EF +E  +M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L +  +
Sbjct: 62  DTMEVE---EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR 118
Query: 203 GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262
                  LL +A  +S  M YL + N IHRDL   N L+ EN +VKVADFG++R+     
Sbjct: 119 QEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GD 177
Query: 263 VMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVG 318
             TA  G     +W APE + +  +  K+DV++FG+ LWE+ T G  PY G+  L     
Sbjct: 178 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYE 236
Query: 319 VVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           +++K  R   P+    ++ EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 237 LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 285

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score =  186 bits (473), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 103/285 (36%), Positives = 161/285 (56%), Gaps = 20/285 (7%)
Query: 90  SSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN 147
           SSPN         D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + + 
Sbjct: 6   SSPN--------YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME 57
Query: 148 TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQ 206
            E   EF +E  +M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L +  +    
Sbjct: 58  VE---EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVN 114
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266
              LL +A  +S  M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA
Sbjct: 115 AVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTA 173
Query: 267 ETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK 322
             G     +W APE + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K
Sbjct: 174 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEK 232
Query: 323 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
             R   P+    ++ EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 233 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 277

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score =  186 bits (473), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 99/272 (36%), Positives = 157/272 (57%), Gaps = 12/272 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
           D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + +  E   EF +E  +
Sbjct: 4   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 60
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSK 219
           M++I+H N+VQ +G CTR P   I+ EFM  G++ D+L +  +       LL +A  +S 
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 120
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAP 276
            M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 121 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAP 179
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E + +  +  K+DV++FG+ LWE+ T G  PY G+ P Q    +++K  R   P+    +
Sbjct: 180 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQ-VYELLEKDYRMERPEGCPEK 238
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           + EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 239 VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 270

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score =  186 bits (473), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 103/285 (36%), Positives = 161/285 (56%), Gaps = 20/285 (7%)
Query: 90  SSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN 147
           SSPN         D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + + 
Sbjct: 6   SSPN--------YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME 57
Query: 148 TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQ 206
            E   EF +E  +M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L +  +    
Sbjct: 58  VE---EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVN 114
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266
              LL +A  +S  M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA
Sbjct: 115 AVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTA 173
Query: 267 ETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK 322
             G     +W APE + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K
Sbjct: 174 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEK 232
Query: 323 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
             R   P+    ++ EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 233 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 277

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score =  186 bits (473), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 103/285 (36%), Positives = 161/285 (56%), Gaps = 20/285 (7%)
Query: 90  SSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN 147
           SSPN         D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + + 
Sbjct: 6   SSPN--------YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME 57
Query: 148 TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQ 206
            E   EF +E  +M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L +  +    
Sbjct: 58  VE---EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVS 114
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266
              LL +A  +S  M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA
Sbjct: 115 AVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTA 173
Query: 267 ETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK 322
             G     +W APE + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K
Sbjct: 174 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEK 232
Query: 323 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
             R   P+    ++ EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 233 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 277

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score =  186 bits (472), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 103/285 (36%), Positives = 161/285 (56%), Gaps = 20/285 (7%)
Query: 90  SSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN 147
           SSPN         D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + + 
Sbjct: 6   SSPN--------YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME 57
Query: 148 TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQ 206
            E   EF +E  +M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L +  +    
Sbjct: 58  VE---EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVN 114
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266
              LL +A  +S  M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA
Sbjct: 115 AVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTA 173
Query: 267 ETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK 322
             G     +W APE + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K
Sbjct: 174 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEK 232
Query: 323 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
             R   P+    ++ EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 233 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 277

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score =  186 bits (471), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 99/277 (35%), Positives = 158/277 (57%), Gaps = 12/277 (4%)
Query: 98  PTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFS 155
           P+   D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + +  E   EF 
Sbjct: 2   PSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFL 58
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVA 214
           +E  +M++I+H N+VQ +G CTR P   I+ EFM  G++ D+L +  +       LL +A
Sbjct: 59  KEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMA 118
Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---Y 271
             +S  M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA  G     
Sbjct: 119 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPI 177
Query: 272 RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPK 330
           +W APE + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K  R   P+
Sbjct: 178 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPE 236
Query: 331 HAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
               ++ EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 237 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 273

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score =  186 bits (471), Expect = 3e-47,   Method: Compositional matrix adjust.
 Identities = 99/272 (36%), Positives = 157/272 (57%), Gaps = 12/272 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
           D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + +  E   EF +E  +
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 62
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSK 219
           M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L +  +       LL +A  +S 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAP 276
            M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 181
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K  R   P+    +
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 240
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           + EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 241 VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score =  186 bits (471), Expect = 3e-47,   Method: Compositional matrix adjust.
 Identities = 99/272 (36%), Positives = 157/272 (57%), Gaps = 12/272 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
           D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + +  E   EF +E  +
Sbjct: 8   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 64
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSK 219
           M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L +  +       LL +A  +S 
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 124
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAP 276
            M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 125 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 183
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K  R   P+    +
Sbjct: 184 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 242
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           + EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 243 VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 274

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  186 bits (471), Expect = 3e-47,   Method: Compositional matrix adjust.
 Identities = 99/272 (36%), Positives = 157/272 (57%), Gaps = 12/272 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
           D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + +  E   EF +E  +
Sbjct: 8   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 64
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSK 219
           M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L +  +       LL +A  +S 
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 124
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAP 276
            M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 125 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 183
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K  R   P+    +
Sbjct: 184 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 242
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           + EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 243 VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 274

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score =  186 bits (471), Expect = 3e-47,   Method: Compositional matrix adjust.
 Identities = 99/272 (36%), Positives = 157/272 (57%), Gaps = 12/272 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
           D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + +  E   EF +E  +
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 62
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSK 219
           M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L +  +       LL +A  +S 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 122
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAP 276
            M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 181
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K  R   P+    +
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 240
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           + EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 241 VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score =  185 bits (470), Expect = 3e-47,   Method: Compositional matrix adjust.
 Identities = 99/272 (36%), Positives = 157/272 (57%), Gaps = 12/272 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
           D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + +  E   EF +E  +
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 62
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSK 219
           M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L +  +       LL +A  +S 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAP 276
            M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 181
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K  R   P+    +
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 240
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           + EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 241 VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score =  185 bits (470), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 99/272 (36%), Positives = 157/272 (57%), Gaps = 12/272 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
           D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + +  E   EF +E  +
Sbjct: 7   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 63
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSK 219
           M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L +  +       LL +A  +S 
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 123
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAP 276
            M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 124 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAP 182
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K  R   P+    +
Sbjct: 183 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 241
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           + EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 242 VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 273

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  185 bits (470), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 99/272 (36%), Positives = 157/272 (57%), Gaps = 12/272 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
           D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + +  E   EF +E  +
Sbjct: 8   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 64
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSK 219
           M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L +  +       LL +A  +S 
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 124
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAP 276
            M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 125 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAP 183
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K  R   P+    +
Sbjct: 184 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 242
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           + EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 243 VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 274

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  184 bits (468), Expect = 5e-47,   Method: Compositional matrix adjust.
 Identities = 97/250 (38%), Positives = 156/250 (62%), Gaps = 15/250 (6%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY 159
           D +  WEI+A ++ +  ++ SGS+G +YKG +   +VA+K+LK      E  + F  EV 
Sbjct: 26  DSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVA 84
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           ++RK RH N++ F+G  T+  NL IVT++    S+Y  LH Q+  FQ+  L+ +A   ++
Sbjct: 85  VLRKTRHVNILLFMGYMTKD-NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQ 143
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAE--TGTYRWMAP 276
           GM+YLH  NIIHRD+K+ N+ + E   VK+ DFG+A V+++ SG    E  TG+  WMAP
Sbjct: 144 GMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAP 203
Query: 277 EVI---EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH 333
           EVI   ++ P+ +++DV+S+GI L+EL+TGELPY+ +      + +V +        +A 
Sbjct: 204 EVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRG-------YAS 256
Query: 334 PRLAELLERC 343
           P L++L + C
Sbjct: 257 PDLSKLYKNC 266

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score =  184 bits (467), Expect = 7e-47,   Method: Compositional matrix adjust.
 Identities = 102/285 (35%), Positives = 160/285 (56%), Gaps = 20/285 (7%)
Query: 90  SSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN 147
           SSPN         D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + + 
Sbjct: 6   SSPN--------YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME 57
Query: 148 TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQ 206
            E   EF +E  +M++I+H N+VQ +G CTR P   I+ EFM  G++ D+L +  +    
Sbjct: 58  VE---EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVN 114
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266
              LL +A  +S  M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA
Sbjct: 115 AVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTA 173
Query: 267 ETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK 322
             G     +W APE + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K
Sbjct: 174 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEK 232
Query: 323 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
             R   P+    ++ EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 233 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 277

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score =  183 bits (465), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 98/272 (36%), Positives = 156/272 (57%), Gaps = 12/272 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
           D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + +  E   EF +E  +
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 62
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSK 219
           M++I+H N+VQ +G CTR P   I+ EFM  G++ D+L +  +       LL +A  +S 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAP 276
            M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 181
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K  R   P+    +
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 240
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           + EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 241 VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score =  183 bits (465), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 98/270 (36%), Positives = 155/270 (57%), Gaps = 12/270 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
           D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + +  E   EF +E  +
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 62
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSK 219
           M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L +  +       LL +A  +S 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 122
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAP 276
            M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 181
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K  R   P+    +
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 240
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMM 365
           + EL+  CWQ +P+ RP+F++I    + M 
Sbjct: 241 VYELMRACWQWNPSDRPSFAEIHQAFETMF 270

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score =  183 bits (464), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 98/272 (36%), Positives = 156/272 (57%), Gaps = 12/272 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
           D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + +  E   EF +E  +
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 62
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSK 219
           M++I+H N+VQ +G CTR P   I+ EFM  G++ D+L +  +       LL +A  +S 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAP 276
            M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 181
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K  R   P+    +
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 240
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           + EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 241 VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score =  183 bits (464), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 98/272 (36%), Positives = 157/272 (57%), Gaps = 12/272 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
           D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + +  E   EF +E  +
Sbjct: 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 269
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSK 219
           M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L +  +       LL +A  +S 
Sbjct: 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 329
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAP 276
            M YL + N IHR+L   N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 330 AMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 388
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K  R   P+    +
Sbjct: 389 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 447
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           + EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 448 VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score =  182 bits (463), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 98/272 (36%), Positives = 157/272 (57%), Gaps = 12/272 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
           D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + +  E   EF +E  +
Sbjct: 252 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 308
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSK 219
           M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L +  +       LL +A  +S 
Sbjct: 309 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 368
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAP 276
            M YL + N IHR+L   N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 369 AMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 427
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K  R   P+    +
Sbjct: 428 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 486
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           + EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 487 VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 518

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  182 bits (461), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 99/269 (36%), Positives = 162/269 (60%), Gaps = 12/269 (4%)
Query: 99  TDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEV 158
           +D +D WEI   Q+ +  ++ SGS+G +YKG +   +VA+K+L       + L+ F  EV
Sbjct: 2   SDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEV 60
Query: 159 YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS 218
            ++RK RH N++ F+G  T+P  L IVT++    S+Y  LH  +  F++  L+ +A   +
Sbjct: 61  GVLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTA 119
Query: 219 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAE--TGTYRWMA 275
           +GM+YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A V+++ SG    E  +G+  WMA
Sbjct: 120 QGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 179
Query: 276 PEVI---EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-LRPTIPK- 330
           PEVI   +  PY +++DV++FGI L+EL+TG+LPY+ +      + +V +  L P + K 
Sbjct: 180 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 239
Query: 331 --HAHPRLAELLERCWQHDPTQRPNFSQI 357
             +    +  L+  C +    +RP F QI
Sbjct: 240 RSNCPKAMKRLMAECLKKKRDERPLFPQI 268

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  182 bits (461), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 99/269 (36%), Positives = 162/269 (60%), Gaps = 12/269 (4%)
Query: 99  TDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEV 158
           +D +D WEI   Q+ +  ++ SGS+G +YKG +   +VA+K+L       + L+ F  EV
Sbjct: 2   SDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEV 60
Query: 159 YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS 218
            ++RK RH N++ F+G  T+P  L IVT++    S+Y  LH  +  F++  L+ +A   +
Sbjct: 61  GVLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTA 119
Query: 219 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAE--TGTYRWMA 275
           +GM+YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A V+++ SG    E  +G+  WMA
Sbjct: 120 QGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 179
Query: 276 PEVI---EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-LRPTIPK- 330
           PEVI   +  PY +++DV++FGI L+EL+TG+LPY+ +      + +V +  L P + K 
Sbjct: 180 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 239
Query: 331 --HAHPRLAELLERCWQHDPTQRPNFSQI 357
             +    +  L+  C +    +RP F QI
Sbjct: 240 RSNCPKAMKRLMAECLKKKRDERPLFPQI 268

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  182 bits (461), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 99/272 (36%), Positives = 152/272 (55%), Gaps = 16/272 (5%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLK--PECVNTEMLKEFSQEVYIMRK 163
           EID  +L +E  +  G +G +Y+  +   EVA+K  +  P+   ++ ++   QE  +   
Sbjct: 3   EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAM 62
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 223
           ++H N++   G C + PNLC+V EF   G +   L  ++       L+  A+ +++GMNY
Sbjct: 63  LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNY 120
Query: 224 LHQNNI---IHRDLKTANLLM---DENG-----VVKVADFGVARVQAQSGVMTAETGTYR 272
           LH   I   IHRDLK++N+L+    ENG     ++K+ DFG+AR   ++  M+A  G Y 
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGAYA 179
Query: 273 WMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHA 332
           WMAPEVI    +   +DV+S+G+ LWELLTGE+P+ G+  L  A GV    L   IP   
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTC 239
Query: 333 HPRLAELLERCWQHDPTQRPNFSQITDILKQM 364
               A+L+E CW  DP  RP+F+ I D L  +
Sbjct: 240 PEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  181 bits (460), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 99/268 (36%), Positives = 161/268 (60%), Gaps = 12/268 (4%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY 159
           D +D WEI   Q+ +  ++ SGS+G +YKG +   +VA+K+L       + L+ F  EV 
Sbjct: 25  DSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVG 83
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           ++RK RH N++ F+G  T+P  L IVT++    S+Y  LH  +  F++  L+ +A   ++
Sbjct: 84  VLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ 142
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAE--TGTYRWMAP 276
           GM+YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A V+++ SG    E  +G+  WMAP
Sbjct: 143 GMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 202
Query: 277 EVI---EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-LRPTIPK-- 330
           EVI   +  PY +++DV++FGI L+EL+TG+LPY+ +      + +V +  L P + K  
Sbjct: 203 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 262
Query: 331 -HAHPRLAELLERCWQHDPTQRPNFSQI 357
            +    +  L+  C +    +RP F QI
Sbjct: 263 SNCPKAMKRLMAECLKKKRDERPLFPQI 290

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  181 bits (459), Expect = 6e-46,   Method: Compositional matrix adjust.
 Identities = 99/268 (36%), Positives = 161/268 (60%), Gaps = 12/268 (4%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY 159
           D +D WEI   Q+ +  ++ SGS+G +YKG +   +VA+K+L       + L+ F  EV 
Sbjct: 26  DSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVG 84
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           ++RK RH N++ F+G  T+P  L IVT++    S+Y  LH  +  F++  L+ +A   ++
Sbjct: 85  VLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ 143
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAE--TGTYRWMAP 276
           GM+YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A V+++ SG    E  +G+  WMAP
Sbjct: 144 GMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 203
Query: 277 EVI---EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-LRPTIPK-- 330
           EVI   +  PY +++DV++FGI L+EL+TG+LPY+ +      + +V +  L P + K  
Sbjct: 204 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 263
Query: 331 -HAHPRLAELLERCWQHDPTQRPNFSQI 357
            +    +  L+  C +    +RP F QI
Sbjct: 264 SNCPKAMKRLMAECLKKKRDERPLFPQI 291

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  179 bits (454), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 98/266 (36%), Positives = 160/266 (60%), Gaps = 12/266 (4%)
Query: 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +D WEI   Q+ +  ++ SGS+G +YKG +   +VA+K+L       + L+ F  EV ++
Sbjct: 2   SDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVL 60
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
           RK RH N++ F+G  T+P  L IVT++    S+Y  LH  +  F++  L+ +A   ++GM
Sbjct: 61  RKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 119
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAE--TGTYRWMAPEV 278
           +YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A V+++ SG    E  +G+  WMAPEV
Sbjct: 120 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 179
Query: 279 I---EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-LRPTIPK---H 331
           I   +  PY +++DV++FGI L+EL+TG+LPY+ +      + +V +  L P + K   +
Sbjct: 180 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 239
Query: 332 AHPRLAELLERCWQHDPTQRPNFSQI 357
               +  L+  C +    +RP F QI
Sbjct: 240 CPKAMKRLMAECLKKKRDERPLFPQI 265

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  179 bits (453), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 98/268 (36%), Positives = 160/268 (59%), Gaps = 12/268 (4%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY 159
           D +D WEI   Q+ +  ++ SGS+G +YKG +   +VA+K+L       + L+ F  EV 
Sbjct: 26  DSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVG 84
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           ++RK RH N++ F+G  T+P  L IVT++    S+Y  LH  +  F++  L+ +A   ++
Sbjct: 85  VLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ 143
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAE--TGTYRWMAP 276
           GM+YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A  +++ SG    E  +G+  WMAP
Sbjct: 144 GMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 203
Query: 277 EVI---EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-LRPTIPK-- 330
           EVI   +  PY +++DV++FGI L+EL+TG+LPY+ +      + +V +  L P + K  
Sbjct: 204 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 263
Query: 331 -HAHPRLAELLERCWQHDPTQRPNFSQI 357
            +    +  L+  C +    +RP F QI
Sbjct: 264 SNCPKAMKRLMAECLKKKRDERPLFPQI 291

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  178 bits (452), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 98/268 (36%), Positives = 160/268 (59%), Gaps = 12/268 (4%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY 159
           D +D WEI   Q+ +  ++ SGS+G +YKG +   +VA+K+L       + L+ F  EV 
Sbjct: 18  DSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVG 76
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           ++RK RH N++ F+G  T+P  L IVT++    S+Y  LH  +  F++  L+ +A   ++
Sbjct: 77  VLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ 135
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAE--TGTYRWMAP 276
           GM+YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A  +++ SG    E  +G+  WMAP
Sbjct: 136 GMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 195
Query: 277 EVI---EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-LRPTIPK-- 330
           EVI   +  PY +++DV++FGI L+EL+TG+LPY+ +      + +V +  L P + K  
Sbjct: 196 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 255
Query: 331 -HAHPRLAELLERCWQHDPTQRPNFSQI 357
            +    +  L+  C +    +RP F QI
Sbjct: 256 SNCPKAMKRLMAECLKKKRDERPLFPQI 283

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  178 bits (452), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 98/265 (36%), Positives = 159/265 (60%), Gaps = 12/265 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 162
           D WEI   Q+ +  ++ SGS+G +YKG +   +VA+K+L       + L+ F  EV ++R
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 163 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 222
           K RH N++ F+G  T+P  L IVT++    S+Y  LH  +  F++  L+ +A   ++GM+
Sbjct: 60  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAE--TGTYRWMAPEVI 279
           YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A V+++ SG    E  +G+  WMAPEVI
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 280 ---EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-LRPTIPK---HA 332
              +  PY +++DV++FGI L+EL+TG+LPY+ +      + +V +  L P + K   + 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 333 HPRLAELLERCWQHDPTQRPNFSQI 357
              +  L+  C +    +RP F QI
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQI 263

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score =  178 bits (451), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 97/272 (35%), Positives = 152/272 (55%), Gaps = 12/272 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
           D WE++   + ++ K+  G YG++Y G +   S  VA+K LK + +  E   EF +E  +
Sbjct: 25  DKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 81
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSK 219
           M++I+H N+VQ +G CT  P   IVTE+M  G++ D+L +  +       LL +A  +S 
Sbjct: 82  MKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISS 141
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAP 276
            M YL + N IHRDL   N L+ EN VVKVADFG++R+       TA  G     +W AP
Sbjct: 142 AMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 200
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K  R   P+   P+
Sbjct: 201 ESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYDLLEKGYRMEQPEGCPPK 259
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           + EL+  CW+  P  RP+F++     + M  +
Sbjct: 260 VYELMRACWKWSPADRPSFAETHQAFETMFHD 291

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  177 bits (450), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 101/266 (37%), Positives = 157/266 (59%), Gaps = 12/266 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           D WEI  + L++E K+  G +G+++ GT+  +  VAIK LKP  ++ E    F QE  +M
Sbjct: 11  DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 67
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKG 220
           +KIRH+ +VQ     +  P + IVTE+M++GS+ DFL  + G + +L  L+ +A  ++ G
Sbjct: 68  KKIRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 126
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 277
           M Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 127 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 185
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
              +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 244
Query: 337 AELLERCWQHDPTQRPNFSQITDILK 362
            +L+ +CW+ DP +RP F  +   L+
Sbjct: 245 HDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  177 bits (449), Expect = 9e-45,   Method: Compositional matrix adjust.
 Identities = 98/265 (36%), Positives = 158/265 (59%), Gaps = 12/265 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 162
           D WEI   Q+ +  ++ SGS+G +YKG +   +VA+K+L       + L+ F  EV ++R
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 163 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 222
           K RH N++ F+G  T  P L IVT++    S+Y  LH  +  F++  L+ +A   ++GM+
Sbjct: 60  KTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAE--TGTYRWMAPEVI 279
           YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A V+++ SG    E  +G+  WMAPEVI
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 280 ---EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-LRPTIPK---HA 332
              +  PY +++DV++FGI L+EL+TG+LPY+ +      + +V +  L P + K   + 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 333 HPRLAELLERCWQHDPTQRPNFSQI 357
              +  L+  C +    +RP F QI
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQI 263

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 100/266 (37%), Positives = 157/266 (59%), Gaps = 12/266 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           D WEI  + L++E K+  G +G+++ GT+  +  VAIK LKP  ++ E    F QE  +M
Sbjct: 2   DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 58
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKG 220
           +K+RH+ +VQ     +  P + IVTE+M++GS+ DFL  + G + +L  L+ +A  ++ G
Sbjct: 59  KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 117
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 277
           M Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 118 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 176
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
              +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L
Sbjct: 177 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 235
Query: 337 AELLERCWQHDPTQRPNFSQITDILK 362
            +L+ +CW+ DP +RP F  +   L+
Sbjct: 236 HDLMCQCWRKDPEERPTFEYLQAFLE 261

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 100/266 (37%), Positives = 157/266 (59%), Gaps = 12/266 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           D WEI  + L++E K+  G +G+++ GT+  +  VAIK LKP  ++ E    F QE  +M
Sbjct: 11  DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 67
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKG 220
           +K+RH+ +VQ     +  P + IVTE+M++GS+ DFL  + G + +L  L+ +A  ++ G
Sbjct: 68  KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 126
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 277
           M Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 127 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 185
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
              +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 244
Query: 337 AELLERCWQHDPTQRPNFSQITDILK 362
            +L+ +CW+ DP +RP F  +   L+
Sbjct: 245 HDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  176 bits (445), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 97/265 (36%), Positives = 158/265 (59%), Gaps = 12/265 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 162
           D WEI   Q+ +  ++ SGS+G +YKG +   +VA+K+L       + L+ F  EV ++R
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 163 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 222
           K RH N++ F+G  T+P  L IVT++    S+Y  LH  +  F++  L+ +A   ++GM+
Sbjct: 60  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAE--TGTYRWMAPEVI 279
           YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A  +++ SG    E  +G+  WMAPEVI
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 280 ---EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-LRPTIPK---HA 332
              +  PY +++DV++FGI L+EL+TG+LPY+ +      + +V +  L P + K   + 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 333 HPRLAELLERCWQHDPTQRPNFSQI 357
              +  L+  C +    +RP F QI
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQI 263

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  176 bits (445), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 99/266 (37%), Positives = 157/266 (59%), Gaps = 12/266 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           D WEI  + L++E K+  G +G+++ GT+  +  VAIK LKP  ++ E    F QE  +M
Sbjct: 1   DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 57
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKG 220
           +K+RH+ +VQ     +  P + IVTE+M++GS+ DFL  + G + +L  L+ +A  ++ G
Sbjct: 58  KKLRHEKLVQLYAVVSEEP-IXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 116
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 277
           M Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 117 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEXTARQGAKFPIKWTAPE 175
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
              +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L
Sbjct: 176 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 234
Query: 337 AELLERCWQHDPTQRPNFSQITDILK 362
            +L+ +CW+ +P +RP F  +   L+
Sbjct: 235 HDLMCQCWRKEPEERPTFEYLQAFLE 260

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  176 bits (445), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 99/266 (37%), Positives = 157/266 (59%), Gaps = 12/266 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           D WEI  + L++E K+  G +G+++ GT+  +  VAIK LKP  ++ E    F QE  +M
Sbjct: 4   DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 60
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKG 220
           +K+RH+ +VQ     +  P + IVTE+M++GS+ DFL  + G + +L  L+ +A  ++ G
Sbjct: 61  KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 119
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 277
           M Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 120 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 178
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
              +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L
Sbjct: 179 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 237
Query: 337 AELLERCWQHDPTQRPNFSQITDILK 362
            +L+ +CW+ +P +RP F  +   L+
Sbjct: 238 HDLMCQCWRKEPEERPTFEYLQAFLE 263

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  176 bits (445), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 99/266 (37%), Positives = 157/266 (59%), Gaps = 12/266 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           D WEI  + L++E K+  G +G+++ GT+  +  VAIK LKP  ++ E    F QE  +M
Sbjct: 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 233
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKG 220
           +K+RH+ +VQ     +  P + IVTE+M++GS+ DFL  + G + +L  L+ +A  ++ G
Sbjct: 234 KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 292
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 277
           M Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 293 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 351
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
              +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 410
Query: 337 AELLERCWQHDPTQRPNFSQITDILK 362
            +L+ +CW+ +P +RP F  +   L+
Sbjct: 411 HDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  175 bits (444), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 99/266 (37%), Positives = 157/266 (59%), Gaps = 12/266 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           D WEI  + L++E K+  G +G+++ GT+  +  VAIK LKP  ++ E    F QE  +M
Sbjct: 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 233
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKG 220
           +K+RH+ +VQ     +  P + IVTE+M++GS+ DFL  + G + +L  L+ +A  ++ G
Sbjct: 234 KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 292
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 277
           M Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 293 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 351
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
              +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 410
Query: 337 AELLERCWQHDPTQRPNFSQITDILK 362
            +L+ +CW+ +P +RP F  +   L+
Sbjct: 411 HDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  175 bits (444), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 100/266 (37%), Positives = 156/266 (58%), Gaps = 12/266 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           D WEI  + L++E K+  G +G+++ GT+  +  VAIK LKP  ++ E    F QE  +M
Sbjct: 11  DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 67
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKG 220
           +K+RH+ +VQ     +  P + IVTE+M++GS+ DFL  + G + +L  L+ +A  ++ G
Sbjct: 68  KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 126
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 277
           M Y+ + N +HRDL  AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 127 MAYVERMNYVHRDLAAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 185
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
              +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 244
Query: 337 AELLERCWQHDPTQRPNFSQITDILK 362
            +L+ +CW+ DP +RP F  +   L+
Sbjct: 245 HDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  175 bits (443), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 99/266 (37%), Positives = 156/266 (58%), Gaps = 12/266 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           D WEI  + L++E K+  G +G+++ GT+  +  VAIK LKP  ++ E    F QE  +M
Sbjct: 11  DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 67
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKG 220
           +K+RH+ +VQ     +  P + IV E+M++GS+ DFL  + G + +L  L+ +A  ++ G
Sbjct: 68  KKLRHEKLVQLYAVVSEEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 126
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 277
           M Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 127 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEXTARQGAKFPIKWTAPE 185
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
              +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 244
Query: 337 AELLERCWQHDPTQRPNFSQITDILK 362
            +L+ +CW+ DP +RP F  +   L+
Sbjct: 245 HDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  174 bits (442), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 99/266 (37%), Positives = 156/266 (58%), Gaps = 12/266 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           D WEI  + L++E K+  G +G+++ GT+  +  VAIK LKP  ++ E    F QE  +M
Sbjct: 178 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEA---FLQEAQVM 234
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKG 220
           +K+RH+ +VQ     +  P + IVTE+M++GS+ DFL  + G + +L  L+ +A  ++ G
Sbjct: 235 KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 293
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 277
           M Y+ + N +HRDL+ AN+L+ EN V KVADFG+ R+  +    TA  G     +W APE
Sbjct: 294 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLGRL-IEDNEYTARQGAKFPIKWTAPE 352
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
              +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L
Sbjct: 353 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 411
Query: 337 AELLERCWQHDPTQRPNFSQITDILK 362
            +L+ +CW+ DP +RP F  +   L+
Sbjct: 412 HDLMCQCWRKDPEERPTFEYLQAFLE 437

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score =  174 bits (442), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 99/266 (37%), Positives = 156/266 (58%), Gaps = 12/266 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           D WEI  + L++E K+  G +G+++ GT+  +  VAIK LKP  ++ E    F QE  +M
Sbjct: 11  DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 67
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKG 220
           +K+RH+ +VQ     +  P + IVTE+M++G + DFL  + G + +L  L+ +A  ++ G
Sbjct: 68  KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASG 126
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 277
           M Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 127 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 185
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
              +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 244
Query: 337 AELLERCWQHDPTQRPNFSQITDILK 362
            +L+ +CW+ DP +RP F  +   L+
Sbjct: 245 HDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score =  174 bits (442), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 93/264 (35%), Positives = 155/264 (58%), Gaps = 10/264 (3%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 161
           D WEI  + LK+E K+ +G +G+++  TY    +VA+K +KP  ++ E    F  E  +M
Sbjct: 8   DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA---FLAEANVM 64
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ-LTSLLKVAIDVSKG 220
           + ++H  +V+     T+ P + I+TEFMA+GS+ DFL   +G  Q L  L+  +  +++G
Sbjct: 65  KTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 123
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEV 278
           M ++ Q N IHRDL+ AN+L+  + V K+ADFG+ARV   +     E   +  +W APE 
Sbjct: 124 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 183
Query: 279 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 337
           I    +  K+DV+SFGI L E++T G +PY G++  +  +  +++  R   P++    L 
Sbjct: 184 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-VIRALERGYRMPRPENCPEELY 242
Query: 338 ELLERCWQHDPTQRPNFSQITDIL 361
            ++ RCW++ P +RP F  I  +L
Sbjct: 243 NIMMRCWKNRPEERPTFEYIQSVL 266

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  174 bits (442), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 99/266 (37%), Positives = 156/266 (58%), Gaps = 12/266 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           D WEI  + L++E K+  G +G+++ GT+  +  VAIK LKP  ++ E    F QE  +M
Sbjct: 11  DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 67
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKG 220
           +K+RH+ +VQ     +  P + IV E+M++GS+ DFL  + G + +L  L+ +A  ++ G
Sbjct: 68  KKLRHEKLVQLYAVVSEEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 126
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 277
           M Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 127 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 185
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
              +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 244
Query: 337 AELLERCWQHDPTQRPNFSQITDILK 362
            +L+ +CW+ DP +RP F  +   L+
Sbjct: 245 HDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  174 bits (442), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 99/266 (37%), Positives = 156/266 (58%), Gaps = 12/266 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           D WEI  + L++E K+  G +G+++ GT+  +  VAIK LKP  ++ E    F QE  +M
Sbjct: 11  DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 67
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKG 220
           +K+RH+ +VQ     +  P + IV E+M++GS+ DFL  + G + +L  L+ +A  ++ G
Sbjct: 68  KKLRHEKLVQLYAVVSEEP-IYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 126
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 277
           M Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 127 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 185
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
              +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 244
Query: 337 AELLERCWQHDPTQRPNFSQITDILK 362
            +L+ +CW+ DP +RP F  +   L+
Sbjct: 245 HDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  174 bits (442), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 99/266 (37%), Positives = 157/266 (59%), Gaps = 12/266 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           D WEI  + L++E K+  G +G+++ GT+  +  VAIK LKP  ++ E    F QE  +M
Sbjct: 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 316
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKG 220
           +K+RH+ +VQ     +  P + IVTE+M++GS+ DFL  + G + +L  L+ +A  ++ G
Sbjct: 317 KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 375
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 277
           M Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 376 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 434
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
              +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQVERGYRMPCPPECPESL 493
Query: 337 AELLERCWQHDPTQRPNFSQITDILK 362
            +L+ +CW+ +P +RP F  +   L+
Sbjct: 494 HDLMCQCWRKEPEERPTFEYLQAFLE 519

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  174 bits (442), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 99/265 (37%), Positives = 156/265 (58%), Gaps = 12/265 (4%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 162
            WEI  + L++E K+  G +G+++ GT+  +  VAIK LKP  ++ E    F QE  +M+
Sbjct: 1   AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMK 57
Query: 163 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKGM 221
           K+RH+ +VQ     +  P + IVTE+M++GS+ DFL  + G + +L  L+ +A  ++ GM
Sbjct: 58  KLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 116
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEV 278
            Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE 
Sbjct: 117 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEA 175
Query: 279 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 337
             +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L 
Sbjct: 176 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESLH 234
Query: 338 ELLERCWQHDPTQRPNFSQITDILK 362
           +L+ +CW+ DP +RP F  +   L+
Sbjct: 235 DLMCQCWRKDPEERPTFEYLQAFLE 259

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score =  174 bits (441), Expect = 8e-44,   Method: Compositional matrix adjust.
 Identities = 93/264 (35%), Positives = 155/264 (58%), Gaps = 10/264 (3%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 161
           D WEI  + LK+E K+ +G +G+++  TY    +VA+K +KP  ++ E    F  E  +M
Sbjct: 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA---FLAEANVM 237
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ-LTSLLKVAIDVSKG 220
           + ++H  +V+     T+ P + I+TEFMA+GS+ DFL   +G  Q L  L+  +  +++G
Sbjct: 238 KTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 296
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEV 278
           M ++ Q N IHRDL+ AN+L+  + V K+ADFG+ARV   +     E   +  +W APE 
Sbjct: 297 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 356
Query: 279 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 337
           I    +  K+DV+SFGI L E++T G +PY G++  +  +  +++  R   P++    L 
Sbjct: 357 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-VIRALERGYRMPRPENCPEELY 415
Query: 338 ELLERCWQHDPTQRPNFSQITDIL 361
            ++ RCW++ P +RP F  I  +L
Sbjct: 416 NIMMRCWKNRPEERPTFEYIQSVL 439

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score =  174 bits (440), Expect = 9e-44,   Method: Compositional matrix adjust.
 Identities = 98/271 (36%), Positives = 154/271 (56%), Gaps = 14/271 (5%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 164
           W ++ K+LK+   +  G +GD+  G Y   +VA+K +K    N    + F  E  +M ++
Sbjct: 16  WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQL 71
Query: 165 RHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLH-KQKGVFQLTSLLKVAIDVSKGMN 222
           RH N+VQ +G        L IVTE+MA+GS+ D+L  + + V     LLK ++DV + M 
Sbjct: 72  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 131
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIE 280
           YL  NN +HRDL   N+L+ E+ V KV+DFG+ + +A S   T +TG    +W APE + 
Sbjct: 132 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-EASS---TQDTGKLPVKWTAPEALR 187
Query: 281 HKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
            K +  K+DV+SFGI LWE+ + G +PY  + PL+  V  V+K  +   P    P + E+
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPAVYEV 246
Query: 340 LERCWQHDPTQRPNFSQITDILKQMMKEVLY 370
           ++ CW  D   RP+F Q+ + L+ +    L+
Sbjct: 247 MKNCWHLDAAMRPSFLQLREQLEHIKTHELH 277

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score =  174 bits (440), Expect = 9e-44,   Method: Compositional matrix adjust.
 Identities = 98/271 (36%), Positives = 154/271 (56%), Gaps = 14/271 (5%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 164
           W ++ K+LK+   +  G +GD+  G Y   +VA+K +K    N    + F  E  +M ++
Sbjct: 1   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQL 56
Query: 165 RHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMN 222
           RH N+VQ +G        L IVTE+MA+GS+ D+L  + + V     LLK ++DV + M 
Sbjct: 57  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 116
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIE 280
           YL  NN +HRDL   N+L+ E+ V KV+DFG+ + +A S   T +TG    +W APE + 
Sbjct: 117 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-EASS---TQDTGKLPVKWTAPEALR 172
Query: 281 HKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
            K +  K+DV+SFGI LWE+ + G +PY  + PL+  V  V+K  +   P    P + E+
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPAVYEV 231
Query: 340 LERCWQHDPTQRPNFSQITDILKQMMKEVLY 370
           ++ CW  D   RP+F Q+ + L+ +    L+
Sbjct: 232 MKNCWHLDAAMRPSFLQLREQLEHIKTHELH 262

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 93/262 (35%), Positives = 155/262 (59%), Gaps = 16/262 (6%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 161
           D WEI  + LK+E K+ +G +G+++  TY    +VA+K +KP  ++ E    F  E  +M
Sbjct: 175 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA---FLAEANVM 231
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ-LTSLLKVAIDVSKG 220
           + ++H  +V+     T+ P + I+TEFMA+GS+ DFL   +G  Q L  L+  +  +++G
Sbjct: 232 KTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 290
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 280
           M ++ Q N IHRDL+ AN+L+  + V K+ADFG+ARV A+  +        +W APE I 
Sbjct: 291 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVGAKFPI--------KWTAPEAIN 342
Query: 281 HKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
              +  K+DV+SFGI L E++T G +PY G++  +  +  +++  R   P++    L  +
Sbjct: 343 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-VIRALERGYRMPRPENCPEELYNI 401
Query: 340 LERCWQHDPTQRPNFSQITDIL 361
           + RCW++ P +RP F  I  +L
Sbjct: 402 MMRCWKNRPEERPTFEYIQSVL 423

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 98/266 (36%), Positives = 156/266 (58%), Gaps = 12/266 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           D WEI  + L++E K+  G +G+++ GT+  +  VAIK LKP  ++ E    F QE  +M
Sbjct: 8   DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 64
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKG 220
           +K+RH+ +VQ     +  P + IVTE+M +GS+ DFL  + G + +L  L+ ++  ++ G
Sbjct: 65  KKLRHEKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASG 123
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 277
           M Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 124 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 182
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
              +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L
Sbjct: 183 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 241
Query: 337 AELLERCWQHDPTQRPNFSQITDILK 362
            +L+ +CW+ +P +RP F  +   L+
Sbjct: 242 HDLMCQCWRKEPEERPTFEYLQAFLE 267

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 98/266 (36%), Positives = 156/266 (58%), Gaps = 12/266 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           D WEI  + L++E K+  G +G+++ GT+  +  VAIK LKP  ++ E    F QE  +M
Sbjct: 8   DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 64
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKG 220
           +K+RH+ +VQ     +  P + IVTE+M +GS+ DFL  + G + +L  L+ ++  ++ G
Sbjct: 65  KKLRHEKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASG 123
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 277
           M Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 124 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEWTARQGAKFPIKWTAPE 182
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
              +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L
Sbjct: 183 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 241
Query: 337 AELLERCWQHDPTQRPNFSQITDILK 362
            +L+ +CW+ +P +RP F  +   L+
Sbjct: 242 HDLMCQCWRKEPEERPTFEYLQAFLE 267

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 98/266 (36%), Positives = 156/266 (58%), Gaps = 12/266 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           D WEI  + L++E K+  G +G+++ GT+  +  VAIK LKP  ++ E    F QE  +M
Sbjct: 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 233
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKG 220
           +K+RH+ +VQ     +  P + IV E+M++GS+ DFL  + G + +L  L+ +A  ++ G
Sbjct: 234 KKLRHEKLVQLYAVVSEEP-IYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 292
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 277
           M Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 293 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 351
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
              +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 410
Query: 337 AELLERCWQHDPTQRPNFSQITDILK 362
            +L+ +CW+ +P +RP F  +   L+
Sbjct: 411 HDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 98/266 (36%), Positives = 155/266 (58%), Gaps = 12/266 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           D WEI  + L++E K+  G +G+++ GT+  +  VAIK LKP  ++ E    F QE  +M
Sbjct: 11  DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 67
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKG 220
           +K+RH+ +VQ     +  P + IV E+M++G + DFL  + G + +L  L+ +A  ++ G
Sbjct: 68  KKLRHEKLVQLYAVVSEEP-IYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASG 126
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 277
           M Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 127 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 185
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
              +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 244
Query: 337 AELLERCWQHDPTQRPNFSQITDILK 362
            +L+ +CW+ DP +RP F  +   L+
Sbjct: 245 HDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 97/271 (35%), Positives = 153/271 (56%), Gaps = 14/271 (5%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 164
           W ++ K+LK+   +  G +GD+  G Y   +VA+K +K    N    + F  E  +M ++
Sbjct: 7   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQL 62
Query: 165 RHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLH-KQKGVFQLTSLLKVAIDVSKGMN 222
           RH N+VQ +G        L IVTE+MA+GS+ D+L  + + V     LLK ++DV + M 
Sbjct: 63  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 122
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIE 280
           YL  NN +HRDL   N+L+ E+ V KV+DFG+ + +A S   T +TG    +W APE + 
Sbjct: 123 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-EASS---TQDTGKLPVKWTAPEALR 178
Query: 281 HKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
              +  K+DV+SFGI LWE+ + G +PY  + PL+  V  V+K  +   P    P + E+
Sbjct: 179 EAAFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPAVYEV 237
Query: 340 LERCWQHDPTQRPNFSQITDILKQMMKEVLY 370
           ++ CW  D   RP+F Q+ + L+ +    L+
Sbjct: 238 MKNCWHLDAAMRPSFLQLREQLEHIKTHELH 268

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score =  171 bits (434), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 97/271 (35%), Positives = 153/271 (56%), Gaps = 14/271 (5%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 164
           W ++ K+LK+   +  G +GD+  G Y   +VA+K +K    N    + F  E  +M ++
Sbjct: 188 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQL 243
Query: 165 RHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMN 222
           RH N+VQ +G        L IVTE+MA+GS+ D+L  + + V     LLK ++DV + M 
Sbjct: 244 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 303
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIE 280
           YL  NN +HRDL   N+L+ E+ V KV+DFG+ + +A S   T +TG    +W APE + 
Sbjct: 304 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-EASS---TQDTGKLPVKWTAPEALR 359
Query: 281 HKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
            K +  K+DV+SFGI LWE+ + G +PY  + PL+  V  V+K  +   P    P + ++
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPAVYDV 418
Query: 340 LERCWQHDPTQRPNFSQITDILKQMMKEVLY 370
           ++ CW  D   RP F Q+ + L+ +    L+
Sbjct: 419 MKNCWHLDAATRPTFLQLREQLEHIRTHELH 449

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 91/270 (33%), Positives = 151/270 (55%), Gaps = 10/270 (3%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQE-VAIKVLKPECVNTEMLKEFSQEVYIMRK 163
           W ID  +L    ++ SG +G ++ G + +++ VAIK ++   ++ E   +F +E  +M K
Sbjct: 3   WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMK 59
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 223
           + H  +VQ  G C     +C+VTEFM  G + D+L  Q+G+F   +LL + +DV +GM Y
Sbjct: 60  LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 119
Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVIE 280
           L +  +IHRDL   N L+ EN V+KV+DFG+ R        T+ TGT    +W +PEV  
Sbjct: 120 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFS 178
Query: 281 HKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
              Y  K+DV+SFG+ +WE+ + G++PY   +  +  V  +    R   P+ A   + ++
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVEDISTGFRLYKPRLASTHVYQI 237
Query: 340 LERCWQHDPTQRPNFSQITDILKQMMKEVL 369
           +  CW+  P  RP FS++   L ++ +  L
Sbjct: 238 MNHCWRERPEDRPAFSRLLRQLAEIAESGL 267

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 152/274 (55%), Gaps = 10/274 (3%)
Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE-VAIKVLKPECVNTEMLKEFSQEVY 159
           G+  W ID  +L    ++ SG +G ++ G + +++ VAIK ++   ++ E   +F +E  
Sbjct: 1   GSGKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAE 57
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           +M K+ H  +VQ  G C     +C+V EFM  G + D+L  Q+G+F   +LL + +DV +
Sbjct: 58  VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 117
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAP 276
           GM YL +  +IHRDL   N L+ EN V+KV+DFG+ R        T+ TGT    +W +P
Sbjct: 118 GMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASP 176
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           EV     Y  K+DV+SFG+ +WE+ + G++PY   +  +  V  +    R   P+ A   
Sbjct: 177 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVEDISTGFRLYKPRLASTH 235
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKEVL 369
           + +++  CW+  P  RP FS++   L ++ +  L
Sbjct: 236 VYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 269

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  169 bits (427), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 97/266 (36%), Positives = 157/266 (59%), Gaps = 12/266 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           DVWEI  + L++  ++ +G +G+++ GT+  + +VAIK LKP  ++ E    F +E  IM
Sbjct: 2   DVWEIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPE---SFLEEAQIM 58
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKG 220
           +K++H  +VQ     +  P + IVTE+M +GS+ DFL   +G   +L +L+ +A  V+ G
Sbjct: 59  KKLKHDKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAG 117
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 277
           M Y+ + N IHRDL++AN+L+    + K+ADFG+AR+  +    TA  G     +W APE
Sbjct: 118 MAYIERMNYIHRDLRSANILVGNGLICKIADFGLARL-IEDNEXTARQGAKFPIKWTAPE 176
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
              +  +  K+DV+SFGI L EL+T G +PY G+   +  +  V++  R   P+     L
Sbjct: 177 AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-REVLEQVERGYRMPCPQDCPISL 235
Query: 337 AELLERCWQHDPTQRPNFSQITDILK 362
            EL+  CW+ DP +RP F  +   L+
Sbjct: 236 HELMIHCWKKDPEERPTFEYLQSFLE 261

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  164 bits (416), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 87/256 (33%), Positives = 145/256 (56%), Gaps = 10/256 (3%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQE-VAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
           ID  +L    ++ SG +G ++ G + +++ VAIK ++   ++ E   +F +E  +M K+ 
Sbjct: 4   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLS 60
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
           H  +VQ  G C     +C+V EFM  G + D+L  Q+G+F   +LL + +DV +GM YL 
Sbjct: 61  HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 120
Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVIEHK 282
           + ++IHRDL   N L+ EN V+KV+DFG+ R        T+ TGT    +W +PEV    
Sbjct: 121 EASVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFS 179
Query: 283 PYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE 341
            Y  K+DV+SFG+ +WE+ + G++PY   +  +  V  +    R   P+ A   + +++ 
Sbjct: 180 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVEDISTGFRLYKPRLASTHVYQIMN 238
Query: 342 RCWQHDPTQRPNFSQI 357
            CW+  P  RP FS++
Sbjct: 239 HCWKERPEDRPAFSRL 254

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  164 bits (415), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 89/268 (33%), Positives = 149/268 (55%), Gaps = 10/268 (3%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQE-VAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
           ID  +L    ++ SG +G ++ G + +++ VAIK ++   ++ E   +F +E  +M K+ 
Sbjct: 2   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLS 58
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
           H  +VQ  G C     +C+V EFM  G + D+L  Q+G+F   +LL + +DV +GM YL 
Sbjct: 59  HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVIEHK 282
           +  +IHRDL   N L+ EN V+KV+DFG+ R        T+ TGT    +W +PEV    
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 283 PYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE 341
            Y  K+DV+SFG+ +WE+ + G++PY   +  +  V  +    R   P+ A   + +++ 
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVEDISTGFRLYKPRLASTHVYQIMN 236
Query: 342 RCWQHDPTQRPNFSQITDILKQMMKEVL 369
            CW+  P  RP FS++   L ++ +  L
Sbjct: 237 HCWKERPEDRPAFSRLLRQLAEIAESGL 264

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  164 bits (415), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 89/268 (33%), Positives = 149/268 (55%), Gaps = 10/268 (3%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQE-VAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
           ID  +L    ++ SG +G ++ G + +++ VAIK ++   ++ E   +F +E  +M K+ 
Sbjct: 4   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLS 60
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
           H  +VQ  G C     +C+V EFM  G + D+L  Q+G+F   +LL + +DV +GM YL 
Sbjct: 61  HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 120
Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVIEHK 282
           +  +IHRDL   N L+ EN V+KV+DFG+ R        T+ TGT    +W +PEV    
Sbjct: 121 EACVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFS 179
Query: 283 PYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE 341
            Y  K+DV+SFG+ +WE+ + G++PY   +  +  V  +    R   P+ A   + +++ 
Sbjct: 180 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVEDISTGFRLYKPRLASTHVYQIMN 238
Query: 342 RCWQHDPTQRPNFSQITDILKQMMKEVL 369
            CW+  P  RP FS++   L ++ +  L
Sbjct: 239 HCWKERPEDRPAFSRLLRQLAEIAESGL 266

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 88/264 (33%), Positives = 152/264 (57%), Gaps = 9/264 (3%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           D WEI  + +K+  ++ +G +G+++ G Y  S +VA+K LKP    T  ++ F +E  +M
Sbjct: 6   DAWEIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKP---GTMSVQAFLEEANLM 62
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSKG 220
           + ++H  +V+     TR   + I+TE+MA+GS+ DFL   + G   L  L+  +  +++G
Sbjct: 63  KTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEG 122
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEV 278
           M Y+ + N IHRDL+ AN+L+ E+ + K+ADFG+ARV   +     E   +  +W APE 
Sbjct: 123 MAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 182
Query: 279 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 337
           I    +  K+DV+SFGI L+E++T G++PY G T       + Q    P + ++    L 
Sbjct: 183 INFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRV-ENCPDELY 241
Query: 338 ELLERCWQHDPTQRPNFSQITDIL 361
           ++++ CW+    +RP F  +  +L
Sbjct: 242 DIMKMCWKEKAEERPTFDYLQSVL 265

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  163 bits (413), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 89/268 (33%), Positives = 149/268 (55%), Gaps = 10/268 (3%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQE-VAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
           ID  +L    ++ SG +G ++ G + +++ VAIK +K   ++ +   +F +E  +M K+ 
Sbjct: 24  IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSED---DFIEEAEVMMKLS 80
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
           H  +VQ  G C     +C+V EFM  G + D+L  Q+G+F   +LL + +DV +GM YL 
Sbjct: 81  HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 140
Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVIEHK 282
           +  +IHRDL   N L+ EN V+KV+DFG+ R        T+ TGT    +W +PEV    
Sbjct: 141 EACVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFS 199
Query: 283 PYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE 341
            Y  K+DV+SFG+ +WE+ + G++PY   +  +  V  +    R   P+ A   + +++ 
Sbjct: 200 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVEDISTGFRLYKPRLASTHVYQIMN 258
Query: 342 RCWQHDPTQRPNFSQITDILKQMMKEVL 369
            CW+  P  RP FS++   L ++ +  L
Sbjct: 259 HCWKERPEDRPAFSRLLRQLAEIAESGL 286

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 86/270 (31%), Positives = 148/270 (54%), Gaps = 8/270 (2%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
           WEID K L    ++ +G +G +  G +  Q +VAIK++K   ++ +   EF +E  +M  
Sbjct: 4   WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMN 60
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 223
           + H+ +VQ  G CT+   + I+TE+MA G + ++L + +  FQ   LL++  DV + M Y
Sbjct: 61  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 120
Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIEH 281
           L     +HRDL   N L+++ GVVKV+DFG++R        ++    +  RW  PEV+ +
Sbjct: 121 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 180
Query: 282 KPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELL 340
             +  K+D+++FG+ +WE+ + G++PY   T  + A  + Q  LR   P  A  ++  ++
Sbjct: 181 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKVYTIM 239
Query: 341 ERCWQHDPTQRPNFSQITDILKQMMKEVLY 370
             CW     +RP F  +   +  +M E LY
Sbjct: 240 YSCWHEKADERPTFKILLSNILDVMDENLY 269

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  159 bits (402), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 87/263 (33%), Positives = 151/263 (57%), Gaps = 9/263 (3%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMR 162
            WEI  + +K+  K+ +G +G+++ G Y  S +VA+K LKP    T  ++ F +E  +M+
Sbjct: 6   AWEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKP---GTMSVQAFLEEANLMK 62
Query: 163 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSKGM 221
            ++H  +V+     T+   + I+TEFMA+GS+ DFL   + G   L  L+  +  +++GM
Sbjct: 63  TLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGM 122
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVI 279
            Y+ + N IHRDL+ AN+L+ E+ + K+ADFG+ARV   +     E   +  +W APE I
Sbjct: 123 AYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 182
Query: 280 EHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE 338
               +  K++V+SFGI L+E++T G++PY G T       + Q    P + ++    L +
Sbjct: 183 NFGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRM-ENCPDELYD 241
Query: 339 LLERCWQHDPTQRPNFSQITDIL 361
           +++ CW+    +RP F  +  +L
Sbjct: 242 IMKMCWKEKAEERPTFDYLQSVL 264

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score =  159 bits (402), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 86/271 (31%), Positives = 148/271 (54%), Gaps = 12/271 (4%)
Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVY 159
           G   WEID K L    ++ +G +G +  G +  Q +VAIK++K   ++ +   EF +E  
Sbjct: 6   GYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAK 62
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           +M  + H+ +VQ  G CT+   + I+TE+MA G + ++L + +  FQ   LL++  DV +
Sbjct: 63  VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE 122
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPE 277
            M YL     +HRDL   N L+++ GVVKV+DFG++R        ++    +  RW  PE
Sbjct: 123 AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPE 182
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
           V+ +  +  K+D+++FG+ +WE+ + G++PY   T  + A  + Q  LR   P  A  ++
Sbjct: 183 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKV 241
Query: 337 AELLERCWQHDPTQRPNF----SQITDILKQ 363
             ++  CW     +RP F    S I D++ +
Sbjct: 242 YTIMYSCWHEKADERPTFKILLSNILDVMDE 272

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score =  159 bits (402), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 85/265 (32%), Positives = 146/265 (55%), Gaps = 12/265 (4%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
           WEID K L    ++ +G +G +  G +  Q +VAIK++K   ++ +   EF +E  +M  
Sbjct: 4   WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMN 60
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 223
           + H+ +VQ  G CT+   + I+TE+MA G + ++L + +  FQ   LL++  DV + M Y
Sbjct: 61  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 120
Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIEH 281
           L     +HRDL   N L+++ GVVKV+DFG++R        ++    +  RW  PEV+ +
Sbjct: 121 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMY 180
Query: 282 KPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELL 340
             +  K+D+++FG+ +WE+ + G++PY   T  + A  + Q  LR   P  A  ++  ++
Sbjct: 181 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKVYTIM 239
Query: 341 ERCWQHDPTQRPNF----SQITDIL 361
             CW     +RP F    S I D++
Sbjct: 240 YSCWHEKADERPTFKILLSNILDVM 264

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score =  159 bits (402), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 88/281 (31%), Positives = 150/281 (53%), Gaps = 12/281 (4%)
Query: 91  SPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTE 149
           S N       G   WEID K L    ++ +G +G +  G +  Q +VAIK++K   ++ +
Sbjct: 5   SKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED 64
Query: 150 MLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTS 209
              EF +E  +M  + H+ +VQ  G CT+   + I+TE+MA G + ++L + +  FQ   
Sbjct: 65  ---EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQ 121
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETG 269
           LL++  DV + M YL     +HRDL   N L+++ GVVKV+DFG++R        ++   
Sbjct: 122 LLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 181
Query: 270 TY--RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRP 326
            +  RW  PEV+ +  +  K+D+++FG+ +WE+ + G++PY   T  + A  + Q  LR 
Sbjct: 182 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRL 240
Query: 327 TIPKHAHPRLAELLERCWQHDPTQRPNF----SQITDILKQ 363
             P  A  ++  ++  CW     +RP F    S I D++ +
Sbjct: 241 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 88/281 (31%), Positives = 150/281 (53%), Gaps = 12/281 (4%)
Query: 91  SPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTE 149
           S N       G   WEID K L    ++ +G +G +  G +  Q +VAIK++K   ++ +
Sbjct: 5   SKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED 64
Query: 150 MLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTS 209
              EF +E  +M  + H+ +VQ  G CT+   + I+TE+MA G + ++L + +  FQ   
Sbjct: 65  ---EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQ 121
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETG 269
           LL++  DV + M YL     +HRDL   N L+++ GVVKV+DFG++R        ++   
Sbjct: 122 LLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGS 181
Query: 270 TY--RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRP 326
            +  RW  PEV+ +  +  K+D+++FG+ +WE+ + G++PY   T  + A  + Q  LR 
Sbjct: 182 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRL 240
Query: 327 TIPKHAHPRLAELLERCWQHDPTQRPNF----SQITDILKQ 363
             P  A  ++  ++  CW     +RP F    S I D++ +
Sbjct: 241 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 85/267 (31%), Positives = 147/267 (55%), Gaps = 12/267 (4%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
           WEID K L    ++ +G +G +  G +  Q +VAIK++K   ++ +   EF +E  +M  
Sbjct: 3   WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMN 59
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 223
           + H+ +VQ  G CT+   + I+TE+MA G + ++L + +  FQ   LL++  DV + M Y
Sbjct: 60  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 119
Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIEH 281
           L     +HRDL   N L+++ GVVKV+DFG++R        ++    +  RW  PEV+ +
Sbjct: 120 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 179
Query: 282 KPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELL 340
             +  K+D+++FG+ +WE+ + G++PY   T  + A  + Q  LR   P  A  ++  ++
Sbjct: 180 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKVYTIM 238
Query: 341 ERCWQHDPTQRPNF----SQITDILKQ 363
             CW     +RP F    S I D++ +
Sbjct: 239 YSCWHEKADERPTFKILLSNILDVMDE 265

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  157 bits (398), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 92/268 (34%), Positives = 145/268 (54%), Gaps = 17/268 (6%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH 166
           ID K++++E  V  G++G + K  + +++VAIK ++ E      + E  Q    + ++ H
Sbjct: 5   IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQ----LSRVNH 60
Query: 167 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV--FQLTSLLKVAIDVSKGMNYL 224
            N+V+  GAC  P  +C+V E+   GS+Y+ LH  + +  +     +   +  S+G+ YL
Sbjct: 61  PNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 225 HQ---NNIIHRDLKTANLLMDENG-VVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVI 279
           H      +IHRDLK  NLL+   G V+K+ DFG A  +Q     MT   G+  WMAPEV 
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---MTNNKGSAAWMAPEVF 175
Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAGL-TPLQAAVGVVQKSLRPTIPKHAHPRLAE 338
           E   Y  K DVFS+GI LWE++T   P+  +  P    +  V    RP + K+    +  
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIES 235
Query: 339 LLERCWQHDPTQRPNFSQITDILKQMMK 366
           L+ RCW  DP+QRP+  +I  I+  +M+
Sbjct: 236 LMTRCWSKDPSQRPSMEEIVKIMTHLMR 263

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  157 bits (398), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 92/268 (34%), Positives = 145/268 (54%), Gaps = 17/268 (6%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH 166
           ID K++++E  V  G++G + K  + +++VAIK ++ E      + E  Q    + ++ H
Sbjct: 6   IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQ----LSRVNH 61
Query: 167 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV--FQLTSLLKVAIDVSKGMNYL 224
            N+V+  GAC  P  +C+V E+   GS+Y+ LH  + +  +     +   +  S+G+ YL
Sbjct: 62  PNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 119
Query: 225 HQ---NNIIHRDLKTANLLMDENG-VVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVI 279
           H      +IHRDLK  NLL+   G V+K+ DFG A  +Q     MT   G+  WMAPEV 
Sbjct: 120 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---MTNNKGSAAWMAPEVF 176
Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAGL-TPLQAAVGVVQKSLRPTIPKHAHPRLAE 338
           E   Y  K DVFS+GI LWE++T   P+  +  P    +  V    RP + K+    +  
Sbjct: 177 EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIES 236
Query: 339 LLERCWQHDPTQRPNFSQITDILKQMMK 366
           L+ RCW  DP+QRP+  +I  I+  +M+
Sbjct: 237 LMTRCWSKDPSQRPSMEEIVKIMTHLMR 264

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 88/266 (33%), Positives = 149/266 (56%), Gaps = 12/266 (4%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH 166
           ID KQL    K+     G+L+KG +   ++ +KVLK    +T   ++F++E   +R   H
Sbjct: 7   IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 167 KNVVQFIGACTRPP--NLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNY 223
            NV+  +GAC  PP  +  ++T +M  GS+Y+ LH+    V   +  +K A+D+++GM +
Sbjct: 67  PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAF 126
Query: 224 LH--QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH 281
           LH  +  I    L + ++++DE+   +++   V       G M A      W+APE ++ 
Sbjct: 127 LHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPA----WVAPEALQK 182
Query: 282 KPYD---YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE 338
           KP D     AD++SF + LWEL+T E+P+A L+ ++  + V  + LRPTIP    P +++
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSK 242
Query: 339 LLERCWQHDPTQRPNFSQITDILKQM 364
           L++ C   DP +RP F  I  IL++M
Sbjct: 243 LMKICMNEDPAKRPKFDMIVPILEKM 268

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 86/275 (31%), Positives = 145/275 (52%), Gaps = 11/275 (4%)
Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFS 155
            T  +EI  +++++   +  G +GD+++G Y S E     VAIK  K  C +  + ++F 
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFL 59
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           QE   MR+  H ++V+ IG  T  P + I+ E    G +  FL  +K    L SL+  A 
Sbjct: 60  QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAY 118
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RW 273
            +S  + YL     +HRD+   N+L+  N  VK+ DFG++R    S    A  G    +W
Sbjct: 119 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKW 178
Query: 274 MAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHA 332
           MAPE I  + +   +DV+ FG+ +WE+L  G  P+ G+      +G ++   R  +P + 
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPNC 237
Query: 333 HPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
            P L  L+ +CW +DP++RP F+++   L  +++E
Sbjct: 238 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 272

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 86/275 (31%), Positives = 145/275 (52%), Gaps = 11/275 (4%)
Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFS 155
            T  +EI  +++++   +  G +GD+++G Y S E     VAIK  K  C +  + ++F 
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFL 59
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           QE   MR+  H ++V+ IG  T  P + I+ E    G +  FL  +K    L SL+  A 
Sbjct: 60  QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 118
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RW 273
            +S  + YL     +HRD+   N+L+  N  VK+ DFG++R    S    A  G    +W
Sbjct: 119 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 178
Query: 274 MAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHA 332
           MAPE I  + +   +DV+ FG+ +WE+L  G  P+ G+      +G ++   R  +P + 
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPNC 237
Query: 333 HPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
            P L  L+ +CW +DP++RP F+++   L  +++E
Sbjct: 238 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 272

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 86/275 (31%), Positives = 145/275 (52%), Gaps = 11/275 (4%)
Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFS 155
            T  +EI  +++++   +  G +GD+++G Y S E     VAIK  K  C +  + ++F 
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFL 59
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           QE   MR+  H ++V+ IG  T  P + I+ E    G +  FL  +K    L SL+  A 
Sbjct: 60  QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 118
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RW 273
            +S  + YL     +HRD+   N+L+  N  VK+ DFG++R    S    A  G    +W
Sbjct: 119 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 178
Query: 274 MAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHA 332
           MAPE I  + +   +DV+ FG+ +WE+L  G  P+ G+      +G ++   R  +P + 
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPNC 237
Query: 333 HPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
            P L  L+ +CW +DP++RP F+++   L  +++E
Sbjct: 238 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 272

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 86/276 (31%), Positives = 145/276 (52%), Gaps = 11/276 (3%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEF 154
             T  +EI  +++++   +  G +GD+++G Y S E     VAIK  K  C +  + ++F
Sbjct: 28  SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKF 86
Query: 155 SQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVA 214
            QE   MR+  H ++V+ IG  T  P + I+ E    G +  FL  +K    L SL+  A
Sbjct: 87  LQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYA 145
Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--R 272
             +S  + YL     +HRD+   N+L+  N  VK+ DFG++R    S    A  G    +
Sbjct: 146 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 205
Query: 273 WMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKH 331
           WMAPE I  + +   +DV+ FG+ +WE+L  G  P+ G+      +G ++   R  +P +
Sbjct: 206 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPN 264
Query: 332 AHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
             P L  L+ +CW +DP++RP F+++   L  +++E
Sbjct: 265 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 300

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 84/265 (31%), Positives = 151/265 (56%), Gaps = 10/265 (3%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 161
           D WE+  + LK+  ++ +G +G+++ G Y    +VA+K LK   ++ +    F  E  +M
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 62
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKG 220
           ++++H+ +V+     T+ P + I+TE+M  GS+ DFL    G+   +  LL +A  +++G
Sbjct: 63  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEV 278
           M ++ + N IHRDL+ AN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 181
Query: 279 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 337
           I +  +  K+DV+SFGI L E++T G +PY G+T  +  +  +++  R   P +    L 
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 240
Query: 338 ELLERCWQHDPTQRPNFSQITDILK 362
           +L+  CW+  P  RP F  +  +L+
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 86/277 (31%), Positives = 146/277 (52%), Gaps = 11/277 (3%)
Query: 99  TDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKE 153
           +  T  +EI  +++++   +  G +GD+++G Y S E     VAIK  K  C +  + ++
Sbjct: 2   SGSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREK 60
Query: 154 FSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKV 213
           F QE   MR+  H ++V+ IG  T  P + I+ E    G +  FL  +K    L SL+  
Sbjct: 61  FLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILY 119
Query: 214 AIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY-- 271
           A  +S  + YL     +HRD+   N+L+  N  VK+ DFG++R    S    A  G    
Sbjct: 120 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 179
Query: 272 RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPK 330
           +WMAPE I  + +   +DV+ FG+ +WE+L  G  P+ G+      +G ++   R  +P 
Sbjct: 180 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPP 238
Query: 331 HAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           +  P L  L+ +CW +DP++RP F+++   L  +++E
Sbjct: 239 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 275

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 84/265 (31%), Positives = 151/265 (56%), Gaps = 10/265 (3%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 161
           D WE+  + LK+  ++ +G +G+++ G Y    +VA+K LK   ++ +    F  E  +M
Sbjct: 1   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 57
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKG 220
           ++++H+ +V+     T+ P + I+TE+M  GS+ DFL    G+   +  LL +A  +++G
Sbjct: 58  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 116
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEV 278
           M ++ + N IHRDL+ AN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 117 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 176
Query: 279 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 337
           I +  +  K+DV+SFGI L E++T G +PY G+T  +  +  +++  R   P +    L 
Sbjct: 177 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 235
Query: 338 ELLERCWQHDPTQRPNFSQITDILK 362
           +L+  CW+  P  RP F  +  +L+
Sbjct: 236 QLMRLCWKERPEDRPTFDYLRSVLE 260

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 84/265 (31%), Positives = 151/265 (56%), Gaps = 10/265 (3%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 161
           D WE+  + LK+  ++ +G +G+++ G Y    +VA+K LK   ++ +    F  E  +M
Sbjct: 7   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 63
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKG 220
           ++++H+ +V+     T+ P + I+TE+M  GS+ DFL    G+   +  LL +A  +++G
Sbjct: 64  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 122
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEV 278
           M ++ + N IHRDL+ AN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 123 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 182
Query: 279 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 337
           I +  +  K+DV+SFGI L E++T G +PY G+T  +  +  +++  R   P +    L 
Sbjct: 183 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 241
Query: 338 ELLERCWQHDPTQRPNFSQITDILK 362
           +L+  CW+  P  RP F  +  +L+
Sbjct: 242 QLMRLCWKERPEDRPTFDYLRSVLE 266

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 84/265 (31%), Positives = 151/265 (56%), Gaps = 10/265 (3%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 161
           D WE+  + LK+  ++ +G +G+++ G Y    +VA+K LK   ++ +    F  E  +M
Sbjct: 11  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 67
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKG 220
           ++++H+ +V+     T+ P + I+TE+M  GS+ DFL    G+   +  LL +A  +++G
Sbjct: 68  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 126
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEV 278
           M ++ + N IHRDL+ AN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 127 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 186
Query: 279 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 337
           I +  +  K+DV+SFGI L E++T G +PY G+T  +  +  +++  R   P +    L 
Sbjct: 187 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 245
Query: 338 ELLERCWQHDPTQRPNFSQITDILK 362
           +L+  CW+  P  RP F  +  +L+
Sbjct: 246 QLMRLCWKERPEDRPTFDYLRSVLE 270

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 84/268 (31%), Positives = 151/268 (56%), Gaps = 10/268 (3%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 161
           D WE+  + LK+  ++ +G +G+++ G Y    +VA+K LK   ++ +    F  E  +M
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 62
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKG 220
           ++++H+ +V+     T+ P + I+TE+M  GS+ DFL    G+   +  LL +A  +++G
Sbjct: 63  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEV 278
           M ++ + N IHRDL+ AN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181
Query: 279 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 337
           I +  +  K+DV+SFGI L E++T G +PY G+T  +  +  +++  R   P +    L 
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 240
Query: 338 ELLERCWQHDPTQRPNFSQITDILKQMM 365
           +L+  CW+  P  RP F  +  +L+   
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 86/274 (31%), Positives = 145/274 (52%), Gaps = 11/274 (4%)
Query: 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQ 156
           T  +EI  +++++   +  G +GD+++G Y S E     VAIK  K  C +  + ++F Q
Sbjct: 7   TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQ 65
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 216
           E   MR+  H ++V+ IG  T  P + I+ E    G +  FL  +K    L SL+  A  
Sbjct: 66  EALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 124
Query: 217 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWM 274
           +S  + YL     +HRD+   N+L+  N  VK+ DFG++R    S    A  G    +WM
Sbjct: 125 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 184
Query: 275 APEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAH 333
           APE I  + +   +DV+ FG+ +WE+L  G  P+ G+      +G ++   R  +P +  
Sbjct: 185 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPNCP 243
Query: 334 PRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           P L  L+ +CW +DP++RP F+++   L  +++E
Sbjct: 244 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 84/265 (31%), Positives = 151/265 (56%), Gaps = 10/265 (3%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 161
           D WE+  + LK+  ++ +G +G+++ G Y    +VA+K LK   ++ +    F  E  +M
Sbjct: 12  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 68
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKG 220
           ++++H+ +V+     T+ P + I+TE+M  GS+ DFL    G+   +  LL +A  +++G
Sbjct: 69  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 127
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEV 278
           M ++ + N IHRDL+ AN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 128 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 187
Query: 279 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 337
           I +  +  K+DV+SFGI L E++T G +PY G+T  +  +  +++  R   P +    L 
Sbjct: 188 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 246
Query: 338 ELLERCWQHDPTQRPNFSQITDILK 362
           +L+  CW+  P  RP F  +  +L+
Sbjct: 247 QLMRLCWKERPEDRPTFDYLRSVLE 271

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 84/265 (31%), Positives = 151/265 (56%), Gaps = 10/265 (3%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 161
           D WE+  + LK+  ++ +G +G+++ G Y    +VA+K LK   ++ +    F  E  +M
Sbjct: 8   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 64
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKG 220
           ++++H+ +V+     T+ P + I+TE+M  GS+ DFL    G+   +  LL +A  +++G
Sbjct: 65  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 123
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEV 278
           M ++ + N IHRDL+ AN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 124 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 183
Query: 279 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 337
           I +  +  K+DV+SFGI L E++T G +PY G+T  +  +  +++  R   P +    L 
Sbjct: 184 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 242
Query: 338 ELLERCWQHDPTQRPNFSQITDILK 362
           +L+  CW+  P  RP F  +  +L+
Sbjct: 243 QLMRLCWKERPEDRPTFDYLRSVLE 267

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 86/274 (31%), Positives = 145/274 (52%), Gaps = 11/274 (4%)
Query: 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQ 156
           T  +EI  +++++   +  G +GD+++G Y S E     VAIK  K  C +  + ++F Q
Sbjct: 4   TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQ 62
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 216
           E   MR+  H ++V+ IG  T  P + I+ E    G +  FL  +K    L SL+  A  
Sbjct: 63  EALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 121
Query: 217 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWM 274
           +S  + YL     +HRD+   N+L+  N  VK+ DFG++R    S    A  G    +WM
Sbjct: 122 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 181
Query: 275 APEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAH 333
           APE I  + +   +DV+ FG+ +WE+L  G  P+ G+      +G ++   R  +P +  
Sbjct: 182 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPNCP 240
Query: 334 PRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           P L  L+ +CW +DP++RP F+++   L  +++E
Sbjct: 241 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 274

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 86/275 (31%), Positives = 145/275 (52%), Gaps = 11/275 (4%)
Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFS 155
            T  +EI  +++++   +  G +GD+++G Y S E     VAIK  K  C +  + ++F 
Sbjct: 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFL 439
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           QE   MR+  H ++V+ IG  T  P + I+ E    G +  FL  +K    L SL+  A 
Sbjct: 440 QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAY 498
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RW 273
            +S  + YL     +HRD+   N+L+  N  VK+ DFG++R    S    A  G    +W
Sbjct: 499 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 558
Query: 274 MAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHA 332
           MAPE I  + +   +DV+ FG+ +WE+L  G  P+ G+      +G ++   R  +P + 
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPNC 617
Query: 333 HPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
            P L  L+ +CW +DP++RP F+++   L  +++E
Sbjct: 618 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 84/265 (31%), Positives = 151/265 (56%), Gaps = 10/265 (3%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 161
           D WE+  + LK+  ++ +G +G+++ G Y    +VA+K LK   ++ +    F  E  +M
Sbjct: 15  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 71
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKG 220
           ++++H+ +V+     T+ P + I+TE+M  GS+ DFL    G+   +  LL +A  +++G
Sbjct: 72  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 130
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEV 278
           M ++ + N IHRDL+ AN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 131 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 190
Query: 279 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 337
           I +  +  K+DV+SFGI L E++T G +PY G+T  +  +  +++  R   P +    L 
Sbjct: 191 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 249
Query: 338 ELLERCWQHDPTQRPNFSQITDILK 362
           +L+  CW+  P  RP F  +  +L+
Sbjct: 250 QLMRLCWKERPEDRPTFDYLRSVLE 274

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 85/271 (31%), Positives = 144/271 (53%), Gaps = 11/271 (4%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVY 159
           +EI  +++++   +  G +GD+++G Y S E     VAIK  K  C +  + ++F QE  
Sbjct: 2   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEAL 60
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
            MR+  H ++V+ IG  T  P + I+ E    G +  FL  +K    L SL+  A  +S 
Sbjct: 61  TMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPE 277
            + YL     +HRD+   N+L+  N  VK+ DFG++R    S    A  G    +WMAPE
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
            I  + +   +DV+ FG+ +WE+L  G  P+ G+      +G ++   R  +P +  P L
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPNCPPTL 238
Query: 337 AELLERCWQHDPTQRPNFSQITDILKQMMKE 367
             L+ +CW +DP++RP F+++   L  +++E
Sbjct: 239 YSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 84/265 (31%), Positives = 151/265 (56%), Gaps = 10/265 (3%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 161
           D WE+  + LK+  ++ +G +G+++ G Y    +VA+K LK   ++ +    F  E  +M
Sbjct: 14  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 70
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKG 220
           ++++H+ +V+     T+ P + I+TE+M  GS+ DFL    G+   +  LL +A  +++G
Sbjct: 71  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 129
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEV 278
           M ++ + N IHRDL+ AN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 130 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 189
Query: 279 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 337
           I +  +  K+DV+SFGI L E++T G +PY G+T  +  +  +++  R   P +    L 
Sbjct: 190 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 248
Query: 338 ELLERCWQHDPTQRPNFSQITDILK 362
           +L+  CW+  P  RP F  +  +L+
Sbjct: 249 QLMRLCWKERPEDRPTFDYLRSVLE 273

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 84/265 (31%), Positives = 151/265 (56%), Gaps = 10/265 (3%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 161
           D WE+  + LK+  ++ +G +G+++ G Y    +VA+K LK   ++ +    F  E  +M
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 62
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKG 220
           ++++H+ +V+     T+ P + I+TE+M  GS+ DFL    G+   +  LL +A  +++G
Sbjct: 63  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEV 278
           M ++ + N IHRDL+ AN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 181
Query: 279 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 337
           I +  +  K+DV+SFGI L E++T G +PY G+T  +  +  +++  R   P +    L 
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 240
Query: 338 ELLERCWQHDPTQRPNFSQITDILK 362
           +L+  CW+  P  RP F  +  +L+
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 84/265 (31%), Positives = 151/265 (56%), Gaps = 10/265 (3%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 161
           D WE+  + LK+  ++ +G +G+++ G Y    +VA+K LK   ++ +    F  E  +M
Sbjct: 12  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 68
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKG 220
           ++++H+ +V+     T+ P + I+TE+M  GS+ DFL    G+   +  LL +A  +++G
Sbjct: 69  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 127
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEV 278
           M ++ + N IHRDL+ AN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 128 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 187
Query: 279 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 337
           I +  +  K+DV+SFGI L E++T G +PY G+T  +  +  +++  R   P +    L 
Sbjct: 188 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 246
Query: 338 ELLERCWQHDPTQRPNFSQITDILK 362
           +L+  CW+  P  RP F  +  +L+
Sbjct: 247 QLMRLCWKERPEDRPTFDYLRSVLE 271

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 92/273 (33%), Positives = 144/273 (52%), Gaps = 14/273 (5%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTY---CSQE--VAIKVLKPECVNTEMLKEFSQEVYI 160
           EID   +KIE  + +G +G++  G       +E  VAIK LK      +  ++F  E  I
Sbjct: 29  EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK-SGYTEKQRRDFLSEASI 87
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
           M +  H NV+   G  T+   + I+TEFM  GS+  FL +  G F +  L+ +   ++ G
Sbjct: 88  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 147
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV---QAQSGVMTAETG---TYRWM 274
           M YL   N +HRDL   N+L++ N V KV+DFG++R           T+  G     RW 
Sbjct: 148 MKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 207
Query: 275 APEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAH 333
           APE I+++ +   +DV+S+GI +WE+++ GE PY  +T  Q  +  +++  R   P    
Sbjct: 208 APEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-QDVINAIEQDYRLPPPMDCP 266
Query: 334 PRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
             L +L+  CWQ D   RP F QI + L +M++
Sbjct: 267 SALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 299

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  155 bits (392), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 84/265 (31%), Positives = 151/265 (56%), Gaps = 10/265 (3%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 161
           D WE+  + LK+  ++ +G +G+++ G Y    +VA+K LK   ++ +    F  E  +M
Sbjct: 16  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 72
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKG 220
           ++++H+ +V+     T+ P + I+TE+M  GS+ DFL    G+   +  LL +A  +++G
Sbjct: 73  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 131
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEV 278
           M ++ + N IHRDL+ AN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 132 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 191
Query: 279 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 337
           I +  +  K+DV+SFGI L E++T G +PY G+T  +  +  +++  R   P +    L 
Sbjct: 192 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 250
Query: 338 ELLERCWQHDPTQRPNFSQITDILK 362
           +L+  CW+  P  RP F  +  +L+
Sbjct: 251 QLMRLCWKERPEDRPTFDYLRSVLE 275

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  155 bits (391), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 84/265 (31%), Positives = 150/265 (56%), Gaps = 10/265 (3%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 161
           D WE+  + LK+  ++ +G  G+++ G Y    +VA+K LK   ++ +    F  E  +M
Sbjct: 6   DAWEVPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 62
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKG 220
           ++++H+ +V+     T+ P + I+TE+M  GS+ DFL    G+   +  LL +A  +++G
Sbjct: 63  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEV 278
           M ++ + N IHRDL+ AN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEA 181
Query: 279 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 337
           I +  +  K+DV+SFGI L E++T G +PY G+T  +  +  +++  R   P +    L 
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 240
Query: 338 ELLERCWQHDPTQRPNFSQITDILK 362
           +L+  CW+  P  RP F  +  +L+
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score =  155 bits (391), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 89/271 (32%), Positives = 147/271 (54%), Gaps = 10/271 (3%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE--VAIKVLKPECVNTEMLKEFSQEVYI 160
           D W ++ + L +  ++  G++G+++ G   +    VA+K  + E +  ++  +F QE  I
Sbjct: 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQEARI 165
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
           +++  H N+V+ IG CT+   + IV E +  G    FL  +    ++ +LL++  D + G
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAG 225
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETG----TYRWMAP 276
           M YL     IHRDL   N L+ E  V+K++DFG++R +A  GV  A  G      +W AP
Sbjct: 226 MEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA-DGVXAASGGLRQVPVKWTAP 284
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E + +  Y  ++DV+SFGI LWE  + G  PY  L+  Q     V+K  R   P+     
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-QQTREFVEKGGRLPCPELCPDA 343
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMK 366
           +  L+E+CW ++P QRP+FS I   L+ + K
Sbjct: 344 VFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score =  155 bits (391), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 89/271 (32%), Positives = 147/271 (54%), Gaps = 10/271 (3%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE--VAIKVLKPECVNTEMLKEFSQEVYI 160
           D W ++ + L +  ++  G++G+++ G   +    VA+K  + E +  ++  +F QE  I
Sbjct: 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQEARI 165
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
           +++  H N+V+ IG CT+   + IV E +  G    FL  +    ++ +LL++  D + G
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAG 225
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETG----TYRWMAP 276
           M YL     IHRDL   N L+ E  V+K++DFG++R +A  GV  A  G      +W AP
Sbjct: 226 MEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA-DGVYAASGGLRQVPVKWTAP 284
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E + +  Y  ++DV+SFGI LWE  + G  PY  L+  Q     V+K  R   P+     
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-QQTREFVEKGGRLPCPELCPDA 343
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMK 366
           +  L+E+CW ++P QRP+FS I   L+ + K
Sbjct: 344 VFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 93/271 (34%), Positives = 143/271 (52%), Gaps = 12/271 (4%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
           E+DA  +KIE  + +G +G++  G           VAIK LK      +  ++F  E  I
Sbjct: 39  ELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQR-RDFLCEASI 97
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
           M +  H NVV   G  TR   + IV EFM  G++  FL K  G F +  L+ +   ++ G
Sbjct: 98  MGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAG 157
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGT--YRWMAP 276
           M YL     +HRDL   N+L++ N V KV+DFG++RV       V T   G    RW AP
Sbjct: 158 MRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAP 217
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I+++ +   +DV+S+GI +WE+++ GE PY  ++  Q  +  +++  R   P      
Sbjct: 218 EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKAIEEGYRLPAPMDCPAG 276
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMK 366
           L +L+  CWQ +  +RP F QI  IL +M++
Sbjct: 277 LHQLMLDCWQKERAERPKFEQIVGILDKMIR 307

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 85/275 (30%), Positives = 144/275 (52%), Gaps = 11/275 (4%)
Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFS 155
            T  +EI  +++++   +  G +GD+++G Y S E     VAIK  K  C +  + ++F 
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFL 59
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           QE   MR+  H ++V+ IG  T  P + I+ E    G +  FL  +K    L SL+  A 
Sbjct: 60  QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAY 118
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RW 273
            +S  + YL     +HRD+   N+L+     VK+ DFG++R    S    A  G    +W
Sbjct: 119 QLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 178
Query: 274 MAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHA 332
           MAPE I  + +   +DV+ FG+ +WE+L  G  P+ G+      +G ++   R  +P + 
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPNC 237
Query: 333 HPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
            P L  L+ +CW +DP++RP F+++   L  +++E
Sbjct: 238 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 272

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 94/274 (34%), Positives = 155/274 (56%), Gaps = 26/274 (9%)
Query: 111 QLKIECKVASGSYGDLYKGTYCSQE--VAIKVL-----KPECVNTEMLKEFSQEVYIMRK 163
           +++ E ++  G +G ++KG     +  VAIK L     + E    E  +EF +EV+IM  
Sbjct: 20  EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 223
           + H N+V+  G    PP +  V EF+  G +Y  L  +    + +  L++ +D++ G+ Y
Sbjct: 80  LNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEY 137
Query: 224 LHQNN--IIHRDLKTANLLM---DENGVV--KVADFGVAR--VQAQSGVMTAETGTYRWM 274
           +   N  I+HRDL++ N+ +   DEN  V  KVADFG+++  V + SG++    G ++WM
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLL----GNFQWM 193
Query: 275 APEVI--EHKPYDYKADVFSFGIALWELLTGELPYAGLT--PLQAAVGVVQKSLRPTIPK 330
           APE I  E + Y  KAD +SF + L+ +LTGE P+   +   ++    + ++ LRPTIP+
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE 253
Query: 331 HAHPRLAELLERCWQHDPTQRPNFSQITDILKQM 364
              PRL  ++E CW  DP +RP+FS I   L ++
Sbjct: 254 DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 85/275 (30%), Positives = 144/275 (52%), Gaps = 11/275 (4%)
Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFS 155
            T  +EI  +++++   +  G +GD+++G Y S E     VAIK  K  C +  + ++F 
Sbjct: 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFL 439
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           QE   MR+  H ++V+ IG  T  P + I+ E    G +  FL  +K    L SL+  A 
Sbjct: 440 QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAY 498
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RW 273
            +S  + YL     +HRD+   N+L+     VK+ DFG++R    S    A  G    +W
Sbjct: 499 QLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 558
Query: 274 MAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHA 332
           MAPE I  + +   +DV+ FG+ +WE+L  G  P+ G+      +G ++   R  +P + 
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPNC 617
Query: 333 HPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
            P L  L+ +CW +DP++RP F+++   L  +++E
Sbjct: 618 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 91/273 (33%), Positives = 143/273 (52%), Gaps = 14/273 (5%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTY---CSQE--VAIKVLKPECVNTEMLKEFSQEVYI 160
           EID   +KIE  + +G +G++  G       +E  VAIK LK      +  ++F  E  I
Sbjct: 3   EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR-RDFLSEASI 61
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
           M +  H NV+   G  T+   + I+TEFM  GS+  FL +  G F +  L+ +   ++ G
Sbjct: 62  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 121
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV---QAQSGVMTAETG---TYRWM 274
           M YL   N +HR L   N+L++ N V KV+DFG++R           T+  G     RW 
Sbjct: 122 MKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 181
Query: 275 APEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAH 333
           APE I+++ +   +DV+S+GI +WE+++ GE PY  +T  Q  +  +++  R   P    
Sbjct: 182 APEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-QDVINAIEQDYRLPPPMDCP 240
Query: 334 PRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
             L +L+  CWQ D   RP F QI + L +M++
Sbjct: 241 SALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 273

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 94/274 (34%), Positives = 154/274 (56%), Gaps = 26/274 (9%)
Query: 111 QLKIECKVASGSYGDLYKGTYCSQE--VAIKVL-----KPECVNTEMLKEFSQEVYIMRK 163
           +++ E ++  G +G ++KG     +  VAIK L     + E    E  +EF +EV+IM  
Sbjct: 20  EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 223
           + H N+V+  G    PP +  V EF+  G +Y  L  +    + +  L++ +D++ G+ Y
Sbjct: 80  LNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEY 137
Query: 224 LHQNN--IIHRDLKTANLLM---DENGVV--KVADFGVAR--VQAQSGVMTAETGTYRWM 274
           +   N  I+HRDL++ N+ +   DEN  V  KVADFG ++  V + SG++    G ++WM
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSGLL----GNFQWM 193
Query: 275 APEVI--EHKPYDYKADVFSFGIALWELLTGELPYAGLT--PLQAAVGVVQKSLRPTIPK 330
           APE I  E + Y  KAD +SF + L+ +LTGE P+   +   ++    + ++ LRPTIP+
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE 253
Query: 331 HAHPRLAELLERCWQHDPTQRPNFSQITDILKQM 364
              PRL  ++E CW  DP +RP+FS I   L ++
Sbjct: 254 DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 150/263 (57%), Gaps = 10/263 (3%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
           WE+  + LK+  ++ +G +G+++ G Y    +VA+K LK   ++ +    F  E  +M++
Sbjct: 4   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQ 60
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMN 222
           ++H+ +V+     T+ P + I+TE+M  GS+ DFL    G+   +  LL +A  +++GM 
Sbjct: 61  LQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 119
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIE 280
           ++ + N IHR+L+ AN+L+ +    K+ADFG+AR+   +     E   +  +W APE I 
Sbjct: 120 FIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 179
Query: 281 HKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
           +  +  K+DV+SFGI L E++T G +PY G+T  +  +  +++  R   P +    L +L
Sbjct: 180 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELYQL 238
Query: 340 LERCWQHDPTQRPNFSQITDILK 362
           +  CW+  P  RP F  +  +L+
Sbjct: 239 MRLCWKERPEDRPTFDYLRSVLE 261

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 94/287 (32%), Positives = 146/287 (50%), Gaps = 14/287 (4%)
Query: 92  PNCIEIPTDGTDVW--EIDAKQLKIECKVASGSYGDLYKG-----TYCSQEVAIKVLKPE 144
           P+  E PT     +  E+DA  + I+  V +G +G++  G     +     VAIK LK  
Sbjct: 25  PHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 145 CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV 204
               +  ++F  E  IM +  H N+++  G  T+   + IVTE+M  GS+  FL K    
Sbjct: 85  YTEKQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ 143
Query: 205 FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSG 262
           F +  L+ +   ++ GM YL     +HRDL   N+L++ N V KV+DFG+ARV       
Sbjct: 144 FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEA 203
Query: 263 VMTAETGT--YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGV 319
             T   G    RW +PE I ++ +   +DV+S+GI LWE+++ GE PY  ++  Q  +  
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKA 262
Query: 320 VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
           V +  R   P      L +L+  CWQ D   RP F QI  IL ++++
Sbjct: 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 145/265 (54%), Gaps = 12/265 (4%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
           ID K L    ++ +G +G +  G +  Q +VAIK++K   ++ +   EF +E  +M  + 
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLS 57
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
           H+ +VQ  G CT+   + I+TE+MA G + ++L + +  FQ   LL++  DV + M YL 
Sbjct: 58  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIEHKP 283
               +HRDL   N L+++ GVVKV+DFG++R        ++    +  RW  PEV+ +  
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 284 YDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER 342
           +  K+D+++FG+ +WE+ + G++PY   T  + A  + Q  LR   P  A  ++  ++  
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKVYTIMYS 236
Query: 343 CWQHDPTQRPNF----SQITDILKQ 363
           CW     +RP F    S I D++ +
Sbjct: 237 CWHEKADERPTFKILLSNILDVMDE 261

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 93/287 (32%), Positives = 146/287 (50%), Gaps = 14/287 (4%)
Query: 92  PNCIEIPTDGTDVW--EIDAKQLKIECKVASGSYGDLYKG-----TYCSQEVAIKVLKPE 144
           P+  E PT     +  E+DA  + I+  V +G +G++  G     +     VAIK LK  
Sbjct: 25  PHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 145 CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV 204
               +  ++F  E  IM +  H N+++  G  T+   + IVTE+M  GS+  FL K    
Sbjct: 85  YTEKQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ 143
Query: 205 FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSG 262
           F +  L+ +   ++ GM YL     +HRDL   N+L++ N V KV+DFG++RV       
Sbjct: 144 FTVIQLVGMLRGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 203
Query: 263 VMTAETGT--YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGV 319
             T   G    RW +PE I ++ +   +DV+S+GI LWE+++ GE PY  ++  Q  +  
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKA 262
Query: 320 VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
           V +  R   P      L +L+  CWQ D   RP F QI  IL ++++
Sbjct: 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 95/271 (35%), Positives = 136/271 (50%), Gaps = 12/271 (4%)
Query: 106 EIDAKQLKIECKVASGS-----YGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
           EI+A ++ IE  + SG      YG L         VAIK LK      +  ++F  E  I
Sbjct: 45  EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR-RDFLSEASI 103
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
           M +  H N+++  G  TR     IVTE+M  GS+  FL    G F +  L+ +   V  G
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAG 163
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGT---YRWMAP 276
           M YL     +HRDL   N+L+D N V KV+DFG++RV +         TG     RW AP
Sbjct: 164 MRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAP 223
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I  + +   +DV+SFG+ +WE+L  GE PY  +T  +  +  V++  R   P      
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-RDVISSVEEGYRLPAPMGCPHA 282
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMK 366
           L +L+  CW  D  QRP FSQI  +L  +++
Sbjct: 283 LHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 93/287 (32%), Positives = 146/287 (50%), Gaps = 14/287 (4%)
Query: 92  PNCIEIPTDGTDVW--EIDAKQLKIECKVASGSYGDLYKG-----TYCSQEVAIKVLKPE 144
           P+  E PT     +  E+DA  + I+  V +G +G++  G     +     VAIK LK  
Sbjct: 25  PHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 145 CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV 204
               +  ++F  E  IM +  H N+++  G  T+   + IVTE+M  GS+  FL K    
Sbjct: 85  YTEKQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ 143
Query: 205 FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSG 262
           F +  L+ +   ++ GM YL     +HRDL   N+L++ N V KV+DFG++RV       
Sbjct: 144 FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 203
Query: 263 VMTAETGT--YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGV 319
             T   G    RW +PE I ++ +   +DV+S+GI LWE+++ GE PY  ++  Q  +  
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKA 262
Query: 320 VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
           V +  R   P      L +L+  CWQ D   RP F QI  IL ++++
Sbjct: 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 93/287 (32%), Positives = 146/287 (50%), Gaps = 14/287 (4%)
Query: 92  PNCIEIPTDGTDVW--EIDAKQLKIECKVASGSYGDLYKG-----TYCSQEVAIKVLKPE 144
           P+  E PT     +  E+DA  + I+  V +G +G++  G     +     VAIK LK  
Sbjct: 25  PHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 145 CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV 204
               +  ++F  E  IM +  H N+++  G  T+   + IVTE+M  GS+  FL K    
Sbjct: 85  YTEKQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ 143
Query: 205 FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSG 262
           F +  L+ +   ++ GM YL     +HRDL   N+L++ N V KV+DFG++RV       
Sbjct: 144 FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 203
Query: 263 VMTAETGT--YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGV 319
             T   G    RW +PE I ++ +   +DV+S+GI LWE+++ GE PY  ++  Q  +  
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKA 262
Query: 320 VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
           V +  R   P      L +L+  CWQ D   RP F QI  IL ++++
Sbjct: 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score =  151 bits (381), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 86/273 (31%), Positives = 142/273 (52%), Gaps = 14/273 (5%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYI 160
           EID   +KIE  + +G +G++ +G   +       VAIK LK      +  +EF  E  I
Sbjct: 12  EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR-REFLSEASI 70
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
           M +  H N+++  G  T    + I+TEFM  G++  FL    G F +  L+ +   ++ G
Sbjct: 71  MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASG 130
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY------RWM 274
           M YL + + +HRDL   N+L++ N V KV+DFG++R   ++     ET +       RW 
Sbjct: 131 MRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWT 190
Query: 275 APEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAH 333
           APE I  + +   +D +S+GI +WE+++ GE PY  ++  Q  +  +++  R   P    
Sbjct: 191 APEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSN-QDVINAIEQDYRLPPPPDCP 249
Query: 334 PRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
             L +L+  CWQ D   RP F Q+   L +M++
Sbjct: 250 TSLHQLMLDCWQKDRNARPRFPQVVSALDKMIR 282

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score =  151 bits (381), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 93/287 (32%), Positives = 145/287 (50%), Gaps = 14/287 (4%)
Query: 92  PNCIEIPTDGTDVW--EIDAKQLKIECKVASGSYGDLYKG-----TYCSQEVAIKVLKPE 144
           P+  E PT     +  E+DA  + I+  V +G +G++  G     +     VAIK LK  
Sbjct: 25  PHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 145 CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV 204
               +  ++F  E  IM +  H N+++  G  T+   + IVTE+M  GS+  FL K    
Sbjct: 85  YTEKQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ 143
Query: 205 FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSG 262
           F +  L+ +   ++ GM YL     +HRDL   N+L++ N V KV+DFG+ RV       
Sbjct: 144 FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA 203
Query: 263 VMTAETGT--YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGV 319
             T   G    RW +PE I ++ +   +DV+S+GI LWE+++ GE PY  ++  Q  +  
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKA 262
Query: 320 VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
           V +  R   P      L +L+  CWQ D   RP F QI  IL ++++
Sbjct: 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  151 bits (381), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 95/271 (35%), Positives = 136/271 (50%), Gaps = 12/271 (4%)
Query: 106 EIDAKQLKIECKVASGS-----YGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
           EI+A ++ IE  + SG      YG L         VAIK LK      +  ++F  E  I
Sbjct: 45  EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR-RDFLSEASI 103
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
           M +  H N+++  G  TR     IVTE+M  GS+  FL    G F +  L+ +   V  G
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAG 163
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGT---YRWMAP 276
           M YL     +HRDL   N+L+D N V KV+DFG++RV +         TG     RW AP
Sbjct: 164 MRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAP 223
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I  + +   +DV+SFG+ +WE+L  GE PY  +T  +  +  V++  R   P      
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-RDVISSVEEGYRLPAPMGCPHA 282
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMK 366
           L +L+  CW  D  QRP FSQI  +L  +++
Sbjct: 283 LHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score =  151 bits (381), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 93/287 (32%), Positives = 146/287 (50%), Gaps = 14/287 (4%)
Query: 92  PNCIEIPTDGTDVW--EIDAKQLKIECKVASGSYGDLYKG-----TYCSQEVAIKVLKPE 144
           P+  E PT     +  E+DA  + I+  V +G +G++  G     +     VAIK LK  
Sbjct: 25  PHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 145 CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV 204
               +  ++F  E  IM +  H N+++  G  T+   + IVTE+M  GS+  FL K    
Sbjct: 85  YTEKQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ 143
Query: 205 FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSG 262
           F +  L+ +   ++ GM YL     +HRDL   N+L++ N V KV+DFG++RV       
Sbjct: 144 FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 203
Query: 263 VMTAETGT--YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGV 319
             T   G    RW +PE I ++ +   +DV+S+GI LWE+++ GE PY  ++  Q  +  
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKA 262
Query: 320 VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
           V +  R   P      L +L+  CWQ D   RP F QI  IL ++++
Sbjct: 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score =  150 bits (380), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 93/287 (32%), Positives = 146/287 (50%), Gaps = 14/287 (4%)
Query: 92  PNCIEIPTDGTDVW--EIDAKQLKIECKVASGSYGDLYKG-----TYCSQEVAIKVLKPE 144
           P+  E PT     +  E+DA  + I+  V +G +G++  G     +     VAIK LK  
Sbjct: 25  PHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 145 CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV 204
               +  ++F  E  IM +  H N+++  G  T+   + IVTE+M  GS+  FL K    
Sbjct: 85  YTEKQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ 143
Query: 205 FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSG 262
           F +  L+ +   ++ GM YL     +HRDL   N+L++ N V KV+DFG++RV       
Sbjct: 144 FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 203
Query: 263 VMTAETGT--YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGV 319
             T   G    RW +PE I ++ +   +DV+S+GI LWE+++ GE PY  ++  Q  +  
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKA 262
Query: 320 VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
           V +  R   P      L +L+  CWQ D   RP F QI  IL ++++
Sbjct: 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score =  150 bits (380), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 89/271 (32%), Positives = 140/271 (51%), Gaps = 12/271 (4%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKG-----TYCSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
           E+DA  + I+  V +G +G++  G     +     VAIK LK      +  ++F  E  I
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASI 70
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
           M +  H N+++  G  T+   + IVTE+M  GS+  FL K    F +  L+ +   ++ G
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 130
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGT--YRWMAP 276
           M YL     +HRDL   N+L++ N V KV+DFG++RV         T   G    RW +P
Sbjct: 131 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 190
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I ++ +   +DV+S+GI LWE+++ GE PY  ++  Q  +  V +  R   P      
Sbjct: 191 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYRLPPPMDCPAA 249
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMK 366
           L +L+  CWQ D   RP F QI  IL ++++
Sbjct: 250 LYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 280

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score =  150 bits (380), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 89/271 (32%), Positives = 140/271 (51%), Gaps = 12/271 (4%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKG-----TYCSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
           E+DA  + I+  V +G +G++  G     +     VAIK LK      +  ++F  E  I
Sbjct: 29  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASI 87
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
           M +  H N+++  G  T+   + IVTE+M  GS+  FL K    F +  L+ +   ++ G
Sbjct: 88  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 147
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGT--YRWMAP 276
           M YL     +HRDL   N+L++ N V KV+DFG++RV         T   G    RW +P
Sbjct: 148 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 207
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I ++ +   +DV+S+GI LWE+++ GE PY  ++  Q  +  V +  R   P      
Sbjct: 208 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYRLPPPMDCPAA 266
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMK 366
           L +L+  CWQ D   RP F QI  IL ++++
Sbjct: 267 LYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 297

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 141/266 (53%), Gaps = 12/266 (4%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNT-EMLKEFSQEVYI 160
           I  K L++  K+  GS+G + +G + +       VA+K LKP+ ++  E + +F +EV  
Sbjct: 9   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 68
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
           M  + H+N+++  G    PP + +VTE    GS+ D L K +G F L +L + A+ V++G
Sbjct: 69  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 127
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---VMTAETGT-YRWMAP 276
           M YL     IHRDL   NLL+    +VK+ DFG+ R   Q+    VM       + W AP
Sbjct: 128 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 187
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E ++ + + + +D + FG+ LWE+ T G+ P+ GL   Q    + ++  R   P+     
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 247
Query: 336 LAELLERCWQHDPTQRPNFSQITDIL 361
           +  ++ +CW H P  RP F  + D L
Sbjct: 248 IYNVMVQCWAHKPEDRPTFVALRDFL 273

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 93/274 (33%), Positives = 154/274 (56%), Gaps = 26/274 (9%)
Query: 111 QLKIECKVASGSYGDLYKGTYCSQE--VAIKVL-----KPECVNTEMLKEFSQEVYIMRK 163
           +++ E ++  G +G ++KG     +  VAIK L     + E    E  +EF +EV+IM  
Sbjct: 20  EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 223
           + H N+V+  G    PP +  V EF+  G +Y  L  +    + +  L++ +D++ G+ Y
Sbjct: 80  LNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEY 137
Query: 224 LHQNN--IIHRDLKTANLLM---DENGVV--KVADFGVAR--VQAQSGVMTAETGTYRWM 274
           +   N  I+HRDL++ N+ +   DEN  V  KVADF +++  V + SG++    G ++WM
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSGLL----GNFQWM 193
Query: 275 APEVI--EHKPYDYKADVFSFGIALWELLTGELPYAGLT--PLQAAVGVVQKSLRPTIPK 330
           APE I  E + Y  KAD +SF + L+ +LTGE P+   +   ++    + ++ LRPTIP+
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE 253
Query: 331 HAHPRLAELLERCWQHDPTQRPNFSQITDILKQM 364
              PRL  ++E CW  DP +RP+FS I   L ++
Sbjct: 254 DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 93/287 (32%), Positives = 146/287 (50%), Gaps = 14/287 (4%)
Query: 92  PNCIEIPTDGTDVW--EIDAKQLKIECKVASGSYGDLYKG-----TYCSQEVAIKVLKPE 144
           P+  E PT     +  E+DA  + I+  V +G +G++  G     +     VAIK LK  
Sbjct: 23  PHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 82
Query: 145 CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV 204
               +  ++F  E  IM +  H N+++  G  T+   + IVTE+M  GS+  FL K    
Sbjct: 83  YTEKQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ 141
Query: 205 FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSG 262
           F +  L+ +   ++ GM YL     +HRDL   N+L++ N V KV+DFG++RV       
Sbjct: 142 FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 201
Query: 263 VMTAETGT--YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGV 319
             T   G    RW +PE I ++ +   +DV+S+GI LWE+++ GE PY  ++  Q  +  
Sbjct: 202 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKA 260
Query: 320 VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
           V +  R   P      L +L+  CWQ D   RP F QI  IL ++++
Sbjct: 261 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 307

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 141/266 (53%), Gaps = 12/266 (4%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNT-EMLKEFSQEVYI 160
           I  K L++  K+  GS+G + +G + +       VA+K LKP+ ++  E + +F +EV  
Sbjct: 9   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 68
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
           M  + H+N+++  G    PP + +VTE    GS+ D L K +G F L +L + A+ V++G
Sbjct: 69  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 127
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---VMTAETGT-YRWMAP 276
           M YL     IHRDL   NLL+    +VK+ DFG+ R   Q+    VM       + W AP
Sbjct: 128 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 187
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E ++ + + + +D + FG+ LWE+ T G+ P+ GL   Q    + ++  R   P+     
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 247
Query: 336 LAELLERCWQHDPTQRPNFSQITDIL 361
           +  ++ +CW H P  RP F  + D L
Sbjct: 248 IYNVMVQCWAHKPEDRPTFVALRDFL 273

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 89/271 (32%), Positives = 145/271 (53%), Gaps = 12/271 (4%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTY---CSQE--VAIKVLKPECVNTEMLKEFSQEVYI 160
           EIDA  +KIE  +  G +G++  G       +E  VAIK LK    + +  ++F  E  I
Sbjct: 4   EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR-RDFLSEASI 62
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
           M +  H N++   G  T+   + I+TE+M  GS+  FL K  G F +  L+ +   +  G
Sbjct: 63  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSG 122
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGT--YRWMAP 276
           M YL   + +HRDL   N+L++ N V KV+DFG++RV         T   G    RW AP
Sbjct: 123 MKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAP 182
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I ++ +   +DV+S+GI +WE+++ GE PY  ++  Q  +  +++  R   P      
Sbjct: 183 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKAIEEGYRLPPPMDCPIA 241
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMK 366
           L +L+  CWQ + + RP F QI ++L ++++
Sbjct: 242 LHQLMLDCWQKERSDRPKFGQIVNMLDKLIR 272

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 141/266 (53%), Gaps = 12/266 (4%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNT-EMLKEFSQEVYI 160
           I  K L++  K+  GS+G + +G + +       VA+K LKP+ ++  E + +F +EV  
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
           M  + H+N+++  G    PP + +VTE    GS+ D L K +G F L +L + A+ V++G
Sbjct: 65  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---VMTAETGT-YRWMAP 276
           M YL     IHRDL   NLL+    +VK+ DFG+ R   Q+    VM       + W AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 183
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E ++ + + + +D + FG+ LWE+ T G+ P+ GL   Q    + ++  R   P+     
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 243
Query: 336 LAELLERCWQHDPTQRPNFSQITDIL 361
           +  ++ +CW H P  RP F  + D L
Sbjct: 244 IYNVMVQCWAHKPEDRPTFVALRDFL 269

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 141/266 (53%), Gaps = 12/266 (4%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNT-EMLKEFSQEVYI 160
           I  K L++  K+  GS+G + +G + +       VA+K LKP+ ++  E + +F +EV  
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
           M  + H+N+++  G    PP + +VTE    GS+ D L K +G F L +L + A+ V++G
Sbjct: 65  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---VMTAETGT-YRWMAP 276
           M YL     IHRDL   NLL+    +VK+ DFG+ R   Q+    VM       + W AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E ++ + + + +D + FG+ LWE+ T G+ P+ GL   Q    + ++  R   P+     
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 243
Query: 336 LAELLERCWQHDPTQRPNFSQITDIL 361
           +  ++ +CW H P  RP F  + D L
Sbjct: 244 IYNVMVQCWAHKPEDRPTFVALRDFL 269

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 141/266 (53%), Gaps = 12/266 (4%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNT-EMLKEFSQEVYI 160
           I  K L++  K+  GS+G + +G + +       VA+K LKP+ ++  E + +F +EV  
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
           M  + H+N+++  G    PP + +VTE    GS+ D L K +G F L +L + A+ V++G
Sbjct: 65  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---VMTAETGT-YRWMAP 276
           M YL     IHRDL   NLL+    +VK+ DFG+ R   Q+    VM       + W AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E ++ + + + +D + FG+ LWE+ T G+ P+ GL   Q    + ++  R   P+     
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 243
Query: 336 LAELLERCWQHDPTQRPNFSQITDIL 361
           +  ++ +CW H P  RP F  + D L
Sbjct: 244 IYNVMVQCWAHKPEDRPTFVALRDFL 269

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 89/271 (32%), Positives = 145/271 (53%), Gaps = 12/271 (4%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTY---CSQE--VAIKVLKPECVNTEMLKEFSQEVYI 160
           EIDA  +KIE  +  G +G++  G       +E  VAIK LK    + +  ++F  E  I
Sbjct: 25  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR-RDFLSEASI 83
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
           M +  H N++   G  T+   + I+TE+M  GS+  FL K  G F +  L+ +   +  G
Sbjct: 84  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSG 143
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGT--YRWMAP 276
           M YL   + +HRDL   N+L++ N V KV+DFG++RV         T   G    RW AP
Sbjct: 144 MKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAP 203
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I ++ +   +DV+S+GI +WE+++ GE PY  ++  Q  +  +++  R   P      
Sbjct: 204 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKAIEEGYRLPPPMDCPIA 262
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMK 366
           L +L+  CWQ + + RP F QI ++L ++++
Sbjct: 263 LHQLMLDCWQKERSDRPKFGQIVNMLDKLIR 293

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 89/271 (32%), Positives = 145/271 (53%), Gaps = 12/271 (4%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTY---CSQE--VAIKVLKPECVNTEMLKEFSQEVYI 160
           EIDA  +KIE  +  G +G++  G       +E  VAIK LK    + +  ++F  E  I
Sbjct: 10  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR-RDFLSEASI 68
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
           M +  H N++   G  T+   + I+TE+M  GS+  FL K  G F +  L+ +   +  G
Sbjct: 69  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSG 128
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGT--YRWMAP 276
           M YL   + +HRDL   N+L++ N V KV+DFG++RV         T   G    RW AP
Sbjct: 129 MKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAP 188
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I ++ +   +DV+S+GI +WE+++ GE PY  ++  Q  +  +++  R   P      
Sbjct: 189 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKAIEEGYRLPPPMDCPIA 247
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMK 366
           L +L+  CWQ + + RP F QI ++L ++++
Sbjct: 248 LHQLMLDCWQKERSDRPKFGQIVNMLDKLIR 278

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 141/266 (53%), Gaps = 12/266 (4%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNT-EMLKEFSQEVYI 160
           I  K L++  K+  GS+G + +G + +       VA+K LKP+ ++  E + +F +EV  
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 74
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
           M  + H+N+++  G    PP + +VTE    GS+ D L K +G F L +L + A+ V++G
Sbjct: 75  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---VMTAETGT-YRWMAP 276
           M YL     IHRDL   NLL+    +VK+ DFG+ R   Q+    VM       + W AP
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 193
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E ++ + + + +D + FG+ LWE+ T G+ P+ GL   Q    + ++  R   P+     
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 253
Query: 336 LAELLERCWQHDPTQRPNFSQITDIL 361
           +  ++ +CW H P  RP F  + D L
Sbjct: 254 IYNVMVQCWAHKPEDRPTFVALRDFL 279

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 141/266 (53%), Gaps = 12/266 (4%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNT-EMLKEFSQEVYI 160
           I  K L++  K+  GS+G + +G + +       VA+K LKP+ ++  E + +F +EV  
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 74
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
           M  + H+N+++  G    PP + +VTE    GS+ D L K +G F L +L + A+ V++G
Sbjct: 75  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---VMTAETGT-YRWMAP 276
           M YL     IHRDL   NLL+    +VK+ DFG+ R   Q+    VM       + W AP
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 193
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E ++ + + + +D + FG+ LWE+ T G+ P+ GL   Q    + ++  R   P+     
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 253
Query: 336 LAELLERCWQHDPTQRPNFSQITDIL 361
           +  ++ +CW H P  RP F  + D L
Sbjct: 254 IYNVMVQCWAHKPEDRPTFVALRDFL 279

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 93/287 (32%), Positives = 145/287 (50%), Gaps = 14/287 (4%)
Query: 92  PNCIEIPTDGTDVW--EIDAKQLKIECKVASGSYGDLYKG-----TYCSQEVAIKVLKPE 144
           P+  E PT     +  E+DA  + I+  V +G +G++  G     +     VAIK LK  
Sbjct: 25  PHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 145 CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV 204
               +  ++F  E  IM +  H N+++  G  T+   + IVTE M  GS+  FL K    
Sbjct: 85  YTEKQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQ 143
Query: 205 FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSG 262
           F +  L+ +   ++ GM YL     +HRDL   N+L++ N V KV+DFG++RV       
Sbjct: 144 FTVIQLVGMLRGIASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 203
Query: 263 VMTAETGT--YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGV 319
             T   G    RW +PE I ++ +   +DV+S+GI LWE+++ GE PY  ++  Q  +  
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKA 262
Query: 320 VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
           V +  R   P      L +L+  CWQ D   RP F QI  IL ++++
Sbjct: 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 88/281 (31%), Positives = 151/281 (53%), Gaps = 25/281 (8%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 164
           W+I  +QL+I   +  G +G +Y G +   EVAI+++  E  N + LK F +EV   R+ 
Sbjct: 28  WDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQT 86
Query: 165 RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
           RH+NVV F+GAC  PP+L I+T      ++Y  +   K V  +    ++A ++ KGM YL
Sbjct: 87  RHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA---------ETGTYRWMA 275
           H   I+H+DLK+ N+  D NG V + DFG+  +   SGV+ A         + G    +A
Sbjct: 147 HAKGILHKDLKSKNVFYD-NGKVVITDFGLFSI---SGVLQAGRREDKLRIQNGWLCHLA 202
Query: 276 PEVI---------EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP 326
           PE+I         +  P+   +DVF+ G   +EL   E P+    P +A +  +   ++P
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK-TQPAEAIIWQMGTGMKP 261
Query: 327 TIPKHAHPR-LAELLERCWQHDPTQRPNFSQITDILKQMMK 366
            + +    + ++++L  CW  +  +RP F+++ D+L+++ K
Sbjct: 262 NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 93/287 (32%), Positives = 145/287 (50%), Gaps = 14/287 (4%)
Query: 92  PNCIEIPTDGTDVW--EIDAKQLKIECKVASGSYGDLYKG-----TYCSQEVAIKVLKPE 144
           P+  E PT     +  E+DA  + I+  V +G +G++  G     +     VAIK LK  
Sbjct: 25  PHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 145 CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV 204
               +  ++F  E  IM +  H N+++  G  T+   + IVTE M  GS+  FL K    
Sbjct: 85  YTEKQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQ 143
Query: 205 FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSG 262
           F +  L+ +   ++ GM YL     +HRDL   N+L++ N V KV+DFG++RV       
Sbjct: 144 FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 203
Query: 263 VMTAETGT--YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGV 319
             T   G    RW +PE I ++ +   +DV+S+GI LWE+++ GE PY  ++  Q  +  
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKA 262
Query: 320 VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
           V +  R   P      L +L+  CWQ D   RP F QI  IL ++++
Sbjct: 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 89/271 (32%), Positives = 139/271 (51%), Gaps = 12/271 (4%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKG-----TYCSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
           E+DA  + I+  V +G +G++  G     +     VAIK LK      +  ++F  E  I
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASI 70
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
           M +  H N+++  G  T+   + IVTE M  GS+  FL K    F +  L+ +   ++ G
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 130
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGT--YRWMAP 276
           M YL     +HRDL   N+L++ N V KV+DFG++RV         T   G    RW +P
Sbjct: 131 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 190
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I ++ +   +DV+S+GI LWE+++ GE PY  ++  Q  +  V +  R   P      
Sbjct: 191 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYRLPPPMDCPAA 249
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMK 366
           L +L+  CWQ D   RP F QI  IL ++++
Sbjct: 250 LYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 280

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  149 bits (375), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 82/260 (31%), Positives = 138/260 (53%), Gaps = 13/260 (5%)
Query: 118 VASGSYGDLYKGTYCSQE------VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQ 171
           + +G +G++YKG   +        VAIK LK      + + +F  E  IM +  H N+++
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV-DFLGEAGIMGQFSHHNIIR 110
Query: 172 FIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 231
             G  ++   + I+TE+M  G++  FL ++ G F +  L+ +   ++ GM YL   N +H
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVH 170
Query: 232 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT----YRWMAPEVIEHKPYDYK 287
           RDL   N+L++ N V KV+DFG++RV       T  T       RW APE I ++ +   
Sbjct: 171 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSA 230
Query: 288 ADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH 346
           +DV+SFGI +WE++T GE PY  L+     +  +    R   P      + +L+ +CWQ 
Sbjct: 231 SDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQ 289
Query: 347 DPTQRPNFSQITDILKQMMK 366
           +  +RP F+ I  IL ++++
Sbjct: 290 ERARRPKFADIVSILDKLIR 309

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score =  148 bits (374), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 85/273 (31%), Positives = 141/273 (51%), Gaps = 14/273 (5%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYI 160
           EID   +KIE  + +G +G++ +G   +       VAIK LK      +  +EF  E  I
Sbjct: 10  EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR-REFLSEASI 68
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
           M +  H N+++  G  T    + I+TEFM  G++  FL    G F +  L+ +   ++ G
Sbjct: 69  MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASG 128
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY------RWM 274
           M YL + + +HRDL   N+L++ N V KV+DFG++R   ++      T +       RW 
Sbjct: 129 MRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWT 188
Query: 275 APEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAH 333
           APE I  + +   +D +S+GI +WE+++ GE PY  ++  Q  +  +++  R   P    
Sbjct: 189 APEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSN-QDVINAIEQDYRLPPPPDCP 247
Query: 334 PRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
             L +L+  CWQ D   RP F Q+   L +M++
Sbjct: 248 TSLHQLMLDCWQKDRNARPRFPQVVSALDKMIR 280

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 90/271 (33%), Positives = 142/271 (52%), Gaps = 12/271 (4%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTY---CSQE--VAIKVLKPECVNTEMLKEFSQEVYI 160
           EI+A  + IE  + +G +G++  G       +E  VAIK LK      +  ++F  E  I
Sbjct: 18  EIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQR-RDFLGEASI 76
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
           M +  H N++   G  T+   + IVTE+M  GS+  FL K  G F +  L+ +   +S G
Sbjct: 77  MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAG 136
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGT--YRWMAP 276
           M YL     +HRDL   N+L++ N V KV+DFG++RV         T   G    RW AP
Sbjct: 137 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAP 196
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I  + +   +DV+S+GI +WE+++ GE PY  +T  Q  +  V++  R   P      
Sbjct: 197 EAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTN-QDVIKAVEEGYRLPSPMDCPAA 255
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMK 366
           L +L+  CWQ +   RP F +I ++L ++++
Sbjct: 256 LYQLMLDCWQKERNSRPKFDEIVNMLDKLIR 286

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score =  145 bits (365), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 149/299 (49%), Gaps = 26/299 (8%)
Query: 93  NCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKG-------TYCSQEVAIKVLKPEC 145
           +C  +P D +  WE    +LK+   +  G++G + +        T   + VA+K+LK   
Sbjct: 13  HCERLPYDASK-WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGA 71
Query: 146 VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGV 204
            ++E     S+   ++    H NVV  +GACT+P   L ++ EF   G++  +L  ++  
Sbjct: 72  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE 131
Query: 205 F-------------QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 251
           F              L  L+  +  V+KGM +L     IHRDL   N+L+ E  VVK+ D
Sbjct: 132 FVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICD 191
Query: 252 FGVAR--VQAQSGVMTAETG-TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPY 307
           FG+AR   +    V   +     +WMAPE I  + Y  ++DV+SFG+ LWE+ + G  PY
Sbjct: 192 FGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251
Query: 308 AGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
            G+   +     +++  R   P +  P + + +  CW  +P+QRP FS++ + L  +++
Sbjct: 252 PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score =  144 bits (363), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 88/301 (29%), Positives = 150/301 (49%), Gaps = 28/301 (9%)
Query: 93  NCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKG-------TYCSQEVAIKVLKPEC 145
           +C  +P D +  WE    +LK+   +  G++G + +        T   + VA+K+LK   
Sbjct: 2   HCERLPYDASK-WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 60
Query: 146 VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGV 204
            ++E     S+   ++    H NVV  +GACT+P   L ++TEF   G++  +L  ++  
Sbjct: 61  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNE 120
Query: 205 F---------------QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV 249
           F                L  L+  +  V+KGM +L     IHRDL   N+L+ E  VVK+
Sbjct: 121 FVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKI 180
Query: 250 ADFGVAR--VQAQSGVMTAETG-TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GEL 305
            DFG+AR   +    V   +     +WMAPE I  + Y  ++DV+SFG+ LWE+ + G  
Sbjct: 181 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 240
Query: 306 PYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
           PY G+   +     +++  R   P +  P + + +  CW  +P+QRP FS++ + L  ++
Sbjct: 241 PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 300
Query: 366 K 366
           +
Sbjct: 301 Q 301

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 86/297 (28%), Positives = 148/297 (49%), Gaps = 24/297 (8%)
Query: 93  NCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKG-------TYCSQEVAIKVLKPEC 145
           +C  +P D +  WE    +L +   +  G++G + +        T   + VA+K+LK   
Sbjct: 11  HCERLPYDASK-WEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGA 69
Query: 146 VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGV 204
            ++E     S+   ++    H NVV  +GACT+P   L ++ EF   G++  +L  ++  
Sbjct: 70  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE 129
Query: 205 F-----------QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG 253
           F            L  L+  +  V+KGM +L     IHRDL   N+L+ E  VVK+ DFG
Sbjct: 130 FVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFG 189
Query: 254 VAR--VQAQSGVMTAETG-TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAG 309
           +AR   +    V   +     +WMAPE I  + Y  ++DV+SFG+ LWE+ + G  PY G
Sbjct: 190 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 249
Query: 310 LTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
           +   +     +++  R   P +  P + + +  CW  +P+QRP FS++ + L  +++
Sbjct: 250 VKIDEEFXRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 306

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 87/301 (28%), Positives = 149/301 (49%), Gaps = 28/301 (9%)
Query: 93  NCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKG-------TYCSQEVAIKVLKPEC 145
           +C  +P D +  WE    +LK+   +  G++G + +        T   + VA+K+LK   
Sbjct: 11  HCERLPYDASK-WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 69
Query: 146 VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGV 204
            ++E     S+   ++    H NVV  +GACT+P   L ++ EF   G++  +L  ++  
Sbjct: 70  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE 129
Query: 205 F---------------QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV 249
           F                L  L+  +  V+KGM +L     IHRDL   N+L+ E  VVK+
Sbjct: 130 FVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKI 189
Query: 250 ADFGVAR--VQAQSGVMTAETG-TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GEL 305
            DFG+AR   +    V   +     +WMAPE I  + Y  ++DV+SFG+ LWE+ + G  
Sbjct: 190 CDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249
Query: 306 PYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
           PY G+   +     +++  R   P +  P + + +  CW  +P+QRP FS++ + L  ++
Sbjct: 250 PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309
Query: 366 K 366
           +
Sbjct: 310 Q 310

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 87/301 (28%), Positives = 149/301 (49%), Gaps = 28/301 (9%)
Query: 93  NCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKG-------TYCSQEVAIKVLKPEC 145
           +C  +P D +  WE    +LK+   +  G++G + +        T   + VA+K+LK   
Sbjct: 11  HCERLPYDASK-WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 69
Query: 146 VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGV 204
            ++E     S+   ++    H NVV  +GACT+P   L ++ EF   G++  +L  ++  
Sbjct: 70  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE 129
Query: 205 F---------------QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV 249
           F                L  L+  +  V+KGM +L     IHRDL   N+L+ E  VVK+
Sbjct: 130 FVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKI 189
Query: 250 ADFGVAR--VQAQSGVMTAETG-TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GEL 305
            DFG+AR   +    V   +     +WMAPE I  + Y  ++DV+SFG+ LWE+ + G  
Sbjct: 190 CDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249
Query: 306 PYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
           PY G+   +     +++  R   P +  P + + +  CW  +P+QRP FS++ + L  ++
Sbjct: 250 PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309
Query: 366 K 366
           +
Sbjct: 310 Q 310

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 84/265 (31%), Positives = 139/265 (52%), Gaps = 12/265 (4%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH 166
           ID KQL    K+     G+L+KG +   ++ +KVLK    +T   ++F++E   +R   H
Sbjct: 7   IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 167 KNVVQFIGACTRPP--NLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNY 223
            NV+  +GAC  PP  +  ++T +   GS+Y+ LH+    V   +  +K A+D ++G  +
Sbjct: 67  PNVLPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAF 126
Query: 224 LH--QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH 281
           LH  +  I    L + ++ +DE+   +++   V       G   A      W+APE ++ 
Sbjct: 127 LHTLEPLIPRHALNSRSVXIDEDXTARISXADVKFSFQSPGRXYAPA----WVAPEALQK 182
Query: 282 KPYD---YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE 338
           KP D     AD +SF + LWEL+T E+P+A L+  +    V  + LRPTIP    P +++
Sbjct: 183 KPEDTNRRSADXWSFAVLLWELVTREVPFADLSNXEIGXKVALEGLRPTIPPGISPHVSK 242
Query: 339 LLERCWQHDPTQRPNFSQITDILKQ 363
           L + C   DP +RP F  I  IL++
Sbjct: 243 LXKICXNEDPAKRPKFDXIVPILEK 267

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score =  142 bits (359), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 86/297 (28%), Positives = 148/297 (49%), Gaps = 24/297 (8%)
Query: 93  NCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKG-------TYCSQEVAIKVLKPEC 145
           +C  +P D +  WE    +L +   +  G++G + +        T   + VA+K+LK   
Sbjct: 11  HCERLPYDASK-WEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGA 69
Query: 146 VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGV 204
            ++E     S+   ++    H NVV  +GACT+P   L ++ EF   G++  +L  ++  
Sbjct: 70  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE 129
Query: 205 F-----------QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG 253
           F            L  L+  +  V+KGM +L     IHRDL   N+L+ E  VVK+ DFG
Sbjct: 130 FVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFG 189
Query: 254 VAR--VQAQSGVMTAETG-TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAG 309
           +AR   +    V   +     +WMAPE I  + Y  ++DV+SFG+ LWE+ + G  PY G
Sbjct: 190 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 249
Query: 310 LTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
           +   +     +++  R   P +  P + + +  CW  +P+QRP FS++ + L  +++
Sbjct: 250 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 306

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score =  142 bits (359), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 87/301 (28%), Positives = 149/301 (49%), Gaps = 28/301 (9%)
Query: 93  NCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKG-------TYCSQEVAIKVLKPEC 145
           +C  +P D +  WE    +LK+   +  G++G + +        T   + VA+K+LK   
Sbjct: 11  HCERLPYDASK-WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 69
Query: 146 VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGV 204
            ++E     S+   ++    H NVV  +GACT+P   L ++ EF   G++  +L  ++  
Sbjct: 70  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE 129
Query: 205 F---------------QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV 249
           F                L  L+  +  V+KGM +L     IHRDL   N+L+ E  VVK+
Sbjct: 130 FVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKI 189
Query: 250 ADFGVAR--VQAQSGVMTAETG-TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GEL 305
            DFG+AR   +    V   +     +WMAPE I  + Y  ++DV+SFG+ LWE+ + G  
Sbjct: 190 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249
Query: 306 PYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
           PY G+   +     +++  R   P +  P + + +  CW  +P+QRP FS++ + L  ++
Sbjct: 250 PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309
Query: 366 K 366
           +
Sbjct: 310 Q 310

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score =  142 bits (359), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 87/301 (28%), Positives = 149/301 (49%), Gaps = 28/301 (9%)
Query: 93  NCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKG-------TYCSQEVAIKVLKPEC 145
           +C  +P D +  WE    +LK+   +  G++G + +        T   + VA+K+LK   
Sbjct: 48  HCERLPYDASK-WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 106
Query: 146 VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGV 204
            ++E     S+   ++    H NVV  +GACT+P   L ++ EF   G++  +L  ++  
Sbjct: 107 THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE 166
Query: 205 F---------------QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV 249
           F                L  L+  +  V+KGM +L     IHRDL   N+L+ E  VVK+
Sbjct: 167 FVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKI 226
Query: 250 ADFGVAR--VQAQSGVMTAETG-TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GEL 305
            DFG+AR   +    V   +     +WMAPE I  + Y  ++DV+SFG+ LWE+ + G  
Sbjct: 227 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 286
Query: 306 PYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
           PY G+   +     +++  R   P +  P + + +  CW  +P+QRP FS++ + L  ++
Sbjct: 287 PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346
Query: 366 K 366
           +
Sbjct: 347 Q 347

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 87/301 (28%), Positives = 149/301 (49%), Gaps = 28/301 (9%)
Query: 93  NCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKG-------TYCSQEVAIKVLKPEC 145
           +C  +P D +  WE    +LK+   +  G++G + +        T   + VA+K+LK   
Sbjct: 13  HCERLPYDASK-WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 71
Query: 146 VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGV 204
            ++E     S+   ++    H NVV  +GACT+P   L ++ EF   G++  +L  ++  
Sbjct: 72  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE 131
Query: 205 F---------------QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV 249
           F                L  L+  +  V+KGM +L     IHRDL   N+L+ E  VVK+
Sbjct: 132 FVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKI 191
Query: 250 ADFGVAR--VQAQSGVMTAETG-TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GEL 305
            DFG+AR   +    V   +     +WMAPE I  + Y  ++DV+SFG+ LWE+ + G  
Sbjct: 192 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 251
Query: 306 PYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
           PY G+   +     +++  R   P +  P + + +  CW  +P+QRP FS++ + L  ++
Sbjct: 252 PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 311
Query: 366 K 366
           +
Sbjct: 312 Q 312

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 87/298 (29%), Positives = 148/298 (49%), Gaps = 28/298 (9%)
Query: 96  EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKG-------TYCSQEVAIKVLKPECVNT 148
            +P D +  WE    +LK+   +  G++G + +        T   + VA+K+LK    ++
Sbjct: 5   RLPYDASK-WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 63
Query: 149 EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGVF-- 205
           E     S+   ++    H NVV  +GACT+P   L ++TEF   G++  +L  ++  F  
Sbjct: 64  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVP 123
Query: 206 -------------QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADF 252
                         L  L+  +  V+KGM +L     IHRDL   N+L+ E  VVK+ DF
Sbjct: 124 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDF 183
Query: 253 GVAR--VQAQSGVMTAETG-TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYA 308
           G+AR   +    V   +     +WMAPE I  + Y  ++DV+SFG+ LWE+ + G  PY 
Sbjct: 184 GLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 243
Query: 309 GLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
           G+   +     +++  R   P +  P + + +  CW  +P+QRP FS++ + L  +++
Sbjct: 244 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 301

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score =  142 bits (358), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 144/282 (51%), Gaps = 23/282 (8%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 162
           +D   +K +  +  G++G + K          + AIK +K E  + +  ++F+ E+ ++ 
Sbjct: 12  LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLC 70
Query: 163 KI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQ 206
           K+  H N++  +GAC     L +  E+   G++ DFL K +                   
Sbjct: 71  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 130
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266
              LL  A DV++GM+YL Q   IHRDL   N+L+ EN V K+ADFG++R Q      T 
Sbjct: 131 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 190
Query: 267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLR 325
                RWMA E + +  Y   +DV+S+G+ LWE+++ G  PY G+T  +    + Q   R
Sbjct: 191 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYR 249
Query: 326 PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
              P +    + +L+ +CW+  P +RP+F+QI   L +M++E
Sbjct: 250 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 291

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 143/291 (49%), Gaps = 28/291 (9%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQE 157
           WE    +L     + +G++G + + T         +  VA+K+LKP    TE     S+ 
Sbjct: 18  WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSEL 77
Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF------------ 205
             +     H N+V  +GACT      ++TE+   G + +FL +++  F            
Sbjct: 78  KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 206 -----QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQA 259
                 L  LL  +  V+KGM +L   N IHRDL   N+L+    + K+ DFG+AR ++ 
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 260 QSGVMTAETGTY--RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAA 316
            S  +         +WMAPE I +  Y +++DV+S+GI LWEL + G  PY G+      
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257
Query: 317 VGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
             ++++  R   P+HA   + ++++ CW  DP +RP F QI  ++++ + E
Sbjct: 258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 148/291 (50%), Gaps = 23/291 (7%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 162
           +D   +K +  +  G++G + K          + AIK +K E  + +  ++F+ E+ ++ 
Sbjct: 22  LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLC 80
Query: 163 KI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQ 206
           K+  H N++  +GAC     L +  E+   G++ DFL K +                   
Sbjct: 81  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266
              LL  A DV++GM+YL Q   IHRDL   N+L+ EN V K+ADFG++R Q      T 
Sbjct: 141 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 200
Query: 267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLR 325
                RWMA E + +  Y   +DV+S+G+ LWE+++ G  PY G+T  +    + Q   R
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYR 259
Query: 326 PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNL 376
              P +    + +L+ +CW+  P +RP+F+QI   L +M++E   +++  L
Sbjct: 260 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTL 310

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score =  142 bits (357), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 143/291 (49%), Gaps = 28/291 (9%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQE 157
           WE    +L     + +G++G + + T         +  VA+K+LKP    TE     S+ 
Sbjct: 34  WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSEL 93
Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF------------ 205
             +     H N+V  +GACT      ++TE+   G + +FL +++  F            
Sbjct: 94  KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 153
Query: 206 -----QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQA 259
                 L  LL  +  V+KGM +L   N IHRDL   N+L+    + K+ DFG+AR ++ 
Sbjct: 154 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 213
Query: 260 QSGVMTAETGTY--RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAA 316
            S  +         +WMAPE I +  Y +++DV+S+GI LWEL + G  PY G+      
Sbjct: 214 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 273
Query: 317 VGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
             ++++  R   P+HA   + ++++ CW  DP +RP F QI  ++++ + E
Sbjct: 274 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 324

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 148/300 (49%), Gaps = 27/300 (9%)
Query: 93  NCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKG-------TYCSQEVAIKVLKPEC 145
           +C  +P D +  WE    +L +   +  G++G + +        T   + VA+K+LK   
Sbjct: 12  HCERLPYDASK-WEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 70
Query: 146 VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGV 204
            ++E     S+   ++    H NVV  +GACT+P   L ++ EF   G++  +L  ++  
Sbjct: 71  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE 130
Query: 205 F--------------QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
           F               L  L+  +  V+KGM +L     IHRDL   N+L+ E  VVK+ 
Sbjct: 131 FVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 190
Query: 251 DFGVAR--VQAQSGVMTAETG-TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 306
           DFG+AR   +    V   +     +WMAPE I  + Y  ++DV+SFG+ LWE+ + G  P
Sbjct: 191 DFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
Query: 307 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
           Y G+   +     +++  R   P +  P + + +  CW  +P+QRP FS++ + L  +++
Sbjct: 251 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 87/298 (29%), Positives = 148/298 (49%), Gaps = 28/298 (9%)
Query: 96  EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKG-------TYCSQEVAIKVLKPECVNT 148
            +P D +  WE    +LK+   +  G++G + +        T   + VA+K+LK    ++
Sbjct: 5   RLPYDASK-WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 63
Query: 149 EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGVF-- 205
           E     S+   ++    H NVV  +GACT+P   L ++TEF   G++  +L  ++  F  
Sbjct: 64  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVP 123
Query: 206 -------------QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADF 252
                         L  L+  +  V+KGM +L     IHRDL   N+L+ E  VVK+ DF
Sbjct: 124 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDF 183
Query: 253 GVAR--VQAQSGVMTAETG-TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYA 308
           G+AR   +    V   +     +WMAPE I  + Y  ++DV+SFG+ LWE+ + G  PY 
Sbjct: 184 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 243
Query: 309 GLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
           G+   +     +++  R   P +  P + + +  CW  +P+QRP FS++ + L  +++
Sbjct: 244 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 301

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 143/291 (49%), Gaps = 28/291 (9%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQE 157
           WE    +L     + +G++G + + T         +  VA+K+LKP    TE     S+ 
Sbjct: 36  WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSEL 95
Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF------------ 205
             +     H N+V  +GACT      ++TE+   G + +FL +++  F            
Sbjct: 96  KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 155
Query: 206 -----QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQA 259
                 L  LL  +  V+KGM +L   N IHRDL   N+L+    + K+ DFG+AR ++ 
Sbjct: 156 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 215
Query: 260 QSGVMTAETGTY--RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAA 316
            S  +         +WMAPE I +  Y +++DV+S+GI LWEL + G  PY G+      
Sbjct: 216 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 275
Query: 317 VGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
             ++++  R   P+HA   + ++++ CW  DP +RP F QI  ++++ + E
Sbjct: 276 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 326

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 143/291 (49%), Gaps = 28/291 (9%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQE 157
           WE    +L     + +G++G + + T         +  VA+K+LKP    TE     S+ 
Sbjct: 41  WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSEL 100
Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTS-------- 209
             +     H N+V  +GACT      ++TE+   G + +FL +++  F  +         
Sbjct: 101 KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 160
Query: 210 ---------LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQA 259
                    LL  +  V+KGM +L   N IHRDL   N+L+    + K+ DFG+AR ++ 
Sbjct: 161 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 220
Query: 260 QSGVMTAETGTY--RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAA 316
            S  +         +WMAPE I +  Y +++DV+S+GI LWEL + G  PY G+      
Sbjct: 221 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 280
Query: 317 VGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
             ++++  R   P+HA   + ++++ CW  DP +RP F QI  ++++ + E
Sbjct: 281 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 331

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score =  141 bits (356), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 143/291 (49%), Gaps = 28/291 (9%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQE 157
           WE    +L     + +G++G + + T         +  VA+K+LKP    TE     S+ 
Sbjct: 41  WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSEL 100
Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTS-------- 209
             +     H N+V  +GACT      ++TE+   G + +FL +++  F  +         
Sbjct: 101 KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 160
Query: 210 ---------LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQA 259
                    LL  +  V+KGM +L   N IHRDL   N+L+    + K+ DFG+AR ++ 
Sbjct: 161 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKN 220
Query: 260 QSGVMTAETGTY--RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAA 316
            S  +         +WMAPE I +  Y +++DV+S+GI LWEL + G  PY G+      
Sbjct: 221 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 280
Query: 317 VGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
             ++++  R   P+HA   + ++++ CW  DP +RP F QI  ++++ + E
Sbjct: 281 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 331

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score =  141 bits (355), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 79/256 (30%), Positives = 141/256 (55%), Gaps = 8/256 (3%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRKI 164
           E+  +++ +  ++ SG +G +  G +  Q +VA+K++K   ++ +   EF QE   M K+
Sbjct: 4   ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMKL 60
Query: 165 RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
            H  +V+F G C++   + IVTE+++ G + ++L       + + LL++  DV +GM +L
Sbjct: 61  SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIEHK 282
             +  IHRDL   N L+D +  VKV+DFG+ R       +++    +  +W APEV  + 
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYF 180
Query: 283 PYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE 341
            Y  K+DV++FGI +WE+ + G++PY   T  +  + V Q   R   P  A   + +++ 
Sbjct: 181 KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH-RLYRPHLASDTIYQIMY 239
Query: 342 RCWQHDPTQRPNFSQI 357
            CW   P +RP F Q+
Sbjct: 240 SCWHELPEKRPTFQQL 255

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 86/298 (28%), Positives = 147/298 (49%), Gaps = 28/298 (9%)
Query: 96  EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKG-------TYCSQEVAIKVLKPECVNT 148
            +P D +  WE    +LK+   +  G++G + +        T   + VA+K+LK    ++
Sbjct: 5   RLPYDASK-WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 63
Query: 149 EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGVF-- 205
           E     S+   ++    H NVV  +GACT+P   L ++ EF   G++  +L  ++  F  
Sbjct: 64  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 123
Query: 206 -------------QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADF 252
                         L  L+  +  V+KGM +L     IHRDL   N+L+ E  VVK+ DF
Sbjct: 124 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDF 183
Query: 253 GVAR--VQAQSGVMTAETG-TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYA 308
           G+AR   +    V   +     +WMAPE I  + Y  ++DV+SFG+ LWE+ + G  PY 
Sbjct: 184 GLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 243
Query: 309 GLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
           G+   +     +++  R   P +  P + + +  CW  +P+QRP FS++ + L  +++
Sbjct: 244 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 301

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 85/282 (30%), Positives = 144/282 (51%), Gaps = 23/282 (8%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 162
           +D   +K +  +  G++G + K          + AIK +K E  + +  ++F+ E+ ++ 
Sbjct: 19  LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLC 77
Query: 163 KI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQ 206
           K+  H N++  +GAC     L +  E+   G++ DFL K +                   
Sbjct: 78  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 137
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266
              LL  A DV++GM+YL Q   IHR+L   N+L+ EN V K+ADFG++R Q      T 
Sbjct: 138 SQQLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 197
Query: 267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLR 325
                RWMA E + +  Y   +DV+S+G+ LWE+++ G  PY G+T  +    + Q   R
Sbjct: 198 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYR 256
Query: 326 PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
              P +    + +L+ +CW+  P +RP+F+QI   L +M++E
Sbjct: 257 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 298

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 155/299 (51%), Gaps = 33/299 (11%)
Query: 96  EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECV 146
           E+P D    WE+   +L +   +  G++G +                 +VA+K+LK +  
Sbjct: 16  ELPEDPR--WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 73
Query: 147 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 205
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++   
Sbjct: 74  EKD-LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPG 132
Query: 206 -------------QLTS--LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
                        QL+S  L+  A  V++GM YL     IHRDL   N+L+ E+ V+K+A
Sbjct: 133 LEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 192
Query: 251 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 306
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ LWE+ T G  P
Sbjct: 193 DFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 252
Query: 307 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++
Sbjct: 253 YPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 310

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 155/299 (51%), Gaps = 33/299 (11%)
Query: 96  EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECV 146
           E+P D    WE+   +L +   +  G++G +                 +VA+K+LK +  
Sbjct: 16  ELPEDPR--WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 73
Query: 147 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 205
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++   
Sbjct: 74  EKD-LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPG 132
Query: 206 -------------QLTS--LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
                        QL+S  L+  A  V++GM YL     IHRDL   N+L+ E+ V+K+A
Sbjct: 133 LEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 192
Query: 251 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 306
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ LWE+ T G  P
Sbjct: 193 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 252
Query: 307 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++
Sbjct: 253 YPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 310

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 155/299 (51%), Gaps = 33/299 (11%)
Query: 96  EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECV 146
           E+P D    WE+   +L +   +  G++G +                 +VA+K+LK +  
Sbjct: 1   ELPEDPR--WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 58
Query: 147 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 205
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++   
Sbjct: 59  EKD-LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPG 117
Query: 206 -------------QLTS--LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
                        QL+S  L+  A  V++GM YL     IHRDL   N+L+ E+ V+K+A
Sbjct: 118 LEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 177
Query: 251 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 306
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ LWE+ T G  P
Sbjct: 178 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 237
Query: 307 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++
Sbjct: 238 YPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 155/299 (51%), Gaps = 33/299 (11%)
Query: 96  EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECV 146
           E+P D    WE+   +L +   +  G++G +                 +VA+K+LK +  
Sbjct: 9   ELPEDPR--WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 66
Query: 147 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 205
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++   
Sbjct: 67  EKD-LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPG 125
Query: 206 -------------QLTS--LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
                        QL+S  L+  A  V++GM YL     IHRDL   N+L+ E+ V+K+A
Sbjct: 126 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 185
Query: 251 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 306
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ LWE+ T G  P
Sbjct: 186 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 245
Query: 307 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++
Sbjct: 246 YPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 303

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 155/299 (51%), Gaps = 33/299 (11%)
Query: 96  EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECV 146
           E+P D    WE+   +L +   +  G++G +                 +VA+K+LK +  
Sbjct: 57  ELPEDPR--WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 114
Query: 147 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 205
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++   
Sbjct: 115 EKD-LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPG 173
Query: 206 -------------QLTS--LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
                        QL+S  L+  A  V++GM YL     IHRDL   N+L+ E+ V+K+A
Sbjct: 174 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 233
Query: 251 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 306
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ LWE+ T G  P
Sbjct: 234 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
Query: 307 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++
Sbjct: 294 YPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score =  138 bits (347), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 155/299 (51%), Gaps = 33/299 (11%)
Query: 96  EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECV 146
           E+P D    WE+   +L +   +  G++G +                 +VA+K+LK +  
Sbjct: 5   ELPEDPR--WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 62
Query: 147 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 205
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++   
Sbjct: 63  EKD-LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPG 121
Query: 206 -------------QLTS--LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
                        QL+S  L+  A  V++GM YL     IHRDL   N+L+ E+ V+K+A
Sbjct: 122 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 181
Query: 251 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 306
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ LWE+ T G  P
Sbjct: 182 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 241
Query: 307 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++
Sbjct: 242 YPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 299

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score =  138 bits (347), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 155/299 (51%), Gaps = 33/299 (11%)
Query: 96  EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECV 146
           E+P D    WE+   +L +   +  G++G +                 +VA+K+LK +  
Sbjct: 16  ELPEDPR--WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 73
Query: 147 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 205
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++   
Sbjct: 74  EKD-LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPG 132
Query: 206 -------------QLTS--LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
                        QL+S  L+  A  V++GM YL     IHRDL   N+L+ E+ V+K+A
Sbjct: 133 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 192
Query: 251 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 306
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ LWE+ T G  P
Sbjct: 193 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 252
Query: 307 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++
Sbjct: 253 YPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 310

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score =  138 bits (347), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 155/299 (51%), Gaps = 33/299 (11%)
Query: 96  EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECV 146
           E+P D    WE+   +L +   +  G++G +                 +VA+K+LK +  
Sbjct: 8   ELPEDPR--WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 65
Query: 147 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 205
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++   
Sbjct: 66  EKD-LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPG 124
Query: 206 -------------QLTS--LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
                        QL+S  L+  A  V++GM YL     IHRDL   N+L+ E+ V+K+A
Sbjct: 125 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 184
Query: 251 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 306
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ LWE+ T G  P
Sbjct: 185 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 244
Query: 307 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++
Sbjct: 245 YPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 302

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score =  137 bits (346), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 151/299 (50%), Gaps = 33/299 (11%)
Query: 96  EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECV 146
           E+P D    WE+   +L +   +  G++G +                 +VA+K+LK +  
Sbjct: 16  ELPEDPR--WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 73
Query: 147 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL------- 198
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L       
Sbjct: 74  EKD-LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPG 132
Query: 199 --------HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
                   H  +       L+  A  V++GM YL     IHRDL   N+L+ E+ V+K+A
Sbjct: 133 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 192
Query: 251 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 306
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ LWE+ T G  P
Sbjct: 193 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 252
Query: 307 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++
Sbjct: 253 YPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 310

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 83/245 (33%), Positives = 135/245 (55%), Gaps = 9/245 (3%)
Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           ++  GS+G++YKG   +  + VAIK++  E    E+     QE+ ++ +     + ++ G
Sbjct: 26  RIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDSPYITRYFG 84
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +  +   L I+ E++  GS  D L  + G  + T +  +  ++ KG++YLH    IHRD+
Sbjct: 85  SYLKSTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLHSERKIHRDI 142
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFSF 293
           K AN+L+ E G VK+ADFGVA     + +      GT  WMAPEVI+   YD+KAD++S 
Sbjct: 143 KAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFKADIWSL 202
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP-KHAHPRLAELLERCWQHDPTQRP 352
           GI   EL  GE P + L P++    ++ K+  PT+  +H+ P   E +E C   DP  RP
Sbjct: 203 GITAIELAKGEPPNSDLHPMRVLF-LIPKNSPPTLEGQHSKP-FKEFVEACLNKDPRFRP 260
Query: 353 NFSQI 357
              ++
Sbjct: 261 TAKEL 265

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 151/299 (50%), Gaps = 33/299 (11%)
Query: 96  EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE---------VAIKVLKPECV 146
           E+P D    WE    +L +   +  G++G +        +         VA+K+LK +  
Sbjct: 23  ELPEDPK--WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 80
Query: 147 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK--G 203
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++  G
Sbjct: 81  EKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 139
Query: 204 V-------------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
           +                  L+     +++GM YL     IHRDL   N+L+ EN V+K+A
Sbjct: 140 MEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 199
Query: 251 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 306
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ +WE+ T G  P
Sbjct: 200 DFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 307 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++
Sbjct: 260 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 151/299 (50%), Gaps = 33/299 (11%)
Query: 96  EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE---------VAIKVLKPECV 146
           E+P D    WE    +L +   +  G++G +        +         VA+K+LK +  
Sbjct: 23  ELPEDPK--WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 80
Query: 147 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK--G 203
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++  G
Sbjct: 81  EKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 139
Query: 204 V-------------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
           +                  L+     +++GM YL     IHRDL   N+L+ EN V+K+A
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 199
Query: 251 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 306
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ +WE+ T G  P
Sbjct: 200 DFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 307 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++
Sbjct: 260 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 87/271 (32%), Positives = 144/271 (53%), Gaps = 10/271 (3%)
Query: 91  SPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNT 148
           SP  +++P    ++ + +    K+E ++  GS+G+++KG      Q VAIK++  E    
Sbjct: 5   SPVAVQVPGMQNNIADPEELFTKLE-RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED 63
Query: 149 EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQL 207
           E+     QE+ ++ +     V ++ G+  +   L I+ E++  GS  D L       FQ+
Sbjct: 64  EIEDI-QQEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQI 122
Query: 208 TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-MTA 266
            ++LK   ++ KG++YLH    IHRD+K AN+L+ E G VK+ADFGVA     + +    
Sbjct: 123 ATMLK---EILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 179
Query: 267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP 326
             GT  WMAPEVI+   YD KAD++S GI   EL  GE P + + P++    ++ K+  P
Sbjct: 180 FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF-LIPKNNPP 238
Query: 327 TIPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
           T+         E ++ C   DP+ RP   ++
Sbjct: 239 TLVGDFTKSFKEFIDACLNKDPSFRPTAKEL 269

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 82/277 (29%), Positives = 147/277 (53%), Gaps = 16/277 (5%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
           E + K++K+   + SG++G +YKG +  +       VAIK+L  E    +   EF  E  
Sbjct: 37  ETELKRVKV---LGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEAL 92
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           IM  + H ++V+ +G C  P  + +VT+ M  G + +++H+ K       LL   + ++K
Sbjct: 93  IMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAK 151
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 276
           GM YL +  ++HRDL   N+L+     VK+ DFG+AR ++       A+ G    +WMA 
Sbjct: 152 GMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 211
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I ++ + +++DV+S+G+ +WEL+T G  PY G+ P +    +++K  R   P      
Sbjct: 212 ECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERLPQPPICTID 270
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWL 372
           +  ++ +CW  D   RP F ++     +M ++   +L
Sbjct: 271 VYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRYL 307

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 82/277 (29%), Positives = 147/277 (53%), Gaps = 16/277 (5%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
           E + K++K+   + SG++G +YKG +  +       VAIK+L  E    +   EF  E  
Sbjct: 14  ETELKRVKV---LGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEAL 69
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           IM  + H ++V+ +G C  P  + +VT+ M  G + +++H+ K       LL   + ++K
Sbjct: 70  IMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAK 128
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 276
           GM YL +  ++HRDL   N+L+     VK+ DFG+AR ++       A+ G    +WMA 
Sbjct: 129 GMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 188
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I ++ + +++DV+S+G+ +WEL+T G  PY G+ P +    +++K  R   P      
Sbjct: 189 ECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERLPQPPICTID 247
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWL 372
           +  ++ +CW  D   RP F ++     +M ++   +L
Sbjct: 248 VYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRYL 284

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 151/299 (50%), Gaps = 33/299 (11%)
Query: 96  EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE---------VAIKVLKPECV 146
           E+P D    WE    +L +   +  G++G +        +         VA+K+LK +  
Sbjct: 23  ELPEDPK--WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 80
Query: 147 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK--G 203
             E L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++  G
Sbjct: 81  E-EDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 139
Query: 204 V-------------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
           +                  L+     +++GM YL     IHRDL   N+L+ EN V+K+A
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 199
Query: 251 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 306
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ +WE+ T G  P
Sbjct: 200 DFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 307 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++
Sbjct: 260 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 151/299 (50%), Gaps = 33/299 (11%)
Query: 96  EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE---------VAIKVLKPECV 146
           E+P D    WE    +L +   +  G++G +        +         VA+K+LK +  
Sbjct: 23  ELPEDPK--WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 80
Query: 147 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK--G 203
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++  G
Sbjct: 81  EKD-LSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 139
Query: 204 V-------------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
           +                  L+     +++GM YL     IHRDL   N+L+ EN V+K+A
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 199
Query: 251 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 306
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ +WE+ T G  P
Sbjct: 200 DFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 307 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++
Sbjct: 260 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 151/299 (50%), Gaps = 33/299 (11%)
Query: 96  EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE---------VAIKVLKPECV 146
           E+P D    WE    +L +   +  G++G +        +         VA+K+LK +  
Sbjct: 23  ELPEDPK--WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 80
Query: 147 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK--G 203
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++  G
Sbjct: 81  EKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 139
Query: 204 V-------------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
           +                  L+     +++GM YL     IHRDL   N+L+ EN V+K+A
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 199
Query: 251 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 306
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ +WE+ T G  P
Sbjct: 200 DFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 307 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++
Sbjct: 260 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 151/299 (50%), Gaps = 33/299 (11%)
Query: 96  EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE---------VAIKVLKPECV 146
           E+P D    WE    +L +   +  G++G +        +         VA+K+LK +  
Sbjct: 23  ELPEDPK--WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 80
Query: 147 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK--G 203
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++  G
Sbjct: 81  EKD-LSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 139
Query: 204 V-------------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
           +                  L+     +++GM YL     IHRDL   N+L+ EN V+K+A
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 199
Query: 251 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 306
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ +WE+ T G  P
Sbjct: 200 DFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 307 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++
Sbjct: 260 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 150/299 (50%), Gaps = 33/299 (11%)
Query: 96  EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE---------VAIKVLKPECV 146
           E+P D    WE    +L +   +  G +G +        +         VA+K+LK +  
Sbjct: 12  ELPEDPK--WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 69
Query: 147 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK--G 203
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++  G
Sbjct: 70  EKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 128
Query: 204 V-------------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
           +                  L+     +++GM YL     IHRDL   N+L+ EN V+K+A
Sbjct: 129 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 188
Query: 251 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 306
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ +WE+ T G  P
Sbjct: 189 DFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 248
Query: 307 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++
Sbjct: 249 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 306

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 87/268 (32%), Positives = 146/268 (54%), Gaps = 10/268 (3%)
Query: 95  IEIPTDGTDVWEIDAKQL--KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEM 150
           +++ T+      +D ++L  K+E K+  GS+G+++KG      + VAIK++  E    E+
Sbjct: 11  VDLGTENLYFQSMDPEELFTKLE-KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI 69
Query: 151 LKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSL 210
                QE+ ++ +     V ++ G+  +   L I+ E++  GS  D L  + G    T +
Sbjct: 70  EDI-QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQI 126
Query: 211 LKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-MTAETG 269
             +  ++ KG++YLH    IHRD+K AN+L+ E+G VK+ADFGVA     + +      G
Sbjct: 127 ATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVG 186
Query: 270 TYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP 329
           T  WMAPEVI+   YD KAD++S GI   EL  GE P++ L P++    ++ K+  PT+ 
Sbjct: 187 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF-LIPKNNPPTLE 245
Query: 330 KHAHPRLAELLERCWQHDPTQRPNFSQI 357
            +    L E +E C   +P+ RP   ++
Sbjct: 246 GNYSKPLKEFVEACLNKEPSFRPTAKEL 273

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 151/299 (50%), Gaps = 33/299 (11%)
Query: 96  EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE---------VAIKVLKPECV 146
           E+P D    WE    +L +   +  G++G +        +         VA+K+LK +  
Sbjct: 23  ELPEDPK--WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 80
Query: 147 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK--G 203
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++  G
Sbjct: 81  EKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 139
Query: 204 V-------------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
           +                  L+     +++GM YL     IHRDL   N+L+ EN V+++A
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIA 199
Query: 251 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 306
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ +WE+ T G  P
Sbjct: 200 DFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 307 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++
Sbjct: 260 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 150/299 (50%), Gaps = 33/299 (11%)
Query: 96  EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE---------VAIKVLKPECV 146
           E+P D    WE    +L +   +  G +G +        +         VA+K+LK +  
Sbjct: 15  ELPEDPK--WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 72
Query: 147 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK--G 203
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++  G
Sbjct: 73  EKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 131
Query: 204 V-------------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
           +                  L+     +++GM YL     IHRDL   N+L+ EN V+K+A
Sbjct: 132 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 191
Query: 251 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 306
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ +WE+ T G  P
Sbjct: 192 DFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 251
Query: 307 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++
Sbjct: 252 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 309

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 150/299 (50%), Gaps = 33/299 (11%)
Query: 96  EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE---------VAIKVLKPECV 146
           E+P D    WE    +L +   +  G +G +        +         VA+K+LK +  
Sbjct: 10  ELPEDPK--WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 67
Query: 147 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK--G 203
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++  G
Sbjct: 68  EKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 126
Query: 204 V-------------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
           +                  L+     +++GM YL     IHRDL   N+L+ EN V+K+A
Sbjct: 127 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIA 186
Query: 251 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 306
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ +WE+ T G  P
Sbjct: 187 DFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 246
Query: 307 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++
Sbjct: 247 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 304

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 82/244 (33%), Positives = 133/244 (54%), Gaps = 7/244 (2%)
Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           K+  GS+G+++KG      + VAIK++  E    E+     QE+ ++ +     V ++ G
Sbjct: 14  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDSPYVTKYYG 72
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +  +   L I+ E++  GS  D L  + G    T +  +  ++ KG++YLH    IHRD+
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSEKKIHRDI 130
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFSF 293
           K AN+L+ E+G VK+ADFGVA     + +      GT  WMAPEVI+   YD KAD++S 
Sbjct: 131 KAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSL 190
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPN 353
           GI   EL  GE P++ L P++    ++ K+  PT+  +    L E +E C   +P+ RP 
Sbjct: 191 GITAIELARGEPPHSELHPMKVLF-LIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPT 249
Query: 354 FSQI 357
             ++
Sbjct: 250 AKEL 253

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 80/244 (32%), Positives = 134/244 (54%), Gaps = 7/244 (2%)
Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           K+  GS+G+++KG      + VAIK++       + +++  QE+ ++ +     V ++ G
Sbjct: 29  KIGKGSFGEVFKGIDNRTQKVVAIKIID-LEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +  +   L I+ E++  GS  D L  + G    T +  +  ++ KG++YLH    IHRD+
Sbjct: 88  SYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSEKKIHRDI 145
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFSF 293
           K AN+L+ E+G VK+ADFGVA     + +      GT  WMAPEVI+   YD KAD++S 
Sbjct: 146 KAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSL 205
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPN 353
           GI   EL  GE P++ L P++    ++ K+  PT+  +    L E +E C   +P+ RP 
Sbjct: 206 GITAIELARGEPPHSELHPMKVLF-LIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPT 264
Query: 354 FSQI 357
             ++
Sbjct: 265 AKEL 268

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 82/244 (33%), Positives = 133/244 (54%), Gaps = 7/244 (2%)
Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           K+  GS+G+++KG      + VAIK++  E    E+     QE+ ++ +     V ++ G
Sbjct: 14  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDSPYVTKYYG 72
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +  +   L I+ E++  GS  D L  + G    T +  +  ++ KG++YLH    IHRD+
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSEKKIHRDI 130
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGV-MTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K AN+L+ E+G VK+ADFGVA     + +      GT  WMAPEVI+   YD KAD++S 
Sbjct: 131 KAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSL 190
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPN 353
           GI   EL  GE P++ L P++    ++ K+  PT+  +    L E +E C   +P+ RP 
Sbjct: 191 GITAIELARGEPPHSELHPMKVLF-LIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPT 249
Query: 354 FSQI 357
             ++
Sbjct: 250 AKEL 253

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 148/295 (50%), Gaps = 26/295 (8%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFS 155
           D WE+  +++ +  ++  GS+G +Y+G             VAIK +       E + EF 
Sbjct: 3   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFL 61
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--------- 206
            E  +M++    +VV+ +G  ++     ++ E M RG +  +L   +   +         
Sbjct: 62  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 121
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMT 265
           L+ ++++A +++ GM YL+ N  +HRDL   N ++ E+  VK+ DFG+ R +        
Sbjct: 122 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRK 181
Query: 266 AETG--TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK 322
              G    RWM+PE ++   +   +DV+SFG+ LWE+ T  E PY GL+  Q    V++ 
Sbjct: 182 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 241
Query: 323 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM----KEVLYWLS 373
            L    P +    L EL+  CWQ++P  RP+F +I   +K+ M    +EV ++ S
Sbjct: 242 GLLDK-PDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYS 295

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 150/299 (50%), Gaps = 33/299 (11%)
Query: 96  EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE---------VAIKVLKPECV 146
           E+P D    WE    +L +   +  G +G +        +         VA+K+LK +  
Sbjct: 69  ELPEDPK--WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 126
Query: 147 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK--G 203
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++  G
Sbjct: 127 EKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 185
Query: 204 V-------------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
           +                  L+     +++GM YL     IHRDL   N+L+ EN V+K+A
Sbjct: 186 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 245
Query: 251 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 306
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ +WE+ T G  P
Sbjct: 246 DFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
Query: 307 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++
Sbjct: 306 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score =  135 bits (339), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 148/295 (50%), Gaps = 26/295 (8%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFS 155
           D WE+  +++ +  ++  GS+G +Y+G             VAIK +       E + EF 
Sbjct: 12  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFL 70
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--------- 206
            E  +M++    +VV+ +G  ++     ++ E M RG +  +L   +   +         
Sbjct: 71  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 130
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMT 265
           L+ ++++A +++ GM YL+ N  +HRDL   N ++ E+  VK+ DFG+ R +        
Sbjct: 131 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRK 190
Query: 266 AETG--TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK 322
              G    RWM+PE ++   +   +DV+SFG+ LWE+ T  E PY GL+  Q    V++ 
Sbjct: 191 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 250
Query: 323 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM----KEVLYWLS 373
            L    P +    L EL+  CWQ++P  RP+F +I   +K+ M    +EV ++ S
Sbjct: 251 GLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYS 304

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score =  134 bits (337), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 95/328 (28%), Positives = 157/328 (47%), Gaps = 30/328 (9%)
Query: 84  SKLLIESSPN-CIEIPTDG-TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ------- 134
           S ++ + +PN C    T   +D+ E+  K + +   +  G++G++Y+G            
Sbjct: 43  STIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPL 102
Query: 135 EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 194
           +VA+K L   C   + L +F  E  I+ K  H+N+V+ IG   +     I+ E MA G +
Sbjct: 103 QVAVKTLPEVCSEQDEL-DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDL 161
Query: 195 YDFLHK------QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG--- 245
             FL +      Q     +  LL VA D++ G  YL +N+ IHRD+   N L+   G   
Sbjct: 162 KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 221
Query: 246 VVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT 302
           V K+ DFG+AR   ++G            +WM PE      +  K D +SFG+ LWE+ +
Sbjct: 222 VAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
Query: 303 -GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDIL 361
            G +PY   +  Q  +  V    R   PK+    +  ++ +CWQH P  RPNF+ I + +
Sbjct: 282 LGYMPYPSKS-NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 340
Query: 362 KQMMKEVLYWLSPNLINTNIQSTYKHLL 389
           +   ++      P++INT +   Y  L+
Sbjct: 341 EYCTQD------PDVINTALPIEYGPLV 362

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  134 bits (337), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 150/299 (50%), Gaps = 33/299 (11%)
Query: 96  EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE---------VAIKVLKPECV 146
           E+P D    WE    +L +   +  G++G +        +         VA+K+LK +  
Sbjct: 23  ELPEDPK--WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 80
Query: 147 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK--G 203
             + L +   E+ +M+ I +HKN++  +GACT+   L ++  + ++G++ ++L  ++  G
Sbjct: 81  EKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPG 139
Query: 204 V-------------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
           +                  L+     +++GM YL     IHRDL   N+L+ EN V+K+A
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 199
Query: 251 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 306
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ +WE+ T G  P
Sbjct: 200 DFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 307 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++
Sbjct: 260 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score =  134 bits (337), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 95/328 (28%), Positives = 157/328 (47%), Gaps = 30/328 (9%)
Query: 84  SKLLIESSPN-CIEIPTDG-TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ------- 134
           S ++ + +PN C    T   +D+ E+  K + +   +  G++G++Y+G            
Sbjct: 20  STIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPL 79
Query: 135 EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 194
           +VA+K L   C   + L +F  E  I+ K  H+N+V+ IG   +     I+ E MA G +
Sbjct: 80  QVAVKTLPEVCSEQDEL-DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDL 138
Query: 195 YDFLHK------QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG--- 245
             FL +      Q     +  LL VA D++ G  YL +N+ IHRD+   N L+   G   
Sbjct: 139 KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 198
Query: 246 VVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT 302
           V K+ DFG+AR   ++G            +WM PE      +  K D +SFG+ LWE+ +
Sbjct: 199 VAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258
Query: 303 -GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDIL 361
            G +PY   +  Q  +  V    R   PK+    +  ++ +CWQH P  RPNF+ I + +
Sbjct: 259 LGYMPYPSKS-NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 317
Query: 362 KQMMKEVLYWLSPNLINTNIQSTYKHLL 389
           +   ++      P++INT +   Y  L+
Sbjct: 318 EYCTQD------PDVINTALPIEYGPLV 339

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score =  134 bits (337), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 97/334 (29%), Positives = 159/334 (47%), Gaps = 31/334 (9%)
Query: 79  GVPMHSKLLIE-SSPN-CIEIPTDG-TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ- 134
           G+P    L  + S+PN C    T   +D+ E+  K + +   +  G++G++Y+G      
Sbjct: 11  GIPTTENLYFQGSNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMP 70
Query: 135 ------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188
                 +VA+K L   C   + L +F  E  I+ K+ H+N+V+ IG   +     I+ E 
Sbjct: 71  NDPSPLQVAVKTLPEVCSEQDEL-DFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLEL 129
Query: 189 MARGSIYDFLHK------QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD 242
           MA G +  FL +      Q     +  LL VA D++ G  YL +N+ IHRD+   N L+ 
Sbjct: 130 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLT 189
Query: 243 ENG---VVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVIEHKPYDYKADVFSFGIA 296
             G   V K+ DFG+AR   ++             +WM PE      +  K D +SFG+ 
Sbjct: 190 CPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 249
Query: 297 LWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFS 355
           LWE+ + G +PY   +  Q  +  V    R   PK+    +  ++ +CWQH P  RPNF+
Sbjct: 250 LWEIFSLGYMPYPSKS-NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA 308
Query: 356 QITDILKQMMKEVLYWLSPNLINTNIQSTYKHLL 389
            I + ++   ++      P++INT +   Y  L+
Sbjct: 309 IILERIEYCTQD------PDVINTALPIEYGPLV 336

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 85/278 (30%), Positives = 143/278 (51%), Gaps = 27/278 (9%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCS---QEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           W I+    +++  + SG+   + +  YC+   ++VAIK +  E   T M  E  +E+  M
Sbjct: 10  WSINRDDYELQEVIGSGATA-VVQAAYCAPKKEKVAIKRINLEKCQTSM-DELLKEIQAM 67
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL-------HKQKGVFQLTSLLKVA 214
            +  H N+V +  +      L +V + ++ GS+ D +         + GV   +++  + 
Sbjct: 68  SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127
Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE------T 268
            +V +G+ YLH+N  IHRD+K  N+L+ E+G V++ADFGV+   A  G +T         
Sbjct: 128 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 269 GTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK---SL 324
           GT  WMAPEV+E  + YD+KAD++SFGI   EL TG  PY    P++  +  +Q    SL
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 247
Query: 325 RPTIP-----KHAHPRLAELLERCWQHDPTQRPNFSQI 357
              +      K       +++  C Q DP +RP  +++
Sbjct: 248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAEL 285

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 85/278 (30%), Positives = 143/278 (51%), Gaps = 27/278 (9%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCS---QEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           W I+    +++  + SG+   + +  YC+   ++VAIK +  E   T M  E  +E+  M
Sbjct: 5   WSINRDDYELQEVIGSGATA-VVQAAYCAPKKEKVAIKRINLEKCQTSM-DELLKEIQAM 62
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL-------HKQKGVFQLTSLLKVA 214
            +  H N+V +  +      L +V + ++ GS+ D +         + GV   +++  + 
Sbjct: 63  SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 122
Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE------T 268
            +V +G+ YLH+N  IHRD+K  N+L+ E+G V++ADFGV+   A  G +T         
Sbjct: 123 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 182
Query: 269 GTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK---SL 324
           GT  WMAPEV+E  + YD+KAD++SFGI   EL TG  PY    P++  +  +Q    SL
Sbjct: 183 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 242
Query: 325 RPTIP-----KHAHPRLAELLERCWQHDPTQRPNFSQI 357
              +      K       +++  C Q DP +RP  +++
Sbjct: 243 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAEL 280

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 150/299 (50%), Gaps = 33/299 (11%)
Query: 96  EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE---------VAIKVLKPECV 146
           E+P D    WE    +L +   +  G++G +        +         VA+K+LK +  
Sbjct: 23  ELPEDPK--WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 80
Query: 147 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK--G 203
             + L +   E+ +M+ I +HKN++  +GACT+   L ++  + ++G++ ++L  ++  G
Sbjct: 81  EKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPG 139
Query: 204 V-------------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
           +                  L+     +++GM YL     IHRDL   N+L+ EN V+K+A
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 199
Query: 251 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 306
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ +WE+ T G  P
Sbjct: 200 DFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 307 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++
Sbjct: 260 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 150/300 (50%), Gaps = 36/300 (12%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFS 155
           D WE+  +++ +  ++  GS+G +Y+G             VAIK +       E + EF 
Sbjct: 12  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFL 70
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--------- 206
            E  +M++    +VV+ +G  ++     ++ E M RG +  +L   +   +         
Sbjct: 71  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 130
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--------VQ 258
           L+ ++++A +++ GM YL+ N  +HRDL   N ++ E+  VK+ DFG+ R         +
Sbjct: 131 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 190
Query: 259 AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 317
              G++       RWM+PE ++   +   +DV+SFG+ LWE+ T  E PY GL+  Q   
Sbjct: 191 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 245
Query: 318 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM----KEVLYWLS 373
            V++  L    P +    L EL+  CWQ++P  RP+F +I   +K+ M    +EV ++ S
Sbjct: 246 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYS 304

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 149/300 (49%), Gaps = 36/300 (12%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFS 155
           D WE+  +++ +  ++  GS+G +Y+G             VAIK +       E + EF 
Sbjct: 8   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFL 66
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF---------Q 206
            E  +M++    +VV+ +G  ++     ++ E M RG +  +L   +             
Sbjct: 67  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 126
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--------VQ 258
           L+ ++++A +++ GM YL+ N  +HRDL   N ++ E+  VK+ DFG+ R         +
Sbjct: 127 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 186
Query: 259 AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 317
              G++       RWM+PE ++   +   +DV+SFG+ LWE+ T  E PY GL+  Q   
Sbjct: 187 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 241
Query: 318 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM----KEVLYWLS 373
            V++  L    P +    L EL+  CWQ++P  RP+F +I   +K+ M    +EV ++ S
Sbjct: 242 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYS 300

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 150/300 (50%), Gaps = 36/300 (12%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFS 155
           D WE+  +++ +  ++  GS+G +Y+G             VAIK +       E + EF 
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFL 69
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--------- 206
            E  +M++    +VV+ +G  ++     ++ E M RG +  +L   +   +         
Sbjct: 70  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 129
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--------VQ 258
           L+ ++++A +++ GM YL+ N  +HRDL   N ++ E+  VK+ DFG+ R         +
Sbjct: 130 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 189
Query: 259 AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 317
              G++       RWM+PE ++   +   +DV+SFG+ LWE+ T  E PY GL+  Q   
Sbjct: 190 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 244
Query: 318 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM----KEVLYWLS 373
            V++  L    P +    L EL+  CWQ++P  RP+F +I   +K+ M    +EV ++ S
Sbjct: 245 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYS 303

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 149/300 (49%), Gaps = 36/300 (12%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFS 155
           D WE+  +++ +  ++  GS+G +Y+G             VAIK +  E  +     EF 
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFL 76
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF---------Q 206
            E  +M++    +VV+ +G  ++     ++ E M RG +  +L   +             
Sbjct: 77  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--------VQ 258
           L+ ++++A +++ GM YL+ N  +HRDL   N ++ E+  VK+ DFG+ R         +
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196
Query: 259 AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 317
              G++       RWM+PE ++   +   +DV+SFG+ LWE+ T  E PY GL+  Q   
Sbjct: 197 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251
Query: 318 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM----KEVLYWLS 373
            V++  L    P +    L EL+  CWQ++P  RP+F +I   +K+ M    +EV ++ S
Sbjct: 252 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYS 310

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 150/300 (50%), Gaps = 36/300 (12%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFS 155
           D WE+  +++ +  ++  GS+G +Y+G             VAIK +       E + EF 
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFL 63
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--------- 206
            E  +M++    +VV+ +G  ++     ++ E M RG +  +L   +   +         
Sbjct: 64  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 123
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--------VQ 258
           L+ ++++A +++ GM YL+ N  +HRDL   N ++ E+  VK+ DFG+ R         +
Sbjct: 124 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 183
Query: 259 AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 317
              G++       RWM+PE ++   +   +DV+SFG+ LWE+ T  E PY GL+  Q   
Sbjct: 184 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 238
Query: 318 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM----KEVLYWLS 373
            V++  L    P +    L EL+  CWQ++P  RP+F +I   +K+ M    +EV ++ S
Sbjct: 239 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYS 297

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 150/300 (50%), Gaps = 36/300 (12%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFS 155
           D WE+  +++ +  ++  GS+G +Y+G             VAIK +       E + EF 
Sbjct: 9   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFL 67
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--------- 206
            E  +M++    +VV+ +G  ++     ++ E M RG +  +L   +   +         
Sbjct: 68  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 127
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--------VQ 258
           L+ ++++A +++ GM YL+ N  +HRDL   N ++ E+  VK+ DFG+ R         +
Sbjct: 128 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 187
Query: 259 AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 317
              G++       RWM+PE ++   +   +DV+SFG+ LWE+ T  E PY GL+  Q   
Sbjct: 188 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 242
Query: 318 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM----KEVLYWLS 373
            V++  L    P +    L EL+  CWQ++P  RP+F +I   +K+ M    +EV ++ S
Sbjct: 243 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYS 301

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 150/300 (50%), Gaps = 36/300 (12%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFS 155
           D WE+  +++ +  ++  GS+G +Y+G             VAIK +       E + EF 
Sbjct: 40  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFL 98
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--------- 206
            E  +M++    +VV+ +G  ++     ++ E M RG +  +L   +   +         
Sbjct: 99  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 158
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--------VQ 258
           L+ ++++A +++ GM YL+ N  +HRDL   N ++ E+  VK+ DFG+ R         +
Sbjct: 159 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 218
Query: 259 AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 317
              G++       RWM+PE ++   +   +DV+SFG+ LWE+ T  E PY GL+  Q   
Sbjct: 219 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 273
Query: 318 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM----KEVLYWLS 373
            V++  L    P +    L EL+  CWQ++P  RP+F +I   +K+ M    +EV ++ S
Sbjct: 274 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYS 332

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 150/300 (50%), Gaps = 36/300 (12%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFS 155
           D WE+  +++ +  ++  GS+G +Y+G             VAIK +  E  +     EF 
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFL 76
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--------- 206
            E  +M++    +VV+ +G  ++     ++ E M RG +  +L   +   +         
Sbjct: 77  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 136
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--------VQ 258
           L+ ++++A +++ GM YL+ N  +HRDL   N ++ E+  VK+ DFG+ R         +
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196
Query: 259 AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 317
              G++       RWM+PE ++   +   +DV+SFG+ LWE+ T  E PY GL+  Q   
Sbjct: 197 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251
Query: 318 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM----KEVLYWLS 373
            V++  L    P +    L EL+  CWQ++P  RP+F +I   +K+ M    +EV ++ S
Sbjct: 252 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYS 310

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 150/300 (50%), Gaps = 36/300 (12%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFS 155
           D WE+  +++ +  ++  GS+G +Y+G             VAIK +       E + EF 
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFL 69
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--------- 206
            E  +M++    +VV+ +G  ++     ++ E M RG +  +L   +   +         
Sbjct: 70  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 129
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--------VQ 258
           L+ ++++A +++ GM YL+ N  +HRDL   N ++ E+  VK+ DFG+ R         +
Sbjct: 130 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 189
Query: 259 AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 317
              G++       RWM+PE ++   +   +DV+SFG+ LWE+ T  E PY GL+  Q   
Sbjct: 190 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 244
Query: 318 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM----KEVLYWLS 373
            V++  L    P +    L EL+  CWQ++P  RP+F +I   +K+ M    +EV ++ S
Sbjct: 245 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYS 303

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 97/334 (29%), Positives = 158/334 (47%), Gaps = 31/334 (9%)
Query: 79  GVPMHSKLLIE-SSPN-CIEIPTDG-TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ- 134
           G+P    L  + S+PN C    T   +D+ E+  K + +   +  G++G++Y+G      
Sbjct: 11  GIPTTENLYFQGSNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMP 70
Query: 135 ------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188
                 +VA+K L   C   + L +F  E  I+ K  H+N+V+ IG   +     I+ E 
Sbjct: 71  NDPSPLQVAVKTLPEVCSEQDEL-DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMEL 129
Query: 189 MARGSIYDFLHK------QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD 242
           MA G +  FL +      Q     +  LL VA D++ G  YL +N+ IHRD+   N L+ 
Sbjct: 130 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLT 189
Query: 243 ENG---VVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVIEHKPYDYKADVFSFGIA 296
             G   V K+ DFG+AR   ++             +WM PE      +  K D +SFG+ 
Sbjct: 190 CPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 249
Query: 297 LWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFS 355
           LWE+ + G +PY   +  Q  +  V    R   PK+    +  ++ +CWQH P  RPNF+
Sbjct: 250 LWEIFSLGYMPYPSKS-NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA 308
Query: 356 QITDILKQMMKEVLYWLSPNLINTNIQSTYKHLL 389
            I + ++   ++      P++INT +   Y  L+
Sbjct: 309 IILERIEYCTQD------PDVINTALPIEYGPLV 336

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 135/262 (51%), Gaps = 14/262 (5%)
Query: 118 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 172
           +  G +G++Y+G Y + +     VA+K  K +C   +  ++F  E  IM+ + H ++V+ 
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 232
           IG     P   I+ E    G +  +L + K   ++ +L+  ++ + K M YL   N +HR
Sbjct: 75  IGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHR 133
Query: 233 DLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIEHKPYDYKADV 290
           D+   N+L+     VK+ DFG++R         A       +WM+PE I  + +   +DV
Sbjct: 134 DIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDV 193
Query: 291 FSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPT 349
           + F + +WE+L+ G+ P+  L   +  +GV++K  R   P    P L  L+ RCW +DP+
Sbjct: 194 WMFAVCMWEILSFGKQPFFWLEN-KDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPS 252
Query: 350 QRPNFSQITDILK---QMMKEV 368
            RP F+++   L    QM K++
Sbjct: 253 DRPRFTELVCSLSDVYQMEKDI 274

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 144/272 (52%), Gaps = 16/272 (5%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 14  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 69
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           +M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++K
Sbjct: 70  VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 276
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 247
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 248 VYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 135/262 (51%), Gaps = 14/262 (5%)
Query: 118 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 172
           +  G +G++Y+G Y + +     VA+K  K +C   +  ++F  E  IM+ + H ++V+ 
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 232
           IG     P   I+ E    G +  +L + K   ++ +L+  ++ + K M YL   N +HR
Sbjct: 79  IGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHR 137
Query: 233 DLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIEHKPYDYKADV 290
           D+   N+L+     VK+ DFG++R         A       +WM+PE I  + +   +DV
Sbjct: 138 DIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDV 197
Query: 291 FSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPT 349
           + F + +WE+L+ G+ P+  L   +  +GV++K  R   P    P L  L+ RCW +DP+
Sbjct: 198 WMFAVCMWEILSFGKQPFFWLEN-KDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPS 256
Query: 350 QRPNFSQITDILK---QMMKEV 368
            RP F+++   L    QM K++
Sbjct: 257 DRPRFTELVCSLSDVYQMEKDI 278

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 135/262 (51%), Gaps = 14/262 (5%)
Query: 118 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 172
           +  G +G++Y+G Y + +     VA+K  K +C   +  ++F  E  IM+ + H ++V+ 
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 232
           IG     P   I+ E    G +  +L + K   ++ +L+  ++ + K M YL   N +HR
Sbjct: 91  IGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHR 149
Query: 233 DLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIEHKPYDYKADV 290
           D+   N+L+     VK+ DFG++R         A       +WM+PE I  + +   +DV
Sbjct: 150 DIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDV 209
Query: 291 FSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPT 349
           + F + +WE+L+ G+ P+  L   +  +GV++K  R   P    P L  L+ RCW +DP+
Sbjct: 210 WMFAVCMWEILSFGKQPFFWLEN-KDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPS 268
Query: 350 QRPNFSQITDILK---QMMKEV 368
            RP F+++   L    QM K++
Sbjct: 269 DRPRFTELVCSLSDVYQMEKDI 290

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 144/272 (52%), Gaps = 16/272 (5%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 17  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 72
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           +M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++K
Sbjct: 73  VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 131
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 276
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 132 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 192 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 250
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 251 VYMIMRKCWMIDADSRPKFRELIIEFSKMARD 282

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 144/272 (52%), Gaps = 16/272 (5%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 24  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 79
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           +M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++K
Sbjct: 80  VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 138
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 276
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 139 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 198
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 199 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 257
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 258 VYMIMRKCWMIDADSRPKFRELIIEFSKMARD 289

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 97/334 (29%), Positives = 159/334 (47%), Gaps = 31/334 (9%)
Query: 79  GVPMHSKLLIE-SSPN-CIEIPTDG-TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ- 134
           G+P    L  + S+PN C    T   +D+ E+  K + +   +  G++G++Y+G      
Sbjct: 11  GIPTTENLYFQGSNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMP 70
Query: 135 ------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188
                 +VA+K L PE  + +   +F  E  I+ K  H+N+V+ IG   +     I+ E 
Sbjct: 71  NDPSPLQVAVKTL-PEVYSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLEL 129
Query: 189 MARGSIYDFLHK------QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD 242
           MA G +  FL +      Q     +  LL VA D++ G  YL +N+ IHRD+   N L+ 
Sbjct: 130 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLT 189
Query: 243 ENG---VVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVIEHKPYDYKADVFSFGIA 296
             G   V K+ DFG+AR   ++             +WM PE      +  K D +SFG+ 
Sbjct: 190 CPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 249
Query: 297 LWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFS 355
           LWE+ + G +PY   +  Q  +  V    R   PK+    +  ++ +CWQH P  RPNF+
Sbjct: 250 LWEIFSLGYMPYPSKS-NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA 308
Query: 356 QITDILKQMMKEVLYWLSPNLINTNIQSTYKHLL 389
            I + ++   ++      P++INT +   Y  L+
Sbjct: 309 IILERIEYCTQD------PDVINTALPIEYGPLV 336

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 149/300 (49%), Gaps = 36/300 (12%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFS 155
           D WE+  +++ +  ++  GS+G +Y+G             VAIK +       E + EF 
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFL 63
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--------- 206
            E  +M++    +VV+ +G  ++     ++ E M RG +  +L   +   +         
Sbjct: 64  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 123
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--------VQ 258
           L+ ++++A +++ GM YL+ N  +HRDL   N  + E+  VK+ DFG+ R         +
Sbjct: 124 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRK 183
Query: 259 AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 317
              G++       RWM+PE ++   +   +DV+SFG+ LWE+ T  E PY GL+  Q   
Sbjct: 184 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 238
Query: 318 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM----KEVLYWLS 373
            V++  L    P +    L EL+  CWQ++P  RP+F +I   +K+ M    +EV ++ S
Sbjct: 239 FVMEGGLLDK-PDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYS 297

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 145/272 (53%), Gaps = 16/272 (5%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
           E + K++K+   ++SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 14  ETEFKKIKV---LSSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 69
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           +M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++K
Sbjct: 70  VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 276
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 247
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 248 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 145/272 (53%), Gaps = 16/272 (5%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
           E + K++K+   ++SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 21  ETEFKKIKV---LSSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 76
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           +M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++K
Sbjct: 77  VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 135
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 276
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 136 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 196 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 254
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 255 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 286

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 144/272 (52%), Gaps = 16/272 (5%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 8   ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 63
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           +M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++K
Sbjct: 64  VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 122
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 276
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 123 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 241
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 242 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score =  132 bits (332), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 144/272 (52%), Gaps = 16/272 (5%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 14  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 69
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           +M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++K
Sbjct: 70  VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 276
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 247
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 248 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score =  132 bits (332), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 144/272 (52%), Gaps = 16/272 (5%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 17  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 72
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           +M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++K
Sbjct: 73  VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 131
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 276
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 132 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 192 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 250
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 251 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 282

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score =  132 bits (332), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 144/272 (52%), Gaps = 16/272 (5%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 14  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 69
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           +M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++K
Sbjct: 70  VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 276
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 247
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 248 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score =  132 bits (332), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 144/272 (52%), Gaps = 16/272 (5%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 39  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 94
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           +M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++K
Sbjct: 95  VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 153
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 276
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 154 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 213
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 214 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 272
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 273 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 304

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score =  132 bits (332), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 144/272 (52%), Gaps = 16/272 (5%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 21  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 76
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           +M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++K
Sbjct: 77  VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 135
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 276
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 136 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 196 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 254
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 255 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 286

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score =  132 bits (332), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 144/272 (52%), Gaps = 16/272 (5%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 20  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 75
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           +M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++K
Sbjct: 76  VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 134
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 276
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 135 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 194
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 195 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 253
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 254 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 285

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 144/272 (52%), Gaps = 16/272 (5%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 16  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 71
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           +M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++K
Sbjct: 72  VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 130
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 276
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 131 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 249
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 250 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 281

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 144/272 (52%), Gaps = 16/272 (5%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 17  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 72
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           +M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++K
Sbjct: 73  VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 131
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 276
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 132 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 192 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 250
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 251 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 282

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 145/277 (52%), Gaps = 16/277 (5%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 16  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 71
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           +M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++K
Sbjct: 72  VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 130
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 276
           GMNYL    ++HRDL   N+L+     VK+ DFG A+ + A+     AE G    +WMA 
Sbjct: 131 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 249
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWL 372
           +  ++ +CW  D   RP F ++     +M ++   +L
Sbjct: 250 VYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYL 286

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score =  131 bits (330), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 94/328 (28%), Positives = 156/328 (47%), Gaps = 30/328 (9%)
Query: 84  SKLLIESSPN-CIEIPTDG-TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ------- 134
           S ++ + +PN C    T   +D+ E+  K + +   +  G++G++Y+G            
Sbjct: 19  STIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPL 78
Query: 135 EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 194
           +VA+K L   C   + L +F  E  I+ K  H+N+V+ IG   +     I+ E MA G +
Sbjct: 79  QVAVKTLPEVCSEQDEL-DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDL 137
Query: 195 YDFLHK------QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG--- 245
             FL +      Q     +  LL VA D++ G  YL +N+ IHRD+   N L+   G   
Sbjct: 138 KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 197
Query: 246 VVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT 302
           V K+ DFG+AR   ++             +WM PE      +  K D +SFG+ LWE+ +
Sbjct: 198 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257
Query: 303 -GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDIL 361
            G +PY   +  Q  +  V    R   PK+    +  ++ +CWQH P  RPNF+ I + +
Sbjct: 258 LGYMPYPSKS-NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 316
Query: 362 KQMMKEVLYWLSPNLINTNIQSTYKHLL 389
           +   ++      P++INT +   Y  L+
Sbjct: 317 EYCTQD------PDVINTALPIEYGPLV 338

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score =  131 bits (330), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 147/295 (49%), Gaps = 36/295 (12%)
Query: 105 WEIDAKQLKIECKVASGSYGDL-------YKGTYCSQEVAIKVLKPECVNTEMLKEFSQE 157
           WE   K L +   +  G +G +        KG      VA+K+LK     +E L++   E
Sbjct: 18  WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE-LRDLLSE 76
Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV------------- 204
             +++++ H +V++  GAC++   L ++ E+   GS+  FL + + V             
Sbjct: 77  FNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNS 136
Query: 205 ----------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 254
                       +  L+  A  +S+GM YL + +++HRDL   N+L+ E   +K++DFG+
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 255 AR-VQAQSGVMTAETGT--YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGL 310
           +R V  +   +    G    +WMA E +    Y  ++DV+SFG+ LWE++T G  PY G+
Sbjct: 197 SRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256
Query: 311 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
            P +    +++   R   P +    +  L+ +CW+ +P +RP F+ I+  L++MM
Sbjct: 257 PP-ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score =  131 bits (329), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 89/308 (28%), Positives = 148/308 (48%), Gaps = 28/308 (9%)
Query: 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEF 154
           +D+ E+  K + +   +  G++G++Y+G            +VA+K L   C   + L +F
Sbjct: 23  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DF 81
Query: 155 SQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK------QKGVFQLT 208
             E  I+ K+ H+N+V+ IG   +     I+ E MA G +  FL +      Q     + 
Sbjct: 82  LMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 141
Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADFGVARVQAQSGVMT 265
            LL VA D++ G  YL +N+ IHRD+   N L+   G   V K+ DFG+AR   ++    
Sbjct: 142 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 201
Query: 266 AETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQ 321
                    +WM PE      +  K D +SFG+ LWE+ + G +PY   +  Q  +  V 
Sbjct: 202 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEVLEFVT 260
Query: 322 KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINTNI 381
              R   PK+    +  ++ +CWQH P  RPNF+ I + ++   ++      P++INT +
Sbjct: 261 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD------PDVINTAL 314
Query: 382 QSTYKHLL 389
              Y  L+
Sbjct: 315 PIEYGPLV 322

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score =  131 bits (329), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 139/284 (48%), Gaps = 22/284 (7%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQE 157
           WE     L+    + +G++G + + T           +VA+K+LK    + +  +    E
Sbjct: 33  WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-STAHADEKEALMSE 91
Query: 158 VYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV---------FQL 207
           + IM  + +H+N+V  +GACT    + ++TE+   G + +FL ++             +L
Sbjct: 92  LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLEL 151
Query: 208 TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTA 266
             LL  +  V++GM +L   N IHRD+   N+L+    V K+ DFG+AR +   S  +  
Sbjct: 152 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 211
Query: 267 ETGTY--RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKS 323
                  +WMAPE I    Y  ++DV+S+GI LWE+ + G  PY G+        +V+  
Sbjct: 212 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG 271
Query: 324 LRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
            +   P  A   +  +++ CW  +PT RP F QI   L++  +E
Sbjct: 272 YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 315

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score =  131 bits (329), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 146/295 (49%), Gaps = 36/295 (12%)
Query: 105 WEIDAKQLKIECKVASGSYGDL-------YKGTYCSQEVAIKVLKPECVNTEMLKEFSQE 157
           WE   K L +   +  G +G +        KG      VA+K+LK     +E L++   E
Sbjct: 18  WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE-LRDLLSE 76
Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV------------- 204
             +++++ H +V++  GAC++   L ++ E+   GS+  FL + + V             
Sbjct: 77  FNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNS 136
Query: 205 ----------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 254
                       +  L+  A  +S+GM YL +  ++HRDL   N+L+ E   +K++DFG+
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 255 AR-VQAQSGVMTAETGT--YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGL 310
           +R V  +   +    G    +WMA E +    Y  ++DV+SFG+ LWE++T G  PY G+
Sbjct: 197 SRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256
Query: 311 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
            P +    +++   R   P +    +  L+ +CW+ +P +RP F+ I+  L++MM
Sbjct: 257 PP-ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score =  131 bits (329), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 147/295 (49%), Gaps = 36/295 (12%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQE-------VAIKVLKPECVNTEMLKEFSQE 157
           WE   K L +   +  G +G + K T    +       VA+K+LK     +E L++   E
Sbjct: 18  WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE-LRDLLSE 76
Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV------------- 204
             +++++ H +V++  GAC++   L ++ E+   GS+  FL + + V             
Sbjct: 77  FNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNS 136
Query: 205 ----------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 254
                       +  L+  A  +S+GM YL +  ++HRDL   N+L+ E   +K++DFG+
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 255 AR-VQAQSGVMTAETGT--YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGL 310
           +R V  +   +    G    +WMA E +    Y  ++DV+SFG+ LWE++T G  PY G+
Sbjct: 197 SRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256
Query: 311 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
            P +    +++   R   P +    +  L+ +CW+ +P +RP F+ I+  L++MM
Sbjct: 257 PP-ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score =  131 bits (329), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 89/308 (28%), Positives = 147/308 (47%), Gaps = 28/308 (9%)
Query: 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEF 154
           +D+ E+  K + +   +  G++G++Y+G            +VA+K L   C   + L +F
Sbjct: 22  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DF 80
Query: 155 SQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK------QKGVFQLT 208
             E  I+ K  H+N+V+ IG   +     I+ E MA G +  FL +      Q     + 
Sbjct: 81  LMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAML 140
Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADFGVARVQAQSGVMT 265
            LL VA D++ G  YL +N+ IHRD+   N L+   G   V K+ DFG+AR   ++    
Sbjct: 141 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 200
Query: 266 AETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQ 321
                    +WM PE      +  K D +SFG+ LWE+ + G +PY   +  Q  +  V 
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEVLEFVT 259
Query: 322 KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINTNI 381
              R   PK+    +  ++ +CWQH P  RPNF+ I + ++   ++      P++INT +
Sbjct: 260 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD------PDVINTAL 313
Query: 382 QSTYKHLL 389
              Y  L+
Sbjct: 314 PIEYGPLV 321

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score =  131 bits (329), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 89/308 (28%), Positives = 147/308 (47%), Gaps = 28/308 (9%)
Query: 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEF 154
           +D+ E+  K + +   +  G++G++Y+G            +VA+K L   C   + L +F
Sbjct: 14  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DF 72
Query: 155 SQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK------QKGVFQLT 208
             E  I+ K  H+N+V+ IG   +     I+ E MA G +  FL +      Q     + 
Sbjct: 73  LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 132
Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADFGVARVQAQSGVMT 265
            LL VA D++ G  YL +N+ IHRD+   N L+   G   V K+ DFG+AR   ++    
Sbjct: 133 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 192
Query: 266 AETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQ 321
                    +WM PE      +  K D +SFG+ LWE+ + G +PY   +  Q  +  V 
Sbjct: 193 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEVLEFVT 251
Query: 322 KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINTNI 381
              R   PK+    +  ++ +CWQH P  RPNF+ I + ++   ++      P++INT +
Sbjct: 252 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD------PDVINTAL 305
Query: 382 QSTYKHLL 389
              Y  L+
Sbjct: 306 PIEYGPLV 313

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score =  130 bits (328), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 89/308 (28%), Positives = 147/308 (47%), Gaps = 28/308 (9%)
Query: 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEF 154
           +D+ E+  K + +   +  G++G++Y+G            +VA+K L   C   + L +F
Sbjct: 22  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DF 80
Query: 155 SQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK------QKGVFQLT 208
             E  I+ K  H+N+V+ IG   +     I+ E MA G +  FL +      Q     + 
Sbjct: 81  LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 140
Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADFGVARVQAQSGVMT 265
            LL VA D++ G  YL +N+ IHRD+   N L+   G   V K+ DFG+AR   ++    
Sbjct: 141 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 200
Query: 266 AETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQ 321
                    +WM PE      +  K D +SFG+ LWE+ + G +PY   +  Q  +  V 
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEVLEFVT 259
Query: 322 KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINTNI 381
              R   PK+    +  ++ +CWQH P  RPNF+ I + ++   ++      P++INT +
Sbjct: 260 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD------PDVINTAL 313
Query: 382 QSTYKHLL 389
              Y  L+
Sbjct: 314 PIEYGPLV 321

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score =  130 bits (328), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 143/272 (52%), Gaps = 16/272 (5%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 14  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 69
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           +M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++K
Sbjct: 70  VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 276
           GMNYL    ++HRDL   N+L+     VK+ DFG A+ + A+     AE G    +WMA 
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 247
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 248 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score =  130 bits (328), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 139/284 (48%), Gaps = 22/284 (7%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQE 157
           WE     L+    + +G++G + + T           +VA+K+LK    + +  +    E
Sbjct: 41  WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-STAHADEKEALMSE 99
Query: 158 VYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV---------FQL 207
           + IM  + +H+N+V  +GACT    + ++TE+   G + +FL ++             +L
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLEL 159
Query: 208 TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTA 266
             LL  +  V++GM +L   N IHRD+   N+L+    V K+ DFG+AR +   S  +  
Sbjct: 160 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 219
Query: 267 ETGTY--RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKS 323
                  +WMAPE I    Y  ++DV+S+GI LWE+ + G  PY G+        +V+  
Sbjct: 220 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG 279
Query: 324 LRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
            +   P  A   +  +++ CW  +PT RP F QI   L++  +E
Sbjct: 280 YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 323

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score =  130 bits (328), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 143/272 (52%), Gaps = 16/272 (5%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 21  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 76
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           +M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++K
Sbjct: 77  VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 135
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 276
           GMNYL    ++HRDL   N+L+     VK+ DFG A+ + A+     AE G    +WMA 
Sbjct: 136 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 196 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 254
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 255 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 286

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 144/272 (52%), Gaps = 16/272 (5%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 11  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 66
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           +M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + +++
Sbjct: 67  VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAE 125
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 276
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 126 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 185
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 186 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 244
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 245 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 276

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 89/308 (28%), Positives = 147/308 (47%), Gaps = 28/308 (9%)
Query: 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEF 154
           +D+ E+  K + +   +  G++G++Y+G            +VA+K L   C   + L +F
Sbjct: 23  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DF 81
Query: 155 SQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK------QKGVFQLT 208
             E  I+ K  H+N+V+ IG   +     I+ E MA G +  FL +      Q     + 
Sbjct: 82  LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 141
Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADFGVARVQAQSGVMT 265
            LL VA D++ G  YL +N+ IHRD+   N L+   G   V K+ DFG+AR   ++    
Sbjct: 142 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 201
Query: 266 AETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQ 321
                    +WM PE      +  K D +SFG+ LWE+ + G +PY   +  Q  +  V 
Sbjct: 202 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEVLEFVT 260
Query: 322 KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINTNI 381
              R   PK+    +  ++ +CWQH P  RPNF+ I + ++   ++      P++INT +
Sbjct: 261 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD------PDVINTAL 314
Query: 382 QSTYKHLL 389
              Y  L+
Sbjct: 315 PIEYGPLV 322

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 89/308 (28%), Positives = 147/308 (47%), Gaps = 28/308 (9%)
Query: 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEF 154
           +D+ E+  K + +   +  G++G++Y+G            +VA+K L   C   + L +F
Sbjct: 29  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DF 87
Query: 155 SQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK------QKGVFQLT 208
             E  I+ K  H+N+V+ IG   +     I+ E MA G +  FL +      Q     + 
Sbjct: 88  LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 147
Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADFGVARVQAQSGVMT 265
            LL VA D++ G  YL +N+ IHRD+   N L+   G   V K+ DFG+AR   ++    
Sbjct: 148 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 207
Query: 266 AETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQ 321
                    +WM PE      +  K D +SFG+ LWE+ + G +PY   +  Q  +  V 
Sbjct: 208 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEVLEFVT 266
Query: 322 KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINTNI 381
              R   PK+    +  ++ +CWQH P  RPNF+ I + ++   ++      P++INT +
Sbjct: 267 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD------PDVINTAL 320
Query: 382 QSTYKHLL 389
              Y  L+
Sbjct: 321 PIEYGPLV 328

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 89/308 (28%), Positives = 147/308 (47%), Gaps = 28/308 (9%)
Query: 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEF 154
           +D+ E+  K + +   +  G++G++Y+G            +VA+K L   C   + L +F
Sbjct: 49  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DF 107
Query: 155 SQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK------QKGVFQLT 208
             E  I+ K  H+N+V+ IG   +     I+ E MA G +  FL +      Q     + 
Sbjct: 108 LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 167
Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADFGVARVQAQSGVMT 265
            LL VA D++ G  YL +N+ IHRD+   N L+   G   V K+ DFG+AR   ++    
Sbjct: 168 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 227
Query: 266 AETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQ 321
                    +WM PE      +  K D +SFG+ LWE+ + G +PY   +  Q  +  V 
Sbjct: 228 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVT 286
Query: 322 KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINTNI 381
              R   PK+    +  ++ +CWQH P  RPNF+ I + ++   ++      P++INT +
Sbjct: 287 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD------PDVINTAL 340
Query: 382 QSTYKHLL 389
              Y  L+
Sbjct: 341 PIEYGPLV 348

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 143/272 (52%), Gaps = 16/272 (5%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 17  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 72
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           +M  + + +V + +G C     + ++ + M  G + D++ + K       LL   + ++K
Sbjct: 73  VMASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 131
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 276
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 132 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 192 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 250
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 251 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 282

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 143/272 (52%), Gaps = 16/272 (5%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 18  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 73
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           +M  + + +V + +G C     + ++ + M  G + D++ + K       LL   + ++K
Sbjct: 74  VMASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 132
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 276
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 133 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 192
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 193 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 251
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 252 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 283

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 144/272 (52%), Gaps = 16/272 (5%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
           E + K++K+   ++SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 21  ETEFKKIKV---LSSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 76
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           +M  + + +V + +G C     + ++ + M  G + D++ + K       LL   + ++K
Sbjct: 77  VMASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 135
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 276
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 136 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 196 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 254
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 255 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 286

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 143/272 (52%), Gaps = 16/272 (5%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 15  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 70
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           +M  + + +V + +G C     + ++ + M  G + D++ + K       LL   + ++K
Sbjct: 71  VMASVDNPHVCRLLGICLTS-TVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAK 129
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 276
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 130 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 189
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 190 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 248
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 249 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 280

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 143/272 (52%), Gaps = 16/272 (5%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 14  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 69
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           +M  + + +V + +G C     + ++ + M  G + D++ + K       LL   + ++K
Sbjct: 70  VMASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 276
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 247
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 248 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 143/272 (52%), Gaps = 16/272 (5%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 15  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 70
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           +M  + + +V + +G C     + ++ + M  G + D++ + K       LL   + ++K
Sbjct: 71  VMASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 129
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 276
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 130 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 189
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 190 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 248
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 249 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 280

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 143/272 (52%), Gaps = 16/272 (5%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 16  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 71
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           +M  + + +V + +G C     + ++ + M  G + D++ + K       LL   + ++K
Sbjct: 72  VMASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 130
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 276
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 131 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 249
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 250 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 281

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 142/272 (52%), Gaps = 16/272 (5%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 16  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 71
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           +M  + + +V + +G C     + ++ + M  G + D++ + K       LL   + ++K
Sbjct: 72  VMASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 130
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 276
           GMNYL    ++HRDL   N+L+     VK+ DFG A+ + A+     AE G    +WMA 
Sbjct: 131 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 249
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 250 VYMIMRKCWMIDADSRPKFRELIIEFSKMARD 281

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 143/272 (52%), Gaps = 16/272 (5%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
           E + K++K+   + SG++G +YKG +  +       VAI  L+ E  + +  KE   E Y
Sbjct: 48  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIMELR-EATSPKANKEILDEAY 103
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           +M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++K
Sbjct: 104 VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 162
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 276
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 163 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 222
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 223 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 281
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 282 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 313

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 132/264 (50%), Gaps = 14/264 (5%)
Query: 118 VASGSYGDLYKGTYCSQ-----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 172
           +  G +G +Y G Y  Q     + AIK L       + ++ F +E  +MR + H NV+  
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLS-RITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 173 IGACTRPPNLC-IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 231
           IG    P  L  ++  +M  G +  F+   +    +  L+   + V++GM YL +   +H
Sbjct: 88  IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVH 147
Query: 232 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY-----RWMAPEVIEHKPYDY 286
           RDL   N ++DE+  VKVADFG+AR        + +   +     +W A E ++   +  
Sbjct: 148 RDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTT 207
Query: 287 KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 345
           K+DV+SFG+ LWELLT G  PY  + P      + Q    P  P++    L +++++CW+
Sbjct: 208 KSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ-PEYCPDSLYQVMQQCWE 266
Query: 346 HDPTQRPNFSQITDILKQMMKEVL 369
            DP  RP F  +   ++Q++  +L
Sbjct: 267 ADPAVRPTFRVLVGEVEQIVSALL 290

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 139/288 (48%), Gaps = 26/288 (9%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQE 157
           WE     L+    + +G++G + + T           +VA+K+LK    + +  +    E
Sbjct: 41  WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-STAHADEKEALMSE 99
Query: 158 VYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQL--------- 207
           + IM  + +H+N+V  +GACT    + ++TE+   G + +FL ++  V +          
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANS 159
Query: 208 ----TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSG 262
                 LL  +  V++GM +L   N IHRD+   N+L+    V K+ DFG+AR +   S 
Sbjct: 160 TASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 219
Query: 263 VMTAETGTY--RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGV 319
            +         +WMAPE I    Y  ++DV+S+GI LWE+ + G  PY G+        +
Sbjct: 220 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL 279
Query: 320 VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           V+   +   P  A   +  +++ CW  +PT RP F QI   L++  +E
Sbjct: 280 VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 139/288 (48%), Gaps = 26/288 (9%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQE 157
           WE     L+    + +G++G + + T           +VA+K+LK    + +  +    E
Sbjct: 41  WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-STAHADEKEALMSE 99
Query: 158 VYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQL--------- 207
           + IM  + +H+N+V  +GACT    + ++TE+   G + +FL ++  V +          
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANS 159
Query: 208 ----TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSG 262
                 LL  +  V++GM +L   N IHRD+   N+L+    V K+ DFG+AR +   S 
Sbjct: 160 TLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 219
Query: 263 VMTAETGTY--RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGV 319
            +         +WMAPE I    Y  ++DV+S+GI LWE+ + G  PY G+        +
Sbjct: 220 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL 279
Query: 320 VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           V+   +   P  A   +  +++ CW  +PT RP F QI   L++  +E
Sbjct: 280 VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 142/272 (52%), Gaps = 16/272 (5%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 18  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 73
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           +M  + + +V + +G C     + ++ + M  G + D++ + K       LL   + ++K
Sbjct: 74  VMASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 132
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 276
           GMNYL    ++HRDL   N+L+     VK+ DFG A+ + A+     AE G    +WMA 
Sbjct: 133 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 192
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 193 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 251
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 252 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 283

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 142/272 (52%), Gaps = 16/272 (5%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 16  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 71
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           +M  + + +V + +G C     + ++ + M  G + D++ + K       LL   + ++K
Sbjct: 72  VMASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 130
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 276
           GMNYL    ++HRDL   N+L+     VK+ DFG A+ + A+     AE G    +WMA 
Sbjct: 131 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 249
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 250 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 281

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 147/308 (47%), Gaps = 28/308 (9%)
Query: 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEF 154
           +D+ E+  K + +   +  G++G++Y+G            +VA+K L   C   + L +F
Sbjct: 23  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DF 81
Query: 155 SQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK------QKGVFQLT 208
             E  I+ K  H+N+V+ IG   +     I+ E MA G +  FL +      Q     + 
Sbjct: 82  LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 141
Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADFGVARVQAQSGVMT 265
            LL VA D++ G  YL +N+ IHRD+   N L+   G   V K+ DFG+A+   ++    
Sbjct: 142 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYR 201
Query: 266 AETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQ 321
                    +WM PE      +  K D +SFG+ LWE+ + G +PY   +  Q  +  V 
Sbjct: 202 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEVLEFVT 260
Query: 322 KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINTNI 381
              R   PK+    +  ++ +CWQH P  RPNF+ I + ++   ++      P++INT +
Sbjct: 261 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD------PDVINTAL 314
Query: 382 QSTYKHLL 389
              Y  L+
Sbjct: 315 PIEYGPLV 322

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 74/199 (37%), Positives = 120/199 (60%), Gaps = 13/199 (6%)
Query: 117 KVASGSYGDLYKGTYCSQEVAIKVLKP--ECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           K+  G +G +YKG   +  VA+K L    +    E+ ++F QE+ +M K +H+N+V+ +G
Sbjct: 38  KMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT--SLLKVAIDVSKGMNYLHQNNIIHR 232
             +   +LC+V  +M  GS+ D L    G   L+     K+A   + G+N+LH+N+ IHR
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHR 157
Query: 233 DLKTANLLMDENGVVKVADFGVARVQ---AQSGVMTAETGTYRWMAPEVI--EHKPYDYK 287
           D+K+AN+L+DE    K++DFG+AR     AQ+ + +   GT  +MAPE +  E  P   K
Sbjct: 158 DIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALRGEITP---K 214
Query: 288 ADVFSFGIALWELLTGELP 306
           +D++SFG+ L E++TG LP
Sbjct: 215 SDIYSFGVVLLEIITG-LP 232

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  127 bits (320), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 74/199 (37%), Positives = 119/199 (59%), Gaps = 13/199 (6%)
Query: 117 KVASGSYGDLYKGTYCSQEVAIKVLKP--ECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           K+  G +G +YKG   +  VA+K L    +    E+ ++F QE+ +M K +H+N+V+ +G
Sbjct: 38  KMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT--SLLKVAIDVSKGMNYLHQNNIIHR 232
             +   +LC+V  +M  GS+ D L    G   L+     K+A   + G+N+LH+N+ IHR
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHR 157
Query: 233 DLKTANLLMDENGVVKVADFGVARVQ---AQSGVMTAETGTYRWMAPEVI--EHKPYDYK 287
           D+K+AN+L+DE    K++DFG+AR     AQ+ +     GT  +MAPE +  E  P   K
Sbjct: 158 DIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALRGEITP---K 214
Query: 288 ADVFSFGIALWELLTGELP 306
           +D++SFG+ L E++TG LP
Sbjct: 215 SDIYSFGVVLLEIITG-LP 232

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 142/290 (48%), Gaps = 28/290 (9%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQE 157
           WE     L+    + +G++G + + T           +VA+K+LK    + +  +    E
Sbjct: 41  WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-STAHADEKEALMSE 99
Query: 158 VYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF----------- 205
           + IM  + +H+N+V  +GACT    + ++TE+   G + +FL +++              
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNP 159
Query: 206 --QLTS--LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQ 260
             QL+S  LL  +  V++GM +L   N IHRD+   N+L+    V K+ DFG+AR +   
Sbjct: 160 EEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 219
Query: 261 SGVMTAETGTY--RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 317
           S  +         +WMAPE I    Y  ++DV+S+GI LWE+ + G  PY G+       
Sbjct: 220 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 279
Query: 318 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
            +V+   +   P  A   +  +++ CW  +PT RP F QI   L++  +E
Sbjct: 280 KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 329

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 74/199 (37%), Positives = 118/199 (59%), Gaps = 13/199 (6%)
Query: 117 KVASGSYGDLYKGTYCSQEVAIKVLKP--ECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           K+  G +G +YKG   +  VA+K L    +    E+ ++F QE+ +M K +H+N+V+ +G
Sbjct: 32  KMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 91
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT--SLLKVAIDVSKGMNYLHQNNIIHR 232
             +   +LC+V  +M  GS+ D L    G   L+     K+A   + G+N+LH+N+ IHR
Sbjct: 92  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHR 151
Query: 233 DLKTANLLMDENGVVKVADFGVARVQ---AQSGVMTAETGTYRWMAPEVI--EHKPYDYK 287
           D+K+AN+L+DE    K++DFG+AR     AQ  +     GT  +MAPE +  E  P   K
Sbjct: 152 DIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRGEITP---K 208
Query: 288 ADVFSFGIALWELLTGELP 306
           +D++SFG+ L E++TG LP
Sbjct: 209 SDIYSFGVVLLEIITG-LP 226

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 143/290 (49%), Gaps = 44/290 (15%)
Query: 118 VASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG 174
           V +G+YG +YKG +    Q  AIKV+    V  +  +E  QE+ +++K   H+N+  + G
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHHRNIATYYG 88
Query: 175 ACTR--PPN----LCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQN 227
           A  +  PP     L +V EF   GS+ D +   KG   +   +  +  ++ +G+++LHQ+
Sbjct: 89  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 148
Query: 228 NIIHRDLKTANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVI--EHKP- 283
            +IHRD+K  N+L+ EN  VK+ DFGV A++    G      GT  WMAPEVI  +  P 
Sbjct: 149 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPD 208
Query: 284 --YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA---- 337
             YD+K+D++S GI   E+  G  P   + P++A            IP++  PRL     
Sbjct: 209 ATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF---------LIPRNPAPRLKSKKW 259
Query: 338 -----ELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINTNIQ 382
                  +E C   + +QRP         +Q+MK       PN     IQ
Sbjct: 260 SKKFQSFIESCLVKNHSQRP-------ATEQLMKHPFIRDQPNERQVRIQ 302

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 145/295 (49%), Gaps = 35/295 (11%)
Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLYKG-------TYCSQEVAIKVLKPECVNTEMLKE 153
           G  V  I  + + ++ ++  G++G ++         T     VA+K LK   +     K+
Sbjct: 6   GIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KD 63
Query: 154 FSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLH-------------- 199
           F +E  ++  ++H+++V+F G C     L +V E+M  G +  FL               
Sbjct: 64  FQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 123
Query: 200 -KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258
            + KG   L+ +L +A  ++ GM YL   + +HRDL T N L+  N +VK+ DFG++R  
Sbjct: 124 RQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV 183
Query: 259 AQSGVMTAETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQ 314
             +        T    RWM PE I ++ +  ++DV+SFG+ LWE+ T G+ P+  L+  +
Sbjct: 184 YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 243
Query: 315 AAVGVVQKSL--RPTI-PKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
               + Q  +  RP + PK  +    +++  CWQ +P QR N  +I  IL  + K
Sbjct: 244 VIECITQGRVLERPRVCPKEVY----DVMLGCWQREPQQRLNIKEIYKILHALGK 294

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 140/291 (48%), Gaps = 26/291 (8%)
Query: 92  PNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPE 144
           P+ + +P    D WE+  +++ +  ++  GS+G +Y+G             VA+K +   
Sbjct: 3   PSSVYVP----DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES 58
Query: 145 CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV 204
               E + EF  E  +M+     +VV+ +G  ++     +V E MA G +  +L   +  
Sbjct: 59  ASLRERI-EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPE 117
Query: 205 FQ---------LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255
            +         L  ++++A +++ GM YL+    +HRDL   N ++  +  VK+ DFG+ 
Sbjct: 118 AENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMT 177
Query: 256 R-VQAQSGVMTAETG--TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLT 311
           R +           G    RWMAPE ++   +   +D++SFG+ LWE+ +  E PY GL+
Sbjct: 178 RDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 237
Query: 312 PLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK 362
             Q    V+        P +   R+ +L+  CWQ +P  RP F +I ++LK
Sbjct: 238 NEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 139/297 (46%), Gaps = 35/297 (11%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQE 157
           WE     L+    + +G++G + + T           +VA+K+LK    + +  +    E
Sbjct: 26  WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-STAHADEKEALMSE 84
Query: 158 VYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV------------ 204
           + IM  + +H+N+V  +GACT    + ++TE+   G + +FL ++               
Sbjct: 85  LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDP 144
Query: 205 ----------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 254
                      +L  LL  +  V++GM +L   N IHRD+   N+L+    V K+ DFG+
Sbjct: 145 EGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGL 204
Query: 255 AR-VQAQSGVMTAETGTY--RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGL 310
           AR +   S  +         +WMAPE I    Y  ++DV+S+GI LWE+ + G  PY G+
Sbjct: 205 ARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 264
Query: 311 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
                   +V+   +   P  A   +  +++ CW  +PT RP F QI   L++  +E
Sbjct: 265 LVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 321

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 140/291 (48%), Gaps = 26/291 (8%)
Query: 92  PNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPE 144
           P+ + +P    D WE+  +++ +  ++  GS+G +Y+G             VA+K +   
Sbjct: 3   PSSVFVP----DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES 58
Query: 145 CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV 204
               E + EF  E  +M+     +VV+ +G  ++     +V E MA G +  +L   +  
Sbjct: 59  ASLRERI-EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPE 117
Query: 205 FQ---------LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255
            +         L  ++++A +++ GM YL+    +HRDL   N ++  +  VK+ DFG+ 
Sbjct: 118 AENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMT 177
Query: 256 R-VQAQSGVMTAETG--TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLT 311
           R +           G    RWMAPE ++   +   +D++SFG+ LWE+ +  E PY GL+
Sbjct: 178 RDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 237
Query: 312 PLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK 362
             Q    V+        P +   R+ +L+  CWQ +P  RP F +I ++LK
Sbjct: 238 NEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 146/273 (53%), Gaps = 18/273 (6%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNT-------EMLKEFSQEV 158
           E + ++LK+   + SG +G ++KG +  +  +IK+  P C+         +  +  +  +
Sbjct: 30  ETELRKLKV---LGSGVFGTVHKGVWIPEGESIKI--PVCIKVIEDKSGRQSFQAVTDHM 84
Query: 159 YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS 218
             +  + H ++V+ +G C    +L +VT+++  GS+ D + + +G      LL   + ++
Sbjct: 85  LAIGSLDHAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 143
Query: 219 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGT-YRWMA 275
           KGM YL ++ ++HR+L   N+L+     V+VADFGVA +       ++ +E  T  +WMA
Sbjct: 144 KGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 203
Query: 276 PEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP 334
            E I    Y +++DV+S+G+ +WEL+T G  PYAGL  L     +++K  R   P+    
Sbjct: 204 LESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR-LAEVPDLLEKGERLAQPQICTI 262
Query: 335 RLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
            +  ++ +CW  D   RP F ++ +   +M ++
Sbjct: 263 DVYMVMVKCWMIDENIRPTFKELANEFTRMARD 295

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 146/273 (53%), Gaps = 18/273 (6%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNT-------EMLKEFSQEV 158
           E + ++LK+   + SG +G ++KG +  +  +IK+  P C+         +  +  +  +
Sbjct: 12  ETELRKLKV---LGSGVFGTVHKGVWIPEGESIKI--PVCIKVIEDKSGRQSFQAVTDHM 66
Query: 159 YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS 218
             +  + H ++V+ +G C    +L +VT+++  GS+ D + + +G      LL   + ++
Sbjct: 67  LAIGSLDHAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 125
Query: 219 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA--QSGVMTAETGT-YRWMA 275
           KGM YL ++ ++HR+L   N+L+     V+VADFGVA +       ++ +E  T  +WMA
Sbjct: 126 KGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 185
Query: 276 PEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP 334
            E I    Y +++DV+S+G+ +WEL+T G  PYAGL  L     +++K  R   P+    
Sbjct: 186 LESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR-LAEVPDLLEKGERLAQPQICTI 244
Query: 335 RLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
            +  ++ +CW  D   RP F ++ +   +M ++
Sbjct: 245 DVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 141/291 (48%), Gaps = 26/291 (8%)
Query: 92  PNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPE 144
           P+ + +P    D WE+  +++ +  ++  GS+G +Y+G             VA+K +   
Sbjct: 3   PSSVFVP----DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES 58
Query: 145 CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV 204
               E + EF  E  +M+     +VV+ +G  ++     +V E MA G +  +L   +  
Sbjct: 59  ASLRERI-EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPE 117
Query: 205 FQ---------LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255
            +         L  ++++A +++ GM YL+    +HRDL   N ++  +  VK+ DFG+ 
Sbjct: 118 AENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMT 177
Query: 256 R-VQAQSGVMTAETG--TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLT 311
           R +   +       G    RWMAPE ++   +   +D++SFG+ LWE+ +  E PY GL+
Sbjct: 178 RDIYETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 237
Query: 312 PLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK 362
             Q    V+        P +   R+ +L+  CWQ +P  RP F +I ++LK
Sbjct: 238 NEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 77/256 (30%), Positives = 124/256 (48%), Gaps = 29/256 (11%)
Query: 136 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
           VA+K+LK E  + +M  +F +E  +M +  + N+V+ +G C     +C++ E+MA G + 
Sbjct: 80  VAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 138
Query: 196 DFLHKQKG-----------------------VFQLTSLLKVAIDVSKGMNYLHQNNIIHR 232
           +FL                                   L +A  V+ GM YL +   +HR
Sbjct: 139 EFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198
Query: 233 DLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKAD 289
           DL T N L+ EN VVK+ADFG++R    +    A+       RWM PE I +  Y  ++D
Sbjct: 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESD 258
Query: 290 VFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDP 348
           V+++G+ LWE+ + G  PY G+   +  +  V+       P++    L  L+  CW   P
Sbjct: 259 VWAYGVVLWEIFSYGLQPYYGMA-HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLP 317
Query: 349 TQRPNFSQITDILKQM 364
             RP+F  I  IL++M
Sbjct: 318 ADRPSFCSIHRILQRM 333

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 142/296 (47%), Gaps = 36/296 (12%)
Query: 92  PNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPE 144
           P+ + +P    D WE+  +++ +  ++  GS+G +Y+G             VA+K +   
Sbjct: 3   PSSVFVP----DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES 58
Query: 145 CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV 204
               E + EF  E  +M+     +VV+ +G  ++     +V E MA G +  +L   +  
Sbjct: 59  ASLRERI-EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPE 117
Query: 205 FQ---------LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255
            +         L  ++++A +++ GM YL+    +HRDL   N ++  +  VK+ DFG+ 
Sbjct: 118 AENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMT 177
Query: 256 R--------VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 306
           R         +   G++       RWMAPE ++   +   +D++SFG+ LWE+ +  E P
Sbjct: 178 RDIYETDYYRKGGKGLLPV-----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 232
Query: 307 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK 362
           Y GL+  Q    V+        P +   R+ +L+  CWQ +P  RP F +I ++LK
Sbjct: 233 YQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 135/280 (48%), Gaps = 22/280 (7%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFS 155
           D WE+  +++ +  ++  GS+G +Y+G             VA+K +       E + EF 
Sbjct: 7   DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFL 65
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--------- 206
            E  +M+     +VV+ +G  ++     +V E MA G +  +L   +   +         
Sbjct: 66  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 125
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMT 265
           L  ++++A +++ GM YL+    +HRDL   N ++  +  VK+ DFG+ R +        
Sbjct: 126 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRK 185
Query: 266 AETG--TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK 322
              G    RWMAPE ++   +   +D++SFG+ LWE+ +  E PY GL+  Q    V+  
Sbjct: 186 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG 245
Query: 323 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK 362
                 P +   R+ +L+  CWQ +P  RP F +I ++LK
Sbjct: 246 GYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 284

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score =  124 bits (311), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 129/265 (48%), Gaps = 20/265 (7%)
Query: 118 VASGSYGDLYKGTYCSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           +  G +G   K T+  +E    ++  E +  + E  + F +EV +MR + H NV++FIG 
Sbjct: 18  LGKGCFGQAIKVTH--RETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
             +   L  +TE++  G++   +      +  +  +  A D++ GM YLH  NIIHRDL 
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLN 135
Query: 236 TANLLMDENGVVKVADFGVARVQAQ-----SGVMTAE----------TGTYRWMAPEVIE 280
           + N L+ EN  V VADFG+AR+         G+ + +           G   WMAPE+I 
Sbjct: 136 SHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN 195
Query: 281 HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV-VQKSLRPTIPKHAHPRLAEL 339
            + YD K DVFSFGI L E++          P     G+ V+  L    P +  P    +
Sbjct: 196 GRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPI 255
Query: 340 LERCWQHDPTQRPNFSQITDILKQM 364
             RC   DP +RP+F ++   L+ +
Sbjct: 256 TVRCCDLDPEKRPSFVKLEHWLETL 280

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score =  124 bits (311), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 123/252 (48%), Gaps = 14/252 (5%)
Query: 118 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 172
           +  G +G +Y GT    +      A+K L     +   + +F  E  IM+   H NV+  
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 173 IGACTRPP-NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 231
           +G C R   +  +V  +M  G + +F+  +     +  L+   + V+KGM YL     +H
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVH 155
Query: 232 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT-----YRWMAPEVIEHKPYDY 286
           RDL   N ++DE   VKVADFG+AR        +    T      +WMA E ++ + +  
Sbjct: 156 RDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFTT 215
Query: 287 KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 345
           K+DV+SFG+ LWEL+T G  PY  +      V ++Q   R   P++    L E++ +CW 
Sbjct: 216 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCWH 274
Query: 346 HDPTQRPNFSQI 357
                RP+FS++
Sbjct: 275 PKAEMRPSFSEL 286

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score =  124 bits (311), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 123/252 (48%), Gaps = 14/252 (5%)
Query: 118 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 172
           +  G +G +Y GT    +      A+K L     +   + +F  E  IM+   H NV+  
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLSL 114
Query: 173 IGACTRPP-NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 231
           +G C R   +  +V  +M  G + +F+  +     +  L+   + V+KGM YL     +H
Sbjct: 115 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVH 174
Query: 232 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT-----YRWMAPEVIEHKPYDY 286
           RDL   N ++DE   VKVADFG+AR        +    T      +WMA E ++ + +  
Sbjct: 175 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 234
Query: 287 KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 345
           K+DV+SFG+ LWEL+T G  PY  +      V ++Q   R   P++    L E++ +CW 
Sbjct: 235 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCWH 293
Query: 346 HDPTQRPNFSQI 357
                RP+FS++
Sbjct: 294 PKAEMRPSFSEL 305

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 123/252 (48%), Gaps = 14/252 (5%)
Query: 118 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 172
           +  G +G +Y GT    +      A+K L     +   + +F  E  IM+   H NV+  
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 173 IGACTRPP-NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 231
           +G C R   +  +V  +M  G + +F+  +     +  L+   + V+KGM YL     +H
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVH 156
Query: 232 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT-----YRWMAPEVIEHKPYDY 286
           RDL   N ++DE   VKVADFG+AR        +    T      +WMA E ++ + +  
Sbjct: 157 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 216
Query: 287 KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 345
           K+DV+SFG+ LWEL+T G  PY  +      V ++Q   R   P++    L E++ +CW 
Sbjct: 217 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCWH 275
Query: 346 HDPTQRPNFSQI 357
                RP+FS++
Sbjct: 276 PKAEMRPSFSEL 287

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 123/252 (48%), Gaps = 14/252 (5%)
Query: 118 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 172
           +  G +G +Y GT    +      A+K L     +   + +F  E  IM+   H NV+  
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLSL 115
Query: 173 IGACTRPP-NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 231
           +G C R   +  +V  +M  G + +F+  +     +  L+   + V+KGM YL     +H
Sbjct: 116 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVH 175
Query: 232 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT-----YRWMAPEVIEHKPYDY 286
           RDL   N ++DE   VKVADFG+AR        +    T      +WMA E ++ + +  
Sbjct: 176 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 235
Query: 287 KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 345
           K+DV+SFG+ LWEL+T G  PY  +      V ++Q   R   P++    L E++ +CW 
Sbjct: 236 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCWH 294
Query: 346 HDPTQRPNFSQI 357
                RP+FS++
Sbjct: 295 PKAEMRPSFSEL 306

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 123/252 (48%), Gaps = 14/252 (5%)
Query: 118 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 172
           +  G +G +Y GT    +      A+K L     +   + +F  E  IM+   H NV+  
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 173 IGACTRPP-NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 231
           +G C R   +  +V  +M  G + +F+  +     +  L+   + V+KGM YL     +H
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVH 154
Query: 232 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT-----YRWMAPEVIEHKPYDY 286
           RDL   N ++DE   VKVADFG+AR        +    T      +WMA E ++ + +  
Sbjct: 155 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 214
Query: 287 KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 345
           K+DV+SFG+ LWEL+T G  PY  +      V ++Q   R   P++    L E++ +CW 
Sbjct: 215 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCWH 273
Query: 346 HDPTQRPNFSQI 357
                RP+FS++
Sbjct: 274 PKAEMRPSFSEL 285

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 123/252 (48%), Gaps = 14/252 (5%)
Query: 118 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 172
           +  G +G +Y GT    +      A+K L     +   + +F  E  IM+   H NV+  
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLSL 88
Query: 173 IGACTRPP-NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 231
           +G C R   +  +V  +M  G + +F+  +     +  L+   + V+KGM YL     +H
Sbjct: 89  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVH 148
Query: 232 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT-----YRWMAPEVIEHKPYDY 286
           RDL   N ++DE   VKVADFG+AR        +    T      +WMA E ++ + +  
Sbjct: 149 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 208
Query: 287 KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 345
           K+DV+SFG+ LWEL+T G  PY  +      V ++Q   R   P++    L E++ +CW 
Sbjct: 209 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCWH 267
Query: 346 HDPTQRPNFSQI 357
                RP+FS++
Sbjct: 268 PKAEMRPSFSEL 279

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 123/252 (48%), Gaps = 14/252 (5%)
Query: 118 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 172
           +  G +G +Y GT    +      A+K L     +   + +F  E  IM+   H NV+  
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 173 IGACTRPP-NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 231
           +G C R   +  +V  +M  G + +F+  +     +  L+   + V+KGM YL     +H
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVH 151
Query: 232 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT-----YRWMAPEVIEHKPYDY 286
           RDL   N ++DE   VKVADFG+AR        +    T      +WMA E ++ + +  
Sbjct: 152 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 211
Query: 287 KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 345
           K+DV+SFG+ LWEL+T G  PY  +      V ++Q   R   P++    L E++ +CW 
Sbjct: 212 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCWH 270
Query: 346 HDPTQRPNFSQI 357
                RP+FS++
Sbjct: 271 PKAEMRPSFSEL 282

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 123/252 (48%), Gaps = 14/252 (5%)
Query: 118 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 172
           +  G +G +Y GT    +      A+K L     +   + +F  E  IM+   H NV+  
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 173 IGACTRPP-NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 231
           +G C R   +  +V  +M  G + +F+  +     +  L+   + V+KGM YL     +H
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVH 155
Query: 232 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT-----YRWMAPEVIEHKPYDY 286
           RDL   N ++DE   VKVADFG+AR        +    T      +WMA E ++ + +  
Sbjct: 156 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 215
Query: 287 KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 345
           K+DV+SFG+ LWEL+T G  PY  +      V ++Q   R   P++    L E++ +CW 
Sbjct: 216 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCWH 274
Query: 346 HDPTQRPNFSQI 357
                RP+FS++
Sbjct: 275 PKAEMRPSFSEL 286

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 123/252 (48%), Gaps = 14/252 (5%)
Query: 118 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 172
           +  G +G +Y GT    +      A+K L     +   + +F  E  IM+   H NV+  
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 173 IGACTRPP-NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 231
           +G C R   +  +V  +M  G + +F+  +     +  L+   + V+KGM YL     +H
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVH 156
Query: 232 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT-----YRWMAPEVIEHKPYDY 286
           RDL   N ++DE   VKVADFG+AR        +    T      +WMA E ++ + +  
Sbjct: 157 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 216
Query: 287 KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 345
           K+DV+SFG+ LWEL+T G  PY  +      V ++Q   R   P++    L E++ +CW 
Sbjct: 217 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCWH 275
Query: 346 HDPTQRPNFSQI 357
                RP+FS++
Sbjct: 276 PKAEMRPSFSEL 287

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 123/252 (48%), Gaps = 14/252 (5%)
Query: 118 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 172
           +  G +G +Y GT    +      A+K L     +   + +F  E  IM+   H NV+  
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 173 IGACTRPP-NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 231
           +G C R   +  +V  +M  G + +F+  +     +  L+   + V+KGM YL     +H
Sbjct: 94  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVH 153
Query: 232 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT-----YRWMAPEVIEHKPYDY 286
           RDL   N ++DE   VKVADFG+AR        +    T      +WMA E ++ + +  
Sbjct: 154 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 213
Query: 287 KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 345
           K+DV+SFG+ LWEL+T G  PY  +      V ++Q   R   P++    L E++ +CW 
Sbjct: 214 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCWH 272
Query: 346 HDPTQRPNFSQI 357
                RP+FS++
Sbjct: 273 PKAEMRPSFSEL 284

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 136/290 (46%), Gaps = 33/290 (11%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQE 157
           WE   + L+    + SG++G +   T         S +VA+K+LK +  ++E     S+ 
Sbjct: 40  WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSEL 99
Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK--------------- 202
             + +   H+N+V  +GACT    + ++ E+   G + ++L  ++               
Sbjct: 100 KMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 159
Query: 203 -------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255
                   V     LL  A  V+KGM +L   + +HRDL   N+L+    VVK+ DFG+A
Sbjct: 160 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219
Query: 256 R-VQAQSGVMTAETGTY--RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLT 311
           R + + S  +         +WMAPE +    Y  K+DV+S+GI LWE+ + G  PY G+ 
Sbjct: 220 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279
Query: 312 PLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDIL 361
                  ++Q   +   P +A   +  +++ CW  D  +RP+F  +T  L
Sbjct: 280 VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 142/296 (47%), Gaps = 36/296 (12%)
Query: 92  PNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPE 144
           P+ + +P    D WE+  +++ +  ++  GS+G +Y+G             VA+K +   
Sbjct: 3   PSSVYVP----DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES 58
Query: 145 CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV 204
               E + EF  E  +M+     +VV+ +G  ++     +V E MA G +  +L   +  
Sbjct: 59  ASLRERI-EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPE 117
Query: 205 FQ---------LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255
            +         L  ++++A +++ GM YL+    +HR+L   N ++  +  VK+ DFG+ 
Sbjct: 118 AENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMT 177
Query: 256 R--------VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 306
           R         +   G++       RWMAPE ++   +   +D++SFG+ LWE+ +  E P
Sbjct: 178 RDIYETDYYRKGGKGLLPV-----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 232
Query: 307 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK 362
           Y GL+  Q    V+        P +   R+ +L+  CWQ +P  RP F +I ++LK
Sbjct: 233 YQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 142/296 (47%), Gaps = 36/296 (12%)
Query: 92  PNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPE 144
           P+ + +P    D WE+  +++ +  ++  GS+G +Y+G             VA+K +   
Sbjct: 4   PSSVYVP----DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES 59
Query: 145 CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV 204
               E + EF  E  +M+     +VV+ +G  ++     +V E MA G +  +L   +  
Sbjct: 60  ASLRERI-EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPE 118
Query: 205 FQ---------LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255
            +         L  ++++A +++ GM YL+    +HR+L   N ++  +  VK+ DFG+ 
Sbjct: 119 AENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMT 178
Query: 256 R--------VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 306
           R         +   G++       RWMAPE ++   +   +D++SFG+ LWE+ +  E P
Sbjct: 179 RDIYETDYYRKGGKGLLPV-----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 233
Query: 307 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK 362
           Y GL+  Q    V+        P +   R+ +L+  CWQ +P  RP F +I ++LK
Sbjct: 234 YQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 288

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 147/267 (55%), Gaps = 10/267 (3%)
Query: 117 KVASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           K+  GS+G   L K T   ++  IK +    ++++  +E  +EV ++  ++H N+VQ+  
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
           +     +L IV ++   G ++  ++ QKGV FQ   +L   + +   + ++H   I+HRD
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRD 150
Query: 234 LKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 292
           +K+ N+ + ++G V++ DFG+ARV  +   +  A  GT  +++PE+ E+KPY+ K+D+++
Sbjct: 151 IKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWA 210
Query: 293 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRP 352
            G  L+EL T +  +   +     + ++  S  P +  H    L  L+ + ++ +P  RP
Sbjct: 211 LGCVLYELCTLKHAFEAGSMKNLVLKIISGSF-PPVSLHYSYDLRSLVSQLFKRNPRDRP 269
Query: 353 NFSQITDILKQ--MMKEVLYWLSPNLI 377
           +   +  IL++  + K +  +LSP LI
Sbjct: 270 S---VNSILEKGFIAKRIEKFLSPQLI 293

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 127/252 (50%), Gaps = 14/252 (5%)
Query: 118 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 172
           +  G +G +Y GT    +      A+K L     +   + +F  E  IM+   H NV+  
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 173 IGACTRPP-NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 231
           +G C R   +  +V  +M  G + +F+  +     +  L+   + V+KGM +L     +H
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVH 157
Query: 232 RDLKTANLLMDENGVVKVADFGVAR--VQAQSGVMTAETGT---YRWMAPEVIEHKPYDY 286
           RDL   N ++DE   VKVADFG+AR  +  +   +  +TG     +WMA E ++ + +  
Sbjct: 158 RDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 217
Query: 287 KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 345
           K+DV+SFG+ LWEL+T G  PY  +      V ++Q   R   P++    L E++ +CW 
Sbjct: 218 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCWH 276
Query: 346 HDPTQRPNFSQI 357
                RP+FS++
Sbjct: 277 PKAEMRPSFSEL 288

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 140/272 (51%), Gaps = 16/272 (5%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
           E + +++K+   + SG++G +YKG +          VAIKVL+ E  + +  KE   E Y
Sbjct: 16  ETELRKVKV---LGSGAFGTVYKGIWIPDGENVKIPVAIKVLR-ENTSPKANKEILDEAY 71
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           +M  +    V + +G C     + +VT+ M  G + D + + +G      LL   + ++K
Sbjct: 72  VMAGVGSPYVSRLLGICLTS-TVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAK 130
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 276
           GM+YL    ++HRDL   N+L+     VK+ DFG+AR +        A+ G    +WMA 
Sbjct: 131 GMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMAL 190
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E I  + + +++DV+S+G+ +WEL+T G  PY G+ P +    +++K  R   P      
Sbjct: 191 ESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGI-PAREIPDLLEKGERLPQPPICTID 249
Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 250 VYMIMVKCWMIDSECRPRFRELVSEFSRMARD 281

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 86/291 (29%), Positives = 145/291 (49%), Gaps = 32/291 (10%)
Query: 102 TDVWEIDAKQLKIECKVASGSYGDLYKG---TYCSQE----VAIKVLKPECVNTEMLKEF 154
           T V  I    + ++ ++  G++G ++       C ++    VA+K LK    N    K+F
Sbjct: 5   TFVQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR--KDF 62
Query: 155 SQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL--HKQKGVF------- 205
            +E  ++  ++H+++V+F G C     L +V E+M  G +  FL  H    V        
Sbjct: 63  HREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPP 122
Query: 206 -QLTS--LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262
            +LT   +L +A  ++ GM YL   + +HRDL T N L+ EN +VK+ DFG++R    + 
Sbjct: 123 TELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD 182
Query: 263 VMTAETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVG 318
                  T    RWM PE I ++ +  ++DV+S G+ LWE+ T G+ P+  L+  +    
Sbjct: 183 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 242
Query: 319 VVQKSL--RP-TIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
           + Q  +  RP T P+  +    EL+  CWQ +P  R N   I  +L+ + K
Sbjct: 243 ITQGRVLQRPRTCPQEVY----ELMLGCWQREPHMRKNIKGIHTLLQNLAK 289

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 126/252 (50%), Gaps = 14/252 (5%)
Query: 118 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 172
           +  G +G +Y GT    +      A+K L     +   + +F  E  IM+   H NV+  
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 173 IGACTRPP-NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 231
           +G C R   +  +V  +M  G + +F+  +     +  L+   + V+KGM +L     +H
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVH 154
Query: 232 RDLKTANLLMDENGVVKVADFGVAR--VQAQSGVMTAETGT---YRWMAPEVIEHKPYDY 286
           RDL   N ++DE   VKVADFG+AR     +   +  +TG     +WMA E ++ + +  
Sbjct: 155 RDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 214
Query: 287 KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 345
           K+DV+SFG+ LWEL+T G  PY  +      V ++Q   R   P++    L E++ +CW 
Sbjct: 215 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCWH 273
Query: 346 HDPTQRPNFSQI 357
                RP+FS++
Sbjct: 274 PKAEMRPSFSEL 285

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 130/263 (49%), Gaps = 16/263 (6%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 162
           D WEI  +       +  G++G +YK       V       +  + E L+++  E+ I+ 
Sbjct: 37  DFWEIIGE-------LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILA 89
Query: 163 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 222
              H N+V+ + A     NL I+ EF A G++   + + +     + +  V       +N
Sbjct: 90  SCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALN 149
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGTYRWMAPEVI-- 279
           YLH N IIHRDLK  N+L   +G +K+ADFGV+    ++     +  GT  WMAPEV+  
Sbjct: 150 YLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 209
Query: 280 ---EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHP 334
              + +PYDYKADV+S GI L E+   E P+  L P++  + +  KS  PT+  P     
Sbjct: 210 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA-KSEPPTLAQPSRWSS 268
Query: 335 RLAELLERCWQHDPTQRPNFSQI 357
              + L++C + +   R   SQ+
Sbjct: 269 NFKDFLKKCLEKNVDARWTTSQL 291

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 82/267 (30%), Positives = 131/267 (49%), Gaps = 24/267 (8%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 162
           D WEI  +       +  G++G +YK       V       +  + E L+++  E+ I+ 
Sbjct: 37  DFWEIIGE-------LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILA 89
Query: 163 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 222
              H N+V+ + A     NL I+ EF A G++   + + +     + +  V       +N
Sbjct: 90  SCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALN 149
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVA-----RVQAQSGVMTAETGTYRWMAPE 277
           YLH N IIHRDLK  N+L   +G +K+ADFGV+      +Q +   +    GT  WMAPE
Sbjct: 150 YLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFI----GTPYWMAPE 205
Query: 278 VI-----EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PK 330
           V+     + +PYDYKADV+S GI L E+   E P+  L P++  + +  KS  PT+  P 
Sbjct: 206 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA-KSEPPTLAQPS 264
Query: 331 HAHPRLAELLERCWQHDPTQRPNFSQI 357
                  + L++C + +   R   SQ+
Sbjct: 265 RWSSNFKDFLKKCLEKNVDARWTTSQL 291

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 136/279 (48%), Gaps = 16/279 (5%)
Query: 118 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 172
           +  G +G +Y GT    +      A+K L     +   + +F  E  IM+   H NV+  
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 173 IGACTRPP-NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 231
           +G C R   +  +V  +M  G + +F+  +     +  L+   + V+KGM +L     +H
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVH 156
Query: 232 RDLKTANLLMDENGVVKVADFGVAR--VQAQSGVMTAETGT---YRWMAPEVIEHKPYDY 286
           RDL   N ++DE   VKVADFG+AR     +   +  +TG     +WMA E ++ + +  
Sbjct: 157 RDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 216
Query: 287 KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 345
           K+DV+SFG+ LWEL+T G  PY  +      V ++Q   R   P++    L E++ +CW 
Sbjct: 217 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCWH 275
Query: 346 HDPTQRPNFSQITDILKQMMKEVL--YWLSPNLINTNIQ 382
                RP+FS++   +  +    +  +++  N    N++
Sbjct: 276 PKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYVNVK 314

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 126/252 (50%), Gaps = 14/252 (5%)
Query: 118 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 172
           +  G +G +Y GT    +      A+K L     +   + +F  E  IM+   H NV+  
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 173 IGACTRPP-NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 231
           +G C R   +  +V  +M  G + +F+  +     +  L+   + V+KGM +L     +H
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVH 157
Query: 232 RDLKTANLLMDENGVVKVADFGVAR--VQAQSGVMTAETGT---YRWMAPEVIEHKPYDY 286
           RDL   N ++DE   VKVADFG+AR     +   +  +TG     +WMA E ++ + +  
Sbjct: 158 RDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 217
Query: 287 KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 345
           K+DV+SFG+ LWEL+T G  PY  +      V ++Q   R   P++    L E++ +CW 
Sbjct: 218 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCWH 276
Query: 346 HDPTQRPNFSQI 357
                RP+FS++
Sbjct: 277 PKAEMRPSFSEL 288

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 126/252 (50%), Gaps = 14/252 (5%)
Query: 118 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 172
           +  G +G +Y GT    +      A+K L     +   + +F  E  IM+   H NV+  
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 173 IGACTRPP-NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 231
           +G C R   +  +V  +M  G + +F+  +     +  L+   + V+KGM +L     +H
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVH 156
Query: 232 RDLKTANLLMDENGVVKVADFGVAR--VQAQSGVMTAETGT---YRWMAPEVIEHKPYDY 286
           RDL   N ++DE   VKVADFG+AR     +   +  +TG     +WMA E ++ + +  
Sbjct: 157 RDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 216
Query: 287 KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 345
           K+DV+SFG+ LWEL+T G  PY  +      V ++Q   R   P++    L E++ +CW 
Sbjct: 217 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCWH 275
Query: 346 HDPTQRPNFSQI 357
                RP+FS++
Sbjct: 276 PKAEMRPSFSEL 287

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 126/252 (50%), Gaps = 14/252 (5%)
Query: 118 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 172
           +  G +G +Y GT    +      A+K L     +   + +F  E  IM+   H NV+  
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 173 IGACTRPP-NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 231
           +G C R   +  +V  +M  G + +F+  +     +  L+   + V+KGM +L     +H
Sbjct: 102 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVH 161
Query: 232 RDLKTANLLMDENGVVKVADFGVAR--VQAQSGVMTAETGT---YRWMAPEVIEHKPYDY 286
           RDL   N ++DE   VKVADFG+AR     +   +  +TG     +WMA E ++ + +  
Sbjct: 162 RDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 221
Query: 287 KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 345
           K+DV+SFG+ LWEL+T G  PY  +      V ++Q   R   P++    L E++ +CW 
Sbjct: 222 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCWH 280
Query: 346 HDPTQRPNFSQI 357
                RP+FS++
Sbjct: 281 PKAEMRPSFSEL 292

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 126/252 (50%), Gaps = 14/252 (5%)
Query: 118 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 172
           +  G +G +Y GT    +      A+K L     +   + +F  E  IM+   H NV+  
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 173 IGACTRPP-NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 231
           +G C R   +  +V  +M  G + +F+  +     +  L+   + V+KGM +L     +H
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVH 215
Query: 232 RDLKTANLLMDENGVVKVADFGVAR--VQAQSGVMTAETGT---YRWMAPEVIEHKPYDY 286
           RDL   N ++DE   VKVADFG+AR     +   +  +TG     +WMA E ++ + +  
Sbjct: 216 RDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 275
Query: 287 KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 345
           K+DV+SFG+ LWEL+T G  PY  +      V ++Q   R   P++    L E++ +CW 
Sbjct: 276 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCWH 334
Query: 346 HDPTQRPNFSQI 357
                RP+FS++
Sbjct: 335 PKAEMRPSFSEL 346

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 126/261 (48%), Gaps = 25/261 (9%)
Query: 128 KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN--LCIV 185
           +G    ++VA+K LKPE      + +  +E+ I+R + H+N+V++ G CT      + ++
Sbjct: 33  EGDNTGEQVAVKSLKPESGGNH-IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLI 91
Query: 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 245
            EF+  GS+ ++L K K    L   LK A+ + KGM+YL     +HRDL   N+L++   
Sbjct: 92  MEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH 151
Query: 246 VVKVADFGVARV----QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELL 301
            VK+ DFG+ +     +    V         W APE +    +   +DV+SFG+ L ELL
Sbjct: 152 QVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 211
Query: 302 T----------------GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 345
           T                G  P  G   +   V  +++  R   P +    + +L+ +CW+
Sbjct: 212 TYCDSDSSPMALFLKMIG--PTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWE 269
Query: 346 HDPTQRPNFSQITDILKQMMK 366
             P+ R +F  + +  + ++K
Sbjct: 270 FQPSNRTSFQNLIEGFEALLK 290

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 137/297 (46%), Gaps = 31/297 (10%)
Query: 98  PTDGTDVWEIDAKQLKIECKVASGSYGDLY------KGTYCSQEVAIKVLKPECVNTEML 151
           P    D    + + LK    +  G +G +       +G    ++VA+K LKPE      +
Sbjct: 9   PATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH-I 67
Query: 152 KEFSQEVYIMRKIRHKNVVQFIGACTRPPN--LCIVTEFMARGSIYDFLHKQKGVFQLTS 209
            +  +E+ I+R + H+N+V++ G CT      + ++ EF+  GS+ ++L K K    L  
Sbjct: 68  ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ 127
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMT 265
            LK A+ + KGM+YL     +HRDL   N+L++    VK+ DFG+ +     +    V  
Sbjct: 128 QLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKD 187
Query: 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT----------------GELPYAG 309
                  W APE +    +   +DV+SFG+ L ELLT                G  P  G
Sbjct: 188 DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG--PTHG 245
Query: 310 LTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
              +   V  +++  R   P +    + +L+ +CW+  P+ R +F  + +  + ++K
Sbjct: 246 QMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  121 bits (303), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 82/267 (30%), Positives = 131/267 (49%), Gaps = 24/267 (8%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 162
           D WEI  +       +  G++G +YK       V       +  + E L+++  E+ I+ 
Sbjct: 37  DFWEIIGE-------LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILA 89
Query: 163 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 222
              H N+V+ + A     NL I+ EF A G++   + + +     + +  V       +N
Sbjct: 90  SCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALN 149
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVA-----RVQAQSGVMTAETGTYRWMAPE 277
           YLH N IIHRDLK  N+L   +G +K+ADFGV+      +Q +   +    GT  WMAPE
Sbjct: 150 YLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFI----GTPYWMAPE 205
Query: 278 VI-----EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PK 330
           V+     + +PYDYKADV+S GI L E+   E P+  L P++  + +  KS  PT+  P 
Sbjct: 206 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA-KSEPPTLAQPS 264
Query: 331 HAHPRLAELLERCWQHDPTQRPNFSQI 357
                  + L++C + +   R   SQ+
Sbjct: 265 RWSSNFKDFLKKCLEKNVDARWTTSQL 291

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  121 bits (303), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 79/246 (32%), Positives = 127/246 (51%), Gaps = 10/246 (4%)
Query: 117 KVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           K+  GSYG +YK  +    Q VAIK +  E    E++KE S    IM++    +VV++ G
Sbjct: 36  KLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEIS----IMQQCDSPHVVKYYG 91
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +  +  +L IV E+   GS+ D +  +        +  +     KG+ YLH    IHRD+
Sbjct: 92  SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDI 151
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  N+L++  G  K+ADFGVA ++           GT  WMAPEVI+   Y+  AD++S 
Sbjct: 152 KAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIWSL 211
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELLERCWQHDPTQR 351
           GI   E+  G+ PYA + P++ A+ ++  +  PT   P+       + +++C    P QR
Sbjct: 212 GITAIEMAEGKPPYADIHPMR-AIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQR 270
Query: 352 PNFSQI 357
              +Q+
Sbjct: 271 ATATQL 276

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 74/249 (29%), Positives = 124/249 (49%), Gaps = 21/249 (8%)
Query: 136 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
           VA+K LK    +    ++F +E  ++  ++H+++V+F G CT    L +V E+M  G + 
Sbjct: 74  VAVKALKEASESAR--QDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLN 131
Query: 196 DFLHKQK--------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 241
            FL                  G   L  LL VA  V+ GM YL   + +HRDL T N L+
Sbjct: 132 RFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV 191
Query: 242 DENGVVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVIEHKPYDYKADVFSFGIALW 298
            +  VVK+ DFG++R    +        T    RWM PE I ++ +  ++DV+SFG+ LW
Sbjct: 192 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLW 251
Query: 299 ELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
           E+ T G+ P+  L+  + A+  + +      P+   P +  ++  CWQ +P QR +   +
Sbjct: 252 EIFTYGKQPWYQLSNTE-AIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDV 310
Query: 358 TDILKQMMK 366
              L+ + +
Sbjct: 311 HARLQALAQ 319

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 74/249 (29%), Positives = 124/249 (49%), Gaps = 21/249 (8%)
Query: 136 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
           VA+K LK    +    ++F +E  ++  ++H+++V+F G CT    L +V E+M  G + 
Sbjct: 51  VAVKALKEASESAR--QDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLN 108
Query: 196 DFLHKQK--------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 241
            FL                  G   L  LL VA  V+ GM YL   + +HRDL T N L+
Sbjct: 109 RFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV 168
Query: 242 DENGVVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVIEHKPYDYKADVFSFGIALW 298
            +  VVK+ DFG++R    +        T    RWM PE I ++ +  ++DV+SFG+ LW
Sbjct: 169 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLW 228
Query: 299 ELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
           E+ T G+ P+  L+  + A+  + +      P+   P +  ++  CWQ +P QR +   +
Sbjct: 229 EIFTYGKQPWYQLSNTE-AIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDV 287
Query: 358 TDILKQMMK 366
              L+ + +
Sbjct: 288 HARLQALAQ 296

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 74/249 (29%), Positives = 124/249 (49%), Gaps = 21/249 (8%)
Query: 136 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
           VA+K LK    +    ++F +E  ++  ++H+++V+F G CT    L +V E+M  G + 
Sbjct: 45  VAVKALKEASESAR--QDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLN 102
Query: 196 DFLHKQK--------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 241
            FL                  G   L  LL VA  V+ GM YL   + +HRDL T N L+
Sbjct: 103 RFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV 162
Query: 242 DENGVVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVIEHKPYDYKADVFSFGIALW 298
            +  VVK+ DFG++R    +        T    RWM PE I ++ +  ++DV+SFG+ LW
Sbjct: 163 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLW 222
Query: 299 ELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
           E+ T G+ P+  L+  + A+  + +      P+   P +  ++  CWQ +P QR +   +
Sbjct: 223 EIFTYGKQPWYQLSNTE-AIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDV 281
Query: 358 TDILKQMMK 366
              L+ + +
Sbjct: 282 HARLQALAQ 290

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 71/199 (35%), Positives = 114/199 (57%), Gaps = 13/199 (6%)
Query: 117 KVASGSYGDLYKGTYCSQEVAIKVLKP--ECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           K   G +G +YKG   +  VA+K L    +    E+ ++F QE+ +  K +H+N+V+ +G
Sbjct: 29  KXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLG 88
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT--SLLKVAIDVSKGMNYLHQNNIIHR 232
             +   +LC+V  +   GS+ D L    G   L+     K+A   + G+N+LH+N+ IHR
Sbjct: 89  FSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHHIHR 148
Query: 233 DLKTANLLMDENGVVKVADFGVARVQ---AQSGVMTAETGTYRWMAPEVI--EHKPYDYK 287
           D+K+AN+L+DE    K++DFG+AR     AQ    +   GT  + APE +  E  P   K
Sbjct: 149 DIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALRGEITP---K 205
Query: 288 ADVFSFGIALWELLTGELP 306
           +D++SFG+ L E++TG LP
Sbjct: 206 SDIYSFGVVLLEIITG-LP 223

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 135/270 (50%), Gaps = 23/270 (8%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIM 161
           I  +Q  +   +  G +G + +     ++     VA+K+LK + + +  ++EF +E   M
Sbjct: 20  IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACM 79
Query: 162 RKIRHKNVVQFIGACTRP------PNLCIVTEFMARGSIYDFLHKQK-----GVFQLTSL 210
           ++  H +V + +G   R       P   ++  FM  G ++ FL   +         L +L
Sbjct: 80  KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTL 139
Query: 211 LKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM----TA 266
           ++  +D++ GM YL   N IHRDL   N ++ E+  V VADFG++R +  SG       A
Sbjct: 140 VRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSR-KIYSGDYYRQGCA 198
Query: 267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLR 325
                +W+A E +    Y   +DV++FG+ +WE++T G+ PYAG+   +    ++  + R
Sbjct: 199 SKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN-R 257
Query: 326 PTIPKHAHPRLAELLERCWQHDPTQRPNFS 355
              P      + +L+ +CW  DP QRP+F+
Sbjct: 258 LKQPPECMEEVYDLMYQCWSADPKQRPSFT 287

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 140/271 (51%), Gaps = 20/271 (7%)
Query: 117 KVASGSYGDLYKGTYCSQ----EVAIKVLK--PECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           ++  G++G + +G Y  +    +VAIKVLK   E  +TE   E  +E  IM ++ +  +V
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE---EMMREAQIMHQLDNPYIV 73
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
           + IG C +   L +V E    G ++ FL  ++    ++++ ++   VS GM YL + N +
Sbjct: 74  RLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 132
Query: 231 HRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGT---YRWMAPEVIEHKPYDY 286
           HRDL   N+L+      K++DFG+++ + A     TA +      +W APE I  + +  
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 287 KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 345
           ++DV+S+G+ +WE L+ G+ PY  +   +  +  +++  R   P    P L  L+  CW 
Sbjct: 193 RSDVWSYGVTMWEALSYGQKPYKKMKGPE-VMAFIEQGKRMECPPECPPELYALMSDCWI 251
Query: 346 HDPTQRPNFSQITDILKQMMKEVLYWLSPNL 376
           +    RP+F  +    +Q M+   Y L+  +
Sbjct: 252 YKWEDRPDFLTV----EQRMRACYYSLASKV 278

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 136/285 (47%), Gaps = 29/285 (10%)
Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEF 154
           G+D  + + + LK   ++  G++G +    Y        + VA+K L+      E L++F
Sbjct: 1   GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDF 58
Query: 155 SQEVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLK 212
            +E+ I++ ++H N+V++ G C      NL ++ E++  GS+ D+L K K       LL+
Sbjct: 59  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118
Query: 213 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGT 270
               + KGM YL     IHRDL T N+L++    VK+ DFG+ +V  Q +      E G 
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 178
Query: 271 YR--WMAPEVIEHKPYDYKADVFSFGIALWELLT----GELPYA-----------GLTPL 313
               W APE +    +   +DV+SFG+ L+EL T     + P A           G   +
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238
Query: 314 QAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQIT 358
              + +++ + R   P      +  ++  CW ++  QRP+F  + 
Sbjct: 239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 283

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 146/273 (53%), Gaps = 13/273 (4%)
Query: 107 IDAKQLKIECK-VASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +D K L +E K + SG++G + KG Y      + VA+K+LK E  +  +  E   E  +M
Sbjct: 3   LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 62
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
           +++ +  +V+ IG C    +  +V E    G +  +L + + V +  +++++   VS GM
Sbjct: 63  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGM 120
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAET-GTY--RWMAPE 277
            YL ++N +HRDL   N+L+      K++DFG+++ ++A      A+T G +  +W APE
Sbjct: 121 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
            I +  +  K+DV+SFG+ +WE  + G+ PY G+   +    +++K  R   P      +
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGCPAGCPREM 239
Query: 337 AELLERCWQHDPTQRPNFSQITDILKQMMKEVL 369
            +L+  CW +D   RP F+ +   L+    +V+
Sbjct: 240 YDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 272

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 135/282 (47%), Gaps = 32/282 (11%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEV 158
           E+  +++ +  ++  GS+G +Y+G             VA+K +       E + EF  E 
Sbjct: 12  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEA 70
Query: 159 YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ---------LTS 209
            +M+     +VV+ +G  ++     +V E MA G +  +L   +   +         L  
Sbjct: 71  SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 130
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--------VQAQS 261
           ++++A +++ GM YL+    +HRDL   N ++  +  VK+ DFG+ R         +   
Sbjct: 131 MIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGK 190
Query: 262 GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVV 320
           G++       RWMAPE ++   +   +D++SFG+ LWE+ +  E PY GL+  Q    V+
Sbjct: 191 GLLPV-----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 245
Query: 321 QKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK 362
                   P +   R+ +L+  CWQ +P  RP F +I ++LK
Sbjct: 246 DGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 286

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 146/273 (53%), Gaps = 13/273 (4%)
Query: 107 IDAKQLKIECK-VASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +D K L +E K + SG++G + KG Y      + VA+K+LK E  +  +  E   E  +M
Sbjct: 1   LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 60
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
           +++ +  +V+ IG C    +  +V E    G +  +L + + V +  +++++   VS GM
Sbjct: 61  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGM 118
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAET-GTY--RWMAPE 277
            YL ++N +HRDL   N+L+      K++DFG+++ ++A      A+T G +  +W APE
Sbjct: 119 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 178
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
            I +  +  K+DV+SFG+ +WE  + G+ PY G+   +    +++K  R   P      +
Sbjct: 179 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGCPAGCPREM 237
Query: 337 AELLERCWQHDPTQRPNFSQITDILKQMMKEVL 369
            +L+  CW +D   RP F+ +   L+    +V+
Sbjct: 238 YDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 270

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 136/285 (47%), Gaps = 29/285 (10%)
Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEF 154
           G+D  + + + LK   ++  G++G +    Y        + VA+K L+      E L++F
Sbjct: 1   GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDF 58
Query: 155 SQEVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLK 212
            +E+ I++ ++H N+V++ G C      NL ++ E++  GS+ D+L K K       LL+
Sbjct: 59  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118
Query: 213 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGT 270
               + KGM YL     IHRDL T N+L++    VK+ DFG+ +V  Q +      E G 
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178
Query: 271 YR--WMAPEVIEHKPYDYKADVFSFGIALWELLT----GELPYA-----------GLTPL 313
               W APE +    +   +DV+SFG+ L+EL T     + P A           G   +
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238
Query: 314 QAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQIT 358
              + +++ + R   P      +  ++  CW ++  QRP+F  + 
Sbjct: 239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 283

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 146/273 (53%), Gaps = 13/273 (4%)
Query: 107 IDAKQLKIECK-VASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +D K L +E K + SG++G + KG Y      + VA+K+LK E  +  +  E   E  +M
Sbjct: 23  LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 82
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
           +++ +  +V+ IG C    +  +V E    G +  +L + + V +  +++++   VS GM
Sbjct: 83  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGM 140
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAET-GTY--RWMAPE 277
            YL ++N +HRDL   N+L+      K++DFG+++ ++A      A+T G +  +W APE
Sbjct: 141 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 200
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
            I +  +  K+DV+SFG+ +WE  + G+ PY G+   +    +++K  R   P      +
Sbjct: 201 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGCPAGCPREM 259
Query: 337 AELLERCWQHDPTQRPNFSQITDILKQMMKEVL 369
            +L+  CW +D   RP F+ +   L+    +V+
Sbjct: 260 YDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 292

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 146/273 (53%), Gaps = 13/273 (4%)
Query: 107 IDAKQLKIECK-VASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +D K L +E K + SG++G + KG Y      + VA+K+LK E  +  +  E   E  +M
Sbjct: 23  LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 82
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
           +++ +  +V+ IG C    +  +V E    G +  +L + + V +  +++++   VS GM
Sbjct: 83  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGM 140
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAET-GTY--RWMAPE 277
            YL ++N +HRDL   N+L+      K++DFG+++ ++A      A+T G +  +W APE
Sbjct: 141 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 200
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
            I +  +  K+DV+SFG+ +WE  + G+ PY G+   +    +++K  R   P      +
Sbjct: 201 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGCPAGCPREM 259
Query: 337 AELLERCWQHDPTQRPNFSQITDILKQMMKEVL 369
            +L+  CW +D   RP F+ +   L+    +V+
Sbjct: 260 YDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 292

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score =  117 bits (294), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 146/273 (53%), Gaps = 13/273 (4%)
Query: 107 IDAKQLKIECK-VASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +D K L +E K + SG++G + KG Y      + VA+K+LK E  +  +  E   E  +M
Sbjct: 7   LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 66
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
           +++ +  +V+ IG C    +  +V E    G +  +L + + V +  +++++   VS GM
Sbjct: 67  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGM 124
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAET-GTY--RWMAPE 277
            YL ++N +HRDL   N+L+      K++DFG+++ ++A      A+T G +  +W APE
Sbjct: 125 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPE 184
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
            I +  +  K+DV+SFG+ +WE  + G+ PY G+   +    +++K  R   P      +
Sbjct: 185 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGCPAGCPREM 243
Query: 337 AELLERCWQHDPTQRPNFSQITDILKQMMKEVL 369
            +L+  CW +D   RP F+ +   L+    +V+
Sbjct: 244 YDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 276

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score =  117 bits (294), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 146/273 (53%), Gaps = 13/273 (4%)
Query: 107 IDAKQLKIECK-VASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +D K L +E K + SG++G + KG Y      + VA+K+LK E  +  +  E   E  +M
Sbjct: 13  LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 72
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
           +++ +  +V+ IG C    +  +V E    G +  +L + + V +  +++++   VS GM
Sbjct: 73  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGM 130
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAET-GTY--RWMAPE 277
            YL ++N +HRDL   N+L+      K++DFG+++ ++A      A+T G +  +W APE
Sbjct: 131 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 190
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
            I +  +  K+DV+SFG+ +WE  + G+ PY G+   +    +++K  R   P      +
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGCPAGCPREM 249
Query: 337 AELLERCWQHDPTQRPNFSQITDILKQMMKEVL 369
            +L+  CW +D   RP F+ +   L+    +V+
Sbjct: 250 YDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score =  117 bits (294), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 146/273 (53%), Gaps = 13/273 (4%)
Query: 107 IDAKQLKIECK-VASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +D K L +E K + SG++G + KG Y      + VA+K+LK E  +  +  E   E  +M
Sbjct: 7   LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 66
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
           +++ +  +V+ IG C    +  +V E    G +  +L + + V +  +++++   VS GM
Sbjct: 67  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGM 124
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAET-GTY--RWMAPE 277
            YL ++N +HRDL   N+L+      K++DFG+++ ++A      A+T G +  +W APE
Sbjct: 125 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 184
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
            I +  +  K+DV+SFG+ +WE  + G+ PY G+   +    +++K  R   P      +
Sbjct: 185 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGCPAGCPREM 243
Query: 337 AELLERCWQHDPTQRPNFSQITDILKQMMKEVL 369
            +L+  CW +D   RP F+ +   L+    +V+
Sbjct: 244 YDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 276

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 146/273 (53%), Gaps = 13/273 (4%)
Query: 107 IDAKQLKIECK-VASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +D K L +E K + SG++G + KG Y      + VA+K+LK E  +  +  E   E  +M
Sbjct: 21  LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 80
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
           +++ +  +V+ IG C    +  +V E    G +  +L + + V +  +++++   VS GM
Sbjct: 81  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGM 138
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAET-GTY--RWMAPE 277
            YL ++N +HRDL   N+L+      K++DFG+++ ++A      A+T G +  +W APE
Sbjct: 139 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 198
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
            I +  +  K+DV+SFG+ +WE  + G+ PY G+   +    +++K  R   P      +
Sbjct: 199 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGCPAGCPREM 257
Query: 337 AELLERCWQHDPTQRPNFSQITDILKQMMKEVL 369
            +L+  CW +D   RP F+ +   L+    +V+
Sbjct: 258 YDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 290

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 137/289 (47%), Gaps = 29/289 (10%)
Query: 97  IPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEM 150
           +P    ++ + + + LK   ++  G++G +    Y        + VA+K L+      E 
Sbjct: 15  VPRGSHNMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEH 72
Query: 151 LKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLT 208
           L++F +E+ I++ ++H N+V++ G C      NL ++ E++  GS+ D+L K K      
Sbjct: 73  LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI 132
Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTA 266
            LL+    + KGM YL     IHRDL T N+L++    VK+ DFG+ +V  Q +      
Sbjct: 133 KLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 192
Query: 267 ETGTYR--WMAPEVIEHKPYDYKADVFSFGIALWELLT----GELPYA-----------G 309
           E G     W APE +    +   +DV+SFG+ L+EL T     + P A           G
Sbjct: 193 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 252
Query: 310 LTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQIT 358
              +   + +++ + R   P      +  ++  CW ++  QRP+F  + 
Sbjct: 253 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 301

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 137/289 (47%), Gaps = 29/289 (10%)
Query: 97  IPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEM 150
           +P    ++ + + + LK   ++  G++G +    Y        + VA+K L+      E 
Sbjct: 15  VPRGSHNMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEH 72
Query: 151 LKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLT 208
           L++F +E+ I++ ++H N+V++ G C      NL ++ E++  GS+ D+L K K      
Sbjct: 73  LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI 132
Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTA 266
            LL+    + KGM YL     IHRDL T N+L++    VK+ DFG+ +V  Q +      
Sbjct: 133 KLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 192
Query: 267 ETGTYR--WMAPEVIEHKPYDYKADVFSFGIALWELLT----GELPYA-----------G 309
           E G     W APE +    +   +DV+SFG+ L+EL T     + P A           G
Sbjct: 193 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 252
Query: 310 LTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQIT 358
              +   + +++ + R   P      +  ++  CW ++  QRP+F  + 
Sbjct: 253 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 301

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 87/274 (31%), Positives = 129/274 (47%), Gaps = 15/274 (5%)
Query: 117 KVASGSYGDLY--KGTYCSQEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNVVQFI 173
           ++  GS+G +Y  +    S+ VAIK +      + E  ++  +EV  ++K+RH N +Q+ 
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
           G   R     +V E+   GS  D L   K   Q   +  V     +G+ YLH +N+IHRD
Sbjct: 82  GCYLREHTAWLVMEY-CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI---EHKPYDYKADV 290
           +K  N+L+ E G+VK+ DFG A + A +       GT  WMAPEVI   +   YD K DV
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYDGKVDV 197
Query: 291 FSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ 350
           +S GI   EL   + P   +  + A   + Q         H        ++ C Q  P  
Sbjct: 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQD 257
Query: 351 RPNFSQITDILKQMMKEVLYWLSPNLINTNIQST 384
           RP  S++  +LK     VL    P +I   IQ T
Sbjct: 258 RPT-SEV--LLKHRF--VLRERPPTVIMDLIQRT 286

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 87/274 (31%), Positives = 130/274 (47%), Gaps = 15/274 (5%)
Query: 117 KVASGSYGDLY--KGTYCSQEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNVVQFI 173
           ++  GS+G +Y  +    S+ VAIK +      + E  ++  +EV  ++K+RH N +Q+ 
Sbjct: 61  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
           G   R     +V E+   GS  D L   K   Q   +  V     +G+ YLH +N+IHRD
Sbjct: 121 GCYLREHTAWLVMEY-CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 179
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI---EHKPYDYKADV 290
           +K  N+L+ E G+VK+ DFG A + A +       GT  WMAPEVI   +   YD K DV
Sbjct: 180 VKAGNILLSEPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYDGKVDV 236
Query: 291 FSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ 350
           +S GI   EL   + P   +  + A   + Q         H        ++ C Q  P  
Sbjct: 237 WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQD 296
Query: 351 RPNFSQITDILKQMMKEVLYWLSPNLINTNIQST 384
           RP  S++  +LK   + VL    P +I   IQ T
Sbjct: 297 RPT-SEV--LLKH--RFVLRERPPTVIMDLIQRT 325

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 138/282 (48%), Gaps = 22/282 (7%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           ID   L +   +  G +G + +G        S +VA+K +K +  +   ++EF  E   M
Sbjct: 31  IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACM 90
Query: 162 RKIRHKNVVQFIGACTRP-----PNLCIVTEFMARGSIYDFLHKQK-----GVFQLTSLL 211
           +   H NV++ +G C        P   ++  FM  G ++ +L   +         L +LL
Sbjct: 91  KDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLL 150
Query: 212 KVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT- 270
           K  +D++ GM YL   N +HRDL   N ++ ++  V VADFG+++ +  SG    +    
Sbjct: 151 KFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSK-KIYSGDYYRQGRIA 209
Query: 271 ---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRP 326
               +W+A E +  + Y  K+DV++FG+ +WE+ T G  PY G+   +    ++    R 
Sbjct: 210 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH-RL 268
Query: 327 TIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV 368
             P+     L E++  CW+ DP  RP FS +   L+++++ +
Sbjct: 269 KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 72/243 (29%), Positives = 132/243 (54%), Gaps = 11/243 (4%)
Query: 118 VASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
           +  G+YG +Y G   S +V I + +    ++   +   +E+ + + ++HKN+VQ++G+ +
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLT--SLLKVAIDVSKGMNYLHQNNIIHRDLK 235
               + I  E +  GS+   L  + G  +    ++      + +G+ YLH N I+HRD+K
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149
Query: 236 TANLLMDE-NGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDY--KADVF 291
             N+L++  +GV+K++DFG ++  A     T   TGT ++MAPE+I+  P  Y   AD++
Sbjct: 150 GDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIW 209
Query: 292 SFGIALWELLTGELPYAGLTPLQAA---VGVVQKSLRPTIPKHAHPRLAELLERCWQHDP 348
           S G  + E+ TG+ P+  L   QAA   VG+ +  + P IP+         + +C++ DP
Sbjct: 210 SLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK--VHPEIPESMSAEAKAFILKCFEPDP 267
Query: 349 TQR 351
            +R
Sbjct: 268 DKR 270

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 88/301 (29%), Positives = 147/301 (48%), Gaps = 52/301 (17%)
Query: 109 AKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHK 167
           AKQ+++  ++  G YG+++ G +  ++VA+KV       TE    F + E+Y    +RH+
Sbjct: 36  AKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVF----FTTEEASWFRETEIYQTVLMRHE 91
Query: 168 NVVQFIGACTRPPN----LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 223
           N++ FI A  +       L ++T++   GS+YD+L  +       S+LK+A     G+ +
Sbjct: 92  NILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGLCH 149
Query: 224 LH--------QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE------TG 269
           LH        +  I HRDLK+ N+L+ +NG   +AD G+A V+  S     +       G
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VKFISDTNEVDIPPNTRVG 208
Query: 270 TYRWMAPEVIE------HKPYDYKADVFSFGIALWEL----LTG------ELPYAGLTPL 313
           T R+M PEV++      H      AD++SFG+ LWE+    ++G      +LPY  L P 
Sbjct: 209 TKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS 268
Query: 314 QAAVG-----VVQKSLRPTIPKHAHP-----RLAELLERCWQHDPTQRPNFSQITDILKQ 363
             +       V  K LRP+ P          ++ +L+  CW H+P  R    ++   L +
Sbjct: 269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328
Query: 364 M 364
           M
Sbjct: 329 M 329

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 72/243 (29%), Positives = 132/243 (54%), Gaps = 11/243 (4%)
Query: 118 VASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
           +  G+YG +Y G   S +V I + +    ++   +   +E+ + + ++HKN+VQ++G+ +
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLT--SLLKVAIDVSKGMNYLHQNNIIHRDLK 235
               + I  E +  GS+   L  + G  +    ++      + +G+ YLH N I+HRD+K
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 135
Query: 236 TANLLMDE-NGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDY--KADVF 291
             N+L++  +GV+K++DFG ++  A     T   TGT ++MAPE+I+  P  Y   AD++
Sbjct: 136 GDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIW 195
Query: 292 SFGIALWELLTGELPYAGLTPLQAA---VGVVQKSLRPTIPKHAHPRLAELLERCWQHDP 348
           S G  + E+ TG+ P+  L   QAA   VG+ +  + P IP+         + +C++ DP
Sbjct: 196 SLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK--VHPEIPESMSAEAKAFILKCFEPDP 253
Query: 349 TQR 351
            +R
Sbjct: 254 DKR 256

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 139/268 (51%), Gaps = 20/268 (7%)
Query: 117 KVASGSYGDLYKGTYCSQ----EVAIKVLK--PECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           ++  G++G + +G Y  +    +VAIKVLK   E  +TE   E  +E  IM ++ +  +V
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE---EMMREAQIMHQLDNPYIV 399
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
           + IG C +   L +V E    G ++ FL  ++    ++++ ++   VS GM YL + N +
Sbjct: 400 RLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 458
Query: 231 HRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETG---TYRWMAPEVIEHKPYDY 286
           HR+L   N+L+      K++DFG+++ + A     TA +      +W APE I  + +  
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518
Query: 287 KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 345
           ++DV+S+G+ +WE L+ G+ PY  +   +  +  +++  R   P    P L  L+  CW 
Sbjct: 519 RSDVWSYGVTMWEALSYGQKPYKKMKGPE-VMAFIEQGKRMECPPECPPELYALMSDCWI 577
Query: 346 HDPTQRPNFSQITDILKQMMKEVLYWLS 373
           +    RP+F  +    +Q M+   Y L+
Sbjct: 578 YKWEDRPDFLTV----EQRMRACYYSLA 601

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 146/273 (53%), Gaps = 13/273 (4%)
Query: 107 IDAKQLKIECK-VASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +D K L +E K + SG++G + KG Y      + VA+K+LK E  +  +  E   E  +M
Sbjct: 365 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 424
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
           +++ +  +V+ IG C    +  +V E    G +  +L + + V +  +++++   VS GM
Sbjct: 425 QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGM 482
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAET-GTY--RWMAPE 277
            YL ++N +HRDL   N+L+      K++DFG+++ ++A      A+T G +  +W APE
Sbjct: 483 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 542
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
            I +  +  K+DV+SFG+ +WE  + G+ PY G+   +    +++K  R   P      +
Sbjct: 543 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA-MLEKGERMGCPAGCPREM 601
Query: 337 AELLERCWQHDPTQRPNFSQITDILKQMMKEVL 369
            +L+  CW +D   RP F+ +   L+    +V+
Sbjct: 602 YDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 634

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 146/273 (53%), Gaps = 13/273 (4%)
Query: 107 IDAKQLKIECK-VASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +D K L +E K + SG++G + KG Y      + VA+K+LK E  +  +  E   E  +M
Sbjct: 366 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 425
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
           +++ +  +V+ IG C    +  +V E    G +  +L + + V +  +++++   VS GM
Sbjct: 426 QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGM 483
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAET-GTY--RWMAPE 277
            YL ++N +HRDL   N+L+      K++DFG+++ ++A      A+T G +  +W APE
Sbjct: 484 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 543
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
            I +  +  K+DV+SFG+ +WE  + G+ PY G+   +    +++K  R   P      +
Sbjct: 544 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA-MLEKGERMGCPAGCPREM 602
Query: 337 AELLERCWQHDPTQRPNFSQITDILKQMMKEVL 369
            +L+  CW +D   RP F+ +   L+    +V+
Sbjct: 603 YDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 635

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 136/287 (47%), Gaps = 29/287 (10%)
Query: 99  TDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLK 152
           ++  D  + + + LK   ++  G++G +    Y        + VA+K L+      E L+
Sbjct: 2   SEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLR 59
Query: 153 EFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSL 210
           +F +E+ I++ ++H N+V++ G C      NL ++ E++  GS+ D+L K K       L
Sbjct: 60  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 119
Query: 211 LKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAET 268
           L+    + KGM YL     IHRDL T N+L++    VK+ DFG+ +V  Q +      E 
Sbjct: 120 LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 179
Query: 269 GTYR--WMAPEVIEHKPYDYKADVFSFGIALWELLT----GELPYA-----------GLT 311
           G     W APE +    +   +DV+SFG+ L+EL T     + P A           G  
Sbjct: 180 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 239
Query: 312 PLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQIT 358
            +   + +++ + R   P      +  ++  CW ++  QRP+F  + 
Sbjct: 240 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 286

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 134/283 (47%), Gaps = 29/283 (10%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQ 156
           D  + + + LK   ++  G++G +    Y        + VA+K L+      E L++F +
Sbjct: 1   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFER 58
Query: 157 EVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVA 214
           E+ I++ ++H N+V++ G C      NL ++ E++  GS+ D+L K K       LL+  
Sbjct: 59  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 118
Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGTYR 272
             + KGM YL     IHRDL T N+L++    VK+ DFG+ +V  Q +      E G   
Sbjct: 119 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 178
Query: 273 --WMAPEVIEHKPYDYKADVFSFGIALWELLT----GELPYA-----------GLTPLQA 315
             W APE +    +   +DV+SFG+ L+EL T     + P A           G   +  
Sbjct: 179 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 238
Query: 316 AVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQIT 358
            + +++ + R   P      +  ++  CW ++  QRP+F  + 
Sbjct: 239 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 281

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 134/283 (47%), Gaps = 29/283 (10%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQ 156
           D  + + + LK   ++  G++G +    Y        + VA+K L+      E L++F +
Sbjct: 8   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFER 65
Query: 157 EVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVA 214
           E+ I++ ++H N+V++ G C      NL ++ E++  GS+ D+L K K       LL+  
Sbjct: 66  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 125
Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGTYR 272
             + KGM YL     IHRDL T N+L++    VK+ DFG+ +V  Q +      E G   
Sbjct: 126 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 185
Query: 273 --WMAPEVIEHKPYDYKADVFSFGIALWELLT----GELPYA-----------GLTPLQA 315
             W APE +    +   +DV+SFG+ L+EL T     + P A           G   +  
Sbjct: 186 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 245
Query: 316 AVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQIT 358
            + +++ + R   P      +  ++  CW ++  QRP+F  + 
Sbjct: 246 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 288

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 139/291 (47%), Gaps = 48/291 (16%)
Query: 119 ASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR 178
           A G +G ++K    ++ VA+K+     +  +   +   EVY +  ++H+N++QFIGA  R
Sbjct: 33  ARGRFGCVWKAQLLNEYVAVKIFP---IQDKQSWQNEYEVYSLPGMKHENILQFIGAEKR 89
Query: 179 PP----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN------- 227
                 +L ++T F  +GS+ DFL  +  V     L  +A  +++G+ YLH++       
Sbjct: 90  GTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAETMARGLAYLHEDIPGLKDG 147
Query: 228 ---NIIHRDLKTANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIE- 280
               I HRD+K+ N+L+  N    +ADFG+A        +G    + GT R+MAPEV+E 
Sbjct: 148 HKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEG 207
Query: 281 ----HKPYDYKADVFSFGIALWELLTGELPYAG-----LTPLQAAVG-----------VV 320
                +    + D+++ G+ LWEL +      G     + P +  +G           VV
Sbjct: 208 AINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVV 267
Query: 321 QKSLRPTI----PKHAH-PRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
            K  RP +     KHA    L E +E CW HD   R +   + + + QM +
Sbjct: 268 HKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 134/283 (47%), Gaps = 29/283 (10%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQ 156
           D  + + + LK   ++  G++G +    Y        + VA+K L+      E L++F +
Sbjct: 34  DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFER 91
Query: 157 EVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVA 214
           E+ I++ ++H N+V++ G C      NL ++ E++  GS+ D+L K K       LL+  
Sbjct: 92  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 151
Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGTYR 272
             + KGM YL     IHRDL T N+L++    VK+ DFG+ +V  Q +      E G   
Sbjct: 152 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 211
Query: 273 --WMAPEVIEHKPYDYKADVFSFGIALWELLT----GELPYA-----------GLTPLQA 315
             W APE +    +   +DV+SFG+ L+EL T     + P A           G   +  
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271
Query: 316 AVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQIT 358
            + +++ + R   P      +  ++  CW ++  QRP+F  + 
Sbjct: 272 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 314

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 134/283 (47%), Gaps = 29/283 (10%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQ 156
           D  + + + LK   ++  G++G +    Y        + VA+K L+      E L++F +
Sbjct: 10  DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFER 67
Query: 157 EVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVA 214
           E+ I++ ++H N+V++ G C      NL ++ E++  GS+ D+L K K       LL+  
Sbjct: 68  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 127
Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGTYR 272
             + KGM YL     IHRDL T N+L++    VK+ DFG+ +V  Q +      E G   
Sbjct: 128 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 187
Query: 273 --WMAPEVIEHKPYDYKADVFSFGIALWELLT----GELPYA-----------GLTPLQA 315
             W APE +    +   +DV+SFG+ L+EL T     + P A           G   +  
Sbjct: 188 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 247
Query: 316 AVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQIT 358
            + +++ + R   P      +  ++  CW ++  QRP+F  + 
Sbjct: 248 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 290

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 134/283 (47%), Gaps = 29/283 (10%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQ 156
           D  + + + LK   ++  G++G +    Y        + VA+K L+      E L++F +
Sbjct: 3   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFER 60
Query: 157 EVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVA 214
           E+ I++ ++H N+V++ G C      NL ++ E++  GS+ D+L K K       LL+  
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120
Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGTYR 272
             + KGM YL     IHRDL T N+L++    VK+ DFG+ +V  Q +      E G   
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 180
Query: 273 --WMAPEVIEHKPYDYKADVFSFGIALWELLT----GELPYA-----------GLTPLQA 315
             W APE +    +   +DV+SFG+ L+EL T     + P A           G   +  
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240
Query: 316 AVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQIT 358
            + +++ + R   P      +  ++  CW ++  QRP+F  + 
Sbjct: 241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 283

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 134/283 (47%), Gaps = 29/283 (10%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQ 156
           D  + + + LK   ++  G++G +    Y        + VA+K L+      E L++F +
Sbjct: 7   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFER 64
Query: 157 EVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVA 214
           E+ I++ ++H N+V++ G C      NL ++ E++  GS+ D+L K K       LL+  
Sbjct: 65  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 124
Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGTYR 272
             + KGM YL     IHRDL T N+L++    VK+ DFG+ +V  Q +      E G   
Sbjct: 125 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 184
Query: 273 --WMAPEVIEHKPYDYKADVFSFGIALWELLT----GELPYA-----------GLTPLQA 315
             W APE +    +   +DV+SFG+ L+EL T     + P A           G   +  
Sbjct: 185 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 244
Query: 316 AVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQIT 358
            + +++ + R   P      +  ++  CW ++  QRP+F  + 
Sbjct: 245 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 287

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 134/283 (47%), Gaps = 29/283 (10%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQ 156
           D  + + + LK   ++  G++G +    Y        + VA+K L+      E L++F +
Sbjct: 2   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFER 59
Query: 157 EVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVA 214
           E+ I++ ++H N+V++ G C      NL ++ E++  GS+ D+L K K       LL+  
Sbjct: 60  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 119
Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGTYR 272
             + KGM YL     IHRDL T N+L++    VK+ DFG+ +V  Q +      E G   
Sbjct: 120 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 179
Query: 273 --WMAPEVIEHKPYDYKADVFSFGIALWELLT----GELPYA-----------GLTPLQA 315
             W APE +    +   +DV+SFG+ L+EL T     + P A           G   +  
Sbjct: 180 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 239
Query: 316 AVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQIT 358
            + +++ + R   P      +  ++  CW ++  QRP+F  + 
Sbjct: 240 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 282

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 134/283 (47%), Gaps = 29/283 (10%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQ 156
           D  + + + LK   ++  G++G +    Y        + VA+K L+      E L++F +
Sbjct: 9   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFER 66
Query: 157 EVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVA 214
           E+ I++ ++H N+V++ G C      NL ++ E++  GS+ D+L K K       LL+  
Sbjct: 67  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 126
Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGTYR 272
             + KGM YL     IHRDL T N+L++    VK+ DFG+ +V  Q +      E G   
Sbjct: 127 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 186
Query: 273 --WMAPEVIEHKPYDYKADVFSFGIALWELLT----GELPYA-----------GLTPLQA 315
             W APE +    +   +DV+SFG+ L+EL T     + P A           G   +  
Sbjct: 187 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 246
Query: 316 AVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQIT 358
            + +++ + R   P      +  ++  CW ++  QRP+F  + 
Sbjct: 247 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 289

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 77/246 (31%), Positives = 129/246 (52%), Gaps = 10/246 (4%)
Query: 117 KVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176
           K+  GS G +   T  S    + V K +    +  +    EV IMR  +H+NVV+   + 
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 177 TRPPNLCIVTEFMARGSIYDFL-HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
                L +V EF+  G++ D + H +    Q+ +   V + V + ++ LH   +IHRD+K
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---VCLAVLQALSVLHAQGVIHRDIK 143
Query: 236 TANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           + ++L+  +G VK++DFG  A+V  +        GT  WMAPE+I   PY  + D++S G
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 203
Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH---PRLAELLERCWQHDPTQR 351
           I + E++ GE PY    PL+ A+ +++ +L P + K+ H   P L   L+R    DP QR
Sbjct: 204 IMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRL-KNLHKVSPSLKGFLDRLLVRDPAQR 261
Query: 352 PNFSQI 357
              +++
Sbjct: 262 ATAAEL 267

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 77/246 (31%), Positives = 129/246 (52%), Gaps = 10/246 (4%)
Query: 117 KVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176
           K+  GS G +   T  S    + V K +    +  +    EV IMR  +H+NVV+   + 
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 90
Query: 177 TRPPNLCIVTEFMARGSIYDFL-HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
                L +V EF+  G++ D + H +    Q+ +   V + V + ++ LH   +IHRD+K
Sbjct: 91  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---VCLAVLQALSVLHAQGVIHRDIK 147
Query: 236 TANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           + ++L+  +G VK++DFG  A+V  +        GT  WMAPE+I   PY  + D++S G
Sbjct: 148 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 207
Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH---PRLAELLERCWQHDPTQR 351
           I + E++ GE PY    PL+ A+ +++ +L P + K+ H   P L   L+R    DP QR
Sbjct: 208 IMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRL-KNLHKVSPSLKGFLDRLLVRDPAQR 265
Query: 352 PNFSQI 357
              +++
Sbjct: 266 ATAAEL 271

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score =  114 bits (285), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 134/283 (47%), Gaps = 29/283 (10%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQ 156
           D  + + + LK   ++  G++G +    Y        + VA+K L+      E L++F +
Sbjct: 6   DPTQFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFER 63
Query: 157 EVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVA 214
           E+ I++ ++H N+V++ G C      NL ++ EF+  GS+ ++L K K       LL+  
Sbjct: 64  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYT 123
Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGTYR 272
             + KGM YL     IHRDL T N+L++    VK+ DFG+ +V  Q +      E G   
Sbjct: 124 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 183
Query: 273 --WMAPEVIEHKPYDYKADVFSFGIALWELLT----GELPYA-----------GLTPLQA 315
             W APE +    +   +DV+SFG+ L+EL T     + P A           G   +  
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 243
Query: 316 AVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQIT 358
            + +++ + R   P      +  ++  CW ++  QRP+F  + 
Sbjct: 244 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 286

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score =  114 bits (285), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 139/278 (50%), Gaps = 51/278 (18%)
Query: 119 ASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR 178
           A G +G ++K    +  VA+K+     +  +   +  +E++    ++H+N++QFI A  R
Sbjct: 24  ARGRFGCVWKAQLMNDFVAVKIFP---LQDKQSWQSEREIFSTPGMKHENLLQFIAAEKR 80
Query: 179 PPNL----CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN------- 227
             NL     ++T F  +GS+ D+L  +  +     L  VA  +S+G++YLH++       
Sbjct: 81  GSNLEVELWLITAFHDKGSLTDYL--KGNIITWNELCHVAETMSRGLSYLHEDVPWCRGE 138
Query: 228 ----NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET----GTYRWMAPEVI 279
               +I HRD K+ N+L+  +    +ADFG+A V+ + G    +T    GT R+MAPEV+
Sbjct: 139 GHKPSIAHRDFKSKNVLLKSDLTAVLADFGLA-VRFEPGKPPGDTHGQVGTRRYMAPEVL 197
Query: 280 E-----HKPYDYKADVFSFGIALWELLTGELPYAG-----LTPLQAAVG----------- 318
           E      +    + D+++ G+ LWEL++      G     + P +  +G           
Sbjct: 198 EGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFEEEIGQHPSLEELQEV 257
Query: 319 VVQKSLRPTIPKH--AHPRLAEL---LERCWQHDPTQR 351
           VV K +RPTI  H   HP LA+L   +E CW HD   R
Sbjct: 258 VVHKKMRPTIKDHWLKHPGLAQLCVTIEECWDHDAEAR 295

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  114 bits (285), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 77/246 (31%), Positives = 129/246 (52%), Gaps = 10/246 (4%)
Query: 117 KVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176
           K+  GS G +   T  S    + V K +    +  +    EV IMR  +H+NVV+   + 
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 95
Query: 177 TRPPNLCIVTEFMARGSIYDFL-HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
                L +V EF+  G++ D + H +    Q+ +   V + V + ++ LH   +IHRD+K
Sbjct: 96  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---VCLAVLQALSVLHAQGVIHRDIK 152
Query: 236 TANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           + ++L+  +G VK++DFG  A+V  +        GT  WMAPE+I   PY  + D++S G
Sbjct: 153 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 212
Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH---PRLAELLERCWQHDPTQR 351
           I + E++ GE PY    PL+ A+ +++ +L P + K+ H   P L   L+R    DP QR
Sbjct: 213 IMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRL-KNLHKVSPSLKGFLDRLLVRDPAQR 270
Query: 352 PNFSQI 357
              +++
Sbjct: 271 ATAAEL 276

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  114 bits (285), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 77/246 (31%), Positives = 129/246 (52%), Gaps = 10/246 (4%)
Query: 117 KVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176
           K+  GS G +   T  S    + V K +    +  +    EV IMR  +H+NVV+   + 
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 97
Query: 177 TRPPNLCIVTEFMARGSIYDFL-HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
                L +V EF+  G++ D + H +    Q+ +   V + V + ++ LH   +IHRD+K
Sbjct: 98  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---VCLAVLQALSVLHAQGVIHRDIK 154
Query: 236 TANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           + ++L+  +G VK++DFG  A+V  +        GT  WMAPE+I   PY  + D++S G
Sbjct: 155 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 214
Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH---PRLAELLERCWQHDPTQR 351
           I + E++ GE PY    PL+ A+ +++ +L P + K+ H   P L   L+R    DP QR
Sbjct: 215 IMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRL-KNLHKVSPSLKGFLDRLLVRDPAQR 272
Query: 352 PNFSQI 357
              +++
Sbjct: 273 ATAAEL 278

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score =  114 bits (285), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 94/163 (57%), Gaps = 4/163 (2%)
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266
           +  L+  +  V++GM +L     IHRDL   N+L+ EN VVK+ DFG+AR   ++     
Sbjct: 198 MEDLISYSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVR 257
Query: 267 ETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK 322
           +  T    +WMAPE I  K Y  K+DV+S+G+ LWE+ + G  PY G+   +     +++
Sbjct: 258 KGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRLRE 317
Query: 323 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
            +R   P+++ P + +++  CW  DP +RP F+++ + L  ++
Sbjct: 318 GMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKLGDLL 360

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 131/266 (49%), Gaps = 25/266 (9%)
Query: 117 KVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176
           KV+   Y     GT   + VA+K LK +C   +    + QE+ I+R + H++++++ G C
Sbjct: 29  KVSLYCYDPTNDGT--GEMVAVKALKADC-GPQHRSGWKQEIDILRTLYHEHIIKYKGCC 85
Query: 177 TR--PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                 +L +V E++  GS+ D+L +      L  LL  A  + +GM YLH  + IHR+L
Sbjct: 86  EDQGEKSLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHSQHYIHRNL 143
Query: 235 KTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGTYR--WMAPEVIEHKPYDYKADV 290
              N+L+D + +VK+ DFG+A+   +        E G     W APE ++   + Y +DV
Sbjct: 144 AARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDV 203
Query: 291 FSFGIALWELLTG-ELPYAGLTPLQAAVGVVQKSL-------------RPTIPKHAHPRL 336
           +SFG+ L+ELLT  +   +  T     +G+ Q  +             R   P      +
Sbjct: 204 WSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEV 263
Query: 337 AELLERCWQHDPTQRPNFSQITDILK 362
             L++ CW+ + + RP F  +  ILK
Sbjct: 264 YHLMKNCWETEASFRPTFENLIPILK 289

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 131/266 (49%), Gaps = 25/266 (9%)
Query: 117 KVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176
           KV+   Y     GT   + VA+K LK +C   +    + QE+ I+R + H++++++ G C
Sbjct: 29  KVSLYCYDPTNDGT--GEMVAVKALKADC-GPQHRSGWKQEIDILRTLYHEHIIKYKGCC 85
Query: 177 TR--PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                 +L +V E++  GS+ D+L +      L  LL  A  + +GM YLH  + IHR+L
Sbjct: 86  EDQGEKSLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQHYIHRNL 143
Query: 235 KTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGTYR--WMAPEVIEHKPYDYKADV 290
              N+L+D + +VK+ DFG+A+   +        E G     W APE ++   + Y +DV
Sbjct: 144 AARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDV 203
Query: 291 FSFGIALWELLTG-ELPYAGLTPLQAAVGVVQKSL-------------RPTIPKHAHPRL 336
           +SFG+ L+ELLT  +   +  T     +G+ Q  +             R   P      +
Sbjct: 204 WSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEV 263
Query: 337 AELLERCWQHDPTQRPNFSQITDILK 362
             L++ CW+ + + RP F  +  ILK
Sbjct: 264 YHLMKNCWETEASFRPTFENLIPILK 289

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 123/247 (49%), Gaps = 23/247 (9%)
Query: 136 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC--TRPPNLCIVTEFMARGS 193
           VA+K LK +    +    + QE+ I+R + H++++++ G C      +L +V E++  GS
Sbjct: 63  VAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGS 121
Query: 194 IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG 253
           + D+L +      L  LL  A  + +GM YLH  + IHRDL   N+L+D + +VK+ DFG
Sbjct: 122 LRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFG 179
Query: 254 VARV--QAQSGVMTAETGTYR--WMAPEVIEHKPYDYKADVFSFGIALWELLTG-ELPYA 308
           +A+   +        E G     W APE ++   + Y +DV+SFG+ L+ELLT  +   +
Sbjct: 180 LAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239
Query: 309 GLTPLQAAVGVVQKSL-------------RPTIPKHAHPRLAELLERCWQHDPTQRPNFS 355
             T     +G+ Q  +             R   P      +  L++ CW+ + + RP F 
Sbjct: 240 PPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFE 299
Query: 356 QITDILK 362
            +  ILK
Sbjct: 300 NLIPILK 306

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 149/304 (49%), Gaps = 52/304 (17%)
Query: 109 AKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHK 167
           A+ + ++  +  G +G++++G +  +EVA+K+      + E    F + E+Y    +RH+
Sbjct: 3   ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFS----SREERSWFREAEIYQTVMLRHE 58
Query: 168 NVVQFIGACTRP----PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 223
           N++ FI A  +       L +V+++   GS++D+L++      +  ++K+A+  + G+ +
Sbjct: 59  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAH 116
Query: 224 LHQN--------NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE------TG 269
           LH           I HRDLK+ N+L+ +NG   +AD G+A V+  S   T +       G
Sbjct: 117 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVG 175
Query: 270 TYRWMAPEVIE------HKPYDYKADVFSFGIALWELLTG----------ELPYAGLTPL 313
           T R+MAPEV++      H     +AD+++ G+  WE+             +LPY  L P 
Sbjct: 176 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 235
Query: 314 QAAVG-----VVQKSLRPTIPKH-----AHPRLAELLERCWQHDPTQRPNFSQITDILKQ 363
             +V      V ++ LRP IP       A   +A+++  CW  +   R    +I   L Q
Sbjct: 236 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 295
Query: 364 MMKE 367
           + ++
Sbjct: 296 LSQQ 299

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 149/304 (49%), Gaps = 52/304 (17%)
Query: 109 AKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHK 167
           A+ + ++  +  G +G++++G +  +EVA+K+      + E    F + E+Y    +RH+
Sbjct: 28  ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFS----SREERSWFREAEIYQTVMLRHE 83
Query: 168 NVVQFIGACTRP----PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 223
           N++ FI A  +       L +V+++   GS++D+L++      +  ++K+A+  + G+ +
Sbjct: 84  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAH 141
Query: 224 LHQN--------NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE------TG 269
           LH           I HRDLK+ N+L+ +NG   +AD G+A V+  S   T +       G
Sbjct: 142 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVG 200
Query: 270 TYRWMAPEVIE------HKPYDYKADVFSFGIALWELLTG----------ELPYAGLTPL 313
           T R+MAPEV++      H     +AD+++ G+  WE+             +LPY  L P 
Sbjct: 201 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 260
Query: 314 QAAVG-----VVQKSLRPTIPKH-----AHPRLAELLERCWQHDPTQRPNFSQITDILKQ 363
             +V      V ++ LRP IP       A   +A+++  CW  +   R    +I   L Q
Sbjct: 261 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 320
Query: 364 MMKE 367
           + ++
Sbjct: 321 LSQQ 324

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 149/304 (49%), Gaps = 52/304 (17%)
Query: 109 AKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHK 167
           A+ + ++  +  G +G++++G +  +EVA+K+      + E    F + E+Y    +RH+
Sbjct: 41  ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFS----SREERSWFREAEIYQTVMLRHE 96
Query: 168 NVVQFIGACTRP----PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 223
           N++ FI A  +       L +V+++   GS++D+L++      +  ++K+A+  + G+ +
Sbjct: 97  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAH 154
Query: 224 LHQN--------NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE------TG 269
           LH           I HRDLK+ N+L+ +NG   +AD G+A V+  S   T +       G
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVG 213
Query: 270 TYRWMAPEVIE------HKPYDYKADVFSFGIALWELLTG----------ELPYAGLTPL 313
           T R+MAPEV++      H     +AD+++ G+  WE+             +LPY  L P 
Sbjct: 214 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 273
Query: 314 QAAVG-----VVQKSLRPTIPKH-----AHPRLAELLERCWQHDPTQRPNFSQITDILKQ 363
             +V      V ++ LRP IP       A   +A+++  CW  +   R    +I   L Q
Sbjct: 274 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333
Query: 364 MMKE 367
           + ++
Sbjct: 334 LSQQ 337

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 149/304 (49%), Gaps = 52/304 (17%)
Query: 109 AKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHK 167
           A+ + ++  +  G +G++++G +  +EVA+K+      + E    F + E+Y    +RH+
Sbjct: 8   ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFS----SREERSWFREAEIYQTVMLRHE 63
Query: 168 NVVQFIGACTRP----PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 223
           N++ FI A  +       L +V+++   GS++D+L++      +  ++K+A+  + G+ +
Sbjct: 64  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAH 121
Query: 224 LHQN--------NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE------TG 269
           LH           I HRDLK+ N+L+ +NG   +AD G+A V+  S   T +       G
Sbjct: 122 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVG 180
Query: 270 TYRWMAPEVIE------HKPYDYKADVFSFGIALWELLTG----------ELPYAGLTPL 313
           T R+MAPEV++      H     +AD+++ G+  WE+             +LPY  L P 
Sbjct: 181 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 240
Query: 314 QAAVG-----VVQKSLRPTIPKH-----AHPRLAELLERCWQHDPTQRPNFSQITDILKQ 363
             +V      V ++ LRP IP       A   +A+++  CW  +   R    +I   L Q
Sbjct: 241 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 300
Query: 364 MMKE 367
           + ++
Sbjct: 301 LSQQ 304

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 149/304 (49%), Gaps = 52/304 (17%)
Query: 109 AKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHK 167
           A+ + ++  +  G +G++++G +  +EVA+K+      + E    F + E+Y    +RH+
Sbjct: 2   ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFS----SREERSWFREAEIYQTVMLRHE 57
Query: 168 NVVQFIGACTRP----PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 223
           N++ FI A  +       L +V+++   GS++D+L++      +  ++K+A+  + G+ +
Sbjct: 58  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAH 115
Query: 224 LHQN--------NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE------TG 269
           LH           I HRDLK+ N+L+ +NG   +AD G+A V+  S   T +       G
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVG 174
Query: 270 TYRWMAPEVIE------HKPYDYKADVFSFGIALWELLTG----------ELPYAGLTPL 313
           T R+MAPEV++      H     +AD+++ G+  WE+             +LPY  L P 
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234
Query: 314 QAAVG-----VVQKSLRPTIPKH-----AHPRLAELLERCWQHDPTQRPNFSQITDILKQ 363
             +V      V ++ LRP IP       A   +A+++  CW  +   R    +I   L Q
Sbjct: 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
Query: 364 MMKE 367
           + ++
Sbjct: 295 LSQQ 298

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 77/246 (31%), Positives = 129/246 (52%), Gaps = 10/246 (4%)
Query: 117 KVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176
           K+  GS G +   T  S    + V K +    +  +    EV IMR  +H+NVV+   + 
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 177 TRPPNLCIVTEFMARGSIYDFL-HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
                L +V EF+  G++ D + H +    Q+ +   V + V + ++ LH   +IHRD+K
Sbjct: 141 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---VCLAVLQALSVLHAQGVIHRDIK 197
Query: 236 TANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           + ++L+  +G VK++DFG  A+V  +        GT  WMAPE+I   PY  + D++S G
Sbjct: 198 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 257
Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH---PRLAELLERCWQHDPTQR 351
           I + E++ GE PY    PL+ A+ +++ +L P + K+ H   P L   L+R    DP QR
Sbjct: 258 IMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRL-KNLHKVSPSLKGFLDRLLVRDPAQR 315
Query: 352 PNFSQI 357
              +++
Sbjct: 316 ATAAEL 321

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 149/304 (49%), Gaps = 52/304 (17%)
Query: 109 AKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHK 167
           A+ + ++  +  G +G++++G +  +EVA+K+      + E    F + E+Y    +RH+
Sbjct: 5   ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFS----SREERSWFREAEIYQTVMLRHE 60
Query: 168 NVVQFIGACTRP----PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 223
           N++ FI A  +       L +V+++   GS++D+L++      +  ++K+A+  + G+ +
Sbjct: 61  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAH 118
Query: 224 LHQN--------NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE------TG 269
           LH           I HRDLK+ N+L+ +NG   +AD G+A V+  S   T +       G
Sbjct: 119 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVG 177
Query: 270 TYRWMAPEVIE------HKPYDYKADVFSFGIALWELLTG----------ELPYAGLTPL 313
           T R+MAPEV++      H     +AD+++ G+  WE+             +LPY  L P 
Sbjct: 178 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 237
Query: 314 QAAVG-----VVQKSLRPTIPKH-----AHPRLAELLERCWQHDPTQRPNFSQITDILKQ 363
             +V      V ++ LRP IP       A   +A+++  CW  +   R    +I   L Q
Sbjct: 238 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 297
Query: 364 MMKE 367
           + ++
Sbjct: 298 LSQQ 301

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 134/283 (47%), Gaps = 29/283 (10%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQ 156
           D  + + + LK   ++  G++G +    Y        + VA+K L+      E L++F +
Sbjct: 4   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFER 61
Query: 157 EVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVA 214
           E+ I++ ++H N+V++ G C      NL ++ E++  GS+ D+L K K       LL+  
Sbjct: 62  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 121
Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGTYR 272
             + KGM YL     IHR+L T N+L++    VK+ DFG+ +V  Q +      E G   
Sbjct: 122 SQICKGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 181
Query: 273 --WMAPEVIEHKPYDYKADVFSFGIALWELLT----GELPYA-----------GLTPLQA 315
             W APE +    +   +DV+SFG+ L+EL T     + P A           G   +  
Sbjct: 182 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 241
Query: 316 AVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQIT 358
            + +++ + R   P      +  ++  CW ++  QRP+F  + 
Sbjct: 242 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 284

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 77/246 (31%), Positives = 129/246 (52%), Gaps = 10/246 (4%)
Query: 117 KVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176
           K+  GS G +   T  S    + V K +    +  +    EV IMR  +H+NVV+   + 
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 177 TRPPNLCIVTEFMARGSIYDFL-HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
                L +V EF+  G++ D + H +    Q+ +   V + V + ++ LH   +IHRD+K
Sbjct: 218 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---VCLAVLQALSVLHAQGVIHRDIK 274
Query: 236 TANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           + ++L+  +G VK++DFG  A+V  +        GT  WMAPE+I   PY  + D++S G
Sbjct: 275 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 334
Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH---PRLAELLERCWQHDPTQR 351
           I + E++ GE PY    PL+ A+ +++ +L P + K+ H   P L   L+R    DP QR
Sbjct: 335 IMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRL-KNLHKVSPSLKGFLDRLLVRDPAQR 392
Query: 352 PNFSQI 357
              +++
Sbjct: 393 ATAAEL 398

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 133/266 (50%), Gaps = 25/266 (9%)
Query: 117 KVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176
           KV+   Y     GT   + VA+K LK  C   ++   + +E+ I+R + H+++V++ G C
Sbjct: 23  KVSLYCYDPTNDGT--GEMVAVKALKEGC-GPQLRSGWQREIEILRTLYHEHIVKYKGCC 79
Query: 177 TR--PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                 ++ +V E++  GS+ D+L +      L  LL  A  + +GM YLH  + IHR L
Sbjct: 80  EDQGEKSVQLVMEYVPLGSLRDYLPRH--CVGLAQLLLFAQQICEGMAYLHAQHYIHRAL 137
Query: 235 KTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGTYR--WMAPEVIEHKPYDYKADV 290
              N+L+D + +VK+ DFG+A+   +        E G     W APE ++   + Y +DV
Sbjct: 138 AARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDV 197
Query: 291 FSFGIALWELLT----GELPYAGLTPL----QAAVGV------VQKSLRPTIPKHAHPRL 336
           +SFG+ L+ELLT     + P+   T L    Q  + V      +++  R   P      +
Sbjct: 198 WSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLPRPDRCPCEI 257
Query: 337 AELLERCWQHDPTQRPNFSQITDILK 362
             L++ CW+ + + RP F  +  IL+
Sbjct: 258 YHLMKNCWETEASFRPTFQNLVPILQ 283

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 133/266 (50%), Gaps = 25/266 (9%)
Query: 117 KVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176
           KV+   Y     GT   + VA+K LK  C   ++   + +E+ I+R + H+++V++ G C
Sbjct: 24  KVSLYCYDPTNDGT--GEMVAVKALKEGC-GPQLRSGWQREIEILRTLYHEHIVKYKGCC 80
Query: 177 TR--PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                 ++ +V E++  GS+ D+L +      L  LL  A  + +GM YLH  + IHR L
Sbjct: 81  EDQGEKSVQLVMEYVPLGSLRDYLPRH--CVGLAQLLLFAQQICEGMAYLHAQHYIHRAL 138
Query: 235 KTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGTYR--WMAPEVIEHKPYDYKADV 290
              N+L+D + +VK+ DFG+A+   +        E G     W APE ++   + Y +DV
Sbjct: 139 AARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDV 198
Query: 291 FSFGIALWELLT----GELPYAGLTPL----QAAVGV------VQKSLRPTIPKHAHPRL 336
           +SFG+ L+ELLT     + P+   T L    Q  + V      +++  R   P      +
Sbjct: 199 WSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLPRPDRCPCEI 258
Query: 337 AELLERCWQHDPTQRPNFSQITDILK 362
             L++ CW+ + + RP F  +  IL+
Sbjct: 259 YHLMKNCWETEASFRPTFQNLVPILQ 284

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 124/241 (51%), Gaps = 12/241 (4%)
Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFS-QEVYIMRKIRHKNVVQFI 173
           K+  G+ G +Y        QEVAI+ +    +  +  KE    E+ +MR+ ++ N+V ++
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYL 84
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
            +      L +V E++A GS+ D + +         +  V  +  + + +LH N +IHRD
Sbjct: 85  DSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRD 142
Query: 234 LKTANLLMDENGVVKVADFG-VARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 292
           +K+ N+L+  +G VK+ DFG  A++  +    +   GT  WMAPEV+  K Y  K D++S
Sbjct: 143 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWS 202
Query: 293 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELLERCWQHDPTQ 350
            GI   E++ GE PY    PL+ A+ ++  +  P +  P+       + L RC + D  +
Sbjct: 203 LGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEK 261
Query: 351 R 351
           R
Sbjct: 262 R 262

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 132/270 (48%), Gaps = 20/270 (7%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQE 157
           D  +VWEI  +       +  G++G +YK          A KV+  E  + E L+++  E
Sbjct: 8   DPNEVWEIVGE-------LGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELEDYIVE 58
Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 217
           + I+    H  +V+ +GA      L I+ EF   G++   + +         +  V   +
Sbjct: 59  IEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQM 118
Query: 218 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGTYRWMAP 276
            + +N+LH   IIHRDLK  N+LM   G +++ADFGV+    ++     +  GT  WMAP
Sbjct: 119 LEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAP 178
Query: 277 EVI-----EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--P 329
           EV+     +  PYDYKAD++S GI L E+   E P+  L P++  + +  KS  PT+  P
Sbjct: 179 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSDPPTLLTP 237
Query: 330 KHAHPRLAELLERCWQHDPTQRPNFSQITD 359
                   + L+     +P  RP+ +Q+ +
Sbjct: 238 SKWSVEFRDFLKIALDKNPETRPSAAQLLE 267

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 132/270 (48%), Gaps = 20/270 (7%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQE 157
           D  +VWEI  +       +  G++G +YK          A KV+  E  + E L+++  E
Sbjct: 16  DPNEVWEIVGE-------LGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELEDYIVE 66
Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 217
           + I+    H  +V+ +GA      L I+ EF   G++   + +         +  V   +
Sbjct: 67  IEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQM 126
Query: 218 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGTYRWMAP 276
            + +N+LH   IIHRDLK  N+LM   G +++ADFGV+    ++     +  GT  WMAP
Sbjct: 127 LEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAP 186
Query: 277 EVI-----EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--P 329
           EV+     +  PYDYKAD++S GI L E+   E P+  L P++  + +  KS  PT+  P
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSDPPTLLTP 245
Query: 330 KHAHPRLAELLERCWQHDPTQRPNFSQITD 359
                   + L+     +P  RP+ +Q+ +
Sbjct: 246 SKWSVEFRDFLKIALDKNPETRPSAAQLLE 275

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 72/243 (29%), Positives = 122/243 (50%), Gaps = 6/243 (2%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           +  G++    L +     +EVAIK++    +N   L++  +EV IM+ + H N+V+    
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
                 L ++ E+ + G ++D+L     + +  +  K    VS  + Y HQ  I+HRDLK
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS-AVQYCHQKRIVHRDLK 141
Query: 236 TANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY-KADVFSFG 294
             NLL+D +  +K+ADFG +      G + A  G   + APE+ + K YD  + DV+S G
Sbjct: 142 AENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLG 201
Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 354
           + L+ L++G LP+ G    +    V++   R  IP +       LL+R    +P +R   
Sbjct: 202 VILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYMSTDCENLLKRFLVLNPIKRGTL 259
Query: 355 SQI 357
            QI
Sbjct: 260 EQI 262

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 124/241 (51%), Gaps = 12/241 (4%)
Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFS-QEVYIMRKIRHKNVVQFI 173
           K+  G+ G +Y        QEVAI+ +    +  +  KE    E+ +MR+ ++ N+V ++
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
            +      L +V E++A GS+ D + +         +  V  +  + + +LH N +IHRD
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRD 141
Query: 234 LKTANLLMDENGVVKVADFG-VARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 292
           +K+ N+L+  +G VK+ DFG  A++  +    +   GT  WMAPEV+  K Y  K D++S
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWS 201
Query: 293 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELLERCWQHDPTQ 350
            GI   E++ GE PY    PL+ A+ ++  +  P +  P+       + L RC + D  +
Sbjct: 202 LGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEK 260
Query: 351 R 351
           R
Sbjct: 261 R 261

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 123/241 (51%), Gaps = 12/241 (4%)
Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFS-QEVYIMRKIRHKNVVQFI 173
           K+  G+ G +Y        QEVAI+ +    +  +  KE    E+ +MR+ ++ N+V ++
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
            +      L +V E++A GS+ D + +         +  V  +  + + +LH N +IHRD
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRD 141
Query: 234 LKTANLLMDENGVVKVADFG-VARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 292
           +K+ N+L+  +G VK+ DFG  A++  +    +   GT  WMAPEV+  K Y  K D++S
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 201
Query: 293 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELLERCWQHDPTQ 350
            GI   E++ GE PY    PL+ A+ ++  +  P +  P+       + L RC   D  +
Sbjct: 202 LGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEK 260
Query: 351 R 351
           R
Sbjct: 261 R 261

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 132/283 (46%), Gaps = 29/283 (10%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQ 156
           D  + + + LK   ++  G++G +    Y        + VA+K L+      E L++F +
Sbjct: 6   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFER 63
Query: 157 EVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVA 214
           E+ I++ ++H N+V++ G C      NL ++ E++  GS+ D+L           LL+  
Sbjct: 64  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYT 123
Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGTYR 272
             + KGM YL     IHRDL T N+L++    VK+ DFG+ +V  Q +      E G   
Sbjct: 124 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 183
Query: 273 --WMAPEVIEHKPYDYKADVFSFGIALWELLT----GELPYA-----------GLTPLQA 315
             W APE +    +   +DV+SFG+ L+EL T     + P A           G   +  
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 243
Query: 316 AVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQIT 358
            + +++ + R   P      +  ++  CW ++  QRP+F  + 
Sbjct: 244 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 286

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 77/252 (30%), Positives = 128/252 (50%), Gaps = 18/252 (7%)
Query: 117 KVASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           K+  GS G   L +  +  ++VA+K++  +    +  +    EV IMR  +H NVV+   
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQHFNVVEMYK 109
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +      L ++ EF+  G++ D + + +       +  V   V + + YLH   +IHRD+
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIVSQVR--LNEEQIATVCEAVLQALAYLHAQGVIHRDI 167
Query: 235 KTANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K+ ++L+  +G VK++DFG  A++           GT  WMAPEVI    Y  + D++S 
Sbjct: 168 KSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEVDIWSL 227
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP---KHAH---PRLAELLERCWQHD 347
           GI + E++ GE PY   +P+QA      K LR + P   K++H   P L + LER    D
Sbjct: 228 GIMVIEMVDGEPPYFSDSPVQAM-----KRLRDSPPPKLKNSHKVSPVLRDFLERMLVRD 282
Query: 348 PTQRPNFSQITD 359
           P +R    ++ D
Sbjct: 283 PQERATAQELLD 294

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 123/241 (51%), Gaps = 12/241 (4%)
Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFS-QEVYIMRKIRHKNVVQFI 173
           K+  G+ G +Y        QEVAI+ +    +  +  KE    E+ +MR+ ++ N+V ++
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
            +      L +V E++A GS+ D + +         +  V  +  + + +LH N +IHRD
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRD 141
Query: 234 LKTANLLMDENGVVKVADFG-VARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 292
           +K+ N+L+  +G VK+ DFG  A++  +    +   GT  WMAPEV+  K Y  K D++S
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKVDIWS 201
Query: 293 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELLERCWQHDPTQ 350
            GI   E++ GE PY    PL+ A+ ++  +  P +  P+       + L RC   D  +
Sbjct: 202 LGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEK 260
Query: 351 R 351
           R
Sbjct: 261 R 261

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 122/243 (50%), Gaps = 6/243 (2%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           +  G++    L +     +EVAIK++    +N   L++  +EV IM+ + H N+V+    
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
                 L ++ E+ + G ++D+L     + +  +  K    VS  + Y HQ  I+HRDLK
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS-AVQYCHQKRIVHRDLK 138
Query: 236 TANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY-KADVFSFG 294
             NLL+D +  +K+ADFG +      G +    G+  + APE+ + K YD  + DV+S G
Sbjct: 139 AENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLG 198
Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 354
           + L+ L++G LP+ G    +    V++   R  IP +       LL+R    +P +R   
Sbjct: 199 VILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYMSTDCENLLKRFLVLNPIKRGTL 256
Query: 355 SQI 357
            QI
Sbjct: 257 EQI 259

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 111/209 (53%), Gaps = 4/209 (1%)
Query: 152 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL 211
           ++ S E+ I R + H++VV F G       + +V E   R S+ + LHK++         
Sbjct: 62  EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEAR 120
Query: 212 KVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGT 270
                +  G  YLH+N +IHRDLK  NL ++E+  VK+ DFG+A +V+          GT
Sbjct: 121 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGT 180
Query: 271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK 330
             ++APEV+  K + ++ DV+S G  ++ LL G+ P+      +  + + +     +IPK
Sbjct: 181 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--SIPK 238
Query: 331 HAHPRLAELLERCWQHDPTQRPNFSQITD 359
           H +P  A L+++  Q DPT RP  +++ +
Sbjct: 239 HINPVAASLIQKMLQTDPTARPTINELLN 267

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 111/209 (53%), Gaps = 4/209 (1%)
Query: 152 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL 211
           ++ S E+ I R + H++VV F G       + +V E   R S+ + LHK++         
Sbjct: 60  EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEAR 118
Query: 212 KVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGT 270
                +  G  YLH+N +IHRDLK  NL ++E+  VK+ DFG+A +V+          GT
Sbjct: 119 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGT 178
Query: 271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK 330
             ++APEV+  K + ++ DV+S G  ++ LL G+ P+      +  + + +     +IPK
Sbjct: 179 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--SIPK 236
Query: 331 HAHPRLAELLERCWQHDPTQRPNFSQITD 359
           H +P  A L+++  Q DPT RP  +++ +
Sbjct: 237 HINPVAASLIQKMLQTDPTARPTINELLN 265

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 111/209 (53%), Gaps = 4/209 (1%)
Query: 152 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL 211
           ++ S E+ I R + H++VV F G       + +V E   R S+ + LHK++         
Sbjct: 62  EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEAR 120
Query: 212 KVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGT 270
                +  G  YLH+N +IHRDLK  NL ++E+  VK+ DFG+A +V+          GT
Sbjct: 121 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGT 180
Query: 271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK 330
             ++APEV+  K + ++ DV+S G  ++ LL G+ P+      +  + + +     +IPK
Sbjct: 181 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--SIPK 238
Query: 331 HAHPRLAELLERCWQHDPTQRPNFSQITD 359
           H +P  A L+++  Q DPT RP  +++ +
Sbjct: 239 HINPVAASLIQKMLQTDPTARPTINELLN 267

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 111/209 (53%), Gaps = 4/209 (1%)
Query: 152 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL 211
           ++ S E+ I R + H++VV F G       + +V E   R S+ + LHK++         
Sbjct: 84  EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEAR 142
Query: 212 KVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGT 270
                +  G  YLH+N +IHRDLK  NL ++E+  VK+ DFG+A +V+          GT
Sbjct: 143 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGT 202
Query: 271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK 330
             ++APEV+  K + ++ DV+S G  ++ LL G+ P+      +  + + +     +IPK
Sbjct: 203 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--SIPK 260
Query: 331 HAHPRLAELLERCWQHDPTQRPNFSQITD 359
           H +P  A L+++  Q DPT RP  +++ +
Sbjct: 261 HINPVAASLIQKMLQTDPTARPTINELLN 289

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 111/209 (53%), Gaps = 4/209 (1%)
Query: 152 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL 211
           ++ S E+ I R + H++VV F G       + +V E   R S+ + LHK++         
Sbjct: 66  EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEAR 124
Query: 212 KVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGT 270
                +  G  YLH+N +IHRDLK  NL ++E+  VK+ DFG+A +V+          GT
Sbjct: 125 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGT 184
Query: 271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK 330
             ++APEV+  K + ++ DV+S G  ++ LL G+ P+      +  + + +     +IPK
Sbjct: 185 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--SIPK 242
Query: 331 HAHPRLAELLERCWQHDPTQRPNFSQITD 359
           H +P  A L+++  Q DPT RP  +++ +
Sbjct: 243 HINPVAASLIQKMLQTDPTARPTINELLN 271

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 107/207 (51%), Gaps = 10/207 (4%)
Query: 134 QEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQF--IGACTRP--PNLCIVTEF 188
           ++VA+KVL+ +   +      F +E      + H  +V     G    P  P   IV E+
Sbjct: 38  RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEY 97
Query: 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVK 248
           +   ++ D +H + G       ++V  D  + +N+ HQN IIHRD+K AN+L+     VK
Sbjct: 98  VDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANILISATNAVK 156
Query: 249 VADFGVARVQAQSGVMTAET----GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE 304
           V DFG+AR  A SG    +T    GT ++++PE       D ++DV+S G  L+E+LTGE
Sbjct: 157 VVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
Query: 305 LPYAGLTPLQAAVGVVQKSLRPTIPKH 331
            P+ G +P+  A   V++   P   +H
Sbjct: 217 PPFTGDSPVSVAYQHVREDPIPPSARH 243

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 73/227 (32%), Positives = 119/227 (52%), Gaps = 18/227 (7%)
Query: 117 KVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           K+  GS G +   T  +  ++VA+K  K +    +  +    EV IMR   H NVV    
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVK--KMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYS 109
Query: 175 ACTRPPNLCIVTEFMARGSIYDFL-HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
           +      L +V EF+  G++ D + H +    Q+ +   V + V + ++YLH   +IHRD
Sbjct: 110 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT---VCLSVLRALSYLHNQGVIHRD 166
Query: 234 LKTANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 292
           +K+ ++L+  +G +K++DFG  A+V  +        GT  WMAPEVI   PY  + D++S
Sbjct: 167 IKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWS 226
Query: 293 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
            GI + E++ GE PY    PLQA      + +R ++P    PR+ +L
Sbjct: 227 LGIMVIEMIDGEPPYFNEPPLQA-----MRRIRDSLP----PRVKDL 264

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 111/209 (53%), Gaps = 4/209 (1%)
Query: 152 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL 211
           ++ S E+ I R + H++VV F G       + +V E   R S+ + LHK++         
Sbjct: 86  EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEAR 144
Query: 212 KVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGT 270
                +  G  YLH+N +IHRDLK  NL ++E+  VK+ DFG+A +V+          GT
Sbjct: 145 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGT 204
Query: 271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK 330
             ++APEV+  K + ++ DV+S G  ++ LL G+ P+      +  + + +     +IPK
Sbjct: 205 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--SIPK 262
Query: 331 HAHPRLAELLERCWQHDPTQRPNFSQITD 359
           H +P  A L+++  Q DPT RP  +++ +
Sbjct: 263 HINPVAASLIQKMLQTDPTARPTINELLN 291

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 70/241 (29%), Positives = 124/241 (51%), Gaps = 12/241 (4%)
Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFS-QEVYIMRKIRHKNVVQFI 173
           K+  G+ G +Y        QEVAI+ +    +  +  KE    E+ +MR+ ++ N+V ++
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYL 84
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
            +      L +V E++A GS+ D + +         +  V  +  + + +LH N +IHR+
Sbjct: 85  DSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRN 142
Query: 234 LKTANLLMDENGVVKVADFG-VARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 292
           +K+ N+L+  +G VK+ DFG  A++  +    +   GT  WMAPEV+  K Y  K D++S
Sbjct: 143 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 202
Query: 293 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELLERCWQHDPTQ 350
            GI   E++ GE PY    PL+ A+ ++  +  P +  P+       + L RC + D  +
Sbjct: 203 LGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEK 261
Query: 351 R 351
           R
Sbjct: 262 R 262

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 134/283 (47%), Gaps = 28/283 (9%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEV 158
           EI    ++   ++    +G +YKG          +Q VAIK LK +     + +EF  E 
Sbjct: 22  EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEA 80
Query: 159 YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL-----HKQKGVFQLTSLLKV 213
            +  +++H NVV  +G  T+   L ++  + + G +++FL     H   G       +K 
Sbjct: 81  MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 140
Query: 214 AID----------VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQS- 261
           A++          ++ GM YL  ++++H+DL T N+L+ +   VK++D G+ R V A   
Sbjct: 141 ALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY 200
Query: 262 -GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGV 319
             ++       RWMAPE I +  +   +D++S+G+ LWE+ + G  PY G +       +
Sbjct: 201 YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 260
Query: 320 VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK 362
             + + P  P      +  L+  CW   P++RP F  I   L+
Sbjct: 261 RNRQVLPC-PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 302

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 134/283 (47%), Gaps = 28/283 (9%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEV 158
           EI    ++   ++    +G +YKG          +Q VAIK LK +     + +EF  E 
Sbjct: 5   EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEA 63
Query: 159 YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL-----HKQKGVFQLTSLLKV 213
            +  +++H NVV  +G  T+   L ++  + + G +++FL     H   G       +K 
Sbjct: 64  MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 214 AID----------VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQS- 261
           A++          ++ GM YL  ++++H+DL T N+L+ +   VK++D G+ R V A   
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY 183
Query: 262 -GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGV 319
             ++       RWMAPE I +  +   +D++S+G+ LWE+ + G  PY G +       +
Sbjct: 184 YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 243
Query: 320 VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK 362
             + + P  P      +  L+  CW   P++RP F  I   L+
Sbjct: 244 RNRQVLPC-PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 285

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 107/207 (51%), Gaps = 10/207 (4%)
Query: 134 QEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQF--IGACTRP--PNLCIVTEF 188
           ++VA+KVL+ +   +      F +E      + H  +V     G    P  P   IV E+
Sbjct: 38  RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEY 97
Query: 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVK 248
           +   ++ D +H + G       ++V  D  + +N+ HQN IIHRD+K AN+++     VK
Sbjct: 98  VDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVK 156
Query: 249 VADFGVARVQAQSGVMTAET----GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE 304
           V DFG+AR  A SG    +T    GT ++++PE       D ++DV+S G  L+E+LTGE
Sbjct: 157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
Query: 305 LPYAGLTPLQAAVGVVQKSLRPTIPKH 331
            P+ G +P+  A   V++   P   +H
Sbjct: 217 PPFTGDSPVSVAYQHVREDPIPPSARH 243

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 107/207 (51%), Gaps = 10/207 (4%)
Query: 134 QEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQF--IGACTRP--PNLCIVTEF 188
           ++VA+KVL+ +   +      F +E      + H  +V     G    P  P   IV E+
Sbjct: 38  RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEY 97
Query: 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVK 248
           +   ++ D +H + G       ++V  D  + +N+ HQN IIHRD+K AN+++     VK
Sbjct: 98  VDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVK 156
Query: 249 VADFGVARVQAQSGVMTAET----GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE 304
           V DFG+AR  A SG    +T    GT ++++PE       D ++DV+S G  L+E+LTGE
Sbjct: 157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
Query: 305 LPYAGLTPLQAAVGVVQKSLRPTIPKH 331
            P+ G +P+  A   V++   P   +H
Sbjct: 217 PPFTGDSPVSVAYQHVREDPIPPSARH 243

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 127/263 (48%), Gaps = 20/263 (7%)
Query: 118 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                  + ++ E+  RG +Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDI 139
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           K  NLL+   G +K+ADFG + V A S   T   GT  ++ PE+IE + +D K D++S G
Sbjct: 140 KPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 198
Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 354
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 199 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRP-- 254
Query: 355 SQITDILKQMMKEVLY--WLSPN 375
                    M++EVL   W++ N
Sbjct: 255 ---------MLREVLEHPWITAN 268

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 126/267 (47%), Gaps = 14/267 (5%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 162
           W+  A+ LK   ++  G+YG + K  +    Q +A+K ++      E  +       +MR
Sbjct: 17  WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMR 76
Query: 163 KIRHKNVVQFIGACTRPPNLCIVTEFMARG--SIYDFLHK-QKGVFQLTSLLKVAIDVSK 219
                 +VQF GA  R  +  I  E M+      Y +++     V     L K+ +   K
Sbjct: 77  SSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVK 136
Query: 220 GMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
            +N+L +N  IIHRD+K +N+L+D +G +K+ DFG++     S   T + G   +MAPE 
Sbjct: 137 ALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPER 196
Query: 279 IE----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP----K 330
           I+     + YD ++DV+S GI L+EL TG  PY     +   +  V K   P +     +
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEER 256
Query: 331 HAHPRLAELLERCWQHDPTQRPNFSQI 357
              P     +  C   D ++RP + ++
Sbjct: 257 EFSPSFINFVNLCLTKDESKRPKYKEL 283

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 63/262 (24%), Positives = 132/262 (50%), Gaps = 9/262 (3%)
Query: 112 LKIECKVASGSYGDLYKGTYCSQEVAIKVLKPEC---VNTEMLKEFSQEVYIMRKIRHKN 168
            +IE K+  G + ++Y+       V + + K +    ++ +   +  +E+ +++++ H N
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 169 VVQFIGACTRPPNLCIVTEFMARGSIYDFLH---KQKGVFQLTSLLKVAIDVSKGMNYLH 225
           V+++  +      L IV E    G +   +    KQK +    ++ K  + +   + ++H
Sbjct: 94  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVIEHKPY 284
              ++HRD+K AN+ +   GVVK+ D G+ R   +++    +  GT  +M+PE I    Y
Sbjct: 154 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 213
Query: 285 DYKADVFSFGIALWELLTGELPYAG-LTPLQAAVGVVQKSLRPTIPK-HAHPRLAELLER 342
           ++K+D++S G  L+E+   + P+ G    L +    +++   P +P  H    L +L+  
Sbjct: 214 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNM 273
Query: 343 CWQHDPTQRPNFSQITDILKQM 364
           C   DP +RP+ + + D+ K+M
Sbjct: 274 CINPDPEKRPDVTYVYDVAKRM 295

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 107/207 (51%), Gaps = 10/207 (4%)
Query: 134 QEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQF--IGACTRP--PNLCIVTEF 188
           ++VA+KVL+ +   +      F +E      + H  +V     G    P  P   IV E+
Sbjct: 38  RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEY 97
Query: 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVK 248
           +   ++ D +H + G       ++V  D  + +N+ HQN IIHRD+K AN+++     VK
Sbjct: 98  VDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVK 156
Query: 249 VADFGVARVQAQSGVMTAET----GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE 304
           V DFG+AR  A SG    +T    GT ++++PE       D ++DV+S G  L+E+LTGE
Sbjct: 157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
Query: 305 LPYAGLTPLQAAVGVVQKSLRPTIPKH 331
            P+ G +P+  A   V++   P   +H
Sbjct: 217 PPFTGDSPVSVAYQHVREDPIPPSARH 243

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 117/227 (51%), Gaps = 4/227 (1%)
Query: 132 CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191
             +EVA+K++    +N+  L++  +EV IM+ + H N+V+          L +V E+ + 
Sbjct: 38  TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 97
Query: 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 251
           G ++D+L     + +  +  K    VS  + Y HQ  I+HRDLK  NLL+D +  +K+AD
Sbjct: 98  GEVFDYLVAHGRMKEKEARAKFRQIVS-AVQYCHQKFIVHRDLKAENLLLDADMNIKIAD 156
Query: 252 FGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY-KADVFSFGIALWELLTGELPYAGL 310
           FG +        + A  G   + APE+ + K YD  + DV+S G+ L+ L++G LP+ G 
Sbjct: 157 FGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 216
Query: 311 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
              +    V++   R  IP +       LL++    +P++R    QI
Sbjct: 217 NLKELRERVLRGKYR--IPFYMSTDCENLLKKFLILNPSKRGTLEQI 261

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 107/207 (51%), Gaps = 10/207 (4%)
Query: 134 QEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQF--IGACTRP--PNLCIVTEF 188
           ++VA+KVL+ +   +      F +E      + H  +V     G    P  P   IV E+
Sbjct: 55  RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEY 114
Query: 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVK 248
           +   ++ D +H + G       ++V  D  + +N+ HQN IIHRD+K AN+++     VK
Sbjct: 115 VDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVK 173
Query: 249 VADFGVARVQAQSGVMTAET----GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE 304
           V DFG+AR  A SG    +T    GT ++++PE       D ++DV+S G  L+E+LTGE
Sbjct: 174 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 233
Query: 305 LPYAGLTPLQAAVGVVQKSLRPTIPKH 331
            P+ G +P+  A   V++   P   +H
Sbjct: 234 PPFTGDSPVSVAYQHVREDPIPPSARH 260

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 74/248 (29%), Positives = 126/248 (50%), Gaps = 11/248 (4%)
Query: 117 KVASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           K+ SG+YG+  L +      E AIK+++   V+T    +  +EV +++ + H N+++   
Sbjct: 44  KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD 103
Query: 175 ACTRPPNLCIVTEFMARGSIYD-FLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
                 N  +V E    G ++D  +H+ K  F       +   V  G+ YLH++NI+HRD
Sbjct: 104 FFEDKRNYYLVMECYKGGELFDEIIHRMK--FNEVDAAVIIKQVLSGVTYLHKHNIVHRD 161
Query: 234 LKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADV 290
           LK  NLL+   +++ ++K+ DFG++ V      M    GT  ++APEV+  K YD K DV
Sbjct: 162 LKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL-RKKYDEKCDV 220
Query: 291 FSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP--KHAHPRLAELLERCWQHDP 348
           +S G+ L+ LL G  P+ G T  +    V +       P  K+      +L+++  Q D 
Sbjct: 221 WSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDS 280
Query: 349 TQRPNFSQ 356
            +R +  Q
Sbjct: 281 QRRISAQQ 288

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 142/283 (50%), Gaps = 14/283 (4%)
Query: 110 KQLKIECKVASGSYG--DLYKGTYCSQEVAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRH 166
           +  +I   + +GS+G   L +  +  +  A+KVLK E  V  + ++  + E  ++  + H
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 167 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 226
             +++  G       + ++ +++  G ++  L K +      +    A +V   + YLH 
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-EVCLALEYLHS 124
Query: 227 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY 286
            +II+RDLK  N+L+D+NG +K+ DFG A+      V     GT  ++APEV+  KPY+ 
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VTYXLCGTPDYIAPEVVSTKPYNK 182
Query: 287 KADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH 346
             D +SFGI ++E+L G  P+     ++    ++   LR   P   +  + +LL R    
Sbjct: 183 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR--FPPFFNEDVKDLLSRLITR 240
Query: 347 DPTQR-PNFSQITDILKQM--MKEVLYWLSPNLINTNIQSTYK 386
           D +QR  N    T+ +K     KEV++     L++ NI++ Y+
Sbjct: 241 DLSQRLGNLQNGTEDVKNHPWFKEVVW---EKLLSRNIETPYE 280

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 134/280 (47%), Gaps = 22/280 (7%)
Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQE 157
           G+  W ++    +I   +  G +G++Y       +  +A+KVL K +     +  +  +E
Sbjct: 4   GSRQWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 217
           V I   +RH N+++  G       + ++ E+   G++Y  L K    F          ++
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 120
Query: 218 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 277
           +  ++Y H   +IHRD+K  NLL+   G +K+ADFG + V A S    A  GT  ++ PE
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPE 179
Query: 278 VIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 337
           +IE + +D K D++S G+  +E L G+ P+   T  +    + +     T P        
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGAR 237
Query: 338 ELLERCWQHDPTQRPNFSQITDILKQMMKEVLY--WLSPN 375
           +L+ R  +H+P+QRP           M++EVL   W++ N
Sbjct: 238 DLISRLLKHNPSQRP-----------MLREVLEHPWITAN 266

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 150/302 (49%), Gaps = 54/302 (17%)
Query: 109 AKQLKI-ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK 167
           A+Q+ + EC V  G YG++++G++  + VA+K+           +E   E+Y    +RH+
Sbjct: 36  ARQITLLEC-VGKGRYGEVWRGSWQGENVAVKIFSSR-DEKSWFRE--TELYNTVMLRHE 91
Query: 168 NVVQFIGA--CTR--PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 223
           N++ FI +   +R     L ++T +   GS+YD+L  Q       S L++ + ++ G+ +
Sbjct: 92  NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAH 149
Query: 224 LH--------QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM-----TAETGT 270
           LH        +  I HRDLK+ N+L+ +NG   +AD G+A + +QS            GT
Sbjct: 150 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 209
Query: 271 YRWMAPEVIEH----KPYDY--KADVFSFGIALWELLTGEL----------PYAGLTP-- 312
            R+MAPEV++       +D   + D+++FG+ LWE+    +          P+  + P  
Sbjct: 210 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 269
Query: 313 -----LQAAVGVVQKSLRPTIPKH--AHP---RLAELLERCWQHDPTQRPNFSQITDILK 362
                ++  V V Q+  RP IP    + P    LA+L++ CW  +P+ R    +I   L 
Sbjct: 270 PSFEDMRKVVCVDQQ--RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 327
Query: 363 QM 364
           ++
Sbjct: 328 KI 329

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 106/207 (51%), Gaps = 10/207 (4%)
Query: 134 QEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQF--IGACTRP--PNLCIVTEF 188
           ++VA+KVL+ +   +      F +E      + H  +V     G    P  P   IV E+
Sbjct: 38  RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEY 97
Query: 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVK 248
           +   ++ D +H + G       ++V  D  + +N+ HQN IIHRD+K AN+++     VK
Sbjct: 98  VDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVK 156
Query: 249 VADFGVARVQAQSGVMTAET----GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE 304
           V DFG+AR  A SG    +T    GT ++++PE       D ++DV+S G  L+E+LTGE
Sbjct: 157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
Query: 305 LPYAGLTPLQAAVGVVQKSLRPTIPKH 331
            P+ G +P   A   V++   P   +H
Sbjct: 217 PPFTGDSPDSVAYQHVREDPIPPSARH 243

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 56/169 (33%), Positives = 91/169 (53%), Gaps = 4/169 (2%)
Query: 202 KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--VQA 259
           K    L  L+  +  V+KGM +L     IHRDL   N+L+ E  VVK+ DFG+AR   + 
Sbjct: 185 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 244
Query: 260 QSGVMTAETG-TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 317
              V   +     +WMAPE I  + Y  ++DV+SFG+ LWE+ + G  PY G+   +   
Sbjct: 245 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 304
Query: 318 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
             +++  R   P +  P + + +  CW  +P+QRP FS++ + L  +++
Sbjct: 305 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 353

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 117/227 (51%), Gaps = 4/227 (1%)
Query: 132 CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191
             +EVA+K++    +N+  L++  +EV IM+ + H N+V+          L +V E+ + 
Sbjct: 38  TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 97
Query: 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 251
           G ++D+L     + +  +  K    VS  + Y HQ  I+HRDLK  NLL+D +  +K+AD
Sbjct: 98  GEVFDYLVAHGRMKEKEARAKFRQIVS-AVQYCHQKFIVHRDLKAENLLLDADMNIKIAD 156
Query: 252 FGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY-KADVFSFGIALWELLTGELPYAGL 310
           FG +        +    G+  + APE+ + K YD  + DV+S G+ L+ L++G LP+ G 
Sbjct: 157 FGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 216
Query: 311 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
              +    V++   R  IP +       LL++    +P++R    QI
Sbjct: 217 NLKELRERVLRGKYR--IPFYMSTDCENLLKKFLILNPSKRGTLEQI 261

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 56/169 (33%), Positives = 91/169 (53%), Gaps = 4/169 (2%)
Query: 202 KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--VQA 259
           K    L  L+  +  V+KGM +L     IHRDL   N+L+ E  VVK+ DFG+AR   + 
Sbjct: 192 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 251
Query: 260 QSGVMTAETG-TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 317
              V   +     +WMAPE I  + Y  ++DV+SFG+ LWE+ + G  PY G+   +   
Sbjct: 252 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 311
Query: 318 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
             +++  R   P +  P + + +  CW  +P+QRP FS++ + L  +++
Sbjct: 312 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 360

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 56/169 (33%), Positives = 91/169 (53%), Gaps = 4/169 (2%)
Query: 202 KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--VQA 259
           K    L  L+  +  V+KGM +L     IHRDL   N+L+ E  VVK+ DFG+AR   + 
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246
Query: 260 QSGVMTAETG-TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 317
              V   +     +WMAPE I  + Y  ++DV+SFG+ LWE+ + G  PY G+   +   
Sbjct: 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 306
Query: 318 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
             +++  R   P +  P + + +  CW  +P+QRP FS++ + L  +++
Sbjct: 307 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 117/227 (51%), Gaps = 4/227 (1%)
Query: 132 CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191
             +EVA+K++    +N+  L++  +EV IM+ + H N+V+          L +V E+ + 
Sbjct: 38  TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 97
Query: 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 251
           G ++D+L     + +  +  K    VS  + Y HQ  I+HRDLK  NLL+D +  +K+AD
Sbjct: 98  GEVFDYLVAHGRMKEKEARAKFRQIVS-AVQYCHQKFIVHRDLKAENLLLDADMNIKIAD 156
Query: 252 FGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY-KADVFSFGIALWELLTGELPYAGL 310
           FG +        +    G+  + APE+ + K YD  + DV+S G+ L+ L++G LP+ G 
Sbjct: 157 FGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 216
Query: 311 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
              +    V++   R  IP +       LL++    +P++R    QI
Sbjct: 217 NLKELRERVLRGKYR--IPFYMSTDCENLLKKFLILNPSKRGTLEQI 261

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 56/169 (33%), Positives = 91/169 (53%), Gaps = 4/169 (2%)
Query: 202 KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--VQA 259
           K    L  L+  +  V+KGM +L     IHRDL   N+L+ E  VVK+ DFG+AR   + 
Sbjct: 194 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 253
Query: 260 QSGVMTAETG-TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 317
              V   +     +WMAPE I  + Y  ++DV+SFG+ LWE+ + G  PY G+   +   
Sbjct: 254 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 313
Query: 318 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
             +++  R   P +  P + + +  CW  +P+QRP FS++ + L  +++
Sbjct: 314 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 362

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 117/227 (51%), Gaps = 4/227 (1%)
Query: 132 CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191
             +EVA+K++    +N+  L++  +EV IM+ + H N+V+          L +V E+ + 
Sbjct: 31  TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 90
Query: 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 251
           G ++D+L     + +  +  K    VS  + Y HQ  I+HRDLK  NLL+D +  +K+AD
Sbjct: 91  GEVFDYLVAHGWMKEKEARAKFRQIVS-AVQYCHQKFIVHRDLKAENLLLDADMNIKIAD 149
Query: 252 FGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY-KADVFSFGIALWELLTGELPYAGL 310
           FG +        +    G+  + APE+ + K YD  + DV+S G+ L+ L++G LP+ G 
Sbjct: 150 FGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 209
Query: 311 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
              +    V++   R  IP +       LL++    +P++R    QI
Sbjct: 210 NLKELRERVLRGKYR--IPFYMSTDCENLLKKFLILNPSKRGTLEQI 254

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 146/296 (49%), Gaps = 53/296 (17%)
Query: 114 IECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
           +EC V  G YG++++G++  + VA+K+           +E   E+Y    +RH+N++ FI
Sbjct: 13  LEC-VGKGRYGEVWRGSWQGENVAVKIFSSR-DEKSWFRE--TELYNTVMLRHENILGFI 68
Query: 174 GA--CTR--PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH---- 225
            +   +R     L ++T +   GS+YD+L  Q       S L++ + ++ G+ +LH    
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 226 ----QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM-----TAETGTYRWMAP 276
               +  I HRDLK+ N+L+ +NG   +AD G+A + +QS            GT R+MAP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 277 EVIEH----KPYDY--KADVFSFGIALWELLTGEL----------PYAGLTP-------L 313
           EV++       +D   + D+++FG+ LWE+    +          P+  + P       +
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDM 246
Query: 314 QAAVGVVQKSLRPTIPKH--AHP---RLAELLERCWQHDPTQRPNFSQITDILKQM 364
           +  V V Q+  RP IP    + P    LA+L++ CW  +P+ R    +I   L ++
Sbjct: 247 RKVVCVDQQ--RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 146/296 (49%), Gaps = 53/296 (17%)
Query: 114 IECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
           +EC V  G YG++++G++  + VA+K+           +E   E+Y    +RH+N++ FI
Sbjct: 13  LEC-VGKGRYGEVWRGSWQGENVAVKIFSSR-DEKSWFRE--TELYNTVMLRHENILGFI 68
Query: 174 GA--CTR--PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH---- 225
            +   +R     L ++T +   GS+YD+L  Q       S L++ + ++ G+ +LH    
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 226 ----QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM-----TAETGTYRWMAP 276
               +  I HRDLK+ N+L+ +NG   +AD G+A + +QS            GT R+MAP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 277 EVIEH----KPYDY--KADVFSFGIALWELLTGEL----------PYAGLTP-------L 313
           EV++       +D   + D+++FG+ LWE+    +          P+  + P       +
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDM 246
Query: 314 QAAVGVVQKSLRPTIPKH--AHP---RLAELLERCWQHDPTQRPNFSQITDILKQM 364
           +  V V Q+  RP IP    + P    LA+L++ CW  +P+ R    +I   L ++
Sbjct: 247 RKVVCVDQQ--RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 133/280 (47%), Gaps = 22/280 (7%)
Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQE 157
           G   W ++    +I   +  G +G++Y       +  +A+KVL K +     +  +  +E
Sbjct: 1   GPRQWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 58
Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 217
           V I   +RH N+++  G       + ++ E+   G++Y  L K    F          ++
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 117
Query: 218 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 277
           +  ++Y H   +IHRD+K  NLL+   G +K+ADFG + V A S   T   GT  ++ PE
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE 176
Query: 278 VIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 337
           +IE + +D K D++S G+  +E L G+ P+   T  +    + +     T P        
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGAR 234
Query: 338 ELLERCWQHDPTQRPNFSQITDILKQMMKEVLY--WLSPN 375
           +L+ R  +H+P+QRP           M++EVL   W++ N
Sbjct: 235 DLISRLLKHNPSQRP-----------MLREVLEHPWITAN 263

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 126/263 (47%), Gaps = 20/263 (7%)
Query: 118 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                  + ++ E+  RG +Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDI 139
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           K  NLL+   G +K+ADFG + V A S       GT  ++ PE+IE + +D K D++S G
Sbjct: 140 KPENLLLGSAGELKIADFGWS-VHAPSSRRXXLXGTLDYLPPEMIEGRMHDEKVDLWSLG 198
Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 354
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 199 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRP-- 254
Query: 355 SQITDILKQMMKEVLY--WLSPN 375
                    M++EVL   W++ N
Sbjct: 255 ---------MLREVLEHPWITAN 268

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 133/280 (47%), Gaps = 22/280 (7%)
Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQE 157
           G   W ++    +I   +  G +G++Y       +  +A+KVL K +     +  +  +E
Sbjct: 1   GKRQWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 58
Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 217
           V I   +RH N+++  G       + ++ E+   G++Y  L K    F          ++
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 117
Query: 218 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 277
           +  ++Y H   +IHRD+K  NLL+   G +K+ADFG + V A S   T   GT  ++ PE
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTXLCGTLDYLPPE 176
Query: 278 VIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 337
           +IE + +D K D++S G+  +E L G+ P+   T  +    + +     T P        
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGAR 234
Query: 338 ELLERCWQHDPTQRPNFSQITDILKQMMKEVLY--WLSPN 375
           +L+ R  +H+P+QRP           M++EVL   W++ N
Sbjct: 235 DLISRLLKHNPSQRP-----------MLREVLEHPWITAN 263

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 128/263 (48%), Gaps = 20/263 (7%)
Query: 118 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G +G++Y      ++  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 73  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDI 131
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           K  NLL+   G +K+ADFG + V A S   T   GT  ++ PE+IE + +D K D++S G
Sbjct: 132 KPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 190
Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 354
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 191 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRP-- 246
Query: 355 SQITDILKQMMKEVLY--WLSPN 375
                    M++EVL   W++ N
Sbjct: 247 ---------MLREVLEHPWITAN 260

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 133/280 (47%), Gaps = 22/280 (7%)
Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQE 157
           G   W ++    +I   +  G +G++Y       +  +A+KVL K +     +  +  +E
Sbjct: 1   GPRQWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 58
Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 217
           V I   +RH N+++  G       + ++ E+   G++Y  L K    F          ++
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 117
Query: 218 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 277
           +  ++Y H   +IHRD+K  NLL+   G +K+ADFG + V A S   T   GT  ++ PE
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTELCGTLDYLPPE 176
Query: 278 VIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 337
           +IE + +D K D++S G+  +E L G+ P+   T  +    + +     T P        
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGAR 234
Query: 338 ELLERCWQHDPTQRPNFSQITDILKQMMKEVLY--WLSPN 375
           +L+ R  +H+P+QRP           M++EVL   W++ N
Sbjct: 235 DLISRLLKHNPSQRP-----------MLREVLEHPWITAN 263

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 117/227 (51%), Gaps = 4/227 (1%)
Query: 132 CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191
             +EVA++++    +N+  L++  +EV IM+ + H N+V+          L +V E+ + 
Sbjct: 38  TGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 97
Query: 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 251
           G ++D+L     + +  +  K    VS  + Y HQ  I+HRDLK  NLL+D +  +K+AD
Sbjct: 98  GEVFDYLVAHGRMKEKEARAKFRQIVS-AVQYCHQKFIVHRDLKAENLLLDADMNIKIAD 156
Query: 252 FGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY-KADVFSFGIALWELLTGELPYAGL 310
           FG +        +    G+  + APE+ + K YD  + DV+S G+ L+ L++G LP+ G 
Sbjct: 157 FGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 216
Query: 311 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
              +    V++   R  IP +       LL++    +P++R    QI
Sbjct: 217 NLKELRERVLRGKYR--IPFYMSTDCENLLKKFLILNPSKRGTLEQI 261

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 127/263 (48%), Gaps = 20/263 (7%)
Query: 118 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 75  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDI 133
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           K  NLL+   G +K+ADFG + V A S   T   GT  ++ PE+IE + +D K D++S G
Sbjct: 134 KPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 192
Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 354
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 193 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRP-- 248
Query: 355 SQITDILKQMMKEVLY--WLSPN 375
                    M++EVL   W++ N
Sbjct: 249 ---------MLREVLEHPWITAN 262

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 127/263 (48%), Gaps = 20/263 (7%)
Query: 118 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDI 137
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           K  NLL+   G +K+ADFG + V A S   T   GT  ++ PE+IE + +D K D++S G
Sbjct: 138 KPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 196
Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 354
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 197 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRP-- 252
Query: 355 SQITDILKQMMKEVLY--WLSPN 375
                    M++EVL   W++ N
Sbjct: 253 ---------MLREVLEHPWITAN 266

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 127/263 (48%), Gaps = 20/263 (7%)
Query: 118 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDI 139
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           K  NLL+   G +K+ADFG + V A S   T   GT  ++ PE+IE + +D K D++S G
Sbjct: 140 KPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 198
Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 354
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 199 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRP-- 254
Query: 355 SQITDILKQMMKEVLY--WLSPN 375
                    M++EVL   W++ N
Sbjct: 255 ---------MLREVLEHPWITAN 268

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 127/263 (48%), Gaps = 20/263 (7%)
Query: 118 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 93  YFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDI 151
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           K  NLL+   G +K+ADFG + V A S   T   GT  ++ PE+IE + +D K D++S G
Sbjct: 152 KPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 210
Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 354
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 211 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRP-- 266
Query: 355 SQITDILKQMMKEVLY--WLSPN 375
                    M++EVL   W++ N
Sbjct: 267 ---------MLREVLEHPWITAN 280

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 127/263 (48%), Gaps = 20/263 (7%)
Query: 118 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDI 137
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           K  NLL+   G +K+ADFG + V A S   T   GT  ++ PE+IE + +D K D++S G
Sbjct: 138 KPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 196
Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 354
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 197 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRP-- 252
Query: 355 SQITDILKQMMKEVLY--WLSPN 375
                    M++EVL   W++ N
Sbjct: 253 ---------MLREVLEHPWITAN 266

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 117/227 (51%), Gaps = 4/227 (1%)
Query: 132 CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191
             +EVA++++    +N+  L++  +EV IM+ + H N+V+          L +V E+ + 
Sbjct: 38  TGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 97
Query: 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 251
           G ++D+L     + +  +  K    VS  + Y HQ  I+HRDLK  NLL+D +  +K+AD
Sbjct: 98  GEVFDYLVAHGRMKEKEARAKFRQIVS-AVQYCHQKFIVHRDLKAENLLLDADMNIKIAD 156
Query: 252 FGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY-KADVFSFGIALWELLTGELPYAGL 310
           FG +        +    G+  + APE+ + K YD  + DV+S G+ L+ L++G LP+ G 
Sbjct: 157 FGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 216
Query: 311 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
              +    V++   R  IP +       LL++    +P++R    QI
Sbjct: 217 NLKELRERVLRGKYR--IPFYMSTDCENLLKKFLILNPSKRGTLEQI 261

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 115/227 (50%), Gaps = 4/227 (1%)
Query: 132 CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191
             +EVA+K++    +N+  L++  +EV I + + H N+V+          L +V E+ + 
Sbjct: 38  TGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASG 97
Query: 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 251
           G ++D+L       +  +  K    VS  + Y HQ  I+HRDLK  NLL+D +  +K+AD
Sbjct: 98  GEVFDYLVAHGRXKEKEARAKFRQIVS-AVQYCHQKFIVHRDLKAENLLLDADXNIKIAD 156
Query: 252 FGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY-KADVFSFGIALWELLTGELPYAGL 310
           FG +        + A  G   + APE+ + K YD  + DV+S G+ L+ L++G LP+ G 
Sbjct: 157 FGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 216
Query: 311 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
              +    V++   R  IP +       LL++    +P++R    QI
Sbjct: 217 NLKELRERVLRGKYR--IPFYXSTDCENLLKKFLILNPSKRGTLEQI 261

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 127/263 (48%), Gaps = 20/263 (7%)
Query: 118 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDI 138
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           K  NLL+   G +K+ADFG + V A S   T   GT  ++ PE+IE + +D K D++S G
Sbjct: 139 KPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 197
Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 354
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 198 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRP-- 253
Query: 355 SQITDILKQMMKEVLY--WLSPN 375
                    M++EVL   W++ N
Sbjct: 254 ---------MLREVLEHPWITAN 267

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 127/263 (48%), Gaps = 20/263 (7%)
Query: 118 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDI 134
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           K  NLL+   G +K+ADFG + V A S   T   GT  ++ PE+IE + +D K D++S G
Sbjct: 135 KPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLG 193
Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 354
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 194 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRP-- 249
Query: 355 SQITDILKQMMKEVLY--WLSPN 375
                    M++EVL   W++ N
Sbjct: 250 ---------MLREVLEHPWITAN 263

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 127/263 (48%), Gaps = 20/263 (7%)
Query: 118 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDI 134
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           K  NLL+   G +K+ADFG + V A S    A  GT  ++ PE+IE + +D K D++S G
Sbjct: 135 KPENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLG 193
Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 354
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 194 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRP-- 249
Query: 355 SQITDILKQMMKEVLY--WLSPN 375
                    M++EVL   W++ N
Sbjct: 250 ---------MLREVLEHPWITAN 263

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 136/277 (49%), Gaps = 18/277 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLY--KGTYCSQEVAIK-VLKPECVNTEMLKEFSQEVYI 160
           + +I  ++ KI  K+  G    +Y  + T  + +VAIK +  P     E LK F +EV+ 
Sbjct: 5   IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHN 64
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
             ++ H+N+V  I          +V E++   ++ +++    G   + + +     +  G
Sbjct: 65  SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDG 123
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE--TGTYRWMAPEV 278
           + + H   I+HRD+K  N+L+D N  +K+ DFG+A+  +++ +       GT ++ +PE 
Sbjct: 124 IKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQ 183
Query: 279 IEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-------LRPTIPKH 331
            + +  D   D++S GI L+E+L GE P+ G T +  A+  +Q S       +R  IP+ 
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ- 242
Query: 332 AHPRLAELLERCWQHDPTQR-PNFSQITDILKQMMKE 367
               L+ ++ R  + D   R     ++ D L  ++ E
Sbjct: 243 ---SLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 127/263 (48%), Gaps = 20/263 (7%)
Query: 118 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDI 134
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           K  NLL+   G +K+ADFG + V A S   T   GT  ++ PE+IE + +D K D++S G
Sbjct: 135 KPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLG 193
Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 354
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 194 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRP-- 249
Query: 355 SQITDILKQMMKEVLY--WLSPN 375
                    M++EVL   W++ N
Sbjct: 250 ---------MLREVLEHPWITAN 263

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 127/263 (48%), Gaps = 20/263 (7%)
Query: 118 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDI 160
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           K  NLL+   G +K+ADFG + V A S   T   GT  ++ PE+IE + +D K D++S G
Sbjct: 161 KPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 219
Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 354
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 220 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRP-- 275
Query: 355 SQITDILKQMMKEVLY--WLSPN 375
                    M++EVL   W++ N
Sbjct: 276 ---------MLREVLEHPWITAN 289

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 127/263 (48%), Gaps = 20/263 (7%)
Query: 118 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDI 139
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           K  NLL+   G +K+ADFG + V A S   T   GT  ++ PE+IE + +D K D++S G
Sbjct: 140 KPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLG 198
Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 354
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 199 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRP-- 254
Query: 355 SQITDILKQMMKEVLY--WLSPN 375
                    M++EVL   W++ N
Sbjct: 255 ---------MLREVLEHPWITAN 268

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 127/263 (48%), Gaps = 20/263 (7%)
Query: 118 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDI 135
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           K  NLL+   G +K+ADFG + V A S   T   GT  ++ PE+IE + +D K D++S G
Sbjct: 136 KPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLG 194
Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 354
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 195 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRP-- 250
Query: 355 SQITDILKQMMKEVLY--WLSPN 375
                    M++EVL   W++ N
Sbjct: 251 ---------MLREVLEHPWITAN 264

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 110/206 (53%), Gaps = 7/206 (3%)
Query: 109 AKQLKIECKVASGSYGDLYK--GTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH 166
           A++  I C +  GS+G++ K       QE A+KV+       +      +EV +++K+ H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 167 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 226
            N+++         +  IV E    G ++D + K+K  F      ++   V  G+ Y+H+
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHK 139
Query: 227 NNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKP 283
           +NI+HRDLK  N+L+   +++  +K+ DFG++    Q+  M    GT  ++APEV+    
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGT 198
Query: 284 YDYKADVFSFGIALWELLTGELPYAG 309
           YD K DV+S G+ L+ LL+G  P+ G
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYG 224

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 119/245 (48%), Gaps = 7/245 (2%)
Query: 118 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDI 139
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           K  NLL+   G +K+ADFG + V A S   T   GT  ++ PE IE + +D K D++S G
Sbjct: 140 KPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEXIEGRXHDEKVDLWSLG 198
Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 354
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 199 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRPXL 256
Query: 355 SQITD 359
            ++ +
Sbjct: 257 REVLE 261

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 127/263 (48%), Gaps = 20/263 (7%)
Query: 118 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G +G++Y     + +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 76  YFHDSTRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKKVIHRDI 134
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           K  NLL+   G +K+ADFG + V A S    A  GT  ++ PE+IE + +D K D++S G
Sbjct: 135 KPENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLG 193
Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 354
           +  +E L G+ P+   T       + +     T P        +L+ R  +H+P+QRP  
Sbjct: 194 VLCYEFLVGKPPFEANTYQDTYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRP-- 249
Query: 355 SQITDILKQMMKEVLY--WLSPN 375
                    M++EVL   W++ N
Sbjct: 250 ---------MLREVLEHPWITAN 263

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 127/263 (48%), Gaps = 20/263 (7%)
Query: 118 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDI 135
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           K  NLL+   G +K+ADFG +   A S   T  +GT  ++ PE+IE + +D K D++S G
Sbjct: 136 KPENLLLGSAGELKIADFGWS-CHAPSSRRTTLSGTLDYLPPEMIEGRMHDEKVDLWSLG 194
Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 354
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 195 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRP-- 250
Query: 355 SQITDILKQMMKEVLY--WLSPN 375
                    M++EVL   W++ N
Sbjct: 251 ---------MLREVLEHPWITAN 264

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 133/280 (47%), Gaps = 22/280 (7%)
Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQE 157
           G+  W ++    +I   +  G +G++Y       +  +A+KVL K +     +  +  +E
Sbjct: 4   GSRQWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 217
           V I   +RH N+++  G       + ++ E+   G++Y  L K    F          ++
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 120
Query: 218 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 277
           +  ++Y H   +IHRD+K  NLL+   G +K+ADFG + V A S       GT  ++ PE
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPE 179
Query: 278 VIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 337
           +IE + +D K D++S G+  +E L G+ P+   T  +    + +     T P        
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGAR 237
Query: 338 ELLERCWQHDPTQRPNFSQITDILKQMMKEVLY--WLSPN 375
           +L+ R  +H+P+QRP           M++EVL   W++ N
Sbjct: 238 DLISRLLKHNPSQRP-----------MLREVLEHPWITAN 266

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 110/206 (53%), Gaps = 7/206 (3%)
Query: 109 AKQLKIECKVASGSYGDLYK--GTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH 166
           A++  I C +  GS+G++ K       QE A+KV+       +      +EV +++K+ H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 167 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 226
            N+++         +  IV E    G ++D + K+K  F      ++   V  G+ Y+H+
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHK 139
Query: 227 NNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKP 283
           +NI+HRDLK  N+L+   +++  +K+ DFG++    Q+  M    GT  ++APEV+    
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGT 198
Query: 284 YDYKADVFSFGIALWELLTGELPYAG 309
           YD K DV+S G+ L+ LL+G  P+ G
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYG 224

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 110/206 (53%), Gaps = 7/206 (3%)
Query: 109 AKQLKIECKVASGSYGDLYK--GTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH 166
           A++  I C +  GS+G++ K       QE A+KV+       +      +EV +++K+ H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 167 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 226
            N+++         +  IV E    G ++D + K+K  F      ++   V  G+ Y+H+
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHK 139
Query: 227 NNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKP 283
           +NI+HRDLK  N+L+   +++  +K+ DFG++    Q+  M    GT  ++APEV+    
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGT 198
Query: 284 YDYKADVFSFGIALWELLTGELPYAG 309
           YD K DV+S G+ L+ LL+G  P+ G
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYG 224

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 132/280 (47%), Gaps = 22/280 (7%)
Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQE 157
           G   W ++    +I   +  G +G++Y       +  +A+KVL K +     +  +  +E
Sbjct: 1   GKRQWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 58
Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 217
           V I   +RH N+++  G       + ++ E+   G++Y  L K    F          ++
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 117
Query: 218 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 277
           +  ++Y H   +IHRD+K  NLL+   G +K+ADFG + V A S       GT  ++ PE
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPE 176
Query: 278 VIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 337
           +IE + +D K D++S G+  +E L G+ P+   T  +    + +     T P        
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGAR 234
Query: 338 ELLERCWQHDPTQRPNFSQITDILKQMMKEVLY--WLSPN 375
           +L+ R  +H+P+QRP           M++EVL   W++ N
Sbjct: 235 DLISRLLKHNPSQRP-----------MLREVLEHPWITAN 263

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 125/281 (44%), Gaps = 36/281 (12%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
            + + LK   ++  G++G +    Y          VA+K L+      +  ++F +E+ I
Sbjct: 4   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQI 61
Query: 161 MRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS 218
           ++ +    +V++ G    P  P L +V E++  G + DFL + +     + LL  +  + 
Sbjct: 62  LKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 121
Query: 219 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA--QSGVMTAETGTYR--WM 274
           KGM YL     +HRDL   N+L++    VK+ADFG+A++    +   +  E G     W 
Sbjct: 122 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWY 181
Query: 275 APEVIEHKPYDYKADVFSFGIALWELLT----GELPYAGLTPLQAAVGVVQKSLR----- 325
           APE +    +  ++DV+SFG+ L+EL T       P A    +      V    R     
Sbjct: 182 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELL 241
Query: 326 ---------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
                    P  P   H    EL++ CW   P  RP+FS +
Sbjct: 242 EEGQRLPAPPACPAEVH----ELMKLCWAPSPQDRPSFSAL 278

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 127/263 (48%), Gaps = 20/263 (7%)
Query: 118 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDI 136
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           K  NLL+   G +K+A+FG + V A S   T   GT  ++ PE+IE + +D K D++S G
Sbjct: 137 KPENLLLGSAGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 195
Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 354
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 196 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRP-- 251
Query: 355 SQITDILKQMMKEVLY--WLSPN 375
                    M++EVL   W++ N
Sbjct: 252 ---------MLREVLEHPWITAN 265

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 127/263 (48%), Gaps = 20/263 (7%)
Query: 118 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDI 137
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           K  NLL+   G +K+A+FG + V A S   T   GT  ++ PE+IE + +D K D++S G
Sbjct: 138 KPENLLLGSAGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 196
Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 354
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 197 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRP-- 252
Query: 355 SQITDILKQMMKEVLY--WLSPN 375
                    M++EVL   W++ N
Sbjct: 253 ---------MLREVLEHPWITAN 266

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 124/271 (45%), Gaps = 27/271 (9%)
Query: 118 VASGSYGDLYKGTYCSQE-VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176
           +  G +G +YKG       VA+K LK E      L +F  EV ++    H+N+++  G C
Sbjct: 46  LGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGEL-QFQTEVEMISMAVHRNLLRLRGFC 104
Query: 177 TRPPNLCIVTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQN---NII 230
             P    +V  +MA GS+   L ++   +         ++A+  ++G+ YLH +    II
Sbjct: 105 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKII 164
Query: 231 HRDLKTANLLMDENGVVKVADFGVARVQ--AQSGVMTAETGTYRWMAPEVIEHKPYDYKA 288
           HRD+K AN+L+DE     V DFG+A++       V  A  GT   +APE +       K 
Sbjct: 165 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKT 224
Query: 289 DVFSFGIALWELLTGELPY-----------------AGLTPLQAAVGVVQKSLRPTIPKH 331
           DVF +G+ L EL+TG+  +                  GL   +    +V   L+      
Sbjct: 225 DVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDE 284
Query: 332 AHPRLAELLERCWQHDPTQRPNFSQITDILK 362
              +L ++   C Q  P +RP  S++  +L+
Sbjct: 285 EVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 126/263 (47%), Gaps = 20/263 (7%)
Query: 118 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDI 135
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           K  NLL+   G +K+ADFG + V A S       GT  ++ PE+IE + +D K D++S G
Sbjct: 136 KPENLLLGSAGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 194
Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 354
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 195 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRP-- 250
Query: 355 SQITDILKQMMKEVLY--WLSPN 375
                    M++EVL   W++ N
Sbjct: 251 ---------MLREVLEHPWITAN 264

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 126/263 (47%), Gaps = 20/263 (7%)
Query: 118 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDI 136
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           K  NLL+   G +K+ADFG + V A S       GT  ++ PE+IE + +D K D++S G
Sbjct: 137 KPENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLG 195
Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 354
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 196 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRP-- 251
Query: 355 SQITDILKQMMKEVLY--WLSPN 375
                    M++EVL   W++ N
Sbjct: 252 ---------MLREVLEHPWITAN 265

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 126/263 (47%), Gaps = 20/263 (7%)
Query: 118 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDI 137
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           K  NLL+   G +K+ADFG + V A S       GT  ++ PE+IE + +D K D++S G
Sbjct: 138 KPENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLG 196
Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 354
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 197 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRP-- 252
Query: 355 SQITDILKQMMKEVLY--WLSPN 375
                    M++EVL   W++ N
Sbjct: 253 ---------MLREVLEHPWITAN 266

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 129/262 (49%), Gaps = 33/262 (12%)
Query: 117 KVASGSYGD--LYKGTYCSQEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNVVQFI 173
           K+ SG+YG+  L K      E AIK++K   V T         EV +++++ H N+++  
Sbjct: 11  KLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLY 70
Query: 174 GACTRPPNLCIVTEFMARGSIYD-FLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 232
                  N  +V E    G ++D  + +QK  F       +   V  G  YLH++NI+HR
Sbjct: 71  EFFEDKRNYYLVMEVYRGGELFDEIILRQK--FSEVDAAVIMKQVLSGTTYLHKHNIVHR 128
Query: 233 DLKTANLLMD---ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKAD 289
           DLK  NLL++    + ++K+ DFG++      G M    GT  ++APEV+  K YD K D
Sbjct: 129 DLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL-RKKYDEKCD 187
Query: 290 VFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPT 349
           V+S G+ L+ LL G  P+ G T  Q  +  V+K                     +  DP 
Sbjct: 188 VWSCGVILYILLCGYPPFGGQTD-QEILKRVEKGK-------------------FSFDP- 226
Query: 350 QRPNFSQITDILKQMMKEVLYW 371
             P+++Q++D  KQ++K +L +
Sbjct: 227 --PDWTQVSDEAKQLVKLMLTY 246

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 129/262 (49%), Gaps = 33/262 (12%)
Query: 117 KVASGSYGD--LYKGTYCSQEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNVVQFI 173
           K+ SG+YG+  L K      E AIK++K   V T         EV +++++ H N+++  
Sbjct: 28  KLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLY 87
Query: 174 GACTRPPNLCIVTEFMARGSIYD-FLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 232
                  N  +V E    G ++D  + +QK  F       +   V  G  YLH++NI+HR
Sbjct: 88  EFFEDKRNYYLVMEVYRGGELFDEIILRQK--FSEVDAAVIMKQVLSGTTYLHKHNIVHR 145
Query: 233 DLKTANLLMD---ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKAD 289
           DLK  NLL++    + ++K+ DFG++      G M    GT  ++APEV+  K YD K D
Sbjct: 146 DLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL-RKKYDEKCD 204
Query: 290 VFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPT 349
           V+S G+ L+ LL G  P+ G T  Q  +  V+K                     +  DP 
Sbjct: 205 VWSCGVILYILLCGYPPFGGQTD-QEILKRVEKGK-------------------FSFDP- 243
Query: 350 QRPNFSQITDILKQMMKEVLYW 371
             P+++Q++D  KQ++K +L +
Sbjct: 244 --PDWTQVSDEAKQLVKLMLTY 263

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 123/271 (45%), Gaps = 27/271 (9%)
Query: 118 VASGSYGDLYKGTYCSQE-VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176
           +  G +G +YKG       VA+K LK E      L +F  EV ++    H+N+++  G C
Sbjct: 38  LGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGEL-QFQTEVEMISMAVHRNLLRLRGFC 96
Query: 177 TRPPNLCIVTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQN---NII 230
             P    +V  +MA GS+   L ++   +         ++A+  ++G+ YLH +    II
Sbjct: 97  MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKII 156
Query: 231 HRDLKTANLLMDENGVVKVADFGVARVQ--AQSGVMTAETGTYRWMAPEVIEHKPYDYKA 288
           HRD+K AN+L+DE     V DFG+A++       V  A  G    +APE +       K 
Sbjct: 157 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEYLSTGKSSEKT 216
Query: 289 DVFSFGIALWELLTGELPY-----------------AGLTPLQAAVGVVQKSLRPTIPKH 331
           DVF +G+ L EL+TG+  +                  GL   +    +V   L+      
Sbjct: 217 DVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDE 276
Query: 332 AHPRLAELLERCWQHDPTQRPNFSQITDILK 362
              +L ++   C Q  P +RP  S++  +L+
Sbjct: 277 EVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 126/263 (47%), Gaps = 20/263 (7%)
Query: 118 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDI 160
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           K  NLL+   G +K+ADFG + V A S       GT  ++ PE+IE + +D K D++S G
Sbjct: 161 KPENLLLGSAGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLG 219
Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 354
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 220 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRP-- 275
Query: 355 SQITDILKQMMKEVLY--WLSPN 375
                    M++EVL   W++ N
Sbjct: 276 ---------MLREVLEHPWITAN 289

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 141/270 (52%), Gaps = 15/270 (5%)
Query: 121 GSYGDLYKGTY--CSQEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
           G++G +  G +     +VA+K+L  + + + +++ +  +E+  ++  RH ++++     +
Sbjct: 27  GTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS 86
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
            P ++ +V E+++ G ++D++ K  G        ++   +  G++Y H++ ++HRDLK  
Sbjct: 87  TPSDIFMVMEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPE 145
Query: 238 NLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPY-DYKADVFSFGIA 296
           N+L+D +   K+ADFG++ + +    +    G+  + APEVI  + Y   + D++S G+ 
Sbjct: 146 NVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGPEVDIWSSGVI 205
Query: 297 LWELLTGELPYAGLTPLQAAVGVVQKSLRPTI---PKHAHPRLAELLERCWQHDPTQRPN 353
           L+ LL G LP+         V  + K +   I   P++ +P +  LL+   Q DP +R  
Sbjct: 206 LYALLCGTLPFD-----DDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRAT 260
Query: 354 FSQITDI--LKQMMKEVLYWLSPNLINTNI 381
              I +    KQ + + L+   P+  +T I
Sbjct: 261 IKDIREHEWFKQDLPKYLFPEDPSYSSTMI 290

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 125/246 (50%), Gaps = 12/246 (4%)
Query: 118 VASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  GS+G +   T+    Q+VA+K +  + +  ++M     +E+  ++ +RH ++++   
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
             T P ++ +V E+ A G ++D++ ++K + +     +    +   + Y H++ I+HRDL
Sbjct: 77  VITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGR-RFFQQIICAIEYCHRHKIVHRDL 134
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPY-DYKADVFSF 293
           K  NLL+D+N  VK+ADFG++ +      +    G+  + APEVI  K Y   + DV+S 
Sbjct: 135 KPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSC 194
Query: 294 GIALWELLTGELPYAG--LTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           GI L+ +L G LP+    +  L   V     S    +P    P    L+ R    DP QR
Sbjct: 195 GIVLYVMLVGRLPFDDEFIPNLFKKVN----SCVYVMPDFLSPGAQSLIRRMIVADPMQR 250
Query: 352 PNFSQI 357
               +I
Sbjct: 251 ITIQEI 256

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 144/302 (47%), Gaps = 54/302 (17%)
Query: 109 AKQLK-IECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK 167
           A+Q+  +EC V  G YG++++G +  + VA+K+        E       E+Y    +RH 
Sbjct: 7   ARQVALVEC-VGKGRYGEVWRGLWHGESVAVKIFSSR---DEQSWFRETEIYNTVLLRHD 62
Query: 168 NVVQFIGACTRPPN----LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 223
           N++ FI +     N    L ++T +   GS+YDFL +Q     L   L++A+  + G+ +
Sbjct: 63  NILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLA--LRLAVSAACGLAH 120
Query: 224 LH--------QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM-----TAETGT 270
           LH        +  I HRD K+ N+L+  N    +AD G+A + +Q             GT
Sbjct: 121 LHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGT 180
Query: 271 YRWMAPEVIEHKPY-----DYK-ADVFSFGIALWELLTGEL----------PYAGLTP-- 312
            R+MAPEV++ +        YK  D+++FG+ LWE+    +          P+  + P  
Sbjct: 181 KRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVNGIVEDYRPPFYDVVPND 240
Query: 313 -----LQAAVGVVQKSLRPTIPKH--AHP---RLAELLERCWQHDPTQRPNFSQITDILK 362
                ++  V V Q++  PTIP    A P    LA+++  CW  +P+ R    +I   L+
Sbjct: 241 PSFEDMKKVVCVDQQT--PTIPNRLAADPVLSGLAQMMRECWYPNPSARLTALRIKKTLQ 298
Query: 363 QM 364
           ++
Sbjct: 299 KI 300

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 123/250 (49%), Gaps = 9/250 (3%)
Query: 108 DAKQLKIECKVASGSYGDLY-----KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 162
           D  Q ++   +  GS+G ++      G+   Q  A+KVLK   +          E  I+ 
Sbjct: 22  DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV 81
Query: 163 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 222
           ++ H  +V+   A      L ++ +F+  G ++  L K+  +F    +     +++  ++
Sbjct: 82  EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALD 140
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEVIEH 281
           +LH   II+RDLK  N+L+DE G +K+ DFG+++          +  GT  +MAPEV+  
Sbjct: 141 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 200
Query: 282 KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE 341
           + +   AD +SFG+ ++E+LTG LP+ G    +    +++  L   +P+   P    LL 
Sbjct: 201 RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL--GMPQFLSPEAQSLLR 258
Query: 342 RCWQHDPTQR 351
             ++ +P  R
Sbjct: 259 MLFKRNPANR 268

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 106/200 (53%), Gaps = 4/200 (2%)
Query: 113 KIECKVASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           +++  +  G++    L +     +EVA+K++    +N   L++  +EV IM+ + H N+V
Sbjct: 18  RLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIV 77
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
           +          L +V E+ + G ++D+L     + +  +  K    VS  + Y HQ  I+
Sbjct: 78  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS-AVQYCHQKYIV 136
Query: 231 HRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY-KAD 289
           HRDLK  NLL+D +  +K+ADFG +        +    G+  + APE+ + K YD  + D
Sbjct: 137 HRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDGPEVD 196
Query: 290 VFSFGIALWELLTGELPYAG 309
           V+S G+ L+ L++G LP+ G
Sbjct: 197 VWSLGVILYTLVSGSLPFDG 216

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 123/250 (49%), Gaps = 9/250 (3%)
Query: 108 DAKQLKIECKVASGSYGDLY-----KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 162
           D  Q ++   +  GS+G ++      G+   Q  A+KVLK   +          E  I+ 
Sbjct: 22  DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV 81
Query: 163 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 222
           ++ H  +V+   A      L ++ +F+  G ++  L K+  +F    +     +++  ++
Sbjct: 82  EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALD 140
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEVIEH 281
           +LH   II+RDLK  N+L+DE G +K+ DFG+++          +  GT  +MAPEV+  
Sbjct: 141 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 200
Query: 282 KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE 341
           + +   AD +SFG+ ++E+LTG LP+ G    +    +++  L   +P+   P    LL 
Sbjct: 201 RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL--GMPQFLSPEAQSLLR 258
Query: 342 RCWQHDPTQR 351
             ++ +P  R
Sbjct: 259 MLFKRNPANR 268

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 123/250 (49%), Gaps = 9/250 (3%)
Query: 108 DAKQLKIECKVASGSYGDLY-----KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 162
           D  Q ++   +  GS+G ++      G+   Q  A+KVLK   +          E  I+ 
Sbjct: 23  DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV 82
Query: 163 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 222
           ++ H  +V+   A      L ++ +F+  G ++  L K+  +F    +     +++  ++
Sbjct: 83  EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALD 141
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEVIEH 281
           +LH   II+RDLK  N+L+DE G +K+ DFG+++          +  GT  +MAPEV+  
Sbjct: 142 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 201
Query: 282 KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE 341
           + +   AD +SFG+ ++E+LTG LP+ G    +    +++  L   +P+   P    LL 
Sbjct: 202 RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL--GMPQFLSPEAQSLLR 259
Query: 342 RCWQHDPTQR 351
             ++ +P  R
Sbjct: 260 MLFKRNPANR 269

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 119/245 (48%), Gaps = 7/245 (2%)
Query: 118 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKL-SRFDEQRTATYITELANALSYCHSKRVIHRDI 138
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           K  NLL+  NG +K+ADFG + V A S   T   GT  ++ PE+IE + +D K D++S G
Sbjct: 139 KPENLLLGSNGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 197
Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 354
           +  +E L G  P+   T  +    + +     T P        +L+ R  +H+ +QR   
Sbjct: 198 VLCYEFLVGMPPFEAHTYQETYRRISRVEF--TFPDFVTEGARDLISRLLKHNASQRLTL 255
Query: 355 SQITD 359
           +++ +
Sbjct: 256 AEVLE 260

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 124/254 (48%), Gaps = 13/254 (5%)
Query: 108 DAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
           D + LK + ++  GS+  +YKG  T  + EVA   L+   +     + F +E   ++ ++
Sbjct: 24  DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQ 83
Query: 166 HKNVVQFIGA--CTRPPNLCIV--TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
           H N+V+F  +   T     CIV  TE    G++  +L + K V ++  L      + KG+
Sbjct: 84  HPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFK-VXKIKVLRSWCRQILKGL 142
Query: 222 NYLHQNN--IIHRDLKTANLLM-DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
            +LH     IIHRDLK  N+ +    G VK+ D G+A ++ ++    A  GT  + APE 
Sbjct: 143 QFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-RASFAKAVIGTPEFXAPEX 201
Query: 279 IEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP-TIPKHAHPRLA 337
            E K YD   DV++FG    E  T E PY+           V   ++P +  K A P + 
Sbjct: 202 YEEK-YDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 260
Query: 338 ELLERCWQHDPTQR 351
           E++E C + +  +R
Sbjct: 261 EIIEGCIRQNKDER 274

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 127/281 (45%), Gaps = 36/281 (12%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
            + + LK   ++  G++G +    Y          VA+K L+      +  ++F +E+ I
Sbjct: 7   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQI 64
Query: 161 MRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS 218
           ++ +    +V++ G    P   +L +V E++  G + DFL + +     + LL  +  + 
Sbjct: 65  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 124
Query: 219 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA--QSGVMTAETGTYR--WM 274
           KGM YL     +HRDL   N+L++    VK+ADFG+A++    +   +  E G     W 
Sbjct: 125 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 184
Query: 275 APEVIEHKPYDYKADVFSFGIALWELLT-----------------GELPYAGLTPLQAAV 317
           APE +    +  ++DV+SFG+ L+EL T                  E     L+ L   +
Sbjct: 185 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELL 244
Query: 318 GVVQK-SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
              Q+    P  P   H    EL++ CW   P  RP+FS +
Sbjct: 245 EEGQRLPAPPACPAEVH----ELMKLCWAPSPQDRPSFSAL 281

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 61/249 (24%), Positives = 132/249 (53%), Gaps = 13/249 (5%)
Query: 118 VASGSYGDLYKGTY--CSQEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G++G +  G +     +VA+K+L  + + + +++ +  +E+  ++  RH ++++   
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
             + P +  +V E+++ G ++D++ K   V ++ +  ++   +   ++Y H++ ++HRDL
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCHRHMVVHRDL 137
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPY-DYKADVFSF 293
           K  N+L+D +   K+ADFG++ + +    +    G+  + APEVI  + Y   + D++S 
Sbjct: 138 KPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSC 197
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT---IPKHAHPRLAELLERCWQHDPTQ 350
           G+ L+ LL G LP+         V  + K +R     IP++ +  +A LL    Q DP +
Sbjct: 198 GVILYALLCGTLPFD-----DEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLK 252
Query: 351 RPNFSQITD 359
           R     I +
Sbjct: 253 RATIKDIRE 261

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 125/281 (44%), Gaps = 36/281 (12%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
            + + LK   ++  G++G +    Y          VA+K L+      +  ++F +E+ I
Sbjct: 8   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQI 65
Query: 161 MRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS 218
           ++ +    +V++ G    P   +L +V E++  G + DFL + +     + LL  +  + 
Sbjct: 66  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 125
Query: 219 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA--QSGVMTAETGTYR--WM 274
           KGM YL     +HRDL   N+L++    VK+ADFG+A++    +   +  E G     W 
Sbjct: 126 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 185
Query: 275 APEVIEHKPYDYKADVFSFGIALWELLT----GELPYAGLTPLQAAVGVVQKSLR----- 325
           APE +    +  ++DV+SFG+ L+EL T       P A    +      V    R     
Sbjct: 186 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELL 245
Query: 326 ---------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
                    P  P   H    EL++ CW   P  RP+FS +
Sbjct: 246 EEGQRLPAPPACPAEVH----ELMKLCWAPSPQDRPSFSAL 282

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 125/281 (44%), Gaps = 36/281 (12%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
            + + LK   ++  G++G +    Y          VA+K L+      +  ++F +E+ I
Sbjct: 20  FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQI 77
Query: 161 MRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS 218
           ++ +    +V++ G    P   +L +V E++  G + DFL + +     + LL  +  + 
Sbjct: 78  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 137
Query: 219 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA--QSGVMTAETGTYR--WM 274
           KGM YL     +HRDL   N+L++    VK+ADFG+A++    +   +  E G     W 
Sbjct: 138 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 197
Query: 275 APEVIEHKPYDYKADVFSFGIALWELLT----GELPYAGLTPLQAAVGVVQKSLR----- 325
           APE +    +  ++DV+SFG+ L+EL T       P A    +      V    R     
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257
Query: 326 ---------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
                    P  P   H    EL++ CW   P  RP+FS +
Sbjct: 258 EEGQRLPAPPACPAEVH----ELMKLCWAPSPQDRPSFSAL 294

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 61/249 (24%), Positives = 132/249 (53%), Gaps = 13/249 (5%)
Query: 118 VASGSYGDLYKGTY--CSQEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G++G +  G +     +VA+K+L  + + + +++ +  +E+  ++  RH ++++   
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
             + P +  +V E+++ G ++D++ K   V ++ +  ++   +   ++Y H++ ++HRDL
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCHRHMVVHRDL 137
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPY-DYKADVFSF 293
           K  N+L+D +   K+ADFG++ + +    +    G+  + APEVI  + Y   + D++S 
Sbjct: 138 KPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGPEVDIWSC 197
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT---IPKHAHPRLAELLERCWQHDPTQ 350
           G+ L+ LL G LP+         V  + K +R     IP++ +  +A LL    Q DP +
Sbjct: 198 GVILYALLCGTLPFD-----DEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLK 252
Query: 351 RPNFSQITD 359
           R     I +
Sbjct: 253 RATIKDIRE 261

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 71/238 (29%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E+M  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G +KVADFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIKVADFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 71/238 (29%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E+M  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G +KVADFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIKVADFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 118/245 (48%), Gaps = 7/245 (2%)
Query: 118 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKL-SRFDEQRTATYITELANALSYCHSKRVIHRDI 138
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           K  NLL+  NG +K+ADFG + V A S       GT  ++ PE+IE + +D K D++S G
Sbjct: 139 KPENLLLGSNGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 197
Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 354
           +  +E L G  P+   T  +    + +     T P        +L+ R  +H+ +QR   
Sbjct: 198 VLCYEFLVGMPPFEAHTYQETYRRISRVEF--TFPDFVTEGARDLISRLLKHNASQRLTL 255
Query: 355 SQITD 359
           +++ +
Sbjct: 256 AEVLE 260

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 108/207 (52%), Gaps = 4/207 (1%)
Query: 152 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL 211
           ++ S E+ I + + + +VV F G       + +V E   R S+ + LHK++         
Sbjct: 71  EKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEAR 129
Query: 212 KVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGT 270
                  +G+ YLH N +IHRDLK  NL ++++  VK+ DFG+A +++          GT
Sbjct: 130 YFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGT 189
Query: 271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK 330
             ++APEV+  K + ++ D++S G  L+ LL G+ P+      +  + + +     ++P+
Sbjct: 190 PNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEY--SVPR 247
Query: 331 HAHPRLAELLERCWQHDPTQRPNFSQI 357
           H +P  + L+ R    DPT RP+ +++
Sbjct: 248 HINPVASALIRRMLHADPTLRPSVAEL 274

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 108/207 (52%), Gaps = 4/207 (1%)
Query: 152 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL 211
           ++ S E+ I + + + +VV F G       + +V E   R S+ + LHK++         
Sbjct: 87  EKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEAR 145
Query: 212 KVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGT 270
                  +G+ YLH N +IHRDLK  NL ++++  VK+ DFG+A +++          GT
Sbjct: 146 YFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGT 205
Query: 271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK 330
             ++APEV+  K + ++ D++S G  L+ LL G+ P+      +  + + +     ++P+
Sbjct: 206 PNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEY--SVPR 263
Query: 331 HAHPRLAELLERCWQHDPTQRPNFSQI 357
           H +P  + L+ R    DPT RP+ +++
Sbjct: 264 HINPVASALIRRMLHADPTLRPSVAEL 290

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 111/217 (51%), Gaps = 11/217 (5%)
Query: 100 DGTDVWEIDAKQLK--IECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLK----E 153
           + +  W+  A+ +K   E K   G+ G   +     ++   K+   +C+  + LK     
Sbjct: 8   ESSSSWKKQAEDIKKIFEFKETLGT-GAFSEVVLAEEKATGKLFAVKCIPKKALKGKESS 66
Query: 154 FSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKV 213
              E+ ++RKI+H+N+V        P +L +V + ++ G ++D +  +KG +       +
Sbjct: 67  IENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRI-VEKGFYTEKDASTL 125
Query: 214 AIDVSKGMNYLHQNNIIHRDLKTANLL---MDENGVVKVADFGVARVQAQSGVMTAETGT 270
              V   + YLH+  I+HRDLK  NLL    DE   + ++DFG+++++ +  VM+   GT
Sbjct: 126 IRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGT 185
Query: 271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
             ++APEV+  KPY    D +S G+  + LL G  P+
Sbjct: 186 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 222

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 108/207 (52%), Gaps = 4/207 (1%)
Query: 152 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL 211
           ++ S E+ I + + + +VV F G       + +V E   R S+ + LHK++         
Sbjct: 87  EKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEAR 145
Query: 212 KVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGT 270
                  +G+ YLH N +IHRDLK  NL ++++  VK+ DFG+A +++          GT
Sbjct: 146 YFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGT 205
Query: 271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK 330
             ++APEV+  K + ++ D++S G  L+ LL G+ P+      +  + + +     ++P+
Sbjct: 206 PNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEY--SVPR 263
Query: 331 HAHPRLAELLERCWQHDPTQRPNFSQI 357
           H +P  + L+ R    DPT RP+ +++
Sbjct: 264 HINPVASALIRRMLHADPTLRPSVAEL 290

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 108/207 (52%), Gaps = 4/207 (1%)
Query: 152 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL 211
           ++ S E+ I + + + +VV F G       + +V E   R S+ + LHK++         
Sbjct: 87  EKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEAR 145
Query: 212 KVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGT 270
                  +G+ YLH N +IHRDLK  NL ++++  VK+ DFG+A +++          GT
Sbjct: 146 YFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGT 205
Query: 271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK 330
             ++APEV+  K + ++ D++S G  L+ LL G+ P+      +  + + +     ++P+
Sbjct: 206 PNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEY--SVPR 263
Query: 331 HAHPRLAELLERCWQHDPTQRPNFSQI 357
           H +P  + L+ R    DPT RP+ +++
Sbjct: 264 HINPVASALIRRMLHADPTLRPSVAEL 290

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 70/238 (29%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 36  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 95
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 96  SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 154
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+DE G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 155 KPENLLIDEQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 211
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 212 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 267

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 70/238 (29%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G +KVADFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIKVADFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 133/268 (49%), Gaps = 18/268 (6%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  GS+G   L   T   Q+VA+K++  + +  ++M     +E+  +R +RH ++++   
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                  + +V E+ A   ++D++  Q+         +    +   + Y H++ I+HRDL
Sbjct: 76  VIKSKDEIIMVIEY-AGNELFDYI-VQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDL 133
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPY-DYKADVFSF 293
           K  NLL+DE+  VK+ADFG++ +      +    G+  + APEVI  K Y   + DV+S 
Sbjct: 134 KPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 193
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRP---TIPKHAHPRLAELLERCWQHDPTQ 350
           G+ L+ +L   LP+        ++ V+ K++     T+PK   P  A L++R    +P  
Sbjct: 194 GVILYVMLCRRLPFD-----DESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLN 248
Query: 351 RPNFSQIT--DILKQMMKEVLYWLSPNL 376
           R +  +I   D  K  + E  Y L P+L
Sbjct: 249 RISIHEIMQDDWFKVDLPE--YLLPPDL 274

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 146/308 (47%), Gaps = 30/308 (9%)
Query: 73  KRQPALGVPMHS--KLLIESSP-------NCIEIPTDGTDVWEIDAKQLKIECKVASGSY 123
           KR P L +P  +  +    S+P        CI I   G   +E+ A  L+   ++  G+Y
Sbjct: 8   KRNPGLKIPKEAFEQPQTSSTPPRDLDSKACISI---GNQNFEVKADDLEPIMELGRGAY 64
Query: 124 GDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI-MRKIRHKNVVQFIGACTRPP 180
           G + K  +    Q +A+K ++   VN++  K    ++ I MR +     V F GA  R  
Sbjct: 65  GVVEKMRHVPSGQIMAVKRIR-ATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG 123
Query: 181 NLCIVTEFMARGSIYDFLHKQ---KGVFQLTSLL-KVAIDVSKGMNYLHQN-NIIHRDLK 235
           ++ I  E M   +  D  +KQ   KG      +L K+A+ + K + +LH   ++IHRD+K
Sbjct: 124 DVWICMELM--DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVK 181
Query: 236 TANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI----EHKPYDYKADVF 291
            +N+L++  G VK+ DFG++     S   T + G   +MAPE I      K Y  K+D++
Sbjct: 182 PSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYSVKSDIW 241
Query: 292 SFGIALWELLTGELPYAGL-TPLQAAVGVVQKSLRPTIPKHA-HPRLAELLERCWQHDPT 349
           S GI + EL     PY    TP Q    VV++   P +P         +   +C + +  
Sbjct: 242 SLGITMIELAILRFPYDSWGTPFQQLKQVVEEP-SPQLPADKFSAEFVDFTSQCLKKNSK 300
Query: 350 QRPNFSQI 357
           +RP + ++
Sbjct: 301 ERPTYPEL 308

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 133/268 (49%), Gaps = 18/268 (6%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  GS+G   L   T   Q+VA+K++  + +  ++M     +E+  +R +RH ++++   
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                  + +V E+ A   ++D++  Q+         +    +   + Y H++ I+HRDL
Sbjct: 72  VIKSKDEIIMVIEY-AGNELFDYI-VQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDL 129
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPY-DYKADVFSF 293
           K  NLL+DE+  VK+ADFG++ +      +    G+  + APEVI  K Y   + DV+S 
Sbjct: 130 KPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 189
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRP---TIPKHAHPRLAELLERCWQHDPTQ 350
           G+ L+ +L   LP+        ++ V+ K++     T+PK   P  A L++R    +P  
Sbjct: 190 GVILYVMLCRRLPFD-----DESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLN 244
Query: 351 RPNFSQIT--DILKQMMKEVLYWLSPNL 376
           R +  +I   D  K  + E  Y L P+L
Sbjct: 245 RISIHEIMQDDWFKVDLPE--YLLPPDL 270

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---AGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 118/235 (50%), Gaps = 11/235 (4%)
Query: 118 VASGSYGDLYK-----GTYCSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKNVV 170
           +  G YG +++     G    +  A+KVLK   +  N +       E  I+ +++H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
             I A      L ++ E+++ G ++  L ++ G+F   +      ++S  + +LHQ  II
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKGII 143
Query: 231 HRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKAD 289
           +RDLK  N++++  G VK+ DFG+ +     G +T    GT  +MAPE++    ++   D
Sbjct: 144 YRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMRSGHNRAVD 203
Query: 290 VFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLAELLER 342
            +S G  ++++LTG  P+ G    +    +++  L   P + + A   L +LL+R
Sbjct: 204 WWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKR 258

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 108/196 (55%), Gaps = 11/196 (5%)
Query: 118 VASGSYGDLYKGTYCSQEVAIKVLKPECVN-TEMLKEFS--QEVYIMRKIRHKNVVQFIG 174
           + SG++ +++      Q +  K+   +C+  +   ++ S   E+ +++KI+H+N+V    
Sbjct: 17  LGSGAFSEVF---LVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                 +  +V + ++ G ++D +  ++GV+       V   V   + YLH+N I+HRDL
Sbjct: 74  IYESTTHYYLVMQLVSGGELFDRI-LERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDL 132
Query: 235 KTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVF 291
           K  NLL    +EN  + + DFG+++++ Q+G+M+   GT  ++APEV+  KPY    D +
Sbjct: 133 KPENLLYLTPEENSKIMITDFGLSKME-QNGIMSTACGTPGYVAPEVLAQKPYSKAVDCW 191
Query: 292 SFGIALWELLTGELPY 307
           S G+  + LL G  P+
Sbjct: 192 SIGVITYILLCGYPPF 207

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---XGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 118/235 (50%), Gaps = 11/235 (4%)
Query: 118 VASGSYGDLYK-----GTYCSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKNVV 170
           +  G YG +++     G    +  A+KVLK   +  N +       E  I+ +++H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
             I A      L ++ E+++ G ++  L ++ G+F   +      ++S  + +LHQ  II
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKGII 143
Query: 231 HRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKAD 289
           +RDLK  N++++  G VK+ DFG+ +     G +T    GT  +MAPE++    ++   D
Sbjct: 144 YRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVD 203
Query: 290 VFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLAELLER 342
            +S G  ++++LTG  P+ G    +    +++  L   P + + A   L +LL+R
Sbjct: 204 WWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKR 258

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 122/246 (49%), Gaps = 12/246 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPN 353
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R  
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR-- 280
Query: 354 FSQITD 359
           F  + D
Sbjct: 281 FGNLKD 286

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 44  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 103
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 104 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 162
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 163 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 219
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 220 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 275

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADEPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/247 (26%), Positives = 124/247 (50%), Gaps = 14/247 (5%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  GS+G   L   T   Q+VA+K++  + +  ++M     +E+  +R +RH ++++   
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                  + +V E+ A   ++D++  Q+         +    +   + Y H++ I+HRDL
Sbjct: 82  VIKSKDEIIMVIEY-AGNELFDYI-VQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDL 139
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPY-DYKADVFSF 293
           K  NLL+DE+  VK+ADFG++ +      +    G+  + APEVI  K Y   + DV+S 
Sbjct: 140 KPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 199
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRP---TIPKHAHPRLAELLERCWQHDPTQ 350
           G+ L+ +L   LP+        ++ V+ K++     T+PK   P  A L++R    +P  
Sbjct: 200 GVILYVMLCRRLPFD-----DESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLN 254
Query: 351 RPNFSQI 357
           R +  +I
Sbjct: 255 RISIHEI 261

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 50  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/247 (26%), Positives = 124/247 (50%), Gaps = 14/247 (5%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  GS+G   L   T   Q+VA+K++  + +  ++M     +E+  +R +RH ++++   
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                  + +V E+ A   ++D++  Q+         +    +   + Y H++ I+HRDL
Sbjct: 81  VIKSKDEIIMVIEY-AGNELFDYI-VQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDL 138
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPY-DYKADVFSF 293
           K  NLL+DE+  VK+ADFG++ +      +    G+  + APEVI  K Y   + DV+S 
Sbjct: 139 KPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 198
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRP---TIPKHAHPRLAELLERCWQHDPTQ 350
           G+ L+ +L   LP+        ++ V+ K++     T+PK   P  A L++R    +P  
Sbjct: 199 GVILYVMLCRRLPFD-----DESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLN 253
Query: 351 RPNFSQI 357
           R +  +I
Sbjct: 254 RISIHEI 260

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 130 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 188
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 189 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 245
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 246 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 301

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 106/198 (53%), Gaps = 8/198 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKE-FSQEVYIMRKIRHKNVVQFIG 174
           +  GS+G+  L K     QE A+KV+    V  +  KE   +EV +++++ H N+++   
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                    +V E    G ++D +  +K  F      ++   V  G+ Y+H+N I+HRDL
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKNKIVHRDL 152
Query: 235 KTANLLMD---ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVF 291
           K  NLL++   ++  +++ DFG++     S  M  + GT  ++APEV+ H  YD K DV+
Sbjct: 153 KPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTYDEKCDVW 211
Query: 292 SFGIALWELLTGELPYAG 309
           S G+ L+ LL+G  P+ G
Sbjct: 212 STGVILYILLSGCPPFNG 229

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFAEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 112/238 (47%), Gaps = 7/238 (2%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G++G   L +     +  A+K+L+ E +   + +     E  +++  RH  +     
Sbjct: 18  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 77
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           A      LC V E+   G ++  L +++ VF          ++   + YLH  ++++RD+
Sbjct: 78  AFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDI 136
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGV-MTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NL++D++G +K+ DFG+ +     G  M    GT  ++APEV+E   Y    D +  
Sbjct: 137 KLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGL 196
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E++ G LP+      +    ++ + +R   P+   P    LL    + DP QR
Sbjct: 197 GVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 252

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 130 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 188
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G ++V DFG A RV+  +  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 189 KPENLLIDQQGYIQVTDFGFAKRVKGATWTL---CGTPEYLAPEIILSKGYNKAVDWWAL 245
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 246 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 301

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 106/198 (53%), Gaps = 8/198 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKE-FSQEVYIMRKIRHKNVVQFIG 174
           +  GS+G+  L K     QE A+KV+    V  +  KE   +EV +++++ H N+++   
Sbjct: 40  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 99
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                    +V E    G ++D +  +K  F      ++   V  G+ Y+H+N I+HRDL
Sbjct: 100 FFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKNKIVHRDL 158
Query: 235 KTANLLMD---ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVF 291
           K  NLL++   ++  +++ DFG++     S  M  + GT  ++APEV+ H  YD K DV+
Sbjct: 159 KPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTYDEKCDVW 217
Query: 292 SFGIALWELLTGELPYAG 309
           S G+ L+ LL+G  P+ G
Sbjct: 218 STGVILYILLSGCPPFNG 235

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 106/198 (53%), Gaps = 8/198 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKE-FSQEVYIMRKIRHKNVVQFIG 174
           +  GS+G+  L K     QE A+KV+    V  +  KE   +EV +++++ H N+++   
Sbjct: 57  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 116
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                    +V E    G ++D +  +K  F      ++   V  G+ Y+H+N I+HRDL
Sbjct: 117 FFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKNKIVHRDL 175
Query: 235 KTANLLMD---ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVF 291
           K  NLL++   ++  +++ DFG++     S  M  + GT  ++APEV+ H  YD K DV+
Sbjct: 176 KPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTYDEKCDVW 234
Query: 292 SFGIALWELLTGELPYAG 309
           S G+ L+ LL+G  P+ G
Sbjct: 235 STGVILYILLSGCPPFNG 252

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 112/238 (47%), Gaps = 7/238 (2%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G++G   L +     +  A+K+L+ E +   + +     E  +++  RH  +     
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           A      LC V E+   G ++  L +++ VF          ++   + YLH  ++++RD+
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NL++D++G +K+ DFG+ +     G  M    GT  ++APEV+E   Y    D +  
Sbjct: 132 KLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 191
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E++ G LP+      +    ++ + +R   P+   P    LL    + DP QR
Sbjct: 192 GVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 106/198 (53%), Gaps = 8/198 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKE-FSQEVYIMRKIRHKNVVQFIG 174
           +  GS+G+  L K     QE A+KV+    V  +  KE   +EV +++++ H N+++   
Sbjct: 58  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 117
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                    +V E    G ++D +  +K  F      ++   V  G+ Y+H+N I+HRDL
Sbjct: 118 FFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKNKIVHRDL 176
Query: 235 KTANLLMD---ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVF 291
           K  NLL++   ++  +++ DFG++     S  M  + GT  ++APEV+ H  YD K DV+
Sbjct: 177 KPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTYDEKCDVW 235
Query: 292 SFGIALWELLTGELPYAG 309
           S G+ L+ LL+G  P+ G
Sbjct: 236 STGVILYILLSGCPPFNG 253

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 112/238 (47%), Gaps = 7/238 (2%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G++G   L +     +  A+K+L+ E +   + +     E  +++  RH  +     
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           A      LC V E+   G ++  L +++ VF          ++   + YLH  ++++RD+
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NL++D++G +K+ DFG+ +     G  M    GT  ++APEV+E   Y    D +  
Sbjct: 132 KLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGL 191
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E++ G LP+      +    ++ + +R   P+   P    LL    + DP QR
Sbjct: 192 GVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 112/238 (47%), Gaps = 7/238 (2%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G++G   L +     +  A+K+L+ E +   + +     E  +++  RH  +     
Sbjct: 16  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 75
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           A      LC V E+   G ++  L +++ VF          ++   + YLH  ++++RD+
Sbjct: 76  AFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDI 134
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGV-MTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NL++D++G +K+ DFG+ +     G  M    GT  ++APEV+E   Y    D +  
Sbjct: 135 KLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 194
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E++ G LP+      +    ++ + +R   P+   P    LL    + DP QR
Sbjct: 195 GVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 250

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 112/238 (47%), Gaps = 7/238 (2%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G++G   L +     +  A+K+L+ E +   + +     E  +++  RH  +     
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           A      LC V E+   G ++  L +++ VF          ++   + YLH  ++++RD+
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NL++D++G +K+ DFG+ +     G  M    GT  ++APEV+E   Y    D +  
Sbjct: 132 KLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 191
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E++ G LP+      +    ++ + +R   P+   P    LL    + DP QR
Sbjct: 192 GVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 70/238 (29%), Positives = 117/238 (49%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I + +    +V+   
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEF 109
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E+   G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVLEYAPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G +KVADFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLLIDQQGYIKVADFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 112/238 (47%), Gaps = 7/238 (2%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G++G   L +     +  A+K+L+ E +   + +     E  +++  RH  +     
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           A      LC V E+   G ++  L +++ VF          ++   + YLH  ++++RD+
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NL++D++G +K+ DFG+ +     G  M    GT  ++APEV+E   Y    D +  
Sbjct: 132 KLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGL 191
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E++ G LP+      +    ++ + +R   P+   P    LL    + DP QR
Sbjct: 192 GVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 112/238 (47%), Gaps = 7/238 (2%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G++G   L +     +  A+K+L+ E +   + +     E  +++  RH  +     
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           A      LC V E+   G ++  L +++ VF          ++   + YLH  ++++RD+
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NL++D++G +K+ DFG+ +     G  M    GT  ++APEV+E   Y    D +  
Sbjct: 132 KLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGL 191
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E++ G LP+      +    ++ + +R   P+   P    LL    + DP QR
Sbjct: 192 GVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 115/239 (48%), Gaps = 8/239 (3%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G++G   L K     +  A+K+LK E  V  + +     E  +++  RH  +     
Sbjct: 16  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 75
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH-QNNIIHRD 233
           +      LC V E+   G ++  L +++ VF          ++   ++YLH + N+++RD
Sbjct: 76  SFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRD 134
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFS 292
           LK  NL++D++G +K+ DFG+ +   + G  M    GT  ++APEV+E   Y    D + 
Sbjct: 135 LKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWG 194
Query: 293 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
            G+ ++E++ G LP+      +    ++ + +R   P+   P    LL    + DP QR
Sbjct: 195 LGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLGPEAKSLLSGLLKKDPKQR 251

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 115/239 (48%), Gaps = 8/239 (3%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G++G   L K     +  A+K+LK E  V  + +     E  +++  RH  +     
Sbjct: 18  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 77
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH-QNNIIHRD 233
           +      LC V E+   G ++  L +++ VF          ++   ++YLH + N+++RD
Sbjct: 78  SFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRD 136
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGV-MTAETGTYRWMAPEVIEHKPYDYKADVFS 292
           LK  NL++D++G +K+ DFG+ +   + G  M    GT  ++APEV+E   Y    D + 
Sbjct: 137 LKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWG 196
Query: 293 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
            G+ ++E++ G LP+      +    ++ + +R   P+   P    LL    + DP QR
Sbjct: 197 LGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLGPEAKSLLSGLLKKDPKQR 253

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 121/246 (49%), Gaps = 12/246 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 35  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 94
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 95  SFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 153
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 154 KPENLLIDQQGYIQVTDFGFAKRVKGRTWTL---CGTPEYLAPEIILSKGYNKAVDWWAL 210
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPN 353
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R  
Sbjct: 211 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR-- 266
Query: 354 FSQITD 359
           F  + D
Sbjct: 267 FGNLKD 272

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NL++D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLIIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIISKGYNKAVDWWAL 224
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 118/241 (48%), Gaps = 12/241 (4%)
Query: 118 VASGSYGDLYKGTYCSQEV--AIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKNVVQFI 173
           +  GS+G +    + ++EV  A+KVL+ + +    E     S+   +++ ++H  +V   
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
            +      L  V +++  G ++  L +++   +  +    A +++  + YLH  NI++RD
Sbjct: 106 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLHSLNIVYRD 164
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFS 292
           LK  N+L+D  G + + DFG+ +   +    T+   GT  ++APEV+  +PYD   D + 
Sbjct: 165 LKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWC 224
Query: 293 FGIALWELLTGELPYAGLTPLQAAVGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQ 350
            G  L+E+L G  P+      +    ++ K   L+P I   A      LLE   Q D T+
Sbjct: 225 LGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSAR----HLLEGLLQKDRTK 280
Query: 351 R 351
           R
Sbjct: 281 R 281

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 114/237 (48%), Gaps = 7/237 (2%)
Query: 118 VASGSYGDLYKGTYCSQE--VAIKVLKPECVNTEMLK-EFSQEVYIMRKIRHKNVVQFIG 174
           +  G +G++Y       +  +A+KVL    +  E ++ +  +E+ I   +RH N+++   
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                  + ++ EF  RG +Y  L K  G F          +++  ++Y H+  +IHRD+
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDI 140
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           K  NLLM   G +K+ADFG + V A S       GT  ++ PE+IE K +D K D++  G
Sbjct: 141 KPENLLMGYKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAG 199
Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           +  +E L G  P+   +  +    +V   L+   P        +L+ +  ++ P QR
Sbjct: 200 VLCYEFLVGMPPFDSPSHTETHRRIVNVDLK--FPPFLSDGSKDLISKLLRYHPPQR 254

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 115/239 (48%), Gaps = 8/239 (3%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G++G   L K     +  A+K+LK E  V  + +     E  +++  RH  +     
Sbjct: 17  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 76
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH-QNNIIHRD 233
           +      LC V E+   G ++  L +++ VF          ++   ++YLH + N+++RD
Sbjct: 77  SFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRD 135
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGV-MTAETGTYRWMAPEVIEHKPYDYKADVFS 292
           LK  NL++D++G +K+ DFG+ +   + G  M    GT  ++APEV+E   Y    D + 
Sbjct: 136 LKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWG 195
Query: 293 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
            G+ ++E++ G LP+      +    ++ + +R   P+   P    LL    + DP QR
Sbjct: 196 LGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLGPEAKSLLSGLLKKDPKQR 252

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 114/237 (48%), Gaps = 7/237 (2%)
Query: 118 VASGSYGDLYKGTYCSQE--VAIKVLKPECVNTEMLK-EFSQEVYIMRKIRHKNVVQFIG 174
           +  G +G++Y       +  +A+KVL    +  E ++ +  +E+ I   +RH N+++   
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                  + ++ EF  RG +Y  L K  G F          +++  ++Y H+  +IHRD+
Sbjct: 83  YFHDRKRIYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDI 141
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           K  NLLM   G +K+ADFG + V A S       GT  ++ PE+IE K +D K D++  G
Sbjct: 142 KPENLLMGYKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAG 200
Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           +  +E L G  P+   +  +    +V   L+   P        +L+ +  ++ P QR
Sbjct: 201 VLCYEFLVGMPPFDSPSHTETHRRIVNVDLK--FPPFLSDGSKDLISKLLRYHPPQR 255

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++++  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYQMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 115/239 (48%), Gaps = 8/239 (3%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G++G   L K     +  A+K+LK E  V  + +     E  +++  RH  +     
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH-QNNIIHRD 233
           +      LC V E+   G ++  L +++ VF          ++   ++YLH + N+++RD
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRD 274
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFS 292
           LK  NL++D++G +K+ DFG+ +   + G  M    GT  ++APEV+E   Y    D + 
Sbjct: 275 LKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWG 334
Query: 293 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
            G+ ++E++ G LP+      +    ++ + +R   P+   P    LL    + DP QR
Sbjct: 335 LGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLGPEAKSLLSGLLKKDPKQR 391

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 138/286 (48%), Gaps = 18/286 (6%)
Query: 108 DAKQLKIECKVASGSYG--DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
           D+ + ++   + +G++G   L +    ++ VA+K ++      E +K   +E+   R +R
Sbjct: 17  DSDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVK---REIINHRSLR 73
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
           H N+V+F      P +L IV E+ + G +++ +    G F           +  G++Y H
Sbjct: 74  HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYAH 132
Query: 226 QNNIIHRDLKTANLLMDENGV--VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKP 283
              + HRDLK  N L+D +    +K+ADFG ++         +  GT  ++APEV+  K 
Sbjct: 133 AMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKE 192
Query: 284 YDYK-ADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK--SLRPTIPKHAH--PRLAE 338
           YD K ADV+S G+ L+ +L G  P+      +     + +  +++  IP + H  P    
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRH 252
Query: 339 LLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINTNIQST 384
           L+ R +  DP +R +  +I +      +  L  L  +L+N N  +T
Sbjct: 253 LISRIFVADPAKRISIPEIRN-----HEWFLKNLPADLMNDNTMTT 293

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 115/239 (48%), Gaps = 8/239 (3%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G++G   L K     +  A+K+LK E  V  + +     E  +++  RH  +     
Sbjct: 159 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 218
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH-QNNIIHRD 233
           +      LC V E+   G ++  L +++ VF          ++   ++YLH + N+++RD
Sbjct: 219 SFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRD 277
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFS 292
           LK  NL++D++G +K+ DFG+ +   + G  M    GT  ++APEV+E   Y    D + 
Sbjct: 278 LKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWG 337
Query: 293 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
            G+ ++E++ G LP+      +    ++ + +R   P+   P    LL    + DP QR
Sbjct: 338 LGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLGPEAKSLLSGLLKKDPKQR 394

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 101
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 102 SFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 160
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 161 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 217
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 218 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 273

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 121/246 (49%), Gaps = 12/246 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPN 353
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R  
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR-- 280
Query: 354 FSQITD 359
           F  + D
Sbjct: 281 FGNLKD 286

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 121/246 (49%), Gaps = 12/246 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPN 353
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R  
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR-- 280
Query: 354 FSQITD 359
           F  + D
Sbjct: 281 FGNLKD 286

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 101
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 102 SFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 160
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 161 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 217
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 218 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 273

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 134/268 (50%), Gaps = 23/268 (8%)
Query: 118 VASGSYGDLYK--GTYCSQEVAIKVLKPECVNTEMLKEFS-QEVYIMRKIRHKNVVQFIG 174
           V  GSYG + K       + VAIK    E  + +M+K+ + +E+ +++++RH+N+V  + 
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFL-ESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
            C +     +V EF+   +I D L           + K    +  G+ + H +NIIHRD+
Sbjct: 92  VCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDI 150
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPE-VIEHKPYDYKADVFS 292
           K  N+L+ ++GVVK+ DFG AR  A  G V   E  T  + APE ++    Y    DV++
Sbjct: 151 KPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWA 210
Query: 293 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKH----------AHPRLAELLER 342
            G  + E+  GE  + G + +     ++   L   IP+H          A  RL E+ ER
Sbjct: 211 IGCLVTEMFMGEPLFPGDSDIDQLYHIMM-CLGNLIPRHQELFNKNPVFAGVRLPEIKER 269
Query: 343 CWQHDPTQRPNFSQITDILKQMMKEVLY 370
               +P +R  + ++++++  + K+ L+
Sbjct: 270 ----EPLER-RYPKLSEVVIDLAKKCLH 292

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAKRVKGRTWTL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT   +APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEALAPEIILSKGYNKAVDWWAL 224
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 121/246 (49%), Gaps = 12/246 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPN 353
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R  
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR-- 280
Query: 354 FSQITD 359
           F  + D
Sbjct: 281 FGNLKD 286

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 117/238 (49%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E+   G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NL++D+ G +KV DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 117/238 (49%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E+   G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NL++D+ G +KV DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++AP +I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPAIILSKGYNKAVDWWAL 224
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 118/237 (49%), Gaps = 10/237 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ 350
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTK 279

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 70  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 130 SFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 188
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 189 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 245
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 246 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 301

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 129/264 (48%), Gaps = 14/264 (5%)
Query: 106 EIDAKQLKIECKVASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMR 162
           +++    +I   +  GS+G   + +     +  A+K + K +CV    ++   +E+ IM+
Sbjct: 11  DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQ 70
Query: 163 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGM 221
            + H  +V    +     ++ +V + +  G +    H Q+ V      +K+ I ++   +
Sbjct: 71  GLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLR--YHLQQNVHFKEETVKLFICELVMAL 128
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH 281
           +YL    IIHRD+K  N+L+DE+G V + DF +A +  +   +T   GT  +MAPE+   
Sbjct: 129 DYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS 188
Query: 282 KP---YDYKADVFSFGIALWELLTGELPY--AGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
           +    Y +  D +S G+  +ELL G  PY     T  +  V   + ++  T P      +
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV-VTYPSAWSQEM 247
Query: 337 AELLERCWQHDPTQRPNFSQITDI 360
             LL++  + +P QR  FSQ++D+
Sbjct: 248 VSLLKKLLEPNPDQR--FSQLSDV 269

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E+   G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NL++D+ G +KV DFG+A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLMIDQQGYIKVTDFGLAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 112/217 (51%), Gaps = 6/217 (2%)
Query: 137 AIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYD 196
           A+KVLK   +          E  I+  + H  VV+   A      L ++ +F+  G ++ 
Sbjct: 60  AMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFT 119
Query: 197 FLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256
            L K+  +F    +     +++ G+++LH   II+RDLK  N+L+DE G +K+ DFG+++
Sbjct: 120 RLSKEV-MFTEEDVKFYLAELALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK 178
Query: 257 VQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ 314
            +A      A +  GT  +MAPEV+  + + + AD +S+G+ ++E+LTG LP+ G    +
Sbjct: 179 -EAIDHEKKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKE 237
Query: 315 AAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
               +++  L   +P+        LL   ++ +P  R
Sbjct: 238 TMTLILKAKL--GMPQFLSTEAQSLLRALFKRNPANR 272

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 136/286 (47%), Gaps = 18/286 (6%)
Query: 108 DAKQLKIECKVASGSYG--DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
           D+ + ++   + SG++G   L +    ++ VA+K ++      ++     +E+   R +R
Sbjct: 17  DSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE---RGEKIAANVKREIINHRSLR 73
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
           H N+V+F      P +L IV E+ + G +++ +    G F           +  G++Y H
Sbjct: 74  HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 132
Query: 226 QNNIIHRDLKTANLLMDENGV--VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKP 283
              + HRDLK  N L+D +    +K+ DFG ++         +  GT  ++APEV+  K 
Sbjct: 133 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 192
Query: 284 YDYK-ADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK--SLRPTIPKHAH--PRLAE 338
           YD K ADV+S G+ L+ +L G  P+      +     + +  +++  IP + H  P    
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRH 252
Query: 339 LLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINTNIQST 384
           L+ R +  DP +R +  +I +      +  L  L  +L+N N  +T
Sbjct: 253 LISRIFVADPAKRISIPEIRN-----HEWFLKNLPADLMNDNTMTT 293

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 137/286 (47%), Gaps = 18/286 (6%)
Query: 108 DAKQLKIECKVASGSYG--DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
           D+ + ++   + SG++G   L +    ++ VA+K ++      ++ +   +E+   R +R
Sbjct: 16  DSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE---RGEKIDENVKREIINHRSLR 72
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
           H N+V+F      P +L IV E+ + G +++ +    G F           +  G++Y H
Sbjct: 73  HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 131
Query: 226 QNNIIHRDLKTANLLMDENGV--VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKP 283
              + HRDLK  N L+D +    +K+ DFG ++         +  GT  ++APEV+  K 
Sbjct: 132 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 191
Query: 284 YDYK-ADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK--SLRPTIPKHAH--PRLAE 338
           YD K ADV+S G+ L+ +L G  P+      +     + +  +++  IP + H  P    
Sbjct: 192 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRH 251
Query: 339 LLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINTNIQST 384
           L+ R +  DP +R +  +I +      +  L  L  +L+N N  +T
Sbjct: 252 LISRIFVADPAKRISIPEIRN-----HEWFLKNLPADLMNDNTMTT 292

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E++  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 117/238 (49%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E+   G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NL++D+ G +KV DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 8/205 (3%)
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI----YDFLHKQKGVFQLTSLLK 212
           E  I+ K+  + +V    A     +LC+V   M  G I    Y+      G FQ    + 
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG-FQEPRAIF 293
Query: 213 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTY 271
               +  G+ +LHQ NII+RDLK  N+L+D++G V+++D G+A  ++A         GT 
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 272 RWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP--TIP 329
            +MAPE++  + YD+  D F+ G+ L+E++    P+           + Q+ L    T P
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP 413
Query: 330 KHAHPRLAELLERCWQHDPTQRPNF 354
               P   +  E   Q DP +R  F
Sbjct: 414 DKFSPASKDFCEALLQKDPEKRLGF 438

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 137/274 (50%), Gaps = 35/274 (12%)
Query: 93  NCIEIPTDGTDVWEIDAKQLKIECKVASGSYGD----LYKGTYCSQEVAIKVLKPECVNT 148
           N I+  TDG +V E           +  GSY      ++K T  + E A+K++       
Sbjct: 16  NSIQF-TDGYEVKE----------DIGVGSYSVCKRCIHKAT--NMEFAVKIID------ 56
Query: 149 EMLKEFSQEVYIM-RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQL 207
           +  ++ ++E+ I+ R  +H N++           + +VTE M  G + D + +QK  F  
Sbjct: 57  KSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK-FFSE 115
Query: 208 TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL-MDENG---VVKVADFGVAR-VQAQSG 262
                V   ++K + YLH   ++HRDLK +N+L +DE+G    +++ DFG A+ ++A++G
Sbjct: 116 REASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175
Query: 263 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL---TP--LQAAV 317
           ++     T  ++APEV+E + YD   D++S G+ L+ +LTG  P+A     TP  + A +
Sbjct: 176 LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI 235
Query: 318 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G  + SL             +L+ +    DP QR
Sbjct: 236 GSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQR 269

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 8/205 (3%)
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI----YDFLHKQKGVFQLTSLLK 212
           E  I+ K+  + +V    A     +LC+V   M  G I    Y+      G FQ    + 
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG-FQEPRAIF 293
Query: 213 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTY 271
               +  G+ +LHQ NII+RDLK  N+L+D++G V+++D G+A  ++A         GT 
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 272 RWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP--TIP 329
            +MAPE++  + YD+  D F+ G+ L+E++    P+           + Q+ L    T P
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP 413
Query: 330 KHAHPRLAELLERCWQHDPTQRPNF 354
               P   +  E   Q DP +R  F
Sbjct: 414 DKFSPASKDFCEALLQKDPEKRLGF 438

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 94/176 (53%), Gaps = 8/176 (4%)
Query: 139 KVLKPECVNTEMLK----EFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 194
           K++  +C+  E L+        E+ ++ KI+H N+V          +L ++ + ++ G +
Sbjct: 44  KLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL 103
Query: 195 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL---MDENGVVKVAD 251
           +D +  +KG +      ++   V   + YLH   I+HRDLK  NLL   +DE+  + ++D
Sbjct: 104 FDRI-VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISD 162
Query: 252 FGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
           FG+++++    V++   GT  ++APEV+  KPY    D +S G+  + LL G  P+
Sbjct: 163 FGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 8/205 (3%)
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI----YDFLHKQKGVFQLTSLLK 212
           E  I+ K+  + +V    A     +LC+V   M  G I    Y+      G FQ    + 
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG-FQEPRAIF 293
Query: 213 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTY 271
               +  G+ +LHQ NII+RDLK  N+L+D++G V+++D G+A  ++A         GT 
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 272 RWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP--TIP 329
            +MAPE++  + YD+  D F+ G+ L+E++    P+           + Q+ L    T P
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP 413
Query: 330 KHAHPRLAELLERCWQHDPTQRPNF 354
               P   +  E   Q DP +R  F
Sbjct: 414 DKFSPASKDFCEALLQKDPEKRLGF 438

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 8/205 (3%)
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI----YDFLHKQKGVFQLTSLLK 212
           E  I+ K+  + +V    A     +LC+V   M  G I    Y+      G FQ    + 
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG-FQEPRAIF 293
Query: 213 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTY 271
               +  G+ +LHQ NII+RDLK  N+L+D++G V+++D G+A  ++A         GT 
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 272 RWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP--TIP 329
            +MAPE++  + YD+  D F+ G+ L+E++    P+           + Q+ L    T P
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP 413
Query: 330 KHAHPRLAELLERCWQHDPTQRPNF 354
               P   +  E   Q DP +R  F
Sbjct: 414 DKFSPASKDFCEALLQKDPEKRLGF 438

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 94/176 (53%), Gaps = 8/176 (4%)
Query: 139 KVLKPECVNTEMLK----EFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 194
           K++  +C+  E L+        E+ ++ KI+H N+V          +L ++ + ++ G +
Sbjct: 44  KLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL 103
Query: 195 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL---MDENGVVKVAD 251
           +D +  +KG +      ++   V   + YLH   I+HRDLK  NLL   +DE+  + ++D
Sbjct: 104 FDRI-VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISD 162
Query: 252 FGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
           FG+++++    V++   GT  ++APEV+  KPY    D +S G+  + LL G  P+
Sbjct: 163 FGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 94/176 (53%), Gaps = 8/176 (4%)
Query: 139 KVLKPECVNTEMLK----EFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 194
           K++  +C+  E L+        E+ ++ KI+H N+V          +L ++ + ++ G +
Sbjct: 44  KLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL 103
Query: 195 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL---MDENGVVKVAD 251
           +D +  +KG +      ++   V   + YLH   I+HRDLK  NLL   +DE+  + ++D
Sbjct: 104 FDRI-VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISD 162
Query: 252 FGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
           FG+++++    V++   GT  ++APEV+  KPY    D +S G+  + LL G  P+
Sbjct: 163 FGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 116/238 (48%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    + +   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E+   G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NL++D+ G +KV DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 116/238 (48%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    + +   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E+   G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NL++D+ G +KV DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 117/241 (48%), Gaps = 17/241 (7%)
Query: 128 KGTYCSQEVAIKVLKPECVNTEML----KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183
           KGT   +E A K +K   +++       +E  +EV I+R+IRH N++          ++ 
Sbjct: 27  KGT--GKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84
Query: 184 IVTEFMARGSIYDFLHKQKGVFQ--LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 241
           ++ E ++ G ++DFL +++ + +   T  LK  +D   G++YLH   I H DLK  N+++
Sbjct: 85  LILELVSGGELFDFLAEKESLTEDEATQFLKQILD---GVHYLHSKRIAHFDLKPENIML 141
Query: 242 DENGV----VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 297
            +  V    +K+ DFG+A             GT  ++APE++ ++P   +AD++S G+  
Sbjct: 142 LDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
Query: 298 WELLTGELPYAGLTPLQ--AAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFS 355
           + LL+G  P+ G T  +    +  V          +      + + R    DP +R   +
Sbjct: 202 YILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIA 261
Query: 356 Q 356
           Q
Sbjct: 262 Q 262

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 116/238 (48%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    + +   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E+   G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NL++D+ G +KV DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 117/238 (49%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E+   G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NL++D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLMIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           +     NL +V E+   G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 235 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NL++D+ G ++V DFG+A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLMIDQQGYIQVTDFGLAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 117/241 (48%), Gaps = 17/241 (7%)
Query: 128 KGTYCSQEVAIKVLKPECVNTEML----KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183
           KGT   +E A K +K   +++       +E  +EV I+R+IRH N++          ++ 
Sbjct: 34  KGT--GKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 91
Query: 184 IVTEFMARGSIYDFLHKQKGVFQ--LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 241
           ++ E ++ G ++DFL +++ + +   T  LK  +D   G++YLH   I H DLK  N+++
Sbjct: 92  LILELVSGGELFDFLAEKESLTEDEATQFLKQILD---GVHYLHSKRIAHFDLKPENIML 148
Query: 242 DENGV----VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 297
            +  V    +K+ DFG+A             GT  ++APE++ ++P   +AD++S G+  
Sbjct: 149 LDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
Query: 298 WELLTGELPYAGLTPLQ--AAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFS 355
           + LL+G  P+ G T  +    +  V          +      + + R    DP +R   +
Sbjct: 209 YILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMXIA 268
Query: 356 Q 356
           Q
Sbjct: 269 Q 269

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 119/249 (47%), Gaps = 13/249 (5%)
Query: 118 VASGSYG--DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           + SG++G   L +     + VA+K ++      E ++   +E+   R +RH N+V+F   
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ---REIINHRSLRHPNIVRFKEV 84
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
              P +L I+ E+ + G +Y+ +    G F           +  G++Y H   I HRDLK
Sbjct: 85  ILTPTHLAIIMEYASGGELYERI-CNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLK 143
Query: 236 TANLLMDENGV--VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVFS 292
             N L+D +    +K+ DFG ++         +  GT  ++APEV+  + YD K ADV+S
Sbjct: 144 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWS 203
Query: 293 FGIALWELLTGELPYAGLTPLQAAVGVVQK--SLRPTIPK--HAHPRLAELLERCWQHDP 348
            G+ L+ +L G  P+      +     +Q+  S++ +IP      P    L+ R +  DP
Sbjct: 204 CGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADP 263
Query: 349 TQRPNFSQI 357
             R +  +I
Sbjct: 264 ATRISIPEI 272

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 116/241 (48%), Gaps = 17/241 (7%)
Query: 128 KGTYCSQEVAIKVLKPECVNTEML----KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183
           KGT   +E A K +K   + +       +E  +EV I+R+IRH N++          ++ 
Sbjct: 48  KGT--GKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 105
Query: 184 IVTEFMARGSIYDFLHKQKGVFQ--LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 241
           ++ E ++ G ++DFL +++ + +   T  LK  +D   G++YLH   I H DLK  N+++
Sbjct: 106 LILELVSGGELFDFLAEKESLTEDEATQFLKQILD---GVHYLHSKRIAHFDLKPENIML 162
Query: 242 DENGV----VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 297
            +  V    +K+ DFG+A             GT  ++APE++ ++P   +AD++S G+  
Sbjct: 163 LDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 222
Query: 298 WELLTGELPYAGLTPLQ--AAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFS 355
           + LL+G  P+ G T  +    +  V          +      + + R    DP +R   +
Sbjct: 223 YILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMXIA 282
Query: 356 Q 356
           Q
Sbjct: 283 Q 283

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 46/130 (35%), Positives = 79/130 (60%), Gaps = 2/130 (1%)
Query: 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240
            L  V E++  G +  +  +Q G F+    +  A ++S G+ +LH+  II+RDLK  N++
Sbjct: 94  RLYFVMEYVNGGDLM-YHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLDNVM 152
Query: 241 MDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFSFGIALWE 299
           +D  G +K+ADFG+ +     GV T E  GT  ++APE+I ++PY    D +++G+ L+E
Sbjct: 153 LDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYE 212
Query: 300 LLTGELPYAG 309
           +L G+ P+ G
Sbjct: 213 MLAGQPPFDG 222

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 103/198 (52%), Gaps = 8/198 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKE-FSQEVYIMRKIRHKNVVQFIG 174
           +  GS+G+  L K     QE A+KV+    V  +  KE   +EV +++++ H N+ +   
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYE 93
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                    +V E    G ++D +  +K  F      ++   V  G+ Y H+N I+HRDL
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYXHKNKIVHRDL 152
Query: 235 KTANLLMD---ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVF 291
           K  NLL++   ++  +++ DFG++     S     + GT  ++APEV+ H  YD K DV+
Sbjct: 153 KPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVL-HGTYDEKCDVW 211
Query: 292 SFGIALWELLTGELPYAG 309
           S G+ L+ LL+G  P+ G
Sbjct: 212 STGVILYILLSGCPPFNG 229

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 103/191 (53%), Gaps = 9/191 (4%)
Query: 118 VASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176
           +  G +G +YKG      +VA+K   PE  +++ ++EF  E+  +   RH ++V  IG C
Sbjct: 47  IGHGVFGKVYKGVLRDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFC 104
Query: 177 TRPPNLCIVTEFMARGSIYDFLHKQK---GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
                + ++ ++M  G++   L+              L++ I  ++G++YLH   IIHRD
Sbjct: 105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRD 164
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADV 290
           +K+ N+L+DEN V K+ DFG+++   + G   +     GT  ++ PE         K+DV
Sbjct: 165 VKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDV 224
Query: 291 FSFGIALWELL 301
           +SFG+ L+E+L
Sbjct: 225 YSFGVVLFEVL 235

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 96/176 (54%), Gaps = 8/176 (4%)
Query: 139 KVLKPECVNTEML--KEFS--QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 194
           K++  +C+  + L  KE S   E+ ++ KI+H N+V          +L ++ + ++ G +
Sbjct: 44  KLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL 103
Query: 195 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL---MDENGVVKVAD 251
           +D +  +KG +      ++   V   + YLH   I+HRDLK  NLL   +DE+  + ++D
Sbjct: 104 FDRI-VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISD 162
Query: 252 FGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
           FG+++++    V++   GT  ++APEV+  KPY    D +S G+  + LL G  P+
Sbjct: 163 FGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 103/191 (53%), Gaps = 9/191 (4%)
Query: 118 VASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176
           +  G +G +YKG      +VA+K   PE  +++ ++EF  E+  +   RH ++V  IG C
Sbjct: 47  IGHGVFGKVYKGVLRDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFC 104
Query: 177 TRPPNLCIVTEFMARGSIYDFLHKQK---GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
                + ++ ++M  G++   L+              L++ I  ++G++YLH   IIHRD
Sbjct: 105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRD 164
Query: 234 LKTANLLMDENGVVKVADFGVARVQA---QSGVMTAETGTYRWMAPEVIEHKPYDYKADV 290
           +K+ N+L+DEN V K+ DFG+++      Q+ +     GT  ++ PE         K+DV
Sbjct: 165 VKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDV 224
Query: 291 FSFGIALWELL 301
           +SFG+ L+E+L
Sbjct: 225 YSFGVVLFEVL 235

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 106/200 (53%), Gaps = 8/200 (4%)
Query: 117 KVASGSYGDLYKGTYCSQE-VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           KV  G+YG +YK        VA+K ++ +  +  +     +E+ +++++ H N+V  I  
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
                 L +V EFM +  +   L + K   Q + +      + +G+ + HQ+ I+HRDLK
Sbjct: 88  IHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLK 146
Query: 236 TANLLMDENGVVKVADFGVAR---VQAQSGVMTAETGTYRWMAPEVI-EHKPYDYKADVF 291
             NLL++ +G +K+ADFG+AR   +  +S   T E  T  + AP+V+   K Y    D++
Sbjct: 147 PQNLLINSDGALKLADFGLARAFGIPVRS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIW 204
Query: 292 SFGIALWELLTGELPYAGLT 311
           S G    E++TG+  + G+T
Sbjct: 205 SIGCIFAEMITGKPLFPGVT 224

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 106/200 (53%), Gaps = 8/200 (4%)
Query: 117 KVASGSYGDLYKGTYCSQE-VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           KV  G+YG +YK        VA+K ++ +  +  +     +E+ +++++ H N+V  I  
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
                 L +V EFM +  +   L + K   Q + +      + +G+ + HQ+ I+HRDLK
Sbjct: 88  IHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLK 146
Query: 236 TANLLMDENGVVKVADFGVAR---VQAQSGVMTAETGTYRWMAPEVI-EHKPYDYKADVF 291
             NLL++ +G +K+ADFG+AR   +  +S   T E  T  + AP+V+   K Y    D++
Sbjct: 147 PQNLLINSDGALKLADFGLARAFGIPVRS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIW 204
Query: 292 SFGIALWELLTGELPYAGLT 311
           S G    E++TG+  + G+T
Sbjct: 205 SIGCIFAEMITGKPLFPGVT 224

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 118/243 (48%), Gaps = 16/243 (6%)
Query: 118 VASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-----RHKNVV 170
           +  GS+G ++   +   +Q  AIK LK + V   ++ +  +   + +++      H  + 
Sbjct: 26  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVV---LMDDDVECTMVEKRVLSLAWEHPFLT 82
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNI 229
                     NL  V E++  G +    H Q    F L+     A ++  G+ +LH   I
Sbjct: 83  HMFCTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGI 140
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKA 288
           ++RDLK  N+L+D++G +K+ADFG+ +        T E  GT  ++APE++  + Y++  
Sbjct: 141 VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQKYNHSV 200
Query: 289 DVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDP 348
           D +SFG+ L+E+L G+ P+ G    +    +   +  P  P+       +LL + +  +P
Sbjct: 201 DWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--PFYPRWLEKEAKDLLVKLFVREP 258
Query: 349 TQR 351
            +R
Sbjct: 259 EKR 261

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 111/210 (52%), Gaps = 20/210 (9%)
Query: 117 KVASGSYGD--LYKGTYCSQEVAIKVLKPECVN-------TEMLKEFSQEVY----IMRK 163
           K+ SG+YG+  L K      E AIKV+K    +        + +++F +E+Y    +++ 
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYD-FLHKQKGVFQLTSLLKVAIDVSKGMN 222
           + H N+++            +VTEF   G +++  +++ K  F       +   +  G+ 
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK--FDECDAANIMKQILSGIC 160
Query: 223 YLHQNNIIHRDLKTANLLMDENGV---VKVADFGVARVQAQSGVMTAETGTYRWMAPEVI 279
           YLH++NI+HRD+K  N+L++       +K+ DFG++   ++   +    GT  ++APEV+
Sbjct: 161 YLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVL 220
Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAG 309
           + K Y+ K DV+S G+ ++ LL G  P+ G
Sbjct: 221 K-KKYNEKCDVWSCGVIMYILLCGYPPFGG 249

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/245 (28%), Positives = 115/245 (46%), Gaps = 16/245 (6%)
Query: 118 VASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY-----IMRKIRHKNVVQF 172
           +  G +G++Y    C +    K+   +C++ + +K    E       IM  +       F
Sbjct: 197 IGRGGFGEVYG---CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 173 I----GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 228
           I     A   P  L  + + M  G ++  L  Q GVF    +   A ++  G+ ++H   
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGLEHMHNRF 312
Query: 229 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK-PYDYK 287
           +++RDLK AN+L+DE+G V+++D G+A          A  GT+ +MAPEV++    YD  
Sbjct: 313 VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSS 371
Query: 288 ADVFSFGIALWELLTGELPYAG-LTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH 346
           AD FS G  L++LL G  P+    T  +  +  +  ++   +P    P L  LLE   Q 
Sbjct: 372 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 431
Query: 347 DPTQR 351
           D  +R
Sbjct: 432 DVNRR 436

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/245 (28%), Positives = 115/245 (46%), Gaps = 16/245 (6%)
Query: 118 VASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY-----IMRKIRHKNVVQF 172
           +  G +G++Y    C +    K+   +C++ + +K    E       IM  +       F
Sbjct: 197 IGRGGFGEVYG---CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 173 I----GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 228
           I     A   P  L  + + M  G ++  L  Q GVF    +   A ++  G+ ++H   
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGLEHMHNRF 312
Query: 229 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK-PYDYK 287
           +++RDLK AN+L+DE+G V+++D G+A          A  GT+ +MAPEV++    YD  
Sbjct: 313 VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSS 371
Query: 288 ADVFSFGIALWELLTGELPYAG-LTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH 346
           AD FS G  L++LL G  P+    T  +  +  +  ++   +P    P L  LLE   Q 
Sbjct: 372 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 431
Query: 347 DPTQR 351
           D  +R
Sbjct: 432 DVNRR 436

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 136/286 (47%), Gaps = 18/286 (6%)
Query: 108 DAKQLKIECKVASGSYG--DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
           D+ + ++   + SG++G   L +    ++ VA+K ++      ++ +   +E+   R +R
Sbjct: 17  DSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE---RGEKIDENVKREIINHRSLR 73
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
           H N+V+F      P +L IV E+ + G +++ +    G F           +  G++Y H
Sbjct: 74  HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 132
Query: 226 QNNIIHRDLKTANLLMDENGV--VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKP 283
              + HRDLK  N L+D +    +K+  FG ++         +  GT  ++APEV+  K 
Sbjct: 133 AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 192
Query: 284 YDYK-ADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK--SLRPTIPKHAH--PRLAE 338
           YD K ADV+S G+ L+ +L G  P+      +     + +  +++  IP + H  P    
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRH 252
Query: 339 LLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINTNIQST 384
           L+ R +  DP +R +  +I +      +  L  L  +L+N N  +T
Sbjct: 253 LISRIFVADPAKRISIPEIRN-----HEWFLKNLPADLMNDNTMTT 293

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/245 (28%), Positives = 115/245 (46%), Gaps = 16/245 (6%)
Query: 118 VASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY-----IMRKIRHKNVVQF 172
           +  G +G++Y    C +    K+   +C++ + +K    E       IM  +       F
Sbjct: 197 IGRGGFGEVYG---CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 173 I----GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 228
           I     A   P  L  + + M  G ++  L  Q GVF    +   A ++  G+ ++H   
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGLEHMHNRF 312
Query: 229 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK-PYDYK 287
           +++RDLK AN+L+DE+G V+++D G+A          A  GT+ +MAPEV++    YD  
Sbjct: 313 VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSS 371
Query: 288 ADVFSFGIALWELLTGELPY-AGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH 346
           AD FS G  L++LL G  P+    T  +  +  +  ++   +P    P L  LLE   Q 
Sbjct: 372 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 431
Query: 347 DPTQR 351
           D  +R
Sbjct: 432 DVNRR 436

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/245 (28%), Positives = 115/245 (46%), Gaps = 16/245 (6%)
Query: 118 VASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY-----IMRKIRHKNVVQF 172
           +  G +G++Y    C +    K+   +C++ + +K    E       IM  +       F
Sbjct: 196 IGRGGFGEVYG---CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 252
Query: 173 I----GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 228
           I     A   P  L  + + M  G ++  L  Q GVF    +   A ++  G+ ++H   
Sbjct: 253 IVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGLEHMHNRF 311
Query: 229 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK-PYDYK 287
           +++RDLK AN+L+DE+G V+++D G+A          A  GT+ +MAPEV++    YD  
Sbjct: 312 VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSS 370
Query: 288 ADVFSFGIALWELLTGELPY-AGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH 346
           AD FS G  L++LL G  P+    T  +  +  +  ++   +P    P L  LLE   Q 
Sbjct: 371 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 430
Query: 347 DPTQR 351
           D  +R
Sbjct: 431 DVNRR 435

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 109/199 (54%), Gaps = 15/199 (7%)
Query: 118 VASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIM-RKIRHKNVVQFIG 174
           +  GSY +  +  +   + E A+KV+       +  ++ S+E+ I+ R  +H N++    
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVID------KSKRDPSEEIEILLRYGQHPNIITLKD 88
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                 ++ +VTE M  G + D + +QK  F       V   + K + YLH   ++HRDL
Sbjct: 89  VYDDGKHVYLVTELMRGGELLDKILRQK-FFSEREASFVLHTIGKTVEYLHSQGVVHRDL 147
Query: 235 KTANLL-MDENG---VVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKAD 289
           K +N+L +DE+G    +++ DFG A+ ++A++G++     T  ++APEV++ + YD   D
Sbjct: 148 KPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCD 207
Query: 290 VFSFGIALWELLTGELPYA 308
           ++S GI L+ +L G  P+A
Sbjct: 208 IWSLGILLYTMLAGYTPFA 226

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 118/241 (48%), Gaps = 22/241 (9%)
Query: 97  IPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEF 154
           +PT     WE+  +       + +G +G + +  +    ++VAIK  + E ++ +  + +
Sbjct: 8   LPTQTCGPWEMKER-------LGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERW 59
Query: 155 SQEVYIMRKIRHKNVVQFI----GACTRPPN--LCIVTEFMARGSIYDFLHKQKGVFQLT 208
             E+ IM+K+ H NVV       G     PN    +  E+   G +  +L++ +    L 
Sbjct: 60  CLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK 119
Query: 209 S--LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD---ENGVVKVADFGVARVQAQSGV 263
              +  +  D+S  + YLH+N IIHRDLK  N+++    +  + K+ D G A+   Q  +
Sbjct: 120 EGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 179
Query: 264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY-AGLTPLQAAVGVVQK 322
            T   GT +++APE++E K Y    D +SFG   +E +TG  P+     P+Q    V +K
Sbjct: 180 CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREK 239
Query: 323 S 323
           S
Sbjct: 240 S 240

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 99/179 (55%), Gaps = 11/179 (6%)
Query: 152 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--LTS 209
           +E  +EV I+R++ H NV+          ++ ++ E ++ G ++DFL +++ + +   TS
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMT 265
            +K  +D   G+NYLH   I H DLK  N+++ +  +    +K+ DFG+A  + + GV  
Sbjct: 120 FIKQILD---GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEF 175
Query: 266 AET-GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS 323
               GT  ++APE++ ++P   +AD++S G+  + LL+G  P+ G T  +    +   S
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVS 234

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 118/241 (48%), Gaps = 22/241 (9%)
Query: 97  IPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEF 154
           +PT     WE+  +       + +G +G + +  +    ++VAIK  + E ++ +  + +
Sbjct: 9   LPTQTCGPWEMKER-------LGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERW 60
Query: 155 SQEVYIMRKIRHKNVVQFI----GACTRPPN--LCIVTEFMARGSIYDFLHKQKGVFQLT 208
             E+ IM+K+ H NVV       G     PN    +  E+   G +  +L++ +    L 
Sbjct: 61  CLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK 120
Query: 209 S--LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD---ENGVVKVADFGVARVQAQSGV 263
              +  +  D+S  + YLH+N IIHRDLK  N+++    +  + K+ D G A+   Q  +
Sbjct: 121 EGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 180
Query: 264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY-AGLTPLQAAVGVVQK 322
            T   GT +++APE++E K Y    D +SFG   +E +TG  P+     P+Q    V +K
Sbjct: 181 CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREK 240
Query: 323 S 323
           S
Sbjct: 241 S 241

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 109/199 (54%), Gaps = 15/199 (7%)
Query: 118 VASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIM-RKIRHKNVVQFIG 174
           +  GSY +  +  +   + E A+KV+       +  ++ S+E+ I+ R  +H N++    
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVID------KSKRDPSEEIEILLRYGQHPNIITLKD 88
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                 ++ +VTE M  G + D + +QK  F       V   + K + YLH   ++HRDL
Sbjct: 89  VYDDGKHVYLVTELMRGGELLDKILRQK-FFSEREASFVLHTIGKTVEYLHSQGVVHRDL 147
Query: 235 KTANLL-MDENG---VVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKAD 289
           K +N+L +DE+G    +++ DFG A+ ++A++G++     T  ++APEV++ + YD   D
Sbjct: 148 KPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCD 207
Query: 290 VFSFGIALWELLTGELPYA 308
           ++S GI L+ +L G  P+A
Sbjct: 208 IWSLGILLYTMLAGYTPFA 226

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 135/274 (49%), Gaps = 35/274 (12%)
Query: 93  NCIEIPTDGTDVWEIDAKQLKIECKVASGSYGD----LYKGTYCSQEVAIKVLKPECVNT 148
           N I+  TDG +V E           +  GSY      ++K T  + E A+K++       
Sbjct: 16  NSIQF-TDGYEVKE----------DIGVGSYSVCKRCIHKAT--NXEFAVKIID------ 56
Query: 149 EMLKEFSQEVYIM-RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQL 207
           +  ++ ++E+ I+ R  +H N++           + +VTE    G + D + +QK  F  
Sbjct: 57  KSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQK-FFSE 115
Query: 208 TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL-MDENG---VVKVADFGVAR-VQAQSG 262
                V   ++K + YLH   ++HRDLK +N+L +DE+G    +++ DFG A+ ++A++G
Sbjct: 116 REASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175
Query: 263 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL---TP--LQAAV 317
           ++     T  ++APEV+E + YD   D++S G+ L+  LTG  P+A     TP  + A +
Sbjct: 176 LLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARI 235
Query: 318 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           G  + SL             +L+ +    DP QR
Sbjct: 236 GSGKFSLSGGYWNSVSDTAKDLVSKXLHVDPHQR 269

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 99/179 (55%), Gaps = 11/179 (6%)
Query: 152 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--LTS 209
           +E  +EV I+R++ H NV+          ++ ++ E ++ G ++DFL +++ + +   TS
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMT 265
            +K  +D   G+NYLH   I H DLK  N+++ +  +    +K+ DFG+A  + + GV  
Sbjct: 120 FIKQILD---GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEF 175
Query: 266 AET-GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS 323
               GT  ++APE++ ++P   +AD++S G+  + LL+G  P+ G T  +    +   S
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVS 234

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 99/179 (55%), Gaps = 11/179 (6%)
Query: 152 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--LTS 209
           +E  +EV I+R++ H NV+          ++ ++ E ++ G ++DFL +++ + +   TS
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMT 265
            +K  +D   G+NYLH   I H DLK  N+++ +  +    +K+ DFG+A  + + GV  
Sbjct: 120 FIKQILD---GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEF 175
Query: 266 AET-GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS 323
               GT  ++APE++ ++P   +AD++S G+  + LL+G  P+ G T  +    +   S
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVS 234

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 126/255 (49%), Gaps = 21/255 (8%)
Query: 117 KVASGSYGDLY--KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           K+ SG++GD++  +      E  IK +  +     M ++   E+ +++ + H N+++   
Sbjct: 29  KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPM-EQIEAEIEVLKSLDHPNIIKIFE 87
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN---YLHQNNIIH 231
                 N+ IV E    G + + +   +   +  S   VA  + + MN   Y H  +++H
Sbjct: 88  VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVH 147
Query: 232 RDLKTANLLMDE---NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKA 288
           +DLK  N+L  +   +  +K+ DFG+A +       T   GT  +MAPEV + +   +K 
Sbjct: 148 KDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKC 206
Query: 289 DVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHA------HPRLAELLER 342
           D++S G+ ++ LLTG LP+ G T L+     VQ+      P +A       P+  +LL++
Sbjct: 207 DIWSAGVVMYFLLTGCLPFTG-TSLEE----VQQKATYKEPNYAVECRPLTPQAVDLLKQ 261
Query: 343 CWQHDPTQRPNFSQI 357
               DP +RP+ +Q+
Sbjct: 262 MLTKDPERRPSAAQV 276

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 112/222 (50%), Gaps = 16/222 (7%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
           E+ + Q  I  K    S G  Y   +  +  +    +  C      +E  +EV I+R++ 
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVC-----REEIEREVSILRQVL 73
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--LTSLLKVAIDVSKGMNY 223
           H N++          ++ ++ E ++ G ++DFL +++ + +   TS +K  +D   G+NY
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD---GVNY 130
Query: 224 LHQNNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMTAET-GTYRWMAPEV 278
           LH   I H DLK  N+++ +  +    +K+ DFG+A  + + GV      GT  ++APE+
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEFKNIFGTPEFVAPEI 189
Query: 279 IEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320
           + ++P   +AD++S G+  + LL+G  P+ G T  +    + 
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT 231

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 135/286 (47%), Gaps = 18/286 (6%)
Query: 108 DAKQLKIECKVASGSYG--DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
           D+ + ++   + SG++G   L +    ++ VA+K ++      ++ +   +E+   R +R
Sbjct: 17  DSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE---RGEKIDENVKREIINHRSLR 73
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
           H N+V+F      P +L IV E+ + G +++ +    G F           +  G++Y H
Sbjct: 74  HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 132
Query: 226 QNNIIHRDLKTANLLMDENGV--VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKP 283
              + HRDLK  N L+D +    +K+  FG ++            GT  ++APEV+  K 
Sbjct: 133 AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKE 192
Query: 284 YDYK-ADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK--SLRPTIPKHAH--PRLAE 338
           YD K ADV+S G+ L+ +L G  P+      +     + +  +++  IP + H  P    
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRH 252
Query: 339 LLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINTNIQST 384
           L+ R +  DP +R +  +I +      +  L  L  +L+N N  +T
Sbjct: 253 LISRIFVADPAKRISIPEIRN-----HEWFLKNLPADLMNDNTMTT 293

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 109/215 (50%), Gaps = 13/215 (6%)
Query: 146 VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI-YDFLHKQKGV 204
           ++TE LK   +E  I   ++H ++V+ +   +    L +V EFM    + ++ + +    
Sbjct: 68  LSTEDLK---REASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAG 124
Query: 205 FQLTSLLKVAI--DVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQA 259
           F  +  +       + + + Y H NNIIHRD+K  N+L+   + +  VK+ DFGVA    
Sbjct: 125 FVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLG 184
Query: 260 QSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318
           +SG V     GT  +MAPEV++ +PY    DV+  G+ L+ LL+G LP+ G T  +   G
Sbjct: 185 ESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEG 243
Query: 319 VVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           +++    + P    H      +L+ R    DP +R
Sbjct: 244 IIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAER 278

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 99/179 (55%), Gaps = 11/179 (6%)
Query: 152 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--LTS 209
           +E  +EV I+R++ H NV+          ++ ++ E ++ G ++DFL +++ + +   TS
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMT 265
            +K  +D   G+NYLH   I H DLK  N+++ +  +    +K+ DFG+A  + + GV  
Sbjct: 120 FIKQILD---GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEF 175
Query: 266 AET-GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS 323
               GT  ++APE++ ++P   +AD++S G+  + LL+G  P+ G T  +    +   S
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVS 234

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 99/179 (55%), Gaps = 11/179 (6%)
Query: 152 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--LTS 209
           +E  +EV I+R++ H NV+          ++ ++ E ++ G ++DFL +++ + +   TS
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMT 265
            +K  +D   G+NYLH   I H DLK  N+++ +  +    +K+ DFG+A  + + GV  
Sbjct: 120 FIKQILD---GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEF 175
Query: 266 AET-GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS 323
               GT  ++APE++ ++P   +AD++S G+  + LL+G  P+ G T  +    +   S
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVS 234

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 129/271 (47%), Gaps = 15/271 (5%)
Query: 99  TDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQ 156
           T G   ++ +   L+   ++ SG+ G ++K  +      +A+K ++      E  +    
Sbjct: 14  TIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMD 73
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAI 215
              +++      +VQ  G      ++ I  E M  G+  + L K+ +G      L K+ +
Sbjct: 74  LDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTV 131
Query: 216 DVSKGMNYL-HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM 274
            + K + YL  ++ +IHRD+K +N+L+DE G +K+ DFG++             G   +M
Sbjct: 132 AIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYM 191
Query: 275 APEVIE----HKP-YDYKADVFSFGIALWELLTGELPYAGL-TPLQAAVGVVQKSLRPTI 328
           APE I+     KP YD +ADV+S GI+L EL TG+ PY    T  +    V+Q+   P +
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE-PPLL 250
Query: 329 PKHA--HPRLAELLERCWQHDPTQRPNFSQI 357
           P H          ++ C   D  +RP ++++
Sbjct: 251 PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKL 281

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 117/243 (48%), Gaps = 16/243 (6%)
Query: 118 VASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-----RHKNVV 170
           +  GS+G ++   +   +Q  AIK LK + V   ++ +  +   + +++      H  + 
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVV---LMDDDVECTMVEKRVLSLAWEHPFLT 81
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNI 229
                     NL  V E++  G +    H Q    F L+     A ++  G+ +LH   I
Sbjct: 82  HMFCTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGI 139
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKA 288
           ++RDLK  N+L+D++G +K+ADFG+ +        T    GT  ++APE++  + Y++  
Sbjct: 140 VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQKYNHSV 199
Query: 289 DVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDP 348
           D +SFG+ L+E+L G+ P+ G    +    +   +  P  P+       +LL + +  +P
Sbjct: 200 DWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--PFYPRWLEKEAKDLLVKLFVREP 257
Query: 349 TQR 351
            +R
Sbjct: 258 EKR 260

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 128/266 (48%), Gaps = 18/266 (6%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI-MR 162
           E+ A  L+   ++  G+YG + K  +    Q +A+K ++   VN++  K    ++ I MR
Sbjct: 3   EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR-ATVNSQEQKRLLMDLDISMR 61
Query: 163 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQ---KGVFQLTSLL-KVAIDVS 218
            +     V F GA  R  ++ I  E M   +  D  +KQ   KG      +L K+A+ + 
Sbjct: 62  TVDCPFTVTFYGALFREGDVWICMELM--DTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 219 KGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 277
           K + +LH   ++IHRD+K +N+L++  G VK+ DFG++           + G   +MAPE
Sbjct: 120 KALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPE 179
Query: 278 VI----EHKPYDYKADVFSFGIALWELLTGELPYAGL-TPLQAAVGVVQKSLRPTIPKHA 332
            I      K Y  K+D++S GI + EL     PY    TP Q    VV++   P +P   
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP-SPQLPADK 238
Query: 333 -HPRLAELLERCWQHDPTQRPNFSQI 357
                 +   +C + +  +RP + ++
Sbjct: 239 FSAEFVDFTSQCLKKNSKERPTYPEL 264

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 119/259 (45%), Gaps = 31/259 (11%)
Query: 121 GSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180
           G YG L++      EV +KVL     N    + F +   +M K+ HK++V   G C    
Sbjct: 33  GDYGQLHE-----TEVLLKVLDKAHRNYS--ESFFEAASMMSKLSHKHLVLNYGVCVCGD 85
Query: 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240
              +V EF+  GS+  +L K K    +   L+VA  ++  M++L +N +IH ++   N+L
Sbjct: 86  ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNIL 145
Query: 241 M--DENG------VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVF 291
           +  +E+        +K++D G++       ++        W+ PE IE+ K  +   D +
Sbjct: 146 LIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP---WVPPECIENPKNLNLATDKW 202
Query: 292 SFGIALWELLTGELPYAGLTPLQAAVGVVQKSL-----RPTIPKHAHPRLAELLERCWQH 346
           SFG  LWE+ +G     G  PL A     Q+ L     R  +P      LA L+  C  +
Sbjct: 203 SFGTTLWEICSG-----GDKPLSALDS--QRKLQFYEDRHQLPAPKAAELANLINNCMDY 255
Query: 347 DPTQRPNFSQITDILKQMM 365
           +P  RP+F  I   L  + 
Sbjct: 256 EPDHRPSFRAIIRDLNSLF 274

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 127/277 (45%), Gaps = 40/277 (14%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH 166
           +D K++++   + SG +G ++K  +   +    V+K    N E   +  +EV  + K+ H
Sbjct: 11  MDFKEIEL---IGSGGFGQVFKAKH-RIDGKTYVIKRVKYNNE---KAEREVKALAKLDH 63
Query: 167 KNVVQFIGA--------------CTRPPNLC--IVTEFMARGSIYDFLHKQKGVFQLTSL 210
            N+V + G                +R    C  I  EF  +G++  ++ K++G  +L  +
Sbjct: 64  VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-KLDKV 122
Query: 211 LKVAI--DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268
           L + +   ++KG++Y+H   +I+RDLK +N+ + +   VK+ DFG+       G      
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSK 182
Query: 269 GTYRWMAPEVIEHKPYDYKADVFSFGIALWELL----TGELPYAGLTPLQAAVGVVQKSL 324
           GT R+M+PE I  + Y  + D+++ G+ L ELL    T        T L+  +       
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGI------- 235
Query: 325 RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDIL 361
              I      +   LL++     P  RPN S+I   L
Sbjct: 236 ---ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTL 269

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 119/259 (45%), Gaps = 31/259 (11%)
Query: 121 GSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180
           G YG L++      EV +KVL     N    + F +   +M K+ HK++V   G C    
Sbjct: 33  GDYGQLHE-----TEVLLKVLDKAHRNYS--ESFFEAASMMSKLSHKHLVLNYGVCFCGD 85
Query: 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240
              +V EF+  GS+  +L K K    +   L+VA  ++  M++L +N +IH ++   N+L
Sbjct: 86  ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFLEENTLIHGNVCAKNIL 145
Query: 241 M--DENG------VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVF 291
           +  +E+        +K++D G++       ++        W+ PE IE+ K  +   D +
Sbjct: 146 LIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP---WVPPECIENPKNLNLATDKW 202
Query: 292 SFGIALWELLTGELPYAGLTPLQAAVGVVQKSL-----RPTIPKHAHPRLAELLERCWQH 346
           SFG  LWE+ +G     G  PL A     Q+ L     R  +P      LA L+  C  +
Sbjct: 203 SFGTTLWEICSG-----GDKPLSALDS--QRKLQFYEDRHQLPAPKAAELANLINNCMDY 255
Query: 347 DPTQRPNFSQITDILKQMM 365
           +P  RP+F  I   L  + 
Sbjct: 256 EPDHRPSFRAIIRDLNSLF 274

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 109/213 (51%), Gaps = 20/213 (9%)
Query: 151 LKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDF-----LHKQKG 203
           +++  QE+ I++K+ H NVV+ +     P   +L +V E + +G + +      L + + 
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQA 139
Query: 204 VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSG 262
            F    L+K       G+ YLH   IIHRD+K +NLL+ E+G +K+ADFGV+   +    
Sbjct: 140 RFYFQDLIK-------GIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192
Query: 263 VMTAETGTYRWMAPEVIE--HKPYDYKA-DVFSFGIALWELLTGELPYAGLTPLQAAVGV 319
           +++   GT  +MAPE +    K +  KA DV++ G+ L+  + G+ P+     +     +
Sbjct: 193 LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKI 252
Query: 320 VQKSLR-PTIPKHAHPRLAELLERCWQHDPTQR 351
             ++L  P  P  A   L +L+ R    +P  R
Sbjct: 253 KSQALEFPDQPDIAE-DLKDLITRMLDKNPESR 284

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 126/248 (50%), Gaps = 17/248 (6%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHKNVVQFIG 174
           +  GSY    L +     +  A+KV+K E VN +   ++ Q E ++  +  +   +  + 
Sbjct: 28  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 87
Query: 175 ACTRPPN-LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
           +C +  + L  V E++  G +   + +Q+ + +  +    A ++S  +NYLH+  II+RD
Sbjct: 88  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHERGIIYRD 146
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFS 292
           LK  N+L+D  G +K+ D+G+ +   + G  T+   GT  ++APE++  + Y +  D ++
Sbjct: 147 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWA 206
Query: 293 FGIALWELLTGELPY----AGLTPLQAAVG-----VVQKSLRPTIPKHAHPRLAELLERC 343
            G+ ++E++ G  P+    +   P Q         +++K +R  IP+    + A +L+  
Sbjct: 207 LGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IPRSMSVKAASVLKSF 264
Query: 344 WQHDPTQR 351
              DP +R
Sbjct: 265 LNKDPKER 272

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 127/286 (44%), Gaps = 53/286 (18%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH 166
           +D K++++   + SG +G ++K  +   +    V++    N E  +   +EV  + K+ H
Sbjct: 12  MDFKEIEL---IGSGGFGQVFKAKH-RIDGKTYVIRRVKYNNEKAE---REVKALAKLDH 64
Query: 167 KNVVQFIGA---------------------------CTRPPNLC--IVTEFMARGSIYDF 197
            N+V + G                             +R    C  I  EF  +G++  +
Sbjct: 65  VNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQW 124
Query: 198 LHKQKGVFQLTSLLKVAI--DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255
           + K++G  +L  +L + +   ++KG++Y+H   +IHRDLK +N+ + +   VK+ DFG+ 
Sbjct: 125 IEKRRGE-KLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLV 183
Query: 256 RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELL----TGELPYAGLT 311
                 G  T   GT R+M+PE I  + Y  + D+++ G+ L ELL    T        T
Sbjct: 184 TSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFT 243
Query: 312 PLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
            L+  +          I      +   LL++     P  RPN S+I
Sbjct: 244 DLRDGI----------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEI 279

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 126/248 (50%), Gaps = 17/248 (6%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHKNVVQFIG 174
           +  GSY    L +     +  A+KV+K E VN +   ++ Q E ++  +  +   +  + 
Sbjct: 13  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 72
Query: 175 ACTRPPN-LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
           +C +  + L  V E++  G +   + +Q+ + +  +    A ++S  +NYLH+  II+RD
Sbjct: 73  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHERGIIYRD 131
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFS 292
           LK  N+L+D  G +K+ D+G+ +   + G  T+   GT  ++APE++  + Y +  D ++
Sbjct: 132 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWA 191
Query: 293 FGIALWELLTGELPY----AGLTPLQAAVG-----VVQKSLRPTIPKHAHPRLAELLERC 343
            G+ ++E++ G  P+    +   P Q         +++K +R  IP+    + A +L+  
Sbjct: 192 LGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IPRSLSVKAASVLKSF 249
Query: 344 WQHDPTQR 351
              DP +R
Sbjct: 250 LNKDPKER 257

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 76/129 (58%), Gaps = 2/129 (1%)
Query: 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 241
           L  V E++  G +   + +Q G F+    +  A +++ G+ +L    II+RDLK  N+++
Sbjct: 417 LYFVMEYVNGGDLMYHI-QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 475
Query: 242 DENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFSFGIALWEL 300
           D  G +K+ADFG+ +     GV T    GT  ++APE+I ++PY    D ++FG+ L+E+
Sbjct: 476 DSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 535
Query: 301 LTGELPYAG 309
           L G+ P+ G
Sbjct: 536 LAGQAPFEG 544

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 126/248 (50%), Gaps = 17/248 (6%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHKNVVQFIG 174
           +  GSY    L +     +  A+KV+K E VN +   ++ Q E ++  +  +   +  + 
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 175 ACTRPPN-LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
           +C +  + L  V E++  G +   + +Q+ + +  +    A ++S  +NYLH+  II+RD
Sbjct: 77  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHERGIIYRD 135
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFS 292
           LK  N+L+D  G +K+ D+G+ +   + G  T+   GT  ++APE++  + Y +  D ++
Sbjct: 136 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWA 195
Query: 293 FGIALWELLTGELPY----AGLTPLQAAVG-----VVQKSLRPTIPKHAHPRLAELLERC 343
            G+ ++E++ G  P+    +   P Q         +++K +R  IP+    + A +L+  
Sbjct: 196 LGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IPRSLSVKAASVLKSF 253
Query: 344 WQHDPTQR 351
              DP +R
Sbjct: 254 LNKDPKER 261

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 115/247 (46%), Gaps = 20/247 (8%)
Query: 152 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--LTS 209
           ++  +EV I+++I+H NV+          ++ ++ E +A G ++DFL +++ + +   T 
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMT 265
            LK  ++   G+ YLH   I H DLK  N+++ +  V    +K+ DFG+A          
Sbjct: 119 FLKQILN---GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ--AAVGVVQKS 323
              GT  ++APE++ ++P   +AD++S G+  + LL+G  P+ G T  +  A V  V   
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235
Query: 324 LRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINTNIQS 383
                  +      + + R    DP +R     I D L+        W+ P      + S
Sbjct: 236 FEDEYFSNTSALAKDFIRRLLVKDPKKR---MTIQDSLQHP------WIKPKDTQQALSS 286
Query: 384 TYKHLLF 390
            + H  F
Sbjct: 287 AWSHPQF 293

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 115/247 (46%), Gaps = 20/247 (8%)
Query: 152 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--LTS 209
           ++  +EV I+++I+H NV+          ++ ++ E +A G ++DFL +++ + +   T 
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMT 265
            LK  ++   G+ YLH   I H DLK  N+++ +  V    +K+ DFG+A          
Sbjct: 119 FLKQILN---GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ--AAVGVVQKS 323
              GT  ++APE++ ++P   +AD++S G+  + LL+G  P+ G T  +  A V  V   
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235
Query: 324 LRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINTNIQS 383
                  +      + + R    DP +R     I D L+        W+ P      + S
Sbjct: 236 FEDEYFSNTSALAKDFIRRLLVKDPKKR---MTIQDSLQHP------WIKPKDTQQALSS 286
Query: 384 TYKHLLF 390
            + H  F
Sbjct: 287 AWSHPQF 293

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 115/247 (46%), Gaps = 20/247 (8%)
Query: 152 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--LTS 209
           ++  +EV I+++I+H NV+          ++ ++ E +A G ++DFL +++ + +   T 
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMT 265
            LK  ++   G+ YLH   I H DLK  N+++ +  V    +K+ DFG+A          
Sbjct: 119 FLKQILN---GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ--AAVGVVQKS 323
              GT  ++APE++ ++P   +AD++S G+  + LL+G  P+ G T  +  A V  V   
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235
Query: 324 LRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINTNIQS 383
                  +      + + R    DP +R     I D L+        W+ P      + S
Sbjct: 236 FEDEYFSNTSALAKDFIRRLLVKDPKKR---MTIQDSLQHP------WIKPKDTQQALSS 286
Query: 384 TYKHLLF 390
            + H  F
Sbjct: 287 AWSHPQF 293

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 115/247 (46%), Gaps = 20/247 (8%)
Query: 152 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--LTS 209
           ++  +EV I+++I+H NV+          ++ ++ E +A G ++DFL +++ + +   T 
Sbjct: 58  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 117
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMT 265
            LK  ++   G+ YLH   I H DLK  N+++ +  V    +K+ DFG+A          
Sbjct: 118 FLKQILN---GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 174
Query: 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ--AAVGVVQKS 323
              GT  ++APE++ ++P   +AD++S G+  + LL+G  P+ G T  +  A V  V   
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 234
Query: 324 LRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINTNIQS 383
                  +      + + R    DP +R     I D L+        W+ P      + S
Sbjct: 235 FEDEYFSNTSALAKDFIRRLLVKDPKKR---MTIQDSLQHP------WIKPKDTQQALSS 285
Query: 384 TYKHLLF 390
            + H  F
Sbjct: 286 AWSHPQF 292

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 115/247 (46%), Gaps = 20/247 (8%)
Query: 152 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--LTS 209
           ++  +EV I+++I+H NV+          ++ ++ E +A G ++DFL +++ + +   T 
Sbjct: 58  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 117
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMT 265
            LK  ++   G+ YLH   I H DLK  N+++ +  V    +K+ DFG+A          
Sbjct: 118 FLKQILN---GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 174
Query: 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ--AAVGVVQKS 323
              GT  ++APE++ ++P   +AD++S G+  + LL+G  P+ G T  +  A V  V   
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 234
Query: 324 LRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINTNIQS 383
                  +      + + R    DP +R     I D L+        W+ P      + S
Sbjct: 235 FEDEYFSNTSALAKDFIRRLLVKDPKKR---MTIQDSLQHP------WIKPKDTQQALSS 285
Query: 384 TYKHLLF 390
            + H  F
Sbjct: 286 AWSHPQF 292

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 115/247 (46%), Gaps = 20/247 (8%)
Query: 152 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--LTS 209
           ++  +EV I+++I+H NV+          ++ ++ E +A G ++DFL +++ + +   T 
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATE 118
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMT 265
            LK  ++   G+ YLH   I H DLK  N+++ +  V    +K+ DFG+A          
Sbjct: 119 FLKQILN---GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ--AAVGVVQKS 323
              GT  ++APE++ ++P   +AD++S G+  + LL+G  P+ G T  +  A V  V   
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235
Query: 324 LRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINTNIQS 383
                  +      + + R    DP +R     I D L+        W+ P      + S
Sbjct: 236 FEDEYFSNTSALAKDFIRRLLVKDPKKR---MTIQDSLQHP------WIKPKDTQQALSS 286
Query: 384 TYKHLLF 390
            + H  F
Sbjct: 287 AWSHPQF 293

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 81/152 (53%), Gaps = 1/152 (0%)
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI-YDFLHKQKGVFQLTSLLKVAI 215
           E  I+ K+  + VV    A      LC+V   M  G + +   H  +  F     +  A 
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
           ++  G+  LH+  I++RDLK  N+L+D++G ++++D G+A    +   +    GT  +MA
Sbjct: 294 EICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMA 353
Query: 276 PEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
           PEV++++ Y +  D ++ G  L+E++ G+ P+
Sbjct: 354 PEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 81/152 (53%), Gaps = 1/152 (0%)
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI-YDFLHKQKGVFQLTSLLKVAI 215
           E  I+ K+  + VV    A      LC+V   M  G + +   H  +  F     +  A 
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
           ++  G+  LH+  I++RDLK  N+L+D++G ++++D G+A    +   +    GT  +MA
Sbjct: 294 EICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMA 353
Query: 276 PEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
           PEV++++ Y +  D ++ G  L+E++ G+ P+
Sbjct: 354 PEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 76/129 (58%), Gaps = 2/129 (1%)
Query: 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 241
           L  V E++  G +  +  +Q G F+    +  A +++ G+ +L    II+RDLK  N+++
Sbjct: 96  LYFVMEYVNGGDLM-YHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 154
Query: 242 DENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFSFGIALWEL 300
           D  G +K+ADFG+ +     GV T    GT  ++APE+I ++PY    D ++FG+ L+E+
Sbjct: 155 DSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 214
Query: 301 LTGELPYAG 309
           L G+ P+ G
Sbjct: 215 LAGQAPFEG 223

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 104/207 (50%), Gaps = 7/207 (3%)
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           +E+ ++ +     +V F GA      + I  E M  GS+ D + K+ G      L KV+I
Sbjct: 72  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSI 130
Query: 216 DVSKGMNYLHQNN-IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM 274
            V KG+ YL + + I+HRD+K +N+L++  G +K+ DFGV+  Q    +  +  GT  +M
Sbjct: 131 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYM 189
Query: 275 APEVIEHKPYDYKADVFSFGIALWELLTGELPY---AGLTPLQAAVGVVQKSLRPTIPKH 331
           +PE ++   Y  ++D++S G++L E+  G  P    +G   +   +  +     P +P  
Sbjct: 190 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSG 249
Query: 332 AHP-RLAELLERCWQHDPTQRPNFSQI 357
                  + + +C   +P +R +  Q+
Sbjct: 250 VFSLEFQDFVNKCLIKNPAERADLKQL 276

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 121/250 (48%), Gaps = 21/250 (8%)
Query: 114 IECKVASGSYGDL----YKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV 169
           +E  +  GS+G++     KGT   +  A K+ K      E +  F QE+ IM+ + H N+
Sbjct: 13  LENTIGRGSWGEVKIAVQKGTRI-RRAAKKIPK---YFVEDVDRFKQEIEIMKSLDHPNI 68
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYD-FLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 228
           ++         ++ +V E    G +++  +HK+  VF+ +   ++  DV   + Y H+ N
Sbjct: 69  IRLYETFEDNTDIYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLN 126
Query: 229 IIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYD 285
           + HRDLK  N L      +  +K+ DFG+A       +M  + GT  +++P+V+E   Y 
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YG 185
Query: 286 YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK----HAHPRLAELLE 341
            + D +S G+ ++ LL G  P++  T  +  + + + +   T P+    +  P+   L+ 
Sbjct: 186 PECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTF--TFPEKDWLNVSPQAESLIR 243
Query: 342 RCWQHDPTQR 351
           R     P QR
Sbjct: 244 RLLTKSPKQR 253

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 126/248 (50%), Gaps = 17/248 (6%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHKNVVQFIG 174
           +  GSY    L +     +  A++V+K E VN +   ++ Q E ++  +  +   +  + 
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 175 ACTRPPN-LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
           +C +  + L  V E++  G +   + +Q+ + +  +    A ++S  +NYLH+  II+RD
Sbjct: 120 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHERGIIYRD 178
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFS 292
           LK  N+L+D  G +K+ D+G+ +   + G  T+   GT  ++APE++  + Y +  D ++
Sbjct: 179 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWA 238
Query: 293 FGIALWELLTGELPY----AGLTPLQAAVG-----VVQKSLRPTIPKHAHPRLAELLERC 343
            G+ ++E++ G  P+    +   P Q         +++K +R  IP+    + A +L+  
Sbjct: 239 LGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IPRSLSVKAASVLKSF 296
Query: 344 WQHDPTQR 351
              DP +R
Sbjct: 297 LNKDPKER 304

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 118/221 (53%), Gaps = 10/221 (4%)
Query: 117 KVASGSYGDLYK--GTYCSQEVAIKVLKPECVNTEMLKEFS-QEVYIMRKIRHKNVVQFI 173
           K+  GSYG ++K       Q VAIK    E  +  ++K+ + +E+ ++++++H N+V  +
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFL-ESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLK-VAIDVSKGMNYLHQNNIIHR 232
               R   L +V E+     +++    Q+GV +   L+K +     + +N+ H++N IHR
Sbjct: 69  EVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPE--HLVKSITWQTLQAVNFCHKHNCIHR 126
Query: 233 DLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPE-VIEHKPYDYKADV 290
           D+K  N+L+ ++ V+K+ DFG AR +   S     E  T  + +PE ++    Y    DV
Sbjct: 127 DVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDV 186
Query: 291 FSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKH 331
           ++ G    ELL+G   + G + +   + +++K+L   IP+H
Sbjct: 187 WAIGCVFAELLSGVPLWPGKSDVD-QLYLIRKTLGDLIPRH 226

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 121/250 (48%), Gaps = 21/250 (8%)
Query: 114 IECKVASGSYGDL----YKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV 169
           +E  +  GS+G++     KGT   +  A K+ K      E +  F QE+ IM+ + H N+
Sbjct: 30  LENTIGRGSWGEVKIAVQKGTRI-RRAAKKIPK---YFVEDVDRFKQEIEIMKSLDHPNI 85
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYD-FLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 228
           ++         ++ +V E    G +++  +HK+  VF+ +   ++  DV   + Y H+ N
Sbjct: 86  IRLYETFEDNTDIYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLN 143
Query: 229 IIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYD 285
           + HRDLK  N L      +  +K+ DFG+A       +M  + GT  +++P+V+E   Y 
Sbjct: 144 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YG 202
Query: 286 YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK----HAHPRLAELLE 341
            + D +S G+ ++ LL G  P++  T  +  + + + +   T P+    +  P+   L+ 
Sbjct: 203 PECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTF--TFPEKDWLNVSPQAESLIR 260
Query: 342 RCWQHDPTQR 351
           R     P QR
Sbjct: 261 RLLTKSPKQR 270

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 103/204 (50%), Gaps = 5/204 (2%)
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           +E+ ++ +     +V F GA      + I  E M  GS+ D + K+ G      L KV+I
Sbjct: 56  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSI 114
Query: 216 DVSKGMNYLHQNN-IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM 274
            V KG+ YL + + I+HRD+K +N+L++  G +K+ DFGV+  Q    +     GT  +M
Sbjct: 115 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDEMANEFVGTRSYM 173
Query: 275 APEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP 334
           +PE ++   Y  ++D++S G++L E+  G  P   +   +    +V +   P +P     
Sbjct: 174 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVNEP-PPKLPSAVFS 232
Query: 335 -RLAELLERCWQHDPTQRPNFSQI 357
               + + +C   +P +R +  Q+
Sbjct: 233 LEFQDFVNKCLIKNPAERADLKQL 256

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 152 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--LTS 209
           ++  +EV I+++I+H NV+          ++ ++ E +A G ++DFL +++ + +   T 
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMT 265
            LK  ++   G+ YLH   I H DLK  N+++ +  V    +K+ DFG+A          
Sbjct: 119 FLKQILN---GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ--AAVGVVQKS 323
              GT  ++APE++ ++P   +AD++S G+  + LL+G  P+ G T  +  A V  V   
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235
Query: 324 LRPTIPKHAHPRLAELLERCWQHDPTQR 351
                  +      + + R    DP +R
Sbjct: 236 FEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 152 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--LTS 209
           ++  +EV I+++I+H NV+          ++ ++ E +A G ++DFL +++ + +   T 
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMT 265
            LK  ++   G+ YLH   I H DLK  N+++ +  V    +K+ DFG+A          
Sbjct: 119 FLKQILN---GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ--AAVGVVQKS 323
              GT  ++APE++ ++P   +AD++S G+  + LL+G  P+ G T  +  A V  V   
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235
Query: 324 LRPTIPKHAHPRLAELLERCWQHDPTQR 351
                  +      + + R    DP +R
Sbjct: 236 FEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 152 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--LTS 209
           ++  +EV I+++I+H NV+          ++ ++ E +A G ++DFL +++ + +   T 
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMT 265
            LK  ++   G+ YLH   I H DLK  N+++ +  V    +K+ DFG+A          
Sbjct: 119 FLKQILN---GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ--AAVGVVQKS 323
              GT  ++APE++ ++P   +AD++S G+  + LL+G  P+ G T  +  A V  V   
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235
Query: 324 LRPTIPKHAHPRLAELLERCWQHDPTQR 351
                  +      + + R    DP +R
Sbjct: 236 FEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 152 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--LTS 209
           ++  +EV I+++I+H NV+          ++ ++ E +A G ++DFL +++ + +   T 
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMT 265
            LK  ++   G+ YLH   I H DLK  N+++ +  V    +K+ DFG+A          
Sbjct: 119 FLKQILN---GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ--AAVGVVQKS 323
              GT  ++APE++ ++P   +AD++S G+  + LL+G  P+ G T  +  A V  V   
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235
Query: 324 LRPTIPKHAHPRLAELLERCWQHDPTQR 351
                  +      + + R    DP +R
Sbjct: 236 FEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 152 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--LTS 209
           ++  +EV I+++I+H NV+          ++ ++ E +A G ++DFL +++ + +   T 
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMT 265
            LK  ++   G+ YLH   I H DLK  N+++ +  V    +K+ DFG+A          
Sbjct: 119 FLKQILN---GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ--AAVGVVQKS 323
              GT  ++APE++ ++P   +AD++S G+  + LL+G  P+ G T  +  A V  V   
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235
Query: 324 LRPTIPKHAHPRLAELLERCWQHDPTQR 351
                  +      + + R    DP +R
Sbjct: 236 FEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 152 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--LTS 209
           ++  +EV I+++I+H NV+          ++ ++ E +A G ++DFL +++ + +   T 
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMT 265
            LK  ++   G+ YLH   I H DLK  N+++ +  V    +K+ DFG+A          
Sbjct: 119 FLKQILN---GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ--AAVGVVQKS 323
              GT  ++APE++ ++P   +AD++S G+  + LL+G  P+ G T  +  A V  V   
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235
Query: 324 LRPTIPKHAHPRLAELLERCWQHDPTQR 351
                  +      + + R    DP +R
Sbjct: 236 FEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 152 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--LTS 209
           ++  +EV I+++I+H NV+          ++ ++ E +A G ++DFL +++ + +   T 
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMT 265
            LK  ++   G+ YLH   I H DLK  N+++ +  V    +K+ DFG+A          
Sbjct: 119 FLKQILN---GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ--AAVGVVQKS 323
              GT  ++APE++ ++P   +AD++S G+  + LL+G  P+ G T  +  A V  V   
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235
Query: 324 LRPTIPKHAHPRLAELLERCWQHDPTQR 351
                  +      + + R    DP +R
Sbjct: 236 FEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/254 (24%), Positives = 113/254 (44%), Gaps = 6/254 (2%)
Query: 110 KQLKIECKVASGSYGDLYKG--TYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRH 166
           +  K+   +  GS+  +Y+    +   EVAIK++ K       M++    EV I  +++H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 167 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 226
            ++++          + +V E    G +  +L  +   F           +  GM YLH 
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 227 NNIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYD 285
           + I+HRDL  +NLL+  N  +K+ADFG+A +++          GT  +++PE+     + 
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHG 190
Query: 286 YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 345
            ++DV+S G   + LL G  P+   T       VV       +P        +L+ +  +
Sbjct: 191 LESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYE--MPSFLSIEAKDLIHQLLR 248
Query: 346 HDPTQRPNFSQITD 359
            +P  R + S + D
Sbjct: 249 RNPADRLSLSSVLD 262

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 152 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--LTS 209
           ++  +EV I+++I+H NV+          ++ ++ E +A G ++DFL +++ + +   T 
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMT 265
            LK  ++   G+ YLH   I H DLK  N+++ +  V    +K+ DFG+A          
Sbjct: 119 FLKQILN---GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ--AAVGVVQKS 323
              GT  ++APE++ ++P   +AD++S G+  + LL+G  P+ G T  +  A V  V   
Sbjct: 176 NIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235
Query: 324 LRPTIPKHAHPRLAELLERCWQHDPTQR 351
                  +      + + R    DP +R
Sbjct: 236 FEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 112 LKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRH 166
            ++E ++  G+   +Y+   C Q+      A+KVLK + V+ ++++    E+ ++ ++ H
Sbjct: 55  FEVESELGRGATSIVYR---CKQKGTQKPYALKVLK-KTVDKKIVR---TEIGVLLRLSH 107
Query: 167 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 226
            N+++       P  + +V E +  G ++D +  +KG +           + + + YLH+
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGELFDRI-VEKGYYSERDAADAVKQILEAVAYLHE 166
Query: 227 NNIIHRDLKTANLLMDE---NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKP 283
           N I+HRDLK  NLL      +  +K+ADFG++++     +M    GT  + APE++    
Sbjct: 167 NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCA 226
Query: 284 YDYKADVFSFGIALWELLTGELPY 307
           Y  + D++S GI  + LL G  P+
Sbjct: 227 YGPEVDMWSVGIITYILLCGFEPF 250

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 122/246 (49%), Gaps = 11/246 (4%)
Query: 118 VASGSYGDLYKGTYCSQE--VAIKVLKPECVNTEMLK-EFSQEVYIMRKIRHKNVVQFIG 174
           +  G +G++Y          VA+KVL    +  E ++ +  +E+ I   + H N+++   
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYN 90
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                  + ++ E+  RG +Y  L K    F       +  +++  + Y H   +IHRD+
Sbjct: 91  YFYDRRRIYLILEYAPRGELYKELQKS-CTFDEQRTATIMEELADALMYCHGKKVIHRDI 149
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           K  NLL+   G +K+ADFG + V A S       GT  ++ PE+IE + ++ K D++  G
Sbjct: 150 KPENLLLGLKGELKIADFGWS-VHAPSLRRKTMCGTLDYLPPEMIEGRMHNEKVDLWCIG 208
Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLAELLERCWQHDPTQRP 352
           +  +ELL G  P+   +  +    +V+  L+   ++P  A   +++LL    +H+P++R 
Sbjct: 209 VLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTGAQDLISKLL----RHNPSERL 264
Query: 353 NFSQIT 358
             +Q++
Sbjct: 265 PLAQVS 270

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 97/180 (53%), Gaps = 9/180 (5%)
Query: 135 EVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEFMARGS 193
           EV  + L PE +  E+ +   +E +I+R++  H +++  I +      + +V + M +G 
Sbjct: 128 EVTAERLSPEQLE-EVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGE 186
Query: 194 IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG 253
           ++D+L  +K          +   + + +++LH NNI+HRDLK  N+L+D+N  ++++DFG
Sbjct: 187 LFDYL-TEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFG 245
Query: 254 VARVQAQSGVMTAETGTYRWMAPEVIE------HKPYDYKADVFSFGIALWELLTGELPY 307
            +        +    GT  ++APE+++      H  Y  + D+++ G+ L+ LL G  P+
Sbjct: 246 FSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           +  G+YG+  L       + VA+K++  +    +  +   +E+ I + + H+NVV+F G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEIXINKMLNHENVVKFYGH 73
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
                   +  E+ + G ++D +    G+ +  +  +    +  G+ YLH   I HRD+K
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHGIGITHRDIK 132
Query: 236 TANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVF 291
             NLL+DE   +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVW 192
Query: 292 SFGIALWELLTGELPY 307
           S GI L  +L GELP+
Sbjct: 193 SCGIVLTAMLAGELPW 208

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 77/313 (24%), Positives = 127/313 (40%), Gaps = 59/313 (18%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH 166
           +D   LK+   +  G YG +YKG+   + VA+KV      N +      + +Y +  + H
Sbjct: 10  LDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFS--FANRQNFIN-EKNIYRVPLMEH 66
Query: 167 KNVVQFIGACTRPP-----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
            N+ +FI    R          +V E+   GS+  +L      +   S  ++A  V++G+
Sbjct: 67  DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDW--VSSCRLAHSVTRGL 124
Query: 222 NYLHQN---------NIIHRDLKTANLLMDENGVVKVADFGVA---------RVQAQSGV 263
            YLH            I HRDL + N+L+  +G   ++DFG++         R   +   
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 264 MTAETGTYRWMAPEVIE-------HKPYDYKADVFSFGIALWE-------LLTGELPYAG 309
             +E GT R+MAPEV+E        +    + D+++ G+  WE       L  GE     
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244
Query: 310 LTPLQAAVG-----------VVQKSLRPTIPKH------AHPRLAELLERCWQHDPTQRP 352
               Q  VG           V ++  RP  P+       A   L E +E CW  D   R 
Sbjct: 245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARL 304
Query: 353 NFSQITDILKQMM 365
                 + + ++M
Sbjct: 305 TAQXAEERMAELM 317

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           +  G+YG+  L       + VA+K++  +    +  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
                   +  E+ + G ++D +    G+ +  +  +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHGIGITHRDIK 131
Query: 236 TANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVF 291
             NLL+DE   +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVW 191
Query: 292 SFGIALWELLTGELPY 307
           S GI L  +L GELP+
Sbjct: 192 SCGIVLTAMLAGELPW 207

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           +  G+YG+  L       + VA+K++  +    +  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
                   +  E+ + G ++D +    G+ +  +  +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHGIGITHRDIK 131
Query: 236 TANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVF 291
             NLL+DE   +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 292 SFGIALWELLTGELPY 307
           S GI L  +L GELP+
Sbjct: 192 SCGIVLTAMLAGELPW 207

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 13/215 (6%)
Query: 146 VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI-YDFLHKQKGV 204
           ++TE LK   +E  I   ++H ++V+ +   +    L +V EFM    + ++ + +    
Sbjct: 68  LSTEDLK---REASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAG 124
Query: 205 FQLTSLLKVAI--DVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQA 259
           F  +  +       + + + Y H NNIIHRD+K   +L+   + +  VK+  FGVA    
Sbjct: 125 FVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG 184
Query: 260 QSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318
           +SG V     GT  +MAPEV++ +PY    DV+  G+ L+ LL+G LP+ G T  +   G
Sbjct: 185 ESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEG 243
Query: 319 VVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           +++    + P    H      +L+ R    DP +R
Sbjct: 244 IIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAER 278

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           +  G+YG+  L       + VA+K++  +    +  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
                   +  E+ + G ++D +    G+ +  +  +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHGIGITHRDIK 131
Query: 236 TANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVF 291
             NLL+DE   +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 292 SFGIALWELLTGELPY 307
           S GI L  +L GELP+
Sbjct: 192 SCGIVLTAMLAGELPW 207

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 102/196 (52%), Gaps = 8/196 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           +  G+YG+  L       + VA+K++  +    +  +   +E+ I + + H+NVV+F G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
                   +  E+ + G ++D +    G+ +     +    +  G+ YLH   I HRD+K
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 132
Query: 236 TANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVF 291
             NLL+DE   +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 292 SFGIALWELLTGELPY 307
           S GI L  +L GELP+
Sbjct: 193 SCGIVLTAMLAGELPW 208

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 13/215 (6%)
Query: 146 VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI-YDFLHKQKGV 204
           ++TE LK   +E  I   ++H ++V+ +   +    L +V EFM    + ++ + +    
Sbjct: 70  LSTEDLK---REASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAG 126
Query: 205 FQLTSLLKVAI--DVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQA 259
           F  +  +       + + + Y H NNIIHRD+K   +L+   + +  VK+  FGVA    
Sbjct: 127 FVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG 186
Query: 260 QSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318
           +SG V     GT  +MAPEV++ +PY    DV+  G+ L+ LL+G LP+ G T  +   G
Sbjct: 187 ESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEG 245
Query: 319 VVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           +++    + P    H      +L+ R    DP +R
Sbjct: 246 IIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAER 280

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 102/196 (52%), Gaps = 8/196 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           +  G+YG+  L       + VA+K++  +    +  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
                   +  E+ + G ++D +    G+ +     +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 131
Query: 236 TANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVF 291
             NLL+DE   +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 292 SFGIALWELLTGELPY 307
           S GI L  +L GELP+
Sbjct: 192 SCGIVLTAMLAGELPW 207

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 102/214 (47%), Gaps = 12/214 (5%)
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPN--LCIVTEFMARGSIYDFLHK---QKGVFQLTSLL 211
           EV ++R+++H N+V++        N  L IV E+   G +   + K   ++       +L
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 212 KVAIDVSKGMNYLHQNN-----IIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMT 265
           +V   ++  +   H+ +     ++HRDLK AN+ +D    VK+ DFG+AR+    +    
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK 174
Query: 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR 325
           A  GT  +M+PE +    Y+ K+D++S G  L+EL     P+   +  + A  + +   R
Sbjct: 175 AFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR 234
Query: 326 PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD 359
             IP      L E++ R        RP+  +I +
Sbjct: 235 -RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           +  G+YG+  L       + VA+K++  +    +  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
                   +  E+ + G ++D +    G+ +  +  +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHGIGITHRDIK 131
Query: 236 TANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVF 291
             NLL+DE   +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 292 SFGIALWELLTGELPY 307
           S GI L  +L GELP+
Sbjct: 192 SCGIVLTAMLAGELPW 207

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           +  G+YG+  L       + VA+K++  +    +  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
                   +  E+ + G ++D +    G+ +  +  +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHGIGITHRDIK 131
Query: 236 TANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVF 291
             NLL+DE   +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 292 SFGIALWELLTGELPY 307
           S GI L  +L GELP+
Sbjct: 192 SCGIVLTAMLAGELPW 207

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           +  G+YG+  L       + VA+K++  +    +  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
                   +  E+ + G ++D +    G+ +  +  +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHGIGITHRDIK 131
Query: 236 TANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVF 291
             NLL+DE   +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVW 191
Query: 292 SFGIALWELLTGELPY 307
           S GI L  +L GELP+
Sbjct: 192 SCGIVLTAMLAGELPW 207

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           +  G+YG+  L       + VA+K++  +    +  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
                   +  E+ + G ++D +    G+ +  +  +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHGIGITHRDIK 131
Query: 236 TANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVF 291
             NLL+DE   +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVW 191
Query: 292 SFGIALWELLTGELPY 307
           S GI L  +L GELP+
Sbjct: 192 SCGIVLTAMLAGELPW 207

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 81/311 (26%), Positives = 131/311 (42%), Gaps = 70/311 (22%)
Query: 118 VASGSYGDLYKGTY--CSQEVAIKV------LKPECVNTEMLKEFSQEVYIMRKIRHKNV 169
           +  G+  ++++G +       AIKV      L+P  V+ +M     +E  +++K+ HKN+
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQM-----REFEVLKKLNHKNI 69
Query: 170 VQF--IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQL--TSLLKVAIDVSKGMNYLH 225
           V+   I   T   +  ++ EF   GS+Y  L +    + L  +  L V  DV  GMN+L 
Sbjct: 70  VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 226 QNNIIHRDLKTANLLM----DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE- 280
           +N I+HR++K  N++     D   V K+ DFG AR         +  GT  ++ P++ E 
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYER 189
Query: 281 -------HKPYDYKADVFSFGIALWELLTGELPYAGL----------------TPLQAAV 317
                   K Y    D++S G+  +   TG LP+                    P  A  
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAIS 249
Query: 318 GV---------------VQKSLRPTIPKHAHPRLAELL----ERCWQHDPTQRPNFSQIT 358
           GV               V  SL   +     P LA +L    E+CW  D      F++ +
Sbjct: 250 GVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF----FAETS 305
Query: 359 DILKQMMKEVL 369
           DIL +M+  V 
Sbjct: 306 DILHRMVIHVF 316

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           +  G+YG+  L       + VA+K++  +    +  +   +E+ I + + H+NVV+F G 
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
                   +  E+ + G ++D +    G+ +  +  +    +  G+ YLH   I HRD+K
Sbjct: 72  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHGIGITHRDIK 130
Query: 236 TANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVF 291
             NLL+DE   +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 131 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 190
Query: 292 SFGIALWELLTGELPY 307
           S GI L  +L GELP+
Sbjct: 191 SCGIVLTAMLAGELPW 206

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           +  G+YG+  L       + VA+K++  +    +  +   +E+ I + + H+NVV+F G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
                   +  E+ + G ++D +    G+ +  +  +    +  G+ YLH   I HRD+K
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHGIGITHRDIK 132
Query: 236 TANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVF 291
             NLL+DE   +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 292 SFGIALWELLTGELPY 307
           S GI L  +L GELP+
Sbjct: 193 SCGIVLTAMLAGELPW 208

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 102/196 (52%), Gaps = 8/196 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           +  G+YG+  L       + VA+K++  +    +  +   +E+ I + + H+NVV+F G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
                   +  E+ + G ++D +    G+ +     +    +  G+ YLH   I HRD+K
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 132
Query: 236 TANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVF 291
             NLL+DE   +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 292 SFGIALWELLTGELPY 307
           S GI L  +L GELP+
Sbjct: 193 SCGIVLTAMLAGELPW 208

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 102/196 (52%), Gaps = 8/196 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           +  G+YG+  L       + VA+K++  +    +  +   +E+ I + + H+NVV+F G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
                   +  E+ + G ++D +    G+ +     +    +  G+ YLH   I HRD+K
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 132
Query: 236 TANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVF 291
             NLL+DE   +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 292 SFGIALWELLTGELPY 307
           S GI L  +L GELP+
Sbjct: 193 SCGIVLTAMLAGELPW 208

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           +  G+YG+  L       + VA+K++  +    +  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
                   +  E+ + G ++D +    G+ +  +  +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHGIGITHRDIK 131
Query: 236 TANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVF 291
             NLL+DE   +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 292 SFGIALWELLTGELPY 307
           S GI L  +L GELP+
Sbjct: 192 SCGIVLTAMLAGELPW 207

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 102/196 (52%), Gaps = 8/196 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           +  G+YG+  L       + VA+K++  +    +  +   +E+ I + + H+NVV+F G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
                   +  E+ + G ++D +    G+ +     +    +  G+ YLH   I HRD+K
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 132
Query: 236 TANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVF 291
             NLL+DE   +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 292 SFGIALWELLTGELPY 307
           S GI L  +L GELP+
Sbjct: 193 SCGIVLTAMLAGELPW 208

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           +  G+YG+  L       + VA+K++  +    +  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
                   +  E+ + G ++D +    G+ +  +  +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHGIGITHRDIK 131
Query: 236 TANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVF 291
             NLL+DE   +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVW 191
Query: 292 SFGIALWELLTGELPY 307
           S GI L  +L GELP+
Sbjct: 192 SCGIVLTAMLAGELPW 207

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           +  G+YG+  L       + VA+K++  +    +  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
                   +  E+ + G ++D +    G+ +  +  +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHGIGITHRDIK 131
Query: 236 TANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVF 291
             NLL+DE   +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 292 SFGIALWELLTGELPY 307
           S GI L  +L GELP+
Sbjct: 192 SCGIVLTAMLAGELPW 207

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           +  G+YG+  L       + VA+K++  +    +  +   +E+ I + + H+NVV+F G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
                   +  E+ + G ++D +    G+ +  +  +    +  G+ YLH   I HRD+K
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHGIGITHRDIK 132
Query: 236 TANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVF 291
             NLL+DE   +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 292 SFGIALWELLTGELPY 307
           S GI L  +L GELP+
Sbjct: 193 SCGIVLTAMLAGELPW 208

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 85/152 (55%), Gaps = 3/152 (1%)
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           +E+ ++ +     +V F GA      + I  E M  GS+ D + K+ G      L KV+I
Sbjct: 53  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSI 111
Query: 216 DVSKGMNYLHQNN-IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM 274
            V KG+ YL + + I+HRD+K +N+L++  G +K+ DFGV+  Q    +  +  GT  +M
Sbjct: 112 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYM 170
Query: 275 APEVIEHKPYDYKADVFSFGIALWELLTGELP 306
           +PE ++   Y  ++D++S G++L E+  G  P
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 85/152 (55%), Gaps = 3/152 (1%)
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           +E+ ++ +     +V F GA      + I  E M  GS+ D + K+ G      L KV+I
Sbjct: 53  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSI 111
Query: 216 DVSKGMNYLHQNN-IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM 274
            V KG+ YL + + I+HRD+K +N+L++  G +K+ DFGV+  Q    +  +  GT  +M
Sbjct: 112 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYM 170
Query: 275 APEVIEHKPYDYKADVFSFGIALWELLTGELP 306
           +PE ++   Y  ++D++S G++L E+  G  P
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 85/152 (55%), Gaps = 3/152 (1%)
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           +E+ ++ +     +V F GA      + I  E M  GS+ D + K+ G      L KV+I
Sbjct: 53  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSI 111
Query: 216 DVSKGMNYLHQNN-IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM 274
            V KG+ YL + + I+HRD+K +N+L++  G +K+ DFGV+  Q    +  +  GT  +M
Sbjct: 112 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYM 170
Query: 275 APEVIEHKPYDYKADVFSFGIALWELLTGELP 306
           +PE ++   Y  ++D++S G++L E+  G  P
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 85/152 (55%), Gaps = 3/152 (1%)
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           +E+ ++ +     +V F GA      + I  E M  GS+ D + K+ G      L KV+I
Sbjct: 53  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSI 111
Query: 216 DVSKGMNYLHQNN-IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM 274
            V KG+ YL + + I+HRD+K +N+L++  G +K+ DFGV+  Q    +  +  GT  +M
Sbjct: 112 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYM 170
Query: 275 APEVIEHKPYDYKADVFSFGIALWELLTGELP 306
           +PE ++   Y  ++D++S G++L E+  G  P
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 46/208 (22%), Positives = 108/208 (51%), Gaps = 8/208 (3%)
Query: 117 KVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEM-LKEFS--QEVYIMRKIRHKNVVQFI 173
           ++ SG++G +++   C ++   +V   + +NT   L +++   E+ IM ++ H  ++   
Sbjct: 58  ELGSGAFGVVHR---CVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 114
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
            A      + ++ EF++ G ++D +  +        ++       +G+ ++H+++I+H D
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLD 174
Query: 234 LKTANLLMD--ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVF 291
           +K  N++ +  +   VK+ DFG+A       ++   T T  + APE+++ +P  +  D++
Sbjct: 175 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMW 234
Query: 292 SFGIALWELLTGELPYAGLTPLQAAVGV 319
           + G+  + LL+G  P+AG   L+    V
Sbjct: 235 AIGVLGYVLLSGLSPFAGEDDLETLQNV 262

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 12/212 (5%)
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPN--LCIVTEFMARGSIYDFLHK---QKGVFQLTSLL 211
           EV ++R+++H N+V++        N  L IV E+   G +   + K   ++       +L
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 212 KVAIDVSKGMNYLHQNN-----IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266
           +V   ++  +   H+ +     ++HRDLK AN+ +D    VK+ DFG+AR+         
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAK 174
Query: 267 E-TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR 325
           E  GT  +M+PE +    Y+ K+D++S G  L+EL     P+   +  + A  + +   R
Sbjct: 175 EFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR 234
Query: 326 PTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
             IP      L E++ R        RP+  +I
Sbjct: 235 -RIPYRYSDELNEIITRMLNLKDYHRPSVEEI 265

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 85/152 (55%), Gaps = 3/152 (1%)
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           +E+ ++ +     +V F GA      + I  E M  GS+ D + K+ G      L KV+I
Sbjct: 53  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSI 111
Query: 216 DVSKGMNYLHQNN-IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM 274
            V KG+ YL + + I+HRD+K +N+L++  G +K+ DFGV+  Q    +  +  GT  +M
Sbjct: 112 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYM 170
Query: 275 APEVIEHKPYDYKADVFSFGIALWELLTGELP 306
           +PE ++   Y  ++D++S G++L E+  G  P
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 85/152 (55%), Gaps = 3/152 (1%)
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           +E+ ++ +     +V F GA      + I  E M  GS+ D + K+ G      L KV+I
Sbjct: 115 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSI 173
Query: 216 DVSKGMNYLHQNN-IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM 274
            V KG+ YL + + I+HRD+K +N+L++  G +K+ DFGV+  Q    +  +  GT  +M
Sbjct: 174 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYM 232
Query: 275 APEVIEHKPYDYKADVFSFGIALWELLTGELP 306
           +PE ++   Y  ++D++S G++L E+  G  P
Sbjct: 233 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 101/198 (51%), Gaps = 10/198 (5%)
Query: 118 VASGSYGDLYK--GTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           +  G +G ++K   T    ++A K++K   +  +  +E   E+ +M ++ H N++Q   A
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK--EEVKNEISVMNQLDHANLIQLYDA 154
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI--DVSKGMNYLHQNNIIHRD 233
                ++ +V E++  G ++D +  +   + LT L  +     + +G+ ++HQ  I+H D
Sbjct: 155 FESKNDIVLVMEYVDGGELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQMYILHLD 212
Query: 234 LKTANLLMDENGV--VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVF 291
           LK  N+L        +K+ DFG+AR       +    GT  ++APEV+ +    +  D++
Sbjct: 213 LKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMW 272
Query: 292 SFGIALWELLTGELPYAG 309
           S G+  + LL+G  P+ G
Sbjct: 273 SVGVIAYMLLSGLSPFLG 290

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 85/152 (55%), Gaps = 3/152 (1%)
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           +E+ ++ +     +V F GA      + I  E M  GS+ D + K+ G      L KV+I
Sbjct: 80  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSI 138
Query: 216 DVSKGMNYLHQNN-IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM 274
            V KG+ YL + + I+HRD+K +N+L++  G +K+ DFGV+  Q    +  +  GT  +M
Sbjct: 139 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYM 197
Query: 275 APEVIEHKPYDYKADVFSFGIALWELLTGELP 306
           +PE ++   Y  ++D++S G++L E+  G  P
Sbjct: 198 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 104/209 (49%), Gaps = 29/209 (13%)
Query: 116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
            K+  G++G+++K  +    Q+VA+K +  E           +E+ I++ ++H+NVV  I
Sbjct: 23  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 82
Query: 174 GAC---TRPPNLCIVTEFMARGSIY---DFL-HKQKGV-------FQLTSLLKVAIDVSK 219
             C     P N C       +GSIY   DF  H   G+       F L+ + +V   +  
Sbjct: 83  EICRTKASPYNRC-------KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 135
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-----QAQSGVMTAETGTYRWM 274
           G+ Y+H+N I+HRD+K AN+L+  +GV+K+ADFG+AR       +Q         T  + 
Sbjct: 136 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 195
Query: 275 APE-VIEHKPYDYKADVFSFGIALWELLT 302
            PE ++  + Y    D++  G  + E+ T
Sbjct: 196 PPELLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 104/206 (50%), Gaps = 23/206 (11%)
Query: 116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
            K+  G++G+++K  +    Q+VA+K +  E           +E+ I++ ++H+NVV  I
Sbjct: 24  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 83
Query: 174 GAC---TRPPNLCIVTEFMARGSIYDFL-HKQKGV-------FQLTSLLKVAIDVSKGMN 222
             C     P N C  + ++    ++DF  H   G+       F L+ + +V   +  G+ 
Sbjct: 84  EICRTKASPYNRCKASIYL----VFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 139
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-----QAQSGVMTAETGTYRWMAPE 277
           Y+H+N I+HRD+K AN+L+  +GV+K+ADFG+AR       +Q         T  +  PE
Sbjct: 140 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPE 199
Query: 278 -VIEHKPYDYKADVFSFGIALWELLT 302
            ++  + Y    D++  G  + E+ T
Sbjct: 200 LLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 104/209 (49%), Gaps = 29/209 (13%)
Query: 116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
            K+  G++G+++K  +    Q+VA+K +  E           +E+ I++ ++H+NVV  I
Sbjct: 24  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 83
Query: 174 GAC---TRPPNLCIVTEFMARGSIY---DFL-HKQKGV-------FQLTSLLKVAIDVSK 219
             C     P N C       +GSIY   DF  H   G+       F L+ + +V   +  
Sbjct: 84  EICRTKASPYNRC-------KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 136
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-----QAQSGVMTAETGTYRWM 274
           G+ Y+H+N I+HRD+K AN+L+  +GV+K+ADFG+AR       +Q         T  + 
Sbjct: 137 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 196
Query: 275 APE-VIEHKPYDYKADVFSFGIALWELLT 302
            PE ++  + Y    D++  G  + E+ T
Sbjct: 197 PPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 102/196 (52%), Gaps = 18/196 (9%)
Query: 118 VASGSYGDLYKG--TYCSQEVAIKVLK-------PECVNTEMLKEFSQEVYIMRKIRHKN 168
           +  G +  +YK      +Q VAIK +K        + +N   L+E    + +++++ H N
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE----IKLLQELSHPN 73
Query: 169 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS-KGMNYLHQN 227
           ++  + A     N+ +V +FM   +  + + K   +    S +K  + ++ +G+ YLHQ+
Sbjct: 74  IIGLLDAFGHKSNISLVFDFME--TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 131
Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM-APEVI-EHKPYD 285
            I+HRDLK  NLL+DENGV+K+ADFG+A+               RW  APE++   + Y 
Sbjct: 132 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYG 191
Query: 286 YKADVFSFGIALWELL 301
              D+++ G  L ELL
Sbjct: 192 VGVDMWAVGCILAELL 207

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 104/209 (49%), Gaps = 29/209 (13%)
Query: 116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
            K+  G++G+++K  +    Q+VA+K +  E           +E+ I++ ++H+NVV  I
Sbjct: 24  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 83
Query: 174 GAC---TRPPNLCIVTEFMARGSIY---DFL-HKQKGV-------FQLTSLLKVAIDVSK 219
             C     P N C       +GSIY   DF  H   G+       F L+ + +V   +  
Sbjct: 84  EICRTKASPYNRC-------KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 136
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-----QAQSGVMTAETGTYRWM 274
           G+ Y+H+N I+HRD+K AN+L+  +GV+K+ADFG+AR       +Q         T  + 
Sbjct: 137 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 196
Query: 275 APE-VIEHKPYDYKADVFSFGIALWELLT 302
            PE ++  + Y    D++  G  + E+ T
Sbjct: 197 PPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 109/227 (48%), Gaps = 15/227 (6%)
Query: 133 SQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191
           S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +   
Sbjct: 55  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 114
Query: 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 251
           G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ D
Sbjct: 115 GELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 173
Query: 252 FGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 308
           FG A+V   +++     A  GT ++++PE++  K     +D+++ G  +++L+      A
Sbjct: 174 FGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV------A 227
Query: 309 GLTPLQAA--VGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           GL P +A     + QK   L    P+   P+  +L+E+    D T+R
Sbjct: 228 GLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 274

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 102/196 (52%), Gaps = 8/196 (4%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           +  G+YG+  L       + VA+K++  +    +  +   +E+ I   + H+NVV+F G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINAMLNHENVVKFYGH 73
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
                   +  E+ + G ++D +    G+ +  +  +    +  G+ YLH   I HRD+K
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHGIGITHRDIK 132
Query: 236 TANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVF 291
             NLL+DE   +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 292 SFGIALWELLTGELPY 307
           S GI L  +L GELP+
Sbjct: 193 SCGIVLTAMLAGELPW 208

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 99/201 (49%), Gaps = 8/201 (3%)
Query: 114 IECKVASGSYGDLYKGT--YCSQEVAIK-VLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           I  ++ +G++G +++ T        A K V+ P   + E ++   +E+  M  +RH  +V
Sbjct: 55  IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR---KEIQTMSVLRHPTLV 111
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
               A      + ++ EFM+ G +++ +  +         ++    V KG+ ++H+NN +
Sbjct: 112 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 171
Query: 231 HRDLKTANLLM--DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKA 288
           H DLK  N++     +  +K+ DFG+         +   TGT  + APEV E KP  Y  
Sbjct: 172 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYT 231
Query: 289 DVFSFGIALWELLTGELPYAG 309
           D++S G+  + LL+G  P+ G
Sbjct: 232 DMWSVGVLSYILLSGLSPFGG 252

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 109/227 (48%), Gaps = 15/227 (6%)
Query: 133 SQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191
           S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +   
Sbjct: 57  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 116
Query: 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 251
           G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ D
Sbjct: 117 GCLLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175
Query: 252 FGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 308
           FG A+V   +++     +  GT ++++PE++  K     +D+++ G  +++L+      A
Sbjct: 176 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSASKSSDLWALGCIIYQLV------A 229
Query: 309 GLTPLQAA--VGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           GL P +A     + QK   L    P+   P+  +L+E+    D T+R
Sbjct: 230 GLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 276

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 119/270 (44%), Gaps = 42/270 (15%)
Query: 118 VASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF--- 172
           +  G++G + K      S+  AIK ++      E L     EV ++  + H+ VV++   
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAA 70
Query: 173 ----------IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 222
                     + A  +   L I  E+   G++YD +H +    Q     ++   + + ++
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALS 130
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR---------------VQAQSGVMTAE 267
           Y+H   IIHRDLK  N+ +DE+  VK+ DFG+A+               +   S  +T+ 
Sbjct: 131 YIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSA 190
Query: 268 TGTYRWMAPEVIEHKP-YDYKADVFSFGIALWELL----TGELPYAGLTPLQAAVGVVQK 322
            GT  ++A EV++    Y+ K D++S GI  +E++    TG      L  L++    V  
Sbjct: 191 IGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRS----VSI 246
Query: 323 SLRPTIPKHAHPRLAELLERCWQHDPTQRP 352
              P    +      +++     HDP +RP
Sbjct: 247 EFPPDFDDNKMKVEKKIIRLLIDHDPNKRP 276

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 99/201 (49%), Gaps = 8/201 (3%)
Query: 114 IECKVASGSYGDLYKGT--YCSQEVAIK-VLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           I  ++ +G++G +++ T        A K V+ P   + E ++   +E+  M  +RH  +V
Sbjct: 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR---KEIQTMSVLRHPTLV 217
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
               A      + ++ EFM+ G +++ +  +         ++    V KG+ ++H+NN +
Sbjct: 218 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 277
Query: 231 HRDLKTANLLM--DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKA 288
           H DLK  N++     +  +K+ DFG+         +   TGT  + APEV E KP  Y  
Sbjct: 278 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYT 337
Query: 289 DVFSFGIALWELLTGELPYAG 309
           D++S G+  + LL+G  P+ G
Sbjct: 338 DMWSVGVLSYILLSGLSPFGG 358

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 121/237 (51%), Gaps = 17/237 (7%)
Query: 109 AKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFS-QEVYIMRKIRHK 167
           + Q K   K+ +G+Y  +YKG   +  V + + + +  + E     + +E+ +M++++H+
Sbjct: 4   SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHE 63
Query: 168 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQ------KGVFQLTSLLKVAIDVSKGM 221
           N+V+          L +V EFM    +  ++  +      +G+ +L  +      + +G+
Sbjct: 64  NIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGL-ELNLVKYFQWQLLQGL 121
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEVI- 279
            + H+N I+HRDLK  NLL+++ G +K+ DFG+AR         ++E  T  + AP+V+ 
Sbjct: 122 AFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLM 181
Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAG------LTPLQAAVGVVQKSLRPTIPK 330
             + Y    D++S G  L E++TG+  + G      L  +   +G   +SL P++ K
Sbjct: 182 GSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 89/185 (48%), Gaps = 9/185 (4%)
Query: 124 GDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183
           GDLY      ++V ++    EC  TE      + + + R   H  + Q       P  L 
Sbjct: 48  GDLYAVKVLKKDVILQDDDVECTMTE-----KRILSLARN--HPFLTQLFCCFQTPDRLF 100
Query: 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE 243
            V EF+  G +   + K +  F        A ++   + +LH   II+RDLK  N+L+D 
Sbjct: 101 FVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDH 159
Query: 244 NGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT 302
            G  K+ADFG+ +    +GV TA   GT  ++APE+++   Y    D ++ G+ L+E+L 
Sbjct: 160 EGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLC 219
Query: 303 GELPY 307
           G  P+
Sbjct: 220 GHAPF 224

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 101/214 (47%), Gaps = 12/214 (5%)
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPN--LCIVTEFMARGSIYDFLHK---QKGVFQLTSLL 211
           EV ++R+++H N+V++        N  L IV E+   G +   + K   ++       +L
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 212 KVAIDVSKGMNYLHQNN-----IIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMT 265
           +V   ++  +   H+ +     ++HRDLK AN+ +D    VK+ DFG+AR+    +    
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK 174
Query: 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR 325
              GT  +M+PE +    Y+ K+D++S G  L+EL     P+   +  + A  + +   R
Sbjct: 175 TFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR 234
Query: 326 PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD 359
             IP      L E++ R        RP+  +I +
Sbjct: 235 -RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 85/152 (55%), Gaps = 3/152 (1%)
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           +E+ ++ +     +V F GA      + I  E M  GS+   L + K + +   L KV+I
Sbjct: 63  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE-EILGKVSI 121
Query: 216 DVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM 274
            V +G+ YL + + I+HRD+K +N+L++  G +K+ DFGV+  Q    +  +  GT  +M
Sbjct: 122 AVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYM 180
Query: 275 APEVIEHKPYDYKADVFSFGIALWELLTGELP 306
           APE ++   Y  ++D++S G++L EL  G  P
Sbjct: 181 APERLQGTHYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 25/211 (11%)
Query: 118 VASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFS---QEVYIMRKIRHKNVVQF 172
           +  G+  ++++G +       AIKV      N   L+      +E  +++K+ HKN+V+ 
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFN----NISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 173 --IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQL--TSLLKVAIDVSKGMNYLHQNN 228
             I   T   +  ++ EF   GS+Y  L +    + L  +  L V  DV  GMN+L +N 
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 229 IIHRDLKTANLLM----DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE---- 280
           I+HR++K  N++     D   V K+ DFG AR            GT  ++ P++ E    
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDMYERAVL 192
Query: 281 ----HKPYDYKADVFSFGIALWELLTGELPY 307
                K Y    D++S G+  +   TG LP+
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 109/227 (48%), Gaps = 15/227 (6%)
Query: 133 SQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191
           S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +   
Sbjct: 54  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 113
Query: 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 251
           G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ D
Sbjct: 114 GELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 172
Query: 252 FGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 308
           FG A+V   +++     +  GT ++++PE++  K     +D+++ G  +++L+      A
Sbjct: 173 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV------A 226
Query: 309 GLTPLQAA--VGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           GL P +A     + QK   L    P+   P+  +L+E+    D T+R
Sbjct: 227 GLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 273

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 24  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 83  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 141
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR  A    MT    T  + A
Sbjct: 142 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE--MTGYVATRWYRA 197
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 24  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 83  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 141
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR  A    MT    T  + A
Sbjct: 142 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE--MTGYVATRWYRA 197
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 24  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 83  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 141
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR  A    MT    T  + A
Sbjct: 142 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE--MTGYVATRWYRA 197
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 109/227 (48%), Gaps = 15/227 (6%)
Query: 133 SQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191
           S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +   
Sbjct: 58  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 117
Query: 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 251
           G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ D
Sbjct: 118 GELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 176
Query: 252 FGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 308
           FG A+V   +++     +  GT ++++PE++  K     +D+++ G  +++L+      A
Sbjct: 177 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV------A 230
Query: 309 GLTPLQAA--VGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           GL P +A     + QK   L    P+   P+  +L+E+    D T+R
Sbjct: 231 GLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 277

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKXQKLTDDHVQFLIYQI 134
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGYVATRWYRA 190
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 108/227 (47%), Gaps = 15/227 (6%)
Query: 133 SQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191
           S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +   
Sbjct: 39  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 98
Query: 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 251
           G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ D
Sbjct: 99  GELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 157
Query: 252 FGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 308
           FG A+V   +++        GT ++++PE++  K     +D+++ G  +++L+      A
Sbjct: 158 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV------A 211
Query: 309 GLTPLQAA--VGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           GL P +A     + QK   L    P+   P+  +L+E+    D T+R
Sbjct: 212 GLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 258

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 109/236 (46%), Gaps = 22/236 (9%)
Query: 118 VASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           + SG+ G +         + VAIK L     N    K   +E+ +M+ + HKN++  +  
Sbjct: 32  IGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 176 CTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
            T   +L       IV E M   ++   +  +    +++ LL   +    G+ +LH   I
Sbjct: 92  FTPQKSLEEFQDVYIVMELMD-ANLSQVIQMELDHERMSYLLYQML---VGIKHLHSAGI 147
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKAD 289
           IHRDLK +N+++  +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D
Sbjct: 148 IHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 207
Query: 290 VFSFGIALWELLTGELPYAGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 335
           ++S G+ + E++ G + + G   +     V++          K L+PT+  +   R
Sbjct: 208 IWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENR 263

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 95/179 (53%), Gaps = 5/179 (2%)
Query: 133 SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARG 192
           +QE A K++  + ++    ++  +E  I R ++H N+V+   + +      +V + +  G
Sbjct: 56  TQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGG 115
Query: 193 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD---ENGVVKV 249
            +++ +  ++  +           + + +N++HQ++I+HRDLK  NLL+    +   VK+
Sbjct: 116 ELFEDIVARE-YYSEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKL 174
Query: 250 ADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
           ADFG+A  VQ +        GT  +++PEV+   PY    D+++ G+ L+ LL G  P+
Sbjct: 175 ADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPF 233

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 87/160 (54%), Gaps = 5/160 (3%)
Query: 152 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL 211
           +   +E+ I + + H+NVV+F G         +  E+ + G ++D +    G+ +  +  
Sbjct: 49  ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ- 107
Query: 212 KVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA---RVQAQSGVMTAET 268
           +    +  G+ YLH   I HRD+K  NLL+DE   +K++DFG+A   R   +  ++    
Sbjct: 108 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 269 GTYRWMAPEVIEHKPYDYK-ADVFSFGIALWELLTGELPY 307
           GT  ++APE+++ + +  +  DV+S GI L  +L GELP+
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 108/227 (47%), Gaps = 15/227 (6%)
Query: 133 SQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191
           S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +   
Sbjct: 54  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 113
Query: 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 251
           G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ D
Sbjct: 114 GELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 172
Query: 252 FGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 308
           FG A+V   +++        GT ++++PE++  K     +D+++ G  +++L+      A
Sbjct: 173 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV------A 226
Query: 309 GLTPLQAA--VGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           GL P +A     + QK   L    P+   P+  +L+E+    D T+R
Sbjct: 227 GLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 273

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 107/213 (50%), Gaps = 15/213 (7%)
Query: 110 KQLKIECKVASGSYGDLYKGT---YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR- 165
           +Q +   ++  G+YG ++K        + VA+K ++ +     M     +EV ++R +  
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 166 --HKNVVQFIGACT-----RPPNLCIVTEFMARGSIYDFLHK--QKGVFQLTSLLKVAID 216
             H NVV+    CT     R   L +V E + +  +  +L K  + GV    ++  +   
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV-PTETIKDMMFQ 128
Query: 217 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAP 276
           + +G+++LH + ++HRDLK  N+L+  +G +K+ADFG+AR+ +    +T+   T  + AP
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 188
Query: 277 EVIEHKPYDYKADVFSFGIALWELLTGELPYAG 309
           EV+    Y    D++S G    E+   +  + G
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 221

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 123/267 (46%), Gaps = 18/267 (6%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI-M 161
           +E+ A  L+   ++  G+YG + K  +    Q  A+K ++   VN++  K    ++ I  
Sbjct: 29  FEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIR-ATVNSQEQKRLLXDLDISX 87
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQ---KGVFQLTSLL-KVAIDV 217
           R +     V F GA  R  ++ I  E     +  D  +KQ   KG      +L K+A+ +
Sbjct: 88  RTVDCPFTVTFYGALFREGDVWICXELX--DTSLDKFYKQVIDKGQTIPEDILGKIAVSI 145
Query: 218 SKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAP 276
            K + +LH   ++IHRD+K +N+L++  G VK  DFG++           + G   + AP
Sbjct: 146 VKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAP 205
Query: 277 EVI----EHKPYDYKADVFSFGIALWELLTGELPYAGL-TPLQAAVGVVQKSLRPTIPKH 331
           E I      K Y  K+D++S GI   EL     PY    TP Q    VV++   P +P  
Sbjct: 206 ERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEP-SPQLPAD 264
Query: 332 A-HPRLAELLERCWQHDPTQRPNFSQI 357
                  +   +C + +  +RP + ++
Sbjct: 265 KFSAEFVDFTSQCLKKNSKERPTYPEL 291

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 108/227 (47%), Gaps = 15/227 (6%)
Query: 133 SQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191
           S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +   
Sbjct: 55  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 114
Query: 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 251
           G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ D
Sbjct: 115 GELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 173
Query: 252 FGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 308
           FG A+V   +++        GT ++++PE++  K     +D+++ G  +++L+      A
Sbjct: 174 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV------A 227
Query: 309 GLTPLQAA--VGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           GL P +A     + QK   L    P+   P+  +L+E+    D T+R
Sbjct: 228 GLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 274

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 108/227 (47%), Gaps = 15/227 (6%)
Query: 133 SQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191
           S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +   
Sbjct: 55  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 114
Query: 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 251
           G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ D
Sbjct: 115 GELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 173
Query: 252 FGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 308
           FG A+V   +++        GT ++++PE++  K     +D+++ G  +++L+      A
Sbjct: 174 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV------A 227
Query: 309 GLTPLQAA--VGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           GL P +A     + QK   L    P+   P+  +L+E+    D T+R
Sbjct: 228 GLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 274

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 108/227 (47%), Gaps = 15/227 (6%)
Query: 133 SQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191
           S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +   
Sbjct: 55  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 114
Query: 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 251
           G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ D
Sbjct: 115 GELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 173
Query: 252 FGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 308
           FG A+V   +++        GT ++++PE++  K     +D+++ G  +++L+      A
Sbjct: 174 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV------A 227
Query: 309 GLTPLQAA--VGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           GL P +A     + QK   L    P+   P+  +L+E+    D T+R
Sbjct: 228 GLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 274

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 20/220 (9%)
Query: 132 CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIV 185
             + VAIK L     N    K   +E+ +M+ + HKN++  +   T   +L       IV
Sbjct: 48  LERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIV 107
Query: 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 245
            E M   ++   +  +    +++ LL   +    G+ +LH   IIHRDLK +N+++  + 
Sbjct: 108 MELMD-ANLSQVIQMELDHERMSYLLYQML---VGIKHLHSAGIIHRDLKPSNIVVKSDA 163
Query: 246 VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGEL 305
            +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G+ + E++ G +
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGV 223
Query: 306 PYAGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 335
            + G   +     V++          K L+PT+  +   R
Sbjct: 224 LFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENR 263

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 107/213 (50%), Gaps = 15/213 (7%)
Query: 110 KQLKIECKVASGSYGDLYKG---TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR- 165
           +Q +   ++  G+YG ++K        + VA+K ++ +     M     +EV ++R +  
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 166 --HKNVVQFIGACT-----RPPNLCIVTEFMARGSIYDFLHK--QKGVFQLTSLLKVAID 216
             H NVV+    CT     R   L +V E + +  +  +L K  + GV    ++  +   
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV-PTETIKDMMFQ 128
Query: 217 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAP 276
           + +G+++LH + ++HRDLK  N+L+  +G +K+ADFG+AR+ +    +T+   T  + AP
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 188
Query: 277 EVIEHKPYDYKADVFSFGIALWELLTGELPYAG 309
           EV+    Y    D++S G    E+   +  + G
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 221

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 108/227 (47%), Gaps = 15/227 (6%)
Query: 133 SQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191
           S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +   
Sbjct: 32  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 91
Query: 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 251
           G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ D
Sbjct: 92  GELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 150
Query: 252 FGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 308
           FG A+V   +++        GT ++++PE++  K     +D+++ G  +++L+      A
Sbjct: 151 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV------A 204
Query: 309 GLTPLQAA--VGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           GL P +A     + QK   L    P+   P+  +L+E+    D T+R
Sbjct: 205 GLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 251

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 108/227 (47%), Gaps = 15/227 (6%)
Query: 133 SQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191
           S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +   
Sbjct: 62  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFCFQDDEKLYFGLSYAKN 121
Query: 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 251
           G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ D
Sbjct: 122 GELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 180
Query: 252 FGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 308
           FG A+V   +++        GT ++++PE++  K     +D+++ G  +++L+      A
Sbjct: 181 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV------A 234
Query: 309 GLTPLQAA--VGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           GL P +A     + QK   L    P+   P+  +L+E+    D T+R
Sbjct: 235 GLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 281

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 27  IWEVPERYQNL-APVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 85
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 86  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 144
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 145 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 200
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 201 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 235

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 108/227 (47%), Gaps = 15/227 (6%)
Query: 133 SQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191
           S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +   
Sbjct: 33  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 92
Query: 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 251
           G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ D
Sbjct: 93  GELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 151
Query: 252 FGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 308
           FG A+V   +++        GT ++++PE++  K     +D+++ G  +++L+      A
Sbjct: 152 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV------A 205
Query: 309 GLTPLQAA--VGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           GL P +A     + QK   L    P+   P+  +L+E+    D T+R
Sbjct: 206 GLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 252

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 108/227 (47%), Gaps = 15/227 (6%)
Query: 133 SQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191
           S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +   
Sbjct: 57  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 116
Query: 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 251
           G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ D
Sbjct: 117 GELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175
Query: 252 FGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 308
           FG A+V   +++        GT ++++PE++  K     +D+++ G  +++L+      A
Sbjct: 176 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV------A 229
Query: 309 GLTPLQAA--VGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           GL P +A     + QK   L    P+   P+  +L+E+    D T+R
Sbjct: 230 GLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 276

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 108/227 (47%), Gaps = 15/227 (6%)
Query: 133 SQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191
           S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +   
Sbjct: 57  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 116
Query: 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 251
           G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ D
Sbjct: 117 GELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175
Query: 252 FGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 308
           FG A+V   +++        GT ++++PE++  K     +D+++ G  +++L+      A
Sbjct: 176 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV------A 229
Query: 309 GLTPLQAA--VGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           GL P +A     + QK   L    P+   P+  +L+E+    D T+R
Sbjct: 230 GLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 276

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 23  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 82  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 140
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 141 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 196
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 231

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 107/213 (50%), Gaps = 15/213 (7%)
Query: 110 KQLKIECKVASGSYGDLYKG---TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR- 165
           +Q +   ++  G+YG ++K        + VA+K ++ +     M     +EV ++R +  
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 166 --HKNVVQFIGACT-----RPPNLCIVTEFMARGSIYDFLHK--QKGVFQLTSLLKVAID 216
             H NVV+    CT     R   L +V E + +  +  +L K  + GV    ++  +   
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV-PTETIKDMMFQ 128
Query: 217 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAP 276
           + +G+++LH + ++HRDLK  N+L+  +G +K+ADFG+AR+ +    +T+   T  + AP
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 188
Query: 277 EVIEHKPYDYKADVFSFGIALWELLTGELPYAG 309
           EV+    Y    D++S G    E+   +  + G
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 221

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 108/227 (47%), Gaps = 15/227 (6%)
Query: 133 SQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191
           S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +   
Sbjct: 57  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 116
Query: 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 251
           G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ D
Sbjct: 117 GELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175
Query: 252 FGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 308
           FG A+V   +++        GT ++++PE++  K     +D+++ G  +++L+      A
Sbjct: 176 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV------A 229
Query: 309 GLTPLQAA--VGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           GL P +A     + QK   L    P+   P+  +L+E+    D T+R
Sbjct: 230 GLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 276

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 108/227 (47%), Gaps = 15/227 (6%)
Query: 133 SQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191
           S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +   
Sbjct: 34  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 93
Query: 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 251
           G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ D
Sbjct: 94  GELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 152
Query: 252 FGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 308
           FG A+V   +++        GT ++++PE++  K     +D+++ G  +++L+      A
Sbjct: 153 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV------A 206
Query: 309 GLTPLQAA--VGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           GL P +A     + QK   L    P+   P+  +L+E+    D T+R
Sbjct: 207 GLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 253

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 190
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 23  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 82  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 140
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 141 --LRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLAR--HTDDEMTGYVATRWYRA 196
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 231

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 108/227 (47%), Gaps = 15/227 (6%)
Query: 133 SQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191
           S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +   
Sbjct: 58  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 117
Query: 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 251
           G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ D
Sbjct: 118 GELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 176
Query: 252 FGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 308
           FG A+V   +++        GT ++++PE++  K     +D+++ G  +++L+      A
Sbjct: 177 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV------A 230
Query: 309 GLTPLQAA--VGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           GL P +A     + QK   L    P+   P+  +L+E+    D T+R
Sbjct: 231 GLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 277

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKXQKLTDDHVQFLIYQI 134
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 190
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 36  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 94
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 95  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 153
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 154 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 209
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 210 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 244

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 19  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 78  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 136
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 137 --LRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLAR--HTDDEMTGYVATRWYRA 192
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 227

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 37  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 95
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 96  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 154
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 155 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 210
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 245

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 108/227 (47%), Gaps = 15/227 (6%)
Query: 133 SQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191
           S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +   
Sbjct: 35  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 94
Query: 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 251
           G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ D
Sbjct: 95  GELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 153
Query: 252 FGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 308
           FG A+V   +++        GT ++++PE++  K     +D+++ G  +++L+      A
Sbjct: 154 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV------A 207
Query: 309 GLTPLQAA--VGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           GL P +A     + QK   L    P+   P+  +L+E+    D T+R
Sbjct: 208 GLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 254

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 13  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 72  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 130
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 131 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 186
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 20/218 (9%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTE 187
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T   +L       IV E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 247
            M   ++   +  +    +++ LL     +  G+ +LH   IIHRDLK +N+++  +  +
Sbjct: 110 LMD-ANLCQVIQMELDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 248 KVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
           K+ DFG+AR    S +MT E  T  + APEVI    Y    D++S G  + E++ G + +
Sbjct: 166 KILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225
Query: 308 AGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 335
            G   +     V++          K L+PT+  +   R
Sbjct: 226 PGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR 263

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 108/228 (47%), Gaps = 15/228 (6%)
Query: 132 CSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
            S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +  
Sbjct: 56  TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK 115
Query: 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
            G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ 
Sbjct: 116 NGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQIT 174
Query: 251 DFGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
           DFG A+V   +++        GT ++++PE++  K     +D+++ G  +++L+      
Sbjct: 175 DFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLV------ 228
Query: 308 AGLTPLQAA-VGVVQK---SLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           AGL P +A   G++      L    P+   P+  +L+E+    D T+R
Sbjct: 229 AGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 276

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGXVATRWYRA 190
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 126/274 (45%), Gaps = 38/274 (13%)
Query: 118 VASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           V SG+YG +         ++VAIK L     +    K   +E+ +++ ++H+NV+  +  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 176 CTRPPNLCIVTEF-MARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
            T   +L    +F +    +   L K  G+ F    +  +   + KG+ Y+H   ++HRD
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRD 151
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI-EHKPYDYKADVFS 292
           LK  NL ++E+  +K+ DFG+AR       MT    T  + APEVI     Y+   D++S
Sbjct: 152 LKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWS 209
Query: 293 FGIALWELLTGELPYAG------LTPLQAAVGV-----VQK-----------SLRPTIPK 330
            G  + E+LTG+  + G      LT +    GV     VQK           SL P  P+
Sbjct: 210 VGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSL-PQTPR 268
Query: 331 --------HAHPRLAELLERCWQHDPTQRPNFSQ 356
                    A P+ A+LLE+  + D  +R   +Q
Sbjct: 269 KDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQ 302

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 112/253 (44%), Gaps = 17/253 (6%)
Query: 118 VASGSYGD----LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
           +  GSYG     L   T C + V I   K             +E+ ++R++RHKNV+Q +
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 174 GAC--TRPPNLCIVTEFMARG--SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
                     + +V E+   G   + D + +++  F +         +  G+ YLH   I
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR--FPVCQAHGYFCQLIDGLEYLHSQGI 130
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQ---AQSGVMTAETGTYRWMAPEVIE--HKPY 284
           +H+D+K  NLL+   G +K++  GVA      A         G+  +  PE+        
Sbjct: 131 VHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFS 190
Query: 285 DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW 344
            +K D++S G+ L+ + TG  P+ G    +    + + S    IP    P L++LL+   
Sbjct: 191 GFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY--AIPGDCGPPLSDLLKGML 248
Query: 345 QHDPTQRPNFSQI 357
           +++P +R +  QI
Sbjct: 249 EYEPAKRFSIRQI 261

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 101/195 (51%), Gaps = 22/195 (11%)
Query: 133 SQEVAIKVL--KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
           SQE A+K++  +P  + + + +E      + +   H+NV++ I          +V E M 
Sbjct: 38  SQEYAVKIIEKQPGHIRSRVFREVEM---LYQCQGHRNVLELIEFFEEEDRFYLVFEKMR 94
Query: 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGV--V 247
            GSI   +HK++   +L + + V  DV+  +++LH   I HRDLK  N+L +  N V  V
Sbjct: 95  GGSILSHIHKRRHFNELEASV-VVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPV 153
Query: 248 KVADFGVARVQAQSG----VMTAE----TGTYRWMAPEVI-----EHKPYDYKADVFSFG 294
           K+ DFG+      +G    + T E     G+  +MAPEV+     E   YD + D++S G
Sbjct: 154 KICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG 213
Query: 295 IALWELLTGELPYAG 309
           + L+ LL+G  P+ G
Sbjct: 214 VILYILLSGYPPFVG 228

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 190
Query: 276 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 309
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKSQKLTDDHVQFLIYQI 134
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+ R       MT    T  + A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCR--HTDDEMTGYVATRWYRA 190
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 123/272 (45%), Gaps = 29/272 (10%)
Query: 107 IDAKQLKIECKVASG--SYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 164
           ID K      K+  G  SY DL +G +     A+K +   C   +  +E  +E  + R  
Sbjct: 26  IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL--CHEQQDREEAQREADMHRLF 83
Query: 165 RHKNVVQFIGACTRPPNL----CIVTEFMARGSIYDFLH--KQKGVFQLT--SLLKVAID 216
            H N+++ +  C R         ++  F  RG++++ +   K KG F LT   +L + + 
Sbjct: 84  NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF-LTEDQILWLLLG 142
Query: 217 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG-----VARVQAQSGVMT-----A 266
           + +G+  +H     HRDLK  N+L+ + G   + D G        V+     +T     A
Sbjct: 143 ICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202
Query: 267 ETGTYRWMAPE---VIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV-VQK 322
           +  T  + APE   V  H   D + DV+S G  L+ ++ GE PY  +     +V + VQ 
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN 262
Query: 323 SLR-PTIPKHAHPRLAELLERCWQHDPTQRPN 353
            L  P  P+H+   L +LL      DP QRP+
Sbjct: 263 QLSIPQSPRHS-SALWQLLNSMMTVDPHQRPH 293

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 130/288 (45%), Gaps = 39/288 (13%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
            WE+  K       V SG+YG +         ++VAIK L     +    K   +E+ ++
Sbjct: 37  AWEL-PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLL 95
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEF-MARGSIYDFLHKQKGV-FQLTSLLKVAIDVSK 219
           + ++H+NV+  +   T   +L    +F +    +   L K  G+ F    +  +   + K
Sbjct: 96  KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLK 155
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI 279
           G+ Y+H   ++HRDLK  NL ++E+  +K+ DFG+AR       MT    T  + APEVI
Sbjct: 156 GLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVVTRWYRAPEVI 213
Query: 280 -EHKPYDYKADVFSFGIALWELLTGELPYAG------LTPLQAAVGV-----VQK----- 322
                Y+   D++S G  + E+LTG+  + G      LT +    GV     VQK     
Sbjct: 214 LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 273
Query: 323 ------SLRPTIPK--------HAHPRLAELLERCWQHDPTQRPNFSQ 356
                 SL P  P+         A P+ A+LLE+  + D  +R   +Q
Sbjct: 274 AKSYIQSL-PQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQ 320

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 22  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 81  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 139
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 140 --LRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGYVATRWYRA 195
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 230

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 28  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 86
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 87  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 145
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 146 --LRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGYVATRWYRA 201
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 202 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 236

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 29  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLL 87
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 88  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 146
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 147 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 202
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 237

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 22  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 81  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 139
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 140 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 195
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 230

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 107/227 (47%), Gaps = 15/227 (6%)
Query: 133 SQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191
           S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +   
Sbjct: 60  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 119
Query: 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 251
           G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ D
Sbjct: 120 GELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 178
Query: 252 FGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 308
           FG A+V   +++        GT ++++PE++  K     +D+++ G  +++L+      A
Sbjct: 179 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV------A 232
Query: 309 GLTPLQAA--VGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           GL P +A     + QK   L    P    P+  +L+E+    D T+R
Sbjct: 233 GLPPFRAGNEYLIFQKIIKLEYDFPAAFFPKARDLVEKLLVLDATKR 279

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 23  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 82  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 140
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 141 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 196
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 231

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 190
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 37  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 95
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 96  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 154
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 155 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 210
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 245

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 19  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 78  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 136
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 137 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 192
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 227

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 190
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 23  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 82  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 140
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 141 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 196
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 231

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 40  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 98
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 99  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 157
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 158 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 213
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 214 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 248

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 15  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 73
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 74  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 132
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 133 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 188
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 189 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 223

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 190
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 19  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 78  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 136
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 137 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 192
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 227

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 19  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 78  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 136
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 137 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 192
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 227

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 190
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 190
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 36  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 94
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 95  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 153
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 154 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 209
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 210 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 244

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 22  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 81  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 139
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 140 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 195
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 230

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 13  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 72  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 130
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 131 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 186
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 16  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 74
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 75  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 133
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 134 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 189
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 190 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 224

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 14  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 72
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 73  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 131
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 132 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 187
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 222

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 190
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 29  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 87
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 88  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 146
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 147 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 202
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 237

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 14  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 72
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 73  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 131
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 132 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 187
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 222

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 24  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 83  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 141
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 142 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 197
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 29  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 87
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 88  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 146
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 147 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 202
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 237

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 190
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   + SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 22  IWEVPERYQNL-SPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 81  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 139
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 140 --LRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGYVATRWYRA 195
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 230

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 28  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 86
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 87  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 145
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 146 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 201
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 202 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 236

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 102/222 (45%), Gaps = 28/222 (12%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 193
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T   +L    EF     
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSL---EEFQDVYI 106
Query: 194 IYDFLHKQKGVFQLTSLLKVAIDVSK----------GMNYLHQNNIIHRDLKTANLLMDE 243
           + + +        L+ ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 107 VMELMDAN-----LSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 244 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG 303
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++ G
Sbjct: 162 DATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
Query: 304 ELPYAGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 335
            + + G   +     V++          K L+PT+  +   R
Sbjct: 222 GVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENR 263

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 20/218 (9%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTE 187
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T   +L       IV E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 247
            M   ++   +  +    +++ LL   +    G+ +LH   IIHRDLK +N+++  +  +
Sbjct: 110 LMD-ANLSQVIQMELDHERMSYLLYQML---VGIKHLHSAGIIHRDLKPSNIVVKSDATL 165
Query: 248 KVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
           K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++ G + +
Sbjct: 166 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225
Query: 308 AGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 335
            G   +     V++          K L+PT+  +   R
Sbjct: 226 PGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENR 263

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 108/227 (47%), Gaps = 15/227 (6%)
Query: 133 SQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191
           S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +   
Sbjct: 57  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 116
Query: 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 251
           G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ D
Sbjct: 117 GELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175
Query: 252 FGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 308
           FG A+V   +++        GT ++++PE++  K     +D+++ G  +++L+      A
Sbjct: 176 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV------A 229
Query: 309 GLTPLQAA-VGVVQK---SLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           GL P +A   G++      L    P+   P+  +L+E+    D T+R
Sbjct: 230 GLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 276

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 85/160 (53%), Gaps = 10/160 (6%)
Query: 156 QEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVA 214
           +EV I+RK+  H N++Q            +V + M +G ++D+L  +K         K+ 
Sbjct: 59  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIM 117
Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET-GTYRW 273
             + + +  LH+ NI+HRDLK  N+L+D++  +K+ DFG +  Q   G    E  GT  +
Sbjct: 118 RALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS-CQLDPGEKLREVCGTPSY 176
Query: 274 MAPEVIE------HKPYDYKADVFSFGIALWELLTGELPY 307
           +APE+IE      H  Y  + D++S G+ ++ LL G  P+
Sbjct: 177 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 216

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 97/198 (48%), Gaps = 4/198 (2%)
Query: 117 KVASGSYGDLYKGTYCSQEV-AIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           K+  G+YG +YK      E  A+K ++ E  +  +     +E+ I+++++H N+V+    
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
                 L +V E + +  +   L   +G  +  +     + +  G+ Y H   ++HRDLK
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127
Query: 236 TANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEVI-EHKPYDYKADVFSF 293
             NLL++  G +K+ADFG+AR         T E  T  + AP+V+   K Y    D++S 
Sbjct: 128 PQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWSV 187
Query: 294 GIALWELLTGELPYAGLT 311
           G    E++ G   + G++
Sbjct: 188 GCIFAEMVNGAPLFPGVS 205

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 84/159 (52%), Gaps = 8/159 (5%)
Query: 156 QEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVA 214
           +EV I+RK+  H N++Q            +V + M +G ++D+L  +K         K+ 
Sbjct: 72  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIM 130
Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM 274
             + + +  LH+ NI+HRDLK  N+L+D++  +K+ DFG +        + +  GT  ++
Sbjct: 131 RALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYL 190
Query: 275 APEVIE------HKPYDYKADVFSFGIALWELLTGELPY 307
           APE+IE      H  Y  + D++S G+ ++ LL G  P+
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 37  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 95
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 96  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 154
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       M     T  + A
Sbjct: 155 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMXGXVATRWYRA 210
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 245

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 105/220 (47%), Gaps = 25/220 (11%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 13  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVA------- 214
           + ++H+NV+  +   T   +L    EF     +Y   H       L +++K A       
Sbjct: 72  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGA--DLNNIVKCAKLTDDHV 123
Query: 215 ----IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT 270
                 + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 124 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 181
Query: 271 YRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
             + APE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 85/160 (53%), Gaps = 10/160 (6%)
Query: 156 QEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVA 214
           +EV I+RK+  H N++Q            +V + M +G ++D+L  +K         K+ 
Sbjct: 72  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIM 130
Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET-GTYRW 273
             + + +  LH+ NI+HRDLK  N+L+D++  +K+ DFG +  Q   G    E  GT  +
Sbjct: 131 RALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS-CQLDPGEKLREVCGTPSY 189
Query: 274 MAPEVIE------HKPYDYKADVFSFGIALWELLTGELPY 307
           +APE+IE      H  Y  + D++S G+ ++ LL G  P+
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 102/222 (45%), Gaps = 28/222 (12%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 193
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T   +L    EF     
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL---EEFQDVYI 106
Query: 194 IYDFLHKQKGVFQLTSLLKVAIDVSK----------GMNYLHQNNIIHRDLKTANLLMDE 243
           + + +        L+ ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 107 VMELMDAN-----LSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 244 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG 303
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++ G
Sbjct: 162 DATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
Query: 304 ELPYAGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 335
            + + G   +     V++          K L+PT+  +   R
Sbjct: 222 GVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENR 263

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/270 (24%), Positives = 118/270 (43%), Gaps = 42/270 (15%)
Query: 118 VASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF--- 172
           +  G++G + K      S+  AIK ++      E L     EV ++  + H+ VV++   
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAA 70
Query: 173 ----------IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 222
                     + A  +   L I  E+    ++YD +H +    Q     ++   + + ++
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALS 130
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR---------------VQAQSGVMTAE 267
           Y+H   IIHRDLK  N+ +DE+  VK+ DFG+A+               +   S  +T+ 
Sbjct: 131 YIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSA 190
Query: 268 TGTYRWMAPEVIEHKP-YDYKADVFSFGIALWELL----TGELPYAGLTPLQAAVGVVQK 322
            GT  ++A EV++    Y+ K D++S GI  +E++    TG      L  L++    V  
Sbjct: 191 IGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRS----VSI 246
Query: 323 SLRPTIPKHAHPRLAELLERCWQHDPTQRP 352
              P    +      +++     HDP +RP
Sbjct: 247 EFPPDFDDNKMKVEKKIIRLLIDHDPNKRP 276

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 97/198 (48%), Gaps = 4/198 (2%)
Query: 117 KVASGSYGDLYKGTYCSQEV-AIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           K+  G+YG +YK      E  A+K ++ E  +  +     +E+ I+++++H N+V+    
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
                 L +V E + +  +   L   +G  +  +     + +  G+ Y H   ++HRDLK
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127
Query: 236 TANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEVI-EHKPYDYKADVFSF 293
             NLL++  G +K+ADFG+AR         T E  T  + AP+V+   K Y    D++S 
Sbjct: 128 PQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWSV 187
Query: 294 GIALWELLTGELPYAGLT 311
           G    E++ G   + G++
Sbjct: 188 GCIFAEMVNGTPLFPGVS 205

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 97/198 (48%), Gaps = 4/198 (2%)
Query: 117 KVASGSYGDLYKGTYCSQEV-AIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           K+  G+YG +YK      E  A+K ++ E  +  +     +E+ I+++++H N+V+    
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
                 L +V E + +  +   L   +G  +  +     + +  G+ Y H   ++HRDLK
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127
Query: 236 TANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEVI-EHKPYDYKADVFSF 293
             NLL++  G +K+ADFG+AR         T E  T  + AP+V+   K Y    D++S 
Sbjct: 128 PQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSV 187
Query: 294 GIALWELLTGELPYAGLT 311
           G    E++ G   + G++
Sbjct: 188 GCIFAEMVNGTPLFPGVS 205

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 105/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
            WE+ A    ++  V SG+YG +          +VAIK L     +    K   +E+ ++
Sbjct: 20  AWEVRAVYRDLQ-PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 78
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + +RH+NV+  +   T    L       +V  FM         H++ G  ++  L+   +
Sbjct: 79  KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML 138
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              KG+ Y+H   IIHRDLK  NL ++E+  +K+ DFG+AR QA S  M     T  + A
Sbjct: 139 ---KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-QADSE-MXGXVVTRWYRA 193
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PEVI +   Y    D++S G  + E++TG+  + G
Sbjct: 194 PEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 228

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 13  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 72  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 130
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR           T  YR  A
Sbjct: 131 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATRWYR--A 186
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       M     T  + A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMAGFVATRWYRA 190
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       M     T  + A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMAGFVATRWYRA 190
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 136/284 (47%), Gaps = 57/284 (20%)
Query: 118 VASGSYGDL-YKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGA 175
           +  G+ G + Y+G + +++VA+K + PEC +        +EV ++R+   H NV+++   
Sbjct: 32  LGHGAEGTIVYRGMFDNRDVAVKRILPECFSFA-----DREVQLLRESDEHPNVIRYF-- 84
Query: 176 CTRPPN--------LCIVT--EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
           CT            LC  T  E++ +    DF H   G+  +T L +     + G+ +LH
Sbjct: 85  CTEKDRQFQYIAIELCAATLQEYVEQK---DFAHL--GLEPITLLQQT----TSGLAHLH 135
Query: 226 QNNIIHRDLKTANLLM---DENGVVK--VADFGVARVQA--------QSGVMTAETGTYR 272
             NI+HRDLK  N+L+   + +G +K  ++DFG+ +  A        +SGV     GT  
Sbjct: 136 SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV----PGTEG 191
Query: 273 WMAPEVIEHKPYD---YKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTI 328
           W+APE++     +   Y  D+FS G   + +++ G  P+      QA + +   SL    
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLH 251
Query: 329 P-KHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYW 371
           P KH      EL+E+    DP +RP+        K ++K   +W
Sbjct: 252 PEKHEDVIARELIEKMIAMDPQKRPS-------AKHVLKHPFFW 288

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 111/238 (46%), Gaps = 22/238 (9%)
Query: 118 VASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           + SG+ G +     T     VA+K L     N    K   +E+ +++ + HKN++  +  
Sbjct: 30  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 89
Query: 176 CTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
            T    L       +V E M   ++   +H +    +++ LL   +    G+ +LH   I
Sbjct: 90  FTPQKTLEEFQDVYLVMELM-DANLCQVIHMELDHERMSYLLYQML---CGIKHLHSAGI 145
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKAD 289
           IHRDLK +N+++  +  +K+ DFG+AR  + + +MT    T  + APEVI    Y    D
Sbjct: 146 IHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEVILGMGYKENVD 205
Query: 290 VFSFGIALWELLTGELPYAGLTPLQAAVGVVQK----------SLRPTIPKHAHPRLA 337
           ++S G  + EL+ G + + G   +     V+++          +L+PT+  +   R A
Sbjct: 206 IWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVENRPA 263

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 101/202 (50%), Gaps = 7/202 (3%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 10  KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 68
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 229
           + +        L +V EF++   + DF+           L+K  +  + +G+ + H + +
Sbjct: 69  KLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 127
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 287
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 128 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 187
Query: 288 ADVFSFGIALWELLTGELPYAG 309
            D++S G    E++T    + G
Sbjct: 188 VDIWSLGCIFAEMVTRRALFPG 209

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ D+G+AR       MT    T  + A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLAR--HTDDEMTGYVATRWYRA 190
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 102/202 (50%), Gaps = 7/202 (3%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 7   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 65
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 229
           + +        L +V EF+ +  +  F+           L+K  +  + +G+++ H + +
Sbjct: 66  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHRV 124
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 287
           +HRDLK  NLL++  G +K+ADFG+AR         T E  T  + APE++   K Y   
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 184
Query: 288 ADVFSFGIALWELLTGELPYAG 309
            D++S G    E++T    + G
Sbjct: 185 VDIWSLGCIFAEMVTRRALFPG 206

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 94/194 (48%), Gaps = 5/194 (2%)
Query: 117 KVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           K+  G+YG ++K       + VA+K ++ +  +  +     +E+ ++++++HKN+V+   
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                  L +V EF  +  +  +     G      +      + KG+ + H  N++HRDL
Sbjct: 69  VLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDL 127
Query: 235 KTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEVI-EHKPYDYKADVFS 292
           K  NLL++ NG +K+ADFG+AR         +AE  T  +  P+V+   K Y    D++S
Sbjct: 128 KPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWS 187
Query: 293 FGIALWELLTGELP 306
            G    EL     P
Sbjct: 188 AGCIFAELANAARP 201

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 100/195 (51%), Gaps = 22/195 (11%)
Query: 133 SQEVAIKVL--KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
           SQE A+K++  +P  + + + +E      + +   H+NV++ I          +V E M 
Sbjct: 38  SQEYAVKIIEKQPGHIRSRVFREVEM---LYQCQGHRNVLELIEFFEEEDRFYLVFEKMR 94
Query: 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGV--V 247
            GSI   +HK++   +L + + V  DV+  +++LH   I HRDLK  N+L +  N V  V
Sbjct: 95  GGSILSHIHKRRHFNELEASV-VVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPV 153
Query: 248 KVADF----GVARVQAQSGVMTAE----TGTYRWMAPEVI-----EHKPYDYKADVFSFG 294
           K+ DF    G+      S + T E     G+  +MAPEV+     E   YD + D++S G
Sbjct: 154 KICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG 213
Query: 295 IALWELLTGELPYAG 309
           + L+ LL+G  P+ G
Sbjct: 214 VILYILLSGYPPFVG 228

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 101/202 (50%), Gaps = 7/202 (3%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 9   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 67
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 229
           + +        L +V EF++   + DF+           L+K  +  + +G+ + H + +
Sbjct: 68  KLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 126
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 287
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 127 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 186
Query: 288 ADVFSFGIALWELLTGELPYAG 309
            D++S G    E++T    + G
Sbjct: 187 VDIWSLGCIFAEMVTRRALFPG 208

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 102/222 (45%), Gaps = 28/222 (12%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 193
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T   +L    EF     
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL---EEFQDVYI 106
Query: 194 IYDFLHKQKGVFQLTSLLKVAIDVSK----------GMNYLHQNNIIHRDLKTANLLMDE 243
           + + +        L+ ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 107 VMELMDAN-----LSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 244 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG 303
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++ G
Sbjct: 162 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
Query: 304 ELPYAGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 335
            + + G   +     V++          K L+PT+  +   R
Sbjct: 222 GVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENR 263

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 101/202 (50%), Gaps = 7/202 (3%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 7   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 65
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 229
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 66  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEV-IEHKPYDYK 287
           +HRDLK  NLL++  G +K+ADFG+AR         T E  T  + APE+ +  K Y   
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTA 184
Query: 288 ADVFSFGIALWELLTGELPYAG 309
            D++S G    E++T    + G
Sbjct: 185 VDIWSLGCIFAEMVTRRALFPG 206

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 115/248 (46%), Gaps = 31/248 (12%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQ 156
           +WE+  ++ +    V SG+YG +     CS        ++A+K L     +    K   +
Sbjct: 46  IWEV-PERYQTLSPVGSGAYGSV-----CSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYR 99
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSL 210
           E+ +++ ++H+NV+  +   T   +L       +VT  M    + + +  QK        
Sbjct: 100 ELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF 158
Query: 211 LKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT 270
           L   I   +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 159 LIYQI--LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 214
Query: 271 YRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG------LTPLQAAVGVVQKS 323
             + APE++ +   Y+   D++S G  + ELLTG   + G      L  +    G    S
Sbjct: 215 RWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPAS 274
Query: 324 LRPTIPKH 331
           +   +P H
Sbjct: 275 VISRMPSH 282

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 101/202 (50%), Gaps = 7/202 (3%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 7   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 65
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 229
           + +        L +V EF+ +  + DF+           L+K  +  + +G+ + H + +
Sbjct: 66  KLLDVIHTENKLYLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 287
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 125 LHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 184
Query: 288 ADVFSFGIALWELLTGELPYAG 309
            D++S G    E++T    + G
Sbjct: 185 VDIWSLGCIFAEMVTRRALFPG 206

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 87/181 (48%), Gaps = 5/181 (2%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH-KNVVQFIGACTRPPNLCIVTEFMARG 192
           QE A K LK      +   E   E+ ++   +    V+           + ++ E+ A G
Sbjct: 55  QEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG 114
Query: 193 SIYDF-LHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN---GVVK 248
            I+   L +   +     ++++   + +G+ YLHQNNI+H DLK  N+L+      G +K
Sbjct: 115 EIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIK 174
Query: 249 VADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 308
           + DFG++R    +  +    GT  ++APE++ + P     D+++ GI  + LLT   P+ 
Sbjct: 175 IVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFV 234
Query: 309 G 309
           G
Sbjct: 235 G 235

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 85/166 (51%), Gaps = 11/166 (6%)
Query: 153 EFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDF------LHKQKGVFQ 206
           +F  E+ I+  I+++  +   G  T    + I+ E+M   SI  F      L K    F 
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 207 LTSLLKVAI-DVSKGMNYLH-QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 264
              ++K  I  V    +Y+H + NI HRD+K +N+LMD+NG VK++DFG +       + 
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI- 207
Query: 265 TAETGTYRWMAPEVIEHK-PYD-YKADVFSFGIALWELLTGELPYA 308
               GTY +M PE   ++  Y+  K D++S GI L+ +    +P++
Sbjct: 208 KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 118 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           +  G+YG       CS         VAIK + P    T   +   +E+ I+ + RH+N++
Sbjct: 51  IGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENII 104
Query: 171 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
             I    R P      ++ +VT  M    +Y  L  Q        +      + +G+ Y+
Sbjct: 105 G-INDIIRAPTIEQMKDVYLVTHLMG-ADLYKLLKTQH--LSNDHICYFLYQILRGLKYI 160
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 279
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 161 HSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 320
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 264

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 102/208 (49%), Gaps = 6/208 (2%)
Query: 107 IDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 164
           +D +  +   K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++
Sbjct: 4   VDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 165 RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNY 223
            H N+V+ +        L +V EF+ +  +  F+           L+K  +  + +G+ +
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 122
Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH- 281
            H + ++HRDLK  NLL++  G +K+ADFG+AR         T E  T  + APE++   
Sbjct: 123 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 182
Query: 282 KPYDYKADVFSFGIALWELLTGELPYAG 309
           K Y    D++S G    E++T    + G
Sbjct: 183 KYYSTAVDIWSLGCIFAEMVTRRALFPG 210

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 101/202 (50%), Gaps = 7/202 (3%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 14  KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 72
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 229
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 73  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 131
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEV-IEHKPYDYK 287
           +HRDLK  NLL++  G +K+ADFG+AR         T E  T  + APE+ +  K Y   
Sbjct: 132 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTA 191
Query: 288 ADVFSFGIALWELLTGELPYAG 309
            D++S G    E++T    + G
Sbjct: 192 VDIWSLGCIFAEMVTRRALFPG 213

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 20/218 (9%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTE 187
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T   +L       IV E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 247
            M   ++   +  +    +++ LL   +    G+ +LH   IIHRDLK +N+++  +  +
Sbjct: 110 LMD-ANLCQVIQMELDHERMSYLLYQML---CGIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 248 KVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
           K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++ G + +
Sbjct: 166 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225
Query: 308 AGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 335
            G   +     V++          K L+PT+  +   R
Sbjct: 226 PGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR 263

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/313 (22%), Positives = 129/313 (41%), Gaps = 68/313 (21%)
Query: 127 YKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186
           YK T   + V ++ +  E  + EM+     E+++ +   H N+V +         L +VT
Sbjct: 32  YKPT--GEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 89
Query: 187 EFMARGSIYDFL--HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 244
            FMA GS  D +  H   G+ +L ++  +   V K ++Y+H    +HR +K +++L+  +
Sbjct: 90  SFMAYGSAKDLICTHFMDGMNEL-AIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD 148
Query: 245 GVVKVADFG-----VARVQAQSGVMTAETGTYR---WMAPEVIEH--KPYDYKADVFSFG 294
           G V ++        ++  Q Q  V      + +   W++PEV++   + YD K+D++S G
Sbjct: 149 GKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVG 208
Query: 295 IALWELLTGELPYAGLTPLQAAV------------------------------------G 318
           I   EL  G +P+  +   Q  +                                     
Sbjct: 209 ITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDS 268
Query: 319 VVQKSLRPT---IPKHAH-----PRLAELLERCWQHDPTQRPN---------FSQITDIL 361
           +   + RP+    P H +     P     +E+C Q +P  RP+         F QI    
Sbjct: 269 LTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRA 328
Query: 362 KQMMKEVLYWLSP 374
            + + E+L  ++P
Sbjct: 329 SEALPELLRPVTP 341

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/313 (22%), Positives = 129/313 (41%), Gaps = 68/313 (21%)
Query: 127 YKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186
           YK T   + V ++ +  E  + EM+     E+++ +   H N+V +         L +VT
Sbjct: 48  YKPT--GEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 105
Query: 187 EFMARGSIYDFL--HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 244
            FMA GS  D +  H   G+ +L ++  +   V K ++Y+H    +HR +K +++L+  +
Sbjct: 106 SFMAYGSAKDLICTHFMDGMNEL-AIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD 164
Query: 245 GVVKVADFG-----VARVQAQSGVMTAETGTYR---WMAPEVIEH--KPYDYKADVFSFG 294
           G V ++        ++  Q Q  V      + +   W++PEV++   + YD K+D++S G
Sbjct: 165 GKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVG 224
Query: 295 IALWELLTGELPYAGLTPLQAAV------------------------------------G 318
           I   EL  G +P+  +   Q  +                                     
Sbjct: 225 ITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDS 284
Query: 319 VVQKSLRPT---IPKHAH-----PRLAELLERCWQHDPTQRPN---------FSQITDIL 361
           +   + RP+    P H +     P     +E+C Q +P  RP+         F QI    
Sbjct: 285 LTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRA 344
Query: 362 KQMMKEVLYWLSP 374
            + + E+L  ++P
Sbjct: 345 SEALPELLRPVTP 357

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 90/179 (50%), Gaps = 5/179 (2%)
Query: 133 SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARG 192
            QE A K++  + ++    ++  +E  I R ++H N+V+   + +      +V + +  G
Sbjct: 29  GQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGG 88
Query: 193 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKV 249
            +++ +  ++  +           + + +N+ H N I+HRDLK  NLL+    +   VK+
Sbjct: 89  ELFEDIVARE-YYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKL 147
Query: 250 ADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
           ADFG+A  VQ          GT  +++PEV+   PY    D+++ G+ L+ LL G  P+
Sbjct: 148 ADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 20/218 (9%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTE 187
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T   +L       IV E
Sbjct: 51  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 110
Query: 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 247
            M   ++   +  +    +++ LL   +    G+ +LH   IIHRDLK +N+++  +  +
Sbjct: 111 LMD-ANLCQVIQMELDHERMSYLLYQML---CGIKHLHSAGIIHRDLKPSNIVVKSDCTL 166
Query: 248 KVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
           K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++ G + +
Sbjct: 167 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 226
Query: 308 AGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 335
            G   +     V++          K L+PT+  +   R
Sbjct: 227 PGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR 264

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 119/245 (48%), Gaps = 24/245 (9%)
Query: 70  SCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKG 129
           +  KRQ   G P +     +   + +++P D        A + ++   +  GS+G + K 
Sbjct: 64  NAKKRQGMTGGPNNGGY-DDDQGSYVQVPHDHV------AYRYEVLKVIGKGSFGQVVKA 116
Query: 130 --TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK------NVVQFIGACTRPPN 181
                 Q VA+K+++ E       ++ ++E+ I+  +R +      NV+  +   T   +
Sbjct: 117 YDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173
Query: 182 LCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240
           +C+  E ++  ++Y+ + K K   F L  + K A  + + ++ LH+N IIH DLK  N+L
Sbjct: 174 ICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENIL 232
Query: 241 MDENGV--VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALW 298
           + + G   +KV DFG +  + Q      ++  YR  APEVI    Y    D++S G  L 
Sbjct: 233 LKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRFYR--APEVILGARYGMPIDMWSLGCILA 290
Query: 299 ELLTG 303
           ELLTG
Sbjct: 291 ELLTG 295

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 124/275 (45%), Gaps = 31/275 (11%)
Query: 118 VASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           + SG+ G +     T     VA+K L     N    K   +E+ +++ + HKN++  +  
Sbjct: 32  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 91
Query: 176 CTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
            T    L       +V E M   ++   +H +    +++ LL   +    G+ +LH   I
Sbjct: 92  FTPQKTLEEFQDVYLVMELM-DANLCQVIHMELDHERMSYLLYQML---CGIKHLHSAGI 147
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKAD 289
           IHRDLK +N+++  +  +K+ DFG+AR    + +MT    T  + APEVI    Y    D
Sbjct: 148 IHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYAANVD 207
Query: 290 VFSFGIALWELLTGELPYAGLTPLQAAVGVVQK----------SLRPTI-------PKHA 332
           ++S G  + EL+ G + + G   +     V+++          +L+PT+       PK+ 
Sbjct: 208 IWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVENRPKYP 267
Query: 333 HPRLAELLERCWQHDPTQRPNF--SQITDILKQMM 365
             +  EL         ++R     SQ  D+L +M+
Sbjct: 268 GIKFEELFPDWIFPSESERDKIKTSQARDLLSKML 302

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 101/197 (51%), Gaps = 17/197 (8%)
Query: 118 VASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK------NV 169
           +  GS+G + K       Q VA+K+++ E       ++ ++E+ I+  +R +      NV
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNN 228
           +  +   T   ++C+  E ++  ++Y+ + K K   F L  + K A  + + ++ LH+N 
Sbjct: 162 IHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR 220
Query: 229 IIHRDLKTANLLMDENGV--VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY 286
           IIH DLK  N+L+ + G   +KV DFG +  + Q      ++  YR  APEVI    Y  
Sbjct: 221 IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRFYR--APEVILGARYGM 278
Query: 287 KADVFSFGIALWELLTG 303
             D++S G  L ELLTG
Sbjct: 279 PIDMWSLGCILAELLTG 295

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 90/178 (50%), Gaps = 5/178 (2%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 193
           QE A K++  + ++    ++  +E  I R ++H N+V+   + +      +V + +  G 
Sbjct: 30  QEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGE 89
Query: 194 IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVA 250
           +++ +  ++  +           + + +N+ H N I+HRDLK  NLL+    +   VK+A
Sbjct: 90  LFEDIVARE-YYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLA 148
Query: 251 DFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
           DFG+A  VQ          GT  +++PEV+   PY    D+++ G+ L+ LL G  P+
Sbjct: 149 DFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 20/218 (9%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTE 187
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T   +L       IV E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 247
            M   ++   +  +    +++ LL   +    G+ +LH   IIHRDLK +N+++  +  +
Sbjct: 110 LMD-ANLCQVIQMELDHERMSYLLYQML---CGIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 248 KVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
           K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++ G + +
Sbjct: 166 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225
Query: 308 AGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 335
            G   +     V++          K L+PT+  +   R
Sbjct: 226 PGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENR 263

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 101/202 (50%), Gaps = 7/202 (3%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 7   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 65
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 229
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 66  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 287
           +HRDLK  NLL++  G +K+ADFG+AR         T E  T  + APE++   K Y   
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 184
Query: 288 ADVFSFGIALWELLTGELPYAG 309
            D++S G    E++T    + G
Sbjct: 185 VDIWSLGCIFAEMVTRRALFPG 206

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 40  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 98
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 99  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 157
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       M     T  + A
Sbjct: 158 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMXGYVATRWYRA 213
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 214 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 248

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 101/202 (50%), Gaps = 7/202 (3%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 6   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 64
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 229
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 65  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 123
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 287
           +HRDLK  NLL++  G +K+ADFG+AR         T E  T  + APE++   K Y   
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 183
Query: 288 ADVFSFGIALWELLTGELPYAG 309
            D++S G    E++T    + G
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPG 205

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 101/202 (50%), Gaps = 7/202 (3%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 7   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 65
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 229
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 66  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 287
           +HRDLK  NLL++  G +K+ADFG+AR         T E  T  + APE++   K Y   
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 184
Query: 288 ADVFSFGIALWELLTGELPYAG 309
            D++S G    E++T    + G
Sbjct: 185 VDIWSLGCIFAEMVTRRALFPG 206

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 101/202 (50%), Gaps = 7/202 (3%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 8   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 66
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 229
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 67  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 125
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 287
           +HRDLK  NLL++  G +K+ADFG+AR         T E  T  + APE++   K Y   
Sbjct: 126 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 185
Query: 288 ADVFSFGIALWELLTGELPYAG 309
            D++S G    E++T    + G
Sbjct: 186 VDIWSLGCIFAEMVTRRALFPG 207

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DF +AR       MT    T  + A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLAR--HTDDEMTGYVATRWYRA 190
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 101/202 (50%), Gaps = 7/202 (3%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 14  KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 72
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 229
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 73  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 131
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 287
           +HRDLK  NLL++  G +K+ADFG+AR         T E  T  + APE++   K Y   
Sbjct: 132 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 191
Query: 288 ADVFSFGIALWELLTGELPYAG 309
            D++S G    E++T    + G
Sbjct: 192 VDIWSLGCIFAEMVTRRALFPG 213

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 101/202 (50%), Gaps = 7/202 (3%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 6   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 64
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 229
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 65  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 123
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 287
           +HRDLK  NLL++  G +K+ADFG+AR         T E  T  + APE++   K Y   
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 183
Query: 288 ADVFSFGIALWELLTGELPYAG 309
            D++S G    E++T    + G
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPG 205

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 106/206 (51%), Gaps = 18/206 (8%)
Query: 118 VASGSYGDL---YKGTYCSQEVAIKVLKPECVNTEMLKE------FSQEVYIMRKIRHKN 168
           + SG+ G++   ++   C ++VAIK++          +E         E+ I++K+ H  
Sbjct: 18  LGSGACGEVKLAFERKTC-KKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 169 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 228
           +++ I       +  IV E M  G ++D +   K + + T  L     +   + YLH+N 
Sbjct: 77  IIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-YQMLLAVQYLHENG 134
Query: 229 IIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV---IEHK 282
           IIHRDLK  N+L+   +E+ ++K+ DFG +++  ++ +M    GT  ++APEV   +   
Sbjct: 135 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTA 194
Query: 283 PYDYKADVFSFGIALWELLTGELPYA 308
            Y+   D +S G+ L+  L+G  P++
Sbjct: 195 GYNRAVDCWSLGVILFICLSGYPPFS 220

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 88/176 (50%), Gaps = 4/176 (2%)
Query: 135 EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 194
           E A K++  + ++    ++  +E  I RK++H N+V+   +        +V + +  G +
Sbjct: 33  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 92
Query: 195 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD---ENGVVKVAD 251
           ++ +  ++  +           + + + Y H N I+HR+LK  NLL+    +   VK+AD
Sbjct: 93  FEDIVARE-FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLAD 151
Query: 252 FGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
           FG+A     S       GT  +++PEV++  PY    D+++ G+ L+ LL G  P+
Sbjct: 152 FGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 88/176 (50%), Gaps = 4/176 (2%)
Query: 135 EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 194
           E A K++  + ++    ++  +E  I RK++H N+V+   +        +V + +  G +
Sbjct: 32  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 91
Query: 195 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD---ENGVVKVAD 251
           ++ +  ++  +           + + + Y H N I+HR+LK  NLL+    +   VK+AD
Sbjct: 92  FEDIVARE-FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLAD 150
Query: 252 FGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
           FG+A     S       GT  +++PEV++  PY    D+++ G+ L+ LL G  P+
Sbjct: 151 FGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 206

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 20/218 (9%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTE 187
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T    L       +V E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVME 109
Query: 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 247
            M   ++   +  +    +++ LL     +  G+ +LH   IIHRDLK +N+++  +  +
Sbjct: 110 LMD-ANLXQVIQMELDHERMSYLL---YQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTL 165
Query: 248 KVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
           K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++  ++ +
Sbjct: 166 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 225
Query: 308 AGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 335
            G   +     V++          K L+PT+  +   R
Sbjct: 226 PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 263

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 106/206 (51%), Gaps = 18/206 (8%)
Query: 118 VASGSYGDL---YKGTYCSQEVAIKVLKPECVNTEMLKE------FSQEVYIMRKIRHKN 168
           + SG+ G++   ++   C ++VAIK++          +E         E+ I++K+ H  
Sbjct: 18  LGSGACGEVKLAFERKTC-KKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 169 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 228
           +++ I       +  IV E M  G ++D +   K + + T  L     +   + YLH+N 
Sbjct: 77  IIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-YQMLLAVQYLHENG 134
Query: 229 IIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV---IEHK 282
           IIHRDLK  N+L+   +E+ ++K+ DFG +++  ++ +M    GT  ++APEV   +   
Sbjct: 135 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTA 194
Query: 283 PYDYKADVFSFGIALWELLTGELPYA 308
            Y+   D +S G+ L+  L+G  P++
Sbjct: 195 GYNRAVDCWSLGVILFICLSGYPPFS 220

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 88/176 (50%), Gaps = 4/176 (2%)
Query: 135 EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 194
           E A K++  + ++    ++  +E  I RK++H N+V+   +        +V + +  G +
Sbjct: 33  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 92
Query: 195 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD---ENGVVKVAD 251
           ++ +  ++  +           + + + Y H N I+HR+LK  NLL+    +   VK+AD
Sbjct: 93  FEDIVARE-FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLAD 151
Query: 252 FGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
           FG+A     S       GT  +++PEV++  PY    D+++ G+ L+ LL G  P+
Sbjct: 152 FGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 106/206 (51%), Gaps = 18/206 (8%)
Query: 118 VASGSYGDL---YKGTYCSQEVAIKVLKPECVNTEMLKE------FSQEVYIMRKIRHKN 168
           + SG+ G++   ++   C ++VAIK++          +E         E+ I++K+ H  
Sbjct: 17  LGSGACGEVKLAFERKTC-KKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 75
Query: 169 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 228
           +++ I       +  IV E M  G ++D +   K + + T  L     +   + YLH+N 
Sbjct: 76  IIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-YQMLLAVQYLHENG 133
Query: 229 IIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV---IEHK 282
           IIHRDLK  N+L+   +E+ ++K+ DFG +++  ++ +M    GT  ++APEV   +   
Sbjct: 134 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTA 193
Query: 283 PYDYKADVFSFGIALWELLTGELPYA 308
            Y+   D +S G+ L+  L+G  P++
Sbjct: 194 GYNRAVDCWSLGVILFICLSGYPPFS 219

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 106/206 (51%), Gaps = 18/206 (8%)
Query: 118 VASGSYGDL---YKGTYCSQEVAIKVLKPECVNTEMLKE------FSQEVYIMRKIRHKN 168
           + SG+ G++   ++   C ++VAIK++          +E         E+ I++K+ H  
Sbjct: 24  LGSGACGEVKLAFERKTC-KKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 82
Query: 169 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 228
           +++ I       +  IV E M  G ++D +   K + + T  L     +   + YLH+N 
Sbjct: 83  IIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-YQMLLAVQYLHENG 140
Query: 229 IIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV---IEHK 282
           IIHRDLK  N+L+   +E+ ++K+ DFG +++  ++ +M    GT  ++APEV   +   
Sbjct: 141 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTA 200
Query: 283 PYDYKADVFSFGIALWELLTGELPYA 308
            Y+   D +S G+ L+  L+G  P++
Sbjct: 201 GYNRAVDCWSLGVILFICLSGYPPFS 226

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 116/248 (46%), Gaps = 15/248 (6%)
Query: 118 VASGSYGDLY-----KGTYCSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKN-V 169
           + +G+YG ++      G    +  A+KVLK   +    +  +    E  ++  IR    +
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
           V    A      L ++ +++  G ++  L +++   +    + V  ++   + +LH+  I
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG-EIVLALEHLHKLGI 180
Query: 230 IHRDLKTANLLMDENGVVKVADFGVAR--VQAQSGVMTAETGTYRWMAPEVIE--HKPYD 285
           I+RD+K  N+L+D NG V + DFG+++  V  ++       GT  +MAP+++      +D
Sbjct: 181 IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHD 240
Query: 286 YKADVFSFGIALWELLTGELPYA--GLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC 343
              D +S G+ ++ELLTG  P+   G    QA +        P  P+       +L++R 
Sbjct: 241 KAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRL 300
Query: 344 WQHDPTQR 351
              DP +R
Sbjct: 301 LMKDPKKR 308

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 106/206 (51%), Gaps = 18/206 (8%)
Query: 118 VASGSYGDL---YKGTYCSQEVAIKVLKPECVNTEMLKE------FSQEVYIMRKIRHKN 168
           + SG+ G++   ++   C ++VAIK++          +E         E+ I++K+ H  
Sbjct: 18  LGSGACGEVKLAFERKTC-KKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 169 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 228
           +++ I       +  IV E M  G ++D +   K + + T  L     +   + YLH+N 
Sbjct: 77  IIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-YQMLLAVQYLHENG 134
Query: 229 IIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV---IEHK 282
           IIHRDLK  N+L+   +E+ ++K+ DFG +++  ++ +M    GT  ++APEV   +   
Sbjct: 135 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTA 194
Query: 283 PYDYKADVFSFGIALWELLTGELPYA 308
            Y+   D +S G+ L+  L+G  P++
Sbjct: 195 GYNRAVDCWSLGVILFICLSGYPPFS 220

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 193
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T    L    EF     
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTL---EEFQDVYL 106
Query: 194 IYDFLHKQKGVFQLTSLLKVAIDVSK----------GMNYLHQNNIIHRDLKTANLLMDE 243
           + + +        L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 107 VMELMDAN-----LXQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 244 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG 303
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++  
Sbjct: 162 DXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 221
Query: 304 ELPYAGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 335
           ++ + G   +     V++          K L+PT+  +   R
Sbjct: 222 KILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 263

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 193
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T    L    EF     
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTL---EEFQDVYL 106
Query: 194 IYDFLHKQKGVFQLTSLLKVAIDVSK----------GMNYLHQNNIIHRDLKTANLLMDE 243
           + + +        L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 107 VMELMDAN-----LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 244 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG 303
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++  
Sbjct: 162 DXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 221
Query: 304 ELPYAGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 335
           ++ + G   +     V++          K L+PT+  +   R
Sbjct: 222 KILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 263

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 88/176 (50%), Gaps = 4/176 (2%)
Query: 135 EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 194
           E A K++  + ++    ++  +E  I RK++H N+V+   +        +V + +  G +
Sbjct: 56  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 115
Query: 195 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD---ENGVVKVAD 251
           ++ +  ++  +           + + + Y H N I+HR+LK  NLL+    +   VK+AD
Sbjct: 116 FEDIVARE-FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLAD 174
Query: 252 FGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
           FG+A     S       GT  +++PEV++  PY    D+++ G+ L+ LL G  P+
Sbjct: 175 FGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 230

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+  FG+AR       MT    T  + A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLAR--HTDDEMTGYVATRWYRA 190
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 15/200 (7%)
Query: 116 CKVASGSYGDLYKG--TYCSQEVAIKVLK-PECVNTEMLKEFS--QEVYIMRKIR---HK 167
            ++  G+YG +YK    +    VA+K ++ P           S  +EV ++R++    H 
Sbjct: 15  AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74
Query: 168 NVVQFIGACT-----RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLK-VAIDVSKGM 221
           NVV+ +  C      R   + +V E + +  +  +L K          +K +     +G+
Sbjct: 75  NVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGL 133
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH 281
           ++LH N I+HRDLK  N+L+   G VK+ADFG+AR+ +    +T    T  + APEV+  
Sbjct: 134 DFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQ 193
Query: 282 KPYDYKADVFSFGIALWELL 301
             Y    D++S G    E+ 
Sbjct: 194 STYATPVDMWSVGCIFAEMF 213

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 98/199 (49%), Gaps = 6/199 (3%)
Query: 117 KVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           K+  G+Y  +YKG        VA+K ++ E           +EV +++ ++H N+V    
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHANIVTLHD 67
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                 +L +V E++ +  +  +L     +  + ++      + +G+ Y H+  ++HRDL
Sbjct: 68  IIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDL 126
Query: 235 KTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEV-IEHKPYDYKADVFS 292
           K  NLL++E G +K+ADFG+AR ++  +     E  T  +  P++ +    Y  + D++ 
Sbjct: 127 KPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWG 186
Query: 293 FGIALWELLTGELPYAGLT 311
            G   +E+ TG   + G T
Sbjct: 187 VGCIFYEMATGRPLFPGST 205

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 20/218 (9%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTE 187
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T   +L       IV E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 247
            M   ++   +  +    +++ LL     +  G+ +LH   IIHRDLK +N+++  +  +
Sbjct: 110 LMD-ANLCQVIQMELDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 248 KVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
           K+ DFG+AR    S +M  E  T  + APEVI    Y    D++S G  + E++  ++ +
Sbjct: 166 KILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHKILF 225
Query: 308 AG----------LTPLQAAVGVVQKSLRPTIPKHAHPR 335
            G          +  L        K L+PT+  +   R
Sbjct: 226 PGRDYIDQWNKVIEQLGTPCPAFMKKLQPTVRNYVENR 263

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 115/270 (42%), Gaps = 42/270 (15%)
Query: 118 VASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           +  G++G + K      S+  AIK ++      E L     EV ++  + H+ VV++  A
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVXLLASLNHQYVVRYYAA 70
Query: 176 -------------CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 222
                          +   L I  E+    ++YD +H +    Q     ++   + + ++
Sbjct: 71  WLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALS 130
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR---------------VQAQSGVMTAE 267
           Y+H   IIHR+LK  N+ +DE+  VK+ DFG+A+               +   S  +T+ 
Sbjct: 131 YIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSA 190
Query: 268 TGTYRWMAPEVIEHKP-YDYKADVFSFGIALWELL----TGELPYAGLTPLQAAVGVVQK 322
            GT  ++A EV++    Y+ K D +S GI  +E +    TG      L  L++    V  
Sbjct: 191 IGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIYPFSTGXERVNILKKLRS----VSI 246
Query: 323 SLRPTIPKHAHPRLAELLERCWQHDPTQRP 352
              P    +      +++     HDP +RP
Sbjct: 247 EFPPDFDDNKXKVEKKIIRLLIDHDPNKRP 276

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 118 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           +  G+YG       CS         VAIK + P    T   +   +E+ I+ + RH+N++
Sbjct: 35  IGEGAYG-----MVCSAYDNLNKVRVAIKKISPFEHQTYXQRTL-REIKILLRFRHENII 88
Query: 171 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 89  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 144
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 279
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 145 HSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 320
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 107/222 (48%), Gaps = 29/222 (13%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           VWE+  ++L+    V SG+YG +         Q+VA+K L     +    +   +E+ ++
Sbjct: 23  VWEV-PQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLL 81
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMA-------RGSIYDFLHKQKGVFQLT 208
           + ++H+NV+  +   T   ++       +VT  M        +       H Q  V+QL 
Sbjct: 82  KHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLL 141
Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268
                     +G+ Y+H   IIHRDLK +N+ ++E+  +++ DFG+AR   +   MT   
Sbjct: 142 ----------RGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE--MTGYV 189
Query: 269 GTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
            T  + APE++ +   Y+   D++S G  + ELL G+  + G
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPG 231

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 86/158 (54%), Gaps = 8/158 (5%)
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 216
           E+ I++K+ H  +++ I       +  IV E M  G ++D +   K + + T  L     
Sbjct: 190 EIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-YQ 247
Query: 217 VSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRW 273
           +   + YLH+N IIHRDLK  N+L+   +E+ ++K+ DFG +++  ++ +M    GT  +
Sbjct: 248 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY 307
Query: 274 MAPEV---IEHKPYDYKADVFSFGIALWELLTGELPYA 308
           +APEV   +    Y+   D +S G+ L+  L+G  P++
Sbjct: 308 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 345

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 86/158 (54%), Gaps = 8/158 (5%)
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 216
           E+ I++K+ H  +++ I       +  IV E M  G ++D +   K + + T  L     
Sbjct: 204 EIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-YQ 261
Query: 217 VSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRW 273
           +   + YLH+N IIHRDLK  N+L+   +E+ ++K+ DFG +++  ++ +M    GT  +
Sbjct: 262 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY 321
Query: 274 MAPEV---IEHKPYDYKADVFSFGIALWELLTGELPYA 308
           +APEV   +    Y+   D +S G+ L+  L+G  P++
Sbjct: 322 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 359

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 118 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           +  G+YG       CS         VAIK + P    T   +   +E+ I+ + RH+N++
Sbjct: 31  IGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENII 84
Query: 171 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 85  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 140
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 279
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 141 HSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 320
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 244

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ D G+AR       MT    T  + A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLAR--HTDDEMTGYVATRWYRA 190
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 118 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           +  G+YG       CS         VAIK + P    T   +   +E+ I+ + RH+N++
Sbjct: 31  IGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENII 84
Query: 171 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 85  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 140
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 279
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 141 HSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 320
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 244

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 94/189 (49%), Gaps = 13/189 (6%)
Query: 182 LCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240
           L I+ E M  G ++  + ++    F      ++  D+   + +LH +NI HRD+K  NLL
Sbjct: 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 160
Query: 241 M---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 297
               +++ V+K+ DFG A+   Q+ + T     Y ++APEV+  + YD   D++S G+ +
Sbjct: 161 YTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIM 219
Query: 298 WELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ-------HDPTQ 350
           + LL G  P+   T  QA    +++ +R       +P  +E+ E   Q        DPT+
Sbjct: 220 YILLCGFPPFYSNTG-QAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTE 278
Query: 351 RPNFSQITD 359
           R   +Q  +
Sbjct: 279 RLTITQFMN 287

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 20/218 (9%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTE 187
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T    L       +V E
Sbjct: 43  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 102
Query: 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 247
            M   ++   +  +    +++ LL   +    G+ +LH   IIHRDLK +N+++  +  +
Sbjct: 103 LMD-ANLXQVIQMELDHERMSYLLYQML---XGIKHLHSAGIIHRDLKPSNIVVKSDXTL 158
Query: 248 KVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
           K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++  ++ +
Sbjct: 159 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 218
Query: 308 AGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 335
            G   +     V++          K L+PT+  +   R
Sbjct: 219 PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 256

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 118 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           +  G+YG       CS         VAIK + P    T   +   +E+ I+ + RH+N++
Sbjct: 35  IGEGAYG-----MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENII 88
Query: 171 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 89  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 144
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 279
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 145 HSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 320
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 94/189 (49%), Gaps = 13/189 (6%)
Query: 182 LCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240
           L I+ E M  G ++  + ++    F      ++  D+   + +LH +NI HRD+K  NLL
Sbjct: 82  LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 141
Query: 241 M---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 297
               +++ V+K+ DFG A+   Q+ + T     Y ++APEV+  + YD   D++S G+ +
Sbjct: 142 YTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIM 200
Query: 298 WELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ-------HDPTQ 350
           + LL G  P+   T  QA    +++ +R       +P  +E+ E   Q        DPT+
Sbjct: 201 YILLCGFPPFYSNTG-QAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTE 259
Query: 351 RPNFSQITD 359
           R   +Q  +
Sbjct: 260 RLTITQFMN 268

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ D G+AR       MT    T  + A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLAR--HTDDEMTGYVATRWYRA 190
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 118 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           +  G+YG       CS         VAIK + P    T   +   +E+ I+ + RH+N++
Sbjct: 31  IGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENII 84
Query: 171 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 85  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 140
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 279
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 141 HSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 320
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 244

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 97/198 (48%), Gaps = 12/198 (6%)
Query: 117 KVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           K+  G+YG ++K       + VA+K ++ +  +  +     +E+ ++++++HKN+V+   
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                  L +V EF  +  +  +     G      +      + KG+ + H  N++HRDL
Sbjct: 69  VLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDL 127
Query: 235 KTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           K  NLL++ NG +K+A+FG+AR         +AE  T  +  P+V+      + A ++S 
Sbjct: 128 KPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL------FGAKLYST 181
Query: 294 GIALWE--LLTGELPYAG 309
            I +W    +  EL  AG
Sbjct: 182 SIDMWSAGCIFAELANAG 199

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 20/218 (9%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTE 187
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T    L       +V E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 109
Query: 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 247
            M   ++   +  +    +++ LL   +    G+ +LH   IIHRDLK +N+++  +  +
Sbjct: 110 LMD-ANLXQVIQMELDHERMSYLLYQML---XGIKHLHSAGIIHRDLKPSNIVVKSDXTL 165
Query: 248 KVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
           K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++  ++ +
Sbjct: 166 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 225
Query: 308 AGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 335
            G   +     V++          K L+PT+  +   R
Sbjct: 226 PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 263

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 118 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           +  G+YG       CS         VAIK + P    T   +   +E+ I+ + RH+N++
Sbjct: 31  IGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENII 84
Query: 171 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 85  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 140
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 279
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 141 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 320
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 244

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 118 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           +  G+YG       CS         VAIK + P    T   +   +E+ I+ + RH+N++
Sbjct: 39  IGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENII 92
Query: 171 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 93  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 148
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 279
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 149 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 208
Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 320
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 209 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 252

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 118 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           +  G+YG       CS         VAIK + P    T   +   +E+ I+ + RH+N++
Sbjct: 31  IGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENII 84
Query: 171 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 85  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 140
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 279
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 141 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 320
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 244

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ D G+AR       MT    T  + A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLAR--HTDDEMTGYVATRWYRA 190
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
           PE++ +   Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 118 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           +  G+YG       CS         VAIK + P    T   +   +E+ I+ + RH+N++
Sbjct: 33  IGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENII 86
Query: 171 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 87  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 142
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 279
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 143 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 320
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 246

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 118 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           +  G+YG       CS         VAIK + P    T   +   +E+ I+ + RH+N++
Sbjct: 29  IGEGAYG-----MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENII 82
Query: 171 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 83  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 138
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 279
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 139 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 320
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 242

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 118 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           +  G+YG       CS         VAIK + P    T   +   +E+ I+ + RH+N++
Sbjct: 51  IGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENII 104
Query: 171 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 105 G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 160
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 279
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 161 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 320
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 264

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 116 CKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR---HKNVV 170
            ++  G+YG +YK    +    VA+K ++       +     +EV ++R++    H NVV
Sbjct: 10  AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVV 69
Query: 171 QFIGACT-----RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLK-VAIDVSKGMNYL 224
           + +  C      R   + +V E + +  +  +L K          +K +     +G+++L
Sbjct: 70  RLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFL 128
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPY 284
           H N I+HRDLK  N+L+   G VK+ADFG+AR+ +    +     T  + APEV+    Y
Sbjct: 129 HANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEVLLQSTY 188
Query: 285 DYKADVFSFGIALWELL 301
               D++S G    E+ 
Sbjct: 189 ATPVDMWSVGCIFAEMF 205

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 118 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           +  G+YG       CS         VAIK + P    T   +   +E+ I+ + RH+N++
Sbjct: 29  IGEGAYG-----MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENII 82
Query: 171 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 83  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 138
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 279
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 139 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 320
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 242

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 100/197 (50%), Gaps = 17/197 (8%)
Query: 118 VASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK------NV 169
           +  G +G + K       Q VA+K+++ E       ++ ++E+ I+  +R +      NV
Sbjct: 105 IGKGXFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNN 228
           +  +   T   ++C+  E ++  ++Y+ + K K   F L  + K A  + + ++ LH+N 
Sbjct: 162 IHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR 220
Query: 229 IIHRDLKTANLLMDENGV--VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY 286
           IIH DLK  N+L+ + G   +KV DFG +  + Q      ++  YR  APEVI    Y  
Sbjct: 221 IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYXXIQSRFYR--APEVILGARYGM 278
Query: 287 KADVFSFGIALWELLTG 303
             D++S G  L ELLTG
Sbjct: 279 PIDMWSLGCILAELLTG 295

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 118 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           +  G+YG       CS         VAIK + P    T   +   +E+ I+ + RH+N++
Sbjct: 36  IGEGAYG-----MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENII 89
Query: 171 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 90  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 145
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 279
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 146 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 205
Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 320
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 249

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 118 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           +  G+YG       CS         VAIK + P    T   +   +E+ I+ + RH+N++
Sbjct: 37  IGEGAYG-----MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENII 90
Query: 171 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 91  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 146
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 279
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 147 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 206
Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 320
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 207 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 250

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 118 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           +  G+YG       CS         VAIK + P    T   +   +E+ I+ + RH+N++
Sbjct: 28  IGEGAYG-----MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENII 81
Query: 171 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 82  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 137
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 279
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 138 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 197
Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 320
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 198 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 241

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 118 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           +  G+YG       CS         VAIK + P    T   +   +E+ I+ + RH+N++
Sbjct: 35  IGEGAYG-----MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENII 88
Query: 171 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 89  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 144
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 279
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 320
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 193
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T    L    EF     
Sbjct: 88  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQDVYL 144
Query: 194 IYDFLHKQKGVFQLTSLLKVAIDVSK----------GMNYLHQNNIIHRDLKTANLLMDE 243
           + + +        L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 145 VMELMDAN-----LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
Query: 244 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG 303
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++  
Sbjct: 200 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 259
Query: 304 ELPYAGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 335
           ++ + G   +     V++          K L+PT+  +   R
Sbjct: 260 KILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 301

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 10  KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 68
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 229
           + +        L +V EF++   +  F+           L+K  +  + +G+ + H + +
Sbjct: 69  KLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 127
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 287
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 128 LHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 187
Query: 288 ADVFSFGIALWELLTGELPYAG 309
            D++S G    E++T    + G
Sbjct: 188 VDIWSLGCIFAEMVTRRALFPG 209

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 8   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 66
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 229
           + +        L +V EF++   +  F+           L+K  +  + +G+ + H + +
Sbjct: 67  KLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 125
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 287
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 126 LHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 185
Query: 288 ADVFSFGIALWELLTGELPYAG 309
            D++S G    E++T    + G
Sbjct: 186 VDIWSLGCIFAEMVTRRALFPG 207

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 10  KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 68
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL---------KVAIDVSKGM 221
           + +        L +V         ++FLH+    F   S L              + +G+
Sbjct: 69  KLLDVIHTENKLYLV---------FEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIE 280
            + H + ++HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++ 
Sbjct: 120 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 179
Query: 281 H-KPYDYKADVFSFGIALWELLTGELPYAG 309
             K Y    D++S G    E++T    + G
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRRALFPG 209

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 116 CKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR---HKNVV 170
            ++  G+YG +YK    +    VA+K ++       +     +EV ++R++    H NVV
Sbjct: 10  AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVV 69
Query: 171 QFIGACT-----RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLK-VAIDVSKGMNYL 224
           + +  C      R   + +V E + +  +  +L K          +K +     +G+++L
Sbjct: 70  RLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFL 128
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPY 284
           H N I+HRDLK  N+L+   G VK+ADFG+AR+ +    +     T  + APEV+    Y
Sbjct: 129 HANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEVLLQSTY 188
Query: 285 DYKADVFSFGIALWELL 301
               D++S G    E+ 
Sbjct: 189 ATPVDMWSVGCIFAEMF 205

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 193
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T    L    EF     
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQDVYL 106
Query: 194 IYDFLHKQKGVFQLTSLLKVAIDVSK----------GMNYLHQNNIIHRDLKTANLLMDE 243
           + + +        L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 107 VMELMDAN-----LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 244 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG 303
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++  
Sbjct: 162 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 221
Query: 304 ELPYAGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 335
           ++ + G   +     V++          K L+PT+  +   R
Sbjct: 222 KILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 263

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/235 (24%), Positives = 106/235 (45%), Gaps = 24/235 (10%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 193
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T    L    EF     
Sbjct: 88  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQDVYL 144
Query: 194 IYDFLHKQKGVFQLTSLLKVAIDVSK----------GMNYLHQNNIIHRDLKTANLLMDE 243
           + + +        L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 145 VMELMDAN-----LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
Query: 244 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG 303
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++  
Sbjct: 200 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 259
Query: 304 ELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQIT 358
           ++ + G   +     V+++   P       P   + L+   ++    RP ++ +T
Sbjct: 260 KILFPGRDYIDQWNKVIEQLGTPC------PEFMKKLQPTVRNYVENRPKYAGLT 308

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 10  KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 68
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 229
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 69  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 127
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 287
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 128 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 187
Query: 288 ADVFSFGIALWELLTGELPYAG 309
            D++S G    E++T    + G
Sbjct: 188 VDIWSLGCIFAEMVTRRALFPG 209

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 9   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 67
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 229
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 68  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 126
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 287
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 127 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 186
Query: 288 ADVFSFGIALWELLTGELPYAG 309
            D++S G    E++T    + G
Sbjct: 187 VDIWSLGCIFAEMVTRRALFPG 208

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 193
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T    L    EF     
Sbjct: 51  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQDVYL 107
Query: 194 IYDFLHKQKGVFQLTSLLKVAIDVSK----------GMNYLHQNNIIHRDLKTANLLMDE 243
           + + +        L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 108 VMELMDAN-----LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 162
Query: 244 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG 303
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++  
Sbjct: 163 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 222
Query: 304 ELPYAGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 335
           ++ + G   +     V++          K L+PT+  +   R
Sbjct: 223 KILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 264

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 193
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T    L    EF     
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQDVYL 106
Query: 194 IYDFLHKQKGVFQLTSLLKVAIDVSK----------GMNYLHQNNIIHRDLKTANLLMDE 243
           + + +        L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 107 VMELMDAN-----LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 244 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG 303
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++  
Sbjct: 162 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 221
Query: 304 ELPYAGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 335
           ++ + G   +     V++          K L+PT+  +   R
Sbjct: 222 KILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 263

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 31/224 (13%)
Query: 118 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           +  G+YG       CS         VAIK + P    T   +   +E+ I+   RH+N++
Sbjct: 33  IGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLAFRHENII 86
Query: 171 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 87  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 142
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 279
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 143 HSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 320
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 246

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           K+E K+  G+YG +YK       + VA+  ++ +     +     +E+ +++++ H N+V
Sbjct: 7   KVE-KIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIV 65
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 229
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 66  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 287
           +HRDLK  NLL++  G +K+ADFG+AR         T E  T  + APE++   K Y   
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 184
Query: 288 ADVFSFGIALWELLTGELPYAG 309
            D++S G    E++T    + G
Sbjct: 185 VDIWSLGCIFAEMVTRRALFPG 206

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           K+E K+  G+YG +YK       + VA+  ++ +     +     +E+ +++++ H N+V
Sbjct: 6   KVE-KIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIV 64
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 229
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 65  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 123
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 287
           +HRDLK  NLL++  G +K+ADFG+AR         T E  T  + APE++   K Y   
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 183
Query: 288 ADVFSFGIALWELLTGELPYAG 309
            D++S G    E++T    + G
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPG 205

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 6   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 64
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 229
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 65  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 123
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 287
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 183
Query: 288 ADVFSFGIALWELLTGELPYAG 309
            D++S G    E++T    + G
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPG 205

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 193
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T    L    EF     
Sbjct: 49  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQDVYL 105
Query: 194 IYDFLHKQKGVFQLTSLLKVAIDVSK----------GMNYLHQNNIIHRDLKTANLLMDE 243
           + + +        L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 106 VMELMDAN-----LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 160
Query: 244 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG 303
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++  
Sbjct: 161 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 220
Query: 304 ELPYAGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 335
           ++ + G   +     V++          K L+PT+  +   R
Sbjct: 221 KILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 262

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 193
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T    L    EF     
Sbjct: 51  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQDVYL 107
Query: 194 IYDFLHKQKGVFQLTSLLKVAIDVSK----------GMNYLHQNNIIHRDLKTANLLMDE 243
           + + +        L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 108 VMELMDAN-----LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 162
Query: 244 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG 303
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++  
Sbjct: 163 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 222
Query: 304 ELPYAGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 335
           ++ + G   +     V++          K L+PT+  +   R
Sbjct: 223 KILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 264

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 7   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 65
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 229
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 66  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 287
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 184
Query: 288 ADVFSFGIALWELLTGELPYAG 309
            D++S G    E++T    + G
Sbjct: 185 VDIWSLGCIFAEMVTRRALFPG 206

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 193
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T    L    EF     
Sbjct: 44  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQDVYL 100
Query: 194 IYDFLHKQKGVFQLTSLLKVAIDVSK----------GMNYLHQNNIIHRDLKTANLLMDE 243
           + + +        L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 101 VMELMDAN-----LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 155
Query: 244 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG 303
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++  
Sbjct: 156 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 215
Query: 304 ELPYAGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 335
           ++ + G   +     V++          K L+PT+  +   R
Sbjct: 216 KILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 257

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 6   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 64
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 229
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 65  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 123
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 287
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 183
Query: 288 ADVFSFGIALWELLTGELPYAG 309
            D++S G    E++T    + G
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPG 205

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 8   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 66
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 229
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 67  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 125
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 287
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 126 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 185
Query: 288 ADVFSFGIALWELLTGELPYAG 309
            D++S G    E++T    + G
Sbjct: 186 VDIWSLGCIFAEMVTRRALFPG 207

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 9   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 67
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 229
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 68  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 126
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 287
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 127 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 186
Query: 288 ADVFSFGIALWELLTGELPYAG 309
            D++S G    E++T    + G
Sbjct: 187 VDIWSLGCIFAEMVTRRALFPG 208

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 7   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 65
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 229
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 66  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 287
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 184
Query: 288 ADVFSFGIALWELLTGELPYAG 309
            D++S G    E++T    + G
Sbjct: 185 VDIWSLGCIFAEMVTRRALFPG 206

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 193
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T    L    EF     
Sbjct: 44  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQDVYL 100
Query: 194 IYDFLHKQKGVFQLTSLLKVAIDVSK----------GMNYLHQNNIIHRDLKTANLLMDE 243
           + + +        L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 101 VMELMDAN-----LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 155
Query: 244 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG 303
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++  
Sbjct: 156 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 215
Query: 304 ELPYAGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 335
           ++ + G   +     V++          K L+PT+  +   R
Sbjct: 216 KILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 257

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 7   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 65
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 229
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 66  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 287
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 184
Query: 288 ADVFSFGIALWELLTGELPYAG 309
            D++S G    E++T    + G
Sbjct: 185 VDIWSLGCIFAEMVTRRALFPG 206

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 8   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 66
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 229
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 67  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 125
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 287
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 126 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 185
Query: 288 ADVFSFGIALWELLTGELPYAG 309
            D++S G    E++T    + G
Sbjct: 186 VDIWSLGCIFAEMVTRRALFPG 207

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 11  KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 69
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 229
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 70  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 128
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 287
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 129 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 188
Query: 288 ADVFSFGIALWELLTGELPYAG 309
            D++S G    E++T    + G
Sbjct: 189 VDIWSLGCIFAEMVTRRALFPG 210

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 8   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 66
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 229
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 67  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 125
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 287
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 126 LHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 185
Query: 288 ADVFSFGIALWELLTGELPYAG 309
            D++S G    E++T    + G
Sbjct: 186 VDIWSLGCIFAEMVTRRALFPG 207

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 193
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T    L    EF     
Sbjct: 43  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQDVYL 99
Query: 194 IYDFLHKQKGVFQLTSLLKVAIDVSK----------GMNYLHQNNIIHRDLKTANLLMDE 243
           + + +        L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 100 VMELMDAN-----LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 154
Query: 244 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG 303
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++  
Sbjct: 155 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 214
Query: 304 ELPYAGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 335
           ++ + G   +     V++          K L+PT+  +   R
Sbjct: 215 KILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 256

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 10  KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 68
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 229
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 69  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 127
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 287
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 128 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 187
Query: 288 ADVFSFGIALWELLTGELPYAG 309
            D++S G    E++T    + G
Sbjct: 188 VDIWSLGCIFAEMVTRRALFPG 209

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 9   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 67
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 229
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 68  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 126
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 287
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 127 LHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 186
Query: 288 ADVFSFGIALWELLTGELPYAG 309
            D++S G    E++T    + G
Sbjct: 187 VDIWSLGCIFAEMVTRRALFPG 208

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 107/222 (48%), Gaps = 29/222 (13%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           VWE+  ++L+    V SG+YG +         Q+VA+K L     +    +   +E+ ++
Sbjct: 23  VWEV-PQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLL 81
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMA-------RGSIYDFLHKQKGVFQLT 208
           + ++H+NV+  +   T   ++       +VT  M        +       H Q  V+QL 
Sbjct: 82  KHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLL 141
Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268
                     +G+ Y+H   IIHRDLK +N+ ++E+  +++ DFG+AR   +   MT   
Sbjct: 142 ----------RGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE--MTGYV 189
Query: 269 GTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
            T  + APE++ +   Y+   D++S G  + ELL G+  + G
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPG 231

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 7   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 65
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 229
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 66  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 287
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 184
Query: 288 ADVFSFGIALWELLTGELPYAG 309
            D++S G    E++T    + G
Sbjct: 185 VDIWSLGCIFAEMVTRRALFPG 206

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 102/218 (46%), Gaps = 20/218 (9%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTE 187
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T   +L       IV E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 247
            M   ++   +  +    +++ LL     +  G+ +LH   IIHRDLK +N+++  +  +
Sbjct: 110 LMD-ANLCQVIQMELDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 248 KVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
           K+ DFG+AR    S +M  E  T  + APEVI    Y    D++S G  + E++  ++ +
Sbjct: 166 KILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILF 225
Query: 308 AGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 335
            G   +     V++          K L+PT+  +   R
Sbjct: 226 PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR 263

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 116 CKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR---HKNVV 170
            ++  G+YG +YK    +    VA+K ++       +     +EV ++R++    H NVV
Sbjct: 10  AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVV 69
Query: 171 QFIGACT-----RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLK-VAIDVSKGMNYL 224
           + +  C      R   + +V E + +  +  +L K          +K +     +G+++L
Sbjct: 70  RLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFL 128
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPY 284
           H N I+HRDLK  N+L+   G VK+ADFG+AR+ +    +     T  + APEV+    Y
Sbjct: 129 HANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEVLLQSTY 188
Query: 285 DYKADVFSFGIALWELL 301
               D++S G    E+ 
Sbjct: 189 ATPVDMWSVGCIFAEMF 205

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 118 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           +  G+YG       CS         VAIK + P    T   +   +E+ I+ + RH+N++
Sbjct: 35  IGEGAYG-----MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENII 88
Query: 171 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 89  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKCQH--LSNDHICYFLYQILRGLKYI 144
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 279
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 320
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 118 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           +  G+YG       CS         VAI+ + P    T   +   +E+ I+ + RH+N++
Sbjct: 35  IGEGAYG-----MVCSAYDNLNKVRVAIRKISPFEHQTYCQRTL-REIKILLRFRHENII 88
Query: 171 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 89  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 144
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 279
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 320
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 20/218 (9%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTE 187
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T   +L       IV E
Sbjct: 52  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 111
Query: 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 247
            M   ++   +  +    +++ LL     +  G+ +LH   IIHRDLK +N+++  +  +
Sbjct: 112 LMD-ANLCQVIQMELDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 167
Query: 248 KVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
           K+ DFG+AR    S +M     T  + APEVI    Y    D++S G  + E++ G + +
Sbjct: 168 KILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 227
Query: 308 AGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 335
            G   +     V++          K L+PT+  +   R
Sbjct: 228 PGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR 265

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 31/224 (13%)
Query: 118 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           +  G+YG       CS         VAIK + P    T   +   +E+ I+   RH+N++
Sbjct: 33  IGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLAFRHENII 86
Query: 171 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 87  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 142
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 279
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 143 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 320
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 246

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 102/218 (46%), Gaps = 20/218 (9%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTE 187
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T   +L       IV E
Sbjct: 55  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 114
Query: 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 247
            M   ++   +  +    +++ LL     +  G+ +LH   IIHRDLK +N+++  +  +
Sbjct: 115 LMD-ANLCQVIQMELDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 170
Query: 248 KVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
           K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++  ++ +
Sbjct: 171 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILF 230
Query: 308 AGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 335
            G   +     V++          K L+PT+  +   R
Sbjct: 231 PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR 268

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 102/218 (46%), Gaps = 20/218 (9%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTE 187
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T   +L       IV E
Sbjct: 44  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 103
Query: 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 247
            M   ++   +  +    +++ LL   +    G+ +LH   IIHRDLK +N+++  +  +
Sbjct: 104 LMD-ANLCQVIQMELDHERMSYLLYQML---CGIKHLHSAGIIHRDLKPSNIVVKSDCTL 159
Query: 248 KVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
           K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++  ++ +
Sbjct: 160 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILF 219
Query: 308 AGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 335
            G   +     V++          K L+PT+  +   R
Sbjct: 220 PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR 257

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 118 VASGSYGDLYKGTY---CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV---Q 171
           +  G+YG +    Y       VAIK + P    T   +   +E+ I+ + RH+NV+    
Sbjct: 51  IGEGAYG-MVSSAYDHVRKTRVAIKKISPFEHQTYCQRTL-REIQILLRFRHENVIGIRD 108
Query: 172 FIGACTRPP--NLCIVTEFMARGSIYDFLHKQKGVFQLTS--LLKVAIDVSKGMNYLHQN 227
            + A T     ++ IV + M    +Y  L  Q    QL++  +      + +G+ Y+H  
Sbjct: 109 ILRASTLEAMRDVYIVQDLM-ETDLYKLLKSQ----QLSNDHICYFLYQILRGLKYIHSA 163
Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-IEHK 282
           N++HRDLK +NLL++    +K+ DFG+AR+       +G +T    T  + APE+ +  K
Sbjct: 164 NVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSK 223
Query: 283 PYDYKADVFSFGIALWELLTGELPYAG 309
            Y    D++S G  L E+L+    + G
Sbjct: 224 GYTKSIDIWSVGCILAEMLSNRPIFPG 250

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 31/224 (13%)
Query: 118 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           +  G+YG       CS         VAIK + P    T   +   +E+ I+ + RH+N++
Sbjct: 35  IGEGAYG-----MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENII 88
Query: 171 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 89  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 144
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 279
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +     T  + APE+ +
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 204
Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 320
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 31/224 (13%)
Query: 118 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           +  G+YG       CS         VAIK + P    T   +   +E+ I+ + RH+N++
Sbjct: 36  IGEGAYG-----MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENII 89
Query: 171 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 90  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 145
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 279
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +     T  + APE+ +
Sbjct: 146 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 205
Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 320
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 249

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 129/292 (44%), Gaps = 42/292 (14%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
           E+   +L++   +A G +  +Y+       +E A+K L       E  +   QEV  M+K
Sbjct: 24  ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKK 81
Query: 164 IR-HKNVVQFIGAC--------TRPPNLCIVTEFMARGSIYDFLHK--QKGVFQLTSLLK 212
           +  H N+VQF  A         T      ++TE + +G + +FL K   +G     ++LK
Sbjct: 82  LSGHPNIVQFCSAASIGKEESDTGQAEFLLLTE-LCKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 213 VAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGVARV---------QAQS 261
           +     + + ++H+    IIHRDLK  NLL+   G +K+ DFG A            AQ 
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQR 200
Query: 262 GVMTAE----TGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ 314
             +  E      T  +  PE+I+   + P   K D+++ G  L+ L   + P+     L+
Sbjct: 201 RALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR 260
Query: 315 AAVGVVQKSLRPTIPKH--AHPRLAELLERCWQHDPTQRPNFSQITDILKQM 364
              G      + +IP H   +     L+    Q +P +R + +++   L+++
Sbjct: 261 IVNG------KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/284 (23%), Positives = 123/284 (43%), Gaps = 29/284 (10%)
Query: 111 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 164
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 165 RH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
                 V++ +    RP +  ++ E M     ++DF+  ++G  Q          V + +
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 127
Query: 222 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 280
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 128 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 186
Query: 281 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
            H+ +   A V+S GI L++++ G++P+     +       Q   R  +          L
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSECQ----HL 238
Query: 340 LERCWQHDPTQRPNFSQITD-------ILKQMMKEV-LYWLSPN 375
           +  C    P+ RP F +I +       +L Q   E+ L+ LSP 
Sbjct: 239 IRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPG 282

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 81/324 (25%), Positives = 131/324 (40%), Gaps = 74/324 (22%)
Query: 110 KQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKP------ECVNTEMLKEFSQEVYIMRK 163
           K+  ++  +  GSYG + +    +Q  AI+ +K         +N + ++    EV +M+K
Sbjct: 26  KKYHLKGAIGQGSYG-VVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK---- 219
           + H N+ +          +C+V E    G + D L+    VF   S  K A+DV K    
Sbjct: 85  LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLN----VFIDDSTGKCAMDVVKTQIC 140
Query: 220 ---------------------------------------GMNYLHQNNIIHRDLKTANLL 240
                                                   ++YLH   I HRD+K  N L
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFL 200
Query: 241 MDENGV--VKVADFGVAR--VQAQSGV---MTAETGTYRWMAPEVIE--HKPYDYKADVF 291
              N    +K+ DFG+++   +  +G    MT + GT  ++APEV+   ++ Y  K D +
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260
Query: 292 SFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKH------AHPRLAELL----- 340
           S G+ L  LL G +P+ G+        V+ K L    P +      A   L+ LL     
Sbjct: 261 SAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVD 320
Query: 341 ERCWQHDPTQRPNFSQITDILKQM 364
           ER       Q P  SQ +D + +M
Sbjct: 321 ERFDAMRALQHPWISQFSDKIYKM 344

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 107/222 (48%), Gaps = 29/222 (13%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           VWE+  ++L+    V SG+YG +         Q+VA+K L     +    +   +E+ ++
Sbjct: 15  VWEV-PQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLL 73
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMA-------RGSIYDFLHKQKGVFQLT 208
           + ++H+NV+  +   T   ++       +VT  M        +       H Q  V+QL 
Sbjct: 74  KHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLL 133
Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268
                     +G+ Y+H   IIHRDLK +N+ ++E+  +++ DFG+AR   +   MT   
Sbjct: 134 ----------RGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEE--MTGYV 181
Query: 269 GTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
            T  + APE++ +   Y+   D++S G  + ELL G+  + G
Sbjct: 182 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPG 223

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 101/216 (46%), Gaps = 29/216 (13%)
Query: 114 IECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKE-FSQEVYIMRKIRHKNVVQF 172
           I+C +  G +G +++      +    + +    N E+ +E   +EV  + K+ H  +V++
Sbjct: 10  IQC-LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRY 68
Query: 173 IGA--------CTRPPN----LCIVTEFMARGSIYDFLHKQKGV--FQLTSLLKVAIDVS 218
             A          +P +    L I  +   + ++ D+++ +  +   + +  L + + ++
Sbjct: 69  FNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIA 128
Query: 219 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-------------GVMT 265
           + + +LH   ++HRDLK +N+    + VVKV DFG+     Q                 T
Sbjct: 129 EAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188
Query: 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELL 301
            + GT  +M+PE I    Y +K D+FS G+ L+ELL
Sbjct: 189 GQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 83/174 (47%), Gaps = 23/174 (13%)
Query: 211 LKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS--------- 261
           L + I +++ + +LH   ++HRDLK +N+    + VVKV DFG+     Q          
Sbjct: 167 LHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 226
Query: 262 ----GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAA- 316
                    + GT  +M+PE I    Y +K D+FS G+ L+ELL     Y+  T ++   
Sbjct: 227 MPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL-----YSFSTQMERVR 281
Query: 317 -VGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVL 369
            +  V+    P +    +P+   +++      PT+RP   + TDI++  + E L
Sbjct: 282 IITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERP---EATDIIENAIFENL 332

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 6   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 64
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 229
           + +        L +V E + +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 65  KLLDVIHTENKLYLVFEHVHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 123
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 287
           +HRDLK  NLL++  G +K+ADFG+AR         T E  T  + APE++   K Y   
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 183
Query: 288 ADVFSFGIALWELLTGELPYAG 309
            D++S G    E++T    + G
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPG 205

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 91/179 (50%), Gaps = 5/179 (2%)
Query: 133 SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARG 192
            QE A K++  + ++    ++  +E  I R ++H N+V+   + +   +  ++ + +  G
Sbjct: 47  GQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGG 106
Query: 193 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD---ENGVVKV 249
            +++ +  ++  +           + + + + HQ  ++HRDLK  NLL+    +   VK+
Sbjct: 107 ELFEDIVARE-YYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKL 165
Query: 250 ADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
           ADFG+A  V+ +        GT  +++PEV+   PY    D+++ G+ L+ LL G  P+
Sbjct: 166 ADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPF 224

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 104/211 (49%), Gaps = 41/211 (19%)
Query: 132 CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF--------------IGACT 177
           C + VAIK  K    + + +K   +E+ I+R++ H N+V+               +G+ T
Sbjct: 35  CDKRVAIK--KIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLT 92
Query: 178 RPPNLCIVTEFMA--------RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
              ++ IV E+M         +G + +  H +  ++QL           +G+ Y+H  N+
Sbjct: 93  ELNSVYIVQEYMETDLANVLEQGPLLEE-HARLFMYQLL----------RGLKYIHSANV 141
Query: 230 IHRDLKTANLLMD-ENGVVKVADFGVARVQ----AQSGVMTAETGTYRWMAPE-VIEHKP 283
           +HRDLK ANL ++ E+ V+K+ DFG+AR+     +  G ++    T  + +P  ++    
Sbjct: 142 LHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNN 201
Query: 284 YDYKADVFSFGIALWELLTGELPYAGLTPLQ 314
           Y    D+++ G    E+LTG+  +AG   L+
Sbjct: 202 YTKAIDMWAAGCIFAEMLTGKTLFAGAHELE 232

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G++G+  L +     +  A+K+L K E +       F +E  IM       VVQ   
Sbjct: 83  IGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 142
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHK----QKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
           A      L +V E+M  G + + +      +K     T+ + +A+D       +H   +I
Sbjct: 143 AFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDA------IHSMGLI 196
Query: 231 HRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKP----Y 284
           HRD+K  N+L+D++G +K+ADFG      ++G++  +T  GT  +++PEV++ +     Y
Sbjct: 197 HRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYY 256
Query: 285 DYKADVFSFGIALWELLTGELPY 307
             + D +S G+ L+E+L G+ P+
Sbjct: 257 GRECDWWSVGVFLFEMLVGDTPF 279

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 99/202 (49%), Gaps = 7/202 (3%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 10  KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 68
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 229
           + +        L +V E + +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 69  KLLDVIHTENKLYLVFEHVDQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 127
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 287
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 128 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 187
Query: 288 ADVFSFGIALWELLTGELPYAG 309
            D++S G    E++T    + G
Sbjct: 188 VDIWSLGCIFAEMVTRRALFPG 209

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 122/284 (42%), Gaps = 29/284 (10%)
Query: 111 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 164
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 165 RH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 156
Query: 222 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 280
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 157 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 215
Query: 281 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
            H+ +   A V+S GI L++++ G++P+     +       Q   R  +          L
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG----QVFFRQRVSSECQ----HL 267
Query: 340 LERCWQHDPTQRPNFSQITD-------ILKQMMKEV-LYWLSPN 375
           +  C    P+ RP F +I +       +L Q   E+ L+ LSP 
Sbjct: 268 IRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPG 311

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 122/284 (42%), Gaps = 29/284 (10%)
Query: 111 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 164
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 165 RH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 155
Query: 222 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 280
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 156 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 214
Query: 281 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
            H+ +   A V+S GI L++++ G++P+     +       Q   R  +          L
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG----QVFFRQRVSSECQ----HL 266
Query: 340 LERCWQHDPTQRPNFSQITD-------ILKQMMKEV-LYWLSPN 375
           +  C    P+ RP F +I +       +L Q   E+ L+ LSP 
Sbjct: 267 IRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPG 310

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 122/284 (42%), Gaps = 29/284 (10%)
Query: 111 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 164
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 165 RH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 156
Query: 222 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 280
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 157 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 215
Query: 281 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
            H+ +   A V+S GI L++++ G++P+     +       Q   R  +          L
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG----QVFFRQRVSSECQ----HL 267
Query: 340 LERCWQHDPTQRPNFSQITD-------ILKQMMKEV-LYWLSPN 375
           +  C    P+ RP F +I +       +L Q   E+ L+ LSP 
Sbjct: 268 IRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPG 311

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 122/284 (42%), Gaps = 29/284 (10%)
Query: 111 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 164
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 165 RH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 155
Query: 222 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 280
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 156 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 214
Query: 281 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
            H+ +   A V+S GI L++++ G++P+     +       Q   R  +          L
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG----QVFFRQRVSSECQ----HL 266
Query: 340 LERCWQHDPTQRPNFSQITD-------ILKQMMKEV-LYWLSPN 375
           +  C    P+ RP F +I +       +L Q   E+ L+ LSP 
Sbjct: 267 IRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPG 310

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/271 (23%), Positives = 117/271 (43%), Gaps = 23/271 (8%)
Query: 110 KQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRK 163
            Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 164 IRH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
           +      V++ +    RP +  ++ E       ++DF+  ++G  Q          V + 
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEA 122
Query: 221 MNYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI 279
           + + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWI 181
Query: 280 E-HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE 338
             H+ +   A V+S GI L++++ G++P+     +       Q   R  +          
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG----QVFFRQRVSSECQ----H 233
Query: 339 LLERCWQHDPTQRPNFSQITDILKQMMKEVL 369
           L+  C    P+ RP F +I +     M++VL
Sbjct: 234 LIRWCLALRPSDRPTFEEIQN--HPWMQDVL 262

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 122/284 (42%), Gaps = 29/284 (10%)
Query: 111 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 164
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 165 RH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 156
Query: 222 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 280
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 157 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 215
Query: 281 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
            H+ +   A V+S GI L++++ G++P+     +       Q   R  +          L
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG----QVFFRQRVSXECQ----HL 267
Query: 340 LERCWQHDPTQRPNFSQITD-------ILKQMMKEV-LYWLSPN 375
           +  C    P+ RP F +I +       +L Q   E+ L+ LSP 
Sbjct: 268 IRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPG 311

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 122/284 (42%), Gaps = 29/284 (10%)
Query: 111 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 164
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 165 RH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 156
Query: 222 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 280
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 157 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 215
Query: 281 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
            H+ +   A V+S GI L++++ G++P+     +       Q   R  +          L
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG----QVFFRQRVSXECQ----HL 267
Query: 340 LERCWQHDPTQRPNFSQITD-------ILKQMMKEV-LYWLSPN 375
           +  C    P+ RP F +I +       +L Q   E+ L+ LSP 
Sbjct: 268 IRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPG 311

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 122/284 (42%), Gaps = 29/284 (10%)
Query: 111 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 164
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 165 RH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 155
Query: 222 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 280
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 156 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 214
Query: 281 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
            H+ +   A V+S GI L++++ G++P+     +       Q   R  +          L
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG----QVFFRQRVSXECQ----HL 266
Query: 340 LERCWQHDPTQRPNFSQITD-------ILKQMMKEV-LYWLSPN 375
           +  C    P+ RP F +I +       +L Q   E+ L+ LSP 
Sbjct: 267 IRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPG 310

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 122/284 (42%), Gaps = 29/284 (10%)
Query: 111 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 164
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 165 RH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 127
Query: 222 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 280
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 128 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 186
Query: 281 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
            H+ +   A V+S GI L++++ G++P+     +       Q   R  +          L
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSECQ----HL 238
Query: 340 LERCWQHDPTQRPNFSQITD-------ILKQMMKEV-LYWLSPN 375
           +  C    P+ RP F +I +       +L Q   E+ L+ LSP 
Sbjct: 239 IRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPG 282

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 88/189 (46%), Gaps = 12/189 (6%)
Query: 182 LCIVTEFMARGSIYDFLH-KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240
           L IV E +  G ++  +  +    F      ++   + + + YLH  NI HRD+K  NLL
Sbjct: 88  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 147
Query: 241 MDE---NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 297
                 N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G+ +
Sbjct: 148 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 207
Query: 298 WELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE-------LLERCWQHDPTQ 350
           + LL G  P+     L  + G ++  +R    +  +P  +E       L+    + +PTQ
Sbjct: 208 YILLCGYPPFYSNHGLAISPG-MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 266
Query: 351 RPNFSQITD 359
           R   ++  +
Sbjct: 267 RMTITEFMN 275

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 122/284 (42%), Gaps = 29/284 (10%)
Query: 111 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 164
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 165 RH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 128
Query: 222 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 280
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 129 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 187
Query: 281 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
            H+ +   A V+S GI L++++ G++P+     +       Q   R  +          L
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSECQ----HL 239
Query: 340 LERCWQHDPTQRPNFSQITD-------ILKQMMKEV-LYWLSPN 375
           +  C    P+ RP F +I +       +L Q   E+ L+ LSP 
Sbjct: 240 IRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPG 283

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 88/189 (46%), Gaps = 12/189 (6%)
Query: 182 LCIVTEFMARGSIYDFLH-KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240
           L IV E +  G ++  +  +    F      ++   + + + YLH  NI HRD+K  NLL
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 149
Query: 241 MDE---NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 297
                 N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G+ +
Sbjct: 150 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 209
Query: 298 WELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE-------LLERCWQHDPTQ 350
           + LL G  P+     L  + G ++  +R    +  +P  +E       L+    + +PTQ
Sbjct: 210 YILLCGYPPFYSNHGLAISPG-MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 268
Query: 351 RPNFSQITD 359
           R   ++  +
Sbjct: 269 RMTITEFMN 277

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 77/146 (52%), Gaps = 5/146 (3%)
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
           H N+V+         +  +V E +  G +++ + K+K  F  T    +   +   ++++H
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH-FSETEASYIMRKLVSAVSHMH 123
Query: 226 QNNIIHRDLKTANLLM---DENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEVIEH 281
              ++HRDLK  NLL    ++N  +K+ DFG AR++   +  +     T  + APE++  
Sbjct: 124 DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQ 183
Query: 282 KPYDYKADVFSFGIALWELLTGELPY 307
             YD   D++S G+ L+ +L+G++P+
Sbjct: 184 NGYDESCDLWSLGVILYTMLSGQVPF 209

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 88/189 (46%), Gaps = 12/189 (6%)
Query: 182 LCIVTEFMARGSIYDFLH-KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240
           L IV E +  G ++  +  +    F      ++   + + + YLH  NI HRD+K  NLL
Sbjct: 95  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 154
Query: 241 MDE---NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 297
                 N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G+ +
Sbjct: 155 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 214
Query: 298 WELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE-------LLERCWQHDPTQ 350
           + LL G  P+     L  + G ++  +R    +  +P  +E       L+    + +PTQ
Sbjct: 215 YILLCGYPPFYSNHGLAISPG-MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 273
Query: 351 RPNFSQITD 359
           R   ++  +
Sbjct: 274 RMTITEFMN 282

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 88/189 (46%), Gaps = 12/189 (6%)
Query: 182 LCIVTEFMARGSIYDFLH-KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240
           L IV E +  G ++  +  +    F      ++   + + + YLH  NI HRD+K  NLL
Sbjct: 89  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 148
Query: 241 MDE---NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 297
                 N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G+ +
Sbjct: 149 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 208
Query: 298 WELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE-------LLERCWQHDPTQ 350
           + LL G  P+     L  + G ++  +R    +  +P  +E       L+    + +PTQ
Sbjct: 209 YILLCGYPPFYSNHGLAISPG-MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 267
Query: 351 RPNFSQITD 359
           R   ++  +
Sbjct: 268 RMTITEFMN 276

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 122/284 (42%), Gaps = 29/284 (10%)
Query: 111 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 164
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 165 RH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 128
Query: 222 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 280
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 129 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 187
Query: 281 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
            H+ +   A V+S GI L++++ G++P+     +       Q   R  +          L
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSECQ----HL 239
Query: 340 LERCWQHDPTQRPNFSQITD-------ILKQMMKEV-LYWLSPN 375
           +  C    P+ RP F +I +       +L Q   E+ L+ LSP 
Sbjct: 240 IRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPG 283

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 88/189 (46%), Gaps = 12/189 (6%)
Query: 182 LCIVTEFMARGSIYDFLH-KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240
           L IV E +  G ++  +  +    F      ++   + + + YLH  NI HRD+K  NLL
Sbjct: 94  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 153
Query: 241 MDE---NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 297
                 N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G+ +
Sbjct: 154 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 213
Query: 298 WELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE-------LLERCWQHDPTQ 350
           + LL G  P+     L  + G ++  +R    +  +P  +E       L+    + +PTQ
Sbjct: 214 YILLCGYPPFYSNHGLAISPG-MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 272
Query: 351 RPNFSQITD 359
           R   ++  +
Sbjct: 273 RMTITEFMN 281

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/270 (23%), Positives = 117/270 (43%), Gaps = 23/270 (8%)
Query: 111 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 164
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 165 RH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 123
Query: 222 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 280
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 124 RHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 182
Query: 281 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
            H+ +   A V+S GI L++++ G++P+     +       Q   R  +          L
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSXECQ----HL 234
Query: 340 LERCWQHDPTQRPNFSQITDILKQMMKEVL 369
           +  C    P+ RP F +I +     M++VL
Sbjct: 235 IRWCLALRPSDRPTFEEIQN--HPWMQDVL 262

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 122/284 (42%), Gaps = 29/284 (10%)
Query: 111 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 164
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 165 RH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 162
Query: 222 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 280
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 163 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 221
Query: 281 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
            H+ +   A V+S GI L++++ G++P+     +       Q   R  +          L
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSECQ----HL 273
Query: 340 LERCWQHDPTQRPNFSQITD-------ILKQMMKEV-LYWLSPN 375
           +  C    P+ RP F +I +       +L Q   E+ L+ LSP 
Sbjct: 274 IRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPG 317

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 122/284 (42%), Gaps = 29/284 (10%)
Query: 111 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 164
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 165 RH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 155
Query: 222 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 280
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 156 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 214
Query: 281 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
            H+ +   A V+S GI L++++ G++P+         +   Q   R  +          L
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSSECQ----HL 266
Query: 340 LERCWQHDPTQRPNFSQITD-------ILKQMMKEV-LYWLSPN 375
           +  C    P+ RP F +I +       +L Q   E+ L+ LSP 
Sbjct: 267 IRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPG 310

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 122/284 (42%), Gaps = 29/284 (10%)
Query: 111 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 164
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 165 RH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 128
Query: 222 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 280
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 129 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 187
Query: 281 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
            H+ +   A V+S GI L++++ G++P+     +       Q   R  +          L
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSECQ----HL 239
Query: 340 LERCWQHDPTQRPNFSQITD-------ILKQMMKEV-LYWLSPN 375
           +  C    P+ RP F +I +       +L Q   E+ L+ LSP 
Sbjct: 240 IRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPG 283

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 88/189 (46%), Gaps = 12/189 (6%)
Query: 182 LCIVTEFMARGSIYDFLH-KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240
           L IV E +  G ++  +  +    F      ++   + + + YLH  NI HRD+K  NLL
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 149
Query: 241 MDE---NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 297
                 N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G+ +
Sbjct: 150 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 209
Query: 298 WELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE-------LLERCWQHDPTQ 350
           + LL G  P+     L  + G ++  +R    +  +P  +E       L+    + +PTQ
Sbjct: 210 YILLCGYPPFYSNHGLAISPG-MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 268
Query: 351 RPNFSQITD 359
           R   ++  +
Sbjct: 269 RMTITEFMN 277

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 122/284 (42%), Gaps = 29/284 (10%)
Query: 111 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 164
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 165 RH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 143
Query: 222 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 280
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 144 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 202
Query: 281 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
            H+ +   A V+S GI L++++ G++P+     +       Q   R  +          L
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSECQ----HL 254
Query: 340 LERCWQHDPTQRPNFSQITD-------ILKQMMKEV-LYWLSPN 375
           +  C    P+ RP F +I +       +L Q   E+ L+ LSP 
Sbjct: 255 IRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPG 298

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 88/189 (46%), Gaps = 12/189 (6%)
Query: 182 LCIVTEFMARGSIYDFLH-KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240
           L IV E +  G ++  +  +    F      ++   + + + YLH  NI HRD+K  NLL
Sbjct: 96  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 155
Query: 241 MDE---NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 297
                 N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G+ +
Sbjct: 156 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 215
Query: 298 WELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE-------LLERCWQHDPTQ 350
           + LL G  P+     L  + G ++  +R    +  +P  +E       L+    + +PTQ
Sbjct: 216 YILLCGYPPFYSNHGLAISPG-MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 274
Query: 351 RPNFSQITD 359
           R   ++  +
Sbjct: 275 RMTITEFMN 283

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 88/189 (46%), Gaps = 12/189 (6%)
Query: 182 LCIVTEFMARGSIYDFLH-KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240
           L IV E +  G ++  +  +    F      ++   + + + YLH  NI HRD+K  NLL
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 193
Query: 241 MDE---NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 297
                 N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G+ +
Sbjct: 194 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
Query: 298 WELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE-------LLERCWQHDPTQ 350
           + LL G  P+     L  + G ++  +R    +  +P  +E       L+    + +PTQ
Sbjct: 254 YILLCGYPPFYSNHGLAISPG-MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 312
Query: 351 RPNFSQITD 359
           R   ++  +
Sbjct: 313 RMTITEFMN 321

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 122/284 (42%), Gaps = 29/284 (10%)
Query: 111 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 164
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 32  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 91
Query: 165 RH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 92  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 150
Query: 222 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 280
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 151 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 209
Query: 281 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
            H+ +   A V+S GI L++++ G++P+     +       Q   R  +          L
Sbjct: 210 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSXECQ----HL 261
Query: 340 LERCWQHDPTQRPNFSQITD-------ILKQMMKEV-LYWLSPN 375
           +  C    P+ RP F +I +       +L Q   E+ L+ LSP 
Sbjct: 262 IRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPG 305

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 95/193 (49%), Gaps = 18/193 (9%)
Query: 133 SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARG 192
            +E A+K+++ +  ++   + F +   + +   +KN+++ I          +V E +  G
Sbjct: 38  GKEYAVKIIEKQAGHSRS-RVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGG 96
Query: 193 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN---GVVKV 249
           SI   + KQK  F      +V  DV+  +++LH   I HRDLK  N+L +       VK+
Sbjct: 97  SILAHIQKQKH-FNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKI 155
Query: 250 ADF----GVARVQAQSGVMTAE----TGTYRWMAPEVIE-----HKPYDYKADVFSFGIA 296
            DF    G+    + + + T E     G+  +MAPEV+E        YD + D++S G+ 
Sbjct: 156 CDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVV 215
Query: 297 LWELLTGELPYAG 309
           L+ +L+G  P+ G
Sbjct: 216 LYIMLSGYPPFVG 228

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G++G+  L +     +  A+K+L K E +       F +E  IM       VVQ   
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHK----QKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
           A      L +V E+M  G + + +      +K     T+ + +A+D       +H    I
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDA------IHSMGFI 190
Query: 231 HRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKP----Y 284
           HRD+K  N+L+D++G +K+ADFG      + G++  +T  GT  +++PEV++ +     Y
Sbjct: 191 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYY 250
Query: 285 DYKADVFSFGIALWELLTGELPY 307
             + D +S G+ L+E+L G+ P+
Sbjct: 251 GRECDWWSVGVFLYEMLVGDTPF 273

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 88/189 (46%), Gaps = 12/189 (6%)
Query: 182 LCIVTEFMARGSIYDFLH-KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240
           L IV E +  G ++  +  +    F      ++   + + + YLH  NI HRD+K  NLL
Sbjct: 140 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 199
Query: 241 MDE---NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 297
                 N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G+ +
Sbjct: 200 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 259
Query: 298 WELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE-------LLERCWQHDPTQ 350
           + LL G  P+     L  + G ++  +R    +  +P  +E       L+    + +PTQ
Sbjct: 260 YILLCGYPPFYSNHGLAISPG-MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 318
Query: 351 RPNFSQITD 359
           R   ++  +
Sbjct: 319 RMTITEFMN 327

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G++G+  L +     +  A+K+L K E +       F +E  IM       VVQ   
Sbjct: 82  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 141
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHK----QKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
           A      L +V E+M  G + + +      +K     T+ + +A+D       +H    I
Sbjct: 142 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDA------IHSMGFI 195
Query: 231 HRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKP----Y 284
           HRD+K  N+L+D++G +K+ADFG      + G++  +T  GT  +++PEV++ +     Y
Sbjct: 196 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYY 255
Query: 285 DYKADVFSFGIALWELLTGELPY 307
             + D +S G+ L+E+L G+ P+
Sbjct: 256 GRECDWWSVGVFLYEMLVGDTPF 278

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +  G++G+  L +     +  A+K+L K E +       F +E  IM       VVQ   
Sbjct: 82  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 141
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHK----QKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
           A      L +V E+M  G + + +      +K     T+ + +A+D       +H    I
Sbjct: 142 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDA------IHSMGFI 195
Query: 231 HRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKP----Y 284
           HRD+K  N+L+D++G +K+ADFG      + G++  +T  GT  +++PEV++ +     Y
Sbjct: 196 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYY 255
Query: 285 DYKADVFSFGIALWELLTGELPY 307
             + D +S G+ L+E+L G+ P+
Sbjct: 256 GRECDWWSVGVFLYEMLVGDTPF 278

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 122/284 (42%), Gaps = 29/284 (10%)
Query: 111 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 164
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 165 RH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 170
Query: 222 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 280
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 171 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 229
Query: 281 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
            H+ +   A V+S GI L++++ G++P+     +       Q   R  +          L
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSECQ----HL 281
Query: 340 LERCWQHDPTQRPNFSQITD-------ILKQMMKEV-LYWLSPN 375
           +  C    P+ RP F +I +       +L Q   E+ L+ LSP 
Sbjct: 282 IRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPG 325

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 88/189 (46%), Gaps = 12/189 (6%)
Query: 182 LCIVTEFMARGSIYDFLH-KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240
           L IV E +  G ++  +  +    F      ++   + + + YLH  NI HRD+K  NLL
Sbjct: 88  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 147
Query: 241 MDE---NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 297
                 N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G+ +
Sbjct: 148 YTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 207
Query: 298 WELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE-------LLERCWQHDPTQ 350
           + LL G  P+     L  + G ++  +R    +  +P  +E       L+    + +PTQ
Sbjct: 208 YILLCGYPPFYSNHGLAISPG-MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 266
Query: 351 RPNFSQITD 359
           R   ++  +
Sbjct: 267 RMTITEFMN 275

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 88/189 (46%), Gaps = 12/189 (6%)
Query: 182 LCIVTEFMARGSIYDFLH-KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240
           L IV E +  G ++  +  +    F      ++   + + + YLH  NI HRD+K  NLL
Sbjct: 104 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 163
Query: 241 MDE---NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 297
                 N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G+ +
Sbjct: 164 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 223
Query: 298 WELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE-------LLERCWQHDPTQ 350
           + LL G  P+     L  + G ++  +R    +  +P  +E       L+    + +PTQ
Sbjct: 224 YILLCGYPPFYSNHGLAISPG-MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 282
Query: 351 RPNFSQITD 359
           R   ++  +
Sbjct: 283 RMTITEFMN 291

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/271 (23%), Positives = 117/271 (43%), Gaps = 23/271 (8%)
Query: 110 KQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRK 163
            Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 164 IRH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
           +      V++ +    RP +  ++ E       ++DF+  ++G  Q          V + 
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEA 122
Query: 221 MNYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI 279
           + + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWI 181
Query: 280 E-HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE 338
             H+ +   A V+S GI L++++ G++P+     +       Q   R  +          
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSECQ----H 233
Query: 339 LLERCWQHDPTQRPNFSQITDILKQMMKEVL 369
           L+  C    P+ RP F +I +     M++VL
Sbjct: 234 LIRWCLALRPSDRPTFEEIQN--HPWMQDVL 262

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 122/284 (42%), Gaps = 29/284 (10%)
Query: 111 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 164
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 165 RH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 142
Query: 222 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 280
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 143 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 201
Query: 281 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
            H+ +   A V+S GI L++++ G++P+         +   Q   R  +          L
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSSECQ----HL 253
Query: 340 LERCWQHDPTQRPNFSQITD-------ILKQMMKEV-LYWLSPN 375
           +  C    P+ RP F +I +       +L Q   E+ L+ LSP 
Sbjct: 254 IRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPG 297

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 122/284 (42%), Gaps = 29/284 (10%)
Query: 111 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 164
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 165 RH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 143
Query: 222 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 280
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 144 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 202
Query: 281 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
            H+ +   A V+S GI L++++ G++P+     +       Q   R  +          L
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSXECQ----HL 254
Query: 340 LERCWQHDPTQRPNFSQITD-------ILKQMMKEV-LYWLSPN 375
           +  C    P+ RP F +I +       +L Q   E+ L+ LSP 
Sbjct: 255 IRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPG 298

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 122/284 (42%), Gaps = 29/284 (10%)
Query: 111 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 164
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 165 RH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 170
Query: 222 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 280
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 171 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 229
Query: 281 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
            H+ +   A V+S GI L++++ G++P+         +   Q   R  +          L
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSXECQ----HL 281
Query: 340 LERCWQHDPTQRPNFSQITD-------ILKQMMKEV-LYWLSPN 375
           +  C    P+ RP F +I +       +L Q   E+ L+ LSP 
Sbjct: 282 IRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPG 325

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 122/284 (42%), Gaps = 29/284 (10%)
Query: 111 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 164
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 165 RH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 142
Query: 222 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 280
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 143 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 201
Query: 281 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
            H+ +   A V+S GI L++++ G++P+     +       Q   R  +          L
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSXECQ----HL 253
Query: 340 LERCWQHDPTQRPNFSQITD-------ILKQMMKEV-LYWLSPN 375
           +  C    P+ RP F +I +       +L Q   E+ L+ LSP 
Sbjct: 254 IRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPG 297

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/270 (23%), Positives = 117/270 (43%), Gaps = 23/270 (8%)
Query: 111 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 164
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 8   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 67
Query: 165 RH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 68  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 126
Query: 222 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 280
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 127 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 185
Query: 281 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
            H+ +   A V+S GI L++++ G++P+     +       Q   R  +          L
Sbjct: 186 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSECQ----HL 237
Query: 340 LERCWQHDPTQRPNFSQITDILKQMMKEVL 369
           +  C    P+ RP F +I +     M++VL
Sbjct: 238 IRWCLALRPSDRPTFEEIQN--HPWMQDVL 265

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 122/284 (42%), Gaps = 29/284 (10%)
Query: 111 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 164
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 57  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 116
Query: 165 RH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 117 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 175
Query: 222 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 280
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 176 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 234
Query: 281 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
            H+ +   A V+S GI L++++ G++P+     +       Q   R  +          L
Sbjct: 235 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSXECQ----HL 286
Query: 340 LERCWQHDPTQRPNFSQITD-------ILKQMMKEV-LYWLSPN 375
           +  C    P+ RP F +I +       +L Q   E+ L+ LSP 
Sbjct: 287 IRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPG 330

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 96/199 (48%), Gaps = 15/199 (7%)
Query: 123 YGDLYKGTY---------CS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 172
           Y D+ KG +         C+  E A K++  + ++    ++  +E  I R ++H N+V+ 
Sbjct: 9   YEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRL 68
Query: 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 232
             + +      +V + +  G +++ +  ++  +           + + + + HQ  ++HR
Sbjct: 69  HDSISEEGFHYLVFDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCHQMGVVHR 127
Query: 233 DLKTANLLMD---ENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKA 288
           DLK  NLL+    +   VK+ADFG+A  VQ          GT  +++PEV+  + Y    
Sbjct: 128 DLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEAYGKPV 187
Query: 289 DVFSFGIALWELLTGELPY 307
           D+++ G+ L+ LL G  P+
Sbjct: 188 DIWACGVILYILLVGYPPF 206

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 85/189 (44%), Gaps = 12/189 (6%)
Query: 182 LCIVTEFMARGSIYDFLH-KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240
           L IV E +  G ++  +  +    F      ++   + + + YLH  NI HRD+K  NLL
Sbjct: 134 LLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSINIAHRDVKPENLL 193
Query: 241 MDE---NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 297
                 N ++K+ DFG A+       +T    T  ++APEV+  + YD   D +S G+  
Sbjct: 194 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDXWSLGVIX 253
Query: 298 WELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE-------LLERCWQHDPTQ 350
           + LL G  P+     L  + G  +  +R    +  +P  +E       L+    + +PTQ
Sbjct: 254 YILLCGYPPFYSNHGLAISPG-XKTRIRXGQYEFPNPEWSEVSEEVKXLIRNLLKTEPTQ 312
Query: 351 RPNFSQITD 359
           R   ++  +
Sbjct: 313 RXTITEFXN 321

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 121/284 (42%), Gaps = 29/284 (10%)
Query: 111 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 164
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 165 RH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 143
Query: 222 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 280
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 144 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 202
Query: 281 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
            H+ +   A V+S GI L++++ G++P+     +       Q   R  +          L
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSXECQ----HL 254
Query: 340 LERCWQHDPTQRPNFSQITD-------ILKQMMKEV-LYWLSPN 375
           +  C    P  RP F +I +       +L Q   E+ L+ LSP 
Sbjct: 255 IRWCLALRPXDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPG 298

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 110/242 (45%), Gaps = 48/242 (19%)
Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFI 173
           K+  G+YG ++K       + VA+K +     N+   +   +E+ I+ ++  H+N+V  +
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLL 75
Query: 174 GA--CTRPPNLCIVTEFMA-------RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
                    ++ +V ++M        R +I + +HKQ  V+QL  ++K          YL
Sbjct: 76  NVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIK----------YL 125
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVAR----------------------VQAQSG 262
           H   ++HRD+K +N+L++    VKVADFG++R                            
Sbjct: 126 HSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 263 VMTAETGTYRWMAPEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVG 318
           ++T    T  + APE+ +    Y    D++S G  L E+L G+  + G   +  L+  +G
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245
Query: 319 VV 320
           V+
Sbjct: 246 VI 247

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 95/198 (47%), Gaps = 17/198 (8%)
Query: 116 CKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
            K+  G+YG++YK   T  ++ VAIK ++ E     +     +EV ++++++H+N+++  
Sbjct: 40  TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELK 99
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
                   L ++ E+ A   +  ++ K   V  +  +      +  G+N+ H    +HRD
Sbjct: 100 SVIHHNHRLHLIFEY-AENDLKKYMDKNPDV-SMRVIKSFLYQLINGVNFCHSRRCLHRD 157
Query: 234 LKTANLLM-----DENGVVKVADFGVARVQAQSGV----MTAETGTYRWMAPEV-IEHKP 283
           LK  NLL+      E  V+K+ DFG+AR     G+     T E  T  +  PE+ +  + 
Sbjct: 158 LKPQNLLLSVSDASETPVLKIGDFGLARA---FGIPIRQFTHEIITLWYRPPEILLGSRH 214
Query: 284 YDYKADVFSFGIALWELL 301
           Y    D++S      E+L
Sbjct: 215 YSTSVDIWSIACIWAEML 232

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 98/199 (49%), Gaps = 15/199 (7%)
Query: 123 YGDLYKGTYCSQEVAIKVLKPE-----CVNTEML-----KEFSQEVYIMRKIRHKNVVQF 172
           + +L KG +      +KVL  +      +NT+ L     ++  +E  I R ++H N+V+ 
Sbjct: 16  FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRL 75
Query: 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 232
             + +   +  ++ + +  G +++ +  ++  +           + + + + HQ  ++HR
Sbjct: 76  HDSISEEGHHYLIFDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCHQMGVVHR 134
Query: 233 DLKTANLLMD---ENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKA 288
           +LK  NLL+    +   VK+ADFG+A  V+ +        GT  +++PEV+   PY    
Sbjct: 135 NLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPV 194
Query: 289 DVFSFGIALWELLTGELPY 307
           D+++ G+ L+ LL G  P+
Sbjct: 195 DLWACGVILYILLVGYPPF 213

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 117/276 (42%), Gaps = 23/276 (8%)
Query: 109 AKQLKIECKVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH 166
             + ++  K+ SGS+GD+Y GT     +EVAIK+   ECV T+   +   E  I + ++ 
Sbjct: 8   GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKH-PQLHIESKIYKMMQG 63
Query: 167 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 226
              +  I  C    +  ++   +   S+ D  +     F L ++L +A  +   + Y+H 
Sbjct: 64  GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 123
Query: 227 NNIIHRDLKTANLLM---DENGVVKVADFGVAR----VQAQSGVMTAE----TGTYRWMA 275
            N IHRD+K  N LM    +  +V + DFG+A+     +    +   E    TGT R+ +
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183
Query: 276 PEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL---TPLQAAVGVVQKSLRPTIP--- 329
                      + D+ S G  L     G LP+ GL   T  Q    + +K +   I    
Sbjct: 184 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 243
Query: 330 KHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
           K      A  L  C       +P++S +  + + + 
Sbjct: 244 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 117/276 (42%), Gaps = 23/276 (8%)
Query: 109 AKQLKIECKVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH 166
             + ++  K+ SGS+GD+Y GT     +EVAIK+   ECV T+   +   E  I + ++ 
Sbjct: 6   GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKH-PQLHIESKIYKMMQG 61
Query: 167 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 226
              +  I  C    +  ++   +   S+ D  +     F L ++L +A  +   + Y+H 
Sbjct: 62  GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 227 NNIIHRDLKTANLLM---DENGVVKVADFGVAR----VQAQSGVMTAE----TGTYRWMA 275
            N IHRD+K  N LM    +  +V + DFG+A+     +    +   E    TGT R+ +
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 276 PEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL---TPLQAAVGVVQKSLRPTIP--- 329
                      + D+ S G  L     G LP+ GL   T  Q    + +K +   I    
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241
Query: 330 KHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
           K      A  L  C       +P++S +  + + + 
Sbjct: 242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 116/244 (47%), Gaps = 30/244 (12%)
Query: 116 CKV-ASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
           CKV  +GS+G +++     S EVAIK    + +  +  K  ++E+ IMR ++H NVV   
Sbjct: 45  CKVIGNGSFGVVFQAKLVESDEVAIK----KVLQDKRFK--NRELQIMRIVKHPNVVDLK 98
Query: 174 ------GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI---DVSKGMNYL 224
                 G       L +V E++   ++Y        + Q   +L + +    + + + Y+
Sbjct: 99  AFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYI 157
Query: 225 HQNNIIHRDLKTANLLMD-ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI-EHK 282
           H   I HRD+K  NLL+D  +GV+K+ DFG A++        +   +  + APE+I    
Sbjct: 158 HSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRAPELIFGAT 217
Query: 283 PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ----------KSLRPTIPKHA 332
            Y    D++S G  + EL+ G+  + G + +   V +++          K++ P   +H 
Sbjct: 218 NYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHK 277
Query: 333 HPRL 336
            P++
Sbjct: 278 FPQI 281

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 88/200 (44%), Gaps = 17/200 (8%)
Query: 117 KVASGSYGDLY--KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +V  GS+G+++  K      + A+K ++ E    E       E+     +    +V   G
Sbjct: 81  RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYG 133
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           A    P + I  E +  GS+   + KQ G       L       +G+ YLH   I+H D+
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 192
Query: 235 KTANLLMDENGV-VKVADFGVARVQAQSG----VMTAE--TGTYRWMAPEVIEHKPYDYK 287
           K  N+L+  +G    + DFG A      G    ++T +   GT   MAPEV+  KP D K
Sbjct: 193 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK 252
Query: 288 ADVFSFGIALWELLTGELPY 307
            D++S    +  +L G  P+
Sbjct: 253 VDIWSSCCMMLHMLNGCHPW 272

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 88/200 (44%), Gaps = 17/200 (8%)
Query: 117 KVASGSYGDLY--KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           +V  GS+G+++  K      + A+K ++ E    E       E+     +    +V   G
Sbjct: 65  RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYG 117
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           A    P + I  E +  GS+   + KQ G       L       +G+ YLH   I+H D+
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 176
Query: 235 KTANLLMDENGV-VKVADFGVARVQAQSG----VMTAE--TGTYRWMAPEVIEHKPYDYK 287
           K  N+L+  +G    + DFG A      G    ++T +   GT   MAPEV+  KP D K
Sbjct: 177 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK 236
Query: 288 ADVFSFGIALWELLTGELPY 307
            D++S    +  +L G  P+
Sbjct: 237 VDIWSSCCMMLHMLNGCHPW 256

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 116/269 (43%), Gaps = 20/269 (7%)
Query: 117 KVASGSYGDLYK--GTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           ++  GS+G++++        + A+K ++ E    E       E+     +    +V   G
Sbjct: 81  RLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE-------ELMACAGLTSPRIVPLYG 133
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           A    P + I  E +  GS+   + K++G       L       +G+ YLH   I+H D+
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLV-KEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDV 192
Query: 235 KTANLLMDENGV-VKVADFGVARVQAQSG----VMTAE--TGTYRWMAPEVIEHKPYDYK 287
           K  N+L+  +G    + DFG A      G    ++T +   GT   MAPEV+  +  D K
Sbjct: 193 KADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAK 252
Query: 288 ADVFSFGIALWELLTGELPYAGL--TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 345
            DV+S    +  +L G  P+      PL   +      +R  IP    P  A+ ++   +
Sbjct: 253 VDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVR-EIPPSCAPLTAQAIQEGLR 311
Query: 346 HDPTQRPNFSQITDILKQMMKEVLYWLSP 374
            +P  R + +++   + + +++V    SP
Sbjct: 312 KEPIHRVSAAELGGKVNRALQQVGGLKSP 340

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/273 (23%), Positives = 117/273 (42%), Gaps = 28/273 (10%)
Query: 117 KVASGSYGDLYK------GTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           ++  GS+G++++      G  C    A+K ++ E    E       E+     +    +V
Sbjct: 100 RLGRGSFGEVHRMEDKQTGFQC----AVKKVRLEVFRAE-------ELMACAGLTSPRIV 148
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
              GA    P + I  E +  GS+   + K++G       L       +G+ YLH   I+
Sbjct: 149 PLYGAVREGPWVNIFMELLEGGSLGQLV-KEQGCLPEDRALYYLGQALEGLEYLHSRRIL 207
Query: 231 HRDLKTANLLMDENGV-VKVADFGVARVQAQSG----VMTAE--TGTYRWMAPEVIEHKP 283
           H D+K  N+L+  +G    + DFG A      G    ++T +   GT   MAPEV+  + 
Sbjct: 208 HGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRS 267
Query: 284 YDYKADVFSFGIALWELLTGELPYAGL--TPLQAAVGVVQKSLRPTIPKHAHPRLAELLE 341
            D K DV+S    +  +L G  P+      PL   +      +R  IP    P  A+ ++
Sbjct: 268 CDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVR-EIPPSCAPLTAQAIQ 326
Query: 342 RCWQHDPTQRPNFSQITDILKQMMKEVLYWLSP 374
              + +P  R + +++   + + +++V    SP
Sbjct: 327 EGLRKEPIHRVSAAELGGKVNRALQQVGGLKSP 359

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/258 (24%), Positives = 112/258 (43%), Gaps = 19/258 (7%)
Query: 67  KDQSCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYG-- 124
           +D S     P    P H+   + ++ N   +     DV      + +I   + +G+YG  
Sbjct: 12  EDGSAEPPGPVKAEPAHTAASV-AAKNLALLKARSFDVTFDVGDEYEIIETIGNGAYGVV 70
Query: 125 DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP----- 179
              +     Q+VAIK +          K   +E+ I++  +H N++  I    RP     
Sbjct: 71  SSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIA-IKDILRPTVPYG 129
Query: 180 --PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
              ++ +V + M    ++  +H  + +  L  +      + +G+ Y+H   +IHRDLK +
Sbjct: 130 EFKSVYVVLDLM-ESDLHQIIHSSQPL-TLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPS 187
Query: 238 NLLMDENGVVKVADFGVARVQAQSGV-----MTAETGTYRWMAPEV-IEHKPYDYKADVF 291
           NLL++EN  +K+ DFG+AR    S       MT    T  + APE+ +    Y    D++
Sbjct: 188 NLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLW 247
Query: 292 SFGIALWELLTGELPYAG 309
           S G    E+L     + G
Sbjct: 248 SVGCIFGEMLARRQLFPG 265

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 116/255 (45%), Gaps = 24/255 (9%)
Query: 118 VASGSYGDLYKGT--YCSQEVAIKVLKPE-----C-VNTEMLKEFSQEVYIMRKIRHKNV 169
           + SG++G ++       ++EV +K +K E     C +    L + + E+ I+ ++ H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 170 VQFIGACTRPPNLCIVTEFMARG-SIYDFLHKQKGVFQLTSLLKVAI--DVSKGMNYLHQ 226
           ++ +          +V E    G  ++ F+ +     +L   L   I   +   + YL  
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRL 148
Query: 227 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPY-D 285
            +IIHRD+K  N+++ E+  +K+ DFG A    +  +     GT  + APEV+   PY  
Sbjct: 149 KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRG 208
Query: 286 YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 345
            + +++S G+ L+ L+  E P+  L         V+ ++ P  P      L  L+    Q
Sbjct: 209 PELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIHP--PYLVSKELMSLVSGLLQ 260
Query: 346 HDPTQRPNFSQ-ITD 359
             P +R    + +TD
Sbjct: 261 PVPERRTTLEKLVTD 275

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/258 (24%), Positives = 112/258 (43%), Gaps = 19/258 (7%)
Query: 67  KDQSCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYG-- 124
           +D S     P    P H+   + ++ N   +     DV      + +I   + +G+YG  
Sbjct: 13  EDGSAEPPGPVKAEPAHTAASV-AAKNLALLKARSFDVTFDVGDEYEIIETIGNGAYGVV 71
Query: 125 DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP----- 179
              +     Q+VAIK +          K   +E+ I++  +H N++  I    RP     
Sbjct: 72  SSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIA-IKDILRPTVPYG 130
Query: 180 --PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
              ++ +V + M    ++  +H  + +  L  +      + +G+ Y+H   +IHRDLK +
Sbjct: 131 EFKSVYVVLDLM-ESDLHQIIHSSQPL-TLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPS 188
Query: 238 NLLMDENGVVKVADFGVARVQAQSGV-----MTAETGTYRWMAPEV-IEHKPYDYKADVF 291
           NLL++EN  +K+ DFG+AR    S       MT    T  + APE+ +    Y    D++
Sbjct: 189 NLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLW 248
Query: 292 SFGIALWELLTGELPYAG 309
           S G    E+L     + G
Sbjct: 249 SVGCIFGEMLARRQLFPG 266

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 19/218 (8%)
Query: 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH 166
           +   +++  +  G+YG +   T+    + VAIK ++P       L+   +E+ I++  +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-REIKILKHFKH 68
Query: 167 KNVVQFIGACTRPPNLCIVTE-FMARGSIYDFLHKQKGVFQLTS--LLKVAIDVSKGMNY 223
           +N++  I    RP +     E ++ +  +   LH+      L+   +        + +  
Sbjct: 69  ENIIT-IFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-----------MTAETGTYR 272
           LH +N+IHRDLK +NLL++ N  +KV DFG+AR+  +S             MT    T  
Sbjct: 128 LHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRW 187
Query: 273 WMAPEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 309
           + APEV +    Y    DV+S G  L EL      + G
Sbjct: 188 YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG 225

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 17/200 (8%)
Query: 117 KVASGSYGDLY--KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
           ++  GS+G+++  K      + A+K ++ E    E       E+     +    +V   G
Sbjct: 79  RLGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYG 131
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
           A    P + I  E +  GS+   + KQ G       L       +G+ YLH   I+H D+
Sbjct: 132 AVREGPWVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 190
Query: 235 KTANLLMDENGV-VKVADFGVARVQAQSG----VMTAE--TGTYRWMAPEVIEHKPYDYK 287
           K  N+L+  +G    + DFG A      G    ++T +   GT   MAPEV+  KP D K
Sbjct: 191 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK 250
Query: 288 ADVFSFGIALWELLTGELPY 307
            D++S    +  +L G  P+
Sbjct: 251 VDIWSSCCMMLHMLNGCHPW 270

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 19/218 (8%)
Query: 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH 166
           +   +++  +  G+YG +   T+    + VAIK ++P       L+   +E+ I++  +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-REIKILKHFKH 68
Query: 167 KNVVQFIGACTRPPNLCIVTE-FMARGSIYDFLHKQKGVFQLTS--LLKVAIDVSKGMNY 223
           +N++  I    RP +     E ++ +  +   LH+      L+   +        + +  
Sbjct: 69  ENIIT-IFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-----------MTAETGTYR 272
           LH +N+IHRDLK +NLL++ N  +KV DFG+AR+  +S             MT    T  
Sbjct: 128 LHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRW 187
Query: 273 WMAPEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 309
           + APEV +    Y    DV+S G  L EL      + G
Sbjct: 188 YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG 225

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 117/249 (46%), Gaps = 28/249 (11%)
Query: 95  IEIPTDGTD-VWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEML 151
           +  P  G D   E+     K+   + +GS+G +Y+   C   + VAIK    + +  +  
Sbjct: 7   VATPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIK----KVLQGKAF 59
Query: 152 KEFSQEVYIMRKIRHKNVVQF------IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 205
           K  ++E+ IMRK+ H N+V+        G       L +V +++   ++Y          
Sbjct: 60  K--NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ATVYRVARHYSRAK 116
Query: 206 QLTSLLKVAI---DVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVAR--VQA 259
           Q   ++ V +    + + + Y+H   I HRD+K  NLL+D +  V+K+ DFG A+  V+ 
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 260 QSGVMTAETGTYRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318
           +  V    +  YR  APE+I     Y    DV+S G  L ELL G+  + G + +   V 
Sbjct: 177 EPNVSXICSRYYR--APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234
Query: 319 VVQKSLRPT 327
           +++    PT
Sbjct: 235 IIKVLGTPT 243

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 106/233 (45%), Gaps = 32/233 (13%)
Query: 118 VASGSYGDL--YKGTYCSQEVAIKVLKPECVNTEMLKE-----FSQEVYIMRKIRHKNVV 170
           +  G++G++   K     +  A+K+L       EMLK      F +E  ++     K + 
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILN----KWEMLKRAETACFREERDVLVNGDSKWIT 137
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHK-------QKGVFQLTSLLKVAIDVSKGMNY 223
               A     NL +V ++   G +   L K       +   F L  ++ +AID       
Sbjct: 138 TLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMV-IAIDS------ 190
Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM--TAETGTYRWMAPEVIE- 280
           +HQ + +HRD+K  N+LMD NG +++ADFG      + G +  +   GT  +++PE+++ 
Sbjct: 191 VHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250
Query: 281 ----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP 329
                  Y  + D +S G+ ++E+L GE P+   + ++    ++    R   P
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 303

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 19/218 (8%)
Query: 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH 166
           +   +++  +  G+YG +   T+    + VAIK ++P       L+   +E+ I++  +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-REIKILKHFKH 68
Query: 167 KNVVQFIGACTRPPNLCIVTE-FMARGSIYDFLHKQKGVFQLTS--LLKVAIDVSKGMNY 223
           +N++  I    RP +     E ++ +  +   LH+      L+   +        + +  
Sbjct: 69  ENIIT-IFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TG---------TYRW 273
           LH +N+IHRDLK +NLL++ N  +KV DFG+AR+  +S    +E TG           RW
Sbjct: 128 LHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRW 187
Query: 274 M-APEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 309
             APEV +    Y    DV+S G  L EL      + G
Sbjct: 188 YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG 225

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 117/249 (46%), Gaps = 28/249 (11%)
Query: 95  IEIPTDGTD-VWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEML 151
           +  P  G D   E+     K+   + +GS+G +Y+   C   + VAIK    + +  +  
Sbjct: 7   VATPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRF 59
Query: 152 KEFSQEVYIMRKIRHKNVVQF------IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 205
           K  ++E+ IMRK+ H N+V+        G       L +V +++   ++Y          
Sbjct: 60  K--NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAK 116
Query: 206 QLTSLLKVAI---DVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVAR--VQA 259
           Q   ++ V +    + + + Y+H   I HRD+K  NLL+D +  V+K+ DFG A+  V+ 
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 260 QSGVMTAETGTYRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318
           +  V    +  YR  APE+I     Y    DV+S G  L ELL G+  + G + +   V 
Sbjct: 177 EPNVSXICSRYYR--APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234
Query: 319 VVQKSLRPT 327
           +++    PT
Sbjct: 235 IIKVLGTPT 243

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 117/249 (46%), Gaps = 28/249 (11%)
Query: 95  IEIPTDGTD-VWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEML 151
           +  P  G D   E+     K+   + +GS+G +Y+   C   + VAIK    + +  +  
Sbjct: 8   VATPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRF 60
Query: 152 KEFSQEVYIMRKIRHKNVVQF------IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 205
           K  ++E+ IMRK+ H N+V+        G       L +V +++   ++Y          
Sbjct: 61  K--NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAK 117
Query: 206 QLTSLLKVAI---DVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVAR--VQA 259
           Q   ++ V +    + + + Y+H   I HRD+K  NLL+D +  V+K+ DFG A+  V+ 
Sbjct: 118 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 177
Query: 260 QSGVMTAETGTYRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318
           +  V    +  YR  APE+I     Y    DV+S G  L ELL G+  + G + +   V 
Sbjct: 178 EPNVSXICSRYYR--APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 235
Query: 319 VVQKSLRPT 327
           +++    PT
Sbjct: 236 IIKVLGTPT 244

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 117/249 (46%), Gaps = 28/249 (11%)
Query: 95  IEIPTDGTD-VWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEML 151
           +  P  G D   E+     K+   + +GS+G +Y+   C   + VAIK    + +  +  
Sbjct: 26  VATPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRF 78
Query: 152 KEFSQEVYIMRKIRHKNVVQF------IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 205
           K  ++E+ IMRK+ H N+V+        G       L +V +++   ++Y          
Sbjct: 79  K--NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAK 135
Query: 206 QLTSLLKVAI---DVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVAR--VQA 259
           Q   ++ V +    + + + Y+H   I HRD+K  NLL+D +  V+K+ DFG A+  V+ 
Sbjct: 136 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 195
Query: 260 QSGVMTAETGTYRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318
           +  V    +  YR  APE+I     Y    DV+S G  L ELL G+  + G + +   V 
Sbjct: 196 EPNVSXICSRYYR--APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 253
Query: 319 VVQKSLRPT 327
           +++    PT
Sbjct: 254 IIKVLGTPT 262

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 117/249 (46%), Gaps = 28/249 (11%)
Query: 95  IEIPTDGTD-VWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEML 151
           +  P  G D   E+     K+   + +GS+G +Y+   C   + VAIK    + +  +  
Sbjct: 7   VATPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRF 59
Query: 152 KEFSQEVYIMRKIRHKNVVQF------IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 205
           K  ++E+ IMRK+ H N+V+        G       L +V +++   ++Y          
Sbjct: 60  K--NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAK 116
Query: 206 QLTSLLKVAI---DVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVAR--VQA 259
           Q   ++ V +    + + + Y+H   I HRD+K  NLL+D +  V+K+ DFG A+  V+ 
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 260 QSGVMTAETGTYRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318
           +  V    +  YR  APE+I     Y    DV+S G  L ELL G+  + G + +   V 
Sbjct: 177 EPNVSXICSRYYR--APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234
Query: 319 VVQKSLRPT 327
           +++    PT
Sbjct: 235 IIKVLGTPT 243

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 18/207 (8%)
Query: 116 CKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQ---- 171
           CKV  G+YG +YK      +        +   T +     +E+ ++R+++H NV+     
Sbjct: 27  CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKV 86
Query: 172 FIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-----DVSKGMNYLHQ 226
           F+    R   L           I  F    K   +   L +  +      +  G++YLH 
Sbjct: 87  FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 146
Query: 227 NNIIHRDLKTANLLM----DENGVVKVADFGVARVQAQSGVMTAETG----TYRWMAPE- 277
           N ++HRDLK AN+L+     E G VK+AD G AR+        A+      T+ + APE 
Sbjct: 147 NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPEL 206
Query: 278 VIEHKPYDYKADVFSFGIALWELLTGE 304
           ++  + Y    D+++ G    ELLT E
Sbjct: 207 LLGARHYTKAIDIWAIGCIFAELLTSE 233

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 117/249 (46%), Gaps = 28/249 (11%)
Query: 95  IEIPTDGTD-VWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEML 151
           +  P  G D   E+     K+   + +GS+G +Y+   C   + VAIK    + +  +  
Sbjct: 19  VATPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRF 71
Query: 152 KEFSQEVYIMRKIRHKNVVQF------IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 205
           K  ++E+ IMRK+ H N+V+        G       L +V +++   ++Y          
Sbjct: 72  K--NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAK 128
Query: 206 QLTSLLKVAI---DVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVAR--VQA 259
           Q   ++ V +    + + + Y+H   I HRD+K  NLL+D +  V+K+ DFG A+  V+ 
Sbjct: 129 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 188
Query: 260 QSGVMTAETGTYRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318
           +  V    +  YR  APE+I     Y    DV+S G  L ELL G+  + G + +   V 
Sbjct: 189 EPNVSXICSRYYR--APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 246
Query: 319 VVQKSLRPT 327
           +++    PT
Sbjct: 247 IIKVLGTPT 255

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 117/249 (46%), Gaps = 28/249 (11%)
Query: 95  IEIPTDGTD-VWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEML 151
           +  P  G D   E+     K+   + +GS+G +Y+   C   + VAIK    + +  +  
Sbjct: 15  VATPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRF 67
Query: 152 KEFSQEVYIMRKIRHKNVVQF------IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 205
           K  ++E+ IMRK+ H N+V+        G       L +V +++   ++Y          
Sbjct: 68  K--NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAK 124
Query: 206 QLTSLLKVAI---DVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVAR--VQA 259
           Q   ++ V +    + + + Y+H   I HRD+K  NLL+D +  V+K+ DFG A+  V+ 
Sbjct: 125 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 184
Query: 260 QSGVMTAETGTYRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318
           +  V    +  YR  APE+I     Y    DV+S G  L ELL G+  + G + +   V 
Sbjct: 185 EPNVSXICSRYYR--APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 242
Query: 319 VVQKSLRPT 327
           +++    PT
Sbjct: 243 IIKVLGTPT 251

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 117/249 (46%), Gaps = 28/249 (11%)
Query: 95  IEIPTDGTD-VWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEML 151
           +  P  G D   E+     K+   + +GS+G +Y+   C   + VAIK    + +  +  
Sbjct: 11  VATPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRF 63
Query: 152 KEFSQEVYIMRKIRHKNVVQF------IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 205
           K  ++E+ IMRK+ H N+V+        G       L +V +++   ++Y          
Sbjct: 64  K--NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAK 120
Query: 206 QLTSLLKVAI---DVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVAR--VQA 259
           Q   ++ V +    + + + Y+H   I HRD+K  NLL+D +  V+K+ DFG A+  V+ 
Sbjct: 121 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 180
Query: 260 QSGVMTAETGTYRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318
           +  V    +  YR  APE+I     Y    DV+S G  L ELL G+  + G + +   V 
Sbjct: 181 EPNVSXICSRYYR--APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 238
Query: 319 VVQKSLRPT 327
           +++    PT
Sbjct: 239 IIKVLGTPT 247

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 117/249 (46%), Gaps = 28/249 (11%)
Query: 95  IEIPTDGTD-VWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEML 151
           +  P  G D   E+     K+   + +GS+G +Y+   C   + VAIK    + +  +  
Sbjct: 19  VATPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRF 71
Query: 152 KEFSQEVYIMRKIRHKNVVQF------IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 205
           K  ++E+ IMRK+ H N+V+        G       L +V +++   ++Y          
Sbjct: 72  K--NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAK 128
Query: 206 QLTSLLKVAI---DVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVAR--VQA 259
           Q   ++ V +    + + + Y+H   I HRD+K  NLL+D +  V+K+ DFG A+  V+ 
Sbjct: 129 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 188
Query: 260 QSGVMTAETGTYRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318
           +  V    +  YR  APE+I     Y    DV+S G  L ELL G+  + G + +   V 
Sbjct: 189 EPNVSXICSRYYR--APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 246
Query: 319 VVQKSLRPT 327
           +++    PT
Sbjct: 247 IIKVLGTPT 255

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 119/249 (47%), Gaps = 28/249 (11%)
Query: 95  IEIPTDGTD-VWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEML 151
           +  P  G D   E+     K+   + +GS+G +Y+   C   + VAIK    + +  +  
Sbjct: 7   VATPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRF 59
Query: 152 KEFSQEVYIMRKIRHKNVVQ---FIGACTRPPN---LCIVTEFMARGSIYDFLHKQKGVF 205
           K  ++E+ IMRK+ H N+V+   F  +     +   L +V +++   ++Y          
Sbjct: 60  K--NRELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPE-TVYRVARHYSRAK 116
Query: 206 QLTSLLKVAI---DVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVAR--VQA 259
           Q   ++ V +    + + + Y+H   I HRD+K  NLL+D +  V+K+ DFG A+  V+ 
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 260 QSGVMTAETGTYRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318
           +  V    +  YR  APE+I     Y    DV+S G  L ELL G+  + G + +   V 
Sbjct: 177 EPNVSXICSRYYR--APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234
Query: 319 VVQKSLRPT 327
           +++    PT
Sbjct: 235 IIKVLGTPT 243
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	395
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-159
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-146
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-146
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-145
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-145
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-141
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-140
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-140
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-138
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-120
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-118
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-115
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-114
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-111
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-101
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-92
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	7e-89
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	7e-89
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-88
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-88
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-87
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-87
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-87
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-86
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-86
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	8e-86
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-85
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-85
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-85
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-84
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-84
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-84
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-83
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-83
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-82
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-82
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-82
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-82
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	9e-82
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-81
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-81
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-80
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	6e-80
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-79
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-79
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-79
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-79
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-78
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-78
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-78
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	7e-78
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	8e-78
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-77
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-77
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-77
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-77
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-77
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-77
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	5e-77
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	7e-77
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	7e-77
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	8e-77
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-76
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-76
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-76
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-76
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-74
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-69
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	7e-66
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-63
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-63
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-62
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-62
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-62
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-61
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	7e-61
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-59
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-59
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-59
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-59
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	6e-59
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-58
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-58
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-58
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-57
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-57
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-57
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-57
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-56
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-56
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-56
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-56
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	7e-55
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-54
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-54
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-54
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	4e-52
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-50
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-47
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	7e-47
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	9e-47
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	9e-47
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	9e-47
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-46
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-46
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-19
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	7e-46
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-45
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-45
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-45
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	7e-45
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-44
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	5e-44
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-43
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-43
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-41
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-41
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	9e-41
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-40
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	7e-39
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-38
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-38
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-38
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	9e-38
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-37
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	7e-37
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-36
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-36
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-36
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-36
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-36
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-36
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-36
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-36
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	8e-36
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-35
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-35
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-35
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-35
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-34
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-34
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-34
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-34
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-34
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-34
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	5e-34
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	7e-34
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	8e-34
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-33
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-33
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-33
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-33
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-33
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	6e-33
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-32
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-32
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-32
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-32
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	9e-32
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-31
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-31
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-31
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-31
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-31
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-31
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	6e-31
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-30
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-30
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-29
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-29
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	6e-29
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-28
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-28
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-28
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-28
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	7e-28
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	9e-28
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	9e-28
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-27
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-27
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-27
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-27
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-27
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-27
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-27
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-27
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-26
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-26
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-26
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-26
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-26
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-26
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-26
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-26
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	5e-26
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	6e-26
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	6e-26
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	6e-26
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	7e-26
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-25
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-25
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-25
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-25
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-25
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-25
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-25
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-25
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-25
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	6e-25
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	7e-25
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	9e-25
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-24
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-24
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-24
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-24
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	7e-24
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-23
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-23
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-22
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-22
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-22
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-21
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-21
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-20
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	9e-20
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-19
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	6e-19
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-18
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	8e-18
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	7e-17
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-15
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-15
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	5e-15
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-14
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-12
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	5e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	8e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-04

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  448 bits (1154), Expect = e-159
 Identities = 118/291 (40%), Positives = 185/291 (63%), Gaps = 5/291 (1%)

Query: 84  SKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKP 143
           S   I ++ N         D  +I    L I+ K+ +GS+G +++  +   +VA+K+L  
Sbjct: 11  SDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILME 70

Query: 144 ECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG 203
           +  + E + EF +EV IM+++RH N+V F+GA T+PPNL IVTE+++RGS+Y  LHK   
Sbjct: 71  QDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA 130

Query: 204 VFQLT--SLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGVARVQA 259
             QL     L +A DV+KGMNYLH  N  I+HR+LK+ NLL+D+   VKV DFG++R++A
Sbjct: 131 REQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190

Query: 260 QSGV-MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318
            + +   +  GT  WMAPEV+  +P + K+DV+SFG+ LWEL T + P+  L P Q    
Sbjct: 191 STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAA 250

Query: 319 VVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVL 369
           V  K  R  IP++ +P++A ++E CW ++P +RP+F+ I D+L+ ++K  +
Sbjct: 251 VGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  415 bits (1070), Expect = e-146
 Identities = 94/282 (33%), Positives = 161/282 (57%), Gaps = 12/282 (4%)

Query: 96  EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFS 155
               D  D WEI   Q+ +  ++ SGS+G +YKG +   +VA+K+L       + L+ F 
Sbjct: 10  HGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWH-GDVAVKMLNVTAPTPQQLQAFK 68

Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
            EV ++RK RH N++ F+G  T P  L IVT++    S+Y  LH  +  F++  L+ +A 
Sbjct: 69  NEVGVLRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIAR 127

Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ---SGVMTAETGTYR 272
             ++GM+YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A  +++   S      +G+  
Sbjct: 128 QTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187

Query: 273 WMAPEVI---EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR---- 325
           WMAPEVI   +  PY +++DV++FGI L+EL+TG+LPY+ +      + +V +       
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL 247

Query: 326 PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
             +  +   R+  L+  C +    +RP+F +I   ++++ +E
Sbjct: 248 SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARE 289

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  413 bits (1063), Expect = e-145
 Identities = 85/271 (31%), Positives = 147/271 (54%), Gaps = 12/271 (4%)

Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 164
             ID KQL    K+     G+L+KG +   ++ +KVLK    +T   ++F++E   +R  
Sbjct: 5   SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64

Query: 165 RHKNVVQFIGACTRPP--NLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGM 221
            H NV+  +GAC  PP  +  ++T +M  GS+Y+ LH+    V   +  +K A+D+++GM
Sbjct: 65  SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGM 124

Query: 222 NYLH--QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI 279
            +LH  +  I    L + ++++DE+   +++   V                  W+APE +
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF----QSPGRMYAPAWVAPEAL 180

Query: 280 EHKPYDY---KADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
           + KP D     AD++SF + LWEL+T E+P+A L+ ++  + V  + LRPTIP    P +
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHV 240

Query: 337 AELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           ++L++ C   DP +RP F  I  IL++M  +
Sbjct: 241 SKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  412 bits (1061), Expect = e-145
 Identities = 96/274 (35%), Positives = 151/274 (55%), Gaps = 16/274 (5%)

Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVN--TEMLKEFSQEVYIM 161
           + EID  +L +E  +  G +G +Y+  +   EVA+K  + +     ++ ++   QE  + 
Sbjct: 1   LLEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60

Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
             ++H N++   G C + PNLC+V EF   G +   L  ++       L+  A+ +++GM
Sbjct: 61  AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGM 118

Query: 222 NYLHQNN---IIHRDLKTANLLMDE--------NGVVKVADFGVARVQAQSGVMTAETGT 270
           NYLH      IIHRDLK++N+L+ +        N ++K+ DFG+AR   ++  M+A  G 
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGA 177

Query: 271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK 330
           Y WMAPEVI    +   +DV+S+G+ LWELLTGE+P+ G+  L  A GV    L   IP 
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPS 237

Query: 331 HAHPRLAELLERCWQHDPTQRPNFSQITDILKQM 364
                 A+L+E CW  DP  RP+F+ I D L  +
Sbjct: 238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  404 bits (1039), Expect = e-141
 Identities = 84/294 (28%), Positives = 148/294 (50%), Gaps = 19/294 (6%)

Query: 90  SSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTE 149
           S P      +     W+I  +QL+I   +  G +G +Y G +   EVAI+++  E  N +
Sbjct: 13  SFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWH-GEVAIRLIDIERDNED 71

Query: 150 MLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTS 209
            LK F +EV   R+ RH+NVV F+GAC  PP+L I+T      ++Y  +   K V  +  
Sbjct: 72  QLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNK 131

Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA------QSGV 263
             ++A ++ KGM YLH   I+H+DLK+ N+  D NG V + DFG+  +        +   
Sbjct: 132 TRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDK 190

Query: 264 MTAETGTYRWMAPEVI---------EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ 314
           +  + G    +APE+I         +  P+   +DVF+ G   +EL   E P+       
Sbjct: 191 LRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA 250

Query: 315 AAVGVVQKSLRPTIPKHAHPR-LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
             +  +   ++P + +    + ++++L  CW  +  +RP F+++ D+L+++ K 
Sbjct: 251 -IIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  400 bits (1029), Expect = e-140
 Identities = 87/285 (30%), Positives = 147/285 (51%), Gaps = 22/285 (7%)

Query: 98  PTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVN-----TEM 150
               + +  +   +++ E ++  G +G ++KG        VAIK L            E 
Sbjct: 7   EFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK 66

Query: 151 LKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSL 210
            +EF +EV+IM  + H N+V+  G    PP   +V EF+  G +Y  L  +    + +  
Sbjct: 67  FQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVK 124

Query: 211 LKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENG-----VVKVADFGVARVQAQSGV 263
           L++ +D++ G+ Y+   N  I+HRDL++ N+ +           KVADFG+++    S  
Sbjct: 125 LRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-- 182

Query: 264 MTAETGTYRWMAPEVI--EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAV--GV 319
           ++   G ++WMAPE I  E + Y  KAD +SF + L+ +LTGE P+   +  +      +
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242

Query: 320 VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQM 364
            ++ LRPTIP+   PRL  ++E CW  DP +RP+FS I   L ++
Sbjct: 243 REEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  400 bits (1029), Expect = e-140
 Identities = 80/280 (28%), Positives = 124/280 (44%), Gaps = 16/280 (5%)

Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 164
                  L     +  G +G   K T+      + + +    + E  + F +EV +MR +
Sbjct: 5   RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL 64

Query: 165 RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
            H NV++FIG   +   L  +TE++  G++   +      +  +  +  A D++ GM YL
Sbjct: 65  EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL 124

Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA---------------QSGVMTAETG 269
           H  NIIHRDL + N L+ EN  V VADFG+AR+                          G
Sbjct: 125 HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184

Query: 270 TYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV-VQKSLRPTI 328
              WMAPE+I  + YD K DVFSFGI L E++          P     G+ V+  L    
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYC 244

Query: 329 PKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV 368
           P +  P    +  RC   DP +RP+F ++   L+ +   +
Sbjct: 245 PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  395 bits (1016), Expect = e-138
 Identities = 93/272 (34%), Positives = 145/272 (53%), Gaps = 15/272 (5%)

Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
           +  ID K++++E  V  G++G + K  + +++VAIK ++ E       K F  E+  + +
Sbjct: 2   LHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSR 57

Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT--SLLKVAIDVSKGM 221
           + H N+V+  GAC  P  +C+V E+   GS+Y+ LH  + +   T    +   +  S+G+
Sbjct: 58  VNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115

Query: 222 NYLHQ---NNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQSGVMTAETGTYRWMAPE 277
            YLH      +IHRDLK  NLL+   G V+K+ DFG A        MT   G+  WMAPE
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPE 173

Query: 278 VIEHKPYDYKADVFSFGIALWELLTGELPYAGL-TPLQAAVGVVQKSLRPTIPKHAHPRL 336
           V E   Y  K DVFS+GI LWE++T   P+  +  P    +  V    RP + K+    +
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI 233

Query: 337 AELLERCWQHDPTQRPNFSQITDILKQMMKEV 368
             L+ RCW  DP+QRP+  +I  I+  +M+  
Sbjct: 234 ESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  351 bits (902), Expect = e-120
 Identities = 90/333 (27%), Positives = 147/333 (44%), Gaps = 50/333 (15%)

Query: 80  VPMHSKL--LIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVA 137
           +P    L  LIE S +          V    AKQ+++  ++  G YG+++ G +  ++VA
Sbjct: 5   IPPGESLRDLIEQSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVA 64

Query: 138 IKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP----PNLCIVTEFMARGS 193
           +KV           +E   E+Y    +RH+N++ FI A  +       L ++T++   GS
Sbjct: 65  VKVFFTTEEA-SWFRE--TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGS 121

Query: 194 IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH--------QNNIIHRDLKTANLLMDENG 245
           +YD+L          S+LK+A     G+ +LH        +  I HRDLK+ N+L+ +NG
Sbjct: 122 LYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG 179

Query: 246 VVKVADFGVARVQAQSG-----VMTAETGTYRWMAPEVIE------HKPYDYKADVFSFG 294
              +AD G+A                  GT R+M PEV++      H      AD++SFG
Sbjct: 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFG 239

Query: 295 IALWELLTG----------ELPYAGLTPLQAAVG-----VVQKSLRPTIPKH-----AHP 334
           + LWE+             +LPY  L P   +       V  K LRP+ P          
Sbjct: 240 LILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLR 299

Query: 335 RLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           ++ +L+  CW H+P  R    ++   L +M + 
Sbjct: 300 QMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  343 bits (882), Expect = e-118
 Identities = 75/299 (25%), Positives = 136/299 (45%), Gaps = 48/299 (16%)

Query: 109 AKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN 168
           A+ + +   V  G YG++++G++  + VA+K+           +E   E+Y    +RH+N
Sbjct: 7   ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEK-SWFRE--TELYNTVMLRHEN 63

Query: 169 VVQFIGACTR----PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
           ++ FI +          L ++T +   GS+YD+L          S L++ + ++ G+ +L
Sbjct: 64  ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHL 121

Query: 225 H--------QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM-----TAETGTY 271
           H        +  I HRDLK+ N+L+ +NG   +AD G+A + +QS            GT 
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181

Query: 272 RWMAPEVIEHKP------YDYKADVFSFGIALWELLTG----------ELPYAGLTPLQA 315
           R+MAPEV++            + D+++FG+ LWE+             + P+  + P   
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 241

Query: 316 AV-----GVVQKSLRPTIPKH-----AHPRLAELLERCWQHDPTQRPNFSQITDILKQM 364
           +       V     RP IP           LA+L++ CW  +P+ R    +I   L ++
Sbjct: 242 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  335 bits (862), Expect = e-114
 Identities = 77/307 (25%), Positives = 144/307 (46%), Gaps = 48/307 (15%)

Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
           V    A+ + ++  +  G +G++++G +  +EVA+K+           +E   E+Y    
Sbjct: 36  VQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER-SWFRE--AEIYQTVM 92

Query: 164 IRHKNVVQFIGACTR----PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           +RH+N++ FI A  +       L +V+++   GS++D+L++      +  ++K+A+  + 
Sbjct: 93  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTAS 150

Query: 220 GMNYLHQN--------NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-----VMTA 266
           G+ +LH           I HRDLK+ N+L+ +NG   +AD G+A     +          
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210

Query: 267 ETGTYRWMAPEVIE------HKPYDYKADVFSFGIALWELLTG----------ELPYAGL 310
             GT R+MAPEV++      H     +AD+++ G+  WE+             +LPY  L
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270

Query: 311 TPLQAAVG-----VVQKSLRPTIPKH-----AHPRLAELLERCWQHDPTQRPNFSQITDI 360
            P   +V      V ++ LRP IP       A   +A+++  CW  +   R    +I   
Sbjct: 271 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330

Query: 361 LKQMMKE 367
           L Q+ ++
Sbjct: 331 LSQLSQQ 337

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  327 bits (839), Expect = e-111
 Identities = 83/309 (26%), Positives = 143/309 (46%), Gaps = 48/309 (15%)

Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
           GT+     +  L++    A G +G ++K    ++ VA+K+   +    +   +   EVY 
Sbjct: 15  GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD---KQSWQNEYEVYS 71

Query: 161 MRKIRHKNVVQFIGACTRPPN----LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 216
           +  ++H+N++QFIGA  R  +    L ++T F  +GS+ DFL     V     L  +A  
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAET 129

Query: 217 VSKGMNYLHQN----------NIIHRDLKTANLLMDENGVVKVADFGVARVQ---AQSGV 263
           +++G+ YLH++           I HRD+K+ N+L+  N    +ADFG+A        +G 
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189

Query: 264 MTAETGTYRWMAPEVIEH-----KPYDYKADVFSFGIALWELLTGELPYAG-----LTPL 313
              + GT R+MAPEV+E      +    + D+++ G+ LWEL +      G     + P 
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249

Query: 314 QAAVG-----------VVQKSLRPTIPKHAHP-----RLAELLERCWQHDPTQRPNFSQI 357
           +  +G           VV K  RP +  +         L E +E CW HD   R +   +
Sbjct: 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCV 309

Query: 358 TDILKQMMK 366
            + + QM +
Sbjct: 310 GERITQMQR 318

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  303 bits (777), Expect = e-101
 Identities = 75/318 (23%), Positives = 127/318 (39%), Gaps = 59/318 (18%)

Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 164
             +D   LK+   +  G YG +YKG+   + VA+KV          + E  + +Y +  +
Sbjct: 8   PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQ-NFINE--KNIYRVPLM 64

Query: 165 RHKNVVQFIGACTRPP-----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
            H N+ +FI    R          +V E+   GS+  +L          S  ++A  V++
Sbjct: 65  EHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTR 122

Query: 220 GMNYLH---------QNNIIHRDLKTANLLMDENGVVKVADFGVARVQA---------QS 261
           G+ YLH         +  I HRDL + N+L+  +G   ++DFG++             + 
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182

Query: 262 GVMTAETGTYRWMAPEVIE-------HKPYDYKADVFSFGIALWELL---TGELPYAGLT 311
               +E GT R+MAPEV+E        +    + D+++ G+  WE+    T   P   + 
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242

Query: 312 PLQAA---------------VGVVQKSLRPTIPKH------AHPRLAELLERCWQHDPTQ 350
             Q A               V V ++  RP  P+       A   L E +E CW  D   
Sbjct: 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEA 302

Query: 351 RPNFSQITDILKQMMKEV 368
           R       + + ++M   
Sbjct: 303 RLTAQXAEERMAELMMIW 320

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  281 bits (720), Expect = 3e-92
 Identities = 87/272 (31%), Positives = 143/272 (52%), Gaps = 10/272 (3%)

Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
           D W ++ + L +  ++  G++G+++ G     +  VA+K  +      ++  +F QE  I
Sbjct: 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARI 165

Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
           +++  H N+V+ IG CT+   + IV E +  G    FL  +    ++ +LL++  D + G
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAG 225

Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT----YRWMAP 276
           M YL     IHRDL   N L+ E  V+K++DFG++R     GV  A  G      +W AP
Sbjct: 226 MEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSRE-EADGVYAASGGLRQVPVKWTAP 284

Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E + +  Y  ++DV+SFGI LWE  + G  PY  L+  Q     V+K  R   P+     
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-TREFVEKGGRLPCPELCPDA 343

Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           +  L+E+CW ++P QRP+FS I   L+ + K 
Sbjct: 344 VFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  269 bits (689), Expect = 7e-89
 Identities = 91/274 (33%), Positives = 148/274 (54%), Gaps = 16/274 (5%)

Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 162
             W ++ K+LK+   +  G +GD+  G Y   +VA+K +K +       + F  E  +M 
Sbjct: 14  SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMT 69

Query: 163 KIRHKNVVQFIGACTR-PPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKG 220
           ++RH N+VQ +G        L IVTE+MA+GS+ D+L  +   V     LLK ++DV + 
Sbjct: 70  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 129

Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 277
           M YL  NN +HRDL   N+L+ E+ V KV+DFG+ +  +     + +       +W APE
Sbjct: 130 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPE 184

Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
            +  K +  K+DV+SFGI LWE+ + G +PY  +  L+  V  V+K  +   P    P +
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPRVEKGYKMDAPDGCPPAV 243

Query: 337 AELLERCWQHDPTQRPNFSQITDILKQMMKEVLY 370
            E+++ CW  D   RP+F Q+ + L+ +    L+
Sbjct: 244 YEVMKNCWHLDAAMRPSFLQLREQLEHIKTHELH 277

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  268 bits (688), Expect = 7e-89
 Identities = 91/270 (33%), Positives = 150/270 (55%), Gaps = 10/270 (3%)

Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
           W ID  +L    ++ SG +G ++ G + ++ +VAIK ++   ++ E   +F +E  +M K
Sbjct: 3   WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMK 59

Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 223
           + H  +VQ  G C     +C+VTEFM  G + D+L  Q+G+F   +LL + +DV +GM Y
Sbjct: 60  LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 119

Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVIE 280
           L +  +IHRDL   N L+ EN V+KV+DFG+ R        T+ TGT    +W +PEV  
Sbjct: 120 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFS 178

Query: 281 HKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
              Y  K+DV+SFG+ +WE+ + G++PY   +     V  +    R   P+ A   + ++
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-NSEVVEDISTGFRLYKPRLASTHVYQI 237

Query: 340 LERCWQHDPTQRPNFSQITDILKQMMKEVL 369
           +  CW+  P  RP FS++   L ++ +  L
Sbjct: 238 MNHCWRERPEDRPAFSRLLRQLAEIAESGL 267

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  268 bits (688), Expect = 1e-88
 Identities = 84/270 (31%), Positives = 145/270 (53%), Gaps = 10/270 (3%)

Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 161
             WEID K L    ++ +G +G +  G +  Q +VAIK++K   ++ +   EF +E  +M
Sbjct: 17  GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVM 73

Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
             + H+ +VQ  G CT+   + I+TE+MA G + ++L + +  FQ   LL++  DV + M
Sbjct: 74  MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAM 133

Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEV 278
            YL     +HRDL   N L+++ GVVKV+DFG++R        T+  G+    RW  PEV
Sbjct: 134 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEV 192

Query: 279 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 337
           + +  +  K+D+++FG+ +WE+ + G++PY   T        + + LR   P  A  ++ 
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-NSETAEHIAQGLRLYRPHLASEKVY 251

Query: 338 ELLERCWQHDPTQRPNFSQITDILKQMMKE 367
            ++  CW     +RP F  +   +  +M E
Sbjct: 252 TIMYSCWHEKADERPTFKILLSNILDVMDE 281

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  274 bits (702), Expect = 1e-88
 Identities = 92/300 (30%), Positives = 150/300 (50%), Gaps = 16/300 (5%)

Query: 77  ALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEV 136
           A G+                        W ++ K+LK+   +  G +GD+  G Y   +V
Sbjct: 160 ADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKV 219

Query: 137 AIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-PPNLCIVTEFMARGSIY 195
           A+K +K +       + F  E  +M ++RH N+VQ +G        L IVTE+MA+GS+ 
Sbjct: 220 AVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 275

Query: 196 DFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 254
           D+L  +   V     LLK ++DV + M YL  NN +HRDL   N+L+ E+ V KV+DFG+
Sbjct: 276 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 335

Query: 255 ARVQAQSGVMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGL 310
            +  +     + +       +W APE +  K +  K+DV+SFGI LWE+ + G +PY  +
Sbjct: 336 TKEAS-----STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 390

Query: 311 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLY 370
             L+  V  V+K  +   P    P + ++++ CW  D   RP F Q+ + L+ +    L+
Sbjct: 391 P-LKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHELH 449

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  265 bits (680), Expect = 1e-87
 Identities = 81/271 (29%), Positives = 145/271 (53%), Gaps = 10/271 (3%)

Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
            E+  +++ +  ++ SG +G +  G +  Q +VA+K++K   ++ +   EF QE   M K
Sbjct: 3   MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMK 59

Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 223
           + H  +V+F G C++   + IVTE+++ G + ++L       + + LL++  DV +GM +
Sbjct: 60  LSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAF 119

Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVIE 280
           L  +  IHRDL   N L+D +  VKV+DFG+ R         +  GT    +W APEV  
Sbjct: 120 LESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY-VLDDQYVSSVGTKFPVKWSAPEVFH 178

Query: 281 HKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
           +  Y  K+DV++FGI +WE+ + G++PY   T     V  V +  R   P  A   + ++
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT-NSEVVLKVSQGHRLYRPHLASDTIYQI 237

Query: 340 LERCWQHDPTQRPNFSQITDILKQMMKEVLY 370
           +  CW   P +RP F Q+   ++ + ++  +
Sbjct: 238 MYSCWHELPEKRPTFQQLLSSIEPLREKDKH 268

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  272 bits (697), Expect = 3e-87
 Identities = 99/284 (34%), Positives = 160/284 (56%), Gaps = 12/284 (4%)

Query: 91  SPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT 148
           +   I   +   D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK    +T
Sbjct: 201 NKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DT 257

Query: 149 EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQL 207
             ++EF +E  +M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L +        
Sbjct: 258 MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA 317

Query: 208 TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE 267
             LL +A  +S  M YL + N IHR+L   N L+ EN +VKVADFG++R+       TA 
Sbjct: 318 VVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAH 376

Query: 268 TGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKS 323
            G     +W APE + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K 
Sbjct: 377 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKD 435

Query: 324 LRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
            R   P+    ++ EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 436 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  264 bits (678), Expect = 4e-87
 Identities = 83/279 (29%), Positives = 142/279 (50%), Gaps = 12/279 (4%)

Query: 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNT-EMLKEFS 155
           +    I  K L++  K+  GS+G + +G + +       VA+K LKP+ ++  E + +F 
Sbjct: 10  SLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI 69

Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           +EV  M  + H+N+++  G    PP + +VTE    GS+ D L K +G F L +L + A+
Sbjct: 70  REVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV 128

Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGT---Y 271
            V++GM YL     IHRDL   NLL+    +VK+ DFG+ R +         +      +
Sbjct: 129 QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 188

Query: 272 RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPK 330
            W APE ++ + + + +D + FG+ LWE+ T G+ P+ GL   Q    + ++  R   P+
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE 248

Query: 331 HAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVL 369
                +  ++ +CW H P  RP F  + D L +     +
Sbjct: 249 DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM 287

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  263 bits (675), Expect = 1e-86
 Identities = 98/273 (35%), Positives = 155/273 (56%), Gaps = 12/273 (4%)

Query: 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE--VAIKVLKPECVNTEMLKEFSQEVY 159
            D WE++   + ++ K+  G YG++Y+G +      VA+K LK + +  E   EF +E  
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAA 61

Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVS 218
           +M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L +          LL +A  +S
Sbjct: 62  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 121

Query: 219 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMA 275
             M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA  G     +W A
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTA 180

Query: 276 PEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP 334
           PE + +  +  K+DV++FG+ LWE+ T G  PY G+   Q    +++K  R   P+    
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKDYRMERPEGCPE 239

Query: 335 RLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           ++ EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 240 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  262 bits (671), Expect = 4e-86
 Identities = 75/275 (27%), Positives = 136/275 (49%), Gaps = 11/275 (4%)

Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFS 155
           G   + I  + + +   +  G +G++Y+G Y + +     VA+K  K +C      ++F 
Sbjct: 3   GGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK-EKFM 61

Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
            E  IM+ + H ++V+ IG     P   I+ E    G +  +L + K   ++ +L+  ++
Sbjct: 62  SEAVIMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 120

Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RW 273
            + K M YL   N +HRD+   N+L+     VK+ DFG++R         A       +W
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKW 180

Query: 274 MAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHA 332
           M+PE I  + +   +DV+ F + +WE+L+ G+ P+  L      +GV++K  R   P   
Sbjct: 181 MSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-VIGVLEKGDRLPKPDLC 239

Query: 333 HPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
            P L  L+ RCW +DP+ RP F+++   L  + + 
Sbjct: 240 PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  261 bits (669), Expect = 8e-86
 Identities = 85/275 (30%), Positives = 144/275 (52%), Gaps = 11/275 (4%)

Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFS 155
            T  +EI  +++++   +  G +GD+++G Y S E     VAIK  K    +  + ++F 
Sbjct: 6   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFL 64

Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           QE   MR+  H ++V+ IG  T  P + I+ E    G +  FL  +K    L SL+  A 
Sbjct: 65  QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 123

Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RW 273
            +S  + YL     +HRD+   N+L+  N  VK+ DFG++R    S    A  G    +W
Sbjct: 124 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 183

Query: 274 MAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHA 332
           MAPE I  + +   +DV+ FG+ +WE+L  G  P+ G+      +G ++   R  +P + 
Sbjct: 184 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-NNDVIGRIENGERLPMPPNC 242

Query: 333 HPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
            P L  L+ +CW +DP++RP F+++   L  +++E
Sbjct: 243 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  261 bits (669), Expect = 2e-85
 Identities = 93/274 (33%), Positives = 137/274 (50%), Gaps = 12/274 (4%)

Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQE 157
              EI+A ++ IE  + SG  G++  G           VAIK LK      +  ++F  E
Sbjct: 42  FTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ-RRDFLSE 100

Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 217
             IM +  H N+++  G  TR     IVTE+M  GS+  FL    G F +  L+ +   V
Sbjct: 101 ASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGV 160

Query: 218 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGT---YRW 273
             GM YL     +HRDL   N+L+D N V KV+DFG++R ++         TG     RW
Sbjct: 161 GAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRW 220

Query: 274 MAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHA 332
            APE I  + +   +DV+SFG+ +WE+L  GE PY  +T  +  +  V++  R   P   
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT-NRDVISSVEEGYRLPAPMGC 279

Query: 333 HPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
              L +L+  CW  D  QRP FSQI  +L  +++
Sbjct: 280 PHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  259 bits (664), Expect = 4e-85
 Identities = 86/271 (31%), Positives = 150/271 (55%), Gaps = 12/271 (4%)

Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 161
           D WE+  + LK+  ++ +G +G+++ G Y    +VA+K LK   ++ +    F  E  +M
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLM 62

Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKG 220
           ++++H+ +V+     T+ P + I+TE+M  GS+ DFL    G    +  LL +A  +++G
Sbjct: 63  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121

Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 277
           M ++ + N IHRDL+ AN+L+ +    K+ADFG+AR+  +    TA  G     +W APE
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPE 180

Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
            I +  +  K+DV+SFGI L E++T G +PY G+T     +  +++  R   P +    L
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-NPEVIQNLERGYRMVRPDNCPEEL 239

Query: 337 AELLERCWQHDPTQRPNFSQITDILKQMMKE 367
            +L+  CW+  P  RP F  +  +L+     
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  261 bits (669), Expect = 4e-85
 Identities = 85/307 (27%), Positives = 145/307 (47%), Gaps = 17/307 (5%)

Query: 73  KRQPALGVPMHSKLLIESSPNCIEIPTDGT--DVWEIDAKQLKIECKVASGSYGDLYKGT 130
                  +P    L           P         EI    +  +  + +G +G++YKG 
Sbjct: 7   HHHHDYDIPTTENLYF--QGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGM 64

Query: 131 Y------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184
                      VAIK LK      +   +F  E  IM +  H N+++  G  ++   + I
Sbjct: 65  LKTSSGKKEVPVAIKTLKAGYTEKQR-VDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123

Query: 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 244
           +TE+M  G++  FL ++ G F +  L+ +   ++ GM YL   N +HRDL   N+L++ N
Sbjct: 124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN 183

Query: 245 GVVKVADFGVAR-VQAQSGVMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWEL 300
            V KV+DFG++R ++         +G     RW APE I ++ +   +DV+SFGI +WE+
Sbjct: 184 LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEV 243

Query: 301 LT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD 359
           +T GE PY  L+     +  +    R   P      + +L+ +CWQ +  +RP F+ I  
Sbjct: 244 MTYGERPYWELS-NHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 302

Query: 360 ILKQMMK 366
           IL ++++
Sbjct: 303 ILDKLIR 309

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  259 bits (664), Expect = 2e-84
 Identities = 71/273 (26%), Positives = 137/273 (50%), Gaps = 13/273 (4%)

Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEV 158
                 +L+    + SG +G ++KG +  +       V IKV++ +    +  +  +  +
Sbjct: 8   RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHM 66

Query: 159 YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS 218
             +  + H ++V+ +G C     L +VT+++  GS+ D + + +G      LL   + ++
Sbjct: 67  LAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 125

Query: 219 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMA 275
           KGM YL ++ ++HR+L   N+L+     V+VADFGVA +          +      +WMA
Sbjct: 126 KGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 185

Query: 276 PEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP 334
            E I    Y +++DV+S+G+ +WEL+T G  PYAGL   +    +++K  R   P+    
Sbjct: 186 LESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-VPDLLEKGERLAQPQICTI 244

Query: 335 RLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
            +  ++ +CW  D   RP F ++ +   +M ++
Sbjct: 245 DVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  258 bits (662), Expect = 3e-84
 Identities = 78/271 (28%), Positives = 137/271 (50%), Gaps = 13/271 (4%)

Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVYI 160
           +   + K    + SG++G +YKG +  +       VAIK L+         KE   E Y+
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYV 70

Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
           M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++KG
Sbjct: 71  MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129

Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAPE 277
           MNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA E
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189

Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
            I H+ Y +++DV+S+G+ +WEL+T G  PY G+   +    +++K  R   P      +
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDV 248

Query: 337 AELLERCWQHDPTQRPNFSQITDILKQMMKE 367
             ++ +CW  D   RP F ++     +M ++
Sbjct: 249 YMIMRKCWMIDADSRPKFRELIIEFSKMARD 279

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  257 bits (659), Expect = 4e-84
 Identities = 77/276 (27%), Positives = 139/276 (50%), Gaps = 13/276 (4%)

Query: 103 DVWEIDAKQLKIECKV-ASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQE 157
               +D K L +E K   SG++G + KG Y      + VA+K+LK E  +  +  E   E
Sbjct: 9   KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAE 68

Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 217
             +M+++ +  +V+ IG C       +V E    G +  +L + +   +  +++++   V
Sbjct: 69  ANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQV 126

Query: 218 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGT---YRW 273
           S GM YL ++N +HRDL   N+L+      K++DFG+++ ++A      A+T      +W
Sbjct: 127 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 186

Query: 274 MAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHA 332
            APE I +  +  K+DV+SFG+ +WE  + G+ PY G+        +++K  R   P   
Sbjct: 187 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-GSEVTAMLEKGERMGCPAGC 245

Query: 333 HPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV 368
              + +L+  CW +D   RP F+ +   L+    +V
Sbjct: 246 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  258 bits (662), Expect = 1e-83
 Identities = 87/274 (31%), Positives = 138/274 (50%), Gaps = 12/274 (4%)

Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQE 157
              E+DA  + I+  V +G +G++  G           VAIK LK      +  ++F  E
Sbjct: 38  FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGE 96

Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 217
             IM +  H N+++  G  T+   + IVTE+M  GS+  FL K    F +  L+ +   +
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGI 156

Query: 218 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGT---YRW 273
           + GM YL     +HRDL   N+L++ N V KV+DFG+ R ++          G     RW
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRW 216

Query: 274 MAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHA 332
            +PE I ++ +   +DV+S+GI LWE+++ GE PY  ++  Q  +  V +  R   P   
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS-NQDVIKAVDEGYRLPPPMDC 275

Query: 333 HPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
              L +L+  CWQ D   RP F QI  IL ++++
Sbjct: 276 PAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  254 bits (651), Expect = 4e-83
 Identities = 72/276 (26%), Positives = 135/276 (48%), Gaps = 13/276 (4%)

Query: 103 DVWEIDAKQLKI-ECKVASGSYGDLYKGTYCSQ----EVAIKVLKPECVNTEMLKEFSQE 157
               +    L I + ++  G++G + +G Y  +    +VAIKVLK      +  +E  +E
Sbjct: 2   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT-EEMMRE 60

Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 217
             IM ++ +  +V+ IG C     L +V E    G ++ FL  ++    ++++ ++   V
Sbjct: 61  AQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 119

Query: 218 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGT---YRW 273
           S GM YL + N +HRDL   N+L+      K++DFG+++ + A     TA +      +W
Sbjct: 120 SMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 179

Query: 274 MAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHA 332
            APE I  + +  ++DV+S+G+ +WE L+ G+ PY  +      +  +++  R   P   
Sbjct: 180 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-GPEVMAFIEQGKRMECPPEC 238

Query: 333 HPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV 368
            P L  L+  CW +    RP+F  +   ++     +
Sbjct: 239 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  258 bits (661), Expect = 2e-82
 Identities = 93/271 (34%), Positives = 154/271 (56%), Gaps = 12/271 (4%)

Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           D WEI  + LK+E K+ +G +G+++  TY    +VA+K +KP    +  ++ F  E  +M
Sbjct: 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP---GSMSVEAFLAEANVM 237

Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKG 220
           + ++H  +V+     T+ P + I+TEFMA+GS+ DFL   +G    L  L+  +  +++G
Sbjct: 238 KTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 296

Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 277
           M ++ Q N IHRDL+ AN+L+  + V K+ADFG+ARV  +    TA  G     +W APE
Sbjct: 297 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPE 355

Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
            I    +  K+DV+SFGI L E++T G +PY G++     +  +++  R   P++    L
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-NPEVIRALERGYRMPRPENCPEEL 414

Query: 337 AELLERCWQHDPTQRPNFSQITDILKQMMKE 367
             ++ RCW++ P +RP F  I  +L      
Sbjct: 415 YNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  252 bits (646), Expect = 3e-82
 Identities = 71/295 (24%), Positives = 131/295 (44%), Gaps = 31/295 (10%)

Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEF 154
           G+D  + + + LK   ++  G++G +    Y        + VA+K L+        L++F
Sbjct: 1   GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH--LRDF 58

Query: 155 SQEVYIMRKIRHKNVVQFIGACTRPPN--LCIVTEFMARGSIYDFLHKQKGVFQLTSLLK 212
            +E+ I++ ++H N+V++ G C       L ++ E++  GS+ D+L K K       LL+
Sbjct: 59  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118

Query: 213 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGT- 270
               + KGM YL     IHRDL T N+L++    VK+ DFG+ + +         +    
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178

Query: 271 --YRWMAPEVIEHKPYDYKADVFSFGIALWELLT----------------GELPYAGLTP 312
               W APE +    +   +DV+SFG+ L+EL T                G      +  
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238

Query: 313 LQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
               + +++ + R   P      +  ++  CW ++  QRP+F  +   + Q+   
Sbjct: 239 FH-LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  260 bits (666), Expect = 3e-82
 Identities = 99/271 (36%), Positives = 154/271 (56%), Gaps = 12/271 (4%)

Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 161
           D WEI  + L++E K+  G +G+++ GT+     VAIK LKP    T   + F QE  +M
Sbjct: 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP---GTMSPEAFLQEAQVM 316

Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKG 220
           +K+RH+ +VQ     +  P + IVTE+M++GS+ DFL  + G   +L  L+ +A  ++ G
Sbjct: 317 KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 375

Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 277
           M Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 376 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 434

Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
              +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVERGYRMPCPPECPESL 493

Query: 337 AELLERCWQHDPTQRPNFSQITDILKQMMKE 367
            +L+ +CW+ +P +RP F  +   L+     
Sbjct: 494 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  257 bits (658), Expect = 4e-82
 Identities = 99/271 (36%), Positives = 154/271 (56%), Gaps = 12/271 (4%)

Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 161
           D WEI  + L++E K+  G +G+++ GT+     VAIK LKP    T   + F QE  +M
Sbjct: 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP---GTMSPEAFLQEAQVM 233

Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKG 220
           +K+RH+ +VQ     +  P + IVTE+M++GS+ DFL  + G   +L  L+ +A  ++ G
Sbjct: 234 KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 292

Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 277
           M Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 293 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 351

Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
              +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVERGYRMPCPPECPESL 410

Query: 337 AELLERCWQHDPTQRPNFSQITDILKQMMKE 367
            +L+ +CW+ +P +RP F  +   L+     
Sbjct: 411 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  252 bits (646), Expect = 9e-82
 Identities = 68/291 (23%), Positives = 124/291 (42%), Gaps = 28/291 (9%)

Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQ 156
           D    + + LK   ++  G++G +    Y          VA+K L+      +  ++F +
Sbjct: 16  DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQR 73

Query: 157 EVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVA 214
           E+ I++ +    +V++ G    P   +L +V E++  G + DFL + +     + LL  +
Sbjct: 74  EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS 133

Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGT--- 270
             + KGM YL     +HRDL   N+L++    VK+ADFG+A+ +                
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193

Query: 271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTI- 328
             W APE +    +  ++DV+SFG+ L+EL T  +   +        +G  +     +  
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253

Query: 329 ------------PKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
                       P      + EL++ CW   P  RP+FS +   L  +   
Sbjct: 254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  252 bits (645), Expect = 1e-81
 Identities = 70/305 (22%), Positives = 133/305 (43%), Gaps = 31/305 (10%)

Query: 92  PNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPEC 145
              +    +  D  + + + LK   ++  G++G +    Y        + VA+K L+   
Sbjct: 23  QGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST 82

Query: 146 VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN--LCIVTEFMARGSIYDFLHKQKG 203
                L++F +E+ I++ ++H N+V++ G C       L ++ E++  GS+ D+L K K 
Sbjct: 83  EEH--LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE 140

Query: 204 VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSG 262
                 LL+    + KGM YL     IHRDL T N+L++    VK+ DFG+ + +     
Sbjct: 141 RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 200

Query: 263 VMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT----------------G 303
               +        W APE +    +   +DV+SFG+ L+EL T                G
Sbjct: 201 YYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 260

Query: 304 ELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQ 363
                 +      + +++ + R   P      +  ++  CW ++  QRP+F  +   + Q
Sbjct: 261 NDKQGQMIVFH-LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319

Query: 364 MMKEV 368
           +  ++
Sbjct: 320 IRDQM 324

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  261 bits (669), Expect = 2e-81
 Identities = 92/329 (27%), Positives = 159/329 (48%), Gaps = 15/329 (4%)

Query: 47  WPYDETEDLKNVLAKEILKSKDQSCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWE 106
            P  E E     + K     K    S          +++++ E       +P+     +E
Sbjct: 331 RPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTY--TMPST--RDYE 386

Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIM 161
           I  +++++   +  G +GD+++G Y S E     VAIK  K    +  + ++F QE   M
Sbjct: 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTM 445

Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
           R+  H ++V+ IG  T  P + I+ E    G +  FL  +K    L SL+  A  +S  +
Sbjct: 446 RQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTAL 504

Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVI 279
            YL     +HRD+   N+L+  N  VK+ DFG++R    S    A  G    +WMAPE I
Sbjct: 505 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 564

Query: 280 EHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE 338
             + +   +DV+ FG+ +WE+L  G  P+ G+      +G ++   R  +P +  P L  
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-VIGRIENGERLPMPPNCPPTLYS 623

Query: 339 LLERCWQHDPTQRPNFSQITDILKQMMKE 367
           L+ +CW +DP++RP F+++   L  +++E
Sbjct: 624 LMTKCWAYDPSRRPRFTELKAQLSTILEE 652

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  247 bits (634), Expect = 3e-80
 Identities = 76/296 (25%), Positives = 138/296 (46%), Gaps = 29/296 (9%)

Query: 98  PTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEML 151
           P    D    + + LK    +  G +G +    Y        ++VA+K LKPE      +
Sbjct: 9   PATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHI 67

Query: 152 KEFSQEVYIMRKIRHKNVVQFIGACTRPPN--LCIVTEFMARGSIYDFLHKQKGVFQLTS 209
            +  +E+ I+R + H+N+V++ G CT      + ++ EF+  GS+ ++L K K    L  
Sbjct: 68  ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ 127

Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAET 268
            LK A+ + KGM+YL     +HRDL   N+L++    VK+ DFG+ + ++      T + 
Sbjct: 128 QLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD 187

Query: 269 GT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT---------------GELPYAGL 310
                  W APE +    +   +DV+SFG+ L ELLT                   +  +
Sbjct: 188 DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM 247

Query: 311 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
           T  +  V  +++  R   P +    + +L+ +CW+  P+ R +F  + +  + ++K
Sbjct: 248 TVTR-LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  246 bits (630), Expect = 6e-80
 Identities = 71/306 (23%), Positives = 127/306 (41%), Gaps = 42/306 (13%)

Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY---------CSQEVAIKVLKPECVNTEMLKEFS 155
            +I  + L     +  G++  ++KG              EV +KVL     N    + F 
Sbjct: 3   HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS--ESFF 60

Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           +   +M K+ HK++V   G C       +V EF+  GS+  +L K K    +   L+VA 
Sbjct: 61  EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK 120

Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMD--------ENGVVKVADFGVARVQAQSGVMTAE 267
            ++  M++L +N +IH ++   N+L+             +K++D G++            
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-------VLP 173

Query: 268 TGTY----RWMAPEVIEH-KPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQ 321
                    W+ PE IE+ K  +   D +SFG  LWE+ + G+ P + L   Q  +   +
Sbjct: 174 KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-SQRKLQFYE 232

Query: 322 KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINTNI 381
              +  +P      LA L+  C  ++P  RP+F  I   L  +        +P+L+    
Sbjct: 233 DRHQ--LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL-------FTPDLVPRGS 283

Query: 382 QSTYKH 387
              + H
Sbjct: 284 HHHHHH 289

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  246 bits (630), Expect = 1e-79
 Identities = 75/283 (26%), Positives = 132/283 (46%), Gaps = 20/283 (7%)

Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQE 157
           +   ID   L +   +  G +G + +G        S +VA+K +K +  +   ++EF  E
Sbjct: 27  EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSE 86

Query: 158 VYIMRKIRHKNVVQFIGACTR-----PPNLCIVTEFMARGSIYDFL-----HKQKGVFQL 207
              M+   H NV++ +G C        P   ++  FM  G ++ +L             L
Sbjct: 87  AACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL 146

Query: 208 TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE 267
            +LLK  +D++ GM YL   N +HRDL   N ++ ++  V VADFG+++           
Sbjct: 147 QTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQG 206

Query: 268 TGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKS 323
                  +W+A E +  + Y  K+DV++FG+ +WE+ T G  PY G+   +     +   
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE-MYDYLLHG 265

Query: 324 LRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
            R   P+     L E++  CW+ DP  RP FS +   L+++++
Sbjct: 266 HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  246 bits (631), Expect = 2e-79
 Identities = 80/283 (28%), Positives = 140/283 (49%), Gaps = 16/283 (5%)

Query: 96  EIPTDGTDVWE-IDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNT 148
           E P     +   +   + K    + SG++G +YKG +  +       VAIK L+      
Sbjct: 2   EAPNQA--LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK 59

Query: 149 EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT 208
              KE   E Y+M  + + +V + +G C     + ++T+ M  G + D++ + K      
Sbjct: 60  AN-KEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQ 117

Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAE 267
            LL   + ++KGMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE
Sbjct: 118 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177

Query: 268 TGTY--RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSL 324
            G    +WMA E I H+ Y +++DV+S+G+ +WEL+T G  PY G+   +    +++K  
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGE 236

Query: 325 RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           R   P      +  ++ +CW  D   RP F ++     +M ++
Sbjct: 237 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  246 bits (630), Expect = 2e-79
 Identities = 73/286 (25%), Positives = 136/286 (47%), Gaps = 21/286 (7%)

Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQE 157
           +   I  +Q  +   +  G +G + +           +VA+K+LK + + +  ++EF +E
Sbjct: 16  EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75

Query: 158 VYIMRKIRHKNVVQFIGACTR------PPNLCIVTEFMARGSIYDFL-----HKQKGVFQ 206
              M++  H +V + +G   R       P   ++  FM  G ++ FL      +      
Sbjct: 76  AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135

Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266
           L +L++  +D++ GM YL   N IHRDL   N ++ E+  V VADFG++R          
Sbjct: 136 LQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQ 195

Query: 267 ETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK 322
              +    +W+A E +    Y   +DV++FG+ +WE++T G+ PYAG+   +     +  
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-IYNYLIG 254

Query: 323 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV 368
             R   P      + +L+ +CW  DP QRP+F+ +   L+ ++  +
Sbjct: 255 GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  245 bits (627), Expect = 4e-79
 Identities = 85/304 (27%), Positives = 145/304 (47%), Gaps = 32/304 (10%)

Query: 93  NCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPEC 145
           +  ++P D    WE    +L     + +G++G + + T         +  VA+K+LKP  
Sbjct: 8   DPTQLPYD--HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA 65

Query: 146 VNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL------ 198
             TE  +    E+ ++  +  H N+V  +GACT      ++TE+   G + +FL      
Sbjct: 66  HLTER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDS 124

Query: 199 -----------HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 247
                         +    L  LL  +  V+KGM +L   N IHRDL   N+L+    + 
Sbjct: 125 FICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT 184

Query: 248 KVADFGVARVQAQSGVMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-G 303
           K+ DFG+AR          +       +WMAPE I +  Y +++DV+S+GI LWEL + G
Sbjct: 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244

Query: 304 ELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQ 363
             PY G+        ++++  R   P+HA   + ++++ CW  DP +RP F QI  ++++
Sbjct: 245 SSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304

Query: 364 MMKE 367
            + E
Sbjct: 305 QISE 308

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  243 bits (623), Expect = 2e-78
 Identities = 77/306 (25%), Positives = 137/306 (44%), Gaps = 31/306 (10%)

Query: 89  ESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLK 142
                   +     D      + LK    +  G +G +    Y        + VA+K LK
Sbjct: 10  HHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK 69

Query: 143 PECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHK 200
            +    +    + QE+ I+R + H++++++ G C      +L +V E++  GS+ D+L +
Sbjct: 70  ADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR 128

Query: 201 QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQA 259
                 L  LL  A  + +GM YLH  + IHRDL   N+L+D + +VK+ DFG+A+ V  
Sbjct: 129 HS--IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186

Query: 260 QSGVMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-------------- 302
                           W APE ++   + Y +DV+SFG+ L+ELLT              
Sbjct: 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE 246

Query: 303 -GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDIL 361
              +    +T L+    ++++  R   P      +  L++ CW+ + + RP F  +  IL
Sbjct: 247 LIGIAQGQMTVLR-LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPIL 305

Query: 362 KQMMKE 367
           K + ++
Sbjct: 306 KTVHEK 311

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  243 bits (622), Expect = 2e-78
 Identities = 81/311 (26%), Positives = 149/311 (47%), Gaps = 38/311 (12%)

Query: 91  SPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKP 143
           S +  +I  D    WE   K L +   +  G +G + K T            VA+K+LK 
Sbjct: 6   SVDAFKILED--PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE 63

Query: 144 ECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL----- 198
               +E+ ++   E  +++++ H +V++  GAC++   L ++ E+   GS+  FL     
Sbjct: 64  NASPSEL-RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRK 122

Query: 199 ------------------HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240
                             H  +    +  L+  A  +S+GM YL +  ++HRDL   N+L
Sbjct: 123 VGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNIL 182

Query: 241 MDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIAL 297
           + E   +K++DFG++R   +       +      +WMA E +    Y  ++DV+SFG+ L
Sbjct: 183 VAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242

Query: 298 WELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQ 356
           WE++T G  PY G+ P +    +++   R   P +    +  L+ +CW+ +P +RP F+ 
Sbjct: 243 WEIVTLGGNPYPGIPPER-LFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFAD 301

Query: 357 ITDILKQMMKE 367
           I+  L++MM +
Sbjct: 302 ISKDLEKMMVK 312

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  241 bits (618), Expect = 6e-78
 Identities = 75/275 (27%), Positives = 125/275 (45%), Gaps = 14/275 (5%)

Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEV 158
           V    +  +     +  G +G +Y GT           A+K L     +   + +F  E 
Sbjct: 19  VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEG 77

Query: 159 YIMRKIRHKNVVQFIGACTRP-PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 217
            IM+   H NV+  +G C R   +  +V  +M  G + +F+  +     +  L+   + V
Sbjct: 78  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 137

Query: 218 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY-----R 272
           +KGM YL     +HRDL   N ++DE   VKVADFG+AR        +    T      +
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 197

Query: 273 WMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKH 331
           WMA E ++ + +  K+DV+SFG+ LWEL+T G  PY  +         + +  R   P++
Sbjct: 198 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLLQGRRLLQPEY 256

Query: 332 AHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
               L E++ +CW      RP+FS++   +  +  
Sbjct: 257 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  244 bits (624), Expect = 7e-78
 Identities = 80/341 (23%), Positives = 140/341 (41%), Gaps = 16/341 (4%)

Query: 38  SLDVFVVDGWPYDETEDLKNVLAKEILKSKDQSCSKRQPALGVPMHSKLLIESSPNCIEI 97
           +     +         D    + +       ++ S+     G       L   +P  ++ 
Sbjct: 19  ASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQA 78

Query: 98  PTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLK 152
                 V    +  +     +  G +G +Y GT           A+K L       E+  
Sbjct: 79  VQH--VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-S 135

Query: 153 EFSQEVYIMRKIRHKNVVQFIGACTRP-PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL 211
           +F  E  IM+   H NV+  +G C R   +  +V  +M  G + +F+  +     +  L+
Sbjct: 136 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 195

Query: 212 KVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY 271
              + V+KGM +L     +HRDL   N ++DE   VKVADFG+AR        +    T 
Sbjct: 196 GFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 255

Query: 272 -----RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLR 325
                +WMA E ++ + +  K+DV+SFG+ LWEL+T G  PY  +         + +  R
Sbjct: 256 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLLQGRR 314

Query: 326 PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
              P++    L E++ +CW      RP+FS++   +  +  
Sbjct: 315 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  242 bits (619), Expect = 8e-78
 Identities = 80/298 (26%), Positives = 143/298 (47%), Gaps = 22/298 (7%)

Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFS 155
           D WE+  +++ +  ++  GS+G +Y+G             VAIK +     +     EF 
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFL 76

Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL---------HKQKGVFQ 206
            E  +M++    +VV+ +G  ++     ++ E M RG +  +L         +       
Sbjct: 77  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136

Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266
           L+ ++++A +++ GM YL+ N  +HRDL   N ++ E+  VK+ DFG+ R   ++     
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196

Query: 267 ETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK 322
                   RWM+PE ++   +   +DV+SFG+ LWE+ T  E PY GL+  Q  +  V +
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-VLRFVME 255

Query: 323 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINTN 380
                 P +    L EL+  CWQ++P  RP+F +I   +K+ M+     +S      N
Sbjct: 256 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEEN 313

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  240 bits (616), Expect = 1e-77
 Identities = 79/293 (26%), Positives = 141/293 (48%), Gaps = 29/293 (9%)

Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLK 152
            G  V  I  + + ++ ++  G++G ++               VA+K LK   +     K
Sbjct: 5   SGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--K 62

Query: 153 EFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL-------------- 198
           +F +E  ++  ++H+++V+F G C     L +V E+M  G +  FL              
Sbjct: 63  DFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQ 122

Query: 199 -HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV 257
             + KG   L+ +L +A  ++ GM YL   + +HRDL T N L+  N +VK+ DFG++R 
Sbjct: 123 PRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD 182

Query: 258 QAQSGVMTAETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPL 313
              +        T    RWM PE I ++ +  ++DV+SFG+ LWE+ T G+ P+  L+  
Sbjct: 183 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 242

Query: 314 QAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
           +  +  + +      P+     + +++  CWQ +P QR N  +I  IL  + K
Sbjct: 243 E-VIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGK 294

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  240 bits (615), Expect = 2e-77
 Identities = 75/276 (27%), Positives = 131/276 (47%), Gaps = 16/276 (5%)

Query: 105 WEI--DAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQE 157
             I  +      +  +  G +G +Y G Y        + AIK L       ++ + F +E
Sbjct: 14  VLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQV-EAFLRE 72

Query: 158 VYIMRKIRHKNVVQFIGACTRP-PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 216
             +MR + H NV+  IG    P     ++  +M  G +  F+   +    +  L+   + 
Sbjct: 73  GLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQ 132

Query: 217 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY----- 271
           V++GM YL +   +HRDL   N ++DE+  VKVADFG+AR        + +   +     
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPV 192

Query: 272 RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPK 330
           +W A E ++   +  K+DV+SFG+ LWELLT G  PY  + P       + +  R   P+
Sbjct: 193 KWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-LTHFLAQGRRLPQPE 251

Query: 331 HAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
           +    L +++++CW+ DP  RP F  +   ++Q++ 
Sbjct: 252 YCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  241 bits (618), Expect = 2e-77
 Identities = 86/306 (28%), Positives = 142/306 (46%), Gaps = 28/306 (9%)

Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFS 155
           D+ E+  K + +   +  G++G++Y+G            +VA+K L   C + +   +F 
Sbjct: 23  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFL 81

Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL------HKQKGVFQLTS 209
            E  I+ K  H+N+V+ IG   +     I+ E MA G +  FL        Q     +  
Sbjct: 82  MEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 141

Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD---ENGVVKVADFGVARVQAQSGVMTA 266
           LL VA D++ G  YL +N+ IHRD+   N L+       V K+ DFG+AR   ++     
Sbjct: 142 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 201

Query: 267 ETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK 322
                   +WM PE      +  K D +SFG+ LWE+ + G +PY   +  +  +  V  
Sbjct: 202 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-VLEFVTS 260

Query: 323 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINTNIQ 382
             R   PK+    +  ++ +CWQH P  RPNF+ I + ++   +       P++INT + 
Sbjct: 261 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ------DPDVINTALP 314

Query: 383 STYKHL 388
             Y  L
Sbjct: 315 IEYGPL 320

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  241 bits (617), Expect = 2e-77
 Identities = 84/322 (26%), Positives = 145/322 (45%), Gaps = 32/322 (9%)

Query: 70  SCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKG 129
           S S   P  G     +  I  +P           V  I  + + ++ ++  G++G ++  
Sbjct: 5   SGSSLSPTEGKGSGLQGHIIENPQYFSDA----CVHHIKRRDIVLKWELGEGAFGKVFLA 60

Query: 130 TY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182
                        VA+K LK         ++F +E  ++  ++H+++V+F G CT    L
Sbjct: 61  ECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118

Query: 183 CIVTEFMARGSIYDFL--------------HKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 228
            +V E+M  G +  FL                  G   L  LL VA  V+ GM YL   +
Sbjct: 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH 178

Query: 229 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVIEHKPYD 285
            +HRDL T N L+ +  VVK+ DFG++R    +        T    RWM PE I ++ + 
Sbjct: 179 FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT 238

Query: 286 YKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW 344
            ++DV+SFG+ LWE+ T G+ P+  L+  + A+  + +      P+   P +  ++  CW
Sbjct: 239 TESDVWSFGVVLWEIFTYGKQPWYQLSNTE-AIDCITQGRELERPRACPPEVYAIMRGCW 297

Query: 345 QHDPTQRPNFSQITDILKQMMK 366
           Q +P QR +   +   L+ + +
Sbjct: 298 QREPQQRHSIKDVHARLQALAQ 319

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  241 bits (616), Expect = 4e-77
 Identities = 82/300 (27%), Positives = 142/300 (47%), Gaps = 28/300 (9%)

Query: 93  NCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPEC 145
           +  ++P +  + WE     L+    + +G++G + + T           +VA+K+LK   
Sbjct: 31  DPTQLPYN--EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA 88

Query: 146 VNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV 204
              E  +    E+ IM  + +H+N+V  +GACT    + ++TE+   G + +FL ++  V
Sbjct: 89  HADEK-EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRV 147

Query: 205 FQ-------------LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 251
            +                LL  +  V++GM +L   N IHRD+   N+L+    V K+ D
Sbjct: 148 LETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGD 207

Query: 252 FGVARVQAQSGVMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPY 307
           FG+AR          +       +WMAPE I    Y  ++DV+S+GI LWE+ + G  PY
Sbjct: 208 FGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267

Query: 308 AGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
            G+        +V+   +   P  A   +  +++ CW  +PT RP F QI   L++  +E
Sbjct: 268 PGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  239 bits (611), Expect = 5e-77
 Identities = 70/287 (24%), Positives = 130/287 (45%), Gaps = 28/287 (9%)

Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQ 156
           + EI    ++   ++    +G +YKG          +Q VAIK LK +     + +EF  
Sbjct: 3   LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRH 61

Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL---------------HKQ 201
           E  +  +++H NVV  +G  T+   L ++  + + G +++FL                  
Sbjct: 62  EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121

Query: 202 KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261
           K   +    + +   ++ GM YL  ++++H+DL T N+L+ +   VK++D G+ R    +
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 181

Query: 262 GVMTAETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 317
                   +    RWMAPE I +  +   +D++S+G+ LWE+ + G  PY G +     V
Sbjct: 182 DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-VV 240

Query: 318 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQM 364
            +++       P      +  L+  CW   P++RP F  I   L+  
Sbjct: 241 EMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 287

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  242 bits (619), Expect = 5e-77
 Identities = 88/347 (25%), Positives = 163/347 (46%), Gaps = 38/347 (10%)

Query: 72  SKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY 131
                           + +  +  E+P D    WE+   +L +   +  G++G +     
Sbjct: 33  HHDYDIPTTENLYFQGMLAGVSEYELPED--PRWELPRDRLVLGKPLGEGAFGQVVLAEA 90

Query: 132 ---------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPN 181
                       +VA+K+LK +    + L +   E+ +M+ I +HKN++  +GACT+   
Sbjct: 91  IGLDKDKPNRVTKVAVKMLKSDATEKD-LSDLISEMEMMKMIGKHKNIINLLGACTQDGP 149

Query: 182 LCIVTEFMARGSIYDFL---------------HKQKGVFQLTSLLKVAIDVSKGMNYLHQ 226
           L ++ E+ ++G++ ++L               H  +       L+  A  V++GM YL  
Sbjct: 150 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 209

Query: 227 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVIEHKP 283
              IHRDL   N+L+ E+ V+K+ADFG+AR           T      +WMAPE +  + 
Sbjct: 210 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI 269

Query: 284 YDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER 342
           Y +++DV+SFG+ LWE+ T G  PY G+   +    ++++  R   P +    L  ++  
Sbjct: 270 YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-LFKLLKEGHRMDKPSNCTNELYMMMRD 328

Query: 343 CWQHDPTQRPNFSQITDILKQMM-----KEVLYWLSPNLINTNIQST 384
           CW   P+QRP F Q+ + L +++     +E+ Y+   +  + +I +T
Sbjct: 329 CWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYYHHHHHHDYDIPTT 375

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  241 bits (617), Expect = 7e-77
 Identities = 81/301 (26%), Positives = 145/301 (48%), Gaps = 33/301 (10%)

Query: 96  EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECV 146
           E+P D    WE    +L +   +  G +G +               +  VA+K+LK +  
Sbjct: 69  ELPED--PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA- 125

Query: 147 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL------- 198
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L       
Sbjct: 126 TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 185

Query: 199 --------HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
                      +       L+     +++GM YL     IHRDL   N+L+ EN V+K+A
Sbjct: 186 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 245

Query: 251 DFGVARVQAQSGVMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 306
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ +WE+ T G  P
Sbjct: 246 DFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305

Query: 307 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
           Y G+   +    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++ 
Sbjct: 306 YPGIPVEE-LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364

Query: 367 E 367
            
Sbjct: 365 L 365

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  239 bits (612), Expect = 7e-77
 Identities = 86/308 (27%), Positives = 144/308 (46%), Gaps = 30/308 (9%)

Query: 88  IESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKV 140
           +    +C  +P D    WE    +LK+   +  G++G + +            + VA+K+
Sbjct: 6   LPLDEHCERLPYD-ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM 64

Query: 141 LKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFL 198
           LK         +    E+ I+  I  H NVV  +GACT+P   L ++ EF   G++  +L
Sbjct: 65  LKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123

Query: 199 ---------------HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE 243
                             K    L  L+  +  V+KGM +L     IHRDL   N+L+ E
Sbjct: 124 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 183

Query: 244 NGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWEL 300
             VVK+ DFG+AR   +      +       +WMAPE I  + Y  ++DV+SFG+ LWE+
Sbjct: 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

Query: 301 LT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD 359
            + G  PY G+   +     +++  R   P +  P + + +  CW  +P+QRP FS++ +
Sbjct: 244 FSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 303

Query: 360 ILKQMMKE 367
            L  +++ 
Sbjct: 304 HLGNLLQA 311

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  240 bits (614), Expect = 8e-77
 Identities = 81/299 (27%), Positives = 146/299 (48%), Gaps = 33/299 (11%)

Query: 96  EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECV 146
           E+P D    WE    +L +   +  G++G +               +  VA+K+LK +  
Sbjct: 23  ELPED--PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA- 79

Query: 147 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL------- 198
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L       
Sbjct: 80  TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 139

Query: 199 --------HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
                      +       L+     +++GM YL     IHRDL   N+L+ EN V+K+A
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 199

Query: 251 DFGVARVQAQSGVMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 306
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ +WE+ T G  P
Sbjct: 200 DFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

Query: 307 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
           Y G+   +    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++
Sbjct: 260 YPGIPVEE-LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  239 bits (613), Expect = 1e-76
 Identities = 83/311 (26%), Positives = 142/311 (45%), Gaps = 37/311 (11%)

Query: 91  SPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKP 143
             +  E   D    WE   + L+    + SG++G +   T         S +VA+K+LK 
Sbjct: 28  YVDFREYEYD--LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE 85

Query: 144 ECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK 202
           +  ++E  +    E+ +M ++  H+N+V  +GACT    + ++ E+   G + ++L  ++
Sbjct: 86  KADSSER-EALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKR 144

Query: 203 GVF--------------------QLTS--LLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240
             F                     LT   LL  A  V+KGM +L   + +HRDL   N+L
Sbjct: 145 EKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL 204

Query: 241 MDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIAL 297
           +    VVK+ DFG+AR                  +WMAPE +    Y  K+DV+S+GI L
Sbjct: 205 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 264

Query: 298 WELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQ 356
           WE+ + G  PY G+        ++Q   +   P +A   +  +++ CW  D  +RP+F  
Sbjct: 265 WEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 324

Query: 357 ITDILKQMMKE 367
           +T  L   + +
Sbjct: 325 LTSFLGCQLAD 335

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  240 bits (615), Expect = 1e-76
 Identities = 88/306 (28%), Positives = 145/306 (47%), Gaps = 28/306 (9%)

Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFS 155
           D+ E+  K + +   +  G++G++Y+G            +VA+K L   C + +   +F 
Sbjct: 64  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFL 122

Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK------QKGVFQLTS 209
            E  I+ K  H+N+V+ IG   +     I+ E MA G +  FL +      Q     +  
Sbjct: 123 MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182

Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADFGVARVQAQSGVMTA 266
           LL VA D++ G  YL +N+ IHRD+   N L+   G   V K+ DFG+AR   ++G    
Sbjct: 183 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK 242

Query: 267 ETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK 322
                   +WM PE      +  K D +SFG+ LWE+ + G +PY   +  +  +  V  
Sbjct: 243 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-VLEFVTS 301

Query: 323 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINTNIQ 382
             R   PK+    +  ++ +CWQH P  RPNF+ I + ++   +       P++INT + 
Sbjct: 302 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ------DPDVINTALP 355

Query: 383 STYKHL 388
             Y  L
Sbjct: 356 IEYGPL 361

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  239 bits (612), Expect = 1e-76
 Identities = 89/312 (28%), Positives = 150/312 (48%), Gaps = 36/312 (11%)

Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFS 155
           D T    +D   +K +  +  G++G + K          + AIK +K      +  ++F+
Sbjct: 15  DPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFA 73

Query: 156 QEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL---------------H 199
            E+ ++ K+  H N++  +GAC     L +  E+   G++ DFL               +
Sbjct: 74  GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 133

Query: 200 KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259
                     LL  A DV++GM+YL Q   IHRDL   N+L+ EN V K+ADFG++R   
Sbjct: 134 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--- 190

Query: 260 QSGVMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQA 315
              V   +T      RWMA E + +  Y   +DV+S+G+ LWE+++ G  PY G+T    
Sbjct: 191 GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AE 249

Query: 316 AVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPN 375
               + +  R   P +    + +L+ +CW+  P +RP+F+QI   L +M++E        
Sbjct: 250 LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE-----RKT 304

Query: 376 LINTNI--QSTY 385
            +NT +  + TY
Sbjct: 305 YVNTTLYEKFTY 316

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  246 bits (630), Expect = 3e-76
 Identities = 74/321 (23%), Positives = 144/321 (44%), Gaps = 20/321 (6%)

Query: 65  KSKDQSCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKI--------EC 116
           +    +     P                +     +  +D  E+  K+L +        + 
Sbjct: 283 RIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADI 342

Query: 117 KVASGSYGDLYKGTYCSQ----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 172
           ++  G++G + +G Y  +    +VAIKVLK         +E  +E  IM ++ +  +V+ 
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYIVRL 401

Query: 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 232
           IG C     L +V E    G ++ FL  ++    ++++ ++   VS GM YL + N +HR
Sbjct: 402 IGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 460

Query: 233 DLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGT---YRWMAPEVIEHKPYDYKA 288
           +L   N+L+      K++DFG+++ + A     TA +      +W APE I  + +  ++
Sbjct: 461 NLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRS 520

Query: 289 DVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHD 347
           DV+S+G+ +WE L+ G+ PY  +      +  +++  R   P    P L  L+  CW + 
Sbjct: 521 DVWSYGVTMWEALSYGQKPYKKMK-GPEVMAFIEQGKRMECPPECPPELYALMSDCWIYK 579

Query: 348 PTQRPNFSQITDILKQMMKEV 368
              RP+F  +   ++     +
Sbjct: 580 WEDRPDFLTVEQRMRACYYSL 600

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  234 bits (598), Expect = 2e-74
 Identities = 80/306 (26%), Positives = 137/306 (44%), Gaps = 36/306 (11%)

Query: 96  EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNT 148
            +        E     ++    +  G++G +++              VA+K+LK E  + 
Sbjct: 33  LLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SA 91

Query: 149 EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL---------- 198
           +M  +F +E  +M +  + N+V+ +G C     +C++ E+MA G + +FL          
Sbjct: 92  DMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCS 151

Query: 199 -------------HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 245
                                    L +A  V+ GM YL +   +HRDL T N L+ EN 
Sbjct: 152 LSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM 211

Query: 246 VVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT 302
           VVK+ADFG++R    +    A+       RWM PE I +  Y  ++DV+++G+ LWE+ +
Sbjct: 212 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

Query: 303 -GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDIL 361
            G  PY G+   +  +  V+       P++    L  L+  CW   P  RP+F  I  IL
Sbjct: 272 YGLQPYYGMAHEE-VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 330

Query: 362 KQMMKE 367
           ++M + 
Sbjct: 331 QRMCER 336

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  219 bits (560), Expect = 2e-69
 Identities = 76/280 (27%), Positives = 133/280 (47%), Gaps = 15/280 (5%)

Query: 89  ESSPNCIEIPTDGTDVWEID--AKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPE 144
           E +    +I    T    +    + LK + ++  GS+  +YKG  T  + EVA   L+  
Sbjct: 3   ERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDR 62

Query: 145 CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA----CTRPPNLCIVTEFMARGSIYDFLHK 200
            +     + F +E  +++ ++H N+V+F  +          + +VTE M  G++  +L +
Sbjct: 63  KLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR 122

Query: 201 QKGVFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMD-ENGVVKVADFGVARV 257
              V ++  L      + KG+ +LH     IIHRDLK  N+ +    G VK+ D G+A +
Sbjct: 123 F-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181

Query: 258 QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAV 317
           +  S       GT  +MAPE+ E K YD   DV++FG+ + E+ T E PY+         
Sbjct: 182 KRASFAKA-VIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY 239

Query: 318 GVVQKSLRP-TIPKHAHPRLAELLERCWQHDPTQRPNFSQ 356
             V   ++P +  K A P + E++E C + +  +R +   
Sbjct: 240 RRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKD 279

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  212 bits (541), Expect = 7e-66
 Identities = 73/275 (26%), Positives = 143/275 (52%), Gaps = 12/275 (4%)

Query: 120 SGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
            GS+G       T   ++  IK +    ++++  +E  +EV ++  ++H N+VQ+  +  
Sbjct: 34  EGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE 93

Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT 236
              +L IV ++   G ++  ++ QKGV FQ   +L   + +   + ++H   I+HRD+K+
Sbjct: 94  ENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKS 153

Query: 237 ANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFSFG 294
            N+ + ++G V++ DFG+ARV   S V  A    GT  +++PE+ E+KPY+ K+D+++ G
Sbjct: 154 QNIFLTKDGTVQLGDFGIARV-LNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALG 212

Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 354
             L+EL T +  +   +     + ++  S  P +  H    L  L+ + ++ +P  RP+ 
Sbjct: 213 CVLYELCTLKHAFEAGSMKNLVLKIISGSFPP-VSLHYSYDLRSLVSQLFKRNPRDRPS- 270

Query: 355 SQITDILKQ--MMKEVLYWLSPNLINTNIQSTYKH 387
             +  IL++  + K +  +LSP LI          
Sbjct: 271 --VNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFS 303

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  203 bits (519), Expect = 4e-63
 Identities = 70/242 (28%), Positives = 126/242 (52%), Gaps = 11/242 (4%)

Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
            G+YG +Y G   S    +AIK +     ++   +   +E+ + + ++HKN+VQ++G+ +
Sbjct: 32  KGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLT-SLLKV-AIDVSKGMNYLHQNNIIHRDLK 235
               + I  E +  GS+   L  + G  +     +      + +G+ YLH N I+HRD+K
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149

Query: 236 TANLLMD-ENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKP--YDYKADVF 291
             N+L++  +GV+K++DFG + R+   +      TGT ++MAPE+I+  P  Y   AD++
Sbjct: 150 GDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIW 209

Query: 292 SFGIALWELLTGELPYAGLT-PLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ 350
           S G  + E+ TG+ P+  L  P  A   V    + P IP+         + +C++ DP +
Sbjct: 210 SLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDK 269

Query: 351 RP 352
           R 
Sbjct: 270 RA 271

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  204 bits (520), Expect = 4e-63
 Identities = 59/280 (21%), Positives = 99/280 (35%), Gaps = 8/280 (2%)

Query: 81  PMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAI 138
           P       E+S        D +       +  +   ++  GSYG+++K       +  A+
Sbjct: 28  PRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAV 87

Query: 139 KVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDF 197
           K         +       EV    K+ +H   V+   A      L + TE     S+   
Sbjct: 88  KRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTEL-CGPSLQQH 146

Query: 198 LHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV 257
                       +     D    + +LH   ++H D+K AN+ +   G  K+ DFG+   
Sbjct: 147 CEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206

Query: 258 QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAV 317
              +G    + G  R+MAPE+++   Y   ADVFS G+ + E+        G    Q   
Sbjct: 207 LGTAGAGEVQEGDPRYMAPELLQ-GSYGTAADVFSLGLTILEVACNMELPHGGEGWQQ-- 263

Query: 318 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
            + Q  L P         L  +L    + DP  R     +
Sbjct: 264 -LRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEAL 302

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  202 bits (516), Expect = 1e-62
 Identities = 82/281 (29%), Positives = 132/281 (46%), Gaps = 43/281 (15%)

Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMR 162
           W I+    +++  + SG+   +         ++VAIK +  E   T  + E  +E+  M 
Sbjct: 10  WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS-MDELLKEIQAMS 68

Query: 163 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL--HKQKGVFQLTSLLKVAI----- 215
           +  H N+V +  +      L +V + ++ GS+ D +     KG  +   L +  I     
Sbjct: 69  QCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128

Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET------G 269
           +V +G+ YLH+N  IHRD+K  N+L+ E+G V++ADFGV+   A  G +T         G
Sbjct: 129 EVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188

Query: 270 TYRWMAPEVIE-HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI 328
           T  WMAPEV+E  + YD+KAD++SFGI   EL TG  PY    P++              
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL---------MLT 239

Query: 329 PKHAHPRLA-----------------ELLERCWQHDPTQRP 352
            ++  P L                  +++  C Q DP +RP
Sbjct: 240 LQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP 280

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  202 bits (516), Expect = 1e-62
 Identities = 87/275 (31%), Positives = 143/275 (52%), Gaps = 16/275 (5%)

Query: 82  MHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIK 139
           M    +    P    +  D  +++           K+  GS+G+++KG      + VAIK
Sbjct: 1   MAHSPVQSGLPGMQNLKADPEELFTK-------LEKIGKGSFGEVFKGIDNRTQKVVAIK 53

Query: 140 VLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLH 199
           ++  E    E +++  QE+ ++ +     V ++ G+  +   L I+ E++  GS  D L 
Sbjct: 54  IIDLEEAEDE-IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL- 111

Query: 200 KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259
            + G    T +  +  ++ KG++YLH    IHRD+K AN+L+ E+G VK+ADFGVA  Q 
Sbjct: 112 -EPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA-GQL 169

Query: 260 QSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAV 317
               +   T  GT  WMAPEVI+   YD KAD++S GI   EL  GE P++ L P++  +
Sbjct: 170 TDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK-VL 228

Query: 318 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRP 352
            ++ K+  PT+  +    L E +E C   +P+ RP
Sbjct: 229 FLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRP 263

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  203 bits (517), Expect = 2e-62
 Identities = 57/243 (23%), Positives = 98/243 (40%), Gaps = 18/243 (7%)

Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
            GS+G++++        + A+K ++ E           +E+     +    +V   GA  
Sbjct: 68  RGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVR 120

Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
             P + I  E +  GS+   + KQ G       L       +G+ YLH   I+H D+K  
Sbjct: 121 EGPWVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKAD 179

Query: 238 NLLMDENGV-VKVADFGVARVQAQSGVMTAET------GTYRWMAPEVIEHKPYDYKADV 290
           N+L+  +G    + DFG A      G+  +        GT   MAPEV+  KP D K D+
Sbjct: 180 NVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDI 239

Query: 291 FSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-LRPTIPKHAHPRLAELLERCWQHDPT 349
           +S    +  +L G  P+         + +  +      IP    P  A+ ++   + +P 
Sbjct: 240 WSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPV 299

Query: 350 QRP 352
            R 
Sbjct: 300 HRA 302

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  199 bits (508), Expect = 1e-61
 Identities = 66/276 (23%), Positives = 116/276 (42%), Gaps = 33/276 (11%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           K    + SG +G ++K  +    +   IK +K      E      +EV  + K+ H N+V
Sbjct: 14  KEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE------REVKALAKLDHVNIV 67

Query: 171 QFIGA----------------CTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKV 213
            + G                  ++   L I  EF  +G++  ++ K++G        L++
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127

Query: 214 AIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRW 273
              ++KG++Y+H   +I+RDLK +N+ + +   VK+ DFG+       G  T   GT R+
Sbjct: 128 FEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRY 187

Query: 274 MAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH 333
           M+PE I  + Y  + D+++ G+ L ELL                          I     
Sbjct: 188 MSPEQISSQDYGKEVDLYALGLILAELLHVC------DTAFETSKFFTDLRDGIISDIFD 241

Query: 334 PRLAELLERCWQHDPTQRPNFSQI--TDILKQMMKE 367
            +   LL++     P  RPN S+I  T  + +   E
Sbjct: 242 KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  197 bits (504), Expect = 7e-61
 Identities = 59/268 (22%), Positives = 127/268 (47%), Gaps = 13/268 (4%)

Query: 120 SGSYGDLYKG--TYCSQEVAIKVLK-PECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176
            G + ++Y+         VA+K ++  + ++ +   +  +E+ +++++ H NV+++  + 
Sbjct: 42  RGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF 101

Query: 177 TRPPNLCIVTEFMARGSIYDFLHKQK---GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
                L IV E    G +   +   K    +    ++ K  + +   + ++H   ++HRD
Sbjct: 102 IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRD 161

Query: 234 LKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 292
           +K AN+ +   GVVK+ D G+ R   +++    +  GT  +M+PE I    Y++K+D++S
Sbjct: 162 IKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWS 221

Query: 293 FGIALWELLTGELPYAG--LTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ 350
            G  L+E+   + P+ G  +        + Q    P    H    L +L+  C   DP +
Sbjct: 222 LGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEK 281

Query: 351 RPNFSQITDILKQMMKEVLYWLSPNLIN 378
           RP+ + + D+ K+M        + +L +
Sbjct: 282 RPDVTYVYDVAKRMHA----CTASSLEH 305

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  195 bits (497), Expect = 1e-59
 Identities = 80/272 (29%), Positives = 127/272 (46%), Gaps = 35/272 (12%)

Query: 95  IEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLK 152
             +     +V+++         K+  GSYG +YK  +    Q VAIK +  E      L+
Sbjct: 21  DSLTKQPEEVFDV-------LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQ 69

Query: 153 EFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLK 212
           E  +E+ IM++    +VV++ G+  +  +L IV E+   GS+ D +  +        +  
Sbjct: 70  EIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT 129

Query: 213 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GT 270
           +     KG+ YLH    IHRD+K  N+L++  G  K+ADFGVA  Q    +    T  GT
Sbjct: 130 ILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVA-GQLTDTMAKRNTVIGT 188

Query: 271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK 330
             WMAPEVI+   Y+  AD++S GI   E+  G+ PYA + P++A            IP 
Sbjct: 189 PFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF---------MIPT 239

Query: 331 HAHPRLA----------ELLERCWQHDPTQRP 352
           +  P             + +++C    P QR 
Sbjct: 240 NPPPTFRKPELWSDNFTDFVKQCLVKSPEQRA 271

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  194 bits (495), Expect = 1e-59
 Identities = 71/249 (28%), Positives = 121/249 (48%), Gaps = 12/249 (4%)

Query: 110 KQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK 167
           K+     K+  G+ G +Y     +  QEVAI+ +  +       +    E+ +MR+ ++ 
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNP 77

Query: 168 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN 227
           N+V ++ +      L +V E++A GS+ D + +         +  V  +  + + +LH N
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN 135

Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYD 285
            +IHRD+K+ N+L+  +G VK+ DFG    Q         T  GT  WMAPEV+  K Y 
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFC-AQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194

Query: 286 YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELLERC 343
            K D++S GI   E++ GE PY    PL+A   ++  +  P +  P+       + L RC
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNPEKLSAIFRDFLNRC 253

Query: 344 WQHDPTQRP 352
            + D  +R 
Sbjct: 254 LEMDVEKRG 262

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  193 bits (493), Expect = 4e-59
 Identities = 73/249 (29%), Positives = 119/249 (47%), Gaps = 12/249 (4%)

Query: 110 KQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK 167
             L    K+  GS G +         ++VA+K++       +  +    EV IMR  +H 
Sbjct: 45  LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLR--KQQRRELLFNEVVIMRDYQHF 102

Query: 168 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN 227
           NVV+   +      L ++ EF+  G++ D + +         +  V   V + + YLH  
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQ 160

Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYD 285
            +IHRD+K+ ++L+  +G VK++DFG    Q    V   ++  GT  WMAPEVI    Y 
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFC-AQISKDVPKRKSLVGTPYWMAPEVISRSLYA 219

Query: 286 YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELLERC 343
            + D++S GI + E++ GE PY   +P+QA    ++ S  P +       P L + LER 
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK-RLRDSPPPKLKNSHKVSPVLRDFLERM 278

Query: 344 WQHDPTQRP 352
              DP +R 
Sbjct: 279 LVRDPQERA 287

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  192 bits (490), Expect = 6e-59
 Identities = 56/271 (20%), Positives = 108/271 (39%), Gaps = 33/271 (12%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNV 169
               K+ SG +G ++K          AIK  K     +   +   +EVY    + +H +V
Sbjct: 14  HELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV 73

Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFL---HKQKGVFQLTSLLKVAIDVSKGMNYLHQ 226
           V++  A     ++ I  E+   GS+ D +   ++    F+   L  + + V +G+ Y+H 
Sbjct: 74  VRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS 133

Query: 227 NNIIHRDLKTANLLMDENGV-------------------VKVADFGVARVQAQSGVMTAE 267
            +++H D+K +N+ +    +                    K+ D G      +      E
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV---TRISSPQVE 190

Query: 268 TGTYRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP 326
            G  R++A EV+ E+  +  KAD+F+  + +      E               +++   P
Sbjct: 191 EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE----IRQGRLP 246

Query: 327 TIPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
            IP+       ELL+     DP +RP+   +
Sbjct: 247 RIPQVLSQEFTELLKVMIHPDPERRPSAMAL 277

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  192 bits (489), Expect = 2e-58
 Identities = 82/301 (27%), Positives = 138/301 (45%), Gaps = 23/301 (7%)

Query: 87  LIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPE 144
           +   S   ++I  +    W+  A+ LK   ++  G+YG + K  +    Q +A+K ++  
Sbjct: 1   MSIESSGKLKISPE--QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST 58

Query: 145 CVNTEMLKEFSQEVYI-MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK--- 200
            V+ +  K+   ++ + MR      +VQF GA  R  +  I  E M+  S   F      
Sbjct: 59  -VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYS 116

Query: 201 -QKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQ 258
               V     L K+ +   K +N+L +N  IIHRD+K +N+L+D +G +K+ DFG++   
Sbjct: 117 VLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176

Query: 259 AQSGVMTAETGTYRWMAPEVIE----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ 314
             S   T + G   +MAPE I+     + YD ++DV+S GI L+EL TG  PY     + 
Sbjct: 177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF 236

Query: 315 AAVGVVQKSLRPTIPKHAH----PRLAELLERCWQHDPTQRPNFSQITD---ILKQMMKE 367
             +  V K   P +         P     +  C   D ++RP + ++     IL    + 
Sbjct: 237 DQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERA 296

Query: 368 V 368
           V
Sbjct: 297 V 297

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  191 bits (487), Expect = 2e-58
 Identities = 77/269 (28%), Positives = 129/269 (47%), Gaps = 22/269 (8%)

Query: 95  IEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLK 152
           +    D  +VWEI         ++  G++G +YK          A KV++ +  + E L+
Sbjct: 11  VRRDLDPNEVWEI-------VGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELE 61

Query: 153 EFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLK 212
           ++  E+ I+    H  +V+ +GA      L I+ EF   G++   + +         +  
Sbjct: 62  DYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV 121

Query: 213 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GT 270
           V   + + +N+LH   IIHRDLK  N+LM   G +++ADFGV+  +    +   ++  GT
Sbjct: 122 VCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVS-AKNLKTLQKRDSFIGT 180

Query: 271 YRWMAPEVIEH-----KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR 325
             WMAPEV+        PYDYKAD++S GI L E+   E P+  L P++  +  + KS  
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL-KIAKSDP 239

Query: 326 PTIPKHAH--PRLAELLERCWQHDPTQRP 352
           PT+   +       + L+     +P  RP
Sbjct: 240 PTLLTPSKWSVEFRDFLKIALDKNPETRP 268

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  190 bits (484), Expect = 5e-58
 Identities = 69/278 (24%), Positives = 121/278 (43%), Gaps = 17/278 (6%)

Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYI-MR 162
           E+ A  L+   ++  G+YG + K  +    Q +A+K ++   VN++  K    ++ I MR
Sbjct: 3   EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT-VNSQEQKRLLMDLDISMR 61

Query: 163 KIRHKNVVQFIGACTRPPNLCIVTEFMARGS---IYDFLHKQKGVFQLTSLLKVAIDVSK 219
            +     V F GA  R  ++ I  E M   S    Y  +  +        L K+A+ + K
Sbjct: 62  TVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120

Query: 220 GMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
            + +LH   ++IHRD+K +N+L++  G VK+ DFG++           + G   +MAPE 
Sbjct: 121 ALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPER 180

Query: 279 IE----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH- 333
           I      K Y  K+D++S GI + EL     PY         +  V +   P +P     
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFS 240

Query: 334 PRLAELLERCWQHDPTQRPNFSQITD---ILKQMMKEV 368
               +   +C + +  +RP + ++           K  
Sbjct: 241 AEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGT 278

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  191 bits (486), Expect = 3e-57
 Identities = 61/306 (19%), Positives = 130/306 (42%), Gaps = 41/306 (13%)

Query: 120 SGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN--VVQFIGAC 176
           SG    +++      Q  AIK +  E  + + L  +  E+  + K++  +  +++     
Sbjct: 66  SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125

Query: 177 TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT 236
                + +V E      +  +L K+K             ++ + ++ +HQ+ I+H DLK 
Sbjct: 126 ITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKP 183

Query: 237 ANLLMDENGVVKVADFGVAR-VQAQSGVMTAET--GTYRWMAPEVIEHKP---------- 283
           AN L+  +G++K+ DFG+A  +Q  +  +  ++  G   +M PE I+             
Sbjct: 184 ANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKS 242

Query: 284 -YDYKADVFSFGIALWELLTGELPYAGLT-PLQAAVGVVQKSLRPTIPKHAHPRLAELLE 341
               K+DV+S G  L+ +  G+ P+  +   +     ++  +     P      L ++L+
Sbjct: 243 KISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLK 302

Query: 342 RCWQHDPTQRPNFSQI--------------------TDILKQMMKEVLYWLSPNLINTNI 381
            C + DP QR +  ++                    T+ +K ++ +++   SPN I    
Sbjct: 303 CCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAA 362

Query: 382 QSTYKH 387
           ++ Y+H
Sbjct: 363 KTLYEH 368

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  189 bits (482), Expect = 4e-57
 Identities = 62/306 (20%), Positives = 131/306 (42%), Gaps = 41/306 (13%)

Query: 120 SGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN--VVQFIGAC 176
           SG    +++      Q  AIK +  E  + + L  +  E+  + K++  +  +++     
Sbjct: 19  SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 78

Query: 177 TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT 236
                + +V E      +  +L K+K             ++ + ++ +HQ+ I+H DLK 
Sbjct: 79  ITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKP 136

Query: 237 ANLLMDENGVVKVADFGVAR-VQAQSGVMTAET--GTYRWMAPEVIEHKP---------- 283
           AN L+  +G++K+ DFG+A  +Q  +  +  ++  GT  +M PE I+             
Sbjct: 137 ANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKS 195

Query: 284 -YDYKADVFSFGIALWELLTGELPYAGLT-PLQAAVGVVQKSLRPTIPKHAHPRLAELLE 341
               K+DV+S G  L+ +  G+ P+  +   +     ++  +     P      L ++L+
Sbjct: 196 KISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLK 255

Query: 342 RCWQHDPTQRPNFSQI--------------------TDILKQMMKEVLYWLSPNLINTNI 381
            C + DP QR +  ++                    T+ +K ++ +++   SPN I    
Sbjct: 256 CCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAA 315

Query: 382 QSTYKH 387
           ++ Y+H
Sbjct: 316 KTLYEH 321

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  189 bits (482), Expect = 5e-57
 Identities = 76/255 (29%), Positives = 114/255 (44%), Gaps = 28/255 (10%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNV 169
               ++  GS+G +Y        + VAIK +      + E  ++  +EV  ++K+RH N 
Sbjct: 57  SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 116

Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
           +Q+ G   R     +V E+   GS  D L   K   Q   +  V     +G+ YLH +N+
Sbjct: 117 IQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 175

Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI---EHKPYDY 286
           IHRD+K  N+L+ E G+VK+ DFG A   +      +  GT  WMAPEVI   +   YD 
Sbjct: 176 IHRDVKAGNILLSEPGLVKLGDFGSA---SIMAPANSFVGTPYWMAPEVILAMDEGQYDG 232

Query: 287 KADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA--------- 337
           K DV+S GI   EL   + P   +  + A            I ++  P L          
Sbjct: 233 KVDVWSLGITCIELAERKPPLFNMNAMSALY---------HIAQNESPALQSGHWSEYFR 283

Query: 338 ELLERCWQHDPTQRP 352
             ++ C Q  P  RP
Sbjct: 284 NFVDSCLQKIPQDRP 298

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  188 bits (479), Expect = 5e-57
 Identities = 63/286 (22%), Positives = 111/286 (38%), Gaps = 29/286 (10%)

Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLY--KGTYCSQEVAIKVLKPECVNTEMLKEFSQEV 158
           G  V  ID K      K+  G +  +   +G +     A+K +   C   +  +E  +E 
Sbjct: 21  GHMVI-IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL--CHEQQDREEAQREA 77

Query: 159 YIMRKIRHKNVVQFIGACTRPPN----LCIVTEFMARGSIYDFL---HKQKGVFQLTSLL 211
            + R   H N+++ +  C R         ++  F  RG++++ +     +        +L
Sbjct: 78  DMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL 137

Query: 212 KVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ----------AQS 261
            + + + +G+  +H     HRDLK  N+L+ + G   + D G                  
Sbjct: 138 WLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197

Query: 262 GVMTAETGTYRWMAPEVIEHKPY---DYKADVFSFGIALWELLTGELPY-AGLTPLQAAV 317
               A+  T  + APE+   + +   D + DV+S G  L+ ++ GE PY        +  
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA 257

Query: 318 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQ 363
             VQ  L           L +LL      DP QRP+   I  +L Q
Sbjct: 258 LAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPH---IPLLLSQ 300

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  187 bits (476), Expect = 1e-56
 Identities = 70/284 (24%), Positives = 127/284 (44%), Gaps = 16/284 (5%)

Query: 99  TDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQ 156
           T G   ++ +   L+   ++ SG+ G ++K  +      +A+K ++    N E  K    
Sbjct: 14  TIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS-GNKEENKRILM 72

Query: 157 EVYI-MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           ++ + ++      +VQ  G      ++ I  E M          + +G      L K+ +
Sbjct: 73  DLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMG-TCAEKLKKRMQGPIPERILGKMTV 131

Query: 216 DVSKGMNYLH-QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM 274
            + K + YL  ++ +IHRD+K +N+L+DE G +K+ DFG++             G   +M
Sbjct: 132 AIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYM 191

Query: 275 APEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP 329
           APE I+        YD +ADV+S GI+L EL TG+ PY         +  V +   P +P
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLP 251

Query: 330 KHAH--PRLAELLERCWQHDPTQRPNFSQITD---ILKQMMKEV 368
            H          ++ C   D  +RP ++++ +   I +    EV
Sbjct: 252 GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEV 295

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  188 bits (480), Expect = 2e-56
 Identities = 49/296 (16%), Positives = 106/296 (35%), Gaps = 24/296 (8%)

Query: 105 WEIDAKQLKIECKVASG--SYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYI 160
           +  +    ++   +  G      +    Y    + V ++ +  E  + EM+     E+++
Sbjct: 20  FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHV 79

Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL-HKQKGVFQLTSLLKVAIDVSK 219
            +   H N+V +         L +VT FMA GS  D +           ++  +   V K
Sbjct: 80  SKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLK 139

Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA--------RVQAQSGVMTAETGTY 271
            ++Y+H    +HR +K +++L+  +G V ++             R +             
Sbjct: 140 ALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199

Query: 272 RWMAPEVIEH--KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP 329
            W++PEV++   + YD K+D++S GI   EL  G +P+  +   Q  +            
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL---------EKL 250

Query: 330 KHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINTNIQSTY 385
               P L +      +            + +   +        + +  +     T+
Sbjct: 251 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTF 306

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  186 bits (474), Expect = 3e-56
 Identities = 54/256 (21%), Positives = 113/256 (44%), Gaps = 21/256 (8%)

Query: 120 SGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN--VVQFIGAC 176
           SG    +++      Q  AIK +  E  + + L  +  E+  + K++  +  +++     
Sbjct: 38  SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97

Query: 177 TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT 236
                + +V E      +  +L K+K             ++ + ++ +HQ+ I+H DLK 
Sbjct: 98  ITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKP 155

Query: 237 ANLLMDENGVVKVADFGVAR-VQAQSGVMTAET--GTYRWMAPEVIEHKP---------- 283
           AN L+  +G++K+ DFG+A  +Q  +  +  ++  GT  +M PE I+             
Sbjct: 156 ANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKS 214

Query: 284 -YDYKADVFSFGIALWELLTGELPYAGLT-PLQAAVGVVQKSLRPTIPKHAHPRLAELLE 341
               K+DV+S G  L+ +  G+ P+  +   +     ++  +     P      L ++L+
Sbjct: 215 KISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLK 274

Query: 342 RCWQHDPTQRPNFSQI 357
            C + DP QR +  ++
Sbjct: 275 CCLKRDPKQRISIPEL 290

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  185 bits (471), Expect = 4e-56
 Identities = 55/267 (20%), Positives = 111/267 (41%), Gaps = 33/267 (12%)

Query: 120 SGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC- 176
            G +G +++          AIK ++         ++  +EV  + K+ H  +V++  A  
Sbjct: 15  RGGFGVVFEAKNKVDDCNYAIKRIRLP-NRELAREKVMREVKALAKLEHPGIVRYFNAWL 73

Query: 177 -----------TRPPNLCIVTEFMARGSIYDFLHKQKGVFQL--TSLLKVAIDVSKGMNY 223
                      +    L I  +   + ++ D+++ +  + +   +  L + + +++ + +
Sbjct: 74  EKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEF 133

Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-------------QAQSGVMTAETGT 270
           LH   ++HRDLK +N+    + VVKV DFG+                       T + GT
Sbjct: 134 LHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGT 193

Query: 271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK 330
             +M+PE I    Y +K D+FS G+ L+ELL    P++        +  V+    P +  
Sbjct: 194 KLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPLFT 250

Query: 331 HAHPRLAELLERCWQHDPTQRPNFSQI 357
             +P    +++      P +RP    I
Sbjct: 251 QKYPCEYVMVQDMLSPSPMERPEAINI 277

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  184 bits (468), Expect = 7e-55
 Identities = 63/272 (23%), Positives = 119/272 (43%), Gaps = 7/272 (2%)

Query: 96  EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKE 153
              T    V E+     +   ++ +G+ G ++K ++      +A K++  E +   +  +
Sbjct: 19  AFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQ 77

Query: 154 FSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKV 213
             +E+ ++ +     +V F GA      + I  E M  GS+   L K+ G      L KV
Sbjct: 78  IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKV 136

Query: 214 AIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYR 272
           +I V KG+ YL +   I+HRD+K +N+L++  G +K+ DFGV+     S   +   GT  
Sbjct: 137 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-VGTRS 195

Query: 273 WMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHA 332
           +M+PE ++   Y  ++D++S G++L E+  G  P       +  +    +          
Sbjct: 196 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 255

Query: 333 HPRLAELLERCWQHDPTQRPN-FSQITDILKQ 363
            PR        +  D       F  +  I+ +
Sbjct: 256 RPRTPGRPLNKFGMDSRPPMAIFELLDYIVNE 287

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  180 bits (458), Expect = 2e-54
 Identities = 63/252 (25%), Positives = 114/252 (45%), Gaps = 16/252 (6%)

Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
           +GSYG   K    S  + +  K L    +     +    EV ++R+++H N+V++     
Sbjct: 16  TGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 75

Query: 178 RPPN--LCIVTEFMARGSIYDFL--HKQKGV-FQLTSLLKVAIDVSKGMNYLHQ-----N 227
              N  L IV E+   G +   +    ++        +L+V   ++  +   H+     +
Sbjct: 76  DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGH 135

Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYD 285
            ++HRDLK AN+ +D    VK+ DFG+AR+        A+T  GT  +M+PE +    Y+
Sbjct: 136 TVLHRDLKPANVFLDGKQNVKLGDFGLARI-LNHDTSFAKTFVGTPYYMSPEQMNRMSYN 194

Query: 286 YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 345
            K+D++S G  L+EL     P+   +  +   G +++     IP      L E++ R   
Sbjct: 195 EKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIREGKFRRIPYRYSDELNEIITRMLN 253

Query: 346 HDPTQRPNFSQI 357
                RP+  +I
Sbjct: 254 LKDYHRPSVEEI 265

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  180 bits (460), Expect = 2e-54
 Identities = 68/300 (22%), Positives = 120/300 (40%), Gaps = 43/300 (14%)

Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
            G++G + K       +  AIK ++      E L     EV ++  + H+ VV++  A  
Sbjct: 16  QGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72

Query: 178 RPPN-------------LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
              N             L I  E+   G++YD +H +    Q     ++   + + ++Y+
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYI 132

Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV---------------QAQSGVMTAETG 269
           H   IIHRDLK  N+ +DE+  VK+ DFG+A+                   S  +T+  G
Sbjct: 133 HSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIG 192

Query: 270 TYRWMAPEVIEHKP-YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI 328
           T  ++A EV++    Y+ K D++S GI  +E++           +   +  V     P  
Sbjct: 193 TAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSVSIEFPPDF 252

Query: 329 PKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINTNIQSTYKHL 388
             +      +++     HDP +RP       +L         WL     +  I+   K L
Sbjct: 253 DDNKMKVEKKIIRLLIDHDPNKRPG---ARTLLNSG------WLPVKHQDEVIKEALKSL 303

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  181 bits (460), Expect = 5e-54
 Identities = 79/258 (30%), Positives = 131/258 (50%), Gaps = 23/258 (8%)

Query: 113 KIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNV 169
           ++   V +G+YG +YKG +    Q  AIKV+    V  +  +E  QE+ +++K   H+N+
Sbjct: 27  ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHHRNI 83

Query: 170 VQFIGA------CTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMN 222
             + GA            L +V EF   GS+ D +   K    +   +  +  ++ +G++
Sbjct: 84  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 143

Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIE 280
           +LHQ+ +IHRD+K  N+L+ EN  VK+ DFGV+  Q    V    T  GT  WMAPEVI 
Sbjct: 144 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNTFIGTPYWMAPEVIA 202

Query: 281 HK-----PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI-PKHAHP 334
                   YD+K+D++S GI   E+  G  P   + P++A   ++ ++  P +  K    
Sbjct: 203 CDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-LIPRNPAPRLKSKKWSK 261

Query: 335 RLAELLERCWQHDPTQRP 352
           +    +E C   + +QRP
Sbjct: 262 KFQSFIESCLVKNHSQRP 279

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  175 bits (445), Expect = 4e-52
 Identities = 75/264 (28%), Positives = 134/264 (50%), Gaps = 21/264 (7%)

Query: 121 GSYGDLYKGTYCSQEVAIKVLKPECVNTEM--LKEFSQEVYIMRKIRHKNVVQFIGACTR 178
           G +G +YKG   +  VA+K L      T     ++F QE+ +M K +H+N+V+ +G  + 
Sbjct: 42  GGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD 101

Query: 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQL--TSLLKVAIDVSKGMNYLHQNNIIHRDLKT 236
             +LC+V  +M  GS+ D L    G   L      K+A   + G+N+LH+N+ IHRD+K+
Sbjct: 102 GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKS 161

Query: 237 ANLLMDENGVVKVADFGVAR---VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           AN+L+DE    K++DFG+AR     AQ+ + +   GT  +MAPE +  +    K+D++SF
Sbjct: 162 ANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITP-KSDIYSF 220

Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKSLR----------PTI---PKHAHPRLAELL 340
           G+ L E++TG          Q  + + ++               +      +   +  + 
Sbjct: 221 GVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVA 280

Query: 341 ERCWQHDPTQRPNFSQITDILKQM 364
            +C      +RP+  ++  +L++M
Sbjct: 281 SQCLHEKKNKRPDIKKVQQLLQEM 304

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  171 bits (435), Expect = 2e-50
 Identities = 67/275 (24%), Positives = 130/275 (47%), Gaps = 26/275 (9%)

Query: 115 ECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
           +  +  G +G +YKG      +VA+K   PE  +++ ++EF  E+  +   RH ++V  I
Sbjct: 44  KFLIGHGVFGKVYKGVLRDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLI 101

Query: 174 GACTRPPNLCIVTEFMARGSIYDFLH-KQKGVFQLT--SLLKVAIDVSKGMNYLHQNNII 230
           G C     + ++ ++M  G++   L+        ++    L++ I  ++G++YLH   II
Sbjct: 102 GFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAII 161

Query: 231 HRDLKTANLLMDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPE-VIEHKPYDY 286
           HRD+K+ N+L+DEN V K+ DFG+++   +     + T   GT  ++ PE  I+ +  + 
Sbjct: 162 HRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTE- 220

Query: 287 KADVFSFGIALWELLTGELPYAGLTPLQAA---------------VGVVQKSLRPTIPKH 331
           K+DV+SFG+ L+E+L          P +                   +V  +L   I   
Sbjct: 221 KSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPE 280

Query: 332 AHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
           +  +  +   +C       RP+   +   L+  ++
Sbjct: 281 SLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  161 bits (409), Expect = 4e-47
 Identities = 60/254 (23%), Positives = 108/254 (42%), Gaps = 32/254 (12%)

Query: 121 GSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
           GS+  +Y+        EVAIK++ K       M++    EV I  +++H ++++      
Sbjct: 22  GSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE 81

Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVF----------QLTSLLKVAIDVSKGMNYLHQN 227
               + +V E    G +  +L  +   F          Q+ +          GM YLH +
Sbjct: 82  DSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIIT----------GMLYLHSH 131

Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYD 285
            I+HRDL  +NLL+  N  +K+ADFG+A  Q +       T  GT  +++PE+     + 
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLA-TQLKMPHEKHYTLCGTPNYISPEIATRSAHG 190

Query: 286 YKADVFSFGIALWELLTGELPY--AGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC 343
            ++DV+S G   + LL G  P+    +      V          +P        +L+ + 
Sbjct: 191 LESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV----VLADYEMPSFLSIEAKDLIHQL 246

Query: 344 WQHDPTQRPNFSQI 357
            + +P  R + S +
Sbjct: 247 LRRNPADRLSLSSV 260

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  162 bits (412), Expect = 7e-47
 Identities = 72/253 (28%), Positives = 123/253 (48%), Gaps = 31/253 (12%)

Query: 121 GSYGDLYKGT--YCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
           G +   ++ +     +  A K++ K   +     ++ S E+ I R + H++VV F G   
Sbjct: 52  GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 111

Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVF----------QLTSLLKVAIDVSKGMNYLHQN 227
               + +V E   R S+ + LHK++             Q+            G  YLH+N
Sbjct: 112 DNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVL----------GCQYLHRN 160

Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDY 286
            +IHRDLK  NL ++E+  VK+ DFG+A +V+          GT  ++APEV+  K + +
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF 220

Query: 287 KADVFSFGIALWELLTGELPY--AGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW 344
           + DV+S G  ++ LL G+ P+  + L      +    K    +IPKH +P  A L+++  
Sbjct: 221 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI----KKNEYSIPKHINPVAASLIQKML 276

Query: 345 QHDPTQRPNFSQI 357
           Q DPT RP  +++
Sbjct: 277 QTDPTARPTINEL 289

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  160 bits (407), Expect = 9e-47
 Identities = 64/240 (26%), Positives = 118/240 (49%), Gaps = 7/240 (2%)

Query: 121 GSYGDLY--KGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
           G +G++Y  +       +A+KVL K +     +  +  +EV I   +RH N+++  G   
Sbjct: 20  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 79

Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
               + ++ E+   G++Y  L ++   F          +++  ++Y H   +IHRD+K  
Sbjct: 80  DATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 138

Query: 238 NLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 297
           NLL+   G +K+ADFG + V A S   T   GT  ++ PE+IE + +D K D++S G+  
Sbjct: 139 NLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLC 197

Query: 298 WELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
           +E L G+ P+   T  +    + +       P        +L+ R  +H+P+QRP   ++
Sbjct: 198 YEFLVGKPPFEANTYQETYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREV 255

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  160 bits (408), Expect = 9e-47
 Identities = 72/253 (28%), Positives = 123/253 (48%), Gaps = 31/253 (12%)

Query: 121 GSYGDLYKGT--YCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
           G +   ++ +     +  A K++ K   +     ++ S E+ I R + H++VV F G   
Sbjct: 26  GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 85

Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVF----------QLTSLLKVAIDVSKGMNYLHQN 227
               + +V E   R S+ + LHK++             Q+            G  YLH+N
Sbjct: 86  DNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVL----------GCQYLHRN 134

Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDY 286
            +IHRDLK  NL ++E+  VK+ DFG+A +V+          GT  ++APEV+  K + +
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF 194

Query: 287 KADVFSFGIALWELLTGELPY--AGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW 344
           + DV+S G  ++ LL G+ P+  + L      +    K    +IPKH +P  A L+++  
Sbjct: 195 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI----KKNEYSIPKHINPVAASLIQKML 250

Query: 345 QHDPTQRPNFSQI 357
           Q DPT RP  +++
Sbjct: 251 QTDPTARPTINEL 263

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  161 bits (409), Expect = 9e-47
 Identities = 62/283 (21%), Positives = 109/283 (38%), Gaps = 46/283 (16%)

Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA-- 175
            G+  ++++G +       AIKV          +    +E  +++K+ HKN+V+      
Sbjct: 19  QGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEE 77

Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT--SLLKVAIDVSKGMNYLHQNNIIHRD 233
            T   +  ++ EF   GS+Y  L +    + L     L V  DV  GMN+L +N I+HR+
Sbjct: 78  ETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRN 137

Query: 234 LKTANLLM----DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE--------H 281
           +K  N++     D   V K+ DFG AR         +  GT  ++ P++ E         
Sbjct: 138 IKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQ 197

Query: 282 KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR---------------- 325
           K Y    D++S G+  +   TG LP+      +    V+ K +                 
Sbjct: 198 KKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENG 257

Query: 326 -----------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
                       ++ +     L  +L    + D  +   F Q 
Sbjct: 258 PIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  162 bits (411), Expect = 1e-46
 Identities = 69/299 (23%), Positives = 127/299 (42%), Gaps = 43/299 (14%)

Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLY--KGTYCSQEVAIKVLKPECVNTEMLKEFSQEV 158
           G  V E+   +L++   +A G +  +Y  +     +E A+K L       E  +   QEV
Sbjct: 20  GQTV-ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLL--SNEEEKNRAIIQEV 76

Query: 159 YIMRKIR-HKNVVQFIGACTRPPN--------LCIVTEFMARGSIYDFL--HKQKGVFQL 207
             M+K+  H N+VQF  A +              ++TE   +G + +FL   + +G    
Sbjct: 77  CFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTEL-CKGQLVEFLKKMESRGPLSC 135

Query: 208 TSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT 265
            ++LK+     + + ++H+    IIHRDLK  NLL+   G +K+ DFG A   +     +
Sbjct: 136 DTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYS 195

Query: 266 AET-------------GTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAG 309
                            T  +  PE+I+   + P   K D+++ G  L+ L   + P+  
Sbjct: 196 WSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255

Query: 310 LTPLQAAVGVVQKSLRPTIPKHAH--PRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
              L+   G      + +IP H         L+    Q +P +R + +++   L+++  
Sbjct: 256 GAKLRIVNG------KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score =  162 bits (410), Expect = 2e-46
 Identities = 63/250 (25%), Positives = 113/250 (45%), Gaps = 7/250 (2%)

Query: 122 SYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181
            +G+L      S+       K +       K++   + +  K R  ++     + +    
Sbjct: 110 KFGNLST-YLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV 168

Query: 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 241
                  +      + L+K      L  L+  +  V+KGM +L     IHRDL   N+L+
Sbjct: 169 EEKSLSDVEEEEAPEDLYK--DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 226

Query: 242 DENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIALW 298
            E  VVK+ DFG+AR   +      +       +WMAPE I  + Y  ++DV+SFG+ LW
Sbjct: 227 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 286

Query: 299 ELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
           E+ + G  PY G+   +     +++  R   P +  P + + +  CW  +P+QRP FS++
Sbjct: 287 EIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL 346

Query: 358 TDILKQMMKE 367
            + L  +++ 
Sbjct: 347 VEHLGNLLQA 356

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 88.1 bits (218), Expect = 1e-19
 Identities = 39/151 (25%), Positives = 67/151 (44%), Gaps = 16/151 (10%)

Query: 94  CIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECV 146
           C  +P D    WE    +LK+   +  G++G + +            + VA+K+LK    
Sbjct: 7   CERLPYD-ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT 65

Query: 147 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGV 204
           ++E  +    E+ I+  I  H NVV  +GACT+P   L ++ EF   G++  +L  ++  
Sbjct: 66  HSEH-RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE 124

Query: 205 FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
           F             +G +Y+     I  DLK
Sbjct: 125 FVPYKTKGA--RFRQGKDYV---GAIPVDLK 150

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  158 bits (401), Expect = 7e-46
 Identities = 63/240 (26%), Positives = 114/240 (47%), Gaps = 7/240 (2%)

Query: 121 GSYGDLY--KGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
           G +G++Y  +       +A+KVL K +     +  +  +E+ I   +RH N+++      
Sbjct: 25  GKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH 84

Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
               + ++ EF  RG +Y  L ++ G F          +++  ++Y H+  +IHRD+K  
Sbjct: 85  DRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPE 143

Query: 238 NLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 297
           NLLM   G +K+ADFG + V A S       GT  ++ PE+IE K +D K D++  G+  
Sbjct: 144 NLLMGYKGELKIADFGWS-VHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLC 202

Query: 298 WELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
           +E L G  P+   +  +    +V   L+   P        +L+ +  ++ P QR     +
Sbjct: 203 YEFLVGMPPFDSPSHTETHRRIVNVDLK--FPPFLSDGSKDLISKLLRYHPPQRLPLKGV 260

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  158 bits (401), Expect = 2e-45
 Identities = 52/251 (20%), Positives = 104/251 (41%), Gaps = 21/251 (8%)

Query: 127 YKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186
           ++       +  +       +   +   S ++  M     KN V  +   +    L I  
Sbjct: 81  WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQM 140

Query: 187 EFMARGSIYDFLHKQKGVFQL--TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 244
           +   + ++ D+++++  +        L + I +++ + +LH   ++HRDLK +N+    +
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD 200

Query: 245 GVVKVADFGVARV-------------QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVF 291
            VVKV DFG+                       T + GT  +M+PE I    Y +K D+F
Sbjct: 201 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIF 260

Query: 292 SFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           S G+ L+ELL     ++        +  V+    P +    +P+   +++      PT+R
Sbjct: 261 SLGLILFELLY---SFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTER 317

Query: 352 PNFSQITDILK 362
           P     TDI++
Sbjct: 318 PE---ATDIIE 325

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  158 bits (401), Expect = 2e-45
 Identities = 75/274 (27%), Positives = 123/274 (44%), Gaps = 27/274 (9%)

Query: 115 ECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
           +  +  G +G +YKG       VA+K LK E        +F  EV ++    H+N+++  
Sbjct: 35  KNILGRGGFGKVYKGRLADGTLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLR 93

Query: 174 GACTRPPNLCIVTEFMARGSIYDFLH-KQKGVFQLT--SLLKVAIDVSKGMNYLHQN--- 227
           G C  P    +V  +MA GS+   L  + +    L      ++A+  ++G+ YLH +   
Sbjct: 94  GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDP 153

Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVARVQ--AQSGVMTAETGTYRWMAPEVIEHKPYD 285
            IIHRD+K AN+L+DE     V DFG+A++     + V TA  GT   +APE +      
Sbjct: 154 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 213

Query: 286 YKADVFSFGIALWELLTGELPYAGLTPLQA-----------------AVGVVQKSLRPTI 328
            K DVF +G+ L EL+TG+  +                            +V   L+   
Sbjct: 214 EKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNY 273

Query: 329 PKHAHPRLAELLERCWQHDPTQRPNFSQITDILK 362
                 +L ++   C Q  P +RP  S++  +L+
Sbjct: 274 KDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  160 bits (407), Expect = 2e-45
 Identities = 60/254 (23%), Positives = 114/254 (44%), Gaps = 22/254 (8%)

Query: 120 SGSYGD-LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACT 177
            G+ G  +Y+G + +++VA+K + PEC          +EV ++R+   H NV+++     
Sbjct: 34  HGAEGTIVYRGMFDNRDVAVKRILPEC-----FSFADREVQLLRESDEHPNVIRYFCTEK 88

Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
                 I  E  A  ++ +++ ++         + +    + G+ +LH  NI+HRDLK  
Sbjct: 89  DRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPH 147

Query: 238 NLLMDENG-----VVKVADFGVARV----QAQSGVMTAETGTYRWMAPEVIE---HKPYD 285
           N+L+            ++DFG+ +     +      +   GT  W+APE++     +   
Sbjct: 148 NILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPT 207

Query: 286 YKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSL-RPTIPKHAHPRLAELLERC 343
           Y  D+FS G   + +++ G  P+      QA + +   SL      KH      EL+E+ 
Sbjct: 208 YTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKM 267

Query: 344 WQHDPTQRPNFSQI 357
              DP +RP+   +
Sbjct: 268 IAMDPQKRPSAKHV 281

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  158 bits (402), Expect = 7e-45
 Identities = 67/300 (22%), Positives = 117/300 (39%), Gaps = 50/300 (16%)

Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA-- 175
            G+  ++++G +       AIKV          +    +E  +++K+ HKN+V+      
Sbjct: 19  QGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEE 77

Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT--SLLKVAIDVSKGMNYLHQNNIIHRD 233
            T   +  ++ EF   GS+Y  L +    + L     L V  DV  GMN+L +N I+HR+
Sbjct: 78  ETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRN 137

Query: 234 LKTANLLM----DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE--------H 281
           +K  N++     D   V K+ DFG AR         +  GT  ++ P++ E         
Sbjct: 138 IKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQ 197

Query: 282 KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR---------------- 325
           K Y    D++S G+  +   TG LP+      +    V+ K +                 
Sbjct: 198 KKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENG 257

Query: 326 -----------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQI----TDILKQMMKEVLY 370
                       ++ +     L  +L    + D  +   F Q     +DIL +M+  V  
Sbjct: 258 PIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVIHVFS 317

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  162 bits (411), Expect = 2e-44
 Identities = 69/274 (25%), Positives = 113/274 (41%), Gaps = 38/274 (13%)

Query: 120 SGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI---- 173
           +G +G + +       ++VAIK  + E ++ +  + +  E+ IM+K+ H NVV       
Sbjct: 24  TGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPD 82

Query: 174 --GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT--SLLKVAIDVSKGMNYLHQNNI 229
                       +  E+   G +  +L++ +    L    +  +  D+S  + YLH+N I
Sbjct: 83  GLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRI 142

Query: 230 IHRDLKTANLLMDENG---VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY 286
           IHRDLK  N+++       + K+ D G A+   Q  + T   GT +++APE++E K Y  
Sbjct: 143 IHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTV 202

Query: 287 KADVFSFGIALWELLTGELPYAGLTP------------------LQAAVGVVQKSLRPTI 328
             D +SFG   +E +TG  P+                            G V+ S     
Sbjct: 203 TVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPT 262

Query: 329 PKHAHPRLAELLERCW-----QHDPTQRPNFSQI 357
           P H    LA  LER W          QR    Q 
Sbjct: 263 PNHLSGILAGKLER-WLQCMLMWHQRQRGTDPQN 295

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  153 bits (389), Expect = 5e-44
 Identities = 64/249 (25%), Positives = 119/249 (47%), Gaps = 11/249 (4%)

Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRHKNV 169
           KI  K+  G    +Y    T  + +VAIK +        E LK F +EV+   ++ H+N+
Sbjct: 14  KIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNI 73

Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
           V  I          +V E++   ++ +++    G   + + +     +  G+ + H   I
Sbjct: 74  VSMIDVDEEDDCYYLVMEYIEGPTLSEYIE-SHGPLSVDTAINFTNQILDGIKHAHDMRI 132

Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYK 287
           +HRD+K  N+L+D N  +K+ DFG+A+  +++ +       GT ++ +PE  + +  D  
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192

Query: 288 ADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE----RC 343
            D++S GI L+E+L GE P+ G T +  A+  +Q S+ P +       + + L     R 
Sbjct: 193 TDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV-PNVTTDVRKDIPQSLSNVILRA 251

Query: 344 WQHDPTQRP 352
            + D   R 
Sbjct: 252 TEKDKANRY 260

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  152 bits (387), Expect = 4e-43
 Identities = 55/281 (19%), Positives = 101/281 (35%), Gaps = 46/281 (16%)

Query: 121 GSYGDLYKGTYCSQEVAIKVLK---------------PECVNTEMLKEFSQEVYIMRKIR 165
           G +  +      ++  A+K  +                +        +F  E+ I+  I+
Sbjct: 42  GKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK 101

Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK------ 219
           ++  +   G  T    + I+ E+M   SI  F      V        + I V K      
Sbjct: 102 NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEY-FFVLDKNYTCFIPIQVIKCIIKSV 160

Query: 220 --GMNYLH-QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAP 276
               +Y+H + NI HRD+K +N+LMD+NG VK++DFG +        +    GTY +M P
Sbjct: 161 LNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES-EYMVDKKIKGSRGTYEFMPP 219

Query: 277 EVIEHKP--YDYKADVFSFGIALWELLTGELPYAGLTPLQA------------------A 316
           E   ++      K D++S GI L+ +    +P++    L                     
Sbjct: 220 EFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHF 279

Query: 317 VGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
           +  +                 + L+   + +P +R      
Sbjct: 280 LYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDA 320

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  151 bits (383), Expect = 6e-43
 Identities = 67/257 (26%), Positives = 118/257 (45%), Gaps = 22/257 (8%)

Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRHKNV 169
           ++   +  G   +++        ++VA+KVL+ +   +      F +E      + H  +
Sbjct: 15  ELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 74

Query: 170 VQF--IGACTRPPNLC--IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
           V     G    P      IV E++   ++ D +H  +G       ++V  D  + +N+ H
Sbjct: 75  VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNFSH 133

Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET----GTYRWMAPEVIEH 281
           QN IIHRD+K AN+++     VKV DFG+AR  A SG    +T    GT ++++PE    
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193

Query: 282 KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ------KSLRPTIPKHAHPR 335
              D ++DV+S G  L+E+LTGE P+ G +P+  A   V+       +    +       
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS----AD 249

Query: 336 LAELLERCWQHDPTQRP 352
           L  ++ +    +P  R 
Sbjct: 250 LDAVVLKALAKNPENRY 266

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  148 bits (376), Expect = 2e-41
 Identities = 49/313 (15%), Positives = 111/313 (35%), Gaps = 43/313 (13%)

Query: 106 EIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEV 158
           ++ +K + +   +  G++  +Y+ T          Q+  +KV KP     E      Q +
Sbjct: 61  QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW-EFYIGT-QLM 118

Query: 159 YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK----GVFQLTSLLKVA 214
             ++       ++F  A        +V E  + G++ + ++  K     V     ++  A
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178

Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLM-----------DENGVVKVADFGVA---RVQAQ 260
           + +   +  +H   IIH D+K  N ++           D +  + + D G +   ++  +
Sbjct: 179 MRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK 238

Query: 261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320
             + TA+  T  +   E++ +KP++Y+ D F     ++ +L G                 
Sbjct: 239 GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG-------G 291

Query: 321 QKSLRPTIPKHAHPRL-AELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINT 379
           +        +  H  +  E                    D+L+Q +K+       +  N 
Sbjct: 292 ECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHL---PSLDLLRQKLKK---VFQQHYTNK 345

Query: 380 NIQSTYKHLLFFL 392
                 ++ L  L
Sbjct: 346 IR--ALRNRLIVL 356

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  147 bits (374), Expect = 2e-41
 Identities = 71/236 (30%), Positives = 115/236 (48%), Gaps = 26/236 (11%)

Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 193
           +EVAIK++    +N   L++  +EV IM+ + H N+V+          L ++ E+ + G 
Sbjct: 41  REVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGE 100

Query: 194 IYDFLHKQKGV--------F-QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 244
           ++D+L     +        F Q+ S           + Y HQ  I+HRDLK  NLL+D +
Sbjct: 101 VFDYLVAHGRMKEKEARSKFRQIVS----------AVQYCHQKRIVHRDLKAENLLLDAD 150

Query: 245 GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYD-YKADVFSFGIALWELLTG 303
             +K+ADFG +      G + A  G   + APE+ + K YD  + DV+S G+ L+ L++G
Sbjct: 151 MNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

Query: 304 ELPYAG--LTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
            LP+ G  L  L+  V       +  IP +       LL+R    +P +R    QI
Sbjct: 211 SLPFDGQNLKELRERV----LRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQI 262

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  147 bits (371), Expect = 9e-41
 Identities = 33/291 (11%), Positives = 86/291 (29%), Gaps = 45/291 (15%)

Query: 110 KQLKIECKVASGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRH 166
           ++LK+   +  G    ++        ++ A+KV       +   L+   +  +   ++  
Sbjct: 62  RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG 121

Query: 167 KNVVQFIGAC--------------------------TRPPNLCIVTEFMAR-----GSIY 195
           ++  +                                   N  ++    +       S  
Sbjct: 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTL 181

Query: 196 DFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255
           DF++  +G   + +L  +   + +    L    ++H      NL +  +G + + D    
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSAL 241

Query: 256 RVQAQSGVMTAETGTYRWMAPEVIEHK--PYDYKADVFSFGIALWELLTGELPYAGLTPL 313
                 G  ++   TY     E +      + +  + +  G++++ +    LP+  +TP 
Sbjct: 242 WKVGTRGPASSVPVTY--APREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299

Query: 314 QAAVGVVQKSLRPTIP-------KHAHPRLAELLERCWQHDPTQRPNFSQI 357
                       P                +  L+ R    D  +R    + 
Sbjct: 300 IKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEA 350

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  144 bits (365), Expect = 4e-40
 Identities = 57/257 (22%), Positives = 107/257 (41%), Gaps = 37/257 (14%)

Query: 120 SGSYGDLYKGTYCS--QEVAIKVL------KPECVNTEMLKEFSQEVYIMRKIRHKNVVQ 171
           SG++G ++        +EV +K +      +   +    L + + E+ I+ ++ H N+++
Sbjct: 34  SGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIK 93

Query: 172 FIGACTRPPNLCIVTEFMARGS-IYDFLHKQ--------KGVF-QLTSLLKVAIDVSKGM 221
            +          +V E    G  ++ F+ +           +F QL S    A+      
Sbjct: 94  VLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS----AVG----- 144

Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH 281
            YL   +IIHRD+K  N+++ E+  +K+ DFG A    +  +     GT  + APEV+  
Sbjct: 145 -YLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMG 203

Query: 282 KPYD-YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELL 340
            PY   + +++S G+ L+ L+  E P+  L     A            P      L  L+
Sbjct: 204 NPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEA--------AIHPPYLVSKELMSLV 255

Query: 341 ERCWQHDPTQRPNFSQI 357
               Q  P +R    ++
Sbjct: 256 SGLLQPVPERRTTLEKL 272

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  140 bits (355), Expect = 7e-39
 Identities = 51/251 (20%), Positives = 97/251 (38%), Gaps = 17/251 (6%)

Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKE-FSQEVYIMRKIRHKNV 169
           ++   V  G  GD+Y+   T   + VA+K++     +  + +    +E     +++  +V
Sbjct: 37  RLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHV 96

Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
           V           L +    +    +   L +++G       + +   +   ++  H    
Sbjct: 97  VPIHDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAHAAGA 155

Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYK 287
            HRD+K  N+L+  +    + DFG+A       +       GT  +MAPE        Y+
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYR 215

Query: 288 ADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ------KSLRPTIPKHAHPRLAELLE 341
           AD+++    L+E LTG  PY G   L      +        ++RP IP         ++ 
Sbjct: 216 ADIYALTCVLYECLTGSPPYQG-DQLSVMGAHINQAIPRPSTVRPGIP----VAFDAVIA 270

Query: 342 RCWQHDPTQRP 352
           R    +P  R 
Sbjct: 271 RGMAKNPEDRY 281

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  139 bits (352), Expect = 1e-38
 Identities = 62/252 (24%), Positives = 127/252 (50%), Gaps = 29/252 (11%)

Query: 121 GSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
           G++G +  G +     +VA+K+L + +  + +++ +  +E+  ++  RH ++++     +
Sbjct: 22  GTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS 81

Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGV--------F-QLTSLLKVAIDVSKGMNYLHQNN 228
            P +  +V E+++ G ++D++ K   V        F Q+ S           ++Y H++ 
Sbjct: 82  TPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS----------AVDYCHRHM 131

Query: 229 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYD-YK 287
           ++HRDLK  N+L+D +   K+ADFG++ + +    +    G+  + APEVI  + Y   +
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPE 191

Query: 288 ADVFSFGIALWELLTGELPYAG--LTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 345
            D++S G+ L+ LL G LP+    +  L   +    +     IP++ +  +A LL    Q
Sbjct: 192 VDIWSCGVILYALLCGTLPFDDEHVPTLFKKI----RGGVFYIPEYLNRSVATLLMHMLQ 247

Query: 346 HDPTQRPNFSQI 357
            DP +R     I
Sbjct: 248 VDPLKRATIKDI 259

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  139 bits (352), Expect = 1e-38
 Identities = 70/281 (24%), Positives = 117/281 (41%), Gaps = 58/281 (20%)

Query: 121 GSYGDLYKGT--YCSQEVAIKVL------------------------KPECVNTEMLKEF 154
           GSYG +        +   A+KVL                                 +++ 
Sbjct: 24  GSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQV 83

Query: 155 SQEVYIMRKIRHKNVVQF---IGACTRPPNLCIVTEFMARGSIYDFLHKQK-------GV 204
            QE+ I++K+ H NVV+    +       +L +V E + +G + +    +          
Sbjct: 84  YQEIAILKKLDHPNVVKLVEVLDDPNED-HLYMVFELVNQGPVMEVPTLKPLSEDQARFY 142

Query: 205 FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 264
           FQ         D+ KG+ YLH   IIHRD+K +NLL+ E+G +K+ADFGV+     S  +
Sbjct: 143 FQ---------DLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193

Query: 265 TAET-GTYRWMAPEVI--EHKPYD-YKADVFSFGIALWELLTGELPYAG--LTPLQAAVG 318
            + T GT  +MAPE +    K +     DV++ G+ L+  + G+ P+    +  L + + 
Sbjct: 194 LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKI- 252

Query: 319 VVQKSLRPTIPKHAH--PRLAELLERCWQHDPTQRPNFSQI 357
              KS     P        L +L+ R    +P  R    +I
Sbjct: 253 ---KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEI 290

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  140 bits (355), Expect = 6e-38
 Identities = 57/276 (20%), Positives = 114/276 (41%), Gaps = 45/276 (16%)

Query: 120 SGSYGDL-YKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACT 177
            GS G + ++G++  + VA+K +  +            E+ ++ +   H NV+++  + T
Sbjct: 25  YGSSGTVVFQGSFQGRPVAVKRMLIDFC-----DIALMEIKLLTESDDHPNVIRYYCSET 79

Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK-------GMNYLHQNNII 230
               L I  E     ++ D + + K V      L+   +          G+ +LH   II
Sbjct: 80  TDRFLYIALELCN-LNLQDLV-ESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKII 137

Query: 231 HRDLKTANLLMD-------------ENGVVKVADFGVARV-----QAQSGVMTAETGTYR 272
           HRDLK  N+L+              EN  + ++DFG+ +       +    +   +GT  
Sbjct: 138 HRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSG 197

Query: 273 WMAPEVIE-------HKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV--GVVQ- 321
           W APE++E        +      D+FS G   + +L+ G+ P+      ++ +  G+   
Sbjct: 198 WRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSL 257

Query: 322 KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
             ++    +       +L+ +   HDP +RP   ++
Sbjct: 258 DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  136 bits (345), Expect = 9e-38
 Identities = 64/254 (25%), Positives = 113/254 (44%), Gaps = 27/254 (10%)

Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
            G+YG++         + VA+K++  +    +  +   +E+ I + + H+NVV+F G   
Sbjct: 17  EGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRR 75

Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGV--------F-QLTSLLKVAIDVSKGMNYLHQNN 228
                 +  E+ + G ++D +    G+        F QL +          G+ YLH   
Sbjct: 76  EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA----------GVVYLHGIG 125

Query: 229 IIHRDLKTANLLMDENGVVKVADFG---VARVQAQSGVMTAETGTYRWMAPEVIEHKPYD 285
           I HRD+K  NLL+DE   +K++DFG   V R   +  ++    GT  ++APE+++ + + 
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185

Query: 286 -YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP-KHAHPRLAELLERC 343
               DV+S GI L  +L GELP+   +         ++      P K        LL + 
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 245

Query: 344 WQHDPTQRPNFSQI 357
              +P+ R     I
Sbjct: 246 LVENPSARITIPDI 259

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  135 bits (343), Expect = 7e-37
 Identities = 71/252 (28%), Positives = 123/252 (48%), Gaps = 30/252 (11%)

Query: 121 GSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
           GS+G +   T+    Q+VA+K + +     ++M     +E+  ++ +RH ++++     T
Sbjct: 20  GSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT 79

Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGV--------F-QLTSLLKVAIDVSKGMNYLHQNN 228
            P ++ +V E+ A G ++D++ ++K +        F Q+             + Y H++ 
Sbjct: 80  TPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIIC----------AIEYCHRHK 128

Query: 229 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYD-YK 287
           I+HRDLK  NLL+D+N  VK+ADFG++ +      +    G+  + APEVI  K Y   +
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPE 188

Query: 288 ADVFSFGIALWELLTGELPYAG--LTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 345
            DV+S GI L+ +L G LP+    +  L   V     S    +P    P    L+ R   
Sbjct: 189 VDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV----NSCVYVMPDFLSPGAQSLIRRMIV 244

Query: 346 HDPTQRPNFSQI 357
            DP QR    +I
Sbjct: 245 ADPMQRITIQEI 256

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  135 bits (341), Expect = 1e-36
 Identities = 64/254 (25%), Positives = 113/254 (44%), Gaps = 27/254 (10%)

Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
            G+YG++         + VA+K++  +    +  +   +E+ I + + H+NVV+F G   
Sbjct: 17  EGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRR 75

Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGV--------F-QLTSLLKVAIDVSKGMNYLHQNN 228
                 +  E+ + G ++D +    G+        F QL +          G+ YLH   
Sbjct: 76  EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA----------GVVYLHGIG 125

Query: 229 IIHRDLKTANLLMDENGVVKVADFG---VARVQAQSGVMTAETGTYRWMAPEVIEHKPYD 285
           I HRD+K  NLL+DE   +K++DFG   V R   +  ++    GT  ++APE+++ + + 
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185

Query: 286 -YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP-KHAHPRLAELLERC 343
               DV+S GI L  +L GELP+   +         ++      P K        LL + 
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 245

Query: 344 WQHDPTQRPNFSQI 357
              +P+ R     I
Sbjct: 246 LVENPSARITIPDI 259

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  138 bits (349), Expect = 1e-36
 Identities = 61/252 (24%), Positives = 128/252 (50%), Gaps = 29/252 (11%)

Query: 121 GSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
           G++G +  G +     +VA+K+L + +  + +++ +  +E+  ++  RH ++++     +
Sbjct: 27  GTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS 86

Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGV--------F-QLTSLLKVAIDVSKGMNYLHQNN 228
            P ++ +V E+++ G ++D++ K   +        F Q+ S          G++Y H++ 
Sbjct: 87  TPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS----------GVDYCHRHM 136

Query: 229 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYD-YK 287
           ++HRDLK  N+L+D +   K+ADFG++ + +    +    G+  + APEVI  + Y   +
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPE 196

Query: 288 ADVFSFGIALWELLTGELPYAG--LTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 345
            D++S G+ L+ LL G LP+    +  L   +           P++ +P +  LL+   Q
Sbjct: 197 VDIWSSGVILYALLCGTLPFDDDHVPTLFKKI----CDGIFYTPQYLNPSVISLLKHMLQ 252

Query: 346 HDPTQRPNFSQI 357
            DP +R     I
Sbjct: 253 VDPMKRATIKDI 264

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  134 bits (339), Expect = 1e-36
 Identities = 61/262 (23%), Positives = 105/262 (40%), Gaps = 45/262 (17%)

Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNT----EMLKEFSQEVYIMRKIR----HKNV 169
            G +G ++ G   +   +VAIKV+    V              EV ++ K+     H  V
Sbjct: 41  KGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGV 100

Query: 170 VQFIGACTRPPNLCIVTEFMARGS-IYDFLHKQ--------KGVF-QLTSLLKVAIDVSK 219
           ++ +          +V E       ++D++ ++        +  F Q+ +    AI    
Sbjct: 101 IRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA----AIQ--- 153

Query: 220 GMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
              + H   ++HRD+K  N+L+D   G  K+ DFG   +       T   GT  +  PE 
Sbjct: 154 ---HCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL-HDEPYTDFDGTRVYSPPEW 209

Query: 279 IEHKPYD-YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPR 335
           I    Y    A V+S GI L++++ G++P+             Q+ L      P H  P 
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVCGDIPFER----------DQEILEAELHFPAHVSPD 259

Query: 336 LAELLERCWQHDPTQRPNFSQI 357
              L+ RC    P+ RP+  +I
Sbjct: 260 CCALIRRCLAPKPSSRPSLEEI 281

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  138 bits (349), Expect = 1e-36
 Identities = 70/256 (27%), Positives = 124/256 (48%), Gaps = 17/256 (6%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           +   K+ SG+YG++          E AIK+++   V+T    +  +EV +++ + H N++
Sbjct: 40  QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99

Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
           +         N  +V E    G ++D +   +  F       +   V  G+ YLH++NI+
Sbjct: 100 KLYDFFEDKRNYYLVMECYKGGELFDEI-IHRMKFNEVDAAVIIKQVLSGVTYLHKHNIV 158

Query: 231 HRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK 287
           HRDLK  NLL+   +++ ++K+ DFG++ V      M    GT  ++APEV+  K YD K
Sbjct: 159 HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL-RKKYDEK 217

Query: 288 ADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR------PTIPKHAHPRLAELLE 341
            DV+S G+ L+ LL G  P+ G T  +    V +            + + A     +L++
Sbjct: 218 CDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGA----KDLIK 273

Query: 342 RCWQHDPTQRPNFSQI 357
           +  Q D  +R +  Q 
Sbjct: 274 QMLQFDSQRRISAQQA 289

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  137 bits (347), Expect = 2e-36
 Identities = 63/257 (24%), Positives = 118/257 (45%), Gaps = 18/257 (7%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNV 169
           K +  +  GS+G++         QE A+KV+ K +       +   +EV +++++ H N+
Sbjct: 29  KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88

Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
           ++            +V E    G ++D +   +  F      ++   V  G+ Y+H+N I
Sbjct: 89  MKLYEFFEDKGYFYLVGEVYTGGELFDEI-ISRKRFSEVDAARIIRQVLSGITYMHKNKI 147

Query: 230 IHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY 286
           +HRDLK  NLL+    ++  +++ DFG++     S  M  + GT  ++APEV+ H  YD 
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTYDE 206

Query: 287 KADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR------PTIPKHAHPRLAELL 340
           K DV+S G+ L+ LL+G  P+ G         V +            + + A     +L+
Sbjct: 207 KCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA----KDLI 262

Query: 341 ERCWQHDPTQRPNFSQI 357
            +   + P+ R +    
Sbjct: 263 RKMLTYVPSMRISARDA 279

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  134 bits (338), Expect = 2e-36
 Identities = 59/258 (22%), Positives = 110/258 (42%), Gaps = 39/258 (15%)

Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNT----EMLKEFSQEVYIMRKIRHK--NVVQ 171
           SG +G +Y G   S    VAIK ++ + ++             EV +++K+      V++
Sbjct: 53  SGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 112

Query: 172 FIGACTRPPNLCIVTEFMA-RGSIYDFLHKQ--------KGVF-QLTSLLKVAIDVSKGM 221
            +    RP +  ++ E       ++DF+ ++        +  F Q+      A+      
Sbjct: 113 LLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE----AVR----- 163

Query: 222 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 280
            + H   ++HRD+K  N+L+D N G +K+ DFG   +  +  V T   GT  +  PE I 
Sbjct: 164 -HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIR 221

Query: 281 HKPYD-YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
           +  Y    A V+S GI L++++ G++P+     +           +    +        L
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG--------QVFFRQRVSSECQHL 273

Query: 340 LERCWQHDPTQRPNFSQI 357
           +  C    P+ RP F +I
Sbjct: 274 IRWCLALRPSDRPTFEEI 291

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  137 bits (347), Expect = 2e-36
 Identities = 68/256 (26%), Positives = 119/256 (46%), Gaps = 17/256 (6%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
            I C +  GS+G++ K       QE A+KV+       +      +EV +++K+ H N++
Sbjct: 25  NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84

Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
           +         +  IV E    G ++D +  ++  F      ++   V  G+ Y+H++NI+
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAARIIKQVFSGITYMHKHNIV 143

Query: 231 HRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK 287
           HRDLK  N+L+   +++  +K+ DFG++    Q+  M    GT  ++APEV+    YD K
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYDEK 202

Query: 288 ADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR------PTIPKHAHPRLAELLE 341
            DV+S G+ L+ LL+G  P+ G         V             TI   A     +L+ 
Sbjct: 203 CDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA----KDLIR 258

Query: 342 RCWQHDPTQRPNFSQI 357
           +     P+ R   +Q 
Sbjct: 259 KMLTFHPSLRITATQC 274

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  134 bits (339), Expect = 4e-36
 Identities = 68/257 (26%), Positives = 113/257 (43%), Gaps = 33/257 (12%)

Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
           SG++G           + VA+K ++      E ++   +E+   R +RH N+V+F     
Sbjct: 30  SGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ---REIINHRSLRHPNIVRFKEVIL 86

Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVF----------QLTSLLKVAIDVSKGMNYLHQN 227
            P +L I+ E+ + G +Y+ +    G F          QL S          G++Y H  
Sbjct: 87  TPTHLAIIMEYASGGELYERI-CNAGRFSEDEARFFFQQLLS----------GVSYCHSM 135

Query: 228 NIIHRDLKTANLLMDENGV--VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYD 285
            I HRDLK  N L+D +    +K+ DFG ++         +  GT  ++APEV+  + YD
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYD 195

Query: 286 -YKADVFSFGIALWELLTGELPYAG--LTPLQAAVGVVQKSLRPTIPKHAH--PRLAELL 340
              ADV+S G+ L+ +L G  P+                 S++ +IP      P    L+
Sbjct: 196 GKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLI 255

Query: 341 ERCWQHDPTQRPNFSQI 357
            R +  DP  R +  +I
Sbjct: 256 SRIFVADPATRISIPEI 272

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  132 bits (333), Expect = 8e-36
 Identities = 64/261 (24%), Positives = 115/261 (44%), Gaps = 39/261 (14%)

Query: 121 GSYGDLYKGTYCS--QEVAIKVLKPECVNT--EMLKEFSQEVYIMRKIRHKNVVQF---I 173
           GSYG + +          A+K+LK + +           +E+ ++R++RHKNV+Q    +
Sbjct: 16  GSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVL 75

Query: 174 GACTRPPNLCIVTEFMARGS--IYDFLHKQK-------GVF-QLTSLLKVAIDVSKGMNY 223
                   + +V E+   G   + D + +++       G F QL            G+ Y
Sbjct: 76  YNEE-KQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID----------GLEY 124

Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ---AQSGVMTAETGTYRWMAPEVIE 280
           LH   I+H+D+K  NLL+   G +K++  GVA      A         G+  +  PE+  
Sbjct: 125 LHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184

Query: 281 -HKPYD-YKADVFSFGIALWELLTGELPYAG--LTPLQAAVGVVQKSLRPTIPKHAHPRL 336
               +  +K D++S G+ L+ + TG  P+ G  +  L   +          IP    P L
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI----GKGSYAIPGDCGPPL 240

Query: 337 AELLERCWQHDPTQRPNFSQI 357
           ++LL+   +++P +R +  QI
Sbjct: 241 SDLLKGMLEYEPAKRFSIRQI 261

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  133 bits (336), Expect = 1e-35
 Identities = 39/286 (13%), Positives = 88/286 (30%), Gaps = 59/286 (20%)

Query: 120 SGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIR----------- 165
                   + T     +   + V    E   +  +K+  +EV  +R +R           
Sbjct: 83  QEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 142

Query: 166 --------------HKNVVQFIGACTRPPNLCIVTEFM-ARGSIYDFLH------KQKGV 204
                          K +++          L     +   + ++  F             
Sbjct: 143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS 202

Query: 205 FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 264
               + L++ + V + +  LH   ++H  L+  ++++D+ G V +  F       + G  
Sbjct: 203 LVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV---RDGAR 259

Query: 265 TAETGTYRWMAPEVI-----------EHKPYDYKADVFSFGIALWELLTGELPYAGLTPL 313
              + +  +  PE+                  +  D ++ G+ ++ +   +LP       
Sbjct: 260 VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK---- 315

Query: 314 QAAVGVVQKSLR--PTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
            AA+G  +   R    IP+        LLE   ++    R    Q 
Sbjct: 316 DAALGGSEWIFRSCKNIPQPVR----ALLEGFLRYPKEDRLLPLQA 357

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  130 bits (329), Expect = 3e-35
 Identities = 57/192 (29%), Positives = 101/192 (52%), Gaps = 7/192 (3%)

Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
            GS+G++ K       QE A+KV+       +      +EV +++K+ H N+++      
Sbjct: 32  KGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE 91

Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
              +  IV E    G ++D +  ++  F      ++   V  G+ Y+H++NI+HRDLK  
Sbjct: 92  DSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPE 150

Query: 238 NLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           N+L+   +++  +K+ DFG++    Q+  M    GT  ++APEV+    YD K DV+S G
Sbjct: 151 NILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYDEKCDVWSAG 209

Query: 295 IALWELLTGELP 306
           + L+ LL+G  P
Sbjct: 210 VILYILLSGTPP 221

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  129 bits (328), Expect = 3e-35
 Identities = 46/192 (23%), Positives = 93/192 (48%), Gaps = 6/192 (3%)

Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
            G++  + +  + +   E A K++  + ++    ++  +E  I RK++H N+V+   +  
Sbjct: 16  KGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 75

Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
                 +V + +  G +++ +   +  +           + + + Y H N I+HR+LK  
Sbjct: 76  EESFHYLVFDLVTGGELFEDI-VAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPE 134

Query: 238 NLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           NLL+    +   VK+ADFG+A     S       GT  +++PEV++  PY    D+++ G
Sbjct: 135 NLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACG 194

Query: 295 IALWELLTGELP 306
           + L+ LL G  P
Sbjct: 195 VILYILLVGYPP 206

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  135 bits (342), Expect = 4e-35
 Identities = 48/248 (19%), Positives = 89/248 (35%), Gaps = 25/248 (10%)

Query: 113 KIECKVASGSYGDLYKGT---YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV 169
           +++  +A G  G +Y         + V +K L     + E       E   + ++ H ++
Sbjct: 83  EVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSI 141

Query: 170 VQFI-----GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
           VQ             P   IV E++   S+            +   +   +++   ++YL
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVAEAIAYLLEILPALSYL 198

Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPY 284
           H   +++ DLK  N+++ E   +K+ D G        G +    GT  + APE++   P 
Sbjct: 199 HSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSFGYL---YGTPGFQAPEIVRTGPT 254

Query: 285 DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW 344
               D+++ G  L  L        G    +   G+ +                 LL R  
Sbjct: 255 V-ATDIYTVGRTLAALTLDLPTRNG----RYVDGLPEDDPVLKTY----DSYGRLLRRAI 305

Query: 345 QHDPTQRP 352
             DP QR 
Sbjct: 306 DPDPRQRF 313

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  129 bits (326), Expect = 1e-34
 Identities = 41/201 (20%), Positives = 89/201 (44%), Gaps = 7/201 (3%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
            I   +  G +G +++    S  +    K +K +  +  ++K   +E+ I+   RH+N++
Sbjct: 8   MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHRNIL 64

Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
               +      L ++ EF++   I++ ++          ++     V + + +LH +NI 
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124

Query: 231 HRDLKTANLLM--DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKA 288
           H D++  N++     +  +K+ +FG AR                + APEV +H       
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT 184

Query: 289 DVFSFGIALWELLTGELPYAG 309
           D++S G  ++ LL+G  P+  
Sbjct: 185 DMWSLGTLVYVLLSGINPFLA 205

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  131 bits (330), Expect = 1e-34
 Identities = 35/283 (12%), Positives = 89/283 (31%), Gaps = 50/283 (17%)

Query: 120 SGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIR----------- 165
                   + T     +   + V    E   +  +K+  +EV  +R +R           
Sbjct: 88  QEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 147

Query: 166 -----------HKNVVQFIGACTRPPNLCIVTEFM----ARGSIYDFLH------KQKGV 204
                           + I       ++ +++ F      + ++  F             
Sbjct: 148 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS 207

Query: 205 FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 264
               + L++ + V + +  LH   ++H  L+  ++++D+ G V +  F        +  +
Sbjct: 208 LVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR-DGASAV 266

Query: 265 TAETGTY---RWMAPEVIEHKP-----YDYKADVFSFGIALWELLTGELPYAGLTPLQAA 316
           +     +      A  ++           +  D ++ G+A++ +   +LP      L  +
Sbjct: 267 SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS 326

Query: 317 VGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD 359
             + +      IP      +  LLE   ++    R    Q  +
Sbjct: 327 EWIFRSC--KNIP----QPVRALLEGFLRYPKEDRLLPLQAME 363

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  128 bits (323), Expect = 2e-34
 Identities = 49/193 (25%), Positives = 91/193 (47%), Gaps = 11/193 (5%)

Query: 120 SGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176
            GS+G++            A K + K    + +  K   QE+ IM+ + H N+++     
Sbjct: 19  RGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK---QEIEIMKSLDHPNIIRLYETF 75

Query: 177 TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT 236
               ++ +V E    G +++ +   K VF+ +   ++  DV   + Y H+ N+ HRDLK 
Sbjct: 76  EDNTDIYLVMELCTGGELFERV-VHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKP 134

Query: 237 ANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
            N L      +  +K+ DFG+A       +M  + GT  +++P+V+    Y  + D +S 
Sbjct: 135 ENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL-EGLYGPECDEWSA 193

Query: 294 GIALWELLTGELP 306
           G+ ++ LL G  P
Sbjct: 194 GVMMYVLLCGYPP 206

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  129 bits (326), Expect = 2e-34
 Identities = 61/297 (20%), Positives = 110/297 (37%), Gaps = 63/297 (21%)

Query: 120 SGSYGDLYKGTYCS--QEVAIKVL---KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
            GSYG +            AIK++   K   +N + ++    EV +M+K+ H N+ +   
Sbjct: 36  QGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYE 95

Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL----------------------- 211
                  +C+V E    G + D L+           +                       
Sbjct: 96  VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIH 155

Query: 212 ----------------KVAIDVSKGMNYLHQNNIIHRDLKTANLLM--DENGVVKVADFG 253
                            +   +   ++YLH   I HRD+K  N L   +++  +K+ DFG
Sbjct: 156 GFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFG 215

Query: 254 VARV-----QAQSGVMTAETGTYRWMAPEVIE--HKPYDYKADVFSFGIALWELLTGELP 306
           +++        +   MT + GT  ++APEV+   ++ Y  K D +S G+ L  LL G +P
Sbjct: 216 LSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275

Query: 307 YAGLTPLQAAVGVVQKSLR------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
           + G+        V+ K L         +   A     +LL      +  +R +  + 
Sbjct: 276 FPGVNDADTISQVLNKKLCFENPNYNVLSPLAR----DLLSNLLNRNVDERFDAMRA 328

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  130 bits (328), Expect = 2e-34
 Identities = 43/205 (20%), Positives = 104/205 (50%), Gaps = 14/205 (6%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNV 169
            I  ++ SG++G +++    +  +    K +  P  ++   +K    E+ IM ++ H  +
Sbjct: 54  DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK---NEISIMNQLHHPKL 110

Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF---QLTSLLKVAIDVSKGMNYLHQ 226
           +    A      + ++ EF++ G ++D +  +       ++ + ++      +G+ ++H+
Sbjct: 111 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR---QACEGLKHMHE 167

Query: 227 NNIIHRDLKTANLLM--DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPY 284
           ++I+H D+K  N++    +   VK+ DFG+A       ++   T T  + APE+++ +P 
Sbjct: 168 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV 227

Query: 285 DYKADVFSFGIALWELLTGELPYAG 309
            +  D+++ G+  + LL+G  P+AG
Sbjct: 228 GFYTDMWAIGVLGYVLLSGLSPFAG 252

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  128 bits (323), Expect = 2e-34
 Identities = 56/193 (29%), Positives = 103/193 (53%), Gaps = 11/193 (5%)

Query: 120 SGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176
           SG++ +++        +  A+K + K        L+    E+ +++KI+H+N+V      
Sbjct: 19  SGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIKHENIVTLEDIY 75

Query: 177 TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT 236
               +  +V + ++ G ++D +  ++GV+       V   V   + YLH+N I+HRDLK 
Sbjct: 76  ESTTHYYLVMQLVSGGELFDRI-LERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKP 134

Query: 237 ANLL---MDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
            NLL    +EN  + + DFG+++++ Q+G+M+   GT  ++APEV+  KPY    D +S 
Sbjct: 135 ENLLYLTPEENSKIMITDFGLSKME-QNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSI 193

Query: 294 GIALWELLTGELP 306
           G+  + LL G  P
Sbjct: 194 GVITYILLCGYPP 206

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  129 bits (327), Expect = 5e-34
 Identities = 56/263 (21%), Positives = 111/263 (42%), Gaps = 35/263 (13%)

Query: 120 SGSYGDLYKGTYCS--QEVAIKVLK------PECVNTEMLKEFSQEVYIMRKIRHKNVVQ 171
           SG+ G++         ++VAI+++             +       E+ I++K+ H  +++
Sbjct: 145 SGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK 204

Query: 172 FIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 231
                    +  IV E M  G ++D +       +  +       +   + YLH+N IIH
Sbjct: 205 IKNFFD-AEDYYIVLELMEGGELFDKV-VGNKRLKEATCKLYFYQMLLAVQYLHENGIIH 262

Query: 232 RDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE---HKPYD 285
           RDLK  N+L+   +E+ ++K+ DFG +++  ++ +M    GT  ++APEV+       Y+
Sbjct: 263 RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYN 322

Query: 286 YKADVFSFGIALWELLTGELP-YAGLTPLQAAVGVVQKSLR----------PTIPKHAHP 334
              D +S G+ L+  L+G  P     T     V +  +               + + A  
Sbjct: 323 RAVDCWSLGVILFICLSGYPPFSEHRTQ----VSLKDQITSGKYNFIPEVWAEVSEKA-- 376

Query: 335 RLAELLERCWQHDPTQRPNFSQI 357
              +L+++    DP  R    + 
Sbjct: 377 --LDLVKKLLVVDPKARFTTEEA 397

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  128 bits (323), Expect = 7e-34
 Identities = 46/192 (23%), Positives = 93/192 (48%), Gaps = 6/192 (3%)

Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
            G++  + +  + +   E A K++  + ++    ++  +E  I RK++H N+V+   +  
Sbjct: 39  KGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 98

Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
                 +V + +  G +++ +   +  +           + + + Y H N I+HR+LK  
Sbjct: 99  EESFHYLVFDLVTGGELFEDI-VAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPE 157

Query: 238 NLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           NLL+    +   VK+ADFG+A     S       GT  +++PEV++  PY    D+++ G
Sbjct: 158 NLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACG 217

Query: 295 IALWELLTGELP 306
           + L+ LL G  P
Sbjct: 218 VILYILLVGYPP 229

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  127 bits (321), Expect = 8e-34
 Identities = 53/218 (24%), Positives = 98/218 (44%), Gaps = 19/218 (8%)

Query: 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVY 159
            + + + +K+L        G +  + +    S  QE A K LK      +   E   E+ 
Sbjct: 27  NNFYILTSKEL------GRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIA 80

Query: 160 IMRKIRH-KNVVQFIGACTRPPNLCIVTEFMARGSIYDFL-HKQKGVF---QLTSLLKVA 214
           ++   +    V+           + ++ E+ A G I+     +   +     +  L+K  
Sbjct: 81  VLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIK-- 138

Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTY 271
             + +G+ YLHQNNI+H DLK  N+L+      G +K+ DFG++R    +  +    GT 
Sbjct: 139 -QILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTP 197

Query: 272 RWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAG 309
            ++APE++ + P     D+++ GI  + LLT   P+ G
Sbjct: 198 EYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVG 235

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  130 bits (329), Expect = 2e-33
 Identities = 52/202 (25%), Positives = 99/202 (49%), Gaps = 8/202 (3%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNV 169
            I  ++ +G++G +++ T  +     A K +  P   + E ++   +E+  M  +RH  +
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR---KEIQTMSVLRHPTL 216

Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
           V    A      + ++ EFM+ G +++ +  +         ++    V KG+ ++H+NN 
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNY 276

Query: 230 IHRDLKTANLLM--DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK 287
           +H DLK  N++     +  +K+ DFG+         +   TGT  + APEV E KP  Y 
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY 336

Query: 288 ADVFSFGIALWELLTGELPYAG 309
            D++S G+  + LL+G  P+ G
Sbjct: 337 TDMWSVGVLSYILLSGLSPFGG 358

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  127 bits (320), Expect = 2e-33
 Identities = 53/201 (26%), Positives = 95/201 (47%), Gaps = 16/201 (7%)

Query: 120 SGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEML--KEFSQEVYIMRKIRHKNVVQFIG 174
            G +  + +       Q+ A+K++   +  ++  L  ++  +E  I   ++H ++V+ + 
Sbjct: 34  KGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLE 93

Query: 175 ACTRPPNLCIVTEFMARGSIYDFL-HKQKGVFQLTSLLKVAIDVSK----GMNYLHQNNI 229
             +    L +V EFM    +   +  +    F  +    VA    +     + Y H NNI
Sbjct: 94  TYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSE--AVASHYMRQILEALRYCHDNNI 151

Query: 230 IHRDLKTANLLM---DENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVIEHKPYD 285
           IHRD+K   +L+   + +  VK+  FGVA  +     V     GT  +MAPEV++ +PY 
Sbjct: 152 IHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYG 211

Query: 286 YKADVFSFGIALWELLTGELP 306
              DV+  G+ L+ LL+G LP
Sbjct: 212 KPVDVWGCGVILFILLSGCLP 232

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  124 bits (315), Expect = 2e-33
 Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 17/210 (8%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLK----PECVNTEMLKEFSQEVYIMRKIRH 166
           ++  ++ SG +  + K       +E A K +K             +E  +EV I+R+IRH
Sbjct: 8   EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67

Query: 167 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF---QLTSLLKVAIDVSKGMNY 223
            N++          ++ ++ E ++ G ++DFL  +K      + T  LK    +  G++Y
Sbjct: 68  PNIITLHDIFENKTDVVLILELVSGGELFDFL-AEKESLTEDEATQFLK---QILDGVHY 123

Query: 224 LHQNNIIHRDLKTANLLM----DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI 279
           LH   I H DLK  N+++      N  +K+ DFG+A             GT  ++APE++
Sbjct: 124 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 183

Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAG 309
            ++P   +AD++S G+  + LL+G  P+ G
Sbjct: 184 NYEPLGLEADMWSIGVITYILLSGASPFLG 213

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  124 bits (314), Expect = 3e-33
 Identities = 57/247 (23%), Positives = 114/247 (46%), Gaps = 11/247 (4%)

Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
           SG++GD++     S   E  IK +  +      +++   E+ +++ + H N+++      
Sbjct: 32  SGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEVFE 90

Query: 178 RPPNLCIVTEFMARGSIYDFL---HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
              N+ IV E    G + + +     +        + ++   +   + Y H  +++H+DL
Sbjct: 91  DYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDL 150

Query: 235 KTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVF 291
           K  N+L      +  +K+ DFG+A +       T   GT  +MAPEV   +   +K D++
Sbjct: 151 KPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF-KRDVTFKCDIW 209

Query: 292 SFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR-PTIPKHAHPRLAELLERCWQHDPTQ 350
           S G+ ++ LLTG LP+ G +  +       K        +   P+  +LL++    DP +
Sbjct: 210 SAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPER 269

Query: 351 RPNFSQI 357
           RP+ +Q+
Sbjct: 270 RPSAAQV 276

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  125 bits (317), Expect = 5e-33
 Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 11/200 (5%)

Query: 120 SGSYGDLYKGTYCS--QEVAIKVLK----PECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
           SG +  + K    S   E A K +K             +E  +EV I+R++ H N++   
Sbjct: 22  SGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLH 81

Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
                  ++ ++ E ++ G ++DFL  QK              +  G+NYLH   I H D
Sbjct: 82  DVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLHTKKIAHFD 140

Query: 234 LKTANLLM----DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKAD 289
           LK  N+++         +K+ DFG+A             GT  ++APE++ ++P   +AD
Sbjct: 141 LKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEAD 200

Query: 290 VFSFGIALWELLTGELPYAG 309
           ++S G+  + LL+G  P+ G
Sbjct: 201 MWSIGVITYILLSGASPFLG 220

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  124 bits (314), Expect = 6e-33
 Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 11/200 (5%)

Query: 120 SGSYGDLYKGTYCS--QEVAIKVLK----PECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
           SG +  + K    S   E A K +K             +E  +EV I+R++ H NV+   
Sbjct: 22  SGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLH 81

Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
                  ++ ++ E ++ G ++DFL  QK              +  G+NYLH   I H D
Sbjct: 82  DVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLHTKKIAHFD 140

Query: 234 LKTANLLM----DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKAD 289
           LK  N+++         +K+ DFG+A             GT  ++APE++ ++P   +AD
Sbjct: 141 LKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEAD 200

Query: 290 VFSFGIALWELLTGELPYAG 309
           ++S G+  + LL+G  P+ G
Sbjct: 201 MWSIGVITYILLSGASPFLG 220

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  126 bits (319), Expect = 1e-32
 Identities = 42/193 (21%), Positives = 93/193 (48%), Gaps = 7/193 (3%)

Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
            G++  + +       QE A  ++  + ++    ++  +E  I R ++H N+V+   + +
Sbjct: 21  KGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS 80

Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
              +  ++ + +  G +++ +   +  +           + + + + HQ  ++HR+LK  
Sbjct: 81  EEGHHYLIFDLVTGGELFEDI-VAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPE 139

Query: 238 NLLM---DENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
           NLL+    +   VK+ADFG+A  V+ +        GT  +++PEV+   PY    D+++ 
Sbjct: 140 NLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWAC 199

Query: 294 GIALWELLTGELP 306
           G+ L+ LL G  P
Sbjct: 200 GVILYILLVGYPP 212

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  127 bits (320), Expect = 1e-32
 Identities = 61/260 (23%), Positives = 114/260 (43%), Gaps = 28/260 (10%)

Query: 120 SGSYGDLYKGTYCS--QEVAIKVLK-----------PECVNTEMLKEFSQEVYIMRKIRH 166
           SG+YG++      +   E AIKV+K                 +  +E   E+ +++ + H
Sbjct: 46  SGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDH 105

Query: 167 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 226
            N+++            +VTEF   G +++ +   +  F       +   +  G+ YLH+
Sbjct: 106 PNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI-INRHKFDECDAANIMKQILSGICYLHK 164

Query: 227 NNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKP 283
           +NI+HRD+K  N+L+   +    +K+ DFG++   ++   +    GT  ++APEV+  K 
Sbjct: 165 HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVL-KKK 223

Query: 284 YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR------PTIPKHAHPRLA 337
           Y+ K DV+S G+ ++ LL G  P+ G         V +            I   A     
Sbjct: 224 YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEA----K 279

Query: 338 ELLERCWQHDPTQRPNFSQI 357
           EL++    +D  +R    + 
Sbjct: 280 ELIKLMLTYDYNKRCTAEEA 299

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  123 bits (311), Expect = 2e-32
 Identities = 51/208 (24%), Positives = 96/208 (46%), Gaps = 17/208 (8%)

Query: 120 SGSYGDLYKGTYCS--QEVAIKVLK------PECVNTEMLKEFSQEVYIMRKIRHKNVVQ 171
           SG+ G++         ++VAIK++             +       E+ I++K+ H  +++
Sbjct: 20  SGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK 79

Query: 172 FIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 231
                    +  IV E M  G ++D +       +  +       +   + YLH+N IIH
Sbjct: 80  IKNFFD-AEDYYIVLELMEGGELFDKV-VGNKRLKEATCKLYFYQMLLAVQYLHENGIIH 137

Query: 232 RDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE---HKPYD 285
           RDLK  N+L+   +E+ ++K+ DFG +++  ++ +M    GT  ++APEV+       Y+
Sbjct: 138 RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYN 197

Query: 286 YKADVFSFGIALWELLTGELP-YAGLTP 312
              D +S G+ L+  L+G  P     T 
Sbjct: 198 RAVDCWSLGVILFICLSGYPPFSEHRTQ 225

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  123 bits (311), Expect = 2e-32
 Identities = 54/203 (26%), Positives = 98/203 (48%), Gaps = 17/203 (8%)

Query: 120 SGSYGDLYKGTYCS--QEVAIKVL---KPECVNTEMLKE-FSQEVYIMRKIRHKNVVQFI 173
           SG +  + K    S   + A K +   + +     + +E   +EV I+++I+H NV+   
Sbjct: 21  SGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 80

Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVF---QLTSLLKVAIDVSKGMNYLHQNNII 230
                  ++ ++ E +A G ++DFL  +K      + T  LK    +  G+ YLH   I 
Sbjct: 81  EVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLK---QILNGVYYLHSLQIA 136

Query: 231 HRDLKTANLLM----DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY 286
           H DLK  N+++         +K+ DFG+A             GT  ++APE++ ++P   
Sbjct: 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGL 196

Query: 287 KADVFSFGIALWELLTGELPYAG 309
           +AD++S G+  + LL+G  P+ G
Sbjct: 197 EADMWSIGVITYILLSGASPFLG 219

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  121 bits (305), Expect = 9e-32
 Identities = 58/249 (23%), Positives = 109/249 (43%), Gaps = 33/249 (13%)

Query: 121 GSYGDLY----KGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           GS+  +       T  S+E AIK+L K   +    +   ++E  +M ++ H   V+    
Sbjct: 41  GSFSTVVLARELAT--SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT 98

Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK--------GMNYLHQN 227
                 L     +   G +  ++ K  G F            ++         + YLH  
Sbjct: 99  FQDDEKLYFGLSYAKNGELLKYIRKI-GSFD--------ETCTRFYTAEIVSALEYLHGK 149

Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAET--GTYRWMAPEVIEHKPY 284
            IIHRDLK  N+L++E+  +++ DFG A  +  +S    A +  GT ++++PE++  K  
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 209

Query: 285 DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK--SLRPTIPKHAHPRLAELLER 342
              +D+++ G  +++L+ G  P+           + QK   L    P+   P+  +L+E+
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRAGNEYL----IFQKIIKLEYDFPEKFFPKARDLVEK 265

Query: 343 CWQHDPTQR 351
               D T+R
Sbjct: 266 LLVLDATKR 274

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  122 bits (309), Expect = 1e-31
 Identities = 48/198 (24%), Positives = 97/198 (48%), Gaps = 14/198 (7%)

Query: 120 SGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176
            G +G ++K    +   ++A K++      + E +K    E+ +M ++ H N++Q   A 
Sbjct: 99  GGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK---NEISVMNQLDHANLIQLYDAF 155

Query: 177 TRPPNLCIVTEFMARGSIYDFLHKQKGVF---QLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
               ++ +V E++  G ++D +  +            +K    + +G+ ++HQ  I+H D
Sbjct: 156 ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMK---QICEGIRHMHQMYILHLD 212

Query: 234 LKTANLLM--DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVF 291
           LK  N+L    +   +K+ DFG+AR       +    GT  ++APEV+ +    +  D++
Sbjct: 213 LKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMW 272

Query: 292 SFGIALWELLTGELPYAG 309
           S G+  + LL+G  P+ G
Sbjct: 273 SVGVIAYMLLSGLSPFLG 290

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  122 bits (307), Expect = 1e-31
 Identities = 50/189 (26%), Positives = 97/189 (51%), Gaps = 10/189 (5%)

Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
            G+   +Y+       +  A+KVLK + V+ ++++    E+ ++ ++ H N+++      
Sbjct: 63  RGATSIVYRCKQKGTQKPYALKVLK-KTVDKKIVR---TEIGVLLRLSHPNIIKLKEIFE 118

Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
            P  + +V E +  G ++D +  +KG +           + + + YLH+N I+HRDLK  
Sbjct: 119 TPTEISLVLELVTGGELFDRI-VEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPE 177

Query: 238 NLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
           NLL      +  +K+ADFG++++     +M    GT  + APE++    Y  + D++S G
Sbjct: 178 NLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVG 237

Query: 295 IALWELLTG 303
           I  + LL G
Sbjct: 238 IITYILLCG 246

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  121 bits (306), Expect = 2e-31
 Identities = 47/202 (23%), Positives = 101/202 (50%), Gaps = 16/202 (7%)

Query: 120 SGSYGDLYKGTYCS--QEVAIKVLK------PECVNTEMLKEFSQEVYIMRKIR-HKNVV 170
            G    + +  + +   E A+K+++            E+ +   +E +I+R++  H +++
Sbjct: 104 RGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHII 163

Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
             I +      + +V + M +G ++D+L  +K          +   + + +++LH NNI+
Sbjct: 164 TLIDSYESSSFMFLVFDLMRKGELFDYL-TEKVALSEKETRSIMRSLLEAVSFLHANNIV 222

Query: 231 HRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE------HKPY 284
           HRDLK  N+L+D+N  ++++DFG +        +    GT  ++APE+++      H  Y
Sbjct: 223 HRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGY 282

Query: 285 DYKADVFSFGIALWELLTGELP 306
             + D+++ G+ L+ LL G  P
Sbjct: 283 GKEVDLWACGVILFTLLAGSPP 304

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  120 bits (303), Expect = 3e-31
 Identities = 46/200 (23%), Positives = 95/200 (47%), Gaps = 19/200 (9%)

Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGAC 176
            GS+    K  +    Q  A+K      ++  M     +E+  ++    H N+V+     
Sbjct: 21  EGSFSICRKCVHKKSNQAFAVK-----IISKRMEANTQKEITALKLCEGHPNIVKLHEVF 75

Query: 177 TRPPNLCIVTEFMARGSIYDFLHKQKGVF---QLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
               +  +V E +  G +++ + K+K  F   + + +++    +   ++++H   ++HRD
Sbjct: 76  HDQLHTFLVMELLNGGELFERI-KKKKHFSETEASYIMR---KLVSAVSHMHDVGVVHRD 131

Query: 234 LKTANLLM---DENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKAD 289
           LK  NLL    ++N  +K+ DFG AR     +  +     T  + APE++    YD   D
Sbjct: 132 LKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCD 191

Query: 290 VFSFGIALWELLTGELPYAG 309
           ++S G+ L+ +L+G++P+  
Sbjct: 192 LWSLGVILYTMLSGQVPFQS 211

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  121 bits (306), Expect = 3e-31
 Identities = 58/222 (26%), Positives = 107/222 (48%), Gaps = 10/222 (4%)

Query: 137 AIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
           A+K + K +CV    ++   +E+ IM+ + H  +V    +     ++ +V + +  G + 
Sbjct: 44  AMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDL- 102

Query: 196 DFLH-KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 254
              H +Q   F+  ++     ++   ++YL    IIHRD+K  N+L+DE+G V + DF +
Sbjct: 103 -RYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNI 161

Query: 255 ARVQAQSGVMTAETGTYRWMAPEVIEHKP---YDYKADVFSFGIALWELLTGELPYAGL- 310
           A +  +   +T   GT  +MAPE+   +    Y +  D +S G+  +ELL G  PY    
Sbjct: 162 AAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS 221

Query: 311 -TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
            T  +  V   + +   T P      +  LL++  + +P QR
Sbjct: 222 STSSKEIVHTFETT-VVTYPSAWSQEMVSLLKKLLEPNPDQR 262

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  119 bits (301), Expect = 3e-31
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 17/203 (8%)

Query: 120 SGSYGDLYKGTYCS--QEVAIKVL---KPECVNTEMLKE----FSQEVYIMRKI-RHKNV 169
            G    + +  +    +E A+K++        + E ++E      +EV I+RK+  H N+
Sbjct: 27  RGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 86

Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
           +Q            +V + M +G ++D+L  +K         K+   + + +  LH+ NI
Sbjct: 87  IQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLEVICALHKLNI 145

Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE------HKP 283
           +HRDLK  N+L+D++  +K+ DFG +        +    GT  ++APE+IE      H  
Sbjct: 146 VHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPG 205

Query: 284 YDYKADVFSFGIALWELLTGELP 306
           Y  + D++S G+ ++ LL G  P
Sbjct: 206 YGKEVDMWSTGVIMYTLLAGSPP 228

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  119 bits (301), Expect = 6e-31
 Identities = 71/277 (25%), Positives = 116/277 (41%), Gaps = 43/277 (15%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHKNV 169
            +   V  GSYG + K       + VAIK       + +M+K+ +  E+ +++++RH+N+
Sbjct: 29  NLG-LVGEGSYGMVMKCRNKDTGRIVAIKKFLES-DDDKMVKKIAMREIKLLKQLRHENL 86

Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
           V  +  C +     +V EF+   +I D L           + K    +  G+ + H +NI
Sbjct: 87  VNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNI 145

Query: 230 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGT--YRWMAPEVI-EHKPYD 285
           IHRD+K  N+L+ ++GVVK+ DFG AR   A   V   E  T  YR  APE++     Y 
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR--APELLVGDVKYG 203

Query: 286 YKADVFSFGIALWELLTGELPY-------------------------AGLTPLQAAVGVV 320
              DV++ G  + E+  GE P                                    GV 
Sbjct: 204 KAVDVWAIGCLVTEMFMGE-PLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262

Query: 321 QKSLRPTIP-----KHAHPRLAELLERCWQHDPTQRP 352
              ++   P           + +L ++C   DP +RP
Sbjct: 263 LPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRP 299

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  118 bits (297), Expect = 3e-30
 Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 10/218 (4%)

Query: 137 AIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
           A+K+L K + V  + ++    E  I++ +    +V+   +     NL +V E++A G ++
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129

Query: 196 DFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255
             L +  G F        A  +     YLH  ++I+RDLK  NLL+D+ G ++V DFG A
Sbjct: 130 SHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188

Query: 256 RVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL 313
           +           T  GT   +APE+I  K Y+   D ++ G+ ++E+  G  P+    P+
Sbjct: 189 KRVKG----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

Query: 314 QAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
           Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 245 QIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  116 bits (293), Expect = 6e-30
 Identities = 67/277 (24%), Positives = 115/277 (41%), Gaps = 43/277 (15%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHKNV 169
           KI  K+  GSYG ++K       Q VAIK       +  ++K+ +  E+ ++++++H N+
Sbjct: 7   KIG-KIGEGSYGVVFKCRNRDTGQIVAIKKFLES-EDDPVIKKIALREIRMLKQLKHPNL 64

Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
           V  +    R   L +V E+    ++   L + +       +  +     + +N+ H++N 
Sbjct: 65  VNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNC 123

Query: 230 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGT--YRWMAPEVIEH-KPYD 285
           IHRD+K  N+L+ ++ V+K+ DFG AR+    S     E  T  YR  +PE++     Y 
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR--SPELLVGDTQYG 181

Query: 286 YKADVFSFGIALWELLTGELPY-------------------------AGLTPLQAAVGVV 320
              DV++ G    ELL+G  P                             +  Q   GV 
Sbjct: 182 PPVDVWAIGCVFAELLSGV-PLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240

Query: 321 QKSLRPTIP-----KHAHPRLAELLERCWQHDPTQRP 352
                   P      +       LL+ C   DPT+R 
Sbjct: 241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERL 277

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  115 bits (290), Expect = 2e-29
 Identities = 58/263 (22%), Positives = 112/263 (42%), Gaps = 41/263 (15%)

Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGAC 176
            G  G + +  +    Q+ A+K+L           +  QEV    +     ++V  +   
Sbjct: 39  LGVNGKVLECFHRRTGQKCALKLLYDS-------PKARQEVDHHWQASGGPHIVCILDVY 91

Query: 177 ----TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT-----SLLKVAIDVSKGMNYLHQN 227
                    L I+ E M  G ++  + + +G    T      +++   D+   + +LH +
Sbjct: 92  ENMHHGKRCLLIIMECMEGGELFSRIQE-RGDQAFTEREAAEIMR---DIGTAIQFLHSH 147

Query: 228 NIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPY 284
           NI HRD+K  NLL    +++ V+K+ DFG A+ +     +     T  ++APEV+  + Y
Sbjct: 148 NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK-ETTQNALQTPCYTPYYVAPEVLGPEKY 206

Query: 285 DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR----------PTIPKHAHP 334
           D   D++S G+ ++ LL G  P+   T    + G+ ++               + + A  
Sbjct: 207 DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDA-- 264

Query: 335 RLAELLERCWQHDPTQRPNFSQI 357
              +L+    + DPT+R   +Q 
Sbjct: 265 --KQLIRLLLKTDPTERLTITQF 285

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  115 bits (291), Expect = 3e-29
 Identities = 55/312 (17%), Positives = 109/312 (34%), Gaps = 82/312 (26%)

Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCS------QEVAIKVLKPECVNTEMLKEFSQ- 156
           +  + +    ++  ++SGSYG       C+        VAIK +     +   +   S  
Sbjct: 17  LHAMQSPY-TVQRFISSGSYG-----AVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDS 70

Query: 157 --------EVYIMRKIRHKNVVQFIGACTRPPNLC------IVTEFM---------ARGS 193
                   E+ ++    H N++  +                +VTE M          +  
Sbjct: 71  FLCKRVLREIRLLNHFHHPNILG-LRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRI 129

Query: 194 IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG 253
           +    H Q  ++ +            G++ LH+  ++HRDL   N+L+ +N  + + DF 
Sbjct: 130 VISPQHIQYFMYHIL----------LGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN 179

Query: 254 VARVQAQSGVMTAETGT--YRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGELPYAGL 310
           +AR        T       YR  APE++ + K +    D++S G  + E+   +  + G 
Sbjct: 180 LAREDTADANKTHYVTHRWYR--APELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS 237

Query: 311 --------------TPLQAAVGVVQ--------KSLRPTIPK--------HAHPRLAELL 340
                         TP    V +          ++    +P          A P   +L+
Sbjct: 238 TFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLI 297

Query: 341 ERCWQHDPTQRP 352
            +  + +P +R 
Sbjct: 298 AKMLEFNPQRRI 309

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  114 bits (287), Expect = 6e-29
 Identities = 52/201 (25%), Positives = 103/201 (51%), Gaps = 21/201 (10%)

Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRK-IRHKNVVQFIGAC 176
            GSY    +  + +   E A+K      ++       ++E+ I+ +  +H N++      
Sbjct: 32  VGSYSVCKRCIHKATNMEFAVK-----IIDKSKRDP-TEEIEILLRYGQHPNIITLKDVY 85

Query: 177 TRPPNLCIVTEFMARGSIYDFLHKQKGVF---QLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
                + +VTE M  G + D + + +  F   + +++L     ++K + YLH   ++HRD
Sbjct: 86  DDGKYVYVVTELMKGGELLDKILR-QKFFSEREASAVLF---TITKTVEYLHAQGVVHRD 141

Query: 234 LKTANLLM----DENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKA 288
           LK +N+L          +++ DFG A+ ++A++G++     T  ++APEV+E + YD   
Sbjct: 142 LKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAAC 201

Query: 289 DVFSFGIALWELLTGELPYAG 309
           D++S G+ L+ +LTG  P+A 
Sbjct: 202 DIWSLGVLLYTMLTGYTPFAN 222

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  112 bits (282), Expect = 1e-28
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 25/205 (12%)

Query: 113 KIECKVASGSYGDLYKGTYCSQE-VAIKVLKPECVNTEMLKE---FS--QEVYIMRKIRH 166
            +E K+  G+YG +YK      E  A+K ++      E   E    +  +E+ I+++++H
Sbjct: 6   GLE-KIGEGTYGVVYKAQNNYGETFALKKIR-----LEKEDEGIPSTTIREISILKELKH 59

Query: 167 KNVVQFIGACTRPPNLCIVTEFMARGSIYD---FLHKQKGVFQLTSLLKVAIDVSKGMNY 223
            N+V+          L +V E +      D    L   +G  +  +     + +  G+ Y
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLD----QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115

Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGT--YRWMAPEVI- 279
            H   ++HRDLK  NLL++  G +K+ADFG+AR         T E  T  YR  AP+V+ 
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYR--APDVLM 173

Query: 280 EHKPYDYKADVFSFGIALWELLTGE 304
             K Y    D++S G    E++ G 
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGT 198

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  111 bits (280), Expect = 4e-28
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 25/205 (12%)

Query: 113 KIECKVASGSYGDLYKGTYCSQE-VAIKVLKPECVNTEMLKE---FS--QEVYIMRKIRH 166
           K+E KV  G+YG +YK        VA+K ++      +   E    +  +E+ +++++ H
Sbjct: 25  KLE-KVGEGTYGVVYKAKDSQGRIVALKRIR-----LDAEDEGIPSTAIREISLLKELHH 78

Query: 167 KNVVQFIGACTRPPNLCIVTEFMARGSIYD---FLHKQKGVFQLTSLLKVAIDVSKGMNY 223
            N+V  I        L +V EFM      D    L + K   Q + +      + +G+ +
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFME----KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAH 134

Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGT--YRWMAPEVI- 279
            HQ+ I+HRDLK  NLL++ +G +K+ADFG+AR         T E  T  YR  AP+V+ 
Sbjct: 135 CHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR--APDVLM 192

Query: 280 EHKPYDYKADVFSFGIALWELLTGE 304
             K Y    D++S G    E++TG+
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGK 217

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  111 bits (279), Expect = 5e-28
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 24/210 (11%)

Query: 120 SGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGA 175
            G++  +         QE A+K++ K        +    +EV ++ + + H+NV++ I  
Sbjct: 23  EGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF---REVEMLYQCQGHRNVLELIEF 79

Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
                   +V E M  GSI   +HK +  F       V  DV+  +++LH   I HRDLK
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKGIAHRDLK 138

Query: 236 TANLLM---DENGVVKVADFGVARV--------QAQSGVMTAETGTYRWMAPEVIE---- 280
             N+L    ++   VK+ DF +              +  +    G+  +MAPEV+E    
Sbjct: 139 PENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSE 198

Query: 281 -HKPYDYKADVFSFGIALWELLTGELPYAG 309
               YD + D++S G+ L+ LL+G  P+ G
Sbjct: 199 EASIYDKRCDLWSLGVILYILLSGYPPFVG 228

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  111 bits (279), Expect = 5e-28
 Identities = 62/227 (27%), Positives = 108/227 (47%), Gaps = 28/227 (12%)

Query: 137 AIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
           A+KVL K   V  + ++  + E  ++  + H  +++  G       + ++ +++  G + 
Sbjct: 35  AMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL- 93

Query: 196 DFLHKQK-GVFQLTSLLKVAIDVSK--------GMNYLHQNNIIHRDLKTANLLMDENGV 246
            F   +K   F           V+K         + YLH  +II+RDLK  N+L+D+NG 
Sbjct: 94  -FSLLRKSQRF--------PNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH 144

Query: 247 VKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE 304
           +K+ DFG A+           T  GT  ++APEV+  KPY+   D +SFGI ++E+L G 
Sbjct: 145 IKITDFGFAKYVPD----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 200

Query: 305 LPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
            P+     ++    ++   LR   P   +  + +LL R    D +QR
Sbjct: 201 TPFYDSNTMKTYEKILNAELR--FPPFFNEDVKDLLSRLITRDLSQR 245

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  112 bits (282), Expect = 7e-28
 Identities = 56/264 (21%), Positives = 106/264 (40%), Gaps = 42/264 (15%)

Query: 120 SGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGA 175
            G  G + +       ++ A+K+L               +EV +  +  +  ++V+ +  
Sbjct: 72  LGINGKVLQIFNKRTQEKFALKMLQDCPKA--------RREVELHWRASQCPHIVRIVDV 123

Query: 176 C----TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT-----SLLKVAIDVSKGMNYLHQ 226
                     L IV E +  G ++  +   +G    T      ++K    + + + YLH 
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMK---SIGEAIQYLHS 179

Query: 227 NNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKP 283
            NI HRD+K  NLL      N ++K+ DFG A+       +T    T  ++APEV+  + 
Sbjct: 180 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK 239

Query: 284 YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR----------PTIPKHAH 333
           YD   D++S G+ ++ LL G  P+     L  + G+  +               + +   
Sbjct: 240 YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV- 298

Query: 334 PRLAELLERCWQHDPTQRPNFSQI 357
                L+    + +PTQR   ++ 
Sbjct: 299 ---KMLIRNLLKTEPTQRMTITEF 319

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  113 bits (285), Expect = 9e-28
 Identities = 66/248 (26%), Positives = 113/248 (45%), Gaps = 25/248 (10%)

Query: 121 GSYGDLY----KGTYCSQEVAIKVLKPECV----NTEMLKEFSQEVYIMRKIRHKNVVQF 172
           G +G+++    K T   +  A K L  + +      +       E  I+ K+  + +V  
Sbjct: 196 GGFGEVFACQMKAT--GKLYACKKLNKKRLKKRKGYQGAM---VEKKILAKVHSRFIVSL 250

Query: 173 IGACTRPPNLCIVTEFMARGSIYDFLH-----KQKGVFQLTSLLKVAIDVSKGMNYLHQN 227
             A     +LC+V   M  G I    H     +    FQ    +     +  G+ +LHQ 
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDI--RYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308

Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYD 285
           NII+RDLK  N+L+D++G V+++D G+A V+ ++G    +   GT  +MAPE++  + YD
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLA-VELKAGQTKTKGYAGTPGFMAPELLLGEEYD 367

Query: 286 YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLAELLERC 343
           +  D F+ G+ L+E++    P+           + Q+ L    T P    P   +  E  
Sbjct: 368 FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEAL 427

Query: 344 WQHDPTQR 351
            Q DP +R
Sbjct: 428 LQKDPEKR 435

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  111 bits (279), Expect = 9e-28
 Identities = 69/288 (23%), Positives = 120/288 (41%), Gaps = 63/288 (21%)

Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKE---FS--QEVYIMRKIR 165
           K++  +  G +  +YK      +Q VAIK +K    +    K+    +  +E+ +++++ 
Sbjct: 14  KLD-FLGEGQFATVYKARDKNTNQIVAIKKIKLG--HRSEAKDGINRTALREIKLLQELS 70

Query: 166 HKNVVQFIGACTRPPNLCIVTEFM---------ARGSIYDFLHKQKGVFQLTSLLKVAID 216
           H N++  + A     N+ +V +FM             +    H +  +            
Sbjct: 71  HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTL-------- 122

Query: 217 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGT--YRW 273
             +G+ YLHQ+ I+HRDLK  NLL+DENGV+K+ADFG+A+   + +   T +  T  YR 
Sbjct: 123 --QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYR- 179

Query: 274 MAPEVIEH-KPYDYKADVFSFGIALWELLTGE--LP----------------------YA 308
            APE++   + Y    D+++ G  L ELL     LP                      + 
Sbjct: 180 -APELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238

Query: 309 GLTPLQAAVGVVQ---KSLRPTIPKHAHPRLAELLERCWQHDPTQRPN 353
            +  L   V         L       A   L +L++  +  +P  R  
Sbjct: 239 DMCSLPDYVTFKSFPGIPLHHIFS-AAGDDLLDLIQGLFLFNPCARIT 285

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  109 bits (276), Expect = 1e-27
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 26/209 (12%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKE---FS--QEVYIMRKIR 165
           K+E K+  G+YG ++K       + VA+K ++      +   E    S  +E+ ++++++
Sbjct: 6   KLE-KIGEGTYGTVFKAKNRETHEIVALKRVR-----LDDDDEGVPSSALREICLLKELK 59

Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYD---FLHKQKGVFQLTSLLKVAIDVSKGMN 222
           HKN+V+          L +V EF       D   +     G      +      + KG+ 
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115

Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGT--YRWMAPEVI 279
           + H  N++HRDLK  NLL++ NG +K+A+FG+AR         +AE  T  YR   P+V+
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYR--PPDVL 173

Query: 280 -EHKPYDYKADVFSFGIALWELLTGELPY 307
              K Y    D++S G    EL     P 
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  111 bits (280), Expect = 1e-27
 Identities = 67/310 (21%), Positives = 118/310 (38%), Gaps = 73/310 (23%)

Query: 95  IEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKE 153
             + +DG    + +      +  + +GS+G +++     S EVAIK +  +       K 
Sbjct: 26  KVLASDGKTGEQREIAYTNCK-VIGNGSFGVVFQAKLVESDEVAIKKVLQD-------KR 77

Query: 154 F-SQEVYIMRKIRHKNVVQFIGACTRPPN-------LCIVTEFM------------ARGS 193
           F ++E+ IMR ++H NVV  + A             L +V E++                
Sbjct: 78  FKNRELQIMRIVKHPNVVD-LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQ 136

Query: 194 IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-GVVKVADF 252
               L  +  ++QL           + + Y+H   I HRD+K  NLL+D   GV+K+ DF
Sbjct: 137 TMPMLLIKLYMYQLL----------RSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDF 186

Query: 253 GVARVQAQSGVMTAE--TGTYRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGELPYAG 309
           G A++        +   +  YR  APE+I     Y    D++S G  + EL+ G+  + G
Sbjct: 187 GSAKILIAGEPNVSYICSRYYR--APELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPG 244

Query: 310 L--------------TPLQAAVGVVQ-------------KSLRPTIPKHAHPRLAELLER 342
                          TP +  +  +                          P   +L+ R
Sbjct: 245 ESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISR 304

Query: 343 CWQHDPTQRP 352
             ++ P+ R 
Sbjct: 305 LLEYTPSARL 314

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  110 bits (278), Expect = 1e-27
 Identities = 80/295 (27%), Positives = 118/295 (40%), Gaps = 60/295 (20%)

Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
            WE+ A    ++  V SG+YG +          +VAIK L     +    K   +E+ ++
Sbjct: 20  AWEVRAVYRDLQ-PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 78

Query: 162 RKIRHKNVVQFIGACTRPPNLC------IVTEFMA-------RGSIYDFLHKQKGVFQLT 208
           + +RH+NV+  +   T    L       +V  FM        +         Q  V+Q+ 
Sbjct: 79  KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML 138

Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268
                     KG+ Y+H   IIHRDLK  NL ++E+  +K+ DFG+AR       MT   
Sbjct: 139 ----------KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYV 186

Query: 269 GTYRWM-APEVI-EHKPYDYKADVFSFGIALWELLTGELPYAGL--------------TP 312
            T RW  APEVI     Y    D++S G  + E++TG+  + G               TP
Sbjct: 187 VT-RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP 245

Query: 313 LQAAVGVVQ--------KSLRPTIPK-------HAHPRLAELLERCWQHDPTQRP 352
               V  +Q        K L     K       +A P    LLE+    D  QR 
Sbjct: 246 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 300

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  112 bits (283), Expect = 2e-27
 Identities = 56/244 (22%), Positives = 106/244 (43%), Gaps = 20/244 (8%)

Query: 121 GSYGDLY----KGTYCSQEVAIKVLKPECV----NTEMLKEFSQEVYIMRKIRHKNVVQF 172
           G +G++     + T   +  A K L+ + +       M      E  I+ K+  + VV  
Sbjct: 195 GGFGEVCACQVRAT--GKMYACKKLEKKRIKKRKGEAMAL---NEKQILEKVNSRFVVSL 249

Query: 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
             A      LC+V   M  G +    H     +  F     +  A ++  G+  LH+  I
Sbjct: 250 AYAYETKDALCLVLTLMNGGDL--KFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERI 307

Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKAD 289
           ++RDLK  N+L+D++G ++++D G+A    +   +    GT  +MAPEV++++ Y +  D
Sbjct: 308 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPD 367

Query: 290 VFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLAELLERCWQHD 347
            ++ G  L+E++ G+ P+           V +          +   P+   L  +    D
Sbjct: 368 WWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKD 427

Query: 348 PTQR 351
           P +R
Sbjct: 428 PAER 431

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  108 bits (272), Expect = 2e-27
 Identities = 29/251 (11%), Positives = 72/251 (28%), Gaps = 45/251 (17%)

Query: 114 IECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTE-MLKEFSQEVYIMRKIRHKNVV 170
           +            ++   T   ++VA+  + P+ V  + +L+E       + +I    V 
Sbjct: 35  LLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94

Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
           + +          +V E++  GS+ +              ++    ++   +  H+  + 
Sbjct: 95  RVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGA---IRAMQSLAAAADAAHRAGVA 151

Query: 231 HRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADV 290
                 + + +  +G V +A                                  + + D+
Sbjct: 152 LSIDHPSRVRVSIDGDVVLAYPATMP--------------------------DANPQDDI 185

Query: 291 FSFGIALWELLTGELPYAGLTPLQAAVGVVQ---------KSLRPTIPKHAHPRLAELLE 341
              G +L+ LL    P              +           +   IP     +++ +  
Sbjct: 186 RGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIP----FQISAVAA 241

Query: 342 RCWQHDPTQRP 352
           R  Q D   R 
Sbjct: 242 RSVQGDGGIRS 252

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  109 bits (274), Expect = 3e-27
 Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 35/210 (16%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPEC---VNTEMLKEFSQEVYIMRKIRHK 167
           K++ K+  G+Y  +YKG        VA+K ++ E         ++E S    +++ ++H 
Sbjct: 6   KLD-KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDLKHA 60

Query: 168 NVVQFIGACTRPPNLCIVTEFM---------ARGSIYDFLHKQKGVFQLTSLLKVAIDVS 218
           N+V          +L +V E++           G+I +  + +  +FQL           
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLL---------- 110

Query: 219 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGT--YRWMA 275
           +G+ Y H+  ++HRDLK  NLL++E G +K+ADFG+AR     +     E  T  YR   
Sbjct: 111 RGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYR--P 168

Query: 276 PEVI-EHKPYDYKADVFSFGIALWELLTGE 304
           P+++     Y  + D++  G   +E+ TG 
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  109 bits (274), Expect = 4e-27
 Identities = 62/241 (25%), Positives = 112/241 (46%), Gaps = 19/241 (7%)

Query: 121 GSYGDL----YKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           G++G +     K T   +  A+K+L K   +  + +     E  +++  RH  +     A
Sbjct: 16  GTFGKVILVREKAT--GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA 73

Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
                 LC V E+   G +  F H  +  VF          ++   + YLH  ++++RD+
Sbjct: 74  FQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131

Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFS 292
           K  NL++D++G +K+ DFG+ +     G     T  GT  ++APEV+E   Y    D + 
Sbjct: 132 KLENLMLDKDGHIKITDFGLCKEGISDGATMK-TFCGTPEYLAPEVLEDNDYGRAVDWWG 190

Query: 293 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLAELLERCWQHDPTQ 350
            G+ ++E++ G LP+      +    ++ + +R   T+   A   LA LL++    DP Q
Sbjct: 191 LGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKK----DPKQ 246

Query: 351 R 351
           R
Sbjct: 247 R 247

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  108 bits (272), Expect = 1e-26
 Identities = 73/295 (24%), Positives = 123/295 (41%), Gaps = 60/295 (20%)

Query: 104 VWEIDAKQLKIECKVASGSYGDLYK--GTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 24  IWEVPERYQNLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82

Query: 162 RKIRHKNVVQFIGACTRPPNLC------IVTEFMA-------RGSIYDFLHKQKGVFQLT 208
           + ++H+NV+  +   T   +L       +VT  M        +       H Q  ++Q+ 
Sbjct: 83  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 142

Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268
                     +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR    +  MT   
Sbjct: 143 ----------RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH--TADEMTGYV 190

Query: 269 GTYRW-MAPEVI-EHKPYDYKADVFSFGIALWELLTGELPYAGL--------------TP 312
            T RW  APE++     Y+   D++S G  + ELLTG   + G               TP
Sbjct: 191 AT-RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 249

Query: 313 LQAAVGVVQ--------KSLRPTIPK-------HAHPRLAELLERCWQHDPTQRP 352
               +  +         +SL              A+P   +LLE+    D  +R 
Sbjct: 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 304

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  108 bits (271), Expect = 1e-26
 Identities = 46/180 (25%), Positives = 87/180 (48%), Gaps = 13/180 (7%)

Query: 182 LCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240
           L  V E++  G +    H Q+            + ++S  +NYLH+  II+RDLK  N+L
Sbjct: 85  LFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVL 142

Query: 241 MDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFSFGIALW 298
           +D  G +K+ D+G+ +   + G  T+ T  GT  ++APE++  + Y +  D ++ G+ ++
Sbjct: 143 LDSEGHIKLTDYGMCKEGLRPGDTTS-TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMF 201

Query: 299 ELLTGELPYAGLTPLQAAVGVVQKSL-------RPTIPKHAHPRLAELLERCWQHDPTQR 351
           E++ G  P+  +          +  L       +  IP+    + A +L+     DP +R
Sbjct: 202 EMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 261

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  108 bits (273), Expect = 1e-26
 Identities = 46/180 (25%), Positives = 87/180 (48%), Gaps = 13/180 (7%)

Query: 182 LCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240
           L  V E++  G +    H Q+            + ++S  +NYLH+  II+RDLK  N+L
Sbjct: 128 LFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVL 185

Query: 241 MDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFSFGIALW 298
           +D  G +K+ D+G+ +   + G  T+ T  GT  ++APE++  + Y +  D ++ G+ ++
Sbjct: 186 LDSEGHIKLTDYGMCKEGLRPGDTTS-TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMF 244

Query: 299 ELLTGELPYAGLTPLQAAVGVVQKSL-------RPTIPKHAHPRLAELLERCWQHDPTQR 351
           E++ G  P+  +          +  L       +  IP+    + A +L+     DP +R
Sbjct: 245 EMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 304

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  108 bits (272), Expect = 2e-26
 Identities = 54/240 (22%), Positives = 100/240 (41%), Gaps = 43/240 (17%)

Query: 95  IEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKG----TYCSQEVAIKVLKPECVNTEM 150
            ++          D       CKV  G+YG +YK         ++ A+K ++   ++   
Sbjct: 7   FKVKLSSERERVED-LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA 65

Query: 151 LKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI--VTEFMARGSIYD---FLHKQKGVF 205
            +E    + ++R+++H NV+          +  +  + ++      +D    +   +   
Sbjct: 66  CRE----IALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASK 117

Query: 206 QLTSLLKVAIDVSK--------GMNYLHQNNIIHRDLKTANLLM----DENGVVKVADFG 253
                +++   + K        G++YLH N ++HRDLK AN+L+     E G VK+AD G
Sbjct: 118 ANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 177

Query: 254 VARV-QAQSGVMTAETGT-----YRWMAPEVI---EHKPYDYKADVFSFGIALWELLTGE 304
            AR+  +    +           YR  APE++    H  Y    D+++ G    ELLT E
Sbjct: 178 FARLFNSPLKPLADLDPVVVTFWYR--APELLLGARH--YTKAIDIWAIGCIFAELLTSE 233

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  106 bits (268), Expect = 2e-26
 Identities = 70/285 (24%), Positives = 123/285 (43%), Gaps = 52/285 (18%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPEC---VNTEMLKEFSQEVYIMRKIRHK 167
           ++E K+ +G+Y  +YKG   +    VA+K +K +      +  ++E S    +M++++H+
Sbjct: 9   QLE-KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS----LMKELKHE 63

Query: 168 NVVQFIGACTRPPNLCIVTEFMA---RGSIYDFLHKQKGVFQLTSLLK-VAIDVSKGMNY 223
           N+V+          L +V EFM    +  +              +L+K     + +G+ +
Sbjct: 64  NIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123

Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGT--YRWMAPEVI- 279
            H+N I+HRDLK  NLL+++ G +K+ DFG+AR         ++E  T  YR  AP+V+ 
Sbjct: 124 CHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYR--APDVLM 181

Query: 280 EHKPYDYKADVFSFGIALWELLTG------------------------ELPYAGLTPLQA 315
             + Y    D++S G  L E++TG                        E  +  +T L  
Sbjct: 182 GSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK 241

Query: 316 AVGVVQK----SLRPTIPKHAHPRLAE----LLERCWQHDPTQRP 352
               +Q+     LR  +  H    L       L    Q +P  R 
Sbjct: 242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRL 286

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  107 bits (269), Expect = 2e-26
 Identities = 42/217 (19%), Positives = 93/217 (42%), Gaps = 31/217 (14%)

Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIM 161
            W        +  K+  G Y ++++    +  ++V +K+LKP        K+  +E+ I+
Sbjct: 31  EWGNQDDYQLVR-KLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKIL 84

Query: 162 RKIR-HKNVVQFIGACTRPPNLC---IVTEFMAR--GSIYDFL---HKQKGVFQLTSLLK 212
             +R   N++        P +     +           +Y  L     +  ++++     
Sbjct: 85  ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL---- 140

Query: 213 VAIDVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVARVQAQSGVMTAETGTY 271
                 K ++Y H   I+HRD+K  N+++D E+  +++ D+G+A              + 
Sbjct: 141 ------KALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS- 193

Query: 272 RWM-APEVI-EHKPYDYKADVFSFGIALWELLTGELP 306
           R+   PE++ +++ YDY  D++S G  L  ++  + P
Sbjct: 194 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  107 bits (269), Expect = 2e-26
 Identities = 76/295 (25%), Positives = 121/295 (41%), Gaps = 61/295 (20%)

Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
            WE+          V SG+YG +         ++VAIK L     +    K   +E+ ++
Sbjct: 19  AWELPKT-YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLL 77

Query: 162 RKIRHKNVVQFIGACTRPPNLC------IVTEFMA-------RGSIYDFLHKQKGVFQLT 208
           + ++H+NV+  +   T   +L       +V  FM             +    Q  V+Q+ 
Sbjct: 78  KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEE-KIQYLVYQML 136

Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268
                     KG+ Y+H   ++HRDLK  NL ++E+  +K+ DFG+AR       MT   
Sbjct: 137 ----------KGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYV 184

Query: 269 GTYRW-MAPEVI-EHKPYDYKADVFSFGIALWELLTGELPYAGL--------------TP 312
            T RW  APEVI     Y+   D++S G  + E+LTG+  + G                P
Sbjct: 185 VT-RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP 243

Query: 313 LQAAVGVVQ--------KSLRPTIPK-------HAHPRLAELLERCWQHDPTQRP 352
               V  +         +SL  T  K        A P+ A+LLE+  + D  +R 
Sbjct: 244 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRL 298

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  109 bits (274), Expect = 3e-26
 Identities = 64/228 (28%), Positives = 101/228 (44%), Gaps = 22/228 (9%)

Query: 137 AIKVLKPECVNTEMLKEFSQEVYIM--RKI-------RHKNVVQFIGACTRPPNLCIVTE 187
           A+K L       + +K    E   +  R +           +V    A   P  L  + +
Sbjct: 218 AMKCLD-----KKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 272

Query: 188 FMARGSIYDFLH-KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV 246
            M  G +    H  Q GVF    +   A ++  G+ ++H   +++RDLK AN+L+DE+G 
Sbjct: 273 LMNGGDL--HYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH 330

Query: 247 VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGEL 305
           V+++D G+A          A  GT+ +MAPEV++    YD  AD FS G  L++LL G  
Sbjct: 331 VRISDLGLA-CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389

Query: 306 PYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLAELLERCWQHDPTQR 351
           P+           + + +L     +P    P L  LLE   Q D  +R
Sbjct: 390 PFRQHKTKDKHE-IDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRR 436

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  105 bits (265), Expect = 5e-26
 Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 28/228 (12%)

Query: 137 AIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYD 196
           A+KVLK   +          E  I+ ++ H  +V+   A      L ++ +F+  G +  
Sbjct: 56  AMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL-- 113

Query: 197 FLHKQK-GVFQLTSLLKVAIDVSK--------GMNYLHQNNIIHRDLKTANLLMDENGVV 247
           F    K  +F          +  K         +++LH   II+RDLK  N+L+DE G +
Sbjct: 114 FTRLSKEVMFTE--------EDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHI 165

Query: 248 KVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGEL 305
           K+ DFG+++           +  GT  +MAPEV+  + +   AD +SFG+ ++E+LTG L
Sbjct: 166 KLTDFGLSKESIDHEKKAY-SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224

Query: 306 PYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLAELLERCWQHDPTQR 351
           P+ G    +    +++  L     +   A   L  L +R    +P  R
Sbjct: 225 PFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKR----NPANR 268

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  106 bits (267), Expect = 6e-26
 Identities = 68/301 (22%), Positives = 121/301 (40%), Gaps = 68/301 (22%)

Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKP-ECVNTEMLKEFSQEVYI 160
           V+++  +       +  G+YG +           VAIK + P E  +    +   +E+ I
Sbjct: 22  VFDVGPR-YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKI 78

Query: 161 MRKIRHKNVVQFIGACTRPPNLC------IVTEFMA-------RGSIYDFLHKQKGVFQL 207
           + + RH+N++  I    R P +       IV + M        +       H    ++Q+
Sbjct: 79  LLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI 137

Query: 208 TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGV 263
                      +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G 
Sbjct: 138 L----------RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187

Query: 264 MTAETGT--YRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGELPYAGL---------- 310
           +T    T  YR  APE++   K Y    D++S G  L E+L+    + G           
Sbjct: 188 LTEYVATRWYR--APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

Query: 311 ----TPLQAAVGVVQ--------KSLRPTIPK-------HAHPRLAELLERCWQHDPTQR 351
               +P Q  +  +          SL             +A  +  +LL++    +P +R
Sbjct: 246 GILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKR 305

Query: 352 P 352
            
Sbjct: 306 I 306

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  106 bits (266), Expect = 6e-26
 Identities = 67/300 (22%), Positives = 124/300 (41%), Gaps = 74/300 (24%)

Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLK----PECVNTEMLKEFSQEVYIMRKIRH 166
           K+  K+  G++G+++K       Q+VA+K +      E      L+E      I++ ++H
Sbjct: 21  KLA-KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK----ILQLLKH 75

Query: 167 KNVVQFIGACT--------RPPNLCIVTEFMARGSIYD---FLHKQKGVFQLTSLLKVAI 215
           +NVV  I  C            ++ +V +F      +D    L      F L+ + +V  
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCE----HDLAGLLSNVLVKFTLSEIKRVMQ 131

Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-----VQAQSGVMTAETGT 270
            +  G+ Y+H+N I+HRD+K AN+L+  +GV+K+ADFG+AR       +Q    T    T
Sbjct: 132 MLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 191

Query: 271 --YRWMAPEVI-EHKPYDYKADVFSFGIALWELLTG------------------------ 303
             YR   PE++   + Y    D++  G  + E+ T                         
Sbjct: 192 LWYR--PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249

Query: 304 --------ELP-YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA-ELLERCWQHDPTQRPN 353
                       Y  L  ++      ++ ++  +  +     A +L+++    DP QR +
Sbjct: 250 PEVWPNVDNYELYEKLELVKGQ----KRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 305

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  107 bits (269), Expect = 6e-26
 Identities = 63/242 (26%), Positives = 115/242 (47%), Gaps = 20/242 (8%)

Query: 121 GSYGDLY----KGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           G++G +     K T   +  A+K+L K   V  + +     E  +++  RH  +     +
Sbjct: 159 GTFGKVILVKEKAT--GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS 216

Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLH-QNNIIHRD 233
                 LC V E+   G +  F H  +  VF          ++   ++YLH + N+++RD
Sbjct: 217 FQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 274

Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVF 291
           LK  NL++D++G +K+ DFG+ +   + G     T  GT  ++APEV+E   Y    D +
Sbjct: 275 LKLENLMLDKDGHIKITDFGLCKEGIKDGATMK-TFCGTPEYLAPEVLEDNDYGRAVDWW 333

Query: 292 SFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLAELLERCWQHDPT 349
             G+ ++E++ G LP+      +    ++ + +R   T+   A   L+ LL++    DP 
Sbjct: 334 GLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKK----DPK 389

Query: 350 QR 351
           QR
Sbjct: 390 QR 391

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  107 bits (268), Expect = 7e-26
 Identities = 71/342 (20%), Positives = 118/342 (34%), Gaps = 79/342 (23%)

Query: 67  KDQSCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQL---KIECKVASGSY 123
            +     +QP+      S  +              T     D  Q         + +GS+
Sbjct: 11  AESCKPVQQPS---AFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSF 67

Query: 124 GDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHKNVVQFIGACTRPP 180
           G +Y+   C   + VAIK +  +       K F   E+ IMRK+ H N+V+ +       
Sbjct: 68  GVVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLDHCNIVR-LRYFFYSS 119

Query: 181 N-------LCIVTEFM------------ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
                   L +V +++                    ++ +  ++QL           + +
Sbjct: 120 GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF----------RSL 169

Query: 222 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGT--YRWMAPEV 278
            Y+H   I HRD+K  NLL+D +  V+K+ DFG A+   +     +   +  YR  APE+
Sbjct: 170 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR--APEL 227

Query: 279 I-EHKPYDYKADVFSFGIALWELLTGELPYAGL--------------TPLQAAVGVVQ-- 321
           I     Y    DV+S G  L ELL G+  + G               TP +  +  +   
Sbjct: 228 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 287

Query: 322 -----------KSLRPTIPKHAHPRLAELLERCWQHDPTQRP 352
                                  P    L  R  ++ PT R 
Sbjct: 288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 329

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  106 bits (267), Expect = 1e-25
 Identities = 51/205 (24%), Positives = 95/205 (46%), Gaps = 26/205 (12%)

Query: 121 GSYGDLY----KGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           G++G++     K     +  A+K+L K E +       F +E  ++     K +     A
Sbjct: 85  GAFGEVAVVKLKNA--DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYA 142

Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQL------TSLLKVAIDVSKGMNYLHQNNI 229
                NL +V ++   G +   L K +            + + +AID       +HQ + 
Sbjct: 143 FQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAID------SVHQLHY 196

Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKP---- 283
           +HRD+K  N+LMD NG +++ADFG      + G + +    GT  +++PE+++       
Sbjct: 197 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKG 256

Query: 284 -YDYKADVFSFGIALWELLTGELPY 307
            Y  + D +S G+ ++E+L GE P+
Sbjct: 257 RYGPECDWWSLGVCMYEMLYGETPF 281

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  106 bits (267), Expect = 1e-25
 Identities = 54/218 (24%), Positives = 93/218 (42%), Gaps = 31/218 (14%)

Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
            + +  +  +    + SG+ G +         + VAIK L     N    K   +E+ +M
Sbjct: 57  TFTVLKR-YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 115

Query: 162 RKIRHKNVVQFIGACTRPPNLC------IVTEFMA-------RGSIYDFLHKQKGVFQLT 208
           + + HKN++  +   T    L       +V E M        +  +         ++Q+ 
Sbjct: 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH-ERMSYLLYQML 174

Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268
                      G+ +LH   IIHRDLK +N+++  +  +K+ DFG+AR    S +MT   
Sbjct: 175 ----------CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 224

Query: 269 GT--YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE 304
            T  YR  APEVI    Y    D++S G  + E++  +
Sbjct: 225 VTRYYR--APEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  104 bits (263), Expect = 1e-25
 Identities = 66/249 (26%), Positives = 112/249 (44%), Gaps = 34/249 (13%)

Query: 121 GSYGDL----YKGTYCSQEVAIKVLK---------PECVNTE--MLKEFSQEVYIMRKIR 165
           GS+G +    +K T  +Q  AIK LK          EC   E  +L              
Sbjct: 28  GSFGKVFLAEFKKT--NQFFAIKALKKDVVLMDDDVECTMVEKRVLS---------LAWE 76

Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYL 224
           H  +           NL  V E++  G +    H Q    F L+     A ++  G+ +L
Sbjct: 77  HPFLTHMFCTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAEIILGLQFL 134

Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHK 282
           H   I++RDLK  N+L+D++G +K+ADFG+ +        T  T  GT  ++APE++  +
Sbjct: 135 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN-TFCGTPDYIAPEILLGQ 193

Query: 283 PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER 342
            Y++  D +SFG+ L+E+L G+ P+ G    +    +   +     P+       +LL +
Sbjct: 194 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF--YPRWLEKEAKDLLVK 251

Query: 343 CWQHDPTQR 351
            +  +P +R
Sbjct: 252 LFVREPEKR 260

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  105 bits (263), Expect = 2e-25
 Identities = 67/305 (21%), Positives = 115/305 (37%), Gaps = 69/305 (22%)

Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
            + +  +   ++  + SG+ G +         + VAIK L     N    K   +E+ +M
Sbjct: 20  TFTVLKRYQNLK-PIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLM 78

Query: 162 RKIRHKNVVQFIGACTRPPNLC------IVTEFMA-------RGSIYDFLHKQKGVFQLT 208
           + + HKN++  +   T   +L       IV E M        +  +         ++Q+ 
Sbjct: 79  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH-ERMSYLLYQML 137

Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268
                      G+ +LH   IIHRDLK +N+++  +  +K+ DFG+AR    S +MT   
Sbjct: 138 ----------CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 187

Query: 269 GTYRWM-APEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL--------------TPL 313
            T R+  APEVI    Y    D++S G  + E++ G + + G               TP 
Sbjct: 188 VT-RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 246

Query: 314 QAAVGVVQ---------------KSLRPTIPKHAHPRLAE-----------LLERCWQHD 347
              +  +Q                S     P    P  +E           LL +    D
Sbjct: 247 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 306

Query: 348 PTQRP 352
            ++R 
Sbjct: 307 ASKRI 311

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  104 bits (262), Expect = 2e-25
 Identities = 69/252 (27%), Positives = 105/252 (41%), Gaps = 40/252 (15%)

Query: 121 GSYGDLY----KGTYCSQEVAIKVLK---------PECVNTEMLKEFSQEVYIMRKI--- 164
           GS+G +     K T      A+KVLK          EC  TE            ++I   
Sbjct: 34  GSFGKVMLARVKET--GDLYAVKVLKKDVILQDDDVECTMTE------------KRILSL 79

Query: 165 --RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGM 221
              H  + Q       P  L  V EF+  G +    H QK   F        A ++   +
Sbjct: 80  ARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEIISAL 137

Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVI 279
            +LH   II+RDLK  N+L+D  G  K+ADFG+ +    +GV TA T  GT  ++APE++
Sbjct: 138 MFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTA-TFCGTPDYIAPEIL 196

Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
           +   Y    D ++ G+ L+E+L G  P+           ++   +    P   H     +
Sbjct: 197 QEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV--YPTWLHEDATGI 254

Query: 340 LERCWQHDPTQR 351
           L+     +PT R
Sbjct: 255 LKSFMTKNPTMR 266

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  103 bits (260), Expect = 2e-25
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 28/212 (13%)

Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQ----EVYIMRKIR- 165
            +  ++  G+YG +YK    +    VA+K ++                  EV ++R++  
Sbjct: 13  PVA-EIGVGAYGTVYKARDPHSGHFVALKSVRVP-NGGGGGGGLPISTVREVALLRRLEA 70

Query: 166 --HKNVVQFIGACT-----RPPNLCIVTEFMARGSIYD---FLHKQKGVFQLTSLLK-VA 214
             H NVV+ +  C      R   + +V E +      D   +L K          +K + 
Sbjct: 71  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGLPAETIKDLM 126

Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT--YR 272
               +G+++LH N I+HRDLK  N+L+   G VK+ADFG+AR+ +    +T    T  YR
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYR 186

Query: 273 WMAPEVIEHKPYDYKADVFSFGIALWELLTGE 304
             APEV+    Y    D++S G    E+   +
Sbjct: 187 --APEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  107 bits (267), Expect = 3e-25
 Identities = 65/254 (25%), Positives = 117/254 (46%), Gaps = 44/254 (17%)

Query: 121 GSYGDL----YKGTYCSQEVAIKVLK---------PECVNTEMLKEFSQEVYIMRKI--- 164
           GS+G +     KGT   +  A+K+LK          EC   E            +++   
Sbjct: 352 GSFGKVMLSERKGT--DELYAVKILKKDVVIQDDDVECTMVE------------KRVLAL 397

Query: 165 --RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGM 221
             +   + Q          L  V E++  G +    H Q+ G F+    +  A +++ G+
Sbjct: 398 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIGL 455

Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVI 279
            +L    II+RDLK  N+++D  G +K+ADFG+ +     GV T  T  GT  ++APE+I
Sbjct: 456 FFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK-TFCGTPDYIAPEII 514

Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLA 337
            ++PY    D ++FG+ L+E+L G+ P+ G    +    +++ ++    ++ K A     
Sbjct: 515 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICK 574

Query: 338 ELLERCWQHDPTQR 351
            L+ +     P +R
Sbjct: 575 GLMTK----HPGKR 584

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  103 bits (259), Expect = 4e-25
 Identities = 64/254 (25%), Positives = 116/254 (45%), Gaps = 41/254 (16%)

Query: 121 GSYG-------DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ---EVYIMRKIRHKNVV 170
           G YG            T   +  A+KVLK   +     K+ +    E  I+ +++H  +V
Sbjct: 28  GGYGKVFQVRKVTGANT--GKIFAMKVLKKAMI-VRNAKDTAHTKAERNILEEVKHPFIV 84

Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSK--------GM 221
             I A      L ++ E+++ G +  F+  ++ G+F          D +          +
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFME--------DTACFYLAEISMAL 134

Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVI 279
            +LHQ  II+RDLK  N++++  G VK+ DFG+ +     G +T  T  GT  +MAPE++
Sbjct: 135 GHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT-HTFCGTIEYMAPEIL 193

Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLA 337
               ++   D +S G  ++++LTG  P+ G    +    +++  L   P + + A   L 
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLK 253

Query: 338 ELLERCWQHDPTQR 351
           +LL+R    +   R
Sbjct: 254 KLLKR----NAASR 263

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  103 bits (258), Expect = 6e-25
 Identities = 53/218 (24%), Positives = 96/218 (44%), Gaps = 42/218 (19%)

Query: 113 KIECKVASGSYGDLYKGTYCS---QEVAIKVLKPECVNTE------------MLKEFSQE 157
            +  ++  G+YG ++K        + VA+K ++ +    E            +L+     
Sbjct: 15  CVA-EIGEGAYGKVFKARDLKNGGRFVALKRVRVQ--TGEEGMPLSTIREVAVLRH---- 67

Query: 158 VYIMRKIRHKNVVQFI-----GACTRPPNLCIVTEFMARGSIYD---FLHKQKGVFQLTS 209
              +    H NVV+           R   L +V E +      D   +L K       T 
Sbjct: 68  ---LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTE 120

Query: 210 LLK-VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268
            +K +   + +G+++LH + ++HRDLK  N+L+  +G +K+ADFG+AR+ +    +T+  
Sbjct: 121 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV 180

Query: 269 GT--YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE 304
            T  YR  APEV+    Y    D++S G    E+   +
Sbjct: 181 VTLWYR--APEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  103 bits (258), Expect = 6e-25
 Identities = 62/291 (21%), Positives = 111/291 (38%), Gaps = 68/291 (23%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPEC----VNTEMLKEFSQEVYIMRKIRH 166
           +I  K+  G+YG++YK       + VAIK ++ E     V    ++E S    ++++++H
Sbjct: 38  RIT-KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVS----LLKELQH 92

Query: 167 KNVVQFIGACTRPPNLCIVTEFMA--------RGSIYDFLHKQKGVFQLTSLLKVAIDVS 218
           +N+++          L ++ E+          +         +  ++QL           
Sbjct: 93  RNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLI---------- 142

Query: 219 KGMNYLHQNNIIHRDLKTANLLMD-----ENGVVKVADFGVARV-QAQSGVMTAETGT-- 270
            G+N+ H    +HRDLK  NLL+      E  V+K+ DFG+AR         T E  T  
Sbjct: 143 NGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLW 202

Query: 271 YRWMAPEVI-EHKPYDYKADVFSFGIALWELLTG------------------------EL 305
           YR   PE++   + Y    D++S      E+L                          + 
Sbjct: 203 YR--PPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT 260

Query: 306 PYAGLTPLQAAVGVVQK----SLRPTIPKHAHPRLAELLERCWQHDPTQRP 352
            + G+T L        K    +L+  +         +LL    + DP +R 
Sbjct: 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRI 311

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  103 bits (259), Expect = 7e-25
 Identities = 70/284 (24%), Positives = 124/284 (43%), Gaps = 31/284 (10%)

Query: 87  LIESSPNCIEIPTDGTDVWEIDAKQLKIEC----KV-ASGSYGDLY----KGTYCSQEVA 137
           L+ ++P     P+   ++        K       KV   GS+G +     K        A
Sbjct: 10  LMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAE--EVFYA 67

Query: 138 IKVLKPECVNTEMLKEFSQEVYIM-------RKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
           +KVL+      + + +  +E +IM       + ++H  +V    +      L  V +++ 
Sbjct: 68  VKVLQ-----KKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 122

Query: 191 RGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV 249
            G +  F H Q+   F        A +++  + YLH  NI++RDLK  N+L+D  G + +
Sbjct: 123 GGEL--FYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVL 180

Query: 250 ADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
            DFG+ +   +    T+ T  GT  ++APEV+  +PYD   D +  G  L+E+L G  P+
Sbjct: 181 TDFGLCKENIEHNSTTS-TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 239

Query: 308 AGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 351
                 +    ++ K L+  +  +       LLE   Q D T+R
Sbjct: 240 YSRNTAEMYDNILNKPLQ--LKPNITNSARHLLEGLLQKDRTKR 281

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  102 bits (257), Expect = 9e-25
 Identities = 64/252 (25%), Positives = 114/252 (45%), Gaps = 40/252 (15%)

Query: 121 GSYGDL----YKGTYCSQEVAIKVLK---------PECVNTEMLKEFSQEVYIMRKI--- 164
           GS+G +     KGT   +  A+K+LK          EC   E            +++   
Sbjct: 31  GSFGKVMLSERKGT--DELYAVKILKKDVVIQDDDVECTMVE------------KRVLAL 76

Query: 165 --RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGM 221
             +   + Q          L  V E++  G +    H Q+ G F+    +  A +++ G+
Sbjct: 77  PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIGL 134

Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVI 279
            +L    II+RDLK  N+++D  G +K+ADFG+ +     GV T  T  GT  ++APE+I
Sbjct: 135 FFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK-TFCGTPDYIAPEII 193

Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
            ++PY    D ++FG+ L+E+L G+ P+ G    +    +++ ++    PK        +
Sbjct: 194 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA--YPKSMSKEAVAI 251

Query: 340 LERCWQHDPTQR 351
            +      P +R
Sbjct: 252 CKGLMTKHPGKR 263

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  102 bits (256), Expect = 2e-24
 Identities = 50/258 (19%), Positives = 103/258 (39%), Gaps = 40/258 (15%)

Query: 121 GSYGDLY----KGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           G++ ++     K T   Q  A+K++ K + +    +  F +E  ++     + + Q   A
Sbjct: 72  GAFSEVAVVKMKQT--GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA 129

Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQL------TSLLKVAIDVSKGMNYLHQNNI 229
                 L +V E+   G +   L K              + + +AID       +H+   
Sbjct: 130 FQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAID------SVHRLGY 183

Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIE------- 280
           +HRD+K  N+L+D  G +++ADFG        G + +    GT  +++PE+++       
Sbjct: 184 VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPG 243

Query: 281 HKPYDYKADVFSFGIALWELLTGELPYAGLTP-------LQAAVGVVQKSLRPTIPKHAH 333
              Y  + D ++ G+  +E+  G+ P+   +        +     +    +   +P+ A 
Sbjct: 244 TGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEAR 303

Query: 334 PRLAELLERCWQHDPTQR 351
             +  LL       P  R
Sbjct: 304 DFIQRLL-----CPPETR 316

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  102 bits (255), Expect = 3e-24
 Identities = 47/221 (21%), Positives = 104/221 (47%), Gaps = 39/221 (17%)

Query: 113 KIECKVASGSYG------DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR- 165
            +  K+  G +       D+   T+    VA+K+++ + V TE  ++   E+ +++++  
Sbjct: 22  ILVRKLGWGHFSTVWLAKDMVNNTH----VAMKIVRGDKVYTEAAED---EIKLLQRVND 74

Query: 166 ----------HKNVVQFIGACT-RPPN---LCIVTEFMARGSIYDFLHKQKGV-FQLTSL 210
                       ++++ +     + PN   + +V E +   ++   + K +     L  +
Sbjct: 75  ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYV 133

Query: 211 LKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDE------NGVVKVADFGVARVQAQSGV 263
            +++  +  G++Y+H+   IIH D+K  N+LM+          +K+AD G A    +   
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 193

Query: 264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE 304
            + +T  YR  +PEV+   P+   AD++S    ++EL+TG+
Sbjct: 194 NSIQTREYR--SPEVLLGAPWGCGADIWSTACLIFELITGD 232

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  100 bits (252), Expect = 5e-24
 Identities = 54/233 (23%), Positives = 100/233 (42%), Gaps = 28/233 (12%)

Query: 137 AIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKN-VVQFIGACTRPPNLCIVTEFMARGS 193
           A+KVLK   +    +  +    E  ++  IR    +V    A      L ++ +++  G 
Sbjct: 86  AMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGE 145

Query: 194 IYDFLHKQK-GVFQLTSLLKVAIDVSK--------GMNYLHQNNIIHRDLKTANLLMDEN 244
           +  F H  +   F             +         + +LH+  II+RD+K  N+L+D N
Sbjct: 146 L--FTHLSQRERFTE--------HEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN 195

Query: 245 GVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADV--FSFGIALWEL 300
           G V + DFG+++         A    GT  +MAP+++      +   V  +S G+ ++EL
Sbjct: 196 GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYEL 255

Query: 301 LTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLAELLERCWQHDPTQR 351
           LTG  P+       +   + ++ L+  P  P+       +L++R    DP +R
Sbjct: 256 LTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKR 308

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  100 bits (251), Expect = 5e-24
 Identities = 62/309 (20%), Positives = 116/309 (37%), Gaps = 76/309 (24%)

Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
            +++ ++       +  G  G ++      C + VAIK +     + + +K   +E+ I+
Sbjct: 6   GFDLGSR-YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKII 62

Query: 162 RKIRHKNVVQFIGACTRPPNLC---------------IVTEFMA-------RGSIYDFLH 199
           R++ H N+V+ +     P                   IV E+M                H
Sbjct: 63  RRLDHDNIVK-VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEH 121

Query: 200 KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVARV- 257
            +  ++QL           +G+ Y+H  N++HRDLK ANL ++ E+ V+K+ DFG+AR+ 
Sbjct: 122 ARLFMYQLL----------RGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIM 171

Query: 258 ---QAQSGVMTAETGT--YRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGELPYAGL- 310
               +  G ++    T  YR  +P ++     Y    D+++ G    E+LTG+  +AG  
Sbjct: 172 DPHYSHKGHLSEGLVTKWYR--SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229

Query: 311 -------------TPLQAAVGVVQKSLR------PTIPK--------HAHPRLAELLERC 343
                           +     +   +        T P                + LE+ 
Sbjct: 230 ELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQI 289

Query: 344 WQHDPTQRP 352
               P  R 
Sbjct: 290 LTFSPMDRL 298

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  101 bits (253), Expect = 7e-24
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 15/198 (7%)

Query: 121 GSYGDLY----KGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
           G++G++     K T   +  A+K+L K E +       F +E  IM       VVQ   A
Sbjct: 80  GAFGEVQLVRHKST--RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA 137

Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
                 L +V E+M  G +                     +V   ++ +H    IHRD+K
Sbjct: 138 FQDDRYLYMVMEYMPGGDL--VNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVK 195

Query: 236 TANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKP----YDYKAD 289
             N+L+D++G +K+ADFG      + G++  +T  GT  +++PEV++ +     Y  + D
Sbjct: 196 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 255

Query: 290 VFSFGIALWELLTGELPY 307
            +S G+ L+E+L G+ P+
Sbjct: 256 WWSVGVFLYEMLVGDTPF 273

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 99.3 bits (248), Expect = 2e-23
 Identities = 62/301 (20%), Positives = 107/301 (35%), Gaps = 80/301 (26%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIK--VLKPECVNTEMLKEFSQEVYIMRKIRHKN 168
           ++E     G++G +  G   S    VAIK  +  P   N E+     Q +  +  + H N
Sbjct: 26  QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL-----QIMQDLAVLHHPN 80

Query: 169 VVQFIGACTRPPN--------LCIVTEFM------------ARGSIYDFLHKQKGVFQLT 208
           +VQ + +              L +V E++             R      +  +  +FQL 
Sbjct: 81  IVQ-LQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLI 139

Query: 209 SLLKVAIDVSKGMNYLHQN--NIIHRDLKTANLLMD-ENGVVKVADFGVARVQAQSGVMT 265
                     + +  LH    N+ HRD+K  N+L++  +G +K+ DFG A+  + S    
Sbjct: 140 ----------RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV 189

Query: 266 AETGT--YRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGELPYAGL------------ 310
           A   +  YR  APE+I  ++ Y    D++S G    E++ GE  + G             
Sbjct: 190 AYICSRYYR--APELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247

Query: 311 --TPLQAAV-----GVVQKSLRPTIPKH------------AHPRLAELLERCWQHDPTQR 351
              P +  +           L                         +LL    Q+ P +R
Sbjct: 248 LGCPSREVLRKLNPSHTDVDL-YNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEER 306

Query: 352 P 352
            
Sbjct: 307 M 307

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 98.9 bits (247), Expect = 2e-23
 Identities = 72/309 (23%), Positives = 118/309 (38%), Gaps = 76/309 (24%)

Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKP-ECVNTEMLKEFSQEVYI 160
           V+ I +   +++  +  G+YG +   T+    + VAIK ++P +           +E+ I
Sbjct: 6   VYNISSD-FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKI 62

Query: 161 MRKIRHKNVVQFIGACTRPPNLC------IVTEFMA-------RGSIYDFLHKQKGVFQL 207
           ++  +H+N++  I    RP +        I+ E M           +    H Q  ++Q 
Sbjct: 63  LKHFKHENIIT-IFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQT 121

Query: 208 TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV---------- 257
                      + +  LH +N+IHRDLK +NLL++ N  +KV DFG+AR+          
Sbjct: 122 L----------RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171

Query: 258 -QAQSGVMTAETGT--YRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGE--------- 304
              Q   M     T  YR  APEV+     Y    DV+S G  L EL             
Sbjct: 172 PTGQQSGMVEFVATRWYR--APEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR 229

Query: 305 ------LPYAGLTPLQAAVGVVQ--------KSLRPTIPK-------HAHPRLAELLERC 343
                     G       +  ++        KSL               +P+  +LL+R 
Sbjct: 230 HQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRM 289

Query: 344 WQHDPTQRP 352
              DP +R 
Sbjct: 290 LVFDPAKRI 298

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 96.2 bits (240), Expect = 1e-22
 Identities = 51/263 (19%), Positives = 99/263 (37%), Gaps = 61/263 (23%)

Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGAC 176
            G  G + +       ++ A+K+L+    +    +    EV +  +  +  ++V+ +   
Sbjct: 28  LGINGKVLQIFNKRTQEKFALKMLQ----DCPKARR---EVELHWRASQCPHIVRIVDVY 80

Query: 177 ----TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT-----SLLKVAIDVSKGMNYLHQN 227
                    L IV E +  G ++  + + +G    T      ++K    + + + YLH  
Sbjct: 81  ENLYAGRKCLLIVMECLDGGELFSRI-QDRGDQAFTEREASEIMK---SIGEAIQYLHSI 136

Query: 228 NIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPY 284
           NI HRD+K  NLL      N ++K+ DFG                     A E    + Y
Sbjct: 137 NIAHRDVKPENLLYTSKRPNAILKLTDFG--------------------FAKETT-GEKY 175

Query: 285 DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR----------PTIPKHAHP 334
           D   D++S G+ ++ LL G  P+     L  + G+  +               + +    
Sbjct: 176 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVK- 234

Query: 335 RLAELLERCWQHDPTQRPNFSQI 357
               L+    + +PTQR   ++ 
Sbjct: 235 ---MLIRNLLKTEPTQRMTITEF 254

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 96.3 bits (240), Expect = 4e-22
 Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 23/204 (11%)

Query: 120 SGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK------N 168
            GS+G + K          Q VA+K+++         ++ ++E+ I+  +R +      N
Sbjct: 107 KGSFGQVVK---AYDHKVHQHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMN 160

Query: 169 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQN 227
           V+  +   T   ++C+  E ++  ++Y+ + K K   F L  + K A  + + ++ LH+N
Sbjct: 161 VIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN 219

Query: 228 NIIHRDLKTANLLMDENG--VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYD 285
            IIH DLK  N+L+ + G   +KV DFG +  + Q      ++  YR  APEVI    Y 
Sbjct: 220 RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYR--APEVILGARYG 277

Query: 286 YKADVFSFGIALWELLTGELPYAG 309
              D++S G  L ELLTG     G
Sbjct: 278 MPIDMWSLGCILAELLTGYPLLPG 301

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 95.6 bits (238), Expect = 5e-22
 Identities = 60/333 (18%), Positives = 118/333 (35%), Gaps = 107/333 (32%)

Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQ-EVYIMR 162
           E  +K+  +   + +GS+G + +       +  A+K +  +         +   E+ IM+
Sbjct: 3   ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-------PRYKNRELDIMK 55

Query: 163 KIRHKNVVQ--------------------------------FIGACTRPPN------LCI 184
            + H N+++                                     +   N      L +
Sbjct: 56  VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115

Query: 185 VTEFM-------------ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 231
           + E++             +  SI         ++QL           + + ++H   I H
Sbjct: 116 IMEYVPDTLHKVLKSFIRSGRSIPM-NLISIYIYQLF----------RAVGFIHSLGICH 164

Query: 232 RDLKTANLLMD-ENGVVKVADFGVARVQAQSGVMTAETGT--YRWMAPEVI-EHKPYDYK 287
           RD+K  NLL++ ++  +K+ DFG A+    S    A   +  YR  APE++     Y   
Sbjct: 165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYR--APELMLGATEYTPS 222

Query: 288 ADVFSFGIALWELLTGELPYAGL--------------TPLQAAVGVV-----QKSLRPTI 328
            D++S G    EL+ G+  ++G               TP +  +  +     +    PT+
Sbjct: 223 IDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRF-PTL 281

Query: 329 PKH--------AHPRLA-ELLERCWQHDPTQRP 352
                        P LA +LLE+  +++P  R 
Sbjct: 282 KAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI 314

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 94.5 bits (235), Expect = 2e-21
 Identities = 65/307 (21%), Positives = 109/307 (35%), Gaps = 73/307 (23%)

Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
            W+I  +  +I   + +GSYG + +       + VAIK +     +    K   +E+ I+
Sbjct: 48  DWQIPDR-YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAIL 106

Query: 162 RKIRHKNVVQFIGACTRPPNLC------IVTEFM---------ARGSIYDFLHKQKGVFQ 206
            ++ H +VV+ +     P ++       +V E               + +  H +  ++ 
Sbjct: 107 NRLNHDHVVK-VLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTEL-HIKTLLYN 164

Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--------- 257
           L            G+ Y+H   I+HRDLK AN L++++  VKV DFG+AR          
Sbjct: 165 LL----------VGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNS 214

Query: 258 -------------------QAQSGVMTAETGT--YRWMAPEVI-EHKPYDYKADVFSFGI 295
                              +     +T    T  YR  APE+I   + Y    DV+S G 
Sbjct: 215 QLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYR--APELILLQENYTEAIDVWSIGC 272

Query: 296 ALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFS 355
              ELL            +           P  P  +   L+   +         R N  
Sbjct: 273 IFAELLNMIKENVAYHADR----------GPLFPGSSCFPLSPDQKAGNDFKFHTRGNRD 322

Query: 356 QITDILK 362
           Q+  I  
Sbjct: 323 QLNVIFN 329

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 93.3 bits (232), Expect = 4e-21
 Identities = 56/245 (22%), Positives = 94/245 (38%), Gaps = 58/245 (23%)

Query: 105 WEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 162
             +      I+  +  GSYG +Y        + VAIK +     +    K   +E+ I+ 
Sbjct: 22  VHVPDN-YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILN 80

Query: 163 KIRHKNVVQFIGACTRPPNLC------IVTEFM---------ARGSIYDFLHKQKGVFQL 207
           +++   +++       P +L       IV E               + +  H +  ++ L
Sbjct: 81  RLKSDYIIRLYDLI-IPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEE-HIKTILYNL 138

Query: 208 TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV---------- 257
                       G N++H++ IIHRDLK AN L++++  VKV DFG+AR           
Sbjct: 139 L----------LGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIV 188

Query: 258 -------------QAQSGVMTAETGT--YRWMAPEVI-EHKPYDYKADVFSFGIALWELL 301
                        +     +T+   T  YR  APE+I   + Y    D++S G    ELL
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYR--APELILLQENYTKSIDIWSTGCIFAELL 246

Query: 302 TGELP 306
                
Sbjct: 247 NMLQS 251

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 90.9 bits (226), Expect = 2e-20
 Identities = 59/242 (24%), Positives = 102/242 (42%), Gaps = 62/242 (25%)

Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQE 157
             +  K  ++  K+  G+YG                + VA+K +     N+   +   +E
Sbjct: 5   RHVLRK-YELVKKLGKGAYG-----IVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFRE 58

Query: 158 VYIMRKIR-HKNVVQFIGACTRPPN---LCIVTEFMA-------RGSIYDFLHKQKGVFQ 206
           + I+ ++  H+N+V  +    R  N   + +V ++M        R +I + +HKQ  V+Q
Sbjct: 59  IMILTELSGHENIVNLLNVL-RADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQ 117

Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--------- 257
           L           K + YLH   ++HRD+K +N+L++    VKVADFG++R          
Sbjct: 118 LI----------KVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTN 167

Query: 258 -------------QAQSGVMTAETGT--YRWMAPEVI-EHKPYDYKADVFSFGIALWELL 301
                             ++T    T  YR  APE++     Y    D++S G  L E+L
Sbjct: 168 NIPLSINENTENFDDDQPILTDYVATRWYR--APEILLGSTKYTKGIDMWSLGCILGEIL 225

Query: 302 TG 303
            G
Sbjct: 226 CG 227

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 89.2 bits (221), Expect = 9e-20
 Identities = 54/261 (20%), Positives = 94/261 (36%), Gaps = 79/261 (30%)

Query: 113 KIECKVASGSYG------DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR- 165
            +  K+  G +       D+    +    VA+KV+K     TE   +   E+ +++ +R 
Sbjct: 40  HVIRKLGWGHFSTVWLSWDIQGKKF----VAMKVVKSAEHYTETALD---EIRLLKSVRN 92

Query: 166 -------HKNVVQFIGACT-RPPN---LCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKV 213
                   + VVQ +        N   +C+V E +    +  ++ K       L  + K+
Sbjct: 93  SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKI 151

Query: 214 AIDVSKGMNYLH-QNNIIHRDLKTANLLM------------------------------- 241
              V +G++YLH +  IIH D+K  N+L+                               
Sbjct: 152 IQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211

Query: 242 ------------------DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKP 283
                              E   VK+AD G A    +      +T  YR  + EV+    
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYR--SLEVLIGSG 269

Query: 284 YDYKADVFSFGIALWELLTGE 304
           Y+  AD++S     +EL TG+
Sbjct: 270 YNTPADIWSTACMAFELATGD 290

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 89.0 bits (221), Expect = 1e-19
 Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 25/213 (11%)

Query: 113 KIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH- 166
           +I+  +  GS+G + K          + VAIK++K        L +   EV ++  +   
Sbjct: 57  EIDSLIGKGSFGQVVK---AYDRVEQEWVAIKIIKN---KKAFLNQAQIEVRLLELMNKH 110

Query: 167 -----KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKG 220
                  +V          +LC+V E ++  ++YD L         L    K A  +   
Sbjct: 111 DTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTA 169

Query: 221 MNYLHQN--NIIHRDLKTANLLM--DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAP 276
           + +L     +IIH DLK  N+L+   +   +K+ DFG +    Q      ++  YR  +P
Sbjct: 170 LLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR--SP 227

Query: 277 EVIEHKPYDYKADVFSFGIALWELLTGELPYAG 309
           EV+   PYD   D++S G  L E+ TGE  ++G
Sbjct: 228 EVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 86.2 bits (214), Expect = 6e-19
 Identities = 47/210 (22%), Positives = 84/210 (40%), Gaps = 48/210 (22%)

Query: 134 QEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHK------NVVQFIGACTRPPNLCIVT 186
            +VA+K+++    N    +E ++ E+ +++KI+ K        V          ++CI  
Sbjct: 46  SQVALKIIR----NVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAF 101

Query: 187 EFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 245
           E + + + ++FL +     + L  +  +A  +   + +LH+N + H DLK  N+L   + 
Sbjct: 102 ELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSE 160

Query: 246 V-------------------VKVADFGVARVQAQSGVMTAETGT-------YRWMAPEVI 279
                               ++VADFG       S     E  T       YR   PEVI
Sbjct: 161 FETLYNEHKSCEEKSVKNTSIRVADFG-------SATFDHEHHTTIVATRHYR--PPEVI 211

Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAG 309
               +    DV+S G  L+E   G   +  
Sbjct: 212 LELGWAQPCDVWSIGCILFEYYRGFTLFQT 241

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 85.0 bits (211), Expect = 2e-18
 Identities = 53/204 (25%), Positives = 86/204 (42%), Gaps = 34/204 (16%)

Query: 133 SQEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHK------NVVQFIGACTRPPNLCIV 185
            + VA+K++K    N +   E ++ E+ ++  +           VQ +       ++CIV
Sbjct: 40  GRHVAVKIVK----NVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIV 95

Query: 186 TEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 244
            E +   S YDF+ +   + F+L  + K+A  + K +N+LH N + H DLK  N+L  ++
Sbjct: 96  FELLGL-STYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQS 154

Query: 245 GV-------------------VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYD 285
                                +KV DFG A    +       T  YR  APEVI    + 
Sbjct: 155 DYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYR--APEVILALGWS 212

Query: 286 YKADVFSFGIALWELLTGELPYAG 309
              DV+S G  L E   G   +  
Sbjct: 213 QPCDVWSIGCILIEYYLGFTVFPT 236

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 83.1 bits (206), Expect = 8e-18
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 55/211 (26%)

Query: 134 QEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRH-----KNVVQFIGACTRPPNLCIVTE 187
           +  A+KV++    N +     ++ E  I++KI++      N+V++ G      ++C++ E
Sbjct: 61  KYYAVKVVR----NIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFE 116

Query: 188 FMARGSIYDFL--HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 245
            +   S+Y+ +  +   G F +  +    I++ K +NYL + ++ H DLK  N+L+D+  
Sbjct: 117 PLGP-SLYEIITRNNYNG-FHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPY 174

Query: 246 V-------------------------VKVADFGVARVQAQSGVMTAETGT-------YRW 273
                                     +K+ DFG            ++          YR 
Sbjct: 175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-------CATFKSDYHGSIINTRQYR- 226

Query: 274 MAPEVIEHKPYDYKADVFSFGIALWELLTGE 304
            APEVI +  +D  +D++SFG  L EL TG 
Sbjct: 227 -APEVILNLGWDVSSDMWSFGCVLAELYTGS 256

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 79.3 bits (196), Expect = 7e-17
 Identities = 72/280 (25%), Positives = 116/280 (41%), Gaps = 35/280 (12%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTE--MLKEFSQEVYIMRKIRH-K 167
           ++  K+ SGS+GD+Y GT  +  +EVAIK+   ECV T+   L     E  I + ++   
Sbjct: 12  RLGRKIGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQLH---IESKIYKMMQGGV 65

Query: 168 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN 227
            +              +V E +   S+ D  +     F L ++L +A  +   + Y+H  
Sbjct: 66  GIPTIRWCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 124

Query: 228 NIIHRDLKTANLLM---DENGVVKVADFGVAR--VQAQSGVMTAE------TGTYRWM-- 274
           N IHRD+K  N LM    +  +V + DFG+A+    A++            TGT R+   
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 184

Query: 275 -APEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL---TPLQAAVGVVQKSLRPTIP- 329
                IE    D   D+ S G  L     G LP+ GL   T  Q    + +K +   I  
Sbjct: 185 NTHLGIEQSRRD---DLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241

Query: 330 --KHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
             K      A  L  C       +P++S +  + + +   
Sbjct: 242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 76.3 bits (188), Expect = 1e-15
 Identities = 58/276 (21%), Positives = 110/276 (39%), Gaps = 26/276 (9%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH-KNV 169
           ++  K+  G++G+L  G      + VAIK+   E + +    +   E    +++     +
Sbjct: 12  RVGKKIGCGNFGELRLGKNLYTNEYVAIKL---EPMKSRA-PQLHLEYRFYKQLGSGDGI 67

Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
            Q            +V E +   S+ D        F L ++L +AI +   M Y+H  N+
Sbjct: 68  PQVYYFGPCGKYNAMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNL 126

Query: 230 IHRDLKTANLLMDENG-----VVKVADFGVAR--VQAQSG--VMTAE----TGTYRWMAP 276
           I+RD+K  N L+   G     V+ + DF +A+  +  ++   +   E    TGT R+M+ 
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSI 186

Query: 277 EVIEHKPYDYKADVFSFGIALWELLTGELPYAGL---TPLQAAVGVVQKSLRPTIPK--H 331
                K    + D+ + G      L G LP+ GL   T  +    +        I     
Sbjct: 187 NTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCE 246

Query: 332 AHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
             P +A  L    + D  ++P++  +  +   +   
Sbjct: 247 NFPEMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 74.4 bits (183), Expect = 5e-15
 Identities = 60/307 (19%), Positives = 118/307 (38%), Gaps = 45/307 (14%)

Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQE 157
           +G  + +++  Q  +  K+ SG +G +Y        ++ A  V+K E      L     E
Sbjct: 27  EGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF---SE 83

Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVT-----EFMARGSIYDF------------LHK 200
           +   +++  K+ ++      +   L I           +G  Y F            +  
Sbjct: 84  LKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISG 143

Query: 201 QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV--ADFGVARVQ 258
           Q G F+ +++L++ I +   + Y+H+N  +H D+K ANLL+      +V  AD+G++   
Sbjct: 144 QNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203

Query: 259 AQSGVM--------TAETGTYRWMAPEVIEHKPYDY--KADVFSFGIALWELLTGELPYA 308
             +G              GT  + +  +  HK      ++DV   G  +   L G+LP+ 
Sbjct: 204 CPNGNHKQYQENPRKGHNGTIEFTS--LDAHKGVALSRRSDVEILGYCMLRWLCGKLPWE 261

Query: 309 GLTPLQAAV--------GVVQKSLRPTIPKHAHPR-LAELLERCWQHDPTQRPNFSQITD 359
                  AV          + +S+    P  +    +A+ L         ++PN+  +  
Sbjct: 262 QNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321

Query: 360 ILKQMMK 366
           IL     
Sbjct: 322 ILNPHGI 328

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 75.4 bits (185), Expect = 5e-15
 Identities = 67/309 (21%), Positives = 118/309 (38%), Gaps = 52/309 (16%)

Query: 113 KIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTE--MLKEFSQEVYIMRKIR-HK 167
           ++  K+ SGS+G++Y GT    ++EVAIK+   E V T+   L     E  I R ++   
Sbjct: 10  RLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLL---YESKIYRILQGGT 63

Query: 168 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN 227
            +              +V + +   S+ D  +       L ++L +A  +   + ++H  
Sbjct: 64  GIPNVRWFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122

Query: 228 NIIHRDLKTANLLMDENG---VVKVADFGVARV-------------QAQSGVMTAETGTY 271
           + +HRD+K  N LM        V + DFG+A+              + ++      TGT 
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL-----TGTA 177

Query: 272 RWM---APEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL---TPLQAAVGVVQKSLR 325
           R+        IE    D   D+ S G  L   L G LP+ GL   T  Q    + +K + 
Sbjct: 178 RYASVNTHLGIEQSRRD---DLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA 234

Query: 326 PTIP---KHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLY-------WLSPN 375
            +I    +      A     C       +P++S +  + + +     +       W    
Sbjct: 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILK 294

Query: 376 LINTNIQST 384
              + I S 
Sbjct: 295 YQQSQIASA 303

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 72.0 bits (177), Expect = 2e-14
 Identities = 45/277 (16%), Positives = 103/277 (37%), Gaps = 27/277 (9%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH-KNV 169
           K+  ++  GS+G +++GT     Q+VAIK    E   ++   +   E    + +     +
Sbjct: 13  KVGRRIGEGSFGVIFEGTNLLNNQQVAIKF---EPRRSDA-PQLRDEYRTYKLLAGCTGI 68

Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
                      +  +V + +   S+ D L      F + ++   A  +   +  +H+ ++
Sbjct: 69  PNVYYFGQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSL 127

Query: 230 IHRDLKTANLLMDENG-----VVKVADFGVAR--VQAQSGVMTAE------TGTYRWMAP 276
           ++RD+K  N L+         ++ V DFG+ +      +            +GT R+M+ 
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 187

Query: 277 EVIEHKPYDYKADVFSFGIALWELLTGELPYAGL---TPLQAAVGVVQKSLRPTIP---K 330
                +    + D+ + G      L G LP+ GL   T  Q    + +K     +     
Sbjct: 188 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA 247

Query: 331 HAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
                  + +           P++  +  +  ++++ 
Sbjct: 248 GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 54/309 (17%), Positives = 115/309 (37%), Gaps = 44/309 (14%)

Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPEC--VNTEM 150
            G  + ++ A   K+   +  G +G +Y     S           +KV   +   + TE+
Sbjct: 25  VGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTEL 84

Query: 151 --LKEFSQEVYIMRKIRHKNV-------VQFIGACTRPPNL--CIVTEFMARGSIYDFLH 199
              +  ++   I + IR + +           G   +       ++ +      +     
Sbjct: 85  KFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYE 143

Query: 200 KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV--ADFGVARV 257
                F   ++L++++ +   + Y+H++  +H D+K +NLL++     +V   D+G+A  
Sbjct: 144 ANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203

Query: 258 QAQSGVMTAE--------TGTYRWMAPEVIEHKPYDY--KADVFSFGIALWELLTGELPY 307
               GV  A          GT  + +  +  H       + D+   G  + + LTG LP+
Sbjct: 204 YCPEGVHKAYAADPKRCHDGTIEFTS--IDAHNGVAPSRRGDLEILGYCMIQWLTGHLPW 261

Query: 308 AGLTPLQAAVG---VVQKSLRPTIPKHAHPR------LAELLERCWQHDPTQRPNFSQIT 358
                    V    +  +    ++     P       +A+ +E     D T++P +  + 
Sbjct: 262 EDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLR 321

Query: 359 DILKQMMKE 367
           DIL Q +K 
Sbjct: 322 DILLQGLKA 330

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 66.3 bits (162), Expect = 3e-12
 Identities = 43/246 (17%), Positives = 89/246 (36%), Gaps = 41/246 (16%)

Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGT----------YCSQEVAIKVLKPECVNTE 149
            GT + +   +Q K++      + G LY+               Q+ ++K+   +  +  
Sbjct: 32  TGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL---DAKDGR 88

Query: 150 MLKEFS-----------QEVYIMRKIRHKNVVQFIGACTRPPNL-CIVTEFMARGSIYDF 197
           +  E +            +   +       +   +G          +V   + R S+   
Sbjct: 89  LFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSA 147

Query: 198 LHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV--ADFGV 254
           L    K V    S+L+VA  +   + +LH+N  +H ++   N+ +D     +V  A +G 
Sbjct: 148 LDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGF 207

Query: 255 AR--------VQAQSGVMTAETGTYRWMAPEVIEHKPYDY--KADVFSFGIALWELLTGE 304
           A         V    G  +   G   +++  +  HK      ++D+ S G  + + L G 
Sbjct: 208 AFRYCPSGKHVAYVEGSRSPHEGDLEFIS--MDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265

Query: 305 LPYAGL 310
           LP+   
Sbjct: 266 LPWTNC 271

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 62.2 bits (150), Expect = 5e-11
 Identities = 32/192 (16%), Positives = 65/192 (33%), Gaps = 48/192 (25%)

Query: 111 QLKIECKVASGSYGDLYKGTYCSQEVAIKVL---KPECVNTEM---LKEFSQEVYIMRKI 164
           +L+   K+  G +G++++       VAIK++    P+ VN       +E   E+ I +++
Sbjct: 21  KLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKEL 80

Query: 165 ---------RHKNVVQFIGAC----TRPPNLC--------------------------IV 185
                    R +  +          + PP L                           IV
Sbjct: 81  SLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIV 140

Query: 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDEN 244
            EF   G   D    +  +  L +   +   ++  +     +    HRDL   N+L+ + 
Sbjct: 141 LEFEFGGI--DLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKT 198

Query: 245 GVVKVADFGVAR 256
            + K+      +
Sbjct: 199 SLKKLHYTLNGK 210

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 56.8 bits (136), Expect = 8e-09
 Identities = 58/410 (14%), Positives = 111/410 (27%), Gaps = 105/410 (25%)

Query: 39  LDVFVVDGWPYDETEDLKNVLAKE----ILKSKDQSCSKRQPALGVPMHSKLLIESSPNC 94
            D FV +    D  +  K++L+KE    I+ SKD          G       L+      
Sbjct: 26  EDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKD-------AVSGTLRLFWTLLSKQEEM 78

Query: 95  IEIPTDGTDVWEID----AKQLKIECKVASG---SYGDLYKGTYCSQEVAIK--VLKPEC 145
           ++   +  +V  I+       +K E +  S     Y +     Y   +V  K  V + + 
Sbjct: 79  VQKFVE--EVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQP 136

Query: 146 VNT--EMLKEFSQEVYI----MR---K-------IRHKNVVQF---------IGACTRPP 180
                + L E      +    +    K            V            +  C  P 
Sbjct: 137 YLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPE 196

Query: 181 -------NLC--IVTEFMARGSIYD--FLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
                   L   I   + +R        L       +L  LLK                 
Sbjct: 197 TVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLK----------------- 239

Query: 230 IHRDLKTANLLMDE---NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY 286
             +  +   L++            +    ++     + T       +++     H   D+
Sbjct: 240 -SKPYENCLLVLLNVQNAKAWNAFNLS-CKIL----LTTRFKQVTDFLSAATTTHISLDH 293

Query: 287 KADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH 346
            +   +       LL   L Y    P         + L   +    +PR   ++    + 
Sbjct: 294 HSMTLTPDEVK-SLL---LKYLDCRP---------QDLPREVLTT-NPRRLSIIAESIRD 339

Query: 347 DPTQRPNFSQIT-DILKQMMKEVLYWLSPNLINTNIQSTYKHLLFFLFMD 395
                 N+  +  D L  +++  L  L P       +  +  L   +F  
Sbjct: 340 GLATWDNWKHVNCDKLTTIIESSLNVLEPAE----YRKMFDRL--SVFPP 383

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 41.4 bits (96), Expect = 5e-04
 Identities = 53/296 (17%), Positives = 94/296 (31%), Gaps = 95/296 (32%)

Query: 6   WVLMKVGELTSLLGEIGLNIQEA----HAFSTVDGFSLDVFVVDG----------WPYDE 51
           W  +   +LT+++ E  LN+ E       F       L VF              W    
Sbjct: 347 WKHVNCDKLTTII-ESSLNVLEPAEYRKMF-----DRLSVFPPSAHIPTILLSLIWFDVI 400

Query: 52  TEDLKNVLAKEILKS------KDQSCS--------KRQPALGVPMHSKLLIESSPNCIEI 97
             D+  V+ K    S      K+ + S        K +      +H  ++     +   I
Sbjct: 401 KSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIV-----DHYNI 455

Query: 98  PTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQE 157
           P    D  ++    L            D Y  ++         LK    + E +  F   
Sbjct: 456 P-KTFDSDDLIPPYL------------DQYFYSHIGHH-----LK-NIEHPERMTLFRM- 495

Query: 158 VY-----IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY-DFLHKQKGVF-QLTSL 210
           V+     + +KIRH +      A     N     +F      Y  ++      + +L + 
Sbjct: 496 VFLDFRFLEQKIRHDSTAW--NASGSILNTLQQLKF------YKPYICDNDPKYERLVNA 547

Query: 211 LKVAIDVSKGMNYLHQ--NNII---HRDL-KTANLLMDENGVVKVADFGVARVQAQ 260
           +         +++L +   N+I   + DL + A  LM E+  +    F  A  Q Q
Sbjct: 548 I---------LDFLPKIEENLICSKYTDLLRIA--LMAEDEAI----FEEAHKQVQ 588

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	395
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.87
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.77
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.48
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.32
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.29
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.14
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.98
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.8
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.76
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.75
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.48
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.48
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.46
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.37
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.08
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.0
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.96
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.84
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.73
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.71
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.69
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.57
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.42
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.31
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.31
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.19
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.11
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.73
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.65
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.84
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	92.91
1u8s_A	192	Glycine cleavage system transcriptional repressor,	92.21
1zpv_A	91	ACT domain protein; structural genomics, PSI, prot	90.39
2nyi_A	195	Unknown protein; protein structure initiative, PSI	89.87
2ko1_A	88	CTR148A, GTP pyrophosphokinase; homodimer, alpha+b	85.15
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	80.96
2f1f_A	164	Acetolactate synthase isozyme III small subunit; f	80.56

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=9e-63  Score=467.82  Aligned_cols=264  Identities=37%  Similarity=0.696  Sum_probs=228.7

Q ss_pred             CCCceeecccCcceeeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 016082          101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  180 (395)
Q Consensus       101 ~~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (395)
                      ....|+|+.+++++.++||+|+||+||+|++.+ .||||+++....+.+..+.|.+|+.+|++++|||||+++|++.+ +
T Consensus        27 ~~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~  104 (307)
T 3omv_A           27 SSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-D  104 (307)
T ss_dssp             --CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred             CCcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-C
Confidence            345799999999999999999999999999765 69999998777777788899999999999999999999998865 5


Q ss_pred             cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                      .+||||||++||+|.++|+...+++++..+..++.||++||+|||+++||||||||+|||+++++.+||+|||+|+....
T Consensus       105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~  184 (307)
T 3omv_A          105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR  184 (307)
T ss_dssp             SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred             eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence            68999999999999999988778899999999999999999999999999999999999999999999999999986543


Q ss_pred             C---CccccCCCCcccccccccCC---CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC-C---CCCC
Q 016082          261 S---GVMTAETGTYRWMAPEVIEH---KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR-P---TIPK  330 (395)
Q Consensus       261 ~---~~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~-~---~~~~  330 (395)
                      .   ......+||+.|||||++.+   .+|+.++|||||||++|||+||+.||.+.++.......+..... |   ..+.
T Consensus       185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~  264 (307)
T 3omv_A          185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYK  264 (307)
T ss_dssp             ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCT
T ss_pred             CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Confidence            2   23345689999999999853   46999999999999999999999999988776655555544433 2   3456


Q ss_pred             CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 016082          331 HAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK  366 (395)
Q Consensus       331 ~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~  366 (395)
                      .+++++.++|.+||+.||++|||+.||++.|+.+..
T Consensus       265 ~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~  300 (307)
T 3omv_A          265 NCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH  300 (307)
T ss_dssp             TSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred             cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            789999999999999999999999999999887654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.6e-62  Score=463.95  Aligned_cols=261  Identities=28%  Similarity=0.557  Sum_probs=232.1

Q ss_pred             ceeecccCcceeeeeeeeCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEE
Q 016082          104 VWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC  176 (395)
Q Consensus       104 ~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  176 (395)
                      .+.|+.++|.+.++||+|+||.||+|++.       +..||||+++..  +.+..++|.+|+.+|++++|||||+++|+|
T Consensus         7 ~~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~   84 (299)
T 4asz_A            7 VQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVC   84 (299)
T ss_dssp             CCBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             hcccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence            45688889999999999999999999863       567999999865  466678899999999999999999999999


Q ss_pred             ecCCcEEEEEecCCCCCHHHHHhhcc------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCC
Q 016082          177 TRPPNLCIVTEFMARGSIYDFLHKQK------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN  244 (395)
Q Consensus       177 ~~~~~~~lV~E~~~ggsL~~~l~~~~------------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~  244 (395)
                      .+++.+||||||++||+|.++|+...            ..+++..+..++.||++||.|||+++||||||||+|||++.+
T Consensus        85 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~  164 (299)
T 4asz_A           85 VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN  164 (299)
T ss_dssp             CSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred             eeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC
Confidence            99999999999999999999997642            468999999999999999999999999999999999999999


Q ss_pred             CcEEEeeeccccccccCCcc---ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhh
Q 016082          245 GVVKVADFGVARVQAQSGVM---TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVV  320 (395)
Q Consensus       245 ~~vkl~DFg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~  320 (395)
                      +.+||+|||+|+........   ....||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..+....+.
T Consensus       165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~  244 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT  244 (299)
T ss_dssp             GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred             CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            99999999999865443222   22358999999999999999999999999999999999 999999999887766654


Q ss_pred             hccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 016082          321 QKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE  367 (395)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~  367 (395)
                       .+.++..|..+|+++.++|.+||+.||++|||+.+|.+.|+++.+.
T Consensus       245 -~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          245 -QGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             -HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence             4667788999999999999999999999999999999999988764

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.5e-61  Score=464.67  Aligned_cols=262  Identities=30%  Similarity=0.572  Sum_probs=228.7

Q ss_pred             CceeecccCcceeeeeeeeCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEE
Q 016082          103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA  175 (395)
Q Consensus       103 ~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  175 (395)
                      ..+.|+.+++.+.++||+|+||.||+|++.       ++.||||+++..  +....++|.+|+.+|++++|||||+++|+
T Consensus        34 ~~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~  111 (329)
T 4aoj_A           34 CVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGV  111 (329)
T ss_dssp             CSCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             hhcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            356788889999999999999999999863       578999999865  46667889999999999999999999999


Q ss_pred             EecCCcEEEEEecCCCCCHHHHHhhcc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 016082          176 CTRPPNLCIVTEFMARGSIYDFLHKQK--------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM  241 (395)
Q Consensus       176 ~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl  241 (395)
                      |.+++.+||||||+++|+|.++++...              +++++..+..++.||++||.|||+++||||||||+|||+
T Consensus       112 ~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl  191 (329)
T 4aoj_A          112 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV  191 (329)
T ss_dssp             ECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             EEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE
Confidence            999999999999999999999997642              468999999999999999999999999999999999999


Q ss_pred             CCCCcEEEeeeccccccccCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 016082          242 DENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV  317 (395)
Q Consensus       242 ~~~~~vkl~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~  317 (395)
                      +.++.+||+|||+|+......   ..+...||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..+...
T Consensus       192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~  271 (329)
T 4aoj_A          192 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID  271 (329)
T ss_dssp             ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred             CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            999999999999998654332   2234579999999999999999999999999999999999 999999999887665


Q ss_pred             HhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 016082          318 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE  367 (395)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~  367 (395)
                      .+ ..+.+++.|..+++++.++|.+||+.||++|||+.||++.|+.+.+.
T Consensus       272 ~i-~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          272 CI-TQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             HH-HHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HH-HcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            54 45668888999999999999999999999999999999999988763

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.2e-61  Score=459.46  Aligned_cols=258  Identities=27%  Similarity=0.555  Sum_probs=228.3

Q ss_pred             ceeecccCcceeeeeeeeCceEEEEEEE-------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEE
Q 016082          104 VWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC  176 (395)
Q Consensus       104 ~~~i~~~~~~i~~~lg~G~~G~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  176 (395)
                      ..+|+.+++++.++||+|+||+||+|++       .++.||||+++... .....++|.+|+.+|++++|||||+++|+|
T Consensus        20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~   98 (308)
T 4gt4_A           20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVV   98 (308)
T ss_dssp             CCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence            4577888999999999999999999987       34789999997653 334457899999999999999999999999


Q ss_pred             ecCCcEEEEEecCCCCCHHHHHhhc---------------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 016082          177 TRPPNLCIVTEFMARGSIYDFLHKQ---------------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM  241 (395)
Q Consensus       177 ~~~~~~~lV~E~~~ggsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl  241 (395)
                      .+++.++|||||+++|+|.++|..+               ...+++..+..++.||++||.|||+++||||||||+|||+
T Consensus        99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl  178 (308)
T 4gt4_A           99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV  178 (308)
T ss_dssp             CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence            9999999999999999999999653               2468999999999999999999999999999999999999


Q ss_pred             CCCCcEEEeeeccccccccCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 016082          242 DENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV  317 (395)
Q Consensus       242 ~~~~~vkl~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~  317 (395)
                      ++++.+||+|||+|+......   ..+...||+.|||||++.+..|+.++|||||||++|||+| |..||.+.+..+...
T Consensus       179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~  258 (308)
T 4gt4_A          179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE  258 (308)
T ss_dssp             CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred             CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            999999999999998654332   2345678999999999999999999999999999999999 899999999877666


Q ss_pred             HhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 016082          318 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQ  363 (395)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~  363 (395)
                      .+ ..+.+++.|..+++++.++|.+||+.||.+||||.||++.|++
T Consensus       259 ~i-~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a  303 (308)
T 4gt4_A          259 MI-RNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA  303 (308)
T ss_dssp             HH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HH-HcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            54 4566778899999999999999999999999999999998864

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=8.3e-61  Score=461.01  Aligned_cols=250  Identities=25%  Similarity=0.464  Sum_probs=222.3

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      .++|++.++||+|+||.||+|++  +++.||||+++....+....+.+.+|+.+|++++|||||++++++.+++.+||||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            46899999999999999999998  5889999999888777777889999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-cc
Q 016082          187 EFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VM  264 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~  264 (395)
                      ||++||+|.+++..+. ..+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+...... ..
T Consensus       103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~  182 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA  182 (350)
T ss_dssp             ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHH
T ss_pred             eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcccc
Confidence            9999999999997654 467999999999999999999999999999999999999999999999999998765432 23


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhh
Q 016082          265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW  344 (395)
Q Consensus       265 ~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  344 (395)
                      +..+||+.|||||++.+.+|+.++|||||||++|||++|+.||.+.+..+....+.... .+..+..+|+++.+||.+||
T Consensus       183 ~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~~~~~~s~~~~~li~~~L  261 (350)
T 4b9d_A          183 RACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS-FPPVSLHYSYDLRSLVSQLF  261 (350)
T ss_dssp             HHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-CCCCCTTSCHHHHHHHHHHT
T ss_pred             cccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-CCCCCccCCHHHHHHHHHHc
Confidence            45579999999999999999999999999999999999999999999888777766543 45677889999999999999


Q ss_pred             ccCCCCCCCHHHHHH
Q 016082          345 QHDPTQRPNFSQITD  359 (395)
Q Consensus       345 ~~dp~~RPs~~ell~  359 (395)
                      ++||.+|||+.|+++
T Consensus       262 ~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          262 KRNPRDRPSVNSILE  276 (350)
T ss_dssp             CSSGGGSCCHHHHHT
T ss_pred             cCChhHCcCHHHHhc
Confidence            999999999999986

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.1e-60  Score=462.46  Aligned_cols=265  Identities=31%  Similarity=0.621  Sum_probs=235.8

Q ss_pred             CCceeecccCcceeeeeeeeCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC-CceeeEE
Q 016082          102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH-KNVVQFI  173 (395)
Q Consensus       102 ~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~  173 (395)
                      .+.|+|+.++|++.++||+|+||.||+|++.+       +.||||.++... .....+.|.+|+.+|.+++| ||||+++
T Consensus        56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~  134 (353)
T 4ase_A           56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL  134 (353)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence            35699999999999999999999999998743       579999998654 34556789999999999976 8999999


Q ss_pred             EEEecC-CcEEEEEecCCCCCHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 016082          174 GACTRP-PNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA  237 (395)
Q Consensus       174 ~~~~~~-~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~  237 (395)
                      |+|.+. ..+|||||||++|+|.++|+...               ..+++..+..++.||++||+|||+++||||||||+
T Consensus       135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~  214 (353)
T 4ase_A          135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR  214 (353)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcc
Confidence            999764 56899999999999999997642               34889999999999999999999999999999999


Q ss_pred             CeeeCCCCcEEEeeeccccccccCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 016082          238 NLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPL  313 (395)
Q Consensus       238 NiLl~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~  313 (395)
                      |||+++++.+||+|||+|+.......   .....||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..
T Consensus       215 NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~  294 (353)
T 4ase_A          215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  294 (353)
T ss_dssp             GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             ceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999986544322   233468999999999999999999999999999999998 99999998776


Q ss_pred             HHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 016082          314 QAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE  367 (395)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~  367 (395)
                      +.....+..+.++..|..+++++.++|.+||+.||.+||||.||++.|+++++.
T Consensus       295 ~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          295 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence            767777788889999999999999999999999999999999999999998764

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=6.2e-60  Score=452.88  Aligned_cols=257  Identities=23%  Similarity=0.360  Sum_probs=224.2

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  184 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  184 (395)
                      ...+.|++.++||+|+||.||+|++  +++.||||+++.+...       .+|+.+|++++|||||++++++.+++.+||
T Consensus        55 ~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~~~~~i  127 (336)
T 4g3f_A           55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPWVNI  127 (336)
T ss_dssp             BTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            3456789999999999999999998  5789999999866432       469999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCC-cEEEeeeccccccccCCc
Q 016082          185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQSGV  263 (395)
Q Consensus       185 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~-~vkl~DFg~a~~~~~~~~  263 (395)
                      ||||++||+|.+++++ .+++++..+..++.||+.||+|||++|||||||||+|||++.+| .+||+|||+|+.......
T Consensus       128 vmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          128 FMELLEGGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             EECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             EEeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            9999999999999976 56899999999999999999999999999999999999999987 699999999987654321


Q ss_pred             ------cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC-CCCCCCCcHHH
Q 016082          264 ------MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR-PTIPKHAHPRL  336 (395)
Q Consensus       264 ------~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l  336 (395)
                            ....+||+.|||||++.+.+|+.++|||||||++|||++|+.||.+.+..+....+...... ..+|+.+++++
T Consensus       207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~  286 (336)
T 4g3f_A          207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLT  286 (336)
T ss_dssp             -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHH
T ss_pred             ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHH
Confidence                  12347999999999999999999999999999999999999999987766655555543322 24678899999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHh
Q 016082          337 AELLERCWQHDPTQRPNFSQITDILKQMMKEVLYW  371 (395)
Q Consensus       337 ~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~~~  371 (395)
                      .++|.+||++||.+|||+.|+++.|...+++....
T Consensus       287 ~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l  321 (336)
T 4g3f_A          287 AQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGL  321 (336)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSS
T ss_pred             HHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhc
Confidence            99999999999999999999999999999887653

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.5e-60  Score=451.78  Aligned_cols=251  Identities=26%  Similarity=0.439  Sum_probs=216.1

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEE-----CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  180 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (395)
                      .++.++|++.+.||+|+||+||+|++     +++.||||+++...........+.+|+.+|++++|||||++++++.+++
T Consensus        20 ~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~   99 (304)
T 3ubd_A           20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG   99 (304)
T ss_dssp             CCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT
T ss_pred             cCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence            34567899999999999999999986     3578999999765443333356889999999999999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                      .+||||||++||+|.+++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus       100 ~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          100 KLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             EEEEEECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred             EEEEEEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence            99999999999999999976 56899999999999999999999999999999999999999999999999999986443


Q ss_pred             -CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHH
Q 016082          261 -SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL  339 (395)
Q Consensus       261 -~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  339 (395)
                       .......+||+.|||||++.+.+|+.++||||+||++|||++|+.||.+.+..+....+...  .+..|..+|+++.++
T Consensus       179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~l  256 (304)
T 3ubd_A          179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA--KLGMPQFLSPEAQSL  256 (304)
T ss_dssp             --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHH
T ss_pred             CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC--CCCCCCcCCHHHHHH
Confidence             33445678999999999999999999999999999999999999999999988877776654  456788899999999


Q ss_pred             HHHhhccCCCCCCCH-----HHHHH
Q 016082          340 LERCWQHDPTQRPNF-----SQITD  359 (395)
Q Consensus       340 i~~cl~~dp~~RPs~-----~ell~  359 (395)
                      |.+||++||++|||+     +|+++
T Consensus       257 i~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          257 LRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             HHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             HHHHcccCHHHCCCCCcCCHHHHHc
Confidence            999999999999984     56654

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=5.4e-59  Score=435.21  Aligned_cols=246  Identities=25%  Similarity=0.462  Sum_probs=205.4

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      ++|++.+.||+|+||+||+|++  +++.||||++++.... .+....+.+|+.+|++++|||||++++++.+++.+|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            5899999999999999999987  5799999999766543 334567999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCcccc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA  266 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~  266 (395)
                      ||+ +|+|.+++.+ ++++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..........
T Consensus        93 Ey~-~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~  170 (275)
T 3hyh_A           93 EYA-GNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT  170 (275)
T ss_dssp             ECC-CEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred             eCC-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCC
Confidence            999 6799999976 57899999999999999999999999999999999999999999999999999987766666667


Q ss_pred             CCCCcccccccccCCCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhc
Q 016082          267 ETGTYRWMAPEVIEHKPY-DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ  345 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~~~~-~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  345 (395)
                      .+||+.|||||++.+.+| +.++||||+||++|+|++|+.||.+.+..+....+...  .+.+|..+|+++.++|.+||+
T Consensus       171 ~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~  248 (275)
T 3hyh_A          171 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG--VYTLPKFLSPGAAGLIKRMLI  248 (275)
T ss_dssp             ----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCTTSCHHHHHHHHHHSC
T ss_pred             eeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHcc
Confidence            789999999999999887 57999999999999999999999998877766655543  456778899999999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 016082          346 HDPTQRPNFSQITD  359 (395)
Q Consensus       346 ~dp~~RPs~~ell~  359 (395)
                      .||++|||+.|+++
T Consensus       249 ~dP~~R~s~~eil~  262 (275)
T 3hyh_A          249 VNPLNRISIHEIMQ  262 (275)
T ss_dssp             SSGGGSCCHHHHHH
T ss_pred             CChhHCcCHHHHHc
Confidence            99999999999987

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.7e-60  Score=448.13  Aligned_cols=248  Identities=22%  Similarity=0.397  Sum_probs=222.5

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  185 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  185 (395)
                      .++|++.+.||+|+||+||+|++  +++.||||++++... +.+..+.+.+|+.+|++++|||||++++++.+++.+|||
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv  110 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG  110 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            46899999999999999999998  578999999975322 223356799999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC---C
Q 016082          186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS---G  262 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~---~  262 (395)
                      |||++||+|.+++++ .+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....   .
T Consensus       111 mEy~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~  189 (311)
T 4aw0_A          111 LSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  189 (311)
T ss_dssp             ECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred             EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence            999999999999976 578999999999999999999999999999999999999999999999999999876432   2


Q ss_pred             ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHH
Q 016082          263 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER  342 (395)
Q Consensus       263 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  342 (395)
                      .....+||+.|||||++.+.+|+.++||||+||++|+|++|+.||.+.+..+....+...  .+.+|..+++++++||.+
T Consensus       190 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~dli~~  267 (311)
T 4aw0_A          190 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL--EYDFPEKFFPKARDLVEK  267 (311)
T ss_dssp             CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCTTCCHHHHHHHHH
T ss_pred             cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCcccCHHHHHHHHH
Confidence            344568999999999999999999999999999999999999999999888877776654  346788899999999999


Q ss_pred             hhccCCCCCCCHHHHHH
Q 016082          343 CWQHDPTQRPNFSQITD  359 (395)
Q Consensus       343 cl~~dp~~RPs~~ell~  359 (395)
                      ||++||.+|||+.|++.
T Consensus       268 lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          268 LLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             HSCSSGGGSTTSGGGTC
T ss_pred             HccCCHhHCcChHHHcC
Confidence            99999999999998743

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.3e-59  Score=448.39  Aligned_cols=253  Identities=29%  Similarity=0.463  Sum_probs=223.6

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      .+.|++.++||+|+||.||+|++  +++.||||+++.....  ..+.+.+|+.+|++++|||||++++++.+++.+||||
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm  150 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  150 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            35799999999999999999998  5789999999654322  2356889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-Cccc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMT  265 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-~~~~  265 (395)
                      ||++||+|.+++.+  +++++..+..++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+..... ...+
T Consensus       151 Ey~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~  228 (346)
T 4fih_A          151 EFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  228 (346)
T ss_dssp             CCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred             eCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccc
Confidence            99999999999975  56999999999999999999999999999999999999999999999999999876543 3455


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCC--CCCCCcHHHHHHHHHh
Q 016082          266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT--IPKHAHPRLAELLERC  343 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~c  343 (395)
                      ..+||+.|||||++.+.+|+.++|||||||++|||++|++||.+.+..+....+.. ...+.  .+..+++++.+||.+|
T Consensus       229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~-~~~~~~~~~~~~s~~~~dli~~~  307 (346)
T 4fih_A          229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-NLPPRLKNLHKVSPSLKGFLDRL  307 (346)
T ss_dssp             CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-SSCCCCSCGGGSCHHHHHHHHHH
T ss_pred             ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc-CCCCCCCccccCCHHHHHHHHHH
Confidence            67899999999999999999999999999999999999999999988877666544 33333  3457899999999999


Q ss_pred             hccCCCCCCCHHHHHHHHHHHHHHHHHhhccc
Q 016082          344 WQHDPTQRPNFSQITDILKQMMKEVLYWLSPN  375 (395)
Q Consensus       344 l~~dp~~RPs~~ell~~l~~~~~~~~~~~~~~  375 (395)
                      |+.||.+|||+.|+++         +-|+.+.
T Consensus       308 L~~dP~~R~ta~e~l~---------Hp~~~~~  330 (346)
T 4fih_A          308 LVRDPAQRATAAELLK---------HPFLAKA  330 (346)
T ss_dssp             SCSSTTTSCCHHHHTT---------CGGGGGC
T ss_pred             cCCChhHCcCHHHHhc---------CHhhcCC
Confidence            9999999999999987         6777654

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=6.2e-59  Score=438.31  Aligned_cols=245  Identities=29%  Similarity=0.535  Sum_probs=214.0

Q ss_pred             cceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec----CCcEEEE
Q 016082          112 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR----PPNLCIV  185 (395)
Q Consensus       112 ~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV  185 (395)
                      |++.++||+|+||.||+|++  ++..||+|++..........+.|.+|+.+|++++|||||+++++|..    ++.+|||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            47888999999999999998  46889999998776677777889999999999999999999999864    3458999


Q ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCeeeCC-CCcEEEeeeccccccccCC
Q 016082          186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDE-NGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--iiHrDlkp~NiLl~~-~~~vkl~DFg~a~~~~~~~  262 (395)
                      |||++||+|.+++++ .+.+++..+..++.||+.||+|||++|  ||||||||+|||++. +|.+||+|||+|+..... 
T Consensus       108 mEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~-  185 (290)
T 3fpq_A          108 TELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-  185 (290)
T ss_dssp             EECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred             EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC-
Confidence            999999999999976 568999999999999999999999998  999999999999984 799999999999865433 


Q ss_pred             ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC-CCCCCCCcHHHHHHHH
Q 016082          263 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR-PTIPKHAHPRLAELLE  341 (395)
Q Consensus       263 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~  341 (395)
                      .....+||+.|||||++.+ +|+.++|||||||++|||+||+.||.+.+........+....+ +..+...++++.++|.
T Consensus       186 ~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~  264 (290)
T 3fpq_A          186 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE  264 (290)
T ss_dssp             SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHH
T ss_pred             ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHH
Confidence            3456789999999999875 5999999999999999999999999876655544444444433 3456678899999999


Q ss_pred             HhhccCCCCCCCHHHHHH
Q 016082          342 RCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       342 ~cl~~dp~~RPs~~ell~  359 (395)
                      +||+.||.+|||+.|+++
T Consensus       265 ~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          265 GCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HHSCSSGGGSCCHHHHHT
T ss_pred             HHccCChhHCcCHHHHhc
Confidence            999999999999999986

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.2e-57  Score=448.76  Aligned_cols=254  Identities=28%  Similarity=0.445  Sum_probs=224.2

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      .+.|++.++||+|+||.||+|++  +++.||||+++.....  ..+.+.+|+.+|++++|||||+++++|.+++.+||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm  227 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  227 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence            35699999999999999999998  5789999999755322  2356889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-Cccc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMT  265 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-~~~~  265 (395)
                      |||+||+|.+++..  +++++..+..++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+..... ....
T Consensus       228 Ey~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~  305 (423)
T 4fie_A          228 EFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  305 (423)
T ss_dssp             ECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBC
T ss_pred             eCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcccc
Confidence            99999999999965  56999999999999999999999999999999999999999999999999999876543 3445


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccC-CCCCCCCCcHHHHHHHHHhh
Q 016082          266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL-RPTIPKHAHPRLAELLERCW  344 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl  344 (395)
                      ..+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.++.+....+..... ....+..+++++.+||.+||
T Consensus       306 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L  385 (423)
T 4fie_A          306 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLL  385 (423)
T ss_dssp             CCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHS
T ss_pred             ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHc
Confidence            67899999999999999999999999999999999999999999988887766554321 22344678999999999999


Q ss_pred             ccCCCCCCCHHHHHHHHHHHHHHHHHhhccc
Q 016082          345 QHDPTQRPNFSQITDILKQMMKEVLYWLSPN  375 (395)
Q Consensus       345 ~~dp~~RPs~~ell~~l~~~~~~~~~~~~~~  375 (395)
                      +.||.+|||+.|+++         +-|+.+.
T Consensus       386 ~~dP~~R~ta~ell~---------Hp~~~~~  407 (423)
T 4fie_A          386 VRDPAQRATAAELLK---------HPFLAKA  407 (423)
T ss_dssp             CSSTTTSCCHHHHTT---------CGGGGGC
T ss_pred             CCChhHCcCHHHHhc---------CHHhcCC
Confidence            999999999999987         6677654

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.6e-57  Score=430.29  Aligned_cols=253  Identities=27%  Similarity=0.530  Sum_probs=208.4

Q ss_pred             cCcceeeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC----cEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP----NLCIV  185 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lV  185 (395)
                      ++|.+.++||+|+||.||+|+++|+.||||+++..   ......+..|+..+.+++|||||+++++|.+++    .+|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            47899999999999999999999999999999753   222223345666677899999999999997654    58999


Q ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCCCCeeeCCCCcEEEeeeccccc
Q 016082          186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN--------NIIHRDLKTANLLMDENGVVKVADFGVARV  257 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~  257 (395)
                      |||++||+|.++++.  .++++..+.+++.|+++||+|||++        +||||||||+|||++.++.+||+|||+|+.
T Consensus        80 ~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  157 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             EECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             ecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence            999999999999976  4689999999999999999999987        999999999999999999999999999987


Q ss_pred             cccCCc-----cccCCCCcccccccccCCC------CCCChhhHHHHHHHHHHHHhCCCCCC----------CC-----C
Q 016082          258 QAQSGV-----MTAETGTYRWMAPEVIEHK------PYDYKADVFSFGIALWELLTGELPYA----------GL-----T  311 (395)
Q Consensus       258 ~~~~~~-----~~~~~gt~~y~aPE~~~~~------~~~~k~DvwslG~vl~elltg~~pf~----------~~-----~  311 (395)
                      ......     .....||+.|||||++.+.      .|+.++|||||||++|||+||.+||.          +.     .
T Consensus       158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~  237 (303)
T 3hmm_A          158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence            654332     2234799999999999764      46789999999999999999976553          22     2


Q ss_pred             HHHHHHHhhhccCCCCCCCCC-----cHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 016082          312 PLQAAVGVVQKSLRPTIPKHA-----HPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE  367 (395)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~-----~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~  367 (395)
                      ..+....+.....+|.+|...     ++.+.++|.+||+.||.+|||+.||++.|+++.++
T Consensus       238 ~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            234444455667788777543     45789999999999999999999999999988764

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=6.7e-56  Score=420.33  Aligned_cols=246  Identities=23%  Similarity=0.395  Sum_probs=194.5

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC-------
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP-------  180 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------  180 (395)
                      ++|++.+.||+|+||.||+|++  +++.||||+++... .+...+.+.+|+.+|++++|||||++++++...+       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            3689999999999999999998  57899999997553 3455678999999999999999999999986543       


Q ss_pred             -----cEEEEEecCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeec
Q 016082          181 -----NLCIVTEFMARGSIYDFLHKQK--GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG  253 (395)
Q Consensus       181 -----~~~lV~E~~~ggsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg  253 (395)
                           .+|+||||++||+|.+++....  ...+...++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG  163 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG  163 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence                 3799999999999999997643  224456688999999999999999999999999999999999999999999


Q ss_pred             cccccccCC-------------ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhh
Q 016082          254 VARVQAQSG-------------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV  320 (395)
Q Consensus       254 ~a~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~  320 (395)
                      +|+......             ..+..+||+.|||||++.+.+|+.++|||||||++|||++   ||.+...........
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~  240 (299)
T 4g31_A          164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDV  240 (299)
T ss_dssp             CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHH
T ss_pred             cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHH
Confidence            998654432             1234579999999999999999999999999999999996   776543322222222


Q ss_pred             hccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          321 QKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      .....|+.+...++.+.++|.+||+.||.+|||+.|+++
T Consensus       241 ~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          241 RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            222223333445678899999999999999999999987

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-54  Score=426.09  Aligned_cols=255  Identities=24%  Similarity=0.348  Sum_probs=218.8

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec------CCc
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR------PPN  181 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  181 (395)
                      ++|++.++||+|+||+||+|++  +++.||||+++.........+.+.+|+.+|++++|||||++++++..      ...
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            5899999999999999999998  58999999998776667777889999999999999999999998754      357


Q ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC
Q 016082          182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  261 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~  261 (395)
                      +||||||++ |+|.+++.. .+++++..+..++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.....
T Consensus       134 ~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~  211 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS  211 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred             EEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence            899999996 589999976 578999999999999999999999999999999999999999999999999999865332


Q ss_pred             -----CccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCC--------
Q 016082          262 -----GVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT--------  327 (395)
Q Consensus       262 -----~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~--------  327 (395)
                           ...+..+||+.|||||++.+. .|+.++||||+||++|||++|++||.+.+..+....+......+.        
T Consensus       212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~  291 (398)
T 4b99_A          212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG  291 (398)
T ss_dssp             ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC---
T ss_pred             ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence                 234567899999999998875 569999999999999999999999999888776665543222111        


Q ss_pred             --------------C-------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhccc
Q 016082          328 --------------I-------PKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPN  375 (395)
Q Consensus       328 --------------~-------~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~~~~~~~  375 (395)
                                    .       .+.+++++.+||.+||+.||.+|||+.|+++         +-|+...
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~---------Hp~f~~~  351 (398)
T 4b99_A          292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR---------HPFLAKY  351 (398)
T ss_dssp             --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT---------SGGGTTT
T ss_pred             hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc---------CHhhCcC
Confidence                          1       1346889999999999999999999999987         6677643

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=6.1e-53  Score=433.55  Aligned_cols=248  Identities=22%  Similarity=0.368  Sum_probs=225.1

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      ++|++.+.||+|+||.||+|++  +++.||+|+++...  ....+.+.+|+.+|+.++|||||++++++.+...+|||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E  234 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  234 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            5899999999999999999998  57899999997653  4455778999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCC--CcEEEeeeccccccccCCccc
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN--GVVKVADFGVARVQAQSGVMT  265 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~--~~vkl~DFg~a~~~~~~~~~~  265 (395)
                      |++||+|.+++....+.+++..+..++.||+.||.|||++||+||||||+|||++.+  +.+||+|||+|+.........
T Consensus       235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~  314 (573)
T 3uto_A          235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK  314 (573)
T ss_dssp             CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEE
T ss_pred             ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCcee
Confidence            999999999998777889999999999999999999999999999999999999854  899999999999877666666


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC--CCCCCCCcHHHHHHHHHh
Q 016082          266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLAELLERC  343 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~c  343 (395)
                      ..+||+.|||||++.+.+|+.++||||+||++|+|++|+.||.+.+..+....+......  +..+..+|+++.+||.+|
T Consensus       315 ~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~  394 (573)
T 3uto_A          315 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKL  394 (573)
T ss_dssp             EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTT
T ss_pred             eeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHH
Confidence            778999999999999999999999999999999999999999999988877776654433  233457899999999999


Q ss_pred             hccCCCCCCCHHHHHH
Q 016082          344 WQHDPTQRPNFSQITD  359 (395)
Q Consensus       344 l~~dp~~RPs~~ell~  359 (395)
                      |+.||.+|||+.|+++
T Consensus       395 L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          395 LLADPNTRMTIHQALE  410 (573)
T ss_dssp             SCSSGGGSCCHHHHHH
T ss_pred             ccCChhHCcCHHHHhc
Confidence            9999999999999987

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5.2e-52  Score=395.82  Aligned_cols=267  Identities=42%  Similarity=0.769  Sum_probs=231.8

Q ss_pred             CCceeecccCcceeeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Q 016082          102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  181 (395)
Q Consensus       102 ~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  181 (395)
                      ...+++..++|++.+.||+|+||.||+|++.++.||||++..........+.+.+|+.++++++||||+++++++...+.
T Consensus        29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  108 (309)
T 3p86_A           29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN  108 (309)
T ss_dssp             ---CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred             cccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence            35678899999999999999999999999999999999998877777778899999999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCeeeCCCCcEEEeeeccccc
Q 016082          182 LCIVTEFMARGSIYDFLHKQK--GVFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGVARV  257 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~--iiHrDlkp~NiLl~~~~~vkl~DFg~a~~  257 (395)
                      .++||||+++|+|.+++....  ..+++..++.++.|++.||.|||++|  |+||||||+||+++.++.+||+|||+++.
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  188 (309)
T 3p86_A          109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL  188 (309)
T ss_dssp             CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred             eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence            999999999999999997643  23899999999999999999999999  99999999999999999999999999976


Q ss_pred             cccCC-ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHH
Q 016082          258 QAQSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  336 (395)
Q Consensus       258 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  336 (395)
                      ..... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+....+.....+...|..+++++
T Consensus       189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  268 (309)
T 3p86_A          189 KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQV  268 (309)
T ss_dssp             -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHH
T ss_pred             ccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHH
Confidence            54432 23445789999999999999999999999999999999999999999998887777666677788889999999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHHHHHHHHH
Q 016082          337 AELLERCWQHDPTQRPNFSQITDILKQMMKEV  368 (395)
Q Consensus       337 ~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~  368 (395)
                      .++|.+||+.||.+|||+.++++.|+.+++..
T Consensus       269 ~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          269 AAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence            99999999999999999999999999888754

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1e-51  Score=401.71  Aligned_cols=242  Identities=21%  Similarity=0.337  Sum_probs=198.8

Q ss_pred             cCcceeeeeeeeCceEEEEEEE-----CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  183 (395)
                      ++|++.++||+|+||+||+|++     +++.||||.+.+..    ....+.+|+.+|+.+ +||||+++++++.+.+++|
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~   96 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV   96 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence            5799999999999999999986     35789999987543    235678899999998 5999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCC-CcEEEeeeccccccccCC
Q 016082          184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSG  262 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~-~~vkl~DFg~a~~~~~~~  262 (395)
                      +||||++||+|.++++    .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+......
T Consensus        97 lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~  172 (361)
T 4f9c_A           97 IAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK  172 (361)
T ss_dssp             EEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred             EEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence            9999999999999984    48999999999999999999999999999999999999876 899999999997543221


Q ss_pred             -----------------------------ccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCC-C
Q 016082          263 -----------------------------VMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGL-T  311 (395)
Q Consensus       263 -----------------------------~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwslG~vl~elltg~~pf~~~-~  311 (395)
                                                   ..+..+||+.|||||++.+. .|+.++||||+||++|||++|+.||... +
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~  252 (361)
T 4f9c_A          173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD  252 (361)
T ss_dssp             CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence                                         12345799999999999875 5899999999999999999999999543 3


Q ss_pred             HHHHHHHhhhc------------------------------------c----------------CCCCCCCCCcHHHHHH
Q 016082          312 PLQAAVGVVQK------------------------------------S----------------LRPTIPKHAHPRLAEL  339 (395)
Q Consensus       312 ~~~~~~~~~~~------------------------------------~----------------~~~~~~~~~~~~l~~l  339 (395)
                      ..+....+...                                    .                ........+|+++.+|
T Consensus       253 ~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DL  332 (361)
T 4f9c_A          253 DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDL  332 (361)
T ss_dssp             HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHH
T ss_pred             HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHH
Confidence            33222221110                                    0                0001123578899999


Q ss_pred             HHHhhccCCCCCCCHHHHHH
Q 016082          340 LERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       340 i~~cl~~dp~~RPs~~ell~  359 (395)
                      |.+||+.||.+|||++|+++
T Consensus       333 l~~lL~~dP~~R~ta~eaL~  352 (361)
T 4f9c_A          333 LDKLLDLNPASRITAEEALL  352 (361)
T ss_dssp             HHHHTCSCTTTSCCHHHHHT
T ss_pred             HHHHCcCChhHCcCHHHHhc
Confidence            99999999999999999987

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=8e-52  Score=425.39  Aligned_cols=249  Identities=25%  Similarity=0.410  Sum_probs=211.6

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC----CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV----NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  180 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (395)
                      +..++|++.+.||+|+||.||+|++  +++.||||++++...    ..........++.+++.++|||||+++++|.+..
T Consensus       186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~  265 (689)
T 3v5w_A          186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD  265 (689)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred             CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence            4457899999999999999999998  678999999964321    2222333444566777789999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                      .+||||||++||+|.+++.+ .+.+++..+..++.||+.||+|||++|||||||||+|||++.+|++||+|||+|+....
T Consensus       266 ~lylVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          266 KLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             EEEEEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence            99999999999999999976 57899999999999999999999999999999999999999999999999999987654


Q ss_pred             CCccccCCCCcccccccccC-CCCCCChhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHhhhccCCCCCCCCCcHHH
Q 016082          261 SGVMTAETGTYRWMAPEVIE-HKPYDYKADVFSFGIALWELLTGELPYAGLT---PLQAAVGVVQKSLRPTIPKHAHPRL  336 (395)
Q Consensus       261 ~~~~~~~~gt~~y~aPE~~~-~~~~~~k~DvwslG~vl~elltg~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l  336 (395)
                      .. ....+||+.|||||++. +..|+.++|+|||||++|||++|++||.+.+   ..+....+.  ...+..|..+|+++
T Consensus       345 ~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~--~~~~~~p~~~S~~a  421 (689)
T 3v5w_A          345 KK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--TMAVELPDSFSPEL  421 (689)
T ss_dssp             CC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH--HCCCCCCTTSCHHH
T ss_pred             CC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc--CCCCCCCccCCHHH
Confidence            43 34568999999999996 4689999999999999999999999997642   223233322  33556788899999


Q ss_pred             HHHHHHhhccCCCCCCC-----HHHHHH
Q 016082          337 AELLERCWQHDPTQRPN-----FSQITD  359 (395)
Q Consensus       337 ~~li~~cl~~dp~~RPs-----~~ell~  359 (395)
                      .+||.+||+.||.+|++     ++||++
T Consensus       422 ~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          422 RSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             HHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             HHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            99999999999999998     677765

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.1e-50  Score=388.05  Aligned_cols=248  Identities=27%  Similarity=0.483  Sum_probs=227.1

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      .++|++.+.||+|+||.||+|++  +++.||||++.....+....+.+.+|+.++++++||||+++++++...+..|+||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            46899999999999999999997  6889999999877667777888999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCcccc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA  266 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~  266 (395)
                      ||++||+|.+++.. .+++++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++..........
T Consensus        94 e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~  172 (328)
T 3fe3_A           94 EYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA  172 (328)
T ss_dssp             CCCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGT
T ss_pred             ECCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcccc
Confidence            99999999999976 46799999999999999999999999999999999999999999999999999987766666677


Q ss_pred             CCCCcccccccccCCCCCC-ChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhc
Q 016082          267 ETGTYRWMAPEVIEHKPYD-YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ  345 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~~~~~-~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  345 (395)
                      ..||+.|+|||++.+..++ .++||||+||++|+|++|+.||.+.+..+....+...  ....|...++++.++|.+||+
T Consensus       173 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~  250 (328)
T 3fe3_A          173 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG--KYRIPFYMSTDCENLLKRFLV  250 (328)
T ss_dssp             TSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHCC
T ss_pred             ccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHHCC
Confidence            7899999999999988875 7999999999999999999999999887776666554  345677899999999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 016082          346 HDPTQRPNFSQITD  359 (395)
Q Consensus       346 ~dp~~RPs~~ell~  359 (395)
                      .||.+|||+.|+++
T Consensus       251 ~dP~~R~t~~eil~  264 (328)
T 3fe3_A          251 LNPIKRGTLEQIMK  264 (328)
T ss_dssp             SSTTTSCCHHHHTT
T ss_pred             CChhHCcCHHHHhc
Confidence            99999999999987

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.1e-50  Score=374.88  Aligned_cols=261  Identities=32%  Similarity=0.676  Sum_probs=233.3

Q ss_pred             CceeecccCcceeeeeeeeCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Q 016082          103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  181 (395)
Q Consensus       103 ~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  181 (395)
                      ..|.++.++|++.+.||+|+||.||+|++ .++.||+|+++......   +.+.+|+.++++++||||+++++++.+...
T Consensus         3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   79 (269)
T 4hcu_A            3 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAP   79 (269)
T ss_dssp             --CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             ccEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCCc
Confidence            46889999999999999999999999998 67889999998765443   568899999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC
Q 016082          182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  261 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~  261 (395)
                      .++||||+++++|.+++....+.+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  159 (269)
T 4hcu_A           80 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  159 (269)
T ss_dssp             EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence            99999999999999999887788999999999999999999999999999999999999999999999999999865433


Q ss_pred             C--ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHH
Q 016082          262 G--VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE  338 (395)
Q Consensus       262 ~--~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  338 (395)
                      .  ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+ ....++..+...++++.+
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  238 (269)
T 4hcu_A          160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-STGFRLYKPRLASTHVYQ  238 (269)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-HTTCCCCCCTTSCHHHHH
T ss_pred             ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH-hcCccCCCCCcCCHHHHH
Confidence            2  2234456788999999998999999999999999999999 99999998887765554 345667778889999999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 016082          339 LLERCWQHDPTQRPNFSQITDILKQMMKE  367 (395)
Q Consensus       339 li~~cl~~dp~~RPs~~ell~~l~~~~~~  367 (395)
                      ++.+||+.||.+|||+.++++.|+++.+.
T Consensus       239 li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          239 IMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence            99999999999999999999999998764

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=7.5e-51  Score=398.33  Aligned_cols=263  Identities=32%  Similarity=0.613  Sum_probs=233.9

Q ss_pred             CceeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 016082          103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  180 (395)
Q Consensus       103 ~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (395)
                      +.|+++.++|++.+.||+|+||.||+|++  +++.||||+++.. ...+....+.+|+.+|++++||||+++++++...+
T Consensus       107 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  185 (377)
T 3cbl_A          107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ  185 (377)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             cccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence            46899999999999999999999999998  4789999999855 34555678999999999999999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                      ..|+||||+++|+|.++++.....++...+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       186 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          186 PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD  265 (377)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred             CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence            99999999999999999988767799999999999999999999999999999999999999999999999999986443


Q ss_pred             CCccc---cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHH
Q 016082          261 SGVMT---AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  336 (395)
Q Consensus       261 ~~~~~---~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  336 (395)
                      .....   ...++..|+|||++.+..++.++||||||+++|||++ |..||.+.+..+.... +....++..|..+++++
T Consensus       266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l  344 (377)
T 3cbl_A          266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREF-VEKGGRLPCPELCPDAV  344 (377)
T ss_dssp             SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHH-HHTTCCCCCCTTCCHHH
T ss_pred             CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCCCCCHHH
Confidence            22111   1234678999999998899999999999999999998 9999999887765544 45566777888899999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 016082          337 AELLERCWQHDPTQRPNFSQITDILKQMMKE  367 (395)
Q Consensus       337 ~~li~~cl~~dp~~RPs~~ell~~l~~~~~~  367 (395)
                      .++|.+||+.||.+|||+.++++.|+++.+.
T Consensus       345 ~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          345 FRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence            9999999999999999999999999998764

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=5.4e-50  Score=391.35  Aligned_cols=264  Identities=30%  Similarity=0.624  Sum_probs=232.2

Q ss_pred             CceeecccCcceeeeeeeeCceEEEEEEEC---------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeE
Q 016082          103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQF  172 (395)
Q Consensus       103 ~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l  172 (395)
                      ..|++..++|++.+.||+|+||.||+|++.         +..||||+++... .....+.+.+|+.+++++ +||||+++
T Consensus        74 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~  152 (370)
T 2psq_A           74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINL  152 (370)
T ss_dssp             TTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCE
T ss_pred             ccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence            457788899999999999999999999862         2469999998663 455677899999999999 89999999


Q ss_pred             EEEEecCCcEEEEEecCCCCCHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 016082          173 IGACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA  237 (395)
Q Consensus       173 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~  237 (395)
                      ++++...+.+|+||||++||+|.+++....               ..+++..++.++.||+.||.|||++||+||||||+
T Consensus       153 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~  232 (370)
T 2psq_A          153 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR  232 (370)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred             EEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchh
Confidence            999999999999999999999999998653               34788999999999999999999999999999999


Q ss_pred             CeeeCCCCcEEEeeeccccccccCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 016082          238 NLLMDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPL  313 (395)
Q Consensus       238 NiLl~~~~~vkl~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~  313 (395)
                      |||++.++.+||+|||+++......   ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....
T Consensus       233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~  312 (370)
T 2psq_A          233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  312 (370)
T ss_dssp             GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            9999999999999999998654432   2234467889999999999999999999999999999999 99999988766


Q ss_pred             HHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHH
Q 016082          314 QAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  368 (395)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~  368 (395)
                      +... ......++..|..+++++.++|.+||+.||.+||++.|+++.|++++...
T Consensus       313 ~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~  366 (370)
T 2psq_A          313 ELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  366 (370)
T ss_dssp             GHHH-HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHH-HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence            5544 34556677888899999999999999999999999999999999988643

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3e-50  Score=374.11  Aligned_cols=258  Identities=33%  Similarity=0.620  Sum_probs=234.8

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--CcE
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNL  182 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  182 (395)
                      +.++.++|++.+.||+|+||.||+|++.++.||||+++.........+.+.+|+.++++++||||+++++++...  ...
T Consensus         5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (271)
T 3kmu_A            5 SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP   84 (271)
T ss_dssp             CCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred             CCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence            567788999999999999999999999999999999998777777778899999999999999999999999887  778


Q ss_pred             EEEEecCCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCeeeCCCCcEEEeeeccccccc
Q 016082          183 CIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGVARVQA  259 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~--iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~  259 (395)
                      ++||||+++|+|.+++....+ .+++..++.++.|++.||.|||+.|  |+||||||+||+++.++.++++|||++....
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            999999999999999987543 5899999999999999999999999  9999999999999999999999999876432


Q ss_pred             cCCccccCCCCcccccccccCCCCCCC---hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHH
Q 016082          260 QSGVMTAETGTYRWMAPEVIEHKPYDY---KADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  336 (395)
Q Consensus       260 ~~~~~~~~~gt~~y~aPE~~~~~~~~~---k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  336 (395)
                      .    ....||+.|+|||++.+..++.   ++||||||+++|+|++|+.||.+.+..+..........++..+..+++++
T Consensus       165 ~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (271)
T 3kmu_A          165 S----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHV  240 (271)
T ss_dssp             C----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHH
T ss_pred             c----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHH
Confidence            2    3457899999999998765544   89999999999999999999999998888888888888889999999999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 016082          337 AELLERCWQHDPTQRPNFSQITDILKQMMK  366 (395)
Q Consensus       337 ~~li~~cl~~dp~~RPs~~ell~~l~~~~~  366 (395)
                      .+++.+||+.||.+|||+.++++.|+++.+
T Consensus       241 ~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          241 SKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            999999999999999999999999998753

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.9e-50  Score=384.73  Aligned_cols=262  Identities=35%  Similarity=0.610  Sum_probs=231.1

Q ss_pred             ceeecccCcceeeeeeeeCceEEEEEEEC-----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Q 016082          104 VWEIDAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR  178 (395)
Q Consensus       104 ~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  178 (395)
                      ..++..++|++.+.||+|+||.||+|++.     +..||||+++... .....+.+.+|+.++++++||||+++++++.+
T Consensus        43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  121 (325)
T 3kul_A           43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR  121 (325)
T ss_dssp             CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred             ccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            35778899999999999999999999983     3459999998653 45566789999999999999999999999999


Q ss_pred             CCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccc
Q 016082          179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  258 (395)
Q Consensus       179 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~  258 (395)
                      ....++||||++||+|.++++...+.+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++..
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            99999999999999999999877788999999999999999999999999999999999999999999999999999865


Q ss_pred             ccCC----ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCc
Q 016082          259 AQSG----VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAH  333 (395)
Q Consensus       259 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (395)
                      ....    ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+. ...++..+..++
T Consensus       202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~  280 (325)
T 3kul_A          202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-EGYRLPAPMGCP  280 (325)
T ss_dssp             C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCCCCCTTCC
T ss_pred             ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCCCCCCCCcC
Confidence            4432    1223456788999999998999999999999999999999 999999988877665544 456677788899


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 016082          334 PRLAELLERCWQHDPTQRPNFSQITDILKQMMKE  367 (395)
Q Consensus       334 ~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~  367 (395)
                      +++.++|.+||+.||.+|||+.++++.|+.+++.
T Consensus       281 ~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~  314 (325)
T 3kul_A          281 HALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS  314 (325)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence            9999999999999999999999999999998764

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=9.2e-50  Score=374.21  Aligned_cols=262  Identities=31%  Similarity=0.640  Sum_probs=231.3

Q ss_pred             CCceeecccCcceeeeeeeeCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 016082          102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  180 (395)
Q Consensus       102 ~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (395)
                      ...|+++.++|++.+.||+|+||.||+|++. +..||+|+++......   +++.+|+.++++++||||+++++++.+..
T Consensus        16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   92 (283)
T 3gen_A           16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQR   92 (283)
T ss_dssp             CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             CCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecCC
Confidence            3578999999999999999999999999985 4589999998765443   56889999999999999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                      ..++||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||+++....
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A           93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            99999999999999999988677899999999999999999999999999999999999999999999999999986543


Q ss_pred             CC--ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHH
Q 016082          261 SG--VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA  337 (395)
Q Consensus       261 ~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  337 (395)
                      ..  ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+. ...+...+...++++.
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~  251 (283)
T 3gen_A          173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVY  251 (283)
T ss_dssp             HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHH
T ss_pred             cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh-cccCCCCCCcCCHHHH
Confidence            32  2233456788999999998899999999999999999998 999999988877665544 4566677788899999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 016082          338 ELLERCWQHDPTQRPNFSQITDILKQMMKE  367 (395)
Q Consensus       338 ~li~~cl~~dp~~RPs~~ell~~l~~~~~~  367 (395)
                      +++.+||+.||.+|||+.++++.|.+++.+
T Consensus       252 ~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          252 TIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence            999999999999999999999999998875

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=8.3e-50  Score=399.93  Aligned_cols=258  Identities=34%  Similarity=0.678  Sum_probs=229.2

Q ss_pred             CceeecccCcceeeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC-c
Q 016082          103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP-N  181 (395)
Q Consensus       103 ~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~  181 (395)
                      ..|+++.++|++.++||+|+||.||+|++.++.||||+++...    ..+.|.+|+.+|++++||||+++++++.... .
T Consensus       186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  261 (450)
T 1k9a_A          186 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG  261 (450)
T ss_dssp             TTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred             cccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence            4689999999999999999999999999999999999998653    3467899999999999999999999987665 7


Q ss_pred             EEEEEecCCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          182 LCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                      .|+||||+++|+|.++++.... .++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence            9999999999999999987543 379999999999999999999999999999999999999999999999999985433


Q ss_pred             CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHH
Q 016082          261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL  339 (395)
Q Consensus       261 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  339 (395)
                      .  .....++..|+|||++.+..++.++||||||+++|||++ |+.||.+.+..+.... +..+.++..|..+++++.++
T Consensus       342 ~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~-i~~~~~~~~p~~~~~~l~~l  418 (450)
T 1k9a_A          342 T--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMDAPDGCPPAVYDV  418 (450)
T ss_dssp             -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH-HHTTCCCCCCTTCCHHHHHH
T ss_pred             c--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCCcCCHHHHHH
Confidence            2  233467889999999999999999999999999999998 9999998877665544 44567788889999999999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 016082          340 LERCWQHDPTQRPNFSQITDILKQMMKE  367 (395)
Q Consensus       340 i~~cl~~dp~~RPs~~ell~~l~~~~~~  367 (395)
                      |.+||+.||.+|||+.++++.|+++...
T Consensus       419 i~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          419 MKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence            9999999999999999999999998764

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=7e-50  Score=380.32  Aligned_cols=265  Identities=31%  Similarity=0.492  Sum_probs=226.6

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  182 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  182 (395)
                      +.+..++|++.+.||+|+||.||+|++  +++.||+|++...  +....+.+.+|+.++++++||||+++++++.+.+..
T Consensus         5 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   82 (310)
T 3s95_A            5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL   82 (310)
T ss_dssp             EEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             eeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCee
Confidence            356678999999999999999999998  4789999998654  466778899999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC
Q 016082          183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~  262 (395)
                      ++||||+++|+|.+++....+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK  162 (310)
T ss_dssp             EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred             EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence            99999999999999998877889999999999999999999999999999999999999999999999999998654332


Q ss_pred             cc---------------ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-hhhccCCC
Q 016082          263 VM---------------TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG-VVQKSLRP  326 (395)
Q Consensus       263 ~~---------------~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~-~~~~~~~~  326 (395)
                      ..               ....||+.|+|||++.+..++.++||||||+++|+|++|..||....+...... ........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~  242 (310)
T 3s95_A          163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR  242 (310)
T ss_dssp             -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH
T ss_pred             ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc
Confidence            11               145789999999999999999999999999999999999999876433211100 01111223


Q ss_pred             CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHh
Q 016082          327 TIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYW  371 (395)
Q Consensus       327 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~~~  371 (395)
                      ..+..+++++.+++.+||+.||.+|||+.++++.|+++...+...
T Consensus       243 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~  287 (310)
T 3s95_A          243 YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGH  287 (310)
T ss_dssp             TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHC
T ss_pred             cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCc
Confidence            346678889999999999999999999999999999999877653

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=6.6e-50  Score=377.64  Aligned_cols=262  Identities=28%  Similarity=0.540  Sum_probs=222.2

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEE------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR  178 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  178 (395)
                      .++..++|++.++||+|+||.||+|++      +++.||||+++..  .....+.+.+|+.++++++||||+++++++..
T Consensus         5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   82 (295)
T 3ugc_A            5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS   82 (295)
T ss_dssp             -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred             CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            456778999999999999999999985      5688999999865  45667889999999999999999999999854


Q ss_pred             --CCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccc
Q 016082          179 --PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR  256 (395)
Q Consensus       179 --~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~  256 (395)
                        ...+++||||+++|+|.+++......+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++
T Consensus        83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence              356899999999999999998877779999999999999999999999999999999999999999999999999998


Q ss_pred             ccccCC----ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH---------------HHH
Q 016082          257 VQAQSG----VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ---------------AAV  317 (395)
Q Consensus       257 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~---------------~~~  317 (395)
                      ......    ......++..|+|||++.+..++.++||||||+++|+|++|..||.......               ...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  242 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence            654432    2233457788999999999999999999999999999999999986532211               122


Q ss_pred             HhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHH
Q 016082          318 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  368 (395)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~  368 (395)
                      .......+...+..+++++.++|.+||+.||.+|||+.++++.|+++++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          243 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence            233445566778889999999999999999999999999999999998765

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=7.7e-50  Score=387.33  Aligned_cols=266  Identities=31%  Similarity=0.621  Sum_probs=233.6

Q ss_pred             CCceeecccCcceeeeeeeeCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEE
Q 016082          102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFI  173 (395)
Q Consensus       102 ~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~  173 (395)
                      ...|++..++|++.+.||+|+||.||+|++.       ++.||||+++... .....+.+.+|+.+++++ +||||++++
T Consensus        14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~   92 (359)
T 3vhe_A           14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL   92 (359)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence            4578999999999999999999999999852       3789999998653 445567899999999999 789999999


Q ss_pred             EEEecCCc-EEEEEecCCCCCHHHHHhhccC-------------------------------------------------
Q 016082          174 GACTRPPN-LCIVTEFMARGSIYDFLHKQKG-------------------------------------------------  203 (395)
Q Consensus       174 ~~~~~~~~-~~lV~E~~~ggsL~~~l~~~~~-------------------------------------------------  203 (395)
                      +++...+. .++||||++||+|.+++.....                                                 
T Consensus        93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (359)
T 3vhe_A           93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS  172 (359)
T ss_dssp             EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred             eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence            99987654 8999999999999999976532                                                 


Q ss_pred             ----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC---cc
Q 016082          204 ----------------VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---VM  264 (395)
Q Consensus       204 ----------------~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~---~~  264 (395)
                                      .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......   ..
T Consensus       173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (359)
T 3vhe_A          173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK  252 (359)
T ss_dssp             -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC
T ss_pred             cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhc
Confidence                            18899999999999999999999999999999999999999999999999998654332   22


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHh
Q 016082          265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC  343 (395)
Q Consensus       265 ~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  343 (395)
                      ....||+.|+|||++.+..++.++||||||+++|+|++ |..||.+....+..........++..+..+++++.+++.+|
T Consensus       253 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  332 (359)
T 3vhe_A          253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC  332 (359)
T ss_dssp             --CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHH
T ss_pred             cccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence            33467889999999999999999999999999999998 99999988766666666777777888889999999999999


Q ss_pred             hccCCCCCCCHHHHHHHHHHHHHHH
Q 016082          344 WQHDPTQRPNFSQITDILKQMMKEV  368 (395)
Q Consensus       344 l~~dp~~RPs~~ell~~l~~~~~~~  368 (395)
                      |+.||.+|||+.++++.|+++++..
T Consensus       333 l~~dP~~Rps~~ell~~L~~~~~~~  357 (359)
T 3vhe_A          333 WHGEPSQRPTFSELVEHLGNLLQAN  357 (359)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ccCChhhCCCHHHHHHHHHHHHHHh
Confidence            9999999999999999999998764

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=9.5e-50  Score=375.84  Aligned_cols=265  Identities=35%  Similarity=0.732  Sum_probs=217.0

Q ss_pred             CCCCceeecccCcceeeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 016082          100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP  179 (395)
Q Consensus       100 ~~~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  179 (395)
                      ...+.++|..++|++.++||+|+||.||+|++.+ .||+|+++.........+.+.+|+.++++++||||+++++++ ..
T Consensus        14 ~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~   91 (289)
T 3og7_A           14 DAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA   91 (289)
T ss_dssp             ----CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS
T ss_pred             CCCCCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cC
Confidence            4456789999999999999999999999998765 599999988777777788999999999999999999999965 45


Q ss_pred             CcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccc
Q 016082          180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  259 (395)
Q Consensus       180 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~  259 (395)
                      +..++||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||+++...
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  171 (289)
T 3og7_A           92 PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS  171 (289)
T ss_dssp             SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred             CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccc
Confidence            56899999999999999998777889999999999999999999999999999999999999999999999999997544


Q ss_pred             c---CCccccCCCCcccccccccC---CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC-C---CCC
Q 016082          260 Q---SGVMTAETGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR-P---TIP  329 (395)
Q Consensus       260 ~---~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~-~---~~~  329 (395)
                      .   ........||+.|+|||++.   +.+++.++||||||+++|+|++|+.||.+....+........... +   ..+
T Consensus       172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (289)
T 3og7_A          172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR  251 (289)
T ss_dssp             ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSC
T ss_pred             cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhcc
Confidence            3   22234457899999999986   667899999999999999999999999887665555544443322 2   234


Q ss_pred             CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 016082          330 KHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK  366 (395)
Q Consensus       330 ~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~  366 (395)
                      ..+++++.++|.+||+.||.+|||+.++++.|+++.+
T Consensus       252 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          252 SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            5788999999999999999999999999999988754

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.3e-49  Score=384.80  Aligned_cols=265  Identities=30%  Similarity=0.620  Sum_probs=235.0

Q ss_pred             CCceeecccCcceeeeeeeeCceEEEEEEECC---------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceee
Q 016082          102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQ  171 (395)
Q Consensus       102 ~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~---------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~  171 (395)
                      ...|++..++|++.++||+|+||.||+|++.+         ..||||+++... .......+.+|+.+++++ +||||++
T Consensus        61 ~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~  139 (382)
T 3tt0_A           61 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIIN  139 (382)
T ss_dssp             CTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhh
Confidence            35688999999999999999999999998632         569999998663 455668899999999999 8999999


Q ss_pred             EEEEEecCCcEEEEEecCCCCCHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 016082          172 FIGACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT  236 (395)
Q Consensus       172 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp  236 (395)
                      +++++...+..++||||+++|+|.+++....               ..+++..++.++.||+.||.|||++||+||||||
T Consensus       140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp  219 (382)
T 3tt0_A          140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA  219 (382)
T ss_dssp             EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred             heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence            9999999999999999999999999998754               3589999999999999999999999999999999


Q ss_pred             CCeeeCCCCcEEEeeeccccccccCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCH
Q 016082          237 ANLLMDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTP  312 (395)
Q Consensus       237 ~NiLl~~~~~vkl~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~  312 (395)
                      +|||++.++.+||+|||+++......   ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus       220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~  299 (382)
T 3tt0_A          220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  299 (382)
T ss_dssp             GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999998654432   2334567889999999999999999999999999999999 9999999887


Q ss_pred             HHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHH
Q 016082          313 LQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  368 (395)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~  368 (395)
                      .+... .+....++..+..+++++.++|.+||+.||.+|||+.++++.|++++...
T Consensus       300 ~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  354 (382)
T 3tt0_A          300 EELFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT  354 (382)
T ss_dssp             HHHHH-HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             HHHHH-HHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence            66544 45556677788899999999999999999999999999999999998643

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.9e-49  Score=375.64  Aligned_cols=267  Identities=30%  Similarity=0.630  Sum_probs=236.5

Q ss_pred             CCceeecccCcceeeeeeeeCceEEEEEEE-------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEE
Q 016082          102 TDVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFI  173 (395)
Q Consensus       102 ~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~  173 (395)
                      ...|++..++|++.+.||+|+||.||+|++       .++.||||+++... .....+.+.+|+.+++++ +||||++++
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~   93 (313)
T 1t46_A           15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLL   93 (313)
T ss_dssp             CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEE
Confidence            356889999999999999999999999985       34789999998654 344567899999999999 899999999


Q ss_pred             EEEecCCcEEEEEecCCCCCHHHHHhhccC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 016082          174 GACTRPPNLCIVTEFMARGSIYDFLHKQKG-----------------VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT  236 (395)
Q Consensus       174 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~-----------------~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp  236 (395)
                      +++..++..++||||+++|+|.+++.....                 .+++..++.++.||+.||.|||++||+||||||
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp  173 (313)
T 1t46_A           94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA  173 (313)
T ss_dssp             EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCcc
Confidence            999999999999999999999999987543                 489999999999999999999999999999999


Q ss_pred             CCeeeCCCCcEEEeeeccccccccCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCH
Q 016082          237 ANLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTP  312 (395)
Q Consensus       237 ~NiLl~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~  312 (395)
                      +||+++.++.+||+|||+++.......   .....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.+...
T Consensus       174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  253 (313)
T 1t46_A          174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (313)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence            999999999999999999986554332   223356788999999998999999999999999999999 9999998876


Q ss_pred             HHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHH
Q 016082          313 LQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVL  369 (395)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~  369 (395)
                      ............++..+..+++++.++|.+||+.||.+|||+.++++.|++++++..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  310 (313)
T 1t46_A          254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST  310 (313)
T ss_dssp             SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             hhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence            666666677777777788899999999999999999999999999999999988754

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.2e-49  Score=368.72  Aligned_cols=259  Identities=30%  Similarity=0.582  Sum_probs=229.3

Q ss_pred             ceeecccCcceeeeeeeeCceEEEEEEECC-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Q 016082          104 VWEIDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  182 (395)
Q Consensus       104 ~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  182 (395)
                      .+++..++|++.+.||+|+||.||+|++.+ ..||+|+++......   +++.+|+.++++++||||+++++++......
T Consensus         2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (268)
T 3sxs_A            2 HMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI   78 (268)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             ceEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence            357788899999999999999999999854 579999998765443   5688999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC
Q 016082          183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~  262 (395)
                      ++||||+++++|.+++......+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||.++......
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            99999999999999998877779999999999999999999999999999999999999999999999999998654433


Q ss_pred             c--cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHH
Q 016082          263 V--MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL  339 (395)
Q Consensus       263 ~--~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  339 (395)
                      .  .....+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+. ...++..|...++++.++
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l  237 (268)
T 3sxs_A          159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHRLYRPHLASDTIYQI  237 (268)
T ss_dssp             EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTSCHHHHHH
T ss_pred             hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH-cCCCCCCCCcChHHHHHH
Confidence            2  223456778999999999899999999999999999999 999999988877665543 455666677889999999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHHHHHHH
Q 016082          340 LERCWQHDPTQRPNFSQITDILKQMMK  366 (395)
Q Consensus       340 i~~cl~~dp~~RPs~~ell~~l~~~~~  366 (395)
                      +.+||+.||.+|||+.++++.|+++.+
T Consensus       238 i~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          238 MYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             HHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             HHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence            999999999999999999999987754

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.6e-49  Score=370.24  Aligned_cols=263  Identities=30%  Similarity=0.590  Sum_probs=219.8

Q ss_pred             CceeecccCcceeeeeeeeCceEEEEEEEC-----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Q 016082          103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT  177 (395)
Q Consensus       103 ~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  177 (395)
                      ..+++..++|++.+.||+|+||.||+|.+.     +..||+|+++... .....+.+.+|+.++++++||||+++++++.
T Consensus         8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   86 (281)
T 1mp8_A            8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT   86 (281)
T ss_dssp             -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence            357888899999999999999999999873     3469999987643 4556678999999999999999999999985


Q ss_pred             cCCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccc
Q 016082          178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV  257 (395)
Q Consensus       178 ~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~  257 (395)
                       .+..++||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.
T Consensus        87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  165 (281)
T 1mp8_A           87 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  165 (281)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             -cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence             4568999999999999999987777899999999999999999999999999999999999999999999999999986


Q ss_pred             cccCCc--cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcH
Q 016082          258 QAQSGV--MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP  334 (395)
Q Consensus       258 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (395)
                      ......  .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+. ...++..+..+++
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~-~~~~~~~~~~~~~  244 (281)
T 1mp8_A          166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPP  244 (281)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTCCH
T ss_pred             cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH-cCCCCCCCCCCCH
Confidence            554332  233456789999999998899999999999999999997 999999887766554433 4455667888999


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHH
Q 016082          335 RLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  368 (395)
Q Consensus       335 ~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~  368 (395)
                      ++.++|.+||+.||.+|||+.++++.|++++++-
T Consensus       245 ~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  278 (281)
T 1mp8_A          245 TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  278 (281)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            9999999999999999999999999999998753

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.8e-49  Score=368.37  Aligned_cols=256  Identities=37%  Similarity=0.727  Sum_probs=217.7

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEECCceEEEEEecCCCCC--HHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVN--TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  183 (395)
                      +++.++|++.+.||+|+||.||+|++.++.||||+++.....  ....+.+.+|+.+++.++||||+++++++..++..+
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (271)
T 3dtc_A            3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC   82 (271)
T ss_dssp             BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred             ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence            567789999999999999999999999999999998755322  233567899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCCCCeeeCC--------CCcEEEeee
Q 016082          184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN---IIHRDLKTANLLMDE--------NGVVKVADF  252 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---iiHrDlkp~NiLl~~--------~~~vkl~DF  252 (395)
                      +||||+++++|.+++.  .+++++..++.++.|++.||.|||++|   |+||||||+||+++.        ++.+||+||
T Consensus        83 lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           83 LVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            9999999999999985  357899999999999999999999999   999999999999986        778999999


Q ss_pred             ccccccccCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCC
Q 016082          253 GVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHA  332 (395)
Q Consensus       253 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  332 (395)
                      |.++...... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+.................+..+
T Consensus       161 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (271)
T 3dtc_A          161 GLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTC  239 (271)
T ss_dssp             CC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTC
T ss_pred             Cccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCccc
Confidence            9997654432 234578999999999999999999999999999999999999999999888877777777778888999


Q ss_pred             cHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 016082          333 HPRLAELLERCWQHDPTQRPNFSQITDILKQM  364 (395)
Q Consensus       333 ~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~  364 (395)
                      ++++.+++.+||+.||.+|||+.++++.|+++
T Consensus       240 ~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          240 PEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            99999999999999999999999999998754

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=9.7e-49  Score=363.69  Aligned_cols=260  Identities=33%  Similarity=0.685  Sum_probs=231.7

Q ss_pred             ceeecccCcceeeeeeeeCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Q 016082          104 VWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  182 (395)
Q Consensus       104 ~~~i~~~~~~i~~~lg~G~~G~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  182 (395)
                      .|.++.++|++.+.||+|+||.||+|++ .++.||+|+++......   +.+.+|+.++++++||||+++++++...+..
T Consensus         2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   78 (267)
T 3t9t_A            2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI   78 (267)
T ss_dssp             -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence            4788999999999999999999999998 56789999998765443   5788999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC
Q 016082          183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~  262 (395)
                      ++||||+++++|.+++....+.+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||.++......
T Consensus        79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  158 (267)
T 3t9t_A           79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  158 (267)
T ss_dssp             EEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             EEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence            99999999999999998877789999999999999999999999999999999999999999999999999998654321


Q ss_pred             --ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHH
Q 016082          263 --VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL  339 (395)
Q Consensus       263 --~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  339 (395)
                        ......++..|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+ ....++..+...++++.++
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i-~~~~~~~~~~~~~~~l~~l  237 (267)
T 3t9t_A          159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-STGFRLYKPRLASTHVYQI  237 (267)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-HTTCCCCCCTTSCHHHHHH
T ss_pred             ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHH-hcCCcCCCCccCcHHHHHH
Confidence              2233467889999999998899999999999999999999 99999998877665554 3455667778889999999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 016082          340 LERCWQHDPTQRPNFSQITDILKQMMKE  367 (395)
Q Consensus       340 i~~cl~~dp~~RPs~~ell~~l~~~~~~  367 (395)
                      +.+||+.||.+|||+.++++.|+++.++
T Consensus       238 i~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          238 MNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            9999999999999999999999998764

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=4.7e-49  Score=380.02  Aligned_cols=250  Identities=22%  Similarity=0.440  Sum_probs=220.4

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  183 (395)
                      +..++|++.+.||+|+||.||+|++  +++.||+|++++... .......+.+|+.++++++||||+++++++.....+|
T Consensus         2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~   81 (337)
T 1o6l_A            2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence            3457899999999999999999998  578999999975321 1223467889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc-CC
Q 016082          184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SG  262 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~-~~  262 (395)
                      +||||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.... ..
T Consensus        82 lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  160 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence            99999999999999976 56799999999999999999999999999999999999999999999999999985332 23


Q ss_pred             ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHH
Q 016082          263 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER  342 (395)
Q Consensus       263 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  342 (395)
                      ......||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+..+....+...  ....|..+++++.++|.+
T Consensus       161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~  238 (337)
T 1o6l_A          161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLLAG  238 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHHH
T ss_pred             cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHH
Confidence            345567999999999999999999999999999999999999999998887766665544  345678899999999999


Q ss_pred             hhccCCCCCC-----CHHHHHH
Q 016082          343 CWQHDPTQRP-----NFSQITD  359 (395)
Q Consensus       343 cl~~dp~~RP-----s~~ell~  359 (395)
                      ||+.||.+||     ++.++++
T Consensus       239 lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          239 LLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HhhcCHHHhcCCCCCCHHHHHc
Confidence            9999999999     8998876

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-49  Score=379.31  Aligned_cols=263  Identities=30%  Similarity=0.575  Sum_probs=230.0

Q ss_pred             ceeecccCcceeeeeeeeCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEE
Q 016082          104 VWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC  176 (395)
Q Consensus       104 ~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  176 (395)
                      .+++..++|++.+.||+|+||.||+|++.+       +.||||+++... ..+..+.+.+|+.++++++||||+++++++
T Consensus        41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  119 (343)
T 1luf_A           41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC  119 (343)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            457788899999999999999999999854       789999998653 455677899999999999999999999999


Q ss_pred             ecCCcEEEEEecCCCCCHHHHHhhcc-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Q 016082          177 TRPPNLCIVTEFMARGSIYDFLHKQK-----------------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD  233 (395)
Q Consensus       177 ~~~~~~~lV~E~~~ggsL~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrD  233 (395)
                      ...+..++||||+++|+|.+++....                       ..+++..++.++.||+.||.|||++||+|||
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D  199 (343)
T 1luf_A          120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD  199 (343)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            99999999999999999999997742                       5789999999999999999999999999999


Q ss_pred             CCCCCeeeCCCCcEEEeeeccccccccCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 016082          234 LKTANLLMDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAG  309 (395)
Q Consensus       234 lkp~NiLl~~~~~vkl~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~  309 (395)
                      |||+||+++.++.+||+|||+++......   ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            99999999999999999999997654322   2234567899999999998899999999999999999999 9999999


Q ss_pred             CCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHH
Q 016082          310 LTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  368 (395)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~  368 (395)
                      .+..+....+. ....+..+..+++++.++|.+||+.||.+||++.++++.|+++.+..
T Consensus       280 ~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~  337 (343)
T 1luf_A          280 MAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA  337 (343)
T ss_dssp             SCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred             CChHHHHHHHh-CCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence            88776655543 44556678889999999999999999999999999999999887654

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-49  Score=381.15  Aligned_cols=266  Identities=29%  Similarity=0.572  Sum_probs=229.6

Q ss_pred             CceeecccCcceeeeeeeeCceEEEEEEE-------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEE
Q 016082          103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG  174 (395)
Q Consensus       103 ~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~  174 (395)
                      ..|++..++|++.+.||+|+||.||+|++       .+..||||+++... .....+.+.+|+.+++++ +||||+++++
T Consensus        38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  116 (344)
T 1rjb_A           38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG  116 (344)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            46899999999999999999999999986       34579999997543 333457899999999999 8999999999


Q ss_pred             EEecCCcEEEEEecCCCCCHHHHHhhccC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 016082          175 ACTRPPNLCIVTEFMARGSIYDFLHKQKG----------------------VFQLTSLLKVAIDVSKGMNYLHQNNIIHR  232 (395)
Q Consensus       175 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~----------------------~l~~~~~~~i~~~i~~~l~~LH~~~iiHr  232 (395)
                      ++...+..++||||+++|+|.+++.....                      .+++..++.++.||+.||.|||++||+||
T Consensus       117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~  196 (344)
T 1rjb_A          117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR  196 (344)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred             EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            99999999999999999999999987543                      37889999999999999999999999999


Q ss_pred             CCCCCCeeeCCCCcEEEeeeccccccccCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCC
Q 016082          233 DLKTANLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYA  308 (395)
Q Consensus       233 Dlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~  308 (395)
                      ||||+||+++.++.+||+|||+++.......   .....||+.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            9999999999999999999999986544322   123356789999999998999999999999999999998 999999


Q ss_pred             CCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHH
Q 016082          309 GLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVL  369 (395)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~  369 (395)
                      +...............++..+..+++++.++|.+||+.||.+|||+.++++.|+.+..+..
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  337 (344)
T 1rjb_A          277 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE  337 (344)
T ss_dssp             TCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred             cCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence            8876666667777777888888999999999999999999999999999999998876543

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.9e-49  Score=385.03  Aligned_cols=263  Identities=33%  Similarity=0.603  Sum_probs=221.1

Q ss_pred             ceeecccCcceeeeeeeeCceEEEEEEEC-----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Q 016082          104 VWEIDAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR  178 (395)
Q Consensus       104 ~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  178 (395)
                      ..+++.++|++.+.||+|+||.||+|++.     +..||||+++... .....+.+.+|+.++++++||||+++++++..
T Consensus        39 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  117 (373)
T 2qol_A           39 AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK  117 (373)
T ss_dssp             SCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             HhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence            34678889999999999999999999863     5679999998653 45567789999999999999999999999999


Q ss_pred             CCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccc
Q 016082          179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  258 (395)
Q Consensus       179 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~  258 (395)
                      ....++||||+++|+|.++++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence            99999999999999999999887778999999999999999999999999999999999999999999999999999865


Q ss_pred             ccCCc----cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCc
Q 016082          259 AQSGV----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAH  333 (395)
Q Consensus       259 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (395)
                      .....    .....++..|+|||++.+..++.++||||||+++|||++ |+.||...+..+....+ ....+...+..++
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i-~~~~~~~~~~~~~  276 (373)
T 2qol_A          198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV-DEGYRLPPPMDCP  276 (373)
T ss_dssp             ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHH-HTTEECCCCTTCB
T ss_pred             ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCcccc
Confidence            44321    122345778999999999999999999999999999998 99999998877665543 4455666677899


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHH
Q 016082          334 PRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  368 (395)
Q Consensus       334 ~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~  368 (395)
                      .++.++|.+||+.||.+||++.++++.|+++++.-
T Consensus       277 ~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          277 AALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             HHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence            99999999999999999999999999999998753

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=6.1e-49  Score=394.06  Aligned_cols=259  Identities=34%  Similarity=0.692  Sum_probs=228.9

Q ss_pred             CCceeecccCcceeeeeeeeCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 016082          102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  180 (395)
Q Consensus       102 ~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (395)
                      .+.|++..++|++.++||+|+||.||+|++. +..||||+++.....   .+.|.+|+.+|++++||||+++++++. .+
T Consensus       180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~  255 (454)
T 1qcf_A          180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVT-KE  255 (454)
T ss_dssp             TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred             ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc---HHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence            4579999999999999999999999999985 678999999876433   478999999999999999999999987 55


Q ss_pred             cEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  259 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~  259 (395)
                      ..++||||+++|+|.++++... ..++...++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE  335 (454)
T ss_dssp             SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred             ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence            7899999999999999997643 368899999999999999999999999999999999999999999999999998654


Q ss_pred             cCC--ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHH
Q 016082          260 QSG--VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  336 (395)
Q Consensus       260 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  336 (395)
                      ...  ......++..|+|||++.+..++.++||||||+++|||++ |+.||.+.+..+....+ ....+...|..+++++
T Consensus       336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-~~~~~~~~~~~~~~~l  414 (454)
T 1qcf_A          336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-ERGYRMPRPENCPEEL  414 (454)
T ss_dssp             CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-HHTCCCCCCTTSCHHH
T ss_pred             CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHH
Confidence            322  1223456789999999998899999999999999999999 99999999887766554 4566777888999999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 016082          337 AELLERCWQHDPTQRPNFSQITDILKQMM  365 (395)
Q Consensus       337 ~~li~~cl~~dp~~RPs~~ell~~l~~~~  365 (395)
                      .++|.+||+.||.+|||+.+|++.|+++.
T Consensus       415 ~~li~~cl~~dp~~RPt~~~i~~~L~~~~  443 (454)
T 1qcf_A          415 YNIMMRCWKNRPEERPTFEYIQSVLDDFY  443 (454)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             HHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence            99999999999999999999999887654

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.2e-48  Score=370.27  Aligned_cols=247  Identities=28%  Similarity=0.486  Sum_probs=217.6

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      .++|++.++||+|+||.||+|.+  +++.||||++......  ..+.+.+|+.++++++||||+++++++...+..|+||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   96 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence            45899999999999999999986  6789999998654322  2366889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-ccc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT  265 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~  265 (395)
                      ||++||+|.+++...  .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++...... ...
T Consensus        97 e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  174 (297)
T 3fxz_A           97 EYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  174 (297)
T ss_dssp             ECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred             ECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccC
Confidence            999999999999763  58999999999999999999999999999999999999999999999999987655432 334


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccC-CCCCCCCCcHHHHHHHHHhh
Q 016082          266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL-RPTIPKHAHPRLAELLERCW  344 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl  344 (395)
                      ...||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.++......+..... ....+..+++.+.++|.+||
T Consensus       175 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  254 (297)
T 3fxz_A          175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL  254 (297)
T ss_dssp             CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHS
T ss_pred             CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHc
Confidence            56799999999999999999999999999999999999999999888766655444332 33446678999999999999


Q ss_pred             ccCCCCCCCHHHHHH
Q 016082          345 QHDPTQRPNFSQITD  359 (395)
Q Consensus       345 ~~dp~~RPs~~ell~  359 (395)
                      +.||.+|||+.|+++
T Consensus       255 ~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          255 EMDVEKRGSAKELLQ  269 (297)
T ss_dssp             CSSTTTSCCHHHHTT
T ss_pred             cCChhHCcCHHHHhh
Confidence            999999999999987

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.6e-49  Score=379.03  Aligned_cols=263  Identities=30%  Similarity=0.504  Sum_probs=220.2

Q ss_pred             CCCCceeecccCcceeeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 016082          100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP  179 (395)
Q Consensus       100 ~~~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  179 (395)
                      +++..+.++.++|++.++||+|+||.||+|++.++.||||+++..   ......+..|+.++++++||||+++++++...
T Consensus        14 ~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   90 (322)
T 3soc_A           14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRG   90 (322)
T ss_dssp             CCCCCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred             cCccccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccC
Confidence            445678899999999999999999999999999999999999754   33345567799999999999999999999775


Q ss_pred             C----cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC----------CccccCCCCCCeeeCCCC
Q 016082          180 P----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN----------NIIHRDLKTANLLMDENG  245 (395)
Q Consensus       180 ~----~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----------~iiHrDlkp~NiLl~~~~  245 (395)
                      .    .+++||||+++|+|.++++.  ..+++..++.++.|++.||.|||+.          ||+||||||+|||++.++
T Consensus        91 ~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~  168 (322)
T 3soc_A           91 TSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL  168 (322)
T ss_dssp             CSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC
T ss_pred             CCCCceEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC
Confidence            4    37999999999999999976  4589999999999999999999999          999999999999999999


Q ss_pred             cEEEeeeccccccccCC---ccccCCCCcccccccccCC-----CCCCChhhHHHHHHHHHHHHhCCCCCCCCC------
Q 016082          246 VVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEH-----KPYDYKADVFSFGIALWELLTGELPYAGLT------  311 (395)
Q Consensus       246 ~vkl~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwslG~vl~elltg~~pf~~~~------  311 (395)
                      .+||+|||+++......   ......||+.|+|||++.+     ..++.++|||||||++|||++|+.||.+..      
T Consensus       169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~  248 (322)
T 3soc_A          169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP  248 (322)
T ss_dssp             CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred             eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence            99999999997654432   2334578999999999987     356678999999999999999999997532      


Q ss_pred             ----------HHHHHHHhhhccCCCCCCCC-----CcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 016082          312 ----------PLQAAVGVVQKSLRPTIPKH-----AHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE  367 (395)
Q Consensus       312 ----------~~~~~~~~~~~~~~~~~~~~-----~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~  367 (395)
                                .............++..+..     .++++.++|.+||+.||.+|||+.++++.|+++.+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             THHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                      22222333344444444432     345699999999999999999999999999998763

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.6e-48  Score=379.86  Aligned_cols=250  Identities=21%  Similarity=0.393  Sum_probs=222.6

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      .++|++.+.||+|+||.||+|.+  +++.||+|+++.........+.+.+|+.++++++||||+++++++.+....|+||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            35799999999999999999998  4789999999877767777788999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCC---cEEEeeeccccccccCCc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADFGVARVQAQSGV  263 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~---~vkl~DFg~a~~~~~~~~  263 (395)
                      ||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++.......
T Consensus       108 e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~  186 (362)
T 2bdw_A          108 DLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA  186 (362)
T ss_dssp             CCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS
T ss_pred             ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc
Confidence            99999999999976 46789999999999999999999999999999999999998654   599999999987766555


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCC--CCCcHHHHHHHH
Q 016082          264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP--KHAHPRLAELLE  341 (395)
Q Consensus       264 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~  341 (395)
                      .....||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+....+.........+  ..+++++.++|.
T Consensus       187 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  266 (362)
T 2bdw_A          187 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID  266 (362)
T ss_dssp             CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHH
T ss_pred             cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence            566789999999999999999999999999999999999999999988777666655544332222  357899999999


Q ss_pred             HhhccCCCCCCCHHHHHH
Q 016082          342 RCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       342 ~cl~~dp~~RPs~~ell~  359 (395)
                      +||+.||.+||++.++++
T Consensus       267 ~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          267 SMLTVNPKKRITADQALK  284 (362)
T ss_dssp             HHSCSSGGGSCCHHHHTT
T ss_pred             HHcCCChhhCcCHHHHhc
Confidence            999999999999999875

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.3e-48  Score=380.44  Aligned_cols=250  Identities=22%  Similarity=0.379  Sum_probs=220.3

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCH----HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT----EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  182 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  182 (395)
                      .+.|++.+.||+|+||.||+|++  +++.||+|+++......    ...+.+.+|+.+|++++||||+++++++.+...+
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            35799999999999999999998  47899999997654321    1346789999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCC----cEEEeeecccccc
Q 016082          183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG----VVKVADFGVARVQ  258 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~----~vkl~DFg~a~~~  258 (395)
                      |+||||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||+++.++    .+||+|||+++..
T Consensus        91 ~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~  169 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI  169 (361)
T ss_dssp             EEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred             EEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence            999999999999999976 56799999999999999999999999999999999999998877    7999999999876


Q ss_pred             ccCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCC--CCCCCCcHHH
Q 016082          259 AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP--TIPKHAHPRL  336 (395)
Q Consensus       259 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l  336 (395)
                      ..........||+.|+|||++.+.+++.++|||||||++|+|++|..||.+.+..+....+.......  ..+..+++++
T Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  249 (361)
T 2yab_A          170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELA  249 (361)
T ss_dssp             CTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHH
T ss_pred             CCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHH
Confidence            66555566789999999999999999999999999999999999999999988877766655433221  2235688999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHH
Q 016082          337 AELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       337 ~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      .++|.+||+.||.+|||+.|+++
T Consensus       250 ~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          250 KDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHCCCChhHCcCHHHHhc
Confidence            99999999999999999999985

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.6e-49  Score=375.25  Aligned_cols=248  Identities=18%  Similarity=0.285  Sum_probs=221.4

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      .++|++.+.||+|+||.||+|++  +++.||+|+++..   ......+.+|+.+++.++||||+++++++.+....++||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   80 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF   80 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence            35899999999999999999998  4788999999754   334567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCC--CCcEEEeeeccccccccCCcc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE--NGVVKVADFGVARVQAQSGVM  264 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~--~~~vkl~DFg~a~~~~~~~~~  264 (395)
                      ||++||+|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.  ++.+||+|||+++........
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~  160 (321)
T 1tki_A           81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF  160 (321)
T ss_dssp             CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred             EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc
Confidence            999999999999876678999999999999999999999999999999999999987  789999999999877655555


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCC--CCCCcHHHHHHHHH
Q 016082          265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELLER  342 (395)
Q Consensus       265 ~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~  342 (395)
                      ....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+.........  ...+++++.++|.+
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  240 (321)
T 1tki_A          161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR  240 (321)
T ss_dssp             EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHT
T ss_pred             ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHH
Confidence            5667999999999999999999999999999999999999999998887777666654433221  24688999999999


Q ss_pred             hhccCCCCCCCHHHHHH
Q 016082          343 CWQHDPTQRPNFSQITD  359 (395)
Q Consensus       343 cl~~dp~~RPs~~ell~  359 (395)
                      ||+.||.+|||+.|+++
T Consensus       241 ~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          241 LLVKERKSRMTASEALQ  257 (321)
T ss_dssp             TSCSSGGGSCCHHHHHH
T ss_pred             HcCCChhHCcCHHHHhc
Confidence            99999999999999987

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.9e-48  Score=373.95  Aligned_cols=265  Identities=30%  Similarity=0.593  Sum_probs=233.7

Q ss_pred             CceeecccCcceeeeeeeeCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEE
Q 016082          103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG  174 (395)
Q Consensus       103 ~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~  174 (395)
                      ..|++..++|++.+.||+|+||.||+|++.+       ..||+|+++... .....+.+.+|+.+++++ +||||+++++
T Consensus        39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~  117 (333)
T 2i1m_A           39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLG  117 (333)
T ss_dssp             GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            4689999999999999999999999999743       379999998654 445567899999999999 8999999999


Q ss_pred             EEecCCcEEEEEecCCCCCHHHHHhhc-------------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 016082          175 ACTRPPNLCIVTEFMARGSIYDFLHKQ-------------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM  241 (395)
Q Consensus       175 ~~~~~~~~~lV~E~~~ggsL~~~l~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl  241 (395)
                      ++...+..++||||+++|+|.+++...             ...+++..++.++.|++.||.|||++||+||||||+||++
T Consensus       118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL  197 (333)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence            999999999999999999999999764             2457999999999999999999999999999999999999


Q ss_pred             CCCCcEEEeeeccccccccCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 016082          242 DENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV  317 (395)
Q Consensus       242 ~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~  317 (395)
                      +.++.+||+|||+++.......   .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+........
T Consensus       198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~  277 (333)
T 2i1m_A          198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY  277 (333)
T ss_dssp             EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred             CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence            9999999999999986543322   123356789999999998899999999999999999998 999999877666666


Q ss_pred             HhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHH
Q 016082          318 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  368 (395)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~  368 (395)
                      .......++..+..+++++.++|.+||+.||.+|||+.++++.|+++.++.
T Consensus       278 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  328 (333)
T 2i1m_A          278 KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED  328 (333)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence            667777777778889999999999999999999999999999999887753

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-48  Score=380.67  Aligned_cols=265  Identities=31%  Similarity=0.569  Sum_probs=229.8

Q ss_pred             CceeecccCcceeeeeeeeCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEE
Q 016082          103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA  175 (395)
Q Consensus       103 ~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  175 (395)
                      +.+++..++|++.++||+|+||.||+|++.       ++.||||+++... .......+.+|+.++++++||||++++++
T Consensus        64 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~  142 (367)
T 3l9p_A           64 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGV  142 (367)
T ss_dssp             GSCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             chhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            345778889999999999999999999853       4579999997543 45556789999999999999999999999


Q ss_pred             EecCCcEEEEEecCCCCCHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCC---c
Q 016082          176 CTRPPNLCIVTEFMARGSIYDFLHKQK------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---V  246 (395)
Q Consensus       176 ~~~~~~~~lV~E~~~ggsL~~~l~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~---~  246 (395)
                      +......++||||++||+|.+++....      ..+++..++.++.||+.||.|||++||+||||||+|||++.++   .
T Consensus       143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~  222 (367)
T 3l9p_A          143 SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV  222 (367)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred             EecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCce
Confidence            999999999999999999999997653      4588999999999999999999999999999999999999555   5


Q ss_pred             EEEeeeccccccccCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc
Q 016082          247 VKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK  322 (395)
Q Consensus       247 vkl~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~  322 (395)
                      +||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+.... +..
T Consensus       223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~-i~~  301 (367)
T 3l9p_A          223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF-VTS  301 (367)
T ss_dssp             EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-HHT
T ss_pred             EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHc
Confidence            9999999997543322   2233467899999999999999999999999999999998 9999999887766554 444


Q ss_pred             cCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHH
Q 016082          323 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVL  369 (395)
Q Consensus       323 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~  369 (395)
                      ..++..+..+++++.++|.+||+.||.+|||+.++++.|+.+.+.-.
T Consensus       302 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~  348 (367)
T 3l9p_A          302 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  348 (367)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence            55667788899999999999999999999999999999998877543

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.7e-48  Score=368.56  Aligned_cols=259  Identities=25%  Similarity=0.452  Sum_probs=220.3

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  183 (395)
                      +-.++|++.+.||+|+||.||+|++  .++.||+|++.... ......+.+.+|+.++++++||||+++++++...+..|
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   87 (294)
T 4eqm_A            8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY   87 (294)
T ss_dssp             CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred             HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence            3356899999999999999999987  57899999986543 34566788999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCc
Q 016082          184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV  263 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~  263 (395)
                      +||||++|++|.+++.. .+++++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus        88 lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  166 (294)
T 4eqm_A           88 LVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL  166 (294)
T ss_dssp             EEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred             EEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence            99999999999999976 46799999999999999999999999999999999999999999999999999986554322


Q ss_pred             --cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCC---CCCCCCcHHHHH
Q 016082          264 --MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP---TIPKHAHPRLAE  338 (395)
Q Consensus       264 --~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~  338 (395)
                        .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+...............   ..+..+++.+.+
T Consensus       167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  246 (294)
T 4eqm_A          167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSN  246 (294)
T ss_dssp             --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHH
T ss_pred             cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHH
Confidence              233468999999999999999999999999999999999999999988877666555443321   234678899999


Q ss_pred             HHHHhhccCCCCCC-CHHHHHHHHHHHHH
Q 016082          339 LLERCWQHDPTQRP-NFSQITDILKQMMK  366 (395)
Q Consensus       339 li~~cl~~dp~~RP-s~~ell~~l~~~~~  366 (395)
                      +|.+||+.||.+|| ++.++.+.|++++.
T Consensus       247 li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          247 VILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             HHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             HHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence            99999999999998 88888887776543

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.1e-48  Score=370.82  Aligned_cols=265  Identities=31%  Similarity=0.593  Sum_probs=227.5

Q ss_pred             ceeecccCcceeeeeeeeCceEEEEEEECC------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Q 016082          104 VWEIDAKQLKIECKVASGSYGDLYKGTYCS------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT  177 (395)
Q Consensus       104 ~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  177 (395)
                      .+++..++|++.+.||+|+||.||+|++..      ..||||+++... .......+.+|+.++++++||||+++++++.
T Consensus        38 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  116 (333)
T 1mqb_A           38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS  116 (333)
T ss_dssp             CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             cccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence            357888999999999999999999998732      359999998653 4555678999999999999999999999999


Q ss_pred             cCCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccc
Q 016082          178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV  257 (395)
Q Consensus       178 ~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~  257 (395)
                      .....++||||+++|+|.+++....+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.
T Consensus       117 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  196 (333)
T 1mqb_A          117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV  196 (333)
T ss_dssp             SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence            99999999999999999999988778899999999999999999999999999999999999999999999999999986


Q ss_pred             cccCC----ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCC
Q 016082          258 QAQSG----VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHA  332 (395)
Q Consensus       258 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  332 (395)
                      .....    ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.+....+....+ ....++..+..+
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~  275 (333)
T 1mqb_A          197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI-NDGFRLPTPMDC  275 (333)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-HTTCCCCCCTTC
T ss_pred             hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHH-HCCCcCCCcccC
Confidence            54332    1123356789999999999999999999999999999999 99999988876655543 445566777889


Q ss_pred             cHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHH
Q 016082          333 HPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLY  370 (395)
Q Consensus       333 ~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~~  370 (395)
                      ++++.++|.+||+.||.+||++.++++.|+++++....
T Consensus       276 ~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~  313 (333)
T 1mqb_A          276 PSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS  313 (333)
T ss_dssp             BHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence            99999999999999999999999999999999875543

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.8e-48  Score=370.33  Aligned_cols=263  Identities=29%  Similarity=0.601  Sum_probs=231.6

Q ss_pred             CceeecccCcceeeeeeeeCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEE
Q 016082          103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA  175 (395)
Q Consensus       103 ~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  175 (395)
                      ..|++..++|++.+.||+|+||.||+|++.       ++.||||+++... .....+.+.+|+.++++++||||++++++
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   94 (314)
T 2ivs_A           16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGA   94 (314)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence            457888999999999999999999999862       3789999998653 45667889999999999999999999999


Q ss_pred             EecCCcEEEEEecCCCCCHHHHHhhcc-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 016082          176 CTRPPNLCIVTEFMARGSIYDFLHKQK-----------------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHR  232 (395)
Q Consensus       176 ~~~~~~~~lV~E~~~ggsL~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHr  232 (395)
                      +...+..++||||+++|+|.+++....                       ..+++..++.++.||+.||.|||++||+||
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~  174 (314)
T 2ivs_A           95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR  174 (314)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence            999999999999999999999997643                       248899999999999999999999999999


Q ss_pred             CCCCCCeeeCCCCcEEEeeeccccccccCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCC
Q 016082          233 DLKTANLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYA  308 (395)
Q Consensus       233 Dlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~  308 (395)
                      ||||+||+++.++.+||+|||+++.......   .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus       175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  254 (314)
T 2ivs_A          175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP  254 (314)
T ss_dssp             CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999986544322   233467889999999998899999999999999999999 999999


Q ss_pred             CCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 016082          309 GLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE  367 (395)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~  367 (395)
                      +....+.... .....++..+..+++++.++|.+||+.||.+||++.++++.|++++++
T Consensus       255 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          255 GIPPERLFNL-LKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             TCCGGGHHHH-HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCHHHHHHH-hhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            8877665443 445556777888999999999999999999999999999999998764

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3.4e-48  Score=365.38  Aligned_cols=264  Identities=28%  Similarity=0.548  Sum_probs=227.6

Q ss_pred             ceeecccCcceee-eeeeeCceEEEEEEE----CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Q 016082          104 VWEIDAKQLKIEC-KVASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR  178 (395)
Q Consensus       104 ~~~i~~~~~~i~~-~lg~G~~G~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  178 (395)
                      .+.++.++|++.+ .||+|+||.||+|.+    .++.||||+++....+....+.+.+|+.++++++||||+++++++ .
T Consensus        10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~   88 (291)
T 1xbb_A           10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E   88 (291)
T ss_dssp             -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred             eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence            4567788999998 999999999999965    357899999987655556678899999999999999999999999 5


Q ss_pred             CCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccc
Q 016082          179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  258 (395)
Q Consensus       179 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~  258 (395)
                      .+..++||||+++++|.+++.. .+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus        89 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           89 AESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CCCcEEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            5678999999999999999977 567999999999999999999999999999999999999999999999999999865


Q ss_pred             ccCCc----cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCc
Q 016082          259 AQSGV----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAH  333 (395)
Q Consensus       259 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (395)
                      .....    .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.+.+..+.... .....++..+..++
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~  246 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-LEKGERMGCPAGCP  246 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCCCCCCTTCC
T ss_pred             ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-HHcCCCCCCCCCCC
Confidence            44322    223456789999999998889999999999999999999 9999999887665444 44556677888899


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHH
Q 016082          334 PRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLY  370 (395)
Q Consensus       334 ~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~~  370 (395)
                      +++.++|.+||+.||.+||++.++++.|++++.+...
T Consensus       247 ~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~  283 (291)
T 1xbb_A          247 REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN  283 (291)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhh
Confidence            9999999999999999999999999999999988764

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=5.5e-48  Score=385.69  Aligned_cols=250  Identities=18%  Similarity=0.349  Sum_probs=221.0

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      .++|++.+.||+|+||.||+|.+  +++.||+|+++.........+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            35899999999999999999987  6789999999877666666778999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeC---CCCcEEEeeeccccccccCC-
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD---ENGVVKVADFGVARVQAQSG-  262 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~---~~~~vkl~DFg~a~~~~~~~-  262 (395)
                      ||++||+|.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++...... 
T Consensus        90 E~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~  168 (444)
T 3soa_A           90 DLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ  168 (444)
T ss_dssp             CCCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred             EeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence            99999999999987 46799999999999999999999999999999999999998   46789999999997655432 


Q ss_pred             ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCC--CCCcHHHHHHH
Q 016082          263 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP--KHAHPRLAELL  340 (395)
Q Consensus       263 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li  340 (395)
                      ......||+.|+|||++.+.+|+.++||||+||++|+|++|..||.+.+..+....+.........+  ..+++++.++|
T Consensus       169 ~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  248 (444)
T 3soa_A          169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLI  248 (444)
T ss_dssp             BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHH
T ss_pred             eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHH
Confidence            3345689999999999999999999999999999999999999999988877776666554433322  46899999999


Q ss_pred             HHhhccCCCCCCCHHHHHH
Q 016082          341 ERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       341 ~~cl~~dp~~RPs~~ell~  359 (395)
                      .+||+.||.+|||+.|+++
T Consensus       249 ~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          249 NKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             HHHSCSSTTTSCCHHHHHH
T ss_pred             HHHcCCChhHCCCHHHHhc
Confidence            9999999999999999987

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.7e-48  Score=389.15  Aligned_cols=259  Identities=36%  Similarity=0.683  Sum_probs=224.6

Q ss_pred             CCceeecccCcceeeeeeeeCceEEEEEEECC-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 016082          102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  180 (395)
Q Consensus       102 ~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (395)
                      .+.|++..++|++.++||+|+||.||+|++.+ ..||||+++.....   .+.|.+|+.+|++++||||+++++++.+ +
T Consensus       176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~  251 (452)
T 1fmk_A          176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E  251 (452)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             ccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence            45799999999999999999999999999964 67999999876543   3678999999999999999999999977 6


Q ss_pred             cEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  259 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~  259 (395)
                      ..++||||+++|+|.++++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  331 (452)
T 1fmk_A          252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE  331 (452)
T ss_dssp             SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence            789999999999999999764 3568999999999999999999999999999999999999999999999999998654


Q ss_pred             cCC--ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHH
Q 016082          260 QSG--VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  336 (395)
Q Consensus       260 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  336 (395)
                      ...  ......++..|+|||++.+..++.++||||||+++|||++ |+.||.+.+..+....+ ..+.++..|..+++++
T Consensus       332 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-~~~~~~~~~~~~~~~l  410 (452)
T 1fmk_A          332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGYRMPCPPECPESL  410 (452)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-HTTCCCCCCTTSCHHH
T ss_pred             CCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHH
Confidence            332  1223456789999999998899999999999999999999 99999999887765554 4567778888999999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 016082          337 AELLERCWQHDPTQRPNFSQITDILKQMM  365 (395)
Q Consensus       337 ~~li~~cl~~dp~~RPs~~ell~~l~~~~  365 (395)
                      .++|.+||+.||.+|||+.++++.|+++.
T Consensus       411 ~~li~~cl~~dP~~Rpt~~~l~~~L~~~~  439 (452)
T 1fmk_A          411 HDLMCQCWRKEPEERPTFEYLQAFLEDYF  439 (452)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            99999999999999999999999887654

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=5.4e-48  Score=368.18  Aligned_cols=253  Identities=26%  Similarity=0.387  Sum_probs=212.6

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  184 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  184 (395)
                      +.-.++|++.++||+|+||.||+|++ .++.||+|+++....+......+.+|+.++++++||||+++++++......++
T Consensus        17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   96 (311)
T 3niz_A           17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL   96 (311)
T ss_dssp             ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred             cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence            33456899999999999999999998 67899999998765555566789999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-Cc
Q 016082          185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GV  263 (395)
Q Consensus       185 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-~~  263 (395)
                      ||||+++ +|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..... ..
T Consensus        97 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~  175 (311)
T 3niz_A           97 VFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS  175 (311)
T ss_dssp             EEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred             EEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCccc
Confidence            9999986 899999887778999999999999999999999999999999999999999999999999999865433 23


Q ss_pred             cccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCC---------------
Q 016082          264 MTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT---------------  327 (395)
Q Consensus       264 ~~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~---------------  327 (395)
                      .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......+.               
T Consensus       176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  255 (311)
T 3niz_A          176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ  255 (311)
T ss_dssp             --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHS
T ss_pred             ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhh
Confidence            445678999999999876 5689999999999999999999999988766555444332111110               


Q ss_pred             -------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          328 -------------IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       328 -------------~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                   ..+.+++++.++|.+||+.||.+|||+.|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                         12346789999999999999999999999987

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.4e-48  Score=365.27  Aligned_cols=263  Identities=36%  Similarity=0.703  Sum_probs=233.4

Q ss_pred             CceeecccCcceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 016082          103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  180 (395)
Q Consensus       103 ~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (395)
                      +.|++..++|++.+.||+|+||.||+|++.  +..||+|+++...   ...+.+.+|+.++++++||||+++++++.+.+
T Consensus         6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   82 (288)
T 3kfa_A            6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP   82 (288)
T ss_dssp             CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            578899999999999999999999999984  7889999998653   34578899999999999999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  259 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~  259 (395)
                      ..++||||++|++|.+++... ...+++..++.++.+++.||.|||++||+||||||+||+++.++.++|+|||.++...
T Consensus        83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~  162 (288)
T 3kfa_A           83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT  162 (288)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred             CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence            999999999999999999774 3568999999999999999999999999999999999999999999999999998655


Q ss_pred             cCCc--cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHH
Q 016082          260 QSGV--MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  336 (395)
Q Consensus       260 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  336 (395)
                      ....  .....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+.... .....++..+..+++++
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l  241 (288)
T 3kfa_A          163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-LEKDYRMERPEGCPEKV  241 (288)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-HHTTCCCCCCTTCCHHH
T ss_pred             CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HhccCCCCCCCCCCHHH
Confidence            4332  222346788999999998999999999999999999999 9999998877655443 44566777788899999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHH
Q 016082          337 AELLERCWQHDPTQRPNFSQITDILKQMMKEVL  369 (395)
Q Consensus       337 ~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~  369 (395)
                      .+++.+||+.||.+|||+.++++.|++++++..
T Consensus       242 ~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~  274 (288)
T 3kfa_A          242 YELMRACWQWNPSDRPSFAEIHQAFETMFQESS  274 (288)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence            999999999999999999999999999988654

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.4e-48  Score=371.66  Aligned_cols=264  Identities=28%  Similarity=0.536  Sum_probs=214.1

Q ss_pred             ceeecccCcceeeeeeeeCceEEEEEEECC-----ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Q 016082          104 VWEIDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR  178 (395)
Q Consensus       104 ~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  178 (395)
                      .+.+..++|++.+.||+|+||.||+|++..     ..||||+++.........+.+.+|+.++++++||||+++++++..
T Consensus        17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   96 (323)
T 3qup_A           17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR   96 (323)
T ss_dssp             TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred             hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence            456778899999999999999999998743     279999998776566667889999999999999999999999987


Q ss_pred             CCcE------EEEEecCCCCCHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcE
Q 016082          179 PPNL------CIVTEFMARGSIYDFLHKQK-----GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV  247 (395)
Q Consensus       179 ~~~~------~lV~E~~~ggsL~~~l~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~v  247 (395)
                      ....      ++||||+++|+|.+++....     ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+
T Consensus        97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A           97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCE
T ss_pred             cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCE
Confidence            7654      99999999999999996542     258999999999999999999999999999999999999999999


Q ss_pred             EEeeeccccccccCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc
Q 016082          248 KVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKS  323 (395)
Q Consensus       248 kl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~  323 (395)
                      ||+|||+++.......   .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+. ..
T Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~  255 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI-GG  255 (323)
T ss_dssp             EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TT
T ss_pred             EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh-cC
Confidence            9999999986544322   223456789999999999999999999999999999999 999999988776655544 34


Q ss_pred             CCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHH
Q 016082          324 LRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  368 (395)
Q Consensus       324 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~  368 (395)
                      .++..+..+++++.+++.+||+.||.+|||+.++++.|+++++..
T Consensus       256 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          256 NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            456677889999999999999999999999999999999998854

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.2e-48  Score=362.90  Aligned_cols=263  Identities=27%  Similarity=0.537  Sum_probs=231.1

Q ss_pred             ceeecccCcceee-eeeeeCceEEEEEEE----CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Q 016082          104 VWEIDAKQLKIEC-KVASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR  178 (395)
Q Consensus       104 ~~~i~~~~~~i~~-~lg~G~~G~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  178 (395)
                      .+.+..++|.+.+ .||+|+||.||+|++    .+..||||+++... .....+.+.+|+.++++++||||+++++++. 
T Consensus         3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-   80 (287)
T 1u59_A            3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-   80 (287)
T ss_dssp             CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred             cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEec-
Confidence            4667788898887 999999999999986    46789999998653 4556788999999999999999999999994 


Q ss_pred             CCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccc
Q 016082          179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  258 (395)
Q Consensus       179 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~  258 (395)
                      .+..++||||+++++|.+++......+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++..
T Consensus        81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  160 (287)
T 1u59_A           81 AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL  160 (287)
T ss_dssp             SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence            45699999999999999999877778999999999999999999999999999999999999999999999999999865


Q ss_pred             ccCCc----cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCc
Q 016082          259 AQSGV----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAH  333 (395)
Q Consensus       259 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (395)
                      .....    .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+.... .....++..+..++
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-i~~~~~~~~~~~~~  239 (287)
T 1u59_A          161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-IEQGKRMECPPECP  239 (287)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH-HHTTCCCCCCTTCC
T ss_pred             ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH-HhcCCcCCCCCCcC
Confidence            43322    223456889999999998889999999999999999998 9999998877665544 44456677888999


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHH
Q 016082          334 PRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVL  369 (395)
Q Consensus       334 ~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~  369 (395)
                      +++.++|.+||+.||.+||++.++++.|++++.+..
T Consensus       240 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  275 (287)
T 1u59_A          240 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  275 (287)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence            999999999999999999999999999999987654

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=6.3e-48  Score=361.54  Aligned_cols=265  Identities=26%  Similarity=0.549  Sum_probs=227.4

Q ss_pred             CceeecccCcceeeeeeeeCceEEEEEEECC-----ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Q 016082          103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT  177 (395)
Q Consensus       103 ~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  177 (395)
                      ..+.+..++|++.+.||+|+||.||+|++.+     ..||+|+++... ..+..+.+.+|+.++++++||||+++++++.
T Consensus         5 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   83 (281)
T 3cc6_A            5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE   83 (281)
T ss_dssp             CCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred             ccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence            3467788899999999999999999998632     359999998653 4556688999999999999999999999987


Q ss_pred             cCCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccc
Q 016082          178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV  257 (395)
Q Consensus       178 ~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~  257 (395)
                      ++ ..++||||+++++|.+++......++...+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.
T Consensus        84 ~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           84 EE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             SS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             CC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence            54 57899999999999999988777899999999999999999999999999999999999999999999999999986


Q ss_pred             cccCC--ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcH
Q 016082          258 QAQSG--VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP  334 (395)
Q Consensus       258 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (395)
                      .....  ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||........... .....++..+..+++
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~  241 (281)
T 3cc6_A          163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV-LEKGDRLPKPDLCPP  241 (281)
T ss_dssp             C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH-HHHTCCCCCCTTCCH
T ss_pred             cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHH-HhcCCCCCCCCCCCH
Confidence            54432  2233457889999999998899999999999999999998 9999987766654443 344556667788999


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHH
Q 016082          335 RLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLY  370 (395)
Q Consensus       335 ~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~~  370 (395)
                      .+.++|.+||+.||.+|||+.++++.|+++.+...+
T Consensus       242 ~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~  277 (281)
T 3cc6_A          242 VLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD  277 (281)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhhh
Confidence            999999999999999999999999999998876543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4e-48  Score=363.77  Aligned_cols=254  Identities=33%  Similarity=0.642  Sum_probs=220.8

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHH-----HHHHHHHHHHHhcCCCceeeEEEEEec
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEML-----KEFSQEVYIMRKIRHKNVVQFIGACTR  178 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~  178 (395)
                      .+..++|++.+.||+|+||.||+|++  +++.||+|++..........     +.+.+|+.++++++||||+++++++.+
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (287)
T 4f0f_A           15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN   94 (287)
T ss_dssp             BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred             hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence            45667999999999999999999998  57899999997654322211     678999999999999999999999976


Q ss_pred             CCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCeeeCCCCc-----EEEee
Q 016082          179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGV-----VKVAD  251 (395)
Q Consensus       179 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--iiHrDlkp~NiLl~~~~~-----vkl~D  251 (395)
                      ..  ++||||+++|+|.+++......+++..++.++.|++.||.|||+.|  |+||||||+||+++.++.     +||+|
T Consensus        95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence            65  7999999999999999887778999999999999999999999999  999999999999988776     99999


Q ss_pred             eccccccccCCccccCCCCcccccccccC--CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHhhhccCCCC
Q 016082          252 FGVARVQAQSGVMTAETGTYRWMAPEVIE--HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQA--AVGVVQKSLRPT  327 (395)
Q Consensus       252 Fg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~--~~~~~~~~~~~~  327 (395)
                      ||+++....  ......||+.|+|||++.  ...++.++||||||+++|+|++|+.||...+....  .........++.
T Consensus       173 fg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  250 (287)
T 4f0f_A          173 FGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT  250 (287)
T ss_dssp             CTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCC
T ss_pred             CCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCC
Confidence            999975433  344567999999999984  55678999999999999999999999987654333  444555677788


Q ss_pred             CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 016082          328 IPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQ  363 (395)
Q Consensus       328 ~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~  363 (395)
                      .+..+++++.++|.+||+.||.+|||+.++++.|++
T Consensus       251 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            889999999999999999999999999999999875

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.3e-47  Score=359.60  Aligned_cols=250  Identities=20%  Similarity=0.374  Sum_probs=224.2

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      .++|++.+.||+|+||.||+|.+  +++.||+|+++.........+.+.+|+.++++++||||+++++++...+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            45899999999999999999987  4789999999877667777788999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCc---EEEeeeccccccccCCc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV---VKVADFGVARVQAQSGV  263 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~---vkl~DFg~a~~~~~~~~  263 (395)
                      ||+++++|.+.+.. .+.+++..+..++.|++.||.|||++||+||||||+||+++.++.   +||+|||.+........
T Consensus        85 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~  163 (284)
T 3kk8_A           85 DLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA  163 (284)
T ss_dssp             CCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred             ecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence            99999999999876 467999999999999999999999999999999999999987655   99999999987766655


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCC--CCCCcHHHHHHHH
Q 016082          264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELLE  341 (395)
Q Consensus       264 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~  341 (395)
                      .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.........+.........  ...+++++.++|.
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (284)
T 3kk8_A          164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID  243 (284)
T ss_dssp             CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHH
T ss_pred             ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHH
Confidence            56678999999999999999999999999999999999999999998887776665554443332  2468999999999


Q ss_pred             HhhccCCCCCCCHHHHHH
Q 016082          342 RCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       342 ~cl~~dp~~RPs~~ell~  359 (395)
                      +||+.||.+|||+.|+++
T Consensus       244 ~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          244 SMLTVNPKKRITADQALK  261 (284)
T ss_dssp             HHSCSSTTTSCCHHHHTT
T ss_pred             HHcccChhhCCCHHHHhc
Confidence            999999999999999988

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3e-48  Score=367.10  Aligned_cols=261  Identities=28%  Similarity=0.556  Sum_probs=222.5

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEE------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR  178 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  178 (395)
                      ..+..+.|++.++||+|+||.||+|++      .++.||||+++... .....+.+.+|+.++++++||||+++++++..
T Consensus        16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (302)
T 4e5w_A           16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTE   94 (302)
T ss_dssp             TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence            345667899999999999999999984      57889999998653 23345778999999999999999999999987


Q ss_pred             C--CcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccc
Q 016082          179 P--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR  256 (395)
Q Consensus       179 ~--~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~  256 (395)
                      .  ..+++||||+++|+|.+++....+.+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||+++
T Consensus        95 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A           95 DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             CCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccc
Confidence            6  66899999999999999998777889999999999999999999999999999999999999999999999999998


Q ss_pred             ccccCC----ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC--------------CHHHHHHH
Q 016082          257 VQAQSG----VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL--------------TPLQAAVG  318 (395)
Q Consensus       257 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~--------------~~~~~~~~  318 (395)
                      ......    ......||..|+|||++.+..++.++||||||+++|+|++|..|+...              ........
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN  254 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence            665432    223456788899999999999999999999999999999999876432              22333334


Q ss_pred             hhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 016082          319 VVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK  366 (395)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~  366 (395)
                      ......+...+..+++++.++|.+||+.||.+|||+.++++.|+++++
T Consensus       255 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~  302 (302)
T 4e5w_A          255 TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK  302 (302)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             HHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence            455566777788999999999999999999999999999999998863

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=9.8e-49  Score=380.11  Aligned_cols=251  Identities=23%  Similarity=0.376  Sum_probs=214.9

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCc
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPN  181 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  181 (395)
                      .+..++|++.+.||+|+||.||+|++  +++.||||+++.... .......+.+|..+++.+ +||||+++++++.+...
T Consensus        19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~   98 (353)
T 3txo_A           19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR   98 (353)
T ss_dssp             ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence            45667999999999999999999998  478999999975421 223346688999999988 69999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC
Q 016082          182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  261 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~  261 (395)
                      +|+||||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus        99 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~  177 (353)
T 3txo_A           99 LFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN  177 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence            9999999999999999976 467999999999999999999999999999999999999999999999999999853322


Q ss_pred             -CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHH
Q 016082          262 -GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELL  340 (395)
Q Consensus       262 -~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  340 (395)
                       ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+...  ....|..+++++.++|
T Consensus       178 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li  255 (353)
T 3txo_A          178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND--EVVYPTWLHEDATGIL  255 (353)
T ss_dssp             --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHH
T ss_pred             CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHH
Confidence             2334568999999999999999999999999999999999999999999988877776654  3456778999999999


Q ss_pred             HHhhccCCCCCCCH------HHHHH
Q 016082          341 ERCWQHDPTQRPNF------SQITD  359 (395)
Q Consensus       341 ~~cl~~dp~~RPs~------~ell~  359 (395)
                      .+||+.||.+||++      .++++
T Consensus       256 ~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          256 KSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             HHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             HHHhhhCHHHccCCcccCCHHHHhh
Confidence            99999999999998      66665

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=9.8e-48  Score=369.63  Aligned_cols=265  Identities=29%  Similarity=0.614  Sum_probs=232.5

Q ss_pred             CceeecccCcceeeeeeeeCceEEEEEEEC---------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeE
Q 016082          103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQF  172 (395)
Q Consensus       103 ~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l  172 (395)
                      ..|++..++|++.+.||+|+||.||+|++.         +..||||+++... .....+.+.+|+.+++++ +||||+++
T Consensus        28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~  106 (334)
T 2pvf_A           28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINL  106 (334)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence            468899999999999999999999999863         4679999998653 455677899999999999 89999999


Q ss_pred             EEEEecCCcEEEEEecCCCCCHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 016082          173 IGACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA  237 (395)
Q Consensus       173 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~  237 (395)
                      ++++...+..++||||+++|+|.+++....               ..+++..++.++.||+.||.|||++||+||||||+
T Consensus       107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~  186 (334)
T 2pvf_A          107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR  186 (334)
T ss_dssp             EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence            999999999999999999999999997653               24889999999999999999999999999999999


Q ss_pred             CeeeCCCCcEEEeeeccccccccCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 016082          238 NLLMDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPL  313 (395)
Q Consensus       238 NiLl~~~~~vkl~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~  313 (395)
                      ||+++.++.+||+|||+++......   ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..
T Consensus       187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  266 (334)
T 2pvf_A          187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  266 (334)
T ss_dssp             GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence            9999999999999999998655432   1233467889999999988889999999999999999999 99999998876


Q ss_pred             HHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHH
Q 016082          314 QAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVL  369 (395)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~  369 (395)
                      +.... .....++..+..+++++.++|.+||+.||.+|||+.++++.|++++....
T Consensus       267 ~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          267 ELFKL-LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             HHHHH-HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHHHH-HhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence            65544 44455677788899999999999999999999999999999999987543

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.5e-48  Score=371.21  Aligned_cols=249  Identities=22%  Similarity=0.380  Sum_probs=218.7

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCH----HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT----EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  183 (395)
                      +.|++.+.||+|+||.||+|++  +++.||+|+++......    ...+.+.+|+.++++++||||+++++++......+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            5799999999999999999998  47899999997554321    13567899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCC----cEEEeeeccccccc
Q 016082          184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG----VVKVADFGVARVQA  259 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~----~vkl~DFg~a~~~~  259 (395)
                      +||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++    .+||+|||+++...
T Consensus        91 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~  169 (326)
T 2y0a_A           91 LILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  169 (326)
T ss_dssp             EEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence            99999999999999976 56799999999999999999999999999999999999999887    89999999998776


Q ss_pred             cCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCC--CCCCCCcHHHH
Q 016082          260 QSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP--TIPKHAHPRLA  337 (395)
Q Consensus       260 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~  337 (395)
                      .........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+.......  ..+..+++.+.
T Consensus       170 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (326)
T 2y0a_A          170 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK  249 (326)
T ss_dssp             TTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred             CCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHH
Confidence            5555556789999999999999999999999999999999999999999988776665554432221  12256789999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHH
Q 016082          338 ELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       338 ~li~~cl~~dp~~RPs~~ell~  359 (395)
                      ++|.+||+.||.+|||+.++++
T Consensus       250 ~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          250 DFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCChhhCCCHHHHhc
Confidence            9999999999999999999987

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=7.9e-48  Score=360.28  Aligned_cols=261  Identities=31%  Similarity=0.643  Sum_probs=229.0

Q ss_pred             CceeecccCcceeeeeeeeCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Q 016082          103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  181 (395)
Q Consensus       103 ~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  181 (395)
                      +.|++..++|++.+.||+|+||.||+|++. +..||||+++.....   .+.+.+|+.++++++||||+++++++.. +.
T Consensus         6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~   81 (279)
T 1qpc_A            6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP   81 (279)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             hhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC-CC
Confidence            578999999999999999999999999985 468999999866433   3678899999999999999999999874 46


Q ss_pred             EEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          182 LCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                      .++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||.++....
T Consensus        82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  161 (279)
T 1qpc_A           82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (279)
T ss_dssp             CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence            899999999999999997643 3689999999999999999999999999999999999999999999999999986654


Q ss_pred             CCc--cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHH
Q 016082          261 SGV--MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA  337 (395)
Q Consensus       261 ~~~--~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  337 (395)
                      ...  .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+.+..+....+ ....++..+..+++++.
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~  240 (279)
T 1qpc_A          162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-ERGYRMVRPDNCPEELY  240 (279)
T ss_dssp             SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-HTTCCCCCCTTCCHHHH
T ss_pred             cccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHH-hcccCCCCcccccHHHH
Confidence            322  223456789999999998889999999999999999999 99999998877655543 44566677888999999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHHHHHHHHHH
Q 016082          338 ELLERCWQHDPTQRPNFSQITDILKQMMKEV  368 (395)
Q Consensus       338 ~li~~cl~~dp~~RPs~~ell~~l~~~~~~~  368 (395)
                      +++.+||+.||.+|||+.++++.|++++...
T Consensus       241 ~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  271 (279)
T 1qpc_A          241 QLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (279)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence            9999999999999999999999999988754

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.5e-48  Score=390.28  Aligned_cols=252  Identities=23%  Similarity=0.438  Sum_probs=212.5

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  181 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  181 (395)
                      ..+..++|++.+.||+|+||.||+|++  +++.||||+++.... .......+.+|+.++++++||||+++++++...+.
T Consensus       143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~  222 (446)
T 4ejn_A          143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR  222 (446)
T ss_dssp             -CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTE
T ss_pred             cCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE
Confidence            456678999999999999999999987  578999999975421 23345678899999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                      +|+||||++||+|.+++.. .+.+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+++....
T Consensus       223 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          223 LCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  301 (446)
T ss_dssp             EEEEECCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred             EEEEEeeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence            9999999999999999976 4679999999999999999999998 9999999999999999999999999999986333


Q ss_pred             -CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHH
Q 016082          261 -SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL  339 (395)
Q Consensus       261 -~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  339 (395)
                       ........||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+...  ....|..+++++.++
T Consensus       302 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~l  379 (446)
T 4ejn_A          302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLGPEAKSL  379 (446)
T ss_dssp             -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHH
T ss_pred             CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHHHHH
Confidence             23345678999999999999999999999999999999999999999998887777666554  345677899999999


Q ss_pred             HHHhhccCCCCCC-----CHHHHHH
Q 016082          340 LERCWQHDPTQRP-----NFSQITD  359 (395)
Q Consensus       340 i~~cl~~dp~~RP-----s~~ell~  359 (395)
                      |.+||+.||.+||     ++.|+++
T Consensus       380 i~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          380 LSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             HHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HHHHcccCHHHhCCCCCCCHHHHHh
Confidence            9999999999999     9999987

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.5e-48  Score=371.97  Aligned_cols=264  Identities=28%  Similarity=0.579  Sum_probs=223.7

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEEC--Cc----eEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTYC--SQ----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP  179 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~~--~~----~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  179 (395)
                      .+..++|++.+.||+|+||.||+|++.  ++    +||+|.++... .....+.+.+|+.++++++||||+++++++...
T Consensus        11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   89 (327)
T 3poz_A           11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred             hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence            456779999999999999999999873  33    36888886443 234457899999999999999999999999876


Q ss_pred             CcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccc
Q 016082          180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  259 (395)
Q Consensus       180 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~  259 (395)
                      . .++|+||+.+|+|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            4 889999999999999999878889999999999999999999999999999999999999999999999999998655


Q ss_pred             cCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHH
Q 016082          260 QSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR  335 (395)
Q Consensus       260 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (395)
                      ....   .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.+.+..+... ......+...+..++.+
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  247 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLPQPPICTID  247 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-HHHTTCCCCCCTTBCHH
T ss_pred             CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHH-HHHcCCCCCCCccCCHH
Confidence            4322   223456889999999999999999999999999999999 999999887765443 44456667778889999


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 016082          336 LAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWL  372 (395)
Q Consensus       336 l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~~~~  372 (395)
                      +.+++.+||+.||.+||++.++++.|+.+.++...++
T Consensus       248 ~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~~~  284 (327)
T 3poz_A          248 VYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYL  284 (327)
T ss_dssp             HHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSHHHHB
T ss_pred             HHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhhhhhh
Confidence            9999999999999999999999999999987655443

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4.8e-48  Score=363.99  Aligned_cols=249  Identities=24%  Similarity=0.416  Sum_probs=211.2

Q ss_pred             cCcceeeeeeeeCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Q 016082          110 KQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  188 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  188 (395)
                      ++|++.+.||+|+||.||+|++ .++.||+|+++...........+.+|+.++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            5799999999999999999998 478999999976654444456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-CccccC
Q 016082          189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAE  267 (395)
Q Consensus       189 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-~~~~~~  267 (395)
                      +++ +|.+++....+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..... ......
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE  160 (288)
T ss_dssp             CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred             cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccccc
Confidence            986 999999887788999999999999999999999999999999999999999999999999999865432 233455


Q ss_pred             CCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCC--------------------
Q 016082          268 TGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP--------------------  326 (395)
Q Consensus       268 ~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~--------------------  326 (395)
                      .||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......+                    
T Consensus       161 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (288)
T 1ob3_A          161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV  240 (288)
T ss_dssp             -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCC
T ss_pred             cccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccccc
Confidence            78999999999976 468999999999999999999999999988766555443311100                    


Q ss_pred             -------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          327 -------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       327 -------~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                             .....+++++.++|.+||+.||.+|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                   112357899999999999999999999999987

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=4.3e-48  Score=368.09  Aligned_cols=265  Identities=31%  Similarity=0.618  Sum_probs=231.1

Q ss_pred             CceeecccCcceeeeeeeeCceEEEEEEE-------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEE
Q 016082          103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG  174 (395)
Q Consensus       103 ~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~  174 (395)
                      ..|++..++|++.+.||+|+||.||+|++       .++.||||+++... .....+.+.+|+.+++++ +||||+++++
T Consensus        20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~   98 (316)
T 2xir_A           20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLG   98 (316)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence            46788899999999999999999999985       34789999998653 445567899999999999 6899999999


Q ss_pred             EEecCC-cEEEEEecCCCCCHHHHHhhccCC---------------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 016082          175 ACTRPP-NLCIVTEFMARGSIYDFLHKQKGV---------------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN  238 (395)
Q Consensus       175 ~~~~~~-~~~lV~E~~~ggsL~~~l~~~~~~---------------l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~N  238 (395)
                      ++...+ .+++||||+++|+|.+++......               +++..++.++.|++.||.|||++||+||||||+|
T Consensus        99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N  178 (316)
T 2xir_A           99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN  178 (316)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence            987755 489999999999999999875432               7899999999999999999999999999999999


Q ss_pred             eeeCCCCcEEEeeeccccccccCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 016082          239 LLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQ  314 (395)
Q Consensus       239 iLl~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~  314 (395)
                      |+++.++.+||+|||+++.......   .....||+.|+|||++.+..++.++||||||+++|+|++ |..||.+.....
T Consensus       179 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~  258 (316)
T 2xir_A          179 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  258 (316)
T ss_dssp             EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             EEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence            9999999999999999986543321   223456889999999999999999999999999999998 999998877655


Q ss_pred             HHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHH
Q 016082          315 AAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  368 (395)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~  368 (395)
                      ..........++..+..+++++.++|.+||+.||.+|||+.++++.|++++++.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  312 (316)
T 2xir_A          259 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  312 (316)
T ss_dssp             HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            555556666677778889999999999999999999999999999999998754

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=8.9e-48  Score=378.52  Aligned_cols=247  Identities=21%  Similarity=0.387  Sum_probs=211.0

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCC
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPP  180 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  180 (395)
                      ..+..++|++.+.||+|+||.||+|++  +++.||+|++++.... ......+.+|..+++++ +||||+++++++.+..
T Consensus        47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~  126 (396)
T 4dc2_A           47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES  126 (396)
T ss_dssp             --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence            456678999999999999999999988  4688999999765432 33445688999999887 7999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccc-
Q 016082          181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA-  259 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~-  259 (395)
                      .+|+||||++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++... 
T Consensus       127 ~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          127 RLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             EEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEEEEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence            99999999999999999976 4679999999999999999999999999999999999999999999999999998633 


Q ss_pred             cCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC---------HHHHHHHhhhccCCCCCCC
Q 016082          260 QSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT---------PLQAAVGVVQKSLRPTIPK  330 (395)
Q Consensus       260 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~---------~~~~~~~~~~~~~~~~~~~  330 (395)
                      ........+||+.|+|||++.+..|+.++|+|||||++|||++|+.||....         .......+.  .....+|.
T Consensus       206 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~--~~~~~~p~  283 (396)
T 4dc2_A          206 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL--EKQIRIPR  283 (396)
T ss_dssp             TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHH--HCCCCCCT
T ss_pred             CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHh--ccccCCCC
Confidence            3334456689999999999999999999999999999999999999996432         122222222  23456788


Q ss_pred             CCcHHHHHHHHHhhccCCCCCCCH
Q 016082          331 HAHPRLAELLERCWQHDPTQRPNF  354 (395)
Q Consensus       331 ~~~~~l~~li~~cl~~dp~~RPs~  354 (395)
                      .+++++.++|.+||+.||.+||++
T Consensus       284 ~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          284 SLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             TSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             cCCHHHHHHHHHHhcCCHhHcCCC
Confidence            899999999999999999999985

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2e-48  Score=394.35  Aligned_cols=260  Identities=36%  Similarity=0.719  Sum_probs=231.3

Q ss_pred             CCceeecccCcceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 016082          102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP  179 (395)
Q Consensus       102 ~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  179 (395)
                      .+.|++..++|++.++||+|+||.||+|++.  +..||||+++.....   .+.|.+|+.+|++++||||++++++|...
T Consensus       212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~  288 (495)
T 1opk_A          212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTRE  288 (495)
T ss_dssp             SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            3569999999999999999999999999985  688999999866433   46799999999999999999999999999


Q ss_pred             CcEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccc
Q 016082          180 PNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  258 (395)
Q Consensus       180 ~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~  258 (395)
                      ..+++||||+++|+|.++++.. ...++...++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  368 (495)
T 1opk_A          289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM  368 (495)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred             CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceec
Confidence            9999999999999999999864 356899999999999999999999999999999999999999999999999999865


Q ss_pred             ccCCc--cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHH
Q 016082          259 AQSGV--MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR  335 (395)
Q Consensus       259 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (395)
                      .....  .....++..|+|||++.+..++.++||||||+++|||++ |..||.+.+..+... .+....+...|..++++
T Consensus       369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  447 (495)
T 1opk_A          369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDYRMERPEGCPEK  447 (495)
T ss_dssp             TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-HHHTTCCCCCCTTCCHH
T ss_pred             cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHcCCCCCCCCCCCHH
Confidence            43321  223346789999999998899999999999999999999 999999988766544 35566778888999999


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 016082          336 LAELLERCWQHDPTQRPNFSQITDILKQMM  365 (395)
Q Consensus       336 l~~li~~cl~~dp~~RPs~~ell~~l~~~~  365 (395)
                      +.++|.+||+.||.+|||+.+|++.|+.++
T Consensus       448 l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          448 VYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             HHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            999999999999999999999999988764

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.6e-47  Score=367.62  Aligned_cols=252  Identities=23%  Similarity=0.425  Sum_probs=211.0

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEE-----CCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKNVVQFIGACT  177 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~-----~~~~vAvK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  177 (395)
                      ..+..++|++.+.||+|+||.||+++.     .++.||+|+++....  +......+.+|+.++++++||||+++++++.
T Consensus        12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   91 (327)
T 3a62_A           12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ   91 (327)
T ss_dssp             -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence            346678999999999999999999986     578899999986543  2234566889999999999999999999999


Q ss_pred             cCCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccc
Q 016082          178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV  257 (395)
Q Consensus       178 ~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~  257 (395)
                      ..+.+|+||||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           92 TGGKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE  170 (327)
T ss_dssp             CSSCEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence            99999999999999999999976 46789999999999999999999999999999999999999999999999999975


Q ss_pred             cccC-CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHH
Q 016082          258 QAQS-GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  336 (395)
Q Consensus       258 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  336 (395)
                      .... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+....+...  ....|..+++++
T Consensus       171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~  248 (327)
T 3a62_A          171 SIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC--KLNLPPYLTQEA  248 (327)
T ss_dssp             --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT--CCCCCTTSCHHH
T ss_pred             cccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHH
Confidence            4332 2334557999999999999999999999999999999999999999998887766665543  345677899999


Q ss_pred             HHHHHHhhccCCCCCC-----CHHHHHH
Q 016082          337 AELLERCWQHDPTQRP-----NFSQITD  359 (395)
Q Consensus       337 ~~li~~cl~~dp~~RP-----s~~ell~  359 (395)
                      .++|.+||+.||.+||     ++.++++
T Consensus       249 ~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          249 RDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             HHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             HHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            9999999999999999     7777776

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4.7e-48  Score=370.58  Aligned_cols=273  Identities=31%  Similarity=0.584  Sum_probs=232.2

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEE--CCce--EEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEEEEecC
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQE--VAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRP  179 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~--vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  179 (395)
                      ..++.++|++.+.||+|+||.||+|++  .+..  +|+|.++... .....+.+.+|+.+++++ +||||+++++++...
T Consensus        20 p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~   98 (327)
T 1fvr_A           20 PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   98 (327)
T ss_dssp             SBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred             ccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeC
Confidence            356778999999999999999999987  4554  5999987542 334456789999999999 899999999999999


Q ss_pred             CcEEEEEecCCCCCHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCC
Q 016082          180 PNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN  244 (395)
Q Consensus       180 ~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~  244 (395)
                      +..++||||+++|+|.+++....               ..+++..++.++.||+.||.|||++||+||||||+||+++.+
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~  178 (327)
T 1fvr_A           99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN  178 (327)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred             CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCC
Confidence            99999999999999999997643               479999999999999999999999999999999999999999


Q ss_pred             CcEEEeeeccccccccCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc
Q 016082          245 GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKS  323 (395)
Q Consensus       245 ~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~  323 (395)
                      +.+||+|||+++............+++.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..+....+ ...
T Consensus       179 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~-~~~  257 (327)
T 1fvr_A          179 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-PQG  257 (327)
T ss_dssp             GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG-GGT
T ss_pred             CeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh-hcC
Confidence            9999999999975444333445567889999999998889999999999999999998 99999998877665544 445


Q ss_pred             CCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhccccccc
Q 016082          324 LRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINT  379 (395)
Q Consensus       324 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~~~~~~~~~~~  379 (395)
                      .++..+..+++++.++|.+||+.||.+|||+.++++.|.+++++...+.+..+..+
T Consensus       258 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~~~~  313 (327)
T 1fvr_A          258 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEK  313 (327)
T ss_dssp             CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSBCCBCTTC
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCccccchhcc
Confidence            66677888999999999999999999999999999999999998776666555443

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=4.4e-48  Score=362.07  Aligned_cols=258  Identities=34%  Similarity=0.678  Sum_probs=220.2

Q ss_pred             CceeecccCcceeeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-Cc
Q 016082          103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP-PN  181 (395)
Q Consensus       103 ~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~  181 (395)
                      ..|.++.++|++.+.||+|+||.||+|++.++.||||+++...    ..+.+.+|+.++++++||||+++++++... +.
T Consensus        14 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (278)
T 1byg_A           14 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG   89 (278)
T ss_dssp             -CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred             ccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence            4578889999999999999999999999999999999998553    346789999999999999999999997554 47


Q ss_pred             EEEEEecCCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          182 LCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                      .++||||+++++|.+++..... .+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||+++....
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            8999999999999999976432 388999999999999999999999999999999999999999999999999975543


Q ss_pred             CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHH
Q 016082          261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL  339 (395)
Q Consensus       261 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  339 (395)
                      .  .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||......+.... .....++..+..+++++.++
T Consensus       170 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~l  246 (278)
T 1byg_A          170 T--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMDAPDGCPPAVYEV  246 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH-HTTTCCCCCCTTCCHHHHHH
T ss_pred             c--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HhcCCCCCCcccCCHHHHHH
Confidence            3  233467889999999998899999999999999999998 9999998776655444 34456677788899999999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 016082          340 LERCWQHDPTQRPNFSQITDILKQMMKE  367 (395)
Q Consensus       340 i~~cl~~dp~~RPs~~ell~~l~~~~~~  367 (395)
                      |.+||+.||.+|||+.++++.|+++...
T Consensus       247 i~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          247 MKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence            9999999999999999999999998765

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.1e-47  Score=369.71  Aligned_cols=245  Identities=22%  Similarity=0.402  Sum_probs=212.7

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcE
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNL  182 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  182 (395)
                      +..++|++.+.||+|+||.||+|++  +++.||+|+++.... .....+.+.+|..+++++ +||||+++++++.+...+
T Consensus         6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   85 (345)
T 3a8x_A            6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL   85 (345)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence            4467899999999999999999998  478999999976543 445667889999999988 899999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc-C
Q 016082          183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-S  261 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~-~  261 (395)
                      |+||||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.... .
T Consensus        86 ~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~  164 (345)
T 3a8x_A           86 FFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  164 (345)
T ss_dssp             EEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred             EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence            999999999999999976 46799999999999999999999999999999999999999999999999999985332 2


Q ss_pred             CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHhhhccCCCCCCCCC
Q 016082          262 GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL---------TPLQAAVGVVQKSLRPTIPKHA  332 (395)
Q Consensus       262 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~---------~~~~~~~~~~~~~~~~~~~~~~  332 (395)
                      .......||+.|+|||++.+..++.++|+|||||++|||++|+.||...         ........+..  ....+|..+
T Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~--~~~~~p~~~  242 (345)
T 3a8x_A          165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--KQIRIPRSL  242 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH--CCCCCCTTS
T ss_pred             CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc--CCCCCCCCC
Confidence            3345568999999999999999999999999999999999999999752         22222222232  245677889


Q ss_pred             cHHHHHHHHHhhccCCCCCCCH
Q 016082          333 HPRLAELLERCWQHDPTQRPNF  354 (395)
Q Consensus       333 ~~~l~~li~~cl~~dp~~RPs~  354 (395)
                      ++++.++|.+||+.||.+||++
T Consensus       243 s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          243 SVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             CHHHHHHHHHHTCSSTTTSTTC
T ss_pred             CHHHHHHHHHHhcCCHhHCCCC
Confidence            9999999999999999999995

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-48  Score=369.18  Aligned_cols=248  Identities=26%  Similarity=0.467  Sum_probs=219.8

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  183 (395)
                      +..++|++.+.||+|+||.||+|+.  +++.||+|+++.... .....+.+.+|+.+++.++||||+++++++.+...+|
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~   82 (318)
T 1fot_A            3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   82 (318)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence            3457899999999999999999998  578999999975321 1123466889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCc
Q 016082          184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV  263 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~  263 (395)
                      +||||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....  
T Consensus        83 lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--  159 (318)
T 1fot_A           83 MIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  159 (318)
T ss_dssp             EEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             EEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence            99999999999999976 567999999999999999999999999999999999999999999999999999865432  


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHh
Q 016082          264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC  343 (395)
Q Consensus       264 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  343 (395)
                      .....||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+..+....+....  ...|..+++++.++|.+|
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~l  237 (318)
T 1fot_A          160 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE--LRFPPFFNEDVKDLLSRL  237 (318)
T ss_dssp             BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHH
T ss_pred             cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHH
Confidence            345689999999999999999999999999999999999999999988877777666543  456778999999999999


Q ss_pred             hccCCCCCC-----CHHHHHH
Q 016082          344 WQHDPTQRP-----NFSQITD  359 (395)
Q Consensus       344 l~~dp~~RP-----s~~ell~  359 (395)
                      |+.||.+||     +++++++
T Consensus       238 L~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          238 ITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             TCSCTTTCTTSSTTTTHHHHT
T ss_pred             hccCHHHcCCCcCCCHHHHhc
Confidence            999999999     8888876

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.7e-47  Score=360.72  Aligned_cols=249  Identities=23%  Similarity=0.392  Sum_probs=213.1

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      ++|++.++||+|+||.||+|++  +++.||||+++...........+.+|+.++++++||||+++++++.++...++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            5799999999999999999998  57889999998776666667889999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-Ccccc
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTA  266 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-~~~~~  266 (395)
                      |+++ ++.+.+....+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..... .....
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  160 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA  160 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCS
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccC
Confidence            9986 777777776788999999999999999999999999999999999999999999999999999865433 23445


Q ss_pred             CCCCcccccccccCCCC-CCChhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHhhhccCCC------------------
Q 016082          267 ETGTYRWMAPEVIEHKP-YDYKADVFSFGIALWELLTGELP-YAGLTPLQAAVGVVQKSLRP------------------  326 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~~~-~~~k~DvwslG~vl~elltg~~p-f~~~~~~~~~~~~~~~~~~~------------------  326 (395)
                      ..||+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+..+....+......+                  
T Consensus       161 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  240 (292)
T 3o0g_A          161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP  240 (292)
T ss_dssp             CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred             CccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccc
Confidence            67899999999998765 89999999999999999987766 56665555444433211111                  


Q ss_pred             ---------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          327 ---------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       327 ---------~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                               ...+.+++++.++|.+||+.||.+|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                     112357889999999999999999999999987

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.2e-47  Score=362.10  Aligned_cols=259  Identities=17%  Similarity=0.274  Sum_probs=220.5

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcE
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNL  182 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  182 (395)
                      .+..++|++.+.||+|+||.||+|++  +++.||||+++.....    ..+.+|+.+++++ +|+|++++++++......
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~   81 (298)
T 1csn_A            6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN   81 (298)
T ss_dssp             CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred             cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence            35567899999999999999999996  6899999998754322    4577899999999 799999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCc-----EEEeeeccccc
Q 016082          183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV-----VKVADFGVARV  257 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~-----vkl~DFg~a~~  257 (395)
                      ++||||+ +++|.+++.....++++..+..++.||+.||.|||++||+||||||+||+++.++.     +||+|||+++.
T Consensus        82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            9999999 88999999887677999999999999999999999999999999999999987776     99999999986


Q ss_pred             cccCCc--------cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHhhhccCC-
Q 016082          258 QAQSGV--------MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT---PLQAAVGVVQKSLR-  325 (395)
Q Consensus       258 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~---~~~~~~~~~~~~~~-  325 (395)
                      ......        .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+..   ..+....+...... 
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  240 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence            554321        234568999999999999999999999999999999999999998743   33333332222211 


Q ss_pred             --CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHH
Q 016082          326 --PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVL  369 (395)
Q Consensus       326 --~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~  369 (395)
                        +.....+++++.+++.+||+.||.+||++.+|++.|++++++..
T Consensus       241 ~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~  286 (298)
T 1csn_A          241 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  286 (298)
T ss_dssp             CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence              12334688999999999999999999999999999999988653

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.2e-47  Score=376.62  Aligned_cols=256  Identities=21%  Similarity=0.414  Sum_probs=216.1

Q ss_pred             ceeecccCcceeeeeeee--CceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 016082          104 VWEIDAKQLKIECKVASG--SYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP  179 (395)
Q Consensus       104 ~~~i~~~~~~i~~~lg~G--~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  179 (395)
                      .+....++|++.++||+|  +||.||+|++  +++.||||+++.........+.+.+|+.++++++||||+++++++...
T Consensus        19 ~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   98 (389)
T 3gni_B           19 SFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD   98 (389)
T ss_dssp             CCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             cccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC
Confidence            345567799999999999  9999999998  478999999987766777788899999999999999999999999999


Q ss_pred             CcEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccc
Q 016082          180 PNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  258 (395)
Q Consensus       180 ~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~  258 (395)
                      +.+|+||||+++|+|.+++... .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||.+...
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B           99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            9999999999999999999764 367999999999999999999999999999999999999999999999999998643


Q ss_pred             ccCC--------ccccCCCCcccccccccCC--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccC----
Q 016082          259 AQSG--------VMTAETGTYRWMAPEVIEH--KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL----  324 (395)
Q Consensus       259 ~~~~--------~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~----  324 (395)
                      ....        ......||+.|+|||++.+  ..++.++|||||||++|+|++|+.||.+.+..+..........    
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  258 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL  258 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence            3221        1223478999999999987  6799999999999999999999999988665544433322111    


Q ss_pred             ----------------------------------------CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          325 ----------------------------------------RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       325 ----------------------------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                                              ....+..+++++.+||.+||+.||.+|||+.|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence                                                    01234567889999999999999999999999986

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-47  Score=364.43  Aligned_cols=248  Identities=22%  Similarity=0.272  Sum_probs=209.0

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcEE
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  183 (395)
                      +-.++|++.++||+|+||+||+|++  +++.||||++............+..|+..+.++ +||||+++++++.+.+..|
T Consensus        54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~  133 (311)
T 3p1a_A           54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY  133 (311)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence            3446899999999999999999998  478999999977655555556666677666666 8999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCc
Q 016082          184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV  263 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~  263 (395)
                      +||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus       134 lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~  212 (311)
T 3p1a_A          134 LQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA  212 (311)
T ss_dssp             EEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred             EEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCC
Confidence            999999 6699999988777899999999999999999999999999999999999999999999999999987766555


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHh
Q 016082          264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC  343 (395)
Q Consensus       264 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  343 (395)
                      .....||+.|+|||++.+ .++.++||||||+++|||++|..|+.+....   ..+......+..+..+++++.++|.+|
T Consensus       213 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~~  288 (311)
T 3p1a_A          213 GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW---QQLRQGYLPPEFTAGLSSELRSVLVMM  288 (311)
T ss_dssp             --CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH---HHHTTTCCCHHHHTTSCHHHHHHHHHH
T ss_pred             CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHhccCCCcccccCCCHHHHHHHHHH
Confidence            566679999999999886 6899999999999999999997766553322   222333333445567899999999999


Q ss_pred             hccCCCCCCCHHHHHH
Q 016082          344 WQHDPTQRPNFSQITD  359 (395)
Q Consensus       344 l~~dp~~RPs~~ell~  359 (395)
                      |+.||.+|||+.++++
T Consensus       289 L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          289 LEPDPKLRATAEALLA  304 (311)
T ss_dssp             SCSSTTTSCCHHHHHT
T ss_pred             cCCChhhCcCHHHHHh
Confidence            9999999999999987

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.4e-47  Score=364.70  Aligned_cols=267  Identities=28%  Similarity=0.528  Sum_probs=222.5

Q ss_pred             CCceeecccCcceeeeeeeeCceEEEEEEEC-----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEE
Q 016082          102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC  176 (395)
Q Consensus       102 ~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  176 (395)
                      ...+.++.++|++.+.||+|+||.||+|++.     ++.||+|+++.........+.+.+|+.++++++||||+++++++
T Consensus        26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  105 (313)
T 3brb_A           26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC  105 (313)
T ss_dssp             TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence            3556788899999999999999999999863     34799999987766777778899999999999999999999999


Q ss_pred             ecCC-----cEEEEEecCCCCCHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCc
Q 016082          177 TRPP-----NLCIVTEFMARGSIYDFLHKQ-----KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV  246 (395)
Q Consensus       177 ~~~~-----~~~lV~E~~~ggsL~~~l~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~  246 (395)
                      ....     ..++||||+++|+|.+++...     ...+++..++.++.||+.||.|||++||+||||||+||+++.++.
T Consensus       106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC
T ss_pred             eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc
Confidence            7755     359999999999999998532     356999999999999999999999999999999999999999999


Q ss_pred             EEEeeeccccccccCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc
Q 016082          247 VKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK  322 (395)
Q Consensus       247 vkl~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~  322 (395)
                      +||+|||+++......   ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+. .
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~  264 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL-H  264 (313)
T ss_dssp             EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-T
T ss_pred             EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH-c
Confidence            9999999997654332   1233457889999999999999999999999999999999 999999887766555433 4


Q ss_pred             cCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHH
Q 016082          323 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVL  369 (395)
Q Consensus       323 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~  369 (395)
                      ..++..+..+++++.++|.+||+.||.+|||+.++++.|+++++.+-
T Consensus       265 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          265 GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             TCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             CCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence            55677788899999999999999999999999999999999987653

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=6.5e-48  Score=374.31  Aligned_cols=251  Identities=22%  Similarity=0.390  Sum_probs=217.4

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCc
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPN  181 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  181 (395)
                      .+..++|++.+.||+|+||.||+|++.  ++.||||+++.... .....+.+..|..++..+ +||||+++++++.+...
T Consensus        16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   95 (353)
T 2i0e_A           16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR   95 (353)
T ss_dssp             ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred             CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence            456679999999999999999999985  57899999975321 112346688999999988 79999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc-
Q 016082          182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-  260 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~-  260 (395)
                      +|+||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.... 
T Consensus        96 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  174 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  174 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence            9999999999999999976 46799999999999999999999999999999999999999999999999999986432 


Q ss_pred             CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHH
Q 016082          261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELL  340 (395)
Q Consensus       261 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  340 (395)
                      .......+||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+..+....+...  ....|..+++++.++|
T Consensus       175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li  252 (353)
T 2i0e_A          175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--NVAYPKSMSKEAVAIC  252 (353)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHH
T ss_pred             CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHHHHH
Confidence            22344568999999999999999999999999999999999999999998888777766654  3456788999999999


Q ss_pred             HHhhccCCCCCCC-----HHHHHH
Q 016082          341 ERCWQHDPTQRPN-----FSQITD  359 (395)
Q Consensus       341 ~~cl~~dp~~RPs-----~~ell~  359 (395)
                      .+||+.||.+||+     +.++++
T Consensus       253 ~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          253 KGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             HHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             HHHhhcCHHHcCCCCCCCHHHHhc
Confidence            9999999999996     466654

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.3e-48  Score=375.21  Aligned_cols=251  Identities=24%  Similarity=0.446  Sum_probs=217.8

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCc
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPN  181 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  181 (395)
                      .+..++|++.+.||+|+||.||+|++  +++.||||+++.... ..+....+..|..+++.+ +||||+++++++.+...
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            45567999999999999999999998  478999999975321 112345678899999987 89999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc-
Q 016082          182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-  260 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~-  260 (395)
                      +|+||||++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.... 
T Consensus        93 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  171 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  171 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence            9999999999999999976 46799999999999999999999999999999999999999999999999999985432 


Q ss_pred             CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHH
Q 016082          261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELL  340 (395)
Q Consensus       261 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  340 (395)
                      ........||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+..+....+...  .+..|..+++++.++|
T Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li  249 (345)
T 1xjd_A          172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEAKDLL  249 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHH
T ss_pred             CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC--CCCCCcccCHHHHHHH
Confidence            22345568999999999999999999999999999999999999999998887776665543  4567788999999999


Q ss_pred             HHhhccCCCCCCCHH-HHHH
Q 016082          341 ERCWQHDPTQRPNFS-QITD  359 (395)
Q Consensus       341 ~~cl~~dp~~RPs~~-ell~  359 (395)
                      .+||+.||.+||++. ++++
T Consensus       250 ~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          250 VKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             HHHSCSSGGGSBTTBSCGGG
T ss_pred             HHHhcCCHhHcCCChHHHHc
Confidence            999999999999997 6653

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4.3e-48  Score=379.39  Aligned_cols=252  Identities=23%  Similarity=0.412  Sum_probs=216.7

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  181 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  181 (395)
                      ..+..++|++.+.||+|+||.||++++  +++.||+|+++.... .....+.+.+|+.+|++++||||+++++++.+...
T Consensus        10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   89 (384)
T 4fr4_A           10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED   89 (384)
T ss_dssp             CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            456778999999999999999999998  468899999864321 12234678899999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC
Q 016082          182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  261 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~  261 (395)
                      +|+||||+.||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus        90 ~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           90 MFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             EEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            9999999999999999976 567999999999999999999999999999999999999999999999999999877666


Q ss_pred             CccccCCCCcccccccccCC---CCCCChhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHhhhccCCCCCCCCCcHH
Q 016082          262 GVMTAETGTYRWMAPEVIEH---KPYDYKADVFSFGIALWELLTGELPYAGLTP---LQAAVGVVQKSLRPTIPKHAHPR  335 (395)
Q Consensus       262 ~~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwslG~vl~elltg~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  335 (395)
                      .......||+.|+|||++.+   ..|+.++|||||||++|+|++|+.||.....   .+....+.  ......|..++++
T Consensus       169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~--~~~~~~p~~~s~~  246 (384)
T 4fr4_A          169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE--TTVVTYPSAWSQE  246 (384)
T ss_dssp             CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH--HCCCCCCTTSCHH
T ss_pred             CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh--hcccCCCCcCCHH
Confidence            66677789999999999964   4689999999999999999999999975332   22222222  2345667889999


Q ss_pred             HHHHHHHhhccCCCCCCC-HHHHHH
Q 016082          336 LAELLERCWQHDPTQRPN-FSQITD  359 (395)
Q Consensus       336 l~~li~~cl~~dp~~RPs-~~ell~  359 (395)
                      +.++|.+||+.||.+||+ ++++++
T Consensus       247 ~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          247 MVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             HHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             HHHHHHHHhcCCHhHhcccHHHHHc
Confidence            999999999999999998 666654

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=8.1e-48  Score=368.96  Aligned_cols=267  Identities=25%  Similarity=0.484  Sum_probs=224.7

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEE------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEe--
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT--  177 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--  177 (395)
                      -++.++|++.+.||+|+||.||+|++      .++.||||+++..  .....+.+.+|+.++++++||||+++++++.  
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   96 (327)
T 3lxl_A           19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGP   96 (327)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence            36678999999999999999999985      5688999999865  4556678999999999999999999999886  


Q ss_pred             cCCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccc
Q 016082          178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV  257 (395)
Q Consensus       178 ~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~  257 (395)
                      +....++||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A           97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence            44568999999999999999988677899999999999999999999999999999999999999999999999999986


Q ss_pred             cccCC----ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH--------------HHHHHh
Q 016082          258 QAQSG----VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL--------------QAAVGV  319 (395)
Q Consensus       258 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~--------------~~~~~~  319 (395)
                      .....    ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......              ......
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL  256 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            54432    223346788899999999989999999999999999999999998654322              233344


Q ss_pred             hhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcc
Q 016082          320 VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSP  374 (395)
Q Consensus       320 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~~~~~~  374 (395)
                      .....++..+..+++++.++|.+||+.||.+|||+.++++.|+.+......+...
T Consensus       257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~  311 (327)
T 3lxl_A          257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETH  311 (327)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----------
T ss_pred             hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcccc
Confidence            4556677778899999999999999999999999999999999998877666543

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-47  Score=375.92  Aligned_cols=249  Identities=19%  Similarity=0.379  Sum_probs=220.8

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      .+.|++.+.||+|+||.||+|.+  +++.||+|++....  ......+.+|+.+|++++||||+++++++.+....++||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  127 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL  127 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence            35899999999999999999998  57889999997653  334567899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCC--CCcEEEeeeccccccccCCcc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE--NGVVKVADFGVARVQAQSGVM  264 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~--~~~vkl~DFg~a~~~~~~~~~  264 (395)
                      ||++||+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||+++........
T Consensus       128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~  207 (387)
T 1kob_A          128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV  207 (387)
T ss_dssp             ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred             EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcce
Confidence            999999999999876668999999999999999999999999999999999999974  467999999999876655555


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccC--CCCCCCCCcHHHHHHHHH
Q 016082          265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL--RPTIPKHAHPRLAELLER  342 (395)
Q Consensus       265 ~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~  342 (395)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.....  .+.....+++++.++|.+
T Consensus       208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  287 (387)
T 1kob_A          208 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKN  287 (387)
T ss_dssp             EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHT
T ss_pred             eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHH
Confidence            556899999999999999999999999999999999999999999887776666554332  233345789999999999


Q ss_pred             hhccCCCCCCCHHHHHH
Q 016082          343 CWQHDPTQRPNFSQITD  359 (395)
Q Consensus       343 cl~~dp~~RPs~~ell~  359 (395)
                      ||+.||.+|||+.++++
T Consensus       288 ~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          288 LLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             TSCSSGGGSCCHHHHHT
T ss_pred             HcCCChhHCcCHHHHhh
Confidence            99999999999999986

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.8e-47  Score=365.15  Aligned_cols=263  Identities=30%  Similarity=0.561  Sum_probs=229.4

Q ss_pred             CCceeecccCcceeeeeeeeCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEE
Q 016082          102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG  174 (395)
Q Consensus       102 ~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  174 (395)
                      .+.|++..++|++.+.||+|+||.||+|++.       ++.||||+++... .......+.+|+.++++++||||+++++
T Consensus        17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~   95 (322)
T 1p4o_A           17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLG   95 (322)
T ss_dssp             CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence            4578899999999999999999999999864       4779999997553 3445667999999999999999999999


Q ss_pred             EEecCCcEEEEEecCCCCCHHHHHhhcc---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCC
Q 016082          175 ACTRPPNLCIVTEFMARGSIYDFLHKQK---------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG  245 (395)
Q Consensus       175 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~  245 (395)
                      ++......++||||+++|+|.+++....         ..+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus        96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A           96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred             EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence            9999999999999999999999997642         4578999999999999999999999999999999999999999


Q ss_pred             cEEEeeeccccccccCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhh
Q 016082          246 VVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQ  321 (395)
Q Consensus       246 ~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~  321 (395)
                      .+||+|||+++.......   .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+..
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  255 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME  255 (322)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred             eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc
Confidence            999999999976543321   223456889999999999999999999999999999999 8999999887776655443


Q ss_pred             ccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 016082          322 KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK  366 (395)
Q Consensus       322 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~  366 (395)
                       ...+..+..+++++.++|.+||+.||.+|||+.++++.|++++.
T Consensus       256 -~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          256 -GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             -CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence             34456678899999999999999999999999999999887644

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-47  Score=362.59  Aligned_cols=251  Identities=25%  Similarity=0.405  Sum_probs=210.8

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCH------------------------HHHHHHHHHHHH
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT------------------------EMLKEFSQEVYI  160 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~------------------------~~~~~~~~E~~~  160 (395)
                      +..++|++.+.||+|+||.||+|++  +++.||||+++......                        ...+.+.+|+.+
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            3457899999999999999999987  57899999997653211                        124568999999


Q ss_pred             HHhcCCCceeeEEEEEec--CCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 016082          161 MRKIRHKNVVQFIGACTR--PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN  238 (395)
Q Consensus       161 l~~l~h~niv~l~~~~~~--~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~N  238 (395)
                      +++++||||+++++++..  ....++||||+++++|.+++.  .+++++..++.++.||+.||.|||++||+||||||+|
T Consensus        90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N  167 (298)
T 2zv2_A           90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN  167 (298)
T ss_dssp             HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence            999999999999999986  567999999999999988653  4579999999999999999999999999999999999


Q ss_pred             eeeCCCCcEEEeeeccccccccCC-ccccCCCCcccccccccCCCC---CCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 016082          239 LLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEVIEHKP---YDYKADVFSFGIALWELLTGELPYAGLTPLQ  314 (395)
Q Consensus       239 iLl~~~~~vkl~DFg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~---~~~k~DvwslG~vl~elltg~~pf~~~~~~~  314 (395)
                      |+++.++.+||+|||+++...... ......||+.|+|||++.+..   ++.++||||||+++|+|++|+.||.+.....
T Consensus       168 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~  247 (298)
T 2zv2_A          168 LLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC  247 (298)
T ss_dssp             EEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             EEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH
Confidence            999999999999999998655432 334567999999999998765   4788999999999999999999999887766


Q ss_pred             HHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          315 AAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      ....+.......+.+..+++++.++|.+||+.||.+|||+.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          248 LHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            655555544444445678999999999999999999999999876

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.9e-47  Score=372.17  Aligned_cols=249  Identities=25%  Similarity=0.426  Sum_probs=202.0

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  184 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  184 (395)
                      ...++|++.+.||+|+||.||++++  +++.||||++.......   +.+.+|+.++++++||||+++++++......++
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   93 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   93 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence            4567899999999999999999998  57899999997653322   567899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCc--EEEeeeccccccccCC
Q 016082          185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV--VKVADFGVARVQAQSG  262 (395)
Q Consensus       185 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~--vkl~DFg~a~~~~~~~  262 (395)
                      ||||++||+|.+++.. .+++++..++.++.|++.||.|||++||+||||||+||+++.++.  +||+|||+++......
T Consensus        94 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~  172 (361)
T 3uc3_A           94 IMEYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  172 (361)
T ss_dssp             EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             EEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence            9999999999999976 567999999999999999999999999999999999999987765  9999999998555444


Q ss_pred             ccccCCCCcccccccccCCCCCCCh-hhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHhhhccCCCCCCCCCcHHHH
Q 016082          263 VMTAETGTYRWMAPEVIEHKPYDYK-ADVFSFGIALWELLTGELPYAGLTPL----QAAVGVVQKSLRPTIPKHAHPRLA  337 (395)
Q Consensus       263 ~~~~~~gt~~y~aPE~~~~~~~~~k-~DvwslG~vl~elltg~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~  337 (395)
                      ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+....    .....+.......+.+..+++++.
T Consensus       173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  252 (361)
T 3uc3_A          173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECC  252 (361)
T ss_dssp             --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHH
T ss_pred             CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHH
Confidence            4556689999999999988888766 89999999999999999999875442    223333333333333446899999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHH
Q 016082          338 ELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       338 ~li~~cl~~dp~~RPs~~ell~  359 (395)
                      ++|.+||+.||.+|||+.|+++
T Consensus       253 ~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          253 HLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             HHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHccCChhHCcCHHHHHh
Confidence            9999999999999999999987

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=9e-48  Score=372.92  Aligned_cols=247  Identities=26%  Similarity=0.410  Sum_probs=219.3

Q ss_pred             cccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Q 016082          108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  184 (395)
Q Consensus       108 ~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  184 (395)
                      ..++|++.+.||+|+||.||+|++  +++.||||+++.... .....+.+.+|+.++++++||||+++++++.+...+|+
T Consensus        39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  118 (350)
T 1rdq_E           39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM  118 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence            346899999999999999999998  578999999964321 11234678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCcc
Q 016082          185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM  264 (395)
Q Consensus       185 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~  264 (395)
                      ||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....  .
T Consensus       119 v~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--~  195 (350)
T 1rdq_E          119 VMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--T  195 (350)
T ss_dssp             EEECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--B
T ss_pred             EEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--c
Confidence            9999999999999976 467999999999999999999999999999999999999999999999999999865433  3


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhh
Q 016082          265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW  344 (395)
Q Consensus       265 ~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  344 (395)
                      ....||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..+....+...  ....|..+++++.++|.+||
T Consensus       196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~lL  273 (350)
T 1rdq_E          196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFSSDLKDLLRNLL  273 (350)
T ss_dssp             CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTCCHHHHHHHHHHS
T ss_pred             ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHh
Confidence            4557999999999999999999999999999999999999999998887777666654  34567889999999999999


Q ss_pred             ccCCCCCCC-----HHHHHH
Q 016082          345 QHDPTQRPN-----FSQITD  359 (395)
Q Consensus       345 ~~dp~~RPs-----~~ell~  359 (395)
                      +.||.+||+     +.++++
T Consensus       274 ~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          274 QVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CSCTTTCTTSSTTTTHHHHT
T ss_pred             hcCHHhccCCccCCHHHHHh
Confidence            999999998     777765

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=8.3e-48  Score=376.23  Aligned_cols=249  Identities=23%  Similarity=0.395  Sum_probs=209.8

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHH-HHhcCCCceeeEEEEEecCCc
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYI-MRKIRHKNVVQFIGACTRPPN  181 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~  181 (395)
                      .+..++|++.+.||+|+||.||+|++  +++.||||+++.... .......+.+|..+ ++.++||||+++++++.+.+.
T Consensus        34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~  113 (373)
T 2r5t_A           34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK  113 (373)
T ss_dssp             TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred             CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence            34567899999999999999999998  467899999976543 23344567777776 577899999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc-
Q 016082          182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-  260 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~-  260 (395)
                      +|+||||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.... 
T Consensus       114 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          114 LYFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            9999999999999999976 56789999999999999999999999999999999999999999999999999986433 


Q ss_pred             CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHH
Q 016082          261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELL  340 (395)
Q Consensus       261 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  340 (395)
                      .......+||+.|+|||++.+..|+.++|+|||||++|||++|..||.+.+..+....+...  ....+..+++++.++|
T Consensus       193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li  270 (373)
T 2r5t_A          193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK--PLQLKPNITNSARHLL  270 (373)
T ss_dssp             CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS--CCCCCSSSCHHHHHHH
T ss_pred             CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--ccCCCCCCCHHHHHHH
Confidence            33345568999999999999999999999999999999999999999998888777776654  3456778999999999


Q ss_pred             HHhhccCCCCCCCHHHH
Q 016082          341 ERCWQHDPTQRPNFSQI  357 (395)
Q Consensus       341 ~~cl~~dp~~RPs~~el  357 (395)
                      .+||+.||.+||++.+.
T Consensus       271 ~~lL~~dp~~R~~~~~~  287 (373)
T 2r5t_A          271 EGLLQKDRTKRLGAKDD  287 (373)
T ss_dssp             HHHTCSSGGGSTTTTTT
T ss_pred             HHHcccCHHhCCCCCCC
Confidence            99999999999998543

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.8e-48  Score=371.22  Aligned_cols=264  Identities=27%  Similarity=0.573  Sum_probs=223.6

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEEC--Cce----EEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTYC--SQE----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP  179 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~~--~~~----vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  179 (395)
                      .+..++|++.+.||+|+||.||+|++.  ++.    ||+|++.... .......+.+|+.++++++||||+++++++. .
T Consensus         9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~   86 (325)
T 3kex_A            9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G   86 (325)
T ss_dssp             BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred             hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence            345679999999999999999999973  333    8888876442 1222356778999999999999999999986 4


Q ss_pred             CcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccc
Q 016082          180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  259 (395)
Q Consensus       180 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~  259 (395)
                      +..++||||+.+|+|.+++....+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            56999999999999999998877789999999999999999999999999999999999999999999999999998764


Q ss_pred             cCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHH
Q 016082          260 QSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR  335 (395)
Q Consensus       260 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (395)
                      ...   ......+|..|+|||++.+..++.++||||||+++|+|++ |+.||.+....+.... .....++..+..++++
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  245 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL-LEKGERLAQPQICTID  245 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHH-HHTTCBCCCCTTBCTT
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHH-HHcCCCCCCCCcCcHH
Confidence            432   2234567889999999998999999999999999999999 9999998776655443 4455566777889999


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 016082          336 LAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWL  372 (395)
Q Consensus       336 l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~~~~  372 (395)
                      +.++|.+||+.||.+||++.++++.|+++.++...++
T Consensus       246 ~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~~~~~  282 (325)
T 3kex_A          246 VYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYL  282 (325)
T ss_dssp             TTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSHHHHB
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhhh
Confidence            9999999999999999999999999999877655444

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.4e-47  Score=396.91  Aligned_cols=263  Identities=28%  Similarity=0.553  Sum_probs=226.4

Q ss_pred             ceeecccCcceee-eeeeeCceEEEEEEE----CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Q 016082          104 VWEIDAKQLKIEC-KVASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR  178 (395)
Q Consensus       104 ~~~i~~~~~~i~~-~lg~G~~G~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  178 (395)
                      .|.++...+.+.. +||+|+||.||+|.+    .++.||||+++....+....+++.+|+.+|++++||||+++++++..
T Consensus       362 ~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  441 (635)
T 4fl3_A          362 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA  441 (635)
T ss_dssp             SSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             cccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            3555666666644 899999999999966    34789999998766556667889999999999999999999999975


Q ss_pred             CCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccc
Q 016082          179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  258 (395)
Q Consensus       179 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~  258 (395)
                       +..++||||+++|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       442 -~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~  519 (635)
T 4fl3_A          442 -ESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL  519 (635)
T ss_dssp             -SSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHT
T ss_pred             -CCEEEEEEccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCcccc
Confidence             458999999999999999976 567999999999999999999999999999999999999999999999999999865


Q ss_pred             ccCC----ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCc
Q 016082          259 AQSG----VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAH  333 (395)
Q Consensus       259 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (395)
                      ....    ..+...+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+.... +....++..|..++
T Consensus       520 ~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~-i~~~~~~~~p~~~~  598 (635)
T 4fl3_A          520 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-LEKGERMGCPAGCP  598 (635)
T ss_dssp             TC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCCCCCCTTCC
T ss_pred             ccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCCCCC
Confidence            4332    2233456789999999999999999999999999999998 9999999988765554 44566778888999


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHH
Q 016082          334 PRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVL  369 (395)
Q Consensus       334 ~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~  369 (395)
                      +++.++|.+||+.||++||++.++++.|+++..++.
T Consensus       599 ~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l~  634 (635)
T 4fl3_A          599 REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV  634 (635)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhc
Confidence            999999999999999999999999999999988764

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.9e-47  Score=394.17  Aligned_cols=262  Identities=26%  Similarity=0.536  Sum_probs=225.3

Q ss_pred             ceeecccCcceee-eeeeeCceEEEEEEE----CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Q 016082          104 VWEIDAKQLKIEC-KVASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR  178 (395)
Q Consensus       104 ~~~i~~~~~~i~~-~lg~G~~G~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  178 (395)
                      .+.+..+++.+.+ +||+|+||.||+|.+    .+..||||+++... .....+.+.+|+.+|++++||||+++++++..
T Consensus       329 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~  407 (613)
T 2ozo_A          329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA  407 (613)
T ss_dssp             CSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES
T ss_pred             ceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc
Confidence            4556667777777 899999999999987    34579999998653 23345789999999999999999999999987


Q ss_pred             CCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccc
Q 016082          179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  258 (395)
Q Consensus       179 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~  258 (395)
                       +.+++||||+++|+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       408 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~  486 (613)
T 2ozo_A          408 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL  486 (613)
T ss_dssp             -SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred             -CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence             5699999999999999999877778999999999999999999999999999999999999999999999999999865


Q ss_pred             ccCCc----cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCc
Q 016082          259 AQSGV----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAH  333 (395)
Q Consensus       259 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (395)
                      .....    .....+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+.... +..+.++..|..++
T Consensus       487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~-i~~~~~~~~p~~~~  565 (613)
T 2ozo_A          487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-IEQGKRMECPPECP  565 (613)
T ss_dssp             C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHH-HHTTCCCCCCTTCC
T ss_pred             cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH-HHcCCCCCCCCcCC
Confidence            43221    122345689999999999999999999999999999998 9999999887765544 44566778888999


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHH
Q 016082          334 PRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  368 (395)
Q Consensus       334 ~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~  368 (395)
                      +++.++|.+||+.||.+||++.++++.|+++....
T Consensus       566 ~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~  600 (613)
T 2ozo_A          566 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  600 (613)
T ss_dssp             HHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence            99999999999999999999999999999987765

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=6.9e-48  Score=375.27  Aligned_cols=265  Identities=19%  Similarity=0.293  Sum_probs=213.3

Q ss_pred             ceeecccCcceeeeeeeeCceEEEEEEEC-------CceEEEEEecCCCCCHHH---------HHHHHHHHHHHHhcCCC
Q 016082          104 VWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEM---------LKEFSQEVYIMRKIRHK  167 (395)
Q Consensus       104 ~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~-------~~~vAvK~~~~~~~~~~~---------~~~~~~E~~~l~~l~h~  167 (395)
                      ..++..++|++.+.||+|+||.||+|.+.       ++.||||++.........         ...+.+|+..++.++||
T Consensus        29 i~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~  108 (364)
T 3op5_A           29 ITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYL  108 (364)
T ss_dssp             EECTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCC
T ss_pred             eeccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCC
Confidence            34466779999999999999999999873       368999999765311000         01234456667777899


Q ss_pred             ceeeEEEEEecC----CcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeC-
Q 016082          168 NVVQFIGACTRP----PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD-  242 (395)
Q Consensus       168 niv~l~~~~~~~----~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~-  242 (395)
                      ||+++++++...    ...|+||||+ |++|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++ 
T Consensus       109 ~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~  187 (364)
T 3op5_A          109 GVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY  187 (364)
T ss_dssp             CSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES
T ss_pred             CCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec
Confidence            999999998764    4589999999 9999999988778899999999999999999999999999999999999999 


Q ss_pred             -CCCcEEEeeeccccccccCCcc--------ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 016082          243 -ENGVVKVADFGVARVQAQSGVM--------TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL  313 (395)
Q Consensus       243 -~~~~vkl~DFg~a~~~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~  313 (395)
                       .++.+||+|||+++........        ....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence             8899999999999765433211        2335999999999999999999999999999999999999999864332


Q ss_pred             HHHHHhhhccCCCC---------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHH
Q 016082          314 QAAVGVVQKSLRPT---------IPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVL  369 (395)
Q Consensus       314 ~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~  369 (395)
                      ...........++.         .+..+++++.+++.+||+.+|.+||++.+|++.|++++++..
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~  332 (364)
T 3op5_A          268 PKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG  332 (364)
T ss_dssp             HHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence            22222111111111         125678999999999999999999999999999999998764

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=4.8e-47  Score=370.95  Aligned_cols=247  Identities=20%  Similarity=0.346  Sum_probs=213.9

Q ss_pred             Ccce--eeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          111 QLKI--ECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       111 ~~~i--~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      .|.+  .+.||+|+||.||+|++  +++.||+|+++...  ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus        88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  165 (373)
T 2x4f_A           88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVM  165 (373)
T ss_dssp             TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            3444  67899999999999987  57899999998653  345678999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee--CCCCcEEEeeeccccccccCCcc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM--DENGVVKVADFGVARVQAQSGVM  264 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl--~~~~~vkl~DFg~a~~~~~~~~~  264 (395)
                      ||+++|+|.+++......+++..++.++.||+.||.|||+.||+||||||+|||+  +.++.+||+|||+++........
T Consensus       166 E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~  245 (373)
T 2x4f_A          166 EYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL  245 (373)
T ss_dssp             ECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC
T ss_pred             eCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc
Confidence            9999999999998767789999999999999999999999999999999999999  56789999999999877665555


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCC--CCCCCcHHHHHHHHH
Q 016082          265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT--IPKHAHPRLAELLER  342 (395)
Q Consensus       265 ~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~  342 (395)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+........  ....+++++.++|.+
T Consensus       246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~  325 (373)
T 2x4f_A          246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISK  325 (373)
T ss_dssp             CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHT
T ss_pred             ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHH
Confidence            566799999999999999999999999999999999999999999888777766665443322  225689999999999


Q ss_pred             hhccCCCCCCCHHHHHH
Q 016082          343 CWQHDPTQRPNFSQITD  359 (395)
Q Consensus       343 cl~~dp~~RPs~~ell~  359 (395)
                      ||+.||.+|||+.|+++
T Consensus       326 ~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          326 LLIKEKSWRISASEALK  342 (373)
T ss_dssp             TSCSSGGGSCCHHHHHH
T ss_pred             HcCCChhhCCCHHHHhc
Confidence            99999999999999987

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3e-47  Score=362.25  Aligned_cols=255  Identities=35%  Similarity=0.673  Sum_probs=213.9

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  185 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  185 (395)
                      .++.++|++.+.||+|+||.||+|++.++.||||+++..    ...+.+.+|+.++++++||||+++++++.+  ..++|
T Consensus         4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv   77 (307)
T 2eva_A            4 MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLV   77 (307)
T ss_dssp             BCCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEE
T ss_pred             cCCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEE
Confidence            466789999999999999999999999999999999743    345789999999999999999999998874  47999


Q ss_pred             EecCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCCCCeeeCCCCc-EEEeeeccccccc
Q 016082          186 TEFMARGSIYDFLHKQKG--VFQLTSLLKVAIDVSKGMNYLHQ---NNIIHRDLKTANLLMDENGV-VKVADFGVARVQA  259 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~~~~--~l~~~~~~~i~~~i~~~l~~LH~---~~iiHrDlkp~NiLl~~~~~-vkl~DFg~a~~~~  259 (395)
                      |||++||+|.+++.....  .++...++.++.|+++||.|||+   +||+||||||+||+++.++. +||+|||+++...
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~  157 (307)
T 2eva_A           78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ  157 (307)
T ss_dssp             EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred             EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence            999999999999976432  47888999999999999999999   89999999999999998886 7999999997544


Q ss_pred             cCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHhhhccCCCCCCCCCcHHHHH
Q 016082          260 QSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ-AAVGVVQKSLRPTIPKHAHPRLAE  338 (395)
Q Consensus       260 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~  338 (395)
                      ..  .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ..........++..+..+++.+.+
T Consensus       158 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  235 (307)
T 2eva_A          158 TH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIES  235 (307)
T ss_dssp             ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHH
T ss_pred             cc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHH
Confidence            32  234578999999999999999999999999999999999999998653322 222233445567777889999999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHHHHHHHHH
Q 016082          339 LLERCWQHDPTQRPNFSQITDILKQMMKEV  368 (395)
Q Consensus       339 li~~cl~~dp~~RPs~~ell~~l~~~~~~~  368 (395)
                      +|.+||+.||.+|||+.++++.|+++.+..
T Consensus       236 li~~~l~~dp~~Rps~~ell~~L~~~~~~~  265 (307)
T 2eva_A          236 LMTRCWSKDPSQRPSMEEIVKIMTHLMRYF  265 (307)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred             HHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence            999999999999999999999999886544

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3e-47  Score=357.88  Aligned_cols=254  Identities=26%  Similarity=0.436  Sum_probs=204.4

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  182 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  182 (395)
                      +++..++|++.+.||+|+||.||+|++  +++.||+|+++.........+.+.++...++.++||||+++++++..++..
T Consensus         2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~   81 (290)
T 3fme_A            2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV   81 (290)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred             CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence            467788999999999999999999998  688999999987654444555566666678888999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCeeeCCCCcEEEeeecccccc
Q 016082          183 CIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQ  258 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~-~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~  258 (395)
                      ++||||++| +|.+++..   ....+++..++.++.|++.||.|||++ ||+||||||+||+++.++.+||+|||+++..
T Consensus        82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999999985 88887754   356899999999999999999999998 9999999999999999999999999999876


Q ss_pred             ccCCccccCCCCccccccccc----CCCCCCChhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHhhhccCCCCCCCCCc
Q 016082          259 AQSGVMTAETGTYRWMAPEVI----EHKPYDYKADVFSFGIALWELLTGELPYAG-LTPLQAAVGVVQKSLRPTIPKHAH  333 (395)
Q Consensus       259 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~k~DvwslG~vl~elltg~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~  333 (395)
                      ..........||+.|+|||++    .+..++.++||||||+++|+|++|+.||.. ..+................+..++
T Consensus       161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (290)
T 3fme_A          161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFS  240 (290)
T ss_dssp             ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSC
T ss_pred             cccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCC
Confidence            655555556899999999996    566789999999999999999999999987 344444444444444444456789


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          334 PRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       334 ~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      +++.++|.+||+.||.+|||+.++++
T Consensus       241 ~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          241 AEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            99999999999999999999999987

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2e-47  Score=366.79  Aligned_cols=257  Identities=20%  Similarity=0.327  Sum_probs=216.5

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcEE
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  183 (395)
                      +..++|++.+.||+|+||.||+|++  +++.||||++......    ..+.+|+.+++++ +||||+++++++......+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~   81 (330)
T 2izr_A            6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA   81 (330)
T ss_dssp             EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred             EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence            3356899999999999999999996  6889999999754322    3578899999999 8999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCc-----EEEeeecccccc
Q 016082          184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV-----VKVADFGVARVQ  258 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~-----vkl~DFg~a~~~  258 (395)
                      +||||+ +++|.+++....+.+++..++.++.|++.||+|||++||+||||||+|||++.++.     +||+|||+++..
T Consensus        82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            999999 89999999877778999999999999999999999999999999999999998887     999999999865


Q ss_pred             ccCCc--------cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHhhhccCCCC
Q 016082          259 AQSGV--------MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP---LQAAVGVVQKSLRPT  327 (395)
Q Consensus       259 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~---~~~~~~~~~~~~~~~  327 (395)
                      .....        .....||+.|+|||++.+..++.++||||||+++|||++|+.||.+.+.   .+....+........
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~  240 (330)
T 2izr_A          161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP  240 (330)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred             ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence            43321        2355799999999999999999999999999999999999999987533   222222221111111


Q ss_pred             ---CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHH
Q 016082          328 ---IPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVL  369 (395)
Q Consensus       328 ---~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~  369 (395)
                         ....++ ++.+++.+||+.||.+||++.+|.+.|+++.+...
T Consensus       241 ~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~  284 (330)
T 2izr_A          241 IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG  284 (330)
T ss_dssp             HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence               112344 99999999999999999999999999999988753

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=4.9e-47  Score=367.50  Aligned_cols=246  Identities=32%  Similarity=0.494  Sum_probs=218.3

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      +.|++.+.||+|+||.||+|++  +++.||||+++.... .....+.+.+|+.++++++||||+++++++......++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4699999999999999999996  678999999976543 3445578999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCcccc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA  266 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~  266 (395)
                      ||+. |+|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....   ..
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---~~  209 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NS  209 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---CC
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---Cc
Confidence            9997 5899988776788999999999999999999999999999999999999999999999999999765432   34


Q ss_pred             CCCCcccccccccC---CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHh
Q 016082          267 ETGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC  343 (395)
Q Consensus       267 ~~gt~~y~aPE~~~---~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  343 (395)
                      ..||+.|+|||++.   +..++.++|||||||++|||++|+.||.+.+.......+.........+..+++.+.++|.+|
T Consensus       210 ~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  289 (348)
T 1u5q_A          210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC  289 (348)
T ss_dssp             CCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHH
T ss_pred             ccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence            57999999999984   567899999999999999999999999998887776666655555555677899999999999


Q ss_pred             hccCCCCCCCHHHHHH
Q 016082          344 WQHDPTQRPNFSQITD  359 (395)
Q Consensus       344 l~~dp~~RPs~~ell~  359 (395)
                      |+.||.+|||+.++++
T Consensus       290 l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          290 LQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             TCSSGGGSCCHHHHTT
T ss_pred             cccChhhCcCHHHHhh
Confidence            9999999999999875

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.1e-47  Score=366.90  Aligned_cols=252  Identities=22%  Similarity=0.389  Sum_probs=215.0

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC--CceeeEEEEEecCCc
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH--KNVVQFIGACTRPPN  181 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~  181 (395)
                      ..+..++|++.+.||+|+||.||++.+ .++.||||+++.........+.+.+|+.++++++|  |||+++++++.....
T Consensus         4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~   83 (343)
T 3dbq_A            4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY   83 (343)
T ss_dssp             EESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             eeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence            456778999999999999999999987 56789999998777677778899999999999987  999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC
Q 016082          182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  261 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~  261 (395)
                      .++||| +.+++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.....
T Consensus        84 ~~lv~e-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~  160 (343)
T 3dbq_A           84 IYMVME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  160 (343)
T ss_dssp             EEEEEC-CCSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred             EEEEEe-CCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence            999999 557799999987 56799999999999999999999999999999999999997 678999999999865433


Q ss_pred             C---ccccCCCCcccccccccCC-----------CCCCChhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHhhhccCCC
Q 016082          262 G---VMTAETGTYRWMAPEVIEH-----------KPYDYKADVFSFGIALWELLTGELPYAGLTP-LQAAVGVVQKSLRP  326 (395)
Q Consensus       262 ~---~~~~~~gt~~y~aPE~~~~-----------~~~~~k~DvwslG~vl~elltg~~pf~~~~~-~~~~~~~~~~~~~~  326 (395)
                      .   ......||+.|+|||++.+           ..++.++|||||||++|+|++|+.||..... ..............
T Consensus       161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  240 (343)
T 3dbq_A          161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI  240 (343)
T ss_dssp             ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred             cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCccc
Confidence            2   2234579999999999864           6789999999999999999999999987543 34444445555566


Q ss_pred             CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          327 TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       327 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      ..|...++++.++|.+||+.||.+|||+.++++
T Consensus       241 ~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          241 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence            777888899999999999999999999999986

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.4e-48  Score=374.84  Aligned_cols=247  Identities=28%  Similarity=0.482  Sum_probs=213.5

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  185 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  185 (395)
                      .++|++.+.||+|+||.||+|++  +++.||||+++..... .+....+.+|+.+++.++||||+++++++..+...++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            46899999999999999999998  6789999998643211 11235688999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCccc
Q 016082          186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT  265 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~  265 (395)
                      |||+ +|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus        88 ~E~~-~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~  165 (336)
T 3h4j_B           88 IEYA-GGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK  165 (336)
T ss_dssp             ECCC-CEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTC
T ss_pred             EECC-CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcccc
Confidence            9999 6799999876 4679999999999999999999999999999999999999999999999999998776665566


Q ss_pred             cCCCCcccccccccCCCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhh
Q 016082          266 AETGTYRWMAPEVIEHKPY-DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW  344 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~~~~~-~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  344 (395)
                      ...||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.+.........+  .......|..+++++.++|++||
T Consensus       166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--~~~~~~~p~~~s~~~~~li~~~L  243 (336)
T 3h4j_B          166 TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSPGAQSLIRRMI  243 (336)
T ss_dssp             CCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--CSSCCCCCTTSCHHHHHHHHTTS
T ss_pred             cccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--HcCCCCCcccCCHHHHHHHHHHc
Confidence            7789999999999998876 78999999999999999999999875433222111  12234567788999999999999


Q ss_pred             ccCCCCCCCHHHHHH
Q 016082          345 QHDPTQRPNFSQITD  359 (395)
Q Consensus       345 ~~dp~~RPs~~ell~  359 (395)
                      +.||.+|||+.|+++
T Consensus       244 ~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          244 VADPMQRITIQEIRR  258 (336)
T ss_dssp             CSSGGGSCCHHHHTT
T ss_pred             CCChhHCcCHHHHHh
Confidence            999999999999987

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7e-47  Score=356.74  Aligned_cols=257  Identities=30%  Similarity=0.572  Sum_probs=221.5

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CC---ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE-EE
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CS---QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL-CI  184 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~l  184 (395)
                      .|++.+.||+|+||.||+|++  .+   ..||+|+++... .....+.+.+|+.++++++||||+++++++...+.. ++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  100 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV  100 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence            566789999999999999986  22   269999997643 455668899999999999999999999999876655 99


Q ss_pred             EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC--
Q 016082          185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--  262 (395)
Q Consensus       185 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~--  262 (395)
                      ||||+.+|+|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++......  
T Consensus       101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  180 (298)
T 3pls_A          101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY  180 (298)
T ss_dssp             EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred             EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence            999999999999998877789999999999999999999999999999999999999999999999999997543321  


Q ss_pred             ---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHH
Q 016082          263 ---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE  338 (395)
Q Consensus       263 ---~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  338 (395)
                         ......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||...+..+.... ......+..+..+++++.+
T Consensus       181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~  259 (298)
T 3pls_A          181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF-LAQGRRLPQPEYCPDSLYQ  259 (298)
T ss_dssp             CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHH-HHTTCCCCCCTTCCHHHHH
T ss_pred             ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHH-hhcCCCCCCCccchHHHHH
Confidence               2234567899999999999999999999999999999999 5566666666554433 4445566778889999999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHHHHHHHHHH
Q 016082          339 LLERCWQHDPTQRPNFSQITDILKQMMKEVL  369 (395)
Q Consensus       339 li~~cl~~dp~~RPs~~ell~~l~~~~~~~~  369 (395)
                      ++.+||+.||.+|||+.++++.|+++++++.
T Consensus       260 li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          260 VMQQCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence            9999999999999999999999999988754

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.7e-47  Score=391.09  Aligned_cols=259  Identities=36%  Similarity=0.683  Sum_probs=228.7

Q ss_pred             CCceeecccCcceeeeeeeeCceEEEEEEECC-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 016082          102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  180 (395)
Q Consensus       102 ~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (395)
                      .+.|++..++|++.++||+|+||.||+|++.+ ..||||+++.....   .+.|.+|+.+|++++||||+++++++.+ .
T Consensus       259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~  334 (535)
T 2h8h_A          259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E  334 (535)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence            45799999999999999999999999999964 67999999876543   3678999999999999999999999977 6


Q ss_pred             cEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  259 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~  259 (395)
                      ..|+||||+++|+|.++++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE  414 (535)
T ss_dssp             SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred             cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence            789999999999999999764 3568999999999999999999999999999999999999999999999999998654


Q ss_pred             cCC--ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHH
Q 016082          260 QSG--VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  336 (395)
Q Consensus       260 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  336 (395)
                      ...  ......++..|+|||++.+..++.++||||||+++|||++ |+.||.+....+.... +....+...+..+++++
T Consensus       415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~-i~~~~~~~~~~~~~~~l  493 (535)
T 2h8h_A          415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECPESL  493 (535)
T ss_dssp             CHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHH-HHTTCCCCCCTTCCHHH
T ss_pred             CCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCCCCCHHH
Confidence            321  1223456789999999998899999999999999999999 9999999888776555 44566777888999999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 016082          337 AELLERCWQHDPTQRPNFSQITDILKQMM  365 (395)
Q Consensus       337 ~~li~~cl~~dp~~RPs~~ell~~l~~~~  365 (395)
                      .++|.+||+.||++|||+.+|++.|+++.
T Consensus       494 ~~li~~cl~~dP~~RPt~~~l~~~L~~~~  522 (535)
T 2h8h_A          494 HDLMCQCWRKEPEERPTFEYLQAFLEDYF  522 (535)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             HHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            99999999999999999999999887654

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.3e-47  Score=360.55  Aligned_cols=251  Identities=29%  Similarity=0.591  Sum_probs=207.5

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHh--cCCCceeeEEEEEec----CC
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK--IRHKNVVQFIGACTR----PP  180 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~----~~  180 (395)
                      +-.++|++.+.||+|+||.||+|+++++.||||+++..     ....+..|.+++..  ++||||+++++++..    ..
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~   79 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST   79 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence            34578999999999999999999999999999999743     23556677777777  789999999998644    34


Q ss_pred             cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--------HCCccccCCCCCCeeeCCCCcEEEeee
Q 016082          181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH--------QNNIIHRDLKTANLLMDENGVVKVADF  252 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~iiHrDlkp~NiLl~~~~~vkl~DF  252 (395)
                      ..++||||+++|+|.++++.  ..+++..++.++.|++.||.|||        +.||+||||||+|||++.++.+||+||
T Consensus        80 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  157 (301)
T 3q4u_A           80 QLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL  157 (301)
T ss_dssp             EEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             eeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence            58999999999999999954  56899999999999999999999        999999999999999999999999999


Q ss_pred             ccccccccCCc-----cccCCCCcccccccccCCC------CCCChhhHHHHHHHHHHHHhC----------CCCCCCCC
Q 016082          253 GVARVQAQSGV-----MTAETGTYRWMAPEVIEHK------PYDYKADVFSFGIALWELLTG----------ELPYAGLT  311 (395)
Q Consensus       253 g~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~------~~~~k~DvwslG~vl~elltg----------~~pf~~~~  311 (395)
                      |+++.......     .....||+.|+|||++.+.      .++.++||||||+++|||++|          +.||....
T Consensus       158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~  237 (301)
T 3q4u_A          158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV  237 (301)
T ss_dssp             TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence            99976544322     2234799999999999876      455799999999999999999          88886532


Q ss_pred             H-----HHHHHHhhhccCCCCCCC-----CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 016082          312 P-----LQAAVGVVQKSLRPTIPK-----HAHPRLAELLERCWQHDPTQRPNFSQITDILKQM  364 (395)
Q Consensus       312 ~-----~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~  364 (395)
                      +     ............++..+.     ..++++.++|.+||+.||.+|||+.++++.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            2     222222233344444443     2567899999999999999999999999999875

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=6.9e-48  Score=362.29  Aligned_cols=254  Identities=26%  Similarity=0.480  Sum_probs=217.1

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEEC--C-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEE
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTYC--S-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA  175 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~~--~-------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  175 (395)
                      .++..++|++.+.||+|+||.||+|++.  +       ..||+|+++...  ....+.+.+|+.++++++||||++++++
T Consensus         3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~   80 (289)
T 4fvq_A            3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGV   80 (289)
T ss_dssp             CBCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred             EEechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence            3567789999999999999999999874  2       469999997542  3445789999999999999999999999


Q ss_pred             EecCCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCc--------E
Q 016082          176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV--------V  247 (395)
Q Consensus       176 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~--------v  247 (395)
                      +..++..++||||++||+|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.        +
T Consensus        81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence            99999999999999999999999887666999999999999999999999999999999999999998887        9


Q ss_pred             EEeeeccccccccCCccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCC
Q 016082          248 KVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLR  325 (395)
Q Consensus       248 kl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~  325 (395)
                      ||+|||.++.....   ....||+.|+|||++.+ ..++.++||||||+++|+|++ +.+||........... .  ..+
T Consensus       161 kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~-~--~~~  234 (289)
T 4fvq_A          161 KLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF-Y--EDR  234 (289)
T ss_dssp             EECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-H--HTT
T ss_pred             eeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH-h--hcc
Confidence            99999999754332   22357889999999987 779999999999999999999 5666666665443332 2  224


Q ss_pred             CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 016082          326 PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK  366 (395)
Q Consensus       326 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~  366 (395)
                      +..+...++++.++|.+||+.||.+|||+.++++.|++++.
T Consensus       235 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          235 HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            55667778899999999999999999999999999887654

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.2e-47  Score=366.65  Aligned_cols=263  Identities=28%  Similarity=0.579  Sum_probs=221.3

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEE--CCce----EEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQE----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP  179 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~----vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  179 (395)
                      .+..++|++.+.||+|+||.||+|++  .++.    ||+|.++... .....+.+.+|+.++++++||||+++++++...
T Consensus        11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   89 (327)
T 3lzb_A           11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred             ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence            45677999999999999999999997  3443    5778776443 233457889999999999999999999999876


Q ss_pred             CcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccc
Q 016082          180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  259 (395)
Q Consensus       180 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~  259 (395)
                      . .++|+|++.+|+|.+++....+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus        90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            5 889999999999999998878889999999999999999999999999999999999999999999999999998654


Q ss_pred             cCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHH
Q 016082          260 QSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR  335 (395)
Q Consensus       260 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (395)
                      ...   ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+....+... ......++..+..++++
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  247 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLPQPPICTID  247 (327)
T ss_dssp             -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-HHHTTCCCCCCTTBCHH
T ss_pred             CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH-HHHcCCCCCCCccCCHH
Confidence            332   2233456889999999999999999999999999999999 999999887766544 34455667778889999


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHh
Q 016082          336 LAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYW  371 (395)
Q Consensus       336 l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~~~  371 (395)
                      +.++|.+||+.||.+||++.++++.|+.+.++-..+
T Consensus       248 l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~  283 (327)
T 3lzb_A          248 VYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRY  283 (327)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHHHH
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcCce
Confidence            999999999999999999999999999998654433

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.1e-47  Score=364.87  Aligned_cols=263  Identities=27%  Similarity=0.531  Sum_probs=224.7

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEE------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR  178 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  178 (395)
                      ..+..++|++.+.||+|+||.||+|++      .++.||||+++..  .....+.+.+|+.++++++||||+++++++..
T Consensus        36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  113 (326)
T 2w1i_A           36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS  113 (326)
T ss_dssp             -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred             cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Confidence            355677899999999999999999985      5788999999865  34566789999999999999999999999866


Q ss_pred             CC--cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccc
Q 016082          179 PP--NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR  256 (395)
Q Consensus       179 ~~--~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~  256 (395)
                      ..  ..++||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++
T Consensus       114 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          114 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             cCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence            54  7899999999999999998877789999999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCc----cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH---------------HHHH
Q 016082          257 VQAQSGV----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL---------------QAAV  317 (395)
Q Consensus       257 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~---------------~~~~  317 (395)
                      .......    .....++..|+|||.+.+..++.++||||||+++|+|++|..||......               ....
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  273 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence            7654322    22345778899999999888999999999999999999999998643111               1112


Q ss_pred             HhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHH
Q 016082          318 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVL  369 (395)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~  369 (395)
                      ..+....++..+..+++++.++|.+||+.||.+|||+.++++.|+++.+++.
T Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~  325 (326)
T 2w1i_A          274 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA  325 (326)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence            2334445666778899999999999999999999999999999999988764

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.8e-47  Score=380.91  Aligned_cols=255  Identities=20%  Similarity=0.344  Sum_probs=219.6

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  181 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  181 (395)
                      ..+..++|++.++||+|+||.||+|++  +++.||+|+++.... .......+.+|+.++..++||||++++++|.+...
T Consensus        69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~  148 (437)
T 4aw2_A           69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN  148 (437)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred             ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence            456678999999999999999999998  468899999964211 01112338899999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC
Q 016082          182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  261 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~  261 (395)
                      +|+||||++||+|.+++....+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus       149 ~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~  228 (437)
T 4aw2_A          149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  228 (437)
T ss_dssp             EEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence            99999999999999999886788999999999999999999999999999999999999999999999999999765443


Q ss_pred             Cc--cccCCCCcccccccccC-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCC---CC
Q 016082          262 GV--MTAETGTYRWMAPEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP---KH  331 (395)
Q Consensus       262 ~~--~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~---~~  331 (395)
                      ..  .....||+.|+|||++.     +..|+.++|||||||++|||++|+.||.+.+..+....+.....+...|   ..
T Consensus       229 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  308 (437)
T 4aw2_A          229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTD  308 (437)
T ss_dssp             SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCC
T ss_pred             CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCccccc
Confidence            32  23458999999999986     5678999999999999999999999999998888777766543333333   45


Q ss_pred             CcHHHHHHHHHhhccCCCC--CCCHHHHHH
Q 016082          332 AHPRLAELLERCWQHDPTQ--RPNFSQITD  359 (395)
Q Consensus       332 ~~~~l~~li~~cl~~dp~~--RPs~~ell~  359 (395)
                      +++++.++|++||..+|++  ||+++|+++
T Consensus       309 ~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          309 VSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             SCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             CCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            8999999999999888888  999999987

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.5e-47  Score=371.36  Aligned_cols=250  Identities=24%  Similarity=0.392  Sum_probs=210.6

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC---CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV---NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  183 (395)
                      .+.|++.+.||+|+||.||+|++  +++.||||+++....   .....+.+.+|+.++++++||||+++++++...+.+|
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            45899999999999999999987  578999999863211   1112467899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCc---EEEeeeccccc
Q 016082          184 IVTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV---VKVADFGVARV  257 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~---vkl~DFg~a~~  257 (395)
                      +||||++||+|.+++...   ...+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++.
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~  182 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ  182 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence            999999999999888653   235899999999999999999999999999999999999987654   99999999987


Q ss_pred             cccCCc-cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCC--CCCCCcH
Q 016082          258 QAQSGV-MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT--IPKHAHP  334 (395)
Q Consensus       258 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~  334 (395)
                      ...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.. .+....+........  ....+++
T Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~s~  261 (351)
T 3c0i_A          183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISE  261 (351)
T ss_dssp             CCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred             ecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccCCH
Confidence            655432 345679999999999999999999999999999999999999998853 333333333322211  1246789


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          335 RLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       335 ~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      ++.++|.+||+.||.+|||+.++++
T Consensus       262 ~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          262 SAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhc
Confidence            9999999999999999999999986

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=6e-47  Score=361.80  Aligned_cols=260  Identities=28%  Similarity=0.552  Sum_probs=222.7

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP-  179 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-  179 (395)
                      ++.+.|++.++||+|+||.||++.+      +++.||||+++... .....+.+.+|+.++++++||||+++++++.+. 
T Consensus        28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (318)
T 3lxp_A           28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG  106 (318)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence            4444559999999999999999875      56889999998663 455677899999999999999999999999874 


Q ss_pred             -CcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccc
Q 016082          180 -PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  258 (395)
Q Consensus       180 -~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~  258 (395)
                       ..+++||||+++|+|.+++...  .+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++..
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          107 AASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             TTEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             CceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence             5689999999999999999753  4899999999999999999999999999999999999999999999999999876


Q ss_pred             ccCC----ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH--------------HHHHHhh
Q 016082          259 AQSG----VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL--------------QAAVGVV  320 (395)
Q Consensus       259 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~--------------~~~~~~~  320 (395)
                      ....    ......+|..|+|||++.+..++.++||||||+++|+|++|..||......              .......
T Consensus       185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (318)
T 3lxp_A          185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL  264 (318)
T ss_dssp             CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred             cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence            5432    123446788999999999989999999999999999999999999754221              1122334


Q ss_pred             hccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHH
Q 016082          321 QKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVL  369 (395)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~  369 (395)
                      ....++..+..+++++.++|.+||+.||.+|||+.++++.|+.+.++..
T Consensus       265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  313 (318)
T 3lxp_A          265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ  313 (318)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence            4556677788899999999999999999999999999999999988765

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.7e-47  Score=366.80  Aligned_cols=256  Identities=24%  Similarity=0.404  Sum_probs=213.5

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      ++|++.+.||+|+||.||+|++  +++.||||++..... ....+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            5899999999999999999988  578999999975532 2334678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC---Ccc
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS---GVM  264 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~---~~~  264 (395)
                      |++||+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.....   ...
T Consensus        86 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  164 (323)
T 3tki_A           86 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  164 (323)
T ss_dssp             CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             cCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence            9999999999865 457999999999999999999999999999999999999999999999999999765432   223


Q ss_pred             ccCCCCcccccccccCCCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHhhhccCCCCCCCCCcHHHHHHHHH
Q 016082          265 TAETGTYRWMAPEVIEHKPY-DYKADVFSFGIALWELLTGELPYAGLTPLQAA-VGVVQKSLRPTIPKHAHPRLAELLER  342 (395)
Q Consensus       265 ~~~~gt~~y~aPE~~~~~~~-~~k~DvwslG~vl~elltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~  342 (395)
                      ....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......... ...............+++++.++|.+
T Consensus       165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  244 (323)
T 3tki_A          165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK  244 (323)
T ss_dssp             CSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHH
T ss_pred             CCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHH
Confidence            45679999999999987765 78999999999999999999999876553222 22222222223335688999999999


Q ss_pred             hhccCCCCCCCHHHHHHHHHHHHHHHHHhhcccc
Q 016082          343 CWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNL  376 (395)
Q Consensus       343 cl~~dp~~RPs~~ell~~l~~~~~~~~~~~~~~~  376 (395)
                      ||+.||.+|||+.|+++         +-|+...+
T Consensus       245 ~L~~dP~~R~t~~eil~---------h~~~~~~~  269 (323)
T 3tki_A          245 ILVENPSARITIPDIKK---------DRWYNKPL  269 (323)
T ss_dssp             HSCSSTTTSCCHHHHTT---------CTTTTCCC
T ss_pred             HccCChhhCcCHHHHhh---------Chhhcccc
Confidence            99999999999999987         66765543

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=9.1e-47  Score=371.11  Aligned_cols=253  Identities=21%  Similarity=0.383  Sum_probs=215.5

Q ss_pred             ceeecccCcceeeeeeeeCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC--CCceeeEEEEEecCC
Q 016082          104 VWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR--HKNVVQFIGACTRPP  180 (395)
Q Consensus       104 ~~~i~~~~~~i~~~lg~G~~G~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~  180 (395)
                      ...+....|++.+.||+|+||.||+|.+ .++.||||+++....+....+.+.+|+.+|++++  ||||+++++++....
T Consensus        50 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~  129 (390)
T 2zmd_A           50 CISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ  129 (390)
T ss_dssp             CEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             cccccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence            3456677899999999999999999987 4788999999877667777889999999999997  599999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                      .+|+||| +.+++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....
T Consensus       130 ~~~lv~E-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          130 YIYMVME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             EEEEEEE-CCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             EEEEEEe-cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            9999999 567899999987 45789999999999999999999999999999999999995 58999999999986543


Q ss_pred             CC---ccccCCCCcccccccccCC-----------CCCCChhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHhhhccCC
Q 016082          261 SG---VMTAETGTYRWMAPEVIEH-----------KPYDYKADVFSFGIALWELLTGELPYAGLTP-LQAAVGVVQKSLR  325 (395)
Q Consensus       261 ~~---~~~~~~gt~~y~aPE~~~~-----------~~~~~k~DvwslG~vl~elltg~~pf~~~~~-~~~~~~~~~~~~~  325 (395)
                      ..   ......||+.|+|||++.+           ..++.++|||||||++|+|++|+.||..... ......+......
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~  286 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE  286 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSC
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcccc
Confidence            32   2345579999999999865           4689999999999999999999999987643 3444455555555


Q ss_pred             CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          326 PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       326 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      ...|...++++.++|.+||+.||.+|||+.|+++
T Consensus       287 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          287 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence            6677778899999999999999999999999985

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=6e-47  Score=366.93  Aligned_cols=248  Identities=23%  Similarity=0.378  Sum_probs=197.7

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  184 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  184 (395)
                      .-.+.|++.+.||+|+||.||+|++.  ++.||||+++...    ..+.+.+|+.++++++||||+++++++......++
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  125 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL  125 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence            33567999999999999999999984  6789999998542    23568899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCC---CCcEEEeeeccccccccC
Q 016082          185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NGVVKVADFGVARVQAQS  261 (395)
Q Consensus       185 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~---~~~vkl~DFg~a~~~~~~  261 (395)
                      ||||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||+++.   ++.+||+|||+++.....
T Consensus       126 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  204 (349)
T 2w4o_A          126 VLELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ  204 (349)
T ss_dssp             EECCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred             EEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence            9999999999999976 567999999999999999999999999999999999999975   889999999999876655


Q ss_pred             CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHhhhccCC--CCCCCCCcHHHHH
Q 016082          262 GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQA-AVGVVQKSLR--PTIPKHAHPRLAE  338 (395)
Q Consensus       262 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~l~~  338 (395)
                      .......||+.|+|||++.+..++.++|||||||++|+|++|..||......+. ...+......  ......++.++.+
T Consensus       205 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  284 (349)
T 2w4o_A          205 VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKD  284 (349)
T ss_dssp             --------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHH
T ss_pred             cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHH
Confidence            445566899999999999999999999999999999999999999987665443 3333332222  2223568999999


Q ss_pred             HHHHhhccCCCCCCCHHHHHH
Q 016082          339 LLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       339 li~~cl~~dp~~RPs~~ell~  359 (395)
                      +|.+||+.||.+|||+.++++
T Consensus       285 li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          285 LVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCChhhCcCHHHHhc
Confidence            999999999999999999987

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.4e-48  Score=370.58  Aligned_cols=268  Identities=30%  Similarity=0.573  Sum_probs=222.9

Q ss_pred             CCceeecccCcceeeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Q 016082          102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  181 (395)
Q Consensus       102 ~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  181 (395)
                      ...|++..++|++.+.||+|+||.||+|++.+ .||+|+++....+....+.+.+|+.++++++||||+++++++...+.
T Consensus        25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (319)
T 2y4i_B           25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH  103 (319)
T ss_dssp             GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred             cccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence            35788999999999999999999999999865 59999998665444445668889999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC
Q 016082          182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  261 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~  261 (395)
                      .++||||++|++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++ ++.++|+|||+++.....
T Consensus       104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~  182 (319)
T 2y4i_B          104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL  182 (319)
T ss_dssp             EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred             eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence            9999999999999999987666899999999999999999999999999999999999998 689999999998754321


Q ss_pred             ------CccccCCCCcccccccccCC---------CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCC
Q 016082          262 ------GVMTAETGTYRWMAPEVIEH---------KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP  326 (395)
Q Consensus       262 ------~~~~~~~gt~~y~aPE~~~~---------~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~  326 (395)
                            .......||+.|+|||++.+         ..++.++||||||+++|+|++|+.||...........+.......
T Consensus       183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  262 (319)
T 2y4i_B          183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN  262 (319)
T ss_dssp             -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC
T ss_pred             cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC
Confidence                  12234468999999999874         457899999999999999999999999988777665544433333


Q ss_pred             CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHh
Q 016082          327 TIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYW  371 (395)
Q Consensus       327 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~~~  371 (395)
                      ..+..+++++.+++.+||+.||.+|||+.++++.|+++.+.....
T Consensus       263 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~  307 (319)
T 2y4i_B          263 LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRL  307 (319)
T ss_dssp             CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-------
T ss_pred             CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccC
Confidence            334468899999999999999999999999999999988775544

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.5e-47  Score=360.03  Aligned_cols=261  Identities=32%  Similarity=0.639  Sum_probs=219.7

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEEC---C--ceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTYC---S--QEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR  178 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~~---~--~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  178 (395)
                      ..+..++|++.+.||+|+||.||+|++.   +  ..||||+++.... +....+.+.+|+.++++++||||+++++++..
T Consensus        13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   92 (291)
T 1u46_A           13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT   92 (291)
T ss_dssp             EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence            4667789999999999999999999862   2  2589999986543 34566789999999999999999999999987


Q ss_pred             CCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccc
Q 016082          179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  258 (395)
Q Consensus       179 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~  258 (395)
                      +. .++||||+++++|.+++....+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus        93 ~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           93 PP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             SS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence            65 89999999999999999887778999999999999999999999999999999999999999999999999999865


Q ss_pred             ccCCc----cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCc
Q 016082          259 AQSGV----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAH  333 (395)
Q Consensus       259 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (395)
                      .....    .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..+....+.....++..+..++
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP  251 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred             cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcC
Confidence            44321    223457889999999998889999999999999999999 9999999988887777766666777788899


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 016082          334 PRLAELLERCWQHDPTQRPNFSQITDILKQMMK  366 (395)
Q Consensus       334 ~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~  366 (395)
                      +++.++|.+||+.||.+|||+.++++.|+++..
T Consensus       252 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          252 QDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence            999999999999999999999999999987754

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.7e-46  Score=355.33  Aligned_cols=266  Identities=24%  Similarity=0.449  Sum_probs=212.6

Q ss_pred             cccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Q 016082          108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  184 (395)
Q Consensus       108 ~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  184 (395)
                      ..++|++.+.||+|+||.||+|++  +++.||||+++... .+......+.+|+.++++++||||+++++++...+..++
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            346899999999999999999997  57899999998643 345667889999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC
Q 016082          185 VTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  261 (395)
Q Consensus       185 V~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~  261 (395)
                      ||||+++++|.+++..   ....+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||+++.....
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~  189 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  189 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence            9999999999999865   3466899999999999999999999999999999999999999999999999999765443


Q ss_pred             C-ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHhhhccCCCCCCCCCcHHHHH
Q 016082          262 G-VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT--PLQAAVGVVQKSLRPTIPKHAHPRLAE  338 (395)
Q Consensus       262 ~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~  338 (395)
                      . ......|++.|+|||++.+..++.++||||||+++|+|++|+.||.+..  .......+......+..+..+++++.+
T Consensus       190 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  269 (310)
T 2wqm_A          190 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ  269 (310)
T ss_dssp             ---------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHH
T ss_pred             CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHH
Confidence            2 2234578999999999999999999999999999999999999997642  223333333333333344678999999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc
Q 016082          339 LLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLS  373 (395)
Q Consensus       339 li~~cl~~dp~~RPs~~ell~~l~~~~~~~~~~~~  373 (395)
                      +|.+||+.||.+|||+.++++.|+++......=++
T Consensus       270 li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~  304 (310)
T 2wqm_A          270 LVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE  304 (310)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC----
T ss_pred             HHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhh
Confidence            99999999999999999999999999887655444

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=6.3e-47  Score=362.01  Aligned_cols=250  Identities=23%  Similarity=0.391  Sum_probs=218.9

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCH----HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT----EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  182 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  182 (395)
                      .++|++.+.||+|+||.||+|++  +++.||+|+++......    ...+.+.+|+.++++++||||+++++++......
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            45799999999999999999998  47899999997554321    1356789999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCC----cEEEeeecccccc
Q 016082          183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG----VVKVADFGVARVQ  258 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~----~vkl~DFg~a~~~  258 (395)
                      ++||||+++++|.+++.. .+.+++..++.++.|++.||.|||+.||+||||||+||+++.++    .++|+|||+++..
T Consensus        91 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~  169 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI  169 (321)
T ss_dssp             EEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred             EEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence            999999999999999976 56789999999999999999999999999999999999999888    7999999999876


Q ss_pred             ccCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC--CCCCCCCcHHH
Q 016082          259 AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRL  336 (395)
Q Consensus       259 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l  336 (395)
                      ..........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+......  +..+...++.+
T Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  249 (321)
T 2a2a_A          170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELA  249 (321)
T ss_dssp             CTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHH
T ss_pred             CccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHH
Confidence            6555555667999999999999999999999999999999999999999998877666554433221  11225688999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHH
Q 016082          337 AELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       337 ~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      .++|.+||+.||.+|||+.++++
T Consensus       250 ~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          250 KDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHhc
Confidence            99999999999999999999987

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=5.5e-47  Score=357.95  Aligned_cols=258  Identities=29%  Similarity=0.547  Sum_probs=220.6

Q ss_pred             ccCcceeeeeeeeCceEEEEEEECC-----ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEe-cCCcE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT-RPPNL  182 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~  182 (395)
                      ..+|++.+.||+|+||.||+|++..     ..+|+|.++... .....+.+.+|+.++++++||||+++++++. ..+..
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  102 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence            3478999999999999999998632     358999997643 4556678999999999999999999999864 45678


Q ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC
Q 016082          183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~  262 (395)
                      ++||||+++|+|.+++......++...++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus       103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~  182 (298)
T 3f66_A          103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  182 (298)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred             EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccc
Confidence            99999999999999998777789999999999999999999999999999999999999999999999999997654322


Q ss_pred             -----ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHH
Q 016082          263 -----VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  336 (395)
Q Consensus       263 -----~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  336 (395)
                           ......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||.+....+...... ...++..+..+++++
T Consensus       183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l  261 (298)
T 3f66_A          183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPL  261 (298)
T ss_dssp             GCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH-TTCCCCCCTTCCHHH
T ss_pred             hhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-cCCCCCCCccCCHHH
Confidence                 2233456789999999999999999999999999999999 777888776655544433 345566678889999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHHHHHHHHH
Q 016082          337 AELLERCWQHDPTQRPNFSQITDILKQMMKEV  368 (395)
Q Consensus       337 ~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~  368 (395)
                      .+++.+||+.||.+|||+.++++.|++++.+.
T Consensus       262 ~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  293 (298)
T 3f66_A          262 YEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  293 (298)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            99999999999999999999999999988753

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.5e-47  Score=371.06  Aligned_cols=248  Identities=22%  Similarity=0.397  Sum_probs=203.0

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCC--cEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPP--NLC  183 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~  183 (395)
                      .++|++.+.||+|+||.||+|.+  +++.||||++.....+......+.+|+.+++++. ||||+++++++...+  .+|
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            45899999999999999999987  5789999999876666777788999999999998 999999999997544  689


Q ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc---
Q 016082          184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ---  260 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~---  260 (395)
                      +||||+++ +|.++++.  +.+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+|+....   
T Consensus        88 lv~e~~~~-~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  164 (388)
T 3oz6_A           88 LVFDYMET-DLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR  164 (388)
T ss_dssp             EEEECCSE-EHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred             EEecccCc-CHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence            99999985 99999875  4689999999999999999999999999999999999999999999999999976432   


Q ss_pred             -------------------CCccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhh
Q 016082          261 -------------------SGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV  320 (395)
Q Consensus       261 -------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~  320 (395)
                                         ....+...||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+.......+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~  244 (388)
T 3oz6_A          165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII  244 (388)
T ss_dssp             CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence                               112344579999999999986 679999999999999999999999999988776655544


Q ss_pred             hccCCCC---------------------------------------------CCCCCcHHHHHHHHHhhccCCCCCCCHH
Q 016082          321 QKSLRPT---------------------------------------------IPKHAHPRLAELLERCWQHDPTQRPNFS  355 (395)
Q Consensus       321 ~~~~~~~---------------------------------------------~~~~~~~~l~~li~~cl~~dp~~RPs~~  355 (395)
                      .....|.                                             .+..+++++.++|.+||+.||.+|||+.
T Consensus       245 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~  324 (388)
T 3oz6_A          245 GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAN  324 (388)
T ss_dssp             HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHH
Confidence            2211111                                             1226788999999999999999999999


Q ss_pred             HHHH
Q 016082          356 QITD  359 (395)
Q Consensus       356 ell~  359 (395)
                      |+++
T Consensus       325 e~l~  328 (388)
T 3oz6_A          325 DALK  328 (388)
T ss_dssp             HHTT
T ss_pred             HHhC
Confidence            9987

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=4.6e-48  Score=369.74  Aligned_cols=258  Identities=26%  Similarity=0.483  Sum_probs=216.5

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  185 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  185 (395)
                      ...++|++.+.||+|+||.||+|++ .++.||||++....  ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  113 (321)
T 2qkw_B           36 EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILI  113 (321)
T ss_dssp             CCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEE
T ss_pred             HHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence            3457899999999999999999997 47899999987653  34467899999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC
Q 016082          186 TEFMARGSIYDFLHKQK---GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~  262 (395)
                      |||+++|+|.+++....   ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  193 (321)
T 2qkw_B          114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELD  193 (321)
T ss_dssp             EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSS
T ss_pred             EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            99999999999986543   358999999999999999999999999999999999999999999999999997643321


Q ss_pred             ---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHh-----h----hccC
Q 016082          263 ---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAA------VGV-----V----QKSL  324 (395)
Q Consensus       263 ---~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~------~~~-----~----~~~~  324 (395)
                         ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+..+.+..      ...     .    ....
T Consensus       194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (321)
T 2qkw_B          194 QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL  273 (321)
T ss_dssp             CCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSC
T ss_pred             ccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhh
Confidence               223345899999999999889999999999999999999999999765432110      000     0    1111


Q ss_pred             CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 016082          325 RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK  366 (395)
Q Consensus       325 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~  366 (395)
                      ....+...+.++.+++.+||+.||++|||+.++++.|+.+++
T Consensus       274 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          274 ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            222334456789999999999999999999999999998875

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.9e-47  Score=358.34  Aligned_cols=249  Identities=24%  Similarity=0.377  Sum_probs=209.1

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      ++|++.++||+|+||.||+|++  +++.||||++..........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            5799999999999999999998  47899999998776666667889999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-Ccccc
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTA  266 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-~~~~~  266 (395)
                      |+++++|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||.++..... .....
T Consensus        83 ~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  161 (311)
T 4agu_A           83 YCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD  161 (311)
T ss_dssp             CCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred             eCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCC
Confidence            9999999988765 567999999999999999999999999999999999999999999999999999865533 23345


Q ss_pred             CCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc-------------------CCC
Q 016082          267 ETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-------------------LRP  326 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~-------------------~~~  326 (395)
                      ..||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+....+....+....                   ...
T Consensus       162 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (311)
T 4agu_A          162 EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKI  241 (311)
T ss_dssp             ----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCC
T ss_pred             CcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcC
Confidence            678999999999875 678999999999999999999999999987766544332210                   000


Q ss_pred             CCC----------CCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          327 TIP----------KHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       327 ~~~----------~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      ..+          +.+++++.++|.+||+.||.+|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          242 PDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             CCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             CCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            001          357889999999999999999999999987

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1e-47  Score=380.13  Aligned_cols=254  Identities=17%  Similarity=0.300  Sum_probs=216.7

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  181 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  181 (395)
                      ..+..++|++.+.||+|+||.||++++  +++.||||++++... .......+.+|..++.+++||||+++++++.+.+.
T Consensus        56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~  135 (412)
T 2vd5_A           56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY  135 (412)
T ss_dssp             HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred             ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence            345678999999999999999999998  578999999974311 11223458899999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC
Q 016082          182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  261 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~  261 (395)
                      +|+||||++||+|.+++.+....+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus       136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~  215 (412)
T 2vd5_A          136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD  215 (412)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence            99999999999999999876668999999999999999999999999999999999999999999999999999866544


Q ss_pred             Cc--cccCCCCcccccccccC-------CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccC---CCCCC
Q 016082          262 GV--MTAETGTYRWMAPEVIE-------HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL---RPTIP  329 (395)
Q Consensus       262 ~~--~~~~~gt~~y~aPE~~~-------~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~---~~~~~  329 (395)
                      ..  ....+||+.|+|||++.       +..|+.++|+|||||++|||++|+.||.+.+..+....+.....   .|..+
T Consensus       216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  295 (412)
T 2vd5_A          216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVD  295 (412)
T ss_dssp             SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC---
T ss_pred             CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccc
Confidence            32  23458999999999987       45789999999999999999999999999988877766654322   23344


Q ss_pred             CCCcHHHHHHHHHhhccCCCCC---CCHHHHHH
Q 016082          330 KHAHPRLAELLERCWQHDPTQR---PNFSQITD  359 (395)
Q Consensus       330 ~~~~~~l~~li~~cl~~dp~~R---Ps~~ell~  359 (395)
                      ..+++++.++|++||. +|.+|   |+++++++
T Consensus       296 ~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          296 EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             -CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            6799999999999999 99998   58888876

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=7e-48  Score=381.04  Aligned_cols=253  Identities=21%  Similarity=0.323  Sum_probs=218.0

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  181 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  181 (395)
                      ..+..++|++.+.||+|+||.||+|++  +++.||+|+++.... .......+.+|+.+++.++||||+++++++.+...
T Consensus        64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~  143 (410)
T 3v8s_A           64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  143 (410)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            445677999999999999999999998  468899999964211 01112347899999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC
Q 016082          182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  261 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~  261 (395)
                      +|+||||++||+|.++++.  ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus       144 ~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~  221 (410)
T 3v8s_A          144 LYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE  221 (410)
T ss_dssp             EEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence            9999999999999999975  46899999999999999999999999999999999999999999999999999866544


Q ss_pred             Cc--cccCCCCcccccccccCCCC----CCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCC--CCCCc
Q 016082          262 GV--MTAETGTYRWMAPEVIEHKP----YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAH  333 (395)
Q Consensus       262 ~~--~~~~~gt~~y~aPE~~~~~~----~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~  333 (395)
                      ..  ....+||+.|+|||++.+..    |+.++|||||||++|||++|+.||.+.+.......+.........  ...++
T Consensus       222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s  301 (410)
T 3v8s_A          222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS  301 (410)
T ss_dssp             SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCC
T ss_pred             CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCccccc
Confidence            32  33568999999999997665    889999999999999999999999999888877776654322233  34789


Q ss_pred             HHHHHHHHHhhccCCCC--CCCHHHHHH
Q 016082          334 PRLAELLERCWQHDPTQ--RPNFSQITD  359 (395)
Q Consensus       334 ~~l~~li~~cl~~dp~~--RPs~~ell~  359 (395)
                      +++.++|.+||+.+|.+  ||++.||++
T Consensus       302 ~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          302 KEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             HHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             HHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            99999999999999988  999999987

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.8e-47  Score=363.09  Aligned_cols=256  Identities=23%  Similarity=0.384  Sum_probs=212.5

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC--cE
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP--NL  182 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~  182 (395)
                      +..++|++.+.||+|+||.||+|++.  ++.||||+++.... ....+.+.+|+.++++++||||+++++++....  ..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence            34568999999999999999999984  78999999975432 223467789999999999999999999997665  78


Q ss_pred             EEEEecCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee----CCCCcEEEeeecccc
Q 016082          183 CIVTEFMARGSIYDFLHKQKG--VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM----DENGVVKVADFGVAR  256 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl----~~~~~vkl~DFg~a~  256 (395)
                      ++||||+++++|.+++.....  .+++..++.++.||+.||.|||++||+||||||+||++    +.++.+||+|||+++
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999999976532  38999999999999999999999999999999999999    788889999999998


Q ss_pred             ccccCCccccCCCCcccccccccC--------CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHhhhccC
Q 016082          257 VQAQSGVMTAETGTYRWMAPEVIE--------HKPYDYKADVFSFGIALWELLTGELPYAGLTP----LQAAVGVVQKSL  324 (395)
Q Consensus       257 ~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~k~DvwslG~vl~elltg~~pf~~~~~----~~~~~~~~~~~~  324 (395)
                      ............||+.|+|||++.        +..++.++|||||||++|||++|+.||.....    .+....+.....
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p  244 (319)
T 4euu_A          165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP  244 (319)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred             ecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence            776665556678999999999986        57789999999999999999999999975432    222222222111


Q ss_pred             -----------------------CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 016082          325 -----------------------RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQ  363 (395)
Q Consensus       325 -----------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~  363 (395)
                                             ....+...++.+.++|++||+.||++|||+.|+++...+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d  306 (319)
T 4euu_A          245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD  306 (319)
T ss_dssp             TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred             cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence                                   011223456789999999999999999999999987664

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.6e-46  Score=359.59  Aligned_cols=244  Identities=29%  Similarity=0.467  Sum_probs=213.8

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  188 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  188 (395)
                      .|...++||+|+||.||+|+.  +++.||||+++....  ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  123 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF  123 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence            477788999999999999987  588999999976542  2346788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-ccccC
Q 016082          189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAE  267 (395)
Q Consensus       189 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~~~  267 (395)
                      ++|++|.+++..  ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++...... .....
T Consensus       124 ~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  201 (321)
T 2c30_A          124 LQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL  201 (321)
T ss_dssp             CCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred             CCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccc
Confidence            999999999864  468999999999999999999999999999999999999999999999999997655432 33456


Q ss_pred             CCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCC--CCCCCcHHHHHHHHHhhc
Q 016082          268 TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT--IPKHAHPRLAELLERCWQ  345 (395)
Q Consensus       268 ~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~  345 (395)
                      .||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+....+... ..+.  .+..+++++.++|.+||+
T Consensus       202 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~  280 (321)
T 2c30_A          202 VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS-PPPKLKNSHKVSPVLRDFLERMLV  280 (321)
T ss_dssp             CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-SCCCCTTGGGSCHHHHHHHHHHSC
T ss_pred             cCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CCCCcCccccCCHHHHHHHHHHcc
Confidence            7999999999999999999999999999999999999999998877765554432 2222  234578999999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 016082          346 HDPTQRPNFSQITD  359 (395)
Q Consensus       346 ~dp~~RPs~~ell~  359 (395)
                      .||.+|||+.++++
T Consensus       281 ~dp~~Rps~~ell~  294 (321)
T 2c30_A          281 RDPQERATAQELLD  294 (321)
T ss_dssp             SSTTTSCCHHHHHT
T ss_pred             CChhhCcCHHHHhc
Confidence            99999999999987

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=4.7e-47  Score=383.45  Aligned_cols=249  Identities=27%  Similarity=0.494  Sum_probs=216.6

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      .++|++.++||+|+||.||+|++  +++.||||+++...........+.+|+.++++++||||+++++++.....+|+||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            35899999999999999999998  5789999998643222223467899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeC---CCCcEEEeeeccccccccCCc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD---ENGVVKVADFGVARVQAQSGV  263 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~---~~~~vkl~DFg~a~~~~~~~~  263 (395)
                      ||+.||+|.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.......
T Consensus       101 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~  179 (486)
T 3mwu_A          101 ELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK  179 (486)
T ss_dssp             CCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred             EcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc
Confidence            99999999999976 46799999999999999999999999999999999999995   456799999999987766655


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCC--CCCcHHHHHHHH
Q 016082          264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP--KHAHPRLAELLE  341 (395)
Q Consensus       264 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~  341 (395)
                      .....||+.|+|||++.+ .|+.++||||+||++|+|++|..||.+.+..+....+.........|  ..+++++.++|.
T Consensus       180 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  258 (486)
T 3mwu_A          180 MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR  258 (486)
T ss_dssp             --CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHH
T ss_pred             cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHH
Confidence            666789999999999976 49999999999999999999999999998887777766554443333  467899999999


Q ss_pred             HhhccCCCCCCCHHHHHH
Q 016082          342 RCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       342 ~cl~~dp~~RPs~~ell~  359 (395)
                      +||+.||.+|||+.++++
T Consensus       259 ~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          259 KMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             HHTCSSTTTSCCHHHHHH
T ss_pred             HHcCCChhhCcCHHHHhc
Confidence            999999999999999987

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.2e-46  Score=351.81  Aligned_cols=247  Identities=24%  Similarity=0.411  Sum_probs=216.5

Q ss_pred             ccCcceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      .++|++.+.||+|+||.||+|++.  +..||+|++......  ..+.+.+|+.++++++||||+++++++......++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM   85 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence            357999999999999999999984  568999998754322  2467899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee---CCCCcEEEeeeccccccccCCc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGV  263 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl---~~~~~vkl~DFg~a~~~~~~~~  263 (395)
                      ||+++++|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+||++   +.++.++|+|||.+........
T Consensus        86 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~  164 (277)
T 3f3z_A           86 ELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM  164 (277)
T ss_dssp             ECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred             eccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence            99999999999876 5679999999999999999999999999999999999999   7889999999999987666555


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCC--CCCcHHHHHHHH
Q 016082          264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP--KHAHPRLAELLE  341 (395)
Q Consensus       264 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~  341 (395)
                      .....||+.|+|||++.+. ++.++||||||+++|+|++|+.||...+..+....+..........  ..+++++.++|.
T Consensus       165 ~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (277)
T 3f3z_A          165 MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIR  243 (277)
T ss_dssp             BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHH
T ss_pred             hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHH
Confidence            5667899999999998765 8999999999999999999999999988877666655443322211  267899999999


Q ss_pred             HhhccCCCCCCCHHHHHH
Q 016082          342 RCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       342 ~cl~~dp~~RPs~~ell~  359 (395)
                      +||+.||.+|||+.++++
T Consensus       244 ~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          244 RLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HHTCSSTTTSCCHHHHTT
T ss_pred             HHccCChhhCcCHHHHhc
Confidence            999999999999999987

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.8e-47  Score=383.43  Aligned_cols=250  Identities=23%  Similarity=0.489  Sum_probs=221.0

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  183 (395)
                      +..++|.+.+.||+|+||.||+|++  +++.||||+++..... .+....+.+|+.+++.++||||+++++++......|
T Consensus        13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~   92 (476)
T 2y94_A           13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF   92 (476)
T ss_dssp             CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            4457899999999999999999998  5889999999743211 123467899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCc
Q 016082          184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV  263 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~  263 (395)
                      +||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus        93 lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~  171 (476)
T 2y94_A           93 MVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF  171 (476)
T ss_dssp             EEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred             EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence            99999999999999975 56799999999999999999999999999999999999999999999999999987766555


Q ss_pred             cccCCCCcccccccccCCCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHH
Q 016082          264 MTAETGTYRWMAPEVIEHKPY-DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER  342 (395)
Q Consensus       264 ~~~~~gt~~y~aPE~~~~~~~-~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  342 (395)
                      ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+...  ....|..+++++.++|.+
T Consensus       172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~  249 (476)
T 2y94_A          172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG--IFYTPQYLNPSVISLLKH  249 (476)
T ss_dssp             BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTT--CCCCCTTCCHHHHHHHHH
T ss_pred             ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CcCCCccCCHHHHHHHHH
Confidence            566789999999999998876 68999999999999999999999988776666555443  234567889999999999


Q ss_pred             hhccCCCCCCCHHHHHH
Q 016082          343 CWQHDPTQRPNFSQITD  359 (395)
Q Consensus       343 cl~~dp~~RPs~~ell~  359 (395)
                      ||+.||.+|||+.++++
T Consensus       250 ~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          250 MLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             HTCSSTTTSCCHHHHHT
T ss_pred             HcCCCchhCcCHHHHHh
Confidence            99999999999999987

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=7.2e-47  Score=359.21  Aligned_cols=252  Identities=23%  Similarity=0.392  Sum_probs=210.1

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC---CHHHHHHHHHHHHHHHhcC---CCceeeEEEEEec
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV---NTEMLKEFSQEVYIMRKIR---HKNVVQFIGACTR  178 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~  178 (395)
                      +..++|++.++||+|+||.||+|++  +++.||||+++....   .......+.+|+.++++++   ||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            4467999999999999999999996  678999999863321   1112245667777777765   9999999999977


Q ss_pred             CC-----cEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeee
Q 016082          179 PP-----NLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADF  252 (395)
Q Consensus       179 ~~-----~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DF  252 (395)
                      ..     ..++||||+.+ +|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+||
T Consensus        86 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df  164 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF  164 (308)
T ss_dssp             CCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred             cCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence            65     48999999975 9999998754 34999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCC-----
Q 016082          253 GVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT-----  327 (395)
Q Consensus       253 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~-----  327 (395)
                      |+++............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+......+.     
T Consensus       165 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  244 (308)
T 3g33_A          165 GLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  244 (308)
T ss_dssp             SCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred             ccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence            999877665556667899999999999999999999999999999999999999999888776665543221111     


Q ss_pred             --------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          328 --------------------IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       328 --------------------~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                          ..+.+++++.++|.+||+.||.+|||+.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             SSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             chhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence                                11357889999999999999999999999987

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=9e-47  Score=382.19  Aligned_cols=248  Identities=29%  Similarity=0.464  Sum_probs=214.2

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      ++|++.++||+|+||.||+|++  ++..||+|+++...........+.+|+.++++++||||+++++++.....+|+|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            4799999999999999999998  57889999998665444445778999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCC---CcEEEeeeccccccccCCcc
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN---GVVKVADFGVARVQAQSGVM  264 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~---~~vkl~DFg~a~~~~~~~~~  264 (395)
                      |++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++..   +.+||+|||+++........
T Consensus       117 ~~~~g~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~  195 (494)
T 3lij_A          117 CYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM  195 (494)
T ss_dssp             CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCB
T ss_pred             cCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccc
Confidence            9999999999876 4679999999999999999999999999999999999999764   45999999999877666556


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCC--CCCcHHHHHHHHH
Q 016082          265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP--KHAHPRLAELLER  342 (395)
Q Consensus       265 ~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~  342 (395)
                      ....||+.|+|||++. ..|+.++||||+||++|+|++|..||.+.+..+....+.........+  ..+++++.++|.+
T Consensus       196 ~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  274 (494)
T 3lij_A          196 KERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQ  274 (494)
T ss_dssp             CCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHH
T ss_pred             cccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHH
Confidence            6678999999999987 469999999999999999999999999999887777666554443332  4689999999999


Q ss_pred             hhccCCCCCCCHHHHHH
Q 016082          343 CWQHDPTQRPNFSQITD  359 (395)
Q Consensus       343 cl~~dp~~RPs~~ell~  359 (395)
                      ||+.||.+|||+.++++
T Consensus       275 ~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          275 MLQFDSQRRISAQQALE  291 (494)
T ss_dssp             HTCSSTTTSCCHHHHHT
T ss_pred             HCCCChhhCccHHHHhc
Confidence            99999999999999986

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=6.4e-47  Score=361.61  Aligned_cols=249  Identities=25%  Similarity=0.427  Sum_probs=198.1

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      .++|++.++||+|+||.||+|++  +++.||+|+++... .......+.+|+.++++++||||+++++++..++..++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            35899999999999999999987  47899999997653 2223467889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC
Q 016082          187 EFMARGSIYDFLHKQK-----GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  261 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~  261 (395)
                      ||++| +|.+++....     ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus        83 e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  161 (317)
T 2pmi_A           83 EFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP  161 (317)
T ss_dssp             ECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred             EecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence            99985 9999987643     45899999999999999999999999999999999999999999999999999865433


Q ss_pred             -CccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccC---------------
Q 016082          262 -GVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL---------------  324 (395)
Q Consensus       262 -~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~---------------  324 (395)
                       .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....               
T Consensus       162 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  241 (317)
T 2pmi_A          162 VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK  241 (317)
T ss_dssp             CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTT
T ss_pred             cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhh
Confidence             23345678999999999976 4689999999999999999999999999887665554432110               


Q ss_pred             -----------------CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          325 -----------------RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       325 -----------------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                       .+..+...++++.++|.+||+.||.+|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence                             01122357889999999999999999999999987

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.6e-46  Score=353.21  Aligned_cols=248  Identities=23%  Similarity=0.421  Sum_probs=207.4

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      ++|.+.++||+|+||.||++++  .+..||+|++..... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            5899999999999999999997  478899999975532 2234678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee---CCCCcEEEeeeccccccccC
Q 016082          188 FMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQS  261 (395)
Q Consensus       188 ~~~ggsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl---~~~~~vkl~DFg~a~~~~~~  261 (395)
                      |+++|+|.+++...   ...+++..++.++.|++.||+|||++||+||||||+||++   +.++.+||+|||+++.....
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~  180 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD  180 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence            99999999998653   3679999999999999999999999999999999999999   45678999999999876655


Q ss_pred             CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCC-CCCCCcHHHHHHH
Q 016082          262 GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT-IPKHAHPRLAELL  340 (395)
Q Consensus       262 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li  340 (395)
                      .......||+.|+|||++. ..++.++||||||+++|+|++|+.||.+.+..+............. .....++++.++|
T Consensus       181 ~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  259 (285)
T 3is5_A          181 EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLL  259 (285)
T ss_dssp             ------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHH
T ss_pred             ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHHH
Confidence            5556678999999999986 4689999999999999999999999999887766554443322221 2234789999999


Q ss_pred             HHhhccCCCCCCCHHHHHH
Q 016082          341 ERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       341 ~~cl~~dp~~RPs~~ell~  359 (395)
                      .+||+.||.+|||+.|+++
T Consensus       260 ~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          260 KQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             HHHTCSCTTTSCCHHHHHT
T ss_pred             HHHccCChhhCcCHHHHhc
Confidence            9999999999999999986

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.6e-47  Score=363.06  Aligned_cols=254  Identities=26%  Similarity=0.436  Sum_probs=210.2

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc----
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN----  181 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  181 (395)
                      .++|++.+.||+|+||.||+|++  +++.||||+++.... +......+.+|+.++++++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46899999999999999999997  678999999987643 34556789999999999999999999999876543    


Q ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC
Q 016082          182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  261 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~  261 (395)
                      .|+||||++|++|.++++. .+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus        91 ~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  169 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS  169 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred             cEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence            4999999999999999976 467999999999999999999999999999999999999999999999999999865443


Q ss_pred             C----ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCC--CCCCCcHH
Q 016082          262 G----VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT--IPKHAHPR  335 (395)
Q Consensus       262 ~----~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  335 (395)
                      .    ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+..+.............+.  .+..++++
T Consensus       170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (311)
T 3ork_A          170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD  249 (311)
T ss_dssp             ------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHH
T ss_pred             ccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHH
Confidence            2    12234689999999999999999999999999999999999999999888777666555433322  13568899


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHH-HHHHH
Q 016082          336 LAELLERCWQHDPTQRPNFSQIT-DILKQ  363 (395)
Q Consensus       336 l~~li~~cl~~dp~~RPs~~ell-~~l~~  363 (395)
                      +.++|.+||+.||.+||+..+++ ..+.+
T Consensus       250 l~~li~~~l~~dP~~R~~~~~~l~~~l~~  278 (311)
T 3ork_A          250 LDAVVLKALAKNPENRYQTAAEMRADLVR  278 (311)
T ss_dssp             HHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             HHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence            99999999999999999766554 34433

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.8e-46  Score=359.59  Aligned_cols=263  Identities=30%  Similarity=0.557  Sum_probs=224.3

Q ss_pred             ceeecccCcceeeeeeeeCceEEEEEEE-------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEE
Q 016082          104 VWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC  176 (395)
Q Consensus       104 ~~~i~~~~~~i~~~lg~G~~G~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  176 (395)
                      ..++..++|++.+.||+|+||.||+|++       .++.||||++.... .......+.+|+.++++++||||+++++++
T Consensus        24 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  102 (327)
T 2yfx_A           24 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVS  102 (327)
T ss_dssp             SCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEE
Confidence            4567788999999999999999999984       35679999997443 455667899999999999999999999999


Q ss_pred             ecCCcEEEEEecCCCCCHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCC---CCcE
Q 016082          177 TRPPNLCIVTEFMARGSIYDFLHKQK------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NGVV  247 (395)
Q Consensus       177 ~~~~~~~lV~E~~~ggsL~~~l~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~---~~~v  247 (395)
                      ......|+||||+++++|.+++....      ..+++..++.++.|++.||.|||++||+||||||+||+++.   +..+
T Consensus       103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~  182 (327)
T 2yfx_A          103 LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA  182 (327)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceE
Confidence            99999999999999999999998754      45888999999999999999999999999999999999984   4469


Q ss_pred             EEeeeccccccccCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc
Q 016082          248 KVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKS  323 (395)
Q Consensus       248 kl~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~  323 (395)
                      +|+|||+++......   ......||+.|+|||++.+..++.++||||||+++|+|++ |..||......+.... ....
T Consensus       183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-~~~~  261 (327)
T 2yfx_A          183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF-VTSG  261 (327)
T ss_dssp             EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-HHTT
T ss_pred             EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHH-HhcC
Confidence            999999997543322   1233467889999999998899999999999999999998 9999998877665544 3445


Q ss_pred             CCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHH
Q 016082          324 LRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  368 (395)
Q Consensus       324 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~  368 (395)
                      .++..+..+++.+.++|.+||+.||.+||++.++++.|..+.++-
T Consensus       262 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          262 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence            566777889999999999999999999999999999999887643

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=9.5e-47  Score=353.19  Aligned_cols=249  Identities=26%  Similarity=0.466  Sum_probs=215.0

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  183 (395)
                      ...++|++.+.||+|+||.||+|++.  ++.||+|++...... ......+.+|+.++++++||||+++++++.+....+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   85 (279)
T 3fdn_A            6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY   85 (279)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEE
Confidence            44578999999999999999999884  568999998643211 112456889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCc
Q 016082          184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV  263 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~  263 (395)
                      +||||+++|+|.+++.. .+.+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++...... .
T Consensus        86 lv~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-~  163 (279)
T 3fdn_A           86 LILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-R  163 (279)
T ss_dssp             EEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred             EEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-c
Confidence            99999999999999976 467999999999999999999999999999999999999999999999999998654433 2


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHh
Q 016082          264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC  343 (395)
Q Consensus       264 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  343 (395)
                      .....||+.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+..  .....|..+++++.++|.+|
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~  241 (279)
T 3fdn_A          164 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRL  241 (279)
T ss_dssp             ----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--TCCCCCTTSCHHHHHHHHHH
T ss_pred             ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh--CCCCCCCcCCHHHHHHHHHH
Confidence            3456789999999999999999999999999999999999999999887766655443  34556778999999999999


Q ss_pred             hccCCCCCCCHHHHHH
Q 016082          344 WQHDPTQRPNFSQITD  359 (395)
Q Consensus       344 l~~dp~~RPs~~ell~  359 (395)
                      |+.||.+|||+.|+++
T Consensus       242 l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          242 LKHNPSQRPMLREVLE  257 (279)
T ss_dssp             CCSSGGGSCCHHHHHH
T ss_pred             hccChhhCCCHHHHhh
Confidence            9999999999999998

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.9e-46  Score=380.74  Aligned_cols=249  Identities=24%  Similarity=0.431  Sum_probs=216.1

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCH-----------HHHHHHHHHHHHHHhcCCCceeeEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT-----------EMLKEFSQEVYIMRKIRHKNVVQFIGA  175 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv~l~~~  175 (395)
                      .++|++.++||+|+||.||+|++  +++.||||+++......           ...+.+.+|+.++++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            46899999999999999999998  46889999997654321           235678999999999999999999999


Q ss_pred             EecCCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCC---cEEEeee
Q 016082          176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADF  252 (395)
Q Consensus       176 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~---~vkl~DF  252 (395)
                      +.+...+|+||||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++   .+||+||
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  193 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF  193 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence            9999999999999999999999976 46799999999999999999999999999999999999999876   6999999


Q ss_pred             ccccccccCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCC--C
Q 016082          253 GVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP--K  330 (395)
Q Consensus       253 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~  330 (395)
                      |+++............||+.|+|||++.+ .|+.++||||+||++|+|++|..||.+.+..+....+.........+  .
T Consensus       194 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  272 (504)
T 3q5i_A          194 GLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWK  272 (504)
T ss_dssp             TTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHT
T ss_pred             CCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccC
Confidence            99987766656667789999999999874 58999999999999999999999999998887777666544332222  5


Q ss_pred             CCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          331 HAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       331 ~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      .+++++.++|.+||+.||.+|||+.|+++
T Consensus       273 ~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          273 NISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            68999999999999999999999999986

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.1e-46  Score=361.78  Aligned_cols=250  Identities=22%  Similarity=0.365  Sum_probs=203.8

Q ss_pred             cccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Q 016082          108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  185 (395)
Q Consensus       108 ~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  185 (395)
                      ..++|++.++||+|+||.||+|++  +++.||||+++...........+.+|+.++++++||||+++++++......++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            356899999999999999999987  578999999987765555667788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeC-----CCCcEEEeeecccccccc
Q 016082          186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD-----ENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~-----~~~~vkl~DFg~a~~~~~  260 (395)
                      |||++| +|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++     .++.+||+|||+++....
T Consensus       112 ~e~~~~-~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~  189 (329)
T 3gbz_A          112 FEYAEN-DLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI  189 (329)
T ss_dssp             EECCSE-EHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred             EecCCC-CHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence            999986 99999977 45699999999999999999999999999999999999994     455699999999986543


Q ss_pred             C-CccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCC----------
Q 016082          261 S-GVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI----------  328 (395)
Q Consensus       261 ~-~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~----------  328 (395)
                      . .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+......+..          
T Consensus       190 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (329)
T 3gbz_A          190 PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALP  269 (329)
T ss_dssp             ----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhh
Confidence            3 233455789999999999874 5899999999999999999999999998887766655443211111          


Q ss_pred             ------------------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          329 ------------------PKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       329 ------------------~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                        +..+++++.++|.+||+.||.+|||+.|+++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          270 DWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence                              0126789999999999999999999999987

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-47  Score=371.34  Aligned_cols=257  Identities=29%  Similarity=0.546  Sum_probs=212.7

Q ss_pred             cCcceeeeeeeeCceEEEEEEEC--C---ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec-CCcEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTYC--S---QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-PPNLC  183 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~~--~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~  183 (395)
                      ..|++.+.||+|+||.||+|++.  +   ..||+|.++... .....+.+.+|+.++++++||||+++++++.. .+..+
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~  167 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  167 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence            35788999999999999999862  2   358999987543 34556889999999999999999999998754 45789


Q ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-
Q 016082          184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-  262 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-  262 (395)
                      +||||+++|+|.++++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...... 
T Consensus       168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~  247 (373)
T 3c1x_A          168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  247 (373)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence            9999999999999998777778999999999999999999999999999999999999999999999999998554322 


Q ss_pred             ----ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHH
Q 016082          263 ----VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA  337 (395)
Q Consensus       263 ----~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  337 (395)
                          ......+|+.|+|||++.+..++.++||||||+++|||++ |.+||...+..+....+ ....++..|..+++++.
T Consensus       248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~-~~~~~~~~p~~~~~~l~  326 (373)
T 3c1x_A          248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRRLLQPEYCPDPLY  326 (373)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH-HTTCCCCCCTTCCHHHH
T ss_pred             ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHH
Confidence                1233457789999999999999999999999999999999 78899887665544443 34556677788999999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHHHHHHHHHH
Q 016082          338 ELLERCWQHDPTQRPNFSQITDILKQMMKEV  368 (395)
Q Consensus       338 ~li~~cl~~dp~~RPs~~ell~~l~~~~~~~  368 (395)
                      ++|.+||+.||.+|||+.++++.|++++...
T Consensus       327 ~li~~cl~~dp~~RPs~~ell~~L~~i~~~~  357 (373)
T 3c1x_A          327 EVMLKCWHPKAEMRPSFSELVSRISAIFSTF  357 (373)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             HHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            9999999999999999999999999988654

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=6.4e-47  Score=382.16  Aligned_cols=251  Identities=26%  Similarity=0.437  Sum_probs=222.3

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  183 (395)
                      +-.++|++.+.||+|+||.||+|++  +++.||||++...... ......+.+|+.++++++||||+++++++.+....|
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  102 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY  102 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            3356899999999999999999998  5789999999755432 334577899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee---CCCCcEEEeeecccccccc
Q 016082          184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl---~~~~~vkl~DFg~a~~~~~  260 (395)
                      +||||+.||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++....
T Consensus       103 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  181 (484)
T 3nyv_A          103 LVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA  181 (484)
T ss_dssp             EEECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred             EEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence            99999999999999976 5679999999999999999999999999999999999999   5678999999999987766


Q ss_pred             CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCC--CCCcHHHHH
Q 016082          261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP--KHAHPRLAE  338 (395)
Q Consensus       261 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~  338 (395)
                      ........||+.|+|||++.+ .|+.++||||+||++|+|++|.+||.+.+..+....+.........|  ..+++++.+
T Consensus       182 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  260 (484)
T 3nyv_A          182 SKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD  260 (484)
T ss_dssp             CCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHH
T ss_pred             ccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHH
Confidence            655566789999999999876 69999999999999999999999999999888777766655544433  468999999


Q ss_pred             HHHHhhccCCCCCCCHHHHHH
Q 016082          339 LLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       339 li~~cl~~dp~~RPs~~ell~  359 (395)
                      +|.+||+.||.+|||+.|+++
T Consensus       261 li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          261 LIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHCCCChhHCcCHHHHhh
Confidence            999999999999999999986

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.3e-46  Score=352.90  Aligned_cols=256  Identities=25%  Similarity=0.381  Sum_probs=214.0

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEE-ecCCcEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC-TRPPNLCIV  185 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lV  185 (395)
                      .++|++.+.||+|+||.||+|++  +++.||||++......    ..+.+|+.++++++|++++..+..+ ......++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence            46899999999999999999996  6889999998765432    3578999999999988766655555 666778999


Q ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeC---CCCcEEEeeeccccccccCC
Q 016082          186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD---ENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~---~~~~vkl~DFg~a~~~~~~~  262 (395)
                      |||+ +++|.+++....+.+++..++.++.|++.||.|||++||+||||||+||+++   .++.+||+|||+++......
T Consensus        84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~  162 (296)
T 3uzp_A           84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             EEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence            9999 8899999987777899999999999999999999999999999999999994   88899999999998655432


Q ss_pred             c--------cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHhhhccCC---CCC
Q 016082          263 V--------MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP---LQAAVGVVQKSLR---PTI  328 (395)
Q Consensus       263 ~--------~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~---~~~~~~~~~~~~~---~~~  328 (395)
                      .        .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+...   .+....+......   +..
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (296)
T 3uzp_A          163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL  242 (296)
T ss_dssp             TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred             cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHH
Confidence            2        2345789999999999999999999999999999999999999987432   1222222221111   123


Q ss_pred             CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHH
Q 016082          329 PKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVL  369 (395)
Q Consensus       329 ~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~  369 (395)
                      +..+++++.+++.+||+.||.+|||+.++++.|+++.++..
T Consensus       243 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  283 (296)
T 3uzp_A          243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence            36688999999999999999999999999999999988764

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.6e-46  Score=350.54  Aligned_cols=249  Identities=23%  Similarity=0.429  Sum_probs=213.2

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCH----HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT----EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  183 (395)
                      ++|++.+.||+|+||.||+|++  +++.||+|+++......    ...+.+.+|+.++++++||||+++++++......+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            5799999999999999999998  47899999997654321    13577899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCC----cEEEeeeccccccc
Q 016082          184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG----VVKVADFGVARVQA  259 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~----~vkl~DFg~a~~~~  259 (395)
                      +||||+++++|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+||+++.++    .++|+|||.++...
T Consensus        85 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~  163 (283)
T 3bhy_A           85 LILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE  163 (283)
T ss_dssp             EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence            99999999999999976 46799999999999999999999999999999999999998877    89999999998765


Q ss_pred             cCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC--CCCCCCCcHHHH
Q 016082          260 QSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLA  337 (395)
Q Consensus       260 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~  337 (395)
                      .........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+......  +..+...++.+.
T Consensus       164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (283)
T 3bhy_A          164 AGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAK  243 (283)
T ss_dssp             --------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHH
T ss_pred             CCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHH
Confidence            554445567999999999999999999999999999999999999999998877665554432221  112256788999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHH
Q 016082          338 ELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       338 ~li~~cl~~dp~~RPs~~ell~  359 (395)
                      +++.+||+.||.+|||+.++++
T Consensus       244 ~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          244 DFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCCHhHCcCHHHHHh
Confidence            9999999999999999999987

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=9.4e-47  Score=352.77  Aligned_cols=251  Identities=24%  Similarity=0.408  Sum_probs=217.9

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEe--cCCcEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT--RPPNLCI  184 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~l  184 (395)
                      .++|++.+.||+|+||.||+|++  +++.||+|+++.........+.+.+|+.++++++||||+++++++.  .....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            45899999999999999999998  5789999999887767777888999999999999999999999874  4567999


Q ss_pred             EEecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCCCCeeeCCCCcEEEeeecccc
Q 016082          185 VTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNN-----IIHRDLKTANLLMDENGVVKVADFGVAR  256 (395)
Q Consensus       185 V~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~-----iiHrDlkp~NiLl~~~~~vkl~DFg~a~  256 (395)
                      ||||+++++|.+++...   ...+++..++.++.|++.||.|||+.|     |+||||||+||+++.++.+||+|||.++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            99999999999999764   245899999999999999999999999     9999999999999999999999999998


Q ss_pred             ccccCCc-cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHH
Q 016082          257 VQAQSGV-MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR  335 (395)
Q Consensus       257 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (395)
                      ....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+ .....+..+..++++
T Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i-~~~~~~~~~~~~~~~  243 (279)
T 2w5a_A          165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI-REGKFRRIPYRYSDE  243 (279)
T ss_dssp             HC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HHTCCCCCCTTSCHH
T ss_pred             eeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHH-hhcccccCCcccCHH
Confidence            6544321 22346899999999999999999999999999999999999999998876655443 344556778889999


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHH
Q 016082          336 LAELLERCWQHDPTQRPNFSQITDI  360 (395)
Q Consensus       336 l~~li~~cl~~dp~~RPs~~ell~~  360 (395)
                      +.++|.+||+.||.+|||+.++++.
T Consensus       244 l~~li~~~l~~~p~~Rps~~~ll~~  268 (279)
T 2w5a_A          244 LNEIITRMLNLKDYHRPSVEEILEN  268 (279)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHHcCCCcccCCCHHHHHhC
Confidence            9999999999999999999999873

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4.8e-46  Score=350.30  Aligned_cols=250  Identities=29%  Similarity=0.524  Sum_probs=214.9

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec----CC
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR----PP  180 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~  180 (395)
                      .+...|++.+.||+|+||.||+|.+  ++..||+|+++....+....+.+.+|+.++++++||||+++++++..    ..
T Consensus        23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  102 (290)
T 1t4h_A           23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK  102 (290)
T ss_dssp             TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred             cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence            3455789999999999999999988  46789999998776677778889999999999999999999998865    34


Q ss_pred             cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCeeeC-CCCcEEEeeeccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMD-ENGVVKVADFGVARV  257 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--iiHrDlkp~NiLl~-~~~~vkl~DFg~a~~  257 (395)
                      .+++||||+++++|.+++.. .+.+++..++.++.|++.||.|||+.|  |+||||||+||+++ .++.+||+|||++..
T Consensus       103 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          103 CIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             eEEEEEEecCCCCHHHHHHH-ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            58999999999999999976 467899999999999999999999999  99999999999998 789999999999975


Q ss_pred             cccCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccC-CCCCCCCCcHHH
Q 016082          258 QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL-RPTIPKHAHPRL  336 (395)
Q Consensus       258 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l  336 (395)
                      .... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||................. ....+...++++
T Consensus       182 ~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  259 (290)
T 1t4h_A          182 KRAS-FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV  259 (290)
T ss_dssp             CCTT-SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred             cccc-ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHH
Confidence            4443 3345679999999998875 489999999999999999999999988655544444343333 334456678899


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHH
Q 016082          337 AELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       337 ~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      .++|.+||+.||.+|||+.++++
T Consensus       260 ~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          260 KEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHccCChhhCCCHHHHhh
Confidence            99999999999999999999986

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.6e-46  Score=353.71  Aligned_cols=256  Identities=25%  Similarity=0.384  Sum_probs=210.9

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEE-ecCCcEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC-TRPPNLCIV  185 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lV  185 (395)
                      .++|++.+.||+|+||.||+|++  +++.||||++......    ..+.+|+.+++.++|++++..++.+ ......++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            35899999999999999999996  6789999997654322    4578899999999988776666655 667778999


Q ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee---CCCCcEEEeeeccccccccCC
Q 016082          186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl---~~~~~vkl~DFg~a~~~~~~~  262 (395)
                      |||+ +++|.+++....+.+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||+++......
T Consensus        84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~  162 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence            9999 889999998777789999999999999999999999999999999999999   788999999999998655432


Q ss_pred             c--------cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHhhhccCCC---CC
Q 016082          263 V--------MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL---QAAVGVVQKSLRP---TI  328 (395)
Q Consensus       263 ~--------~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~---~~~~~~~~~~~~~---~~  328 (395)
                      .        .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+....   +....+.......   ..
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (296)
T 4hgt_A          163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL  242 (296)
T ss_dssp             TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred             cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhh
Confidence            1        23457899999999999999999999999999999999999999874332   1122222211111   12


Q ss_pred             CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHH
Q 016082          329 PKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVL  369 (395)
Q Consensus       329 ~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~  369 (395)
                      ...+++++.++|.+||+.||.+|||+.++++.|++++++..
T Consensus       243 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~  283 (296)
T 4hgt_A          243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence            35678999999999999999999999999999999998765

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.8e-47  Score=363.54  Aligned_cols=251  Identities=25%  Similarity=0.421  Sum_probs=211.4

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCC---CCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC---VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  183 (395)
                      .++|++.+.||+|+||.||+|++  +++.||+|+++...   .+....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            45899999999999999999988  46789999986432   13345678999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhc---------------------------------------cCCCCHHHHHHHHHHHHHHHHHH
Q 016082          184 IVTEFMARGSIYDFLHKQ---------------------------------------KGVFQLTSLLKVAIDVSKGMNYL  224 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~---------------------------------------~~~l~~~~~~~i~~~i~~~l~~L  224 (395)
                      +||||++||+|.+++...                                       ...+++..++.++.||+.||.||
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            999999999999998521                                       11235677889999999999999


Q ss_pred             HHCCccccCCCCCCeeeCCCC--cEEEeeeccccccccCC-----ccccCCCCcccccccccCC--CCCCChhhHHHHHH
Q 016082          225 HQNNIIHRDLKTANLLMDENG--VVKVADFGVARVQAQSG-----VMTAETGTYRWMAPEVIEH--KPYDYKADVFSFGI  295 (395)
Q Consensus       225 H~~~iiHrDlkp~NiLl~~~~--~vkl~DFg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwslG~  295 (395)
                      |++||+||||||+||+++.++  .+||+|||+++......     ......||+.|+|||++.+  ..++.++||||||+
T Consensus       185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~  264 (345)
T 3hko_A          185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV  264 (345)
T ss_dssp             HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred             HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence            999999999999999998777  89999999998643321     2345679999999999975  67899999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCC--CCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          296 ALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK--HAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       296 vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      ++|+|++|+.||.+.+..+....+.........+.  .+++++.++|.+||+.||.+||++.++++
T Consensus       265 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred             HHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            99999999999999988887777766554443332  47899999999999999999999999987

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.3e-46  Score=376.17  Aligned_cols=247  Identities=24%  Similarity=0.353  Sum_probs=206.0

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC------
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP------  180 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  180 (395)
                      .++|++.++||+|+||.||+|.+  +++.||||++.....+....+.+.+|+.+|+.++||||+++++++....      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            46899999999999999999987  5789999999876556677788999999999999999999999996553      


Q ss_pred             cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                      ..|+||||+++ +|.+.+..   .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  216 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred             eEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence            57999999987 57776643   489999999999999999999999999999999999999999999999999988776


Q ss_pred             CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCC--------------
Q 016082          261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP--------------  326 (395)
Q Consensus       261 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~--------------  326 (395)
                      ....+...||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+......|              
T Consensus       217 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~  296 (464)
T 3ttj_A          217 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN  296 (464)
T ss_dssp             CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHH
T ss_pred             CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhh
Confidence            666677889999999999999999999999999999999999999999988766555544321111              


Q ss_pred             ------CCC---------C-----------CCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          327 ------TIP---------K-----------HAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       327 ------~~~---------~-----------~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                            ...         .           ..++++.+||.+||+.||.+|||+.|+++
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          297 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                  000         0           01567999999999999999999999987

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1e-46  Score=360.55  Aligned_cols=246  Identities=24%  Similarity=0.399  Sum_probs=201.4

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC-------
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP-------  180 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------  180 (395)
                      ++|++.+.||+|+||.||+|++  +++.||||+++... .....+.+.+|+.++++++||||+++++++.+.+       
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            4799999999999999999998  57899999997654 3445678999999999999999999999985543       


Q ss_pred             --------------------------------------------------cEEEEEecCCCCCHHHHHhhcc--CCCCHH
Q 016082          181 --------------------------------------------------NLCIVTEFMARGSIYDFLHKQK--GVFQLT  208 (395)
Q Consensus       181 --------------------------------------------------~~~lV~E~~~ggsL~~~l~~~~--~~l~~~  208 (395)
                                                                        ..++||||++||+|.+++....  ...+..
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              2899999999999999997743  234555


Q ss_pred             HHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-------------ccccCCCCccccc
Q 016082          209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-------------VMTAETGTYRWMA  275 (395)
Q Consensus       209 ~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-------------~~~~~~gt~~y~a  275 (395)
                      .++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......             ......||+.|+|
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a  244 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS  244 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence            689999999999999999999999999999999999999999999998665432             2234579999999


Q ss_pred             ccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHH
Q 016082          276 PEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFS  355 (395)
Q Consensus       276 PE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~  355 (395)
                      ||++.+..++.++||||||+++|+|++|..|+...   ............+..+...++++.++|.+||+.||.+|||+.
T Consensus       245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  321 (332)
T 3qd2_B          245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER---VRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEAT  321 (332)
T ss_dssp             HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH---HHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHH
T ss_pred             hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH---HHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHH
Confidence            99999999999999999999999999987765321   111111222222223345678899999999999999999999


Q ss_pred             HHHH
Q 016082          356 QITD  359 (395)
Q Consensus       356 ell~  359 (395)
                      |+++
T Consensus       322 ~~l~  325 (332)
T 3qd2_B          322 DIIE  325 (332)
T ss_dssp             HHHH
T ss_pred             HHhh
Confidence            9987

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=6.5e-47  Score=360.54  Aligned_cols=264  Identities=21%  Similarity=0.332  Sum_probs=216.1

Q ss_pred             CCCCceeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Q 016082          100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT  177 (395)
Q Consensus       100 ~~~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  177 (395)
                      .....+.++.++|++.+.||+|+||.||++++  .++.||||++...  .....+.+.+|+.++++++||||+++++++.
T Consensus        19 ~~g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   96 (317)
T 2buj_A           19 FQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCL   96 (317)
T ss_dssp             EEEEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred             ecccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEE
Confidence            33456788999999999999999999999996  6789999998654  3556678999999999999999999999986


Q ss_pred             ----cCCcEEEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEe
Q 016082          178 ----RPPNLCIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA  250 (395)
Q Consensus       178 ----~~~~~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~  250 (395)
                          .....++||||+++|+|.+++..   ....+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+
T Consensus        97 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~  176 (317)
T 2buj_A           97 RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLM  176 (317)
T ss_dssp             EEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEEC
T ss_pred             eccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEE
Confidence                34478999999999999999976   35679999999999999999999999999999999999999999999999


Q ss_pred             eeccccccccCC----------ccccCCCCcccccccccCCCC---CCChhhHHHHHHHHHHHHhCCCCCCCCCHH-HHH
Q 016082          251 DFGVARVQAQSG----------VMTAETGTYRWMAPEVIEHKP---YDYKADVFSFGIALWELLTGELPYAGLTPL-QAA  316 (395)
Q Consensus       251 DFg~a~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~---~~~k~DvwslG~vl~elltg~~pf~~~~~~-~~~  316 (395)
                      |||.++......          ......||+.|+|||++.+..   ++.++||||||+++|+|++|+.||...... ...
T Consensus       177 dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~  256 (317)
T 2buj_A          177 DLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV  256 (317)
T ss_dssp             CCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH
T ss_pred             ecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh
Confidence            999987543211          012335799999999987654   789999999999999999999999542110 001


Q ss_pred             HHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 016082          317 VGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM  365 (395)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~  365 (395)
                      ..........+.+..+++++.++|.+||+.||.+|||+.++++.|+++.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          257 ALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             HHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             hHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence            1122233444455678999999999999999999999999999988753

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=4.7e-46  Score=348.44  Aligned_cols=243  Identities=23%  Similarity=0.370  Sum_probs=211.8

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcEEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      ++|++.+.||+|+||.||+|++  +++.||||+++...........+.+|+..+.++ +||||+++++++...+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~   90 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN   90 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            5899999999999999999998  589999999987765566678899999999999 8999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCC-------------------
Q 016082          187 EFMARGSIYDFLHKQK---GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-------------------  244 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~-------------------  244 (395)
                      ||++|++|.+++....   +.+++..++.++.||+.||.|||++||+||||||+||+++.+                   
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~  170 (289)
T 1x8b_A           91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK  170 (289)
T ss_dssp             ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred             EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence            9999999999997642   678999999999999999999999999999999999999844                   


Q ss_pred             CcEEEeeeccccccccCCccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc
Q 016082          245 GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS  323 (395)
Q Consensus       245 ~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~  323 (395)
                      ..++|+|||.++.....   ....||+.|+|||++.+. .++.++||||||+++|+|++|.+|+.......    .....
T Consensus       171 ~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~----~~~~~  243 (289)
T 1x8b_A          171 VMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH----EIRQG  243 (289)
T ss_dssp             CCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHH----HHHTT
T ss_pred             eEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHH----HHHcC
Confidence            47999999999865543   234689999999999876 66789999999999999999998776543322    23345


Q ss_pred             CCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          324 LRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       324 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      ..+..+..+++++.++|.+||+.||.+|||+.++++
T Consensus       244 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          244 RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            556778889999999999999999999999999987

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5e-46  Score=362.88  Aligned_cols=250  Identities=28%  Similarity=0.426  Sum_probs=209.6

Q ss_pred             ceeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC-
Q 016082          104 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP-  180 (395)
Q Consensus       104 ~~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-  180 (395)
                      .|++ .++|++.+.||+|+||.||+|.+  +++.||||++.....+....+.+.+|+.++++++||||+++++++.... 
T Consensus        20 ~~~~-~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~   98 (367)
T 1cm8_A           20 AWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET   98 (367)
T ss_dssp             EECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred             eeee-cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCc
Confidence            4555 45899999999999999999997  5789999999776656667788999999999999999999999997663 


Q ss_pred             -----cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccc
Q 016082          181 -----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA  255 (395)
Q Consensus       181 -----~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a  255 (395)
                           .+|+||||+ +++|.+++..  +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        99 ~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A           99 LDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             TTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             cccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecc
Confidence                 469999999 7799999875  56899999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCC--------
Q 016082          256 RVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP--------  326 (395)
Q Consensus       256 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~--------  326 (395)
                      +....  ..+...+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+....+......+        
T Consensus       176 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~  253 (367)
T 1cm8_A          176 RQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL  253 (367)
T ss_dssp             EECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred             ccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            86543  2456688999999999876 689999999999999999999999999887765554443211111        


Q ss_pred             ---------------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          327 ---------------------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       327 ---------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                           ......++++.++|.+||+.||.+|||+.++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          254 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence                                 123467899999999999999999999999987

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.8e-47  Score=354.25  Aligned_cols=249  Identities=24%  Similarity=0.421  Sum_probs=193.1

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  185 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  185 (395)
                      .++|++.+.||+|+||.||+|++  +++.||||++..... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            35799999999999999999997  678999999964321 111246789999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-cc
Q 016082          186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VM  264 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~  264 (395)
                      |||+++++|.+++....+.+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||.+....... ..
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~  169 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH  169 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcc
Confidence            99999999999998877889999999999999999999999999999999999999999999999999998654322 22


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhh
Q 016082          265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW  344 (395)
Q Consensus       265 ~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  344 (395)
                      ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+........  ....|..+++++.++|.+||
T Consensus       170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l  247 (278)
T 3cok_A          170 YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA--DYEMPSFLSIEAKDLIHQLL  247 (278)
T ss_dssp             ----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSS--CCCCCTTSCHHHHHHHHHHS
T ss_pred             eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc--ccCCccccCHHHHHHHHHHc
Confidence            3457899999999999999999999999999999999999999876654443333222  23456778999999999999


Q ss_pred             ccCCCCCCCHHHHHH
Q 016082          345 QHDPTQRPNFSQITD  359 (395)
Q Consensus       345 ~~dp~~RPs~~ell~  359 (395)
                      +.||.+|||+.++++
T Consensus       248 ~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          248 RRNPADRLSLSSVLD  262 (278)
T ss_dssp             CSSGGGSCCHHHHTT
T ss_pred             ccCHhhCCCHHHHhc
Confidence            999999999999987

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.8e-46  Score=355.75  Aligned_cols=259  Identities=19%  Similarity=0.323  Sum_probs=210.6

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  185 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  185 (395)
                      .++|++.+.||+|+||.||+|++  .++.||+|+++.... .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            46899999999999999999997  578899999975533 344567899999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC--c
Q 016082          186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--V  263 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~--~  263 (395)
                      |||++|++|.+++.. .+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++......  .
T Consensus       113 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  191 (309)
T 2h34_A          113 MRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ  191 (309)
T ss_dssp             EECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred             EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccccc
Confidence            999999999999976 4679999999999999999999999999999999999999999999999999997654432  2


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC-CCCCCCCcHHHHHHHHH
Q 016082          264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR-PTIPKHAHPRLAELLER  342 (395)
Q Consensus       264 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~  342 (395)
                      .....|++.|+|||++.+..++.++||||||+++|+|++|+.||.+.........+...... ...+..+++++.++|.+
T Consensus       192 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  271 (309)
T 2h34_A          192 LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIAR  271 (309)
T ss_dssp             -----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHHHH
T ss_pred             ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHHHH
Confidence            23457899999999999999999999999999999999999999987655333222221111 23456788999999999


Q ss_pred             hhccCCCCCC-CHHHHHHHHHHHHHHH
Q 016082          343 CWQHDPTQRP-NFSQITDILKQMMKEV  368 (395)
Q Consensus       343 cl~~dp~~RP-s~~ell~~l~~~~~~~  368 (395)
                      ||+.||.+|| +++++++.|++++...
T Consensus       272 ~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          272 GMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             HTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             hccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence            9999999999 9999999998775544

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=7.4e-46  Score=351.56  Aligned_cols=247  Identities=23%  Similarity=0.429  Sum_probs=214.1

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      .++|++.+.||+|+||.||++++  +++.||+|+++...  ......+.+|+.++++++||||+++++++......++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM   85 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence            35899999999999999999998  57899999998653  223357889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee---CCCCcEEEeeeccccccccCCc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGV  263 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl---~~~~~vkl~DFg~a~~~~~~~~  263 (395)
                      ||+++++|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+||++   +.++.++|+|||.++..... .
T Consensus        86 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~  163 (304)
T 2jam_A           86 QLVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-I  163 (304)
T ss_dssp             CCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-T
T ss_pred             EcCCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-c
Confidence            99999999999976 4678999999999999999999999999999999999999   78889999999999754432 2


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC--CCCCCCCcHHHHHHHH
Q 016082          264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLAELLE  341 (395)
Q Consensus       264 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~  341 (395)
                      .....||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+......  ...+..+++++.++|.
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  243 (304)
T 2jam_A          164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFIC  243 (304)
T ss_dssp             THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHH
T ss_pred             cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHH
Confidence            33446899999999999999999999999999999999999999998877666655544332  2334678999999999


Q ss_pred             HhhccCCCCCCCHHHHHH
Q 016082          342 RCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       342 ~cl~~dp~~RPs~~ell~  359 (395)
                      +||+.||.+|||+.++++
T Consensus       244 ~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          244 HLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             HHHCSSTTTSCCHHHHHT
T ss_pred             HHcCCChhHCcCHHHHhc
Confidence            999999999999999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.6e-46  Score=356.70  Aligned_cols=259  Identities=25%  Similarity=0.434  Sum_probs=202.8

Q ss_pred             CCceeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEEEEe-
Q 016082          102 TDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACT-  177 (395)
Q Consensus       102 ~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~-  177 (395)
                      ...+++...+|++.++||+|+||.||+|++  +++.||||++...  .....+.+.+|+.+++++. ||||+++++++. 
T Consensus        20 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~   97 (337)
T 3ll6_A           20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI   97 (337)
T ss_dssp             TCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             cceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence            356788889999999999999999999998  6789999998654  3556678999999999996 999999999994 


Q ss_pred             -------cCCcEEEEEecCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCeeeCCCCc
Q 016082          178 -------RPPNLCIVTEFMARGSIYDFLHK--QKGVFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGV  246 (395)
Q Consensus       178 -------~~~~~~lV~E~~~ggsL~~~l~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~--iiHrDlkp~NiLl~~~~~  246 (395)
                             ....+++||||+. |+|.+++..  ..+++++..++.++.||+.||.|||+.|  |+||||||+||+++.++.
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~  176 (337)
T 3ll6_A           98 GKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT  176 (337)
T ss_dssp             CTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC
T ss_pred             cccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC
Confidence                   3345899999996 599998865  3567999999999999999999999999  999999999999999999


Q ss_pred             EEEeeeccccccccCCcc-------------ccCCCCccccccccc---CCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 016082          247 VKVADFGVARVQAQSGVM-------------TAETGTYRWMAPEVI---EHKPYDYKADVFSFGIALWELLTGELPYAGL  310 (395)
Q Consensus       247 vkl~DFg~a~~~~~~~~~-------------~~~~gt~~y~aPE~~---~~~~~~~k~DvwslG~vl~elltg~~pf~~~  310 (395)
                      +||+|||+++........             ....||+.|+|||++   .+..++.++||||||+++|+|++|+.||...
T Consensus       177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~  256 (337)
T 3ll6_A          177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG  256 (337)
T ss_dssp             EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence            999999999865443211             134589999999998   5677899999999999999999999999876


Q ss_pred             CHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 016082          311 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE  367 (395)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~  367 (395)
                      .....    .........+...++.+.++|.+||+.||.+|||+.++++.|+.+...
T Consensus       257 ~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~  309 (337)
T 3ll6_A          257 AKLRI----VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA  309 (337)
T ss_dssp             -------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hHHHh----hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            54432    223334445566788899999999999999999999999999988764

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.3e-46  Score=348.50  Aligned_cols=251  Identities=23%  Similarity=0.471  Sum_probs=209.9

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  182 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  182 (395)
                      .+..++|++.+.||+|+||.||+|++  +++.||||+++.... ..+..+.+.+|+.++++++||||+++++++......
T Consensus         7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (276)
T 2h6d_A            7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF   86 (276)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence            34567999999999999999999998  478999999864321 112345788999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC
Q 016082          183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~  262 (395)
                      ++||||+++++|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||.+.......
T Consensus        87 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  165 (276)
T 2h6d_A           87 FMVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  165 (276)
T ss_dssp             EEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             EEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence            999999999999999976 4578999999999999999999999999999999999999999999999999998766554


Q ss_pred             ccccCCCCcccccccccCCCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHH
Q 016082          263 VMTAETGTYRWMAPEVIEHKPY-DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE  341 (395)
Q Consensus       263 ~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  341 (395)
                      ......||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||...........+...  ....|..+++++.++|.
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~  243 (276)
T 2h6d_A          166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG--VFYIPEYLNRSVATLLM  243 (276)
T ss_dssp             -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHH
T ss_pred             ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC--cccCchhcCHHHHHHHH
Confidence            4455678999999999988776 68999999999999999999999988776655444332  34567788999999999


Q ss_pred             HhhccCCCCCCCHHHHHH
Q 016082          342 RCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       342 ~cl~~dp~~RPs~~ell~  359 (395)
                      +||+.||.+|||+.++++
T Consensus       244 ~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          244 HMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHccCChhhCCCHHHHHh
Confidence            999999999999999987

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=6.6e-46  Score=372.18  Aligned_cols=252  Identities=24%  Similarity=0.361  Sum_probs=193.7

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec----
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR----  178 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----  178 (395)
                      |.+ .++|++.+.||+|+||.||+|++  +++.||||++.....+....+.+.+|+.+|++++||||+++++++..    
T Consensus        49 ~~~-~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  127 (458)
T 3rp9_A           49 WQI-PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVE  127 (458)
T ss_dssp             CCS-CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTT
T ss_pred             Ccc-CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcc
Confidence            444 35899999999999999999987  57899999998766666677889999999999999999999999843    


Q ss_pred             -CCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccc
Q 016082          179 -PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV  257 (395)
Q Consensus       179 -~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~  257 (395)
                       ...+|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus       128 ~~~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  205 (458)
T 3rp9_A          128 KFDELYVVLEIAD-SDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLART  205 (458)
T ss_dssp             TCCCEEEEECCCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             cCceEEEEEeccc-cchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchh
Confidence             356999999985 599999876 56799999999999999999999999999999999999999999999999999986


Q ss_pred             cccCC----------------------------ccccCCCCccccccccc-CCCCCCChhhHHHHHHHHHHHHh------
Q 016082          258 QAQSG----------------------------VMTAETGTYRWMAPEVI-EHKPYDYKADVFSFGIALWELLT------  302 (395)
Q Consensus       258 ~~~~~----------------------------~~~~~~gt~~y~aPE~~-~~~~~~~k~DvwslG~vl~ellt------  302 (395)
                      .....                            ..+...||+.|+|||++ .+..|+.++|||||||++|||++      
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~  285 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV  285 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence            54221                            23445789999999986 56679999999999999999998      


Q ss_pred             -----CCCCCCCCCHH--------------------HHHHHhhh----------------------ccCC-------CCC
Q 016082          303 -----GELPYAGLTPL--------------------QAAVGVVQ----------------------KSLR-------PTI  328 (395)
Q Consensus       303 -----g~~pf~~~~~~--------------------~~~~~~~~----------------------~~~~-------~~~  328 (395)
                           |+++|.+.+..                    .....+..                      ....       ...
T Consensus       286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (458)
T 3rp9_A          286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER  365 (458)
T ss_dssp             SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred             cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence                 77788765421                    10110000                      0000       001


Q ss_pred             CCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          329 PKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       329 ~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      .+..++++.+||.+||+.||.+|||+.|+++
T Consensus       366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~  396 (458)
T 3rp9_A          366 FPASSADAIHLLKRMLVFNPNKRITINECLA  396 (458)
T ss_dssp             STTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            2356899999999999999999999999988

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-46  Score=358.82  Aligned_cols=250  Identities=27%  Similarity=0.393  Sum_probs=208.5

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCH---HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT---EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  183 (395)
                      .++|++.+.||+|+||.||+|++  +++.||||+++......   ...+.+.+|+.++++++||||+++++++......+
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   88 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS   88 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence            46899999999999999999988  47899999997543221   22356889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-C
Q 016082          184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-G  262 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-~  262 (395)
                      +||||+++ +|.+++......+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..... .
T Consensus        89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  167 (346)
T 1ua2_A           89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  167 (346)
T ss_dssp             EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc
Confidence            99999987 899999877778999999999999999999999999999999999999999999999999999865433 2


Q ss_pred             ccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCC--------------
Q 016082          263 VMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT--------------  327 (395)
Q Consensus       263 ~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~--------------  327 (395)
                      ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+......+.              
T Consensus       168 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  247 (346)
T 1ua2_A          168 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV  247 (346)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred             cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccc
Confidence            34556789999999999754 589999999999999999999999999888776665544221111              


Q ss_pred             -------C-----CCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          328 -------I-----PKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       328 -------~-----~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                             .     ...+++++.++|.+||+.||.+|||+.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          248 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence                   1     1456789999999999999999999999987

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=8.6e-46  Score=356.46  Aligned_cols=248  Identities=26%  Similarity=0.433  Sum_probs=219.8

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  185 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  185 (395)
                      .++|.+.+.||+|+||.||++++  +++.||+|++.... ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            46899999999999999999998  46789999987543 2455667899999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-Ccc
Q 016082          186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVM  264 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-~~~  264 (395)
                      |||+++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..... ...
T Consensus       120 ~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  198 (335)
T 2owb_A          120 LELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK  198 (335)
T ss_dssp             ECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred             EecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcccc
Confidence            999999999999876 467999999999999999999999999999999999999999999999999999865433 233


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhh
Q 016082          265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW  344 (395)
Q Consensus       265 ~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  344 (395)
                      ....||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+...  ....+..+++++.++|.+||
T Consensus       199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l  276 (335)
T 2owb_A          199 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKHINPVAASLIQKML  276 (335)
T ss_dssp             CCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--CCCCCTTSCHHHHHHHHHHT
T ss_pred             cccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC--CCCCCccCCHHHHHHHHHHc
Confidence            4457899999999999999999999999999999999999999988776665554433  34567788999999999999


Q ss_pred             ccCCCCCCCHHHHHH
Q 016082          345 QHDPTQRPNFSQITD  359 (395)
Q Consensus       345 ~~dp~~RPs~~ell~  359 (395)
                      +.||.+|||+.++++
T Consensus       277 ~~dp~~Rps~~ell~  291 (335)
T 2owb_A          277 QTDPTARPTINELLN  291 (335)
T ss_dssp             CSSGGGSCCGGGGGG
T ss_pred             cCChhHCcCHHHHhc
Confidence            999999999999987

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=9.5e-46  Score=348.97  Aligned_cols=248  Identities=26%  Similarity=0.434  Sum_probs=219.6

Q ss_pred             ccCcceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  185 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  185 (395)
                      .++|++.+.||+|+||.||++++.  ++.||+|++..... .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            458999999999999999999984  68899999875532 445667899999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-Ccc
Q 016082          186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVM  264 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-~~~  264 (395)
                      |||+++++|.+++.. .+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||.++..... ...
T Consensus        94 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  172 (294)
T 2rku_A           94 LELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK  172 (294)
T ss_dssp             EECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred             EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcccc
Confidence            999999999998876 467999999999999999999999999999999999999999999999999999865432 223


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhh
Q 016082          265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW  344 (395)
Q Consensus       265 ~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  344 (395)
                      ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||......+....+...  ....|..+++.+.++|.+||
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l  250 (294)
T 2rku_A          173 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKHINPVAASLIQKML  250 (294)
T ss_dssp             CCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--CCCCCTTSCHHHHHHHHHHT
T ss_pred             ccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc--cCCCccccCHHHHHHHHHHc
Confidence            4457899999999999999999999999999999999999999998876665554432  34567788999999999999


Q ss_pred             ccCCCCCCCHHHHHH
Q 016082          345 QHDPTQRPNFSQITD  359 (395)
Q Consensus       345 ~~dp~~RPs~~ell~  359 (395)
                      +.||.+|||+.++++
T Consensus       251 ~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          251 QTDPTARPTINELLN  265 (294)
T ss_dssp             CSSGGGSCCGGGGGG
T ss_pred             ccChhhCcCHHHHhh
Confidence            999999999999987

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-46  Score=361.04  Aligned_cols=248  Identities=23%  Similarity=0.392  Sum_probs=205.0

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      ++|++.++||+|+||.||+|++  +++.||||+++.... ......+.+|+.++++++||||+++++++......++|||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   80 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence            5799999999999999999998  478899999975531 1222345679999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-Ccccc
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTA  266 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-~~~~~  266 (395)
                      |++| +|.+++......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..... .....
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  159 (324)
T 3mtl_A           81 YLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN  159 (324)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred             cccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccccc
Confidence            9985 999999887778999999999999999999999999999999999999999999999999999765433 23344


Q ss_pred             CCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCC------------------
Q 016082          267 ETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT------------------  327 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~------------------  327 (395)
                      ..||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+....+......+.                  
T Consensus       160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
T 3mtl_A          160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNY  239 (324)
T ss_dssp             ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCC
T ss_pred             ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccccc
Confidence            578999999999876 5789999999999999999999999999887766555443211111                  


Q ss_pred             ----------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          328 ----------IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       328 ----------~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                ....+++++.++|.+||+.||.+|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          240 PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             CCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                      11346789999999999999999999999987

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.8e-46  Score=367.84  Aligned_cols=243  Identities=22%  Similarity=0.368  Sum_probs=196.2

Q ss_pred             cCccee-eeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHh-cCCCceeeEEEEEec----CCc
Q 016082          110 KQLKIE-CKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK-IRHKNVVQFIGACTR----PPN  181 (395)
Q Consensus       110 ~~~~i~-~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~  181 (395)
                      ++|.+. +.||+|+||.||+|.+  +++.||||+++..       ..+.+|+.++.+ .+||||+++++++..    ...
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~  133 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC  133 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence            467776 7899999999999998  4788999999743       456788888754 479999999998865    567


Q ss_pred             EEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCC---CCcEEEeeeccccc
Q 016082          182 LCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NGVVKVADFGVARV  257 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~---~~~vkl~DFg~a~~  257 (395)
                      +|+||||++||+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++.
T Consensus       134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~  213 (400)
T 1nxk_A          134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  213 (400)
T ss_dssp             EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccc
Confidence            899999999999999998753 46999999999999999999999999999999999999998   78999999999987


Q ss_pred             cccCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHhhhccCCCC--CCCC
Q 016082          258 QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ----AAVGVVQKSLRPT--IPKH  331 (395)
Q Consensus       258 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~----~~~~~~~~~~~~~--~~~~  331 (395)
                      ...........||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.....    ....+........  ....
T Consensus       214 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  293 (400)
T 1nxk_A          214 TTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE  293 (400)
T ss_dssp             CC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTT
T ss_pred             cCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCccccc
Confidence            665555566789999999999999999999999999999999999999997754321    1122222222222  2256


Q ss_pred             CcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          332 AHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       332 ~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      +++++.++|.+||+.||.+|||+.++++
T Consensus       294 ~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          294 VSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            8999999999999999999999999987

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.2e-45  Score=359.91  Aligned_cols=249  Identities=22%  Similarity=0.423  Sum_probs=217.1

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC--C----HHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCC
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV--N----TEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPP  180 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~--~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  180 (395)
                      ++|++.+.||+|+||.||+|++  +++.||||+++....  .    ....+.+.+|+.+++++ +||||+++++++....
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            5799999999999999999998  488999999976542  1    12346688999999999 7999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                      ..|+||||++|++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~  252 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP  252 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             EEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence            99999999999999999976 46799999999999999999999999999999999999999999999999999987666


Q ss_pred             CCccccCCCCcccccccccC------CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCC--CCC
Q 016082          261 SGVMTAETGTYRWMAPEVIE------HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP--KHA  332 (395)
Q Consensus       261 ~~~~~~~~gt~~y~aPE~~~------~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~  332 (395)
                      ........||+.|+|||++.      ...++.++|||||||++|+|++|..||.+.+.......+.........+  ...
T Consensus       253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  332 (365)
T 2y7j_A          253 GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDR  332 (365)
T ss_dssp             TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSS
T ss_pred             CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccC
Confidence            55556678999999999985      3468899999999999999999999999888776665555443333222  467


Q ss_pred             cHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          333 HPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       333 ~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      ++++.++|.+||+.||.+|||+.++++
T Consensus       333 ~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          333 SSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            889999999999999999999999987

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.6e-46  Score=358.92  Aligned_cols=251  Identities=21%  Similarity=0.379  Sum_probs=215.0

Q ss_pred             ccCccee-eeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCcEEE
Q 016082          109 AKQLKIE-CKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCI  184 (395)
Q Consensus       109 ~~~~~i~-~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  184 (395)
                      .+.|.+. +.||+|+||.||+|++  +++.||+|+++...........+.+|+.+++++. ||||+++++++......++
T Consensus        27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l  106 (327)
T 3lm5_A           27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL  106 (327)
T ss_dssp             HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence            4467777 8899999999999988  4789999999876555555678999999999996 6999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCC---CCcEEEeeecccccccc
Q 016082          185 VTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NGVVKVADFGVARVQAQ  260 (395)
Q Consensus       185 V~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~---~~~vkl~DFg~a~~~~~  260 (395)
                      ||||++||+|.+++... .+.+++..++.++.|++.||.|||++||+||||||+||+++.   ++.+||+|||+++....
T Consensus       107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  186 (327)
T 3lm5_A          107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH  186 (327)
T ss_dssp             EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred             EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence            99999999999998653 467999999999999999999999999999999999999998   78999999999987766


Q ss_pred             CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccC--CCCCCCCCcHHHHH
Q 016082          261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL--RPTIPKHAHPRLAE  338 (395)
Q Consensus       261 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~  338 (395)
                      ........||+.|+|||++.+.+++.++||||||+++|+|++|+.||.+.+..+....+.....  .......+++.+.+
T Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  266 (327)
T 3lm5_A          187 ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATD  266 (327)
T ss_dssp             -------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred             ccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHH
Confidence            5555566899999999999999999999999999999999999999999888776665544332  23344578999999


Q ss_pred             HHHHhhccCCCCCCCHHHHHH
Q 016082          339 LLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       339 li~~cl~~dp~~RPs~~ell~  359 (395)
                      +|.+||+.||.+|||+.++++
T Consensus       267 li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          267 FIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             HHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHHHcCCChhhCcCHHHHhC
Confidence            999999999999999999987

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=9.8e-47  Score=363.42  Aligned_cols=242  Identities=23%  Similarity=0.412  Sum_probs=211.5

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHH------HHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTE------MLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  180 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (395)
                      .++|++.+.||+|+||.||+|++  +++.||||+++.......      ....+.+|+.++++++||||+++++++...+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            35899999999999999999987  678999999986643221      3346778999999999999999999999999


Q ss_pred             cEEEEEecCCCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccc
Q 016082          181 NLCIVTEFMARG-SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  259 (395)
Q Consensus       181 ~~~lV~E~~~gg-sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~  259 (395)
                      ..++||||+.+| +|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  181 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE  181 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence            999999999776 99999976 5679999999999999999999999999999999999999999999999999998776


Q ss_pred             cCCccccCCCCcccccccccCCCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHH
Q 016082          260 QSGVMTAETGTYRWMAPEVIEHKPY-DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE  338 (395)
Q Consensus       260 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  338 (395)
                      .........||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.....      ..  ......|..+++++.+
T Consensus       182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~--~~~~~~~~~~~~~l~~  253 (335)
T 3dls_A          182 RGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TV--EAAIHPPYLVSKELMS  253 (335)
T ss_dssp             TTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GT--TTCCCCSSCCCHHHHH
T ss_pred             CCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HH--hhccCCCcccCHHHHH
Confidence            6555556689999999999988876 7899999999999999999999976432      11  1223445668999999


Q ss_pred             HHHHhhccCCCCCCCHHHHHH
Q 016082          339 LLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       339 li~~cl~~dp~~RPs~~ell~  359 (395)
                      +|.+||+.||.+|||+.++++
T Consensus       254 li~~~L~~dP~~Rps~~ell~  274 (335)
T 3dls_A          254 LVSGLLQPVPERRTTLEKLVT  274 (335)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCChhhCcCHHHHhc
Confidence            999999999999999999988

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.9e-47  Score=368.25  Aligned_cols=258  Identities=20%  Similarity=0.304  Sum_probs=204.9

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEE-----CCceEEEEEecCCCCCHH---------HHHHHHHHHHHHHhcCCCcee
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTE---------MLKEFSQEVYIMRKIRHKNVV  170 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~-----~~~~vAvK~~~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv  170 (395)
                      ..+..++|++.+.||+|+||.||+|++     .+..||||+.........         ....+.+|+.+++.++||||+
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~  111 (345)
T 2v62_A           32 DDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIP  111 (345)
T ss_dssp             ECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCC
T ss_pred             ccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcc
Confidence            445678999999999999999999998     347899999976532110         112366788999999999999


Q ss_pred             eEEEEEec----CCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCC-
Q 016082          171 QFIGACTR----PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-  245 (395)
Q Consensus       171 ~l~~~~~~----~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~-  245 (395)
                      ++++++..    ....|+||||+ |++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.++ 
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~  189 (345)
T 2v62_A          112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN-GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNP  189 (345)
T ss_dssp             CEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG-GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSST
T ss_pred             eeecccccccCCCcEEEEEEecc-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCC
Confidence            99999987    67899999999 89999999764 4899999999999999999999999999999999999999887 


Q ss_pred             -cEEEeeeccccccccCC--------ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 016082          246 -VVKVADFGVARVQAQSG--------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAA  316 (395)
Q Consensus       246 -~vkl~DFg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~  316 (395)
                       .+||+|||+++......        ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.......
T Consensus       190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  269 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA  269 (345)
T ss_dssp             TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred             CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence             99999999997654321        123457899999999999999999999999999999999999999653222111


Q ss_pred             HHhhhccCCCCCC---------CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 016082          317 VGVVQKSLRPTIP---------KHAHPRLAELLERCWQHDPTQRPNFSQITDILKQM  364 (395)
Q Consensus       317 ~~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~  364 (395)
                      .........+..+         ..+++++.++|.+||+.||.+||++.++++.|+++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  326 (345)
T 2v62_A          270 VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH  326 (345)
T ss_dssp             HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred             HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence            1111112222222         26888999999999999999999999999988764

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=6.7e-46  Score=360.29  Aligned_cols=251  Identities=24%  Similarity=0.441  Sum_probs=214.4

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  183 (395)
                      ++..++|++.+.||+|+||.||+|++.  ++.||+|+++... .....+.+.+|+.++++++||||+++++++...+..+
T Consensus        29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  107 (360)
T 3eqc_A           29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS  107 (360)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence            456679999999999999999999985  7899999998663 4566788999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCeeeCCCCcEEEeeeccccccccCC
Q 016082          184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~  262 (395)
                      +||||++|++|.+++.. .+.+++..+..++.+++.||.|||+. ||+||||||+||+++.++.++|+|||+++..... 
T Consensus       108 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  185 (360)
T 3eqc_A          108 ICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  185 (360)
T ss_dssp             EEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred             EEEECCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence            99999999999999976 45799999999999999999999996 9999999999999999999999999999755432 


Q ss_pred             ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh-----------------------
Q 016082          263 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV-----------------------  319 (395)
Q Consensus       263 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~-----------------------  319 (395)
                      ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+.....                       
T Consensus       186 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (360)
T 3eqc_A          186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN  265 (360)
T ss_dssp             C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred             cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence            234457999999999999999999999999999999999999999876654332111                       


Q ss_pred             ------------------hhccCCCCC-CCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          320 ------------------VQKSLRPTI-PKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       320 ------------------~~~~~~~~~-~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                        ......+.. +..++.++.++|.+||+.||.+|||+.++++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             --------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                              111112222 2357889999999999999999999999987

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=352.66  Aligned_cols=250  Identities=31%  Similarity=0.540  Sum_probs=210.2

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEEEEec-----
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTR-----  178 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-----  178 (395)
                      ...++|++.+.||+|+||.||+|++  .++.||||++......   ...+.+|+.+++++ +||||+++++++..     
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   97 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   97 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence            3467899999999999999999998  6789999999765322   36788999999999 79999999999976     


Q ss_pred             -CCcEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccc
Q 016082          179 -PPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR  256 (395)
Q Consensus       179 -~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~  256 (395)
                       ....++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  177 (326)
T 2x7f_A           98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  177 (326)
T ss_dssp             CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred             ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence             457899999999999999998643 578999999999999999999999999999999999999999999999999997


Q ss_pred             ccccC-CccccCCCCcccccccccC-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCC
Q 016082          257 VQAQS-GVMTAETGTYRWMAPEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK  330 (395)
Q Consensus       257 ~~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  330 (395)
                      ..... .......||+.|+|||++.     +..++.++||||||+++|+|++|..||...........+.........+.
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  257 (326)
T 2x7f_A          178 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSK  257 (326)
T ss_dssp             -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCS
T ss_pred             ecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCcc
Confidence            65432 2234457899999999987     56789999999999999999999999999887776665555444444566


Q ss_pred             CCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          331 HAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       331 ~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      .+++.+.++|.+||+.||.+||++.++++
T Consensus       258 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          258 KWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             CSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            78999999999999999999999999987

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.1e-45  Score=358.60  Aligned_cols=249  Identities=24%  Similarity=0.402  Sum_probs=211.2

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-----CCceeeEEEEEe
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-----HKNVVQFIGACT  177 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~~~~  177 (395)
                      ..+-.++|++.++||+|+||.||+|++  +++.||||+++..   ......+..|+.+++.++     ||||+++++++.
T Consensus        30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~  106 (360)
T 3llt_A           30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM  106 (360)
T ss_dssp             TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred             ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence            345577999999999999999999998  6788999999743   455677888999999997     999999999999


Q ss_pred             cCCcEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCC-------------
Q 016082          178 RPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-------------  243 (395)
Q Consensus       178 ~~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~-------------  243 (395)
                      ..+..++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.             
T Consensus       107 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~  185 (360)
T 3llt_A          107 YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRV  185 (360)
T ss_dssp             ETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred             ECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcc
Confidence            999999999999 889999997654 46999999999999999999999999999999999999975             


Q ss_pred             ------------CCcEEEeeeccccccccCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 016082          244 ------------NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT  311 (395)
Q Consensus       244 ------------~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~  311 (395)
                                  ++.+||+|||+++.....  .....||+.|+|||++.+.+++.++|||||||++|+|++|+.||.+.+
T Consensus       186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  263 (360)
T 3llt_A          186 TDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHE  263 (360)
T ss_dssp             TTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence                        789999999999864432  345678999999999999999999999999999999999999999877


Q ss_pred             HHHHHHHhhhccCCC------------------------CCC--------------------CCCcHHHHHHHHHhhccC
Q 016082          312 PLQAAVGVVQKSLRP------------------------TIP--------------------KHAHPRLAELLERCWQHD  347 (395)
Q Consensus       312 ~~~~~~~~~~~~~~~------------------------~~~--------------------~~~~~~l~~li~~cl~~d  347 (395)
                      ..+....+.......                        ..|                    ...++.+.++|.+||+.|
T Consensus       264 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  343 (360)
T 3llt_A          264 HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQID  343 (360)
T ss_dssp             HHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSS
T ss_pred             HHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCC
Confidence            665544332211000                        000                    112367889999999999


Q ss_pred             CCCCCCHHHHHH
Q 016082          348 PTQRPNFSQITD  359 (395)
Q Consensus       348 p~~RPs~~ell~  359 (395)
                      |.+|||+.|+++
T Consensus       344 P~~Rpta~elL~  355 (360)
T 3llt_A          344 PTLRPSPAELLK  355 (360)
T ss_dssp             GGGSCCHHHHTT
T ss_pred             hhhCCCHHHHhc
Confidence            999999999875

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.5e-46  Score=360.84  Aligned_cols=255  Identities=28%  Similarity=0.489  Sum_probs=203.2

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHH--HHhcCCCceeeEEEEEec----
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYI--MRKIRHKNVVQFIGACTR----  178 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~----  178 (395)
                      +.++.++|++.+.||+|+||.||+|++.++.||||+++...     ...+..|..+  +..++||||+++++.+..    
T Consensus         8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~   82 (336)
T 3g2f_A            8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTAD   82 (336)
T ss_dssp             -CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred             CCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence            45677899999999999999999999999999999997432     2334444444  445899999999985532    


Q ss_pred             -CCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---------CccccCCCCCCeeeCCCCcEE
Q 016082          179 -PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN---------NIIHRDLKTANLLMDENGVVK  248 (395)
Q Consensus       179 -~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------~iiHrDlkp~NiLl~~~~~vk  248 (395)
                       ...+++||||+++|+|.+++...  ..++..+..++.||+.||.|||+.         ||+||||||+|||++.++.+|
T Consensus        83 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           83 GRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             SCEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred             CCceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence             23579999999999999999763  458889999999999999999999         999999999999999999999


Q ss_pred             EeeeccccccccCC---------ccccCCCCcccccccccCC-------CCCCChhhHHHHHHHHHHHHhCCCCCCC-CC
Q 016082          249 VADFGVARVQAQSG---------VMTAETGTYRWMAPEVIEH-------KPYDYKADVFSFGIALWELLTGELPYAG-LT  311 (395)
Q Consensus       249 l~DFg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~-------~~~~~k~DvwslG~vl~elltg~~pf~~-~~  311 (395)
                      |+|||+++......         ......||+.|+|||++.+       ..++.++|||||||++|||++|..||.. ..
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            99999997654321         2234569999999999987       4567899999999999999999766532 11


Q ss_pred             -----------------HHHHHHHhhhccCCCCCCCC------CcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 016082          312 -----------------PLQAAVGVVQKSLRPTIPKH------AHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK  366 (395)
Q Consensus       312 -----------------~~~~~~~~~~~~~~~~~~~~------~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~  366 (395)
                                       .............++.+|..      +++++.++|.+||+.||.+|||+.|+++.|++++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~  318 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM  318 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence                             11112222334445555554      45589999999999999999999999999988874

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.3e-46  Score=355.10  Aligned_cols=252  Identities=32%  Similarity=0.614  Sum_probs=208.0

Q ss_pred             ccCcceeeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc--CCCceeeEEEEEecC----CcE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI--RHKNVVQFIGACTRP----PNL  182 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----~~~  182 (395)
                      .++|++.+.||+|+||.||+|++.++.||||++...   .  ...+..|..++...  +||||+++++++...    ...
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  110 (337)
T 3mdy_A           36 AKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTT---E--EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL  110 (337)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGG---G--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred             ccceEEEeEeecCCCeEEEEEEECCceEEEEEEecc---c--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence            468999999999999999999999999999998643   1  23445566666554  899999999999877    679


Q ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCCCCeeeCCCCcEEEeeecc
Q 016082          183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN--------NIIHRDLKTANLLMDENGVVKVADFGV  254 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------~iiHrDlkp~NiLl~~~~~vkl~DFg~  254 (395)
                      ++||||+++|+|.++++.  ..+++..++.++.|++.||.|||+.        ||+||||||+||+++.++.+||+|||+
T Consensus       111 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~  188 (337)
T 3mdy_A          111 YLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  188 (337)
T ss_dssp             EEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCC
Confidence            999999999999999965  4689999999999999999999999        999999999999999999999999999


Q ss_pred             ccccccCCc-----cccCCCCcccccccccCCCCCCCh------hhHHHHHHHHHHHHhC----------CCCCCCCCH-
Q 016082          255 ARVQAQSGV-----MTAETGTYRWMAPEVIEHKPYDYK------ADVFSFGIALWELLTG----------ELPYAGLTP-  312 (395)
Q Consensus       255 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~k------~DvwslG~vl~elltg----------~~pf~~~~~-  312 (395)
                      ++.......     .....||+.|+|||++.+..++.+      +|||||||++|||++|          +.||....+ 
T Consensus       189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~  268 (337)
T 3mdy_A          189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS  268 (337)
T ss_dssp             CEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred             ceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCC
Confidence            975543321     124579999999999988776654      9999999999999999          777765322 


Q ss_pred             ----HHHHHHhhhccCCCCCCC-----CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 016082          313 ----LQAAVGVVQKSLRPTIPK-----HAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE  367 (395)
Q Consensus       313 ----~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~  367 (395)
                          ............++..+.     .+++++.++|.+||+.||.+|||+.++++.|+++.++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  332 (337)
T 3mdy_A          269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES  332 (337)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence                222223333445555554     4567899999999999999999999999999998764

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4.1e-46  Score=353.39  Aligned_cols=255  Identities=28%  Similarity=0.490  Sum_probs=211.8

Q ss_pred             CcceeeeeeeeCceEEEEEEECCceEEEEEecCCC--CCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Q 016082          111 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPEC--VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  188 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  188 (395)
                      .|...++||+|+||.||+|++.++.||||++....  ......+.+.+|+.++++++||||+++++++......++||||
T Consensus        32 ~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  111 (307)
T 2nru_A           32 ISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVY  111 (307)
T ss_dssp             TTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             ccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEe
Confidence            35566899999999999999999999999997543  2345567899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC---c
Q 016082          189 MARGSIYDFLHKQ--KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---V  263 (395)
Q Consensus       189 ~~ggsL~~~l~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~---~  263 (395)
                      +++++|.+++...  ..++++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++......   .
T Consensus       112 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  191 (307)
T 2nru_A          112 MPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM  191 (307)
T ss_dssp             CTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEE
T ss_pred             cCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccccc
Confidence            9999999999753  3568999999999999999999999999999999999999999999999999997654322   1


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhh----------c---cCCCCCCC
Q 016082          264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ----------K---SLRPTIPK  330 (395)
Q Consensus       264 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~----------~---~~~~~~~~  330 (395)
                      .....||+.|+|||++.+. ++.++||||||+++|+|++|..||......+....+..          .   ...+..+.
T Consensus       192 ~~~~~g~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (307)
T 2nru_A          192 TSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADS  270 (307)
T ss_dssp             CSSCCSCGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCH
T ss_pred             ccccCCCcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccch
Confidence            2335789999999998764 79999999999999999999999987543221111100          0   11122334


Q ss_pred             CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 016082          331 HAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK  366 (395)
Q Consensus       331 ~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~  366 (395)
                      ..+..+.+++.+||+.||.+|||+.++++.|+++..
T Consensus       271 ~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          271 TSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             HHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            456789999999999999999999999999998753

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=5.7e-46  Score=348.76  Aligned_cols=250  Identities=24%  Similarity=0.433  Sum_probs=218.4

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  182 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  182 (395)
                      .+..++|++.+.||+|+||.||+|++  +++.||+|++...... ......+.+|+.++++++||||+++++++...+..
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   89 (284)
T 2vgo_A           10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI   89 (284)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence            34567899999999999999999998  4678999998643211 11236788999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC
Q 016082          183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~  262 (395)
                      ++||||+++|+|.+++.. .+.+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++...... 
T Consensus        90 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-  167 (284)
T 2vgo_A           90 YLMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-  167 (284)
T ss_dssp             EEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred             EEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence            999999999999999976 457999999999999999999999999999999999999999999999999998755432 


Q ss_pred             ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHH
Q 016082          263 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER  342 (395)
Q Consensus       263 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  342 (395)
                      ......|++.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+..  .....|..+++++.++|.+
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~  245 (284)
T 2vgo_A          168 RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN--VDLKFPPFLSDGSKDLISK  245 (284)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT--TCCCCCTTSCHHHHHHHHH
T ss_pred             ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhc--cccCCCCcCCHHHHHHHHH
Confidence            23456789999999999999999999999999999999999999998887666555443  2345677899999999999


Q ss_pred             hhccCCCCCCCHHHHHH
Q 016082          343 CWQHDPTQRPNFSQITD  359 (395)
Q Consensus       343 cl~~dp~~RPs~~ell~  359 (395)
                      ||+.||.+||++.++++
T Consensus       246 ~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          246 LLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             HSCSSGGGSCCHHHHHT
T ss_pred             HhhcCHhhCCCHHHHhh
Confidence            99999999999999987

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.1e-45  Score=385.95  Aligned_cols=263  Identities=30%  Similarity=0.591  Sum_probs=228.2

Q ss_pred             CceeecccCcceeeeeeeeCceEEEEEEEC-----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Q 016082          103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT  177 (395)
Q Consensus       103 ~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  177 (395)
                      ..+++..++|++.+.||+|+||.||+|++.     +..||||+++... .....+.+.+|+.++++++||||+++++++.
T Consensus       383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  461 (656)
T 2j0j_A          383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT  461 (656)
T ss_dssp             GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            456788889999999999999999999873     3469999987543 4556678999999999999999999999985


Q ss_pred             cCCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccc
Q 016082          178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV  257 (395)
Q Consensus       178 ~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~  257 (395)
                      + +..++||||+++|+|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       462 ~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~  540 (656)
T 2j0j_A          462 E-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  540 (656)
T ss_dssp             S-SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred             c-CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCee
Confidence            4 568999999999999999987767899999999999999999999999999999999999999999999999999986


Q ss_pred             cccCCc--cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcH
Q 016082          258 QAQSGV--MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP  334 (395)
Q Consensus       258 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (395)
                      ......  .....+|+.|+|||++.+..++.++||||||+++|||++ |..||.+....+....+. ...++..|..+++
T Consensus       541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~~~  619 (656)
T 2j0j_A          541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPP  619 (656)
T ss_dssp             CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-HTCCCCCCTTCCH
T ss_pred             cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCCCCCCccccH
Confidence            544322  223456789999999998899999999999999999997 999999988877655543 4556678889999


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHH
Q 016082          335 RLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  368 (395)
Q Consensus       335 ~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~  368 (395)
                      ++.++|.+||+.||.+|||+.++++.|++++++-
T Consensus       620 ~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~  653 (656)
T 2j0j_A          620 TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  653 (656)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence            9999999999999999999999999999998753

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.4e-45  Score=349.41  Aligned_cols=247  Identities=33%  Similarity=0.580  Sum_probs=219.6

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      .+.|++.+.||+|+||.||+|++  .++.||||+++.... ....+.+.+|+.++++++||||+++++++......++||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   99 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   99 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence            45799999999999999999987  578999999976543 234578999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-ccc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT  265 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~  265 (395)
                      ||+++++|.+++..  +++++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||.++...... ...
T Consensus       100 e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  177 (303)
T 3a7i_A          100 EYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN  177 (303)
T ss_dssp             ECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBC
T ss_pred             EeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccC
Confidence            99999999999864  578999999999999999999999999999999999999999999999999997655432 234


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhc
Q 016082          266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ  345 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  345 (395)
                      ...||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+ .....+..+..++.++.++|.+||+
T Consensus       178 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~  256 (303)
T 3a7i_A          178 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI-PKNNPPTLEGNYSKPLKEFVEACLN  256 (303)
T ss_dssp             CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-HHSCCCCCCSSCCHHHHHHHHHHCC
T ss_pred             ccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHh-hcCCCCCCccccCHHHHHHHHHHcC
Confidence            457899999999999999999999999999999999999999988877655443 3455667778899999999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 016082          346 HDPTQRPNFSQITD  359 (395)
Q Consensus       346 ~dp~~RPs~~ell~  359 (395)
                      .||.+|||+.++++
T Consensus       257 ~dp~~Rps~~~ll~  270 (303)
T 3a7i_A          257 KEPSFRPTAKELLK  270 (303)
T ss_dssp             SSGGGSCCHHHHTT
T ss_pred             CChhhCcCHHHHhh
Confidence            99999999999987

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2e-46  Score=383.32  Aligned_cols=251  Identities=21%  Similarity=0.377  Sum_probs=217.7

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  183 (395)
                      +..++|++.+.||+|+||.||+|++  +++.||||+++.... .......+.+|+.+|++++||||+++++++.+...+|
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence            5667899999999999999999998  578999999964321 1122356889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC
Q 016082          184 IVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~  262 (395)
                      +||||++||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus       261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~  340 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  340 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence            9999999999999997643 459999999999999999999999999999999999999999999999999998776555


Q ss_pred             ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHhhhccCCCCCCCCCcHHHHH
Q 016082          263 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT----PLQAAVGVVQKSLRPTIPKHAHPRLAE  338 (395)
Q Consensus       263 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~  338 (395)
                      ......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+..    ..+....+.  ......+..+++++.+
T Consensus       341 ~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~--~~~~~~p~~~s~~~~d  418 (576)
T 2acx_A          341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK--EVPEEYSERFSPQARS  418 (576)
T ss_dssp             CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH--HCCCCCCTTSCHHHHH
T ss_pred             cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh--cccccCCccCCHHHHH
Confidence            5566789999999999999999999999999999999999999998753    222222222  3345667889999999


Q ss_pred             HHHHhhccCCCCCC-----CHHHHHH
Q 016082          339 LLERCWQHDPTQRP-----NFSQITD  359 (395)
Q Consensus       339 li~~cl~~dp~~RP-----s~~ell~  359 (395)
                      +|.+||+.||.+||     ++.|+++
T Consensus       419 LI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          419 LCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             HHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             HHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            99999999999999     6788876

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2e-45  Score=359.05  Aligned_cols=247  Identities=25%  Similarity=0.363  Sum_probs=202.2

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC------
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP------  180 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  180 (395)
                      .++|++.+.||+|+||.||+|.+  .++.||||+++....+....+.+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            46899999999999999999987  5789999999876666677788999999999999999999999997665      


Q ss_pred             cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                      ..|+||||+++ +|.+.+.   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       104 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~  179 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  179 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred             ceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence            68999999976 7888875   3589999999999999999999999999999999999999999999999999987665


Q ss_pred             CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC---------------
Q 016082          261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR---------------  325 (395)
Q Consensus       261 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~---------------  325 (395)
                      ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+......               
T Consensus       180 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  259 (371)
T 2xrw_A          180 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT  259 (371)
T ss_dssp             ----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHH
T ss_pred             ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence            55556678999999999999999999999999999999999999999998876655554432111               


Q ss_pred             -----CCC--------------CC------CCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          326 -----PTI--------------PK------HAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       326 -----~~~--------------~~------~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                           +..              |.      ..++++.++|.+||+.||.+|||+.|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          260 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             HHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence                 110              00      12568999999999999999999999987

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.1e-47  Score=365.56  Aligned_cols=260  Identities=29%  Similarity=0.485  Sum_probs=212.4

Q ss_pred             CceeecccCcceeeeeeeeCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Q 016082          103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  181 (395)
Q Consensus       103 ~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  181 (395)
                      ....+..++|++.+.||+|+||.||+|+. .++.||||+++..... .....+.+|+.++++++||||+++++++.....
T Consensus        23 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  101 (326)
T 3uim_A           23 RELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE  101 (326)
T ss_dssp             HHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSC
T ss_pred             HHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecCCc
Confidence            34566778999999999999999999987 5788999999865322 122368899999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCCCCeeeCCCCcEEEeeeccc
Q 016082          182 LCIVTEFMARGSIYDFLHKQK---GVFQLTSLLKVAIDVSKGMNYLHQN---NIIHRDLKTANLLMDENGVVKVADFGVA  255 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~LH~~---~iiHrDlkp~NiLl~~~~~vkl~DFg~a  255 (395)
                      .++||||+++|+|.+++....   ..+++..+..++.|++.||.|||+.   ||+||||||+||+++.++.+||+|||++
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~  181 (326)
T 3uim_A          102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA  181 (326)
T ss_dssp             CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSC
T ss_pred             eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccc
Confidence            999999999999999997643   3489999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCC--ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHhh-----
Q 016082          256 RVQAQSG--VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT--------PLQAAVGVV-----  320 (395)
Q Consensus       256 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~--------~~~~~~~~~-----  320 (395)
                      +......  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....        .........     
T Consensus       182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (326)
T 3uim_A          182 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL  261 (326)
T ss_dssp             EECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCS
T ss_pred             cccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhh
Confidence            8654332  2334569999999999988889999999999999999999999995211        001111100     


Q ss_pred             ----hccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 016082          321 ----QKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQ  363 (395)
Q Consensus       321 ----~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~  363 (395)
                          .....+..+...++++.+++.+||+.||.+|||+.++++.|+.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          262 EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             TTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             hhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence                1111122233345789999999999999999999999998874

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2e-46  Score=363.26  Aligned_cols=256  Identities=18%  Similarity=0.281  Sum_probs=212.6

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEEC----------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceee----
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTYC----------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQ----  171 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~~----------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----  171 (395)
                      ....++|++.+.||+|+||.||+|++.          ++.||||+++..       ..+.+|+.++++++||||++    
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~  110 (352)
T 2jii_A           38 DKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKK  110 (352)
T ss_dssp             CTTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHH
T ss_pred             cccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhh
Confidence            445679999999999999999999874          678999999754       46789999999999999987    


Q ss_pred             -----------EEEEEec-CCcEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 016082          172 -----------FIGACTR-PPNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN  238 (395)
Q Consensus       172 -----------l~~~~~~-~~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~N  238 (395)
                                 +++++.. ....|+||||+ +++|.+++... .+.+++..++.++.||+.||.|||++||+||||||+|
T Consensus       111 ~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~N  189 (352)
T 2jii_A          111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAEN  189 (352)
T ss_dssp             HTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGG
T ss_pred             hccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHH
Confidence                       6677765 67789999999 89999999875 3679999999999999999999999999999999999


Q ss_pred             eeeCCCC--cEEEeeeccccccccCC--------ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 016082          239 LLMDENG--VVKVADFGVARVQAQSG--------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA  308 (395)
Q Consensus       239 iLl~~~~--~vkl~DFg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~  308 (395)
                      |+++.++  .+||+|||+++......        ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.
T Consensus       190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  269 (352)
T 2jii_A          190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT  269 (352)
T ss_dssp             EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            9999998  99999999997654322        1233478999999999999999999999999999999999999998


Q ss_pred             CCCH-HHHHHHhhh--ccCCCCCC------CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHH
Q 016082          309 GLTP-LQAAVGVVQ--KSLRPTIP------KHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVL  369 (395)
Q Consensus       309 ~~~~-~~~~~~~~~--~~~~~~~~------~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~  369 (395)
                      ...+ .........  ....+..+      ..+++++.++|.+||+.||.+||++.++++.|++++++..
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  339 (352)
T 2jii_A          270 NCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR  339 (352)
T ss_dssp             GGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             cCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence            7642 222222111  11111111      2468999999999999999999999999999999987754

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.1e-46  Score=361.00  Aligned_cols=244  Identities=24%  Similarity=0.425  Sum_probs=207.7

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIV  185 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV  185 (395)
                      .++|++.+.||+|+||.||+|.+  +++.||||+++....      ...+|+.++.++ +||||+++++++.+....|+|
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   94 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV   94 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence            35799999999999999999998  478999999976542      234688888888 799999999999999999999


Q ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCC----CcEEEeeeccccccccC
Q 016082          186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN----GVVKVADFGVARVQAQS  261 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~----~~vkl~DFg~a~~~~~~  261 (395)
                      |||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+.++    +.+||+|||+++.....
T Consensus        95 ~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~  173 (342)
T 2qr7_A           95 TELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE  173 (342)
T ss_dssp             ECCCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred             EeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence            999999999999976 5679999999999999999999999999999999999998543    35999999999865443


Q ss_pred             -CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHhhhccCC--CCCCCCCcHH
Q 016082          262 -GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVVQKSLR--PTIPKHAHPR  335 (395)
Q Consensus       262 -~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~---~~~~~~~~~~~~~~~~--~~~~~~~~~~  335 (395)
                       .......||+.|+|||++.+..|+.++|||||||++|+|++|..||.+   .+..+....+......  ...+..++++
T Consensus       174 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  253 (342)
T 2qr7_A          174 NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDT  253 (342)
T ss_dssp             TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHH
T ss_pred             CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHH
Confidence             334456889999999999988899999999999999999999999986   3444444444433322  2233578999


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHH
Q 016082          336 LAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       336 l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      +.++|.+||+.||.+||++.++++
T Consensus       254 ~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          254 AKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHCCCChhHCcCHHHHhc
Confidence            999999999999999999999886

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.4e-46  Score=358.42  Aligned_cols=255  Identities=25%  Similarity=0.412  Sum_probs=213.8

Q ss_pred             ceeecccCcceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Q 016082          104 VWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  181 (395)
Q Consensus       104 ~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  181 (395)
                      ......++|++.+.||+|+||.||+|++.  ++.||||++..........+.+.+|+.++++++||||+++++++...+.
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   98 (331)
T 4aaa_A           19 LYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR   98 (331)
T ss_dssp             CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             hhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCE
Confidence            44455679999999999999999999984  7899999998776666677789999999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC
Q 016082          182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  261 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~  261 (395)
                      .++||||+++++|.+++.. .+.+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus        99 ~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A           99 WYLVFEFVDHTILDDLELF-PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             EEEEEECCSEEHHHHHHHS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             EEEEEecCCcchHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            9999999999888887654 567999999999999999999999999999999999999999999999999999765443


Q ss_pred             -CccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccC---------------
Q 016082          262 -GVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL---------------  324 (395)
Q Consensus       262 -~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~---------------  324 (395)
                       .......||+.|+|||++.+. .++.++||||||+++|+|++|+.||.+.+..+....+.....               
T Consensus       178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (331)
T 4aaa_A          178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV  257 (331)
T ss_dssp             ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred             ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence             233456789999999999875 789999999999999999999999998877665544332100               


Q ss_pred             -----CCCC---------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          325 -----RPTI---------PKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       325 -----~~~~---------~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                           .+..         .+.+++++.++|.+||+.||.+|||+.|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                 0111         1357889999999999999999999999986

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=8.9e-46  Score=356.18  Aligned_cols=252  Identities=29%  Similarity=0.598  Sum_probs=215.0

Q ss_pred             ccCcceeeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHh--cCCCceeeEEEEEecCC----cE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK--IRHKNVVQFIGACTRPP----NL  182 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~  182 (395)
                      .++|++.+.||+|+||.||+|++.++.||||+++..     ....+.+|+.++..  ++||||+++++++....    ..
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~  115 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL  115 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred             cccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence            468999999999999999999999999999999643     23667889999988  78999999999998876    79


Q ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--------HCCccccCCCCCCeeeCCCCcEEEeeecc
Q 016082          183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH--------QNNIIHRDLKTANLLMDENGVVKVADFGV  254 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~iiHrDlkp~NiLl~~~~~vkl~DFg~  254 (395)
                      ++||||+++|+|.+++..  .++++..++.++.|++.||.|||        +.||+||||||+||+++.++.+||+|||+
T Consensus       116 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~  193 (342)
T 1b6c_B          116 WLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  193 (342)
T ss_dssp             EEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCC
Confidence            999999999999999975  46899999999999999999999        89999999999999999999999999999


Q ss_pred             ccccccCC-----ccccCCCCcccccccccCCC------CCCChhhHHHHHHHHHHHHhC----------CCCCCCCC--
Q 016082          255 ARVQAQSG-----VMTAETGTYRWMAPEVIEHK------PYDYKADVFSFGIALWELLTG----------ELPYAGLT--  311 (395)
Q Consensus       255 a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~------~~~~k~DvwslG~vl~elltg----------~~pf~~~~--  311 (395)
                      ++......     ......||+.|+|||++.+.      .++.++||||||+++|+|++|          ..||....  
T Consensus       194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~  273 (342)
T 1b6c_B          194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  273 (342)
T ss_dssp             CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred             ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcC
Confidence            97655433     22445799999999999876      234789999999999999999          78987652  


Q ss_pred             ---HHHHHHHhhhccCCCCCCC-----CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 016082          312 ---PLQAAVGVVQKSLRPTIPK-----HAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE  367 (395)
Q Consensus       312 ---~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~  367 (395)
                         .......+.....++.++.     .++..+.++|.+||+.||.+|||+.++++.|+++.++
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~  337 (342)
T 1b6c_B          274 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  337 (342)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             cccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence               2333334445556666654     3456899999999999999999999999999998775

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=7.7e-46  Score=358.64  Aligned_cols=250  Identities=25%  Similarity=0.412  Sum_probs=211.6

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-------
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP-------  179 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------  179 (395)
                      .++|++.++||+|+||.||+|++  +++.||||++............+.+|+.++++++||||+++++++...       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            46899999999999999999998  578999999976655444456788999999999999999999998763       


Q ss_pred             -CcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccc
Q 016082          180 -PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  258 (395)
Q Consensus       180 -~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~  258 (395)
                       +..|+||||+++ +|.+.+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~  174 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF  174 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence             468999999986 888888777778999999999999999999999999999999999999999999999999999765


Q ss_pred             ccC-----CccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC--CCCCC
Q 016082          259 AQS-----GVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPK  330 (395)
Q Consensus       259 ~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~--~~~~~  330 (395)
                      ...     .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+......  +...+
T Consensus       175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  254 (351)
T 3mi9_A          175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP  254 (351)
T ss_dssp             CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence            422     22345578999999999876 56899999999999999999999999998877665544332111  11111


Q ss_pred             C----------------------------CcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          331 H----------------------------AHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       331 ~----------------------------~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      .                            .++++.++|.+||+.||.+|||+.|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          255 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             TGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            1                            2678999999999999999999999987

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.8e-45  Score=347.33  Aligned_cols=250  Identities=23%  Similarity=0.370  Sum_probs=218.5

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC---C----HHHHHHHHHHHHHHHhcC-CCceeeEEEEEec
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV---N----TEMLKEFSQEVYIMRKIR-HKNVVQFIGACTR  178 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~---~----~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  178 (395)
                      .++|++.+.||+|+||.||+|++  +++.||||+++....   .    ....+.+.+|+.+++++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            46899999999999999999998  568999999975531   1    233567889999999996 9999999999999


Q ss_pred             CCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccc
Q 016082          179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  258 (395)
Q Consensus       179 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~  258 (395)
                      ....++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||.++..
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  174 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL  174 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence            9999999999999999999976 467999999999999999999999999999999999999999999999999999876


Q ss_pred             ccCCccccCCCCcccccccccC------CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCC--C
Q 016082          259 AQSGVMTAETGTYRWMAPEVIE------HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP--K  330 (395)
Q Consensus       259 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~  330 (395)
                      ..........|++.|+|||++.      ...++.++||||||+++|+|++|..||...+.......+.........+  .
T Consensus       175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (298)
T 1phk_A          175 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD  254 (298)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGG
T ss_pred             CCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCccccc
Confidence            6555556678999999999984      5578999999999999999999999999888776666555544433332  4


Q ss_pred             CCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          331 HAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       331 ~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      .+++++.++|.+||+.||.+|||+.++++
T Consensus       255 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          255 DYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             GSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            67899999999999999999999999987

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.5e-46  Score=391.86  Aligned_cols=253  Identities=22%  Similarity=0.385  Sum_probs=218.7

Q ss_pred             ceeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCceeeEEEEEecC
Q 016082          104 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRP  179 (395)
Q Consensus       104 ~~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  179 (395)
                      ...+..++|++.+.||+|+||.||+|++  +++.||||+++.... .....+.+..|..++..+ +||+|+++++++.+.
T Consensus       335 ~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~  414 (674)
T 3pfq_A          335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM  414 (674)
T ss_dssp             -----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS
T ss_pred             cccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC
Confidence            3456678999999999999999999998  467899999974321 122346688899999987 699999999999999


Q ss_pred             CcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccc
Q 016082          180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  259 (395)
Q Consensus       180 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~  259 (395)
                      +.+|+||||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus       415 ~~~~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          415 DRLYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             SEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred             CEEEEEEeCcCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence            999999999999999999986 4679999999999999999999999999999999999999999999999999998543


Q ss_pred             c-CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHH
Q 016082          260 Q-SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE  338 (395)
Q Consensus       260 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  338 (395)
                      . ........||+.|+|||++.+..|+.++||||||+++|||++|+.||.+.+..+....+...  ....|..+++++.+
T Consensus       494 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~  571 (674)
T 3pfq_A          494 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--NVAYPKSMSKEAVA  571 (674)
T ss_dssp             CTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS--CCCCCTTSCHHHHH
T ss_pred             cCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHHHH
Confidence            2 23345568999999999999999999999999999999999999999999888877776654  35677889999999


Q ss_pred             HHHHhhccCCCCCCCH-----HHHHH
Q 016082          339 LLERCWQHDPTQRPNF-----SQITD  359 (395)
Q Consensus       339 li~~cl~~dp~~RPs~-----~ell~  359 (395)
                      +|.+||+.||.+||++     ++|++
T Consensus       572 li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          572 ICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             HHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             HHHHHccCCHHHCCCCCCCcHHHHhc
Confidence            9999999999999997     66654

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.4e-46  Score=363.92  Aligned_cols=247  Identities=21%  Similarity=0.343  Sum_probs=207.6

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec-----
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-----  178 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----  178 (395)
                      +...++|++.+.||+|+||.||+|++  +++.||||++.....      ...+|+.+|+.++||||+++++++..     
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   76 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE   76 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence            44567999999999999999999987  678999999875532      23479999999999999999999843     


Q ss_pred             ---------------------------------CCcEEEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHH
Q 016082          179 ---------------------------------PPNLCIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMN  222 (395)
Q Consensus       179 ---------------------------------~~~~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~  222 (395)
                                                       ...+++||||+++ +|.+.+..   ..+.+++..+..++.||++||.
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~  155 (383)
T 3eb0_A           77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG  155 (383)
T ss_dssp             ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence                                             3348999999985 88777753   3567999999999999999999


Q ss_pred             HHHHCCccccCCCCCCeeeC-CCCcEEEeeeccccccccCCccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHH
Q 016082          223 YLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWEL  300 (395)
Q Consensus       223 ~LH~~~iiHrDlkp~NiLl~-~~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwslG~vl~el  300 (395)
                      |||++||+||||||+||+++ .++.+||+|||+++............||+.|+|||++.+. .++.++||||+||++|+|
T Consensus       156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el  235 (383)
T 3eb0_A          156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL  235 (383)
T ss_dssp             HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred             HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence            99999999999999999997 6889999999999876666556677899999999998775 599999999999999999


Q ss_pred             HhCCCCCCCCCHHHHHHHhhhccCCC---------------------------CCCCCCcHHHHHHHHHhhccCCCCCCC
Q 016082          301 LTGELPYAGLTPLQAAVGVVQKSLRP---------------------------TIPKHAHPRLAELLERCWQHDPTQRPN  353 (395)
Q Consensus       301 ltg~~pf~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dp~~RPs  353 (395)
                      ++|+.||.+.+..+....+......|                           ..+...++++.++|.+||+.||.+|||
T Consensus       236 l~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  315 (383)
T 3eb0_A          236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN  315 (383)
T ss_dssp             HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC
Confidence            99999999988777666554321111                           134568899999999999999999999


Q ss_pred             HHHHHH
Q 016082          354 FSQITD  359 (395)
Q Consensus       354 ~~ell~  359 (395)
                      +.|+++
T Consensus       316 ~~e~l~  321 (383)
T 3eb0_A          316 PYEAMA  321 (383)
T ss_dssp             HHHHHT
T ss_pred             HHHHhc
Confidence            999986

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=9.8e-46  Score=347.87  Aligned_cols=249  Identities=27%  Similarity=0.491  Sum_probs=217.0

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      .++|++.+.||+|+||.||+|++  +++.||+|+++...........+.+|+.++++++||||+++++++......++||
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            45899999999999999999998  5789999999765444445678899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCC---CcEEEeeeccccccccCCc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN---GVVKVADFGVARVQAQSGV  263 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~---~~vkl~DFg~a~~~~~~~~  263 (395)
                      ||+++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.+   +.+||+|||+++.......
T Consensus       101 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~  179 (287)
T 2wei_A          101 ELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK  179 (287)
T ss_dssp             CCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS
T ss_pred             EccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc
Confidence            99999999999876 4579999999999999999999999999999999999999764   4699999999987655444


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCC--CCCcHHHHHHHH
Q 016082          264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP--KHAHPRLAELLE  341 (395)
Q Consensus       264 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~  341 (395)
                      .....||+.|+|||.+.+. ++.++||||||+++|+|++|..||.+.+..+....+.........+  ..+++++.++|.
T Consensus       180 ~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  258 (287)
T 2wei_A          180 MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR  258 (287)
T ss_dssp             CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHH
T ss_pred             cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHH
Confidence            4445688999999998765 8999999999999999999999999988777666555544333333  467899999999


Q ss_pred             HhhccCCCCCCCHHHHHH
Q 016082          342 RCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       342 ~cl~~dp~~RPs~~ell~  359 (395)
                      +||+.||.+|||+.++++
T Consensus       259 ~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          259 KMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHcccChhhCcCHHHHhc
Confidence            999999999999999987

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=5.3e-46  Score=348.06  Aligned_cols=246  Identities=26%  Similarity=0.415  Sum_probs=213.1

Q ss_pred             ccCcceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec--------
Q 016082          109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--------  178 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  178 (395)
                      .++|++.+.||+|+||.||+|++.  ++.||+|+++...      ..+.+|+.++++++||||+++++++..        
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS   83 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence            357999999999999999999984  8899999998653      356789999999999999999998854        


Q ss_pred             --------CCcEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEE
Q 016082          179 --------PPNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV  249 (395)
Q Consensus       179 --------~~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl  249 (395)
                              ...+++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl  163 (284)
T 2a19_B           84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI  163 (284)
T ss_dssp             -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred             cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence                    34589999999999999999764 367899999999999999999999999999999999999999999999


Q ss_pred             eeeccccccccCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCC
Q 016082          250 ADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP  329 (395)
Q Consensus       250 ~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  329 (395)
                      +|||+++............||+.|+|||++.+..++.++||||||+++|+|++|..|+....  ...    .......++
T Consensus       164 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~----~~~~~~~~~  237 (284)
T 2a19_B          164 GDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--KFF----TDLRDGIIS  237 (284)
T ss_dssp             CCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHH----HHHHTTCCC
T ss_pred             CcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--HHH----HHhhccccc
Confidence            99999987666555566689999999999999999999999999999999999998875321  111    111233456


Q ss_pred             CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 016082          330 KHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK  366 (395)
Q Consensus       330 ~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~  366 (395)
                      ..+++++.++|.+||+.||.+|||+.++++.|..+.+
T Consensus       238 ~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          238 DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence            7788999999999999999999999999999887654

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=6.8e-46  Score=378.01  Aligned_cols=251  Identities=24%  Similarity=0.397  Sum_probs=215.2

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  183 (395)
                      +..++|.+.+.||+|+||.||+|++  +++.||||+++..... ......+.+|+.++++++||||+++++++.+...+|
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  261 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC  261 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence            4567899999999999999999998  5789999999643211 122467889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          184 IVTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                      +||||++||+|.+++...   ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus       262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            999999999999999764   34699999999999999999999999999999999999999999999999999987654


Q ss_pred             CCc-cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHhhhccCCCCCCCCCcHH
Q 016082          261 SGV-MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT----PLQAAVGVVQKSLRPTIPKHAHPR  335 (395)
Q Consensus       261 ~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  335 (395)
                      ... .....||+.|+|||++.+..|+.++|+|||||++|||++|+.||.+..    ..+....+..  .....|..++++
T Consensus       342 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~--~~~~~p~~~s~~  419 (543)
T 3c4z_A          342 GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE--QAVTYPDKFSPA  419 (543)
T ss_dssp             TCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH--CCCCCCTTSCHH
T ss_pred             CCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh--cccCCCcccCHH
Confidence            433 234589999999999999999999999999999999999999998753    3333333333  244567889999


Q ss_pred             HHHHHHHhhccCCCCCCCH-----HHHHH
Q 016082          336 LAELLERCWQHDPTQRPNF-----SQITD  359 (395)
Q Consensus       336 l~~li~~cl~~dp~~RPs~-----~ell~  359 (395)
                      +.++|.+||+.||.+||++     .++++
T Consensus       420 ~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          420 SKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             HHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             HHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence            9999999999999999975     55554

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.1e-45  Score=348.44  Aligned_cols=250  Identities=30%  Similarity=0.505  Sum_probs=211.3

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  183 (395)
                      ....++|++.+.||+|+||.||+|.+.  ++.||||+++....    ...+.+|+.++++++||||+++++++......+
T Consensus        25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (314)
T 3com_A           25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW  100 (314)
T ss_dssp             -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence            445678999999999999999999984  78999999976532    356889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-
Q 016082          184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-  262 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-  262 (395)
                      +||||+++++|.+++......+++..++.++.+++.||.|||+.||+||||||+||+++.++.++|+|||.++...... 
T Consensus       101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  180 (314)
T 3com_A          101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA  180 (314)
T ss_dssp             EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred             EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence            9999999999999998667889999999999999999999999999999999999999999999999999997654432 


Q ss_pred             ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccC-CCCCCCCCcHHHHHHHH
Q 016082          263 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL-RPTIPKHAHPRLAELLE  341 (395)
Q Consensus       263 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~  341 (395)
                      ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||................. ....+..+++++.++|.
T Consensus       181 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  260 (314)
T 3com_A          181 KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVK  260 (314)
T ss_dssp             CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHH
T ss_pred             ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHH
Confidence            23445789999999999999999999999999999999999999998877665544333211 12234567899999999


Q ss_pred             HhhccCCCCCCCHHHHHH
Q 016082          342 RCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       342 ~cl~~dp~~RPs~~ell~  359 (395)
                      +||+.||.+|||+.++++
T Consensus       261 ~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          261 QCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             HHTCSCTTTSCCHHHHTT
T ss_pred             HHccCChhhCcCHHHHHh
Confidence            999999999999999986

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=5.5e-47  Score=370.76  Aligned_cols=255  Identities=15%  Similarity=0.189  Sum_probs=204.4

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHH---HHHHhcCCCceeeEE-------
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEV---YIMRKIRHKNVVQFI-------  173 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~E~---~~l~~l~h~niv~l~-------  173 (395)
                      ...++|++.+.||+|+||.||+|++  +++.||||+++... ......+.+.+|+   .++++++||||++++       
T Consensus        70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~  149 (377)
T 3byv_A           70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  149 (377)
T ss_dssp             CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred             CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence            3457899999999999999999996  58899999997542 2344667899999   555556799999998       


Q ss_pred             EEEecCC-----------------cEEEEEecCCCCCHHHHHhhccCCCCH-------HHHHHHHHHHHHHHHHHHHCCc
Q 016082          174 GACTRPP-----------------NLCIVTEFMARGSIYDFLHKQKGVFQL-------TSLLKVAIDVSKGMNYLHQNNI  229 (395)
Q Consensus       174 ~~~~~~~-----------------~~~lV~E~~~ggsL~~~l~~~~~~l~~-------~~~~~i~~~i~~~l~~LH~~~i  229 (395)
                      +++..++                 ..|+||||+ +|+|.+++... +.+++       ..++.++.||+.||+|||++||
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~-~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i  227 (377)
T 3byv_A          150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL-LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL  227 (377)
T ss_dssp             EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHH-HHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhc-cccccccccccHHHHHHHHHHHHHHHHHHHhCCe
Confidence            6666553                 389999999 57999999764 33444       7788899999999999999999


Q ss_pred             cccCCCCCCeeeCCCCcEEEeeeccccccccCCccccCCCCcccccccccCCC-----------CCCChhhHHHHHHHHH
Q 016082          230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK-----------PYDYKADVFSFGIALW  298 (395)
Q Consensus       230 iHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~k~DvwslG~vl~  298 (395)
                      +||||||+|||++.++.+||+|||+++....  ......| +.|+|||++.+.           .++.++|||||||++|
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~  304 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY  304 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence            9999999999999999999999999986433  3345567 999999999887           8999999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHHHHHHHHhh
Q 016082          299 ELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD--ILKQMMKEVLYWL  372 (395)
Q Consensus       299 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~--~l~~~~~~~~~~~  372 (395)
                      ||++|+.||.+.+.......+.      ..+..+++++.++|.+||+.||.+|||+.++++  .++++.......+
T Consensus       305 elltg~~Pf~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~l  374 (377)
T 3byv_A          305 WIWCADLPITKDAALGGSEWIF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAAL  374 (377)
T ss_dssp             HHHHSSCCC------CCSGGGG------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHHHHHHHG
T ss_pred             HHHHCCCCCcccccccchhhhh------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHHHHHHhh
Confidence            9999999998765433222211      123568899999999999999999999999996  5666665554443

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.1e-45  Score=346.11  Aligned_cols=264  Identities=27%  Similarity=0.472  Sum_probs=217.4

Q ss_pred             ceeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Q 016082          104 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  181 (395)
Q Consensus       104 ~~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  181 (395)
                      .+.+..+++.....||+|+||.||+|++  +++.||||+++...  ....+.+.+|+.++++++||||+++++++...+.
T Consensus        16 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   93 (295)
T 2clq_A           16 EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF   93 (295)
T ss_dssp             CEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             cccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence            4556667777788999999999999998  56889999997653  3445779999999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCC-CCcEEEeeecccccc
Q 016082          182 LCIVTEFMARGSIYDFLHKQKG--VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVADFGVARVQ  258 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~-~~~vkl~DFg~a~~~  258 (395)
                      .++||||+++++|.+++....+  .+++..+..++.|++.||.|||++||+||||||+||+++. ++.+||+|||.++..
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~  173 (295)
T 2clq_A           94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL  173 (295)
T ss_dssp             EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred             EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeeccccccc
Confidence            9999999999999999987543  4568889999999999999999999999999999999987 899999999999765


Q ss_pred             ccCC-ccccCCCCcccccccccCCCC--CCChhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHhhhccCCCCCCCCCcH
Q 016082          259 AQSG-VMTAETGTYRWMAPEVIEHKP--YDYKADVFSFGIALWELLTGELPYAGLTPLQ-AAVGVVQKSLRPTIPKHAHP  334 (395)
Q Consensus       259 ~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~k~DvwslG~vl~elltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~  334 (395)
                      .... ......||+.|+|||++.+..  ++.++||||||+++|+|++|+.||....... ...........+..+..+++
T Consensus       174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (295)
T 2clq_A          174 AGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSA  253 (295)
T ss_dssp             CC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCH
T ss_pred             CCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCH
Confidence            4322 234457899999999987643  8999999999999999999999997654332 22222333556778888999


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcccccc
Q 016082          335 RLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLIN  378 (395)
Q Consensus       335 ~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~~~~~~~~~~  378 (395)
                      ++.++|.+||+.||++||++.++++         +.|+......
T Consensus       254 ~~~~li~~~l~~dp~~Rps~~~ll~---------~~~~~~~~~~  288 (295)
T 2clq_A          254 EAKAFILKCFEPDPDKRACANDLLV---------DEFLKVSSKK  288 (295)
T ss_dssp             HHHHHHHHTTCSSTTTSCCHHHHHT---------SGGGCC----
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhc---------Chhhhhcccc
Confidence            9999999999999999999999987         5666544433

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=4.3e-45  Score=363.81  Aligned_cols=249  Identities=24%  Similarity=0.345  Sum_probs=202.8

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-----Cc
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP-----PN  181 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  181 (395)
                      .++|++.+.||+|+||.||+|++  +++.||||+++....+....+.+.+|+.+|++++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            45899999999999999999988  568899999987666666778899999999999999999999999766     56


Q ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC
Q 016082          182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  261 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~  261 (395)
                      .|+||||+++ +|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus       105 ~~lv~e~~~~-~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  182 (432)
T 3n9x_A          105 LYIVLEIADS-DLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE  182 (432)
T ss_dssp             EEEEEECCSE-EHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred             EEEEEecCCc-CHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence            9999999975 99999976 567999999999999999999999999999999999999999999999999999865432


Q ss_pred             C-----------------------ccccCCCCccccccccc-CCCCCCChhhHHHHHHHHHHHHh-----------CCCC
Q 016082          262 G-----------------------VMTAETGTYRWMAPEVI-EHKPYDYKADVFSFGIALWELLT-----------GELP  306 (395)
Q Consensus       262 ~-----------------------~~~~~~gt~~y~aPE~~-~~~~~~~k~DvwslG~vl~ellt-----------g~~p  306 (395)
                      .                       ..+...||+.|+|||++ .+..|+.++|||||||++|||++           |.++
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~  262 (432)
T 3n9x_A          183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL  262 (432)
T ss_dssp             ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCS
T ss_pred             ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccccc
Confidence            2                       23567899999999986 56679999999999999999998           4455


Q ss_pred             CCCCCH-----------------HHHHHHh-----------------------hh-ccCCCCC-----CCCCcHHHHHHH
Q 016082          307 YAGLTP-----------------LQAAVGV-----------------------VQ-KSLRPTI-----PKHAHPRLAELL  340 (395)
Q Consensus       307 f~~~~~-----------------~~~~~~~-----------------------~~-~~~~~~~-----~~~~~~~l~~li  340 (395)
                      |.+.+.                 ......+                       .. ...+...     .+.+++++.+||
T Consensus       263 f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl  342 (432)
T 3n9x_A          263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLL  342 (432)
T ss_dssp             CCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHH
T ss_pred             CCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHH
Confidence            544321                 0111000                       00 0011111     145789999999


Q ss_pred             HHhhccCCCCCCCHHHHHH
Q 016082          341 ERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       341 ~~cl~~dp~~RPs~~ell~  359 (395)
                      .+||+.||.+|||+.|+++
T Consensus       343 ~~mL~~dP~~R~ta~e~L~  361 (432)
T 3n9x_A          343 ESMLKFNPNKRITIDQALD  361 (432)
T ss_dssp             HHHSCSSTTTSCCHHHHHT
T ss_pred             HHHhcCCcccCCCHHHHhc
Confidence            9999999999999999987

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=4.8e-46  Score=357.08  Aligned_cols=238  Identities=22%  Similarity=0.394  Sum_probs=183.4

Q ss_pred             eeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCcEEEEEecCCCC
Q 016082          116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEFMARG  192 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~gg  192 (395)
                      +.||+|+||.||+|.+  +++.||||+++..     ....+.+|+.+++++. ||||+++++++.+....|+||||++||
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~   91 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG   91 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence            7899999999999998  4789999999643     3467789999999997 999999999999999999999999999


Q ss_pred             CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCC---cEEEeeeccccccccC-CccccCC
Q 016082          193 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADFGVARVQAQS-GVMTAET  268 (395)
Q Consensus       193 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~---~vkl~DFg~a~~~~~~-~~~~~~~  268 (395)
                      +|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||+++.++   .+||+|||+++..... .......
T Consensus        92 ~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  170 (325)
T 3kn6_A           92 ELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC  170 (325)
T ss_dssp             BHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---------
T ss_pred             cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccC
Confidence            99999987 56799999999999999999999999999999999999998766   8999999999865443 2334567


Q ss_pred             CCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHhhhccCCCCC--CCCCcHHHHHH
Q 016082          269 GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP-------LQAAVGVVQKSLRPTI--PKHAHPRLAEL  339 (395)
Q Consensus       269 gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~-------~~~~~~~~~~~~~~~~--~~~~~~~l~~l  339 (395)
                      ||+.|+|||++.+..++.++||||||+++|+|++|+.||.+...       .+....+.........  ...+++++.++
T Consensus       171 ~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  250 (325)
T 3kn6_A          171 FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDL  250 (325)
T ss_dssp             -------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHH
T ss_pred             CCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHH
Confidence            89999999999999999999999999999999999999987543       2223332222111111  13578999999


Q ss_pred             HHHhhccCCCCCCCHHHHHH
Q 016082          340 LERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       340 i~~cl~~dp~~RPs~~ell~  359 (395)
                      |.+||+.||.+|||+.++++
T Consensus       251 i~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          251 IQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HHHHHCCCTTTCCCTTTSTT
T ss_pred             HHHHCCCChhHCCCHHHHhc
Confidence            99999999999999999886

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.8e-47  Score=372.61  Aligned_cols=259  Identities=22%  Similarity=0.382  Sum_probs=214.1

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC--cE
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP--NL  182 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~  182 (395)
                      +..++|++.+.||+|+||.||+|++.  ++.||||+++.... ....+.+.+|+.++++++||||+++++++....  ..
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~   84 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence            34568999999999999999999984  78999999975432 223467789999999999999999999998765  78


Q ss_pred             EEEEecCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee----CCCCcEEEeeecccc
Q 016082          183 CIVTEFMARGSIYDFLHKQK--GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM----DENGVVKVADFGVAR  256 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl----~~~~~vkl~DFg~a~  256 (395)
                      ++||||++||+|.+++....  ..+++..++.++.||+.||+|||++||+||||||+||++    +.++.+||+|||+++
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            99999999999999997643  338999999999999999999999999999999999999    778889999999998


Q ss_pred             ccccCCccccCCCCcccccccccCC--------CCCCChhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHhhhccC
Q 016082          257 VQAQSGVMTAETGTYRWMAPEVIEH--------KPYDYKADVFSFGIALWELLTGELPYAGLT----PLQAAVGVVQKSL  324 (395)
Q Consensus       257 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~k~DvwslG~vl~elltg~~pf~~~~----~~~~~~~~~~~~~  324 (395)
                      ............||+.|+|||++.+        ..++.++|||||||++|||++|+.||....    ..+....+.....
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p  244 (396)
T 4eut_A          165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP  244 (396)
T ss_dssp             ECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred             EccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence            7766555566789999999999865        567889999999999999999999997432    2233333332111


Q ss_pred             C-----------------------CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 016082          325 R-----------------------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK  366 (395)
Q Consensus       325 ~-----------------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~  366 (395)
                      .                       ..++..+++.+.+++.+||+.||++||++.++++.++++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            0                       01123356789999999999999999999999998887765

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.9e-45  Score=355.86  Aligned_cols=255  Identities=17%  Similarity=0.293  Sum_probs=215.5

Q ss_pred             CCceeecccCcceeeeeeeeCceEEEEEE-------ECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC---CCceee
Q 016082          102 TDVWEIDAKQLKIECKVASGSYGDLYKGT-------YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR---HKNVVQ  171 (395)
Q Consensus       102 ~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~-------~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~  171 (395)
                      ...+++..++|++.+.||+|+||.||+|+       ..++.||||+++...     ..++..|+.++++++   |+||+.
T Consensus        57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~  131 (365)
T 3e7e_A           57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMK  131 (365)
T ss_dssp             SCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCC
T ss_pred             ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhh
Confidence            35678888999999999999999999993       267899999998652     356788888888887   899999


Q ss_pred             EEEEEecCCcEEEEEecCCCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCC----
Q 016082          172 FIGACTRPPNLCIVTEFMARGSIYDFLHK----QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE----  243 (395)
Q Consensus       172 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~----  243 (395)
                      +++++...+..|+||||++||+|.+++..    ..+.+++..++.++.||+.||+|||++||+||||||+|||++.    
T Consensus       132 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~  211 (365)
T 3e7e_A          132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLE  211 (365)
T ss_dssp             EEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTC
T ss_pred             hheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccC
Confidence            99999999999999999999999999975    3467999999999999999999999999999999999999998    


Q ss_pred             -------CCcEEEeeeccccccc---cCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 016082          244 -------NGVVKVADFGVARVQA---QSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL  313 (395)
Q Consensus       244 -------~~~vkl~DFg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~  313 (395)
                             ++.+||+|||+|+...   .........||+.|+|||++.+..|+.++|||||||++|||++|+.||......
T Consensus       212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~  291 (365)
T 3e7e_A          212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG  291 (365)
T ss_dssp             C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred             ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence                   8999999999996543   233445668999999999999999999999999999999999999999654321


Q ss_pred             HHHHHhhhccCCCCC-CCCCcHHHHHHHHHhhccCCCCC-CCHHHHHHHHHHHHHHH
Q 016082          314 QAAVGVVQKSLRPTI-PKHAHPRLAELLERCWQHDPTQR-PNFSQITDILKQMMKEV  368 (395)
Q Consensus       314 ~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dp~~R-Ps~~ell~~l~~~~~~~  368 (395)
                      .     .  ...... ....++.+.+++.+|++.+|.+| |++.++.+.|++++.+.
T Consensus       292 ~-----~--~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~  341 (365)
T 3e7e_A          292 E-----C--KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH  341 (365)
T ss_dssp             E-----E--EECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             c-----e--eechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence            1     0  011111 11346789999999999999999 67888888888887753

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.6e-46  Score=365.04  Aligned_cols=262  Identities=13%  Similarity=0.150  Sum_probs=199.1

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhc--CCCceeeEE-------EEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI--RHKNVVQFI-------GAC  176 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~  176 (395)
                      ..+|++.+.||+|+||.||+|++  +++.||||+++.... .....+.+.+|+.+++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            44699999999999999999997  578999999987654 334566788886555555  699988755       444


Q ss_pred             ecC-----------------CcEEEEEecCCCCCHHHHHhhccCCCCHHHH------HHHHHHHHHHHHHHHHCCccccC
Q 016082          177 TRP-----------------PNLCIVTEFMARGSIYDFLHKQKGVFQLTSL------LKVAIDVSKGMNYLHQNNIIHRD  233 (395)
Q Consensus       177 ~~~-----------------~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~------~~i~~~i~~~l~~LH~~~iiHrD  233 (395)
                      ..+                 ..+|+||||++ |+|.+++......++...+      ..++.||+.||+|||++||+|||
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD  219 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH  219 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence            332                 23899999999 7999999876556666666      78889999999999999999999


Q ss_pred             CCCCCeeeCCCCcEEEeeeccccccccCCccccCCCCcccccccccCC--CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 016082          234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH--KPYDYKADVFSFGIALWELLTGELPYAGLT  311 (395)
Q Consensus       234 lkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwslG~vl~elltg~~pf~~~~  311 (395)
                      |||+|||++.++.+||+|||+++......  ....+|+.|+|||++.+  ..++.++|||||||++|+|++|+.||.+..
T Consensus       220 ikp~NIll~~~~~~kL~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~  297 (371)
T 3q60_A          220 FTPDNLFIMPDGRLMLGDVSALWKVGTRG--PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT  297 (371)
T ss_dssp             CSGGGEEECTTSCEEECCGGGEEETTCEE--EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCC
T ss_pred             CCHHHEEECCCCCEEEEecceeeecCCCc--cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcC
Confidence            99999999999999999999998654322  24567799999999987  789999999999999999999999998875


Q ss_pred             HHHHHHH-------hhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHHHHHHHHhhc
Q 016082          312 PLQAAVG-------VVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD--ILKQMMKEVLYWLS  373 (395)
Q Consensus       312 ~~~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~--~l~~~~~~~~~~~~  373 (395)
                      +......       ..........+..+++++.++|.+||+.||.+|||+.++++  .++++..+...-+|
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~s  368 (371)
T 3q60_A          298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEISSSLS  368 (371)
T ss_dssp             TTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHHHHHHHHC
T ss_pred             cccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHHHHhhhhh
Confidence            4311100       00111122223578999999999999999999999999986  55555555544443

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.3e-45  Score=348.98  Aligned_cols=250  Identities=28%  Similarity=0.501  Sum_probs=211.9

Q ss_pred             cccCcceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Q 016082          108 DAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  185 (395)
Q Consensus       108 ~~~~~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  185 (395)
                      ..++|++.+.||+|+||.||+|++.  ++.||+|++....  ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   94 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM   94 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence            3468999999999999999999984  7889999997653  33457889999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-Ccc
Q 016082          186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVM  264 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-~~~  264 (395)
                      |||+++++|.+++......+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++...... ...
T Consensus        95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  174 (302)
T 2j7t_A           95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR  174 (302)
T ss_dssp             EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-
T ss_pred             EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccccc
Confidence            9999999999999877778999999999999999999999999999999999999999999999999997643221 122


Q ss_pred             ccCCCCccccccccc-----CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC-CCCCCCCcHHHHH
Q 016082          265 TAETGTYRWMAPEVI-----EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR-PTIPKHAHPRLAE  338 (395)
Q Consensus       265 ~~~~gt~~y~aPE~~-----~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~  338 (395)
                      ....||+.|+|||++     .+..++.++||||||+++|+|++|..||...+.............. ...+..++.++.+
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  254 (302)
T 2j7t_A          175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRD  254 (302)
T ss_dssp             ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred             ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHH
Confidence            345789999999998     4678899999999999999999999999998877666554443322 2235678899999


Q ss_pred             HHHHhhccCCCCCCCHHHHHH
Q 016082          339 LLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       339 li~~cl~~dp~~RPs~~ell~  359 (395)
                      +|.+||+.||.+|||+.++++
T Consensus       255 li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          255 FLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             HHHHHSCSCTTTSCCHHHHTT
T ss_pred             HHHHHcccChhhCCCHHHHhc
Confidence            999999999999999999986

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.2e-45  Score=344.55  Aligned_cols=248  Identities=24%  Similarity=0.400  Sum_probs=210.6

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      ++|++.+.||+|+||.||+|++  +++.||||+++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            5799999999999999999988  478999999975432 3345788999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC---cc
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---VM  264 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~---~~  264 (395)
                      |+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||.+.......   ..
T Consensus        86 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  164 (276)
T 2yex_A           86 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  164 (276)
T ss_dssp             CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             ecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence            9999999999865 4679999999999999999999999999999999999999999999999999997654322   23


Q ss_pred             ccCCCCcccccccccCCCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHhhhccCCCCCCCCCcHHHHHHHHH
Q 016082          265 TAETGTYRWMAPEVIEHKPY-DYKADVFSFGIALWELLTGELPYAGLTPLQA-AVGVVQKSLRPTIPKHAHPRLAELLER  342 (395)
Q Consensus       265 ~~~~gt~~y~aPE~~~~~~~-~~k~DvwslG~vl~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~  342 (395)
                      ....||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||........ ................+++++.++|.+
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  244 (276)
T 2yex_A          165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK  244 (276)
T ss_dssp             CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHH
T ss_pred             cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHH
Confidence            45578999999999987765 7899999999999999999999987654322 222222222222234688999999999


Q ss_pred             hhccCCCCCCCHHHHHH
Q 016082          343 CWQHDPTQRPNFSQITD  359 (395)
Q Consensus       343 cl~~dp~~RPs~~ell~  359 (395)
                      ||+.||.+|||+.++++
T Consensus       245 ~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          245 ILVENPSARITIPDIKK  261 (276)
T ss_dssp             HSCSSTTTSCCHHHHTT
T ss_pred             HCCCCchhCCCHHHHhc
Confidence            99999999999999987

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.7e-45  Score=357.63  Aligned_cols=263  Identities=21%  Similarity=0.329  Sum_probs=210.3

Q ss_pred             cccCcceeeeeeeeCceEEEEEEE-CCceEEEEEecCCCC---------CHHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Q 016082          108 DAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECV---------NTEMLKEFSQEVYIMRKIRHKNVVQFIGACT  177 (395)
Q Consensus       108 ~~~~~~i~~~lg~G~~G~Vy~~~~-~~~~vAvK~~~~~~~---------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  177 (395)
                      ..++|++.+.||+|+||.||+|.+ .++.||||++.....         +....+.+.+|+.++++++||||+++++++.
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   99 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV   99 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred             hccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence            356899999999999999999987 578899999864322         2334578999999999999999999999984


Q ss_pred             c-----CCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeee
Q 016082          178 R-----PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADF  252 (395)
Q Consensus       178 ~-----~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DF  252 (395)
                      .     ...+|+||||++ |+|.+++......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+||
T Consensus       100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df  178 (362)
T 3pg1_A          100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF  178 (362)
T ss_dssp             ECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred             eccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEec
Confidence            3     335899999998 4999999877778999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCCccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCC----
Q 016082          253 GVARVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT----  327 (395)
Q Consensus       253 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~----  327 (395)
                      |+++............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......+.    
T Consensus       179 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (362)
T 3pg1_A          179 NLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDV  258 (362)
T ss_dssp             TC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             CcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHh
Confidence            99986665555566789999999999877 6799999999999999999999999999877665554433211111    


Q ss_pred             --------------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcccccccc
Q 016082          328 --------------------------IPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINTN  380 (395)
Q Consensus       328 --------------------------~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~~~~~~~~~~~~  380 (395)
                                                .++..++.+.++|.+||+.||.+|||+.|+++         +-|+........
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~---------hp~f~~~~~~~~  328 (362)
T 3pg1_A          259 VMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR---------HPYFESLFDPLD  328 (362)
T ss_dssp             HHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT---------SGGGTTTCCGGG
T ss_pred             hhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc---------CchhhhccCccc
Confidence                                      12456889999999999999999999999987         667665544333

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=5.4e-46  Score=368.95  Aligned_cols=249  Identities=21%  Similarity=0.368  Sum_probs=198.7

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC------CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV------NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  180 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (395)
                      .++|.+.+.||+|+||.||+|.+  +++.||||++.....      .......+.+|+.+|++++||||+++++++... 
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS-
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence            46899999999999999999988  568999999975422      122234588999999999999999999998654 


Q ss_pred             cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCC---cEEEeeeccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADFGVARV  257 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~---~vkl~DFg~a~~  257 (395)
                      ..|+||||+++|+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++   .+||+|||+++.
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  291 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  291 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred             ceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence            58999999999999998865 56799999999999999999999999999999999999997544   599999999988


Q ss_pred             cccCCccccCCCCcccccccccCC---CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCC---CCCC
Q 016082          258 QAQSGVMTAETGTYRWMAPEVIEH---KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT---IPKH  331 (395)
Q Consensus       258 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~---~~~~  331 (395)
                      ...........||+.|+|||++.+   ..|+.++|||||||++|+|++|+.||....................   ....
T Consensus       292 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~  371 (419)
T 3i6u_A          292 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE  371 (419)
T ss_dssp             CC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTT
T ss_pred             cCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcc
Confidence            766655566789999999999863   6788999999999999999999999987544322222222222222   2246


Q ss_pred             CcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          332 AHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       332 ~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      +++++.++|.+||+.||.+|||+.|+++
T Consensus       372 ~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          372 VSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            7899999999999999999999999987

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.1e-45  Score=353.97  Aligned_cols=256  Identities=30%  Similarity=0.516  Sum_probs=191.4

Q ss_pred             CCceeecccCcceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHH-HHHhcCCCceeeEEEEEec
Q 016082          102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVY-IMRKIRHKNVVQFIGACTR  178 (395)
Q Consensus       102 ~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~  178 (395)
                      ...|.+..++|++.+.||+|+||.||+|.+.  ++.||||+++... .......+..|+. +++.++||||+++++++..
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~   92 (327)
T 3aln_A           14 EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR   92 (327)
T ss_dssp             CEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred             HHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence            4578899999999999999999999999984  8899999998664 3334455556665 7777899999999999999


Q ss_pred             CCcEEEEEecCCCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCeeeCCCCcEEEeeec
Q 016082          179 PPNLCIVTEFMARGSIYDFLHK----QKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFG  253 (395)
Q Consensus       179 ~~~~~lV~E~~~ggsL~~~l~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~-~iiHrDlkp~NiLl~~~~~vkl~DFg  253 (395)
                      .+..++||||+++ +|.+++..    ....+++..+..++.+++.||.|||+. ||+||||||+||+++.++.+||+|||
T Consensus        93 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg  171 (327)
T 3aln_A           93 EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG  171 (327)
T ss_dssp             SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred             CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCC
Confidence            9999999999986 88887753    256789999999999999999999999 99999999999999999999999999


Q ss_pred             cccccccCCccccCCCCccccccccc----CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCC
Q 016082          254 VARVQAQSGVMTAETGTYRWMAPEVI----EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP  329 (395)
Q Consensus       254 ~a~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  329 (395)
                      +++............||+.|+|||++    .+..++.++||||||+++|+|++|+.||.+................+..+
T Consensus       172 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  251 (327)
T 3aln_A          172 ISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLS  251 (327)
T ss_dssp             SSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCC
T ss_pred             CceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCC
Confidence            99876555444555799999999998    46678999999999999999999999998765432222222222222222


Q ss_pred             ----CCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          330 ----KHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       330 ----~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                          ..+++++.++|.+||+.||.+|||+.++++
T Consensus       252 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          252 NSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence                468899999999999999999999999986

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.3e-45  Score=351.47  Aligned_cols=246  Identities=26%  Similarity=0.413  Sum_probs=201.7

Q ss_pred             ccCccee-eeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcEEE
Q 016082          109 AKQLKIE-CKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCI  184 (395)
Q Consensus       109 ~~~~~i~-~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  184 (395)
                      .+.|++. +.||+|+||.||+|++  +++.||||+++...  ......+.+|+.++.++ +||||+++++++...+..|+
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l   88 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL   88 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence            3578885 7899999999999987  57899999997653  22346788999999995 79999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCc---EEEeeeccccccccC
Q 016082          185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV---VKVADFGVARVQAQS  261 (395)
Q Consensus       185 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~---vkl~DFg~a~~~~~~  261 (395)
                      ||||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||+++.++.   +||+|||+++.....
T Consensus        89 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  167 (316)
T 2ac3_A           89 VFEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN  167 (316)
T ss_dssp             EEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred             EEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence            9999999999999977 467999999999999999999999999999999999999998776   999999998754322


Q ss_pred             C--------ccccCCCCcccccccccCC-----CCCCChhhHHHHHHHHHHHHhCCCCCCCCCH---------------H
Q 016082          262 G--------VMTAETGTYRWMAPEVIEH-----KPYDYKADVFSFGIALWELLTGELPYAGLTP---------------L  313 (395)
Q Consensus       262 ~--------~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwslG~vl~elltg~~pf~~~~~---------------~  313 (395)
                      .        ......||+.|+|||++.+     ..++.++|||||||++|+|++|+.||.+...               .
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  247 (316)
T 2ac3_A          168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN  247 (316)
T ss_dssp             --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred             CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence            1        1223469999999999875     5688999999999999999999999987542               1


Q ss_pred             HHHHHhhhccCCCCCC----CCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          314 QAAVGVVQKSLRPTIP----KHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       314 ~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      .....+....  ...|    ..+++++.++|.+||+.||.+|||+.|+++
T Consensus       248 ~~~~~i~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          248 MLFESIQEGK--YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHCC--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHhccC--cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            1222222221  2222    457899999999999999999999999987

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.9e-46  Score=352.22  Aligned_cols=255  Identities=31%  Similarity=0.574  Sum_probs=197.1

Q ss_pred             ceeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Q 016082          104 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  181 (395)
Q Consensus       104 ~~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  181 (395)
                      .|.+..++|++.+.||+|+||.||+|++  +++.||||+++.... ....+++.+|+.++++++||||+++++++...+.
T Consensus         9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   87 (303)
T 2vwi_A            9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE   87 (303)
T ss_dssp             ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred             ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence            4778889999999999999999999987  678999999875532 2345678899999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhh-------ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecc
Q 016082          182 LCIVTEFMARGSIYDFLHK-------QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV  254 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~  254 (395)
                      .++||||++|++|.+++..       ..+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||.
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence            9999999999999999974       245689999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCC------ccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC--
Q 016082          255 ARVQAQSG------VMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--  325 (395)
Q Consensus       255 a~~~~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~--  325 (395)
                      ++......      ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||..................  
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  247 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL  247 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc
Confidence            97654322      1233468999999999875 56899999999999999999999999987766555443332211  


Q ss_pred             ------CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          326 ------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       326 ------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                            +.....+++++.++|.+||+.||.+||++.++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence                  2233567899999999999999999999999987

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1e-45  Score=360.74  Aligned_cols=251  Identities=26%  Similarity=0.427  Sum_probs=197.2

Q ss_pred             CceeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-
Q 016082          103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP-  179 (395)
Q Consensus       103 ~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-  179 (395)
                      ..|++. ++|++.+.||+|+||.||+|.+  +++.||||++.....+....+.+.+|+.++++++||||+++++++... 
T Consensus        23 ~~~~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  101 (367)
T 2fst_X           23 TIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR  101 (367)
T ss_dssp             EEEEEE-TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             cccCCC-CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence            456665 5899999999999999999987  578999999987665666778899999999999999999999999754 


Q ss_pred             -----CcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecc
Q 016082          180 -----PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV  254 (395)
Q Consensus       180 -----~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~  254 (395)
                           ...|+|+|++ +++|.+++..  +.+++..+..++.||++||.|||+.||+||||||+||+++.++.+||+|||+
T Consensus       102 ~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~  178 (367)
T 2fst_X          102 SLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL  178 (367)
T ss_dssp             SGGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred             ccccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence                 5689999999 6799998865  5699999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCC-------
Q 016082          255 ARVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP-------  326 (395)
Q Consensus       255 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~-------  326 (395)
                      ++.....  .+...||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+......|       
T Consensus       179 a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  256 (367)
T 2fst_X          179 ARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  256 (367)
T ss_dssp             --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             ccccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            9865432  355689999999999887 679999999999999999999999999988765554433211110       


Q ss_pred             --------------CC--------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          327 --------------TI--------PKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       327 --------------~~--------~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                    ..        ....++++.+||.+||+.||.+|||+.|+++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence                          01        1346789999999999999999999999987

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=5.7e-45  Score=346.90  Aligned_cols=254  Identities=22%  Similarity=0.385  Sum_probs=215.1

Q ss_pred             CceeecccCcceeeeeeeeCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC--CCceeeEEEEEecC
Q 016082          103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR--HKNVVQFIGACTRP  179 (395)
Q Consensus       103 ~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~  179 (395)
                      ....+..++|++.+.||+|+||.||++++ .++.||||+++....+....+.+.+|+.++++++  ||||+++++++...
T Consensus        21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~  100 (313)
T 3cek_A           21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD  100 (313)
T ss_dssp             CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred             eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence            45678888999999999999999999987 4788999999877667777889999999999998  59999999999999


Q ss_pred             CcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccc
Q 016082          180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  259 (395)
Q Consensus       180 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~  259 (395)
                      +..++||| +.+++|.+++.. .+.+++..++.++.|++.||.|||++||+||||||+||+++ ++.+||+|||+++...
T Consensus       101 ~~~~lv~e-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~  177 (313)
T 3cek_A          101 QYIYMVME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  177 (313)
T ss_dssp             SEEEEEEC-CCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--
T ss_pred             CEEEEEEe-cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccccccc
Confidence            99999999 567799999987 46789999999999999999999999999999999999996 4899999999998654


Q ss_pred             cCC---ccccCCCCcccccccccCC-----------CCCCChhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHhhhccC
Q 016082          260 QSG---VMTAETGTYRWMAPEVIEH-----------KPYDYKADVFSFGIALWELLTGELPYAGLTP-LQAAVGVVQKSL  324 (395)
Q Consensus       260 ~~~---~~~~~~gt~~y~aPE~~~~-----------~~~~~k~DvwslG~vl~elltg~~pf~~~~~-~~~~~~~~~~~~  324 (395)
                      ...   ......||+.|+|||++.+           ..++.++||||||+++|+|++|+.||..... ............
T Consensus       178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  257 (313)
T 3cek_A          178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH  257 (313)
T ss_dssp             ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred             CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccc
Confidence            332   1234578999999999875           4788999999999999999999999987643 333444444555


Q ss_pred             CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          325 RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       325 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      +...+...++++.++|.+||+.||.+||++.++++
T Consensus       258 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          258 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            56677778999999999999999999999999987

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.8e-45  Score=348.03  Aligned_cols=256  Identities=24%  Similarity=0.463  Sum_probs=199.7

Q ss_pred             CCceeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 016082          102 TDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP  179 (395)
Q Consensus       102 ~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  179 (395)
                      ...+.+..++|++.+.||+|+||.||+|++  +++.||||+++.........+.+.++..+++.++||||+++++++...
T Consensus        17 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~   96 (318)
T 2dyl_A           17 GQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN   96 (318)
T ss_dssp             SSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             chhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Confidence            356778888999999999999999999998  578999999987654444555566667788889999999999999999


Q ss_pred             CcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCeeeCCCCcEEEeeecccccc
Q 016082          180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQ  258 (395)
Q Consensus       180 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~  258 (395)
                      +..++||||+ ++.+..+.....+.+++..+..++.+++.||.|||++ ||+||||||+||+++.++.+||+|||+++..
T Consensus        97 ~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A           97 TDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL  175 (318)
T ss_dssp             SEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             CcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence            9999999999 5567666665567899999999999999999999995 9999999999999999999999999999766


Q ss_pred             ccCCccccCCCCcccccccccC-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHhhhccCCCCCC--C
Q 016082          259 AQSGVMTAETGTYRWMAPEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGLT-PLQAAVGVVQKSLRPTIP--K  330 (395)
Q Consensus       259 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwslG~vl~elltg~~pf~~~~-~~~~~~~~~~~~~~~~~~--~  330 (395)
                      ..........||+.|+|||++.     +..++.++||||||+++|+|++|+.||.... ..+...... ....+..+  .
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~  254 (318)
T 2dyl_A          176 VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL-QEEPPLLPGHM  254 (318)
T ss_dssp             -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH-HSCCCCCCSSS
T ss_pred             cCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHh-ccCCCCCCccC
Confidence            5554445567999999999994     5578999999999999999999999998744 333333333 33344444  3


Q ss_pred             CCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          331 HAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       331 ~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      .+++++.++|.+||+.||.+||++.++++
T Consensus       255 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          255 GFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            57999999999999999999999999986

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3e-45  Score=350.15  Aligned_cols=250  Identities=24%  Similarity=0.411  Sum_probs=211.2

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE---CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc---CCCceeeEEEEEe-----
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY---CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI---RHKNVVQFIGACT-----  177 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----  177 (395)
                      .++|++.+.||+|+||.||+|++   .++.||+|+++...........+.+|+.+++.+   +||||+++++++.     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   89 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   89 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence            46899999999999999999987   367899999975433322234566788877776   8999999999987     


Q ss_pred             cCCcEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccc
Q 016082          178 RPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR  256 (395)
Q Consensus       178 ~~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~  256 (395)
                      .....++||||++ |+|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++
T Consensus        90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~  168 (326)
T 1blx_A           90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  168 (326)
T ss_dssp             SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence            5567899999998 59999997753 458999999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC-----------
Q 016082          257 VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR-----------  325 (395)
Q Consensus       257 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~-----------  325 (395)
                      ............||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.......+......           
T Consensus       169 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  248 (326)
T 1blx_A          169 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA  248 (326)
T ss_dssp             CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCS
T ss_pred             cccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccc
Confidence            766554555678999999999999999999999999999999999999999998876665554431110           


Q ss_pred             --------------CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          326 --------------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       326 --------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                    ......+++++.++|.+||+.||.+|||+.++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                          0123567899999999999999999999999987

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.3e-44  Score=346.55  Aligned_cols=244  Identities=18%  Similarity=0.355  Sum_probs=205.5

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEEEEec--CCc
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTR--PPN  181 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~  181 (395)
                      ...++|++.++||+|+||.||+|++  +++.||||+++...     .+.+.+|+.++++++ ||||+++++++..  ...
T Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~  107 (330)
T 3nsz_A           33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRT  107 (330)
T ss_dssp             EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred             cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence            3457899999999999999999987  67899999998542     367889999999997 9999999999987  567


Q ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCC-cEEEeeecccccccc
Q 016082          182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQ  260 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~-~vkl~DFg~a~~~~~  260 (395)
                      .++||||+++++|.+++..    +++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus       108 ~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          108 PALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             EEEEEECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             eEEEEeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            8999999999999998743    78999999999999999999999999999999999999777 899999999987666


Q ss_pred             CCccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHhhh------------c----
Q 016082          261 SGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGL-TPLQAAVGVVQ------------K----  322 (395)
Q Consensus       261 ~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~-~~~~~~~~~~~------------~----  322 (395)
                      ........||..|+|||++.+ ..++.++|||||||++|+|++|+.||... ...+....+..            .    
T Consensus       184 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  263 (330)
T 3nsz_A          184 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  263 (330)
T ss_dssp             TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence            555566789999999999987 67999999999999999999999999543 22222111110            0    


Q ss_pred             -------------------cCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          323 -------------------SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       323 -------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                         ......+..+++++.++|.+||+.||.+|||+.|+++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                               0111222337899999999999999999999999987

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=9.6e-45  Score=361.03  Aligned_cols=254  Identities=27%  Similarity=0.434  Sum_probs=213.2

Q ss_pred             cccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc------CCCceeeEEEEEecC
Q 016082          108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI------RHKNVVQFIGACTRP  179 (395)
Q Consensus       108 ~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~  179 (395)
                      ...+|++.+.||+|+||.||+|.+  +++.||||+++..   ......+.+|+.+++.+      +|+||+++++++...
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~  171 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR  171 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence            356899999999999999999988  4689999999854   44557788899999988      467999999999999


Q ss_pred             CcEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCc--EEEeeecccc
Q 016082          180 PNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV--VKVADFGVAR  256 (395)
Q Consensus       180 ~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~--vkl~DFg~a~  256 (395)
                      ...++||||+. ++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++
T Consensus       172 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          172 NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence            99999999996 59999997754 45999999999999999999999999999999999999999987  9999999997


Q ss_pred             ccccCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCC----------
Q 016082          257 VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP----------  326 (395)
Q Consensus       257 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~----------  326 (395)
                      .....  .....||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+....+......+          
T Consensus       251 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~  328 (429)
T 3kvw_A          251 YEHQR--VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKR  328 (429)
T ss_dssp             ETTCC--CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTT
T ss_pred             ecCCc--ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhh
Confidence            64432  345689999999999999999999999999999999999999999988766554433211000          


Q ss_pred             -----------------------------------------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          327 -----------------------------------------------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       327 -----------------------------------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                                                     .++...++++.+||.+||+.||.+|||+.|+++
T Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~  408 (429)
T 3kvw_A          329 AKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALR  408 (429)
T ss_dssp             HHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhC
Confidence                                                           011234788999999999999999999999998


Q ss_pred             HHHHHHHHHHHhhcccc
Q 016082          360 ILKQMMKEVLYWLSPNL  376 (395)
Q Consensus       360 ~l~~~~~~~~~~~~~~~  376 (395)
                               +-|+...+
T Consensus       409 ---------Hpw~~~~~  416 (429)
T 3kvw_A          409 ---------HPWLRRRL  416 (429)
T ss_dssp             ---------STTTC---
T ss_pred             ---------ChhhccCC
Confidence                     66666543

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.1e-45  Score=353.27  Aligned_cols=249  Identities=22%  Similarity=0.374  Sum_probs=204.0

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC------CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV------NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  180 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (395)
                      .++|++.+.||+|+||.||+|++  +++.||||+++....      .......+.+|+.++++++||||+++++++....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            35799999999999999999988  468999999976532      1223346889999999999999999999997765


Q ss_pred             cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCc---EEEeeeccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV---VKVADFGVARV  257 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~---vkl~DFg~a~~  257 (395)
                       .|+||||+++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.   +||+|||+++.
T Consensus        89 -~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  166 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  166 (322)
T ss_dssp             -EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred             -eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence             8999999999999999875 567999999999999999999999999999999999999987664   99999999987


Q ss_pred             cccCCccccCCCCcccccccccC---CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC---CCCCCC
Q 016082          258 QAQSGVMTAETGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR---PTIPKH  331 (395)
Q Consensus       258 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~---~~~~~~  331 (395)
                      ...........||+.|+|||++.   +..++.++||||||+++|+|++|..||..................   +..+..
T Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (322)
T 2ycf_A          167 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE  246 (322)
T ss_dssp             CCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTT
T ss_pred             cccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhh
Confidence            65544344557899999999973   567899999999999999999999999865433222222222222   222356


Q ss_pred             CcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          332 AHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       332 ~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      +++++.++|.+||+.||.+||++.++++
T Consensus       247 ~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          247 VSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            7899999999999999999999999985

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-46  Score=361.65  Aligned_cols=251  Identities=22%  Similarity=0.399  Sum_probs=210.3

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEE-----CCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhc-CCCceeeEEEEEe
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACT  177 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~-----~~~~vAvK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  177 (395)
                      .+..++|++.+.||+|+||.||+|++     +++.||||+++....  .......+.+|+.+++++ +||||+++++++.
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  129 (355)
T 1vzo_A           50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ  129 (355)
T ss_dssp             CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred             cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence            45567999999999999999999987     578999999975421  112235577899999999 5999999999999


Q ss_pred             cCCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccc
Q 016082          178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV  257 (395)
Q Consensus       178 ~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~  257 (395)
                      .....++||||+++|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       130 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          130 TETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             ETTEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eCceEEEEeecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            99999999999999999999976 45799999999999999999999999999999999999999999999999999976


Q ss_pred             cccCC--ccccCCCCcccccccccCC--CCCCChhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHhhhccCCCCCC
Q 016082          258 QAQSG--VMTAETGTYRWMAPEVIEH--KPYDYKADVFSFGIALWELLTGELPYAGLT----PLQAAVGVVQKSLRPTIP  329 (395)
Q Consensus       258 ~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwslG~vl~elltg~~pf~~~~----~~~~~~~~~~~~~~~~~~  329 (395)
                      .....  ......||+.|+|||++.+  ..++.++|||||||++|+|++|+.||....    .......+.  ...+..+
T Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~  286 (355)
T 1vzo_A          209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL--KSEPPYP  286 (355)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH--HCCCCCC
T ss_pred             cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh--ccCCCCC
Confidence            43322  2334579999999999986  357899999999999999999999997532    222222222  2356677


Q ss_pred             CCCcHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 016082          330 KHAHPRLAELLERCWQHDPTQRP-----NFSQITD  359 (395)
Q Consensus       330 ~~~~~~l~~li~~cl~~dp~~RP-----s~~ell~  359 (395)
                      ..+++.+.++|.+||+.||.+||     ++.++++
T Consensus       287 ~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~  321 (355)
T 1vzo_A          287 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  321 (355)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence            88999999999999999999999     8998876

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=6.5e-45  Score=355.37  Aligned_cols=250  Identities=28%  Similarity=0.456  Sum_probs=211.6

Q ss_pred             CceeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 016082          103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  180 (395)
Q Consensus       103 ~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (395)
                      ..|++. ++|.+.+.||+|+||.||+|.+  +++.||||+++.........+.+.+|+.++++++||||+++++++....
T Consensus        36 ~~~~l~-~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  114 (371)
T 4exu_A           36 TAWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS  114 (371)
T ss_dssp             EEEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             ceeccc-ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccC
Confidence            446664 5899999999999999999987  5789999999877666777788999999999999999999999998776


Q ss_pred             cE------EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecc
Q 016082          181 NL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV  254 (395)
Q Consensus       181 ~~------~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~  254 (395)
                      ..      |+||||+.+ +|.+++.   ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus       115 ~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~  190 (371)
T 4exu_A          115 SLRNFYDFYLVMPFMQT-DLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGL  190 (371)
T ss_dssp             SSTTCCCCEEEEECCCE-EHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred             CcccceeEEEEEccccc-cHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCc
Confidence            54      999999984 8888763   4589999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCC-------
Q 016082          255 ARVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP-------  326 (395)
Q Consensus       255 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~-------  326 (395)
                      ++.....  .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......+       
T Consensus       191 a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  268 (371)
T 4exu_A          191 ARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  268 (371)
T ss_dssp             C----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             ccccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence            9865433  345678999999999987 789999999999999999999999999988766655543311111       


Q ss_pred             ----------------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          327 ----------------------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       327 ----------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                            ..+..+++++.++|.+||+.||.+|||+.|+++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence                                  012457899999999999999999999999987

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.3e-44  Score=352.20  Aligned_cols=255  Identities=24%  Similarity=0.395  Sum_probs=213.9

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-----Cc
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP-----PN  181 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  181 (395)
                      .++|++.+.||+|+||.||+|.+  +++.||||+++... .....+.+.+|+.++++++||||+++++++...     ..
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            35899999999999999999987  57889999997543 455567899999999999999999999999665     36


Q ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC
Q 016082          182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  261 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~  261 (395)
                      .|+||||+++ +|.+++..  +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus       105 ~~iv~e~~~~-~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  181 (364)
T 3qyz_A          105 VYIVQDLMET-DLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD  181 (364)
T ss_dssp             EEEEEECCSE-EHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred             EEEEEcccCc-CHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence            8999999975 99999865  46899999999999999999999999999999999999999999999999999865543


Q ss_pred             Cc----cccCCCCcccccccccC-CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCC----------
Q 016082          262 GV----MTAETGTYRWMAPEVIE-HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP----------  326 (395)
Q Consensus       262 ~~----~~~~~gt~~y~aPE~~~-~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~----------  326 (395)
                      ..    .....||+.|+|||++. +..++.++|||||||++|+|++|+.||.+.+..+....+......+          
T Consensus       182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  261 (364)
T 3qyz_A          182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN  261 (364)
T ss_dssp             GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCC
T ss_pred             CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            22    24457999999999865 5568999999999999999999999999877655544433211111          


Q ss_pred             --------------C-----CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcccc
Q 016082          327 --------------T-----IPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNL  376 (395)
Q Consensus       327 --------------~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~~~~~~~~  376 (395)
                                    .     ....+++++.++|.+||+.||.+|||+.|+++         +-|+.+..
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~---------hp~~~~~~  321 (364)
T 3qyz_A          262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA---------HPYLEQYY  321 (364)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT---------SGGGTTTC
T ss_pred             hhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc---------Ccchhhcc
Confidence                          0     11457889999999999999999999999997         67776543

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4.4e-45  Score=359.57  Aligned_cols=245  Identities=24%  Similarity=0.359  Sum_probs=203.0

Q ss_pred             cccCcceeeeeeeeCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC------
Q 016082          108 DAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP------  180 (395)
Q Consensus       108 ~~~~~~i~~~lg~G~~G~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  180 (395)
                      ...+|++.+.||+|+||.||+|++ .+..||+|.+.....      ...+|+.+++.++||||+++++++....      
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~  111 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV  111 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence            345899999999999999999998 456688888764421      1236999999999999999999985443      


Q ss_pred             cEEEEEecCCCCCHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeC-CCCcEEEeeecccc
Q 016082          181 NLCIVTEFMARGSIYDFLH---KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVAR  256 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~-~~~~vkl~DFg~a~  256 (395)
                      .+++||||++++ +.+.+.   .....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++
T Consensus       112 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~  190 (394)
T 4e7w_A          112 FLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK  190 (394)
T ss_dssp             EEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence            388999999874 444332   2356799999999999999999999999999999999999999 79999999999998


Q ss_pred             ccccCCccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCC---------
Q 016082          257 VQAQSGVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP---------  326 (395)
Q Consensus       257 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~---------  326 (395)
                      ............||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+..+....+......|         
T Consensus       191 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~  270 (394)
T 4e7w_A          191 ILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN  270 (394)
T ss_dssp             ECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             cccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence            76655555667899999999998765 59999999999999999999999999988766655544321110         


Q ss_pred             ------------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          327 ------------------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       327 ------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                        ..+..+++++.++|.+||+.||.+|||+.|+++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence                              123457889999999999999999999999987

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=4.1e-45  Score=362.69  Aligned_cols=244  Identities=25%  Similarity=0.355  Sum_probs=203.1

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC------C
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP------P  180 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  180 (395)
                      ..+|++.+.||+|+||.||+|++  +++.||||++....      ....+|+.+|++++||||+++++++...      .
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~  126 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV  126 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence            34799999999999999999998  57899999987542      2234699999999999999999988432      2


Q ss_pred             cEEEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCC-CcEEEeeecccc
Q 016082          181 NLCIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVAR  256 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~-~~vkl~DFg~a~  256 (395)
                      .+++||||+++ ++.+.+..   ....+++..++.++.||++||.|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus       127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            37899999987 67666543   35679999999999999999999999999999999999999965 578999999998


Q ss_pred             ccccCCccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC----------
Q 016082          257 VQAQSGVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR----------  325 (395)
Q Consensus       257 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~----------  325 (395)
                      ............||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+..+....+......          
T Consensus       206 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~  285 (420)
T 1j1b_A          206 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  285 (420)
T ss_dssp             ECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHC
T ss_pred             hcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence            76555555567899999999998764 7999999999999999999999999998876655554431110          


Q ss_pred             --------CC---------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          326 --------PT---------IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       326 --------~~---------~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                              +.         ++...++++.+||.+||+.||.+||++.|+++
T Consensus       286 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence                    11         23456899999999999999999999999986

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=342.32  Aligned_cols=247  Identities=24%  Similarity=0.439  Sum_probs=209.1

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCC--HHHHHHHHHHHHHHHhcCCCceeeEEEEE--ecCCcEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN--TEMLKEFSQEVYIMRKIRHKNVVQFIGAC--TRPPNLC  183 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~--~~~~~~~  183 (395)
                      ++|++.+.||+|+||.||+|.+  +++.||+|+++.....  ......+.+|+.++++++||||+++++++  ......+
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY   84 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence            5899999999999999999998  5688999999754211  23457799999999999999999999998  4456799


Q ss_pred             EEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc--
Q 016082          184 IVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ--  260 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~--  260 (395)
                      +||||++++ |.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||.+.....  
T Consensus        85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~  163 (305)
T 2wtk_C           85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA  163 (305)
T ss_dssp             EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred             EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence            999999886 77777653 46799999999999999999999999999999999999999999999999999976542  


Q ss_pred             -CCccccCCCCcccccccccCCCC--CCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHH
Q 016082          261 -SGVMTAETGTYRWMAPEVIEHKP--YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA  337 (395)
Q Consensus       261 -~~~~~~~~gt~~y~aPE~~~~~~--~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  337 (395)
                       ........||+.|+|||++.+..  ++.++||||||+++|+|++|+.||.+.+..+....+...  ....+..+++++.
T Consensus       164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~--~~~~~~~~~~~l~  241 (305)
T 2wtk_C          164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--SYAIPGDCGPPLS  241 (305)
T ss_dssp             SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC--CCCCCSSSCHHHH
T ss_pred             cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC--CCCCCCccCHHHH
Confidence             22233457899999999998654  378999999999999999999999998776665554433  3456778999999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHH
Q 016082          338 ELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       338 ~li~~cl~~dp~~RPs~~ell~  359 (395)
                      ++|.+||+.||.+|||+.++++
T Consensus       242 ~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          242 DLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHccCChhhCCCHHHHhc
Confidence            9999999999999999999987

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.3e-45  Score=356.14  Aligned_cols=250  Identities=23%  Similarity=0.409  Sum_probs=213.7

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEECCceEEEEEecCCCCCH---------------HHHHHHHHHHHHHHhcCCCceee
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNT---------------EMLKEFSQEVYIMRKIRHKNVVQ  171 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~---------------~~~~~~~~E~~~l~~l~h~niv~  171 (395)
                      +..++|++.+.||+|+||.||+|+++++.||||++.......               ...+.+.+|+.++++++||||++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           28 KYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             EEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            445799999999999999999999999999999986432111               11278899999999999999999


Q ss_pred             EEEEEecCCcEEEEEecCCCCCHHHH------Hhhc-cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeeeCC
Q 016082          172 FIGACTRPPNLCIVTEFMARGSIYDF------LHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDE  243 (395)
Q Consensus       172 l~~~~~~~~~~~lV~E~~~ggsL~~~------l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~-~~iiHrDlkp~NiLl~~  243 (395)
                      +++++...+..++||||+++|+|.++      +... ...+++..++.++.|++.||.|||+ .||+||||||+||+++.
T Consensus       108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~  187 (348)
T 2pml_X          108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK  187 (348)
T ss_dssp             CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECT
T ss_pred             EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcC
Confidence            99999999999999999999999998      6543 5679999999999999999999999 99999999999999999


Q ss_pred             CCcEEEeeeccccccccCCccccCCCCcccccccccCCC-CCCC-hhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHhh
Q 016082          244 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK-PYDY-KADVFSFGIALWELLTGELPYAGLTP-LQAAVGVV  320 (395)
Q Consensus       244 ~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-k~DvwslG~vl~elltg~~pf~~~~~-~~~~~~~~  320 (395)
                      ++.++|+|||.++..... ......||+.|+|||++.+. .++. ++||||||+++|+|++|+.||...+. .+....+.
T Consensus       188 ~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~  266 (348)
T 2pml_X          188 NGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR  266 (348)
T ss_dssp             TSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHT
T ss_pred             CCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh
Confidence            999999999999865443 34556899999999999887 6766 99999999999999999999998776 44333333


Q ss_pred             hccCCCCCC-------------------CCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          321 QKSLRPTIP-------------------KHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       321 ~~~~~~~~~-------------------~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      ..  ....|                   ..+++++.++|.+||+.||.+|||+.++++
T Consensus       267 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          267 TK--NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             SC--CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cc--CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            22  22233                   568999999999999999999999999987

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.7e-44  Score=363.78  Aligned_cols=255  Identities=22%  Similarity=0.361  Sum_probs=214.8

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC-CceeeEEEEEecCCcEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH-KNVVQFIGACTRPPNLCIV  185 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV  185 (395)
                      .++|++.++||+|+||.||+|++  .++.||||+++.....    ..+.+|+.+++.++| ++++.+..++......++|
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv   81 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV   81 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence            46899999999999999999997  4789999998755432    347789999999987 5666677777788889999


Q ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee---CCCCcEEEeeeccccccccCC
Q 016082          186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl---~~~~~vkl~DFg~a~~~~~~~  262 (395)
                      |||+ +++|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++......
T Consensus        82 me~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (483)
T 3sv0_A           82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS  160 (483)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             EECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence            9999 889999998777889999999999999999999999999999999999999   588999999999998655432


Q ss_pred             c--------cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHhhhccCCC---CC
Q 016082          263 V--------MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP---LQAAVGVVQKSLRP---TI  328 (395)
Q Consensus       263 ~--------~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~---~~~~~~~~~~~~~~---~~  328 (395)
                      .        .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+...   .+....+.......   ..
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l  240 (483)
T 3sv0_A          161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL  240 (483)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHH
T ss_pred             cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHH
Confidence            2        1245799999999999999999999999999999999999999987543   22222222222111   22


Q ss_pred             CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHH
Q 016082          329 PKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  368 (395)
Q Consensus       329 ~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~  368 (395)
                      +..+++++.++|.+||+.+|.+||++.+|++.|++++...
T Consensus       241 ~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence            3567899999999999999999999999999999998754

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.9e-44  Score=344.20  Aligned_cols=247  Identities=24%  Similarity=0.376  Sum_probs=208.5

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE---CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc------eeeEEEEEe
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY---CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN------VVQFIGACT  177 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~  177 (395)
                      +-.++|++.+.||+|+||.||+|.+   .++.||||+++..   ....+.+.+|+.+++.++|++      ++++++++.
T Consensus        11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~   87 (339)
T 1z57_A           11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE   87 (339)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred             CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence            3456999999999999999999987   4688999999754   455678899999999997654      999999999


Q ss_pred             cCCcEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCC-------------
Q 016082          178 RPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-------------  243 (395)
Q Consensus       178 ~~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~-------------  243 (395)
                      ..+..++||||+ +++|.+++.... .++++..+..++.||+.||+|||++||+||||||+||+++.             
T Consensus        88 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           88 HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             cCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence            999999999999 789999997654 36899999999999999999999999999999999999987             


Q ss_pred             ------CCcEEEeeeccccccccCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 016082          244 ------NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAV  317 (395)
Q Consensus       244 ------~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~  317 (395)
                            ++.+||+|||+++.....  .....||+.|+|||++.+..++.++||||||+++|||++|..||...+..+...
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  244 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA  244 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHH
T ss_pred             ccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence                  668999999999864432  345678999999999999999999999999999999999999999877655433


Q ss_pred             HhhhccCC------------------------------------------CCCCCCCcHHHHHHHHHhhccCCCCCCCHH
Q 016082          318 GVVQKSLR------------------------------------------PTIPKHAHPRLAELLERCWQHDPTQRPNFS  355 (395)
Q Consensus       318 ~~~~~~~~------------------------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~  355 (395)
                      .+......                                          ...+...++++.++|.+||+.||.+|||+.
T Consensus       245 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~  324 (339)
T 1z57_A          245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLR  324 (339)
T ss_dssp             HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHH
Confidence            32111000                                          011223467899999999999999999999


Q ss_pred             HHHH
Q 016082          356 QITD  359 (395)
Q Consensus       356 ell~  359 (395)
                      |+++
T Consensus       325 ell~  328 (339)
T 1z57_A          325 EALK  328 (339)
T ss_dssp             HHTT
T ss_pred             HHhc
Confidence            9986

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3.7e-45  Score=344.94  Aligned_cols=244  Identities=25%  Similarity=0.463  Sum_probs=199.5

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec---------
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR---------  178 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------  178 (395)
                      ++|++.+.||+|+||.||+|++  +++.||||+++..   ....+.+.+|+.++++++||||+++++++.+         
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            4799999999999999999997  5789999999643   4556789999999999999999999998854         


Q ss_pred             ----CCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecc
Q 016082          179 ----PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV  254 (395)
Q Consensus       179 ----~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~  254 (395)
                          ....|+||||+++|+|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||.
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  162 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL  162 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence                3468999999999999999987666788999999999999999999999999999999999999999999999999


Q ss_pred             ccccccC---------------CccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHH
Q 016082          255 ARVQAQS---------------GVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTP-LQAAV  317 (395)
Q Consensus       255 a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwslG~vl~elltg~~pf~~~~~-~~~~~  317 (395)
                      ++.....               .......||+.|+|||++.+. .++.++||||||+++|+|++   ||..... .+...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~  239 (303)
T 1zy4_A          163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK  239 (303)
T ss_dssp             CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred             hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHH
Confidence            9765321               122345689999999999865 68999999999999999998   5543222 22222


Q ss_pred             Hhhh--ccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          318 GVVQ--KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       318 ~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      .+..  ....+..+...++.+.++|.+||+.||.+|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            2111  22334455667888999999999999999999999987

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3e-44  Score=347.87  Aligned_cols=249  Identities=28%  Similarity=0.456  Sum_probs=209.2

Q ss_pred             ceeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Q 016082          104 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  181 (395)
Q Consensus       104 ~~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  181 (395)
                      .|++. ++|.+.+.||+|+||.||+|++  +++.||||++..........+.+.+|+.++++++||||+++++++.....
T Consensus        19 ~~~l~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   97 (353)
T 3coi_A           19 AWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS   97 (353)
T ss_dssp             EEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred             ccccC-ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccc
Confidence            45553 5899999999999999999987  57899999998776666777889999999999999999999999987654


Q ss_pred             ------EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccc
Q 016082          182 ------LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA  255 (395)
Q Consensus       182 ------~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a  255 (395)
                            +|+||||+.+ +|.+++.   ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        98 ~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A           98 LRNFYDFYLVMPFMQT-DLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             GGGCCCCEEEEECCSE-EGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             cccceeEEEEeccccC-CHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccc
Confidence                  4999999985 8888764   35899999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc-----------
Q 016082          256 RVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-----------  323 (395)
Q Consensus       256 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~-----------  323 (395)
                      +.....  .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+....+....           
T Consensus       174 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  251 (353)
T 3coi_A          174 RHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL  251 (353)
T ss_dssp             TC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTC
T ss_pred             cCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHH
Confidence            865432  345678999999999887 678999999999999999999999999887665544332210           


Q ss_pred             ---------------CC---CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          324 ---------------LR---PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       324 ---------------~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                     .+   ......+++++.++|.+||+.||.+|||+.++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          252 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             SCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                           01   1223467899999999999999999999999987

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.2e-44  Score=354.78  Aligned_cols=246  Identities=21%  Similarity=0.323  Sum_probs=202.7

Q ss_pred             cccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC--------CCceeeEEEEEe
Q 016082          108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR--------HKNVVQFIGACT  177 (395)
Q Consensus       108 ~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~  177 (395)
                      -.++|++.++||+|+||.||+|++  .++.||||+++..   ....+.+.+|+.++++++        |+||+++++++.
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~  111 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK  111 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence            357899999999999999999987  5789999999754   455678899999999996        788999999987


Q ss_pred             ----cCCcEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCeeeCCCC------
Q 016082          178 ----RPPNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENG------  245 (395)
Q Consensus       178 ----~~~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~-~iiHrDlkp~NiLl~~~~------  245 (395)
                          .....|+||||+ +++|.+.+... .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++      
T Consensus       112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~  190 (397)
T 1wak_A          112 ISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRL  190 (397)
T ss_dssp             EEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred             ecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhh
Confidence                556799999999 55776666554 36799999999999999999999998 999999999999999776      


Q ss_pred             -------------------------------------------cEEEeeeccccccccCCccccCCCCcccccccccCCC
Q 016082          246 -------------------------------------------VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK  282 (395)
Q Consensus       246 -------------------------------------------~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~  282 (395)
                                                                 .+||+|||.++.....  .....||+.|+|||++.+.
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~  268 (397)
T 1wak_A          191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGS  268 (397)
T ss_dssp             HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTS
T ss_pred             hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCC
Confidence                                                       7999999999865543  3456899999999999999


Q ss_pred             CCCChhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHhhhccC--------------------------------
Q 016082          283 PYDYKADVFSFGIALWELLTGELPYAGLTP------LQAAVGVVQKSL--------------------------------  324 (395)
Q Consensus       283 ~~~~k~DvwslG~vl~elltg~~pf~~~~~------~~~~~~~~~~~~--------------------------------  324 (395)
                      .++.++|||||||++|+|++|+.||...+.      ......+.....                                
T Consensus       269 ~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (397)
T 1wak_A          269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPW  348 (397)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCC
T ss_pred             CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCc
Confidence            999999999999999999999999986542      111111111000                                


Q ss_pred             --------CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          325 --------RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       325 --------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                              ....+...++++.+||.+||+.||.+|||+.|+++
T Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          349 GLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             chhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                    00112334568999999999999999999999987

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.8e-44  Score=346.51  Aligned_cols=247  Identities=24%  Similarity=0.370  Sum_probs=206.8

Q ss_pred             ccCcceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-----Cc
Q 016082          109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP-----PN  181 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  181 (395)
                      .++|++.+.||+|+||.||+|++.  ++.||||+++... .......+.+|+.++++++||||+++++++...     ..
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            468999999999999999999984  7899999997543 455567788999999999999999999988654     67


Q ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC
Q 016082          182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  261 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~  261 (395)
                      .++||||+.+ +|.+++..  +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus        89 ~~lv~e~~~~-~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  165 (353)
T 2b9h_A           89 VYIIQELMQT-DLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES  165 (353)
T ss_dssp             EEEEECCCSE-EHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EEEEEeccCc-cHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence            9999999975 99999875  56899999999999999999999999999999999999999999999999999865432


Q ss_pred             C-----------ccccCCCCcccccccccC-CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCC--
Q 016082          262 G-----------VMTAETGTYRWMAPEVIE-HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT--  327 (395)
Q Consensus       262 ~-----------~~~~~~gt~~y~aPE~~~-~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~--  327 (395)
                      .           ......||+.|+|||++. +..++.++|||||||++|+|++|+.||.+.+.......+......+.  
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  245 (353)
T 2b9h_A          166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD  245 (353)
T ss_dssp             --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCST
T ss_pred             cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchh
Confidence            1           122347899999999875 47789999999999999999999999998876554433222111100  


Q ss_pred             ----------------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          328 ----------------------------IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       328 ----------------------------~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                                  ....+++++.++|.+||+.||.+|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                                        11467899999999999999999999999987

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.4e-44  Score=350.39  Aligned_cols=251  Identities=21%  Similarity=0.244  Sum_probs=198.2

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc-
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-  181 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-  181 (395)
                      .....++|++.+.||+|+||.||+|++  +++.||||++......   ...+.+|+..++.++||||+++++++..... 
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            345567999999999999999999998  4789999998654322   2456678888899999999999999865433 


Q ss_pred             ------EEEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCCCCeeeCC-CCcEEE
Q 016082          182 ------LCIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLH--QNNIIHRDLKTANLLMDE-NGVVKV  249 (395)
Q Consensus       182 ------~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH--~~~iiHrDlkp~NiLl~~-~~~vkl  249 (395)
                            .++||||+++ +|.+.+..   ....+++..+..++.|++.||.|||  +.||+||||||+|||++. ++.+||
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl  173 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKL  173 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEE
Confidence                  8899999987 55554432   3567899999999999999999999  999999999999999997 899999


Q ss_pred             eeeccccccccCCccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC---
Q 016082          250 ADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR---  325 (395)
Q Consensus       250 ~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~---  325 (395)
                      +|||+++............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+......   
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (360)
T 3e3p_A          174 CDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR  253 (360)
T ss_dssp             CCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             eeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCH
Confidence            999999877666555667899999999998665 4899999999999999999999999998877666555432111   


Q ss_pred             ---------------------------CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          326 ---------------------------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       326 ---------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                                 +..+...++++.++|.+||+.||.+|||+.|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          254 EVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence                                       1222346789999999999999999999999987

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.8e-44  Score=340.21  Aligned_cols=246  Identities=23%  Similarity=0.395  Sum_probs=201.5

Q ss_pred             ccCcceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEe---------
Q 016082          109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT---------  177 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~---------  177 (395)
                      .++|++.+.||+|+||.||+|++.  ++.||+|++...  +....+.+.+|+.++++++||||+++++++.         
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   87 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD   87 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence            468999999999999999999984  789999999765  4566788999999999999999999999874         


Q ss_pred             -----cCCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeC-CCCcEEEee
Q 016082          178 -----RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVAD  251 (395)
Q Consensus       178 -----~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~-~~~~vkl~D  251 (395)
                           .....++||||++| +|.+++..  +++++..++.++.|++.||+|||++||+||||||+||+++ +++.+||+|
T Consensus        88 ~~~~~~~~~~~lv~e~~~~-~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D  164 (320)
T 2i6l_A           88 VGSLTELNSVYIVQEYMET-DLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD  164 (320)
T ss_dssp             ---CCSCSEEEEEEECCSE-EHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred             cccccccCceeEEeeccCC-CHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence                 34578999999984 99999864  5789999999999999999999999999999999999997 567999999


Q ss_pred             eccccccccC----CccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccC--
Q 016082          252 FGVARVQAQS----GVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL--  324 (395)
Q Consensus       252 Fg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~--  324 (395)
                      ||+++.....    .......+|..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+..+....+.....  
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  244 (320)
T 2i6l_A          165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV  244 (320)
T ss_dssp             CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred             CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9999865432    12234467899999998865 6789999999999999999999999999887665544332210  


Q ss_pred             ---------------------CCC-----CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          325 ---------------------RPT-----IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       325 ---------------------~~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                           .+.     .+..+++++.++|.+||+.||.+|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence                                 011     12457899999999999999999999999987

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3.6e-43  Score=338.99  Aligned_cols=246  Identities=23%  Similarity=0.369  Sum_probs=205.6

Q ss_pred             cccCcceeeeeeeeCceEEEEEEEC--C-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc------eeeEEEEEec
Q 016082          108 DAKQLKIECKVASGSYGDLYKGTYC--S-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN------VVQFIGACTR  178 (395)
Q Consensus       108 ~~~~~~i~~~lg~G~~G~Vy~~~~~--~-~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~  178 (395)
                      -.++|++.+.||+|+||.||+|.+.  + +.||+|+++..   ....+.+.+|+.++++++|++      ++.+++++..
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~   93 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF   93 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence            3579999999999999999999873  3 68999999753   455678889999999998765      9999999999


Q ss_pred             CCcEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee----------------
Q 016082          179 PPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM----------------  241 (395)
Q Consensus       179 ~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl----------------  241 (395)
                      .+..++||||+ ++++.+++.... .++++..++.++.||+.||.|||++||+||||||+|||+                
T Consensus        94 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           94 HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccc
Confidence            99999999999 557777776543 579999999999999999999999999999999999999                


Q ss_pred             ---CCCCcEEEeeeccccccccCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 016082          242 ---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG  318 (395)
Q Consensus       242 ---~~~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~  318 (395)
                         +.++.+||+|||+++.....  .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  250 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVM  250 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             ccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence               56789999999999864432  3456899999999999999999999999999999999999999998776554433


Q ss_pred             hhhccCCC------------------------------------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHH
Q 016082          319 VVQKSLRP------------------------------------------TIPKHAHPRLAELLERCWQHDPTQRPNFSQ  356 (395)
Q Consensus       319 ~~~~~~~~------------------------------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~e  356 (395)
                      +.......                                          ......++++.++|.+||+.||.+|||+.|
T Consensus       251 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e  330 (355)
T 2eu9_A          251 MEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAE  330 (355)
T ss_dssp             HHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             HHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHH
Confidence            22111000                                          011123568999999999999999999999


Q ss_pred             HHH
Q 016082          357 ITD  359 (395)
Q Consensus       357 ll~  359 (395)
                      +++
T Consensus       331 ~l~  333 (355)
T 2eu9_A          331 ALL  333 (355)
T ss_dssp             HTT
T ss_pred             Hhc
Confidence            986

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.6e-43  Score=345.26  Aligned_cols=245  Identities=25%  Similarity=0.398  Sum_probs=206.1

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CC-----ceeeEEEEEecCC
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HK-----NVVQFIGACTRPP  180 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~  180 (395)
                      .++|++.+.||+|+||.||+|++  +++.||||+++..   ......+..|+.+++.++ |+     +|+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            57899999999999999999987  4788999999753   445677888999999886 44     4999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCCCCeeeC--CCCcEEEeeeccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLH--QNNIIHRDLKTANLLMD--ENGVVKVADFGVA  255 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH--~~~iiHrDlkp~NiLl~--~~~~vkl~DFg~a  255 (395)
                      ..|+||||+++ +|.+++.... +.+++..+..++.|++.||.|||  +.||+||||||+|||++  .++.+||+|||++
T Consensus       130 ~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a  208 (382)
T 2vx3_A          130 HLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS  208 (382)
T ss_dssp             EEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             ceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence            99999999965 9999998754 56999999999999999999999  57999999999999995  4778999999999


Q ss_pred             cccccCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCC--------
Q 016082          256 RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT--------  327 (395)
Q Consensus       256 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~--------  327 (395)
                      +.....  .....||+.|+|||++.+.+++.++|||||||++|||++|+.||.+.+..+....+......+.        
T Consensus       209 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  286 (382)
T 2vx3_A          209 CQLGQR--IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAP  286 (382)
T ss_dssp             EETTCC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCT
T ss_pred             eecccc--cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhH
Confidence            876432  3456899999999999999999999999999999999999999999887766555443211100        


Q ss_pred             --------C------------------CC----------------------------CCcHHHHHHHHHhhccCCCCCCC
Q 016082          328 --------I------------------PK----------------------------HAHPRLAELLERCWQHDPTQRPN  353 (395)
Q Consensus       328 --------~------------------~~----------------------------~~~~~l~~li~~cl~~dp~~RPs  353 (395)
                              +                  ++                            ..++++.+||.+||+.||.+|||
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpt  366 (382)
T 2vx3_A          287 KARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQ  366 (382)
T ss_dssp             THHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCC
T ss_pred             HHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCC
Confidence                    0                  00                            00147899999999999999999


Q ss_pred             HHHHHH
Q 016082          354 FSQITD  359 (395)
Q Consensus       354 ~~ell~  359 (395)
                      +.|+++
T Consensus       367 a~e~L~  372 (382)
T 2vx3_A          367 PYYALQ  372 (382)
T ss_dssp             HHHHTT
T ss_pred             HHHHhc
Confidence            999987

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.3e-44  Score=339.34  Aligned_cols=245  Identities=24%  Similarity=0.437  Sum_probs=200.3

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCH----HHHHHHHHHHHHHHhc----CCCceeeEEE
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT----EMLKEFSQEVYIMRKI----RHKNVVQFIG  174 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~----~~~~~~~~E~~~l~~l----~h~niv~l~~  174 (395)
                      .+.-.++|++.+.||+|+||.||+|++  +++.||||+++......    .....+.+|+.+++++    +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            445567899999999999999999987  57889999997654322    1234567799999999    8999999999


Q ss_pred             EEecCCcEEEEEec-CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeC-CCCcEEEeee
Q 016082          175 ACTRPPNLCIVTEF-MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADF  252 (395)
Q Consensus       175 ~~~~~~~~~lV~E~-~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~-~~~~vkl~DF  252 (395)
                      ++...+..++|||+ +.+++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+||
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~df  184 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF  184 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEc
Confidence            99999999999999 789999999977 56799999999999999999999999999999999999999 8899999999


Q ss_pred             ccccccccCCccccCCCCcccccccccCCCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCC
Q 016082          253 GVARVQAQSGVMTAETGTYRWMAPEVIEHKPY-DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKH  331 (395)
Q Consensus       253 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  331 (395)
                      |+++..... ......||..|+|||++.+..+ +.++||||||+++|+|++|+.||.....      ...  .....+..
T Consensus       185 g~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~--~~~~~~~~  255 (312)
T 2iwi_A          185 GSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILE--AELHFPAH  255 (312)
T ss_dssp             SSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH--TCCCCCTT
T ss_pred             chhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhh--hccCCccc
Confidence            999866543 3355678999999999877665 4589999999999999999999976421      111  23456678


Q ss_pred             CcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          332 AHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       332 ~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      +++++.++|.+||+.||.+|||+.++++
T Consensus       256 ~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          256 VSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            8999999999999999999999999987

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=9.9e-44  Score=350.90  Aligned_cols=251  Identities=22%  Similarity=0.388  Sum_probs=188.9

Q ss_pred             Ccce-eeeeeeeCceEEEEEEEC----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEe--cCCcEE
Q 016082          111 QLKI-ECKVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT--RPPNLC  183 (395)
Q Consensus       111 ~~~i-~~~lg~G~~G~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~  183 (395)
                      .|.+ .++||+|+||.||+|++.    ++.||||+++.....    ..+.+|+.+|++++||||+++++++.  .....|
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVW   96 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence            4655 558999999999999963    678999999865433    45778999999999999999999994  466799


Q ss_pred             EEEecCCCCCHHHHHhhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee----CCCCcEEEee
Q 016082          184 IVTEFMARGSIYDFLHKQK--------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM----DENGVVKVAD  251 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~--------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl----~~~~~vkl~D  251 (395)
                      +||||+++ +|.+++....        ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|
T Consensus        97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D  175 (405)
T 3rgf_A           97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD  175 (405)
T ss_dssp             EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred             EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence            99999975 8888875332        248999999999999999999999999999999999999    6778999999


Q ss_pred             eccccccccC----CccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH---------HHHH
Q 016082          252 FGVARVQAQS----GVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPL---------QAAV  317 (395)
Q Consensus       252 Fg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~---------~~~~  317 (395)
                      ||+++.....    .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....         +...
T Consensus       176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~  255 (405)
T 3rgf_A          176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD  255 (405)
T ss_dssp             TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred             CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence            9999865432    22344578999999999987 45899999999999999999999999765542         1111


Q ss_pred             HhhhccCCCC------------------------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 016082          318 GVVQKSLRPT------------------------------------IPKHAHPRLAELLERCWQHDPTQRPNFSQITDIL  361 (395)
Q Consensus       318 ~~~~~~~~~~------------------------------------~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l  361 (395)
                      .+......|.                                    .....++++.+||.+||+.||.+|||+.|+++  
T Consensus       256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~--  333 (405)
T 3rgf_A          256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ--  333 (405)
T ss_dssp             HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT--
T ss_pred             HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc--
Confidence            1111110010                                    01122678999999999999999999999998  


Q ss_pred             HHHHHHHHHhhccc
Q 016082          362 KQMMKEVLYWLSPN  375 (395)
Q Consensus       362 ~~~~~~~~~~~~~~  375 (395)
                             +-|+...
T Consensus       334 -------hp~f~~~  340 (405)
T 3rgf_A          334 -------DPYFLED  340 (405)
T ss_dssp             -------SGGGTSS
T ss_pred             -------ChhhccC
Confidence                   6676543

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=353.08  Aligned_cols=252  Identities=25%  Similarity=0.409  Sum_probs=201.0

Q ss_pred             CCceeecccCcceeeeeeeeCceE-EEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEEEEecC
Q 016082          102 TDVWEIDAKQLKIECKVASGSYGD-LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRP  179 (395)
Q Consensus       102 ~~~~~i~~~~~~i~~~lg~G~~G~-Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  179 (395)
                      ...+.+...+|.+.+.||+|+||. ||++..+++.||||++.....     ..+.+|+.+|+++ +||||+++++++.+.
T Consensus        16 ~~~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~   90 (432)
T 3p23_A           16 TSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDR   90 (432)
T ss_dssp             --CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEET
T ss_pred             CCcEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence            346778888999999999999998 566777899999999976532     2356899999999 799999999999999


Q ss_pred             CcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCC-----CcEEEeeecc
Q 016082          180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-----GVVKVADFGV  254 (395)
Q Consensus       180 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~-----~~vkl~DFg~  254 (395)
                      ...|+||||+.| +|.+++......++...++.++.||+.||.|||++||+||||||+|||++.+     ..+||+|||+
T Consensus        91 ~~~~lv~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~  169 (432)
T 3p23_A           91 QFQYIAIELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGL  169 (432)
T ss_dssp             TEEEEEEECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred             CEEEEEEECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence            999999999975 9999998876667777788999999999999999999999999999999532     3588999999


Q ss_pred             ccccccC----CccccCCCCcccccccccC---CCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCC
Q 016082          255 ARVQAQS----GVMTAETGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRP  326 (395)
Q Consensus       255 a~~~~~~----~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  326 (395)
                      ++.....    .......||+.|+|||++.   +..++.++|||||||++|||++ |..||......+............
T Consensus       170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~  249 (432)
T 3p23_A          170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC  249 (432)
T ss_dssp             EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTT
T ss_pred             eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccc
Confidence            9865533    2234467999999999997   4567889999999999999999 999997765544333222111111


Q ss_pred             C-CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          327 T-IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       327 ~-~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      . .+...+..+.++|.+||+.||.+|||+.++++
T Consensus       250 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          250 LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            1 12334667899999999999999999999984

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.9e-43  Score=343.86  Aligned_cols=258  Identities=19%  Similarity=0.360  Sum_probs=208.6

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-----------CCceeeE
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-----------HKNVVQF  172 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l  172 (395)
                      .+..++|++.+.||+|+||.||+|++  +++.||||+++..   ......+.+|+.++++++           ||||+++
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~   91 (373)
T 1q8y_A           15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   91 (373)
T ss_dssp             EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence            45667999999999999999999997  6789999999754   445577889999999887           7899999


Q ss_pred             EEEEecCC----cEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCeeeC----
Q 016082          173 IGACTRPP----NLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMD----  242 (395)
Q Consensus       173 ~~~~~~~~----~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~-~iiHrDlkp~NiLl~----  242 (395)
                      ++++....    .+++|||++ +++|.+++... .+.+++..+..++.||+.||.|||++ ||+||||||+|||++    
T Consensus        92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred             HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence            99987654    689999999 88999999764 35699999999999999999999998 999999999999994    


Q ss_pred             --CCCcEEEeeeccccccccCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH------H
Q 016082          243 --ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL------Q  314 (395)
Q Consensus       243 --~~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~------~  314 (395)
                        ..+.+||+|||+++.....  .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..      .
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  248 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  248 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             CcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence              4448999999999865543  34567899999999999999999999999999999999999999865421      1


Q ss_pred             HHHHhhhc----------------------------------------cCCCCCCCCCcHHHHHHHHHhhccCCCCCCCH
Q 016082          315 AAVGVVQK----------------------------------------SLRPTIPKHAHPRLAELLERCWQHDPTQRPNF  354 (395)
Q Consensus       315 ~~~~~~~~----------------------------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~  354 (395)
                      ....+...                                        ......+...++++.++|.+||+.||.+|||+
T Consensus       249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  328 (373)
T 1q8y_A          249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  328 (373)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence            11111110                                        00112334567889999999999999999999


Q ss_pred             HHHHHHHHHHHHHHHHhhcccccc
Q 016082          355 SQITDILKQMMKEVLYWLSPNLIN  378 (395)
Q Consensus       355 ~ell~~l~~~~~~~~~~~~~~~~~  378 (395)
                      .|+++         +-|+...+..
T Consensus       329 ~ell~---------hp~f~~~~~~  343 (373)
T 1q8y_A          329 GGLVN---------HPWLKDTLGM  343 (373)
T ss_dssp             HHHHT---------CGGGTTCTTC
T ss_pred             HHHhh---------ChhhhcccCc
Confidence            99988         6676655443

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.7e-44  Score=342.87  Aligned_cols=245  Identities=24%  Similarity=0.450  Sum_probs=207.8

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCH----HHHHHHHHHHHHHHhcC--CCceeeEEEEE
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT----EMLKEFSQEVYIMRKIR--HKNVVQFIGAC  176 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~----~~~~~~~~E~~~l~~l~--h~niv~l~~~~  176 (395)
                      .+.-.++|++.+.||+|+||.||+|++  +++.||||+++......    .....+.+|+.++++++  ||||+++++++
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~  117 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF  117 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence            445567899999999999999999987  67899999997553221    12245678999999996  59999999999


Q ss_pred             ecCCcEEEEEecCCC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeC-CCCcEEEeeecc
Q 016082          177 TRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGV  254 (395)
Q Consensus       177 ~~~~~~~lV~E~~~g-gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~-~~~~vkl~DFg~  254 (395)
                      ..++..++|||++.+ ++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++ +++.+||+|||+
T Consensus       118 ~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~  196 (320)
T 3a99_A          118 ERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS  196 (320)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred             ecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence            999999999999986 899999976 56799999999999999999999999999999999999999 789999999999


Q ss_pred             ccccccCCccccCCCCcccccccccCCCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCc
Q 016082          255 ARVQAQSGVMTAETGTYRWMAPEVIEHKPY-DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH  333 (395)
Q Consensus       255 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (395)
                      ++..... ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.....      ...  .....+..++
T Consensus       197 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~--~~~~~~~~~~  267 (320)
T 3a99_A          197 GALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR--GQVFFRQRVS  267 (320)
T ss_dssp             CEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH--CCCCCSSCCC
T ss_pred             ccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhc--ccccccccCC
Confidence            9866543 3345679999999999887665 6889999999999999999999976421      111  1234566789


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          334 PRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       334 ~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      +++.++|.+||+.||.+|||+.++++
T Consensus       268 ~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          268 SECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhc
Confidence            99999999999999999999999987

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.8e-43  Score=339.22  Aligned_cols=244  Identities=22%  Similarity=0.355  Sum_probs=176.6

Q ss_pred             ccCcceee-eeeeeCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec----CCc
Q 016082          109 AKQLKIEC-KVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR----PPN  181 (395)
Q Consensus       109 ~~~~~i~~-~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~  181 (395)
                      .++|.+.+ .||+|+||.||+|++.  ++.||||++...   ..   ...+....++.++||||+++++++..    ...
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  100 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PK---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRC  100 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HH---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence            45898865 6999999999999984  789999999753   22   22233344567789999999999865    445


Q ss_pred             EEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCC---CCcEEEeeeccccc
Q 016082          182 LCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NGVVKVADFGVARV  257 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~---~~~vkl~DFg~a~~  257 (395)
                      .++||||++||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.   ++.+||+|||+++.
T Consensus       101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~  180 (336)
T 3fhr_A          101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE  180 (336)
T ss_dssp             EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence            899999999999999998754 46999999999999999999999999999999999999986   45599999999986


Q ss_pred             cccCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhh------ccCCCCCCCC
Q 016082          258 QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ------KSLRPTIPKH  331 (395)
Q Consensus       258 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~------~~~~~~~~~~  331 (395)
                      .... ......||+.|+|||++.+..++.++||||||+++|+|++|..||..............      ..........
T Consensus       181 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (336)
T 3fhr_A          181 TTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE  259 (336)
T ss_dssp             C-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTT
T ss_pred             cccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhcc
Confidence            5433 23456789999999999988999999999999999999999999987655433211111      1112222356


Q ss_pred             CcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          332 AHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       332 ~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      +++++.++|.+||+.||.+|||+.++++
T Consensus       260 ~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          260 VSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            8999999999999999999999999987

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.9e-42  Score=342.74  Aligned_cols=242  Identities=21%  Similarity=0.383  Sum_probs=188.8

Q ss_pred             cCcceeeeeeeeCceEEEE-EEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYK-GTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~-~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      +.|.+.+.||+|+||+||. +..+++.||||++...     ..+.+.+|+.+++++ +||||+++++++.+....|+|||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E   89 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE   89 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence            3566778999999999964 4558899999998743     235678899999987 89999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCC------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCC-------------CcEE
Q 016082          188 FMARGSIYDFLHKQKGV------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-------------GVVK  248 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~------l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~-------------~~vk  248 (395)
                      |++ |+|.+++......      .++..++.++.||+.||.|||++||+||||||+|||++.+             +.+|
T Consensus        90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence            996 5999999764321      1233467899999999999999999999999999999754             4899


Q ss_pred             EeeeccccccccCC-----ccccCCCCcccccccccCC-------CCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 016082          249 VADFGVARVQAQSG-----VMTAETGTYRWMAPEVIEH-------KPYDYKADVFSFGIALWELLT-GELPYAGLTPLQA  315 (395)
Q Consensus       249 l~DFg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~-------~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~  315 (395)
                      |+|||+++......     ......||+.|+|||++.+       ..++.++|||||||++|||++ |..||......+.
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~  248 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES  248 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH
Confidence            99999998655432     1234579999999999976       678999999999999999999 9999987654432


Q ss_pred             HHHhhhccCCCC-C----CCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          316 AVGVVQKSLRPT-I----PKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       316 ~~~~~~~~~~~~-~----~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                        .+........ .    +..+++++.++|.+||+.||.+|||+.++++
T Consensus       249 --~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          249 --NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             --HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence              2222222211 1    1235688999999999999999999999985

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1e-41  Score=321.31  Aligned_cols=231  Identities=13%  Similarity=0.166  Sum_probs=193.4

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  183 (395)
                      +-.++|++.+.||+|+||.||+|++.  ++.||||+++.... +.+..+.+.+|+.++++++||||+++++++...+..|
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  107 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL  107 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence            44568999999999999999999984  78999999987654 3556788999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCc
Q 016082          184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV  263 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~  263 (395)
                      +||||++|++|.++++.  + .....+..++.|++.||.|||++||+||||||+|||++.+|.+||+++|          
T Consensus       108 lv~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------  174 (286)
T 3uqc_A          108 VVAEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------  174 (286)
T ss_dssp             EEEECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred             EEEEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc----------
Confidence            99999999999999954  2 3556788999999999999999999999999999999999999998544          


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HhhhccCCC--CCCCCCcHHHHH
Q 016082          264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAV---GVVQKSLRP--TIPKHAHPRLAE  338 (395)
Q Consensus       264 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~---~~~~~~~~~--~~~~~~~~~l~~  338 (395)
                               |++       +++.++|||||||++|+|++|+.||.+.+......   ........+  ..+..+++++.+
T Consensus       175 ---------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  238 (286)
T 3uqc_A          175 ---------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA  238 (286)
T ss_dssp             ---------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHH
T ss_pred             ---------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHH
Confidence                     222       37899999999999999999999998865432110   001111110  123568899999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 016082          339 LLERCWQHDPTQRPNFSQITDILKQMMKE  367 (395)
Q Consensus       339 li~~cl~~dp~~RPs~~ell~~l~~~~~~  367 (395)
                      +|.+||+.||.+| |+.++++.|+++...
T Consensus       239 li~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          239 VAARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             HHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             HHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence            9999999999999 999999999987654

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.2e-42  Score=357.31  Aligned_cols=248  Identities=25%  Similarity=0.358  Sum_probs=203.7

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec------CCc
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR------PPN  181 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  181 (395)
                      ++|++.++||+|+||.||+|.+  +++.||||+++... .....+.+.+|+.++++++||||+++++++..      .+.
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL-SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC-CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            6899999999999999999987  57899999997653 55667889999999999999999999998765      667


Q ss_pred             EEEEEecCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCc---EEEeeecccc
Q 016082          182 LCIVTEFMARGSIYDFLHKQK--GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV---VKVADFGVAR  256 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~---vkl~DFg~a~  256 (395)
                      .++||||++||+|.+++....  ..+++..++.++.+++.||.|||+.||+||||||+||+++.++.   ++|+|||.++
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~  172 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK  172 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence            899999999999999998643  36899999999999999999999999999999999999997765   9999999998


Q ss_pred             ccccCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh----------hhcc---
Q 016082          257 VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV----------VQKS---  323 (395)
Q Consensus       257 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~----------~~~~---  323 (395)
                      ............||+.|+|||++.+..++.++||||||+++|+|++|..||.+..........          ....   
T Consensus       173 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g  252 (676)
T 3qa8_A          173 ELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTG  252 (676)
T ss_dssp             BTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSS
T ss_pred             ccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhcc
Confidence            776665556678999999999999999999999999999999999999999764332211000          0000   


Q ss_pred             ---C------CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHH
Q 016082          324 ---L------RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQIT  358 (395)
Q Consensus       324 ---~------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell  358 (395)
                         +      ....+..+++.+.++|.+||+.||.+|||+.+++
T Consensus       253 ~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL  296 (676)
T 3qa8_A          253 AVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP  296 (676)
T ss_dssp             SCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred             ccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence               0      0112234678999999999999999999998854

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=4e-41  Score=318.55  Aligned_cols=222  Identities=23%  Similarity=0.405  Sum_probs=182.6

Q ss_pred             cCccee-eeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHH-HhcCCCceeeEEEEEec----CCc
Q 016082          110 KQLKIE-CKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIM-RKIRHKNVVQFIGACTR----PPN  181 (395)
Q Consensus       110 ~~~~i~-~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~  181 (395)
                      ++|.+. +.||+|+||.||+|.+  +++.||+|+++..       ..+.+|+.++ +..+||||+++++++..    ...
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   89 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   89 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence            467777 7799999999999988  5789999999743       4567888888 55689999999999876    667


Q ss_pred             EEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCC---CCcEEEeeeccccc
Q 016082          182 LCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NGVVKVADFGVARV  257 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~---~~~vkl~DFg~a~~  257 (395)
                      .++||||++||+|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.   ++.+||+|||++..
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  169 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  169 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence            999999999999999998753 46999999999999999999999999999999999999998   78999999999864


Q ss_pred             cccCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC--CCCC----CC
Q 016082          258 QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIP----KH  331 (395)
Q Consensus       258 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~--~~~~----~~  331 (395)
                      ..                     +..++.++|||||||++|+|++|+.||.+................  ...+    ..
T Consensus       170 ~~---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (299)
T 3m2w_A          170 TT---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE  228 (299)
T ss_dssp             CT---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTT
T ss_pred             cc---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhccc
Confidence            32                     244788999999999999999999999876654433222211111  1122    46


Q ss_pred             CcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          332 AHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       332 ~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      +++++.++|.+||+.||.+|||+.++++
T Consensus       229 ~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          229 VSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            7899999999999999999999999987

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.8e-42  Score=341.56  Aligned_cols=255  Identities=16%  Similarity=0.198  Sum_probs=195.4

Q ss_pred             cccCcceeeeeeeeCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCC-Cce--------------
Q 016082          108 DAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRH-KNV--------------  169 (395)
Q Consensus       108 ~~~~~~i~~~lg~G~~G~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h-~ni--------------  169 (395)
                      ....|+..+.||+|+||.||+|++.  ++.||||+++.... .....+.+.+|+.+++.++| +|.              
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            3456889999999999999999984  89999999984432 23345779999999999987 221              


Q ss_pred             -------eeEEEEEec-----CCcEEEEEecCCCCCHHHHHhh------ccCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 016082          170 -------VQFIGACTR-----PPNLCIVTEFMARGSIYDFLHK------QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH  231 (395)
Q Consensus       170 -------v~l~~~~~~-----~~~~~lV~E~~~ggsL~~~l~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiH  231 (395)
                             ..+..++..     ...++++|+++ +++|.+++..      ..+.+++..++.++.||++||+|||++||+|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH  234 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH  234 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence                   111111111     22478888876 5699999842      2445778889999999999999999999999


Q ss_pred             cCCCCCCeeeCCCCcEEEeeeccccccccCCccccCCCCccccccccc----------CCCCCCChhhHHHHHHHHHHHH
Q 016082          232 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI----------EHKPYDYKADVFSFGIALWELL  301 (395)
Q Consensus       232 rDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~k~DvwslG~vl~ell  301 (395)
                      |||||+|||++.++.+||+|||+++.....  .....| +.|+|||++          .+..++.++|||||||++|||+
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell  311 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW  311 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred             CCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence            999999999999999999999999865543  445577 999999999          6667899999999999999999


Q ss_pred             hCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH--HHHHHHHHHHhh
Q 016082          302 TGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDI--LKQMMKEVLYWL  372 (395)
Q Consensus       302 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~--l~~~~~~~~~~~  372 (395)
                      +|+.||...+..+....+..      ....+++++.++|.+||+.||.+||++.++++.  ++.+.+.+...+
T Consensus       312 tg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~~~~~~~  378 (413)
T 3dzo_A          312 CADLPNTDDAALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAAL  378 (413)
T ss_dssp             HSSCCCCTTGGGSCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHHHHHHG
T ss_pred             HCCCCCCCcchhhhHHHHHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHHHHHHHHh
Confidence            99999988665433222211      123578999999999999999999999998762  555555444433

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.3e-41  Score=357.02  Aligned_cols=245  Identities=21%  Similarity=0.289  Sum_probs=203.1

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE---CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc--
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY---CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN--  181 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--  181 (395)
                      +-.++|++.+.||+|+||.||+|.+   +++.||||++.... .......+.+|+.++++++||||+++++++...+.  
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  155 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG  155 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence            4457999999999999999999987   46889999987543 45566789999999999999999999999987665  


Q ss_pred             ---EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccc
Q 016082          182 ---LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  258 (395)
Q Consensus       182 ---~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~  258 (395)
                         .|+||||++|++|.+++..   ++++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++..
T Consensus       156 ~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          156 DPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             CEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             CceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence               7999999999999988754   68999999999999999999999999999999999999885 8999999999865


Q ss_pred             ccCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCC-CCCCcHHHH
Q 016082          259 AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI-PKHAHPRLA  337 (395)
Q Consensus       259 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~  337 (395)
                      ...   ....||+.|+|||++.+.. +.++|||||||++|+|++|..||.+...         ....... ....++.+.
T Consensus       232 ~~~---~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~---------~~~~~~~~~~~~~~~l~  298 (681)
T 2pzi_A          232 NSF---GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV---------DGLPEDDPVLKTYDSYG  298 (681)
T ss_dssp             TCC---SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEEC---------SSCCTTCHHHHHCHHHH
T ss_pred             ccC---CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccc---------ccccccccccccCHHHH
Confidence            443   4557999999999987654 8999999999999999999999875211         0111110 112357899


Q ss_pred             HHHHHhhccCCCCCC-CHHHHHHHHHHHHHHHH
Q 016082          338 ELLERCWQHDPTQRP-NFSQITDILKQMMKEVL  369 (395)
Q Consensus       338 ~li~~cl~~dp~~RP-s~~ell~~l~~~~~~~~  369 (395)
                      ++|.+||+.||.+|| +++++...|..++++..
T Consensus       299 ~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~  331 (681)
T 2pzi_A          299 RLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVV  331 (681)
T ss_dssp             HHHHHHTCSSGGGSCSSHHHHHHHHHHHHHHHH
T ss_pred             HHHhhhccCChhhCCCHHHHHHHHHHHHHHHhh
Confidence            999999999999999 57777888888877664

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3.1e-42  Score=331.54  Aligned_cols=240  Identities=15%  Similarity=0.253  Sum_probs=191.2

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEECCceEEEEEecCCCC------CHHHHHHHHHHHHHHHhcC---------CCceee
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECV------NTEMLKEFSQEVYIMRKIR---------HKNVVQ  171 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~------~~~~~~~~~~E~~~l~~l~---------h~niv~  171 (395)
                      +..++|++.++||+|+||.||+|+++++.||||+++....      .....+.+.+|+.+++.++         ||||++
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            4567899999999999999999999999999999976532      2333477889999999986         777777


Q ss_pred             EEEEEe------------------------------cCCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHH
Q 016082          172 FIGACT------------------------------RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM  221 (395)
Q Consensus       172 l~~~~~------------------------------~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l  221 (395)
                      +.+++.                              ....+|+||||+++|++.+.+.+  +.+++..++.++.||+.||
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence            777642                              26789999999999977776643  5689999999999999999


Q ss_pred             HHHH-HCCccccCCCCCCeeeCCCC--------------------cEEEeeeccccccccCCccccCCCCcccccccccC
Q 016082          222 NYLH-QNNIIHRDLKTANLLMDENG--------------------VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE  280 (395)
Q Consensus       222 ~~LH-~~~iiHrDlkp~NiLl~~~~--------------------~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~  280 (395)
                      .||| ++||+||||||+|||++.++                    .+||+|||+|+.....    ...||+.|+|||++.
T Consensus       175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~  250 (336)
T 2vuw_A          175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFT  250 (336)
T ss_dssp             HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGC
T ss_pred             HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhc
Confidence            9999 99999999999999999887                    8999999999866532    347999999999999


Q ss_pred             CCCCCChhhHHHHHHH-HHHHHhCCCCCCCCCHHH-HHHHhhhc-cCCCC----CCCCCcHHHHHHHHHhhccCCCCCCC
Q 016082          281 HKPYDYKADVFSFGIA-LWELLTGELPYAGLTPLQ-AAVGVVQK-SLRPT----IPKHAHPRLAELLERCWQHDPTQRPN  353 (395)
Q Consensus       281 ~~~~~~k~DvwslG~v-l~elltg~~pf~~~~~~~-~~~~~~~~-~~~~~----~~~~~~~~l~~li~~cl~~dp~~RPs  353 (395)
                      +.. +.++||||++++ .+++++|..||.+..... ........ .....    .+..+++++.+||++||+.|     |
T Consensus       251 g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----s  324 (336)
T 2vuw_A          251 GDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----S  324 (336)
T ss_dssp             CCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----S
T ss_pred             CCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----C
Confidence            877 899999998777 777888999985532211 11122211 11111    12357889999999999976     8


Q ss_pred             HHHHH
Q 016082          354 FSQIT  358 (395)
Q Consensus       354 ~~ell  358 (395)
                      +.|++
T Consensus       325 a~e~l  329 (336)
T 2vuw_A          325 ATDLL  329 (336)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            88887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=7.3e-34  Score=291.69  Aligned_cols=182  Identities=12%  Similarity=0.124  Sum_probs=130.7

Q ss_pred             eeeeeCceEEEEEE--ECCceEEEEEecCCCC--------CHHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcEEEE
Q 016082          117 KVASGSYGDLYKGT--YCSQEVAIKVLKPECV--------NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIV  185 (395)
Q Consensus       117 ~lg~G~~G~Vy~~~--~~~~~vAvK~~~~~~~--------~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV  185 (395)
                      ..+.|+.|.+..++  +.|+.+|||++.....        .+...++|.+|+.+|+++ .|+||++++++++++...|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            45567777666554  4789999999976532        123456799999999999 599999999999999999999


Q ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-cc
Q 016082          186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VM  264 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~  264 (395)
                      |||++|++|.+++.. .++++..   +|+.||+.||+|+|++|||||||||+|||++.+|.+||+|||+|+...... ..
T Consensus       321 MEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~  396 (569)
T 4azs_A          321 MEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWP  396 (569)
T ss_dssp             EECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCS
T ss_pred             EecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccc
Confidence            999999999999976 5667654   578999999999999999999999999999999999999999998665432 33


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhC
Q 016082          265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG  303 (395)
Q Consensus       265 ~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg  303 (395)
                      ...+||+.|||||++.+. +..++|+||+|++++++.++
T Consensus       397 ~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~  434 (569)
T 4azs_A          397 TNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQP  434 (569)
T ss_dssp             HHHHHHHHHHHHHHC------------------CCCCTT
T ss_pred             cCceechhhccHHHhCCC-CCCcccccccccchhhhccc
Confidence            456799999999999765 57789999999988776554

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=3.4e-30  Score=263.00  Aligned_cols=185  Identities=19%  Similarity=0.230  Sum_probs=148.3

Q ss_pred             ceeeeeeeeCceEEEEEEECCceEEEEEecCCCCCHH------HHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          113 KIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTE------MLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       113 ~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      ...+.||+|+||.||+|++.++.+|+|..........      ..+.+.+|+.++++++||||+++..++......|+||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm  418 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM  418 (540)
T ss_dssp             ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred             CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence            3466899999999999998999999999765443221      2355899999999999999996555555667789999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCc---
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV---  263 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~---  263 (395)
                      ||++|++|.+++..         +..++.|+++||.|||++||+||||||+|||++.  .+||+|||+++.......   
T Consensus       419 E~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~  487 (540)
T 3en9_A          419 SYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV  487 (540)
T ss_dssp             ECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHH
T ss_pred             ECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccccc
Confidence            99999999999865         5689999999999999999999999999999998  999999999987654321   


Q ss_pred             -----cccCCCCcccccccccCC--CCCCChhhHHHHHHHHHHHHhCCCCCC
Q 016082          264 -----MTAETGTYRWMAPEVIEH--KPYDYKADVFSFGIALWELLTGELPYA  308 (395)
Q Consensus       264 -----~~~~~gt~~y~aPE~~~~--~~~~~k~DvwslG~vl~elltg~~pf~  308 (395)
                           .....||+.|||||++..  ..|+..+|+|+...-..+-..++.+|.
T Consensus       488 ~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          488 DLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             chhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence                 124578999999999987  678888999999888888877777764

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=3.3e-26  Score=214.80  Aligned_cols=146  Identities=14%  Similarity=0.131  Sum_probs=117.0

Q ss_pred             cCcceeeeeeeeCceEEEEEEE-CCceEEEEEecCCCCCH----------------HHHHHHHHHHHHHHhcCCCceeeE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNT----------------EMLKEFSQEVYIMRKIRHKNVVQF  172 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~-~~~~vAvK~~~~~~~~~----------------~~~~~~~~E~~~l~~l~h~niv~l  172 (395)
                      ..|.+.+.||+|+||.||+|++ +++.||||+++....+.                .....+.+|+.+|++++|   +++
T Consensus        90 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v  166 (282)
T 1zar_A           90 KVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAV  166 (282)
T ss_dssp             SCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSS
T ss_pred             eEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCc
Confidence            3456779999999999999998 57899999997543211                245678999999999994   555


Q ss_pred             EEEEecCCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeee
Q 016082          173 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADF  252 (395)
Q Consensus       173 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DF  252 (395)
                      .+++.. +..|+||||++||+|.+ +..       .....++.|++.||.|||+.||+||||||+|||++ ++.+||+||
T Consensus       167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DF  236 (282)
T 1zar_A          167 PKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDF  236 (282)
T ss_dssp             CCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCC
T ss_pred             CeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEEC
Confidence            554443 45699999999999988 421       23557999999999999999999999999999999 999999999


Q ss_pred             ccccccccCCccccCCCCcccccccccC
Q 016082          253 GVARVQAQSGVMTAETGTYRWMAPEVIE  280 (395)
Q Consensus       253 g~a~~~~~~~~~~~~~gt~~y~aPE~~~  280 (395)
                      |+|+.            +..++|||.+.
T Consensus       237 G~a~~------------~~~~~a~e~l~  252 (282)
T 1zar_A          237 PQSVE------------VGEEGWREILE  252 (282)
T ss_dssp             TTCEE------------TTSTTHHHHHH
T ss_pred             CCCeE------------CCCCCHHHHHH
Confidence            99973            23467888874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.87  E-value=2.4e-22  Score=186.01  Aligned_cols=138  Identities=14%  Similarity=0.206  Sum_probs=108.8

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCce--EEEEEecCCCCCH----------------------HHHHHHHHHHHHHHhc
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQE--VAIKVLKPECVNT----------------------EMLKEFSQEVYIMRKI  164 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~--vAvK~~~~~~~~~----------------------~~~~~~~~E~~~l~~l  164 (395)
                      -|.+.+.||+|+||.||+|++  .|+.  ||||+++......                      .....+.+|+.+|+++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            367889999999999999988  7888  9999987542110                      1123688999999999


Q ss_pred             CCCce--eeEEEEEecCCcEEEEEecCCC-C----CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCC
Q 016082          165 RHKNV--VQFIGACTRPPNLCIVTEFMAR-G----SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH-QNNIIHRDLKT  236 (395)
Q Consensus       165 ~h~ni--v~l~~~~~~~~~~~lV~E~~~g-g----sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~iiHrDlkp  236 (395)
                      .|+++  +..++.    ...++||||+.+ |    +|.+....    .++..+..++.|++.+|.||| +.||+||||||
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp  199 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE  199 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence            88753  445543    356899999942 4    66665432    245578899999999999999 99999999999


Q ss_pred             CCeeeCCCCcEEEeeecccccc
Q 016082          237 ANLLMDENGVVKVADFGVARVQ  258 (395)
Q Consensus       237 ~NiLl~~~~~vkl~DFg~a~~~  258 (395)
                      +|||++.  .++|+|||+|...
T Consensus       200 ~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          200 YNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TSEEESS--SEEECCCTTCEET
T ss_pred             HHEEEcC--cEEEEECcccccC
Confidence            9999998  9999999999753

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.77  E-value=9.9e-20  Score=176.43  Aligned_cols=136  Identities=13%  Similarity=0.155  Sum_probs=101.1

Q ss_pred             CcceeeeeeeeCceEEEEEEE-CCceEEEEEecCCCCC---------------H-HH----HHHHHHHHHHHHhcCCCce
Q 016082          111 QLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVN---------------T-EM----LKEFSQEVYIMRKIRHKNV  169 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~-~~~~vAvK~~~~~~~~---------------~-~~----~~~~~~E~~~l~~l~h~ni  169 (395)
                      -|.+.++||.|++|.||+|.. .|+.||||+++....+               . ..    ......|...|.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            489999999999999999987 6889999998753211               0 00    0112456777777755443


Q ss_pred             --eeEEEEEecCCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCC--
Q 016082          170 --VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG--  245 (395)
Q Consensus       170 --v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~--  245 (395)
                        +..++..    ..+|||||++|++|.++..       .+....++.|++.+|.+||+.|||||||||.|||++++|  
T Consensus       176 ~vp~p~~~~----~~~LVME~i~G~~L~~l~~-------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~  244 (397)
T 4gyi_A          176 PVPEPIAQS----RHTIVMSLVDALPMRQVSS-------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA  244 (397)
T ss_dssp             SCCCEEEEE----TTEEEEECCSCEEGGGCCC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred             CCCeeeecc----CceEEEEecCCccHhhhcc-------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence              2333221    2379999999988865431       224567889999999999999999999999999998877  


Q ss_pred             --------cEEEeeeccccc
Q 016082          246 --------VVKVADFGVARV  257 (395)
Q Consensus       246 --------~vkl~DFg~a~~  257 (395)
                              .+.|+||+.+..
T Consensus       245 ~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          245 EDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             SCTTSEEEEEEECCCTTCEE
T ss_pred             ccccccccceEEEEeCCccc
Confidence                    389999998754

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.48  E-value=1.2e-13  Score=127.17  Aligned_cols=139  Identities=12%  Similarity=0.053  Sum_probs=112.9

Q ss_pred             CcceeeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCcEEEEEecC
Q 016082          111 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEFM  189 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~  189 (395)
                      .|++...++.|+.+.||+....++.+++|+.......  ....+.+|+.+++.+. +..++++++++...+..|+||||+
T Consensus        15 ~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i   92 (263)
T 3tm0_A           15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA   92 (263)
T ss_dssp             TSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred             cceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence            5888888999999999999888899999998753111  1235888999999995 677889999998888899999999


Q ss_pred             CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 016082          190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-------------------------------------------  226 (395)
Q Consensus       190 ~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-------------------------------------------  226 (395)
                      +|.+|.+.+.      +......++.++++++..||+                                           
T Consensus        93 ~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (263)
T 3tm0_A           93 DGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD  166 (263)
T ss_dssp             SSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred             CCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence            9999877531      122345778899999999998                                           


Q ss_pred             ----------------CCccccCCCCCCeeeCCCCcEEEeeeccccc
Q 016082          227 ----------------NNIIHRDLKTANLLMDENGVVKVADFGVARV  257 (395)
Q Consensus       227 ----------------~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~  257 (395)
                                      ..++|+|++|.||++++++.+.|+||+.+..
T Consensus       167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                            4489999999999998766677999998753

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.32  E-value=2.8e-12  Score=117.25  Aligned_cols=133  Identities=11%  Similarity=0.107  Sum_probs=98.8

Q ss_pred             CcceeeeeeeeCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc--eeeEEEEEecCCcEEEEEe
Q 016082          111 QLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN--VVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~E  187 (395)
                      .+.+....+.|+.+.||+.... ++.+++|+.....     ...+.+|+.+++.+.+.+  +++++++...++..++|||
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e   95 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG   95 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence            3444444446667999999764 5779999986541     245778999999986544  5678998888888999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---------------------------------------
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN---------------------------------------  228 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------  228 (395)
                      |++|.++.  ...    .+   ...++.++++.+..||+..                                       
T Consensus        96 ~i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (264)
T 1nd4_A           96 EVPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA  166 (264)
T ss_dssp             CCSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred             ecCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence            99998873  211    11   2356667777777777643                                       


Q ss_pred             -------------------ccccCCCCCCeeeCCCCcEEEeeeccccc
Q 016082          229 -------------------IIHRDLKTANLLMDENGVVKVADFGVARV  257 (395)
Q Consensus       229 -------------------iiHrDlkp~NiLl~~~~~vkl~DFg~a~~  257 (395)
                                         ++|+|++|.||++++++.+.|+|||.+..
T Consensus       167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                               99999999999998776677999999864

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.29  E-value=1.3e-11  Score=119.04  Aligned_cols=141  Identities=13%  Similarity=0.198  Sum_probs=108.3

Q ss_pred             eeeeeeeCceEEEEEEECCceEEEEEec--CCCCCHHHHHHHHHHHHHHHhcC--CCceeeEEEEEecC---CcEEEEEe
Q 016082          115 ECKVASGSYGDLYKGTYCSQEVAIKVLK--PECVNTEMLKEFSQEVYIMRKIR--HKNVVQFIGACTRP---PNLCIVTE  187 (395)
Q Consensus       115 ~~~lg~G~~G~Vy~~~~~~~~vAvK~~~--~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lV~E  187 (395)
                      .+.++.|.++.||+.+..+..+++|+..  .... ......+.+|..+++.+.  +..+++++.++.+.   +..|+|||
T Consensus        43 ~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEECCC-CCSCEEEEECSSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEEcCCcccceEEEEEECCceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            5678899999999999888889999876  4321 122356888999999997  45688999988776   34899999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-----------------------------------------  226 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-----------------------------------------  226 (395)
                      |++|..+.+..   ...++......++.++++.|..||+                                         
T Consensus       122 ~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (359)
T 3dxp_A          122 FVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD  198 (359)
T ss_dssp             CCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred             ecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence            99998775421   2346777888899999999999997                                         


Q ss_pred             -----------------CCccccCCCCCCeeeCCCCc--EEEeeeccccccc
Q 016082          227 -----------------NNIIHRDLKTANLLMDENGV--VKVADFGVARVQA  259 (395)
Q Consensus       227 -----------------~~iiHrDlkp~NiLl~~~~~--vkl~DFg~a~~~~  259 (395)
                                       ..++|+|++|.||+++.++.  +.|+||+.+....
T Consensus       199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~  250 (359)
T 3dxp_A          199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGH  250 (359)
T ss_dssp             HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEEC
T ss_pred             HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCC
Confidence                             36899999999999997753  6899999987543

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.14  E-value=8.1e-11  Score=110.76  Aligned_cols=182  Identities=17%  Similarity=0.198  Sum_probs=122.9

Q ss_pred             eeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCc--eeeEEEEEecCC---cEEEEEecC
Q 016082          116 CKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKN--VVQFIGACTRPP---NLCIVTEFM  189 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lV~E~~  189 (395)
                      +.++.|.+..||+..   ..+++|+...    ......+.+|..+|+.+. +..  +++.+.......   ..|+|||++
T Consensus        26 ~~~~~G~~n~v~~v~---~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN---RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CEEEECSSEEEEEST---TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             EecCCCCcceEEEEC---CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            358999999999864   6799999753    345577899999999884 322  456665544433   348999999


Q ss_pred             CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 016082          190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-------------------------------------------  226 (395)
Q Consensus       190 ~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-------------------------------------------  226 (395)
                      +|.++.+...   ..++......++.++++.+..||+                                           
T Consensus        99 ~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  175 (304)
T 3sg8_A           99 KGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD  175 (304)
T ss_dssp             CCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred             CCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence            9988865432   235677777888888888888886                                           


Q ss_pred             ---------------CCccccCCCCCCeeeCC--CCcEEEeeeccccccccCCccccCCCCcccccccccC----CCC--
Q 016082          227 ---------------NNIIHRDLKTANLLMDE--NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE----HKP--  283 (395)
Q Consensus       227 ---------------~~iiHrDlkp~NiLl~~--~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~--  283 (395)
                                     ..++|+|++|.||+++.  ++.+.|+||+.+...+.............-.+|+...    ..+  
T Consensus       176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~  255 (304)
T 3sg8_A          176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHK  255 (304)
T ss_dssp             HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred             HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCC
Confidence                           13799999999999998  5568899999987643321110000000001222111    000  


Q ss_pred             --------CCChhhHHHHHHHHHHHHhCCCCC
Q 016082          284 --------YDYKADVFSFGIALWELLTGELPY  307 (395)
Q Consensus       284 --------~~~k~DvwslG~vl~elltg~~pf  307 (395)
                              .....+.|+++.++|.+.+|..+|
T Consensus       256 ~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          256 DIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence                    122368999999999999998776

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.80  E-value=1e-07  Score=89.71  Aligned_cols=135  Identities=16%  Similarity=0.137  Sum_probs=96.2

Q ss_pred             eeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCC---ceeeEEEEEe-cCCcEEEEEecCC
Q 016082          115 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK---NVVQFIGACT-RPPNLCIVTEFMA  190 (395)
Q Consensus       115 ~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lV~E~~~  190 (395)
                      .+.++.|....||+.   +..+++|+..    .......+.+|..+|+.+.+.   .+++.+.++. ..+..++|||+++
T Consensus        24 v~~l~~G~~n~v~~v---g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~   96 (306)
T 3tdw_A           24 VESLGEGFRNYAILV---NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ   96 (306)
T ss_dssp             EEEEEECSSEEEEEE---TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred             eeecCCCcceeEEEE---CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence            345788888999987   6889999954    234567899999999999752   3677777774 4456789999999


Q ss_pred             CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC-------------------------------------------
Q 016082          191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN-------------------------------------------  227 (395)
Q Consensus       191 ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-------------------------------------------  227 (395)
                      |.++.+..-   ..++......++.++.+.|..||+.                                           
T Consensus        97 G~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~  173 (306)
T 3tdw_A           97 GQILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT  173 (306)
T ss_dssp             SEECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred             CeECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence            988766321   1234444445555555555555532                                           


Q ss_pred             -----------------CccccCCCCCCeeeCC---CCc-EEEeeeccccccc
Q 016082          228 -----------------NIIHRDLKTANLLMDE---NGV-VKVADFGVARVQA  259 (395)
Q Consensus       228 -----------------~iiHrDlkp~NiLl~~---~~~-vkl~DFg~a~~~~  259 (395)
                                       .++|+|++|.||+++.   ++. +.|+||+.+...+
T Consensus       174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd  226 (306)
T 3tdw_A          174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD  226 (306)
T ss_dssp             HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred             HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence                             3599999999999987   455 5899999887543

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.76  E-value=9.3e-08  Score=87.80  Aligned_cols=131  Identities=16%  Similarity=0.214  Sum_probs=97.6

Q ss_pred             eeeeeCce-EEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCcEEEEEecCCCC
Q 016082          117 KVASGSYG-DLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEFMARG  192 (395)
Q Consensus       117 ~lg~G~~G-~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~gg  192 (395)
                      .+..|..| .||+...  .+..+.+|+-...     ....+.+|...|+.+. +--++++++++.+.+..++|||+++|.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~  105 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK  105 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence            34556555 6898765  3567999997633     3467888999999886 334788899999888999999999998


Q ss_pred             CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---------------------------------------------
Q 016082          193 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN---------------------------------------------  227 (395)
Q Consensus       193 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------------------------------------------  227 (395)
                      ++.+.....     ......++.++...+..||+.                                             
T Consensus       106 ~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          106 TAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             EHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             cccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            887765431     223345566666777777741                                             


Q ss_pred             -------------CccccCCCCCCeeeCCCCcEEEeeeccccc
Q 016082          228 -------------NIIHRDLKTANLLMDENGVVKVADFGVARV  257 (395)
Q Consensus       228 -------------~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~  257 (395)
                                   .++|+|+.|.||+++.++.+-|+||+.+..
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                         179999999999999887778999998864

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.48  E-value=1.7e-06  Score=81.75  Aligned_cols=136  Identities=17%  Similarity=0.156  Sum_probs=81.2

Q ss_pred             eeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC--CceeeEEE------EEecCCcEEEEEe
Q 016082          116 CKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH--KNVVQFIG------ACTRPPNLCIVTE  187 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~------~~~~~~~~~lV~E  187 (395)
                      +.|+.|..+.||+....+..+++|+....   .   ..+..|..+++.+..  -.+++++.      +....+..+++||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~~~vlk~~~~~---~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSGAVCLKRIHRP---E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EECC----CEEEEEEETTEEEEEEEECSC---H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeccccccCcEEEEEeCCCCEEEEecCCC---H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            45666788999999887777999998753   2   233455666665531  13344443      1223556899999


Q ss_pred             cCCCCCHH--------------HHHhhccCCC--C-----------HH--------H-----------------------
Q 016082          188 FMARGSIY--------------DFLHKQKGVF--Q-----------LT--------S-----------------------  209 (395)
Q Consensus       188 ~~~ggsL~--------------~~l~~~~~~l--~-----------~~--------~-----------------------  209 (395)
                      |++|.++.              ..++.....+  +           +.        .                       
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            99986432              1122211111  1           00        0                       


Q ss_pred             HHHHHHHHHHHHHHHHH-------------CCccccCCCCCCeeeCCCCcEEEeeeccccc
Q 016082          210 LLKVAIDVSKGMNYLHQ-------------NNIIHRDLKTANLLMDENGVVKVADFGVARV  257 (395)
Q Consensus       210 ~~~i~~~i~~~l~~LH~-------------~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~  257 (395)
                      +..+...+..++.+|++             ..++|+|+++.||+++.++.+.|+||+.+..
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            11111223445666652             5799999999999998888999999998753

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.46  E-value=1.6e-07  Score=89.93  Aligned_cols=81  Identities=11%  Similarity=-0.000  Sum_probs=55.8

Q ss_pred             eeee-eeeCceEEEEEEEC--------CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCC---CceeeEEEEEecC--
Q 016082          115 ECKV-ASGSYGDLYKGTYC--------SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRH---KNVVQFIGACTRP--  179 (395)
Q Consensus       115 ~~~l-g~G~~G~Vy~~~~~--------~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~--  179 (395)
                      .+.| +.|....+|+.+..        ++.+++|+...... .......+.+|..+++.+..   -.+++++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4567 78888999988764        67899998764320 00001346778888888852   3578888887665  


Q ss_pred             -CcEEEEEecCCCCCHH
Q 016082          180 -PNLCIVTEFMARGSIY  195 (395)
Q Consensus       180 -~~~~lV~E~~~ggsL~  195 (395)
                       +..++|||+++|..+.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence             3568999999986543

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.37  E-value=1.5e-06  Score=84.52  Aligned_cols=76  Identities=11%  Similarity=0.004  Sum_probs=50.1

Q ss_pred             eeeeeeeCceEEEEEEE--CCceEEEEEecCCCC--CH---HHHHHHHHHHHHHHhcCC--C-ceeeEEEEEecCCcEEE
Q 016082          115 ECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV--NT---EMLKEFSQEVYIMRKIRH--K-NVVQFIGACTRPPNLCI  184 (395)
Q Consensus       115 ~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~--~~---~~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~l  184 (395)
                      .+.+|.|.++.||+++.  .++.++||...+...  .+   .....+..|..+++.+..  | .+++++.+.  .+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence            45789999999999954  567899998764321  01   112456779999988742  3 455666543  345689


Q ss_pred             EEecCCCC
Q 016082          185 VTEFMARG  192 (395)
Q Consensus       185 V~E~~~gg  192 (395)
                      |||+++|.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999874

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.08  E-value=2.3e-05  Score=73.76  Aligned_cols=75  Identities=16%  Similarity=0.136  Sum_probs=61.7

Q ss_pred             eeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC---CCceeeEEEEEecCCcEEEEEecCCC
Q 016082          115 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR---HKNVVQFIGACTRPPNLCIVTEFMAR  191 (395)
Q Consensus       115 ~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~E~~~g  191 (395)
                      .+.|+.|.+..+|+.+..+..+++|+....     ....+..|...|+.+.   ...+++.++++...+..++||||++|
T Consensus        41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDEVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEECCSSSSEEEEEESSSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEeCCccceeeeEEEECCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            456889999999999887889999997643     2466888999998885   36688999988888889999999998


Q ss_pred             CCH
Q 016082          192 GSI  194 (395)
Q Consensus       192 gsL  194 (395)
                      ..+
T Consensus       116 ~~~  118 (312)
T 3jr1_A          116 SKN  118 (312)
T ss_dssp             CCC
T ss_pred             CCC
Confidence            754

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.00  E-value=8.3e-05  Score=65.51  Aligned_cols=138  Identities=14%  Similarity=0.152  Sum_probs=96.3

Q ss_pred             CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeeeCCCCcEEEeeeccccccccCCccccCCCCc
Q 016082          193 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY  271 (395)
Q Consensus       193 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~~~gt~  271 (395)
                      ||.++|.....++++.++|.++.|.+++|.-+-. ..-..+=+.|..|++..+|.|.+.+ +.+.           ....
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~~  101 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGEP  101 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------cccc
Confidence            8999999999999999999999999999877622 2222344567899999999988764 2111           1122


Q ss_pred             ccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhcc-----
Q 016082          272 RWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH-----  346 (395)
Q Consensus       272 ~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~-----  346 (395)
                      .+.|||... ...+.+.=|||||+++|.-+--                   ++.+..+..+|++|.+||..|..-     
T Consensus       102 ~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy-------------------gL~e~eE~eLS~~LE~LL~~Mt~~~~d~~  161 (229)
T 2yle_A          102 PPVAGKLGY-SQCMETEVIESLGIIIYKALDY-------------------GLKENEERELSPPLEQLIDHMANTVEADG  161 (229)
T ss_dssp             -----CCSS-SSSCHHHHHHHHHHHHHHHHTT-------------------TCCTTEEECCCHHHHHHHHHHTTCCC---
T ss_pred             CCCChhhcc-ccchHHHHHHHHHHHHHHHhhc-------------------CCCcccchhhCHHHHHHHHHHHhcccccc
Confidence            455888763 3456788899999999998752                   223344566788999999999866     


Q ss_pred             --------------------CCCCCCCHHHHHHHHH
Q 016082          347 --------------------DPTQRPNFSQITDILK  362 (395)
Q Consensus       347 --------------------dp~~RPs~~ell~~l~  362 (395)
                                          .+..|+++.+|++.=+
T Consensus       162 ~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~  197 (229)
T 2yle_A          162 SNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCA  197 (229)
T ss_dssp             -----------------CCSCCCCCCSHHHHHHHHH
T ss_pred             cccccccccccccccccccccccCcCCHHHHHHHHH
Confidence                                2468899999987433

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.96  E-value=2.3e-05  Score=76.75  Aligned_cols=78  Identities=17%  Similarity=0.208  Sum_probs=47.4

Q ss_pred             HHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCccccCC--CCcccccccccCCCC---CCChhhHHHHHHHHHH
Q 016082          225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKP---YDYKADVFSFGIALWE  299 (395)
Q Consensus       225 H~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~~~--gt~~y~aPE~~~~~~---~~~k~DvwslG~vl~e  299 (395)
                      +...++|+|++|.|||++.++ +.++||+.+...+.........  -...|++|+......   -.....+.+....+|+
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            356799999999999999877 9999999987544321111100  123456665543211   1123445566667776


Q ss_pred             HHhC
Q 016082          300 LLTG  303 (395)
Q Consensus       300 lltg  303 (395)
                      .+++
T Consensus       309 ~y~~  312 (420)
T 2pyw_A          309 LFNK  312 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            6653

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.84  E-value=4.5e-05  Score=71.08  Aligned_cols=134  Identities=16%  Similarity=0.204  Sum_probs=76.6

Q ss_pred             eeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCce-eeEEEEEecCCcEEEEEecC-CCC
Q 016082          115 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV-VQFIGACTRPPNLCIVTEFM-ARG  192 (395)
Q Consensus       115 ~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E~~-~gg  192 (395)
                      .+.|+.|....+|+.    +.+++|+.....   .......+|..+++.+...++ +++++..  ...-++++||+ +|.
T Consensus        23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~   93 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA----GDLCLRIPGKGT---EEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ   93 (301)
T ss_dssp             CEEEESCSSEEEEEE----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred             eeEcCCcccccccee----eeEEEECCCCCc---cceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence            677888999999998    779999987532   111223568888877753222 5666543  33457899999 654


Q ss_pred             CHHH------------------HHhhccCCCC----H-HHHHHHHH--------------HHHHHHHHHH----H----C
Q 016082          193 SIYD------------------FLHKQKGVFQ----L-TSLLKVAI--------------DVSKGMNYLH----Q----N  227 (395)
Q Consensus       193 sL~~------------------~l~~~~~~l~----~-~~~~~i~~--------------~i~~~l~~LH----~----~  227 (395)
                      ++..                  .++.....++    . ..+..+..              .+.+.+..+.    .    .
T Consensus        94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~  173 (301)
T 3dxq_A           94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL  173 (301)
T ss_dssp             ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred             cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence            4321                  1111111111    1 11111111              1111122121    1    2


Q ss_pred             CccccCCCCCCeeeCCCCcEEEeeecccccc
Q 016082          228 NIIHRDLKTANLLMDENGVVKVADFGVARVQ  258 (395)
Q Consensus       228 ~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~  258 (395)
                      .++|+|+.|.||+ ..++.+.++||..+...
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence            4899999999999 56677899999988643

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.73  E-value=9.5e-05  Score=69.82  Aligned_cols=136  Identities=13%  Similarity=0.125  Sum_probs=74.5

Q ss_pred             eeeeeCceE-EEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC--CceeeEEEEEecCCcEEEEEecCCCC
Q 016082          117 KVASGSYGD-LYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH--KNVVQFIGACTRPPNLCIVTEFMARG  192 (395)
Q Consensus       117 ~lg~G~~G~-Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~E~~~gg  192 (395)
                      .|+.|+... +|+.+.. +..+++|...+...     ..+..|+.+++.+..  -.+++++.+....+  +++||++.+.
T Consensus        25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~-----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~   97 (333)
T 3csv_A           25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG-----GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA   97 (333)
T ss_dssp             C--------CCEEEECTTCCEEEEEECCTTTT-----CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred             ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC-----ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence            354454444 6677653 66777877554320     234456777776642  33567777644333  7899999876


Q ss_pred             CHHHHHhhcc-------------------------CCCCHHHHH-------H-H------------HHHHHHHHHHHH--
Q 016082          193 SIYDFLHKQK-------------------------GVFQLTSLL-------K-V------------AIDVSKGMNYLH--  225 (395)
Q Consensus       193 sL~~~l~~~~-------------------------~~l~~~~~~-------~-i------------~~~i~~~l~~LH--  225 (395)
                      .+.+.+....                         ..+......       . +            ...+...++.+.  
T Consensus        98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~  177 (333)
T 3csv_A           98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA  177 (333)
T ss_dssp             BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence            6655442210                         012111110       0 0            011222233331  


Q ss_pred             ----HCCccccCCCCCCeeeCCC----CcEEEeeeccccccc
Q 016082          226 ----QNNIIHRDLKTANLLMDEN----GVVKVADFGVARVQA  259 (395)
Q Consensus       226 ----~~~iiHrDlkp~NiLl~~~----~~vkl~DFg~a~~~~  259 (395)
                          ...++|+|+.+.||+++.+    +.+.|+||+.+....
T Consensus       178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence                2469999999999999875    689999999987543

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.71  E-value=3.6e-05  Score=72.27  Aligned_cols=139  Identities=12%  Similarity=0.135  Sum_probs=81.4

Q ss_pred             eeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc--eeeEEEE------EecCCcEEEEE
Q 016082          115 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN--VVQFIGA------CTRPPNLCIVT  186 (395)
Q Consensus       115 ~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lV~  186 (395)
                      .+.|+.|....+|+.+..+..+++|+.....    ....+..|..+++.+...+  +++++..      ....+..++++
T Consensus        27 ~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~  102 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTTKDPLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI  102 (322)
T ss_dssp             EEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred             eeccCCCcccceEEEEeCCccEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence            4567788889999998766689999987631    1234556788887775222  3344421      11234578999


Q ss_pred             ecCCCCCHH-----------H---HHhhccCCCC--------HHHHHH---------------HHHHHHHHHHHHHH---
Q 016082          187 EFMARGSIY-----------D---FLHKQKGVFQ--------LTSLLK---------------VAIDVSKGMNYLHQ---  226 (395)
Q Consensus       187 E~~~ggsL~-----------~---~l~~~~~~l~--------~~~~~~---------------i~~~i~~~l~~LH~---  226 (395)
                      +|++|..+.           .   .++.....++        ......               +...+...++.+++   
T Consensus       103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~  182 (322)
T 2ppq_A          103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP  182 (322)
T ss_dssp             ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred             EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence            999986431           1   1222111111        000000               01123445556653   


Q ss_pred             ----CCccccCCCCCCeeeCCCCcEEEeeeccccc
Q 016082          227 ----NNIIHRDLKTANLLMDENGVVKVADFGVARV  257 (395)
Q Consensus       227 ----~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~  257 (395)
                          .+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       183 ~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          183 KDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             CSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence                3699999999999998876668999998864

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.69  E-value=0.00032  Score=64.78  Aligned_cols=78  Identities=13%  Similarity=0.131  Sum_probs=56.1

Q ss_pred             cCcceeeeeeeeCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC---CceeeEEEEEecCCcEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH---KNVVQFIGACTRPPNLCIV  185 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~lV  185 (395)
                      .+..-.+.+|.|..+.||+.+. .|+.|.+|+.......  ....|..|...|+.+..   --+++.+++.    .-++|
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv   88 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPA--LDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLA   88 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCC--CTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEE
T ss_pred             CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcc--hhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEE
Confidence            3455578899999999999987 5789999987644321  12457789999998852   2356666643    24789


Q ss_pred             EecCCCCC
Q 016082          186 TEFMARGS  193 (395)
Q Consensus       186 ~E~~~ggs  193 (395)
                      |||++++.
T Consensus        89 ~e~l~~~~   96 (288)
T 3f7w_A           89 MEWVDERP   96 (288)
T ss_dssp             EECCCCCC
T ss_pred             EEeecccC
Confidence            99998764

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.57  E-value=0.00034  Score=68.73  Aligned_cols=70  Identities=11%  Similarity=0.173  Sum_probs=48.6

Q ss_pred             eeeeeeeCceEEEEEEEC---------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc-eeeEEEEEecCCcEEE
Q 016082          115 ECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN-VVQFIGACTRPPNLCI  184 (395)
Q Consensus       115 ~~~lg~G~~G~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~l  184 (395)
                      .+.|+.|-...+|+.+..         ++.+.+|+..... .   ...+.+|..+++.+...+ .+++++.+.+    .+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~  149 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR  149 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence            456788888999999864         4689999985321 1   134447888888885333 3677776643    38


Q ss_pred             EEecCCCC
Q 016082          185 VTEFMARG  192 (395)
Q Consensus       185 V~E~~~gg  192 (395)
                      |+||++|.
T Consensus       150 v~e~l~G~  157 (429)
T 1nw1_A          150 LEEYIPSR  157 (429)
T ss_dssp             EECCCCEE
T ss_pred             EEEEeCCc
Confidence            99999874

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.42  E-value=0.00028  Score=67.60  Aligned_cols=71  Identities=11%  Similarity=0.162  Sum_probs=44.4

Q ss_pred             eeeeeeCceEEEEEEECC----------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc-eeeEEEEEecCCcEEE
Q 016082          116 CKVASGSYGDLYKGTYCS----------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN-VVQFIGACTRPPNLCI  184 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~~~----------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~l  184 (395)
                      +.++.|....+|+.+..+          +.+++|+.....   ........|..+++.+...+ .+++++...    -++
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~  111 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGR  111 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEecC----CcE
Confidence            457778888999988754          688999876431   11112457888888885333 456776542    268


Q ss_pred             EEecCCCCC
Q 016082          185 VTEFMARGS  193 (395)
Q Consensus       185 V~E~~~ggs  193 (395)
                      ||||++|..
T Consensus       112 v~e~i~G~~  120 (369)
T 3c5i_A          112 IEEWLYGDP  120 (369)
T ss_dssp             EEECCCSEE
T ss_pred             EEEEecCCc
Confidence            999998853

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.31  E-value=0.00063  Score=65.62  Aligned_cols=135  Identities=13%  Similarity=0.193  Sum_probs=80.6

Q ss_pred             eeeeeeCceEEEEEEEC---------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCcEEEE
Q 016082          116 CKVASGSYGDLYKGTYC---------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIV  185 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV  185 (395)
                      +.+..|-...+|+.+..         ++.+.+|+.....   .....+.+|..+++.+. +.-.+++++.+.+    .+|
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v  128 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL  128 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence            35666778888988763         3679999864321   12345568999998885 3334677777654    299


Q ss_pred             EecCCCCCHH--------------HH---HhhccCC----CC--HHHHHHHHHHHH-------------------HHHHH
Q 016082          186 TEFMARGSIY--------------DF---LHKQKGV----FQ--LTSLLKVAIDVS-------------------KGMNY  223 (395)
Q Consensus       186 ~E~~~ggsL~--------------~~---l~~~~~~----l~--~~~~~~i~~~i~-------------------~~l~~  223 (395)
                      |||++|..|.              +.   |+...-+    ..  ..++.++..++-                   ..++.
T Consensus       129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  208 (379)
T 3feg_A          129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN  208 (379)
T ss_dssp             EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred             EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence            9999985432              11   1221111    11  234444544332                   22334


Q ss_pred             HH----H----CCccccCCCCCCeeeCCC----CcEEEeeeccccc
Q 016082          224 LH----Q----NNIIHRDLKTANLLMDEN----GVVKVADFGVARV  257 (395)
Q Consensus       224 LH----~----~~iiHrDlkp~NiLl~~~----~~vkl~DFg~a~~  257 (395)
                      |.    .    ..++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            43    2    258999999999999876    7899999998864

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.31  E-value=0.0017  Score=60.70  Aligned_cols=136  Identities=13%  Similarity=0.108  Sum_probs=79.1

Q ss_pred             eeeeeCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCC--ceeeEEEE-----EecCCcEEEEEec
Q 016082          117 KVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK--NVVQFIGA-----CTRPPNLCIVTEF  188 (395)
Q Consensus       117 ~lg~G~~G~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~-----~~~~~~~~lV~E~  188 (395)
                      .++ |....||+.+. .|+.+++|+..+.....   ..+..|..+++.+...  .+++++..     ....+..+++||+
T Consensus        33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred             eec-CcccceEEEEcCCCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence            455 77888998876 45689999997654333   4556688888877522  24444443     1123456889999


Q ss_pred             CCCCCHH-----------HH---HhhccC--------CCCHHHH----HHH---------------HHHHHHHHHHHH--
Q 016082          189 MARGSIY-----------DF---LHKQKG--------VFQLTSL----LKV---------------AIDVSKGMNYLH--  225 (395)
Q Consensus       189 ~~ggsL~-----------~~---l~~~~~--------~l~~~~~----~~i---------------~~~i~~~l~~LH--  225 (395)
                      ++|..+.           ..   ++....        .++....    ..+               ...+-..++.+.  
T Consensus       109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~  188 (328)
T 1zyl_A          109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH  188 (328)
T ss_dssp             CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence            9885321           11   121110        1111110    001               111111223332  


Q ss_pred             -----HCCccccCCCCCCeeeCCCCcEEEeeecccccc
Q 016082          226 -----QNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  258 (395)
Q Consensus       226 -----~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~  258 (395)
                           ...++|+|+++.||+++ + .+.++||+.+...
T Consensus       189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence                 24589999999999999 4 8999999988643

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.19  E-value=0.0014  Score=64.91  Aligned_cols=72  Identities=21%  Similarity=0.141  Sum_probs=48.1

Q ss_pred             eeeeeeeCceEEEEEEECC--ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCce-eeEEEEEecCCcEEEEEecCCC
Q 016082          115 ECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV-VQFIGACTRPPNLCIVTEFMAR  191 (395)
Q Consensus       115 ~~~lg~G~~G~Vy~~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E~~~g  191 (395)
                      .+.|+.|-...+|+.+..+  ..+++|+.....  ... -...+|..+++.+...++ +++++.+..    .+|+||++|
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G  185 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT--DEI-INREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDG  185 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-C--CSC-SCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCS
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh--hhh-cCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCC
Confidence            4567888889999999876  789999985432  111 112579999998875444 677777632    359999987


Q ss_pred             CC
Q 016082          192 GS  193 (395)
Q Consensus       192 gs  193 (395)
                      .+
T Consensus       186 ~~  187 (458)
T 2qg7_A          186 YA  187 (458)
T ss_dssp             EE
T ss_pred             cc
Confidence            43

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.11  E-value=0.0012  Score=62.52  Aligned_cols=133  Identities=13%  Similarity=0.138  Sum_probs=78.5

Q ss_pred             eeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC---CceeeEEEE------EecCCcEEEEEecC
Q 016082          119 ASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH---KNVVQFIGA------CTRPPNLCIVTEFM  189 (395)
Q Consensus       119 g~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~------~~~~~~~~lV~E~~  189 (395)
                      |.|....||+.+..+..+++|+......        ..|..+++.+..   |++++.+..      ....+..+++|+|+
T Consensus        32 G~g~~N~vy~v~~~~g~~vLK~~~~~~~--------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i  103 (339)
T 3i1a_A           32 GADTNAFAYQADSESKSYFIKLKYGYHD--------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFI  103 (339)
T ss_dssp             TSCSSCEEEEEECSSCEEEEEEEECSSC--------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECC
T ss_pred             cCccccceEEEEeCCCCEEEEEecCccc--------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEecc
Confidence            4444678999987555999999876542        346666666632   325555532      23345689999999


Q ss_pred             CCCCHH-------------HH---HhhccCC-----------CCHH---HHHHHH-------------------------
Q 016082          190 ARGSIY-------------DF---LHKQKGV-----------FQLT---SLLKVA-------------------------  214 (395)
Q Consensus       190 ~ggsL~-------------~~---l~~~~~~-----------l~~~---~~~~i~-------------------------  214 (395)
                      +|..+.             ..   ++.....           +...   .+..+.                         
T Consensus       104 ~G~~~~~~~~~~~~~~~lg~~La~LH~~~~~~~~~~~~~~~~~~~~w~~~i~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  183 (339)
T 3i1a_A          104 HAPNGFTQNLTGKQWKQLGKVLRQIHETSVPISIQQQLRKEIYSPKWREIVRSFYNQIEFDNSDDKLTAAFKSFFNQNSA  183 (339)
T ss_dssp             CCCBTTTSCCCHHHHHHHHHHHHHHHTCCCCHHHHTTSEECCCCCHHHHHHHHHGGGGSCCTTCCHHHHHHHHHHHHTHH
T ss_pred             CCCcCcccCCCHHHHHHHHHHHHHHhCcCCCCCCccCccccccCcchHHHHHHHHHhhhccccCCcHHHHHHHHHHHhHH
Confidence            986541             11   2221111           1100   111111                         


Q ss_pred             --HHHHHHHHHHH--------HCCccccCCCCCCeeeCCCCcEEEeeeccccccc
Q 016082          215 --IDVSKGMNYLH--------QNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  259 (395)
Q Consensus       215 --~~i~~~l~~LH--------~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~  259 (395)
                        ..++..+..+.        ...++|+|+.+.||+++.++.+.++||+.+....
T Consensus       184 ~l~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~  238 (339)
T 3i1a_A          184 AIHRLVDTSEKLSKKIQPDLDKYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP  238 (339)
T ss_dssp             HHHHHHHHHHHHHHHCCCCGGGCEEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred             HHHHHHHHHHHHHHHHhhCCCCceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence              11122222221        2369999999999999988899999999886543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.65  E-value=0.0039  Score=60.94  Aligned_cols=72  Identities=11%  Similarity=0.146  Sum_probs=47.9

Q ss_pred             eeeeeeeCceEEEEEEEC---------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCcEEE
Q 016082          115 ECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCI  184 (395)
Q Consensus       115 ~~~lg~G~~G~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  184 (395)
                      .+.+..|-...+|+.+..         ++.+++|+.....   +..-...+|..+++.+. +.-.+++++.+.    -++
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~  147 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGR  147 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCE
Confidence            345667888899998875         5789999965432   11122357888888875 333456666442    278


Q ss_pred             EEecCCCCC
Q 016082          185 VTEFMARGS  193 (395)
Q Consensus       185 V~E~~~ggs  193 (395)
                      |+||++|..
T Consensus       148 I~efI~G~~  156 (424)
T 3mes_A          148 IEEFIDGEP  156 (424)
T ss_dssp             EEECCCSEE
T ss_pred             EEEEeCCcc
Confidence            999999864

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.84  E-value=0.19  Score=48.37  Aligned_cols=29  Identities=24%  Similarity=0.437  Sum_probs=25.4

Q ss_pred             ccccCCCCCCeee------CCCCcEEEeeeccccc
Q 016082          229 IIHRDLKTANLLM------DENGVVKVADFGVARV  257 (395)
Q Consensus       229 iiHrDlkp~NiLl------~~~~~vkl~DFg~a~~  257 (395)
                      ++|+|+.+.||++      ++++.+.++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6899999999999      4567899999999864

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=92.91  E-value=0.0077  Score=59.59  Aligned_cols=61  Identities=11%  Similarity=0.047  Sum_probs=17.7

Q ss_pred             ceeeeeeeeCceEEEEEEECC--ceEEE------EEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEE
Q 016082          113 KIECKVASGSYGDLYKGTYCS--QEVAI------KVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC  176 (395)
Q Consensus       113 ~i~~~lg~G~~G~Vy~~~~~~--~~vAv------K~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  176 (395)
                      .+.++||   ||.||+|.+.+  .+|||      |..+......+....+.+|..+++.++|||+++.+++.
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~  213 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK  213 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence            4456676   99999999865  57899      77776555556667789999999999999999998865

>1u8s_A Glycine cleavage system transcriptional repressor, putative; structural genomics, protein structure initiative (PSI), domain swapping; 2.45A {Vibrio cholerae} SCOP: d.58.18.5 d.58.18.5

Probab=92.21  E-value=0.11  Score=44.54  Aligned_cols=52  Identities=17%  Similarity=0.223  Sum_probs=40.9

Q ss_pred             HHHHHHHHhhhcCCCeeeeceeccCCCceeeEEEecCCCCcchHHHHHHHHHHH
Q 016082           10 KVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEI   63 (395)
Q Consensus        10 ~~~~~~~~~~~~~l~i~~~~~f~~~~~~~l~~~~v~gw~~~~~~~l~~~l~~~~   63 (395)
                      +++++|.+|++.|+||.++..|.+.++|.+ .++|++- ....+.++.+|.+..
T Consensus        19 iva~vt~~La~~g~NI~d~~~~~~~~~f~~-~~~v~~~-~~~~~~l~~~L~~~~   70 (192)
T 1u8s_A           19 ICNEVVRLVTQAGCNIIDSRIAMFGKEFTL-LMLISGS-PSNITRVETTLPLLG   70 (192)
T ss_dssp             HHHHHHHHHHHTTCEEEEEEEEEETTEEEE-EEEEEEC-HHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHCCCCEEeeeeeecCCceEE-EEEEecC-CCCHHHHHHHHHHHH
Confidence            678999999999999999999998888888 6677652 245566666666543

>1zpv_A ACT domain protein; structural genomics, PSI, protein structure INIT midwest center for structural genomics, MCSG, unknown funct; 1.90A {Streptococcus pneumoniae} SCOP: d.58.18.7

Probab=90.39  E-value=0.55  Score=34.55  Aligned_cols=53  Identities=19%  Similarity=0.143  Sum_probs=42.6

Q ss_pred             HHHHHHHHhhhcCCCeeeeceeccCCCceeeEEEecCCCCcchHHHHHHHHHHH
Q 016082           10 KVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEI   63 (395)
Q Consensus        10 ~~~~~~~~~~~~~l~i~~~~~f~~~~~~~l~~~~v~gw~~~~~~~l~~~l~~~~   63 (395)
                      +|+.+|++|++.|.||.+.+++... |...=.+.++.-.....+++..+|.+..
T Consensus        18 ila~vt~~la~~~~NI~~i~~~~~~-~~~~~~i~v~~~~~~~l~~l~~~L~~~~   70 (91)
T 1zpv_A           18 IVAGVSGKIAELGLNIDDISQTVLD-EYFTMMAVVSSDEKQDFTYLRNEFEAFG   70 (91)
T ss_dssp             HHHHHHHHHHHTTCEEEEEEEEEET-TEEEEEEEEEESSCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHcCCCEEEEEeEEEc-CEEEEEEEEEeCCCCCHHHHHHHHHHHH
Confidence            6889999999999999999998765 6666666666555667888888887654

>2nyi_A Unknown protein; protein structure initiative, PSI, center for eukaryotic structural genomics, CESG, structural genomics; 1.80A {Galdieria sulphuraria}

Probab=89.87  E-value=0.28  Score=42.23  Aligned_cols=35  Identities=17%  Similarity=0.302  Sum_probs=31.5

Q ss_pred             HHHHHHHHhhhcCCCeeeeceeccCCCceeeEEEec
Q 016082           10 KVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVD   45 (395)
Q Consensus        10 ~~~~~~~~~~~~~l~i~~~~~f~~~~~~~l~~~~v~   45 (395)
                      +.+++|..|++.|+||.++..|.+.++|.+ .+.|+
T Consensus        18 iva~vs~~La~~g~NI~da~q~~~~~~f~m-~~~v~   52 (195)
T 2nyi_A           18 IVHDFSWALKNISANVESSRMACLGGDFAM-IVLVS   52 (195)
T ss_dssp             HHHHHHHHHHHTTCEEEEEEEEEETTEEEE-EEEEE
T ss_pred             HHHHHHHHHHHCCCCEEEEEeEEECCeEEE-EEEEE
Confidence            578999999999999999999999999999 55665

>2ko1_A CTR148A, GTP pyrophosphokinase; homodimer, alpha+beta, transferase, structural genomics, PSI-2, protein structure initiative; NMR {Chlorobaculum tepidum} PDB: 3ibw_A

Probab=85.15  E-value=0.98  Score=32.73  Aligned_cols=37  Identities=8%  Similarity=0.001  Sum_probs=28.3

Q ss_pred             HHHHHHHHhhhcCCCeeeeceeccCCCceeeEEEecCC
Q 016082           10 KVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGW   47 (395)
Q Consensus        10 ~~~~~~~~~~~~~l~i~~~~~f~~~~~~~l~~~~v~gw   47 (395)
                      +|++++++|++.|.||....+....+ ....++.++.-
T Consensus        18 ~L~~I~~~la~~~inI~~i~~~~~~~-~~~~~i~v~~~   54 (88)
T 2ko1_A           18 MTNQITGVISKFDTNIRTIVLNAKDG-IFTCNLMIFVK   54 (88)
T ss_dssp             HHHHHHHHHTTSSSCEEEEEEEECSS-EEEEEEEEEES
T ss_pred             HHHHHHHHHHHCCCCeEEEEEEEcCC-EEEEEEEEEEC
Confidence            68999999999999999998876544 55555555543

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=80.96  E-value=4.6  Score=35.14  Aligned_cols=115  Identities=9%  Similarity=0.089  Sum_probs=76.4

Q ss_pred             CCCceeeEEEEEecCCcEEEEEecCCCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCC
Q 016082          165 RHKNVVQFIGACTRPPNLCIVTEFMARG-SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE  243 (395)
Q Consensus       165 ~h~niv~l~~~~~~~~~~~lV~E~~~gg-sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~  243 (395)
                      .||+++.. .+-...+.+.+.++.-+.+ ++.. ++    ..+....++++.+|+....++  ..=+|--|.|+|++++.
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik----~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~  114 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK----SFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTR  114 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG----GSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECT
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH----hcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcC
Confidence            57888876 4555556666666654422 3332 32    357888899999988876444  33467789999999999


Q ss_pred             CCcEEEeeeccccccccCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 016082          244 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA  308 (395)
Q Consensus       244 ~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~  308 (395)
                      ++.++++=.|+....                +|.     .++...=.-.+=|++..+++++..|.
T Consensus       115 ~~~p~i~~RGik~~l----------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          115 DGLPIAKTRGLQNVV----------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             TSCEEESCCEETTTB----------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             CCCEEEEEccCccCC----------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999887764321                222     12223334457788889999988874

>2f1f_A Acetolactate synthase isozyme III small subunit; ferredoxin fold, ACT domain, transferase; HET: P33 1PE; 1.75A {Escherichia coli} SCOP: d.58.18.6 d.58.18.6

Probab=80.56  E-value=2.6  Score=35.06  Aligned_cols=37  Identities=22%  Similarity=0.253  Sum_probs=33.0

Q ss_pred             HHHHHHHHhhhcCCCeeeeceeccCC-CceeeEEEecC
Q 016082           10 KVGELTSLLGEIGLNIQEAHAFSTVD-GFSLDVFVVDG   46 (395)
Q Consensus        10 ~~~~~~~~~~~~~l~i~~~~~f~~~~-~~~l~~~~v~g   46 (395)
                      +|++++.++++-|.||....+..|.| |.+-=.|+|+|
T Consensus        16 vLarIt~lfs~rg~NI~Sl~v~~t~d~~~sriti~V~~   53 (164)
T 2f1f_A           16 ALSRVIGLFSQRGYNIESLTVAPTDDPTLSRMTIQTVG   53 (164)
T ss_dssp             HHHHHHHHHHTTTCCCSEEEEEECSCSSEEEEEEEEES
T ss_pred             HHHHHHHHHHHCCCCeeeceeeecCCCCEEEEEEEEec
Confidence            68999999999999999999998875 88888888883

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	395
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-89
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	6e-81
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	8e-75
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-74
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-74
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-73
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-73
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-73
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-72
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-72
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-72
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-72
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-71
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-71
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-70
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-70
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-70
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-70
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-70
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-69
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-68
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-67
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-67
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-66
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-66
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-66
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-65
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-64
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-64
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-64
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-64
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-64
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-63
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-63
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-62
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	9e-62
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-59
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-59
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-58
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-56
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	7e-56
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	8e-55
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	9e-55
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-53
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-53
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-52
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-52
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-51
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-50
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	8e-49
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	6e-48
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-47
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-46
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-45
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-45
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	6e-44
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	8e-44
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	6e-43
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-40
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	8e-38
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	7e-37
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-28
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	7e-18

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  268 bits (686), Expect = 5e-89
 Identities = 93/276 (33%), Positives = 158/276 (57%), Gaps = 12/276 (4%)

Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 162
           D WEI   Q+ +  ++ SGS+G +YKG +   +VA+K+L       + L+ F  EV ++R
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 59

Query: 163 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 222
           K RH N++ F+G  T P  L IVT++    S+Y  LH  +  F++  L+ +A   ++GM+
Sbjct: 60  KTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118

Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ---SGVMTAETGTYRWMAPEVI 279
           YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A V+++   S      +G+  WMAPEVI
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

Query: 280 EHK---PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR----PTIPKHA 332
             +   PY +++DV++FGI L+EL+TG+LPY+ +      + +V +         +  + 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238

Query: 333 HPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV 368
              +  L+  C +    +RP F QI   ++ + + +
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  247 bits (631), Expect = 6e-81
 Identities = 92/263 (34%), Positives = 147/263 (55%), Gaps = 10/263 (3%)

Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 164
           W ++ K+LK+   +  G +GD+  G Y   +VA+K +K    N    + F  E  +M ++
Sbjct: 2   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQL 57

Query: 165 RHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMN 222
           RH N+VQ +G        L IVTE+MA+GS+ D+L  + + V     LLK ++DV + M 
Sbjct: 58  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117

Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK 282
           YL  NN +HRDL   N+L+ E+ V KV+DFG+ +  + +          +W APE +  K
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREK 175

Query: 283 PYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE 341
            +  K+DV+SFGI LWE+ + G +PY  + PL+  V  V+K  +   P    P + E+++
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPAVYEVMK 234

Query: 342 RCWQHDPTQRPNFSQITDILKQM 364
            CW  D   RP+F Q+ + L+ +
Sbjct: 235 NCWHLDAAMRPSFLQLREQLEHI 257

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (591), Expect = 8e-75
 Identities = 78/266 (29%), Positives = 141/266 (53%), Gaps = 8/266 (3%)

Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           D WE+  + LK+  ++ +G +G+++ G Y    +VA+K LK   ++ +    F  E  +M
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLM 62

Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKG 220
           ++++H+ +V+     T+ P + I+TE+M  GS+ DFL    G+   +  LL +A  +++G
Sbjct: 63  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121

Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGTYRWMAPEV 278
           M ++ + N IHRDL+ AN+L+ +    K+ADFG+AR+    +           +W APE 
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181

Query: 279 IEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE 338
           I +  +  K+DV+SFGI L E++T              +  +++  R   P +    L +
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ 241

Query: 339 LLERCWQHDPTQRPNFSQITDILKQM 364
           L+  CW+  P  RP F  +  +L+  
Sbjct: 242 LMRLCWKERPEDRPTFDYLRSVLEDF 267

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (589), Expect = 2e-74
 Identities = 98/277 (35%), Positives = 154/277 (55%), Gaps = 12/277 (4%)

Query: 98  PTDGT--DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEF 154
            T G   D WEI  + L++E K+  G +G+++ GT+     VAIK LKP  ++ E    F
Sbjct: 3   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AF 59

Query: 155 SQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKV 213
            QE  +M+K+RH+ +VQ     +  P + IVTE+M++GS+ DFL  + G   +L  L+ +
Sbjct: 60  LQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 118

Query: 214 AIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGTY 271
           A  ++ GM Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+    +           
Sbjct: 119 AAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 178

Query: 272 RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPK 330
           +W APE   +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P 
Sbjct: 179 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPP 237

Query: 331 HAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
                L +L+ +CW+ +P +RP F  +   L+     
Sbjct: 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  229 bits (586), Expect = 5e-74
 Identities = 75/273 (27%), Positives = 138/273 (50%), Gaps = 13/273 (4%)

Query: 107 IDAKQLKIECKV-ASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           +D K L +E K   SG++G + KG Y      + VA+K+LK E  +  +  E   E  +M
Sbjct: 3   LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 62

Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
           +++ +  +V+ IG C    +  +V E    G +  +L + +   +  +++++   VS GM
Sbjct: 63  QQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGM 120

Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPE 277
            YL ++N +HRDL   N+L+      K++DFG+++     +      T      +W APE
Sbjct: 121 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180

Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
            I +  +  K+DV+SFG+ +WE  + G+ PY G+   +    +++K  R   P      +
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-TAMLEKGERMGCPAGCPREM 239

Query: 337 AELLERCWQHDPTQRPNFSQITDILKQMMKEVL 369
            +L+  CW +D   RP F+ +   L+    +V+
Sbjct: 240 YDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 272

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  229 bits (585), Expect = 1e-73
 Identities = 92/270 (34%), Positives = 150/270 (55%), Gaps = 8/270 (2%)

Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
           D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK    +T  ++EF +E  +
Sbjct: 10  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAV 66

Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLH-KQKGVFQLTSLLKVAIDVSK 219
           M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L    +       LL +A  +S 
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 126

Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--VMTAETGTYRWMAPE 277
            M YL + N IHRDL   N L+ EN +VKVADFG++R+                +W APE
Sbjct: 127 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186

Query: 278 VIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 337
            + +  +  K+DV++FG+ LWE+ T  +       L     +++K  R   P+    ++ 
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 246

Query: 338 ELLERCWQHDPTQRPNFSQITDILKQMMKE 367
           EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 247 ELMRACWQWNPSDRPSFAEIHQAFETMFQE 276

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  229 bits (585), Expect = 2e-73
 Identities = 78/295 (26%), Positives = 135/295 (45%), Gaps = 35/295 (11%)

Query: 105 WEIDAKQLKIECKVASGSYGDLYKG-------TYCSQEVAIKVLKPECVNTEMLKEFSQE 157
           WE   + L+    + SG++G +          T  S +VA+K+LK +  ++   +    E
Sbjct: 32  WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK-ADSSEREALMSE 90

Query: 158 VYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-------------- 202
           + +M ++  H+N+V  +GACT    + ++ E+   G + ++L  ++              
Sbjct: 91  LKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 150

Query: 203 --------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 254
                    V     LL  A  V+KGM +L   + +HRDL   N+L+    VVK+ DFG+
Sbjct: 151 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL 210

Query: 255 ARVQAQSGVMTAET---GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGL 310
           AR                  +WMAPE +    Y  K+DV+S+GI LWE+ + G  PY G+
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270

Query: 311 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
                   ++Q   +   P +A   +  +++ CW  D  +RP+F  +T  L   +
Sbjct: 271 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 325

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  227 bits (579), Expect = 4e-73
 Identities = 81/263 (30%), Positives = 137/263 (52%), Gaps = 6/263 (2%)

Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
           ID  +L    ++ SG +G ++ G + +  +VAIK ++   ++ E   +F +E  +M K+ 
Sbjct: 2   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLS 58

Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
           H  +VQ  G C     +C+V EFM  G + D+L  Q+G+F   +LL + +DV +GM YL 
Sbjct: 59  HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118

Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKP 283
           +  +IHRDL   N L+ EN V+KV+DFG+ R        ++       +W +PEV     
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178

Query: 284 YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC 343
           Y  K+DV+SFG+ +WE+ +              V  +    R   P+ A   + +++  C
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 238

Query: 344 WQHDPTQRPNFSQITDILKQMMK 366
           W+  P  RP FS++   L ++ +
Sbjct: 239 WKERPEDRPAFSRLLRQLAEIAE 261

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (576), Expect = 1e-72
 Identities = 66/256 (25%), Positives = 122/256 (47%), Gaps = 9/256 (3%)

Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTE-MLKEFSQEVYIM 161
           W ++    +I   +  G +G++Y          +A+KVL    +    +  +  +EV I 
Sbjct: 3   WALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 60

Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
             +RH N+++  G       + ++ E+   G++Y  L K    F          +++  +
Sbjct: 61  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANAL 119

Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH 281
           +Y H   +IHRD+K  NLL+   G +K+ADFG +   A S   T   GT  ++ PE+IE 
Sbjct: 120 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEG 178

Query: 282 KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE 341
           + +D K D++S G+  +E L G+ P+   T  +    + +  +  T P        +L+ 
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLIS 236

Query: 342 RCWQHDPTQRPNFSQI 357
           R  +H+P+QRP   ++
Sbjct: 237 RLLKHNPSQRPMLREV 252

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (576), Expect = 2e-72
 Identities = 70/270 (25%), Positives = 132/270 (48%), Gaps = 13/270 (4%)

Query: 105 WEIDAKQLKI-ECKVASGSYGDLYKGTYCS----QEVAIKVLKPECVNTEMLKEFSQEVY 159
             +    L I + ++  G++G + +G Y       +VAIKVLK         +E  +E  
Sbjct: 3   LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQ 61

Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           IM ++ +  +V+ IG C +   L +V E    G ++ FL  ++    ++++ ++   VS 
Sbjct: 62  IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 120

Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMA 275
           GM YL + N +HRDL   N+L+      K++DFG+++      +     +A     +W A
Sbjct: 121 GMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180

Query: 276 PEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP 334
           PE I  + +  ++DV+S+G+ +WE L+ G+ PY  +   +  +  +++  R   P    P
Sbjct: 181 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-MAFIEQGKRMECPPECPP 239

Query: 335 RLAELLERCWQHDPTQRPNFSQITDILKQM 364
            L  L+  CW +    RP+F  +   ++  
Sbjct: 240 ELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  225 bits (573), Expect = 4e-72
 Identities = 83/268 (30%), Positives = 139/268 (51%), Gaps = 12/268 (4%)

Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNT-EMLKEFSQEVYI 160
           I  K L++  K+  GS+G + +G + +       VA+K LKP+ ++  E + +F +EV  
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64

Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
           M  + H+N+++  G    PP + +VTE    GS+ D L K +G F L +L + A+ V++G
Sbjct: 65  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123

Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAP 276
           M YL     IHRDL   NLL+    +VK+ DFG+ R          +       + W AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 335
           E ++ + + + +D + FG+ LWE+ T G+ P+ GL   Q    + ++  R   P+     
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 243

Query: 336 LAELLERCWQHDPTQRPNFSQITDILKQ 363
           +  ++ +CW H P  RP F  + D L +
Sbjct: 244 IYNVMVQCWAHKPEDRPTFVALRDFLLE 271

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  224 bits (571), Expect = 4e-72
 Identities = 78/262 (29%), Positives = 138/262 (52%), Gaps = 8/262 (3%)

Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
           ID K L    ++ +G +G +  G +    +VAIK++K   ++ +   EF +E  +M  + 
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLS 57

Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
           H+ +VQ  G CT+   + I+TE+MA G + ++L + +  FQ   LL++  DV + M YL 
Sbjct: 58  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117

Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--VMTAETGTYRWMAPEVIEHKP 283
               +HRDL   N L+++ GVVKV+DFG++R                 RW  PEV+ +  
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177

Query: 284 YDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER 342
           +  K+D+++FG+ +WE+ + G++PY   T  + A   + + LR   P  A  ++  ++  
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA-EHIAQGLRLYRPHLASEKVYTIMYS 236

Query: 343 CWQHDPTQRPNFSQITDILKQM 364
           CW     +RP F  +   +  +
Sbjct: 237 CWHEKADERPTFKILLSNILDV 258

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  223 bits (570), Expect = 2e-71
 Identities = 80/272 (29%), Positives = 133/272 (48%), Gaps = 18/272 (6%)

Query: 95  IEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLK 152
           +    +  D WEI  +       +  G++G +YK      S   A KV+  +  + E L+
Sbjct: 4   VTRDLNPEDFWEIIGE-------LGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELE 54

Query: 153 EFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLK 212
           ++  E+ I+    H N+V+ + A     NL I+ EF A G++   + + +     + +  
Sbjct: 55  DYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV 114

Query: 213 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTY 271
           V       +NYLH N IIHRDLK  N+L   +G +K+ADFGV+    ++     +  GT 
Sbjct: 115 VCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTP 174

Query: 272 RWMAPEVI-----EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ-KSLR 325
            WMAPEV+     + +PYDYKADV+S GI L E+   E P+  L P++  + + + +   
Sbjct: 175 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT 234

Query: 326 PTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
              P        + L++C + +   R   SQ+
Sbjct: 235 LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (566), Expect = 4e-71
 Identities = 73/261 (27%), Positives = 128/261 (49%), Gaps = 13/261 (4%)

Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 164
            D + LK + ++  GS+  +YKG       EVA   L+   +     + F +E  +++ +
Sbjct: 6   NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL 65

Query: 165 RHKNVVQFIGAC----TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
           +H N+V+F  +          + +VTE M  G++  +L +   V ++  L      + KG
Sbjct: 66  QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKG 124

Query: 221 MNYLHQNN--IIHRDLKTAN-LLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 277
           + +LH     IIHRDLK  N  +    G VK+ D G+A ++ ++    A  GT  +MAPE
Sbjct: 125 LQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-RASFAKAVIGTPEFMAPE 183

Query: 278 VIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP-TIPKHAHPRL 336
           + E K YD   DV++FG+ + E+ T E PY+           V   ++P +  K A P +
Sbjct: 184 MYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 242

Query: 337 AELLERCWQHDPTQRPNFSQI 357
            E++E C + +  +R +   +
Sbjct: 243 KEIIEGCIRQNKDERYSIKDL 263

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  221 bits (565), Expect = 1e-70
 Identities = 90/274 (32%), Positives = 140/274 (51%), Gaps = 14/274 (5%)

Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEVY 159
            EID   +KIE  + +G +G++  G           VAIK LK      +  ++F  E  
Sbjct: 21  KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEAS 79

Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
           IM +  H NV+   G  T+   + I+TEFM  GS+  FL +  G F +  L+ +   ++ 
Sbjct: 80  IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAA 139

Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET------GTYRW 273
           GM YL   N +HRDL   N+L++ N V KV+DFG++R           T         RW
Sbjct: 140 GMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW 199

Query: 274 MAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHA 332
            APE I+++ +   +DV+S+GI +WE+++ GE PY  +T  Q  +  +++  R   P   
Sbjct: 200 TAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-QDVINAIEQDYRLPPPMDC 258

Query: 333 HPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
              L +L+  CWQ D   RP F QI + L +M++
Sbjct: 259 PSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (563), Expect = 1e-70
 Identities = 77/272 (28%), Positives = 134/272 (49%), Gaps = 11/272 (4%)

Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEV 158
            EI    +  +  + +G +G++YKG            VAIK LK      +   +F  E 
Sbjct: 2   TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEA 60

Query: 159 YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS 218
            IM +  H N+++  G  ++   + I+TE+M  G++  FL ++ G F +  L+ +   ++
Sbjct: 61  GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120

Query: 219 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWM 274
            GM YL   N +HRDL   N+L++ N V KV+DFG++RV       +   +      RW 
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180

Query: 275 APEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP 334
           APE I ++ +   +DV+SFGI +WE++T              +  +    R   P     
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS 240

Query: 335 RLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
            + +L+ +CWQ +  +RP F+ I  IL ++++
Sbjct: 241 AIYQLMMQCWQQERARRPKFADIVSILDKLIR 272

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  221 bits (565), Expect = 2e-70
 Identities = 74/247 (29%), Positives = 112/247 (45%), Gaps = 10/247 (4%)

Query: 117 KVASGSYGDLYKGTYCS--QEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNVVQFI 173
           ++  GS+G +Y        + VAIK +      + E  ++  +EV  ++K+RH N +Q+ 
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
           G   R     +V E+    +  D L   K   Q   +  V     +G+ YLH +N+IHRD
Sbjct: 82  GCYLREHTAWLVMEYCLGSA-SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140

Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE---HKPYDYKADV 290
           +K  N+L+ E G+VK+ DFG A + A +       GT  WMAPEVI       YD K DV
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIMAPANSF---VGTPYWMAPEVILAMDEGQYDGKVDV 197

Query: 291 FSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ 350
           +S GI   EL   + P   +  + A   + Q         H        ++ C Q  P  
Sbjct: 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQD 257

Query: 351 RPNFSQI 357
           RP    +
Sbjct: 258 RPTSEVL 264

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (563), Expect = 3e-70
 Identities = 83/304 (27%), Positives = 145/304 (47%), Gaps = 32/304 (10%)

Query: 93  NCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPEC 145
           +  ++P D    WE    +L     + +G++G + + T            VA+K+LKP  
Sbjct: 8   DPTQLPYD--HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS- 64

Query: 146 VNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-- 202
            +    +    E+ ++  +  H N+V  +GACT      ++TE+   G + +FL +++  
Sbjct: 65  AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDS 124

Query: 203 ---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 247
                              L  LL  +  V+KGM +L   N IHRDL   N+L+    + 
Sbjct: 125 FICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT 184

Query: 248 KVADFGVARVQAQSGVMTAET---GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-G 303
           K+ DFG+AR          +       +WMAPE I +  Y +++DV+S+GI LWEL + G
Sbjct: 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244

Query: 304 ELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQ 363
             PY G+        ++++  R   P+HA   + ++++ CW  DP +RP F QI  ++++
Sbjct: 245 SSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304

Query: 364 MMKE 367
            + E
Sbjct: 305 QISE 308

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  220 bits (562), Expect = 4e-70
 Identities = 86/303 (28%), Positives = 148/303 (48%), Gaps = 28/303 (9%)

Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCS----QEVAIKVLKPECVNTEMLKEFSQEVYIM 161
            +D   +K +  +  G++G + K          + AIK +K    + +  ++F+ E+ ++
Sbjct: 6   VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVL 64

Query: 162 RKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQ---------------KGVF 205
            K+  H N++  +GAC     L +  E+   G++ DFL K                    
Sbjct: 65  CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124

Query: 206 QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT 265
               LL  A DV++GM+YL Q   IHRDL   N+L+ EN V K+ADFG++R Q      T
Sbjct: 125 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 184

Query: 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSL 324
                 RWMA E + +  Y   +DV+S+G+ LWE+++ G  PY G+T  +     + +  
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-YEKLPQGY 243

Query: 325 RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINTNIQST 384
           R   P +    + +L+ +CW+  P +RP+F+QI   L +M++E         +NT +   
Sbjct: 244 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE-----RKTYVNTTLYEK 298

Query: 385 YKH 387
           + +
Sbjct: 299 FTY 301

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (554), Expect = 3e-69
 Identities = 80/270 (29%), Positives = 138/270 (51%), Gaps = 9/270 (3%)

Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVY 159
           +EI  +++++   +  G +GD+++G Y S E     VAIK  K  C +  + ++F QE  
Sbjct: 2   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEAL 60

Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
            MR+  H ++V+ IG  T    + I+ E    G +  FL  +K    L SL+  A  +S 
Sbjct: 61  TMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119

Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPE 277
            + YL     +HRD+   N+L+  N  VK+ DFG++R    S    A       +WMAPE
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179

Query: 278 VIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 337
            I  + +   +DV+ FG+ +WE+L   +           +G ++   R  +P +  P L 
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 239

Query: 338 ELLERCWQHDPTQRPNFSQITDILKQMMKE 367
            L+ +CW +DP++RP F+++   L  +++E
Sbjct: 240 SLMTKCWAYDPSRRPRFTELKAQLSTILEE 269

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (547), Expect = 2e-68
 Identities = 64/258 (24%), Positives = 118/258 (45%), Gaps = 14/258 (5%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           ++   + +GSYG   K    S  + +  K L    +     +    EV ++R+++H N+V
Sbjct: 7   EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66

Query: 171 QFIGACTRPPN--LCIVTEFMARGSIYDFLH---KQKGVFQLTSLLKVAIDVSKGMNYLH 225
           ++        N  L IV E+   G +   +    K++       +L+V   ++  +   H
Sbjct: 67  RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126

Query: 226 Q-----NNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVI 279
           +     + ++HRDLK AN+ +D    VK+ DFG+AR +   +    A  GT  +M+PE +
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM 186

Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 339
               Y+ K+D++S G  L+EL     P+   +  + A G +++     IP      L E+
Sbjct: 187 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA-GKIREGKFRRIPYRYSDELNEI 245

Query: 340 LERCWQHDPTQRPNFSQI 357
           + R        RP+  +I
Sbjct: 246 ITRMLNLKDYHRPSVEEI 263

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (545), Expect = 1e-67
 Identities = 68/252 (26%), Positives = 121/252 (48%), Gaps = 8/252 (3%)

Query: 110 KQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK 167
           K+     K+  G+ G +Y     +  QEVAI+ +  +       +    E+ +MR+ ++ 
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNP 77

Query: 168 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN 227
           N+V ++ +      L +V E++A GS+ D + +         +  V  +  + + +LH N
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSN 135

Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVIEHKPYDY 286
            +IHRD+K+ N+L+  +G VK+ DFG    +  +    +   GT  WMAPEV+  K Y  
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195

Query: 287 KADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK-SLRPTIPKHAHPRLAELLERCWQ 345
           K D++S GI   E++ GE PY    PL+A   +    +     P+       + L RC  
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255

Query: 346 HDPTQRPNFSQI 357
            D  +R +  ++
Sbjct: 256 MDVEKRGSAKEL 267

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  213 bits (542), Expect = 3e-67
 Identities = 80/296 (27%), Positives = 136/296 (45%), Gaps = 36/296 (12%)

Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQE 157
            E     ++    +  G++G +++              VA+K+LK E  + +M  +F +E
Sbjct: 8   LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQRE 66

Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-------------- 203
             +M +  + N+V+ +G C     +C++ E+MA G + +FL                   
Sbjct: 67  AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126

Query: 204 ---------VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 254
                           L +A  V+ GM YL +   +HRDL T N L+ EN VVK+ADFG+
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 186

Query: 255 ARVQAQSGVMTAET---GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGEL-PYAGL 310
           +R    +    A+       RWM PE I +  Y  ++DV+++G+ LWE+ +  L PY G+
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246

Query: 311 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
              +  +  V+       P++    L  L+  CW   P  RP+F  I  IL++M +
Sbjct: 247 AH-EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  213 bits (542), Expect = 1e-66
 Identities = 55/251 (21%), Positives = 108/251 (43%), Gaps = 8/251 (3%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
            I  ++ +G++G +++ T  +     A K +     +    +   +E+  M  +RH  +V
Sbjct: 29  DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLV 86

Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
               A      + ++ EFM+ G +++ +  +         ++    V KG+ ++H+NN +
Sbjct: 87  NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 146

Query: 231 HRDLKTANLLM--DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKA 288
           H DLK  N++     +  +K+ DFG+         +   TGT  + APEV E KP  Y  
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYT 206

Query: 289 DVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK--SLRPTIPKHAHPRLAELLERCWQH 346
           D++S G+  + LL+G  P+ G    +    V     ++  +          + + +    
Sbjct: 207 DMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLA 266

Query: 347 DPTQRPNFSQI 357
           DP  R    Q 
Sbjct: 267 DPNTRMTIHQA 277

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  211 bits (539), Expect = 5e-66
 Identities = 47/251 (18%), Positives = 110/251 (43%), Gaps = 8/251 (3%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
            I  ++ SG++G +++    +  +    K +               E+ IM ++ H  ++
Sbjct: 32  DILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLI 89

Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
               A      + ++ EF++ G ++D +  +        ++       +G+ ++H+++I+
Sbjct: 90  NLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIV 149

Query: 231 HRDLKTANLLMD--ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKA 288
           H D+K  N++ +  +   VK+ DFG+A       ++   T T  + APE+++ +P  +  
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYT 209

Query: 289 DVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK--SLRPTIPKHAHPRLAELLERCWQH 346
           D+++ G+  + LL+G  P+AG   L+    V +              P   + ++   Q 
Sbjct: 210 DMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQK 269

Query: 347 DPTQRPNFSQI 357
           +P +R      
Sbjct: 270 EPRKRLTVHDA 280

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (535), Expect = 5e-66
 Identities = 74/292 (25%), Positives = 126/292 (43%), Gaps = 17/292 (5%)

Query: 105 WEIDAKQLKI--ECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQE 157
             I    L +     +  G +G +Y GT           A+K L     +   + +F  E
Sbjct: 20  VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTE 78

Query: 158 VYIMRKIRHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 216
             IM+   H NV+  +G C R      +V  +M  G + +F+  +     +  L+   + 
Sbjct: 79  GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 138

Query: 217 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-----VMTAETGTY 271
           V+KGM +L     +HRDL   N ++DE   VKVADFG+AR             T      
Sbjct: 139 VAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 198

Query: 272 RWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKH 331
           +WMA E ++ + +  K+DV+SFG+ LWEL+T   P             + +  R   P++
Sbjct: 199 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 258

Query: 332 AHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINTNIQS 383
               L E++ +CW      RP+FS++   +  +      ++  + ++ N   
Sbjct: 259 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST---FIGEHYVHVNATY 307

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (532), Expect = 2e-65
 Identities = 75/279 (26%), Positives = 136/279 (48%), Gaps = 13/279 (4%)

Query: 107 IDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
           +   + K    + SG++G +YKG +          VAIK L+    + +  KE   E Y+
Sbjct: 6   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYV 64

Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
           M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++KG
Sbjct: 65  MASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123

Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV---QAQSGVMTAETGTYRWMAPE 277
           MNYL    ++HRDL   N+L+     VK+ DFG+A++   + +           +WMA E
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183

Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 336
            I H+ Y +++DV+S+G+ +WEL+T G  PY G+        +++K  R   P      +
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEKGERLPQPPICTIDV 242

Query: 337 AELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPN 375
             ++ +CW  D   RP F ++     +M ++   +L   
Sbjct: 243 YMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQ 281

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 1e-64
 Identities = 62/252 (24%), Positives = 113/252 (44%), Gaps = 9/252 (3%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
            +   +  G+YG++         + VA+K++  +    +  +   +E+ I + + H+NVV
Sbjct: 8   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHENVV 66

Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
           +F G         +  E+ + G ++D +    G        +    +  G+ YLH   I 
Sbjct: 67  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLHGIGIT 125

Query: 231 HRDLKTANLLMDENGVVKVADFGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYD-Y 286
           HRD+K  NLL+DE   +K++DFG+A V     +  ++    GT  ++APE+++ + +   
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 185

Query: 287 KADVFSFGIALWELLTGELPYAGLTP-LQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 345
             DV+S GI L  +L GELP+   +   Q      +K       K        LL +   
Sbjct: 186 PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILV 245

Query: 346 HDPTQRPNFSQI 357
            +P+ R     I
Sbjct: 246 ENPSARITIPDI 257

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (526), Expect = 1e-64
 Identities = 62/297 (20%), Positives = 123/297 (41%), Gaps = 48/297 (16%)

Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
           E+     +   ++ +G+ G ++K ++      +A K++  E +   +  +  +E+ ++ +
Sbjct: 2   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHE 60

Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 223
                +V F GA      + I  E M  GS+   L K  G      L KV+I V KG+ Y
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTY 119

Query: 224 LHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK 282
           L + + I+HRD+K +N+L++  G +K+ DFGV+  Q    +  +  GT  +M+PE ++  
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYMSPERLQGT 178

Query: 283 PYDYKADVFSFGIALWELLTGELPYAGLTP------------------------------ 312
            Y  ++D++S G++L E+  G  P                                    
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238

Query: 313 -----------LQAAVGVVQKSLRPTIPKHAHPRLA-ELLERCWQHDPTQRPNFSQI 357
                      +   +  +     P +P         + + +C   +P +R +  Q+
Sbjct: 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 3e-64
 Identities = 82/299 (27%), Positives = 150/299 (50%), Gaps = 33/299 (11%)

Query: 96  EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECV 146
           E+P D    WE+   +L +   +  G++G +                 +VA+K+LK +  
Sbjct: 1   ELPED--PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 58

Query: 147 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK--- 202
             ++  +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++   
Sbjct: 59  EKDL-SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPG 117

Query: 203 ------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
                              L+  A  V++GM YL     IHRDL   N+L+ E+ V+K+A
Sbjct: 118 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 177

Query: 251 DFGVARVQAQSGVMTA---ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 306
           DFG+AR                  +WMAPE +  + Y +++DV+SFG+ LWE+ T G  P
Sbjct: 178 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 237

Query: 307 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 365
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++
Sbjct: 238 YPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 3e-64
 Identities = 84/308 (27%), Positives = 150/308 (48%), Gaps = 30/308 (9%)

Query: 91  SPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKP 143
           S   + +P    D WE+  +++ +  ++  GS+G +Y+G             VAIK +  
Sbjct: 5   SAADVYVP----DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE 60

Query: 144 ECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG 203
              +     EF  E  +M++    +VV+ +G  ++     ++ E M RG +  +L   + 
Sbjct: 61  A-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRP 119

Query: 204 V---------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 254
                       L+ ++++A +++ GM YL+ N  +HRDL   N ++ E+  VK+ DFG+
Sbjct: 120 AMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 179

Query: 255 ARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG-ELPYAGL 310
            R   ++             RWM+PE ++   +   +DV+SFG+ LWE+ T  E PY GL
Sbjct: 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 239

Query: 311 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM----K 366
           +  Q    V++  L    P +    L EL+  CWQ++P  RP+F +I   +K+ M    +
Sbjct: 240 SNEQVLRFVMEGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298

Query: 367 EVLYWLSP 374
           EV ++ S 
Sbjct: 299 EVSFYYSE 306

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (522), Expect = 3e-64
 Identities = 83/297 (27%), Positives = 142/297 (47%), Gaps = 28/297 (9%)

Query: 97  IPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTE 149
           +P D    WE    +LK+   +  G++G + +            + VA+K+LK    ++E
Sbjct: 1   LPYD-ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE 59

Query: 150 MLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQ------- 201
                S+   ++    H NVV  +GACT+P   L ++ EF   G++  +L  +       
Sbjct: 60  HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 119

Query: 202 --------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG 253
                   K    L  L+  +  V+KGM +L     IHRDL   N+L+ E  VVK+ DFG
Sbjct: 120 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG 179

Query: 254 VARVQAQSGVMTAET---GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG-ELPYAG 309
           +AR   +      +       +WMAPE I  + Y  ++DV+SFG+ LWE+ +    PY G
Sbjct: 180 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239

Query: 310 LTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 366
           +   +     +++  R   P +  P + + +  CW  +P+QRP FS++ + L  +++
Sbjct: 240 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 3e-63
 Identities = 53/283 (18%), Positives = 112/283 (39%), Gaps = 11/283 (3%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
            I   +  G +G +++    S  +    K +K +  +  ++K   +E+ I+   RH+N++
Sbjct: 8   MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHRNIL 64

Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
               +      L ++ EF++   I++ ++          ++     V + + +LH +NI 
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124

Query: 231 HRDLKTANLLMD--ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKA 288
           H D++  N++     +  +K+ +FG AR                + APEV +H       
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT 184

Query: 289 DVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT--IPKHAHPRLAELLERCWQH 346
           D++S G  ++ LL+G  P+   T  Q    ++           K       + ++R    
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVK 244

Query: 347 DPTQRPNFSQITD--ILKQMMKEVLYWLSPNLINTNIQSTYKH 387
           +   R   S+      LKQ ++ V   +   L +     T   
Sbjct: 245 ERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIK 287

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 4e-63
 Identities = 55/253 (21%), Positives = 113/253 (44%), Gaps = 9/253 (3%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTE-MLKEFSQEVYIMRKIRHKNV 169
           K    +  GS+  +      +  +E AIK+L+   +  E  +   ++E  +M ++ H   
Sbjct: 11  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 70

Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
           V+          L     +   G +  ++ K  G F  T       ++   + YLH   I
Sbjct: 71  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGI 129

Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDY 286
           IHRDLK  N+L++E+  +++ DFG A+V +         +  GT ++++PE++  K    
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 189

Query: 287 KADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH 346
            +D+++ G  +++L+ G  P+           +++  L    P+   P+  +L+E+    
Sbjct: 190 SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK--LEYDFPEKFFPKARDLVEKLLVL 247

Query: 347 DPTQRPNFSQITD 359
           D T+R    ++  
Sbjct: 248 DATKRLGCEEMEG 260

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (508), Expect = 4e-62
 Identities = 75/302 (24%), Positives = 141/302 (46%), Gaps = 48/302 (15%)

Query: 109 AKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN 168
           A+ + ++  +  G +G++++G +  +EVA+K+        E       E+Y    +RH+N
Sbjct: 2   ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHEN 58

Query: 169 VVQFIGACTRP----PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
           ++ FI A  +       L +V+++   GS++D+L++      +  ++K+A+  + G+ +L
Sbjct: 59  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHL 116

Query: 225 HQ--------NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-----VMTAETGTY 271
           H           I HRDLK+ N+L+ +NG   +AD G+A     +            GT 
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176

Query: 272 RWMAPEVIE------HKPYDYKADVFSFGIALWELLTG----------ELPYAGLTPLQA 315
           R+MAPEV++      H     +AD+++ G+  WE+             +LPY  L P   
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236

Query: 316 AV-----GVVQKSLRPTIPKHAHP-----RLAELLERCWQHDPTQRPNFSQITDILKQMM 365
           +V      V ++ LRP IP           +A+++  CW  +   R    +I   L Q+ 
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296

Query: 366 KE 367
           ++
Sbjct: 297 QQ 298

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  199 bits (507), Expect = 9e-62
 Identities = 60/290 (20%), Positives = 125/290 (43%), Gaps = 18/290 (6%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
                + +G++ ++         + VAIK +  + +  +       E+ ++ KI+H N+V
Sbjct: 12  DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-EGSMENEIAVLHKIKHPNIV 70

Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
                     +L ++ + ++ G ++D + + KG +      ++   V   + YLH   I+
Sbjct: 71  ALDDIYESGGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIV 129

Query: 231 HRDLKTANLL---MDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK 287
           HRDLK  NLL   +DE+  + ++DFG+++++    V++   GT  ++APEV+  KPY   
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKA 189

Query: 288 ADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH--PRLAELLERCWQ 345
            D +S G+  + LL G  P+      +    +++       P          + +    +
Sbjct: 190 VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLME 249

Query: 346 HDPTQRPNFSQI---------TDILKQMMKEVLYWLSPNLINTNIQSTYK 386
            DP +R    Q          T + K + + V   +  N   +  +  + 
Sbjct: 250 KDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKWKQAFN 299

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  192 bits (490), Expect = 1e-59
 Identities = 57/263 (21%), Positives = 117/263 (44%), Gaps = 19/263 (7%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNT-------EMLKEFSQEVYIMRK 163
           + +  +  G    + +  +    +E A+K++      +       E+ +   +EV I+RK
Sbjct: 6   EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 65

Query: 164 IR-HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 222
           +  H N++Q            +V + M +G ++D+L + K         K+   + + + 
Sbjct: 66  VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVIC 124

Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE-- 280
            LH+ NI+HRDLK  N+L+D++  +K+ DFG +        +    GT  ++APE+IE  
Sbjct: 125 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECS 184

Query: 281 ----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH--P 334
               H  Y  + D++S G+ ++ LL G  P+     +     ++  + +   P+      
Sbjct: 185 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSD 244

Query: 335 RLAELLERCWQHDPTQRPNFSQI 357
            + +L+ R     P +R    + 
Sbjct: 245 TVKDLVSRFLVVQPQKRYTAEEA 267

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 3e-59
 Identities = 61/255 (23%), Positives = 115/255 (45%), Gaps = 10/255 (3%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNT-EMLKEFSQEVYIM-RKIRHKN 168
            +   +  GS+G ++   +    Q  AIK LK + V   + ++    E  ++     H  
Sbjct: 5   ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 64

Query: 169 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 228
           +           NL  V E++  G +   +      F L+     A ++  G+ +LH   
Sbjct: 65  LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKG 123

Query: 229 IIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVIEHKPYDYK 287
           I++RDLK  N+L+D++G +K+ADFG+ +             GT  ++APE++  + Y++ 
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHS 183

Query: 288 ADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHD 347
            D +SFG+ L+E+L G+ P+ G    +    +      P  P+       +LL + +  +
Sbjct: 184 VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEAKDLLVKLFVRE 241

Query: 348 PTQRPNFSQITDILK 362
           P +R       DI +
Sbjct: 242 PEKRLGVRG--DIRQ 254

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  190 bits (483), Expect = 3e-58
 Identities = 65/258 (25%), Positives = 120/258 (46%), Gaps = 10/258 (3%)

Query: 110 KQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRH 166
           +  +I   + +GS+G ++        +  A+KVLK E  V  + ++  + E  ++  + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 167 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 226
             +++  G       + ++ +++  G     L ++   F        A +V   + YLH 
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYI-EGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122

Query: 227 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY 286
            +II+RDLK  N+L+D+NG +K+ DFG A+            GT  ++APEV+  KPY+ 
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVSTKPYNK 180

Query: 287 KADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH 346
             D +SFGI ++E+L G  P+     ++    ++        P   +  + +LL R    
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFPPFFNEDVKDLLSRLITR 238

Query: 347 DPTQRPNFSQIT--DILK 362
           D +QR    Q    D+  
Sbjct: 239 DLSQRLGNLQNGTEDVKN 256

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 2e-56
 Identities = 59/257 (22%), Positives = 110/257 (42%), Gaps = 13/257 (5%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTE----MLKEFSQEVYIMRKIRH 166
               ++ SG +  + K    S   + A K +K     +       ++  +EV I+++I+H
Sbjct: 13  DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 72

Query: 167 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 226
            NV+          ++ ++ E +A G ++DF   +K         +    +  G+ YLH 
Sbjct: 73  PNVITLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEFLKQILNGVYYLHS 131

Query: 227 NNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK 282
             I H DLK  N+++ +  V    +K+ DFG+A             GT  ++APE++ ++
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191

Query: 283 PYDYKADVFSFGIALWELLTGELPYAGLTPLQ--AAVGVVQKSLRPTIPKHAHPRLAELL 340
           P   +AD++S G+  + LL+G  P+ G T  +  A V  V          +      + +
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 251

Query: 341 ERCWQHDPTQRPNFSQI 357
            R    DP +R      
Sbjct: 252 RRLLVKDPKKRMTIQDS 268

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  183 bits (464), Expect = 7e-56
 Identities = 68/253 (26%), Positives = 119/253 (47%), Gaps = 14/253 (5%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNV 169
           ++   +  G   +++        ++VA+KVL+ +   +      F +E      + H  +
Sbjct: 10  ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 69

Query: 170 VQFIGAC----TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
           V             P   IV E++   ++ D +H + G       ++V  D  + +N+ H
Sbjct: 70  VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSH 128

Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET----GTYRWMAPEVIEH 281
           QN IIHRD+K AN+++     VKV DFG+AR  A SG    +T    GT ++++PE    
Sbjct: 129 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 188

Query: 282 KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH--PRLAEL 339
              D ++DV+S G  L+E+LTGE P+ G +P+  A   V++   P   +H      L  +
Sbjct: 189 DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAV 248

Query: 340 LERCWQHDPTQRP 352
           + +    +P  R 
Sbjct: 249 VLKALAKNPENRY 261

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  183 bits (464), Expect = 8e-55
 Identities = 62/260 (23%), Positives = 115/260 (44%), Gaps = 12/260 (4%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTE----MLKEFSQEVYIMRKIRH 166
            +   +  G +G++Y        +  A+K L  + +  +    +       + ++     
Sbjct: 7   SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66

Query: 167 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 226
             +V    A   P  L  + + M  G ++  L +  GVF    +   A ++  G+ ++H 
Sbjct: 67  PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHN 125

Query: 227 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH-KPYD 285
             +++RDLK AN+L+DE+G V+++D G+A          A  GT+ +MAPEV++    YD
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQKGVAYD 184

Query: 286 YKADVFSFGIALWELLTGELPYAGLTPL-QAAVGVVQKSLRPTIPKHAHPRLAELLERCW 344
             AD FS G  L++LL G  P+       +  +  +  ++   +P    P L  LLE   
Sbjct: 185 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 244

Query: 345 QHDPTQRPNFSQ--ITDILK 362
           Q D  +R         ++ +
Sbjct: 245 QRDVNRRLGCLGRGAQEVKE 264

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  180 bits (458), Expect = 9e-55
 Identities = 60/274 (21%), Positives = 108/274 (39%), Gaps = 23/274 (8%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           ++  K+ SGS+GD+Y GT  +  +EVAIK+   +        +   E  I + ++    +
Sbjct: 10  RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK----TKHPQLHIESKIYKMMQGGVGI 65

Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
             I  C    +  ++   +   S+ D  +     F L ++L +A  +   + Y+H  N I
Sbjct: 66  PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFI 125

Query: 231 HRDLKTANLLM---DENGVVKVADFGVARVQAQSGV--------MTAETGTYRWMAPEVI 279
           HRD+K  N LM    +  +V + DFG+A+    +              TGT R+ +    
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185

Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR------PTIPKHAH 333
                  + D+ S G  L     G LP+ GL          + S +        + K   
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYP 245

Query: 334 PRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
              A  L  C       +P++S +  + + +   
Sbjct: 246 SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 4e-53
 Identities = 54/261 (20%), Positives = 106/261 (40%), Gaps = 24/261 (9%)

Query: 114 IECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVV 170
               +  G  G + +       ++ A+K+L+          +  +EV +  +  +  ++V
Sbjct: 16  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIV 68

Query: 171 QFIGAC----TRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLH 225
           + +            L IV E +  G ++  +  +    F      ++   + + + YLH
Sbjct: 69  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 128

Query: 226 QNNIIHRDLKTANLLMD---ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK 282
             NI HRD+K  NLL      N ++K+ DFG A+       +T    T  ++APEV+  +
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE 188

Query: 283 PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI------PKHAHPRL 336
            YD   D++S G+ ++ LL G  P+     L  + G+  +                   +
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV 248

Query: 337 AELLERCWQHDPTQRPNFSQI 357
             L+    + +PTQR   ++ 
Sbjct: 249 KMLIRNLLKTEPTQRMTITEF 269

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 4e-53
 Identities = 57/255 (22%), Positives = 107/255 (41%), Gaps = 19/255 (7%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNT----EMLKEFSQEVYIMRKIR- 165
           ++   + SG +G +Y G   S    VAIK ++ + ++             EV +++K+  
Sbjct: 7   QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66

Query: 166 -HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
               V++ +    RP +  ++ E             ++G  Q          V + + + 
Sbjct: 67  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126

Query: 225 HQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKP 283
           H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I +  
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHR 185

Query: 284 Y-DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER 342
           Y    A V+S GI L++++ G++P+     +           +    +        L+  
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG--------QVFFRQRVSSECQHLIRW 237

Query: 343 CWQHDPTQRPNFSQI 357
           C    P+ RP F +I
Sbjct: 238 CLALRPSDRPTFEEI 252

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 1e-52
 Identities = 55/256 (21%), Positives = 113/256 (44%), Gaps = 9/256 (3%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNV 169
                +  G++G +      +  +  A+K+L+ E +   + +     E  +++  RH  +
Sbjct: 8   DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67

Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
                A      LC V E+   G ++  L +++  F          ++   + YLH  ++
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERV-FTEERARFYGAEIVSALEYLHSRDV 126

Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEVIEHKPYDYKA 288
           ++RD+K  NL++D++G +K+ DFG+ +     G  M    GT  ++APEV+E   Y    
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 186

Query: 289 DVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDP 348
           D +  G+ ++E++ G LP+      +    ++ +      P+   P    LL    + DP
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLLAGLLKKDP 244

Query: 349 TQRPNFSQIT--DILK 362
            QR         ++++
Sbjct: 245 KQRLGGGPSDAKEVME 260

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  173 bits (438), Expect = 8e-52
 Identities = 41/276 (14%), Positives = 96/276 (34%), Gaps = 25/276 (9%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           K+  ++  GS+G +++GT     Q+VAIK             +   E    + +     +
Sbjct: 8   KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR----SDAPQLRDEYRTYKLLAGCTGI 63

Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
             +    +     ++   +   S+ D L      F + ++   A  +   +  +H+ +++
Sbjct: 64  PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLV 123

Query: 231 HRDLKTANLLMDE-----NGVVKVADFGVARV--------QAQSGVMTAETGTYRWMAPE 277
           +RD+K  N L+         ++ V DFG+ +                   +GT R+M+  
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183

Query: 278 VIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV------QKSLRPTIPKH 331
               +    + D+ + G      L G LP+ GL                Q +    +   
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAG 243

Query: 332 AHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 367
                 + +           P++  +  +  ++++ 
Sbjct: 244 FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 3e-51
 Identities = 56/281 (19%), Positives = 113/281 (40%), Gaps = 36/281 (12%)

Query: 113 KIECKVASGSYGDLYKGTYCS---QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI---RH 166
           +   ++  G+YG ++K        + VA+K ++ +     M     +EV ++R +    H
Sbjct: 10  ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 69

Query: 167 KNVVQFIGACTRPPN-----LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
            NVV+    CT         L +V E + +          +      ++  +   + +G+
Sbjct: 70  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 129

Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH 281
           ++LH + ++HRDLK  N+L+  +G +K+ADFG+AR+ +    +T+   T  + APEV+  
Sbjct: 130 DFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 189

Query: 282 KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT-------------- 327
             Y    D++S G    E+   +  + G + +     ++     P               
Sbjct: 190 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 249

Query: 328 -----------IPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
                                +LL +C   +P +R +    
Sbjct: 250 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 5e-50
 Identities = 67/278 (24%), Positives = 123/278 (44%), Gaps = 35/278 (12%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNT---EMLKEFSQEVYIMRKIRHK 167
           K++  +  G +  +YK    +  Q VAIK +K    +     + +   +E+ +++++ H 
Sbjct: 2   KLD-FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60

Query: 168 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN 227
           N++  + A     N+ +V +FM    +   +     V   + +    +   +G+ YLHQ+
Sbjct: 61  NIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119

Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVI-EHKPYD 285
            I+HRDLK  NLL+DENGV+K+ADFG+A+   + +   T +  T  + APE++   + Y 
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179

Query: 286 YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT------------------ 327
              D+++ G  L ELL       G + L     + +    PT                  
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239

Query: 328 --------IPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
                   I   A   L +L++  +  +P  R   +Q 
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  166 bits (422), Expect = 8e-49
 Identities = 65/255 (25%), Positives = 113/255 (44%), Gaps = 10/255 (3%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRHKNV 169
                + +GS+G +    +       A+K+L  +  V  + ++    E  I++ +    +
Sbjct: 44  DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL 103

Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
           V+   +     NL +V E++A G ++  L +  G F        A  +     YLH  ++
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDL 162

Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKAD 289
           I+RDLK  NLL+D+ G ++V DFG A+            GT   +APE+I  K Y+   D
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSKGYNKAVD 220

Query: 290 VFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPT 349
            ++ G+ ++E+  G  P+    P+Q    +V    +   P H    L +LL    Q D T
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVDLT 278

Query: 350 QRPNFSQIT--DILK 362
           +R    +    DI  
Sbjct: 279 KRFGNLKNGVNDIKN 293

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (412), Expect = 6e-48
 Identities = 55/276 (19%), Positives = 108/276 (39%), Gaps = 31/276 (11%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           +   K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 5   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 64

Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
           + +        L +V EF+ +               L  +      + +G+ + H + ++
Sbjct: 65  KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124

Query: 231 HRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEVIEHKPY-DYKA 288
           HRDLK  NLL++  G +K+ADFG+AR         T E  T  + APE++    Y     
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184

Query: 289 DVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT--------------------- 327
           D++S G    E++T    + G + +     + +    P                      
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 244

Query: 328 ------IPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
                 +          LL +   +DP +R +    
Sbjct: 245 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  161 bits (407), Expect = 2e-47
 Identities = 59/275 (21%), Positives = 108/275 (39%), Gaps = 31/275 (11%)

Query: 113 KIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQ 171
               K+  G+YG +YK      +  A+K ++ E  +  +     +E+ I+++++H N+V+
Sbjct: 5   HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVK 64

Query: 172 FIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 231
                     L +V E +    +   L   +G  +  +     + +  G+ Y H   ++H
Sbjct: 65  LYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123

Query: 232 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRW-MAPEVIE-HKPYDYKAD 289
           RDLK  NLL++  G +K+ADFG+AR                W  AP+V+   K Y    D
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTID 183

Query: 290 VFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT---------------------- 327
           ++S G    E++ G   + G++     + + +    P                       
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243

Query: 328 -----IPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
                  K       +LL +  + DP QR    Q 
Sbjct: 244 LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 4e-46
 Identities = 59/294 (20%), Positives = 115/294 (39%), Gaps = 44/294 (14%)

Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIM 161
           V+++  +   +   +  G+YG +           VAIK + P   +    +   +E+ I+
Sbjct: 3   VFDVGPRYTNLS-YIGEGAYGMVCSAYDNVNKVRVAIKKISPF-EHQTYCQRTLREIKIL 60

Query: 162 RKIRHKNVVQFIGACTRPP----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 217
            + RH+N++        P         +   +    +Y  L  Q        +      +
Sbjct: 61  LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQI 118

Query: 218 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRW 273
            +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  +
Sbjct: 119 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178

Query: 274 MAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT----- 327
            APE++ +   Y    D++S G  L E+L+    + G   L     ++     P+     
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238

Query: 328 ------------------------IPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
                                   +  +A  +  +LL++    +P +R    Q 
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 1e-45
 Identities = 58/266 (21%), Positives = 121/266 (45%), Gaps = 17/266 (6%)

Query: 113 KIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIR 165
           ++   + +G+YG ++     S     +  A+KVLK   +    +  +    E  ++  IR
Sbjct: 27  ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 86

Query: 166 HK-NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
               +V    A      L ++ +++  G ++  L +++  F    +     ++   + +L
Sbjct: 87  QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHL 145

Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVAR--VQAQSGVMTAETGTYRWMAPEVIEHK 282
           H+  II+RD+K  N+L+D NG V + DFG+++  V  ++       GT  +MAP+++   
Sbjct: 146 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGG 205

Query: 283 PYDY--KADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLAE 338
              +    D +S G+ ++ELLTG  P+       +   + ++ L+  P  P+       +
Sbjct: 206 DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKD 265

Query: 339 LLERCWQHDPTQRPNFSQIT--DILK 362
           L++R    DP +R         +I +
Sbjct: 266 LIQRLLMKDPKKRLGCGPRDADEIKE 291

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 5e-45
 Identities = 64/291 (21%), Positives = 116/291 (39%), Gaps = 47/291 (16%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           +   K+  G++G+++K  +    Q+VA+K +  E           +E+ I++ ++H+NVV
Sbjct: 13  EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVV 72

Query: 171 QFIGACTRPP--------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 222
             I  C            ++ +V +F         L      F L+ + +V   +  G+ 
Sbjct: 73  NLIEICRTKASPYNRCKGSIYLVFDFCEHDL-AGLLSNVLVKFTLSEIKRVMQMLLNGLY 131

Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-----QAQSGVMTAETGTYRWMAPE 277
           Y+H+N I+HRD+K AN+L+  +GV+K+ADFG+AR       +Q    T    T  +  PE
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191

Query: 278 VI-EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT--------- 327
           ++   + Y    D++  G  + E+ T      G T       + Q     T         
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251

Query: 328 ---------------------IPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
                                      P   +L+++    DP QR +    
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 6e-44
 Identities = 72/295 (24%), Positives = 117/295 (39%), Gaps = 44/295 (14%)

Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEV 158
               WE+     +    V SG+YG +          +VAIK L     +    K   +E+
Sbjct: 10  TKTAWEVR-AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYREL 68

Query: 159 YIMRKIRHKNVVQFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLK 212
            +++ +RH+NV+  +   T         +  +V  FM  G+    L K         +  
Sbjct: 69  RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMK-HEKLGEDRIQF 125

Query: 213 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYR 272
           +   + KG+ Y+H   IIHRDLK  NL ++E+  +K+ DFG+AR       MT    T  
Sbjct: 126 LVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYVVTRW 183

Query: 273 WMAPEVI-EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP----- 326
           + APEVI     Y    D++S G  + E++TG+  + G   L     +++ +  P     
Sbjct: 184 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243

Query: 327 ------------------------TIPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
                                   +I  +A P    LLE+    D  QR    + 
Sbjct: 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 8e-44
 Identities = 63/303 (20%), Positives = 114/303 (37%), Gaps = 49/303 (16%)

Query: 95  IEIPTDGTD-VWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEML 151
           +  P  G D   E+     K+   + +GS+G +Y+   C   + VAIK +  +       
Sbjct: 7   VATPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQD------K 57

Query: 152 KEFSQEVYIMRKIRHKNVVQFIGACTRP------PNLCIVTEFMARGSIYDFLH--KQKG 203
           +  ++E+ IMRK+ H N+V+                L +V +++         H  + K 
Sbjct: 58  RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ 117

Query: 204 VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQSG 262
              +  +      + + + Y+H   I HRD+K  NLL+D +  V+K+ DFG A+   +  
Sbjct: 118 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

Query: 263 VMTAETGTYRWMAP-EVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321
              +   +  + AP  +     Y    DV+S G  L ELL G+  + G + +   V +++
Sbjct: 178 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237

Query: 322 ---------------------------KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 354
                                                  P    L  R  ++ PT R   
Sbjct: 238 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP 297

Query: 355 SQI 357
            + 
Sbjct: 298 LEA 300

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 6e-43
 Identities = 60/277 (21%), Positives = 113/277 (40%), Gaps = 33/277 (11%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
           +   K+  G+YG ++K       + VA+K ++ +  +  +     +E+ ++++++HKN+V
Sbjct: 5   EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64

Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
           +          L +V EF  +     F     G      +      + KG+ + H  N++
Sbjct: 65  RLHDVLHSDKKLTLVFEFCDQDLKKYF-DSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVL 123

Query: 231 HRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEVIE-HKPYDYKA 288
           HRDLK  NLL++ NG +K+A+FG+AR         +AE  T  +  P+V+   K Y    
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183

Query: 289 DVFSFGIALWELLTGELP-YAGLTPLQAAVGVVQKSLRPT-------------------- 327
           D++S G    EL     P + G         + +    PT                    
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243

Query: 328 -------IPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
                  +    +    +LL+   + +P QR +  + 
Sbjct: 244 ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 5e-40
 Identities = 58/291 (19%), Positives = 114/291 (39%), Gaps = 40/291 (13%)

Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYI 160
            +WE+  +  +    V SG+YG +           VA+K L     +    K   +E+ +
Sbjct: 12  TIWEVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70

Query: 161 MRKIRHKNVVQFIGACTRPP-----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           ++ ++H+NV+  +   T        N   +   +    + + +  QK       +  +  
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIY 128

Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
            + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR      +       +    
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTGYVATRWYRAP 187

Query: 276 PEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT-------- 327
             ++    Y+   D++S G  + ELLTG   + G   +     +++    P         
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247

Query: 328 ---------------------IPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
                                +   A+P   +LLE+    D  +R   +Q 
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 8e-38
 Identities = 61/305 (20%), Positives = 113/305 (37%), Gaps = 53/305 (17%)

Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEV 158
           G   + +  K+ +    + SG+ G +         + VAIK L     N    K   +E+
Sbjct: 9   GDSTFTVL-KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYREL 67

Query: 159 YIMRKIRHKNVVQFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLK 212
            +M+ + HKN++  +   T         ++ +V E M            +       +  
Sbjct: 68  VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN----LCQVIQMELDHERMSY 123

Query: 213 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYR 272
           +   +  G+ +LH   IIHRDLK +N+++  +  +K+ DFG+AR    S +MT    T  
Sbjct: 124 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 183

Query: 273 WMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT----- 327
           + APEVI    Y    D++S G  + E++  ++ + G   +     V+++   P      
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243

Query: 328 -----------------------------------IPKHAHPRLAELLERCWQHDPTQRP 352
                                                K    +  +LL +    DP +R 
Sbjct: 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303

Query: 353 NFSQI 357
           +    
Sbjct: 304 SVDDA 308

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  134 bits (338), Expect = 7e-37
 Identities = 46/288 (15%), Positives = 105/288 (36%), Gaps = 52/288 (18%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNV 169
           ++  K+  G Y ++++    +  ++V +K+LKP        K+  +E+ I+  +R   N+
Sbjct: 38  QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNI 92

Query: 170 VQFIGACTRPPN--LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN 227
           +        P +    +V E +                    +     ++ K ++Y H  
Sbjct: 93  ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSM 148

Query: 228 NIIHRDLKTANLLMD-ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV-IEHKPYD 285
            I+HRD+K  N+++D E+  +++ D+G+A              +  +  PE+ ++++ YD
Sbjct: 149 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 208

Query: 286 YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL--------------------- 324
           Y  D++S G  L  ++  + P+         +  + K L                     
Sbjct: 209 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 268

Query: 325 ---------------RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 357
                                   P   + L++  ++D   R    + 
Sbjct: 269 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  110 bits (275), Expect = 7e-28
 Identities = 46/315 (14%), Positives = 105/315 (33%), Gaps = 75/315 (23%)

Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
            +  K+  G +  ++          VA+K+++ + V TE       E+ +++++   +  
Sbjct: 16  ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE---AAEDEIKLLQRVNDADNT 72

Query: 171 QFIGACTRPP---------------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
           +                        ++ +V E +    +      +     L  + +++ 
Sbjct: 73  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132

Query: 216 DVSKGMNYLH-QNNIIHRDLKTANLLMDENGV------VKVADFGVARVQAQSGVMTAET 268
            +  G++Y+H +  IIH D+K  N+LM+          +K+AD G A    +    +   
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS--I 190

Query: 269 GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ------- 321
            T  + +PEV+   P+   AD++S    ++EL+TG+  +                     
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250

Query: 322 ---------------------------------------KSLRPTIPKHAHPRLAELLER 342
                                                   + +    K     +++ L  
Sbjct: 251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 310

Query: 343 CWQHDPTQRPNFSQI 357
             Q DP +R +   +
Sbjct: 311 MLQLDPRKRADAGGL 325

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 78.7 bits (193), Expect = 7e-18
 Identities = 27/203 (13%), Positives = 62/203 (30%), Gaps = 36/203 (17%)

Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLK--------EFSQE 157
           +DA    I   +  G    ++        E  +K  K    + + +K         FS  
Sbjct: 1   VDA----IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVL 56

Query: 158 VYIMRKIRHKNVVQFIGACTRPP----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKV 213
                +   + + +  G             ++ E +    +Y    +           +V
Sbjct: 57  AIRSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENP--------DEV 108

Query: 214 AIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETG 269
              + + +   +   I+H DL   N+L+ E G + + DF  +        +  +      
Sbjct: 109 LDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDVRN 167

Query: 270 TYRWMAPEVIEHKPYDYKADVFS 292
              + +      + Y  + D+ S
Sbjct: 168 IITYFS------RTYRTEKDINS 184

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	395
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.94
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.74
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.18
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.91
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.34
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.24
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.91
d2f06a1	71	Hypothetical protein BT0572 {Bacteroides thetaiota	90.17
d1zpva1	83	UPF0237 protein SP0238 {Streptococcus pneumoniae [	88.97
d1u8sa1	86	putative transcriptional repressor VC2159 {Vibrio	86.35
d2f06a2	70	Hypothetical protein BT0572 {Bacteroides thetaiota	85.12
d1ygya3	78	Phosphoglycerate dehydrogenase, regulatory (C-term	84.37
d1sc6a3	84	Phosphoglycerate dehydrogenase, regulatory (C-term	82.24

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-61  Score=450.64  Aligned_cols=263  Identities=35%  Similarity=0.693  Sum_probs=228.9

Q ss_pred             CceeecccCcceeeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Q 016082          103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  182 (395)
Q Consensus       103 ~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  182 (395)
                      ++|+|+.++|++.++||+|+||+||+|++.+ .||||+++....+....+.|.+|+.+|++++||||+++++++.. +.+
T Consensus         1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~   78 (276)
T d1uwha_           1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQL   78 (276)
T ss_dssp             CCCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred             CCcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEE
Confidence            4799999999999999999999999998755 69999998777677778899999999999999999999998765 568


Q ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-
Q 016082          183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-  261 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-  261 (395)
                      ++||||++||+|.+++....+++++..+..++.||++||+|||++|||||||||+|||++.++.+||+|||+|+..... 
T Consensus        79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            9999999999999999887788999999999999999999999999999999999999999999999999999865432 


Q ss_pred             --CccccCCCCcccccccccCC---CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCC----CCCCCC
Q 016082          262 --GVMTAETGTYRWMAPEVIEH---KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP----TIPKHA  332 (395)
Q Consensus       262 --~~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~  332 (395)
                        .......||+.|||||++.+   .+|+.++|||||||++|||+||+.||.+.++.............+    ..+..+
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  238 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC  238 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTC
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccc
Confidence              23345679999999999864   358999999999999999999999999987766655555544432    346678


Q ss_pred             cHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 016082          333 HPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE  367 (395)
Q Consensus       333 ~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~  367 (395)
                      ++++.++|.+||+.||.+|||+.||++.|+.+.+.
T Consensus       239 ~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         239 PKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence            99999999999999999999999999999988763

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.5e-60  Score=443.59  Aligned_cols=262  Identities=35%  Similarity=0.710  Sum_probs=231.1

Q ss_pred             CCCceeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Q 016082          101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR  178 (395)
Q Consensus       101 ~~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  178 (395)
                      ..+.|+|+.++|++.++||+|+||+||+|++  +++.||||+++.....   .++|.+|+.+|++++||||++++++|.+
T Consensus         8 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~   84 (287)
T d1opja_           8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTR   84 (287)
T ss_dssp             TCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEee
Confidence            3467999999999999999999999999998  4788999999866433   4679999999999999999999999999


Q ss_pred             CCcEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccc
Q 016082          179 PPNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV  257 (395)
Q Consensus       179 ~~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~  257 (395)
                      ++.+++||||+++|+|.+++... ...+++..+..++.||++||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus        85 ~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~  164 (287)
T d1opja_          85 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL  164 (287)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred             CCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceee
Confidence            99999999999999999999764 46789999999999999999999999999999999999999999999999999987


Q ss_pred             cccCCc--cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHhhhccCCCCCCCCCcH
Q 016082          258 QAQSGV--MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELP-YAGLTPLQAAVGVVQKSLRPTIPKHAHP  334 (395)
Q Consensus       258 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (395)
                      ......  .+...|++.|+|||++.+..|+.++|||||||++|||++|..| |.+.+..+ ....+....++..|..+++
T Consensus       165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~-~~~~i~~~~~~~~~~~~~~  243 (287)
T d1opja_         165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKDYRMERPEGCPE  243 (287)
T ss_dssp             CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HHHHHHTTCCCCCCTTCCH
T ss_pred             cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH-HHHHHhcCCCCCCCccchH
Confidence            654432  2233578999999999999999999999999999999996555 55555544 4555667788899999999


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 016082          335 RLAELLERCWQHDPTQRPNFSQITDILKQMMK  366 (395)
Q Consensus       335 ~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~  366 (395)
                      ++.++|.+||+.||.+|||+.++++.|+.+++
T Consensus       244 ~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         244 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            99999999999999999999999998877654

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-59  Score=432.26  Aligned_cols=257  Identities=32%  Similarity=0.673  Sum_probs=221.4

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  185 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  185 (395)
                      |+.++|++.++||+|+||.||+|++ +++.||||+++......   ++|.+|+.++++++||||++++|+|..++..++|
T Consensus         2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv   78 (263)
T d1sm2a_           2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV   78 (263)
T ss_dssp             BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcH---HHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence            5678999999999999999999998 46789999998764443   6799999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCc--
Q 016082          186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV--  263 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~--  263 (395)
                      |||+++|+|.+++......+++..+..++.||++||+|||+++|+||||||+|||+++++.+||+|||+|+.......  
T Consensus        79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  158 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  158 (263)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence            999999999999988778899999999999999999999999999999999999999999999999999986654332  


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHH
Q 016082          264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER  342 (395)
Q Consensus       264 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  342 (395)
                      .....||+.|+|||++.+..|+.++|||||||++|||+| |.+||...+..+.... +..+.++..|..+++++.++|.+
T Consensus       159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~-i~~~~~~~~p~~~~~~l~~li~~  237 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED-ISTGFRLYKPRLASTHVYQIMNH  237 (263)
T ss_dssp             ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHH-HHHTCCCCCCTTSCHHHHHHHHH
T ss_pred             ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHH-HHhcCCCCCccccCHHHHHHHHH
Confidence            233568999999999999999999999999999999999 6777877777665554 45577888889999999999999


Q ss_pred             hhccCCCCCCCHHHHHHHHHHHHHH
Q 016082          343 CWQHDPTQRPNFSQITDILKQMMKE  367 (395)
Q Consensus       343 cl~~dp~~RPs~~ell~~l~~~~~~  367 (395)
                      ||+.||++|||++||++.|+++.+.
T Consensus       238 cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         238 CWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HccCCHhHCcCHHHHHHHHHHHHhC
Confidence            9999999999999999999998763

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-58  Score=431.79  Aligned_cols=261  Identities=31%  Similarity=0.644  Sum_probs=229.1

Q ss_pred             CCceeecccCcceeeeeeeeCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 016082          102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  180 (395)
Q Consensus       102 ~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (395)
                      .+.|+|+.++|++.++||+|+||.||+|++. ++.||||+++.....   .+.|.+|+.+|++++|||||+++|++.+ +
T Consensus         5 ~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~   80 (272)
T d1qpca_           5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-E   80 (272)
T ss_dssp             TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             CCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc-C
Confidence            3679999999999999999999999999995 578999999866443   3579999999999999999999998865 4


Q ss_pred             cEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  259 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~  259 (395)
                      ..++||||+++|+|.+++.... .++++..+..++.||++||.|||++||+||||||+|||+++++.+||+|||+|+...
T Consensus        81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~  160 (272)
T d1qpca_          81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE  160 (272)
T ss_dssp             SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEcc
Confidence            6799999999999999876543 468999999999999999999999999999999999999999999999999998765


Q ss_pred             cCC--ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHH
Q 016082          260 QSG--VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  336 (395)
Q Consensus       260 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  336 (395)
                      ...  ......||+.|||||++.+..|+.++|||||||++|||+| |.+||...+..+.... +....++..|..+++++
T Consensus       161 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~-i~~~~~~~~p~~~~~~l  239 (272)
T d1qpca_         161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN-LERGYRMVRPDNCPEEL  239 (272)
T ss_dssp             SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCCCCCCTTCCHHH
T ss_pred             CCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHH-HHhcCCCCCcccChHHH
Confidence            443  2344578999999999998999999999999999999999 5666677666555444 55677888899999999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 016082          337 AELLERCWQHDPTQRPNFSQITDILKQMMKE  367 (395)
Q Consensus       337 ~~li~~cl~~dp~~RPs~~ell~~l~~~~~~  367 (395)
                      .++|.+||+.||++|||+.+|++.|+++...
T Consensus       240 ~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         240 YQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            9999999999999999999999999987653

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.4e-58  Score=435.30  Aligned_cols=259  Identities=34%  Similarity=0.627  Sum_probs=221.6

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEEC--C---ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTYC--S---QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  180 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~~--~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (395)
                      +++.++|++.+.||+|+||+||+|++.  +   ..||||.+.... .....+.|.+|+.+|++++|||||+++|++..++
T Consensus        22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~  100 (299)
T d1jpaa_          22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST  100 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            566788999999999999999999873  2   258899887553 4556678999999999999999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                      .+++||||++||+|.+++....+.+++..+..++.||++||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence            99999999999999999988778899999999999999999999999999999999999999999999999999986544


Q ss_pred             CCc------cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCc
Q 016082          261 SGV------MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAH  333 (395)
Q Consensus       261 ~~~------~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (395)
                      ...      .....||+.|||||.+.+..|+.++|||||||++|||+| |+.||.+.+..+.... +....+++.|..++
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~-i~~~~~~~~~~~~~  259 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA-IEQDYRLPPPMDCP  259 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-HHTTCCCCCCTTCC
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCccch
Confidence            321      122457899999999999999999999999999999998 8999999988776555 44567788888999


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 016082          334 PRLAELLERCWQHDPTQRPNFSQITDILKQMMK  366 (395)
Q Consensus       334 ~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~  366 (395)
                      +++.++|.+||+.||.+|||+.||++.|+++++
T Consensus       260 ~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         260 SALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            999999999999999999999999999998876

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-58  Score=430.33  Aligned_cols=264  Identities=27%  Similarity=0.531  Sum_probs=232.0

Q ss_pred             eeecccCcceee-eeeeeCceEEEEEEEC----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 016082          105 WEIDAKQLKIEC-KVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP  179 (395)
Q Consensus       105 ~~i~~~~~~i~~-~lg~G~~G~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  179 (395)
                      +.+..++|.+.. +||+|+||.||+|.+.    +..||||+++... .....++|.+|+.+|++++|||||+++|++..+
T Consensus         3 l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~   81 (285)
T d1u59a_           3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE   81 (285)
T ss_dssp             CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             eeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC
Confidence            456677888888 5999999999999763    3479999998653 455678899999999999999999999999764


Q ss_pred             CcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccc
Q 016082          180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  259 (395)
Q Consensus       180 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~  259 (395)
                       .+|+||||++||+|.+++...++.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus        82 -~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          82 -ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             -SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             -eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence             6899999999999999998777889999999999999999999999999999999999999999999999999998765


Q ss_pred             cCC----ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcH
Q 016082          260 QSG----VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP  334 (395)
Q Consensus       260 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (395)
                      ...    ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+.... +..+.++..|+.+|+
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~-i~~~~~~~~p~~~~~  239 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-IEQGKRMECPPECPP  239 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH-HHTTCCCCCCTTCCH
T ss_pred             ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCCcCCH
Confidence            432    2234568999999999999999999999999999999998 9999999887665544 556778889999999


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHh
Q 016082          335 RLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYW  371 (395)
Q Consensus       335 ~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~~~  371 (395)
                      ++.++|.+||+.||++||||.+|.+.|+++..++..-
T Consensus       240 ~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~  276 (285)
T d1u59a_         240 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK  276 (285)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhc
Confidence            9999999999999999999999999999887665443

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-58  Score=428.14  Aligned_cols=246  Identities=26%  Similarity=0.477  Sum_probs=220.7

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      ++|++.+.||+|+||+||+|++  +++.||+|++.+.... ....+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            5799999999999999999998  4789999998643221 223467899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCcccc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA  266 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~  266 (395)
                      ||++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..... ....
T Consensus        86 Ey~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-~~~~  163 (263)
T d2j4za1          86 EYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTT  163 (263)
T ss_dssp             ECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-CCEE
T ss_pred             eecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC-cccc
Confidence            99999999999976 567999999999999999999999999999999999999999999999999999865543 3355


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhcc
Q 016082          267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH  346 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  346 (395)
                      ..||+.|||||++.+.+|+.++|||||||++|+|++|+.||.+.+..+....+...  .+.+|..+|+++.++|.+||+.
T Consensus       164 ~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~  241 (263)
T d2j4za1         164 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFTFPDFVTEGARDLISRLLKH  241 (263)
T ss_dssp             TTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--CCCCCTTSCHHHHHHHHHHTCS
T ss_pred             cCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCccCCHHHHHHHHHHccC
Confidence            68999999999999999999999999999999999999999999888776665543  4567788999999999999999


Q ss_pred             CCCCCCCHHHHHH
Q 016082          347 DPTQRPNFSQITD  359 (395)
Q Consensus       347 dp~~RPs~~ell~  359 (395)
                      ||.+|||+.|+++
T Consensus       242 dp~~R~t~~eil~  254 (263)
T d2j4za1         242 NPSQRPMLREVLE  254 (263)
T ss_dssp             SGGGSCCHHHHHT
T ss_pred             CHhHCcCHHHHHc
Confidence            9999999999987

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-58  Score=423.76  Aligned_cols=253  Identities=31%  Similarity=0.630  Sum_probs=229.3

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  185 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  185 (395)
                      ++.++|++.++||+|+||+||+|++. ++.||||+++......   ++|.+|+.++++++||||++++|+|.+++.+++|
T Consensus         1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv   77 (258)
T d1k2pa_           1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred             CChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence            45679999999999999999999994 5689999998765443   5789999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC--c
Q 016082          186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--V  263 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~--~  263 (395)
                      |||+++|+|.+++......+++..+++++.||++||.|||++||+||||||+||+++.++.+||+|||+++......  .
T Consensus        78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  157 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS  157 (258)
T ss_dssp             EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred             EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence            99999999999988878889999999999999999999999999999999999999999999999999998655433  2


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHH
Q 016082          264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER  342 (395)
Q Consensus       264 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  342 (395)
                      .....||+.|+|||.+.+..|+.++||||||+++|||+| |+.||.+.+..+....+ ..+.++..|..+++++.++|.+
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i-~~~~~~~~p~~~~~~l~~li~~  236 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-AQGLRLYRPHLASEKVYTIMYS  236 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHH
T ss_pred             ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHH-HhCCCCCCcccccHHHHHHHHH
Confidence            334678999999999999999999999999999999998 89999999988766654 4577888999999999999999


Q ss_pred             hhccCCCCCCCHHHHHHHHHH
Q 016082          343 CWQHDPTQRPNFSQITDILKQ  363 (395)
Q Consensus       343 cl~~dp~~RPs~~ell~~l~~  363 (395)
                      ||+.||++|||+++|++.|.+
T Consensus       237 cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         237 CWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             TTCSSGGGSCCHHHHHHHHHC
T ss_pred             HccCCHhHCcCHHHHHHHhhC
Confidence            999999999999999998754

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-58  Score=427.88  Aligned_cols=260  Identities=28%  Similarity=0.560  Sum_probs=222.3

Q ss_pred             cccCccee-eeeeeeCceEEEEEEEC----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Q 016082          108 DAKQLKIE-CKVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  182 (395)
Q Consensus       108 ~~~~~~i~-~~lg~G~~G~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  182 (395)
                      +.+.+.+. ++||+|+||+||+|.+.    ++.||||+++....+....++|.+|+.+|++++||||++++++|..+ ..
T Consensus         4 d~~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~   82 (277)
T d1xbba_           4 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SW   82 (277)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SE
T ss_pred             chhhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CE
Confidence            33444554 47999999999999863    36799999987665666678899999999999999999999999754 57


Q ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC
Q 016082          183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~  262 (395)
                      ++||||+++|+|.++++. ..++++..+..++.||++||.|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus        83 ~lvmE~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~  161 (277)
T d1xbba_          83 MLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE  161 (277)
T ss_dssp             EEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred             EEEEEcCCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccc
Confidence            999999999999999976 5679999999999999999999999999999999999999999999999999998654332


Q ss_pred             ----ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHH
Q 016082          263 ----VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA  337 (395)
Q Consensus       263 ----~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  337 (395)
                          ......||+.|||||++.+..++.++|||||||++|||++ |+.||.+.+..+.... +..+.++..|..+|+++.
T Consensus       162 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~-i~~~~~~~~p~~~~~~~~  240 (277)
T d1xbba_         162 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-LEKGERMGCPAGCPREMY  240 (277)
T ss_dssp             SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCCCCCCTTCCHHHH
T ss_pred             cccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHH-HHcCCCCCCCcccCHHHH
Confidence                1233468999999999999999999999999999999998 8999999888765544 456778889999999999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHH
Q 016082          338 ELLERCWQHDPTQRPNFSQITDILKQMMKEVLY  370 (395)
Q Consensus       338 ~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~~  370 (395)
                      ++|.+||+.||.+|||+++|.+.|++...++.+
T Consensus       241 ~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~  273 (277)
T d1xbba_         241 DLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN  273 (277)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHHhhCHHhhcCC
Confidence            999999999999999999999999988776543

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-57  Score=425.80  Aligned_cols=259  Identities=31%  Similarity=0.610  Sum_probs=223.3

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEECC------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTYCS------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP  179 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~~~------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  179 (395)
                      +|+.+.|++.+.||+|+||.||+|.+.+      ..||||+++... ......+|.+|+.+|++++|||||+++|++.+.
T Consensus         3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~   81 (283)
T d1mqba_           3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY   81 (283)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence            6778899999999999999999998742      369999997653 455567899999999999999999999999999


Q ss_pred             CcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccc
Q 016082          180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  259 (395)
Q Consensus       180 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~  259 (395)
                      +..++||||+.+|++.+++....+.+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+...
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence            99999999999999999998878889999999999999999999999999999999999999999999999999998654


Q ss_pred             cCC----ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHhhhccCCCCCCCCCcH
Q 016082          260 QSG----VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG-ELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP  334 (395)
Q Consensus       260 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (395)
                      ...    ......||+.|||||++.+..++.++|||||||++|||++| .+|+.+.+..+. ...+..+.+++.|..+++
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~  240 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-MKAINDGFRLPTPMDCPS  240 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-HHHHHTTCCCCCCTTCBH
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHH-HHHHhccCCCCCchhhHH
Confidence            332    22334689999999999999999999999999999999995 555666665554 445667788889999999


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 016082          335 RLAELLERCWQHDPTQRPNFSQITDILKQMMK  366 (395)
Q Consensus       335 ~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~  366 (395)
                      ++.++|.+||+.||++|||+.+|++.|+++++
T Consensus       241 ~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         241 AIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence            99999999999999999999999999988876

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-58  Score=426.01  Aligned_cols=250  Identities=25%  Similarity=0.414  Sum_probs=213.1

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec--CCcEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--PPNLCI  184 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  184 (395)
                      .++|++.+.||+|+||.||+|++  +++.||||+++....++...+.+.+|+.+|++++||||+++++++.+  ...+|+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            45899999999999999999988  57899999998887777778889999999999999999999999865  456899


Q ss_pred             EEecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCCCCeeeCCCCcEEEeeecccc
Q 016082          185 VTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNN-----IIHRDLKTANLLMDENGVVKVADFGVAR  256 (395)
Q Consensus       185 V~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~-----iiHrDlkp~NiLl~~~~~vkl~DFg~a~  256 (395)
                      ||||++||+|.+++.+.   .+.+++..++.++.||+.||.|||++|     |+||||||+|||++.++.+||+|||+|+
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            99999999999998643   467999999999999999999999976     9999999999999999999999999998


Q ss_pred             ccccCC-ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHH
Q 016082          257 VQAQSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR  335 (395)
Q Consensus       257 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (395)
                      ...... ......||+.|||||++.+.+|+.++|||||||++|||++|+.||.+.+..+....+.. ...+.+|..+|++
T Consensus       163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~  241 (269)
T d2java1         163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-GKFRRIPYRYSDE  241 (269)
T ss_dssp             HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-TCCCCCCTTSCHH
T ss_pred             ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc-CCCCCCCcccCHH
Confidence            765433 33456899999999999999999999999999999999999999999988877666554 4445678889999


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHH
Q 016082          336 LAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       336 l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      +.++|.+||+.||.+|||+.|+++
T Consensus       242 l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         242 LNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHh
Confidence            999999999999999999999875

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-58  Score=438.14  Aligned_cols=259  Identities=30%  Similarity=0.588  Sum_probs=228.2

Q ss_pred             CceeecccCcceeeeeeeeCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEE
Q 016082          103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG  174 (395)
Q Consensus       103 ~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~  174 (395)
                      ..|+|+.++|++.++||+|+||+||+|++.+       ..||+|.+.... +......+.+|+.+|+++ +|||||++++
T Consensus        30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~  108 (325)
T d1rjba_          30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG  108 (325)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence            4689999999999999999999999998732       259999987543 233456789999999998 8999999999


Q ss_pred             EEecCCcEEEEEecCCCCCHHHHHhhcc----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 016082          175 ACTRPPNLCIVTEFMARGSIYDFLHKQK----------------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHR  232 (395)
Q Consensus       175 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHr  232 (395)
                      ++.+.+.+|+||||++||+|.++++...                      +.+++..++.++.||++||+|||++|||||
T Consensus       109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR  188 (325)
T d1rjba_         109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR  188 (325)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred             EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            9999999999999999999999997653                      347888999999999999999999999999


Q ss_pred             CCCCCCeeeCCCCcEEEeeeccccccccCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCC
Q 016082          233 DLKTANLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYA  308 (395)
Q Consensus       233 Dlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~  308 (395)
                      ||||+|||++.++.+||+|||+|+.......   .....||+.|||||++.+..|+.++|||||||++|||+| |+.||.
T Consensus       189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~  268 (325)
T d1rjba_         189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  268 (325)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence            9999999999999999999999986554432   223457999999999999999999999999999999998 899999


Q ss_pred             CCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 016082          309 GLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK  362 (395)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~  362 (395)
                      +.+..+....++....++..|..+++++.++|.+||+.||++|||++||++.|.
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         269 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             TCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            988777777888888899999999999999999999999999999999999885

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-57  Score=423.48  Aligned_cols=261  Identities=30%  Similarity=0.604  Sum_probs=223.0

Q ss_pred             ceeecccCcceeeeeeeeCceEEEEEEECC-----ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Q 016082          104 VWEIDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR  178 (395)
Q Consensus       104 ~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  178 (395)
                      +|+|+.++|++.+.||+|+||.||+|++..     ..||||.++... .....+.+.+|+.+|++++||||+++++++.+
T Consensus         1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~   79 (273)
T d1mp8a_           1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE   79 (273)
T ss_dssp             CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            489999999999999999999999998742     458899886543 45566789999999999999999999999964


Q ss_pred             CCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccc
Q 016082          179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  258 (395)
Q Consensus       179 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~  258 (395)
                       +.+|+||||+++|+|.+++....+.+++..++.++.||++||.|||++||+||||||+||+++.++.+||+|||+|+..
T Consensus        80 -~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          80 -NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             -SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             -CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheec
Confidence             5789999999999999998887888999999999999999999999999999999999999999999999999999865


Q ss_pred             ccCC--ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHH
Q 016082          259 AQSG--VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR  335 (395)
Q Consensus       259 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (395)
                      ....  ..+...||+.|+|||++.+.+|+.++|||||||++|||++ |.+||.+.+..+....+ ..+.+++.|..+|++
T Consensus       159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i-~~~~~~~~~~~~~~~  237 (273)
T d1mp8a_         159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMPPNCPPT  237 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-HTTCCCCCCTTCCHH
T ss_pred             cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHH
Confidence            5332  2344578999999999999999999999999999999998 89999998887766554 456677889999999


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 016082          336 LAELLERCWQHDPTQRPNFSQITDILKQMMKE  367 (395)
Q Consensus       336 l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~  367 (395)
                      +.++|.+||+.||.+|||+.||++.|++++++
T Consensus       238 ~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         238 LYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            99999999999999999999999999998876

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-57  Score=428.45  Aligned_cols=248  Identities=31%  Similarity=0.517  Sum_probs=219.6

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      +.|++.++||+|+||.||+|++  +++.||||+++...  .+..+.+.+|+.+|++++|||||++++++.+++.+|+|||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE   89 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   89 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence            4689999999999999999998  57889999997653  3345778999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-Ccccc
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTA  266 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-~~~~~  266 (395)
                      |++||+|.+++.+..+++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..... .....
T Consensus        90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~  169 (288)
T d2jfla1          90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS  169 (288)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTC
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccccc
Confidence            99999999998876778999999999999999999999999999999999999999999999999999765433 22345


Q ss_pred             CCCCcccccccccC-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccC-CCCCCCCCcHHHHHHH
Q 016082          267 ETGTYRWMAPEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL-RPTIPKHAHPRLAELL  340 (395)
Q Consensus       267 ~~gt~~y~aPE~~~-----~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li  340 (395)
                      ..||+.|+|||++.     +.+|+.++|||||||++|||++|+.||.+.++.+....+..... ....+..+++++.++|
T Consensus       170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li  249 (288)
T d2jfla1         170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL  249 (288)
T ss_dssp             CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHH
T ss_pred             cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHH
Confidence            68999999999984     56789999999999999999999999999988887776665432 2334567899999999


Q ss_pred             HHhhccCCCCCCCHHHHHH
Q 016082          341 ERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       341 ~~cl~~dp~~RPs~~ell~  359 (395)
                      .+||+.||.+|||+.|+++
T Consensus       250 ~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         250 KKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             HHHSCSSTTTSCCHHHHTT
T ss_pred             HHHccCChhHCcCHHHHhc
Confidence            9999999999999999976

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-58  Score=425.79  Aligned_cols=256  Identities=24%  Similarity=0.401  Sum_probs=215.2

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      ++|++.++||+|+||+||+|++  +++.||||+++.... .+..+.+.+|+.+|++++||||+++++++.+++.+|+|||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            4799999999999999999998  478999999976542 2344678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC---Ccc
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS---GVM  264 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~---~~~  264 (395)
                      |++||+|.+++.. .+.+++..++.++.||++||+|||++||+||||||+|||+++++.+||+|||+|+.....   ...
T Consensus        84 y~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~  162 (271)
T d1nvra_          84 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  162 (271)
T ss_dssp             CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             ccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence            9999999999965 568999999999999999999999999999999999999999999999999999865433   234


Q ss_pred             ccCCCCcccccccccCCCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHhhhccCCCCCCCCCcHHHHHHHHH
Q 016082          265 TAETGTYRWMAPEVIEHKPY-DYKADVFSFGIALWELLTGELPYAGLTPLQA-AVGVVQKSLRPTIPKHAHPRLAELLER  342 (395)
Q Consensus       265 ~~~~gt~~y~aPE~~~~~~~-~~k~DvwslG~vl~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~  342 (395)
                      +...||+.|||||++.+.++ +.++||||+||++|||++|+.||...+.... ................+++++.++|.+
T Consensus       163 ~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  242 (271)
T d1nvra_         163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK  242 (271)
T ss_dssp             CCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHH
T ss_pred             cceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHH
Confidence            55689999999999988876 5789999999999999999999987554332 222233333333345789999999999


Q ss_pred             hhccCCCCCCCHHHHHHHHHHHHHHHHHhhcccc
Q 016082          343 CWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNL  376 (395)
Q Consensus       343 cl~~dp~~RPs~~ell~~l~~~~~~~~~~~~~~~  376 (395)
                      ||+.||++|||+.|+++         +-|+++.+
T Consensus       243 ~L~~dP~~R~t~~eil~---------hpwf~~~l  267 (271)
T d1nvra_         243 ILVENPSARITIPDIKK---------DRWYNKPL  267 (271)
T ss_dssp             HSCSSTTTSCCHHHHTT---------CTTTTCCC
T ss_pred             HcCCChhHCcCHHHHhc---------CHhhCcCC
Confidence            99999999999999876         66765443

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-57  Score=424.58  Aligned_cols=246  Identities=28%  Similarity=0.488  Sum_probs=219.1

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      ++|++.++||+|+||+||+|++  +++.||||+++.....  ..+.+.+|+.+|++++||||+++++++.+++.+|+|||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE   97 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence            4799999999999999999987  5899999999754322  24678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-Ccccc
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTA  266 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-~~~~~  266 (395)
                      |++||+|.+++.+  +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..... .....
T Consensus        98 y~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~  175 (293)
T d1yhwa1          98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  175 (293)
T ss_dssp             CCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred             ecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccc
Confidence            9999999998865  46999999999999999999999999999999999999999999999999999876543 33455


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccC-CCCCCCCCcHHHHHHHHHhhc
Q 016082          267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL-RPTIPKHAHPRLAELLERCWQ  345 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~  345 (395)
                      ..||+.|+|||++.+.+|+.++|||||||++|+|++|+.||.+.+..+....+..... ....+..+++++.++|.+||+
T Consensus       176 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  255 (293)
T d1yhwa1         176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD  255 (293)
T ss_dssp             CCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTC
T ss_pred             cccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHcc
Confidence            6799999999999999999999999999999999999999999888776666554432 344567789999999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 016082          346 HDPTQRPNFSQITD  359 (395)
Q Consensus       346 ~dp~~RPs~~ell~  359 (395)
                      .||.+|||+.|+++
T Consensus       256 ~dP~~R~s~~eil~  269 (293)
T d1yhwa1         256 MDVEKRGSAKELLQ  269 (293)
T ss_dssp             SSTTTSCCHHHHTT
T ss_pred             CChhHCcCHHHHhc
Confidence            99999999999876

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-56  Score=424.34  Aligned_cols=246  Identities=30%  Similarity=0.456  Sum_probs=220.3

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      +.|++.++||+|+||.||+|++  +++.||||+++..... ....+.+.+|+.+|++++|||||++++++.+++.+|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            3599999999999999999997  5788999999876543 445678999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCcccc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA  266 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~  266 (395)
                      ||+.||+|..++.. .+++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....   ..
T Consensus        95 E~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---~~  170 (309)
T d1u5ra_          95 EYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NS  170 (309)
T ss_dssp             ECCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---CC
T ss_pred             EecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC---Cc
Confidence            99999998766654 578999999999999999999999999999999999999999999999999999865432   45


Q ss_pred             CCCCcccccccccCC---CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHh
Q 016082          267 ETGTYRWMAPEVIEH---KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC  343 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~---~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  343 (395)
                      ..||+.|||||++.+   .+|+.++|||||||++|||++|+.||.+.+..+....+......+..+..+|+++.+||.+|
T Consensus       171 ~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~  250 (309)
T d1u5ra_         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC  250 (309)
T ss_dssp             CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHH
T ss_pred             cccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Confidence            689999999999864   46899999999999999999999999999988887777776666666678999999999999


Q ss_pred             hccCCCCCCCHHHHHH
Q 016082          344 WQHDPTQRPNFSQITD  359 (395)
Q Consensus       344 l~~dp~~RPs~~ell~  359 (395)
                      |+.||.+|||+.|+++
T Consensus       251 L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         251 LQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             TCSSGGGSCCHHHHTT
T ss_pred             CcCChhHCcCHHHHHh
Confidence            9999999999999975

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-57  Score=419.55  Aligned_cols=255  Identities=35%  Similarity=0.690  Sum_probs=222.3

Q ss_pred             eeecccCcceeeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec-CCcEE
Q 016082          105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-PPNLC  183 (395)
Q Consensus       105 ~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~  183 (395)
                      |+|+.++|++.++||+|+||.||+|++.++.||||+++.+.    ..+.+.+|+.++++++||||++++|+|.+ .+.+|
T Consensus         2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~   77 (262)
T d1byga_           2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY   77 (262)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred             CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence            89999999999999999999999999999999999997653    34678999999999999999999999855 45689


Q ss_pred             EEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC
Q 016082          184 IVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~  262 (395)
                      +||||+++|+|.+++.+.. ..+++..++.++.||+.||.|||+++|+||||||+||+++.++.+|++|||+++..... 
T Consensus        78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-  156 (262)
T d1byga_          78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  156 (262)
T ss_dssp             EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC-
Confidence            9999999999999997643 46899999999999999999999999999999999999999999999999999865433 


Q ss_pred             ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHH
Q 016082          263 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE  341 (395)
Q Consensus       263 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  341 (395)
                       .....+|..|+|||++.+..++.++||||||+++|||+| |++||...+..+.... +..+.+++.|..+++++.++|.
T Consensus       157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~-i~~~~~~~~~~~~~~~~~~li~  234 (262)
T d1byga_         157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMDAPDGCPPAVYEVMK  234 (262)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH-HTTTCCCCCCTTCCHHHHHHHH
T ss_pred             -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHH-HHcCCCCCCCccCCHHHHHHHH
Confidence             344578999999999999999999999999999999998 7999998887776655 4557888999999999999999


Q ss_pred             HhhccCCCCCCCHHHHHHHHHHHHH
Q 016082          342 RCWQHDPTQRPNFSQITDILKQMMK  366 (395)
Q Consensus       342 ~cl~~dp~~RPs~~ell~~l~~~~~  366 (395)
                      +||+.||.+|||+.++++.|++++.
T Consensus       235 ~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         235 NCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHcccCHhHCcCHHHHHHHHHHHHh
Confidence            9999999999999999999998865

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.2e-57  Score=426.52  Aligned_cols=248  Identities=22%  Similarity=0.415  Sum_probs=203.7

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      +.|++.+.||+|+||+||+|++  +++.||||+++...... ....+.+|+.+|++++||||+++++++.+++.+|+|||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            5699999999999999999998  47889999997664332 34568899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeC---CCCcEEEeeeccccccccCCcc
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD---ENGVVKVADFGVARVQAQSGVM  264 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~---~~~~vkl~DFg~a~~~~~~~~~  264 (395)
                      |++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+.   +++.+||+|||+|+........
T Consensus        88 ~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~  166 (307)
T d1a06a_          88 LVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL  166 (307)
T ss_dssp             CCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred             ccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCee
Confidence            9999999999976 56899999999999999999999999999999999999995   5789999999999877666656


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCC--CCCCCCcHHHHHHHHH
Q 016082          265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP--TIPKHAHPRLAELLER  342 (395)
Q Consensus       265 ~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~  342 (395)
                      ....||+.|||||++.+.+|+.++|||||||++|+|++|+.||.+.+..+....+.......  +.+..+|+++.++|.+
T Consensus       167 ~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  246 (307)
T d1a06a_         167 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH  246 (307)
T ss_dssp             ------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHH
T ss_pred             eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHH
Confidence            66789999999999999999999999999999999999999999988887777766554433  3446789999999999


Q ss_pred             hhccCCCCCCCHHHHHH
Q 016082          343 CWQHDPTQRPNFSQITD  359 (395)
Q Consensus       343 cl~~dp~~RPs~~ell~  359 (395)
                      ||++||.+|||+.|+++
T Consensus       247 ~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         247 LMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             HSCSSGGGSCCHHHHHH
T ss_pred             HccCCHhHCcCHHHHhc
Confidence            99999999999999987

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-56  Score=416.28  Aligned_cols=246  Identities=29%  Similarity=0.530  Sum_probs=212.9

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec----CCcEEE
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR----PPNLCI  184 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l  184 (395)
                      -|++.++||+|+||+||+|++  +++.||+|+++.........+.+.+|+++|++++||||+++++++..    ...+|+
T Consensus        10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence            357888999999999999998  46789999998776667777889999999999999999999999864    345899


Q ss_pred             EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCeeeC-CCCcEEEeeeccccccccC
Q 016082          185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMD-ENGVVKVADFGVARVQAQS  261 (395)
Q Consensus       185 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--iiHrDlkp~NiLl~-~~~~vkl~DFg~a~~~~~~  261 (395)
                      ||||++||+|.+++.+ .+.+++..+..++.||++||+|||+++  |+||||||+|||++ +++.+||+|||+|+.....
T Consensus        90 vmE~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~  168 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  168 (270)
T ss_dssp             EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             EEeCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence            9999999999999976 567999999999999999999999998  99999999999997 5789999999999865443


Q ss_pred             CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC-CCCCCCCcHHHHHHH
Q 016082          262 GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR-PTIPKHAHPRLAELL  340 (395)
Q Consensus       262 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li  340 (395)
                       ......||+.|||||++.+ +|+.++|||||||++|||++|+.||.+..........+....+ +..+...++++.++|
T Consensus       169 -~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li  246 (270)
T d1t4ha_         169 -FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII  246 (270)
T ss_dssp             -SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHH
T ss_pred             -ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHH
Confidence             3345689999999999876 5999999999999999999999999876655544444443333 345667899999999


Q ss_pred             HHhhccCCCCCCCHHHHHH
Q 016082          341 ERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       341 ~~cl~~dp~~RPs~~ell~  359 (395)
                      .+||++||++|||+.|+++
T Consensus       247 ~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         247 EGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             HHHSCSSGGGSCCHHHHHT
T ss_pred             HHHccCCHhHCcCHHHHhC
Confidence            9999999999999999976

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-57  Score=426.00  Aligned_cols=248  Identities=22%  Similarity=0.401  Sum_probs=218.6

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  185 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  185 (395)
                      .++|++.+.||+|+||+||+|++  +++.||||++++... +....+.+.+|+.+|++++||||+++++++.+++.+|+|
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv   86 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG   86 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence            45899999999999999999998  478999999974321 222346799999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC---
Q 016082          186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---  262 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~---  262 (395)
                      |||++||+|.+++.. .+.+++..++.++.|++.||+|||++||+||||||+|||+++++.+||+|||+|+......   
T Consensus        87 mEy~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~  165 (288)
T d1uu3a_          87 LSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  165 (288)
T ss_dssp             ECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             EEccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence            999999999999876 5789999999999999999999999999999999999999999999999999998764322   


Q ss_pred             ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHH
Q 016082          263 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER  342 (395)
Q Consensus       263 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  342 (395)
                      ......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+...  .+.+|..+++++.++|.+
T Consensus       166 ~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~  243 (288)
T d1uu3a_         166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--EYDFPEKFFPKARDLVEK  243 (288)
T ss_dssp             ----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT--CCCCCTTCCHHHHHHHHT
T ss_pred             ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC--CCCCCccCCHHHHHHHHH
Confidence            234467999999999999999999999999999999999999999998888777666543  456778899999999999


Q ss_pred             hhccCCCCCCCHHHHHH
Q 016082          343 CWQHDPTQRPNFSQITD  359 (395)
Q Consensus       343 cl~~dp~~RPs~~ell~  359 (395)
                      ||+.||.+|||++|+++
T Consensus       244 ~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         244 LLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             TSCSSGGGSTTSGGGTC
T ss_pred             HccCCHhHCcCHHHHcC
Confidence            99999999999999765

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.4e-56  Score=429.08  Aligned_cols=248  Identities=22%  Similarity=0.364  Sum_probs=224.2

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      ++|++.+.||+|+||.||+|++  +++.||||++....  ....+.+.+|+.+|++++||||+++++++.+.+.+|+|||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE  103 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  103 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            5899999999999999999998  58899999997653  4456789999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCC--CCcEEEeeeccccccccCCccc
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE--NGVVKVADFGVARVQAQSGVMT  265 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~--~~~vkl~DFg~a~~~~~~~~~~  265 (395)
                      |++||+|.+++....+++++..+..++.||+.||.|||++|||||||||+|||++.  ++.+||+|||+|+.........
T Consensus       104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~  183 (350)
T d1koaa2         104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK  183 (350)
T ss_dssp             CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEE
T ss_pred             cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccc
Confidence            99999999999776778999999999999999999999999999999999999964  6789999999998877666666


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCC--CCCCCcHHHHHHHHHh
Q 016082          266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT--IPKHAHPRLAELLERC  343 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~c  343 (395)
                      ...||+.|||||++.+.+|+.++|||||||++|+|++|+.||.+.+..+....+........  ....+++++.+||.+|
T Consensus       184 ~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  263 (350)
T d1koaa2         184 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKL  263 (350)
T ss_dssp             EECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHH
T ss_pred             eecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHH
Confidence            77899999999999999999999999999999999999999999988887777665544322  2356899999999999


Q ss_pred             hccCCCCCCCHHHHHH
Q 016082          344 WQHDPTQRPNFSQITD  359 (395)
Q Consensus       344 l~~dp~~RPs~~ell~  359 (395)
                      |+.||.+|||+.|+++
T Consensus       264 L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         264 LLADPNTRMTIHQALE  279 (350)
T ss_dssp             CCSSGGGSCCHHHHHH
T ss_pred             ccCChhHCcCHHHHhc
Confidence            9999999999999987

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-56  Score=419.52  Aligned_cols=258  Identities=22%  Similarity=0.388  Sum_probs=225.8

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCH----HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT----EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  183 (395)
                      ++|++.+.||+|+||.||+|++  +++.||||++++.....    ...+.+.+|+.+|++++|||||++++++.++..+|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            5799999999999999999998  47899999997554322    23578999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCC----cEEEeeeccccccc
Q 016082          184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG----VVKVADFGVARVQA  259 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~----~vkl~DFg~a~~~~  259 (395)
                      +||||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++    .+|++|||+|+...
T Consensus        90 iv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~  168 (293)
T d1jksa_          90 LILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  168 (293)
T ss_dssp             EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred             EEEEcCCCccccchhcc-ccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence            99999999999999976 46799999999999999999999999999999999999998876    59999999998877


Q ss_pred             cCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCC--CCCCCCcHHHH
Q 016082          260 QSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP--TIPKHAHPRLA  337 (395)
Q Consensus       260 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~  337 (395)
                      .........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+....+.......  ..+..+|+++.
T Consensus       169 ~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  248 (293)
T d1jksa_         169 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK  248 (293)
T ss_dssp             TSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHH
T ss_pred             CCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHH
Confidence            6666667789999999999999999999999999999999999999999998888776665543322  23467899999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhccccc
Q 016082          338 ELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLI  377 (395)
Q Consensus       338 ~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~~~~~~~~~  377 (395)
                      ++|.+||+.||.+|||++|+++         +-|+.+...
T Consensus       249 ~li~~~L~~dP~~R~s~~eil~---------hp~~~~~~~  279 (293)
T d1jksa_         249 DFIRRLLVKDPKKRMTIQDSLQ---------HPWIKPKDT  279 (293)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHH---------STTTCC---
T ss_pred             HHHHHHccCChhHCcCHHHHhc---------CcccCCCCh
Confidence            9999999999999999999987         566655433

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-56  Score=417.31  Aligned_cols=259  Identities=36%  Similarity=0.681  Sum_probs=219.8

Q ss_pred             CCceeecccCcceeeeeeeeCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 016082          102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  180 (395)
Q Consensus       102 ~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (395)
                      .+.|+|+.++|++.++||+|+||.||+|++. ++.||||+++....+.   +.|.+|+.+|++++|||||++++++.+ +
T Consensus         9 ~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~g~~~~-~   84 (285)
T d1fmka3           9 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVSE-E   84 (285)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             CcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCH---HHHHHHHHHHHhcccCCEeEEEEEEec-C
Confidence            4679999999999999999999999999984 4679999998665443   679999999999999999999999865 5


Q ss_pred             cEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  259 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~  259 (395)
                      ..++||||+++|+|..++... .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus        85 ~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~  164 (285)
T d1fmka3          85 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE  164 (285)
T ss_dssp             SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhcc
Confidence            689999999999999998654 4679999999999999999999999999999999999999999999999999998664


Q ss_pred             cCC--ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHH
Q 016082          260 QSG--VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG-ELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  336 (395)
Q Consensus       260 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  336 (395)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||++| .+|+.+....+.. ..+....+++.+..+++++
T Consensus       165 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~-~~i~~~~~~~~~~~~~~~l  243 (285)
T d1fmka3         165 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-DQVERGYRMPCPPECPESL  243 (285)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-HHHHTTCCCCCCTTSCHHH
T ss_pred             CCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHH-HHHHhcCCCCCCcccCHHH
Confidence            332  33446789999999999999999999999999999999995 5555665555444 4455677888899999999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 016082          337 AELLERCWQHDPTQRPNFSQITDILKQMM  365 (395)
Q Consensus       337 ~~li~~cl~~dp~~RPs~~ell~~l~~~~  365 (395)
                      .++|.+||+.||++|||+++|++.|+..+
T Consensus       244 ~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         244 HDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             HHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence            99999999999999999999988776543

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-56  Score=417.82  Aligned_cols=258  Identities=32%  Similarity=0.639  Sum_probs=221.4

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEECC-----ceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP  179 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~~~-----~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  179 (395)
                      -|+.++|++.+.||+|+||.||+|++.+     ..||||++++... .++..++|.+|+.+|++++||||++++|+|.++
T Consensus         4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~   83 (273)
T d1u46a_           4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP   83 (273)
T ss_dssp             ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             EEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec
Confidence            4677899999999999999999998732     3699999986654 344567899999999999999999999999764


Q ss_pred             CcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccc
Q 016082          180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  259 (395)
Q Consensus       180 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~  259 (395)
                       ..++||||+++|++.+++..+.+.+++..++.++.||++||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus        84 -~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          84 -PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             -SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             -chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence             6789999999999999998878889999999999999999999999999999999999999999999999999998765


Q ss_pred             cCCc----cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcH
Q 016082          260 QSGV----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP  334 (395)
Q Consensus       260 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (395)
                      ....    .....|+..|+|||++.+..++.++||||||+++|||+| |+.||.+.+..+....+.....+++.+..+|+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  242 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ  242 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred             cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccH
Confidence            4332    223457889999999999999999999999999999998 89999999999988888888888999999999


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 016082          335 RLAELLERCWQHDPTQRPNFSQITDILKQM  364 (395)
Q Consensus       335 ~l~~li~~cl~~dp~~RPs~~ell~~l~~~  364 (395)
                      ++.++|.+||+.||++|||+.+|.+.|+++
T Consensus       243 ~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         243 DIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            999999999999999999999999888764

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-56  Score=427.13  Aligned_cols=257  Identities=25%  Similarity=0.441  Sum_probs=216.0

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  183 (395)
                      ++..++|++.++||+|+||+||+|++  +++.||+|+++... .......+.+|+.+|++++|||||+++++|.++.++|
T Consensus         2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   80 (322)
T d1s9ja_           2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   80 (322)
T ss_dssp             CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred             CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            46678999999999999999999998  57899999997653 3445578999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeeeCCCCcEEEeeeccccccccCC
Q 016082          184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~  262 (395)
                      +||||++||+|.+++.+ .+.+++..+..++.|++.||.|||+ +||+||||||+|||++.+|.+||+|||+|+......
T Consensus        81 iVmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  159 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  159 (322)
T ss_dssp             EEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred             EEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc
Confidence            99999999999999976 5679999999999999999999997 599999999999999999999999999998654432


Q ss_pred             ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------------------------
Q 016082          263 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG------------------------  318 (395)
Q Consensus       263 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~------------------------  318 (395)
                       .+...||+.|+|||++.+.+|+.++||||+||++|||++|+.||.+.+..+....                        
T Consensus       160 -~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (322)
T d1s9ja_         160 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS  238 (322)
T ss_dssp             -C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred             -cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence             3456899999999999999999999999999999999999999976543221110                        


Q ss_pred             -----------------hhhccCCCCCC-CCCcHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHHH
Q 016082          319 -----------------VVQKSLRPTIP-KHAHPRLAELLERCWQHDPTQRPNFSQITD--ILKQMM  365 (395)
Q Consensus       319 -----------------~~~~~~~~~~~-~~~~~~l~~li~~cl~~dp~~RPs~~ell~--~l~~~~  365 (395)
                                       .......+..+ ...|+++.++|.+||+.||.+|||++|+++  .+++..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~  305 (322)
T d1s9ja_         239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  305 (322)
T ss_dssp             -------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             ccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence                             00111112222 236889999999999999999999999987  455433

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=8.7e-56  Score=426.58  Aligned_cols=248  Identities=19%  Similarity=0.386  Sum_probs=224.4

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      ++|++.+.||+|+||.||+|++  +++.||||+++...  ......+.+|+.+|++++||||+++++++.++..+|+|||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE  106 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  106 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            5799999999999999999998  57899999998653  3345678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeC--CCCcEEEeeeccccccccCCccc
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD--ENGVVKVADFGVARVQAQSGVMT  265 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~--~~~~vkl~DFg~a~~~~~~~~~~  265 (395)
                      |++||+|.+++.....++++..++.++.||+.||.|||++||+||||||+|||++  .++.+||+|||+|+.........
T Consensus       107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~  186 (352)
T d1koba_         107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK  186 (352)
T ss_dssp             CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred             cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCcee
Confidence            9999999998877677899999999999999999999999999999999999998  57899999999999877666666


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC--CCCCCCCcHHHHHHHHHh
Q 016082          266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLAELLERC  343 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~c  343 (395)
                      ...||+.|+|||++.+.+|+.++|||||||++|+|++|+.||.+.+..+....+......  ...+..+++++.+||.+|
T Consensus       187 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  266 (352)
T d1koba_         187 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNL  266 (352)
T ss_dssp             EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTT
T ss_pred             eccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHH
Confidence            778999999999999999999999999999999999999999999888877766654433  334467899999999999


Q ss_pred             hccCCCCCCCHHHHHH
Q 016082          344 WQHDPTQRPNFSQITD  359 (395)
Q Consensus       344 l~~dp~~RPs~~ell~  359 (395)
                      |+.||.+|||+.|+++
T Consensus       267 L~~dp~~R~s~~eil~  282 (352)
T d1koba_         267 LQKEPRKRLTVHDALE  282 (352)
T ss_dssp             SCSSGGGSCCHHHHHT
T ss_pred             ccCChhHCcCHHHHhc
Confidence            9999999999999986

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-56  Score=418.45  Aligned_cols=266  Identities=30%  Similarity=0.605  Sum_probs=224.3

Q ss_pred             CCceeecccCcceeeeeeeeCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEE
Q 016082          102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFI  173 (395)
Q Consensus       102 ~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~  173 (395)
                      .+.|+|+.++|++.++||+|+||.||+|++.       ++.||||+++... .....+.+.+|..++.++ +|+||+.++
T Consensus         5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~   83 (299)
T d1ywna1           5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL   83 (299)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence            3579999999999999999999999999873       2579999997654 344567788888888887 589999999


Q ss_pred             EEEecCC-cEEEEEecCCCCCHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 016082          174 GACTRPP-NLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA  237 (395)
Q Consensus       174 ~~~~~~~-~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~  237 (395)
                      +++...+ .+++||||+++|+|.++++...               ..+++..+..++.||++||.|||++||+||||||+
T Consensus        84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~  163 (299)
T d1ywna1          84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR  163 (299)
T ss_dssp             EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcc
Confidence            9986654 6899999999999999997642               34889999999999999999999999999999999


Q ss_pred             CeeeCCCCcEEEeeeccccccccCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhC-CCCCCCCCHH
Q 016082          238 NLLMDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG-ELPYAGLTPL  313 (395)
Q Consensus       238 NiLl~~~~~vkl~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg-~~pf~~~~~~  313 (395)
                      |||++.++.+||+|||+|+......   ......||+.|+|||++.+..++.++|||||||++|||++| .+||.+....
T Consensus       164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~  243 (299)
T d1ywna1         164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  243 (299)
T ss_dssp             GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999998654332   23345799999999999999999999999999999999985 6789887776


Q ss_pred             HHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHH
Q 016082          314 QAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  368 (395)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~  368 (395)
                      +.....+..+.++..|..+++++.++|.+||+.||.+|||+.|+++.|+++++..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n  298 (299)
T d1ywna1         244 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  298 (299)
T ss_dssp             HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence            7777777788889999999999999999999999999999999999999998753

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-55  Score=417.03  Aligned_cols=260  Identities=30%  Similarity=0.573  Sum_probs=229.0

Q ss_pred             ceeecccCcceeeeeeeeCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEE
Q 016082          104 VWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC  176 (395)
Q Consensus       104 ~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  176 (395)
                      .++++.++|++.++||+|+||+||+|++.+       +.||||+++... ..+..++|.+|+.+|++++||||++++++|
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            467788899999999999999999998743       679999997653 455678899999999999999999999999


Q ss_pred             ecCCcEEEEEecCCCCCHHHHHhhcc-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Q 016082          177 TRPPNLCIVTEFMARGSIYDFLHKQK-----------------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD  233 (395)
Q Consensus       177 ~~~~~~~lV~E~~~ggsL~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrD  233 (395)
                      ......++||||+++|+|.++++...                       ..+++..++.++.|++.||+|||+++|||||
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD  165 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD  165 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence            99999999999999999999997532                       2478889999999999999999999999999


Q ss_pred             CCCCCeeeCCCCcEEEeeeccccccccCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCC-CCCCC
Q 016082          234 LKTANLLMDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE-LPYAG  309 (395)
Q Consensus       234 lkp~NiLl~~~~~vkl~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~-~pf~~  309 (395)
                      |||+|||++.++.+||+|||+|+......   ..+...||+.|+|||.+.+..|+.++|||||||++|||++|. +||.+
T Consensus       166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~  245 (301)
T d1lufa_         166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  245 (301)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence            99999999999999999999998654332   233457889999999999999999999999999999999985 78998


Q ss_pred             CCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 016082          310 LTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM  365 (395)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~  365 (395)
                      .+..+.... +..+.++..|..+++++.++|.+||+.||.+||||.||++.|+++.
T Consensus       246 ~~~~e~~~~-v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         246 MAHEEVIYY-VRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             SCHHHHHHH-HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCHHHHHHH-HHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            888877665 4456678889999999999999999999999999999999998864

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-55  Score=413.84  Aligned_cols=261  Identities=31%  Similarity=0.634  Sum_probs=228.1

Q ss_pred             ceeecccCcceeeeeeeeCceEEEEEEECC---------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEE
Q 016082          104 VWEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFI  173 (395)
Q Consensus       104 ~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~~---------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~  173 (395)
                      .|+|+.++|.+.+.||+|+||.||+|++.+         ..||||+++... ......++.+|...+.++ +||||++++
T Consensus         7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~   85 (299)
T d1fgka_           7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLL   85 (299)
T ss_dssp             TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence            499999999999999999999999998632         369999998764 455567889999999888 799999999


Q ss_pred             EEEecCCcEEEEEecCCCCCHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 016082          174 GACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN  238 (395)
Q Consensus       174 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~N  238 (395)
                      ++|.+++..++||||+++|+|.+++..+.               ..+++..++.++.||+.||+|||+++||||||||+|
T Consensus        86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N  165 (299)
T d1fgka_          86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN  165 (299)
T ss_dssp             EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence            99999999999999999999999997653               358999999999999999999999999999999999


Q ss_pred             eeeCCCCcEEEeeeccccccccCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 016082          239 LLMDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQ  314 (395)
Q Consensus       239 iLl~~~~~vkl~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~  314 (395)
                      ||++.++.+||+|||+++......   ......||+.|+|||.+.+++|+.++||||||+++|||++ |.+||.+.+..+
T Consensus       166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~  245 (299)
T d1fgka_         166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  245 (299)
T ss_dssp             EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence            999999999999999998665433   2334578999999999999999999999999999999998 799999888776


Q ss_pred             HHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 016082          315 AAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK  366 (395)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~  366 (395)
                      .. ..+..+.++..|..+++++.++|.+||+.||.+|||+.||++.|++++.
T Consensus       246 ~~-~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         246 LF-KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             HH-HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HH-HHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence            54 4556678889999999999999999999999999999999999988865

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-55  Score=422.02  Aligned_cols=250  Identities=22%  Similarity=0.437  Sum_probs=222.6

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  183 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  183 (395)
                      |..++|++.+.||+|+||.||+|++  +++.||||++++... ..+..+.+.+|+.+|++++||||+++++++.+...+|
T Consensus         2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   81 (337)
T d1o6la_           2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence            4457899999999999999999997  578999999975422 1223567889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc-CC
Q 016082          184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SG  262 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~-~~  262 (395)
                      +||||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... ..
T Consensus        82 iv~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          82 FVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             cceeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence            99999999999999977 56799999999999999999999999999999999999999999999999999986544 33


Q ss_pred             ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHH
Q 016082          263 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER  342 (395)
Q Consensus       263 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  342 (395)
                      .....+||+.|+|||++.+.+|+.++||||+||++|||++|++||.+.+..+....+...  .+..|..+|+++.+||.+
T Consensus       161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~dli~~  238 (337)
T d1o6la_         161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLLAG  238 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHHH
T ss_pred             ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC--CCCCCccCCHHHHHHHHh
Confidence            445568999999999999999999999999999999999999999999988776665543  456788999999999999


Q ss_pred             hhccCCCCCCC-----HHHHHH
Q 016082          343 CWQHDPTQRPN-----FSQITD  359 (395)
Q Consensus       343 cl~~dp~~RPs-----~~ell~  359 (395)
                      ||++||.+||+     ++|+++
T Consensus       239 ~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         239 LLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HTCSSTTTSTTCSTTTHHHHHT
T ss_pred             hccCCchhhcccccccHHHHHc
Confidence            99999999995     777776

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-55  Score=418.31  Aligned_cols=264  Identities=28%  Similarity=0.584  Sum_probs=227.0

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEEC--Cc----eEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTYC--SQ----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  180 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~~--~~----~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (395)
                      +..++|++.++||+|+||+||+|++.  ++    +||+|.++... +....++|.+|+.+|++++|||||+++|+|.++ 
T Consensus         6 ~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-   83 (317)
T d1xkka_           6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   83 (317)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred             CCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence            34568999999999999999999874  33    58999987543 334467899999999999999999999999875 


Q ss_pred             cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccccc
Q 016082          181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  260 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~  260 (395)
                      ..++++|++.+|+|.+++......+++..++.++.||++||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus        84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            57888999999999999988888999999999999999999999999999999999999999999999999999987654


Q ss_pred             CCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHH
Q 016082          261 SGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  336 (395)
Q Consensus       261 ~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  336 (395)
                      ...   .....||+.|+|||++.++.|+.++|||||||++|||+| |.+||.+.+..+.. ..+..+.+++.|..+++++
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~-~~i~~~~~~~~p~~~~~~~  242 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQPPICTIDV  242 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH-HHHHHTCCCCCCTTBCHHH
T ss_pred             ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH-HHHHcCCCCCCCcccCHHH
Confidence            322   233468999999999999999999999999999999998 89999998776654 4456678888899999999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc
Q 016082          337 AELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLS  373 (395)
Q Consensus       337 ~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~~~~~  373 (395)
                      .++|.+||+.||.+|||+.||++.|..+.++...++.
T Consensus       243 ~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~~~~~~  279 (317)
T d1xkka_         243 YMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLV  279 (317)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSHHHHBC
T ss_pred             HHHHHHhCCCChhhCcCHHHHHHHHHHHHhChHhhcc
Confidence            9999999999999999999999999998887665543

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-55  Score=415.41  Aligned_cols=265  Identities=31%  Similarity=0.636  Sum_probs=237.5

Q ss_pred             CceeecccCcceeeeeeeeCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEE
Q 016082          103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG  174 (395)
Q Consensus       103 ~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~  174 (395)
                      ..|+|+.++|++.++||+|+||.||+|++.       ++.||||+++... ......++.+|+.+++++ +|||||++++
T Consensus        16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g   94 (311)
T d1t46a_          16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLG   94 (311)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence            369999999999999999999999999862       3579999998764 445567899999999999 6999999999


Q ss_pred             EEecCCcEEEEEecCCCCCHHHHHhhcc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 016082          175 ACTRPPNLCIVTEFMARGSIYDFLHKQK-----------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA  237 (395)
Q Consensus       175 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~-----------------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~  237 (395)
                      +|.+++..++||||+++|+|.++++...                 ..+++..+..++.||++||.|||++||+||||||+
T Consensus        95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~  174 (311)
T d1t46a_          95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR  174 (311)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence            9999999999999999999999997643                 25889999999999999999999999999999999


Q ss_pred             CeeeCCCCcEEEeeeccccccccCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 016082          238 NLLMDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPL  313 (395)
Q Consensus       238 NiLl~~~~~vkl~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~ellt-g~~pf~~~~~~  313 (395)
                      ||+++.++.++++|||.++......   ......||+.|+|||.+.+..++.++|||||||++|||+| |.+||.+....
T Consensus       175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~  254 (311)
T d1t46a_         175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (311)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999998665432   2234578999999999999999999999999999999998 77888887777


Q ss_pred             HHHHHhhhccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHH
Q 016082          314 QAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  368 (395)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~  368 (395)
                      .....++..+.++..|..+++++.++|.+||+.||.+|||+++|++.|++++++.
T Consensus       255 ~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~  309 (311)
T d1t46a_         255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (311)
T ss_dssp             HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccC
Confidence            7777788888999999999999999999999999999999999999999988873

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-55  Score=418.11  Aligned_cols=267  Identities=31%  Similarity=0.583  Sum_probs=230.0

Q ss_pred             eecccCcceeeeeeeeCceEEEEEEEC--Cc--eEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCC
Q 016082          106 EIDAKQLKIECKVASGSYGDLYKGTYC--SQ--EVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPP  180 (395)
Q Consensus       106 ~i~~~~~~i~~~lg~G~~G~Vy~~~~~--~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  180 (395)
                      .|+.++|++.++||+|+||+||+|++.  +.  .||||.++... ..+..+.|.+|+.+|+++ +||||+++++++.+.+
T Consensus         6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~   84 (309)
T d1fvra_           6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   84 (309)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred             ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence            477899999999999999999999883  33  57888876443 233456899999999998 7999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHhhc---------------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCC
Q 016082          181 NLCIVTEFMARGSIYDFLHKQ---------------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG  245 (395)
Q Consensus       181 ~~~lV~E~~~ggsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~  245 (395)
                      .+++||||++||+|.++++..               ...+++..+..++.||+.||.|||+++|+||||||+|||++.++
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~  164 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  164 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence            999999999999999999754               36789999999999999999999999999999999999999999


Q ss_pred             cEEEeeeccccccccCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHhhhccC
Q 016082          246 VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG-ELPYAGLTPLQAAVGVVQKSL  324 (395)
Q Consensus       246 ~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg-~~pf~~~~~~~~~~~~~~~~~  324 (395)
                      .+||+|||+|+............||..|+|||.+.+..|+.++|||||||++|||++| .+||.+.+..+....+ ..+.
T Consensus       165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i-~~~~  243 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-PQGY  243 (309)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG-GGTC
T ss_pred             ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH-HhcC
Confidence            9999999999876665555566799999999999999999999999999999999996 5689888887766654 4567


Q ss_pred             CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcc
Q 016082          325 RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSP  374 (395)
Q Consensus       325 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~~~~~~  374 (395)
                      ++..|..+++++.++|.+||+.||++|||+.++++.|++++++....++.
T Consensus       244 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~~~~~  293 (309)
T d1fvra_         244 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNT  293 (309)
T ss_dssp             CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSBCC
T ss_pred             CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcCCCCC
Confidence            88889999999999999999999999999999999999998866544443

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2e-54  Score=403.91  Aligned_cols=249  Identities=22%  Similarity=0.356  Sum_probs=221.4

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCC-------HHHHHHHHHHHHHHHhcC-CCceeeEEEEEecC
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-------TEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRP  179 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~-------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  179 (395)
                      ++|++.+.||+|+||+||+|++  +++.||||+++.....       ....+.+.+|+.+|++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            5899999999999999999998  6789999999765432       123456889999999997 99999999999999


Q ss_pred             CcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccc
Q 016082          180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  259 (395)
Q Consensus       180 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~  259 (395)
                      +..||||||++||+|.++++. ++++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  161 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD  161 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             cceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence            999999999999999999976 5689999999999999999999999999999999999999999999999999999877


Q ss_pred             cCCccccCCCCcccccccccC------CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCC--CCCC
Q 016082          260 QSGVMTAETGTYRWMAPEVIE------HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT--IPKH  331 (395)
Q Consensus       260 ~~~~~~~~~gt~~y~aPE~~~------~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~  331 (395)
                      .....+...||+.|+|||.+.      ...++.++||||+||++|+|++|+.||.+.++......+......+.  ...+
T Consensus       162 ~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  241 (277)
T d1phka_         162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD  241 (277)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGG
T ss_pred             CCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCccccc
Confidence            666666778999999999985      34578999999999999999999999999998877766665544433  3347


Q ss_pred             CcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          332 AHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       332 ~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      +|+++.+++.+||+.||++|||+.|+++
T Consensus       242 ~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         242 YSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             SCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            8999999999999999999999999976

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.7e-54  Score=404.60  Aligned_cols=256  Identities=26%  Similarity=0.442  Sum_probs=218.2

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC----c
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP----N  181 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~  181 (395)
                      .++|++.+.||+|+||.||+|++  +++.||||+++.... +......+.+|+.+|++++||||+++++++....    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            35799999999999999999997  588999999987654 4556678999999999999999999999987654    3


Q ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC
Q 016082          182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  261 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~  261 (395)
                      +|+||||++||+|.+++.. .+++++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||.++.....
T Consensus        86 ~~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~  164 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS  164 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred             EEEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence            8999999999999998876 567999999999999999999999999999999999999999999999999998754332


Q ss_pred             C----ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCC--CCCCCCcHH
Q 016082          262 G----VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP--TIPKHAHPR  335 (395)
Q Consensus       262 ~----~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  335 (395)
                      .    ......||+.|+|||++.+.+|+.++|||||||++|+|+||++||.+.++.+...........+  .....+|++
T Consensus       165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  244 (277)
T d1o6ya_         165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD  244 (277)
T ss_dssp             --------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHH
T ss_pred             cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHH
Confidence            2    3344579999999999999999999999999999999999999999999888777766654443  234678999


Q ss_pred             HHHHHHHhhccCCCCCC-CHHHHHHHHHHHH
Q 016082          336 LAELLERCWQHDPTQRP-NFSQITDILKQMM  365 (395)
Q Consensus       336 l~~li~~cl~~dp~~RP-s~~ell~~l~~~~  365 (395)
                      +.++|.+||++||.+|| |++++++.|.+++
T Consensus       245 l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         245 LDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             HHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             HHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            99999999999999999 8999998887764

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.9e-55  Score=415.52  Aligned_cols=245  Identities=26%  Similarity=0.475  Sum_probs=219.7

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      ++|++.+.||+|+||+||+|++  +++.||||+++.... .....+.+.+|+.+|++++||||+++++++.+++.+|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            5799999999999999999997  478999999974321 1223567899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCcccc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA  266 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~  266 (395)
                      ||++||+|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....  ...
T Consensus        84 E~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--~~~  160 (316)
T d1fota_          84 DYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYT  160 (316)
T ss_dssp             CCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BCC
T ss_pred             eecCCccccccccc-cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc--ccc
Confidence            99999999998876 567899999999999999999999999999999999999999999999999999876543  345


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhcc
Q 016082          267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH  346 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  346 (395)
                      .+||+.|||||++.+.+|+.++|||||||++|+|++|+.||.+.+..+....+...  ....|+.+++++.+++.+||++
T Consensus       161 ~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~  238 (316)
T d1fota_         161 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFPPFFNEDVKDLLSRLITR  238 (316)
T ss_dssp             CCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCS
T ss_pred             ccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhhh
Confidence            68999999999999999999999999999999999999999999988877776654  3456788999999999999999


Q ss_pred             CCCCCC-----CHHHHHH
Q 016082          347 DPTQRP-----NFSQITD  359 (395)
Q Consensus       347 dp~~RP-----s~~ell~  359 (395)
                      ||.+||     |++++++
T Consensus       239 dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         239 DLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             CTTTCTTSSTTTTHHHHT
T ss_pred             CHHhccccchhhHHHHHc
Confidence            999996     8888876

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-54  Score=410.52  Aligned_cols=263  Identities=30%  Similarity=0.553  Sum_probs=232.1

Q ss_pred             CCceeecccCcceeeeeeeeCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEE
Q 016082          102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG  174 (395)
Q Consensus       102 ~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  174 (395)
                      .+.|+|+.++|++.++||+|+||.||+|++.       ++.||||+++... .......|.+|+.++++++||||+++++
T Consensus        12 ~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~   90 (308)
T d1p4oa_          12 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLG   90 (308)
T ss_dssp             CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             ccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeee
Confidence            3569999999999999999999999999874       3679999998653 4555678999999999999999999999


Q ss_pred             EEecCCcEEEEEecCCCCCHHHHHhhcc---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCC
Q 016082          175 ACTRPPNLCIVTEFMARGSIYDFLHKQK---------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG  245 (395)
Q Consensus       175 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~  245 (395)
                      ++...+..++||||+++|+|.+++....         ..++...+.+++.++++||.|||+++|+||||||+|||++.++
T Consensus        91 ~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~  170 (308)
T d1p4oa_          91 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF  170 (308)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred             EEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc
Confidence            9999999999999999999999986542         3467888999999999999999999999999999999999999


Q ss_pred             cEEEeeeccccccccCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHhhh
Q 016082          246 VVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG-ELPYAGLTPLQAAVGVVQ  321 (395)
Q Consensus       246 ~vkl~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg-~~pf~~~~~~~~~~~~~~  321 (395)
                      ++||+|||+|+......   ..+...||+.|+|||.+.+..++.++||||||+++|||+|| .+||.+.+..+....+. 
T Consensus       171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~-  249 (308)
T d1p4oa_         171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM-  249 (308)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH-
T ss_pred             eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-
Confidence            99999999998654432   22344689999999999999999999999999999999997 68999998888776554 


Q ss_pred             ccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 016082          322 KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK  366 (395)
Q Consensus       322 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~  366 (395)
                      .+.++..|..+++.+.++|.+||+.||.+|||+.+|++.|++.++
T Consensus       250 ~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         250 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             hCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            566788889999999999999999999999999999998876543

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-54  Score=411.30  Aligned_cols=247  Identities=18%  Similarity=0.290  Sum_probs=220.9

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      ++|++.+.||+|+||+||+|.+  +++.||||+++...   .....+.+|+.+|++++||||+++++++.+++.+|+|||
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            5799999999999999999998  57899999998653   223568899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCC--CcEEEeeeccccccccCCccc
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN--GVVKVADFGVARVQAQSGVMT  265 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~--~~vkl~DFg~a~~~~~~~~~~  265 (395)
                      |++||+|.+++.....++++..+..++.||+.||+|||++||+||||||+|||++.+  +.+||+|||+++.........
T Consensus        82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~  161 (321)
T d1tkia_          82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR  161 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCccc
Confidence            999999999998766789999999999999999999999999999999999999854  489999999998776655556


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCC--CCCCCcHHHHHHHHHh
Q 016082          266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT--IPKHAHPRLAELLERC  343 (395)
Q Consensus       266 ~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~c  343 (395)
                      ...+|+.|+|||.+.+..|+.++||||+||++|+|++|+.||.+.+..+....+........  ....+|+++.+||.+|
T Consensus       162 ~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  241 (321)
T d1tkia_         162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL  241 (321)
T ss_dssp             EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTT
T ss_pred             ccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHH
Confidence            66899999999999999999999999999999999999999999998887777665543322  1246899999999999


Q ss_pred             hccCCCCCCCHHHHHH
Q 016082          344 WQHDPTQRPNFSQITD  359 (395)
Q Consensus       344 l~~dp~~RPs~~ell~  359 (395)
                      |+.||.+|||+.|+++
T Consensus       242 L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         242 LVKERKSRMTASEALQ  257 (321)
T ss_dssp             SCSSGGGSCCHHHHHH
T ss_pred             ccCChhHCcCHHHHhc
Confidence            9999999999999987

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-53  Score=402.90  Aligned_cols=264  Identities=27%  Similarity=0.500  Sum_probs=221.5

Q ss_pred             ceeeeeeeeCceEEEEEEECC-----ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec-CCcEEEEE
Q 016082          113 KIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-PPNLCIVT  186 (395)
Q Consensus       113 ~i~~~lg~G~~G~Vy~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~  186 (395)
                      .+.++||+|+||+||+|++..     ..||||.++... +....++|.+|+.+|++++||||++++|++.. ++..++||
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~  108 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  108 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence            346789999999999999732     258999997543 56667889999999999999999999999865 55799999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC----
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG----  262 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~----  262 (395)
                      ||+++|+|.+++......++...+++++.|++.||.|||+.+|+||||||+|||+++++.+||+|||+++......    
T Consensus       109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            9999999999998877788899999999999999999999999999999999999999999999999998654332    


Q ss_pred             -ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHH
Q 016082          263 -VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE  341 (395)
Q Consensus       263 -~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  341 (395)
                       ......||+.|+|||.+.+..++.++||||||+++|||++|..||............+..+.++..|..+++++.++|.
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~  268 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML  268 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHH
Confidence             2233468999999999999999999999999999999999776665543333333334556788889999999999999


Q ss_pred             HhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcccccccc
Q 016082          342 RCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNLINTN  380 (395)
Q Consensus       342 ~cl~~dp~~RPs~~ell~~l~~~~~~~~~~~~~~~~~~~  380 (395)
                      +||+.||++||++.||++.|+++++   .+..++....|
T Consensus       269 ~cl~~dP~~RPs~~ei~~~L~~i~~---~~~~~~~~~~~  304 (311)
T d1r0pa_         269 KCWHPKAEMRPSFSELVSRISAIFS---TFIGEHYVHVN  304 (311)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHH---TCCSCCBCCCC
T ss_pred             HHcCCCHhHCcCHHHHHHHHHHHHH---hhhhhhchhcc
Confidence            9999999999999999999999875   35555544333

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.8e-54  Score=413.59  Aligned_cols=245  Identities=27%  Similarity=0.414  Sum_probs=219.5

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  186 (395)
                      ++|++.++||+|+||.||+|++  +++.||||++++... +....+.+.+|+.+|++++||||+++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            5899999999999999999998  588999999864321 1223467899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCCcccc
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA  266 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~~~~~  266 (395)
                      ||+.||+|.+++.+ .+.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.....  ...
T Consensus       121 e~~~~g~l~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--~~~  197 (350)
T d1rdqe_         121 EYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWT  197 (350)
T ss_dssp             ECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BCC
T ss_pred             ccccccchhhhHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--ccc
Confidence            99999999999976 467999999999999999999999999999999999999999999999999999876533  345


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhhcc
Q 016082          267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH  346 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  346 (395)
                      ..||+.|||||++.+.+|+.++|||||||++|+|++|+.||.+.+.......+...  .+..|..+++++.++|.+||+.
T Consensus       198 ~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~  275 (350)
T d1rdqe_         198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFSSDLKDLLRNLLQV  275 (350)
T ss_dssp             CEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTCCHHHHHHHHHHSCS
T ss_pred             ccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC--CCCCCccCCHHHHHHHHHHhhh
Confidence            68999999999999999999999999999999999999999999888877776654  3456788999999999999999


Q ss_pred             CCCCCC-----CHHHHHH
Q 016082          347 DPTQRP-----NFSQITD  359 (395)
Q Consensus       347 dp~~RP-----s~~ell~  359 (395)
                      ||.+|+     |++++++
T Consensus       276 dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         276 DLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CTTTCTTSSTTTTHHHHT
T ss_pred             CHHhccccccccHHHHHc
Confidence            999994     8999876

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-54  Score=407.85  Aligned_cols=247  Identities=24%  Similarity=0.449  Sum_probs=216.9

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHH-hcCCCceeeEEEEEecCCcEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMR-KIRHKNVVQFIGACTRPPNLCIV  185 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lV  185 (395)
                      ++|.+.+.||+|+||+||+|++  +++.||||++++... ..+..+.+..|+.++. .++||||+++++++.+++.+|||
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            5799999999999999999998  679999999974321 1122345666777665 68999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-Ccc
Q 016082          186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVM  264 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-~~~  264 (395)
                      |||++||+|.++++. .+++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..... ...
T Consensus        82 mEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~  160 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT  160 (320)
T ss_dssp             EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred             EeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccc
Confidence            999999999999976 567999999999999999999999999999999999999999999999999999865433 334


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHHHHHHhh
Q 016082          265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW  344 (395)
Q Consensus       265 ~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  344 (395)
                      +...||+.|+|||++.+.+|+.++|||||||++|+|++|+.||.+.++.+....+...  .+..|..+|+++.+||.+||
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~dli~~~L  238 (320)
T d1xjda_         161 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEAKDLLVKLF  238 (320)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHS
T ss_pred             cccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCccCCHHHHHHHHHhc
Confidence            5568999999999999999999999999999999999999999999988877665543  56778889999999999999


Q ss_pred             ccCCCCCCCHH-HHHH
Q 016082          345 QHDPTQRPNFS-QITD  359 (395)
Q Consensus       345 ~~dp~~RPs~~-ell~  359 (395)
                      +.||.+||++. ++++
T Consensus       239 ~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         239 VREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             CSSGGGSBTTBSCGGG
T ss_pred             ccCCCCCcCHHHHHHh
Confidence            99999999995 6754

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=5.4e-53  Score=408.87  Aligned_cols=249  Identities=25%  Similarity=0.404  Sum_probs=209.2

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCC----CHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV----NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  182 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  182 (395)
                      .++|++.+.||+|+||.||+|++  +++.||||++.+...    .........+|+.+++.++||||+++++++.+.+.+
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            46899999999999999999998  578999999864322    111222333456777777899999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC
Q 016082          183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  262 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~  262 (395)
                      |+||||++||+|.+++.+ .+.+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+..... 
T Consensus        83 ~ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~-  160 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-  160 (364)
T ss_dssp             EEEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-
T ss_pred             EEEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC-
Confidence            999999999999999976 567899999999999999999999999999999999999999999999999999866543 


Q ss_pred             ccccCCCCcccccccccC-CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HhhhccCCCCCCCCCcHHHHHHH
Q 016082          263 VMTAETGTYRWMAPEVIE-HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAV-GVVQKSLRPTIPKHAHPRLAELL  340 (395)
Q Consensus       263 ~~~~~~gt~~y~aPE~~~-~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li  340 (395)
                      ......||+.|+|||++. +..|+.++|||||||++|||++|+.||.+.+...... ........+..|..+++++.++|
T Consensus       161 ~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  240 (364)
T d1omwa3         161 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLL  240 (364)
T ss_dssp             CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHH
T ss_pred             cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHH
Confidence            345568999999999986 4579999999999999999999999998754432211 11222345566788999999999


Q ss_pred             HHhhccCCCCCCC-----HHHHHH
Q 016082          341 ERCWQHDPTQRPN-----FSQITD  359 (395)
Q Consensus       341 ~~cl~~dp~~RPs-----~~ell~  359 (395)
                      .+||+.||.+|||     ++|+++
T Consensus       241 ~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         241 EGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             HHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             HHHcccCHHHhCCCcccCHHHHHc
Confidence            9999999999999     688775

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-53  Score=406.02  Aligned_cols=243  Identities=23%  Similarity=0.402  Sum_probs=204.4

Q ss_pred             cCcceee-eeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEEEEec----CCc
Q 016082          110 KQLKIEC-KVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTR----PPN  181 (395)
Q Consensus       110 ~~~~i~~-~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~  181 (395)
                      ++|++.. .||+|+||.||+|++  +++.||||+++..       ..+.+|+.++.++ +||||+++++++.+    ...
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~   83 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   83 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence            5798875 599999999999997  5789999999753       4577899987655 79999999999865    456


Q ss_pred             EEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCC---CCcEEEeeeccccc
Q 016082          182 LCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NGVVKVADFGVARV  257 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~---~~~vkl~DFg~a~~  257 (395)
                      +|+||||++||+|.+++.+.. .++++..++.++.||+.||+|||++||+||||||+|||++.   ++.+||+|||+|+.
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~  163 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  163 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeee
Confidence            899999999999999998653 57999999999999999999999999999999999999985   56799999999987


Q ss_pred             cccCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC--CCCC----CC
Q 016082          258 QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIP----KH  331 (395)
Q Consensus       258 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~--~~~~----~~  331 (395)
                      ...........||+.|||||++.+.+|+.++|||||||++|+|++|+.||.+.+..............  ...|    ..
T Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  243 (335)
T d2ozaa1         164 TTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE  243 (335)
T ss_dssp             CCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHH
T ss_pred             ccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCccccc
Confidence            77666667788999999999999999999999999999999999999999876554433322222111  1122    35


Q ss_pred             CcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          332 AHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       332 ~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                      +|+++.+||.+||+.||.+|||+.|+++
T Consensus       244 ~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         244 VSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            7899999999999999999999999976

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-52  Score=395.84  Aligned_cols=250  Identities=22%  Similarity=0.364  Sum_probs=208.1

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      ++|++.++||+|+||.||+|++  +++.||||+++....++...+.+.+|+++|++++||||+++++++.++.++|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5899999999999999999998  47899999998765545556789999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC-Ccccc
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTA  266 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~-~~~~~  266 (395)
                      |+.++.+..........+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||.|+..... .....
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~  161 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH  161 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTC
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCccccee
Confidence            99774444443444677999999999999999999999999999999999999999999999999999876543 33445


Q ss_pred             CCCCcccccccccCCCC-CCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC----------------CCC-
Q 016082          267 ETGTYRWMAPEVIEHKP-YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR----------------PTI-  328 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~~~-~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~----------------~~~-  328 (395)
                      ..||+.|+|||++.... ++.++|+||+||++|+|++|+.||.+.+..+....+......                ... 
T Consensus       162 ~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (298)
T d1gz8a_         162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP  241 (298)
T ss_dssp             CBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSC
T ss_pred             ecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccc
Confidence            68999999999987665 578999999999999999999999998877665554321111                001 


Q ss_pred             ----------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          329 ----------PKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       329 ----------~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                ...+++++.+||.+||+.||.+|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             CCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence                      1256789999999999999999999999987

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=397.40  Aligned_cols=251  Identities=22%  Similarity=0.376  Sum_probs=213.2

Q ss_pred             ccCcceeeeeeeeCceEEEEEEEC---CceEEEEEecCCCCCHHHHHHHHHHHHHHHhc---CCCceeeEEEEEec----
Q 016082          109 AKQLKIECKVASGSYGDLYKGTYC---SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI---RHKNVVQFIGACTR----  178 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----  178 (395)
                      .++|++.++||+|+||+||+|++.   ++.||||+++.....+.....+.+|+.+|+.+   +||||++++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            368999999999999999999973   46799999975543333334566788887766   79999999999853    


Q ss_pred             -CCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccc
Q 016082          179 -PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV  257 (395)
Q Consensus       179 -~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~  257 (395)
                       ...++++|||+.++++..........+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~  165 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI  165 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence             3468999999999877766666677899999999999999999999999999999999999999999999999999987


Q ss_pred             cccCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC------------
Q 016082          258 QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR------------  325 (395)
Q Consensus       258 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~------------  325 (395)
                      ...........||+.|+|||++.+.+|+.++||||+||++|||++|+.||.+.++.+....+......            
T Consensus       166 ~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  245 (305)
T d1blxa_         166 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL  245 (305)
T ss_dssp             CCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSS
T ss_pred             hcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccc
Confidence            76666667789999999999999999999999999999999999999999998887766554331110            


Q ss_pred             -------------CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          326 -------------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       326 -------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                   +..+..+++++.+||.+||++||++|||+.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                         1123467889999999999999999999999987

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-52  Score=393.46  Aligned_cols=252  Identities=26%  Similarity=0.374  Sum_probs=207.3

Q ss_pred             eeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCH---HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Q 016082          114 IECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT---EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  188 (395)
Q Consensus       114 i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  188 (395)
                      .+++||+|+||+||+|++  +++.||||+++......   ...+.+.+|+.+|++++||||+++++++..++.+|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            357899999999999987  57899999997654322   2235688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-ccccC
Q 016082          189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAE  267 (395)
Q Consensus       189 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~~~  267 (395)
                      +.|+++..+. ...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... .....
T Consensus        82 ~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~  160 (299)
T d1ua2a_          82 METDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ  160 (299)
T ss_dssp             CSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCS
T ss_pred             hcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccce
Confidence            9987666554 446789999999999999999999999999999999999999999999999999998655433 33456


Q ss_pred             CCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCC--------------------
Q 016082          268 TGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP--------------------  326 (395)
Q Consensus       268 ~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~--------------------  326 (395)
                      .||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+....+......+                    
T Consensus       161 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (299)
T d1ua2a_         161 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF  240 (299)
T ss_dssp             CCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCC
T ss_pred             ecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccC
Confidence            79999999999864 568999999999999999999999999988877665544321111                    


Q ss_pred             -CC-----CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhccc
Q 016082          327 -TI-----PKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPN  375 (395)
Q Consensus       327 -~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~~~~~~~  375 (395)
                       ..     .+..++++.+||.+||+.||++|||++|+++         +-|+++.
T Consensus       241 ~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~---------Hp~f~~~  286 (299)
T d1ua2a_         241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK---------MKYFSNR  286 (299)
T ss_dssp             CCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT---------SGGGTSS
T ss_pred             CCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC---------CHhhCCC
Confidence             00     1356889999999999999999999999987         6676543

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-52  Score=392.79  Aligned_cols=254  Identities=26%  Similarity=0.510  Sum_probs=207.0

Q ss_pred             cCcceeeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC----cEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP----NLCIV  185 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lV  185 (395)
                      .+|.+.++||+|+||+||+|+++++.||||+++..   ......+..|+..+.+++||||+++++++.+..    .+|+|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence            57899999999999999999999999999999743   221122334555556789999999999997654    58999


Q ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH--------CCccccCCCCCCeeeCCCCcEEEeeeccccc
Q 016082          186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ--------NNIIHRDLKTANLLMDENGVVKVADFGVARV  257 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~--------~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~  257 (395)
                      |||+++|+|.+++++  .++++..++.++.+++.||.|||+        +||+||||||+|||++.++.+||+|||+++.
T Consensus        80 ~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~  157 (303)
T d1vjya_          80 SDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             EECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence            999999999999976  358999999999999999999996        5999999999999999999999999999986


Q ss_pred             cccCC-----ccccCCCCcccccccccCCCC------CCChhhHHHHHHHHHHHHhCCCCCCC---------------CC
Q 016082          258 QAQSG-----VMTAETGTYRWMAPEVIEHKP------YDYKADVFSFGIALWELLTGELPYAG---------------LT  311 (395)
Q Consensus       258 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~------~~~k~DvwslG~vl~elltg~~pf~~---------------~~  311 (395)
                      .....     ......||+.|+|||++.+..      ++.++|||||||++|||+||..||..               ..
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence            65432     223457999999999987643      67789999999999999999887642               12


Q ss_pred             HHHHHHHhhhccCCCCCCCCC-----cHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHH
Q 016082          312 PLQAAVGVVQKSLRPTIPKHA-----HPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  368 (395)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~-----~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~  368 (395)
                      .............+|.+|...     +..+.+++.+||+.||.+|||+.||++.|+++.++-
T Consensus       238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  299 (303)
T d1vjya_         238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence            333444445556677766543     346999999999999999999999999999988763

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=8.5e-52  Score=387.89  Aligned_cols=249  Identities=24%  Similarity=0.375  Sum_probs=210.0

Q ss_pred             cCcceeeeeeeeCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Q 016082          110 KQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  188 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  188 (395)
                      ++|++.++||+|+||+||+|++ +++.||||+++....++...+.+.+|+.+|++++||||+++++++...+..+++||+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5899999999999999999998 578999999987655555567899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-ccccC
Q 016082          189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAE  267 (395)
Q Consensus       189 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~~~  267 (395)
                      +.++.+..+. ...+.+++..+..++.||+.||+|||+.||+||||||+|||++.++.+|++|||.|....... .....
T Consensus        82 ~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  160 (286)
T d1ob3a_          82 LDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE  160 (286)
T ss_dssp             CSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred             ehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcccccee
Confidence            9876555554 446889999999999999999999999999999999999999999999999999998765433 23445


Q ss_pred             CCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC---------------------
Q 016082          268 TGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR---------------------  325 (395)
Q Consensus       268 ~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~---------------------  325 (395)
                      .|++.|+|||.+.+ ..++.++||||+||++|||++|+.||.+.+..+....+......                     
T Consensus       161 ~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (286)
T d1ob3a_         161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV  240 (286)
T ss_dssp             -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCC
T ss_pred             cccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccccc
Confidence            68999999999875 46799999999999999999999999998877665554321111                     


Q ss_pred             ------CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          326 ------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       326 ------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                            ...+..+++++.+||++||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  1123457889999999999999999999999975

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-52  Score=390.41  Aligned_cols=240  Identities=24%  Similarity=0.463  Sum_probs=205.2

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCH----HHHHHHHHHHHHHHhcC--CCceeeEEEEEecCCc
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT----EMLKEFSQEVYIMRKIR--HKNVVQFIGACTRPPN  181 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~----~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~  181 (395)
                      ++|++.+.||+|+||.||+|++  +++.||||+++......    .....+.+|+.+|++++  ||||+++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            5899999999999999999998  57899999997543221    11234678999999997  8999999999999999


Q ss_pred             EEEEEecCCC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCC-CCcEEEeeeccccccc
Q 016082          182 LCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVADFGVARVQA  259 (395)
Q Consensus       182 ~~lV~E~~~g-gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~-~~~vkl~DFg~a~~~~  259 (395)
                      .|+||||+.+ +++.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+...
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~  162 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK  162 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence            9999999976 578888866 567999999999999999999999999999999999999985 4799999999998654


Q ss_pred             cCCccccCCCCcccccccccCCCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCCCCCCCcHHHHH
Q 016082          260 QSGVMTAETGTYRWMAPEVIEHKPY-DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE  338 (395)
Q Consensus       260 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  338 (395)
                      .. ..+...||+.|+|||++.+..+ +.++||||+||++|||++|+.||.+.+.      +..  .....+..+|+++.+
T Consensus       163 ~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~--~~~~~~~~~s~~~~~  233 (273)
T d1xwsa_         163 DT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR--GQVFFRQRVSSECQH  233 (273)
T ss_dssp             SS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH--CCCCCSSCCCHHHHH
T ss_pred             cc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------Hhh--cccCCCCCCCHHHHH
Confidence            43 3456789999999999987665 5779999999999999999999986421      122  234566789999999


Q ss_pred             HHHHhhccCCCCCCCHHHHHH
Q 016082          339 LLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       339 li~~cl~~dp~~RPs~~ell~  359 (395)
                      +|.+||+.||.+|||++|+++
T Consensus       234 li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         234 LIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHccCCHhHCcCHHHHhc
Confidence            999999999999999999987

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-50  Score=385.59  Aligned_cols=251  Identities=27%  Similarity=0.415  Sum_probs=209.3

Q ss_pred             CceeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 016082          103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  180 (395)
Q Consensus       103 ~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  180 (395)
                      ..|++ .++|++.++||+|+||+||+|++  +++.||||+++....++...+.+.+|+.+|++++|||||+++++|...+
T Consensus        12 ~~~~~-~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~   90 (346)
T d1cm8a_          12 TAWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE   90 (346)
T ss_dssp             SEECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred             ceeec-CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCc
Confidence            34666 46899999999999999999998  4899999999877767777889999999999999999999999997665


Q ss_pred             ------cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecc
Q 016082          181 ------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV  254 (395)
Q Consensus       181 ------~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~  254 (395)
                            .+|+||||+ +.+|..+.+.  +++++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||.
T Consensus        91 ~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          91 TLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             STTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             cccccceEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccc
Confidence                  479999999 5578877654  5799999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC--------
Q 016082          255 ARVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--------  325 (395)
Q Consensus       255 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~--------  325 (395)
                      |+....  ..+...||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..............        
T Consensus       168 a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (346)
T d1cm8a_         168 ARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  245 (346)
T ss_dssp             CEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             eeccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence            986554  3466789999999999865 46789999999999999999999999988766554332221110        


Q ss_pred             ---------------------CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          326 ---------------------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       326 ---------------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                           ......+++++.+||.+||..||.+|||+.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                                 1123467899999999999999999999999987

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.9e-50  Score=378.93  Aligned_cols=253  Identities=24%  Similarity=0.357  Sum_probs=206.6

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc-eeeEEEEEecCCcEEEEE
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN-VVQFIGACTRPPNLCIVT  186 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~  186 (395)
                      ++|++.++||+|+||.||+|++  +++.||||+++.....    .++..|+.++++++|+| |+.+.+++...+..++||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm   82 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence            4799999999999999999998  4789999998765332    35778999999998766 555566667788899999


Q ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCC---CCcEEEeeeccccccccCC-
Q 016082          187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NGVVKVADFGVARVQAQSG-  262 (395)
Q Consensus       187 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~---~~~vkl~DFg~a~~~~~~~-  262 (395)
                      ||+ ++++.+.+....+.+++..+..++.|++.||+|||++||+||||||+|||++.   +..++++|||+|+...... 
T Consensus        83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~  161 (299)
T d1ckia_          83 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  161 (299)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred             EEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence            999 55888888777788999999999999999999999999999999999999864   4579999999998654332 


Q ss_pred             -------ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhh---hccC---CCCCC
Q 016082          263 -------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV---QKSL---RPTIP  329 (395)
Q Consensus       263 -------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~---~~~~---~~~~~  329 (395)
                             ......||+.|||||++.+.+++.++|||||||++|||++|+.||.............   ....   .+..+
T Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (299)
T d1ckia_         162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC  241 (299)
T ss_dssp             CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHT
T ss_pred             ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhc
Confidence                   1234479999999999999999999999999999999999999998765544332211   1111   12234


Q ss_pred             CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 016082          330 KHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE  367 (395)
Q Consensus       330 ~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~  367 (395)
                      ..+|+++.++|.+||+.+|++||+++++.+.|+++...
T Consensus       242 ~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence            67899999999999999999999999999999888654

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1e-49  Score=375.09  Aligned_cols=256  Identities=17%  Similarity=0.277  Sum_probs=214.6

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC-CceeeEEEEEecCCcEEEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH-KNVVQFIGACTRPPNLCIV  185 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV  185 (395)
                      .++|++.++||+|+||+||+|++  +++.||||+++.....    ..+.+|+++++.++| +|++.+++++......++|
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v   79 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   79 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence            56899999999999999999997  5789999998654322    346788999999976 8999999999999999999


Q ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCC-----CCcEEEeeecccccccc
Q 016082          186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-----NGVVKVADFGVARVQAQ  260 (395)
Q Consensus       186 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~-----~~~vkl~DFg~a~~~~~  260 (395)
                      |||+ +++|.++++.....++..++..++.|++.||+|||++||+||||||+|||++.     ++.+||+|||+|+....
T Consensus        80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~  158 (293)
T d1csna_          80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  158 (293)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence            9999 67999999887778999999999999999999999999999999999999974     57899999999986543


Q ss_pred             CC--------ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHhhhccC---CC
Q 016082          261 SG--------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP---LQAAVGVVQKSL---RP  326 (395)
Q Consensus       261 ~~--------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~---~~~~~~~~~~~~---~~  326 (395)
                      ..        ......||+.|||||++.+.+++.++|||||||++|||++|+.||.+...   ......+.....   .+
T Consensus       159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (293)
T d1csna_         159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR  238 (293)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred             CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChH
Confidence            21        12334799999999999999999999999999999999999999986433   222222221111   12


Q ss_pred             CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHH
Q 016082          327 TIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVL  369 (395)
Q Consensus       327 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~  369 (395)
                      ..+..+|+++.+++..|++.+|++||+++.+.+.+++++++..
T Consensus       239 ~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~  281 (293)
T d1csna_         239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  281 (293)
T ss_dssp             HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence            2345688999999999999999999999999998888876553

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-49  Score=381.21  Aligned_cols=251  Identities=24%  Similarity=0.410  Sum_probs=204.7

Q ss_pred             ceeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC-
Q 016082          104 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP-  180 (395)
Q Consensus       104 ~~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-  180 (395)
                      +|+|.. +|++.++||+|+||+||+|++  +++.||||+++... .....+.+.+|+.+|++++||||+++++++.... 
T Consensus         3 ~~~i~~-rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~   80 (345)
T d1pmea_           3 VFDVGP-RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI   80 (345)
T ss_dssp             CCCCCT-TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             ccCcCC-CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence            455544 699999999999999999987  58999999997654 4556678999999999999999999999996543 


Q ss_pred             ----cEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccc
Q 016082          181 ----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR  256 (395)
Q Consensus       181 ----~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~  256 (395)
                          .+|++ +++.||+|.+++..  +++++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+
T Consensus        81 ~~~~~~~l~-~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~  157 (345)
T d1pmea_          81 EQMKDVYLV-THLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR  157 (345)
T ss_dssp             TTCCCEEEE-EECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             cccceEEEE-EeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCcee
Confidence                34555 55668899999965  469999999999999999999999999999999999999999999999999997


Q ss_pred             ccccCC----ccccCCCCcccccccccC-CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCC-----
Q 016082          257 VQAQSG----VMTAETGTYRWMAPEVIE-HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP-----  326 (395)
Q Consensus       257 ~~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~-----  326 (395)
                      ......    ......||+.|+|||++. +..++.++||||+||++|+|++|+.||.+.+..............+     
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (345)
T d1pmea_         158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  237 (345)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence            654332    234457899999999985 5567999999999999999999999999877654443332211000     


Q ss_pred             ------------------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          327 ------------------------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       327 ------------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                              .....+++++.+|+.+||+.||.+|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                                    012457889999999999999999999999987

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-49  Score=383.60  Aligned_cols=243  Identities=25%  Similarity=0.330  Sum_probs=203.0

Q ss_pred             CcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecC------CcE
Q 016082          111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP------PNL  182 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~  182 (395)
                      +|+..++||+|+||+||+|++  +++.||||+++....      ...+|+.+|++++||||++++++|...      .++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~   94 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL   94 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence            799999999999999999998  578999999976532      234799999999999999999998432      347


Q ss_pred             EEEEecCCCCCHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCC-cEEEeeeccccccc
Q 016082          183 CIVTEFMARGSIYDFLH--KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQA  259 (395)
Q Consensus       183 ~lV~E~~~ggsL~~~l~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~-~vkl~DFg~a~~~~  259 (395)
                      ||||||++++.+..+..  .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus        95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~  174 (350)
T d1q5ka_          95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  174 (350)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred             EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence            99999998764443332  2356799999999999999999999999999999999999999775 89999999998776


Q ss_pred             cCCccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccC--------------
Q 016082          260 QSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL--------------  324 (395)
Q Consensus       260 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~--------------  324 (395)
                      .........||+.|+|||.+.+ ..|+.++||||+||++|||++|+.||...+..+....+.....              
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~  254 (350)
T d1q5ka_         175 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY  254 (350)
T ss_dssp             TTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC--
T ss_pred             CCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccch
Confidence            6666667789999999998765 5789999999999999999999999998877665554432100              


Q ss_pred             -C---C---------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          325 -R---P---------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       325 -~---~---------~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                       .   +         ......++++.+||.+||+.||++|||+.|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             -CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0   0         112357899999999999999999999999987

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-49  Score=373.99  Aligned_cols=258  Identities=24%  Similarity=0.367  Sum_probs=208.6

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec--------
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--------  178 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  178 (395)
                      .++|++.++||+|+||+||+|++  +++.||||+++.....+.....+.+|+.+|++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            47999999999999999999998  57899999997665555556778999999999999999999999855        


Q ss_pred             CCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccc
Q 016082          179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  258 (395)
Q Consensus       179 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~  258 (395)
                      ...+|+||||+.++.+. ........+++..++.++.|++.||.|||++||+||||||+|||++.++.+|++|||+++..
T Consensus        89 ~~~~~iv~e~~~~~~~~-~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~  167 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF  167 (318)
T ss_dssp             --CEEEEEECCCEEHHH-HHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CceEEEEEeccCCCccc-hhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence            34689999999876555 44444678999999999999999999999999999999999999999999999999999755


Q ss_pred             ccCC-----ccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCCC--CC-
Q 016082          259 AQSG-----VMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT--IP-  329 (395)
Q Consensus       259 ~~~~-----~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~-  329 (395)
                      ....     ......||+.|+|||++.+. .|+.++||||+||++|||++|+.||.+.+.......+......+.  .. 
T Consensus       168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  247 (318)
T d3blha1         168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP  247 (318)
T ss_dssp             CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence            4321     22334799999999998765 789999999999999999999999998887666554433211111  00 


Q ss_pred             ---------------------------CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcccc
Q 016082          330 ---------------------------KHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVLYWLSPNL  376 (395)
Q Consensus       330 ---------------------------~~~~~~l~~li~~cl~~dp~~RPs~~ell~~l~~~~~~~~~~~~~~~  376 (395)
                                                 ...++++.+||.+||+.||++|||++|+++         +-|+.+.-
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~---------Hpff~~~p  312 (318)
T d3blha1         248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN---------HDFFWSDP  312 (318)
T ss_dssp             TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH---------SGGGSSSS
T ss_pred             ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc---------ChhhccCC
Confidence                                       013667889999999999999999999997         67765443

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-49  Score=368.96  Aligned_cols=249  Identities=23%  Similarity=0.345  Sum_probs=211.6

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  187 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  187 (395)
                      ++|++.++||+|+||+||+|++  +++.||||+++...........+.+|+.+|++++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5899999999999999999998  57889999998776666778899999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccCC-cccc
Q 016082          188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA  266 (395)
Q Consensus       188 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~~-~~~~  266 (395)
                      ++.++++..++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||.|+...... ....
T Consensus        82 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~  160 (292)
T d1unla_          82 FCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA  160 (292)
T ss_dssp             CCSEEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCS
T ss_pred             ecccccccccccc-ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcccee
Confidence            9999888887754 6788999999999999999999999999999999999999999999999999998765543 3334


Q ss_pred             CCCCcccccccccCCCC-CCChhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHhhhcc---------------------
Q 016082          267 ETGTYRWMAPEVIEHKP-YDYKADVFSFGIALWELLTGELPYA-GLTPLQAAVGVVQKS---------------------  323 (395)
Q Consensus       267 ~~gt~~y~aPE~~~~~~-~~~k~DvwslG~vl~elltg~~pf~-~~~~~~~~~~~~~~~---------------------  323 (395)
                      ..+++.|+|||++.+.. ++.++||||+||++|||++|+.||. +.+..+....+....                     
T Consensus       161 ~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (292)
T d1unla_         161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP  240 (292)
T ss_dssp             CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred             eccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccc
Confidence            56788999999987665 6999999999999999999998864 444443333222110                     


Q ss_pred             ------CCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          324 ------LRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       324 ------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                            .....+...++++.+||++||+.||.+|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  011223456889999999999999999999999987

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-50  Score=383.49  Aligned_cols=252  Identities=22%  Similarity=0.395  Sum_probs=211.1

Q ss_pred             ecccCcceeeeeeeeCceEEEEEEE-----CCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhcCC-CceeeEEEEEec
Q 016082          107 IDAKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRH-KNVVQFIGACTR  178 (395)
Q Consensus       107 i~~~~~~i~~~lg~G~~G~Vy~~~~-----~~~~vAvK~~~~~~~--~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~  178 (395)
                      +..++|++.++||+|+||.||+|.+     +++.||||++++...  +....+.+.+|+.+|++++| |||+++++++.+
T Consensus        21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~  100 (322)
T d1vzoa_          21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  100 (322)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence            3457899999999999999999986     367899999975432  12234668899999999987 899999999999


Q ss_pred             CCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecccccc
Q 016082          179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  258 (395)
Q Consensus       179 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~  258 (395)
                      ...++++|||+.||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus       101 ~~~~~~v~e~~~~~~L~~~i~~-~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         101 ETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             CCceeeeeecccccHHHHHHHh-cccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            9999999999999999999976 456789999999999999999999999999999999999999999999999999765


Q ss_pred             ccC--CccccCCCCcccccccccCCC--CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhh--ccCCCCCCCCC
Q 016082          259 AQS--GVMTAETGTYRWMAPEVIEHK--PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ--KSLRPTIPKHA  332 (395)
Q Consensus       259 ~~~--~~~~~~~gt~~y~aPE~~~~~--~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~  332 (395)
                      ...  .......|++.|+|||.+.+.  .++.++|||||||++|+|++|+.||.+.+.......+..  ....+.+|..+
T Consensus       180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~  259 (322)
T d1vzoa_         180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM  259 (322)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred             cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccC
Confidence            432  233456799999999999754  478899999999999999999999987544333222222  23356677889


Q ss_pred             cHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 016082          333 HPRLAELLERCWQHDPTQRPN-----FSQITD  359 (395)
Q Consensus       333 ~~~l~~li~~cl~~dp~~RPs-----~~ell~  359 (395)
                      ++++.++|.+||++||.+|||     ++|+++
T Consensus       260 s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             CHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            999999999999999999995     788765

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-49  Score=380.46  Aligned_cols=246  Identities=25%  Similarity=0.365  Sum_probs=198.0

Q ss_pred             cCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec------CCc
Q 016082          110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR------PPN  181 (395)
Q Consensus       110 ~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  181 (395)
                      ++|++.++||+|+||+||+|.+  +++.||||+++....+......+.+|+.++++++||||++++++|..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            5799999999999999999998  48999999998877777777889999999999999999999999964      357


Q ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeeccccccccC
Q 016082          182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  261 (395)
Q Consensus       182 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~~~~~  261 (395)
                      +|+||||+.++ +.+.+   ...+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||.++.....
T Consensus        97 ~~iv~Ey~~~~-l~~~~---~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~  172 (355)
T d2b1pa1          97 VYLVMELMDAN-LCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  172 (355)
T ss_dssp             EEEEEECCSEE-HHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             eEEEEeccchH-HHHhh---hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence            89999999774 44444   346899999999999999999999999999999999999999999999999999877776


Q ss_pred             CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCC----------------
Q 016082          262 GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR----------------  325 (395)
Q Consensus       262 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~----------------  325 (395)
                      ...+...+|+.|+|||++.+..++.++||||+||++++|++|+.||.+.+.......+......                
T Consensus       173 ~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  252 (355)
T d2b1pa1         173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY  252 (355)
T ss_dssp             --------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHH
T ss_pred             cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHH
Confidence            6667778999999999999999999999999999999999999999887765544433211100                


Q ss_pred             ----CC--------------CC------CCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          326 ----PT--------------IP------KHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       326 ----~~--------------~~------~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                          +.              .+      ...++++.+||++||+.||++|||++|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                00              00      123678999999999999999999999987

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-49  Score=378.05  Aligned_cols=254  Identities=24%  Similarity=0.389  Sum_probs=211.7

Q ss_pred             CCCceeecccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Q 016082          101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR  178 (395)
Q Consensus       101 ~~~~~~i~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  178 (395)
                      +.++|++. ++|++.++||+|+||+||+|++  +++.||||+++....+....+.+.+|+.+|++++||||+++++++..
T Consensus        10 ~~~~~~~~-~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~   88 (348)
T d2gfsa1          10 NKTIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   88 (348)
T ss_dssp             SSSEEEEE-TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred             CCccccCC-CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            34678884 6899999999999999999987  58999999998877677777889999999999999999999999864


Q ss_pred             C-----CcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeec
Q 016082          179 P-----PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG  253 (395)
Q Consensus       179 ~-----~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg  253 (395)
                      .     ...+++++++.||+|.+++..  +++++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||
T Consensus        89 ~~~~~~~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg  166 (348)
T d2gfsa1          89 ARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG  166 (348)
T ss_dssp             CSSTTTCCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC-
T ss_pred             ccccccCceEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccc
Confidence            3     234566677789999999854  569999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccCCC------
Q 016082          254 VARVQAQSGVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP------  326 (395)
Q Consensus       254 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~------  326 (395)
                      .+.....  ......||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+.......+......+      
T Consensus       167 ~a~~~~~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         167 LARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  244 (348)
T ss_dssp             ---CCTG--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             hhcccCc--ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            9975443  23456789999999987765 46899999999999999999999999887766555443322111      


Q ss_pred             ---------------CC--------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          327 ---------------TI--------PKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       327 ---------------~~--------~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                     ..        ....++++.+||.+||+.||.+|||+.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence                           01        1357889999999999999999999999987

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3e-48  Score=370.60  Aligned_cols=242  Identities=18%  Similarity=0.354  Sum_probs=202.1

Q ss_pred             ccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEEEEecC--CcEE
Q 016082          109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRP--PNLC  183 (395)
Q Consensus       109 ~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~  183 (395)
                      .++|++.++||+|+||+||+|++  +++.||||+++...     .+.+.+|+.+|++++ ||||+++++++...  ..++
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~  108 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  108 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence            46899999999999999999998  57899999997542     357889999999996 99999999999744  5699


Q ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCC-cEEEeeeccccccccCC
Q 016082          184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQSG  262 (395)
Q Consensus       184 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~-~vkl~DFg~a~~~~~~~  262 (395)
                      +||||+++++|..+.    +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus       109 ~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         109 LVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             EEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             EEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            999999999987753    4699999999999999999999999999999999999998655 69999999998776666


Q ss_pred             ccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHhhh-------------------
Q 016082          263 VMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQ-AAVGVVQ-------------------  321 (395)
Q Consensus       263 ~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwslG~vl~elltg~~pf~~~~~~~-~~~~~~~-------------------  321 (395)
                      ......+|+.|+|||.+.+. .++.++|+||+||++|++++|+.||....... ....+..                   
T Consensus       185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  264 (328)
T d3bqca1         185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD  264 (328)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred             cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence            66777899999999998765 58999999999999999999999997654321 1111100                   


Q ss_pred             ----------------ccCCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016082          322 ----------------KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  359 (395)
Q Consensus       322 ----------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~  359 (395)
                                      ..........+++++.+||++||+.||.+|||++|+++
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                            00111122346889999999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5e-42  Score=331.23  Aligned_cols=247  Identities=19%  Similarity=0.357  Sum_probs=189.7

Q ss_pred             cccCcceeeeeeeeCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-----------CCceeeEEE
Q 016082          108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-----------HKNVVQFIG  174 (395)
Q Consensus       108 ~~~~~~i~~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~  174 (395)
                      ..++|+++++||+|+||+||+|++  +++.||||+++..   ....+.+.+|+.+++.++           |+||+++++
T Consensus        11 ~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~   87 (362)
T d1q8ya_          11 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   87 (362)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             cCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence            335799999999999999999987  5899999999864   334567888999998885           478999998


Q ss_pred             EEec--CCcEEEEEecCCCCCH--HHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeeeCCCCc---
Q 016082          175 ACTR--PPNLCIVTEFMARGSI--YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGV---  246 (395)
Q Consensus       175 ~~~~--~~~~~lV~E~~~ggsL--~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~iiHrDlkp~NiLl~~~~~---  246 (395)
                      ++..  ....+++++++..+..  ..........+++..+..++.||+.||+|||+ .||+||||||+|||++.++.   
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~  167 (362)
T d1q8ya_          88 HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN  167 (362)
T ss_dssp             EEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred             EeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccc
Confidence            8754  3455666666654432  22233345678999999999999999999998 89999999999999987653   


Q ss_pred             ---EEEeeeccccccccCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHH
Q 016082          247 ---VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ------AAV  317 (395)
Q Consensus       247 ---vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwslG~vl~elltg~~pf~~~~~~~------~~~  317 (395)
                         ++++|||.|+.....  .....||+.|+|||++.+..|+.++|+||+||++++|++|+.||.......      ...
T Consensus       168 ~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~  245 (362)
T d1q8ya_         168 LIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA  245 (362)
T ss_dssp             EEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred             cceeeEeecccccccccc--cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence               999999999765433  345679999999999999999999999999999999999999997543210      000


Q ss_pred             Hhhh----------------------c----c--------------CCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHH
Q 016082          318 GVVQ----------------------K----S--------------LRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI  357 (395)
Q Consensus       318 ~~~~----------------------~----~--------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el  357 (395)
                      ....                      .    .              .....+...++++.+||.+||+.||.+|||+.|+
T Consensus       246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~  325 (362)
T d1q8ya_         246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL  325 (362)
T ss_dssp             HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred             HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence            0000                      0    0              0111223356789999999999999999999999


Q ss_pred             HH
Q 016082          358 TD  359 (395)
Q Consensus       358 l~  359 (395)
                      ++
T Consensus       326 L~  327 (362)
T d1q8ya_         326 VN  327 (362)
T ss_dssp             HT
T ss_pred             hc
Confidence            76

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.94  E-value=1.1e-26  Score=203.30  Aligned_cols=164  Identities=15%  Similarity=0.136  Sum_probs=121.8

Q ss_pred             cceeeeeeeeCceEEEEEEE-CCceEEEEEecCCCCC----------------HHHHHHHHHHHHHHHhcCCCceeeEEE
Q 016082          112 LKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVN----------------TEMLKEFSQEVYIMRKIRHKNVVQFIG  174 (395)
Q Consensus       112 ~~i~~~lg~G~~G~Vy~~~~-~~~~vAvK~~~~~~~~----------------~~~~~~~~~E~~~l~~l~h~niv~l~~  174 (395)
                      +.+.++||+|+||+||+|++ +++.||||+++.....                .........|...+.++.|++++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            35789999999999999987 6899999998753211                112234567899999999999999887


Q ss_pred             EEecCCcEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeCCCCcEEEeeecc
Q 016082          175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV  254 (395)
Q Consensus       175 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iiHrDlkp~NiLl~~~~~vkl~DFg~  254 (395)
                      +..    .+++|||++++.+.+        ++...+..++.|++.++.|||++||+||||||+|||++++ .++|+|||.
T Consensus        82 ~~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~  148 (191)
T d1zara2          82 WEG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ  148 (191)
T ss_dssp             EET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred             ecC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence            642    379999998855432        4556677899999999999999999999999999999865 489999999


Q ss_pred             ccccccCCccccCCCCcccccc--cc---cCCCCCCChhhHHHHHH
Q 016082          255 ARVQAQSGVMTAETGTYRWMAP--EV---IEHKPYDYKADVFSFGI  295 (395)
Q Consensus       255 a~~~~~~~~~~~~~gt~~y~aP--E~---~~~~~~~~k~DvwslG~  295 (395)
                      |+....+...       .|...  +.   +-.+.|+.++|+||+.-
T Consensus       149 a~~~~~~~~~-------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~  187 (191)
T d1zara2         149 SVEVGEEGWR-------EILERDVRNIITYFSRTYRTEKDINSAID  187 (191)
T ss_dssp             CEETTSTTHH-------HHHHHHHHHHHHHHHHHHCCCCCHHHHHH
T ss_pred             cccCCCCCcH-------HHHHHHHHHHHHHHcCCCCCcccHHHHHH
Confidence            9754432211       11111  00   11356888999999643

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.74  E-value=1.1e-08  Score=91.44  Aligned_cols=139  Identities=12%  Similarity=0.053  Sum_probs=98.5

Q ss_pred             CcceeeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCcEEEEEecC
Q 016082          111 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEFM  189 (395)
Q Consensus       111 ~~~i~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~  189 (395)
                      .|++.+..+.++.+.||+.+..++.+.+|+.......  ....+.+|...++.+. +--+++++.++..++..++||+++
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l   92 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA   92 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred             ceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEec
Confidence            5666666555666789999888888999998644211  1234677888888775 334678888888888899999999


Q ss_pred             CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 016082          190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-------------------------------------------  226 (395)
Q Consensus       190 ~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-------------------------------------------  226 (395)
                      +|.++.+....      ......++.++.+.+..||+                                           
T Consensus        93 ~G~~~~~~~~~------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (263)
T d1j7la_          93 DGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD  166 (263)
T ss_dssp             SSEEHHHHTTT------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSS
T ss_pred             ccccccccccc------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchH
Confidence            99877654321      11223344455555555553                                           


Q ss_pred             ----------------CCccccCCCCCCeeeCCCCcEEEeeeccccc
Q 016082          227 ----------------NNIIHRDLKTANLLMDENGVVKVADFGVARV  257 (395)
Q Consensus       227 ----------------~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~  257 (395)
                                      ..++|+|+.|.||++++++.+-|+||+.+..
T Consensus       167 ~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                            1279999999999999877777999998864

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.18  E-value=3.6e-06  Score=74.05  Aligned_cols=135  Identities=10%  Similarity=0.119  Sum_probs=82.9

Q ss_pred             eeeeCc-eEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC--CceeeEEEEEecCCcEEEEEecCCCCC
Q 016082          118 VASGSY-GDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH--KNVVQFIGACTRPPNLCIVTEFMARGS  193 (395)
Q Consensus       118 lg~G~~-G~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~E~~~ggs  193 (395)
                      +..|.. +.||+.+.. +..+.+|+......     ..+..|...++.+..  -.++++++++.+++..++||++++|.+
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~   92 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD   92 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence            344543 678998875 45578898765532     246678888877753  336788888888888999999998864


Q ss_pred             HHH--------------HHhhcc------CCCC--HHHHHHHH--------------------HHHHHHHHHHHHC----
Q 016082          194 IYD--------------FLHKQK------GVFQ--LTSLLKVA--------------------IDVSKGMNYLHQN----  227 (395)
Q Consensus       194 L~~--------------~l~~~~------~~l~--~~~~~~i~--------------------~~i~~~l~~LH~~----  227 (395)
                      +.+              .+.+-+      .++.  ......-.                    ......+..+.+.    
T Consensus        93 ~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  172 (255)
T d1nd4a_          93 LLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDG  172 (255)
T ss_dssp             TTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSS
T ss_pred             cccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCcc
Confidence            422              111100      0000  00000000                    0011223333322    


Q ss_pred             ---CccccCCCCCCeeeCCCCcEEEeeeccccc
Q 016082          228 ---NIIHRDLKTANLLMDENGVVKVADFGVARV  257 (395)
Q Consensus       228 ---~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~  257 (395)
                         .++|+|+.|.||++++++.+-|+||+.+..
T Consensus       173 ~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         173 EDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             CCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence               379999999999999877778999998864

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.91  E-value=1.3e-05  Score=75.53  Aligned_cols=76  Identities=13%  Similarity=0.053  Sum_probs=48.1

Q ss_pred             eeeeeeCceEEEEEEE--CCceEEEEEecCCC-C----CHHHHHHHHHHHHHHHhcC-C--CceeeEEEEEecCCcEEEE
Q 016082          116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-V----NTEMLKEFSQEVYIMRKIR-H--KNVVQFIGACTRPPNLCIV  185 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~--~~~~vAvK~~~~~~-~----~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lV  185 (395)
                      +.||.|....||+.+.  .++.++||.-.+.. .    ......+...|...|+.+. +  ..+++++.+.  +...++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEEE
Confidence            4689999999999875  35678999754311 0    0111234556888887663 2  4566777653  3456789


Q ss_pred             EecCCCCC
Q 016082          186 TEFMARGS  193 (395)
Q Consensus       186 ~E~~~ggs  193 (395)
                      ||++++..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99998754

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.34  E-value=0.00036  Score=63.49  Aligned_cols=129  Identities=13%  Similarity=0.121  Sum_probs=75.3

Q ss_pred             eEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcee--eEEE-----EEecCCcEEEEEecCCCCCH-
Q 016082          124 GDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV--QFIG-----ACTRPPNLCIVTEFMARGSI-  194 (395)
Q Consensus       124 G~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv--~l~~-----~~~~~~~~~lV~E~~~ggsL-  194 (395)
                      -.||+.+. .|+.+++|+.+++..+.   +++..|...+..|...++.  ..+.     .+...+..+.++++++|..+ 
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~  112 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE  112 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCCCH---HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence            57999976 67889999998876554   4566788888887532221  1111     12334567889999987421 


Q ss_pred             ----H------HH---Hhhc--c------CCCCH-------------------HHHHHHHHHHHHHHHHHHH-------C
Q 016082          195 ----Y------DF---LHKQ--K------GVFQL-------------------TSLLKVAIDVSKGMNYLHQ-------N  227 (395)
Q Consensus       195 ----~------~~---l~~~--~------~~l~~-------------------~~~~~i~~~i~~~l~~LH~-------~  227 (395)
                          .      ..   ++..  .      ...+.                   .....+...+-+.++.+..       .
T Consensus       113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~  192 (325)
T d1zyla1         113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV  192 (325)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred             CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence                1      11   1111  0      11111                   1111122222333333332       3


Q ss_pred             CccccCCCCCCeeeCCCCcEEEeeeccccc
Q 016082          228 NIIHRDLKTANLLMDENGVVKVADFGVARV  257 (395)
Q Consensus       228 ~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~  257 (395)
                      ++||+|+.|.|||++++  ..++||+.++.
T Consensus       193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         193 LRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eeecCCCCcccEEEeCC--ceEEechhccc
Confidence            68999999999999743  45899999874

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.24  E-value=0.00066  Score=63.43  Aligned_cols=70  Identities=13%  Similarity=0.187  Sum_probs=48.1

Q ss_pred             eeeeeeCceEEEEEEEC---------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCcEEEE
Q 016082          116 CKVASGSYGDLYKGTYC---------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIV  185 (395)
Q Consensus       116 ~~lg~G~~G~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV  185 (395)
                      +.|+.|-.-.+|+.+..         .+.|.+++....  ..  .....+|..+++.+. +.-.+++++++.+    .+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~--~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I  119 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL  119 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--ch--hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence            46777888899998763         245777876522  11  234567899998886 4334678887753    689


Q ss_pred             EecCCCCC
Q 016082          186 TEFMARGS  193 (395)
Q Consensus       186 ~E~~~ggs  193 (395)
                      +||++|..
T Consensus       120 ~efi~g~~  127 (395)
T d1nw1a_         120 EEYIPSRP  127 (395)
T ss_dssp             ECCCCEEE
T ss_pred             EEEecccc
Confidence            99998753

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.91  E-value=0.00081  Score=60.54  Aligned_cols=139  Identities=12%  Similarity=0.062  Sum_probs=74.4

Q ss_pred             eeeeeeeCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCce--eeEEE------EEecCCcEEEEE
Q 016082          115 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV--VQFIG------ACTRPPNLCIVT  186 (395)
Q Consensus       115 ~~~lg~G~~G~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~------~~~~~~~~~lV~  186 (395)
                      .+.|..|.--+.|+.+..+..+++|+..... +   ..++..|+.++..+...++  +..+.      +.........++
T Consensus        23 ~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~-~---~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~   98 (316)
T d2ppqa1          23 YKGIAEGVENSNFLLHTTKDPLILTLYEKRV-E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI   98 (316)
T ss_dssp             EEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred             eecCCCCcccCeEEEEECCCcEEEEEcCCCC-C---HHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceee
Confidence            3456677778899998877889999986542 1   2345567777777753222  11111      111223456666


Q ss_pred             ecCCCCCHH--------------HHHhhccCCC--------------------------CHHHHHHHHHHHHHHHHHHHH
Q 016082          187 EFMARGSIY--------------DFLHKQKGVF--------------------------QLTSLLKVAIDVSKGMNYLHQ  226 (395)
Q Consensus       187 E~~~ggsL~--------------~~l~~~~~~l--------------------------~~~~~~~i~~~i~~~l~~LH~  226 (395)
                      .+..|....              ..++.....+                          ........+..+...+...+.
T Consensus        99 ~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  178 (316)
T d2ppqa1          99 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP  178 (316)
T ss_dssp             ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred             eecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCc
Confidence            666653221              0111100000                          001112222222222222221


Q ss_pred             ----CCccccCCCCCCeeeCCCCcEEEeeeccccc
Q 016082          227 ----NNIIHRDLKTANLLMDENGVVKVADFGVARV  257 (395)
Q Consensus       227 ----~~iiHrDlkp~NiLl~~~~~vkl~DFg~a~~  257 (395)
                          .|+||+|+.++||+++.++..-|+||+.+..
T Consensus       179 ~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         179 KDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             CSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccccccccCCcchhhhhcccccceeEeccccccc
Confidence                4799999999999999888889999999863

>d2f06a1 d.58.18.11 (A:71-141) Hypothetical protein BT0572 {Bacteroides thetaiotaomicron [TaxId: 818]}

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: BT0572-like
domain: Hypothetical protein BT0572
species: Bacteroides thetaiotaomicron [TaxId: 818]

Probab=90.17  E-value=0.34  Score=32.63  Aligned_cols=47  Identities=15%  Similarity=0.198  Sum_probs=40.7

Q ss_pred             HHHHHHHHhhhcCCCeeeeceeccCCCceeeEEEecCCCCcchHHHHHHHHHH
Q 016082           10 KVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKE   62 (395)
Q Consensus        10 ~~~~~~~~~~~~~l~i~~~~~f~~~~~~~l~~~~v~gw~~~~~~~l~~~l~~~   62 (395)
                      .|.+++++|++-|.||.-..+|.+. ++..-+|.||     +.+...++|++.
T Consensus        12 ~L~~v~~~L~~~~InI~~~y~~~~~-~~~~~vl~vd-----d~~~a~~~L~~~   58 (71)
T d2f06a1          12 ALAKVLGFLSAEGVFIEYMYSFANN-NVANVVIRPS-----NMDKCIEVLKEK   58 (71)
T ss_dssp             HHHHHHHHHHHTTCCEEEEEEEEET-TEEEEEEEES-----CHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHCCCCEEEEEEEcCC-CcEEEEEEEC-----CHHHHHHHHHHC
Confidence            4788999999999999999999986 6888999987     678888888765

>d1zpva1 d.58.18.7 (A:1-83) UPF0237 protein SP0238 {Streptococcus pneumoniae [TaxId: 1313]}

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: SP0238-like
domain: UPF0237 protein SP0238
species: Streptococcus pneumoniae [TaxId: 1313]

Probab=88.97  E-value=0.34  Score=33.57  Aligned_cols=53  Identities=21%  Similarity=0.209  Sum_probs=39.8

Q ss_pred             HHHHHHHHhhhcCCCeeeeceeccCCCceeeEEEecCCCCcchHHHHHHHHHHH
Q 016082           10 KVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEI   63 (395)
Q Consensus        10 ~~~~~~~~~~~~~l~i~~~~~f~~~~~~~l~~~~v~gw~~~~~~~l~~~l~~~~   63 (395)
                      +++.+|.+|++.|.||.+.+.+...+-|...+ .++.=...+.++++++|....
T Consensus        15 iVa~vt~~l~~~g~NI~d~~q~~~~~~f~~~~-~v~~~~~~~~~~l~~~l~~la   67 (83)
T d1zpva1          15 IVAGVSGKIAELGLNIDDISQTVLDEYFTMMA-VVSSDEKQDFTYLRNEFEAFG   67 (83)
T ss_dssp             HHHHHHHHHHHTTCEEEEEEEEEETTEEEEEE-EEEESSCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHCCCeEEEEEeEEeCCEEEEEE-EEEEecCCCHHHHHHHHHHHH
Confidence            57889999999999999999987766666654 455323345788888887654

>d1u8sa1 d.58.18.5 (A:2-87) putative transcriptional repressor VC2159 {Vibrio cholerae [TaxId: 666]}

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: Glycine cleavage system transcriptional repressor
domain: putative transcriptional repressor VC2159
species: Vibrio cholerae [TaxId: 666]

Probab=86.35  E-value=0.42  Score=33.35  Aligned_cols=53  Identities=15%  Similarity=0.165  Sum_probs=38.8

Q ss_pred             HHHHHHHHhhhcCCCeeeeceeccCCCceeeEEEecCCCCcchHHHHHHHHHHHH
Q 016082           10 KVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEIL   64 (395)
Q Consensus        10 ~~~~~~~~~~~~~l~i~~~~~f~~~~~~~l~~~~v~gw~~~~~~~l~~~l~~~~~   64 (395)
                      +++++|.+|++.|.||.+.+.+..-+-|.+ ++.|+ ++....++|+..|.+...
T Consensus        18 iva~vt~~l~~~g~NI~d~~~~~~~~~~~~-~~~v~-~~~~~~~~l~~~L~~l~~   70 (86)
T d1u8sa1          18 ICNEVVRLVTQAGCNIIDSRIAMFGKEFTL-LMLIS-GSPSNITRVETTLPLLGQ   70 (86)
T ss_dssp             HHHHHHHHHHHTTCEEEEEEEEEETTEEEE-EEEEE-ECHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHCCCeEEEeEeEEECCeeEE-EEEEE-cCcccHHHHHHHHHHHHH
Confidence            578999999999999999998766554444 44555 455567777777776543

>d2f06a2 d.58.18.11 (A:1-70) Hypothetical protein BT0572 {Bacteroides thetaiotaomicron [TaxId: 818]}

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: BT0572-like
domain: Hypothetical protein BT0572
species: Bacteroides thetaiotaomicron [TaxId: 818]

Probab=85.12  E-value=1.3  Score=29.45  Aligned_cols=47  Identities=17%  Similarity=0.291  Sum_probs=37.5

Q ss_pred             HHHHHHHHhhhcCCCeeeeceeccCCCceeeEEEecCCCCcchHHHHHHHHHH
Q 016082           10 KVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKE   62 (395)
Q Consensus        10 ~~~~~~~~~~~~~l~i~~~~~f~~~~~~~l~~~~v~gw~~~~~~~l~~~l~~~   62 (395)
                      .|.+++.+|++-|.||.-..++.|.+ +..--++||     +.++..+.|++.
T Consensus        16 ~L~~v~~~~~~~~inI~sl~v~~t~~-~~i~Riiv~-----~~e~a~~~L~~~   62 (70)
T d2f06a2          16 RLTEVTEVLAKENINLSALCIAENAD-FGILRGIVS-----DPDKAYKALKDN   62 (70)
T ss_dssp             HHHHHHHHHHHTTCCEEEEEEEECSS-CEEEEEEES-----CHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHCCCCEEEEEEeecCC-CCEEEEEEC-----ChHHHHHHHHHC
Confidence            58899999999999999999998876 566667887     566766666543

>d1ygya3 d.58.18.1 (A:452-529) Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain
domain: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=84.37  E-value=1.4  Score=29.88  Aligned_cols=49  Identities=24%  Similarity=0.354  Sum_probs=37.3

Q ss_pred             HHHHHHHHhhhcCCCeeeeceeccC-CCceeeEEEecCCCCcchHHHHHHHHH
Q 016082           10 KVGELTSLLGEIGLNIQEAHAFSTV-DGFSLDVFVVDGWPYDETEDLKNVLAK   61 (395)
Q Consensus        10 ~~~~~~~~~~~~~l~i~~~~~f~~~-~~~~l~~~~v~gw~~~~~~~l~~~l~~   61 (395)
                      +|++++++|++-|.||...++..+. .|.+.-++.+|+=   -.+++.+.|++
T Consensus        16 vi~~I~~~l~~~~iNI~~m~~~~~~~g~~a~~vi~vD~~---~~~~vl~~I~~   65 (78)
T d1ygya3          16 ALGKIGTLLGTAGVNIQAAQLSEDAEGPGATILLRLDQD---VPDDVRTAIAA   65 (78)
T ss_dssp             HHHHHHHHHHHTTCCEEEEEEEECSSSSCEEEEEEESSC---CCHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCcChhhheeeecCCCCeEEEEEEcCCC---ccHHHHHHHHc
Confidence            5889999999999999999998754 4567777778763   34555555554

>d1sc6a3 d.58.18.1 (A:327-410) Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain
domain: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain
species: Escherichia coli [TaxId: 562]

Probab=82.24  E-value=0.67  Score=32.13  Aligned_cols=33  Identities=18%  Similarity=0.317  Sum_probs=26.8

Q ss_pred             HHHHHHHHhhhcCCCeeeeceeccCC-CceeeEE
Q 016082           10 KVGELTSLLGEIGLNIQEAHAFSTVD-GFSLDVF   42 (395)
Q Consensus        10 ~~~~~~~~~~~~~l~i~~~~~f~~~~-~~~l~~~   42 (395)
                      +|++++++|++-|+||...+.-+..+ ||.+=.+
T Consensus        24 vla~I~~~l~~~~iNI~~~~~~~~~~~~~a~~~i   57 (84)
T d1sc6a3          24 VLTALNKIFAEQGVNIAAQYLQTSAQMGYVVIDI   57 (84)
T ss_dssp             HHHHHHHHHHHTTCEEEEEEEEECSSEEEEEEEE
T ss_pred             HHHHHHHHHHHcCCCHHHhccccCCCCcEEEEEE
Confidence            58899999999999999999988776 5554333